Citrus Sinensis ID: 007177
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 614 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SJG9 | 606 | Mitogen-activated protein | yes | no | 0.973 | 0.986 | 0.752 | 0.0 | |
| Q5ZCI1 | 611 | Mitogen-activated protein | yes | no | 0.975 | 0.980 | 0.743 | 0.0 | |
| Q5SN53 | 569 | Mitogen-activated protein | no | no | 0.921 | 0.994 | 0.673 | 0.0 | |
| Q67C40 | 569 | Mitogen-activated protein | no | no | 0.921 | 0.994 | 0.680 | 0.0 | |
| Q6L5D4 | 700 | Mitogen-activated protein | no | no | 0.967 | 0.848 | 0.682 | 0.0 | |
| Q9LUC3 | 598 | Mitogen-activated protein | no | no | 0.956 | 0.981 | 0.681 | 0.0 | |
| Q9C5C0 | 615 | Mitogen-activated protein | no | no | 0.960 | 0.959 | 0.652 | 0.0 | |
| Q75KK8 | 542 | Mitogen-activated protein | no | no | 0.837 | 0.948 | 0.692 | 0.0 | |
| Q8W4J2 | 567 | Mitogen-activated protein | no | no | 0.866 | 0.938 | 0.667 | 0.0 | |
| Q53N72 | 498 | Mitogen-activated protein | no | no | 0.762 | 0.939 | 0.732 | 0.0 |
| >sp|Q9SJG9|MPK20_ARATH Mitogen-activated protein kinase 20 OS=Arabidopsis thaliana GN=MPK20 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 900 bits (2326), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 461/613 (75%), Positives = 514/613 (83%), Gaps = 15/613 (2%)
Query: 3 QNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 62
+N+ EMEFFS+YGDA+R+K+QEVIGKGSYGVVCSAIDT TGEKVAIKKIHDIFEHISDAA
Sbjct: 8 KNNLEMEFFSDYGDANRFKVQEVIGKGSYGVVCSAIDTLTGEKVAIKKIHDIFEHISDAA 67
Query: 63 RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH 122
RILREIKLLRLLRHPDIVEIKHIMLPPSRR+FKDIYVVFELMESDLHQVIKANDDLTREH
Sbjct: 68 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTREH 127
Query: 123 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 182
YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT
Sbjct: 128 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 187
Query: 183 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242
DYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVL GKPLFPGKNVVHQLDLMTDLL
Sbjct: 188 DYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLMGKPLFPGKNVVHQLDLMTDLL 247
Query: 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 302
GTPSLDTISRVRN+KARRYLTSMRKK P+ F+QKFPNADP +L+LLERLLAFDPKDRPTA
Sbjct: 248 GTPSLDTISRVRNEKARRYLTSMRKKPPIPFAQKFPNADPLSLKLLERLLAFDPKDRPTA 307
Query: 303 EEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDY 362
EEALADPYFKGL+KVEREPSCQPI+KMEFEFERR+VTKEDIRELI REILEYHPQLLKD+
Sbjct: 308 EEALADPYFKGLAKVEREPSCQPITKMEFEFERRKVTKEDIRELISREILEYHPQLLKDH 367
Query: 363 MNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKE 422
MNG ++ +FLYPSAVDQFR+QFAHLEEN GK+GPV P ERKH SLPRST++HS V
Sbjct: 368 MNGADKASFLYPSAVDQFRRQFAHLEENSGKTGPVAPLERKHASLPRSTVIHSTAVARGG 427
Query: 423 QQNLSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQR-FPLAKPGKVVGPVVPYENASV 481
Q L + N + ++ IP N + T+ AQQR AKP +GPV P++N +
Sbjct: 428 QPKLMNNTNTL------NPETTQNIPFNHA-TIQAQQRNLSAAKPSTFMGPVAPFDNGRI 480
Query: 482 RRDAYDPRTFIRSTVLPQAIPAAYCYRKSSTGKQEMDSEREMPSQVKHVPQCGMAAKFAT 541
RDAYDPR+FIRST LP + +A + GKQ+ R K Q ++A
Sbjct: 481 SRDAYDPRSFIRSTNLPFSQQSAATV---AMGKQQ--ERRTTMEPEKQARQISQYNRYAP 535
Query: 542 DIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATAAAATAAAHRK 601
D+AIN+D+NPF M R G+NK E+I D+I IDTNLLQ + GV AAA AAA +AHRK
Sbjct: 536 DVAINIDNNPFIMARTGMNKAENISDRIIIDTNLLQATAG-IGVAAAAAAAAPGGSAHRK 594
Query: 602 IGTVQYGMTTRMY 614
+G V+YGM ++MY
Sbjct: 595 VGAVRYGM-SKMY 606
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4 |
| >sp|Q5ZCI1|MPK10_ORYSJ Mitogen-activated protein kinase 10 OS=Oryza sativa subsp. japonica GN=MPK10 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 877 bits (2265), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 459/617 (74%), Positives = 510/617 (82%), Gaps = 18/617 (2%)
Query: 3 QNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 62
++S E +FF+EYGDASRYKIQEVIGKGSYGVVCSAID HTGEKVAIKKIHDIFEHISDAA
Sbjct: 8 KSSTEADFFTEYGDASRYKIQEVIGKGSYGVVCSAIDVHTGEKVAIKKIHDIFEHISDAA 67
Query: 63 RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH 122
RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLT+EH
Sbjct: 68 RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTKEH 127
Query: 123 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 182
YQFFLYQLLRALKYIHTANVYHRDLKPKNILAN+NCKLKICDFGLARVAFNDTPTTIFWT
Sbjct: 128 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANSNCKLKICDFGLARVAFNDTPTTIFWT 187
Query: 183 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242
DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL
Sbjct: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247
Query: 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 302
GTPS+DTISRVRNDKARRYL+SMRKK+P+ FSQKFP+ADP AL LL++LLAFDPKDRPTA
Sbjct: 248 GTPSMDTISRVRNDKARRYLSSMRKKEPILFSQKFPSADPLALDLLQKLLAFDPKDRPTA 307
Query: 303 EEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDY 362
EEALA PYFKGL+KVEREPSCQPI+KMEFEFERRRVTKEDIRELIFREILEYHPQLLKDY
Sbjct: 308 EEALAHPYFKGLAKVEREPSCQPITKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDY 367
Query: 363 MNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKE 422
+NGTERT FLYPSAVDQFRKQFAHLEEN G +GPVIP +RKH SLPRSTIVHS +P KE
Sbjct: 368 INGTERTTFLYPSAVDQFRKQFAHLEEN-GGNGPVIPMDRKHTSLPRSTIVHSTPIPAKE 426
Query: 423 QQNLSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENASVR 482
Q + R + N +E + N RT A QR P A+PG+VVGPV+PYEN +
Sbjct: 427 QPRIGPSRDKPSDEPYSNPREFDRFSGNAPRTSQAPQRVPTARPGRVVGPVLPYENGAT- 485
Query: 483 RDAYDPRTFIRSTVLP--QAIPAAYCYRK---SSTGKQEMDSEREMPSQVKHVPQCGMAA 537
+D+YD R ++ P Q IP AY Y + S + +ER Q + C +A
Sbjct: 486 KDSYDARRLAMNSGYPPQQQIPQAYGYYQIPGKSACSELSQAERYTLHQQAYT--CANSA 543
Query: 538 KFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATAAAATAA 597
TD+A++M + PF ++ G K + E +++ +TNL T+S G AATAA A+
Sbjct: 544 T-VTDVALDMRAPPFHLS--GGPKSDSSE-RLAAETNLY-TRSLN---GLAATAAGVAAS 595
Query: 598 AHRKIGTVQYGMTTRMY 614
AHRK+G V YGM +RMY
Sbjct: 596 AHRKVGVVPYGM-SRMY 611
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q5SN53|MPK8_ORYSJ Mitogen-activated protein kinase 8 OS=Oryza sativa subsp. japonica GN=MPK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 846 bits (2186), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/610 (67%), Positives = 493/610 (80%), Gaps = 44/610 (7%)
Query: 8 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 67
M+FFSEYGDA+RYKIQEVIGKGSYGVVCSAID HTG+KVAIKKIH+IFEH+SDAARILRE
Sbjct: 1 MDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDQHTGDKVAIKKIHNIFEHLSDAARILRE 60
Query: 68 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 127
IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM++DLHQVIKANDDLT+EH+QFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMDTDLHQVIKANDDLTKEHHQFFL 120
Query: 128 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 187
YQ+LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT+FWTDYVAT
Sbjct: 121 YQMLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTVFWTDYVAT 180
Query: 188 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247
RWYRAPELCGSFF+KY+PAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLDLMTDLLGTPS+
Sbjct: 181 RWYRAPELCGSFFTKYSPAIDIWSIGCIFAEILTGKPLFPGKNVVHQLDLMTDLLGTPSM 240
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
DT++R+RN+KARRYL+SMRKKQPV FS++FP ADP+AL+LL+RLLAFDPKDRPTAEEALA
Sbjct: 241 DTVTRIRNEKARRYLSSMRKKQPVPFSERFPKADPAALKLLQRLLAFDPKDRPTAEEALA 300
Query: 308 DPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGTE 367
DPYFKGL+K EREPSCQPI+KMEFEFERR+VTKED++ELIFREILEYHPQLLKDYMNGTE
Sbjct: 301 DPYFKGLAKAEREPSCQPITKMEFEFERRKVTKEDVKELIFREILEYHPQLLKDYMNGTE 360
Query: 368 RTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKEQQNLS 427
+TNFLYPSA+D FR+QFA+LEEN GK+G +P +RKHVSLPR+T VHS +PPK+ QN++
Sbjct: 361 KTNFLYPSALDNFRRQFANLEENGGKNGDAVPSDRKHVSLPRTTTVHSAPIPPKDHQNIT 420
Query: 428 RDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENASVRRDAYD 487
+P QR P + G+ PV+P+EN S Y+
Sbjct: 421 SQ-----------------VP----------QRIP-GRTGRGACPVIPFENLSA-MGPYN 451
Query: 488 PRTFIRSTVLPQAIP--AAYCY-RKSSTGKQEMDSEREMPSQVKHVPQCGMAAKFATDIA 544
R +R+ VLP A +AY Y RKS + ++E+ E E + M AK + ++
Sbjct: 452 QRRVVRNPVLPPATTNLSAYAYHRKSDSSERELQQELEKDRMRYQPSEHFMDAKVVSHMS 511
Query: 545 INMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATAAAATAAAHRKIGT 604
++ ++ +++++A + + D+ ++ +N++Q + G+ AA + K+ T
Sbjct: 512 HDLRASSYYVSKAKSD----VADRAALQSNMMQGIGPFNGI-------AAVGGNYNKVST 560
Query: 605 VQYGMTTRMY 614
VQYG+ +RMY
Sbjct: 561 VQYGV-SRMY 569
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q67C40|MPK7_ORYSJ Mitogen-activated protein kinase 7 OS=Oryza sativa subsp. japonica GN=MPK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 823 bits (2126), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/610 (68%), Positives = 481/610 (78%), Gaps = 44/610 (7%)
Query: 8 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 67
M+FFSEYGD+SRYKIQE++GKGSYGVVCSAID HTG+KVAIKKIH+IFEH+SDAARILRE
Sbjct: 1 MDFFSEYGDSSRYKIQEIVGKGSYGVVCSAIDQHTGDKVAIKKIHNIFEHLSDAARILRE 60
Query: 68 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 127
IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM++DLHQVIKANDDLT+EH+QFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMDTDLHQVIKANDDLTKEHHQFFL 120
Query: 128 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 187
YQ+LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT+FWTDYVAT
Sbjct: 121 YQMLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTVFWTDYVAT 180
Query: 188 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247
RWYRAPELCGSFFSKY+PAID WSIGCIFAE+LTGKPLFPGKNVVHQLDLMTDLLGTPS+
Sbjct: 181 RWYRAPELCGSFFSKYSPAIDTWSIGCIFAEILTGKPLFPGKNVVHQLDLMTDLLGTPSM 240
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
D ISR+RNDKARRYL+SMR+KQPV FS+KFPN DP AL+LL+RLLAFDPKDRPTAEEALA
Sbjct: 241 DAISRIRNDKARRYLSSMRRKQPVPFSEKFPNVDPLALKLLQRLLAFDPKDRPTAEEALA 300
Query: 308 DPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGTE 367
DPYFKGL+KVEREPSCQPISKMEFEFERR+VTK+DI+ELIFREILEYHPQLLKDYMNG+E
Sbjct: 301 DPYFKGLAKVEREPSCQPISKMEFEFERRKVTKDDIKELIFREILEYHPQLLKDYMNGSE 360
Query: 368 RTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKEQQNLS 427
T+FLYPSAVD FR+QFA LEEN GKSG + +RKHVSLPR+T VHS ++PP E
Sbjct: 361 NTSFLYPSAVDNFRRQFAILEENGGKSGAL---DRKHVSLPRATTVHSTSIPPNE----- 412
Query: 428 RDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENASVRRDAYD 487
L T QR P A+PG+ VGPV+P+EN D +
Sbjct: 413 ----------------------GLDATSQVTQRIPTARPGRTVGPVLPFENPGA-ADPHS 449
Query: 488 PRTFIRSTVLPQAIP--AAYCYRKSSTGKQEMDSEREMPSQVKHVP-QCGMAAKFATDIA 544
R +R+ ++P A + Y Y S E +V++ P Q M AK A D A
Sbjct: 450 ARRVVRNPMVPPAAANKSGYSYNLKSDYSDRQHQEELEKDRVQYRPAQHLMDAKVAPDTA 509
Query: 545 INMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATAAAATAAAHRKIGT 604
++ S+ ++ TR+ + D+ ++ ++L + + G+ AA A + K+G
Sbjct: 510 PDIRSSQYYFTRSAPRT--DLTDRAALQGSMLYGIAPFNGI-------AAVAGGYSKVGA 560
Query: 605 VQYGMTTRMY 614
VQYG+ +RMY
Sbjct: 561 VQYGV-SRMY 569
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q6L5D4|MPK9_ORYSJ Mitogen-activated protein kinase 9 OS=Oryza sativa subsp. japonica GN=MPK9 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 804 bits (2077), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/617 (68%), Positives = 479/617 (77%), Gaps = 23/617 (3%)
Query: 9 EFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREI 68
EFF+EYGDA+RY+IQEVIGKGSYGVVCSAID HT +KVAIKK+H+IFEH+SDAARILREI
Sbjct: 96 EFFTEYGDANRYRIQEVIGKGSYGVVCSAIDLHTRQKVAIKKVHNIFEHVSDAARILREI 155
Query: 69 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLY 128
KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLT+EHYQFFLY
Sbjct: 156 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTKEHYQFFLY 215
Query: 129 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 188
QLLRALKYIHTA+VYHRDLKPKNILAN+NCKLKICDFGLARVAFNDTPTT+FWTDYVATR
Sbjct: 216 QLLRALKYIHTASVYHRDLKPKNILANSNCKLKICDFGLARVAFNDTPTTVFWTDYVATR 275
Query: 189 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248
WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS+D
Sbjct: 276 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSMD 335
Query: 249 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308
TISRVRN+KARRYL+SMRKK PV FSQKFPNADP AL+LL+RLLAFDPKDRPTAEEAL D
Sbjct: 336 TISRVRNEKARRYLSSMRKKDPVPFSQKFPNADPLALKLLQRLLAFDPKDRPTAEEALTD 395
Query: 309 PYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGTER 368
PYFKGLSK++REPSCQPI K+EFEFE+++++KEDIRELIF+EILEYHPQL K+Y NG ER
Sbjct: 396 PYFKGLSKIDREPSCQPIRKLEFEFEQKKLSKEDIRELIFQEILEYHPQLQKNYRNGRER 455
Query: 369 TNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKEQ---QN 425
FLYPSAVDQF+KQF++LEE+ G SG IP ERKH SLPRST VHS +PPKEQ +
Sbjct: 456 ATFLYPSAVDQFKKQFSNLEESNG-SGSAIPMERKHASLPRSTTVHSTPIPPKEQPLAAS 514
Query: 426 LSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENASVRRDA 485
L R ++E KN G N+ + Q PG+ VG V PYE S D
Sbjct: 515 LKSSRPVSDEPC-KNPWVMGGFSGNIPTSSQVSQVAKPVAPGRPVGSVFPYETGST-NDP 572
Query: 486 YDPRTFIRSTVLP--QAIPAAYCYRK------SSTGKQEMDSEREMPSQVKHVPQCGMAA 537
Y PR + S+ P Q I AY Y + Q MD+ + M SQ + +
Sbjct: 573 YGPRGPVMSSGYPPQQQISQAYGYHQVPARMNCVEQSQAMDAYK-MHSQSQTQAYAYPNS 631
Query: 538 KFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATAAAATAA 597
K D+A++M + F + N D++ T++ T+S G V AA +A T
Sbjct: 632 KVTADVALDMRGSTFHHSAGSKNGS---LDRMVTQTDIY-TRSLNGIVAAATSAGVGT-- 685
Query: 598 AHRKIGTVQYGMTTRMY 614
+RK+G V T+RMY
Sbjct: 686 -NRKVGAVPIS-TSRMY 700
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9LUC3|MPK19_ARATH Mitogen-activated protein kinase 19 OS=Arabidopsis thaliana GN=MPK19 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 787 bits (2033), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/612 (68%), Positives = 476/612 (77%), Gaps = 25/612 (4%)
Query: 3 QNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 62
+N EMEFF+EYGDA+RY+I EVIGKGSYGVVC+AIDT TGEKVAIKKI+D+FEH+SDA
Sbjct: 8 KNMKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTQTGEKVAIKKINDVFEHVSDAL 67
Query: 63 RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH 122
RILRE+KLLRLLRHPDIVEIK IMLPPS+R+FKDIYVVFELMESDLHQVIKANDDLTREH
Sbjct: 68 RILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREH 127
Query: 123 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 182
+QFFLYQ+LRALKY+HTANVYHRDLKPKNILANANCKLK+CDFGLARV+FNDTPTT+FWT
Sbjct: 128 HQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVSFNDTPTTVFWT 187
Query: 183 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242
DYVATRWYRAPELCGSF SKYTPAIDIWSIGCIFAEVLTGKPLFPGK+VVHQLDL+TDLL
Sbjct: 188 DYVATRWYRAPELCGSFCSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247
Query: 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 302
GTP +TI+ VRN+KAR+YL MRKK V FSQKFPNADP ALRLL+RLLAFDPKDRPTA
Sbjct: 248 GTPKSETIAGVRNEKARKYLNEMRKKNLVPFSQKFPNADPLALRLLQRLLAFDPKDRPTA 307
Query: 303 EEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDY 362
EALADPYFK L+KVEREPSCQPISKMEFEFERRR+TK+DIRELI+REILEYHPQLLKDY
Sbjct: 308 AEALADPYFKCLAKVEREPSCQPISKMEFEFERRRLTKDDIRELIYREILEYHPQLLKDY 367
Query: 363 MNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKE 422
MN +E ++FLYPSA+ RKQFA+LEEN GKSGPVIPP+RKH SLPRS VHS+ V
Sbjct: 368 MN-SEGSSFLYPSAIGHLRKQFAYLEENSGKSGPVIPPDRKHASLPRSA-VHSSAVNSNA 425
Query: 423 QQNLSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYEN-ASV 481
Q +L+ + + A ++ L R P KPG+VV V YEN ++
Sbjct: 426 QPSLNASDSRRVSIEPSRNGVVPSTSAYSTKPLGPPPRVPSGKPGRVVESSVTYENDRNL 485
Query: 482 RRDAYDPRT-FIRSTVLPQAIPAAYCYRKSSTGKQEMDSEREMPSQVK--HVPQCGMAAK 538
+ +YD RT + RSTVLP + CY +T QE S E SQ K VP +AK
Sbjct: 486 KESSYDARTSYYRSTVLPPQTVSPNCYFLPNTMNQEKRSGTEAASQPKPQFVPTQCNSAK 545
Query: 539 FATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATAAAATAAA 598
A ++ NP+ + + ++ ID LL +SQYG A AAA AA
Sbjct: 546 PA-----ELNPNPYVQS----------QHKVGIDAKLLHAQSQYG----PAGAAAVAVAA 586
Query: 599 HRKIGTVQYGMT 610
HR IG V YGM+
Sbjct: 587 HRNIGAVGYGMS 598
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9C5C0|MPK18_ARATH Mitogen-activated protein kinase 18 OS=Arabidopsis thaliana GN=MPK18 PE=1 SV=4 | Back alignment and function description |
|---|
Score = 764 bits (1972), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 404/619 (65%), Positives = 468/619 (75%), Gaps = 29/619 (4%)
Query: 7 EMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILR 66
EMEFF+EYGDA+RY+I EVIGKGSYGVVC+AIDTHTGEKVAIKKI+D+FEHISDA RILR
Sbjct: 12 EMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTHTGEKVAIKKINDVFEHISDALRILR 71
Query: 67 EIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFF 126
E+KLLRLLRHPDIVEIK IMLPPS+R+FKDIYVVFELMESDLHQVIKANDDLTREH+QFF
Sbjct: 72 EVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFF 131
Query: 127 LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA 186
LYQ+LRALK++HTANVYHRDLKPKNILANANCKLK+CDFGLARVAFNDTPTT+FWTDYVA
Sbjct: 132 LYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDTPTTVFWTDYVA 191
Query: 187 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 246
TRWYRAPELCGSFFSKYTPAID+WSIGCIFAEVLTGKPLFPGK+VVHQL+L+TDLLGTP
Sbjct: 192 TRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGKPLFPGKSVVHQLELITDLLGTPK 251
Query: 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 306
+TIS VRNDKAR+YLT MRKK PV FSQKF ADP ALRLL+RLLAFDPKDRPT EAL
Sbjct: 252 SETISGVRNDKARKYLTEMRKKNPVTFSQKFSKADPLALRLLQRLLAFDPKDRPTPAEAL 311
Query: 307 ADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGT 366
ADPYFKGLSK+EREPS Q ISKMEFEFERRR+TK+DIRELI+REILEYHPQLLKDYM+G+
Sbjct: 312 ADPYFKGLSKIEREPSSQQISKMEFEFERRRLTKDDIRELIYREILEYHPQLLKDYMSGS 371
Query: 367 ERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKEQQNL 426
E +NF+YPSA+ R+QF +LEEN ++GPVIP ERKH SLPRST VHS V Q NL
Sbjct: 372 EGSNFVYPSAIGHLRQQFTYLEENSSRNGPVIPLERKHASLPRST-VHSTVVHSTSQPNL 430
Query: 427 -SRDRQAAEEVFNKNSKESEGIPANLSRTL----PAQQRFPLAKPGKVVGPVVPYENASV 481
+ D + +KN S G P+ + P + P +PG+VV V YEN
Sbjct: 431 GATDSRRVSFEPSKNGASSAGHPSTSAYPTKSIGPPPRVPPSGRPGRVVESSVSYENGRN 490
Query: 482 RRDAYDPRTFIRSTVLPQAIPAAYCYRKSST----GKQEMDSEREMPSQVKHVPQCG--- 534
++AY RS A+ + +CY + +T + +++ P V Q
Sbjct: 491 LKEAY-----FRS-----AVSSPHCYFRPNTMTNPENRNIEASSFPPKPQNPVHQFSPTE 540
Query: 535 --MAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATAA 592
A D+ NP+F + + ++ID LLQ +SQ+G A AA
Sbjct: 541 PPAATTNQADVETMNHPNPYFQPQLPKTDQLNNNTHMAIDAKLLQAQSQFG----PAGAA 596
Query: 593 AATAAAHRKIGTVQYGMTT 611
A AAHR IGT+ Y +
Sbjct: 597 AVAVAAHRNIGTISYSAAS 615
|
Mitogen-activated protein kinase (MAPK) that is specifically regulated by PHS1 and mediates signaling that regulates cortical microtubule functions, maybe through regulation of microtubule dynamic instability. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q75KK8|MPK14_ORYSJ Mitogen-activated protein kinase 14 OS=Oryza sativa subsp. japonica GN=MPK14 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 751 bits (1939), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/526 (69%), Positives = 431/526 (81%), Gaps = 12/526 (2%)
Query: 8 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 67
M+FF+EYG+ +RYKI+EVIGKGSYGVVCSA+DTHTG+KVAIKKI+DIFEH+SDA RILRE
Sbjct: 1 MDFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGDKVAIKKINDIFEHVSDATRILRE 60
Query: 68 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 127
IKLLRLLRHPDIVEIKHI+LPPSRR+FKDIYVVFELMESDLHQVIKANDDLT EHYQFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 120
Query: 128 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 187
YQLLR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARVAF+DTPT IFWTDY+AT
Sbjct: 121 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYIAT 180
Query: 188 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247
RWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLD++TDLLGTPS
Sbjct: 181 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPSP 240
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
+TISR+RN+KARRYL SMR+K+P+ F+QKFPNADP A+RLLER+LAFDPKDRP+AEEALA
Sbjct: 241 ETISRIRNEKARRYLNSMRRKKPIPFTQKFPNADPLAMRLLERMLAFDPKDRPSAEEALA 300
Query: 308 DPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGTE 367
DPYFK ++ V+REPS QPI+K+EFEFERRR+TKEDIRELI+REILEYHP++L++++ GTE
Sbjct: 301 DPYFKNIANVDREPSAQPITKLEFEFERRRITKEDIRELIYREILEYHPKMLREFLEGTE 360
Query: 368 RTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKEQQNLS 427
T F+YPSAVD F+KQFA+LEE+ K PPER+H SLPR +V+S+ P Q S
Sbjct: 361 STGFMYPSAVDHFKKQFAYLEEHYAKGSTAAPPERQHNSLPRPCVVYSDNRP---QSTAS 417
Query: 428 RDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENASVR--RDA 485
+ + N+ +S+ + + +P A+PGK VG V+ Y N S
Sbjct: 418 VTEDLSRCLIRDNNLKSQDSASVGASRIPQGA---AARPGKAVGSVLRYGNCSTSAAEQQ 474
Query: 486 YDPRTFIRSTVLP--QAIPAAYCY-RKSSTGKQEM-DSEREMPSQV 527
Y+ R +R+ + ++P Y R++ T K E D ER SQ
Sbjct: 475 YEQRRVVRNPAIAPNSSVPLGSSYPRRNQTCKSETGDVERIDSSQT 520
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q8W4J2|MPK16_ARATH Mitogen-activated protein kinase 16 OS=Arabidopsis thaliana GN=MPK16 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 745 bits (1924), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/556 (66%), Positives = 442/556 (79%), Gaps = 24/556 (4%)
Query: 3 QNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 62
++S E++FF+EYG+ SRY+I+EVIGKGSYGVVCSA DTHTGEKVAIKKI+DIFEH+SDA
Sbjct: 8 KSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIFEHVSDAT 67
Query: 63 RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH 122
RILREIKLLRLLRHPDIVEIKHI+LPPSRR+F+DIYVVFELMESDLHQVIKANDDLT EH
Sbjct: 68 RILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEH 127
Query: 123 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 182
YQFFLYQLLR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARVAFNDTPT IFWT
Sbjct: 128 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 187
Query: 183 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242
DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLDLMTD+L
Sbjct: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDLMTDML 247
Query: 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 302
GTPS + I RVRN+KARRYL+SMRKK+P+ FS KFP+ DP ALRLLE++L+F+PKDRPTA
Sbjct: 248 GTPSAEAIGRVRNEKARRYLSSMRKKKPIPFSHKFPHTDPLALRLLEKMLSFEPKDRPTA 307
Query: 303 EEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDY 362
EEALAD YFKGL+KVEREPS QP++K+EFEFERRR+TKED+RELI+RE LEYHP++LK+Y
Sbjct: 308 EEALADVYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDVRELIYRESLEYHPKMLKEY 367
Query: 363 MNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPER-KHVSLPRSTIVHSNTVPPK 421
++G+E TNF+YPSAV+ F+KQFA+LEE+ PPER +H SLPR+ +++S+ P
Sbjct: 368 LDGSEPTNFMYPSAVEHFKKQFAYLEEHYKNGTSHNPPERQQHASLPRACVLYSDNNHPV 427
Query: 422 EQQNLS-----------RDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVV 470
QQ+ + RD + N S IP N+ +T+ Q +A+PGKVV
Sbjct: 428 AQQSSAEVTDGLSKCSIRDERPRGADRNAQMPMSR-IPINVPQTI---QGAAVARPGKVV 483
Query: 471 GPVVPYENA----SVRRDAYDPRTFIRSTVLPQAIPAAYCYRKSSTGKQEMDSEREMPSQ 526
G V+ Y N V R +R+ P KS+ G ++ + E PS+
Sbjct: 484 GSVLRYNNCGAATGVEALEQQQRRMVRNPAAASQYPKRTQPCKSNRGDEDCATAAEGPSR 543
Query: 527 VK----HVPQCGMAAK 538
+K ++PQ AA+
Sbjct: 544 LKPNTQYIPQKVSAAQ 559
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q53N72|MPK15_ORYSJ Mitogen-activated protein kinase 15 OS=Oryza sativa subsp. japonica GN=MPK15 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 740 bits (1911), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/475 (73%), Positives = 411/475 (86%), Gaps = 7/475 (1%)
Query: 8 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 67
M+FF+EYG+ +RYKI+EVIGKGSYGVVCSA+DTHTGEKVAIKKI+DIFEH+SDA RILRE
Sbjct: 1 MDFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGEKVAIKKINDIFEHVSDATRILRE 60
Query: 68 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 127
IKLLRLLRHPDIVEIKHI+LPPSRR+FKDIYVVFELMESDLHQVIKANDDLT EHYQFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 120
Query: 128 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 187
YQLLR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARVAF+DTPT IFWTDYVAT
Sbjct: 121 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYVAT 180
Query: 188 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247
RWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLD++TDLLGTPS
Sbjct: 181 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPST 240
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
+ ISR+RN+KARRYL+SMR+K+P+ F+QKFPNADP ALRLLER+L+F+PKDRP AEEALA
Sbjct: 241 EAISRIRNEKARRYLSSMRRKKPIPFTQKFPNADPLALRLLERMLSFEPKDRPNAEEALA 300
Query: 308 DPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGTE 367
DPYF+ ++ V+REPS QP++K+EFEFERRR+TKEDIRELI+R+ILEYHP +L++Y+ GTE
Sbjct: 301 DPYFRNIANVDREPSAQPVTKLEFEFERRRITKEDIRELIYRDILEYHPNMLREYLEGTE 360
Query: 368 RTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKEQQNLS 427
F+YPSAVD F+KQFA+LEE+ K PPER+H SLPR ++++S+ P+ N++
Sbjct: 361 SAGFMYPSAVDHFKKQFAYLEEHYAKGSTAAPPERQHNSLPRPSVLYSDDR-PQNTANIA 419
Query: 428 RDRQAAEEVFNKNS-KESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENASV 481
D ++ V N+ K +G + + +P A+PGKVVG + Y N S
Sbjct: 420 ED--LSKCVLGDNTQKMHQGSASVCANRVPQGG---AARPGKVVGSALRYGNCST 469
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 614 | ||||||
| 224062744 | 621 | predicted protein [Populus trichocarpa] | 0.990 | 0.979 | 0.857 | 0.0 | |
| 359485144 | 610 | PREDICTED: mitogen-activated protein kin | 0.985 | 0.991 | 0.848 | 0.0 | |
| 356567418 | 614 | PREDICTED: mitogen-activated protein kin | 0.977 | 0.977 | 0.820 | 0.0 | |
| 255575287 | 627 | big map kinase/bmk, putative [Ricinus co | 0.985 | 0.964 | 0.827 | 0.0 | |
| 399106790 | 610 | MAP kinase [Nicotiana tabacum] | 0.980 | 0.986 | 0.817 | 0.0 | |
| 356526989 | 615 | PREDICTED: mitogen-activated protein kin | 0.977 | 0.975 | 0.816 | 0.0 | |
| 224085324 | 577 | predicted protein [Populus trichocarpa] | 0.929 | 0.989 | 0.818 | 0.0 | |
| 357463659 | 614 | Mitogen activated protein kinase 20-4 [M | 0.977 | 0.977 | 0.806 | 0.0 | |
| 350539497 | 621 | mitogen-activated protein kinase 12 [Sol | 0.990 | 0.979 | 0.800 | 0.0 | |
| 115345808 | 606 | mitogen-activated protein kinase 20 [Ara | 0.960 | 0.973 | 0.792 | 0.0 |
| >gi|224062744|ref|XP_002300882.1| predicted protein [Populus trichocarpa] gi|222842608|gb|EEE80155.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1068 bits (2762), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 530/618 (85%), Positives = 575/618 (93%), Gaps = 10/618 (1%)
Query: 3 QNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 62
+NS EM+FFSEYGDA+RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA
Sbjct: 8 KNSTEMDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 67
Query: 63 RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH 122
RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH
Sbjct: 68 RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH 127
Query: 123 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 182
YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP+TIFWT
Sbjct: 128 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPSTIFWT 187
Query: 183 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242
DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL
Sbjct: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247
Query: 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 302
GTPSLDTIS VRNDKARRYLTSMRKKQPV +QKFPNADP ALRLLERLLAFDPKDRPTA
Sbjct: 248 GTPSLDTISLVRNDKARRYLTSMRKKQPVPLAQKFPNADPLALRLLERLLAFDPKDRPTA 307
Query: 303 EEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDY 362
EEALADPYFKGL++VEREPSCQPI+KMEFEFERRRVTKED+RELIFREILEYHPQLLKDY
Sbjct: 308 EEALADPYFKGLARVEREPSCQPITKMEFEFERRRVTKEDVRELIFREILEYHPQLLKDY 367
Query: 363 MNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKE 422
+NGTERTNFLYPSAVDQFRKQFAHLEEN GKSGPVIP ERKH SLPRSTIVHS+++P KE
Sbjct: 368 LNGTERTNFLYPSAVDQFRKQFAHLEENGGKSGPVIPLERKHASLPRSTIVHSSSIPTKE 427
Query: 423 QQNLS--RDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENAS 480
QQNL+ +DR AEE +NKN +++EGIP N+SRTL AQQR PLAKPGKVVG VV YEN S
Sbjct: 428 QQNLASFKDRHTAEEAYNKNPRDTEGIPVNISRTLQAQQRVPLAKPGKVVGQVVSYENGS 487
Query: 481 VRRDAYDPRTFIRSTVL-PQAIPAAYCYRKSSTGKQE---MDSEREMPSQVKHVPQCGMA 536
+ +DA DPRT+IRS VL P A P+AYCYRKS++GKQE M+++ ++ SQ K V QCGMA
Sbjct: 488 IVKDARDPRTYIRSAVLPPHAAPSAYCYRKSNSGKQEGSTMEADSDLSSQ-KQVQQCGMA 546
Query: 537 AKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATAAAATA 596
AK+A D+AIN+DSNPFFMTR GVNKVEH++D++ IDT+LLQ K+QYGG+ +A+AAAA+
Sbjct: 547 AKYAPDVAINIDSNPFFMTRIGVNKVEHVDDRVMIDTSLLQAKAQYGGI--SASAAAAST 604
Query: 597 AAHRKIGTVQYGMTTRMY 614
AAHRK+GTVQYGM TRMY
Sbjct: 605 AAHRKVGTVQYGM-TRMY 621
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485144|ref|XP_002283794.2| PREDICTED: mitogen-activated protein kinase 20-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1045 bits (2702), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 519/612 (84%), Positives = 568/612 (92%), Gaps = 7/612 (1%)
Query: 8 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 67
M+FFSEYGDA+RYKIQEV+GKGSYGVVCSA+DT TGEKVAIKKIHDIFEHISDAARILRE
Sbjct: 1 MDFFSEYGDANRYKIQEVVGKGSYGVVCSAVDTLTGEKVAIKKIHDIFEHISDAARILRE 60
Query: 68 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 127
IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 120
Query: 128 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 187
YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF+DTPTTIFWTDYVAT
Sbjct: 121 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFSDTPTTIFWTDYVAT 180
Query: 188 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247
RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL
Sbjct: 181 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 240
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
DTISRVRN+KARRYLTSMRKKQPV F+QKFPNADP ALRLLERLLAFDPKDRPTAEEALA
Sbjct: 241 DTISRVRNEKARRYLTSMRKKQPVIFAQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 300
Query: 308 DPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGTE 367
DPYFKGL+KVEREPSCQPI+KMEFEFERRRVTKEDIRELIFREILEYHPQLLKDY+NGTE
Sbjct: 301 DPYFKGLAKVEREPSCQPITKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYVNGTE 360
Query: 368 RTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKEQQNLS 427
RTNFLYPSAVDQFRKQFAHLEEN GK+GPVIP ERKHVSLPRST+VHSNT+P KE ++
Sbjct: 361 RTNFLYPSAVDQFRKQFAHLEENSGKTGPVIPLERKHVSLPRSTVVHSNTIPAKEPHIIA 420
Query: 428 -RDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENASVRRDAY 486
+DRQ AEE +++S++++GIP NLSR+L A QR P+AKPGKVVGP+ P EN S +DAY
Sbjct: 421 FKDRQIAEESCSRSSRDTDGIPGNLSRSLQASQRIPMAKPGKVVGPLAPPENGSAIKDAY 480
Query: 487 DPRTFIRSTVLP-QAIPAAYCYRKSSTGKQEM---DSEREMPSQVKHVPQCGMAAKFATD 542
D RT IR+ VLP QA+P AYCYR++S GKQE ++ER++ SQ K VPQCGM AK A D
Sbjct: 481 DHRTLIRNAVLPSQALPPAYCYRRTSAGKQERCVGEAERDLSSQAKQVPQCGMTAKLAPD 540
Query: 543 IAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATAAAATAAAHRKI 602
IAIN+D+NPF+MTRAGV KV+H++D+I+ID NLLQ K+Q+GG+G AA AAAATAAAHRK+
Sbjct: 541 IAINIDTNPFYMTRAGVTKVDHVDDRITIDANLLQAKAQFGGIG-AAAAAAATAAAHRKV 599
Query: 603 GTVQYGMTTRMY 614
GTVQ+GM +RMY
Sbjct: 600 GTVQFGM-SRMY 610
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567418|ref|XP_003551917.1| PREDICTED: mitogen-activated protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1016 bits (2627), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 508/619 (82%), Positives = 563/619 (90%), Gaps = 19/619 (3%)
Query: 3 QNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 62
++S EM+FFSEYGDA+RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA
Sbjct: 8 KSSAEMDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 67
Query: 63 RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH 122
RILREIKLLRLLRHPDIVEIKHIMLPPSR+DFKDIYVVFELMESDLHQVIKANDDLT+EH
Sbjct: 68 RILREIKLLRLLRHPDIVEIKHIMLPPSRKDFKDIYVVFELMESDLHQVIKANDDLTKEH 127
Query: 123 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 182
YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF+DTPTTIFWT
Sbjct: 128 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFSDTPTTIFWT 187
Query: 183 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242
DYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL
Sbjct: 188 DYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247
Query: 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 302
GTPSLDTISRVRN+KARRYLTSMRKKQPV F+QKFPNADP ALRLLE+LLAFDPK+RPTA
Sbjct: 248 GTPSLDTISRVRNEKARRYLTSMRKKQPVPFAQKFPNADPLALRLLEKLLAFDPKNRPTA 307
Query: 303 EEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDY 362
EEALADPYFKGL+KVEREPSCQPI+KMEFEFERRRVTKE+IRELIFREILEYHPQLLKDY
Sbjct: 308 EEALADPYFKGLAKVEREPSCQPITKMEFEFERRRVTKEEIRELIFREILEYHPQLLKDY 367
Query: 363 MNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKE 422
MNGTERTNFLYPSAVDQFRKQFAHLEEN GK+GPV+P +RKHVSLPRSTIVHSNTV PKE
Sbjct: 368 MNGTERTNFLYPSAVDQFRKQFAHLEEN-GKNGPVMPLDRKHVSLPRSTIVHSNTVHPKE 426
Query: 423 QQNL--SRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENAS 480
Q N+ S++R AEE +NK+ +++E IP + R++ QR PLAKPGKVVGPVVPYE +
Sbjct: 427 QTNIASSKNRPTAEE-YNKHPRDTE-IP--VPRSMQGPQRIPLAKPGKVVGPVVPYEYGN 482
Query: 481 VRRDAYDPRTFIRSTVLP-QAIPAAYCYRKSSTGKQE---MDSEREMPSQVKHVPQCGMA 536
+ +D+YDPR+FIR +VLP Q +P AY Y++SSTG QE ++++ +P Q KH QCG+
Sbjct: 483 IVKDSYDPRSFIRGSVLPTQPVPPAYYYQRSSTGNQERPSTEADKSVPLQAKHAQQCGVN 542
Query: 537 AKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKS-QYGGVGAAATAAAAT 595
AK A DIAIN+D+NPFFMTRAGVNK+E DQI+I+TN+LQ K+ QYGG+ +AAA
Sbjct: 543 AKMAPDIAINIDTNPFFMTRAGVNKLEQ-GDQIAIETNMLQPKAHQYGGI-----SAAAG 596
Query: 596 AAAHRKIGTVQYGMTTRMY 614
A AHRK+G VQYGM TRM+
Sbjct: 597 ATAHRKVGPVQYGM-TRMF 614
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255575287|ref|XP_002528547.1| big map kinase/bmk, putative [Ricinus communis] gi|223532049|gb|EEF33859.1| big map kinase/bmk, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1012 bits (2616), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 512/619 (82%), Positives = 554/619 (89%), Gaps = 14/619 (2%)
Query: 3 QNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 62
+NS EM+FFSEYGDA+RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA
Sbjct: 9 KNSTEMDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 68
Query: 63 RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH 122
RILREIKLLRLLRHPDIVEIKHIMLPPSRR+FKDIYVVFELMESDLHQVIKANDDLTREH
Sbjct: 69 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTREH 128
Query: 123 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 182
YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP TIFWT
Sbjct: 129 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPATIFWT 188
Query: 183 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242
DYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL
Sbjct: 189 DYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 248
Query: 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 302
GTPSLDTISRVRN+KARRYLTSMRKKQPV F+QKFPNADP ALRLLERLLAFDPKDRPTA
Sbjct: 249 GTPSLDTISRVRNEKARRYLTSMRKKQPVPFAQKFPNADPLALRLLERLLAFDPKDRPTA 308
Query: 303 EEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDY 362
EEALADPYFKGLSKVEREPSCQPI+KMEFEFERRRVTKEDIRELIFREILEYHPQLLKDY
Sbjct: 309 EEALADPYFKGLSKVEREPSCQPITKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDY 368
Query: 363 MNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKE 422
+NGTERT+FLYPS VDQFR+QFAHLEEN GKSGPV+P ERKHVSLPRSTIVHSN VPP+E
Sbjct: 369 VNGTERTHFLYPSVVDQFRRQFAHLEENCGKSGPVVPLERKHVSLPRSTIVHSNIVPPRE 428
Query: 423 QQNLSR--DRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENAS 480
QN+S DRQ+AEE +NK+S++SEGI N+ L A QR PL K GKV GPVVPY+N +
Sbjct: 429 -QNVSSLGDRQSAEETYNKSSRDSEGIHVNI-LALQATQRIPLDKSGKVAGPVVPYDNGN 486
Query: 481 VRRDAYDPRTFIRSTVL-PQAIPAAYCYRKSSTGKQE---MDSEREMPSQVKHVPQCGMA 536
+ +D DPRTF+R T L PQA+ AY Y+KSSTG QE ++S+R++ SQ K QCGM+
Sbjct: 487 ITKDVNDPRTFVRGTALPPQAVLPAYSYQKSSTGSQERSALESQRQLSSQ-KQTQQCGMS 545
Query: 537 ----AKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTK-SQYGGVGAAATA 591
AKFA DIAIN+DSNPFFMTR G+NKVEH++D+I+I+ +LLQ K G G A
Sbjct: 546 EKVGAKFAPDIAINIDSNPFFMTRTGMNKVEHVDDRITINASLLQAKAQYGGIGGGGGAA 605
Query: 592 AAATAAAHRKIGTVQYGMT 610
+A AA HRKIGTVQ GMT
Sbjct: 606 SATAAATHRKIGTVQCGMT 624
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|399106790|gb|AFP20228.1| MAP kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 1008 bits (2606), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 503/615 (81%), Positives = 554/615 (90%), Gaps = 13/615 (2%)
Query: 8 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 67
M+FFSEYGDA+RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE
Sbjct: 1 MDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 60
Query: 68 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 127
IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 120
Query: 128 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 187
YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT
Sbjct: 121 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 180
Query: 188 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247
RWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS+
Sbjct: 181 RWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSM 240
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
DTISRVRNDKARRYLTSMRKKQPV F+QKFPNADP AL+LLERLLAFDPKDRPTAEEALA
Sbjct: 241 DTISRVRNDKARRYLTSMRKKQPVSFAQKFPNADPLALKLLERLLAFDPKDRPTAEEALA 300
Query: 308 DPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGTE 367
DPYFKGL+K EREPSC+PISKMEFEFERRRVTKED+RELIFREILEYHPQL KDYMNG E
Sbjct: 301 DPYFKGLAKSEREPSCKPISKMEFEFERRRVTKEDLRELIFREILEYHPQLRKDYMNGVE 360
Query: 368 RTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKEQ---- 423
RTNFLYPSAVDQFRKQFAHLEEN G GPV+P +RKHVSLPRST++HSNT+P KEQ
Sbjct: 361 RTNFLYPSAVDQFRKQFAHLEENGGNGGPVVPMDRKHVSLPRSTVLHSNTIPSKEQPIAA 420
Query: 424 QNLSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENASVRR 483
N+ RDRQ EE ++N ++SEG+ +L+RT+ AQ R LAK GKVVGPV+ Y++ + +
Sbjct: 421 ANM-RDRQNGEESCSRNCRDSEGLANSLTRTMQAQPRIALAKTGKVVGPVLAYDSGN--K 477
Query: 484 DAYDPRTFIRSTVLP-QAIPAAYCYRKSSTGKQE---MDSEREMPSQVKHVPQCGMAAKF 539
+ YDPR+ +R+TV P Q +P+AYCY +S KQE +++ER++ S K +P CGMAAK
Sbjct: 478 EKYDPRSQVRNTVFPSQIMPSAYCYDRSGMVKQERPVVETERDVSSHAKPMPPCGMAAKL 537
Query: 540 ATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATAAAATAAAH 599
A DIAIN+DSNPF+M RAGV K + +ED+I+IDTNLLQ KSQYGG+G A AAA TAAAH
Sbjct: 538 APDIAINIDSNPFYMMRAGVTKPDRVEDRITIDTNLLQAKSQYGGIG-VAAAAATTAAAH 596
Query: 600 RKIGTVQYGMTTRMY 614
RK+GTVQYG+ +RMY
Sbjct: 597 RKVGTVQYGI-SRMY 610
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356526989|ref|XP_003532097.1| PREDICTED: mitogen-activated protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 993 bits (2568), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 506/620 (81%), Positives = 557/620 (89%), Gaps = 20/620 (3%)
Query: 3 QNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 62
++S EM+FFSEYGDA+RYKIQEVIGKGSYGVVCSAIDTHTG+KVAIKKIHDIFEHISDAA
Sbjct: 8 KSSAEMDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGDKVAIKKIHDIFEHISDAA 67
Query: 63 RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH 122
RILREIKLLRLLRHPDIVEIKHIMLPPSR+DFKDIYVVFELMESDLHQVIKANDDLT+EH
Sbjct: 68 RILREIKLLRLLRHPDIVEIKHIMLPPSRKDFKDIYVVFELMESDLHQVIKANDDLTKEH 127
Query: 123 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 182
YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF+DTPTTIFWT
Sbjct: 128 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFSDTPTTIFWT 187
Query: 183 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242
DYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL
Sbjct: 188 DYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247
Query: 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 302
GTPSLDTISRVRN+KARRYLTSMRKKQPV F+QKFPNADP ALRLLE+LLAFDPKDRPTA
Sbjct: 248 GTPSLDTISRVRNEKARRYLTSMRKKQPVPFAQKFPNADPLALRLLEKLLAFDPKDRPTA 307
Query: 303 EEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDY 362
EEALADPYFKGL+KVEREPSCQPI+KMEFEFERRRVTKE+IRELIFREILEYHPQLLKDY
Sbjct: 308 EEALADPYFKGLAKVEREPSCQPITKMEFEFERRRVTKEEIRELIFREILEYHPQLLKDY 367
Query: 363 MNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKE 422
MNGTERTNFLYPSAVDQFRKQFAHLEEN GK+GPV+P +RKHVSLPRSTIVHSNTV KE
Sbjct: 368 MNGTERTNFLYPSAVDQFRKQFAHLEEN-GKNGPVMPLDRKHVSLPRSTIVHSNTVHSKE 426
Query: 423 QQN--LSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENAS 480
Q N S++R EE +NKN +++E IP + R++ QR PLAKPGKVVGPVVPYE+ +
Sbjct: 427 QTNNAASKNRPTVEE-YNKNPRDTE-IP--VPRSMQGPQRIPLAKPGKVVGPVVPYEHGN 482
Query: 481 VRRDAYDPRTFIRSTVLP-QAIPAAYCYRKSSTGKQE---MDSEREMPSQVKHV-PQCGM 535
+ +D+YDPR+FIR +VLP QA+P AY Y++SSTG QE ++ + +P Q KH QCG+
Sbjct: 483 IVKDSYDPRSFIRGSVLPTQAVPPAYYYQRSSTGNQERPATEANKSVPLQAKHAQQQCGV 542
Query: 536 AAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKS-QYGGVGAAATAAAA 594
AK A DIAIN+D+NPFFMTRAGVNK+E DQI+I+TN+LQ K+ QY AAA
Sbjct: 543 NAKMAPDIAINIDTNPFFMTRAGVNKLEQ-GDQIAIETNMLQPKAHQY-----GGIGAAA 596
Query: 595 TAAAHRKIGTVQYGMTTRMY 614
A AHRK+G VQYGM TRM+
Sbjct: 597 GATAHRKVGPVQYGM-TRMF 615
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224085324|ref|XP_002307544.1| predicted protein [Populus trichocarpa] gi|222856993|gb|EEE94540.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 984 bits (2545), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 502/613 (81%), Positives = 539/613 (87%), Gaps = 42/613 (6%)
Query: 8 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 67
M+FFSEYGDA+RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE
Sbjct: 1 MDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 60
Query: 68 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 127
IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 120
Query: 128 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 187
YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP+TIFWTDYVAT
Sbjct: 121 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPSTIFWTDYVAT 180
Query: 188 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247
RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV+TGKPLFPGKNVVHQLDLMTDLLGTPSL
Sbjct: 181 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVITGKPLFPGKNVVHQLDLMTDLLGTPSL 240
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
DTISRVRNDKARRYLTSMRKK PV F+QKF NADP AL LLERLLAFDPKDRPTAEEAL
Sbjct: 241 DTISRVRNDKARRYLTSMRKKAPVPFAQKFLNADPLALCLLERLLAFDPKDRPTAEEALG 300
Query: 308 DPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGTE 367
DPYFKGL+KVEREPSCQPI+KMEFEFERRRVTKEDIRELIFREILEYHPQLLKDY+NGTE
Sbjct: 301 DPYFKGLAKVEREPSCQPITKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYVNGTE 360
Query: 368 RTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKEQQNLS 427
RTNFLYPSAVDQFRKQFAHLEEN GKSGPVIP ERKHVSLPRST+VHS+++P KEQQNL+
Sbjct: 361 RTNFLYPSAVDQFRKQFAHLEENGGKSGPVIPLERKHVSLPRSTVVHSSSIPSKEQQNLA 420
Query: 428 --RDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENASVRRDA 485
+DR +AEEV VG VVPYEN S +DA
Sbjct: 421 SFKDRHSAEEV---------------------------------VGSVVPYENGSNTKDA 447
Query: 486 YDPRTFIRSTVLP-QAIPAAYCYRKSSTGKQE---MDSEREMPSQVKHVPQCGMAAKFAT 541
YDPRT+IRSTVLP QA+P+AYCYRKSSTGK E M++ER++ SQ K V QCGMAAK+A
Sbjct: 448 YDPRTYIRSTVLPLQAVPSAYCYRKSSTGKLERSTMEAERDLSSQ-KQVQQCGMAAKYAP 506
Query: 542 DIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATAAAATAAAHRK 601
D+AIN+DSNPFFMTR G +K EH++D++ IDT+ +QTK+Q G AA AA A+ AA+RK
Sbjct: 507 DVAINIDSNPFFMTRVGGSKEEHVDDRVMIDTSSMQTKAQ-YGGIGAAAAATASRAAYRK 565
Query: 602 IGTVQYGMTTRMY 614
+GTVQYGM RMY
Sbjct: 566 VGTVQYGM-ARMY 577
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357463659|ref|XP_003602111.1| Mitogen activated protein kinase 20-4 [Medicago truncatula] gi|355491159|gb|AES72362.1| Mitogen activated protein kinase 20-4 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 983 bits (2541), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 499/619 (80%), Positives = 547/619 (88%), Gaps = 19/619 (3%)
Query: 3 QNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 62
+ S EM+FFSEYGDA+RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA
Sbjct: 8 KGSTEMDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 67
Query: 63 RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH 122
RILREIKLLRLLRHPDIVEIKHIMLPPSR+DFKDIYVVFELMESDLHQVIKANDDLT+EH
Sbjct: 68 RILREIKLLRLLRHPDIVEIKHIMLPPSRKDFKDIYVVFELMESDLHQVIKANDDLTKEH 127
Query: 123 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 182
YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF+DTPTT+FWT
Sbjct: 128 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFSDTPTTVFWT 187
Query: 183 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242
DYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL
Sbjct: 188 DYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247
Query: 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 302
GTPSLDTISRVRN+KARRYLTSMRKKQPV F+QKF NADP ALRLLERLLAFDPKDRPTA
Sbjct: 248 GTPSLDTISRVRNEKARRYLTSMRKKQPVPFAQKFSNADPLALRLLERLLAFDPKDRPTA 307
Query: 303 EEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDY 362
EEALADPYFKGL+KVEREPSCQPI+KMEFEFERRRVTKE+IRELIFREILEYHPQLLKDY
Sbjct: 308 EEALADPYFKGLAKVEREPSCQPITKMEFEFERRRVTKEEIRELIFREILEYHPQLLKDY 367
Query: 363 MNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKE 422
+NGTERTNFLYPSAVDQFRKQFAHLEEN GK+GPV P +RKHVSLPRSTIVHSNTVP KE
Sbjct: 368 INGTERTNFLYPSAVDQFRKQFAHLEEN-GKNGPVAPLDRKHVSLPRSTIVHSNTVPQKE 426
Query: 423 QQNL--SRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENAS 480
Q ++ S++RQ +EE +NK S+++E IP + R + QR PLAKPGKVVGPVVP+E +
Sbjct: 427 QTSIASSKNRQTSEE-YNKLSRDNE-IP--VPRPIQGPQRIPLAKPGKVVGPVVPFEYGN 482
Query: 481 VRRDAYDPRTFIRS--TVLPQAIPAAYCYRKSSTGKQE---MDSEREMPSQVKHVPQCGM 535
V +D+YDPR FIR PA Y R ST QE +++ +P Q KH QCG+
Sbjct: 483 VVKDSYDPRAFIRGPVLPPQPVPPAYYYQRPGSTANQERPTAGADKGVPLQAKHGQQCGI 542
Query: 536 AAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATAAAAT 595
AK +IAIN+D+NPFFMTR GVNKVE +DQI+I+TNLLQ+K+QYGGVG AAA
Sbjct: 543 NAKIGHEIAINIDTNPFFMTRVGVNKVEK-DDQIAIETNLLQSKAQYGGVG-----AAAG 596
Query: 596 AAAHRKIGTVQYGMTTRMY 614
+HRK+G +QYGM TRM+
Sbjct: 597 TNSHRKVGPIQYGM-TRMF 614
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|350539497|ref|NP_001234664.1| mitogen-activated protein kinase 12 [Solanum lycopersicum] gi|335353080|gb|AEH42669.1| mitogen-activated protein kinase 12 [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 983 bits (2541), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 495/618 (80%), Positives = 548/618 (88%), Gaps = 10/618 (1%)
Query: 3 QNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 62
++S EM+FFSEYGDA+RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA
Sbjct: 8 KSSAEMDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 67
Query: 63 RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH 122
RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH
Sbjct: 68 RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH 127
Query: 123 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 182
YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT
Sbjct: 128 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 187
Query: 183 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242
DYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL
Sbjct: 188 DYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247
Query: 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 302
GTPS+DTISRVRNDKARRYLTSMRKKQPV F+QKFPNADP +L+LLERLLAFDPKDRPTA
Sbjct: 248 GTPSMDTISRVRNDKARRYLTSMRKKQPVSFAQKFPNADPLSLKLLERLLAFDPKDRPTA 307
Query: 303 EEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDY 362
EEALADPYFKGL+K EREPSC+ ISKMEFEFERRRVTKED+RELIFREILEYHPQL KDY
Sbjct: 308 EEALADPYFKGLAKSEREPSCKSISKMEFEFERRRVTKEDLRELIFREILEYHPQLRKDY 367
Query: 363 MNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKE 422
+NG ERTNFLYPSAVDQFRKQFAHLEEN G PV+P +RKHVSLPRST+VHSN P KE
Sbjct: 368 LNGVERTNFLYPSAVDQFRKQFAHLEENGGNGVPVVPMDRKHVSLPRSTVVHSNPNPLKE 427
Query: 423 QQNLS--RDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPL-AKPGKVVGPVVPYENA 479
Q ++ RDRQ EE ++N ++SEG+ ++L+RTL AQ R L AKPGKVVGP + Y++
Sbjct: 428 QPIVANMRDRQNGEESCSRNCRDSEGLASSLTRTLQAQPRNALAAKPGKVVGPGLAYDSG 487
Query: 480 SVRRDAYDPRTFIRSTVL-PQAIPAAYCYRKSSTGKQE--MDSEREMPSQVKHVPQCGMA 536
+ R+ YDPR+ +R+ V PQ + + Y Y +S KQE +++ER+M K + CGMA
Sbjct: 488 N--REKYDPRSQVRNAVGPPQIMSSVYSYDRSGVVKQERSVETERDMNCHSKPMAPCGMA 545
Query: 537 AKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATAAAATA 596
AK A DIAIN+DSNPF+M RAGV K + ++D+I+IDTNLLQ KSQYGG+G A AAA +
Sbjct: 546 AKLAPDIAINIDSNPFYMMRAGVTKPDRVDDRITIDTNLLQAKSQYGGIG-VAAAAATSG 604
Query: 597 AAHRKIGTVQYGMTTRMY 614
AAHRK+GTVQYGM +RMY
Sbjct: 605 AAHRKVGTVQYGM-SRMY 621
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|115345808|gb|ABI95363.1| mitogen-activated protein kinase 20 [Arachis diogoi] | Back alignment and taxonomy information |
|---|
Score = 962 bits (2486), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 492/621 (79%), Positives = 540/621 (86%), Gaps = 31/621 (4%)
Query: 3 QNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 62
++S EMEFFS+YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHD+FEHISDAA
Sbjct: 8 KSSMEMEFFSDYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDVFEHISDAA 67
Query: 63 RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH 122
RILREIKLLRLLRHPDIVEIKH+M+PPSRR+FKDIYVVFELMESDLHQVIKANDDLT+EH
Sbjct: 68 RILREIKLLRLLRHPDIVEIKHVMMPPSRREFKDIYVVFELMESDLHQVIKANDDLTKEH 127
Query: 123 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 182
YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF DTPTT+FWT
Sbjct: 128 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFTDTPTTVFWT 187
Query: 183 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242
DYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVL GKPLFPGKNVVHQLDLMTDLL
Sbjct: 188 DYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLLGKPLFPGKNVVHQLDLMTDLL 247
Query: 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 302
GTPSLDTISRVRNDKARRYLTSMRKKQPV F+QKFPNADP ALRLLERLLAFDPKDRPTA
Sbjct: 248 GTPSLDTISRVRNDKARRYLTSMRKKQPVPFAQKFPNADPLALRLLERLLAFDPKDRPTA 307
Query: 303 EEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDY 362
+EALADPYFKGL+KVEREPSC PI+KMEFEFERRRVTKE+IRELIFREILEYHPQLLKDY
Sbjct: 308 QEALADPYFKGLAKVEREPSCHPITKMEFEFERRRVTKEEIRELIFREILEYHPQLLKDY 367
Query: 363 MNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKE 422
+NGTER NFLYPSAVDQF+KQFAHLEEN GKS PV+P ERKHVSLPRST+VHSN V KE
Sbjct: 368 INGTERANFLYPSAVDQFKKQFAHLEENGGKSSPVMPLERKHVSLPRSTVVHSNMVAQKE 427
Query: 423 QQN--LSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENAS 480
Q N S++RQ AEE +N N QR P AKPGKVVGPVVPYE S
Sbjct: 428 QSNNASSKNRQPAEE-YNNN------------------QRIPPAKPGKVVGPVVPYEYGS 468
Query: 481 VRRDAYDPRTFIRSTVLP-QAIPAAYCYRKSSTGKQEMDSEREMPSQVKHVP-QCGMAAK 538
+ +D++DPRTFIR + +P Q +P Y Y++S+TG Q D+E+ +P + KH P QCG+ AK
Sbjct: 469 IVKDSFDPRTFIRGSFVPSQTVPPTYYYQRSTTGHQ--DTEKGVPLKPKHGPQQCGVNAK 526
Query: 539 FATDIAINMDSNPFFMTRA-GVNKVEHIED----QISIDTNLLQTKSQYGGVGAAATAAA 593
A DIAIN+D+NPFFMTRA GVNK+E ++ +I+IDTNLLQ+K+ G AA AA
Sbjct: 527 IAPDIAINIDTNPFFMTRAIGVNKIEQDDNNNNHRIAIDTNLLQSKAHQYGGIGAAATAA 586
Query: 594 ATAAAHRKIGTVQYGMTTRMY 614
A AHRK+G VQYGM TRM+
Sbjct: 587 TGATAHRKVGPVQYGM-TRMF 606
|
Source: Arachis diogoi Species: Arachis diogoi Genus: Arachis Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 614 | ||||||
| TAIR|locus:2052357 | 606 | MPK20 "MAP kinase 20" [Arabido | 0.972 | 0.985 | 0.710 | 1.6e-228 | |
| TAIR|locus:2089576 | 598 | MPK19 "MAP kinase 19" [Arabido | 0.921 | 0.946 | 0.660 | 8.7e-198 | |
| TAIR|locus:2024887 | 615 | MPK18 "mitogen-activated prote | 0.957 | 0.956 | 0.616 | 5.7e-194 | |
| TAIR|locus:2179609 | 567 | MPK16 "mitogen-activated prote | 0.868 | 0.940 | 0.634 | 1.6e-182 | |
| TAIR|locus:2092717 | 510 | MPK9 "MAP kinase 9" [Arabidops | 0.682 | 0.821 | 0.747 | 3.6e-176 | |
| TAIR|locus:2027814 | 576 | MPK15 "MAP kinase 15" [Arabido | 0.718 | 0.765 | 0.719 | 7.5e-176 | |
| TAIR|locus:2194040 | 589 | ATMPK8 [Arabidopsis thaliana ( | 0.713 | 0.743 | 0.709 | 3.7e-174 | |
| TAIR|locus:2049552 | 486 | MPK17 "MAP kinase 17" [Arabido | 0.666 | 0.841 | 0.692 | 1.2e-159 | |
| TAIR|locus:2124943 | 376 | MPK4 "MAP kinase 4" [Arabidops | 0.529 | 0.864 | 0.490 | 7.7e-87 | |
| DICTYBASE|DDB_G0286353 | 529 | erkA "mitogen-activated protei | 0.555 | 0.644 | 0.485 | 9.9e-87 |
| TAIR|locus:2052357 MPK20 "MAP kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2205 (781.3 bits), Expect = 1.6e-228, P = 1.6e-228
Identities = 436/614 (71%), Positives = 489/614 (79%)
Query: 3 QNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 62
+N+ EMEFFS+YGDA+R+K+QEVIGKGSYGVVCSAIDT TGEKVAIKKIHDIFEHISDAA
Sbjct: 8 KNNLEMEFFSDYGDANRFKVQEVIGKGSYGVVCSAIDTLTGEKVAIKKIHDIFEHISDAA 67
Query: 63 XXXXXXXXXXXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH 122
HPDIVEIKHIMLPPSRR+FKDIYVVFELMESDLHQVIKANDDLTREH
Sbjct: 68 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTREH 127
Query: 123 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 182
YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT
Sbjct: 128 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 187
Query: 183 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242
DYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVL GKPLFPGKNVVHQLDLMTDLL
Sbjct: 188 DYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLMGKPLFPGKNVVHQLDLMTDLL 247
Query: 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 302
GTPSLDTISRVRN+KARRYLTSMRKK P+ F+QKFPNADP +L+LLERLLAFDPKDRPTA
Sbjct: 248 GTPSLDTISRVRNEKARRYLTSMRKKPPIPFAQKFPNADPLSLKLLERLLAFDPKDRPTA 307
Query: 303 EEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDY 362
EEALADPYFKGL+KVEREPSCQPI+KMEFEFERR+VTKEDIRELI REILEYHPQLLKD+
Sbjct: 308 EEALADPYFKGLAKVEREPSCQPITKMEFEFERRKVTKEDIRELISREILEYHPQLLKDH 367
Query: 363 MNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKE 422
MNG ++ +FLYPSAVDQFR+QFAHLEEN GK+GPV P ERKH SLPRST++HS V
Sbjct: 368 MNGADKASFLYPSAVDQFRRQFAHLEENSGKTGPVAPLERKHASLPRSTVIHSTAVARGG 427
Query: 423 QQNLSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQR-FPLAXXXXXXXXXXXYENASV 481
Q L + N + ++ IP N + T+ AQQR A ++N +
Sbjct: 428 QPKLMNNTNTL------NPETTQNIPFNHA-TIQAQQRNLSAAKPSTFMGPVAPFDNGRI 480
Query: 482 RRDAYDPRTFIRSTVLPQAIPAAYCYRKSSTGKQ-EMDSEREMPSQVKHVPQCGMAAKFA 540
RDAYDPR+FIRST LP + +A + GKQ E + E Q + + Q ++A
Sbjct: 481 SRDAYDPRSFIRSTNLPFSQQSAATV---AMGKQQERRTTMEPEKQARQISQYN---RYA 534
Query: 541 TDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGXXXXXXXXXXXXHR 600
D+AIN+D+NPF M R G+NK E+I D+I IDTNLLQ + G V HR
Sbjct: 535 PDVAINIDNNPFIMARTGMNKAENISDRIIIDTNLLQATAGIG-VAAAAAAAAPGGSAHR 593
Query: 601 KIGTVQYGMTTRMY 614
K+G V+YGM+ +MY
Sbjct: 594 KVGAVRYGMS-KMY 606
|
|
| TAIR|locus:2089576 MPK19 "MAP kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1915 (679.2 bits), Expect = 8.7e-198, P = 8.7e-198
Identities = 389/589 (66%), Positives = 445/589 (75%)
Query: 3 QNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 62
+N EMEFF+EYGDA+RY+I EVIGKGSYGVVC+AIDT TGEKVAIKKI+D+FEH+SDA
Sbjct: 8 KNMKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTQTGEKVAIKKINDVFEHVSDAL 67
Query: 63 XXXXXXXXXXXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH 122
HPDIVEIK IMLPPS+R+FKDIYVVFELMESDLHQVIKANDDLTREH
Sbjct: 68 RILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREH 127
Query: 123 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 182
+QFFLYQ+LRALKY+HTANVYHRDLKPKNILANANCKLK+CDFGLARV+FNDTPTT+FWT
Sbjct: 128 HQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVSFNDTPTTVFWT 187
Query: 183 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242
DYVATRWYRAPELCGSF SKYTPAIDIWSIGCIFAEVLTGKPLFPGK+VVHQLDL+TDLL
Sbjct: 188 DYVATRWYRAPELCGSFCSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247
Query: 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 302
GTP +TI+ VRN+KAR+YL MRKK V FSQKFPNADP ALRLL+RLLAFDPKDRPTA
Sbjct: 248 GTPKSETIAGVRNEKARKYLNEMRKKNLVPFSQKFPNADPLALRLLQRLLAFDPKDRPTA 307
Query: 303 EEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDY 362
EALADPYFK L+KVEREPSCQPISKMEFEFERRR+TK+DIRELI+REILEYHPQLLKDY
Sbjct: 308 AEALADPYFKCLAKVEREPSCQPISKMEFEFERRRLTKDDIRELIYREILEYHPQLLKDY 367
Query: 363 MNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKE 422
MN +E ++FLYPSA+ RKQFA+LEEN GKSGPVIPP+RKH SLPRS VHS+ V
Sbjct: 368 MN-SEGSSFLYPSAIGHLRKQFAYLEENSGKSGPVIPPDRKHASLPRSA-VHSSAVNSNA 425
Query: 423 QQNLSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAXXXXXXXXXXXYEN-ASV 481
Q +L+ + + A ++ L R P YEN ++
Sbjct: 426 QPSLNASDSRRVSIEPSRNGVVPSTSAYSTKPLGPPPRVPSGKPGRVVESSVTYENDRNL 485
Query: 482 RRDAYDPRT-FIRSTVLPQAIPAAYCYRKSSTGKQEMDSEREMPSQVK--HVP-QCGMAA 537
+ +YD RT + RSTVLP + CY +T QE S E SQ K VP QC +A
Sbjct: 486 KESSYDARTSYYRSTVLPPQTVSPNCYFLPNTMNQEKRSGTEAASQPKPQFVPTQCN-SA 544
Query: 538 KFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVG 586
K A ++ NP+ + +H ++ ID LL +SQYG G
Sbjct: 545 KPA-----ELNPNPYVQS-------QH---KVGIDAKLLHAQSQYGPAG 578
|
|
| TAIR|locus:2024887 MPK18 "mitogen-activated protein kinase 18" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1879 (666.5 bits), Expect = 5.7e-194, P = 5.7e-194
Identities = 383/621 (61%), Positives = 451/621 (72%)
Query: 3 QNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 62
+ + EMEFF+EYGDA+RY+I EVIGKGSYGVVC+AIDTHTGEKVAIKKI+D+FEHISDA
Sbjct: 8 KGTKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTHTGEKVAIKKINDVFEHISDAL 67
Query: 63 XXXXXXXXXXXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH 122
HPDIVEIK IMLPPS+R+FKDIYVVFELMESDLHQVIKANDDLTREH
Sbjct: 68 RILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREH 127
Query: 123 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 182
+QFFLYQ+LRALK++HTANVYHRDLKPKNILANANCKLK+CDFGLARVAFNDTPTT+FWT
Sbjct: 128 HQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDTPTTVFWT 187
Query: 183 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242
DYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAEVLTGKPLFPGK+VVHQL+L+TDLL
Sbjct: 188 DYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGKPLFPGKSVVHQLELITDLL 247
Query: 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 302
GTP +TIS VRNDKAR+YLT MRKK PV FSQKF ADP ALRLL+RLLAFDPKDRPT
Sbjct: 248 GTPKSETISGVRNDKARKYLTEMRKKNPVTFSQKFSKADPLALRLLQRLLAFDPKDRPTP 307
Query: 303 EEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDY 362
EALADPYFKGLSK+EREPS Q ISKMEFEFERRR+TK+DIRELI+REILEYHPQLLKDY
Sbjct: 308 AEALADPYFKGLSKIEREPSSQQISKMEFEFERRRLTKDDIRELIYREILEYHPQLLKDY 367
Query: 363 MNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKE 422
M+G+E +NF+YPSA+ R+QF +LEEN ++GPVIP ERKH SLPRST VHS V
Sbjct: 368 MSGSEGSNFVYPSAIGHLRQQFTYLEENSSRNGPVIPLERKHASLPRST-VHSTVVHSTS 426
Query: 423 QQNL-SRDRQAAEEVFNKNSKESEGIPANLS---RTLPAQQRFPLAXX-XXXXXXXXXYE 477
Q NL + D + +KN S G P+ + +++ R P + YE
Sbjct: 427 QPNLGATDSRRVSFEPSKNGASSAGHPSTSAYPTKSIGPPPRVPPSGRPGRVVESSVSYE 486
Query: 478 NASVRRDAYDPRTFIRSTVLPQAIPAAYCYRKSST----GKQEMDSEREMPSQVKHVPQC 533
N ++AY RS A+ + +CY + +T + +++ P V Q
Sbjct: 487 NGRNLKEAY-----FRS-----AVSSPHCYFRPNTMTNPENRNIEASSFPPKPQNPVHQF 536
Query: 534 G-----MAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQ--ISIDTNLLQTKSQYGGVG 586
A D+ NP+F + + K + + + ++ID LLQ +SQ+G G
Sbjct: 537 SPTEPPAATTNQADVETMNHPNPYFQPQ--LPKTDQLNNNTHMAIDAKLLQAQSQFGPAG 594
Query: 587 XXXXXXXXXXXXHRKIGTVQY 607
HR IGT+ Y
Sbjct: 595 AAAVAVAA----HRNIGTISY 611
|
|
| TAIR|locus:2179609 MPK16 "mitogen-activated protein kinase 16" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1771 (628.5 bits), Expect = 1.6e-182, P = 1.6e-182
Identities = 352/555 (63%), Positives = 427/555 (76%)
Query: 3 QNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 62
++S E++FF+EYG+ SRY+I+EVIGKGSYGVVCSA DTHTGEKVAIKKI+DIFEH+SDA
Sbjct: 8 KSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIFEHVSDAT 67
Query: 63 XXXXXXXXXXXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH 122
HPDIVEIKHI+LPPSRR+F+DIYVVFELMESDLHQVIKANDDLT EH
Sbjct: 68 RILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEH 127
Query: 123 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 182
YQFFLYQLLR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARVAFNDTPT IFWT
Sbjct: 128 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 187
Query: 183 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242
DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLDLMTD+L
Sbjct: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDLMTDML 247
Query: 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 302
GTPS + I RVRN+KARRYL+SMRKK+P+ FS KFP+ DP ALRLLE++L+F+PKDRPTA
Sbjct: 248 GTPSAEAIGRVRNEKARRYLSSMRKKKPIPFSHKFPHTDPLALRLLEKMLSFEPKDRPTA 307
Query: 303 EEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDY 362
EEALAD YFKGL+KVEREPS QP++K+EFEFERRR+TKED+RELI+RE LEYHP++LK+Y
Sbjct: 308 EEALADVYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDVRELIYRESLEYHPKMLKEY 367
Query: 363 MNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERK-HVSLPRSTIVHSNTVPPK 421
++G+E TNF+YPSAV+ F+KQFA+LEE+ PPER+ H SLPR+ +++S+ P
Sbjct: 368 LDGSEPTNFMYPSAVEHFKKQFAYLEEHYKNGTSHNPPERQQHASLPRACVLYSDNNHPV 427
Query: 422 EQQN-------LSRD--RQAAEEVFNKNSK-ESEGIPANLSRTLPAQQRFPLAXXXXXXX 471
QQ+ LS+ R ++N++ IP N+ +T+ Q +A
Sbjct: 428 AQQSSAEVTDGLSKCSIRDERPRGADRNAQMPMSRIPINVPQTI---QGAAVARPGKVVG 484
Query: 472 XXXXYEN--ASVRRDAYDP--RTFIRSTVLPQAIPAAYCYRKSSTGKQEMDSEREMPSQV 527
Y N A+ +A + R +R+ P KS+ G ++ + E PS++
Sbjct: 485 SVLRYNNCGAATGVEALEQQQRRMVRNPAAASQYPKRTQPCKSNRGDEDCATAAEGPSRL 544
Query: 528 K----HVPQCGMAAK 538
K ++PQ AA+
Sbjct: 545 KPNTQYIPQKVSAAQ 559
|
|
| TAIR|locus:2092717 MPK9 "MAP kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1711 (607.4 bits), Expect = 3.6e-176, P = 3.6e-176
Identities = 316/423 (74%), Positives = 365/423 (86%)
Query: 7 EMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAXXXX 66
E EFF+EYG+ASRY+IQEVIGKGSYGVV SAIDTH+GEKVAIKKI+D+FEH+SDA
Sbjct: 10 ETEFFTEYGEASRYQIQEVIGKGSYGVVASAIDTHSGEKVAIKKINDVFEHVSDATRILR 69
Query: 67 XXXXXXXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFF 126
HPDIVEIKH+MLPPSRR+F+DIYVVFELMESDLHQVIKANDDLT EHYQFF
Sbjct: 70 EIKLLRLLRHPDIVEIKHVMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEHYQFF 129
Query: 127 LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA 186
LYQLLR LK+IHTANV+HRDLKPKNILAN++CKLKICDFGLARV+FND P+ IFWTDYVA
Sbjct: 130 LYQLLRGLKFIHTANVFHRDLKPKNILANSDCKLKICDFGLARVSFNDAPSAIFWTDYVA 189
Query: 187 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 246
TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLD+MTDLLGTP
Sbjct: 190 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDIMTDLLGTPP 249
Query: 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 306
+ I+R+RN+KARRYL +MR+K PV F+ KFP+ DP ALRLL RLLAFDPKDRP+AEEAL
Sbjct: 250 PEAIARIRNEKARRYLGNMRRKPPVPFTHKFPHVDPLALRLLHRLLAFDPKDRPSAEEAL 309
Query: 307 ADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGT 366
ADPYF GL+ V+REPS QPI K+EFEFERR++TKED+RELI+REILEYHPQ+L++Y+ G
Sbjct: 310 ADPYFYGLANVDREPSTQPIPKLEFEFERRKITKEDVRELIYREILEYHPQMLQEYLRGG 369
Query: 367 ERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKEQQNL 426
E+T+F+YPS VD+F++QFAHLEEN GK P +R+H SLPR + P KE +
Sbjct: 370 EQTSFMYPSGVDRFKRQFAHLEENYGKGEKGSPLQRQHASLPRERV----PAPKKENGSH 425
Query: 427 SRD 429
+ D
Sbjct: 426 NHD 428
|
|
| TAIR|locus:2027814 MPK15 "MAP kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1708 (606.3 bits), Expect = 7.5e-176, P = 7.5e-176
Identities = 320/445 (71%), Positives = 373/445 (83%)
Query: 6 PEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAXXX 65
P EFF+EYG+A+RY+IQEV+GKGSYGVV SAIDTHTGE+VAIKKI+D+F+HISDA
Sbjct: 76 PNAEFFTEYGEANRYQIQEVVGKGSYGVVGSAIDTHTGERVAIKKINDVFDHISDATRIL 135
Query: 66 XXXXXXXXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQF 125
HPD+VEIKHIMLPPSRR+F+D+YVVFELMESDLHQVIKANDDLT EH+QF
Sbjct: 136 REIKLLRLLLHPDVVEIKHIMLPPSRREFRDVYVVFELMESDLHQVIKANDDLTPEHHQF 195
Query: 126 FLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYV 185
FLYQLLR LKY+H ANV+HRDLKPKNILANA+CKLKICDFGLARV+FND PT IFWTDYV
Sbjct: 196 FLYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFWTDYV 255
Query: 186 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 245
ATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L GKPLFPGKNVVHQLD+MTD LGTP
Sbjct: 256 ATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDIMTDFLGTP 315
Query: 246 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 305
+ IS++RNDKARRYL +MRKKQPV FS+KFP ADPSALRLLERL+AFDPKDRP+AEEA
Sbjct: 316 PPEAISKIRNDKARRYLGNMRKKQPVPFSKKFPKADPSALRLLERLIAFDPKDRPSAEEA 375
Query: 306 LADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNG 365
LADPYF GLS REPS QPISK+EFEFER+++TK+DIRELI+REILEYHPQ+L++Y+ G
Sbjct: 376 LADPYFNGLSSKVREPSTQPISKLEFEFERKKLTKDDIRELIYREILEYHPQMLEEYLRG 435
Query: 366 TERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKEQQN 425
+ +F+YPS VD+FR+QFAHLEEN G G +R+H SLPR + S +E+ N
Sbjct: 436 GNQLSFMYPSGVDRFRRQFAHLEENQGPGGRSNALQRQHASLPRERVPASKNETVEERSN 495
Query: 426 -LSRDRQAA-EEVFN--KNSKESEG 446
+ R AA + K S+++EG
Sbjct: 496 DIERRTTAAVASTLDSPKASQQAEG 520
|
|
| TAIR|locus:2194040 ATMPK8 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1692 (600.7 bits), Expect = 3.7e-174, P = 3.7e-174
Identities = 315/444 (70%), Positives = 369/444 (83%)
Query: 7 EMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAXXXX 66
E EFF+EYG+A+RY+IQEV+GKGSYGVV SA+D+HTGE+VAIKKI+D+FEH+SDA
Sbjct: 91 ETEFFTEYGEANRYQIQEVVGKGSYGVVASAVDSHTGERVAIKKINDVFEHVSDATRILR 150
Query: 67 XXXXXXXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFF 126
HPD+VEIKHIMLPPSRR+F+DIYVVFELMESDLHQVIKANDDLT EHYQFF
Sbjct: 151 EIKLLRLLRHPDVVEIKHIMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEHYQFF 210
Query: 127 LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA 186
LYQLLR LKY+H ANV+HRDLKPKNILANA+CKLKICDFGLARV+FND PT IFWTDYVA
Sbjct: 211 LYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFWTDYVA 270
Query: 187 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 246
TRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L GKPLFPGKNVVHQLDLMTD LGTP
Sbjct: 271 TRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDLMTDFLGTPP 330
Query: 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 306
++ISR+RN+KARRYL+SMRKKQPV FS KFP ADP ALRLLERLLAFDPKDR +AE+AL
Sbjct: 331 PESISRIRNEKARRYLSSMRKKQPVPFSHKFPKADPLALRLLERLLAFDPKDRASAEDAL 390
Query: 307 ADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGT 366
ADPYF GLS EREP+ QPISK+EF+FER+++ K+D+RELI+REILEYHPQ+L++Y+ G
Sbjct: 391 ADPYFSGLSNSEREPTTQPISKLEFDFERKKLVKDDVRELIYREILEYHPQMLEEYLRGG 450
Query: 367 ERTNFLYPSAVDQFRKQFAHLEENVGKSGPV-----IPPERKHVSLPRSTIVHSNTVPPK 421
++ +F+YPS VD+F++QFAHLEEN GK G R H SLPR + N +
Sbjct: 451 DQLSFMYPSGVDRFKRQFAHLEENQGKPGAAGGGRSTALHRHHASLPRERVPAPNGETAE 510
Query: 422 EQQNLSRDRQAAEEVFNKNSKESE 445
E ++ R R AA S+E++
Sbjct: 511 ESSDVER-RAAAAVASTLESEEAD 533
|
|
| TAIR|locus:2049552 MPK17 "MAP kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1555 (552.4 bits), Expect = 1.2e-159, P = 1.2e-159
Identities = 286/413 (69%), Positives = 350/413 (84%)
Query: 7 EMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAXXXX 66
E EFF+EYG+AS+Y+IQEV+GKGSYGVV SA HTG KVAIKK+ ++FEH+SDA
Sbjct: 3 EKEFFTEYGEASQYQIQEVVGKGSYGVVASAECPHTGGKVAIKKMTNVFEHVSDAIRILR 62
Query: 67 XXXXXXXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFF 126
HPDIVEIKHIMLPP R++FKDIYVVFELMESDLH V+K NDDLT +H+QFF
Sbjct: 63 EIKLLRLLRHPDIVEIKHIMLPPCRKEFKDIYVVFELMESDLHHVLKVNDDLTPQHHQFF 122
Query: 127 LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA 186
LYQLLR LK++H+A+V+HRDLKPKNILANA+CK+KICD GLARV+F D+P+ +FWTDYVA
Sbjct: 123 LYQLLRGLKFMHSAHVFHRDLKPKNILANADCKIKICDLGLARVSFTDSPSAVFWTDYVA 182
Query: 187 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 246
TRWYRAPELCGSF+S YTPAID+WS+GCIFAE+LTGKPLFPGKNVVHQL+L+TDLLGTPS
Sbjct: 183 TRWYRAPELCGSFYSNYTPAIDMWSVGCIFAEMLTGKPLFPGKNVVHQLELVTDLLGTPS 242
Query: 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 306
T+SR+RN+KAR+YL +MR+K PV F+ KFPN DP AL+LL+RL+AFDPKDRP+AEEAL
Sbjct: 243 PITLSRIRNEKARKYLGNMRRKDPVPFTHKFPNIDPVALKLLQRLIAFDPKDRPSAEEAL 302
Query: 307 ADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGT 366
ADPYF+GL+ V+ EPS QPISK+EFEFERR++T++D+REL++REILEYHPQ+L++Y+ G
Sbjct: 303 ADPYFQGLANVDYEPSRQPISKLEFEFERRKLTRDDVRELMYREILEYHPQMLQEYLQGE 362
Query: 367 ERTN--FLYPSAVDQFRKQFAHLEE-NVGKSGPVIPP-ERKHVSLPRSTIVHS 415
E N FLYPS VDQF+++FA LEE N + PP +RK+ SLPR + S
Sbjct: 363 ENINSHFLYPSGVDQFKQEFARLEEHNDDEEEHNSPPHQRKYTSLPRERVCSS 415
|
|
| TAIR|locus:2124943 MPK4 "MAP kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 868 (310.6 bits), Expect = 7.7e-87, P = 7.7e-87
Identities = 163/332 (49%), Positives = 230/332 (69%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAXXXXXXXXXXXXXHPDIVEIKHI 85
IG+G+YG+VC+A ++ TGE+VAIKKI + F++I DA H +++ +K I
Sbjct: 49 IGRGAYGIVCAATNSETGEEVAIKKIGNAFDNIIDAKRTLREIKLLKHMDHENVIAVKDI 108
Query: 86 MLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHR 145
+ PP R +F D+Y+V+ELM++DLHQ+I++N LT +H +FFLYQLLR LKY+H+ANV HR
Sbjct: 109 IKPPQRENFNDVYIVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYVHSANVLHR 168
Query: 146 DLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTP 205
DLKP N+L NANC LK+ DFGLAR T F T+YV TRWYRAPEL + S+YT
Sbjct: 169 DLKPSNLLLNANCDLKLGDFGLARTKSE----TDFMTEYVVTRWYRAPELLLNC-SEYTA 223
Query: 206 AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSM 265
AIDIWS+GCI E +T +PLFPGK+ VHQL L+T+L+G+P ++ +R+D ARRY+ +
Sbjct: 224 AIDIWSVGCILGETMTREPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNARRYVRQL 283
Query: 266 RKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQP 325
+ F+ +FPN A+ LLE++L FDP R T +EAL PY L + EP C
Sbjct: 284 PQYPRQNFAARFPNMSAGAVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDINEEPVC-- 341
Query: 326 ISKMEFEFERRRVTKEDIRELIFREILEYHPQ 357
+ F+FE+ +T+E+I+ELI+RE ++++PQ
Sbjct: 342 VRPFNFDFEQPTLTEENIKELIYRETVKFNPQ 373
|
|
| DICTYBASE|DDB_G0286353 erkA "mitogen-activated protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 867 (310.3 bits), Expect = 9.9e-87, P = 9.9e-87
Identities = 168/346 (48%), Positives = 232/346 (67%)
Query: 12 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAXXXXXXXXX 71
S++ RY I + IG G+YGVVCSA D TGEKVAIKKI F+++ D
Sbjct: 141 SQFTVPRRYSIVKCIGHGAYGVVCSAKDNLTGEKVAIKKISKAFDNLKDTKRTLREIHLL 200
Query: 72 XXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLL 131
H +++ IK I+ P S+ F+D+Y+V ELM++DLHQ+I + L+ +H Q+F+YQ+L
Sbjct: 201 RHFKHENLISIKDILKPNSKEQFEDVYIVSELMDTDLHQIITSPQPLSDDHCQYFVYQML 260
Query: 132 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 191
R LK+IH+ANV HRDLKP N+L N +C LKICD GLARV D F T+YVATRWYR
Sbjct: 261 RGLKHIHSANVLHRDLKPSNLLINEDCLLKICDLGLARV--EDATHQGFMTEYVATRWYR 318
Query: 192 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251
APE+ S+ +KYT AIDIWS+GCIFAE+L KPLF GK+ +HQ+ L+ + +G+PS + I
Sbjct: 319 APEVILSW-NKYTKAIDIWSVGCIFAELLGRKPLFQGKDYIHQITLIIETIGSPSEEDIC 377
Query: 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311
+ N++AR+++ +M + V F+ FP A+P A+ LLER+L FDP R T EEALA PYF
Sbjct: 378 NIANEQARQFIRNMGNQPKVNFANMFPKANPDAIDLLERMLYFDPSKRLTVEEALAHPYF 437
Query: 312 KGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQ 357
+ L EP C + K FE + ++ ++ELI+ E+L YHP+
Sbjct: 438 QSLHDPSDEPIC--LHKFSLNFEAWDLNRDLLKELIYNEMLAYHPE 481
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q5ZCI1 | MPK10_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7439 | 0.9755 | 0.9803 | yes | no |
| A2X0M1 | MPK13_ORYSI | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7389 | 0.6954 | 0.8438 | N/A | no |
| Q9SJG9 | MPK20_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7520 | 0.9739 | 0.9867 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 614 | |||
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.0 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.0 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-161 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-148 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-143 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-122 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-121 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-118 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-105 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-102 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-102 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-96 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-91 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-90 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-89 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-88 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-87 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-87 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-86 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-84 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-82 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-80 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-79 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-79 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-77 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-74 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-72 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-71 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-67 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-67 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-67 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-65 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-65 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-65 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-64 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-63 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-62 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-61 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-61 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-61 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-61 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-60 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-59 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-59 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-59 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-57 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-57 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-53 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-52 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-52 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-50 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-48 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-48 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-48 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-47 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-46 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-43 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-42 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-42 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-41 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-41 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-39 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-39 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-38 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-38 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-36 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-36 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-34 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-31 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-30 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-30 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-28 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-27 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-26 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-26 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-26 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-26 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-24 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-23 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-23 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-22 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-22 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-21 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-21 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-20 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-20 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-19 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-19 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-18 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 5e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-17 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-16 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-16 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-16 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-16 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-15 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-15 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-15 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-14 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-12 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-11 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-10 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 8e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 8e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.001 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.001 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.003 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.004 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 750 bits (1939), Expect = 0.0
Identities = 314/338 (92%), Positives = 331/338 (97%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI+D+FEH+SDA RILREIKLLRLLRHPD
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 138
IVEIKHIMLPPSRR+FKDIYVVFELMESDLHQVIKANDDLT EH+QFFLYQLLRALKYIH
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 139 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 198
TANV+HRDLKPKNILANA+CKLKICDFGLARVAFNDTPT IFWTDYVATRWYRAPELCGS
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180
Query: 199 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 258
FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL+TDLLGTPS +TISRVRN+KA
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240
Query: 259 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 318
RRYL+SMRKKQPV FSQKFPNADP ALRLLERLLAFDPKDRPTAEEALADPYFKGL+KVE
Sbjct: 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE 300
Query: 319 REPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 356
REPS QPI+K+EFEFERRR+TKED+RELI+REILEYHP
Sbjct: 301 REPSAQPITKLEFEFERRRLTKEDVRELIYREILEYHP 338
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 537 bits (1385), Expect = 0.0
Identities = 187/332 (56%), Positives = 242/332 (72%), Gaps = 2/332 (0%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
RY++ + IG G+YGVVCSA+D TG KVAIKKI ++F+ + DA RILREIKLLR LRH +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 138
I+ + I+ PPS DF D+Y+V ELME+DLH+VIK+ LT +H Q+FLYQ+LR LKY+H
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120
Query: 139 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 198
+ANV HRDLKP NIL N+NC LKICDFGLAR D F T+YV TRWYRAPEL S
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180
Query: 199 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 258
S+YT AIDIWS+GCIFAE+LT KPLFPG++ + QL+L+ ++LGTPS + + + ++KA
Sbjct: 181 -SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239
Query: 259 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 318
R YL S+ KK S+ FP A P A+ LLE++L FDPK R TA+EALA PY L E
Sbjct: 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE 299
Query: 319 REPSCQPISKMEFEFERRRVTKEDIRELIFRE 350
EP +P +F F+ +T+E+++ELI+ E
Sbjct: 300 DEPVAKPPFDFDF-FDDDELTEEELKELIYEE 330
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 463 bits (1193), Expect = e-161
Identities = 188/339 (55%), Positives = 247/339 (72%), Gaps = 6/339 (1%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
++Y + IG+G+YG+VCSA ++ T EKVAIKKI + F++ DA R LREIKLLR L H
Sbjct: 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHE 64
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 137
+++ IK IM PP R F D+Y+V+ELM++DLHQ+I+++ L+ +H Q+FLYQLLR LKYI
Sbjct: 65 NVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
H+ANV HRDLKP N+L NANC LKICDFGLAR + F T+YV TRWYRAPEL
Sbjct: 125 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---SEKGDFMTEYVVTRWYRAPELLL 181
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257
+ S+YT AID+WS+GCIFAE+L KPLFPGK+ VHQL L+T+LLG+PS + + +RN+K
Sbjct: 182 N-CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240
Query: 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 317
ARRY+ S+ F++ FP+A+P A+ LLE++L FDP R T EEALA PY L
Sbjct: 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300
Query: 318 EREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 356
EP CQ + F+FE +T+EDI+ELI+ E+L YHP
Sbjct: 301 SDEPVCQ--TPFSFDFEEDALTEEDIKELIYNEMLAYHP 337
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 430 bits (1109), Expect = e-148
Identities = 174/341 (51%), Positives = 237/341 (69%), Gaps = 14/341 (4%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 76
RY+ IG+G+YG+VCSA TG KVAIKKI FEH + R LREIK+LR +H
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP-FEHQTFCQRTLREIKILRRFKH 62
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 136
+I+ I I+ PPS F D+Y+V ELME+DL+++IK L+ +H Q+FLYQ+LR LKY
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH-LSNDHIQYFLYQILRGLKY 121
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 196
IH+ANV HRDLKP N+L N NC LKICDFGLAR+A + T F T+YVATRWYRAPE+
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181
Query: 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256
+ YT AIDIWS+GCI AE+L+ +PLFPGK+ +HQL+L+ +LGTPS + ++ + +
Sbjct: 182 LNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240
Query: 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316
+AR Y+ S+ K V +++ FPNADP AL LL+++L F+P R T EEALA PY
Sbjct: 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY------ 294
Query: 317 VER--EPSCQPISKMEFEFE---RRRVTKEDIRELIFREIL 352
+E+ +PS +P+++ F F+ + KE ++ELIF EI+
Sbjct: 295 LEQYHDPSDEPVAEEPFPFDFELFDDLPKEKLKELIFEEIM 335
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 418 bits (1076), Expect = e-143
Identities = 175/334 (52%), Positives = 241/334 (72%), Gaps = 5/334 (1%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
SRYK E IG G+YGVVCSAIDT +G+KVAIKKI F+ + A R LRE+K+LR +H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 137
+I+ I+ I+ PP DFKD+YVV +LMESDLH +I ++ LT EH ++FLYQLLR LKYI
Sbjct: 65 NIIAIRDILRPPGA-DFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLAR-VAFNDTPTTIFWTDYVATRWYRAPELC 196
H+ANV HRDLKP N+L N +C+L+I DFG+AR ++ + T F T+YVATRWYRAPEL
Sbjct: 124 HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183
Query: 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256
S +YT AID+WS+GCIFAE+L + LFPGKN VHQL L+ +LG+PS + ++R+ +D
Sbjct: 184 LSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242
Query: 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316
+ R+Y+ ++ +KQPV +S+ FP A P AL LL ++L FDP++R T E+AL P+
Sbjct: 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302
Query: 317 VEREPSCQPISKMEFEFERRRVTKEDIRELIFRE 350
+ EP+C P +F+FE +++E ++E I +E
Sbjct: 303 PDDEPTCPP--PFDFDFEAIELSREQLKEAIVKE 334
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 365 bits (939), Expect = e-122
Identities = 148/338 (43%), Positives = 212/338 (62%), Gaps = 11/338 (3%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-H 76
+Y+I + +GKG+YG+V AID T E VA+KKI D F + +DA R REI L+ L H
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDH 66
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 136
P+IV++ +++ + D KDIY+VFE ME+DLH VI+AN L H ++ +YQLL+ALKY
Sbjct: 67 PNIVKLLNVI--KAEND-KDIYLVFEYMETDLHAVIRANI-LEDVHKRYIMYQLLKALKY 122
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVA--FNDTPTTIFWTDYVATRWYRAPE 194
IH+ NV HRDLKP NIL N++C++K+ DFGLAR + P TDYVATRWYRAPE
Sbjct: 123 IHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPE 182
Query: 195 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253
L GS ++YT +D+WS+GCI E+L GKPLFPG + ++QL+ + +++G PS + I +
Sbjct: 183 ILLGS--TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240
Query: 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313
++ A L S+ + + P A AL LL++LL F+P R TAEEAL PY
Sbjct: 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300
Query: 314 LSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREI 351
EP + + + +++ + R ++ EI
Sbjct: 301 FHNPSDEPVLPYPITIPLD-DNVKLSVAEYRNKLYEEI 337
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 361 bits (928), Expect = e-121
Identities = 164/338 (48%), Positives = 222/338 (65%), Gaps = 11/338 (3%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHT--GEKVAIKKIHDIFEHISDAARILREIKLLRLLR- 75
RY++ + +G+G+YG+VCSA + T E VAIKKI ++F A R LRE+KLLR R
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALK 135
H +I + + M +F ++Y+ ELME+DLHQ+I++ LT H+Q F+YQ+L LK
Sbjct: 61 HKNITCL-YDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLK 119
Query: 136 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP--TTIFWTDYVATRWYRAP 193
YIH+ANV HRDLKP N+L NA+C+LKICDFGLAR F++ P F T+YVATRWYRAP
Sbjct: 120 YIHSANVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEYVATRWYRAP 178
Query: 194 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253
E+ SF YT AID+WS+GCI AE+L KP+F GK+ V QL+ + +LGTP +T+SR+
Sbjct: 179 EIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237
Query: 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313
+ KA+ Y+ S+ F FPNA+P AL LLE+LLAFDP R + EEAL PY
Sbjct: 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297
Query: 314 LSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREI 351
+ EP CQ FE E + E++R++I E+
Sbjct: 298 WHDPDDEPVCQKPFDFSFESED---SMEELRDMIIEEV 332
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 354 bits (911), Expect = e-118
Identities = 146/339 (43%), Positives = 212/339 (62%), Gaps = 12/339 (3%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
RY+ +G G+YG VCSA DT TG KVAIKK+ F+ A R RE++LL+ + H +
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHEN 75
Query: 79 IVEIKHIMLPP-SRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 137
++ + + P S DF+D+Y+V LM +DL+ ++K L+ +H QF +YQ+LR LKYI
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK-LSDDHIQFLVYQILRGLKYI 134
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
H+A + HRDLKP NI N +C+LKI DFGLAR ++ T YVATRWYRAPE+
Sbjct: 135 HSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM------TGYVATRWYRAPEIML 188
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257
++ Y +DIWS+GCI AE+LTGK LFPG + + QL + +L+GTP + + ++ ++
Sbjct: 189 NWMH-YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247
Query: 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 317
AR Y+ S+ + F + F A+P A+ LLE++L DP R TA EALA PY
Sbjct: 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307
Query: 318 EREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 356
E EP P + FE R +T ++ +EL+++EI+ + P
Sbjct: 308 EDEPVAPP---YDQSFESRDLTVDEWKELVYKEIMNFKP 343
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 320 bits (822), Expect = e-105
Identities = 154/335 (45%), Positives = 221/335 (65%), Gaps = 18/335 (5%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
+RY + +G G++G+VCSA D TG+ VAIKKI F A R RE+KLL+ LRH
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 137
+I+ + I + P +DIY V EL+ +DLH+++ + L ++ Q+FLYQ+LR LKY+
Sbjct: 70 NIISLSDIFISP----LEDIYFVTELLGTDLHRLLTSRP-LEKQFIQYFLYQILRGLKYV 124
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
H+A V HRDLKP NIL N NC LKICDFGLAR+ T YV+TR+YRAPE+
Sbjct: 125 HSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM------TGYVSTRYYRAPEIML 178
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257
++ KY +DIWS GCIFAE+L GKPLFPGK+ V+Q ++TDLLGTP D I+ + ++
Sbjct: 179 TW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237
Query: 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 317
R++ S+ K++PV FS+KF NADPSA+ LLE++L FDP+ R +A EALA PY
Sbjct: 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY----LAP 293
Query: 318 EREPSCQPISKMEFE--FERRRVTKEDIRELIFRE 350
+P+ +P+++ +F+ F + + + +++ E
Sbjct: 294 YHDPTDEPVAEEKFDWSFNDADLPVDTWKVMMYSE 328
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 312 bits (801), Expect = e-102
Identities = 125/296 (42%), Positives = 173/296 (58%), Gaps = 18/296 (6%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH--ISDAARILREIKLLRLLRHP 77
Y+ E +G+G+YGVV A D TGE VA+KKI E I A LREI LL+ L+HP
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA--LREISLLKELKHP 58
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKY 136
+IV++ ++ + +Y+VFE + DL + + L+ + +YQLLR L Y
Sbjct: 59 NIVKLLDVIHTERK-----LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-L 195
H+ + HRDLKP+NIL N + LK+ DFGLAR AF +T V T WYRAPE L
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGLAR-AF--GIPLRTYTHEVVTLWYRAPEIL 170
Query: 196 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255
GS Y+ A+DIWS+GCIFAE++TGKPLFPG + + QL + +LGTP+ ++ V
Sbjct: 171 LGS--KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV-- 226
Query: 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311
K Y + K P + P DP + LL ++L ++P R +A+EAL PYF
Sbjct: 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 310 bits (797), Expect = e-102
Identities = 133/294 (45%), Positives = 177/294 (60%), Gaps = 13/294 (4%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 79
Y+ IG+G+YGVV A D TGE VAIKKI FE LREIKLL+ L HP+I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 80 VEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD-LTREHYQFFLYQLLRALKYIH 138
+++ + R D+Y+VFE M++DL+++IK L + +LYQLL+ L + H
Sbjct: 61 IKLLDVF-----RHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 139 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCG 197
+ + HRDLKP+N+L N LK+ DFGLAR +T YV TRWYRAPE L G
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSF---GSPVRPYTHYVVTRWYRAPELLLG 172
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257
Y+ +DIWS+GCIFAE+L+ +PLFPGK+ + QL + LGTP + + +
Sbjct: 173 DKG--YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL- 229
Query: 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311
AR Y S KK + + FPNA P AL LL ++L +DP R TAE+ALA PYF
Sbjct: 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 298 bits (765), Expect = 6e-96
Identities = 140/354 (39%), Positives = 207/354 (58%), Gaps = 32/354 (9%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 85
IG G++GVV S D G++VA+KK+ ++F+++ R+ RE+K+L +H +++ I
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 86 MLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHR 145
+ PP F++IYVV ELM+SDLH++I + L+ +H + FLYQ+LR LKY+H+A + HR
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHR 127
Query: 146 DLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYT 204
D+KP N+L N+NC LKICDFGLARV D + T V T++YRAPE L GS YT
Sbjct: 128 DIKPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEVVTQYYRAPEILMGS--RHYT 183
Query: 205 PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTS 264
A+DIWS+GCIFAE+L + LF ++ + QLDL+TDLLGTPSL+ + + AR ++
Sbjct: 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC-EGARAHILR 242
Query: 265 MRKKQPVQFSQKFPNADPS---ALRLLERLLAFDPKDRPTAEEALADPYFKG-------- 313
K P + + + A+ LL R+L FDP R +A +ALA PY
Sbjct: 243 GPHKPPS-LPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTC 301
Query: 314 ------------LSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYH 355
+ + EPS P E+E+ + ++E + + ILE
Sbjct: 302 MCKCCYTTSGGRVYTSDFEPSANPPFD--DEYEKNLTSVRQVKEELHQFILEQQ 353
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 281 bits (722), Expect = 3e-91
Identities = 109/293 (37%), Positives = 153/293 (52%), Gaps = 40/293 (13%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 79
Y+I E +G+GS+G V A D TG+ VAIK I + D RILREIK+L+ L+HP+I
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVI-KKKKIKKDRERILREIKILKKLKHPNI 59
Query: 80 VEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 138
V + + D +Y+V E E DL ++K L+ + +F+L Q+L AL+Y+H
Sbjct: 60 VRLYDVF-----EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLH 114
Query: 139 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 198
+ + HRDLKP+NIL + + +K+ DFGLAR + T +V T Y APE+
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLAR-QLDPGEKL---TTFVGTPEYMAPEVLLG 170
Query: 199 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 258
Y A+DIWS+G I E+LTGKP FPG + QL + +G P
Sbjct: 171 --KGYGKAVDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKP------------- 212
Query: 259 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311
F + P A L+ +LL DP+ R TAEEAL P+F
Sbjct: 213 -----------KPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 282 bits (722), Expect = 4e-90
Identities = 136/340 (40%), Positives = 207/340 (60%), Gaps = 12/340 (3%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
RY+ + +G G+YG VCSA+D TG KVAIKK++ F+ A R RE++LL+ ++H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 78 DIVEIKHIMLPPSRRD-FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 136
+++ + + P D F D Y+V M +DL +++K ++ L+ + QF +YQ+L+ LKY
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKY 133
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 196
IH A + HRDLKP N+ N +C+LKI DFGLAR ++ T YV TRWYRAPE+
Sbjct: 134 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM------TGYVVTRWYRAPEVI 187
Query: 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256
++ YT +DIWS+GCI AE+LTGKPLF G + + QL + + GTPS + + +++++
Sbjct: 188 LNWM-HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246
Query: 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316
A+ Y+ + + + F PNA+P A+ +LE++L D + R TA EALA PYF+
Sbjct: 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306
Query: 317 VEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 356
E E P + F+ + E+ + L F EIL + P
Sbjct: 307 PEDETEAPP---YDDSFDEVDQSLEEWKRLTFTEILSFQP 343
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 279 bits (715), Expect = 5e-89
Identities = 137/339 (40%), Positives = 210/339 (61%), Gaps = 12/339 (3%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
RY+ +G G+YG VC+A DT TG +VA+KK+ F+ I A R RE++LL+ ++H +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 77
Query: 79 IVEIKHIMLPP-SRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 137
++ + + P S +F D+Y+V LM +DL+ ++K LT +H QF +YQ+LR LKYI
Sbjct: 78 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYI 136
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
H+A++ HRDLKP N+ N +C+LKI DFGLAR ++ T YVATRWYRAPE+
Sbjct: 137 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM------TGYVATRWYRAPEIML 190
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257
++ Y +DIWS+GCI AE+LTG+ LFPG + + QL L+ L+GTP + + ++ ++
Sbjct: 191 NWM-HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249
Query: 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 317
AR Y+ S+ + + F+ F A+P A+ LLE++L D R TA +ALA YF
Sbjct: 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309
Query: 318 EREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 356
+ EP P + FE R + ++ + L + E++ + P
Sbjct: 310 DDEPVADPYDQ---SFESRDLLIDEWKSLTYDEVISFVP 345
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 278 bits (712), Expect = 2e-88
Identities = 132/339 (38%), Positives = 198/339 (58%), Gaps = 13/339 (3%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
RY + +G G+YG VCSAID TGEKVAIKK+ F+ A R RE+ LL+ ++H +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 79 IVEIKHIMLP-PSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 137
++ + + S +F+D Y+V M++DL +++ L+ + Q+ +YQ+L LKYI
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYI 133
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
H+A + HRDLKP N+ N +C+LKI DFGLAR A + T YV TRWYRAPE+
Sbjct: 134 HSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM------TGYVVTRWYRAPEVIL 187
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257
++ Y +DIWS+GCI AE+LTGK LF GK+ + QL + + G P + + ++ +
Sbjct: 188 NWM-HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246
Query: 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 317
A+ Y+ S+ K FS FP A P A+ LLE++L D R TA EAL PYF
Sbjct: 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306
Query: 318 EREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 356
+ E QP E +++ ++ ++ I++E+ + P
Sbjct: 307 DEETEQQPYDD---SLENEKLSVDEWKKHIYKEVKSFSP 342
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 273 bits (701), Expect = 1e-87
Identities = 115/302 (38%), Positives = 172/302 (56%), Gaps = 29/302 (9%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIK-LLRLLRHPD 78
YK+ + +G G++G V A + TGE VAIKK+ F + LRE+K L +L HP+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNEHPN 59
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLRALKY 136
IV++K + R+ ++Y VFE ME +L+Q++K + + +YQ+L+ L +
Sbjct: 60 IVKLKEV-----FRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL- 195
IH +HRDLKP+N+L + +KI DFGLAR + P +TDYV+TRWYRAPE+
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP----YTDYVSTRWYRAPEIL 170
Query: 196 --CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253
S Y+ +DIW++GCI AE+ T +PLFPG + + QL + +LGTP+
Sbjct: 171 LRSTS----YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE- 225
Query: 254 RNDKARRYLTSMR----KKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 309
+ + + + P Q PNA P A+ L++ +L +DPK RPTA +AL P
Sbjct: 226 ----GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281
Query: 310 YF 311
YF
Sbjct: 282 YF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 272 bits (699), Expect = 2e-87
Identities = 115/298 (38%), Positives = 171/298 (57%), Gaps = 17/298 (5%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRHP 77
Y+ IG+G+YG V A + TGE VA+KKI E+ + I +REIKLL+ LRHP
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHP 58
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVI-KANDDLTREHYQFFLYQLLRALKY 136
+IV +K I+ + IY+VFE M+ DL ++ T + ++ QLL L+Y
Sbjct: 59 NIVRLKEIVTSKGK---GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-L 195
+H+ + HRD+K NIL N + LK+ DFGLAR + + + T+ V T WYR PE L
Sbjct: 116 LHSNGILHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADY-TNRVITLWYRPPELL 173
Query: 196 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255
G+ ++Y P +D+WS+GCI AE+ GKP+F G + QL+ + +L G+P+ + V
Sbjct: 174 LGA--TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV-- 229
Query: 256 DKARRYLT-SMRKKQPVQFSQKFPNA-DPSALRLLERLLAFDPKDRPTAEEALADPYF 311
K + +K + + F + DPSAL LL++LL DPK R +A++AL YF
Sbjct: 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 271 bits (695), Expect = 4e-86
Identities = 137/339 (40%), Positives = 208/339 (61%), Gaps = 12/339 (3%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
RY+ +G G+YG VCSA DT +KVA+KK+ F+ + A R RE++LL+ ++H +
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHEN 75
Query: 79 IVEIKHIMLPP-SRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 137
++ + + P S +F ++Y+V LM +DL+ ++K L+ EH QF +YQLLR LKYI
Sbjct: 76 VIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK-LSDEHVQFLIYQLLRGLKYI 134
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
H+A + HRDLKP N+ N +C+L+I DFGLAR A ++ T YVATRWYRAPE+
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM------TGYVATRWYRAPEIML 188
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257
++ Y +DIWS+GCI AE+L GK LFPG + + QL + +++GTPS + + ++ ++
Sbjct: 189 NWM-HYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247
Query: 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 317
AR+Y+ S+ + F A+P A+ LLE++L D R +A EALA PYF
Sbjct: 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP 307
Query: 318 EREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 356
E EP +P + E + T E+ +EL + E+ + P
Sbjct: 308 EDEPEAEPYDE---SPENKERTIEEWKELTYEEVSSFKP 343
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 264 bits (678), Expect = 5e-84
Identities = 119/302 (39%), Positives = 162/302 (53%), Gaps = 24/302 (7%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR-----ILREIKLLRL 73
RY+ + +G+G+Y VV A D TG VAIKKI +A LREIKLL+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLG--ERKEAKDGINFTALREIKLLQE 58
Query: 74 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLR 132
L+HP+I+ + + + I +VFE ME+DL +VIK LT + ++ LR
Sbjct: 59 LKHPNIIGLLDVF---GHKSN--INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLR 113
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 192
L+Y+H+ + HRDLKP N+L ++ LK+ DFGLAR +F P T V TRWYRA
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR-SFGS-PNRKM-THQVVTRWYRA 170
Query: 193 PELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250
PEL F Y +D+WS+GCIFAE+L P PG + + QL + + LGTP+ +
Sbjct: 171 PEL---LFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW 227
Query: 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 310
V + + P Q FP A AL LL+RLL +P R TA +AL PY
Sbjct: 228 PGV---TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284
Query: 311 FK 312
F
Sbjct: 285 FS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 259 bits (665), Expect = 3e-82
Identities = 121/301 (40%), Positives = 177/301 (58%), Gaps = 24/301 (7%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRH 76
RYKI IG+G++G+V A D TGE VA+KK+ + I + A LREIK L+ +H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQA--LREIKALQACQH 58
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD-LTREHYQFFLYQLLRALK 135
P +V++ + S +V E M SDL +V++ + L + ++ LL+ +
Sbjct: 59 PYVVKLLDVFPHGSG-----FVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVA 113
Query: 136 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 195
Y+H + HRDLKP N+L +A+ LKI DFGLAR+ + P ++ VATRWYRAPEL
Sbjct: 114 YMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL--YSHQVATRWYRAPEL 171
Query: 196 C-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254
G+ KY P +D+W++GCIFAE+L G PLFPG+N + QL ++ LGTP+ +T +
Sbjct: 172 LYGA--RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229
Query: 255 N----DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 310
+ +K + +P+ + FP+A P AL LL+ LL +DP R +A EAL PY
Sbjct: 230 SLPDYNKIT-----FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284
Query: 311 F 311
F
Sbjct: 285 F 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 257 bits (658), Expect = 2e-80
Identities = 127/348 (36%), Positives = 198/348 (56%), Gaps = 24/348 (6%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
RY+ + IG G+ G+VC+A DT TG+ VAIKK+ F++++ A R RE+ L++L+ H
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 78 DIVEIKHIMLP-PSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 136
+I+ + ++ P S +F+D+Y+V ELM+++L QVI DL E + LYQ+L +K+
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI--QMDLDHERMSYLLYQMLCGIKH 133
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 196
+H+A + HRDLKP NI+ ++C LKI DFGLAR A T YV TR+YRAPE+
Sbjct: 134 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVI 189
Query: 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256
Y +DIWS+GCI E++ G LFPG + + Q + + + LGTPS + +SR+
Sbjct: 190 LGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL-QP 246
Query: 257 KARRYLTSMRKKQPVQFSQKFP-------NADPSALR------LLERLLAFDPKDRPTAE 303
R Y+ + K F + FP + + L+ LL ++L DP+ R + +
Sbjct: 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306
Query: 304 EALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREI 351
+AL PY E P + + + R T E+ +ELI++E+
Sbjct: 307 DALQHPYINVWYD-PSEVEAPPPAPYDHSIDEREHTVEEWKELIYKEV 353
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 251 bits (644), Expect = 1e-79
Identities = 96/293 (32%), Positives = 140/293 (47%), Gaps = 34/293 (11%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 79
Y++ +G GS+G V A TG+ VA+K + E REI++LR L HP+I
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 80 VEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 138
V + D +Y+V E E DL + L+ + + Q+LR L+Y+H
Sbjct: 61 VRLIDAF-----EDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 139 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 198
+ + HRDLKP+NIL + N +KI DFGLA+ + + T +V T WY APE+
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL---TTFVGTPWYMAPEVL-L 171
Query: 199 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 258
+ Y P +D+WS+G I E+LTGKP F G+N LD + +R
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGEN---------------ILDQLQLIRRILG 216
Query: 259 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311
K+ + A L+++ L DP RPTAEE L P+F
Sbjct: 217 PPLEFD---------EPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 252 bits (646), Expect = 2e-79
Identities = 114/296 (38%), Positives = 168/296 (56%), Gaps = 12/296 (4%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
+Y++ V+G+G+YGVV + TGE VAIKK + + LRE+K+LR LRH +
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD-LTREHYQFFLYQLLRALKYI 137
IV +K RR + +Y+VFE +E L ++++A+ L + + +++QLL+A+ Y
Sbjct: 62 IVNLKEAF----RRKGR-LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LC 196
H+ N+ HRD+KP+NIL + + LK+CDFG AR TDYVATRWYRAPE L
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFAR--ALRARPASPLTDYVATRWYRAPELLV 174
Query: 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256
G + Y +D+W+IGCI AE+L G+PLFPG + + QL L+ LG ++
Sbjct: 175 GD--TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232
Query: 257 KARRYLTSMRKKQPVQFSQKFPNA-DPSALRLLERLLAFDPKDRPTAEEALADPYF 311
+ QP +++P AL L+ L DPK+R T +E L PYF
Sbjct: 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 248 bits (635), Expect = 4e-77
Identities = 126/337 (37%), Positives = 182/337 (54%), Gaps = 27/337 (8%)
Query: 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI---LREIKL 70
+ SRY +G GS G+V SA+D+ ++VA+KKI ++D + LREIK+
Sbjct: 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIV-----LTDPQSVKHALREIKI 55
Query: 71 LRLLRHPDIVEIKHIMLPPSRRD---------FKDIYVVFELMESDLHQVIKANDDLTRE 121
+R L H +IV++ ++ P +Y+V E ME+DL V++ L+ E
Sbjct: 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP-LSEE 114
Query: 122 HYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFNDTPTTIF 180
H + F+YQLLR LKYIH+ANV HRDLKP N+ N + LKI DFGLAR+ +
Sbjct: 115 HARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 181 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 240
++ + T+WYR+P L S + YT AID+W+ GCIFAE+LTGKPLF G + + Q+ L+ +
Sbjct: 175 LSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233
Query: 241 ---LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPK 297
++ + + V R R+ P +P AL LE++L F+P
Sbjct: 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRP----LRDLLPGVNPEALDFLEQILTFNPM 289
Query: 298 DRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFE 334
DR TAEEAL PY S EP +E E +
Sbjct: 290 DRLTAEEALMHPYMSCYSCPFDEPVSLHPFHIEDELD 326
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 238 bits (610), Expect = 5e-74
Identities = 120/299 (40%), Positives = 165/299 (55%), Gaps = 19/299 (6%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRHP 77
Y+ I +G+YGVV A D TGE VA+KK+ E + I LREI +L L+HP
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKL--KMEKEKEGFPITSLREINILLKLQHP 64
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKY 136
+IV +K +++ + IY+V E +E DL +++ + + + QLL + +
Sbjct: 65 NIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAH 121
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-L 195
+H + HRDLK N+L N LKICDFGLAR + +T V T WYRAPE L
Sbjct: 122 LHDNWILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKP--YTQLVVTLWYRAPELL 178
Query: 196 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255
G+ +Y+ AID+WS+GCIFAE+LT KPLFPGK+ + QL+ + LLGTP+
Sbjct: 179 LGA--KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236
Query: 256 DKARRYLTSMRKKQPV-QFSQKFPNADPS--ALRLLERLLAFDPKDRPTAEEALADPYF 311
+ T K P Q +KFP S LL RLL +DP R +AE+AL PYF
Sbjct: 237 LPGAKKKT--FTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 233 bits (596), Expect = 8e-72
Identities = 128/309 (41%), Positives = 173/309 (55%), Gaps = 30/309 (9%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRHPDIVEIK 83
IG+G+YG+V A DT +GE VA+KK+ ++ D I LREI LL LRHP+IVE+K
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVR--MDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 84 HIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD-LTREHYQFFLYQLLRALKYIHTANV 142
+++ + I++V E E DL ++ + + + QLLR L+Y+H +
Sbjct: 73 EVVVG---KHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFI 129
Query: 143 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFFS 201
HRDLK N+L LKI DFGLAR + + T V T WYRAPE L G +
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLART-YGLPAKPM--TPKVVTLWYRAPELLLGC--T 184
Query: 202 KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI----SRVRNDK 257
YT AID+W++GCI AE+L KPL PGK+ + QLDL+ LLGTP+ ++I S +
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN-ESIWPGFSDLPL-- 241
Query: 258 ARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316
++ KQP KFP + LRLL LL +DPK R TAEEAL YFK
Sbjct: 242 VGKFTL---PKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK---- 294
Query: 317 VEREPSCQP 325
E+ C+P
Sbjct: 295 -EKPLPCEP 302
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 231 bits (592), Expect = 3e-71
Identities = 112/310 (36%), Positives = 164/310 (52%), Gaps = 22/310 (7%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLR 75
Y+I +G+G++G V A TG VA+KKI + + D I LREIK+L+ L+
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI--LMHNEKDGFPITALREIKILKKLK 65
Query: 76 HPDIVEIKHIML---PPSRRDFKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLL 131
HP++V + + + S+R +Y+V M+ DL +++ LT + ++ QLL
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125
Query: 132 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT--------TIFWTD 183
+ Y+H ++ HRD+K NIL + LKI DFGLAR P T +T+
Sbjct: 126 EGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185
Query: 184 YVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242
V TRWYR PEL G +YT A+DIW IGC+FAE+ T +P+ GK+ + QL L+ L
Sbjct: 186 LVVTRWYRPPELLLGE--RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243
Query: 243 GTPSLDTISRVRN-DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT 301
GTP+ +T R+ + P ++F P L LL +LL+ DP R T
Sbjct: 244 GTPTEETWPGWRSLPGCEGVHSFTNY--PRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT 301
Query: 302 AEEALADPYF 311
A +AL PYF
Sbjct: 302 ASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 221 bits (564), Expect = 2e-67
Identities = 120/297 (40%), Positives = 165/297 (55%), Gaps = 19/297 (6%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA--ARILREIKLLRLLRHP 77
Y+ E IG+G+YGVV A D TGE VA+KKI E + + +REI LL+ L HP
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIR--LETEDEGVPSTAIREISLLKELNHP 58
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVI--KANDDLTREHYQFFLYQLLRALK 135
+IV + ++ ++ +Y+VFE ++ DL + + L + +LYQLL+ +
Sbjct: 59 NIVRLLDVVHSENK-----LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 136 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE- 194
Y H+ V HRDLKP+N+L + LK+ DFGLAR AF P + T V T WYRAPE
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR-AFG-VPVRTY-THEVVTLWYRAPEI 170
Query: 195 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254
L GS Y+ +DIWSIGCIFAE++ +PLFPG + + QL + LGTP D V
Sbjct: 171 LLGSRQ--YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT 228
Query: 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311
Y + K S+ PN D L LL ++L +DP R +A+ AL PYF
Sbjct: 229 --SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 220 bits (564), Expect = 2e-67
Identities = 110/302 (36%), Positives = 175/302 (57%), Gaps = 30/302 (9%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPD 78
YKI IG+G++ V A TG+ AIK + F+ + LREI+ LR L HP+
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPHPN 59
Query: 79 IVEIKHIML-PPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY------QFFLYQLL 131
I+ + ++ + R + +VFELM+ +L+++IK R+ + ++YQLL
Sbjct: 60 ILRLIEVLFDRKTGR----LALVFELMDMNLYELIKG-----RKRPLPEKRVKSYMYQLL 110
Query: 132 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 191
++L ++H ++HRD+KP+NIL + LK+ DFG R ++ P +T+Y++TRWYR
Sbjct: 111 KSLDHMHRNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPP----YTEYISTRWYR 165
Query: 192 APE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 249
APE L + Y P +DIW++GC+F E+L+ PLFPG N + Q+ + D+LGTP +
Sbjct: 166 APECLLTDGY---YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV 222
Query: 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 309
+ + R + Y + K+ + PNA L LL++LLA+DP +R TA++AL P
Sbjct: 223 LKKFRKSRHMNY--NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHP 280
Query: 310 YF 311
YF
Sbjct: 281 YF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 3e-67
Identities = 127/366 (34%), Positives = 206/366 (56%), Gaps = 29/366 (7%)
Query: 7 EMEFFS-EYGDAS-----RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISD 60
+ +F+S + D++ RY+ + IG G+ G+VC+A DT G VA+KK+ F++ +
Sbjct: 4 DSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH 63
Query: 61 AARILREIKLLRLLRHPDIVEIKHIMLP-PSRRDFKDIYVVFELMESDLHQVIKANDDLT 119
A R RE+ LL+ + H +I+ + ++ P S +F+D+Y+V ELM+++L QVI +L
Sbjct: 64 AKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM--ELD 121
Query: 120 REHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 179
E + LYQ+L +K++H+A + HRDLKP NI+ ++C LKI DFGLAR A T
Sbjct: 122 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----CTNF 177
Query: 180 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMT 239
T YV TR+YRAPE+ Y +DIWS+GCI E++ G +F G + + Q + +
Sbjct: 178 MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVI 235
Query: 240 DLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPN-ADPS-----------ALRL 287
+ LGTPS + ++R++ R Y+ + + + F + FP+ PS A L
Sbjct: 236 EQLGTPSAEFMNRLQ-PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDL 294
Query: 288 LERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELI 347
L ++L DP R + +EAL PY + E P + + E R E+ +ELI
Sbjct: 295 LSKMLVIDPDKRISVDEALRHPYIT-VWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELI 353
Query: 348 FREILE 353
++E+++
Sbjct: 354 YKEVMD 359
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 216 bits (551), Expect = 1e-65
Identities = 115/297 (38%), Positives = 168/297 (56%), Gaps = 19/297 (6%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPD 78
+K E +G+G+Y V + TGE VA+K+IH D E A +REI L++ L+H +
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA--IREISLMKELKHEN 59
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD---LTREHYQFFLYQLLRALK 135
IV + ++ ++ + +VFE M+ DL + + + L + F YQLL+ +
Sbjct: 60 IVRLHDVIHTENK-----LMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 136 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE- 194
+ H V HRDLKP+N+L N +LK+ DFGLAR AF P F + V T WYRAP+
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGELKLADFGLAR-AFG-IPVNTFSNE-VVTLWYRAPDV 171
Query: 195 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254
L GS Y+ +IDIWS+GCI AE++TG+PLFPG N QL + ++GTP+ T +
Sbjct: 172 LLGS--RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229
Query: 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311
+ Q +Q Q FP+ADP + LL RLL +P+ R +A +AL P+F
Sbjct: 230 QLPEYKPTFPRYPPQDLQ--QLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 217 bits (554), Expect = 3e-65
Identities = 119/322 (36%), Positives = 166/322 (51%), Gaps = 37/322 (11%)
Query: 17 ASRYK-IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR------------ 63
+ RY +G+G+YG V A DT TG+ VAIKK+ I E +D +
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKII-EISNDVTKDRQLVGMCGIHF 65
Query: 64 -ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH 122
LRE+K++ ++H +I+ + + + DF I +V ++M SDL +V+ LT
Sbjct: 66 TTLRELKIMNEIKHENIMGLVDVYV---EGDF--INLVMDIMASDLKKVVDRKIRLTESQ 120
Query: 123 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND-------- 174
+ L Q+L L +H HRDL P NI N+ KI DFGLAR
Sbjct: 121 VKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 175 ---TPTTIFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 230
T V T WYRAPEL G+ KY A+D+WS+GCIFAE+LTGKPLFPG+N
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGA--EKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238
Query: 231 VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLER 290
+ QL + +LLGTP+ D + + T ++P FPNA A+ LL+
Sbjct: 239 EIDQLGRIFELLGTPNEDNWPQAKKLPL---YTEFTPRKPKDLKTIFPNASDDAIDLLQS 295
Query: 291 LLAFDPKDRPTAEEALADPYFK 312
LL +P +R +A+EAL YFK
Sbjct: 296 LLKLNPLERISAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 3e-65
Identities = 110/306 (35%), Positives = 160/306 (52%), Gaps = 33/306 (10%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA---ARILREIKLLRLLR- 75
Y+ IG+G+YG V A D +TG VA+KK+ +S+ LREI LL+ L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR---VPLSEEGIPLSTLREIALLKQLES 57
Query: 76 --HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIK--ANDDLTREHYQFFLYQLL 131
HP+IV + + P + +VFE ++ DL + L E + + QLL
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 132 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV-AFNDTPTTIFWTDYVATRWY 190
R + ++H+ + HRDLKP+NIL ++ ++KI DFGLAR+ +F T++ V T WY
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSV-----VVTLWY 172
Query: 191 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD- 248
RAPE L S Y +D+WS+GCIFAE+ +PLF G + QLD + D++G PS +
Sbjct: 173 RAPEVLLQ---SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229
Query: 249 ---TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 305
+S R +S P F P L LL+++L F+P R +A EA
Sbjct: 230 WPRNVSLPR--------SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEA 281
Query: 306 LADPYF 311
L PYF
Sbjct: 282 LQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 212 bits (541), Expect = 9e-64
Identities = 120/326 (36%), Positives = 168/326 (51%), Gaps = 43/326 (13%)
Query: 19 RYKIQEVIGKGSYGVVCSAI--DTHTGEKVAIKKIHDIFEH---ISDAARILREIKLLRL 73
+Y+I+ IG+G+YG V A + G++ AIKK E IS +A REI LLR
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSA--CREIALLRE 58
Query: 74 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFF-----LY 128
L+H ++V + + L + K +Y++F+ E DL Q+IK + R L+
Sbjct: 59 LKHENVVSLVEVFLEHAD---KSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 129 QLLRALKYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTTIFWTD- 183
Q+L + Y+H+ V HRDLKP NIL +KI D GLAR+ FN + D
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL-FNAPLKPLADLDP 174
Query: 184 YVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV---------VH 233
V T WYRAPEL G+ YT AIDIW+IGCIFAE+LT +P+F G+
Sbjct: 175 VVVTIWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD 232
Query: 234 QLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFS--------QKFPNADPSAL 285
QL+ + ++LGTP+ ++ K Y T M+ + + +K D
Sbjct: 233 QLERIFEVLGTPTEKDWPDIK--KMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGF 290
Query: 286 RLLERLLAFDPKDRPTAEEALADPYF 311
LL +LL +DP R TAEEAL PYF
Sbjct: 291 DLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 211 bits (538), Expect = 1e-63
Identities = 116/301 (38%), Positives = 172/301 (57%), Gaps = 24/301 (7%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE--HISDAARILREIKLLRLLRH 76
+Y+ IG+GSYGVV + TG+ VAIKK + + I A LREI++L+ L+H
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA--LREIRMLKQLKH 59
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALK 135
P++V + + RR K +++VFE + + L+++ K + + ++Q L+A+
Sbjct: 60 PNLVNLIEVF----RRKRK-LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVN 114
Query: 136 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 195
+ H N HRD+KP+NIL ++K+CDFG AR+ T +TDYVATRWYRAPEL
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL---TGPGDDYTDYVATRWYRAPEL 171
Query: 196 -CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254
G ++Y P +D+W+IGC+FAE+LTG+PL+PGK+ V QL L+ LG D I R +
Sbjct: 172 LVGD--TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG----DLIPRHQ 225
Query: 255 ND-KARRYLTSMRKKQP---VQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 310
++ + +P KFPN AL L+ L DP +R + EE L PY
Sbjct: 226 QIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
Query: 311 F 311
F
Sbjct: 286 F 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 207 bits (529), Expect = 3e-62
Identities = 113/292 (38%), Positives = 166/292 (56%), Gaps = 16/292 (5%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 83
E IG+G+YGVV + TG+ VA+KKI E + +REI LL+ L+HP+IV ++
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 84 HIMLPPSRRDFKDIYVVFELMESDLHQ---VIKANDDLTREHYQFFLYQLLRALKYIHTA 140
+++ SR +Y++FE + DL + + + E + +LYQ+L+ + + H+
Sbjct: 66 DVLMQESR-----LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 141 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSF 199
V HRDLKP+N+L + +K+ DFGLAR AF P ++ T V T WYRAPE L GS
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFG-IPVRVY-THEVVTLWYRAPEVLLGS- 176
Query: 200 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKAR 259
+Y+ +DIWSIG IFAE+ T KPLF G + + QL + +LGTP+ D V
Sbjct: 177 -PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV--TSLP 233
Query: 260 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311
Y + K + N D L LLE++L +DP R +A++AL PYF
Sbjct: 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 205 bits (523), Expect = 1e-61
Identities = 114/301 (37%), Positives = 171/301 (56%), Gaps = 25/301 (8%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRH 76
+Y+ E IG+G+YG V A + T E VA+K++ D E + +A LREI LL+ L+H
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKELKH 58
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALK 135
+IV + ++ + + +VFE + DL + + N D+ E + F++QLL+ L
Sbjct: 59 KNIVRLYDVLHSDKK-----LTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113
Query: 136 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE- 194
+ H+ NV HRDLKP+N+L N N +LK+ DFGLAR AF P + + V T WYR P+
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR-AFG-IPVRCYSAE-VVTLWYRPPDV 170
Query: 195 LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT---I 250
L G+ Y+ +ID+WS GCIFAE+ G+PLFPG +V QL + LLGTP+ ++ +
Sbjct: 171 LFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV 228
Query: 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 310
S++ + K + P + + LL+ LL +P R +AEEAL PY
Sbjct: 229 SKLPDYKPYPMYPAT-----TSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
Query: 311 F 311
F
Sbjct: 284 F 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 207 bits (527), Expect = 2e-61
Identities = 127/366 (34%), Positives = 207/366 (56%), Gaps = 35/366 (9%)
Query: 9 EFFS-EYGDAS-----RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 62
+F+S E GD++ RY+ + IG G+ G+VC+A D VAIKK+ F++ + A
Sbjct: 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 63 RILREIKLLRLLRHPDIVEIKHIMLP-PSRRDFKDIYVVFELMESDLHQVIKANDDLTRE 121
R RE+ L++ + H +I+ + ++ P S +F+D+Y+V ELM+++L QVI+ +L E
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM--ELDHE 119
Query: 122 HYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 181
+ LYQ+L +K++H+A + HRDLKP NI+ ++C LKI DFGLAR A T+
Sbjct: 120 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMM 175
Query: 182 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 241
T YV TR+YRAPE+ Y +DIWS+GCI E++ K LFPG++ + Q + + +
Sbjct: 176 TPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233
Query: 242 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNA------------DPSALRLLE 289
LGTP + + +++ R Y+ + K + F + FP++ A LL
Sbjct: 234 LGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 292
Query: 290 RLLAFDPKDRPTAEEALADPYFKGLSKVEREPS---CQPISKMEFEFERRRVTKEDIREL 346
++L DP R + +EAL PY V +P+ P + + + R T E+ +EL
Sbjct: 293 KMLVIDPAKRISVDEALQHPYI----NVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKEL 348
Query: 347 IFREIL 352
I++E++
Sbjct: 349 IYKEVM 354
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 207 bits (528), Expect = 3e-61
Identities = 130/376 (34%), Positives = 209/376 (55%), Gaps = 35/376 (9%)
Query: 1 MLQNSPEMEFFS-EYGDAS-----RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI 54
M ++ + F+S E GD++ RY+ + IG G+ G+VC+A D VAIKK+
Sbjct: 1 MSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 60
Query: 55 FEHISDAARILREIKLLRLLRHPDIVEIKHIMLP-PSRRDFKDIYVVFELMESDLHQVIK 113
F++ + A R RE+ L++ + H +I+ + ++ P S +F+D+Y+V ELM+++L QVI+
Sbjct: 61 FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ 120
Query: 114 ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173
+L E + LYQ+L +K++H+A + HRDLKP NI+ ++C LKI DFGLAR A
Sbjct: 121 M--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-- 176
Query: 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH 233
T+ T YV TR+YRAPE+ Y +DIWS+GCI E++ G LFPG + +
Sbjct: 177 --GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHID 232
Query: 234 QLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPN----AD-------- 281
Q + + + LGTP + + +++ R Y+ + K F + FP+ AD
Sbjct: 233 QWNKVIEQLGTPCPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKA 291
Query: 282 PSALRLLERLLAFDPKDRPTAEEALADPYFK---GLSKVEREPSCQPISKMEFEFERRRV 338
A LL ++L D R + +EAL PY S+ E P P + + + R
Sbjct: 292 SQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIP----DKQLDEREH 347
Query: 339 TKEDIRELIFREILEY 354
T E+ +ELI++E+++
Sbjct: 348 TIEEWKELIYKEVMDL 363
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 4e-61
Identities = 115/291 (39%), Positives = 163/291 (56%), Gaps = 15/291 (5%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 83
E IG+G+YGVV A + TGE VA+KKI E + +REI LL+ L HP+IV++
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 84 HIMLPPSRRDFKDIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTAN 141
++ +Y+VFE + DL + + A+ + + +L+QLL+ L + H+
Sbjct: 66 DVI-----HTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 142 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFF 200
V HRDLKP+N+L N +K+ DFGLAR AF T +T V T WYRAPE L G +
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT--YTHEVVTLWYRAPEILLGCKY 177
Query: 201 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260
Y+ A+DIWS+GCIFAE++T + LFPG + + QL + LGTP V +
Sbjct: 178 --YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP--D 233
Query: 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311
Y S K FS+ P D LL ++L +DP R +A+ ALA P+F
Sbjct: 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 3e-60
Identities = 117/300 (39%), Positives = 172/300 (57%), Gaps = 16/300 (5%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
+Y+ E IG+G+YGVV A D T E +A+KKI E + +REI LL+ ++H +
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY--QFFLYQLLRALKY 136
IV ++ ++ R +Y+VFE ++ DL + + ++ D + + +LYQ+LR + Y
Sbjct: 63 IVRLQDVVHSEKR-----LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117
Query: 137 IHTANVYHRDLKPKNILAN-ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE- 194
H+ V HRDLKP+N+L + LK+ DFGLAR AF P F T V T WYRAPE
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFG-IPVRTF-THEVVTLWYRAPEI 174
Query: 195 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254
L GS Y+ +DIWS+GCIFAE++ KPLFPG + + +L + +LGTP+ +T V
Sbjct: 175 LLGS--RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232
Query: 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314
+ Y ++ K P + P +P+ + LL ++L DP R TA AL YFK L
Sbjct: 233 S--LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290
|
Length = 294 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 2e-59
Identities = 112/302 (37%), Positives = 164/302 (54%), Gaps = 20/302 (6%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRHP 77
+ I IG+G+YG V A D TGE VA+KK+ ++ + I +REIK+LR L H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVR--LDNEKEGFPITAIREIKILRQLNHR 66
Query: 78 DIVEIKHIMLPPS-----RRDFKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLL 131
+IV +K I+ ++D Y+VFE M+ DL ++++ + +H + F+ QLL
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL 126
Query: 132 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 191
L Y H N HRD+K NIL N ++K+ DFGLAR+ ++ +T+ V T WYR
Sbjct: 127 EGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP--YTNKVITLWYR 184
Query: 192 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250
PE L G +Y PAID+WS GCI E+ T KP+F + QL+L++ L G+P
Sbjct: 185 PPELLLGE--ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242
Query: 251 SRVRNDKARRYLTSMRKKQPVQ--FSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308
V Y +M+ K+ + ++F AL LL+ +L DP R TAEEAL
Sbjct: 243 PDVIK---LPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299
Query: 309 PY 310
P+
Sbjct: 300 PW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 3e-59
Identities = 112/305 (36%), Positives = 166/305 (54%), Gaps = 21/305 (6%)
Query: 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA-RILREIKLLR 72
+G YK + +G+GSY V TG+ VA+K+I EH A +RE LL+
Sbjct: 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIR--LEHEEGAPFTAIREASLLK 58
Query: 73 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVI-KANDDLTREHYQFFLYQLL 131
L+H +IV + I+ K + +VFE +++DL Q + L+ + + FL+QLL
Sbjct: 59 DLKHANIVTLHDII-----HTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLL 113
Query: 132 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 191
R L Y H V HRDLKP+N+L + +LK+ DFGLAR + T +++ V T WYR
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT---YSNEVVTLWYR 170
Query: 192 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KNVVHQLDLMTDLLGTPSLDT 249
P+ L GS ++Y+ ++D+W +GCIF E+ TG+PLFPG +V QL + +LGTP+ +T
Sbjct: 171 PPDVLLGS--TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEET 228
Query: 250 ISRV-RNDKARRYLTSMRKKQPVQFSQKFPNAD--PSALRLLERLLAFDPKDRPTAEEAL 306
V N + + Y S P P D P L + L ++PK R +A EA+
Sbjct: 229 WPGVSSNPEFKPY--SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM 286
Query: 307 ADPYF 311
PYF
Sbjct: 287 KHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 8e-59
Identities = 113/310 (36%), Positives = 178/310 (57%), Gaps = 42/310 (13%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI-LREIKLLRLLRHP 77
+Y+ ++G+GSYG+V TG+ VAIKK + E +I +REI++L+ LRH
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLE-SEDDKMVKKIAMREIRMLKQLRHE 60
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY---------QFFLY 128
++V ++ RR K +Y+VFE ++ H V+ DDL E Y + +L+
Sbjct: 61 NLVN----LIEVFRRK-KRLYLVFEFVD---HTVL---DDL--EKYPNGLDESRVRKYLF 107
Query: 129 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 188
Q+LR +++ H+ N+ HRD+KP+NIL + + +K+CDFG AR P ++ TDYVATR
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVY-TDYVATR 164
Query: 189 WYRAPEL-CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247
WYRAPEL G +KY A+DIW++GC+ E+LTG+PLFPG + + QL + LG
Sbjct: 165 WYRAPELLVGD--TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGN--- 219
Query: 248 DTISRVRN--DKARRY----LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT 301
I R + K + L +++ +P++ ++FP L L ++ L DP DRP+
Sbjct: 220 -LIPRHQEIFQKNPLFAGMRLPEVKEIEPLE--KRFPKLSGLVLDLAKQCLRIDPDDRPS 276
Query: 302 AEEALADPYF 311
+ + L +F
Sbjct: 277 SSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 196 bits (499), Expect = 1e-57
Identities = 110/315 (34%), Positives = 156/315 (49%), Gaps = 33/315 (10%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRL 73
+ S+Y+ IG+G++G V A T + VA+KK+ + E+ + I LREIK+L+L
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALREIKILQL 67
Query: 74 LRHPDIV---EIKHIMLPPSRRDFKDIYVVFELMESDLHQVIK-ANDDLTREHYQFFLYQ 129
L+H ++V EI P R Y+VFE E DL ++ N T + +
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 130 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV---AFNDTPTTIFWTDYVA 186
LL L YIH + HRD+K NIL + LK+ DFGLAR + N P +T+ V
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR--YTNRVV 185
Query: 187 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG-- 243
T WYR PE L G Y P ID+W GCI AE+ T P+ G HQL L++ L G
Sbjct: 186 TLWYRPPELLLGE--RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243
Query: 244 TPS-------LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDP 296
TP L+ ++ + ++ R K V+ DP AL L+++LL DP
Sbjct: 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVK--------DPHALDLIDKLLVLDP 295
Query: 297 KDRPTAEEALADPYF 311
R A+ AL +F
Sbjct: 296 AKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 1e-57
Identities = 112/300 (37%), Positives = 163/300 (54%), Gaps = 16/300 (5%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH-PD 78
Y+ E IG+G+YG V A D +TG+ VA+KK + LREI LL++L
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN-----DDLTREHYQFFLYQLLRA 133
IV + + + +Y+VFE ++SDL + + +N L + + F+YQLL+
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 134 LKYIHTANVYHRDLKPKNILAN-ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 192
+ + H V HRDLKP+N+L + LKI D GL R AF+ P + T + T WYRA
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFS-IPVKSY-THEIVTLWYRA 179
Query: 193 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251
PE L GS + Y+ +DIWS+GCIFAE+ +PLFPG + + QL + LLGTP+
Sbjct: 180 PEVLLGS--THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237
Query: 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311
V R + +P S+ P+ P L LL+++L +DP R +A+ AL PYF
Sbjct: 238 GVSK---LRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 183 bits (465), Expect = 6e-53
Identities = 115/305 (37%), Positives = 166/305 (54%), Gaps = 18/305 (5%)
Query: 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA-ARILREIKLLR 72
+G Y E +G+G+Y V T VA+K+I EH A +RE+ LL+
Sbjct: 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLK 59
Query: 73 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH-YQFFLYQLL 131
L+H +IV + I+ K + +VFE ++ DL Q + ++ H + FLYQ+L
Sbjct: 60 DLKHANIVTLHDIV-----HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQIL 114
Query: 132 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 191
R L Y H V HRDLKP+N+L N +LK+ DFGLAR T T +++ V T WYR
Sbjct: 115 RGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT---YSNEVVTLWYR 171
Query: 192 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250
P+ L GS S+Y+ ID+W +GCIF E+ +G+PLFPG V +L L+ LLGTP+ +T
Sbjct: 172 PPDVLLGS--SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229
Query: 251 SRV-RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 309
+ ND+ + Y K QP P D + LL + L ++ K R +AEEA+
Sbjct: 230 PGISSNDEFKNYNFPKYKPQP--LINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287
Query: 310 YFKGL 314
YF+ L
Sbjct: 288 YFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 3e-52
Identities = 111/302 (36%), Positives = 165/302 (54%), Gaps = 18/302 (5%)
Query: 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA-ARILREIKLLR 72
+G Y + +G+G+Y V T VA+K+I EH A +RE+ LL+
Sbjct: 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLK 58
Query: 73 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH-YQFFLYQLL 131
L+H +IV + I+ + + +VFE ++SDL Q + +L H + F++QLL
Sbjct: 59 NLKHANIVTLHDII-----HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLL 113
Query: 132 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 191
R L Y H + HRDLKP+N+L N +LK+ DFGLAR T T +++ V T WYR
Sbjct: 114 RGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT---YSNEVVTLWYR 170
Query: 192 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250
P+ L GS ++Y+ ID+W +GCI E+ TG+P+FPG V +L L+ LLGTP+ +T
Sbjct: 171 PPDVLLGS--TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW 228
Query: 251 SRV-RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 309
+ N++ R YL + QP+ P D + LL LL ++ K R +AE AL
Sbjct: 229 PGITSNEEFRSYLFPQYRAQPLI--NHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHS 286
Query: 310 YF 311
YF
Sbjct: 287 YF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 3e-52
Identities = 78/294 (26%), Positives = 129/294 (43%), Gaps = 35/294 (11%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
+ E++G+GS+G V A+D TGE +A+K + + + + REI++L L+HP+
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 137
IV + + + E + L ++K L + + Q+L L Y+
Sbjct: 61 IVRYYGSER---DEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL 117
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
H+ + HRD+K NIL +++ +K+ DFG A+ D T T ++ APE+
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFGCAKR-LGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257
+Y A DIWS+GC E+ TGKP + + + + + + + I
Sbjct: 177 G--EEYGRAADIWSLGCTVIEMATGKPPWS--ELGNPMAALYKIGSSGEPPEI------- 225
Query: 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311
P S A L + L DPK RPTA+E L P+
Sbjct: 226 ------------PEHLS-------EEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 6e-52
Identities = 111/307 (36%), Positives = 163/307 (53%), Gaps = 18/307 (5%)
Query: 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA-ARILREIKLLR 72
+G Y + +G+G+Y V T VA+K+I EH A +RE+ LL+
Sbjct: 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLK 59
Query: 73 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH-YQFFLYQLL 131
L+H +IV + I+ K + +VFE ++ DL Q + + H + FL+QLL
Sbjct: 60 DLKHANIVTLHDII-----HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLL 114
Query: 132 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 191
R L Y H V HRDLKP+N+L N +LK+ DFGLAR T T +++ V T WYR
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT---YSNEVVTLWYR 171
Query: 192 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250
P+ L GS + Y+ ID+W +GCIF E+ TG+PLFPG V QL + +LGTP+ +T
Sbjct: 172 PPDILLGS--TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW 229
Query: 251 SRV-RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 309
+ N++ + Y + + P D LL +LL F+ + R +AEEA+ P
Sbjct: 230 PGILSNEEFKSYNYPKYRADCLH--NHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287
Query: 310 YFKGLSK 316
YF L +
Sbjct: 288 YFHCLGE 294
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 6e-50
Identities = 71/196 (36%), Positives = 107/196 (54%), Gaps = 13/196 (6%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 85
+G+G +G V A D TG+KVAIK I + S +LREI++L+ L HP+IV++ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII-KKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 86 MLPPSRRDFKDIYVVFELMES-DLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVY 143
D +Y+V E E L ++K N+ L+ + L Q+L L+Y+H+ +
Sbjct: 60 FE-----DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114
Query: 144 HRDLKPKNIL-ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 202
HRDLKP+NIL + N K+K+ DFGL+++ +D V T Y APE+
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL---KTIVGTPAYMAPEVL-LGKGY 170
Query: 203 YTPAIDIWSIGCIFAE 218
Y+ DIWS+G I E
Sbjct: 171 YSEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 174 bits (440), Expect = 1e-48
Identities = 88/352 (25%), Positives = 140/352 (39%), Gaps = 35/352 (9%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA-RILREIKLLRLLRHPD 78
Y+I +G+GS+G V A D + VA+K + E S R LREI++L L HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 79 -IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD---LTREHYQFFLYQLLRAL 134
IV++ V+ + L ++K L+ F L Q+L AL
Sbjct: 59 NIVKLYDFFQDEGS----LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 135 KYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARVAFNDT---PTTIFWTDYVATRWY 190
+Y+H+ + HRD+KP+NIL + + +K+ DFGLA++ + + V T Y
Sbjct: 115 EYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 191 RAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 249
APE+ G + + + DIWS+G E+LTG P F G+ T
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS-----------QT 223
Query: 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 309
+ + + + P +A LL++LLA DPK+R ++ L+
Sbjct: 224 LKIILELPTPSLASPLSPSNP-------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
Query: 310 YFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKD 361
L E + S + + L D
Sbjct: 277 LLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLD 328
|
Length = 384 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 170 bits (431), Expect = 3e-48
Identities = 101/296 (34%), Positives = 166/296 (56%), Gaps = 11/296 (3%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
+++++ V+G+G+YGVV T E VAIKK D E+ LRE+K+LR L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKY 136
+IVE+K RR K +Y+VFE +E ++ ++++ + + E + ++YQL++A+ +
Sbjct: 61 NIVELKEAF----RRRGK-LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 196
H ++ HRD+KP+N+L + N LK+CDFG AR + +T+YVATRWYR+PEL
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN--YTEYVATRWYRSPELL 173
Query: 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256
+ Y A+D+WS+GCI E+ G+PLFPG++ + QL + +LG + + ++
Sbjct: 174 --LGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231
Query: 257 KARRYLTSMRKKQPVQFSQKFPNADPSA-LRLLERLLAFDPKDRPTAEEALADPYF 311
L P +++ L L++ LL +P DR E+ L P F
Sbjct: 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 174 bits (441), Expect = 4e-48
Identities = 113/337 (33%), Positives = 179/337 (53%), Gaps = 29/337 (8%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 79
YK+ +IG GS+GVV AI T EKVAIKK+ + D RE+ +++ L H +I
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV------LQDPQYKNRELLIMKNLNHINI 121
Query: 80 VEIKHIMLPPS-RRDFKDIY--VVFELMESDLHQVIK----ANDDLTREHYQFFLYQLLR 132
+ +K +++ K+I+ VV E + +H+ +K N L + + YQL R
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCR 181
Query: 133 ALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 191
AL YIH+ + HRDLKP+N+L + N LK+CDFG A+ + Y+ +R+YR
Sbjct: 182 ALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV----SYICSRFYR 237
Query: 192 APEL-CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250
APEL G+ + YT ID+WS+GCI AE++ G P+F G++ V QL + +LGTP+ D +
Sbjct: 238 APELMLGA--TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295
Query: 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADP-SALRLLERLLAFDPKDRPTAEEALADP 309
+ + A ++ K + FP P A+ + + L ++P R EALADP
Sbjct: 296 KEMNPNYADIKFPDVKPK---DLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352
Query: 310 YFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIREL 346
+F L R+P + ++ + +I+E+
Sbjct: 353 FFDDL----RDPCIKLPKYIDKLPDLFNFCDAEIKEM 385
|
Length = 440 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 167 bits (423), Expect = 5e-47
Identities = 115/305 (37%), Positives = 170/305 (55%), Gaps = 21/305 (6%)
Query: 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLR 72
+G A+ Y E +G+GSY V I G+ VA+K I E + A +RE LL+
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTA--IREASLLK 58
Query: 73 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQ-VIKANDDLTREHYQFFLYQLL 131
L+H +IV + I+ F VFE M +DL Q +I+ L + + F++QLL
Sbjct: 59 GLKHANIVLLHDIIHTKETLTF-----VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLL 113
Query: 132 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 191
R L YIH ++ HRDLKP+N+L + +LK+ DFGLAR P+ + ++ V T WYR
Sbjct: 114 RGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARA--KSIPSQTYSSE-VVTLWYR 170
Query: 192 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KNVVHQLDLMTDLLGTPSLDT 249
P+ L G+ + Y+ A+DIW GCIF E+L G+P FPG +V QL+ + +LG P+ DT
Sbjct: 171 PPDVLLGA--TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDT 228
Query: 250 ---ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 306
+S++ N K +L K Q ++ K + P A L ++L PKDR +A++AL
Sbjct: 229 WPGVSKLPNYKPEWFLPC--KPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286
Query: 307 ADPYF 311
PYF
Sbjct: 287 LHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 164 bits (419), Expect = 1e-46
Identities = 89/304 (29%), Positives = 140/304 (46%), Gaps = 57/304 (18%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHP 77
+Y+I + IGKGS+G V G+ +K+I D+ + L E+K+L+ L HP
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEI-DLSNMSEKEREDALNEVKILKKLNHP 59
Query: 78 DIVEIKHIMLPPSRRDFKD---IYVVFELMES-DLHQVIKANDDLTREHYQ-----FFLY 128
+I IK+ F++ + +V E + DL Q IK + + +
Sbjct: 60 NI--IKYYE------SFEEKGKLCIVMEYADGGDLSQKIK-KQKKEGKPFPEEQILDWFV 110
Query: 129 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 188
QL ALKY+H+ + HRD+KP+NI +N +K+ DFG+++V + T V T
Sbjct: 111 QLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSS--TVDLAKTVVGTP 167
Query: 189 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL-GTPSL 247
+Y +PELC + Y DIWS+GC+ E+ T K F G+N L+L +L G
Sbjct: 168 YYLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALKILKGQY-- 220
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
P Q+S + N L+ LL DP++RP+ + L
Sbjct: 221 -------------------PPIPSQYSSELRN-------LVSSLLQKDPEERPSIAQILQ 254
Query: 308 DPYF 311
P+
Sbjct: 255 SPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 1e-43
Identities = 93/306 (30%), Positives = 143/306 (46%), Gaps = 58/306 (18%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRHP 77
Y++ E IGKGS+G V G+ + K+I + ++++ + ++ E+ +LR L+HP
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEID--YGNMTEKEKQQLVSEVNILRELKHP 59
Query: 78 DIVE-IKHIMLPPSRRDFKDIYVVFELMES-DLHQVI---KANDDLTREHY--QFFLYQL 130
+IV I+ ++ +Y+V E E DL Q+I K E + + QL
Sbjct: 60 NIVRYYDRIIDRSNQT----LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT-QL 114
Query: 131 LRALKYIHTAN-----VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYV 185
L AL H + V HRDLKP NI +AN +K+ DFGLA++ +D + F YV
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD---SSFAKTYV 171
Query: 186 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 245
T +Y +PE Y DIWS+GC+ E+ P F +N QL L
Sbjct: 172 GTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQL-------- 218
Query: 246 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPTAEE 304
S+++ K RR P ++S S L +++ +L DP RP+ EE
Sbjct: 219 ----ASKIKEGKFRRI--------PYRYS--------SELNEVIKSMLNVDPDKRPSTEE 258
Query: 305 ALADPY 310
L P
Sbjct: 259 LLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 4e-43
Identities = 82/293 (27%), Positives = 136/293 (46%), Gaps = 43/293 (14%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 79
++I E IGKG +G V A TG++VAIK I E +I+ EI++L+ +HP+I
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK--LESKEKKEKIINEIQILKKCKHPNI 59
Query: 80 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQLLRALKYI 137
V+ L +++V E L ++K+ + LT + +LL+ L+Y+
Sbjct: 60 VKYYGSYLKKDE-----LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYL 114
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
H+ + HRD+K NIL ++ ++K+ DFGL+ +DT V T ++ APE+
Sbjct: 115 HSNGIIHRDIKAANILLTSDGEVKLIDFGLS-AQLSDTKARNTM---VGTPYWMAPEVI- 169
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257
Y DIWS+G E+ GKP + +L M L +
Sbjct: 170 -NGKPYDYKADIWSLGITAIELAEGKPPY------SELPPMKALFKIATNGP-------- 214
Query: 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 310
+ P ++S +F + L++ L +P+ RPTAE+ L P+
Sbjct: 215 -------PGLRNPEKWSDEFKD-------FLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 4e-42
Identities = 106/299 (35%), Positives = 152/299 (50%), Gaps = 17/299 (5%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR--- 75
+Y+ IG G+YG V A D H+G VA+K + +RE+ LL+ L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 76 HPDIVEIKHIMLPPSRRDFK-DIYVVFELMESDLHQVIKA--NDDLTREHYQFFLYQLLR 132
HP+IV + + SR D + + +VFE ++ DL + L E + + Q LR
Sbjct: 61 HPNIVRLMDV-CATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 192
L ++H + HRDLKP+NIL + ++K+ DFGLAR+ + T V T WYRA
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI----YSCQMALTPVVVTLWYRA 175
Query: 193 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252
PE+ S Y +D+WS+GCIFAE+ KPLF G + QL + DL+G P D
Sbjct: 176 PEVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP- 232
Query: 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311
R+ R S R +PVQ P + S +LL +L F+P R +A AL P+F
Sbjct: 233 -RDVTLPRGAFSPRGPRPVQ--SVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 7e-42
Identities = 90/298 (30%), Positives = 139/298 (46%), Gaps = 49/298 (16%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI--HDIFEHISDAARILREIKLLRLLRH 76
Y++ ++IG+G++GVV ++ TG+ VAIK+I I E I++EI LL+ L+H
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE--EALKSIMQEIDLLKNLKH 58
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALK 135
P+IV K+I S +Y++ E E+ L Q+IK ++YQ+L+ L
Sbjct: 59 PNIV--KYI---GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLA 113
Query: 136 YIHTANVYHRDLKPKNILANANCKLKICDFGLA-RVAFNDTPTTIFWTDYVATRWYRAPE 194
Y+H V HRD+K NIL + +K+ DFG+A ++ V T ++ APE
Sbjct: 114 YLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD----ASVVGTPYWMAPE 169
Query: 195 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254
+ S + A DIWS+GC E+LTG P + DL +L I V+
Sbjct: 170 VIE--MSGASTASDIWSLGCTVIELLTGNPPY------------YDLNPMAALFRI--VQ 213
Query: 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPTAEEALADPYF 311
+D P L+ L + DP RPTA++ L P+
Sbjct: 214 DDHPP-----------------LPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 9e-41
Identities = 102/301 (33%), Positives = 157/301 (52%), Gaps = 20/301 (6%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEK-VAIKKIHDIFEHISDAARILREIKLLRLLR-- 75
+Y+ IG+G+YG V A D G + VA+K++ +RE+ +LR L
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 76 -HPDIVEIKHIMLPPSRRDFK-DIYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLL 131
HP++V + + SR D + + +VFE ++ DL + + + E + ++QLL
Sbjct: 62 EHPNVVRLFDV-CTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 132 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 191
R L ++H+ V HRDLKP+NIL ++ ++K+ DFGLAR+ T V T WYR
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV----VVTLWYR 176
Query: 192 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251
APE+ S Y +D+WS+GCIFAE+ KPLF G + V QL + D++G P +
Sbjct: 177 APEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234
Query: 252 RVRNDKA-RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 310
D A R + QP++ + + D LL + L F+P R +A AL+ PY
Sbjct: 235 ---RDVALPRQAFHSKSAQPIE--KFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
Query: 311 F 311
F
Sbjct: 290 F 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 9e-41
Identities = 109/307 (35%), Positives = 166/307 (54%), Gaps = 19/307 (6%)
Query: 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRL 73
+G A Y+ E +G+GSY V G+ VA+K I + E +RE LL+
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIR-LQEEEGTPFTAIREASLLKG 59
Query: 74 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVI-KANDDLTREHYQFFLYQLLR 132
L+H +IV + I+ + + +VFE + +DL Q + K L E+ + FL+QLLR
Sbjct: 60 LKHANIVLLHDII-----HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR 114
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 192
L YIH + HRDLKP+N+L + +LK+ DFGLAR P+ + ++ V T WYR
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTY-SNEVVTLWYRP 171
Query: 193 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KNVVHQLDLMTDLLGTPSLDT- 249
P+ L GS ++Y+ +D+W +GCIF E++ G FPG K++ QL+ + +LGTP+ DT
Sbjct: 172 PDVLLGS--TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW 229
Query: 250 --ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
+ + + K R+ T K Q K + A L +LL PK+R +A+ AL+
Sbjct: 230 PGVHSLPHFKPERF-TLYSPKNLRQAWNKLSYVN-HAEDLASKLLQCFPKNRLSAQAALS 287
Query: 308 DPYFKGL 314
YF L
Sbjct: 288 HEYFSDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 85/300 (28%), Positives = 138/300 (46%), Gaps = 53/300 (17%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRHP 77
YK E IG+G+ G V A D TG++VAIKK+ + + I+ EI +++ +HP
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR-----LRKQNKELIINEILIMKDCKHP 75
Query: 78 DIVE-IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND-DLTREHYQFFLYQLLRAL 134
+IV+ S +++VV E M+ L +I N + + ++L+ L
Sbjct: 76 NIVDYYD------SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGL 129
Query: 135 KYIHTANVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTDYVATRWYRA 192
+Y+H+ NV HRD+K NIL + + +K+ DFG A ++ V T ++ A
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV-----VGTPYWMA 184
Query: 193 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252
PE+ Y P +DIWS+G + E+ G+P + + + L L+T G P L +
Sbjct: 185 PEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIPPLKNPEK 241
Query: 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312
+S +F L + L DP+ RP+AEE L P+ K
Sbjct: 242 --------------------WSPEF-------KDFLNKCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 7e-39
Identities = 79/292 (27%), Positives = 133/292 (45%), Gaps = 48/292 (16%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHPDIVEIK 83
+GKGS+G V TG+ A+K + I + + L E +L + HP IV++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR-KEVEHTLTERNILSRINHPFIVKLH 59
Query: 84 HIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV 142
+ + + + +Y+V E +L + + E +F+ +++ AL+Y+H+ +
Sbjct: 60 Y-----AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGI 114
Query: 143 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 202
+RDLKP+NIL +A+ +K+ DFGLA+ ++ T + T Y APE+
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT---NTFCGTPEYLAPEVLLG--KG 169
Query: 203 YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYL 262
Y A+D WS+G + E+LTGKP F ++ + + +
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKI-------------------- 205
Query: 263 TSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT---AEEALADPYF 311
K P++F + P A L+ LL DP R AEE A P+F
Sbjct: 206 ----LKDPLRFPEFL---SPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 144 bits (363), Expect = 2e-38
Identities = 113/319 (35%), Positives = 162/319 (50%), Gaps = 43/319 (13%)
Query: 26 IGKGSYGVVCSA--IDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 83
+G+G+YG V A D ++ A+K+I E + REI LLR L+HP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIALQ 64
Query: 84 HIMLPPSRRDFKDIYVVFELMESDL------HQVIKAND---DLTREHYQFFLYQLLRAL 134
+ L S R ++++F+ E DL H+ KAN L R + LYQ+L +
Sbjct: 65 KVFLSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 135 KYIHTANVYHRDLKPKNILANANC----KLKICDFGLARVAFNDTPTTIFWTD-YVATRW 189
Y+H V HRDLKP NIL ++KI D G AR+ FN + D V T W
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL-FNSPLKPLADLDPVVVTFW 180
Query: 190 YRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-------NVVH--QLDLMT 239
YRAPEL G+ YT AIDIW+IGCIFAE+LT +P+F + N H QLD +
Sbjct: 181 YRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238
Query: 240 DLLGTPSLDTISRVRNDKARRYL------TSMRKKQPVQFSQKFP-NADPSALRLLERLL 292
++G P+ +R L T+ +++ +K D LL++LL
Sbjct: 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLL 298
Query: 293 AFDPKDRPTAEEALADPYF 311
DP R T+E+AL DPYF
Sbjct: 299 TMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 2e-38
Identities = 80/301 (26%), Positives = 129/301 (42%), Gaps = 67/301 (22%)
Query: 21 KIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDI--FEHISDAARILREIKLLRLL 74
+ + +G+G++G V +VA+K + + + I + LRE +++R L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEE---FLREARIMRKL 58
Query: 75 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQLLR 132
HP++V++ + +Y+V E ME DL ++ N L+ F Q+ R
Sbjct: 59 DHPNVVKLLGVCTEEEP-----LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIAR 113
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT----- 187
++Y+ + N HRDL +N L N +KI DFGL+R ++D DY
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--------DYYRKRGGKL 165
Query: 188 --RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLG 243
RW APE S K+T D+WS G + E+ T G+ +PG +
Sbjct: 166 PIRWM-APE---SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE----------- 210
Query: 244 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE 303
+ + ++N R QP PN P L+ + A DP+DRPT
Sbjct: 211 ----EVLEYLKNGY--------RLPQP-------PNCPPELYDLMLQCWAEDPEDRPTFS 251
Query: 304 E 304
E
Sbjct: 252 E 252
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 113/321 (35%), Positives = 164/321 (51%), Gaps = 47/321 (14%)
Query: 26 IGKGSYGVVCSAI--DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 83
+G+G+YG V A D A+K+I E + REI LLR L+HP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 64
Query: 84 HIMLPPSRRDFKDIYVVFELMESDL------HQVIKAND---DLTREHYQFFLYQLLRAL 134
+ L + R ++++F+ E DL H+ KAN L R + LYQ+L +
Sbjct: 65 KVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 135 KYIHTANVYHRDLKPKNILANANC----KLKICDFGLARVAFNDTPTTIFWTD-YVATRW 189
Y+H V HRDLKP NIL ++KI D G AR+ FN + D V T W
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL-FNSPLKPLADLDPVVVTFW 180
Query: 190 YRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-------NVVH--QLDLMT 239
YRAPEL G+ YT AIDIW+IGCIFAE+LT +P+F + N H QLD +
Sbjct: 181 YRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238
Query: 240 DLLGTPS---------LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLER 290
+++G P+ + S + D R T+ + ++ + P D A LL++
Sbjct: 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP--DSKAFHLLQK 296
Query: 291 LLAFDPKDRPTAEEALADPYF 311
LL DP R T+E+A+ DPYF
Sbjct: 297 LLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 96/321 (29%), Positives = 148/321 (46%), Gaps = 72/321 (22%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIK---KIHDIFEHISDAARILREIKLLRLLRH 76
+K ++IG+GS+ V A + T ++ AIK K I E +I +E+ L RL H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV-LTRLNGH 61
Query: 77 PDIVEIKHIMLPPSRRDFKD---IYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLR 132
P I+++ + F+D +Y V E + +L Q I+ L + +F+ ++L
Sbjct: 62 PGIIKLYYT--------FQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILL 113
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV--------AFNDTPTTIFWTD- 183
AL+Y+H+ + HRDLKP+NIL + + +KI DFG A+V + T I
Sbjct: 114 ALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 184 --------YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 235
+V T Y +PEL + D+W++GCI ++LTGKP F G N
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSN----- 226
Query: 236 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFP-NADPSALRLLERLLAF 294
YLT +K +++S FP N P A L+E+LL
Sbjct: 227 ------------------------EYLT-FQKILKLEYS--FPPNFPPDAKDLIEKLLVL 259
Query: 295 DPKDRPTA----EEALADPYF 311
DP+DR +E A P+F
Sbjct: 260 DPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-36
Identities = 77/302 (25%), Positives = 127/302 (42%), Gaps = 68/302 (22%)
Query: 21 KIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDI--FEHISDAARILREIKLLRLL 74
+ + +G+G++G V +VA+K + + + I + LRE +++R L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEE---FLREARIMRKL 58
Query: 75 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLL 131
HP+IV++ + + +V E M DL ++ N L+ F Q+
Sbjct: 59 DHPNIVKLLGVCTEEEP-----LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIA 113
Query: 132 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT---- 187
R ++Y+ + N HRDL +N L N +KI DFGL+R ++D DY
Sbjct: 114 RGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--------DYYKVKGGK 165
Query: 188 ---RWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLL 242
RW APE S K+T D+WS G + E+ T G+ +PG +
Sbjct: 166 LPIRWM-APE---SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNA---------- 211
Query: 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 302
+ + ++ R +P PN P +L+ + A DP+DRPT
Sbjct: 212 -----EVLEYLKKGY--------RLPKP-------PNCPPELYKLMLQCWAEDPEDRPTF 251
Query: 303 EE 304
E
Sbjct: 252 SE 253
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 81/288 (28%), Positives = 126/288 (43%), Gaps = 35/288 (12%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 85
IG G++G V +A++ TGE +A+K+I I E+K+L LL+HP++V+ +
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 86 MLPPSRRDFKDIYVVFEL-MESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYH 144
+ R+ +Y+ E L ++++ L + + QLL L Y+H+ + H
Sbjct: 68 EV---HRE--KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122
Query: 145 RDLKPKNILANANCKLKICDFGLA-RVAFNDTPTTIFWTDYVATRWYRAPEL-CGSFFSK 202
RD+KP NI + N +K+ DFG A ++ N T T Y APE+ G
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182
Query: 203 YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYL 262
+ A DIWS+GC+ E+ TGK + +LD N+ +
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRPW------SELD------------------NEFQIMFH 218
Query: 263 TSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 310
P L+R L DPK RPTA E L P+
Sbjct: 219 VGA--GHKPPIPDSL-QLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 6e-34
Identities = 82/292 (28%), Positives = 125/292 (42%), Gaps = 41/292 (14%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKH 84
V+G+GS GVV TG+ A+KKIH + ++LRE+K LR P +V+
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 85 IMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANV 142
I +V E M+ L ++K + + Q+L+ L Y+HT ++
Sbjct: 67 AFYKEGE-----ISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHI 121
Query: 143 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD-YVATRWYRAPELCGSFFS 201
HRD+KP N+L N+ ++KI DFG+++V T+ + +V T Y +PE
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKV----LENTLDQCNTFVGTVTYMSPERIQG--E 175
Query: 202 KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRY 261
Y+ A DIWS+G E GK F +LM + P
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSL------------ 223
Query: 262 LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313
+FS +F + + L DPK RP+A E L P+ K
Sbjct: 224 -------PAEEFSPEFRD-------FISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 83/301 (27%), Positives = 137/301 (45%), Gaps = 50/301 (16%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKI---HDIFEHISDAARILREIKLLRLLRHPDIVEI 82
I KG+YG V A TG+ AIK I I ++ D R+I L + P +V++
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDI--LSQAQSPYVVKL 58
Query: 83 KHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN 141
+ S + K++Y+V E + DL +++ L + + ++ +++ AL+Y+H+
Sbjct: 59 YY-----SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG 113
Query: 142 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY-----VATRWYRAPELC 196
+ HRDLKP NIL ++N LK+ DFGL++V + + V T Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256
++ +D WS+GCI E L G P F G+ + + N
Sbjct: 174 LG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---------------EIFQNILNG 216
Query: 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA---EEALADPYFKG 313
K +++ + A+ L+ +LL DP+ R A EE P+FKG
Sbjct: 217 K-------------IEWPE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262
Query: 314 L 314
+
Sbjct: 263 I 263
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 67/291 (23%), Positives = 119/291 (40%), Gaps = 46/291 (15%)
Query: 21 KIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 76
++ + +G+G++G V T KVA+K + + + L E +++ L H
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASE-EEREEFLEEASIMKKLSH 60
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQF-FLYQLLRAL 134
P+IV + + + +Y+V E M DL ++ + + Q+ + +
Sbjct: 61 PNIVRLLGVCTQG-----EPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115
Query: 135 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 194
+Y+ + N HRDL +N L N +KI DFGL+R + D + +W APE
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-APE 174
Query: 195 LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253
K+T D+WS G + E+ T G+ +PG + + + +
Sbjct: 175 SL--KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM---------------SNEEVLELL 217
Query: 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 304
+ R +P N L+ + A+DP+DRPT E
Sbjct: 218 EDGY--------RLPRP-------ENCPDELYELMLQCWAYDPEDRPTFSE 253
|
Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 88/304 (28%), Positives = 130/304 (42%), Gaps = 58/304 (19%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
+ + E IGKGS+G V AID T + VAIK I D+ E + I +EI+ L R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFLSQCRSP 59
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLYQLLRA 133
I + L + K ++++ E DL + K L + F L ++L
Sbjct: 60 YITKYYGSFL----KGSK-LWIIMEYCGGGSCLDLLKPGK----LDETYIAFILREVLLG 110
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 193
L+Y+H HRD+K NIL + +K+ DFG V+ T T +V T ++ AP
Sbjct: 111 LEYLHEEGKIHRDIKAANILLSEEGDVKLADFG---VSGQLTSTMSKRNTFVGTPFWMAP 167
Query: 194 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253
E+ S Y DIWS+G E+ G+P P + L M
Sbjct: 168 EVIKQ--SGYDEKADIWSLGITAIELAKGEP--P----LSDLHPM--------------- 204
Query: 254 RNDKARRYLTSMRKKQP-----VQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308
R L + K P +FS+ F + + L DPK+RP+A+E L
Sbjct: 205 ------RVLFLIPKNNPPSLEGNKFSKPFKD-------FVSLCLNKDPKERPSAKELLKH 251
Query: 309 PYFK 312
+ K
Sbjct: 252 KFIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 75/285 (26%), Positives = 128/285 (44%), Gaps = 47/285 (16%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHP 77
+++ VIGKG++G VC T + A+K ++ E S +L E ++L+ L HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGS-VRNVLNERRILQELNHP 60
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 136
+V + + S +D +++Y+V +L+ DL + + E +F++ +++ AL+Y
Sbjct: 61 FLVNLWY-----SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEY 115
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 196
+H+ + HRD+KP NIL + + I DF +A DT T T T Y APE+
Sbjct: 116 LHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT----TSTSGTPGYMAPEV- 170
Query: 197 GSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255
+ Y+ A+D WS+G E L GK + G SR
Sbjct: 171 --LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGH---------------------SRTIR 207
Query: 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDR 299
D+ R ++ +P + + +LL DP+ R
Sbjct: 208 DQIRA----KQETA----DVLYPATWSTEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 6e-30
Identities = 81/303 (26%), Positives = 139/303 (45%), Gaps = 57/303 (18%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI------HDIFEHISDAARILREIKLLR 72
R++ E++G GS+G V ++ G+ A+K++ E + ++ +EI LL
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVK---QLEQEIALLS 57
Query: 73 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLL 131
L+HP+IV+ + R+ ++Y+ EL+ L +++K + + Q+L
Sbjct: 58 KLQHPNIVQYLG-----TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL 112
Query: 132 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR-VAFNDTPTTIFWTDYVATRWY 190
L+Y+H N HRD+K NIL + N +K+ DFG+A+ V F + + ++
Sbjct: 113 LGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-----FAKSFKGSPYW 167
Query: 191 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL---GTPSL 247
APE+ Y A DIWS+GC E+ TGKP + QL+ + + + L
Sbjct: 168 MAPEVIAQ-QGGYGLAADIWSLGCTVLEMATGKPPW------SQLEGVAAVFKIGRSKEL 220
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
I +D+A+ ++ L+ L+R DP RPTA E L
Sbjct: 221 PPIPDHLSDEAKDFI----------------------LKCLQR----DPSLRPTAAELLE 254
Query: 308 DPY 310
P+
Sbjct: 255 HPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 46/290 (15%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR---ILREIKLLRLLRHPDIVEI 82
IG+GS G+VC A D TG +VA+KK+ + R + E+ ++R +HP+IVE+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD-----LRKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 83 KHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV 142
L +++VV E +E I + + E +L+AL ++H V
Sbjct: 82 YSSYLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGV 136
Query: 143 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 202
HRD+K +IL ++ ++K+ DFG + P V T ++ APE+
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPEVISR--LP 191
Query: 203 YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYL 262
Y +DIWS+G + E++ G+P + P L + R+R++ +
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPPY---------------FNEPPLQAMKRIRDNLPPKL- 235
Query: 263 TSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312
K + S P L+R+L DP R TA E L P+
Sbjct: 236 -----KNLHKVS-------PRLRSFLDRMLVRDPAQRATAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 90/314 (28%), Positives = 132/314 (42%), Gaps = 76/314 (24%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKI---------HDIFEHISDAARILR-EIKLLRL 73
E+IGKG+YG V A++ TGE +A+K++ HD D + LR EI+ L+
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHD--SRQKDMVKALRSEIETLKD 64
Query: 74 LRHPDIV---------EIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQ 124
L H +IV E I L YV + S L + + L R
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLE---------YVPGGSIGSCLRTYGRFEEQLVR---- 111
Query: 125 FFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR----VAFNDTPT--- 177
FF Q+L L Y+H+ + HRDLK N+L +A+ KI DFG+++ + ND
Sbjct: 112 FFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ 171
Query: 178 -TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 236
++FW APE+ S+ Y+ +DIWS+GC+ E+ G+ +
Sbjct: 172 GSVFWM---------APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW---------- 212
Query: 237 LMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDP 296
S A L + R P+ N P AL L +P
Sbjct: 213 --------------SDEEAIAAMFKLGNKRSAPPIP-PDVSMNLSPVALDFLNACFTINP 257
Query: 297 KDRPTAEEALADPY 310
+RPTA E L P+
Sbjct: 258 DNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 69/206 (33%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRHP 77
+KI++ IGKG + VV AI G VA+KK+ IFE + AR L+EI LL+ L HP
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQ-IFEMMDAKARQDCLKEIDLLKQLDHP 62
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIK--ANDDLTREHYQF--FLYQLLR 132
++ IK++ S + ++ +V EL ++ DL ++IK + QL
Sbjct: 63 NV--IKYL---ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 192
AL+++H+ + HRD+KP N+ A +K+ D GL R + T V T +Y +
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTAAHSLVGTPYYMS 174
Query: 193 PELCGSFFSKYTPAIDIWSIGCIFAE 218
PE + Y DIWS+GC+ E
Sbjct: 175 PERIHE--NGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 85/299 (28%), Positives = 135/299 (45%), Gaps = 54/299 (18%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 79
+ I E +G+GSYG V AI TG+ VAIK + + E + + I++EI +L+ P I
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQE---IIKEISILKQCDSPYI 60
Query: 80 VEIKHIMLPPSRRDFKDIYVVFELME-------SDLHQVIKANDDLTREHYQFFLYQLLR 132
V+ S D+++V ME SD+ ++ N LT E LYQ L+
Sbjct: 61 VKYY-----GSYFKNTDLWIV---MEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLK 110
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 192
L+Y+H+ HRD+K NIL N + K+ DFG V+ T T + T ++ A
Sbjct: 111 GLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFG---VSGQLTDTMAKRNTVIGTPFWMA 167
Query: 193 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252
PE+ Y DIWS+G E+ GKP + + + + M P+L
Sbjct: 168 PEVIQE--IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-FMIPNKPPPTL----- 219
Query: 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311
P ++S +F + +++ L DP++RP+A + L P+
Sbjct: 220 ---------------SDPEKWSPEFND-------FVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 83/307 (27%), Positives = 131/307 (42%), Gaps = 53/307 (17%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
Y++ EVIG G+ VV +AI EKVAIK+I D+ + + + +E++ + HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 78 DIVEIKHIMLPPSRRDF---KDIYVVFELMES-DLHQVIK---ANDDLTREHYQFFLYQL 130
++V+ F ++++V + L ++K L L ++
Sbjct: 60 NVVK--------YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEV 111
Query: 131 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL-ARVAFNDTPTTIFWTDYVATRW 189
L+ L+Y+H+ HRD+K NIL + +KI DFG+ A +A T +V T
Sbjct: 112 LKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC 171
Query: 190 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT----- 244
+ APE+ Y DIWS G E+ TG + + M L+ T
Sbjct: 172 WMAPEVMEQ-VHGYDFKADIWSFGITAIELATGAAPY------SKYPPMKVLMLTLQNDP 224
Query: 245 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 304
PSL+T + KK +S+ F ++ L DP RPTAEE
Sbjct: 225 PSLET-------------GADYKK----YSKSFRK-------MISLCLQKDPSKRPTAEE 260
Query: 305 ALADPYF 311
L +F
Sbjct: 261 LLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 73/283 (25%), Positives = 130/283 (45%), Gaps = 54/283 (19%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA---ARILREIKLLRLLRHPDIVEI 82
+G G +G V A+K + HI + I E ++L HP IV++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKK--RHIVETGQQEHIFSEKEILEECNHPFIVKL 58
Query: 83 KHIMLPPSRRDFKDIYVVFELMES----DLHQVIKANDDLTREHYQFFLYQLLRALKYIH 138
R FKD ++ LME +L +++ +F++ ++ A +Y+H
Sbjct: 59 --------YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLH 110
Query: 139 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 198
+ +RDLKP+N+L ++N +K+ DFG A+ + T WT + T Y APE+
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT---WT-FCGTPEYVAPEII-- 164
Query: 199 FFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257
+K Y ++D WS+G + E+LTG+P F G++ +++ D+ L ++
Sbjct: 165 -LNKGYDFSVDYWSLGILLYELLTGRPPF-GEDDEDPMEIYNDI-----LKGNGKL---- 213
Query: 258 ARRYLTSMRKKQPVQFSQKFPN-ADPSALRLLERLLAFDPKDR 299
+FPN D +A L+++LL +P++R
Sbjct: 214 ------------------EFPNYIDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 71/299 (23%), Positives = 121/299 (40%), Gaps = 61/299 (20%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAAR--ILREIKLLRLLRHPD 78
+ +G+G++G V K VA+K + E S+ R L+E ++++ L HP+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK---EDASEEERKDFLKEARVMKKLGHPN 57
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAN---------DDLTREHYQFFLY 128
+V + + + + +Y+V E ME DL ++ + L+ + F
Sbjct: 58 VVRLLGVCT-----EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112
Query: 129 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 188
Q+ + ++Y+ + HRDL +N L + +KI DFGL+R ++D + R
Sbjct: 113 QIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
Query: 189 WYRAPELCGSFFS-KYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPS 246
W APE S +T D+WS G + E+ T G +PG
Sbjct: 173 WM-APE---SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG------------------ 210
Query: 247 LDTISRVRNDKARRYLTS-MRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 304
+ N++ YL R +P L+ DP+DRPT E
Sbjct: 211 ------LSNEEVLEYLRKGYRLPKP-------EYCPDELYELMLSCWQLDPEDRPTFSE 256
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 7e-26
Identities = 85/307 (27%), Positives = 133/307 (43%), Gaps = 50/307 (16%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-R 75
+++ EVIG+G+YG V A TG+ VAIK + I + + I E +LR
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE---IKEEYNILRKYSN 61
Query: 76 HPDIVEIKHIML---PPSRRDFKDIYVVFELME----SDLHQ-VIKANDDLTREHYQFFL 127
HP+I + PP D +++V EL +DL + + K L E + L
Sbjct: 62 HPNIATFYGAFIKKNPPGNDD--QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119
Query: 128 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD-YVA 186
+ LR L Y+H V HRD+K +NIL N ++K+ DFG++ +T+ + ++
Sbjct: 120 RETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA----QLDSTLGRRNTFIG 175
Query: 187 TRWYRAPE--LCG-SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 243
T ++ APE C + Y D+WS+G E+ GKP D+
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL------------CDMHP 223
Query: 244 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE 303
+L I RN K P +S+KF + + L + + RP E
Sbjct: 224 MRALFKI--PRNP-------PPTLKSPENWSKKFND-------FISECLIKNYEQRPFME 267
Query: 304 EALADPY 310
E L P+
Sbjct: 268 ELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 80/300 (26%), Positives = 124/300 (41%), Gaps = 55/300 (18%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRH 76
Y V+GKG++G T V K+++ + E A L EI +L LL+H
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDA--LNEIVILSLLQH 58
Query: 77 PDIVE-IKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDD--LTREHYQFFLYQ 129
P+I+ H F D + ME L+ I E ++L+Q
Sbjct: 59 PNIIAYYNH---------FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ 109
Query: 130 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 189
++ A+ YIH A + HRD+K NI +K+ DFG++++ ++ V T +
Sbjct: 110 IVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA---ETVVGTPY 166
Query: 190 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 249
Y +PELC KY DIW++GC+ E+LT K F N L+L+ +
Sbjct: 167 YMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVVKI-------- 213
Query: 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 309
+ Y + + L+ LL DP+ RPTA+E L P
Sbjct: 214 VQGNYTPVVSVYSSELIS-------------------LVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 85/304 (27%), Positives = 126/304 (41%), Gaps = 62/304 (20%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR-------ILREIKLLRLLRHP 77
+IG GS+G V ++ +GE +A+K++ S R + REI LL+ L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 137
+IV+ L + YV + + L+ + L R F+ Q+L+ L Y+
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRN----FVRQILKGLNYL 122
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLA-RVAFNDTPTTIFWTDYVATRWYRAPELC 196
H + HRD+K NIL + +KI DFG++ ++ N T T R P L
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTK--------TNGAR-PSLQ 173
Query: 197 GSFF---------SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247
GS F + YT DIWS+GC+ E+LTGK FP L
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT---------------QL 218
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFP-NADPSALRLLERLLAFDPKDRPTAEEAL 306
I ++ S + P N A+ LE+ D RPTA E L
Sbjct: 219 QAIFKIGE----------------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELL 262
Query: 307 ADPY 310
P+
Sbjct: 263 KHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 83/299 (27%), Positives = 127/299 (42%), Gaps = 53/299 (17%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRH 76
+K+ + +GKGSYG V + A+K++ +S R + EI++L + H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVD--LGSMSQKEREDAVNEIRILASVNH 58
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTR-----EHYQFFLYQL 130
P+I+ K L D + +V E DL + I + E ++ F+ QL
Sbjct: 59 PNIISYKEAFL-----DGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QL 112
Query: 131 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 190
LR L+ +H + HRDLK NIL AN +KI D G+++V + T + T Y
Sbjct: 113 LRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-----IGTPHY 167
Query: 191 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250
APE+ Y+ DIWS+GC+ E+ T P F ++ M DL
Sbjct: 168 MAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARS-------MQDL--------- 209
Query: 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 309
R R + P +SQ N + +L PK RP ++ LA P
Sbjct: 210 ---RYKVQRGKYPPI----PPIYSQDLQN-------FIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 82/299 (27%), Positives = 135/299 (45%), Gaps = 46/299 (15%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 85
IG+GS G+VC A + HTG++VA+KK+ + E+ ++R H ++V++ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD--LRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 86 MLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHR 145
L +++VV E +E I + + E +LRAL Y+H V HR
Sbjct: 88 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHR 142
Query: 146 DLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTP 205
D+K +IL ++ ++K+ DFG + P V T ++ APE+ Y
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR---KSLVGTPYWMAPEVISRL--PYGT 197
Query: 206 AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSM 265
+DIWS+G + E++ G+P + P L + R+R++ R
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPY---------------FNEPPLQAMRRIRDNLPPR----- 237
Query: 266 RKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSC 323
V+ S K S LR L+ +L +P R TA+E L P+ K+ PSC
Sbjct: 238 -----VKDSHKV----SSVLRGFLDLMLVREPSQRATAQELLQHPFL----KLAGPPSC 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 80/293 (27%), Positives = 123/293 (41%), Gaps = 42/293 (14%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEIK 83
+G G+ GVV + TG+ +A+K I +I E I +ILRE+ +L P IV
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQK--QILRELDILHKCNSPYIVGFY 65
Query: 84 HIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHY-QFFLYQLLRALKYIHTA- 140
+ DI + E M+ L +++K E +L+ L Y+H
Sbjct: 66 GAFY-----NNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH 120
Query: 141 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF 200
+ HRD+KP NIL N+ ++K+CDFG++ N T +V T Y APE
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-----FVGTSSYMAPERIQG-- 173
Query: 201 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260
+ Y+ DIWS+G E+ TG+ FP + + + N+
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGR--FPYPP--ENDPPDGI------FELLQYIVNEPP-- 221
Query: 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313
P S KF P + L DP++RP+ +E L P+ K
Sbjct: 222 ---------PRLPSGKFS---PDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 83/303 (27%), Positives = 128/303 (42%), Gaps = 38/303 (12%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
S Y+ E+IG+G+YG V TG VA+K I ++ D + I RE+ LL LR
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKII-NLDTPDDDVSDIQREVALLSQLRQS 59
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 136
I S ++++ E E + ++KA + ++ + ++L ALKY
Sbjct: 60 QPPNI--TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP-IAEKYISVIIREVLVALKY 116
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 196
IH V HRD+K NIL +K+CDFG VA + + +V T ++ APE+
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFG---VAALLNQNSSKRSTFVGTPYWMAPEVI 173
Query: 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256
Y DIWS+G E+ TG P + + + L+ S+
Sbjct: 174 TE-GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK----------SKPPRL 222
Query: 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316
+ Y +R + A L E +PK+R +AEE L + K SK
Sbjct: 223 EDNGYSKLLR--------------EFVAACLDE-----EPKERLSAEELLKSKWIKAHSK 263
Query: 317 VER 319
Sbjct: 264 TPV 266
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 81/302 (26%), Positives = 131/302 (43%), Gaps = 59/302 (19%)
Query: 19 RYKIQEVIGKGSYGVV--CSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLL 74
+Y+ V+G+G++G+V C + V IK+I E ++ R E ++L+LL
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQ--KLVIIKQIP--VEQMTKDERLAAQNECQVLKLL 56
Query: 75 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVI--KANDDLTREHYQFFLYQLL 131
HP+I+E L + K + +V E L + I + N L + F Q+L
Sbjct: 57 SHPNIIEYYENFL-----EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 132 RALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 190
AL ++HT + HRDLK +NIL + + +KI DFG++++ + + V T Y
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV----VGTPCY 167
Query: 191 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250
+PELC Y DIW++GC+ E+ + K F N+ P+L
Sbjct: 168 ISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANL-------------PAL--- 209
Query: 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNAD---PSALRLLERLLAFDPKDRPTAEEALA 307
L M P +D P +L+ +L DP RP + +A
Sbjct: 210 ----------VLKIMSGTFA-------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252
Query: 308 DP 309
P
Sbjct: 253 QP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 64/216 (29%), Positives = 109/216 (50%), Gaps = 29/216 (13%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIF-----EHISDAARILREIKLLR 72
++ + +G GS+G V +G+ A+K I EH+ + RIL+ I
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI---- 58
Query: 73 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLL 131
RHP +V L S +D ++Y+V E + +L ++ + +F+ Q++
Sbjct: 59 --RHPFLVN-----LYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVV 111
Query: 132 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 191
AL+Y+H+ ++ +RDLKP+N+L +++ +KI DFG A+ T +T T Y
Sbjct: 112 LALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT-----YT-LCGTPEYL 165
Query: 192 APELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLF 226
APE+ SK Y A+D W++G + E+L G P F
Sbjct: 166 APEI---ILSKGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 88/298 (29%), Positives = 130/298 (43%), Gaps = 43/298 (14%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
Y++ + IG G+YG V A D TGE VAIK I E D I +EI +L+ RHP
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK--LEPGDDFEIIQQEISMLKECRHP 60
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLYQLLRA 133
+IV L RRD +++V E D++QV L+ + + L+
Sbjct: 61 NIVAYFGSYL---RRD--KLWIVMEYCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKG 113
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 193
L Y+H HRD+K NIL + +K+ DFG V+ T T ++ T ++ AP
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFG---VSAQLTATIAKRKSFIGTPYWMAP 170
Query: 194 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252
E Y DIW++G E+ +P P M DL +L IS+
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIELAELQP--P----------MFDLHPMRALFLISK 218
Query: 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 310
N + K ++S F + +++ L DPK RPTA + L P+
Sbjct: 219 -SNFPPPKL------KDKEKWSPVFHD-------FIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-23
Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 13/214 (6%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 79
++I IGKGS+GVV + A+K+I + + + E ++L L I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 80 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLRALKY 136
I++ S D + +V E E+ DLH+++K L + F Q+L L +
Sbjct: 62 --IRYY---ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 196
+H+ + HRD+K N+ +A +KI D G+A++ + T F V T +Y +PELC
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELC 173
Query: 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 230
Y D+W++G + E TGK F N
Sbjct: 174 ED--KPYNEKSDVWALGVVLYECCTGKHPFDANN 205
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-23
Identities = 72/298 (24%), Positives = 127/298 (42%), Gaps = 44/298 (14%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR-----ILREIKLLRLL 74
++ +++G+G++G V D TG ++A+K++ F+ S + + EI+LL+ L
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVP--FDPDSPETKKEVNALECEIQLLKNL 61
Query: 75 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRA 133
+H IV+ + RD + + + E M + +KA LT + + Q+L
Sbjct: 62 QHERIVQYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEG 116
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 193
++Y+H+ + HRD+K NIL ++ +K+ DFG ++ + T ++ +P
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 194 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253
E+ Y D+WS+GC E+LT KP P + M +
Sbjct: 177 EVISG--EGYGRKADVWSVGCTVVEMLTEKP--PWAE----FEAMAAIFKI--------- 219
Query: 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311
QP Q + P A L R + K RP+AEE L +
Sbjct: 220 -------------ATQPTNP-QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 6e-23
Identities = 85/299 (28%), Positives = 127/299 (42%), Gaps = 59/299 (19%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKH 84
V+GKG+YG+V +A D T ++AIK+I + + EI L L+H +IV+
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPE--RDSRYVQPLHEEIALHSYLKHRNIVQY-- 70
Query: 85 IMLPPSRRDFKDIYVVFELME-------SDLHQV----IKANDDLTREHYQFFLYQLLRA 133
+ S F I+ ME S L + +K N+ F+ Q+L
Sbjct: 71 -LGSDSENGFFKIF-----MEQVPGGSLSALLRSKWGPLKDNEQTII----FYTKQILEG 120
Query: 134 LKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 192
LKY+H + HRD+K N+L N + +KI DFG ++ P T + T Y A
Sbjct: 121 LKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT---ETFTGTLQYMA 177
Query: 193 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252
PE+ Y DIWS+GC E+ TGKP F + LG P
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF------IE-------LGEP------- 217
Query: 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPTAEEALADPY 310
+A + M K P + P + + + + R DP R +A + L DP+
Sbjct: 218 ----QAAMFKVGMFKIHP-----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 7e-23
Identities = 70/227 (30%), Positives = 108/227 (47%), Gaps = 46/227 (20%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAARI--LREIKL 70
D S I++VIG G +G VC G+K VAIK + SD R+ L E +
Sbjct: 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASI 58
Query: 71 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQ 129
+ HP+I+ ++ ++ ++ + + ++ E ME+ L + ++ ND +F + Q
Sbjct: 59 MGQFDHPNIIRLEGVV---TKS--RPVMIITEYMENGSLDKFLRENDG------KFTVGQ 107
Query: 130 LLRAL-------KYIHTANVYHRDLKPKNILANANCKLKICDFGLARV--AFNDTPTT-- 178
L+ L KY+ N HRDL +NIL N+N K+ DFGL+R T TT
Sbjct: 108 LVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG 167
Query: 179 ----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
I WT APE + K+T A D+WS G + EV++
Sbjct: 168 GKIPIRWT---------APEAIA--YRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 9e-23
Identities = 71/286 (24%), Positives = 125/286 (43%), Gaps = 40/286 (13%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 85
IG+GS G+VC A + H+G +VA+K + + E+ ++R +H ++VE+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 86 MLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHR 145
L ++++V+ E ++ I + L E +L+AL Y+H+ V HR
Sbjct: 87 YLVG-----EELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHR 141
Query: 146 DLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTP 205
D+K +IL + ++K+ DFG D P V T ++ APE+ + Y
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KSLVGTPYWMAPEVISR--TPYGT 196
Query: 206 AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSM 265
+DIWS+G + E++ G+P + + V + + D
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD------------------------- 231
Query: 266 RKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311
P + P LER+L +P++R TA+E L P+
Sbjct: 232 ---SPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-22
Identities = 82/297 (27%), Positives = 129/297 (43%), Gaps = 44/297 (14%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
RY+I + IG+GS+G + A E IK+I + + +E+ LL ++HP+
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLY--QLLRALK 135
IV S ++ +++V E + DL + I + Q + Q+ LK
Sbjct: 61 IVTFFA-----SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 136 YIHTANVYHRDLKPKNILANANCKL-KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 194
+IH + HRD+K +NI + N + K+ DFG+AR ND+ V T +Y +PE
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LNDS--MELAYTCVGTPYYLSPE 172
Query: 195 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254
+C + Y DIWS+GC+ E+ T K F G N +HQL L I +
Sbjct: 173 ICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVL-----------KICQGY 218
Query: 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311
F+ PN L+ +L P+DRP+ L P+
Sbjct: 219 ------------------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 6e-22
Identities = 76/286 (26%), Positives = 125/286 (43%), Gaps = 40/286 (13%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 85
IG+GS G+VC A +G+ VA+KK+ + E+ ++R +H ++VE+ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 86 MLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHR 145
L +++VV E +E I + + E +L+AL +H V HR
Sbjct: 86 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 146 DLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTP 205
D+K +IL + ++K+ DFG + P V T ++ APEL Y P
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPELISRL--PYGP 195
Query: 206 AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSM 265
+DIWS+G + E++ G+P + P L + +R++ + L ++
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPY---------------FNEPPLKAMKMIRDNLPPK-LKNL 239
Query: 266 RKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311
K PS L+RLL DP R TA E L P+
Sbjct: 240 HK------------VSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 66/265 (24%), Positives = 124/265 (46%), Gaps = 36/265 (13%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIF-----EHISDAARILREIKL 70
+ + +G G++G V D + A+K I ++ +H+ + R+L+E+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-- 58
Query: 71 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQ 129
HP I+ L + D + +Y++ E + +L ++ + + F+ +
Sbjct: 59 ----SHPFIIR-----LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE 109
Query: 130 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 189
++ AL+Y+H+ + +RDLKP+NIL + +K+ DFG A+ + T WT T
Sbjct: 110 IVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-----WT-LCGTPE 163
Query: 190 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLMTDLLGTPSL 247
Y APE+ S + A+D W++G + E+L G P F N +++ L L L
Sbjct: 164 YLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHL 221
Query: 248 DTISR------VRNDKARRYLTSMR 266
D ++ + D+ RR L +M+
Sbjct: 222 DLYAKDLIKKLLVVDRTRR-LGNMK 245
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 6e-21
Identities = 93/299 (31%), Positives = 132/299 (44%), Gaps = 54/299 (18%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI---SDAARILREIKLLRLLRHPDIVEI 82
IGKGS+G V T A+K I HI S+ L E +L + P IV +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRK--AHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58
Query: 83 KHIMLPPSRRDFKDIYVVFELM---ESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT 139
K P + +Y+V + E H + DL+R +F+ +LL AL+ +H
Sbjct: 59 KFSFQSPEK-----LYLVLAFINGGELFHHLQREGRFDLSRA--RFYTAELLCALENLHK 111
Query: 140 ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF 199
NV +RDLKP+NIL + + +CDFGL ++ D T + T Y APEL
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT---NTFCGTPEYLAPELLLGH 168
Query: 200 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKAR 259
YT A+D W++G + E+LTG P F +NV N+ R
Sbjct: 169 --GYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----------------------NEMYR 203
Query: 260 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR---PTAEEALADPYFKGLS 315
+ L +P++F F D A LL LL+ DP R A+E P+F LS
Sbjct: 204 KILQ-----EPLRFPDGF---DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 6e-21
Identities = 79/304 (25%), Positives = 128/304 (42%), Gaps = 56/304 (18%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR----ILREIKLLRLLRHPDI 79
+ +G G++ A D TG +A+K++ + S+ + +EI+L+ L HP I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 80 VEIKHIMLPPSRRDFKDIYVVF-ELM-----ESDLHQVIKANDDLTREHYQFFLYQLLRA 133
+ ML + D + +F E M L + + + + QLLR
Sbjct: 66 IR----MLGATCEDSH--FNLFVEWMAGGSVSHLLSKYGAFKEAVIIN----YTEQLLRG 115
Query: 134 LKYIHTANVYHRDLKPKNILANANCK-LKICDFGLA-RVAFNDTPTTIFWTDYVATRWYR 191
L Y+H + HRD+K N+L ++ + L+I DFG A R+A T F + T +
Sbjct: 116 LSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 192 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL---LGTPSLD 248
APE+ +Y + D+WS+GC+ E+ T KP + + + L L+ + PS+
Sbjct: 176 APEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSI- 232
Query: 249 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308
P S P LR LE P+DRP + E L
Sbjct: 233 ---------------------PEHLS---PGLRDVTLRCLEL----QPEDRPPSRELLKH 264
Query: 309 PYFK 312
P F+
Sbjct: 265 PVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 6e-21
Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 14/211 (6%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
+Y + V+G+GS+G ++ +K A+K+I + + S +E LL ++HP+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIR-LPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLRALK 135
IV K S +Y+V E + DL Q IK + + Q+ ++
Sbjct: 60 IVAFKE-----SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ 114
Query: 136 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 195
+IH V HRD+K KNI N K+K+ DFG AR+ + P + YV T +Y PE+
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGA-YACTYVGTPYYVPPEI 171
Query: 196 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 226
+ Y DIWS+GCI E+ T K F
Sbjct: 172 WENM--PYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 9e-21
Identities = 72/221 (32%), Positives = 110/221 (49%), Gaps = 33/221 (14%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAAR--ILREIKL 70
DAS KI++VIG G +G VCS G++ VAIK + + ++ R L E +
Sbjct: 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASI 58
Query: 71 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQ 129
+ HP+I+ ++ ++ K + +V E ME+ L ++ +D QF + Q
Sbjct: 59 MGQFDHPNIIHLEGVVTKS-----KPVMIVTEYMENGSLDAFLRKHDG------QFTVIQ 107
Query: 130 L---LRA----LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 182
L LR +KY+ HRDL +NIL N+N K+ DFGL+RV D P + T
Sbjct: 108 LVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-LEDDPEAAYTT 166
Query: 183 D--YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
+ RW APE + K+T A D+WS G + EV++
Sbjct: 167 RGGKIPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-20
Identities = 84/300 (28%), Positives = 138/300 (46%), Gaps = 43/300 (14%)
Query: 15 GDASR-YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRL 73
GD + Y E IG+G+ G V +AID TG++VAIK+++ + I+ EI ++R
Sbjct: 15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN--LQQQPKKELIINEILVMRE 72
Query: 74 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRA 133
+HP+IV L +++VV E + + + + L+A
Sbjct: 73 NKHPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA 127
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGL-ARVAFNDTPTTIFWTDYVATRWYRA 192
L+++H+ V HRD+K NIL + +K+ DFG A++ TP + V T ++ A
Sbjct: 128 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMA 183
Query: 193 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252
PE+ Y P +DIWS+G + E++ G+P + +N + L L+ GTP L
Sbjct: 184 PEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPEL----- 235
Query: 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312
+ P + S F + L R L D + R +A+E L P+ K
Sbjct: 236 ---------------QNPEKLSAIFRD-------FLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 2e-20
Identities = 81/295 (27%), Positives = 136/295 (46%), Gaps = 42/295 (14%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
+Y E IG+G+ G V +AID TG++VAIK+I+ + I+ EI +++ L++P+
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN--LQKQPKKELIINEILVMKELKNPN 77
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 138
IV L +++VV E + + + + L+AL+++H
Sbjct: 78 IVNFLDSFLVGD-----ELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH 132
Query: 139 TANVYHRDLKPKNILANANCKLKICDFGL-ARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
V HRD+K N+L + +K+ DFG A++ TP + V T ++ APE+
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257
Y P +DIWS+G + E++ G+P + +N + L L+ GTP L
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPEL---------- 235
Query: 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312
+ P + S F + L R L D + R +A+E L P+ K
Sbjct: 236 ----------QNPEKLSPIFRD-------FLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 2e-20
Identities = 81/295 (27%), Positives = 134/295 (45%), Gaps = 42/295 (14%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
+Y E IG+G+ G V +AID TG++VAIK+++ + I+ EI ++R ++P+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN--LQQQPKKELIINEILVMRENKNPN 77
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 138
IV L +++VV E + + + + L+AL ++H
Sbjct: 78 IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH 132
Query: 139 TANVYHRDLKPKNILANANCKLKICDFGL-ARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
+ V HRD+K NIL + +K+ DFG A++ TP + V T ++ APE+
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257
Y P +DIWS+G + E++ G+P + +N + L L+ GTP L
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPEL---------- 235
Query: 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312
+ P + S F + L R L D R +A+E L P+ K
Sbjct: 236 ----------QNPERLSAVFRD-------FLNRCLEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 3e-20
Identities = 84/302 (27%), Positives = 127/302 (42%), Gaps = 53/302 (17%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE---HISDAARILREIKLLRLLR 75
RY +Q+ +GKGS+G V D + +K + +I + ++ + +E +LL L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESD--LHQVIKANDDLTREHYQFFLYQLLRA 133
HP IV+ L R F I E + D L ++ L+ + QLL
Sbjct: 61 HPAIVKFHASFL--ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN--DTPTTIFWTDYVATRWYR 191
+ Y+H + HRDLK KNI N LKI DFG++R+ D TT + T +Y
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-----FTGTPYYM 172
Query: 192 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL--GTPSLDT 249
+PE Y DIWS+GCI E+ F G+N L ++ ++ TPSL
Sbjct: 173 SPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPTPSL-- 225
Query: 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPTAEEALAD 308
P L +++ +L DP RP+A E L +
Sbjct: 226 ----------------------------PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257
Query: 309 PY 310
P+
Sbjct: 258 PF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 7e-20
Identities = 87/331 (26%), Positives = 137/331 (41%), Gaps = 74/331 (22%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE-IKLLRLLRH 76
+++ +VIG+G++G V D TG+ A+K + + I R I +R R
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVL-------RKSDMIKRNQIAHVRAER- 52
Query: 77 PDI-VEIKHIMLPPSRRDFKD---IYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLL 131
DI + + F+D +Y+V E M DL ++ D E +F++ +L+
Sbjct: 53 -DILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV 111
Query: 132 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA----------------RVAFNDT 175
AL +H HRD+KP NIL +A+ +K+ DFGL
Sbjct: 112 LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 176 PTTIFWTDY----------VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 224
+ D+ V T Y APE L G + Y D WS+G I E+L G P
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG---TPYGLECDWWSLGVILYEMLYGFP 228
Query: 225 LFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSA 284
F +T +++ + K+ ++F P P A
Sbjct: 229 PFYSDT---------------LQETYNKI-----------INWKESLRFPPD-PPVSPEA 261
Query: 285 LRLLERLLAFDPKDR-PTAEEALADPYFKGL 314
+ L+ RLL DP+DR + EE + P+FKG+
Sbjct: 262 IDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 90.2 bits (223), Expect = 7e-20
Identities = 78/295 (26%), Positives = 135/295 (45%), Gaps = 42/295 (14%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
+Y E IG+G+ G V +A+D TG++VAI++++ + I+ EI ++R ++P+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 138
IV L +++VV E + + + + L+AL+++H
Sbjct: 79 IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 139 TANVYHRDLKPKNILANANCKLKICDFGL-ARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
+ V HRD+K NIL + +K+ DFG A++ TP + V T ++ APE+
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 189
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257
Y P +DIWS+G + E++ G+P + +N + L L+ GTP L
Sbjct: 190 R--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPEL---------- 236
Query: 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312
+ P + S F + L R L D + R +A+E L + K
Sbjct: 237 ----------QNPEKLSAIFRD-------FLNRCLDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 8e-20
Identities = 74/222 (33%), Positives = 111/222 (50%), Gaps = 33/222 (14%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAAR--ILREIKL 70
D S KI+EVIG G +G VC G++ VAIK + + ++ R L E +
Sbjct: 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASI 58
Query: 71 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQ 129
+ HP+I+ ++ + + SR + ++ E ME+ L ++ ND QF + Q
Sbjct: 59 MGQFDHPNIIHLEGV-VTKSR----PVMIITEFMENGALDSFLRQNDG------QFTVIQ 107
Query: 130 L---LRA----LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT--PT-TI 179
L LR +KY+ N HRDL +NIL N+N K+ DFGL+R +DT PT T
Sbjct: 108 LVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTS 167
Query: 180 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
+ RW APE + K+T A D+WS G + EV++
Sbjct: 168 SLGGKIPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 73/295 (24%), Positives = 129/295 (43%), Gaps = 43/295 (14%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
+Y + IG+GS+G G++ IK+I+ + +E+ +L ++HP+
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQF--FLYQLLRALK 135
IV+ + S + ++Y+V + E DL++ I A + Q + Q+ ALK
Sbjct: 61 IVQYQE-----SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 136 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 195
++H + HRD+K +NI + +K+ DFG+ARV + T + T +Y +PE+
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS---TVELARTCIGTPYYLSPEI 172
Query: 196 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255
C + Y DIW++GC+ E+ T K F N M +L+ L I
Sbjct: 173 CEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGN-------MKNLV----LKIIRGSYP 219
Query: 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 310
+ Y +R L+ +L +P+DRP+ L +
Sbjct: 220 PVSSHYSYDLRN-------------------LVSQLFKRNPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 69/210 (32%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLR 75
+ ++I++ IG+G + V A + VA+KK+ IFE + AR ++EI LL+ L
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQ-IFEMMDAKARQDCVKEIDLLKQLN 60
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVI---KANDDLTREH--YQFFLYQ 129
HP++ IK++ S + ++ +V EL ++ DL Q+I K L E +++F+ Q
Sbjct: 61 HPNV--IKYL---DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV-Q 114
Query: 130 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 189
L A++++H+ V HRD+KP N+ A +K+ D GL R F + TT + V T +
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR--FFSSKTTAAHS-LVGTPY 171
Query: 190 YRAPELCGSFFSKYTPAIDIWSIGCIFAEV 219
Y +PE + Y DIWS+GC+ E+
Sbjct: 172 YMSPERIHE--NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 82/283 (28%), Positives = 132/283 (46%), Gaps = 38/283 (13%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR-ILREIKLLRLLRHPDIVEIKH 84
IG GS+G V A ++HT E VA+KK+ + ++ + I++E+K L+ L+HP+ +E K
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 85 IMLPPSRRDFKDIYVVFELME------SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 138
L K+ + + +ME SDL +V K L + L+ L Y+H
Sbjct: 89 CYL-------KE-HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH 138
Query: 139 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 198
+ N+ HRD+K NIL ++K+ DFG A + +P F V T ++ APE+ +
Sbjct: 139 SHNMIHRDIKAGNILLTEPGQVKLADFGSASKS---SPANSF----VGTPYWMAPEVILA 191
Query: 199 F-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257
+Y +D+WS+G E+ KP N + L + +P+L S D
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NDSPTLQ--SNEWTDS 248
Query: 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP 300
R ++ QK P P++ LL F +DRP
Sbjct: 249 FRGFVDYCL--------QKIPQERPASAELLRH--DFVRRDRP 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 76/303 (25%), Positives = 122/303 (40%), Gaps = 67/303 (22%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 85
I KG++G V A TG+ AIK +L++ ++ + ++ + I
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIK--------------VLKKSDMIAKNQVTNVKAERAI 49
Query: 86 MLPPSRRDF----------KD-IYVVFE-LMESDLHQVIKANDDLTREHYQFFLYQLLRA 133
M+ + KD +Y+V E L D +IK L + + ++ +++
Sbjct: 50 MMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLG 109
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 193
++ +H + HRD+KP+N+L + LK+ DFGL+R + +V T Y AP
Sbjct: 110 VEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-------KKFVGTPDYLAP 162
Query: 194 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252
E + G D WS+GC+ E L G P F TP
Sbjct: 163 ETILG---VGDDKMSDWWSLGCVIFEFLFGYPPFHA--------------ETP------- 198
Query: 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA---EEALADP 309
D + S R P + P A+ L+ RLL DP R A +E + P
Sbjct: 199 ---DAVFDNILSRRINWP---EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP 252
Query: 310 YFK 312
+FK
Sbjct: 253 FFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 88/323 (27%), Positives = 136/323 (42%), Gaps = 73/323 (22%)
Query: 6 PEM-EFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI----HDIFEHISD 60
PE+ E FS+ + IG GS+G V A D T E VAIKK+ E D
Sbjct: 2 PEIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD 61
Query: 61 AARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME------SDLHQVIKA 114
I++E++ L+ LRHP+ +E K L R+ + + +ME SD+ +V K
Sbjct: 62 ---IIKEVRFLQQLRHPNTIEYKGCYL----RE----HTAWLVMEYCLGSASDILEVHK- 109
Query: 115 NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174
L + L+ L Y+H+ HRD+K NIL +K+ DFG A +
Sbjct: 110 -KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV--- 165
Query: 175 TPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVV 232
+P F V T ++ APE+ + +Y +D+WS+G E+ K PLF
Sbjct: 166 SPANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF------ 215
Query: 233 HQLDLMTDLL-----GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRL 287
++ M+ L +P+L +S F N
Sbjct: 216 -NMNAMSALYHIAQNDSPTL---------------------SSNDWSDYFRN-------F 246
Query: 288 LERLLAFDPKDRPTAEEALADPY 310
++ L P+DRP++EE L +
Sbjct: 247 VDSCLQKIPQDRPSSEELLKHRF 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 65/265 (24%), Positives = 121/265 (45%), Gaps = 24/265 (9%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPD 78
++I +G+G YG V A TGE VA+K++ + +++ +L E +L +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI 137
+V++ + + +D + +Y+ E + D ++ L+ +H +F++ ++ A+ +
Sbjct: 63 LVKLLY-----AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDAL 117
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
H HRDLKP+N L +A+ +K+ DFGL++ + + DY+ APE+
Sbjct: 118 HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYM------APEVLR 171
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL------LGTPSLDTIS 251
Y +D WS+GC+ E L G P F G + +L L P D
Sbjct: 172 G--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN---ETWENLKYWKETLQRPVYDDPR 226
Query: 252 RVRNDKARRYLTSMRKKQPVQFSQK 276
+D+A +T + +F
Sbjct: 227 FNLSDEAWDLITKLINDPSRRFGSL 251
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 84/300 (28%), Positives = 131/300 (43%), Gaps = 54/300 (18%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRHP 77
Y V+GKGSYG V G++ IKK++ + S R +E +LL L+HP
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLN--LRNASRRERKAAEQEAQLLSQLKHP 59
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD---LTREHYQFFLYQLLRA 133
+IV + + +Y+V E DL+ +K + ++F+ Q+ A
Sbjct: 60 NIVAYRE----SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFV-QIAMA 114
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN--DTPTTIFWTDYVATRWYR 191
L+Y+H ++ HRDLK +N+ +K+ D G+ARV N D +T+ T Y Y
Sbjct: 115 LQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPY-----YM 169
Query: 192 APELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250
+PEL F +K Y D+W++GC E+ T K F K+ M L +
Sbjct: 170 SPEL---FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-------MNSL--------V 211
Query: 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 310
R+ K L M K P L+ +L+ P+ RP+ + L PY
Sbjct: 212 YRIIEGK----LPPMPKDY-----------SPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKI----HDIFEHISDAARILREIKLLRLLRHPDI 79
EV+GKG+YG V + T+ G+ +A+K++ ++ + ++ E+ LL+ L+H +I
Sbjct: 6 EVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 80 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIH 138
V+ L D I + E + + ++ L + + Q+L + Y+H
Sbjct: 65 VQYLGTCL-----DDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119
Query: 139 TANVYHRDLKPKNILANANCKLKICDFGLAR----VAFNDTPTTIFWTDYVATRWYRAPE 194
V HRD+K N++ N +K+ DFG AR V + T + + + + T ++ APE
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH-GTPYWMAPE 178
Query: 195 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 224
+ S Y DIWSIGC E+ TGKP
Sbjct: 179 VINE--SGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 64/229 (27%), Positives = 106/229 (46%), Gaps = 27/229 (11%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEK-VAIKKIH--------DIFEHISDAARILREIKL 70
Y + E +G G++G V + G+ +A+K+I+ D E I+ E+ +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 71 LR-LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIK-ANDDLTREHYQ 124
++ LRHP+IV L R +Y+V +L+E + +K T E
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDR-----LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW 116
Query: 125 FFLYQLLRALKYIHTAN-VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD 183
Q++ AL+Y+H + HRDL P NI+ + K+ I DFGLA+ ++ T
Sbjct: 117 NIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES----KLTS 172
Query: 184 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 232
V T Y PE+ + Y D+W+ GCI ++ T +P F N++
Sbjct: 173 VVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNML 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 66/226 (29%), Positives = 105/226 (46%), Gaps = 20/226 (8%)
Query: 11 FSEYGDAS-RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIK---KIHDIFEHISDAARILR 66
F + D S ++I E IGKG+YG V ++ G K A+K IHDI E I IL+
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILK 69
Query: 67 EIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQ-VIKANDDLTRE 121
L HP++V+ + ++ +++V EL +DL + +K + +
Sbjct: 70 A-----LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP 124
Query: 122 HYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 181
+ L++ L L+++H HRD+K NIL +K+ DFG V+ T T +
Sbjct: 125 IIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRR 181
Query: 182 TDYVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 224
V T ++ APE+ S Y D+WS+G E+ G P
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 68/219 (31%), Positives = 116/219 (52%), Gaps = 20/219 (9%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLR 75
+ ++I++ IG+G + V A G VA+KK+ IF+ + AR ++EI LL+ L
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQ-IFDLMDAKARADCIKEIDLLKQLN 60
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVI---KANDDLTREH--YQFFLYQ 129
HP++++ + + ++ +V EL ++ DL ++I K L E +++F+ Q
Sbjct: 61 HPNVIKYYASFIEDN-----ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV-Q 114
Query: 130 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 189
L AL+++H+ V HRD+KP N+ A +K+ D GL R F + TT + V T +
Sbjct: 115 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR--FFSSKTTAAHS-LVGTPY 171
Query: 190 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 228
Y +PE + Y DIWS+GC+ E+ + F G
Sbjct: 172 YMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 73/299 (24%), Positives = 132/299 (44%), Gaps = 41/299 (13%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 85
+G+G+ G V +TG A+K I + +ILRE+++ + + P IV+
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTI-TTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 86 MLPPSRRDFKDIYVVFELMES----DLHQVIKANDDLTREHYQFFLYQ-LLRALKYIHTA 140
L S I + E E +++ +K E + + +L+ L Y+H+
Sbjct: 68 FLDESS---SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124
Query: 141 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSF 199
+ HRD+KP NIL ++K+CDFG++ N T + T +Y APE + G
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-----FTGTSFYMAPERIQG-- 177
Query: 200 FSKYTPAIDIWSIGCIFAEVLTGKPLFP--GKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257
Y+ D+WS+G EV + FP G+ + ++L++ ++ P+ + N
Sbjct: 178 -KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG- 235
Query: 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316
+++S++F + +++ L DP RPT + L P+ K K
Sbjct: 236 -------------IKWSEEFKD-------FIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 5e-18
Identities = 91/351 (25%), Positives = 148/351 (42%), Gaps = 62/351 (17%)
Query: 3 QNSPEMEFFSEYG---DAS--RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH 57
Q+ E F+ G D S R+KI ++G+G++G V A D E A+K + ++ ++
Sbjct: 109 QSREEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY 168
Query: 58 ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD----IYVVFELMESDLHQVIK 113
DA +I EI+ + +R D + +M +R F++ + +V L I
Sbjct: 169 TRDA-KI--EIQFMEKVRQADPADRFPLM--KIQRYFQNETGHMCIVMPKYGPCLLDWIM 223
Query: 114 ANDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANAN--------------- 157
+ + H ++Q AL Y HT ++ H DLKP+NIL +
Sbjct: 224 KHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPD 283
Query: 158 -CKLKICDFG------LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 210
C+++ICD G +R A V+TR YR+PE+ Y+ D+W
Sbjct: 284 PCRVRICDLGGCCDERHSRTAI------------VSTRHYRSPEVVLGLGWMYS--TDMW 329
Query: 211 SIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQP 270
S+GCI E+ TGK L+ + + L LM LG + R ++AR S + +P
Sbjct: 330 SMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRP 389
Query: 271 VQFSQKFPN-----------ADPSALRLLERLLAFDPKDRPTAEEALADPY 310
+ D L+ LL +D + R A + PY
Sbjct: 390 CTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440
|
Length = 467 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 9e-18
Identities = 69/214 (32%), Positives = 102/214 (47%), Gaps = 36/214 (16%)
Query: 26 IGKGSYGVVCSA----IDTHTGEKVAIKKI-HDIFE-HISDAARILREIKLLRLLRHPDI 79
+G+G +G V + +TGE+VA+K + H E H SD REI++LR L H +I
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD---FEREIEILRTLDHENI 68
Query: 80 VEIKHIMLPPSRRDFKDIYVVFELMES----DLHQVIKANDDLTREHYQFFLYQLLRALK 135
V+ K + P R + ++ E + S D Q + +L R F Q+ + +
Sbjct: 69 VKYKGVCEKPGGRSLR---LIMEYLPSGSLRDYLQRHRDQINLKR--LLLFSSQICKGMD 123
Query: 136 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR------- 188
Y+ + HRDL +NIL + +KI DFGLA+V D DY +
Sbjct: 124 YLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED-------KDYYYVKEPGESPI 176
Query: 189 -WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
WY APE C SK++ A D+WS G E+ T
Sbjct: 177 FWY-APE-CLR-TSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 23 QEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 79
Q+VIG G +G V I G K VAIK + + L E ++ H +I
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-KQRQDFLSEASIMGQFSHHNI 68
Query: 80 VEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFLYQLLRA----L 134
+ ++ ++ FK ++ E ME+ L + ++ +D E + L +LR +
Sbjct: 69 IRLEGVV-----TKFKPAMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGM 120
Query: 135 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD--YVATRWYRA 192
KY+ N HRDL +NIL N+N + K+ DFGL+RV D P + T + RW A
Sbjct: 121 KYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV-LEDDPEGTYTTSGGKIPIRW-TA 178
Query: 193 PELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
PE + K+T A D+WS G + EV++
Sbjct: 179 PEAIA--YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 57/224 (25%), Positives = 100/224 (44%), Gaps = 30/224 (13%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGE-----KVAIKKIHDIFEHISDAARILREIKL 70
D S + +G G +GVV H G+ VAIK I E + E K+
Sbjct: 2 DPSELTFLKELGSGQFGVV------HLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKV 52
Query: 71 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFL-- 127
+ L HP++V++ + + I++V E M + L ++ + ++ L
Sbjct: 53 MMKLSHPNLVQLYGVCT-----KQRPIFIVTEYMANGCLLNYLRERKG--KLGTEWLLDM 105
Query: 128 -YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA 186
+ A++Y+ + HRDL +N L + +K+ DFGLAR +D T+ T +
Sbjct: 106 CSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF-P 164
Query: 187 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 229
+W PE+ +S+++ D+WS G + EV + GK +
Sbjct: 165 VKW-APPEVFD--YSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 30/223 (13%)
Query: 16 DASRYKIQ-----EVIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIF-----EHISDAAR 63
D S +K+ E +G GS+G V A TGE AIK K +I +H++
Sbjct: 11 DTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKS 70
Query: 64 ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY 123
IL E L HP IV + +R F +VV + + L + + +D+ +
Sbjct: 71 ILME------LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAK--- 121
Query: 124 QFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD 183
F+ +L+ A +Y+H+ ++ +RDLKP+N+L + +K+ DFG A+ + T T
Sbjct: 122 -FYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT------ 174
Query: 184 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 226
T Y APE+ S + A+D W++G + E + G P F
Sbjct: 175 LCGTPEYLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 77/308 (25%), Positives = 122/308 (39%), Gaps = 65/308 (21%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI---------LREIKLLRLLRH 76
+GKG +G VC+ TG+ A KK+ D R+ L E K+L +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKL--------DKKRLKKRKGEQMALNEKKILEKVSS 52
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLRA 133
IV + + D+ +V LM DL I + F+ Q++
Sbjct: 53 RFIVSLAYAFETKD-----DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG 107
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 193
L+++H + +RDLKP+N+L + + ++I D GLA V T Y AP
Sbjct: 108 LEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKI---KGRAGTPGYMAP 163
Query: 194 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253
E+ Y ++D +++GC E++ G+ F R
Sbjct: 164 EVLQG--EVYDFSVDWFALGCTLYEMIAGRSPF-------------------------RQ 196
Query: 254 RNDKARRY-LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALA 307
R +K + L + V++ KF P A L E LL DP+ R +A+E
Sbjct: 197 RKEKVEKEELKRRTLEMAVEYPDKF---SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253
Query: 308 DPYFKGLS 315
P FK L+
Sbjct: 254 HPLFKDLN 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 68/212 (32%), Positives = 109/212 (51%), Gaps = 33/212 (15%)
Query: 26 IGKGSYGVV--C--SAIDTHTGEKVAIKKI-HDIFEHISDAARILREIKLLRLLRHPDIV 80
+GKG++G V C + +TGE VA+KK+ H EH+ D REI++L+ L+H +IV
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRD---FEREIEILKSLQHDNIV 68
Query: 81 EIKHIMLPPSRRDFKDIYVVFE-LMESDLHQVIKANDDLTREHYQFFLY--QLLRALKYI 137
+ K + RR+ + +V E L L ++ + + +H + LY Q+ + ++Y+
Sbjct: 69 KYKGVCYSAGRRNLR---LVMEYLPYGSLRDYLQKHRERL-DHRKLLLYASQICKGMEYL 124
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR--------W 189
+ HRDL +NIL + ++KI DFGL +V D +Y R W
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD-------KEYYKVREPGESPIFW 177
Query: 190 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
Y APE SK++ A D+WS G + E+ T
Sbjct: 178 Y-APESLTE--SKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 79/298 (26%), Positives = 124/298 (41%), Gaps = 33/298 (11%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
+ +G G+ G V TG +A K +H I S +ILRE++++ R
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVH-IGAKSSVRKQILRELQIMHECR 61
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFLYQLLRAL 134
P IV L + +I + E M+ L ++ K + E ++ L
Sbjct: 62 SPYIVSFYGAFLNEN-----NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGL 116
Query: 135 KYIHTAN-VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 193
Y++ + + HRD+KP NIL N+ ++K+CDFG++ N T +V T Y +P
Sbjct: 117 TYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT-----FVGTSTYMSP 171
Query: 194 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253
E KYT D+WS+G E+ GK FP D D +G LD + ++
Sbjct: 172 ERIQG--GKYTVKSDVWSLGISIIELALGK--FPFAFSNIDDDGQDDPMGI--LDLLQQI 225
Query: 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311
+ P S FP ++ L DP +RPT ++ A P F
Sbjct: 226 VQEPP-----------PRLPSSDFP---EDLRDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 4e-17
Identities = 65/203 (32%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 42 TGEKVAIKKIHDIFEHISDA---ARILREIKLLRLLRHPDIVE-IKHIMLPPSRRDFKDI 97
TG +VAIK + + + AR RE L L HP+IV + PP +
Sbjct: 2 TGHEVAIKLLRT--DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-----L 54
Query: 98 YVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL--- 153
+ VFE + L +V+ A+ L + Q+L AL H + HRDLKP+NI+
Sbjct: 55 FAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQ 114
Query: 154 ANANCKLKICDFGLAR----VAFNDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAID 208
K+ DFG+ V D T T+ + T Y APE L G TP D
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRG---EPVTPNSD 171
Query: 209 IWSIGCIFAEVLTGKPLFPGKNV 231
+++ G IF E LTG+ + G +V
Sbjct: 172 LYAWGLIFLECLTGQRVVQGASV 194
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 66/234 (28%), Positives = 103/234 (44%), Gaps = 40/234 (17%)
Query: 21 KIQEVIGKGSYGVVCSAI-DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 79
K++ +G G +G V + T KVA+K + L+E ++++ LRH +
Sbjct: 9 KLERKLGAGQFGEVWMGTWNGTT--KVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKL 63
Query: 80 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND--DLTREHYQFFLYQLLRALKY 136
V++ + S + IY+V E M L +K+ + L Q+ + Y
Sbjct: 64 VQLYAVC---SEEE--PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTDYVATRW 189
+ + N HRDL +NIL N KI DFGLAR+ +D T I WT
Sbjct: 119 LESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT------- 171
Query: 190 YRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLDL 237
APE G F K D+WS G + E++T G+ +PG V+ Q++
Sbjct: 172 --APEAANYGRFTIKS----DVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 5e-17
Identities = 55/211 (26%), Positives = 102/211 (48%), Gaps = 9/211 (4%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH---DIFEHISDAARILREIKLLRLL 74
+ +++ +++G+G++G V D TG ++A+K++ + E + + EI+LL+ L
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 75 RHPDIVEIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKANDDLTREHYQFFLYQLLRA 133
H IV+ + P R + E M + +K+ LT + + Q+L
Sbjct: 62 LHERIVQYYGCLRDPMERTLS---IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEG 118
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 193
+ Y+H+ + HRD+K NIL ++ +K+ DFG ++ + T ++ +P
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 194 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 224
E+ Y DIWS+GC E+LT KP
Sbjct: 179 EVISG--EGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 5e-17
Identities = 55/208 (26%), Positives = 104/208 (50%), Gaps = 7/208 (3%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH---DIFEHISDAARILREIKLLRLLRH 76
+++ +++G+G++G V D TG ++A+K++ D E + + EI+LL+ LRH
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 136
IV+ + P + I+V + + + +KA LT + + Q+L+ + Y
Sbjct: 64 DRIVQYYGCLRDPEEKKLS-IFVEY-MPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 196
+H+ + HRD+K NIL ++ +K+ DFG ++ + T ++ +PE+
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKP 224
Y D+WS+ C E+LT KP
Sbjct: 182 SG--EGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 7e-17
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 26 IGKGSYGVVCSAIDTHTGE-----KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 80
+G G +GVV H G+ KVAIK I++ D + E K++ L HP +V
Sbjct: 12 LGSGQFGVV------HLGKWRAQIKVAIKAINEGAMSEED---FIEEAKVMMKLSHPKLV 62
Query: 81 EIKHIMLPPSRRDFKDIYVVFELMESD--LHQVIKANDDLTREHYQFFLYQLLRALKYIH 138
++ + K +Y+V E ME+ L+ + + L+++ + ++Y+
Sbjct: 63 QLYGVCTQQ-----KPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE 117
Query: 139 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 198
+ HRDL +N L ++ +K+ DFG+ R +D T+ + +W PE+
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKW-SPPEVFN- 174
Query: 199 FFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 230
FSKY+ D+WS G + EV T GK F K+
Sbjct: 175 -FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 8e-17
Identities = 65/208 (31%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRHPDIVEI 82
+G G+ GVV + +G +A K IH E I A R I+RE+K+L P IV
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIH--LE-IKPAIRNQIIRELKVLHECNSPYIVGF 64
Query: 83 KHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA- 140
+ +I + E M+ L QV+K + +LR L Y+
Sbjct: 65 YG-----AFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH 119
Query: 141 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSF 199
+ HRD+KP NIL N+ ++K+CDFG++ + + +V TR Y +PE L G
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQG-- 172
Query: 200 FSKYTPAIDIWSIGCIFAEVLTGKPLFP 227
+ YT DIWS+G E+ G+ +P
Sbjct: 173 -THYTVQSDIWSLGLSLVEMAIGR--YP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 85/350 (24%), Positives = 147/350 (42%), Gaps = 67/350 (19%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLL-RHPDIVEI 82
V+GKGS+G V A T E A+K + D+ D + E ++L L +HP + ++
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 83 KHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 138
R +F +ME DL I+ + +F+ +++ L+++H
Sbjct: 62 HSCFQTKDR--------LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 139 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 198
+ +RDLK N+L ++ +KI DFG+ + TT + + T Y APE+
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPEILS- 169
Query: 199 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 258
+ Y PA+D W++G + E+L G+ F G + D + + +
Sbjct: 170 -YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE----------------DELFQSILEDE 212
Query: 259 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR----PTAEEALAD-PYFKG 313
RY + K+ A +L+ L +P+ R PT E+ + P+F+
Sbjct: 213 VRYPRWLSKE---------------AKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257
Query: 314 L--SKVER---EPSCQPISKMEF-------EFERRRVTKEDIRELIFREI 351
+ K+ER +P +P K F EF + + E I R I
Sbjct: 258 IDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFTKEKPVLTPPDEAIIRNI 307
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTG-----EKVAIKKIHDIFEHISDAARILREIKL 70
S + + IG G +G+V G KVAIK I + D + E ++
Sbjct: 2 HPSELTLVQEIGSGQFGLV------WLGYWLEKRKVAIKTIREGAMSEED---FIEEAQV 52
Query: 71 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKAND-DLTREHYQFFLY 128
+ L HP +V++ + S I +VFE ME L ++A ++E
Sbjct: 53 MMKLSHPKLVQLYGVCTERS-----PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCL 107
Query: 129 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 188
+ + Y+ ++NV HRDL +N L N +K+ DFG+ R +D T+ T + +
Sbjct: 108 DVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF-PVK 166
Query: 189 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
W +PE+ FSKY+ D+WS G + EV +
Sbjct: 167 W-SSPEVFS--FSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 83/286 (29%), Positives = 130/286 (45%), Gaps = 48/286 (16%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR-ILREIKLLRLLRHPDIVEIKH 84
IG GS+G V A D T E VAIKK+ + ++ + I++E+K L+ ++HP+ +E K
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 85 IMLPPSRRDFKDIYVVFELM---ESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN 141
L ++V E SDL +V K L + L+ L Y+H+ N
Sbjct: 93 CYLRE-----HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN 145
Query: 142 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF-F 200
+ HRD+K NIL ++K+ DFG A +A +P F V T ++ APE+ +
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIA---SPANSF----VGTPYWMAPEVILAMDE 198
Query: 201 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260
+Y +D+WS+G E+ KP N + L + +P+L
Sbjct: 199 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPTL------------- 244
Query: 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 306
Q ++S F N S L+ + P+DRPT+EE L
Sbjct: 245 --------QSNEWSDYFRNFVDSCLQKI-------PQDRPTSEELL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 81/293 (27%), Positives = 124/293 (42%), Gaps = 41/293 (13%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 83
E IGKGS+G V ID T E VAIK I D+ E + I +EI +L P I
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68
Query: 84 HIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVY 143
L ++ ++++ E + + L + L ++L+ L Y+H+
Sbjct: 69 GSYLKGTK-----LWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKI 123
Query: 144 HRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKY 203
HRD+K N+L + +K+ DFG VA T T I +V T ++ APE+ S Y
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFG---VAGQLTDTQIKRNTFVGTPFWMAPEVIKQ--SAY 178
Query: 204 TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLT 263
DIWS+G E+ G+P + + L L+ P+L+
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK-NSPPTLEG-------------- 223
Query: 264 SMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316
Q+S+ F +E L DP+ RPTA+E L + +K
Sbjct: 224 --------QYSKPFKE-------FVEACLNKDPRFRPTAKELLKHKFITRYTK 261
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 61/223 (27%), Positives = 107/223 (47%), Gaps = 17/223 (7%)
Query: 24 EVIGKGSYG---VVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 80
+V+G+GS+G +V G+ A+K + + D R E +L + HP IV
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 81 EIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHT 139
++ + + +Y++ + + DL + T E +F+L +L AL ++H+
Sbjct: 62 KLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 116
Query: 140 ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF 199
+ +RDLKP+NIL + +K+ DFGL++ + + + T Y APE+
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVNR- 172
Query: 200 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242
+T + D WS G + E+LTG F GK + + MT +L
Sbjct: 173 -RGHTQSADWWSFGVLMFEMLTGSLPFQGK---DRKETMTMIL 211
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 16/212 (7%)
Query: 25 VIGKGSYGVVCSAIDTH---TGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHPDI 79
V+GKG YG V TG+ A+K K I + D A E +L ++HP I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 80 VEIKHIMLPPSRRDFKDIYVVFE-LMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 138
V++ + + +Y++ E L +L ++ + F+L ++ AL+++H
Sbjct: 63 VDLIYAFQTGGK-----LYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH 117
Query: 139 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 198
+ +RDLKP+NIL +A +K+ DFGL + + ++ T + T Y APE+
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT---HTFCGTIEYMAPEILMR 174
Query: 199 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 230
S + A+D WS+G + ++LTG P F +N
Sbjct: 175 --SGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 4e-16
Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 14/202 (6%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKI-HDIFEHISDAARILREIKLLR---LLRHPDIVE 81
IGKG++G V T A+K + + A + E +L L P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 82 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 140
+K S D+Y+V + M +L ++ + + +F++ +L+ AL+++H
Sbjct: 61 LKFSFQTDS-----DLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 141 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF 200
++ +RDLKP+NIL +A + +CDFGL++ D TT + T Y APE+
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT---NTFCGTTEYLAPEVLLD-E 171
Query: 201 SKYTPAIDIWSIGCIFAEVLTG 222
YT +D WS+G + E+ G
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 76/300 (25%), Positives = 120/300 (40%), Gaps = 61/300 (20%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDT-HTGEKVAIK-KIHDIFEHISDAARILREIKLLRLLR 75
+ IG+G +G V + EK+A+ K S + L+E ++R
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 76 HPDIVE-IKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLR 132
HP IV+ I I P +++V EL +L ++ N L + YQL
Sbjct: 66 HPHIVKLIGVITENP-------VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR---- 188
AL Y+ + HRD+ +N+L ++ +K+ DFGL+R +++ Y A++
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY-------YKASKGKLP 171
Query: 189 --WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPGKNVVHQLDLMTDLLGT 244
W APE F ++T A D+W G E+L KP G
Sbjct: 172 IKWM-APESIN--FRRFTSASDVWMFGVCMWEILMLGVKPFQ----------------GV 212
Query: 245 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 304
+ D I R+ N + R P PN P+ L+ + A+DP RP E
Sbjct: 213 KNNDVIGRIENGE--------RLPMP-------PNCPPTLYSLMTKCWAYDPSKRPRFTE 257
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 6e-16
Identities = 77/293 (26%), Positives = 126/293 (43%), Gaps = 38/293 (12%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 79
+++ + IG G+YG V A + +TGE AIK I E D A + +EI +++ +H +I
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 80 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIH 138
V L RRD +++ E L + L+ + + L+ L Y+H
Sbjct: 69 VAYFGSYL---RRD--KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 139 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG- 197
+ HRD+K NIL N +K+ DFG V+ T T ++ T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFG---VSAQITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257
Y DIW++G E+ +P + + L LMT P
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP----------- 229
Query: 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 310
+ K +++S F + ++ L +PK RPTAE+ L P+
Sbjct: 230 --------KLKDKMKWSNSFHH-------FVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-16
Identities = 73/300 (24%), Positives = 130/300 (43%), Gaps = 52/300 (17%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEI 82
+++GKG++G V + TG+ A+K + ++ + A L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 83 KHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV 142
K+ R F Y + L + ++D R F+ +++ AL Y+H+ +V
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR----FYGAEIVSALGYLHSCDV 116
Query: 143 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 202
+RDLK +N++ + + +KI DFGL + +D T + T Y APE+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED--ND 171
Query: 203 YTPAIDIWSIGCIFAEVLTGKPLFPGK--NVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260
Y A+D W +G + E++ G+ F + + +L LM ++
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI------------------- 212
Query: 261 YLTSMRKKQPVQFSQKFP-NADPSALRLLERLLAFDPKDR-----PTAEEALADPYFKGL 314
+FP P A LL LL DPK R A+E + +F +
Sbjct: 213 ---------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 79/299 (26%), Positives = 123/299 (41%), Gaps = 54/299 (18%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRLL----RHPD 78
V+G+G +G V A TGE AIK K DI D L K + RHP
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR--DEVESLMCEKRIFETANSERHPF 63
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI 137
+V + + V E DL I D + F+ ++ L+Y+
Sbjct: 64 LVNLFACFQTEDH-----VCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYL 117
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTDYVATRWYRAPEL 195
H + +RDLK N+L + +KI DFGL + + F D +T + T + APE+
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-----FCGTPEFLAPEV 172
Query: 196 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255
+ YT A+D W +G + E+L G+ FPG + D + N
Sbjct: 173 LTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD---------------SIVN 215
Query: 256 DKAR--RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312
D+ R R+L+ ++ + ++ +P ER L KD AE+ P+F+
Sbjct: 216 DEVRYPRFLS----REAISIMRRLLRRNP------ERRLGSGEKD---AEDVKKQPFFR 261
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 61/236 (25%), Positives = 99/236 (41%), Gaps = 20/236 (8%)
Query: 1 MLQNSPEMEFFSEYGDAS-RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIK---KIHDIFE 56
+ + M GD + ++I E IGKG+YG V + G A+K I D+ E
Sbjct: 4 LFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE 63
Query: 57 HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESD-----LHQV 111
I IL+ L HP++V+ + + +++V EL + +
Sbjct: 64 EIEAEYNILQS-----LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGL 118
Query: 112 IKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171
+ L + LY L L+++H + HRD+K NIL +K+ DFG V+
Sbjct: 119 LICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG---VS 175
Query: 172 FNDTPTTIFWTDYVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 224
T T + V T ++ APE+ + Y D+WS+G E+ G P
Sbjct: 176 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 8e-16
Identities = 78/331 (23%), Positives = 130/331 (39%), Gaps = 77/331 (23%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHPDIVE 81
+VIG+G++G V TG A+KK+ ++ E A + E +L +P +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEK-EQVAHVRAERDILAEADNPWVVK 65
Query: 82 IKHIMLPPSRRDFKDIYVVFE-LMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 140
+ + S +D +Y++ E L D+ ++ D T E +F++ + + A+ IH
Sbjct: 66 LYY-----SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 141 NVYHRDLKPKNILANANCKLKICDFGL------------ARVAFNDTPTTIFWTDY---- 184
HRD+KP N+L +A +K+ DFGL R+ + P+
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 185 -------------------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 225
V T Y APE+ + Y D WS+G I E+L G P
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIMYEMLVGYPP 238
Query: 226 FPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSAL 285
F ++ Y + K+ +QF + P P A
Sbjct: 239 F--------------------------CSDNPQETYRKIINWKETLQFPDEVP-LSPEAK 271
Query: 286 RLLERLLAFDPKDR---PTAEEALADPYFKG 313
L++RL + + R E + P+FKG
Sbjct: 272 DLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 79/339 (23%), Positives = 135/339 (39%), Gaps = 88/339 (25%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISD--AARILREIKLLRLLR 75
+K +++GKG G V TG+ A+K + D E I R+L E ++L L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVL-DKKEMIKRNKVKRVLTEQEILATLD 59
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDD--LTREHYQFFLYQ 129
HP + + F+ + +M+ +L ++++ L+ E +F+ +
Sbjct: 60 HPFLPTLYA--------SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAE 111
Query: 130 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT------- 182
+L AL+Y+H + +RDLKP+NIL + + + + DF L++ + + P +
Sbjct: 112 VLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQS-DVEPPPVSKALRKGSRR 170
Query: 183 --------------------DYVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEV 219
+V T Y APE+ G + A+D W++G + E+
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-----HGSAVDWWTLGILLYEM 225
Query: 220 LTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPN 279
L G F G N R++ L K+ V F P
Sbjct: 226 LYGTTPFKGSN-----------------------RDETFSNIL-----KKEVTFPGSPP- 256
Query: 280 ADPSALR-LLERLLAFDPKDR----PTAEEALADPYFKG 313
S+ R L+ +LL DP R A E P+F+G
Sbjct: 257 -VSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 63/218 (28%), Positives = 109/218 (50%), Gaps = 17/218 (7%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHD-IFEHISDAARILREIK-LLRLLRHPDIVE 81
+VIGKGS+G V A G+ A+K + I + + I+ E LL+ ++HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 82 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 140
+ + S + + +Y V + + +L ++ +F+ ++ AL Y+H+
Sbjct: 61 LHY-----SFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115
Query: 141 NVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTDYVATRWYRAPELCGS 198
N+ +RDLKP+NIL ++ + + DFGL + +A +DT TT + T Y APE+
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT-----FCGTPEYLAPEVIRK 170
Query: 199 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 236
Y +D W +G + E+L G P F ++V D
Sbjct: 171 --QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 83
E IGKGS+G V ID T + VAIK I D+ E + I +EI +L P + +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 84 HIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVY 143
L ++ ++++ E + + L L ++L+ L Y+H+
Sbjct: 69 GSYLKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI 123
Query: 144 HRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKY 203
HRD+K N+L + + ++K+ DFG VA T T I +V T ++ APE+ S Y
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFG---VAGQLTDTQIKRNTFVGTPFWMAPEVIKQ--SAY 178
Query: 204 TPAIDIWSIGCIFAEVLTGKP 224
DIWS+G E+ G+P
Sbjct: 179 DSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR-ILREIKLLRLLRHPDIVEIKH 84
IG GS+G V A D E VAIKK+ + ++ + I++E++ L+ LRHP+ ++ +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 85 IMLPPSRRDFKDIYVVFELME------SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 138
L + + +ME SDL +V K L + L+ L Y+H
Sbjct: 83 CYLRE--------HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH 132
Query: 139 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 198
+ N+ HRD+K NIL + +K+ DFG A + P F V T ++ APE+ +
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXF----VGTPYWMAPEVILA 185
Query: 199 F-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 235
+Y +D+WS+G E+ KP N + L
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 56/229 (24%), Positives = 99/229 (43%), Gaps = 23/229 (10%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-HDIFEHISDAARILREIKLLRLLRH 76
+ ++ +G G +G V + +VAIK + D D + E++ L+ LRH
Sbjct: 6 EEFTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQK---EVQALKRLRH 61
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLRA 133
++ + + +Y++ ELME L +++ + L Q+
Sbjct: 62 KHLISL-FAVCSVGE----PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEG 116
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD--YVATRWYR 191
+ Y+ N HRDL +NIL + K+ DFGLAR+ D ++ + + +W
Sbjct: 117 MAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED----VYLSSDKKIPYKW-T 171
Query: 192 APELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMT 239
APE ++ D+WS G + E+ T G+ +PG N D +T
Sbjct: 172 APEAAS--HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 17/212 (8%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEI 82
+V+GKGS+G V A T E AIK + D+ D + E ++L L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA------- 53
Query: 83 KHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 138
KH L F+ +F +ME DL I+ + +F+ ++ AL ++H
Sbjct: 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113
Query: 139 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 198
V +RDLK NIL +A K+ DFG+ + + TT T + T Y APE+
Sbjct: 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQE 170
Query: 199 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 230
+Y P++D W++G + E++ G+P F N
Sbjct: 171 L--EYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 73/326 (22%), Positives = 123/326 (37%), Gaps = 57/326 (17%)
Query: 25 VIGKGSYG--VVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEI 82
+IGK +V A T VA+KKI+ D + +EI R L+HP+I+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 83 KHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY---------QFFLYQLLRA 133
+ ++YVV LM + +DL + H+ F L +L A
Sbjct: 65 VTSFI-----VDSELYVVSPLMA------YGSCEDLLKTHFPEGLPELAIAFILKDVLNA 113
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDF---------GLARVAFNDTPTTI----F 180
L YIH+ HR +K +IL + + K+ + G + +D P +
Sbjct: 114 LDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173
Query: 181 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 240
W +PE+ Y DI+S+G E+ G P K++ L+
Sbjct: 174 WL---------SPEVLQQNLQGYNEKSDIYSVGITACELANG--HVPFKDMPATQMLLEK 222
Query: 241 LLGT-PSL-------DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLL 292
+ GT P L + ++ + R +++ F + +E L
Sbjct: 223 VRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTF---SEHFHQFVELCL 279
Query: 293 AFDPKDRPTAEEALADPYFKGLSKVE 318
DP+ RP+A + L +FK +
Sbjct: 280 QRDPESRPSASQLLNHSFFKQCKRRN 305
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 83/304 (27%), Positives = 124/304 (40%), Gaps = 69/304 (22%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 85
+G G++G V A TG A K I E + + EI +L +HP+IV
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKII--QIESEEELEDFMVEIDILSECKHPNIVG---- 66
Query: 86 MLPPSRRDFKDIYVVFELMESDLHQVIK-----ANDD--------LTREHYQFFLYQLLR 132
+ Y E+ L +I+ A D LT ++ Q+L
Sbjct: 67 --------LYEAY----FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE 114
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 192
AL ++H+ V HRDLK NIL + +K+ DFG V+ + T ++ T ++ A
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFG---VSAKNKSTLQKRDTFIGTPYWMA 171
Query: 193 PEL--CGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD- 248
PE+ C +F Y DIWS+G E+ +P P H+L+ M LL +
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQMEP--PH----HELNPMRVLLKILKSEP 225
Query: 249 -TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
T+ QP ++S F + L+ L DP DRPTA E L
Sbjct: 226 PTLD-----------------QPSKWSSSFND-------FLKSCLVKDPDDRPTAAELLK 261
Query: 308 DPYF 311
P+
Sbjct: 262 HPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 64/250 (25%), Positives = 120/250 (48%), Gaps = 19/250 (7%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEI 82
+++GKG++G V + +G+ A+K + ++ + A L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 83 KHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV 142
K+ R F YV + L + ++D TR F+ +++ AL Y+H+ +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTR----FYGAEIVSALDYLHSGKI 116
Query: 143 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 202
+RDLK +N++ + + +KI DFGL + D T + T Y APE+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM---KTFCGTPEYLAPEVLED--ND 171
Query: 203 YTPAIDIWSIGCIFAEVLTGKPLFPGKN--VVHQLDLMTDLLGTPSLDTISRVRNDKARR 260
Y A+D W +G + E++ G+ F ++ + +L LM D+ R + A+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI-------KFPRTLSADAKS 224
Query: 261 YLTSMRKKQP 270
L+ + K P
Sbjct: 225 LLSGLLIKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-15
Identities = 55/205 (26%), Positives = 100/205 (48%), Gaps = 9/205 (4%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH---DIFEHISDAARILREIKLLRLLRHPDIV 80
+++G+G++G V D TG ++A K++ + E + + + EI+LL+ L+H IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 81 EIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHT 139
+ + R K + + E M + +KA LT + + Q+L + Y+H+
Sbjct: 68 QYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 140 ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF 199
+ HRD+K NIL ++ +K+ DFG ++ + T ++ +PE+
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG- 183
Query: 200 FSKYTPAIDIWSIGCIFAEVLTGKP 224
Y D+WS+GC E+LT KP
Sbjct: 184 -EGYGRKADVWSLGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 82/306 (26%), Positives = 130/306 (42%), Gaps = 51/306 (16%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPD 78
++ V+GKG +G VC+ TG+ A KK+ + A L E ++L +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 79 IVEIKHIMLPPSRRDFKD-IYVVFELMES-DL--HQVIKANDDLTREHYQFFLYQLLRAL 134
+V + + + KD + +V LM DL H N E F+ ++ L
Sbjct: 62 VVSLAYAY------ETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGL 115
Query: 135 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 194
+ +H + +RDLKP+NIL + ++I D GLA V + T V T Y APE
Sbjct: 116 EDLHRERIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETI---RGRVGTVGYMAPE 171
Query: 195 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254
+ + +YT + D W +GC+ E++ GK F R R
Sbjct: 172 VVKN--ERYTFSPDWWGLGCLIYEMIEGKSPF-------------------------RQR 204
Query: 255 NDKARRYLTSMR-KKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALAD 308
+K +R R K+ ++S+KF +A + +LL DP R AEE A
Sbjct: 205 KEKVKREEVERRVKEDQEEYSEKF---SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261
Query: 309 PYFKGL 314
P+F+
Sbjct: 262 PFFRTA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 5e-15
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 23/207 (11%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 83
E IGKGS+G V ID T + VAIK I D+ E + I +EI +L P + +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 84 HIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTR----EHYQF--FLYQLLRALKYI 137
L ++ ++++ E + + DL R + +Q L ++L+ L Y+
Sbjct: 69 GSYLKGTK-----LWIIMEYLGGG------SALDLLRAGPFDEFQIATMLKEILKGLDYL 117
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
H+ HRD+K N+L + +K+ DFG VA T T I +V T ++ APE+
Sbjct: 118 HSEKKIHRDIKAANVLLSEQGDVKLADFG---VAGQLTDTQIKRNTFVGTPFWMAPEVIQ 174
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKP 224
S Y DIWS+G E+ G+P
Sbjct: 175 Q--SAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 60/234 (25%), Positives = 100/234 (42%), Gaps = 56/234 (23%)
Query: 24 EVIGKGSYGVV-----CSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRH 76
+G+G++G V + E VA+K + + S+ AR RE +LL +H
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET---ASNDARKDFEREAELLTNFQH 67
Query: 77 PDIVEIKHIML---PPSRRDFKDIYVVFELME-SDLHQVIKAND--------------DL 118
+IV+ + PP +VFE ME DL++ ++++ +L
Sbjct: 68 ENIVKFYGVCTEGDPP--------IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 119 TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 178
T Q+ + Y+ + + HRDL +N L + +KI DFG++R
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR--------D 171
Query: 179 IFWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK 223
++ TDY + RW PE + K+T D+WS G + E+ T GK
Sbjct: 172 VYTTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 7e-15
Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 13/210 (6%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLR-HPDIVE 81
V+GKGS+G V A +G A+K + D+ D + E ++L L R HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 82 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 140
+ P R ++ V E + DL I+ + +F+ ++ AL ++H
Sbjct: 61 LYCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115
Query: 141 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF 200
+ +RDLK N+L + K+ DFG+ + + TT + + T Y APE+
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT---STFCGTPDYIAPEILQEML 172
Query: 201 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 230
Y P++D W++G + E+L G F +N
Sbjct: 173 --YGPSVDWWAMGVLLYEMLCGHAPFEAEN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 9e-15
Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 20/212 (9%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKL-LRLLRHPDIVEI 82
E +G+G+YGVV TG +A+K+I + R+L ++ + +R + P V
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQEQKRLLMDLDISMRSVDCPYTVTF 65
Query: 83 KHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL----YQLLRALKYIH 138
+ R D+++ E+M++ L + K D + L +++AL+Y+H
Sbjct: 66 YGALF---REG--DVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 139 TA-NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
+ +V HRD+KP N+L N N ++K+CDFG++ + TI + Y APE
Sbjct: 121 SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTI----DAGCKPYMAPERIN 176
Query: 198 SFFSK--YTPAIDIWSIGCIFAEVLTGKPLFP 227
++ Y D+WS+G E+ TG+ FP
Sbjct: 177 PELNQKGYDVKSDVWSLGITMIELATGR--FP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 66/255 (25%), Positives = 121/255 (47%), Gaps = 25/255 (9%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEI 82
+++GKG++G V + TG A+K + ++ + A + E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 83 KHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN 141
K+ R F V E +L + T E +F+ +++ AL+Y+H+ +
Sbjct: 61 KYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 115
Query: 142 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFS 201
V +RD+K +N++ + + +KI DFGL + +D T + T Y APE+ +
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED--N 170
Query: 202 KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH----QLDLMTDLLGTPSLDTISRVRNDK 257
Y A+D W +G + E++ G+ P N H +L LM ++ +L +
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELILMEEIRFPRTLSP-------E 221
Query: 258 ARRYLTSMRKKQPVQ 272
A+ L + KK P Q
Sbjct: 222 AKSLLAGLLKKDPKQ 236
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 75/309 (24%), Positives = 126/309 (40%), Gaps = 56/309 (18%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHD----IFEHISDAARILREIKLLRLLR 75
+ ++ ++G+G +G V + TG+ A+K + E +S E +L +
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVS---FFEEERDILSISN 59
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHY-QFFLYQLLRA 133
P I ++++ +D ++Y+V E DL ++ +D E QF+L +L+ A
Sbjct: 60 SPWIPQLQYAF-----QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA 114
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 193
+ +H HRD+KP+N+L + +K+ DFG A A + V T Y AP
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSA--ARLTANKMVNSKLPVGTPDYIAP 172
Query: 194 ELC----GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 249
E+ G Y D WS+G I E++ G+ F T
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA---------------KT 217
Query: 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADP----SALRLLERLLAFDPKDRPTAEEA 305
+ + N + R+L KFP DP L L++ LL K+R E
Sbjct: 218 YNNIMNFQ--RFL-------------KFP-EDPKVSSDFLDLIQSLLC-GQKERLGYEGL 260
Query: 306 LADPYFKGL 314
P+F +
Sbjct: 261 CCHPFFSKI 269
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 67/256 (26%), Positives = 120/256 (46%), Gaps = 26/256 (10%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEI 82
+++GKG++G V + TG A+K + ++ + A L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 83 KHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA- 140
K+ R F V E +L + + + +F+ +++ AL Y+H+
Sbjct: 61 KYSFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 115
Query: 141 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF 200
NV +RDLK +N++ + + +KI DFGL + D T + T Y APE+
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVLED-- 170
Query: 201 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH----QLDLMTDLLGTPSLDTISRVRND 256
+ Y A+D W +G + E++ G+ P N H +L LM ++ R +
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELILMEEI-------RFPRTLSP 221
Query: 257 KARRYLTSMRKKQPVQ 272
+A+ L+ + KK P Q
Sbjct: 222 EAKSLLSGLLKKDPKQ 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 79/313 (25%), Positives = 125/313 (39%), Gaps = 74/313 (23%)
Query: 21 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH--PD 78
+ IG G+ G V TG +A+K++ + + RIL ++ ++ L H P
Sbjct: 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRT-GNKEENKRILMDLDVV-LKSHDCPY 75
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFF--------LYQL 130
IV+ + D D+++ ELM + L D L + +
Sbjct: 76 IVKCYGYFI----TDS-DVFICMELMSTCL-------DKLLKRIQGPIPEDILGKMTVAI 123
Query: 131 LRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA-TR 188
++AL Y+ V HRD+KP NIL +A+ +K+CDFG++ D A TR
Sbjct: 124 VKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG----------RLVDSKAKTR 173
Query: 189 -----WYRAPELCG--SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 241
Y APE KY D+WS+G E+ TG+ FP KN + +++T +
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ--FPYKNCKTEFEVLTKI 231
Query: 242 LGT--PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR 299
L PSL ++ FS F ++ L D + R
Sbjct: 232 LQEEPPSLP------PNE--------------GFSPDF-------CSFVDLCLTKDHRKR 264
Query: 300 PTAEEALADPYFK 312
P E L P+ +
Sbjct: 265 PKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 62/225 (27%), Positives = 97/225 (43%), Gaps = 43/225 (19%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 83
IGKG +G V + G+KVA+K + D + A L E ++ LRHP++V++
Sbjct: 12 ATIGKGEFGDVMLG--DYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTLRHPNLVQLL 66
Query: 84 HIMLPPSRRDFKDIYVVFELME---------SDLHQVIKANDDLTREHYQFFLYQLLRAL 134
++L +Y+V E M S VI T F + +
Sbjct: 67 GVVL-----QGNPLYIVTEYMAKGSLVDYLRSRGRAVI------TLAQQLGFALDVCEGM 115
Query: 135 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF---WTDYVATRWYR 191
+Y+ N HRDL +N+L + + K+ DFGLA+ A + WT
Sbjct: 116 EYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT--------- 166
Query: 192 APELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK---PLFPGKNVV 232
APE K++ D+WS G + E+ + G+ P P K+VV
Sbjct: 167 APEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 3e-14
Identities = 70/234 (29%), Positives = 103/234 (44%), Gaps = 35/234 (14%)
Query: 3 QNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 62
+ SE +R IG G+ G V I TG A+K I+ E D
Sbjct: 65 SAPSAAKSLSELERVNR------IGSGAGGTVYKVIHRPTGRLYALKVIYGNHE---DTV 115
Query: 63 R--ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTR 120
R I REI++LR + HP++V+ H M + +I V+ E M+ + D+
Sbjct: 116 RRQICREIEILRDVNHPNVVKC-HDMFDHN----GEIQVLLEFMDGGSLEGTHIADEQFL 170
Query: 121 EHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT--PTT 178
Q+L + Y+H ++ HRD+KP N+L N+ +KI DFG++R+ T P
Sbjct: 171 ADVAR---QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRI-LAQTMDPC- 225
Query: 179 IFWTDYVATRWYRAPE-----LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 227
V T Y +PE L + Y A DIWS+G E G+ FP
Sbjct: 226 ---NSSVGTIAYMSPERINTDLNHGAYDGY--AGDIWSLGVSILEFYLGR--FP 272
|
Length = 353 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 13/216 (6%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHD--IFEHISDAARILREIKLLRLLRHPDIVE 81
+VIGKGS+G V A G A+K + I + + LL+ L+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 82 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 140
+ + + +Y V + + +L ++ +F+ ++ A+ Y+H+
Sbjct: 61 LHYSFQTAEK-----LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL 115
Query: 141 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF 200
N+ +RDLKP+NIL ++ + + DFGL + TT + + T Y APE+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGTPEYLAPEVLRK-- 170
Query: 201 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 236
Y +D W +G + E+L G P F ++V D
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 37/227 (16%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI---SDAARILREIK-LLRLLRHPDIV 80
VIGKGS+G V A G+ A+K + + I + I+ E LL+ ++HP +V
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQK--KAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 81 EIKHIMLPPSRRDFKDIYVVFELM---ESDLHQVIKANDDLTREHY------QFFLYQLL 131
+ + S + +Y V + + E H L RE +F+ ++
Sbjct: 60 GLHY-----SFQTADKLYFVLDYVNGGELFFH--------LQRERSFPEPRARFYAAEIA 106
Query: 132 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTDYVATRW 189
AL Y+H+ N+ +RDLKP+NIL ++ + + DFGL + + + T +T + T
Sbjct: 107 SALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-----FCGTPE 161
Query: 190 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 236
Y APE+ Y +D W +G + E+L G P F ++ D
Sbjct: 162 YLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 74/311 (23%), Positives = 124/311 (39%), Gaps = 61/311 (19%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 85
+GKG+YG V + TG +A+K+I + S +I+ E+ +L P IV+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE-SKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 86 MLPPSRRDFKDIYVVFELMES---------DLHQVIKANDDLTREHYQFFLYQLLRALKY 136
+Y+ E M++ + D L R Y + + L+ LK
Sbjct: 68 FFIEGA-----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYA--VVKGLKFLKE 120
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-- 194
H N+ HRD+KP N+L N N ++K+CDFG++ + ++ T+ + + Y APE
Sbjct: 121 EH--NIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTN-IGCQSYMAPERI 173
Query: 195 --LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK---NVVHQLDLMTDLLGTPSLDT 249
+ YT D+WS+G E+ G+ +P + N+ QL + D G P
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPP--- 228
Query: 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 309
P +S A + + L P RPT + L P
Sbjct: 229 ------------------TLPSGYS-------DDAQDFVAKCLNKIPNRRPTYAQLLEHP 263
Query: 310 YFKGLSKVERE 320
+ + +
Sbjct: 264 WLVKYKNADVD 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 78/290 (26%), Positives = 122/290 (42%), Gaps = 38/290 (13%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 79
Y++ + +G G+YG V A + HTGE A+K I E D + I +EI +++ +H +I
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 80 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIH 138
V L SR + +++ E L + L+ + + L+ L Y+H
Sbjct: 69 VAYFGSYL--SR---EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH 123
Query: 139 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG- 197
+ HRD+K NIL N +K+ DFG VA T T ++ T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGDVKLADFG---VAAKITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257
Y DIW++G E+ +P P M DL +L
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQP--P----------MFDLHPMRAL---------- 218
Query: 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
+L S QP + K + ++ L +PK RPTAE L
Sbjct: 219 ---FLMSKSNFQPPKLKDKT-KWSSTFHNFVKISLTKNPKKRPTAERLLT 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 12/220 (5%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI--SDAARILREIKLLRLL 74
A Y + +VIG+G++G V + + +KV K+ FE I SD+A E ++
Sbjct: 42 AEDYDVVKVIGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 75 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRAL 134
P +V+ L + +D K +Y+V E M + +N D+ + +F+ +++ AL
Sbjct: 101 NSPWVVQ-----LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLAL 155
Query: 135 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 194
IH+ + HRD+KP N+L + + LK+ DFG D + V T Y +PE
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVRCDTAVGTPDYISPE 213
Query: 195 LCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 232
+ S Y D WS+G E+L G F ++V
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 6e-14
Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 35/228 (15%)
Query: 26 IGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHI-SDAARILREIKLLRLLRHPDIVE 81
+G G++G V + K VA+K + EHI + LRE ++ L HP IV
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ--EHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 82 IKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 140
+ + + +V EL L + +K ++ + +Q+ + Y+ +
Sbjct: 61 LIGVCKGEP------LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114
Query: 141 NVYHRDLKPKNILANANCKLKICDFGLAR-VAFNDTPTTIFWTDYVAT-------RWYRA 192
+ HRDL +N+L + KI DFG++R + Y AT +WY A
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS-------DYYRATTAGRWPLKWY-A 166
Query: 193 PELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPL--FPGKNVVHQLD 236
PE C ++ K++ D+WS G E + KP G V+ L+
Sbjct: 167 PE-CINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE 212
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 7e-14
Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 42/225 (18%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLL 74
+ + + E+IG+G +G V +TG+KVA+K I D+ A L E ++ L
Sbjct: 4 NLQKLTLGEIIGEGEFGAVLQG--EYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKL 56
Query: 75 RHPDIVEIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKANDDLTREHYQFFLYQLLR- 132
H ++V + ++L +Y+V ELM + +L ++ TR + QLL+
Sbjct: 57 HHKNLVRLLGVIL------HNGLYIVMELMSKGNLVNFLR-----TRGRALVSVIQLLQF 105
Query: 133 ------ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV---AFNDTPTTIFWTD 183
++Y+ + + HRDL +NIL + + K+ DFGLARV +++ + WT
Sbjct: 106 SLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT- 164
Query: 184 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFP 227
APE K++ D+WS G + EV + G+ +P
Sbjct: 165 --------APEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 8e-14
Identities = 65/292 (22%), Positives = 118/292 (40%), Gaps = 64/292 (21%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 85
+G G YG V + VA+K + E + L+E +++ ++HP++V++ +
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 86 ML--PPSRRDFKDIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTA 140
PP Y++ E M +L ++ + ++ + Q+ A++Y+
Sbjct: 71 CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 123
Query: 141 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTDYVATRWYRAP 193
N HRDL +N L N +K+ DFGL+R+ DT T I WT AP
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT---------AP 174
Query: 194 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252
E ++K++ D+W+ G + E+ T G +PG ++ +L+
Sbjct: 175 E--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------------ 220
Query: 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 304
R ++P P L+ ++P DRP+ E
Sbjct: 221 -----------GYRMERP-------EGCPPKVYELMRACWQWNPSDRPSFAE 254
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 8e-14
Identities = 53/217 (24%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 24 EVIGKGSYGVVCSA--IDTHTGE-KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 80
VIGKG +G V ID+ + A+K ++ I + + + L+E +++ HP+++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 81 EIKHIMLPPSRRDFKDIYVVFELMESDLHQVIK--ANDDLTREHYQFFLYQLLRALKYIH 138
+ I LP + + V+ + DL I+ ++ ++ F L Q+ + ++Y+
Sbjct: 60 SLLGICLPS---EGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL-QVAKGMEYLA 115
Query: 139 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 198
+ HRDL +N + + + +K+ DFGLAR I+ +Y + + +L
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLAR--------DIYDKEYYSVHNHTGAKLPVK 167
Query: 199 FFS-------KYTPAIDIWSIGCIFAEVLT-GKPLFP 227
+ + K+T D+WS G + E++T G P +P
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 11/208 (5%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEIK 83
V+GKGS+G V A T E AIK + D+ D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 84 HIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV 142
H R +Y V E + DL I+ H F+ ++ L ++H+ +
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 143 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 202
+RDLK N++ +A +KI DFG+ + TT + T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT---RTFCGTPDYIAPEIIA--YQP 177
Query: 203 YTPAIDIWSIGCIFAEVLTGKPLFPGKN 230
Y ++D W+ G + E+L G+P F G++
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 82/296 (27%), Positives = 127/296 (42%), Gaps = 54/296 (18%)
Query: 23 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVE 81
QE++G G+ G V A T +A+K I DI + +I+ E+++L P I+
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ--KQIMSELEILYKCDSPYIIG 63
Query: 82 IKHIMLPPSRRDFKDIYVVFELMES---DLHQVIKANDDLTREH-YQFFLYQLLRALKYI 137
+R I + E M+ D+++ I EH +++ L Y+
Sbjct: 64 FYGAFFVENR-----ISICTEFMDGGSLDVYRKIP-------EHVLGRIAVAVVKGLTYL 111
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
+ + HRD+KP N+L N ++K+CDFG++ N T YV T Y APE
Sbjct: 112 WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT-----YVGTNAYMAPERIS 166
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG--KNVVHQLDLMTDLLGTPSLDTISRVRN 255
+Y D+WS+G F E+ G+ +P KN Q LM L L I V
Sbjct: 167 G--EQYGIHSDVWSLGISFMELALGRFPYPQIQKN---QGSLMPLQL----LQCI--VDE 215
Query: 256 DKARRYLTSMRKKQPV-QFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 310
D PV QFS+KF + + + + PK+RP E + P+
Sbjct: 216 DPPV---------LPVGQFSEKF-------VHFITQCMRKQPKERPAPENLMDHPF 255
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 14/202 (6%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEI 82
E IGKG++G V + +VA+K + + L+E ++L+ HP+IV++
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKL 57
Query: 83 KHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 140
+ + + IY+V EL+ S L + K + LT + ++Y+ +
Sbjct: 58 IGVCV-----QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK 112
Query: 141 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF 200
N HRDL +N L N LKI DFG++R T + +W APE +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW-TAPEALN--Y 169
Query: 201 SKYTPAIDIWSIGCIFAEVLTG 222
+YT D+WS G + E +
Sbjct: 170 GRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-13
Identities = 80/321 (24%), Positives = 127/321 (39%), Gaps = 58/321 (18%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 79
+ I E G+ G + ID T E V IK E +LR + HP I
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKA--------GQRGGTATEAHILRAINHPSI 145
Query: 80 VEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT 139
+++K ++ ++DL+ + A ++ +LRA++Y+H
Sbjct: 146 IQLKGTFTYNKF-----TCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHE 200
Query: 140 ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF-WTDYVATRWYRAPELCGS 198
+ HRD+K +NI N + + DFG A + + W +AT APEL
Sbjct: 201 NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT---NAPELLAR 257
Query: 199 FFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNV------VHQLDLMTDLLGT-PS---L 247
Y PA+DIWS G + E+ T LF + Q+ L+ GT P+ +
Sbjct: 258 --DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLE----------RLLAFDPK 297
D + + Y+ +K S + P + P L E ++LAFD
Sbjct: 316 DAQANLD----EIYIGLAKK------SSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAH 365
Query: 298 DRPTAE--------EALADPY 310
RP+AE + + DPY
Sbjct: 366 HRPSAEALLDFAAFQDIPDPY 386
|
Length = 391 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 11/208 (5%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEIK 83
V+GKGS+G V A T E AIK + D+ D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 84 HIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV 142
H R +Y V E + DL I+ H F+ ++ L ++H+ +
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 143 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 202
+RDLK N++ ++ +KI DFG+ + D TT + T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT---KTFCGTPDYIAPEIIA--YQP 177
Query: 203 YTPAIDIWSIGCIFAEVLTGKPLFPGKN 230
Y ++D W+ G + E+L G+ F G++
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 34/230 (14%)
Query: 21 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 80
++ +G G +G V + +T VA+K + D L E ++++ LRHP
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLK---PGTMDPKDFLAEAQIMKKLRHP--- 61
Query: 81 EIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD--LTREHYQFFLYQLLRALKYI 137
K I L + IY+V ELM+ L + ++ L Q+ + Y+
Sbjct: 62 --KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL 119
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFND-------TPTTIFWTDYVATRWY 190
N HRDL +N+L N K+ DFGLARV D I WT
Sbjct: 120 EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT-------- 171
Query: 191 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQLD 236
APE + +++++ D+WS G + E++T G+ +PG V+ Q+D
Sbjct: 172 -APE--AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 23/221 (10%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIK-LLRLLRHPDIVEIKH 84
IG+G++G V + +G +A+K+I + + R+L ++ ++R P IV+
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 85 IMLPPSRRDFK--DIYVVFELMESDLHQVIKANDDLTREHY-QFFL----YQLLRALKYI 137
+ F+ D ++ ELM+ L + K ++ + + L ++AL Y+
Sbjct: 71 AL-------FREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYL 123
Query: 138 HTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-L 195
+ HRD+KP NIL + N +K+CDFG++ + +I T R Y APE +
Sbjct: 124 KEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD----SIAKTRDAGCRPYMAPERI 179
Query: 196 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KNVVHQL 235
S Y D+WS+G EV TGK +P +V QL
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 32/219 (14%)
Query: 21 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 80
K+ + +G G +G V KVAIK + + L E L++ L+HP +V
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGH-TKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 81 EIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND--DLTREHYQFFLYQLLRALKYI 137
+ ++ + IY++ E ME+ L +K + LT Q+ + +I
Sbjct: 65 RLYAVVTQ------EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTDYVATRWY 190
N HRDL+ NIL + KI DFGLAR+ ++ T I WT
Sbjct: 119 ERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT-------- 170
Query: 191 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 228
APE + +T D+WS G + E++T G+ +PG
Sbjct: 171 -APEAIN--YGTFTIKSDVWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 17/218 (7%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKV--AIKKIHD--IFEHISDAARILREIKLLRLLRHPDI 79
+VIGKGS+G V A H E+ A+K + I + + + LL+ ++HP +
Sbjct: 1 KVIGKGSFGKVLLA--RHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 58
Query: 80 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIH 138
V + + +Y V + + +L ++ +F+ ++ AL Y+H
Sbjct: 59 VGLHFSFQTADK-----LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH 113
Query: 139 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 198
+ N+ +RDLKP+NIL ++ + + DFGL + TT + + T Y APE+
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT---STFCGTPEYLAPEVLHK 170
Query: 199 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 236
Y +D W +G + E+L G P F +N D
Sbjct: 171 --QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 45/305 (14%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA-ARILREIKLLRLLRHPD 78
++I +VIG+G++G V HT E++ KI + +E + A RE + +L + D
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHT-ERIYAMKILNKWEMLKRAETACFREER--NVLVNGD 59
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFEL-MESDLHQVI-KANDDLTREHYQFFLYQLLRALKY 136
I L + +D +Y+V + + DL ++ K D L + +F++ +++ A+
Sbjct: 60 CQWIT--TLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHS 117
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 196
IH + HRD+KP N+L + N +++ DFG D T+ + V T Y +PE+
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD--GTVQSSVAVGTPDYISPEIL 175
Query: 197 GSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253
+ KY P D WS+G E+L G+ F +++V +T ++
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---------------ETYGKI 220
Query: 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD----P 309
N + R QF + A L++RL+ ++R + + D
Sbjct: 221 MNHEER-----------FQFPSHITDVSEEAKDLIQRLIC--SRERRLGQNGIEDFKKHA 267
Query: 310 YFKGL 314
+F+G+
Sbjct: 268 FFEGI 272
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 45/207 (21%)
Query: 120 REHY-----QFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174
REH+ + ++ +++ AL ++H + +RD+K +NIL ++ + + DFGL++ +
Sbjct: 99 REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158
Query: 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ 234
+ + T Y APE+ + A+D WS+G + E+LTG F
Sbjct: 159 EEERAY--SFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF-------- 208
Query: 235 LDLMTDLLGTPSLDTISRVRN---DKARRYLTSMRKKQPVQFSQKFPNA-DPSALRLLER 290
T+ +N + +RR L K +P FP A +++
Sbjct: 209 --------------TVDGEQNSQSEISRRIL----KSKP-----PFPKTMSAEARDFIQK 245
Query: 291 LLAFDPKDR---PTAEEALADPYFKGL 314
LL DPK R A+E P+F+G+
Sbjct: 246 LLEKDPKKRLGANGADEIKNHPFFQGI 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 75/306 (24%), Positives = 130/306 (42%), Gaps = 49/306 (16%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPD 78
++ V+GKG +G VC+ TG+ A KK+ + + L E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 79 IVEIKHIMLPPSRRDFKD-IYVVFELMES-DL--HQVIKANDDLTREHYQFFLYQLLRAL 134
+V + + + KD + +V LM DL H F+ ++ L
Sbjct: 62 VVSLAYAY------ETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGL 115
Query: 135 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 194
+ +H + +RDLKP+NIL + + ++I D GLA P V T Y APE
Sbjct: 116 EDLHQERIVYRDLKPENILLDDHGHIRISDLGLAV----HVPEGQTIKGRVGTVGYMAPE 171
Query: 195 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254
+ + +YT + D W++GC+ E++ G+ F + +++
Sbjct: 172 VVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRK--------------------KKIK 209
Query: 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALADP 309
++ R + K+ ++S+KF P A L + LL DPK+R A E P
Sbjct: 210 REEVERLV----KEVQEEYSEKF---SPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP 262
Query: 310 YFKGLS 315
FK ++
Sbjct: 263 LFKQIN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 21 KIQEVIGKGSYGVVCSAI-DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 79
K+++ +G G +G V A + HT KVA+K + + L E +++ L+H +
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVE---AFLAEANVMKTLQHDKL 63
Query: 80 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQF--FLYQLLRALKY 136
V++ ++ + IY++ E M L +K+++ + + F Q+ + +
Sbjct: 64 VKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 117
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 196
I N HRDL+ NIL +A+ KI DFGLARV D T +W APE
Sbjct: 118 IEQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKW-TAPEAI 175
Query: 197 GSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 228
F +T D+WS G + E++T G+ +PG
Sbjct: 176 N--FGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 79/303 (26%), Positives = 126/303 (41%), Gaps = 53/303 (17%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 85
+G G++G V A + TG A K I E + + EI++L HP IV+
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYMVEIEILATCNHPYIVK---- 73
Query: 86 MLPPSRRDFKDIYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLRALKYIHTANVY 143
+L D K ++++ E I D LT Q Q+L AL+Y+H+ +
Sbjct: 74 LLGAFYWDGK-LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKII 132
Query: 144 HRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKY 203
HRDLK N+L + +K+ DFG V+ + T ++ T ++ APE+ K
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFG---VSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 204 TP---AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT-----PSLDTISRVRN 255
TP DIWS+G E+ +P H+L+ M LL P+L
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPH------HELNPMRVLLKIAKSEPPTLS------- 236
Query: 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315
QP ++S +F + L+ L P+ RP+A + L P+ ++
Sbjct: 237 -------------QPSKWSMEFRD-------FLKTALDKHPETRPSAAQLLEHPFVSSVT 276
Query: 316 KVE 318
Sbjct: 277 SNR 279
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 73/305 (23%), Positives = 135/305 (44%), Gaps = 45/305 (14%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA-ARILREIKLLRLLRHPD 78
++I +VIG+G++G V + + +KV KI + +E + A RE + + +
Sbjct: 3 FEILKVIGRGAFGEV-AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFEL-MESDLHQVI-KANDDLTREHYQFFLYQLLRALKY 136
+ H +D ++Y+V + + DL ++ K D L + +F+L +++ A+
Sbjct: 62 WITTLHYAF----QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS 117
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 196
+H + HRD+KP NIL + N +++ DFG D T+ + V T Y +PE+
Sbjct: 118 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED--GTVQSSVAVGTPDYISPEIL 175
Query: 197 GSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253
+ KY P D WS+G E+L G+ F +++V +T ++
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---------------ETYGKI 220
Query: 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD----P 309
N K R QF + + A L+ RL+ ++ + + D P
Sbjct: 221 MNHKER-----------FQFPAQVTDVSEDAKDLIRRLIC--SREHRLGQNGIEDFKQHP 267
Query: 310 YFKGL 314
+F G+
Sbjct: 268 FFTGI 272
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 69/307 (22%), Positives = 134/307 (43%), Gaps = 44/307 (14%)
Query: 20 YKIQEVIGKGSYGVV--CSAIDTH-TGEKVAIK--KIHDIFEHISDAARILREIKLLRLL 74
+++ +V+G G+YG V + H +G+ A+K K I + E ++L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 75 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRAL 134
R + H + D K ++ + +L + + + Q + +++ AL
Sbjct: 62 RQSPFLVTLHYAF---QTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL 118
Query: 135 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 194
+++H + +RD+K +NIL ++N + + DFGL++ D + + T Y AP+
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY--SFCGTIEYMAPD 176
Query: 195 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254
+ + A+D WS+G + E+LTG F ++D +
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTGASPF-------------------TVDGEKNSQ 217
Query: 255 NDKARRYLTSMRKKQPVQFSQKFP-NADPSALRLLERLLAFDPKDR----PT-AEEALAD 308
+ +RR L K +P +P A +++RLL DPK R P+ A+E
Sbjct: 218 AEISRRIL----KSEP-----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268
Query: 309 PYFKGLS 315
P+F+ ++
Sbjct: 269 PFFQKIN 275
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-12
Identities = 83/338 (24%), Positives = 140/338 (41%), Gaps = 46/338 (13%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 76
A +Y I V+G G+ G V A GE A+K + +D R E+ L
Sbjct: 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDF 90
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTR---EHYQFFLY- 128
IV+ R+ +++ ++ +++ DL Q IK+ R EH L+
Sbjct: 91 FSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFI 150
Query: 129 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 188
Q+L A+ ++H+ ++ HRD+K NIL +N +K+ DFG +++ + T + T
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-FCGTP 209
Query: 189 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248
+Y APE+ Y+ D++S+G + E+LT K F G+N M ++
Sbjct: 210 YYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGEN-------MEEV------- 253
Query: 249 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308
M K ++ P+ P ++ LL+ DPK RP++ + L
Sbjct: 254 ----------------MHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297
Query: 309 PYFKGLSKVERE-PSCQPISKMEFEFERRRVTKEDIRE 345
P K E QP F R I++
Sbjct: 298 PICKLFISGLLEIVQTQP----GFSGPLRDTISRQIQQ 331
|
Length = 496 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 85
+G G +G V KVA+K + L E ++++ LRH +V++ +
Sbjct: 14 LGNGQFGEVWMGTWNGN-TKVAVKTLK---PGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69
Query: 86 MLPPSRRDFKDIYVVFELM-ESDLHQVIKANDDLTREHYQF--FLYQLLRALKYIHTANV 142
+ S IY+V E M + L +K + + Q+ + YI N
Sbjct: 70 V---SEEP---IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY 123
Query: 143 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 202
HRDL+ NIL KI DFGLAR+ D T +W APE + + +
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARL-IEDNEYTARQGAKFPIKW-TAPE--AALYGR 179
Query: 203 YTPAIDIWSIGCIFAEVLT-GKPLFPGKN 230
+T D+WS G + E++T G+ +PG N
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMN 208
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 20/219 (9%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 76
A +++ EV+G G+YG V TG+ AIK + D+ E + I EI +L+ H
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTE--DEEEEIKLEINMLKKYSH 71
Query: 77 PDIVEIKHIML----PPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLY 128
+ + PP D +++V E +DL + K N L + +
Sbjct: 72 HRNIATYYGAFIKKSPPGHDD--QLWLVMEFCGAGSVTDLVKNTKGNA-LKEDWIAYICR 128
Query: 129 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 188
++LR L ++H V HRD+K +N+L N ++K+ DFG V+ T ++ T
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVGRRNTFIGTP 185
Query: 189 WYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 224
++ APE+ + + Y DIWS+G E+ G P
Sbjct: 186 YWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 25 VIGKGSYGVVCSA-----IDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPD 78
+G G++G V A + KVA+K + H S+ ++ E+K++ L H +
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT-AHSSEREALMSELKIMSHLGNHEN 100
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFEL-MESDLHQVIKANDD--LTREHYQFFLYQLLRALK 135
IV L + I V+ E DL ++ + LT E F YQ+ + +
Sbjct: 101 IVN-----LLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155
Query: 136 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 195
++ + N HRDL +N+L +KICDFGLAR ND+ + + +W APE
Sbjct: 156 FLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM-APE- 213
Query: 196 CGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 228
F YT D+WS G + E+ + G +PG
Sbjct: 214 -SIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 75/307 (24%), Positives = 130/307 (42%), Gaps = 51/307 (16%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPD 78
++ V+GKG +G VC+ TG+ A K++ + + L E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 79 IVEIKHIMLPPSRRDFKD-IYVVFELMES-DL--HQVIKANDDLTREHYQFFLYQLLRAL 134
+V + + + KD + +V +M DL H N E F+ ++L L
Sbjct: 62 VVNLAYAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGL 115
Query: 135 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 194
+ +H N +RDLKP+NIL + ++I D GLA P V T Y APE
Sbjct: 116 EDLHRENTVYRDLKPENILLDDYGHIRISDLGLAV----KIPEGESIRGRVGTVGYMAPE 171
Query: 195 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254
+ + +YT + D W +GC+ E++ G+ F G+ +V+
Sbjct: 172 VLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRK--------------------EKVK 209
Query: 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314
++ R + + +FS++ A + + LL DPK R +E +G
Sbjct: 210 REEVDRRVLETEEVYSAKFSEE-------AKSICKMLLTKDPKQRLGCQE-------EGA 255
Query: 315 SKVEREP 321
+V+R P
Sbjct: 256 GEVKRHP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 11/208 (5%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEIK 83
V+GKGS+G V A T E AIK + D+ D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 84 HIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV 142
H R +Y V E + DL I+ F+ ++ L ++H +
Sbjct: 67 HSCFQTVDR----LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGI 122
Query: 143 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 202
+RDLK N++ ++ +KI DFG+ + D TT + T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT---RTFCGTPDYIAPEIIA--YQP 177
Query: 203 YTPAIDIWSIGCIFAEVLTGKPLFPGKN 230
Y ++D W+ G + E+L G+P F G++
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 40/212 (18%)
Query: 97 IYVVFELMESDLHQVIKANDDL-----TREHYQFFLYQLLRALKYIHTANVYHRDLKPKN 151
++ F+ S + DDL T E + +Q+ R ++++ + HRDL +N
Sbjct: 145 LFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARN 204
Query: 152 ILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIW 210
IL + N +KICDFGLAR + D + + +W APE S F K YT D+W
Sbjct: 205 ILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM-APE---SIFDKVYTTQSDVW 260
Query: 211 SIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQ 269
S G + E+ + G +PG ++ + +R R +
Sbjct: 261 SFGVLLWEIFSLGASPYPG----------------------VQINEEFCQRLKDGTRMRA 298
Query: 270 PVQFSQKFPNADPSALRLLERLLAFDPKDRPT 301
P NA P R++ DPK+RPT
Sbjct: 299 P-------ENATPEIYRIMLACWQGDPKERPT 323
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 78/311 (25%), Positives = 120/311 (38%), Gaps = 37/311 (11%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 79
Y + + + GS G V A + V +K I L E LL+ + HP +
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLK--------IGQKGTTLIEAMLLQNVNHPSV 119
Query: 80 VEIKHIMLPPSRRDFKDIY-VVFELMESDLHQVIKANDD-LTREHYQFFLYQLLRALKYI 137
+ +K ++ I +V SDL+ + L + Q+L L+Y+
Sbjct: 120 IRMKDTLV------SGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYL 173
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
H + HRD+K +NI N ++ I D G A+ P + V T APE+
Sbjct: 174 HAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLGLAGTVET---NAPEVLA 229
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLT-GKPLF---------PGKNV-VHQLDLMTDLLGTPS 246
KY DIWS G + E+L +F K+ H L +++ L P
Sbjct: 230 R--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287
Query: 247 ---LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE 303
D SR+ Y + R+ + N L+ ++L FD RP+AE
Sbjct: 288 EFPRDPGSRLVRGFI-EYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAE 346
Query: 304 EALADPYFKGL 314
E L P F L
Sbjct: 347 EILNYPMFAQL 357
|
Length = 357 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 67/262 (25%), Positives = 117/262 (44%), Gaps = 60/262 (22%)
Query: 2 LQNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSA----IDTHTGE-KVAIKKIH-DIF 55
L PE E R + + +G+G++G V A +D VA+K + D
Sbjct: 1 LPLDPEWEL-----PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT 55
Query: 56 EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIK 113
E D + ++ E+++++++ +H +I+ +L ++ +YVV E +L ++
Sbjct: 56 EK--DLSDLVSEMEMMKMIGKHKNIIN----LLGVCTQEGP-LYVVVEYAAHGNLRDFLR 108
Query: 114 AN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN 157
A + LT++ F YQ+ R ++++ + HRDL +N+L +
Sbjct: 109 ARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED 168
Query: 158 CKLKICDFGLARVAFNDTPTTIFWTDY--------VATRWYRAPELCGSFFSK-YTPAID 208
+KI DFGLAR I DY + +W APE + F + YT D
Sbjct: 169 HVMKIADFGLAR--------DIHHIDYYRKTTNGRLPVKWM-APE---ALFDRVYTHQSD 216
Query: 209 IWSIGCIFAEVLT--GKPLFPG 228
+WS G + E+ T G P +PG
Sbjct: 217 VWSFGVLLWEIFTLGGSP-YPG 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 12/220 (5%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI--SDAARILREIKLLRLL 74
A Y++ +VIG+G++G V + + KV K+ FE I SD+A E ++
Sbjct: 42 AEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 75 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRAL 134
P +V++ + +D + +Y+V E M + +N D+ + +F+ +++ AL
Sbjct: 101 NSPWVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 135 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 194
IH+ HRD+KP N+L + + LK+ DFG + + V T Y +PE
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE--GMVRCDTAVGTPDYISPE 213
Query: 195 LCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 232
+ S Y D WS+G E+L G F ++V
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 11/142 (7%)
Query: 88 PPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDL 147
P S + D V L+ D + + D L+ F YQ+ R ++++ + N HRDL
Sbjct: 211 PASYKGSNDSEVK-NLLSDDGSEGLTTLDLLS------FTYQVARGMEFLASKNCVHRDL 263
Query: 148 KPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAI 207
+N+L +KICDFGLAR +D+ + ++ +W APE F + YT
Sbjct: 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWM-APE--SIFDNLYTTLS 320
Query: 208 DIWSIGCIFAEVLT-GKPLFPG 228
D+WS G + E+ + G +PG
Sbjct: 321 DVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 63/218 (28%), Positives = 100/218 (45%), Gaps = 21/218 (9%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 85
+G+G +G V T KVAIK + L+E ++++ LRH +V + +
Sbjct: 14 LGQGCFGEVWMGTWNGT-TKVAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 86 MLPPSRRDFKDIYVVFELM-ESDLHQVIKANDDLTREHYQF--FLYQLLRALKYIHTANV 142
+ + IY+V E M + L +K D + Q Q+ + YI N
Sbjct: 70 V------SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY 123
Query: 143 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 202
HRDL+ NIL N KI DFGLAR+ D T +W APE + + +
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARL-IEDNEYTARQGAKFPIKW-TAPE--AALYGR 179
Query: 203 YTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQLD 236
+T D+WS G + E++T G+ +PG + V+ Q++
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE 217
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 25/228 (10%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRHPDIVEIK 83
+G G+ GVV +G +A K IH I A R I+RE+++L P IV
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIH---LEIKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 84 HIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN- 141
+I + E M+ L QV+K + E +LR L Y+ +
Sbjct: 70 GAFYSDG-----EISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 124
Query: 142 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFF 200
+ HRD+KP NIL N+ ++K+CDFG++ + + +V TR Y +PE L G+ +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQGTHY 179
Query: 201 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248
S + DIWS+G E+ G+ P + + + G P +D
Sbjct: 180 SVQS---DIWSMGLSLVELAIGRYPIPPPDAKE----LEAIFGRPVVD 220
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 59/223 (26%), Positives = 110/223 (49%), Gaps = 25/223 (11%)
Query: 21 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 80
K+ + IGKG +G V + + G KVA+K I ++ + A L E ++ LRH ++V
Sbjct: 9 KLLQTIGKGEFGDV--MLGDYRGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLV 62
Query: 81 EIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKANDD--LTREHYQFFLYQLLRALKYI 137
++ +++ + +Y+V E M + L +++ L + F + A++Y+
Sbjct: 63 QLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
N HRDL +N+L + + K+ DFGL + A ++ T + +W APE
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKW-TAPEALR 172
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLT-GK---PLFPGKNVVHQLD 236
K++ D+WS G + E+ + G+ P P K+VV +++
Sbjct: 173 E--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 213
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 4e-12
Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 20/219 (9%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 76
A +++ E++G G+YG V TG+ AIK + D+ + I +EI +L+ H
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTG--DEEEEIKQEINMLKKYSH 61
Query: 77 PDIVEIKHIML----PPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLY 128
+ + PP D +++V E +DL + K N L E +
Sbjct: 62 HRNIATYYGAFIKKNPPGMDD--QLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICR 118
Query: 129 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 188
++LR L ++H V HRD+K +N+L N ++K+ DFG V+ T ++ T
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVGRRNTFIGTP 175
Query: 189 WYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 224
++ APE+ + + Y D+WS+G E+ G P
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 12/185 (6%)
Query: 41 HTGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98
+TGE+VA+K K HI+D + +EI++LR L H +IV+ K I K
Sbjct: 31 NTGEQVAVKSLKPESGGNHIAD---LKKEIEILRNLYHENIVKYKGICTEDGGNGIK--- 84
Query: 99 VVFELMES-DLHQVIKANDDLTREHYQF-FLYQLLRALKYIHTANVYHRDLKPKNILANA 156
++ E + S L + + N + Q + Q+ + + Y+ + HRDL +N+L +
Sbjct: 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES 144
Query: 157 NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 216
++KI DFGL + D D + ++ APE SK+ A D+WS G
Sbjct: 145 EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL--IQSKFYIASDVWSFGVTL 202
Query: 217 AEVLT 221
E+LT
Sbjct: 203 YELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRL-LRHPDIVEI 82
V+GKGS+G V A T E AIK + D+ D + E ++L L HP +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLT-- 59
Query: 83 KHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 138
H+ F+ +F +ME DL I+++ +F+ +++ L+++H
Sbjct: 60 -HLFC-----TFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH 113
Query: 139 TANVYHRDLKPKNILANANCKLKICDFGLARVAFN-DTPTTIFWTDYVATRWYRAPELCG 197
+ +RDLK N+L + + +KI DFG+ + N + + F T Y APE+
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF----CGTPDYIAPEILK 169
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 230
KY ++D WS G + E+L G+ F G++
Sbjct: 170 G--QKYNESVDWWSFGVLLYEMLIGQSPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 43/128 (33%), Positives = 63/128 (49%), Gaps = 20/128 (15%)
Query: 113 KANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172
+ LT E + +Q+ R ++++ + HRDL +NIL + N +KICDFGLAR +
Sbjct: 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 173 NDTPTTIFWTDYVAT-------RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT-GK 223
D DYV +W APE S F K YT D+WS G + E+ + G
Sbjct: 225 KD-------PDYVRKGDARLPLKWM-APE---SIFDKVYTTQSDVWSFGVLLWEIFSLGA 273
Query: 224 PLFPGKNV 231
+PG +
Sbjct: 274 SPYPGVQI 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 9e-12
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 21 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 80
+++ +G+G +G V T +VAIK + +S A L+E ++++ LRH +V
Sbjct: 9 RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKP--GTMSPEA-FLQEAQVMKKLRHEKLV 64
Query: 81 EIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKANDDLTREHYQF--FLYQLLRALKYI 137
++ ++ + IY+V E M + L +K Q Q+ + Y+
Sbjct: 65 QLYAVV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 118
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
N HRDL+ NIL N K+ DFGLAR+ D T +W APE
Sbjct: 119 ERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKW-TAPE--A 174
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 228
+ + ++T D+WS G + E+ T G+ +PG
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 26 IGKGSYGVVCSAI-DTHTGEK-VAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 83
+G G++G V + EK VA+K + + + +LRE +++ L +P IV +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 84 HIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV 142
I + + +V EL E L++ ++ N +T ++ ++Q+ +KY+ N
Sbjct: 63 GIC------EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 143 YHRDLKPKNILANANCKLKICDFGLARVAFND-----TPTTIFWTDYVATRWYRAPELCG 197
HRDL +N+L KI DFGL++ D T W +WY APE C
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW----PVKWY-APE-CM 170
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLT 221
+++ K++ D+WS G + E +
Sbjct: 171 NYY-KFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 71/285 (24%), Positives = 121/285 (42%), Gaps = 46/285 (16%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKI-HDIFEHISDAARILREIKLLRLLRHPDIVEI 82
E++GKG++G V VA+K D+ + + + L E ++L+ HP+IV++
Sbjct: 1 ELLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELK--IKFLSEARILKQYDHPNIVKL 57
Query: 83 KHIMLPPSRRDFKDIYVVFELMESD--LHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 140
I + R + IY+V EL+ L + K D+L + F + Y+ +
Sbjct: 58 --IGVCTQR---QPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112
Query: 141 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF 200
N HRDL +N L N LKI DFG++R +D + + +W APE +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQE-DDGIYSSSGLKQIPIKW-TAPEALN--Y 168
Query: 201 SKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKAR 259
+Y+ D+WS G + E + G +PG MT+ + R +
Sbjct: 169 GRYSSESDVWSYGILLWETFSLGVCPYPG---------MTN----------QQAREQVEK 209
Query: 260 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 304
Y S +K P ++++R + P++RP E
Sbjct: 210 GYRMSCPQKCPDDVY-----------KVMQRCWDYKPENRPKFSE 243
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 75/308 (24%), Positives = 124/308 (40%), Gaps = 54/308 (17%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIHD---IFEHISDAARILREIKLLRLLRHPDIVE 81
+I G+YG V T ++ A+KKI+ I + + R+I L +P +V
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDI--LTFAENPFVVS 65
Query: 82 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 140
+ S + + +V E +E D ++K L + + + + + AL+Y+H
Sbjct: 66 -----MFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 141 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA--TRWYRAPELCGS 198
+ HRDLKP N+L + +K+ DFGL+++ TT + ++ TR + ++CG+
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL-TTNLYEGHIEKDTREFLDKQVCGT 179
Query: 199 ---------FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 249
Y +D W++G I E L G F G D +L G D
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-------DTPEELFGQVISDD 232
Query: 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR---PTAEEAL 306
I D+A A L+ RLL +P +R A E
Sbjct: 233 IEWPEGDEA---------------------LPADAQDLISRLLRQNPLERLGTGGAFEVK 271
Query: 307 ADPYFKGL 314
+F GL
Sbjct: 272 QHRFFLGL 279
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 23/221 (10%)
Query: 13 EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKL 70
E D KI E +G G+ GVV +G +A K IH I A R I+RE+++
Sbjct: 1 ELKDDDFEKISE-LGAGNGGVVFKVSHKPSGLIMARKLIH---LEIKPAIRNQIIRELQV 56
Query: 71 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQ 129
L P IV +I + E M+ L QV+K + +
Sbjct: 57 LHECNSPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA 111
Query: 130 LLRALKYIHTAN-VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 188
+++ L Y+ + + HRD+KP NIL N+ ++K+CDFG++ + + +V TR
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTR 166
Query: 189 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFP 227
Y +PE L G+ +S + DIWS+G E+ G+ P+ P
Sbjct: 167 SYMSPERLQGTHYSVQS---DIWSMGLSLVEMAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 63/232 (27%), Positives = 103/232 (44%), Gaps = 34/232 (14%)
Query: 21 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 80
K+ + +G G +G V + KVA+K + L E L++ L+H +V
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLK---PGTMSVQAFLEEANLMKTLQHDKLV 64
Query: 81 EIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKAND--DLTREHYQFFLYQLLRALKYI 137
+ ++ + IY++ E M + L +K+++ + F Q+ + YI
Sbjct: 65 RLYAVVTKE-----EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTDYVATRWY 190
N HRDL+ N+L + + KI DFGLARV ++ T I WT
Sbjct: 120 ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT-------- 171
Query: 191 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDL 241
APE F +T D+WS G + E++T GK +PG + D+M+ L
Sbjct: 172 -APEAIN--FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS---NSDVMSAL 217
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 17/228 (7%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEK----VAIKKIHDIFEHISDAARILREIKLLRL 73
+ + +V+G G++G V + GEK VAIK + + ++ IL E ++
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKE-ILDEAYVMAS 65
Query: 74 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQLL 131
+ HP +V + I L + ++ +LM L V D++ ++ + Q+
Sbjct: 66 VDHPHVVRLLGICLSSQ------VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIA 119
Query: 132 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 191
+ + Y+ + HRDL +N+L +KI DFGLA++ D V +W
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM- 178
Query: 192 APELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLM 238
A E YT D+WS G E++T G + G V DL+
Sbjct: 179 ALESI--LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 75/307 (24%), Positives = 122/307 (39%), Gaps = 35/307 (11%)
Query: 19 RYKIQEVIGKGSYG--VVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 76
+Y I + GS G VC+ +KV +K + + REI +L+ + H
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAV-------TGGKTPGREIDILKTISH 145
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 136
I+ + H + R + +V + DL + + L E +LL AL Y
Sbjct: 146 RAIINLIH-----AYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAY 200
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLA--RVAFNDTPTTIFWTDYVATRWYRAPE 194
+H + HRD+K +NI + + DFG A A DTP W+ + T +PE
Sbjct: 201 LHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET---NSPE 257
Query: 195 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV---VHQLD-----LMTDLLGTPS 246
L Y DIWS G + E+ GK V QL + L P
Sbjct: 258 L--LALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315
Query: 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPS--ALRLLERLLAFDPKDRPTAEE 304
+ + ++ K +Y ++ + P L+ ++L FD + RP+A++
Sbjct: 316 NGSTNLCKHFK--QY--AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQD 371
Query: 305 ALADPYF 311
L+ P F
Sbjct: 372 ILSLPLF 378
|
Length = 392 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 66/286 (23%), Positives = 114/286 (39%), Gaps = 52/286 (18%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 83
E IG+G++G V S VA+K + A+ L+E ++L+ HP+IV +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPP-DLKAKFLQEARILKQYSHPNIVRLI 59
Query: 84 HIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLR-------ALKY 136
+ + IY+V EL++ L E + + +L++ ++Y
Sbjct: 60 GVCTQK-----QPIYIVMELVQGGDFLTF-----LRTEGPRLKVKELIQMVENAAAGMEY 109
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 196
+ + + HRDL +N L LKI DFG++R + + + +W APE
Sbjct: 110 LESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPEAL 168
Query: 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256
+ +Y+ D+WS G + E + LG +S N
Sbjct: 169 N--YGRYSSESDVWSFGILLWEAFS--------------------LGAVPYANLS---NQ 203
Query: 257 KARRYLTSMRKKQPVQFSQKFPNADPSAL-RLLERLLAFDPKDRPT 301
+ R + + P P A+ RL+ER +DP RP+
Sbjct: 204 QTREAIEQGVRLPC-------PELCPDAVYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 17/212 (8%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEI 82
+V+GKGS+G V A GE A+K + D+ D + E ++L L +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPF--L 58
Query: 83 KHIMLPPSRRDFKDIYVVFELMES-DL--HQVIKANDDLTREHYQFFLYQLLRALKYIHT 139
H+ ++ ++ V E + DL H K DL R F+ +++ L+++H+
Sbjct: 59 THLYCTFQTKE--HLFFVMEFLNGGDLMFHIQDKGRFDLYRA--TFYAAEIVCGLQFLHS 114
Query: 140 ANVYHRDLKPKNILANANCKLKICDFGLARV-AFNDTPTTIFWTDYVATRWYRAPELCGS 198
+ +RDLK N++ + + +KI DFG+ + F D + F T Y APE+
Sbjct: 115 KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF----CGTPDYIAPEILQG 170
Query: 199 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 230
KYT ++D WS G + E+L G+ F G +
Sbjct: 171 L--KYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-11
Identities = 88/340 (25%), Positives = 138/340 (40%), Gaps = 88/340 (25%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA----RILREIKLLRLL 74
RY I +IGKG G V A D +VA+KKI E +S+ R LRE K+ L
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIR---EDLSENPLLKKRFLREAKIAADL 59
Query: 75 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKA---NDDLTREHYQ-----F 125
HP IV + I D +Y +E L ++K+ + L++E +
Sbjct: 60 IHPGIVPVYSIC-----SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGA 114
Query: 126 FL---YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR-----------VA 171
FL +++ ++Y+H+ V HRDLKP NIL ++ I D+G A +
Sbjct: 115 FLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 172 FNDT---------PTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLT 221
++ P I V T Y APE L G S+ T DI+++G I ++LT
Sbjct: 175 VDERNICYSSMTIPGKI-----VGTPDYMAPERLLGVPASEST---DIYALGVILYQMLT 226
Query: 222 GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNAD 281
FP R K R+ P++ + P +
Sbjct: 227 LS--FP-------------------------YRRKKGRKISYRDVILSPIEVA---PYRE 256
Query: 282 --PSALRLLERLLAFDPKDRPTAEEALAD---PYFKGLSK 316
P ++ + LA DP +R ++ + L P+ +G +
Sbjct: 257 IPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPE 296
|
Length = 932 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 64/232 (27%), Positives = 102/232 (43%), Gaps = 49/232 (21%)
Query: 93 DFKDIYVVFELME----SDLHQVIKANDDLTREHYQF-------FLYQLLRALKYIHTAN 141
DFK + +ME DL++ IK +EH F YQ++ AL +H+
Sbjct: 133 DFKSDDKLLLIMEYGSGGDLNKQIKQR---LKEHLPFQEYEVGLLFYQIVLALDEVHSRK 189
Query: 142 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFS 201
+ HRDLK NI +K+ DFG ++ ++D+ + + + T +Y APEL
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSK-QYSDSVSLDVASSFCGTPYYLAPELWER--K 246
Query: 202 KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRY 261
+Y+ D+WS+G I E+LT F G + Q ++M +L
Sbjct: 247 RYSKKADMWSLGVILYELLTLHRPFKGPS---QREIMQQVL------------------- 284
Query: 262 LTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPTAEEALADPYFK 312
K P FP S ++ LL+ LL+ +P RPT ++ L + K
Sbjct: 285 ---YGKYDP------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 38/115 (33%), Positives = 60/115 (52%), Gaps = 6/115 (5%)
Query: 116 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175
LT E + +Q+ + ++++ + HRDL +NIL + N +KICDFGLAR + D
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD- 232
Query: 176 PTTIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT-GKPLFPG 228
P + D + APE + F + YT D+WS G + E+ + G +PG
Sbjct: 233 PDYVRKGDARLPLKWMAPE---TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 70/299 (23%), Positives = 121/299 (40%), Gaps = 65/299 (21%)
Query: 25 VIGKGSYGVVCSA---IDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIV 80
++GKG +G V A + + +KVA+K + DIF SD LRE ++ HP+++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVI 64
Query: 81 EIKHIMLPPSRRDFKDI-YVVFELME-SDLHQVIKAND------DLTREHYQFFLYQLLR 132
++ + L + I V+ M+ DLH + + L + F+ +
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY-------- 184
++Y+ + N HRDL +N + N N + + DFGL++ I+ DY
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK--------KIYSGDYYRQGCASK 176
Query: 185 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLG 243
+ +W L + YT D+W+ G E++T G+ + G
Sbjct: 177 LPVKWLALESLADNV---YTTHSDVWAFGVTMWEIMTRGQTPYAG--------------- 218
Query: 244 TPSLDTISRVRNDKARRYLTS-MRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT 301
V N + YL R KQP P+ L+ + + +PK RP+
Sbjct: 219 ---------VENSEIYNYLIKGNRLKQP-------PDCLEDVYELMCQCWSPEPKCRPS 261
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 45/146 (30%), Positives = 68/146 (46%), Gaps = 6/146 (4%)
Query: 89 PSRRDFKDIYVVFELMESDLHQVIKANDDLT--REHYQFFLYQLLRALKYIHTANVYHRD 146
P++ D + ++ D+ I D+L E F YQ+ + + ++ + N HRD
Sbjct: 180 PTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRD 239
Query: 147 LKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPA 206
L +NIL KICDFGLAR ND+ + + +W APE F YT
Sbjct: 240 LAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWM-APE--SIFNCVYTFE 296
Query: 207 IDIWSIGCIFAEVLT-GKPLFPGKNV 231
D+WS G + E+ + G +PG V
Sbjct: 297 SDVWSYGILLWEIFSLGSSPYPGMPV 322
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 64/242 (26%), Positives = 106/242 (43%), Gaps = 34/242 (14%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI---------LREIKLLRLLR 75
+IG+G +G V TG+ A+K + D RI L E +L L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCL--------DKKRIKMKQGETLALNERIMLSLVS 52
Query: 76 H---PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLL 131
P IV + + P + F + +LM DLH + + + + +F+ +++
Sbjct: 53 TGDCPFIVCMTYAFHTPDKLCF-----ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEII 107
Query: 132 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 191
L+++H V +RDLKP NIL + + ++I D GLA P V T Y
Sbjct: 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYM 162
Query: 192 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLMTDLLGTPSLDT 249
APE+ + Y + D +S+GC+ ++L G F H++D MT + D+
Sbjct: 163 APEVLQK-GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDS 221
Query: 250 IS 251
S
Sbjct: 222 FS 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 18/205 (8%)
Query: 26 IGKGSYG-VVCSAIDTHTGEKVAIKKIHD--IFEHISDAARILREIKLLRLLRHPDIVEI 82
+G GS+G V+ + VAIK+ I + + E K+L + HP V
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQ-KQVDHVFSERKILNYINHPFCVN- 95
Query: 83 KHIMLPPSRRDFKDIYVVFE-LMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN 141
L S +D +Y+V E ++ + ++ N + F+ Q++ +Y+ + N
Sbjct: 96 ----LYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN 151
Query: 142 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFS 201
+ +RDLKP+N+L + + +K+ DFG A+V T T T Y APE+ +
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT------LCGTPEYIAPEILLNV-- 203
Query: 202 KYTPAIDIWSIGCIFAEVLTGKPLF 226
+ A D W++G E+L G P F
Sbjct: 204 GHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 49/216 (22%), Positives = 91/216 (42%), Gaps = 39/216 (18%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDI--FEHISDAARILREIKLLRLLRHPD 78
+ +G GS+GVV + +G K VA+K + + + D L+E ++ L H +
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD---FLKEAAIMHSLDHEN 57
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELME-----SDLHQVIKANDDLTREHYQFFLYQLLRA 133
++ + ++L + +V EL L + + ++ + Q+
Sbjct: 58 LIRLYGVVLTHP------LMMVTELAPLGSLLDRLRKDALGHFLISTLCD--YAVQIANG 109
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR-VAFNDTPTTIFWTDYVATRWYR- 191
++Y+ + HRDL +NIL ++ K+KI DFGL R + N+ D+ +
Sbjct: 110 MRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE--------DHYVMEEHLK 161
Query: 192 ------APELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
APE ++ A D+W G E+ T
Sbjct: 162 VPFAWCAPESLR--TRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLL-RHPDIVE 81
+++GKGS+G V A T + AIK + D+ D + E ++L L HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT- 59
Query: 82 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 140
H+ ++ +++ V E + DL I++ F+ +++ L+++H+
Sbjct: 60 --HLYCTFQTKE--NLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115
Query: 141 NVYHRDLKPKNILANANCKLKICDFGLARVA-FNDTPTTIFWTDYVATRWYRAPELCGSF 199
+ +RDLK NIL + + +KI DFG+ + D T F T Y APE+
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF----CGTPDYIAPEIL--L 169
Query: 200 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 230
KY ++D WS G + E+L G+ F G +
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 79/310 (25%), Positives = 123/310 (39%), Gaps = 69/310 (22%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI---------LREIKLLRLLR 75
+IG+G +G V TG+ A+K + D RI L E +L L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCL--------DKKRIKMKQGETLALNERIMLSLVS 52
Query: 76 H---PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLL 131
P IV + + P + F + +LM DLH + + + +F+ +++
Sbjct: 53 TGDCPFIVCMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEII 107
Query: 132 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 191
L+++H V +RDLKP NIL + + ++I D GLA P V T Y
Sbjct: 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYM 162
Query: 192 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLMTDLLGTPSLDT 249
APE+ + Y + D +S+GC+ ++L G F H++D MT
Sbjct: 163 APEVLQKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---------- 211
Query: 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEE 304
+M + P FS P LLE LL D R A+E
Sbjct: 212 -------------LTMAVELPDSFS-------PELRSLLEGLLQRDVNRRLGCLGRGAQE 251
Query: 305 ALADPYFKGL 314
P+F+ L
Sbjct: 252 VKEHPFFRSL 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 65/238 (27%), Positives = 103/238 (43%), Gaps = 43/238 (18%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHPDIVE 81
+VIG+G++G V TG A+K + D+ E A I E +L +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEK-EQVAHIRAERDILVEADGAWVVK 65
Query: 82 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 140
+ + S +D +++Y++ E + D+ ++ D L+ E QF++ + + A+ IH
Sbjct: 66 MFY-----SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 141 NVYHRDLKPKNILANANCKLKICDFGLA-------RVAF----NDTPTTIF--------- 180
HRD+KP N+L +A +K+ DFGL R F P + F
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 181 ----WT--------DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 226
W V T Y APE+ + Y D WS+G I E+L G P F
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 73/307 (23%), Positives = 135/307 (43%), Gaps = 47/307 (15%)
Query: 20 YKIQEVIGKGSYG---VVCSAIDTHTGEKVAIKKIHD--IFEHISDAARILREIKLLRLL 74
+++ +V+G G+YG +V TG+ A+K + + + E +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 75 RH-PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRA 133
R P +V + + ++ YV M + L+Q D+ + + +F+ +++ A
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILA 117
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 193
L+++H + +RD+K +NIL ++ + + DFGL++ ++ + + T Y AP
Sbjct: 118 LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY--SFCGTIEYMAP 175
Query: 194 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253
E+ + A+D WS+G + E+LTG F +L+
Sbjct: 176 EIIRG-KGGHGKAVDWWSLGILIFELLTGASPF-------------------TLEGERNT 215
Query: 254 RNDKARRYLTSMRKKQPVQFSQKFPN-ADPSALRLLERLLAFDPKDR-----PTAEEALA 307
+++ +RR L + FP+ P A LL +LL DPK R A E
Sbjct: 216 QSEVSRRIL---------KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266
Query: 308 DPYFKGL 314
P+FKGL
Sbjct: 267 HPFFKGL 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-11
Identities = 77/339 (22%), Positives = 136/339 (40%), Gaps = 58/339 (17%)
Query: 18 SRYKIQEVIGKGSYG--VVCSAIDTHTGEKVAIKKIHDIFEHISDAARIL---------- 65
+ +++ + + G++G +C A+ T E A + ++ + R++
Sbjct: 148 AHFRVIDDLPAGAFGKIFIC-ALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRA 206
Query: 66 -----REIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLH-----QVIKAN 115
EI L L H +I++I+ I+ + + Y++ + + DL+ +
Sbjct: 207 AIQLENEILALGRLNHENILKIEEILRSEA-----NTYMITQKYDFDLYSFMYDEAFDWK 261
Query: 116 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND- 174
D + + + QLL A++YIH + HRD+K +NI N + K+ + DFG A +
Sbjct: 262 DRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER 321
Query: 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL----------TGKP 224
W VAT +PE+ Y DIWS G I ++L GKP
Sbjct: 322 EAFDYGWVGTVATN---SPEILAG--DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376
Query: 225 LFPGKNVVHQLDLMTDLLGTPS---LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNAD 281
++ L + + P D I D A + + + + ++P
Sbjct: 377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYP--- 433
Query: 282 PSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVERE 320
L ++L FD RP A E LA P F ++ E E
Sbjct: 434 ------LVKMLTFDWHLRPGAAELLALPLFS--AEEEEE 464
|
Length = 501 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 73/281 (25%), Positives = 118/281 (41%), Gaps = 46/281 (16%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIK 83
V+GKG +G VC+ TG+ A KK+ + A L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 84 HIMLPPSRRDFKD-IYVVFELMES-DL--HQVIKANDDLTREHYQFFLYQLLRALKYIHT 139
+ + KD + +V +M DL H N + F+ +L L+ +
Sbjct: 67 YAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 140 ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF 199
+ +RDLKP+NIL + ++I D GLA P V T Y APE+ +
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINN- 175
Query: 200 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKAR 259
KYT + D W +GC+ E++ G+ F R R ++ +
Sbjct: 176 -EKYTFSPDWWGLGCLIYEMIQGQSPF-------------------------RKRKERVK 209
Query: 260 RYLTSMR-KKQPVQFSQKFPNADPSALRLLERLLAFDPKDR 299
R R K+ ++S+KF S R+ LL +PK+R
Sbjct: 210 REEVDRRVKEDQEEYSEKFSEDAKSICRM---LLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 6e-11
Identities = 62/226 (27%), Positives = 99/226 (43%), Gaps = 47/226 (20%)
Query: 19 RY-KIQEVIGKGSYGVVC----SAIDTHTGEKVAIKKIHDIFEHISDAARILR-----EI 68
RY K V+G+G +G V + TGE VA+K + + + EI
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK------RECGQQNTSGWKKEI 57
Query: 69 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFF 126
+L+ L H +IV+ K S + K + ++ E + S + K +L + F
Sbjct: 58 NILKTLYHENIVKYKGCC---SEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQ--LLLF 112
Query: 127 LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA----------RVAFN-DT 175
Q+ + Y+H+ + HRDL +N+L + + +KI DFGLA RV + D+
Sbjct: 113 AQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 172
Query: 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
P +FW A E K++ A D+WS G E+LT
Sbjct: 173 P--VFWY---------AVECLKEN--KFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 6e-11
Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 20/169 (11%)
Query: 65 LREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVI---KANDDLTR 120
L+EIK++ L+ P+I+ + + + + ++ E ME+ DL+Q + + + +
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEK 121
Query: 121 EHYQFFLY--------QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172
Y Q+ +KY+ + N HRDL +N L N +KI DFG++R +
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
+ I + RW + K+T A D+W+ G E+LT
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESI---LLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 64/243 (26%), Positives = 101/243 (41%), Gaps = 53/243 (21%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFE-----HISDAARILREIKLLRLLRH 76
+VIG+G++G V TG A+K + D+ E HI IL E L +++
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVK- 65
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALK 135
+ S +D ++Y++ E + D+ ++ D LT E QF++ + + A+
Sbjct: 66 ----------MFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAID 115
Query: 136 YIHTANVYHRDLKPKNILANANCKLKICDFGLA-------RVAFNDTPTTIFWTDY---- 184
IH HRD+KP N+L ++ +K+ DFGL R F +D+
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 185 ---------------------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 223
V T Y APE+ + Y D WS+G I E+L G
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233
Query: 224 PLF 226
P F
Sbjct: 234 PPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 55/232 (23%), Positives = 104/232 (44%), Gaps = 40/232 (17%)
Query: 19 RYKIQEVIGKGSYGVV--CSAID------------THTGEKVAIKKIHDIFEHISDAAR- 63
+ +++E +G+G +G V C A VA+K + ++ AR
Sbjct: 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLR---ADVTKTARN 62
Query: 64 -ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVI--------- 112
L+EIK++ L++P+I+ + + + D + ++ E ME+ DL+Q +
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCV---SDD--PLCMITEYMENGDLNQFLSQREIESTF 117
Query: 113 -KAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 169
AN+ ++ + + Q+ +KY+ + N HRDL +N L + +KI DFG++R
Sbjct: 118 THANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 170 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
++ I + RW + K+T A D+W+ G E+ T
Sbjct: 178 NLYSGDYYRIQGRAVLPIRWMAWESI---LLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 16/208 (7%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA---ARILREIKLLRLLRHPDIV 80
+V+G G++G V I GE V I I + + E ++ + HP +V
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 81 EIKHIMLPPSRRDFKDIYVVFELMESD--LHQVIKANDDLTREHYQFFLYQLLRALKYIH 138
+ + L P+ I +V +LM L V + D++ + + Q+ + + Y+
Sbjct: 73 RLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 139 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 198
+ HRDL +N+L + +KI DFGLAR+ D + +W L
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM---ALECI 183
Query: 199 FFSKYTPAIDIWSIGCIFAEVLT--GKP 224
+ K+T D+WS G E++T GKP
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 64/293 (21%), Positives = 110/293 (37%), Gaps = 46/293 (15%)
Query: 24 EVIGKGSYGVVCSAIDTHTGE--KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVE 81
+ +G+G +G V KVA+K + S+ L E ++ HP+++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 82 IKHIMLPPSRRD-FKDIYVVFELME-SDLHQVI---KANDD---LTREHYQFFLYQLLRA 133
+ + L + + V+ M+ DLH + + D L + F+ +
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 193
++Y+ + + HRDL +N + N N + + DFGL++ +N + +W
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184
Query: 194 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252
L YT D+WS G E+ T G+ +PG
Sbjct: 185 SLADRV---YTTKSDVWSFGVTMWEIATRGQTPYPG------------------------ 217
Query: 253 VRNDKARRYL-TSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 304
V N + YL R KQP P+ L+ +PKDRP+ E
Sbjct: 218 VENSEIYDYLRQGNRLKQP-------PDCLDGLYSLMSSCWLLNPKDRPSFET 263
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 21/222 (9%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 85
+G G++G V A + TG A K I E + + EI +L HP+IV++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 86 MLPPSRRDFKDIYVVFELMESDLHQVI--KANDDLTREHYQFFLYQLLRALKYIHTANVY 143
+ +++++ E + + LT + Q L AL Y+H +
Sbjct: 71 FYYEN-----NLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKII 125
Query: 144 HRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKY 203
HRDLK NIL + +K+ DFG V+ +T T ++ T ++ APE+ SK
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFG---VSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182
Query: 204 TP---AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242
P D+WS+G E+ +P H+L+ M LL
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPH------HELNPMRVLL 218
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 50/204 (24%), Positives = 97/204 (47%), Gaps = 30/204 (14%)
Query: 97 IYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 155
+++V E + DL ++ L EH +F+ ++ AL ++H + +RDLK N+L +
Sbjct: 71 LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130
Query: 156 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 215
A+ +K+ D+G+ + TT + + T Y APE+ +Y ++D W++G +
Sbjct: 131 ADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILRG--EEYGFSVDWWALGVL 185
Query: 216 FAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQ 275
E++ G+ F D++TD P ++T YL + ++P++ +
Sbjct: 186 MFEMMAGRSPF---------DIITD---NPDMNT---------EDYLFQVILEKPIRIPR 224
Query: 276 KFPNADPSALRLLERLLAFDPKDR 299
A +L+ L DPK+R
Sbjct: 225 FL---SVKASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 52/227 (22%), Positives = 92/227 (40%), Gaps = 48/227 (21%)
Query: 22 IQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 76
I+E +G+GS+G+V + +VAIK +++ + + L E +++
Sbjct: 11 IRE-LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-ASMRERIEFLNEASVMKEFNC 68
Query: 77 PDIVEIKHIML---PPSRRDFKDIYVVFELM-ESDLHQVIKA---NDDLTRE----HYQF 125
+V + ++ P VV ELM + DL +++ + Q
Sbjct: 69 HHVVRLLGVVSTGQPT--------LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQK 120
Query: 126 FLY---QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 182
F+ ++ + Y+ HRDL +N + + +KI DFG+ R I+ T
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--------DIYET 172
Query: 183 DY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
DY + RW APE +T D+WS G + E+ T
Sbjct: 173 DYYRKGGKGLLPVRWM-APESLKD--GVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 52/192 (27%), Positives = 89/192 (46%), Gaps = 28/192 (14%)
Query: 46 VAIKKIHDIFEHISDAAR--ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFEL 103
VA+K + D SD AR RE +LL L+H IV+ + + + + +VFE
Sbjct: 38 VAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EGDPLIMVFEY 88
Query: 104 ME-SDLHQVIKAN-------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKP 149
M+ DL++ ++A+ +LT+ Q+ + Y+ + + HRDL
Sbjct: 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLAT 148
Query: 150 KNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDI 209
+N L N +KI DFG++R ++ + + RW PE + K+T D+
Sbjct: 149 RNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDV 205
Query: 210 WSIGCIFAEVLT 221
WS+G + E+ T
Sbjct: 206 WSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKI-HDIFEHISDAARILREIKLLRLLRHPDIVEI-- 82
+GKG +G VC+ +TG+ A KK+ + S L E ++L + P IV +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 83 -----KHIMLPPSRRDFKDI-YVVFELMES--DLHQVIKANDDLTREHYQFFLYQLLRAL 134
H+ L S + D+ Y ++ + E ++ +VI + Q+ +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVI------------HYSAQITCGI 108
Query: 135 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 194
++H+ ++ +RD+KP+N+L + ++ D GLA V D T T T Y APE
Sbjct: 109 LHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTI---TQRAGTNGYMAPE 164
Query: 195 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 226
+ Y+ +D +++GC E++ G+ F
Sbjct: 165 ILKE--EPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 69/308 (22%), Positives = 120/308 (38%), Gaps = 62/308 (20%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDI-------FEHISDAARILREIKLLRLLRHPD 78
+GKG +G V + TG+ A KK++ +E RIL ++ H
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-------HSR 53
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMES-----DLHQVIKANDDLTREHYQFFLYQLLRA 133
+ + L + + D+ +V +M ++ V + N F+ Q++
Sbjct: 54 FI----VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG 109
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 193
L+++H + +RDLKP+N+L + + ++I D GLA V D + Y T + AP
Sbjct: 110 LEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKT--KGYAGTPGFMAP 166
Query: 194 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253
EL +Y ++D +++G E++ + F R
Sbjct: 167 ELLQG--EEYDFSVDYFALGVTLYEMIAARGPF-------------------------RA 199
Query: 254 RNDKA-RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALA 307
R +K + L V + KF A S E LLA DP+ R +
Sbjct: 200 RGEKVENKELKQRILNDSVTYPDKFSPASKS---FCEALLAKDPEKRLGFRDGNCDGLRT 256
Query: 308 DPYFKGLS 315
P F+ L+
Sbjct: 257 HPLFRDLN 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 5/101 (4%)
Query: 126 FLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYV 185
F YQ+ ++++ + N HRDL +N+L +KICDFGLAR D+ + ++
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 186 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKP 224
+W APE F + YT D+WS G + E+ T G P
Sbjct: 304 PLKWM-APE--SIFNNLYTTLSDVWSFGILLWEIFTLGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 39/114 (34%), Positives = 57/114 (50%), Gaps = 9/114 (7%)
Query: 116 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175
DDL R F Q+ + + ++ + N HRD+ +N+L KICDFGLAR ND+
Sbjct: 212 DDLLR-----FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266
Query: 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 228
+ + +W APE F YT D+WS G + E+ + GK +PG
Sbjct: 267 NYVVKGNARLPVKWM-APE--SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLL-RHPDIVEI 82
VIG+GSY V T A+K I ++ D + E + HP +V +
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 83 KHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN 141
SR ++ V E + DL ++ L EH +F+ ++ AL ++H
Sbjct: 62 HSCFQTESR-----LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG 116
Query: 142 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFS 201
+ +RDLK N+L +A +K+ D+G+ + TT + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 202 KYTPAIDIWSIGCIFAEVLTGKPLF 226
Y ++D W++G + E++ G+ F
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 65/243 (26%), Positives = 113/243 (46%), Gaps = 39/243 (16%)
Query: 26 IGKGSYGVVCSA----IDTHTGEK---VAIKKIHDIFEHISDAARILREIKLLRLL-RHP 77
+G+G +G V A ID ++ VA+K + D D + ++ E+++++++ +H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHK 81
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKAND--------DLTR---EHYQF 125
+I+ +L +D +YV+ E + +L + ++A D+ R E F
Sbjct: 82 NIIN----LLGACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF 136
Query: 126 -----FLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 180
YQ+ R ++Y+ + HRDL +N+L N +KI DFGLAR N
Sbjct: 137 KDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 181 WTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GKPLFPGKNVVHQLDL 237
+ +W APE + F + YT D+WS G + E+ T G P +PG V L
Sbjct: 197 TNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKL 251
Query: 238 MTD 240
+ +
Sbjct: 252 LKE 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 57/199 (28%), Positives = 87/199 (43%), Gaps = 43/199 (21%)
Query: 46 VAIKKIHDIFEHISDAARI--LREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFEL 103
VA+K + SD AR L+E+K+L L P+I + L D + ++ E
Sbjct: 49 VAVKVLRP---DASDNAREDFLKEVKILSRLSDPNIARL----LGVCTVD-PPLCMIMEY 100
Query: 104 ME-SDLHQVIKANDDLTREH--------YQFFLY---QLLRALKYIHTANVYHRDLKPKN 151
ME DL+Q ++ + T + LY Q+ ++Y+ + N HRDL +N
Sbjct: 101 MENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160
Query: 152 ILANANCKLKICDFGLARVAF-ND-------TPTTIFWTDYVATRWYRAPELCGSFF-SK 202
L N +KI DFG++R + +D P I RW A E S K
Sbjct: 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPI--------RWM-AWE---SVLLGK 208
Query: 203 YTPAIDIWSIGCIFAEVLT 221
+T D+W+ G E+LT
Sbjct: 209 FTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 34/232 (14%)
Query: 25 VIGKGSYGVVCSAIDTHTGEK-----VAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 79
+G+G +G V A + VA+K + + S+ +L E LL+ + HP +
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE-NASSSELRDLLSEFNLLKQVNHPHV 65
Query: 80 VEI-----------------KHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD---LT 119
+++ K+ L R+ + + + + + + N D LT
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 120 REHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 179
F +Q+ R ++Y+ + HRDL +N+L K+KI DFGL+R + +
Sbjct: 126 MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK 185
Query: 180 FWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GKPLFPG 228
+ +W A E S F YT D+WS G + E++T G P +PG
Sbjct: 186 RSKGRIPVKWM-AIE---SLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 67/305 (21%), Positives = 112/305 (36%), Gaps = 69/305 (22%)
Query: 21 KIQEVIGKGSYGVVCSAI---DTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRH 76
K+ +++G+G +G V D + KVA+K + DI + S+ L E ++ H
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY-SEIEEFLSEAACMKDFDH 60
Query: 77 PDIVEIKHIMLPPSRRD-FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLL--- 131
P+++++ + S V+ M+ DLH + + + Q L
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSR--LGGLPEKLPLQTLLKF 118
Query: 132 -----RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY-- 184
++Y+ N HRDL +N + + + + DFGL++ I+ DY
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK--------KIYSGDYYR 170
Query: 185 ------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDL 237
+ +W L YT D+W+ G E+ T G+ +PG
Sbjct: 171 QGRIAKMPVKWIAIESLADRV---YTSKSDVWAFGVTMWEIATRGQTPYPG--------- 218
Query: 238 MTDLLGTPSLDTISRVRNDKARRYL-TSMRKKQPVQFSQKFPNADPSALRLLERLLAFDP 296
V N + YL R KQP + L+ DP
Sbjct: 219 ---------------VENHEIYDYLRHGNRLKQP-------EDCLDELYDLMYSCWRADP 256
Query: 297 KDRPT 301
KDRPT
Sbjct: 257 KDRPT 261
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI--SDAARILREIKLLRLLRHP 77
+ + +VIG+G++G V + + A+K + FE I SD+A E ++
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSK-FEMIKRSDSAFFWEERDIMAHANSE 103
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 136
IV++ + +D K +Y+V E M DL ++ +N D+ + +F+ +++ AL
Sbjct: 104 WIVQLHYAF-----QDDKYLYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTAEVVLALDA 157
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFG----LARVAFNDTPTTIFWTDYVATRWYRA 192
IH+ HRD+KP N+L + + LK+ DFG + T + DY+ +
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYI------S 211
Query: 193 PELCGS--FFSKYTPAIDIWSIGCIFAEVLTGKPLF 226
PE+ S Y D WS+G E+L G F
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 5e-10
Identities = 83/337 (24%), Positives = 132/337 (39%), Gaps = 86/337 (25%)
Query: 12 SEYGDA----SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 67
+Y D + Y++ + IG G +G V T E K I + ++++ E
Sbjct: 3 GKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIE 62
Query: 68 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIK------------A 114
+ ++R L+H +IV L + + +Y++ E ++ DL + I+ A
Sbjct: 63 VNVMRELKHKNIVRYIDRFLNKAN---QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHA 119
Query: 115 NDDLTREHYQFFLYQLLRALKYIHT-------ANVYHRDLKPKNILANANCK-------- 159
D+TR QLL AL Y H V HRDLKP+NI + +
Sbjct: 120 IVDITR--------QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171
Query: 160 ---------LKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 210
KI DFGL++ + V T +Y +PEL Y D+W
Sbjct: 172 ANNLNGRPIAKIGDFGLSK----NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMW 227
Query: 211 SIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQP 270
++GCI E+ +GK F N Q L+++L P L P
Sbjct: 228 ALGCIIYELCSGKTPFHKANNFSQ--LISELKRGPDL----------------------P 263
Query: 271 VQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
++ K N L++ LL K+RP+A + L
Sbjct: 264 IKGKSKELNI------LIKNLLNLSAKERPSALQCLG 294
|
Length = 1021 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 41/179 (22%)
Query: 66 REIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQ----------VIKA 114
+E +L+ L+HP+IV + + + ++FE + DLH+ V
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCTKE-----QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAE 111
Query: 115 NDDLTREH---YQFFL---YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 168
+ D T + FL Q+ ++Y+ + + HRDL +N L +KI DFGL+
Sbjct: 112 SGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
Query: 169 RVAFNDTPTTIFWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 219
R I+ DY + RW PE + K+T DIWS G + E+
Sbjct: 172 R--------DIYSADYYRVQSKSLLPVRWM-PPE--AILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 7e-10
Identities = 67/278 (24%), Positives = 118/278 (42%), Gaps = 35/278 (12%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLL-RLLRHPDIVEI 82
VIG+GSY V T A+K + ++ D + E + + HP +V +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 83 KHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN 141
SR ++ V E + DL ++ L EH +F+ ++ AL Y+H
Sbjct: 62 HSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 116
Query: 142 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFS 201
+ +RDLK N+L ++ +K+ D+G+ + TT + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 202 KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRY 261
Y ++D W++G + E++ G+ F D++G S D + D +
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPF-------------DIVG--SSDNPDQNTEDYLFQV 216
Query: 262 LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR 299
+ + + P S K A +L+ L DPK+R
Sbjct: 217 ILEKQIRIPRSLSVK-------AASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 36/211 (17%)
Query: 26 IGKGSYGVVCSAIDTHTGE-KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKH 84
+G G +GVV G+ VAIK I E + E K++ L H +V++
Sbjct: 12 LGTGQFGVV--KYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 85 IMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLT---REHYQFF-LYQLLR-------A 133
+ + IY+V E M +N L REH + F QLL
Sbjct: 67 VCTKQ-----RPIYIVTEYM---------SNGCLLNYLREHGKRFQPSQLLEMCKDVCEG 112
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 193
+ Y+ + HRDL +N L + +K+ DFGL+R +D T+ + + RW P
Sbjct: 113 MAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF-PVRW-SPP 170
Query: 194 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK 223
E+ +SK++ D+W+ G + EV + GK
Sbjct: 171 EVL--LYSKFSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 32/222 (14%)
Query: 22 IQEVIGKGSYGVV----CSAID-THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 76
++ +G+G++G V C + T VA+K + D ++ RE +LL L+H
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQH 66
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKA----------------NDDLT 119
IV+ + D + +VFE M+ DL++ ++A +L
Sbjct: 67 EHIVKFYGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121
Query: 120 REHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 179
Q+ + Y+ + + HRDL +N L AN +KI DFG++R ++ +
Sbjct: 122 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181
Query: 180 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
+ RW PE + K+T D+WS G I E+ T
Sbjct: 182 GGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 60/231 (25%), Positives = 100/231 (43%), Gaps = 34/231 (14%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKV--AIKKIHDIFEHISDAARILREIKLL-R 72
+ + K Q+VIG+G++G V A G ++ AIK++ + + D E+++L +
Sbjct: 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCK 63
Query: 73 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFE---------------LMESDLHQVI--KAN 115
L HP+I+ +++ R + +Y+ E ++E+D I
Sbjct: 64 LGHHPNII---NLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 118
Query: 116 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175
L+ + F + R + Y+ HRDL +NIL N KI DFGL+R
Sbjct: 119 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 178
Query: 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV--LTGKP 224
T+ + RW L +S YT D+WS G + E+ L G P
Sbjct: 179 KKTM---GRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 63/250 (25%), Positives = 114/250 (45%), Gaps = 37/250 (14%)
Query: 18 SRYKIQEVIGKGSYGVVCSA----IDTHTGEK---VAIKKIHDIFEHISDAARILREIKL 70
+R + + +G+G +G V A ID K VA+K + D D + ++ E+++
Sbjct: 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD-KDLSDLVSEMEM 70
Query: 71 LRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKA-------------- 114
++++ +H +I+ +L +D +YV+ E + +L + ++A
Sbjct: 71 MKMIGKHKNIIN----LLGACTQD-GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125
Query: 115 --NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172
+ LT + YQ+ R ++Y+ + HRDL +N+L + +KI DFGLAR
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVH 185
Query: 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT-GKPLFPGKN 230
N + +W APE + F + YT D+WS G + E+ T G +PG
Sbjct: 186 NIDYYKKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241
Query: 231 VVHQLDLMTD 240
V L+ +
Sbjct: 242 VEELFKLLKE 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 47/225 (20%)
Query: 26 IGKGSYGVV----CSAIDTHTGEK-VAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 80
+G+G++G V C + + VA+K + + E S RE +LL +L+H IV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREAELLTVLQHQHIV 70
Query: 81 EIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAND---------------DLTREHYQ 124
+ + + + +VFE M DL++ ++++ LT
Sbjct: 71 RFYGVC-----TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 125 FFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY 184
Q+ + Y+ + + HRDL +N L +KI DFG++R I+ TDY
Sbjct: 126 AIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--------DIYSTDY 177
Query: 185 --------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
+ RW PE + K+T DIWS G + E+ T
Sbjct: 178 YRVGGRTMLPIRWM-PPE--SILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 57/228 (25%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 79
++I +VIG+G++G V V +K ++ A +IL + ++L+
Sbjct: 3 FEILKVIGRGAFGEVAV---------VKMKNTGQVY-----AMKILNKWEMLKRAETACF 48
Query: 80 VEIKHIMLPPSRR----------DFKDIYVVFEL-MESDLHQVI-KANDDLTREHYQFFL 127
E + +++ RR D ++Y+V + + DL ++ K D L + +F+L
Sbjct: 49 REERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL 108
Query: 128 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 187
+++ A+ +H HRD+KP N+L + N +++ DFG D T+ V T
Sbjct: 109 AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD--GTVQSNVAVGT 166
Query: 188 RWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 232
Y +PE+ + +Y P D WS+G E+L G+ F +++V
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 60/231 (25%), Positives = 107/231 (46%), Gaps = 39/231 (16%)
Query: 26 IGKGSYGVVCSA----IDTHTGEK---VAIKKIHDIFEHISDAARILREIKLLRLL-RHP 77
+G+G +G V A ID ++ VA+K + D D A ++ E++L++L+ +H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD-KDLADLISEMELMKLIGKHK 78
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKAND--------DLTREHYQFF-- 126
+I+ + + +YV+ E + +L + ++A D+T+ +
Sbjct: 79 NIINLLGVCTQEG-----PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 127 ------LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 180
YQ+ R ++Y+ + HRDL +N+L + +KI DFGLAR +
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 181 WTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GKPLFPG 228
+ +W APE + F + YT D+WS G + E+ T G P +PG
Sbjct: 194 SNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGILMWEIFTLGGSP-YPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 49/176 (27%), Positives = 81/176 (46%), Gaps = 28/176 (15%)
Query: 65 LREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKA--------- 114
L+E+K+L L+ P+I+ + + + D + ++ E ME+ DL+Q + +
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCV-----DEDPLCMITEYMENGDLNQFLSSHHLDDKEEN 121
Query: 115 -NDDLTREH------YQFFLY---QLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 164
ND + H Y L+ Q+ +KY+ + N HRDL +N L N +KI D
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIAD 181
Query: 165 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 220
FG++R + I + RW A E K+T A D+W+ G E+L
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIRWM-AWECI--LMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 69/318 (21%), Positives = 125/318 (39%), Gaps = 77/318 (24%)
Query: 18 SRYKIQE--VIGKGSYGVV----CSAIDTHTGEKVAIKKIHDIFEHISDAARIL---REI 68
R +QE +G+G +G V I+ GE + + K + D RE+
Sbjct: 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKA---LQKTKDENLQSEFRREL 59
Query: 69 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD---------L 118
+ R L H ++V + + R+ + Y++ E + DL Q ++A L
Sbjct: 60 DMFRKLSHKNVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL 114
Query: 119 TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 178
+ + Q+ + ++ A HRDL +N L ++ ++K+ L++ +N
Sbjct: 115 STKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS---- 170
Query: 179 IFWTDY-------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 230
+Y + RW APE ++ D+WS G + EV T G+ F G
Sbjct: 171 ----EYYKLRNALIPLRWL-APE--AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG-- 221
Query: 231 VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSAL-RLLE 289
++D + ++R++ K P PS L +L+
Sbjct: 222 -------LSD------EEVLNRLQAGKLE---------------LPVPEGCPSRLYKLMT 253
Query: 290 RLLAFDPKDRPTAEEALA 307
R A +PKDRP+ E ++
Sbjct: 254 RCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 66/235 (28%), Positives = 102/235 (43%), Gaps = 49/235 (20%)
Query: 26 IGKGSYGVVC--SAID---THTGE-KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 79
+G G++G V +A D +G +VA+K + + L+E L+ HP+I
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK-GATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 80 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLL------- 131
V++ + L + Y++ ELME DL ++ L +LL
Sbjct: 62 VKLLGVCL-----LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 132 RALKYIHTANVYHRDLKPKNILA-----NANCKLKICDFGLARVAFNDTPTTIFWTDY-- 184
+ Y+ + HRDL +N L +A+ +KI DFGLAR I+ +DY
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--------DIYKSDYYR 168
Query: 185 ------VATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 230
+ RW APE L G F T D+WS G + E+LT G+ +P N
Sbjct: 169 KEGEGLLPVRWM-APESLLDGKF----TTQSDVWSFGVLMWEILTLGQQPYPALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 62/229 (27%), Positives = 103/229 (44%), Gaps = 40/229 (17%)
Query: 21 KIQEVIGKGSYGVVCSAIDTHTGEKV--AIKKIHDIFEHISDAARILREIKLL-RLLRHP 77
K ++VIG+G++G V A+ G K+ AIK + + F +D E+++L +L HP
Sbjct: 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHP 63
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFE----------LMESDLHQVIKANDDLTREH---YQ 124
+I+ +++ R + +Y+ E L +S +V++ + +EH
Sbjct: 64 NII---NLLGACENRGY--LYIAIEYAPYGNLLDFLRKS---RVLETDPAFAKEHGTAST 115
Query: 125 FFLYQLLR-------ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 177
QLL+ ++Y+ HRDL +N+L N KI DFGL+R
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175
Query: 178 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV--LTGKP 224
T+ + RW L +S YT D+WS G + E+ L G P
Sbjct: 176 TM---GRLPVRWMAIESLN---YSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 2e-08
Identities = 47/163 (28%), Positives = 78/163 (47%), Gaps = 17/163 (10%)
Query: 107 DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN-ANCKLKICDF 165
DL ++K L+ + + QL+ AL +H N+ H D+K +N+L + A ++ +CD+
Sbjct: 95 DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDY 154
Query: 166 GLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 224
GL ++ TP+ Y T Y +PE + G Y + D W++G + E+LTGK
Sbjct: 155 GLCKII--GTPSC-----YDGTLDYFSPEKIKGHN---YDVSFDWWAVGVLTYELLTGK- 203
Query: 225 LFPGKNVVHQ-LDLMTDLLGTPSLD-TISRVRNDKARRYLTSM 265
P K + LDL LL + + A ++ SM
Sbjct: 204 -HPFKEDEDEELDL-ESLLKRQQKKLPFIKNVSKNANDFVQSM 244
|
Length = 267 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 14/209 (6%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIK-KIHDIFEHISDAA--RILREIKLLRLL 74
+ +K +V+G G++G V + GEKV I I ++ E S A IL E ++ +
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66
Query: 75 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMESD--LHQVIKANDDLTREHYQFFLYQLLR 132
+P + + I L + + ++ +LM L V + D++ ++ + Q+ +
Sbjct: 67 DNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 120
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 192
+ Y+ + HRDL +N+L +KI DFGLA++ D V +W
Sbjct: 121 GMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 193 PELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
+ YT D+WS G E++T
Sbjct: 181 ESI---LHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 38/112 (33%), Positives = 55/112 (49%), Gaps = 24/112 (21%)
Query: 128 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY--- 184
YQ+ R ++Y+ + HRDL +N+L + +KI DFGLAR I DY
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--------DIHHIDYYKK 198
Query: 185 -----VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GKPLFPG 228
+ +W APE + F + YT D+WS G + E+ T G P +PG
Sbjct: 199 TTNGRLPVKWM-APE---ALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-YPG 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 22/218 (10%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIK-KIHDIFEHISDAA--RILREIKLLRLLRHPDIVE 81
V+G G++G V I GE V I I + E+ S A IL E ++ + P +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 82 IKHIMLPPSRRDFKDIYVVFELMESD--LHQVIKANDDLTREHYQFFLYQLLRALKYIHT 139
+ I L + + +V +LM L V + D + + + Q+ + + Y+
Sbjct: 74 LLGICLTST------VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE 127
Query: 140 ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD--YVATRWYRAPELCG 197
+ HRDL +N+L + +KI DFGLAR+ D T + D V +W +
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLL--DIDETEYHADGGKVPIKWMALESI-- 183
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLT--GKPL--FPGKNV 231
++T D+WS G E++T KP P + +
Sbjct: 184 -LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 25/206 (12%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 85
+ KG Y + ID VAIK + + E S ++RE +++ L +P IV + +
Sbjct: 11 VKKGVYKMRKKQID------VAIKVLKNENEK-SVRDEMMREAEIMHQLDNPYIVRMIGV 63
Query: 86 MLPPSRRDFKDIYVVFELMESD-LHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVY 143
+ + + +V E+ L++ + D++T + ++Q+ +KY+ N
Sbjct: 64 C------EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFV 117
Query: 144 HRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW---YRAPELCGSFF 200
HRDL +N+L KI DFGL++ D ++ A +W + APE F
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDS---YYKARSAGKWPLKWYAPECIN--F 172
Query: 201 SKYTPAIDIWSIGCIFAEVLT--GKP 224
K++ D+WS G E + KP
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 7e-08
Identities = 73/269 (27%), Positives = 105/269 (39%), Gaps = 42/269 (15%)
Query: 67 EIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM-------ESDLHQVIKAN-DDL 118
E +LLR L HP ++ + D+ VV L SDL+ + A L
Sbjct: 210 EARLLRRLSHPAVLALL------------DVRVVGGLTCLVLPKYRSDLYTYLGARLRPL 257
Query: 119 TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 178
QLL A+ YIH + HRD+K +N+L N + + DFG A A + +T
Sbjct: 258 GLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFA-RGSWST 316
Query: 179 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG-CIFAEVLTGKPLFPGKN------- 230
F T APE+ YTP++DIWS G IF + LF
Sbjct: 317 PFHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPY 374
Query: 231 ------VVHQLDLMTDLLGT-PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPS 283
++ Q + D +S+ R+ AR + R ++ D
Sbjct: 375 DAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAAR----NRRPAYTRPAWTRYYKLDLD 430
Query: 284 ALRLLERLLAFDPKDRPTAEEALADPYFK 312
L+ R L FD RP+A E L P F+
Sbjct: 431 VEYLVCRALTFDGARRPSAAELLRLPLFQ 459
|
Length = 461 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 1e-07
Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 30/221 (13%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKV--AIKKIHDIFEHISDAARILREIKLL-RLLRHPDIV 80
+VIG+G++G V A G ++ AIK++ + + D E+++L +L HP+I+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 81 EIKHIMLPPSRRDFKDIYVVFELMESDL-----HQVIKANDDLTREH---YQFFLYQLLR 132
+++ R + + + + + L +V++ + + QLL
Sbjct: 60 ---NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 133 -------ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYV 185
+ Y+ HRDL +NIL N KI DFGL+R T+ +
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM---GRL 173
Query: 186 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV--LTGKP 224
RW L +S YT D+WS G + E+ L G P
Sbjct: 174 PVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 84/347 (24%), Positives = 133/347 (38%), Gaps = 90/347 (25%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLR 75
S + + IG G++G VC T A+K + D+ + AA + E +L
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMR-NQAAHVKAERDILAEAD 59
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFEL-----MESDLHQVIKANDDLTREHYQFFLYQL 130
+ +V++ + S +D ++Y V + M S L ++ +DL R F++ +L
Sbjct: 60 NEWVVKLYY-----SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLAR----FYIAEL 110
Query: 131 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL------------------ARVAF 172
A++ +H HRD+KP NIL + + +K+ DFGL R
Sbjct: 111 TCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 173 NDTPTTIFWTD----------------------YVATRWYRAPELCGSFFSKYTPAIDIW 210
+ D V T Y APE+ + YT D W
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWW 228
Query: 211 SIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQP 270
S+G I E+L G+P F L TP +T +V N + ++ S K
Sbjct: 229 SVGVILYEMLVGQPPF--------------LADTP-AETQLKVINWETTLHIPSQAK--- 270
Query: 271 VQFSQKFPNADPSALRLLERLLAFDPKDR---PTAEEALADPYFKGL 314
A L+ RL +DR A+E A P+FKG+
Sbjct: 271 ---------LSREASDLILRLCC-GAEDRLGKNGADEIKAHPFFKGI 307
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 56/250 (22%), Positives = 100/250 (40%), Gaps = 55/250 (22%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHPDIVE 81
+ +G G++G VC A T A+K + D+ + A + E +L + +V+
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNR-NQVAHVKAERDILAEADNEWVVK 65
Query: 82 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 140
+ + S +D ++Y V + + D+ ++ + +F++ +L A++ +H
Sbjct: 66 LYY-----SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM 120
Query: 141 NVYHRDLKPKNILANANCKLKICDFGL----------------ARVAFNDTPTTIFWTD- 183
HRD+KP NIL + + +K+ DFGL + + + + W D
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 184 ---------------------------YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 216
V T Y APE+ YT D WS+G I
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL--LRKGYTQLCDWWSVGVIL 238
Query: 217 AEVLTGKPLF 226
E+L G+P F
Sbjct: 239 FEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 26/209 (12%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEK----VAIKKIHD-----IFEHISDAARILREIKLLRLL 74
+++G G +G V I G+ VAIK I D F+ I+D + + L
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITD------HMLAMGSL 66
Query: 75 RHPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQLLR 132
H IV + I S + +V +L S L V + D L + + Q+ +
Sbjct: 67 DHAYIVRLLGICPGAS------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAK 120
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 192
+ Y+ + HR+L +NIL ++ ++I DFG+A + + D + +W
Sbjct: 121 GMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM-- 178
Query: 193 PELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
L F +YT D+WS G E+++
Sbjct: 179 -ALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 48/223 (21%), Positives = 93/223 (41%), Gaps = 29/223 (13%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTG----EKVAIKKIHDIFEHISDA--ARILREIK 69
R + +++ +G++G + I E+V +K + D H S+ +L+E
Sbjct: 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD---HASEIQVTLLLQESC 60
Query: 70 LLRLLRHPDIVEIKH----------IMLP-PSRRDFKDIYVVFELMESDLHQVIKANDDL 118
LL L H +I+ I H ++ P + + K L E++ Q +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS----- 115
Query: 119 TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 178
T++ + Q+ + Y+H V H+D+ +N + + ++KI D L+R F
Sbjct: 116 TQQLVHMAI-QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC 174
Query: 179 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
+ + +W L +S A D+WS G + E++T
Sbjct: 175 LGDNENRPVKWMALESLVNKEYSS---ASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 50/217 (23%), Positives = 86/217 (39%), Gaps = 27/217 (12%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRL 73
D KI+ ++G G +G +C ++ IH + SD R L E L
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62
Query: 74 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY-QFFLYQLL- 131
H +IV ++ ++ + + +V E M + A D R+H Q QL+
Sbjct: 63 FDHSNIVRLEGVITRGN-----TMMIVTEYMSNG------ALDSFLRKHEGQLVAGQLMG 111
Query: 132 ------RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT-DY 184
+KY+ H+ L +L N++ KI F + D I+ T
Sbjct: 112 MLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ---EDKSEAIYTTMSG 168
Query: 185 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
+ + APE + ++ A D+WS G + EV++
Sbjct: 169 KSPVLWAAPEAIQ--YHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 59/243 (24%), Positives = 95/243 (39%), Gaps = 59/243 (24%)
Query: 19 RYKIQEV--IGKGSYGVVCSA-----IDTHTGEKVAIKKIHDIFEHISD--AARILREIK 69
R I+ V IG+G++G V A + VA+K + E S A RE
Sbjct: 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAA 60
Query: 70 LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAND------------ 116
L+ HP+IV++ + K + ++FE M DL++ ++
Sbjct: 61 LMAEFDHPNIVKLLGVCAVG-----KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTS 115
Query: 117 ----------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFG 166
L+ Q+ + Y+ HRDL +N L N +KI DFG
Sbjct: 116 SARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 175
Query: 167 LARVAFNDTPTTIFWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 218
L+R I+ DY + RW PE F+++YT D+W+ G + E
Sbjct: 176 LSR--------NIYSADYYKASENDAIPIRWM-PPE--SIFYNRYTTESDVWAYGVVLWE 224
Query: 219 VLT 221
+ +
Sbjct: 225 IFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 64/263 (24%), Positives = 107/263 (40%), Gaps = 65/263 (24%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI--HDIFEHISDAARILREIKLLRLLRHP 77
+ +VIGKG++G V TG+ A+K + ++F+ A + E +L P
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKK-DQLAHVKAERDVLAESDSP 61
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLYQLLRA 133
+V + + F+D ++ +ME DL ++ D + + +F++ + + A
Sbjct: 62 WVVSLYY--------SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLA 113
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLA------------------------- 168
++ +H HRD+KP NIL + +K+ DFGL+
Sbjct: 114 IEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173
Query: 169 ----RVAFNDTPTTIFWTDYVATRW----------------YRAPELCGSFFSK-YTPAI 207
VA + T+ D +AT W Y APE+ F + Y
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIAT-WKKNRRLMAYSTVGTPDYIAPEI---FLQQGYGQEC 229
Query: 208 DIWSIGCIFAEVLTGKPLFPGKN 230
D WS+G I E L G P F +N
Sbjct: 230 DWWSLGAIMFECLIGWPPFCSEN 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 58/251 (23%), Positives = 100/251 (39%), Gaps = 57/251 (22%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHPDIVE 81
+ +G G++G VC A T A+K + D+ + A + E +L + +V
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLR-NQVAHVKAERDILAEADNEWVVR 65
Query: 82 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 140
+ + S +D ++Y V + + D+ ++ + +F++ +L A++ +H
Sbjct: 66 LYY-----SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120
Query: 141 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF-----------------WTD 183
HRD+KP NIL + + +K+ DFGL F T + + W D
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLC-TGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 184 ----------------------------YVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 215
V T Y APE+ + YT D WS+G I
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL--LRTGYTQLCDWWSVGVI 237
Query: 216 FAEVLTGKPLF 226
E+L G+P F
Sbjct: 238 LYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 29/225 (12%)
Query: 18 SRYKIQEVIGKGSYGVVCSA--IDTHTGEK---VAIKKIHDIFEHISDAARILREIKLLR 72
S + E +G+ +G V T GE+ VAIK + D E E +
Sbjct: 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRS 63
Query: 73 LLRHPDIV----------EIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLT--- 119
L+HP+IV + I S D + F +M S V +DD T
Sbjct: 64 RLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHE----FLVMRSPHSDVGSTDDDKTVKS 119
Query: 120 -REHYQFF--LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176
E F + Q+ ++++ + +V H+DL +N+L +KI D GL R +
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179
Query: 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
+ + RW +PE + K++ DIWS G + EV +
Sbjct: 180 YKLMGNSLLPIRWM-SPE--AIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 8e-07
Identities = 58/226 (25%), Positives = 86/226 (38%), Gaps = 60/226 (26%)
Query: 124 QFFLYQLLRALKYIHTANVYHRDLKPKNIL-ANANCKLKICDFGLA---RVAFNDTPTTI 179
Q + Q+L AL +H+ + HRD+KP+NI+ + + KI D G A RV N P
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIP--- 314
Query: 180 FWTDYVATRWYRAPELCGSFFSKYTPA----------------------IDIWSIGCIFA 217
+++ Y APE S TP+ DI+S G IF
Sbjct: 315 --KEFLLDPRYAAPE--QYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 370
Query: 218 EVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRY-LTSMRKKQPVQFSQK 276
++ FP L +D + I R K Y L + RK + S
Sbjct: 371 QM-----AFPN--------LRSD------SNLIQFNRQLKRNDYDLVAWRKLVEPRASPD 411
Query: 277 FPNA-------DPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315
+ LL+ ++ F + R +A+ ALA PYF
Sbjct: 412 LRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREG 457
|
Length = 566 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 52/213 (24%), Positives = 85/213 (39%), Gaps = 28/213 (13%)
Query: 26 IGKGSYGVVCSAIDTHTG---EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEI 82
IG G +G V + H G +V +K++ + L+E++ R L HP++
Sbjct: 3 IGNGWFGKVLLG-EAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNV--- 57
Query: 83 KHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQ-----LLRALKY 136
+ + +V E DL +++N + + Q + Q + L +
Sbjct: 58 --LQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW 115
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD---YVATRWYRAP 193
+H A+ H DL +N A+ +KI D+GL A P + T V RW AP
Sbjct: 116 LHQADFIHSDLALRNCQLTADLSVKIGDYGL---ALEQYPEDYYITKDCHAVPLRWL-AP 171
Query: 194 ELCGSFFS-----KYTPAIDIWSIGCIFAEVLT 221
EL T +IWS+G E+ T
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 48/196 (24%), Positives = 87/196 (44%), Gaps = 31/196 (15%)
Query: 46 VAIKKIHDIF--EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE- 102
VAIK + DI + + +E L+ L HP+IV + ++ + + ++FE
Sbjct: 37 VAIKTLKDINNPQQWGE---FQQEASLMAELHHPNIVCLLGVVTQE-----QPVCMLFEY 88
Query: 103 LMESDLHQVI-----------KANDDLT----REHYQFF--LYQLLRALKYIHTANVYHR 145
L + DLH+ + +++D T +H F Q+ ++Y+ + H+
Sbjct: 89 LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHK 148
Query: 146 DLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTP 205
DL +NIL +KI D GL+R ++ + + RW PE + K++
Sbjct: 149 DLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWM-PPE--AIMYGKFSS 205
Query: 206 AIDIWSIGCIFAEVLT 221
DIWS G + E+ +
Sbjct: 206 DSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 7e-06
Identities = 31/104 (29%), Positives = 46/104 (44%), Gaps = 22/104 (21%)
Query: 129 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY---- 184
+++ AL +H + RDL P NIL + +++ F W++
Sbjct: 93 EMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSR-------------WSEVEDSC 139
Query: 185 ---VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 225
Y APE+ G S+ T A D WS+G I E+LTGK L
Sbjct: 140 DGEAVENMYCAPEVGG--ISEETEACDWWSLGAILFELLTGKTL 181
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 52/216 (24%), Positives = 84/216 (38%), Gaps = 32/216 (14%)
Query: 23 QEVIGKGSYG-VVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI-- 79
QE IG G +G V+ S I T TG + K + L++ R+L+HP+I
Sbjct: 1 QE-IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQ 59
Query: 80 -----VEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLY----Q 129
VE +L VFE E DL + R L +
Sbjct: 60 CLGQCVEAIPYLL------------VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACE 107
Query: 130 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 189
+ + ++H N H DL +N ++ +K+ D+G+ + + V RW
Sbjct: 108 IAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRW 167
Query: 190 YRAPELCGSFF-----SKYTPAIDIWSIGCIFAEVL 220
APEL G F ++ T ++W++G E+
Sbjct: 168 L-APELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 40/156 (25%), Positives = 76/156 (48%), Gaps = 19/156 (12%)
Query: 26 IGKGSYGVVCSAIDTHTGEKVAIK---KIHDIFEHISDAARILREIKLLRLLRHPDIVEI 82
I +G++G V + + A+K K I +++ + R+ L L + P IV +
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDA--LALSKSPFIVHL 69
Query: 83 KHIMLPPSRRDFKDIYVVFELM-----ESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 137
+ S + ++Y+V E + +S LH ++++ ++ ++ AL Y+
Sbjct: 70 YY-----SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAV----KYISEVALALDYL 120
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173
H + HRDLKP N+L + +K+ DFGL++V N
Sbjct: 121 HRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 57/244 (23%), Positives = 94/244 (38%), Gaps = 50/244 (20%)
Query: 25 VIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 79
+G G++G V + +VA+K + + D + L E ++ H +I
Sbjct: 13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-QDESDFLMEALIMSKFNHQNI 71
Query: 80 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLR------ 132
V + + R +++ ELM DL ++ N + LL
Sbjct: 72 VRLIGVSFERLPR-----FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 133 -ALKYIHTANVYHRDLKPKNILANANCK-----LKICDFGLARVAFNDTPTTIFWTDY-- 184
KY+ + HRD+ +N L CK KI DFG+AR I+ Y
Sbjct: 127 KGCKYLEENHFIHRDIAARNCL--LTCKGPGRVAKIADFGMAR--------DIYRASYYR 176
Query: 185 ------VATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQL 235
+ +W PE L G F SK D+WS G + E+ + G +PG+ +
Sbjct: 177 KGGRAMLPIKWM-PPEAFLDGIFTSK----TDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231
Query: 236 DLMT 239
+ +T
Sbjct: 232 EFVT 235
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 75/336 (22%), Positives = 133/336 (39%), Gaps = 60/336 (17%)
Query: 25 VIGKG--SYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILR-EIKLLRLLRHPDIVE 81
VIG+G V A TGE V +++I ++ ++ L+ E+ + +L HP+IV
Sbjct: 5 VIGRGFEDLMTVNLARYKPTGEYVTVRRI-NLEACTNEMVTFLQGELHVSKLFNHPNIVP 63
Query: 82 IKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQ---------FFLYQLLR 132
+ + + +++VV M + DL H+ + L +L+
Sbjct: 64 YRATFIADN-----ELWVVTSFM------AYGSAKDLICTHFMDGMSELAIAYILQGVLK 112
Query: 133 ALKYIHTANVYHRDLKPKNILANANCK---------LKICDFGLARVAFNDTPTTIFWTD 183
AL YIH HR +K +IL + + K L + + G +D P
Sbjct: 113 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKY----- 167
Query: 184 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 243
V + +PE+ Y DI+S+G E+ G P K++ L+ L G
Sbjct: 168 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH--VPFKDMPATQMLLEKLNG 225
Query: 244 T-PSLDTISRVRNDK-----ARRYLTSMRKKQPVQFSQKFPNADPSA---LR-------- 286
T P L + + ++ +R S + + + N + S+ R
Sbjct: 226 TVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHH 285
Query: 287 LLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPS 322
+E+ L +P RP+A L +FK +++R S
Sbjct: 286 FVEQCLQRNPDARPSASTLLNHSFFK---QIKRRAS 318
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 27/101 (26%), Positives = 44/101 (43%), Gaps = 19/101 (18%)
Query: 129 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY---- 184
++ + Y++ HRDL +N + + +KI DFG+ R I+ TDY
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--------DIYETDYYRKG 178
Query: 185 ----VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
+ RW L F+ Y+ D+WS G + E+ T
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 84/339 (24%), Positives = 140/339 (41%), Gaps = 74/339 (21%)
Query: 21 KIQEVIGKG--SYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILR-EIKLLRLLRHP 77
++Q IG+G + V A T TG V ++ I D+ + + L+ E+ L RHP
Sbjct: 1 ELQVEIGRGFCNLTSVYLARHTPTGTLVTVR-ITDLENCTEEHLKALQNEVVLSHFFRHP 59
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKA------NDDLTREHYQFFLYQL 130
+I+ + S ++V+ M + ++K ++ L L+
Sbjct: 60 NIMTSWTVFTTGSW-----LWVISPFMAYGSANSLLKTYFPEGMSEALIGN----ILFGA 110
Query: 131 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL------------ARVAFNDTPTT 178
LR L Y+H HR++K +IL + + + + GL A+V + D P
Sbjct: 111 LRGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVY-DFPQ- 166
Query: 179 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLM 238
F T + W +PEL Y DI+S+G E+ TG+ P ++++ L+
Sbjct: 167 -FSTSVLP--WL-SPELLRQDLYGYNVKSDIYSVGITACELATGR--VPFQDMLRTQMLL 220
Query: 239 TDLLGTP--SLDTI------SRVRNDKA---------------RRYLTSMRKKQPVQ--F 273
L G P LD SR++N ++ + +TS R + P F
Sbjct: 221 QKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTF 280
Query: 274 SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312
S F N L+E L DP+ RP+A L+ +FK
Sbjct: 281 SPAFQN-------LVELCLQQDPEKRPSASSLLSHAFFK 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 53/224 (23%), Positives = 97/224 (43%), Gaps = 28/224 (12%)
Query: 4 NSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR 63
+S + + S K + VI +G G G + +K+I+D+ I +
Sbjct: 676 DSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDV-NSIPSS-- 732
Query: 64 ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREH 122
EI + L+HP+IV++ + R K Y++ E +E +L +V++ +L+ E
Sbjct: 733 ---EIADMGKLQHPNIVKLIGLC-----RSEKGAYLIHEYIEGKNLSEVLR---NLSWER 781
Query: 123 YQFFLYQLLRALKYIH---TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 179
+ + +AL+++H + V +L P+ I+ + + + L + DT I
Sbjct: 782 RRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFI 840
Query: 180 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 223
+ Y APE + T DI+ G I E+LTGK
Sbjct: 841 -------SSAYVAPETRET--KDITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 4e-04
Identities = 17/42 (40%), Positives = 28/42 (66%)
Query: 127 LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 168
+ Q+L L+ +H + HRD+KP+N+L + ++KI DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 25/96 (26%), Positives = 41/96 (42%), Gaps = 19/96 (19%)
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY--------V 185
+ Y++ HRDL +N + + +KI DFG+ R I+ TDY +
Sbjct: 132 MAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIYETDYYRKGGKGLL 183
Query: 186 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
RW L F+ + D+WS G + E+ +
Sbjct: 184 PVRWMAPESLKDGVFTTSS---DMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 27/102 (26%), Positives = 43/102 (42%), Gaps = 6/102 (5%)
Query: 124 QFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD 183
Q ++ L ++H N H DL +N L A+ +KI D+GL+ + +
Sbjct: 103 QRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL 162
Query: 184 YVATRWYRAPELCGSFFSKY-----TPAIDIWSIGCIFAEVL 220
+V RW APEL T ++WS+G E+
Sbjct: 163 WVPLRWI-APELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 52/221 (23%), Positives = 77/221 (34%), Gaps = 54/221 (24%)
Query: 23 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEI 82
Q I KG + I T K + DI E EIK LR + +I++I
Sbjct: 33 QNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITE---------NEIKNLRRIDSNNILKI 83
Query: 83 KHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLY---QLLRALKY--- 136
Y + DL ++ + TR + + L L K
Sbjct: 84 ---------------YGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMA 128
Query: 137 ----IHTANVYHRDLKP------KNILANANCKLKICDFGLARV----AFNDTPTTIFWT 182
N+Y KP + L N KLKI GL ++ F +
Sbjct: 129 IDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKN-------- 180
Query: 183 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 223
V Y + ++ FS+YT DI+S+G + E+ TGK
Sbjct: 181 --VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 16/39 (41%), Positives = 26/39 (66%)
Query: 130 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 168
+L L+YIH + H D+KP+NI+ + N + I D+G+A
Sbjct: 135 MLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 614 | |||
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.98 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.76 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.66 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.54 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.5 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.41 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.37 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.35 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.3 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.07 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.05 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.98 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.98 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.98 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.92 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.9 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.74 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.72 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.71 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.63 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.33 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.31 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.28 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.16 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.12 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.12 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.07 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.96 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.92 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.92 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.85 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.71 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.69 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.66 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.58 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.56 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.45 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.38 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.36 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.28 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.2 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.14 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.14 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.06 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.99 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.94 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.77 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.72 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.59 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.3 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.28 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.11 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.1 | |
| PLN02236 | 344 | choline kinase | 95.9 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.79 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.69 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.22 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.26 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.01 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 91.33 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 91.2 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 91.03 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 90.62 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 90.49 | |
| PTZ00296 | 442 | choline kinase; Provisional | 90.25 |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-75 Score=590.70 Aligned_cols=342 Identities=58% Similarity=0.975 Sum_probs=323.9
Q ss_pred ccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 12 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 12 ~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
..+....+|..++.||+|+||+||.|.++.+|+.||||++.+.|.+..++++.+||+++|+.++|+||+.+++++.++..
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 44666778888899999999999999999999999999999999999999999999999999999999999999999888
Q ss_pred CCCCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 92 RDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 92 ~~~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
..++++|+|+|+|+.||+++|+.+..|++++++++++|||+||+|+|+.||+||||||.|+|++.+|.+||||||+|+..
T Consensus 96 ~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 96 DKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred cccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence 89999999999999999999999989999999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
... ....++|+|+.|+||+|||++.. +..|+.++||||+||||+|||+|+++|+|++..+|+..|++++|+|+.+.+.
T Consensus 176 ~~~-~~~~~mTeYVaTRWYRAPElll~-~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 176 DKF-FEDGFMTEYVATRWYRAPELLLN-SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred ccc-CcccchhcceeeeeecCHHHHhc-cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 665 56677899999999999999976 4899999999999999999999999999999999999999999999999999
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCCCCCccchh
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEF 331 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~~~~~~~~~ 331 (614)
.+.++.++.|+.++....+.+|...|+++++.+.|||++||.+||.+|+|++|+|+||||..+++++.||.+++....
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~~-- 331 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFDS-- 331 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCcc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999988876543
Q ss_pred HHHhhcCCHHHHHHHHHHHHHHhCchhh
Q 007177 332 EFERRRVTKEDIRELIFREILEYHPQLL 359 (614)
Q Consensus 332 ~~e~~~~~~e~~~~~~~~ei~~~~~~~~ 359 (614)
++.. .+.+++++++|+|+++++|...
T Consensus 332 -~~~~-~~~~~~r~~i~~e~~~~~~~~~ 357 (359)
T KOG0660|consen 332 -FEHE-LTEEELRELIYKEILDFHPDVS 357 (359)
T ss_pred -cccc-ccHHHHHHHHHHHHHhhCcccc
Confidence 4455 8999999999999999998753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-60 Score=470.75 Aligned_cols=288 Identities=37% Similarity=0.654 Sum_probs=249.4
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
++|+.+..+|+|+||+|++|+++.||+-||||++.....+..-.+-.+|||++|++|+|||+|.++++| +-...+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence 579999999999999999999999999999999987666666666778999999999999999999999 556789
Q ss_pred EEEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 98 YVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 98 ylV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
|+|||||+.++.+.+.. ...++++.++.+++|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.....
T Consensus 77 hLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-- 154 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-- 154 (396)
T ss_pred EEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC--
Confidence 99999999877666665 447999999999999999999999999999999999999999999999999999987542
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhch
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~ 256 (614)
...+|+|+.|+||+|||++.+. ..|+..+||||+||++.||++|.++|+|.++.+|+..|...+|.-...-.+.+...
T Consensus 155 -gd~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred -cchhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 2346899999999999999874 68999999999999999999999999999999999999999998766555443332
Q ss_pred hHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 257 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
....-+.......+.++...+|+++..+.||+++||..||.+|++.+|+|.||||.++
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence 2111112222344455667889999999999999999999999999999999999754
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-59 Score=454.15 Aligned_cols=287 Identities=40% Similarity=0.668 Sum_probs=251.9
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
.||..+++||+|.||+||+|+|..||+.||||+|+.......-....+|||++|+.++|+||+.++++| ...+++
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence 589999999999999999999999999999999986544444455678999999999999999999999 556779
Q ss_pred EEEEecCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 98 YVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 98 ylV~E~~~g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
.||+|||+.||..+|+.+. .|+..+++.|+.++++||+|||+++|+||||||.|+||+++|.+||+|||+|+.......
T Consensus 77 ~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred EEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9999999999999998754 699999999999999999999999999999999999999999999999999998765443
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhch
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~ 256 (614)
. .+..+.|+||+|||++.|. ..|+..+||||+|||++||+.|.|.|+|.++.+|+..|+..+|+|..+.|..+..-
T Consensus 157 ~---~~~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 157 I---QTHQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred c---cccceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 2 2445899999999988774 78999999999999999999999999999999999999999999999999876542
Q ss_pred hHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 257 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
..|.+. +.....+....|+.+++++.||+.+||.+||.+|+|+.|+|+|+||+....
T Consensus 233 --pdY~~~-~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~ 289 (318)
T KOG0659|consen 233 --PDYVKI-QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL 289 (318)
T ss_pred --ccHHHH-hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence 222221 123333445589999999999999999999999999999999999997543
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-57 Score=479.99 Aligned_cols=338 Identities=93% Similarity=1.452 Sum_probs=308.9
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
+|++.+.||+|+||.||+|+++.+|..||||++...........++.+|+.+|+.++||||+++++++......+...+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 69999999999999999999999999999999986555555667889999999999999999999998766555667799
Q ss_pred EEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCc
Q 007177 99 VVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 178 (614)
Q Consensus 99 lV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~ 178 (614)
+|||||+++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.........
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 160 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999998654443333
Q ss_pred cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhH
Q 007177 179 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 258 (614)
Q Consensus 179 ~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~ 258 (614)
..+...+||++|+|||++.+....++.++|||||||++|+|++|++||.+.+...++..+.+.+|.|..+.+..+.....
T Consensus 161 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 240 (338)
T cd07859 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240 (338)
T ss_pred ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence 44566789999999999875435789999999999999999999999999999999999999999999999999888888
Q ss_pred HHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCCCCCccchhHHHhhcC
Q 007177 259 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRV 338 (614)
Q Consensus 259 ~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~ 338 (614)
..++..+....+..+...++.+++.+.+||.+||..||.+|||++|+|+||||+++....+.+..++++.+++.++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (338)
T cd07859 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFERRRL 320 (338)
T ss_pred HHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccccCccccccccHHHHhc
Confidence 88888888888888888889999999999999999999999999999999999999988888999999999999999999
Q ss_pred CHHHHHHHHHHHHHHhCc
Q 007177 339 TKEDIRELIFREILEYHP 356 (614)
Q Consensus 339 ~~e~~~~~~~~ei~~~~~ 356 (614)
+.+++++.+++++++|||
T Consensus 321 ~~~~~~~~~~~~~~~~~~ 338 (338)
T cd07859 321 TKEDVRELIYREILEYHP 338 (338)
T ss_pred CHHHHHHHHHHHHHhcCC
Confidence 999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-59 Score=489.73 Aligned_cols=289 Identities=38% Similarity=0.676 Sum_probs=255.4
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~ 94 (614)
..+||.+++.||.|.||.||+|..+.+|+.||||++++.+....+... +||++.|++|. ||||++|++++.+ .+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-LREvksL~kln~hpniikL~Evi~d----~~ 82 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRD----ND 82 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhc----cC
Confidence 456899999999999999999999999999999999988777555544 58999999998 9999999999943 23
Q ss_pred CcEEEEEecCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 95 KDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 95 ~~~ylV~E~~~g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
..+|+|||||+.+|+++++.+ ..|+++.++.||+||++||+|+|.+|++||||||+|||+..+..|||+||||||...+
T Consensus 83 ~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 83 RILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred ceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 389999999999999999875 4699999999999999999999999999999999999999888999999999997654
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
.. .+|+|+.|+||+|||++... ..|+.++|||++|||++|+.+-+++|+|.++.||+.+|.+.+|+|..+.|..-
T Consensus 163 kp----PYTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 163 KP----PYTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred CC----CcchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 43 46899999999999988753 78999999999999999999999999999999999999999999999887653
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
. .-+...--.+....+..+...++++++++.+||.+||.+||.+||||+|+|+||||+.-.
T Consensus 238 ~-~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 238 Y-NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred H-HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 1 122223334556677788888999999999999999999999999999999999998543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-57 Score=454.60 Aligned_cols=295 Identities=38% Similarity=0.595 Sum_probs=254.7
Q ss_pred ccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 12 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 12 ~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
-.....+.|+.+..|++|+||+||+|.|+.|++.||+|+++-......---.-+|||.+|.+++|||||.+.++..-.
T Consensus 70 ~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~-- 147 (419)
T KOG0663|consen 70 GGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGS-- 147 (419)
T ss_pred cCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc--
Confidence 344556779999999999999999999999999999999986544434344567999999999999999999998654
Q ss_pred CCCCcEEEEEecCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 92 RDFKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 92 ~~~~~~ylV~E~~~g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
+.+.+|||||||+.||..++.... +|+..+++.++.|+|+||+|||.++|+||||||+|+|++..|.+||+|||+||.
T Consensus 148 -~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 148 -NMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred -ccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhh
Confidence 345699999999999999998755 899999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
+.+.. ..+|..+.|.||+|||++.+. ..|+.++|+||+|||++||++++|+|+|+++.+|+++|+.++|+|+...|
T Consensus 227 ygsp~---k~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iw 302 (419)
T KOG0663|consen 227 YGSPL---KPYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIW 302 (419)
T ss_pred hcCCc---ccCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccC
Confidence 87653 245788999999999999874 78999999999999999999999999999999999999999999999999
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCC--CCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPN--ADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~--~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
..+..-....... +.+.....+...|+. ++....+|+..+|.+||++|.||+|+|+|.||...
T Consensus 303 pg~~~lp~~k~~~-f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 303 PGYSELPAVKKMT-FSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred CCccccchhhccc-cCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 8876544433221 223333444455654 45999999999999999999999999999999874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-57 Score=475.34 Aligned_cols=288 Identities=39% Similarity=0.618 Sum_probs=249.8
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..+.|+.+++||+|.||.||+|++..||+.||+|++..............|||.||++|.||||++|.+++... ..+
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~ 191 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSG 191 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCc
Confidence 34678899999999999999999999999999999986655566667788999999999999999999998653 346
Q ss_pred cEEEEEecCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 96 DIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 96 ~~ylV~E~~~g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
.+|||||||+.||.-++...+ .|++.+++.||+||+.||.|||++||+|||||.+|||||.+|.+||+|||||+.+...
T Consensus 192 siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 192 SIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred eEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 899999999999999997743 7999999999999999999999999999999999999999999999999999976544
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
.. ..+|..|.|+||+|||++.+. ..|+.++|+||+||||.||++|++.|+|.++++|+.+|++++|.|+.+.|....
T Consensus 272 ~~--~~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 272 GS--APYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CC--cccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 32 236888999999999999884 789999999999999999999999999999999999999999999999987322
Q ss_pred chhHHHHHHhhcccC--CCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 255 NDKARRYLTSMRKKQ--PVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~--~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
-.. ...+.... ...+.+.|..++..+.+|+..||..||.+|.||.++|.|+||..
T Consensus 349 LP~----~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 349 LPH----ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred CCc----ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 111 11111111 12234557788999999999999999999999999999999953
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-57 Score=460.62 Aligned_cols=263 Identities=35% Similarity=0.565 Sum_probs=223.4
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCCh-----HHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI-----SDAARILREIKLLRLLRHPDIVEIKHIMLPPS 90 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~-----~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 90 (614)
..+.|.+.+.||+|+||.|-+|+++.||+.||||++++..... .....+.+|+++|++|+|||||+++++|
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f---- 245 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF---- 245 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee----
Confidence 3467999999999999999999999999999999997543222 1234467999999999999999999999
Q ss_pred CCCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC---CcEEEeecC
Q 007177 91 RRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN---CKLKICDFG 166 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~---~~vKL~DFG 166 (614)
++....||||||++ |+|++.+..++.+.+..-+.+++|||.||.|||++||+||||||+|||++.+ +.+||+|||
T Consensus 246 -~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 246 -EVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred -ecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence 45566899999999 6999999999999999999999999999999999999999999999999766 889999999
Q ss_pred ccccccCCCCCccccccccCCccccCcccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCChhH-HHHHHHhhhCC
Q 007177 167 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFS-KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLMTDLLGT 244 (614)
Q Consensus 167 la~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~-~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~-~l~~i~~~~g~ 244 (614)
+|+...+ ..++.++|||+.|.|||++.+... .|..++||||||||||-+|+|.+||.+..... ..++|
T Consensus 325 lAK~~g~----~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI------ 394 (475)
T KOG0615|consen 325 LAKVSGE----GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI------ 394 (475)
T ss_pred hhhcccc----ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH------
Confidence 9998653 345678999999999999975322 34458999999999999999999998765322 22222
Q ss_pred CchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 245 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 245 p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
.+.........|..++.++++||..||..||++|||++|+|+||||+..
T Consensus 395 ---------------------~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 395 ---------------------LKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred ---------------------hcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 2233333446788999999999999999999999999999999999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-53 Score=457.29 Aligned_cols=256 Identities=34% Similarity=0.573 Sum_probs=230.2
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.+|+..+.||+|+|..||.+++..+|+.||+|++.+. ..+.....++.+||+|.+.|+|||||+++++| +|..+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence 7899999999999999999999999999999999753 34556678899999999999999999999999 78889
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|||+|+|. ++|.++++.++.|+|.++++|++||+.||.|||+.+|+|||||..|||++++.+|||+|||||.....+.
T Consensus 93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 999999999 7999999999999999999999999999999999999999999999999999999999999998876443
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
... .+.||||.|.|||++.. ..++..+||||+|||||.||+|+|||..++..+.+.+|..-.
T Consensus 173 Erk---~TlCGTPNYIAPEVl~k--~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~------------- 234 (592)
T KOG0575|consen 173 ERK---KTLCGTPNYIAPEVLNK--SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE------------- 234 (592)
T ss_pred ccc---ceecCCCcccChhHhcc--CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC-------------
Confidence 322 46799999999999986 789999999999999999999999999999888887774310
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
.. ....+|.++++||.+||..||.+|||+++||.|+||+.-
T Consensus 235 ---------------Y~---~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 235 ---------------YS---MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred ---------------cc---cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 01 112688999999999999999999999999999999543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-54 Score=440.11 Aligned_cols=285 Identities=38% Similarity=0.668 Sum_probs=246.4
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
.|.-.+++|.|+||+||.|+...+++.||||++-.. ..--.+|+.+|+.++|||||+++.+|......+.-++.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d------~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD------KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCC------CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 478899999999999999999999999999998532 11224799999999999999999998766544456788
Q ss_pred EEEecCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC-CcEEEeecCccccccC
Q 007177 99 VVFELMESDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARVAFN 173 (614)
Q Consensus 99 lV~E~~~g~L~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~-~~vKL~DFGla~~~~~ 173 (614)
+|||||+.+|.++++. +..++.-+++-+++||++||.|||+.||+||||||+|||+|.+ |.+||||||.|+....
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 9999999999999984 6789999999999999999999999999999999999999977 8999999999998766
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
..+. ..|..|++|+|||++.+- ..|+.++||||.||+++||+.|++.|+|++..+|+..|.+.+|+|+.+.+..+
T Consensus 179 ~epn----iSYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 179 GEPN----ISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred CCCc----eeEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 6554 457899999999999874 78999999999999999999999999999999999999999999999999887
Q ss_pred hchhHHHHHHhhcccCCCcccC-CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcc
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQ-KFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 317 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~-~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~ 317 (614)
....... ....-...++.+ .+...++++.+|+.++|.++|.+|.++.|+|.||||+.+.+.
T Consensus 254 n~~y~~~---~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 254 NPNYTEF---KFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred Ccccccc---cCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 6543211 122233344444 456789999999999999999999999999999999988765
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-53 Score=431.62 Aligned_cols=294 Identities=38% Similarity=0.658 Sum_probs=249.5
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC-cceeeeEecCCC-CCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD-IVEIKHIMLPPS-RRDF 94 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn-Iv~l~~v~~~~~-~~~~ 94 (614)
...|..+++||+|+||+||+|+++.+|+.||+|++.-....+.--....+|+.+|+.|+|+| |+.+++++.... .+..
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 44578888999999999999999999999999999865443333345679999999999999 999999986543 2334
Q ss_pred CcEEEEEecCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 95 KDIYVVFELMESDLHQVIKAND----DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 95 ~~~ylV~E~~~g~L~~~i~~~~----~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
..+|+||||++.||..++.... .++...++.|++||++||.|||++||+||||||+||||+++|.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 5799999999999999998755 588889999999999999999999999999999999999999999999999996
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
..-... .++..++|.||+|||++.+. ..|+..+||||+|||++||++++++|+|.++.+|+..|+.++|+|+.+.|
T Consensus 170 ~~ip~~---~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 170 FSIPMR---TYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred hcCCcc---cccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 542222 25778999999999998874 57999999999999999999999999999999999999999999999998
Q ss_pred hhhhchhHHHHHHhhcccC-CCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 251 SRVRNDKARRYLTSMRKKQ-PVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
..+..-...+. ...... +..+....++.++.+.+|+.+||+.||.+|.|++.+|.||||..+..
T Consensus 246 p~v~~~~~~k~--~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 246 PGVSSLPDYKA--PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred CCccccccccc--cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 87643211111 222222 55666677788899999999999999999999999999999997643
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-52 Score=422.98 Aligned_cols=260 Identities=30% Similarity=0.528 Sum_probs=229.3
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
....+.|+++++||+|+||+||.++.+.|++.||+|++++..- ...+...+.+|..||..++||+||+++..| +
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Q 95 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----Q 95 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----c
Confidence 4557889999999999999999999999999999999986422 224677889999999999999999999988 7
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
+...+|+|+||+. |+|+..|++.+.++|..+++++..|+.||.|||++|||||||||+|||+|.+|+++|+|||||+..
T Consensus 96 t~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 96 TEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred cCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 7788999999999 599999999999999999999999999999999999999999999999999999999999999975
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
......+ .++|||+.|||||++.+ ..|+.++|+||||+++||||+|.+||.+.+.....+.|..
T Consensus 176 ~~~~~~t---~tfcGT~eYmAPEil~~--~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~----------- 239 (357)
T KOG0598|consen 176 LKDGDAT---RTFCGTPEYMAPEILLG--KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILK----------- 239 (357)
T ss_pred ccCCCcc---ccccCCccccChHHHhc--CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhc-----------
Confidence 5443332 45899999999999988 6999999999999999999999999999987766666532
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCC-CCHHHHHHHHHhcCCCCCCCC----CHHHHHcCcccccC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPN-ADPSALRLLERLLAFDPKDRP----TAEEALADPYFKGL 314 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~-~s~~l~dLI~~mL~~DP~~Rp----sa~eiL~hp~f~~~ 314 (614)
.+ ....+. ++.++++||+++|..||++|. .++++-+||||.++
T Consensus 240 ----------------~k----~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 240 ----------------GK----LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred ----------------Cc----CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 11 112234 789999999999999999995 78999999999976
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-52 Score=418.99 Aligned_cols=341 Identities=37% Similarity=0.664 Sum_probs=292.8
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCC-CCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPP-SRR 92 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~-~~~ 92 (614)
+....||.-++.+|.|+- .|+.|.|..++..||||++...+.....+++..+|+.++..+.|+||++++.+|.+. ...
T Consensus 13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 445679999999999999 899999999999999999988888878889999999999999999999999999876 345
Q ss_pred CCCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 93 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 93 ~~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
.+.++|+|||+|..+|.+++. -.+..+.+.+|++|++.|++|||+.||+||||||+||+++.+|.+||+|||+|+...
T Consensus 92 ~~~e~y~v~e~m~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 92 EFQEVYLVMELMDANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHhHHHHHHhhhhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 578899999999999999998 458899999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.+ ..+++++.|++|+|||++.+ ..|.+.+||||+|||+.||++|+.+|+|++..+|+.+|.+.+|+|....+.+
T Consensus 170 ~~----~~mtpyVvtRyyrapevil~--~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 170 TD----FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred cc----cccCchhheeeccCchheec--cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 32 45689999999999999988 4699999999999999999999999999999999999999999999999887
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCC------------CCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPN------------ADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVERE 320 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~------------~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~ 320 (614)
+. ..++.|.....+.....|.+.||+ -+..++||+.+||..||++|.|++++|+||||+-+. ...+
T Consensus 244 L~-~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~-~~~e 321 (369)
T KOG0665|consen 244 LQ-PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWY-DPDE 321 (369)
T ss_pred hh-HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeec-cccc
Confidence 64 455666666666555666665553 245789999999999999999999999999999442 2334
Q ss_pred CCCCCCccchhHHHhhcCCHHHHHHHHHHHHHHhCchhhhhhccc
Q 007177 321 PSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNG 365 (614)
Q Consensus 321 ~~~~~~~~~~~~~e~~~~~~e~~~~~~~~ei~~~~~~~~~~~~~~ 365 (614)
+..++....+..++.+..+.++|+++|++|+.+|.+...-+.+++
T Consensus 322 v~ap~pe~~d~~~d~~~~t~~e~ke~If~ev~~f~~~~~~~I~~~ 366 (369)
T KOG0665|consen 322 VEAPPPEIYDKQLDEREHTIEEWKELIFKEVQRFEEFNKNNIMNG 366 (369)
T ss_pred ccCCCCchhhhhcccccCCHHHHHHHHHHHHHhhcccccchhhcC
Confidence 433333345556777888999999999999999998655555544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-51 Score=417.64 Aligned_cols=257 Identities=28% Similarity=0.476 Sum_probs=221.0
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC-c
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK-D 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~-~ 96 (614)
++.+.++.||+|+.|+|++|+++.|++.+|+|+|.. .......+.+.+|+++|+..+||+||++|++|... . .
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~-----~~~ 152 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN-----GEE 152 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC-----Cce
Confidence 367788999999999999999999999999999953 34566778899999999999999999999999543 3 5
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
++|+||||+ |+|..+++.-++++|..+..|++++++||.|||. .+||||||||+||||+..|.|||||||.+....+.
T Consensus 153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 999999999 6999999988999999999999999999999995 99999999999999999999999999999876544
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC-----ChhHHHHHHHhhhCCCchhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-----NVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~-----~~~~~l~~i~~~~g~p~~~~ 249 (614)
...+++||..|||||.+.+ ..|+.++||||||+.++||.+|+.||+.. +..+++..|.
T Consensus 233 -----~a~tfvGT~~YMsPERi~g--~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv---------- 295 (364)
T KOG0581|consen 233 -----IANTFVGTSAYMSPERISG--ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV---------- 295 (364)
T ss_pred -----hcccccccccccChhhhcC--CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh----------
Confidence 3467899999999999998 79999999999999999999999999774 2333333331
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
...+..+... .+|+++++||..||++||.+|||+.|+|+|||+++...
T Consensus 296 -----------------~~ppP~lP~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 296 -----------------DEPPPRLPEG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred -----------------cCCCCCCCcc--cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 1111111111 37899999999999999999999999999999986543
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-51 Score=440.69 Aligned_cols=291 Identities=35% Similarity=0.609 Sum_probs=240.5
Q ss_pred ccccccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-C-----CCcce
Q 007177 8 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-H-----PDIVE 81 (614)
Q Consensus 8 ~~~~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-H-----pnIv~ 81 (614)
+.+.-....+.||.|++.||+|+||.|.+|.|..|++.||||++++ +.........|+.||..|+ | -|||+
T Consensus 176 Y~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN---~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vr 252 (586)
T KOG0667|consen 176 YQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN---KKRFLRQAQIEIRILELLNKHDPDDKYNIVR 252 (586)
T ss_pred eeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeecc---ChHHHHHHHHHHHHHHHHhccCCCCCeeEEE
Confidence 3333444556799999999999999999999999999999999985 3455666778999999997 4 37999
Q ss_pred eeeEecCCCCCCCCcEEEEEecCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC--C
Q 007177 82 IKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA--N 157 (614)
Q Consensus 82 l~~v~~~~~~~~~~~~ylV~E~~~g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~--~ 157 (614)
+++.|. -.+++|||+|+++.+|.++|+.+. .|+...++.|+.|||.||.+||+.||||+||||+|||+.. .
T Consensus 253 m~d~F~-----fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r 327 (586)
T KOG0667|consen 253 MLDYFY-----FRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKR 327 (586)
T ss_pred eeeccc-----cccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCc
Confidence 999984 446799999999999999999875 6899999999999999999999999999999999999965 3
Q ss_pred CcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHH
Q 007177 158 CKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 237 (614)
Q Consensus 158 ~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~ 237 (614)
+.|||+|||+|+...... ..|+.++.|+|||++.+ .+|+.++||||||||++||++|.|+|+|.++.+|+..
T Consensus 328 ~~vKVIDFGSSc~~~q~v------ytYiQSRfYRAPEVILG--lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~ 399 (586)
T KOG0667|consen 328 SRIKVIDFGSSCFESQRV------YTYIQSRFYRAPEVILG--LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLAR 399 (586)
T ss_pred CceeEEecccccccCCcc------eeeeeccccccchhhcc--CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHH
Confidence 479999999998643221 36899999999999999 7999999999999999999999999999999999999
Q ss_pred HHhhhCCCchhhhhhhhchhHHHHHHh----------------------------hcccCCC-----cccCCCC-CCCHH
Q 007177 238 MTDLLGTPSLDTISRVRNDKARRYLTS----------------------------MRKKQPV-----QFSQKFP-NADPS 283 (614)
Q Consensus 238 i~~~~g~p~~~~i~~~~~~~~~~~l~~----------------------------~~~~~~~-----~~~~~~~-~~s~~ 283 (614)
|++++|.|+..++...... ..+++. ....... .+....+ .....
T Consensus 400 I~e~lG~Pp~~mL~~~~~~--~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~ 477 (586)
T KOG0667|consen 400 IIEVLGLPPPKMLDTAKKA--HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKL 477 (586)
T ss_pred HHHHhCCCCHHHHHhcccc--ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHH
Confidence 9999999999887654321 112211 1111111 1122222 23456
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 284 ALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 284 l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
+.|||.+||.+||.+|+|+.++|+||||.....
T Consensus 478 F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 478 FIDFLKRCLEWDPAERITPAQALNHPFLTGTSL 510 (586)
T ss_pred HHHHHHHHhccCchhcCCHHHHhcCcccccccc
Confidence 799999999999999999999999999986544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-51 Score=428.67 Aligned_cols=261 Identities=31% Similarity=0.563 Sum_probs=228.6
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~ 93 (614)
...+|+++++||+|+|++|++|+++.+++.||||++.+... .....+-+.+|-..|.+| .||.|++|+..| +|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----QD 145 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----QD 145 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----ec
Confidence 45789999999999999999999999999999999976432 223345577899999999 799999999998 77
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
...+|+|+||++ |+|.++|++-+.|++..+++++.||+.||.|||++|||||||||+|||+|+|+++||.|||.|+...
T Consensus 146 ~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 146 EESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred ccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 788999999999 7999999999999999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCC----------ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhh
Q 007177 173 NDTPT----------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242 (614)
Q Consensus 173 ~~~~~----------~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~ 242 (614)
..... ......+|||..|.+||++.. ...++.+|||+||||||+|+.|.+||.+.++...+.+|+++.
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~--~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~ 303 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND--SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD 303 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcC--CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc
Confidence 32111 111255899999999999987 678899999999999999999999999999988888886532
Q ss_pred CCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 243 g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
..|. ++.++.++|||+++|..||.+|+|+++|-+||||.++
T Consensus 304 ----------------------------y~fp---~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 304 ----------------------------YEFP---EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred ----------------------------ccCC---CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 2222 3556899999999999999999999999999999876
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=419.52 Aligned_cols=335 Identities=56% Similarity=0.990 Sum_probs=289.6
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
...+|++.+.||.|+||.||+|.+..+++.||||.+............+.+|+.+|+.++||||+++++++.........
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 45789999999999999999999999999999999976544445566788999999999999999999988665545556
Q ss_pred cEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 96 DIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 96 ~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
.+|+|+||+.++|.+++...+.+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 83 DVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred cEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 79999999999999999988889999999999999999999999999999999999999999999999999998653321
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
.....+.++.+|+|||.+... ..++.++|||||||++|+|++|++||.+.+..+.+..+...+|.+..+.+..+..
T Consensus 163 ---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 163 ---DFMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred ---ccccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 123456789999999987642 3588999999999999999999999999999999999999999998888877777
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCCCCCccchhHHHh
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFER 335 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~e~ 335 (614)
....+++..+.......+...++++++.+.+||++||+.||++|||++++|+||||..+......+..+. .++|+|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~~--~~~~~~~~ 316 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQT--PFSFDFEE 316 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccCCC--ccchhhhh
Confidence 7777777665555445555566789999999999999999999999999999999998877766666543 56788888
Q ss_pred hcCCHHHHHHHHHHHHHHhCc
Q 007177 336 RRVTKEDIRELIFREILEYHP 356 (614)
Q Consensus 336 ~~~~~e~~~~~~~~ei~~~~~ 356 (614)
...++++++++++.|++.|||
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~ 337 (337)
T cd07858 317 DALTEEDIKELIYNEMLAYHP 337 (337)
T ss_pred hhcCHHHHHHHHHHHHhhcCC
Confidence 889999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-50 Score=411.58 Aligned_cols=258 Identities=33% Similarity=0.504 Sum_probs=223.1
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|.+.+.||.|+||+||+|+++.++..||||.|.+........+.+..||++|+.++|||||.++++. ...+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~ 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDD 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCC
Confidence 45689999999999999999999999999999999987655666777788999999999999999999999 5556
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC------CcEEEeecCcc
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN------CKLKICDFGLA 168 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~------~~vKL~DFGla 168 (614)
++|||||||+ |||.++|+..+.++|..++.|+.||+.||++||+++||||||||+|||++.. -.+||+|||+|
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 8999999999 7999999999999999999999999999999999999999999999999764 46999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007177 169 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~ 248 (614)
+...+. ....+.||++.|||||++.. ..|+.|+|+||+|+|+|+|++|++||...+..+.+..+..-
T Consensus 163 R~L~~~----~~a~tlcGSplYMAPEV~~~--~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~------- 229 (429)
T KOG0595|consen 163 RFLQPG----SMAETLCGSPLYMAPEVIMS--QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG------- 229 (429)
T ss_pred hhCCch----hHHHHhhCCccccCHHHHHh--ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc-------
Confidence 986533 23467899999999999976 79999999999999999999999999988876665433210
Q ss_pred hhhhhhchhHHHHHHhhcccCCCcccCCC-CCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 249 TISRVRNDKARRYLTSMRKKQPVQFSQKF-PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 249 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
......+ ...++...+|+..+|..+|.+|.+.++-+.|+++..
T Consensus 230 ----------------------~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 230 ----------------------NEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred ----------------------ccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 0111111 134567789999999999999999999999999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=403.06 Aligned_cols=273 Identities=32% Similarity=0.463 Sum_probs=226.3
Q ss_pred CCCCCCCcccccc-CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCc
Q 007177 1 MLQNSPEMEFFSE-YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 79 (614)
Q Consensus 1 m~~~~~~~~~~~~-~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnI 79 (614)
|-+-++-+.+++. ......|+|++.||+|+||.||++.+..+|+.+|.|+++-..-+....+.+..|+.+|++|+||||
T Consensus 1 M~~~~~~~~~~~~~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNI 80 (375)
T KOG0591|consen 1 MDKQSSAMMDFSPPQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNI 80 (375)
T ss_pred CCcccccccCCCCCcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchH
Confidence 4444444555543 344567999999999999999999999999999999998554556667789999999999999999
Q ss_pred ceeeeEecCCCCCCCCcEEEEEecCC-CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh--CC--eEeecCCCC
Q 007177 80 VEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHT--AN--VYHRDLKPK 150 (614)
Q Consensus 80 v~l~~v~~~~~~~~~~~~ylV~E~~~-g~L~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs--~g--IvHrDLKP~ 150 (614)
|++++.-+. ++..-++||||||+ |||.++|+. ...++|..++.++.|+++||..+|+ .. |+||||||.
T Consensus 81 VqYy~~~f~---~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPa 157 (375)
T KOG0591|consen 81 VQYYAHSFI---EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPA 157 (375)
T ss_pred HHHHHHhhh---ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcch
Confidence 999883221 33344999999999 799999963 4579999999999999999999999 55 999999999
Q ss_pred cEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Q 007177 151 NILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 230 (614)
Q Consensus 151 NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~ 230 (614)
||+++.+|.+||+||||++..... +.+...++|||+||+||++.+ .+|+.++|||||||++|||+.-++||.|++
T Consensus 158 NIFl~~~gvvKLGDfGL~r~l~s~---~tfA~S~VGTPyYMSPE~i~~--~~Y~~kSDiWslGCllyEMcaL~~PF~g~n 232 (375)
T KOG0591|consen 158 NIFLTANGVVKLGDFGLGRFLSSK---TTFAHSLVGTPYYMSPERIHE--SGYNFKSDIWSLGCLLYEMCALQSPFYGDN 232 (375)
T ss_pred heEEcCCCceeeccchhHhHhcch---hHHHHhhcCCCcccCHHHHhc--CCCCcchhHHHHHHHHHHHHhcCCCccccc
Confidence 999999999999999999986433 345678999999999999998 799999999999999999999999999998
Q ss_pred hhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCC-CCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCc
Q 007177 231 VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKF-PNADPSALRLLERLLAFDPKDRPTAEEALADP 309 (614)
Q Consensus 231 ~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp 309 (614)
-.....+|... .++..+ ..+|..+..||..|+..||..||+. +|
T Consensus 233 ~~~L~~KI~qg------------------------------d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t-----~~ 277 (375)
T KOG0591|consen 233 LLSLCKKIEQG------------------------------DYPPLPDEHYSTDLRELINMCIAVDPEQRPDT-----VP 277 (375)
T ss_pred HHHHHHHHHcC------------------------------CCCCCcHHHhhhHHHHHHHHHccCCcccCCCc-----ch
Confidence 76666665432 112222 2467899999999999999999997 66
Q ss_pred ccccCCc
Q 007177 310 YFKGLSK 316 (614)
Q Consensus 310 ~f~~~~~ 316 (614)
++.++..
T Consensus 278 ~v~di~~ 284 (375)
T KOG0591|consen 278 YVQDIQS 284 (375)
T ss_pred HHHHHHH
Confidence 6665543
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=413.98 Aligned_cols=328 Identities=41% Similarity=0.786 Sum_probs=267.9
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRD 93 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~-~~~ 93 (614)
...++|++++.||.|+||.||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++.... ...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4567999999999999999999999999999999999765444445667889999999999999999999875432 233
Q ss_pred CCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 94 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 94 ~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
...+|+++|+++++|.++++. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 92 ~~~~~~~~~~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 92 FNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred cCcEEEEeecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 456899999999999888764 4699999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
. ...++||++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..+.+..+
T Consensus 171 ~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 171 E------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred C------cCCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 2 2346799999999998652 46889999999999999999999999999999999999999999988888777
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCCCCCccchhHH
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEF 333 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 333 (614)
.......++..+.......+...+...++.+.+||.+||..||.+|||+.|+|+||||..+.....++...+. ....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~~---~~~~ 320 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEPY---DESP 320 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCccccccCcc---ccch
Confidence 7766666766555444444555566788899999999999999999999999999999987655443333222 1222
Q ss_pred HhhcCCHHHHHHHHHHHHHH
Q 007177 334 ERRRVTKEDIRELIFREILE 353 (614)
Q Consensus 334 e~~~~~~e~~~~~~~~ei~~ 353 (614)
+.+..+.+++++..+.+...
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~ 340 (343)
T cd07878 321 ENKERTIEEWKELTYEEVSS 340 (343)
T ss_pred hhhhccHHHHHHHHHHHHHh
Confidence 33444556666666655443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=396.49 Aligned_cols=258 Identities=30% Similarity=0.512 Sum_probs=227.9
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
+.|++.++||+|.|++|+++.+..||+.+|+|.|+.......+.+.+.+|+.|-+.|+||||+++.+.+ ......
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~~~ 85 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESFH 85 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----ccccee
Confidence 468999999999999999999999999999999976555556888999999999999999999999987 566789
Q ss_pred EEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC---CcEEEeecCccccccC
Q 007177 98 YVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN---CKLKICDFGLARVAFN 173 (614)
Q Consensus 98 ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~---~~vKL~DFGla~~~~~ 173 (614)
|||||+|+| +|..-|.++.-++|..+..+++|||+||.|+|.+||||||+||+|+|+-+. .-+||||||+|....
T Consensus 86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 999999995 998888777789999999999999999999999999999999999998543 359999999998775
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
....+..++|||.|||||++.. .+|+..+|||+.|+|||-||.|++||.+.+..+.++.|+.
T Consensus 165 ---~g~~~~G~~GtP~fmaPEvvrk--dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~------------- 226 (355)
T KOG0033|consen 165 ---DGEAWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA------------- 226 (355)
T ss_pred ---CccccccccCCCcccCHHHhhc--CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc-------------
Confidence 2234678899999999999987 7999999999999999999999999999887777766632
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
.........|+++++++++||++||..||.+|+|+.|+|+|||+.+
T Consensus 227 --------------g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 227 --------------GAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred --------------cccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 2222233479999999999999999999999999999999999975
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-50 Score=399.99 Aligned_cols=293 Identities=39% Similarity=0.626 Sum_probs=242.5
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~----~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
...|++++.||+|.||.||+|..++++. .+|||+++.......-.....||+.+++.|+||||+.+..+++..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~--- 99 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH--- 99 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc---
Confidence 4569999999999999999998776654 689999986534334445667999999999999999999999643
Q ss_pred CCCcEEEEEecCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC----CcEEEe
Q 007177 93 DFKDIYVVFELMESDLHQVIKAN-----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN----CKLKIC 163 (614)
Q Consensus 93 ~~~~~ylV~E~~~g~L~~~i~~~-----~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~----~~vKL~ 163 (614)
+..+++++||.+.||+++|+-+ ..++...++.|++||+.|+.|||++.|+||||||.||||..+ |.|||+
T Consensus 100 -d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 100 -DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred -CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence 5789999999999999999643 369999999999999999999999999999999999999888 899999
Q ss_pred ecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC---------hhHH
Q 007177 164 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN---------VVHQ 234 (614)
Q Consensus 164 DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~---------~~~~ 234 (614)
|||+++.+.+....-......+.|.||+|||++.+- ..|++++|+|++|||++|||+-+|+|.+.. ..+|
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 999999876654443344567899999999999874 789999999999999999999999998853 3589
Q ss_pred HHHHHhhhCCCchhhhhhhhchhHH-HHHHhhcccCCCc-----ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 235 LDLMTDLLGTPSLDTISRVRNDKAR-RYLTSMRKKQPVQ-----FSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 235 l~~i~~~~g~p~~~~i~~~~~~~~~-~~l~~~~~~~~~~-----~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
+++|++++|+|+.+.|..+.+-... ..+..++...... +...+..-++.+.+||.+||+.||.+|.|++++|+|
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 9999999999999999887654322 2233333221111 122344456779999999999999999999999999
Q ss_pred cccccC
Q 007177 309 PYFKGL 314 (614)
Q Consensus 309 p~f~~~ 314 (614)
+||..-
T Consensus 338 ~yF~~d 343 (438)
T KOG0666|consen 338 PYFTED 343 (438)
T ss_pred cccccC
Confidence 999853
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-48 Score=415.40 Aligned_cols=292 Identities=44% Similarity=0.767 Sum_probs=242.9
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
.|++.+.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++..........+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 47899999999999999999999999999999976555555667889999999999999999999998665434445799
Q ss_pred EEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCc
Q 007177 99 VVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 178 (614)
Q Consensus 99 lV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~ 178 (614)
+||||+.++|.+.+.....+++..++.+++||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-- 158 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-- 158 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc--
Confidence 999999999999998888899999999999999999999999999999999999999999999999999986432221
Q ss_pred cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhH
Q 007177 179 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 258 (614)
Q Consensus 179 ~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~ 258 (614)
...+..++|++|+|||++.+. ..|+.++||||||||+|||++|++||.+.+..+++..|.+.+|.|..+.+...... .
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~-~ 236 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG-A 236 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH-H
Confidence 123456789999999998762 45889999999999999999999999999999999999999999988776554322 2
Q ss_pred HHHHHhhcccCCC--cccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 259 RRYLTSMRKKQPV--QFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 259 ~~~l~~~~~~~~~--~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
..++.......+. .........++++.+||.+||+.||++|||++|+|+||||.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 2222211111111 0012234568899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=402.89 Aligned_cols=286 Identities=35% Similarity=0.646 Sum_probs=236.6
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
|+..++|++.+.||.|+||.||+|.++.++..||+|+++.... ......+.+|+.+|+.++||||+++++++ .+
T Consensus 1 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~ 74 (288)
T cd07871 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDII-----HT 74 (288)
T ss_pred CCccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cC
Confidence 4667889999999999999999999999999999999874321 22334577999999999999999999998 44
Q ss_pred CCcEEEEEecCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 94 FKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 94 ~~~~ylV~E~~~g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
....|+||||++++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 75 ERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 56799999999999999887654 57999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.... ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.|..+.+..
T Consensus 155 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07871 155 VPTK---TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG 230 (288)
T ss_pred CCCc---cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc
Confidence 2221 12345789999999988652 5689999999999999999999999999999999999999999998888766
Q ss_pred hhchh-HHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 253 VRNDK-ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 253 ~~~~~-~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
+.... ...++ .......+.....+.+++++++||.+||++||.+|||++|+|+||||
T Consensus 231 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 231 ITSNEEFRSYL--FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cccchhhhccc--cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 54321 11111 11111122223345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=417.82 Aligned_cols=260 Identities=33% Similarity=0.528 Sum_probs=220.0
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC--C-hHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE--H-ISDAARILREIKLLRLLR-HPDIVEIKHIMLPPS 90 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~--~-~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~ 90 (614)
...++|++.+.||+|+||.|++|.+..++..||||++.+... . ......+.+|+.+|+.++ ||||+++++++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~--- 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFA--- 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEe---
Confidence 446799999999999999999999999999999997765311 1 133456678999999999 999999999994
Q ss_pred CCCCCcEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC-CcEEEeecCcc
Q 007177 91 RRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLA 168 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~-~~vKL~DFGla 168 (614)
....+|+|||||.| +|++.|...+++.|.+++.+++||+.||.|||+.||+||||||+|||++.+ +.+||+|||++
T Consensus 91 --t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 91 --TPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred --cCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 44559999999995 999999999999999999999999999999999999999999999999999 99999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCC-CcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007177 169 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~-~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~ 247 (614)
.... .....+.+.+||+.|+|||++.+. ..|+ .++||||+|++||.|++|+.||...+.......|.
T Consensus 169 ~~~~---~~~~~l~t~cGsp~Y~aPEvl~~~-~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~-------- 236 (370)
T KOG0583|consen 169 AISP---GEDGLLKTFCGSPAYAAPEVLSGK-GTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIR-------- 236 (370)
T ss_pred cccC---CCCCcccCCCCCcccCCHHHhCCC-CCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHh--------
Confidence 8763 122345778999999999999883 2164 78999999999999999999998877655544431
Q ss_pred hhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 248 ~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
.....+...+. |+++++||++||..||.+|+|+.+++.||||+.
T Consensus 237 --------------------~~~~~~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 237 --------------------KGEFKIPSYLL--SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred --------------------cCCccCCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 11222222222 899999999999999999999999999999986
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=410.44 Aligned_cols=327 Identities=35% Similarity=0.652 Sum_probs=259.6
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~-~~~~ 94 (614)
..++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ..+.
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 458999999999999999999999999999999999865555566778889999999999999999999886542 2344
Q ss_pred CcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 95 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 95 ~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
..+|+||||++++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred CeEEEEEeCCCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 67899999999999888864 4889999999999999999999999999999999999999999999999999764322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
. .....++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.|..+.+..+.
T Consensus 180 ~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 180 F----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred C----cccCCcccCCcCCHHHHhC--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 1 2245679999999999987 679999999999999999999999999999999999999999998876655543
Q ss_pred chhHHHHHHhhcccCCCcccCC------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCC
Q 007177 255 NDKARRYLTSMRKKQPVQFSQK------------FPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPS 322 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~------------~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~ 322 (614)
.. ...+...........+... ....+..+++||.+||+.||.+|||++|+|+||||..+......+.
T Consensus 254 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~ 332 (364)
T cd07875 254 PT-VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEA 332 (364)
T ss_pred HH-HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCCC
Confidence 22 2233322222111111111 1224568999999999999999999999999999987655443332
Q ss_pred CCC-CccchhHHHhhcCCHHHHHHHHHHHHHH
Q 007177 323 CQP-ISKMEFEFERRRVTKEDIRELIFREILE 353 (614)
Q Consensus 323 ~~~-~~~~~~~~e~~~~~~e~~~~~~~~ei~~ 353 (614)
..+ +.. ...+.+....+++++.+++++++
T Consensus 333 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 362 (364)
T cd07875 333 PPPKIPD--KQLDEREHTIEEWKELIYKEVMD 362 (364)
T ss_pred CCCCCCC--ccchhhhccHHHHHHHHHHHHHc
Confidence 222 222 12334567778888888877753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-48 Score=407.57 Aligned_cols=334 Identities=51% Similarity=0.878 Sum_probs=277.8
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
...++|++.+.||+|+||.||+|.+..+|+.||||++... .......++.+|+.+|+.++||||+++++++........
T Consensus 2 ~~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred ccccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 4567999999999999999999999999999999998642 233445677899999999999999999998876655566
Q ss_pred CcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 95 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 95 ~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
..+|+|+||+.++|.+.+.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 81 NDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ceEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 77999999999999988854 46999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
..........++|+.|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+...++..+.+.++.|..+.+..+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 3222233456889999999987542 468899999999999999999999999999999999999999999888887777
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCCCCCccchhHHH
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFE 334 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~e 334 (614)
......++..........+....+.+++.+.+||.+||+.||++|||+.++|+||||+.+.....++..++...++|+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELF 318 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCCChhhccc
Confidence 66666666655555555555556778999999999999999999999999999999998877655555544334444433
Q ss_pred hhcCCHHHHHHHHHHHHH
Q 007177 335 RRRVTKEDIRELIFREIL 352 (614)
Q Consensus 335 ~~~~~~e~~~~~~~~ei~ 352 (614)
..+.++.++++|+.+++
T Consensus 319 -~~~~~~~~~~~~~~~~~ 335 (336)
T cd07849 319 -DDLPKEKLKELIFEEIM 335 (336)
T ss_pred -cccCHHHHHHHHHHHhc
Confidence 45568899999988874
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-49 Score=416.00 Aligned_cols=264 Identities=30% Similarity=0.480 Sum_probs=225.2
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
-.++|+++++||+|+||.||+|+.+.||+.||+|++++. .........+..|-.+|....+|+||+++-.| ++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence 457899999999999999999999999999999999864 23345667788999999999999999999999 777
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
.++||||||++ ||+..+|...+.|+++++++++.+++.||..||+.|+|||||||+|+|||..|++||+||||+.....
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 88999999999 59999999999999999999999999999999999999999999999999999999999999953211
Q ss_pred -----------------------CCCC--ccc-------------------cccccCCccccCcccccccCCCCCCcccc
Q 007177 174 -----------------------DTPT--TIF-------------------WTDYVATRWYRAPELCGSFFSKYTPAIDI 209 (614)
Q Consensus 174 -----------------------~~~~--~~~-------------------~~~~vgt~~Y~APEvl~~~~~~y~~~~DI 209 (614)
+... +.. ....+|||.|+|||++.+ ..|+..+|+
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~--kgY~~~cDw 371 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG--KGYGKECDW 371 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc--CCCCccccH
Confidence 0000 000 012489999999999998 689999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHH
Q 007177 210 WSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLE 289 (614)
Q Consensus 210 WSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~ 289 (614)
||||||+||||.|.|||.+.+..+...+|..+-.+. .+.. -..++++++|||.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l--------------------------~fP~-~~~~s~eA~DLI~ 424 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL--------------------------KFPE-EVDLSDEAKDLIT 424 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc--------------------------cCCC-cCcccHHHHHHHH
Confidence 999999999999999999999988888875531110 0100 1245689999999
Q ss_pred HhcCCCCCCCC---CHHHHHcCcccccC
Q 007177 290 RLLAFDPKDRP---TAEEALADPYFKGL 314 (614)
Q Consensus 290 ~mL~~DP~~Rp---sa~eiL~hp~f~~~ 314 (614)
+||. ||++|. +++||-+||||+++
T Consensus 425 rll~-d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 425 RLLC-DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HHhc-CHHHhcCcccHHHHhcCCccccC
Confidence 9999 999997 59999999999976
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=409.65 Aligned_cols=294 Identities=38% Similarity=0.706 Sum_probs=241.9
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRD 93 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~-~~~ 93 (614)
...++|++.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++.... ..+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 3468999999999999999999999999999999999765555566778889999999999999999999986543 234
Q ss_pred CCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 94 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 94 ~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
...+|+||||++++|.+.+.. .++++.+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 98 FQDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred cceeEEEEeCCCcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 456899999999998888753 489999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+++..+...++.|..+.+...
T Consensus 176 ~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 176 NF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred Cc----cCCCCcccCCCCCchhccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 21 2244678999999999987 67999999999999999999999999999999999999999999988766554
Q ss_pred hchhHHHHHHhhcccCCCcccCCCC------------CCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcc
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFP------------NADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 317 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~------------~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~ 317 (614)
.. ....+...........+.+.++ ..++.+++||.+||..||++|||+.|+|+||||..+...
T Consensus 250 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 324 (359)
T cd07876 250 QP-TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP 324 (359)
T ss_pred HH-HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence 32 2222322222222222222221 246789999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-49 Score=388.18 Aligned_cols=254 Identities=28% Similarity=0.518 Sum_probs=225.1
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
.++|++++.||.|+||.|.+++++.+|..||+|++++. .-.....+...+|..+|+.+.||++++++..+ .+.+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCC
Confidence 46799999999999999999999999999999999753 22344567788999999999999999999988 6778
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
++|+||||.+ |.|+.++++.+++++.++++++.||+.||.|||+++|++|||||+|||+|.+|.+||+|||+|+.....
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 8999999999 599999999999999999999999999999999999999999999999999999999999999976543
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
. .+.||||.|+|||++.+ ..|+.++|+||||+++|||+.|.+||...+.....++|...
T Consensus 198 T------~TlCGTPeYLAPEii~s--k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~------------- 256 (355)
T KOG0616|consen 198 T------WTLCGTPEYLAPEIIQS--KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG------------- 256 (355)
T ss_pred E------EEecCCccccChHHhhc--CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC-------------
Confidence 2 45699999999999998 79999999999999999999999999999988777777431
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCC-----CCHHHHHcCcccccC
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALADPYFKGL 314 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~R-----psa~eiL~hp~f~~~ 314 (614)
...| .+..+++++|||+++|+.|-.+| ...++|..||||+++
T Consensus 257 ---------------~v~f---P~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 257 ---------------KVKF---PSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred ---------------cccC---CcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 1111 12468899999999999999999 367899999999865
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=417.95 Aligned_cols=256 Identities=34% Similarity=0.589 Sum_probs=231.3
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
++|-+.+.||+|+||.||+|+.+.|.+.||||.+.+......+.+.+.+|++|++.|+||||+.+++.| +...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 579999999999999999999999999999999998878888899999999999999999999999998 677889
Q ss_pred EEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007177 98 YVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 177 (614)
Q Consensus 98 ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 177 (614)
++|+|||.|+|+.++...+.++|+.++.|.+|++.||.|||+++|+|||+||.|||++.+|.+|+||||+|+.... .
T Consensus 77 ~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~---~ 153 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST---N 153 (808)
T ss_pred EEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc---C
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999997643 2
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchh
Q 007177 178 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257 (614)
Q Consensus 178 ~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~ 257 (614)
+...+..-|||.|||||+..+ ..|+..+|+||||||+|||+.|+|||...+..+....|..
T Consensus 154 t~vltsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~----------------- 214 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK----------------- 214 (808)
T ss_pred ceeeeeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc-----------------
Confidence 334566789999999999997 7999999999999999999999999988876666555522
Q ss_pred HHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 258 ~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
.+.. ....++..+++||+.+|.+||.+|.|..++|.|||.++-
T Consensus 215 -----------d~v~---~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 215 -----------DPVK---PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred -----------CCCC---CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 1111 113688999999999999999999999999999999864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-50 Score=392.64 Aligned_cols=288 Identities=42% Similarity=0.739 Sum_probs=249.9
Q ss_pred EEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEE
Q 007177 22 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 22 i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~ 101 (614)
--+.||.|+||+||.+.|..+|+.||+|++.+.+.+....+++.+|+++|.-++|.|++..+++..++...-+..+|+|+
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 35789999999999999999999999999998888888899999999999999999999999998887766678899999
Q ss_pred ecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCcccc
Q 007177 102 ELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 181 (614)
Q Consensus 102 E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~ 181 (614)
|+|..||+.+|.+...|+.++++-+++||++||+|||+.||.||||||.|+|+++||.+||||||+|+....+. ...+
T Consensus 137 ELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~--~~hM 214 (449)
T KOG0664|consen 137 ELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD--RLNM 214 (449)
T ss_pred HHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh--hhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999754333 3346
Q ss_pred ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHH
Q 007177 182 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRY 261 (614)
Q Consensus 182 ~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~ 261 (614)
+..+.|.+|+|||++.+- +.|+.++||||+|||+.|||..+.+|...+..+|++.|++++|+|+.+.+..-......-.
T Consensus 215 TqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~ 293 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV 293 (449)
T ss_pred HHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence 778899999999999874 7899999999999999999999999999999999999999999999988765433333333
Q ss_pred HHhhcccCCCcccCCCC-----CCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 262 LTSMRKKQPVQFSQKFP-----NADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 262 l~~~~~~~~~~~~~~~~-----~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
++.-.+ ...+...+. ....+..+++.+||.+||.+|.+.+++|.|+|+...
T Consensus 294 LR~~~k--~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 294 LRAGLR--APDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hccCCC--CCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 332211 112222211 234578899999999999999999999999998754
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=367.18 Aligned_cols=286 Identities=39% Similarity=0.631 Sum_probs=243.5
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
+|.-.+.||+|.||+||+|+++.+++.||+|.++-....+.--...++||.+|+.|+|.|||+++++. ..++.+-
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeE
Confidence 57778999999999999999999999999999975444444456678999999999999999999998 5567899
Q ss_pred EEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007177 99 VVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 177 (614)
Q Consensus 99 lV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 177 (614)
+|+|||..+|..+..+ ++.+..+.++.++.|+++||.|+|+.++.||||||+|+||+.+|.+||+|||+++..+-.
T Consensus 78 lvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip--- 154 (292)
T KOG0662|consen 78 LVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--- 154 (292)
T ss_pred EeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc---
Confidence 9999999999998876 678999999999999999999999999999999999999999999999999999875422
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhch
Q 007177 178 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256 (614)
Q Consensus 178 ~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~ 256 (614)
...+...+.|.||++|.++.+- .-|+..+|+||.|||++|+.. |+++|+|.+..+|+.+|+.++|+|+.+.|..+..-
T Consensus 155 vrcysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 155 VRCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred eEeeeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 2234556899999999998773 679999999999999999987 89999999999999999999999999998765431
Q ss_pred hHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 257 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
. .|-..........+++..|+++...+||++++|..+|..|++++.+|+||||.+..
T Consensus 234 p--dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 234 P--DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred C--CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 1 11111111122334555677788889999999999999999999999999998653
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=419.48 Aligned_cols=261 Identities=31% Similarity=0.512 Sum_probs=229.4
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
...+-|++++.||.|+-|.|.+|.+..||+.+|||+|.+. .........+.+||-||+.+.|||++.+|+++ ++
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~ 83 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----EN 83 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----cc
Confidence 4456799999999999999999999999999999999865 33445567899999999999999999999999 67
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
..++|+|.||++ |.|++++...++|++.++..+++||+.||.|||..+|+||||||+|+|++.++.+||+|||.|....
T Consensus 84 ~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 84 KQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred CceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 788999999999 6999999999999999999999999999999999999999999999999999999999999998644
Q ss_pred CCCCCccccccccCCccccCcccccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y-~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
++ ..+.+.||++.|.|||++.+ .+| +.++||||+|||||.||+|+.||.+.|....+.++..
T Consensus 164 ~g----klLeTSCGSPHYA~PEIV~G--~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~----------- 226 (786)
T KOG0588|consen 164 PG----KLLETSCGSPHYAAPEIVSG--RPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR----------- 226 (786)
T ss_pred CC----ccccccCCCcccCCchhhcC--CCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc-----------
Confidence 33 34677899999999999998 455 6899999999999999999999998776655554422
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 317 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~ 317 (614)
..+ +...++++++++||.+||.+||.+|+|.+||++|||+.+....
T Consensus 227 -----------------G~f---~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 227 -----------------GVF---EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred -----------------Ccc---cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence 111 1125789999999999999999999999999999999887543
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=399.49 Aligned_cols=291 Identities=34% Similarity=0.581 Sum_probs=230.0
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
||..++|++.+.||+|+||.||+|.++.+++.||||++..... ......+.+|+.+|+.++||||+++++++ .+
T Consensus 1 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~ 74 (303)
T cd07869 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDII-----HT 74 (303)
T ss_pred CCccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEE-----ec
Confidence 5778999999999999999999999999999999999874322 22234567899999999999999999998 44
Q ss_pred CCcEEEEEecCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 94 FKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 94 ~~~~ylV~E~~~g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
...+|+|||||.++|.+.+... +.++++.++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 75 KETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 5679999999999998888664 569999999999999999999999999999999999999999999999999987542
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-hhHHHHHHHhhhCCCchhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN-VVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~-~~~~l~~i~~~~g~p~~~~i~ 251 (614)
.... .....++|+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.. ..+++..+...++.|..+.+.
T Consensus 155 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 155 VPSH---TYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred CCCc---cCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhcc
Confidence 2211 12445789999999988652 468899999999999999999999998854 456778888888888766654
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCC--CCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFP--NADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~--~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
......... ........+..+...|. ..++.+.+||.+||+.||++|||++|+|+||||+++.
T Consensus 231 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 231 GVHSLPHFK-PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred chhhccccc-cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 432110000 00000001111111121 3467899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-47 Score=401.91 Aligned_cols=292 Identities=37% Similarity=0.681 Sum_probs=239.7
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~-~~~~ 94 (614)
..++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457999999999999999999999999999999999866555566778889999999999999999999886543 2344
Q ss_pred CcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 95 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 95 ~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
...|+||||++++|.+.+.. .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 95 ~~~~lv~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred ceeEEEhhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 56899999999999888764 4899999999999999999999999999999999999999999999999999764322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
. .....++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.|..+.+....
T Consensus 173 ~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 173 F----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred c----ccCCccccCCccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 1 2244679999999999977 679999999999999999999999999999999999999999988777665543
Q ss_pred chhHHHHHHhhcccCCCccc------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 255 NDKARRYLTSMRKKQPVQFS------------QKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~------------~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
.. ...+...........+. ......+..+++||.+||..||.+|||++|+|+||||..+..
T Consensus 247 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 247 PT-VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred HH-HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 22 22232221111111111 111234678899999999999999999999999999986643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=401.97 Aligned_cols=330 Identities=52% Similarity=0.943 Sum_probs=281.1
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++.+.||.|+||.||+|.++.+|+.||+|++............+.+|+.+|+.++||||+++++++.... .+..
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~ 81 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFK 81 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCc
Confidence 347899999999999999999999999999999999865444455677889999999999999999999875443 3456
Q ss_pred cEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 96 DIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 96 ~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
.+|+||||+.++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 82 DVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred eEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 79999999999999999888889999999999999999999999999999999999999999999999999997654322
Q ss_pred C-CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 176 P-TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 176 ~-~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
. ........+++.+|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+...++..+...+|.|..+.+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred cCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 1 11122346789999999987652 458899999999999999999999999999999999999999999998888777
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCCCCCccchhHHH
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFE 334 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~e 334 (614)
.+...+++..........+...++..++.+.+||.+||+.||.+|||++++|.||||.+....+.++.+. ..++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~~~--~~~~~~~~ 318 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTCP--PPFDFDFE 318 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccccCC--CCCCCChh
Confidence 7777777766666666666667788899999999999999999999999999999999988877766643 34567777
Q ss_pred hhcCCHHHHHHHHHH
Q 007177 335 RRRVTKEDIRELIFR 349 (614)
Q Consensus 335 ~~~~~~e~~~~~~~~ 349 (614)
....+.|.+.+.|.+
T Consensus 319 ~~~~~~~~~~~~~~~ 333 (334)
T cd07855 319 AIELSREQLKEAIVK 333 (334)
T ss_pred hhhcChhhHHHHhhc
Confidence 777888877776643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=398.63 Aligned_cols=329 Identities=56% Similarity=0.966 Sum_probs=283.5
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
||++.+.||.|+||.||+|.+..+++.||||++..........+.+.+|+.+++.++||||+++++++..........+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 69999999999999999999999999999999986554455667889999999999999999999998665444556799
Q ss_pred EEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCc
Q 007177 99 VVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 178 (614)
Q Consensus 99 lV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~ 178 (614)
+||||+.++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..........
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~ 160 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999998764433211
Q ss_pred cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhH
Q 007177 179 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 258 (614)
Q Consensus 179 ~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~ 258 (614)
.......++.+|+|||++.+. ..++.++|+|||||++|+|++|.+||.+.+..+.+..+...++.|..+.+........
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 161 GFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred ccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 223456789999999998872 3789999999999999999999999999999999999999999999888877777777
Q ss_pred HHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCCCCCccchhHHHhhcC
Q 007177 259 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRV 338 (614)
Q Consensus 259 ~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~ 338 (614)
..++..........+....+.++..+.+||.+||++||.+|||++++|.||||+++.....++......++. .++...+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 318 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFD-FFDDDEL 318 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCccccc-ccchhhc
Confidence 777777666667777777788999999999999999999999999999999999988777666555443321 3566778
Q ss_pred CHHHHHHHHHH
Q 007177 339 TKEDIRELIFR 349 (614)
Q Consensus 339 ~~e~~~~~~~~ 349 (614)
++++.+++|+.
T Consensus 319 ~~~~~~~~~~~ 329 (330)
T cd07834 319 TEEELKELIYE 329 (330)
T ss_pred CHHHHhHHhhc
Confidence 89999988865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-47 Score=390.13 Aligned_cols=284 Identities=34% Similarity=0.581 Sum_probs=230.6
Q ss_pred CCeEEEeEeeecCceEEEEEEECC-CCcEEEEEEecCccCChHHHHHHHHHHHHHHhc---CCCCcceeeeEecCCCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTH-TGEKVAIKKIHDIFEHISDAARILREIKLLRLL---RHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~-tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L---~HpnIv~l~~v~~~~~~~~ 93 (614)
.+|++++.||+|+||.||+|.+.. ++..||+|+++...........+.+|+.+++.+ +||||+++++++.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999864 468899999875433333344566787777765 6999999999986544445
Q ss_pred CCcEEEEEecCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 94 FKDIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 94 ~~~~ylV~E~~~g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
...+|+||||+.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 5679999999999999998753 35899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+.+..|.+..+.|....+.
T Consensus 161 ~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 161 SFQM----ALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred cCCc----ccccccccccccChHHHhC--CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 3221 1234578999999999876 678999999999999999999999999999999999999988887765543
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
...... .. .........+....+.+++.+.+||.+||+.||++|||+.|+|+||||
T Consensus 235 ~~~~~~-~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALP-RQ---AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhccc-ch---hccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 221100 00 111222333444556788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=389.89 Aligned_cols=285 Identities=35% Similarity=0.640 Sum_probs=226.9
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
++|++.+.||+|+||.||+|+++.+++.||+|++............+.+|+.+++.++||||+++++++ .+...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence 479999999999999999999999999999999976444444556788999999999999999999988 455679
Q ss_pred EEEEecCCCcHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 98 YVVFELMESDLHQVIK-ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 98 ylV~E~~~g~L~~~i~-~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
|+||||+++++.+.+. ....++++.++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9999999976655554 345799999999999999999999999999999999999999999999999999986532221
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhch
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~ 256 (614)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||++.+..+.+..+....+....+.+......
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 156 A--NYTEYVATRWYRSPELLLG--APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred c--cccccccccccCCcHHHcC--CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence 1 1234679999999999876 57899999999999999999999999999888888888777777655544322111
Q ss_pred hHHHHHHhhcccCCCcc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 257 KARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 257 ~~~~~l~~~~~~~~~~~-~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
.............+... ......+++.+.+||++||++||++|||++++|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 10000000000000000 11223478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=390.86 Aligned_cols=291 Identities=36% Similarity=0.652 Sum_probs=240.1
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
|+..++|.+.+.||+|+||.||+|.++.+++.||+|+++.... ......+.+|+.+++.++||||+++++++ .+
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 75 (309)
T cd07872 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIV-----HT 75 (309)
T ss_pred CCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEE-----ee
Confidence 5677899999999999999999999999999999999874322 22234567899999999999999999998 44
Q ss_pred CCcEEEEEecCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 94 FKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 94 ~~~~ylV~E~~~g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
....|+||||++++|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 76 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 76 DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecC
Confidence 5679999999999999888654 458999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.... ......+|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.|..+.+..
T Consensus 156 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07872 156 VPTK---TYSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG 231 (309)
T ss_pred CCcc---ccccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence 2221 12345689999999988652 4688999999999999999999999999999999999999999998887765
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
+.......... .....+..+....+.+++++++||.+||..||.+|||++|+|+||||+.+.
T Consensus 232 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 232 ISSNDEFKNYN-FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hcchhhhhhhh-cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 54322111111 112222233344567899999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=395.67 Aligned_cols=331 Identities=44% Similarity=0.826 Sum_probs=283.0
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RD 93 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~-~~ 93 (614)
...++|++.+.||+|+||.||+|.+..++..||||++............+.+|+.+++.++||||+++++++..... ..
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999999999999999987654444456678899999999999999999988754432 33
Q ss_pred CCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 94 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 94 ~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
...+|+|+||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 92 ~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 92 FQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred cccEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 456999999999999998875 4699999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
. ...+.++.+|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+....+.++
T Consensus 171 ~------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 171 E------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred c------ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 2 2345788999999988652 36789999999999999999999999999999999999999999988888888
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCCCCCccchhHH
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEF 333 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 333 (614)
..+....++..+.......+...+...++.+.+||.+||..||.+|||+.++|+||||..+...+.++... ....++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~~---~~~~~~ 320 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVAP---PYDQSF 320 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccccccc---ccCcch
Confidence 77777777777766666666666777899999999999999999999999999999999887766555422 233567
Q ss_pred HhhcCCHHHHHHHHHHHHHHhCc
Q 007177 334 ERRRVTKEDIRELIFREILEYHP 356 (614)
Q Consensus 334 e~~~~~~e~~~~~~~~ei~~~~~ 356 (614)
+...+..+.|+++++.++.+|.|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07851 321 ESRDLTVDEWKELVYKEIMNFKP 343 (343)
T ss_pred hhhhcCHHHHHHHhHHHHHhccC
Confidence 78889999999999999998865
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=410.38 Aligned_cols=286 Identities=36% Similarity=0.633 Sum_probs=229.9
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC---CC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR---RD 93 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~---~~ 93 (614)
..+|++++.||+|+||.||+|.+..+++.||||++... .....+|+.+|+.++||||+++++++..... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC------cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 46899999999999999999999999999999988642 1223579999999999999999998754322 22
Q ss_pred CCcEEEEEecCCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC-cEEEeecCcc
Q 007177 94 FKDIYVVFELMESDLHQVIK----ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLA 168 (614)
Q Consensus 94 ~~~~ylV~E~~~g~L~~~i~----~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~-~vKL~DFGla 168 (614)
...+|+|||||+++|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+|
T Consensus 139 ~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 139 NIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred ceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 23578999999998887775 345799999999999999999999999999999999999998665 6999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007177 169 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~ 248 (614)
+....... ...++||+.|+|||++.+. ..|+.++|||||||++|||++|.+||.+.+..+++..+...+|+|..+
T Consensus 219 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 219 KNLLAGQR----SVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred hhccCCCC----cccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 86543221 2346789999999988652 468999999999999999999999999999999999999999999887
Q ss_pred hhhhhhchhHHHHHHhhcccCCCcccCCCC-CCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 249 TISRVRNDKARRYLTSMRKKQPVQFSQKFP-NADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 249 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
.+.........-. +....+..+...++ ..++++++||.+||.+||.+|||+.|+|+||||..+..
T Consensus 294 ~~~~~~~~~~~~~---~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 294 QLKEMNPNYADIK---FPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHHHhchhhhccc---CCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 6654322110000 00111111222223 46789999999999999999999999999999988754
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=384.71 Aligned_cols=283 Identities=35% Similarity=0.587 Sum_probs=228.9
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc---CCCCcceeeeEecCCCCCCCC
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL---RHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L---~HpnIv~l~~v~~~~~~~~~~ 95 (614)
+|++++.||+|+||.||+|.++.+++.||+|.++...........+.+|+.+++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 69999999999999999999999999999999875433222233455677776655 699999999998655444456
Q ss_pred cEEEEEecCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 96 DIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 96 ~~ylV~E~~~g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
.+++|||++.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 79999999999999988764 3589999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
... .....+|..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+...
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 161 QMA----LTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred ccc----CCCccccccccCchHhhC--CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 221 234578999999999876 67899999999999999999999999999988889999888888765554321
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
..... ...............+.++..+.+||.+||+.||++|||+.|+|.||||
T Consensus 235 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPR----GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccc----cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 11000 0011122223334556788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=401.87 Aligned_cols=282 Identities=25% Similarity=0.348 Sum_probs=223.0
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
.+|++++.||+|+||.||+|.+..+++.||||+.. ...+.+|+.+|+.|+||||+++++++. .....
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~ 158 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFT-----YNKFT 158 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCee
Confidence 57999999999999999999999999999999754 234678999999999999999999983 44568
Q ss_pred EEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007177 98 YVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 177 (614)
Q Consensus 98 ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 177 (614)
|+|||++.++|..++.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 159 ~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~- 237 (391)
T PHA03212 159 CLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA- 237 (391)
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence 9999999999999998888899999999999999999999999999999999999999999999999999975332211
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-------hhHHHHHHHhhhCCCchhhh
Q 007177 178 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN-------VVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 178 ~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~-------~~~~l~~i~~~~g~p~~~~i 250 (614)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.. ...++..+...+|.++.+..
T Consensus 238 -~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 238 -NKYYGWAGTIATNAPELLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred -cccccccCccCCCChhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 11234689999999999987 679999999999999999999998775432 34577778887787654432
Q ss_pred hhhhchhHHHHHHhhcccCCCcc----cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQF----SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~----~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
..........+..........+. ......++.++.+||.+||++||.+|||++|+|+||||+.+..
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 384 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD 384 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence 11111111111111111111100 0111245678999999999999999999999999999987643
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=390.96 Aligned_cols=326 Identities=37% Similarity=0.676 Sum_probs=257.7
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRD 93 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~-~~~ 93 (614)
...++|++.+.||+|+||.||+|.+..+|+.||||.+............+.+|+.+++.++||||+++++++.... ..+
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 3568999999999999999999999999999999999765555556677889999999999999999999886542 234
Q ss_pred CCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 94 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 94 ~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
....|+|||||.++|.+.+... +++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 93 FQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred cCcEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 4578999999999999988654 99999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+++..+...+|.|..+.....
T Consensus 171 ~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 171 SFM----MTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred CCC----CCCCcccccccCHHHHhC--CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 221 234568899999999877 67899999999999999999999999999999999999999999988766554
Q ss_pred hchhHHHHHHhhcccCCCcccCC-------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCC
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQK-------------FPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVERE 320 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~-------------~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~ 320 (614)
... ...+...........+.+. ....++.+++||.+||+.||.+|||+.|+|.||||+.+......
T Consensus 245 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~~ 323 (353)
T cd07850 245 QPT-VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEV 323 (353)
T ss_pred hhh-hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCccC
Confidence 322 1222222111111122221 12346678999999999999999999999999999876553322
Q ss_pred CCCCCCccchhHHHhhcCCHHHHHHHHHHH
Q 007177 321 PSCQPISKMEFEFERRRVTKEDIRELIFRE 350 (614)
Q Consensus 321 ~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e 350 (614)
....+ ...+...+.+..+.++|++.++.+
T Consensus 324 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T cd07850 324 EAPPP-APYDHSIDEREHTVEEWKELIYKE 352 (353)
T ss_pred CCCCC-CccccccccccccHHHHHHHHHhh
Confidence 22111 112334456677778888877654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=402.64 Aligned_cols=256 Identities=30% Similarity=0.518 Sum_probs=221.8
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
..+|...+.||+|+.|.||.|....+++.||||.+... ......-+++|+.+|+.++|+|||.+++.|+.. +.
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~--~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----de 344 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR--KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----DE 344 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEec--cCCchhhhHHHHHHHHhccchHHHHHHHHhccc-----ce
Confidence 35788899999999999999999999999999999753 334456688999999999999999999998543 67
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+++|||||+ |+|.+++... .++|.++..|++++|.||+|||.+||+|||||.+|||++.+|.+||+|||+|.......
T Consensus 345 LWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred eEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999999 5888887655 49999999999999999999999999999999999999999999999999998775544
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
. ...+.+||++|||||++.. ..|++++||||||++..||+-|++||-..+....+.+|.. .|+|.
T Consensus 424 ~---KR~TmVGTPYWMAPEVvtr--k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~--------- 488 (550)
T KOG0578|consen 424 S---KRSTMVGTPYWMAPEVVTR--KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPK--------- 488 (550)
T ss_pred C---ccccccCCCCccchhhhhh--cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCC---------
Confidence 3 2367899999999999987 6899999999999999999999999988776666655532 22221
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
-.....+|+.++|||.+||++|+.+|++|.|+|+||||+.
T Consensus 489 ------------------lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 489 ------------------LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred ------------------cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 2234568999999999999999999999999999999953
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-47 Score=392.48 Aligned_cols=271 Identities=27% Similarity=0.460 Sum_probs=221.8
Q ss_pred cccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC------------ChHHHHHHHHHHHHHHhcCCCC
Q 007177 11 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE------------HISDAARILREIKLLRLLRHPD 78 (614)
Q Consensus 11 ~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~------------~~~~~~~i~~Ei~iL~~L~Hpn 78 (614)
++..-..++|++++.||+|.||+|.+|++..+++.||||++.+... .....+++.+||.||++|.|||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 3444556889999999999999999999999999999999964311 1223467899999999999999
Q ss_pred cceeeeEecCCCCCCCCcEEEEEecCC-CcHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC
Q 007177 79 IVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD-LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA 156 (614)
Q Consensus 79 Iv~l~~v~~~~~~~~~~~~ylV~E~~~-g~L~~~i~~~~~-lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~ 156 (614)
||+|+++..++ ....+|||+|||. |.+.+. -..+. |++.+++.|++.++.||.|||.+|||||||||+|+||++
T Consensus 170 VV~LiEvLDDP---~s~~~YlVley~s~G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 170 VVKLIEVLDDP---ESDKLYLVLEYCSKGEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSS 245 (576)
T ss_pred eeEEEEeecCc---ccCceEEEEEeccCCccccC-CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcC
Confidence 99999998554 4578999999999 554433 23334 999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCccccccC--CCCCccccccccCCccccCccccccc--CCCCCCcccchhHHHHHHHHHhCCCCCCCCChh
Q 007177 157 NCKLKICDFGLARVAFN--DTPTTIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 232 (614)
Q Consensus 157 ~~~vKL~DFGla~~~~~--~~~~~~~~~~~vgt~~Y~APEvl~~~--~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~ 232 (614)
+|++||+|||.+..... +......+...+|||.|+|||+|.+. ....+.+.|||||||+||.|+.|+.||-+....
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 99999999999975421 12222334557999999999998762 123567899999999999999999999999888
Q ss_pred HHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 007177 233 HQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312 (614)
Q Consensus 233 ~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~ 312 (614)
+..++|.. .+..|. ..+.+.+.++|||.+||.+||++|+++.+|..|||..
T Consensus 326 ~l~~KIvn----------------------------~pL~fP-~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 326 ELFDKIVN----------------------------DPLEFP-ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred HHHHHHhc----------------------------CcccCC-CcccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence 88887743 122221 2346788999999999999999999999999999987
Q ss_pred cC
Q 007177 313 GL 314 (614)
Q Consensus 313 ~~ 314 (614)
.-
T Consensus 377 ~~ 378 (576)
T KOG0585|consen 377 RD 378 (576)
T ss_pred cC
Confidence 54
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=388.09 Aligned_cols=264 Identities=30% Similarity=0.458 Sum_probs=213.7
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
..+|...+.||+|+||.||++.++.+|+.+|||.+... +....+.+.+|+.+|+.|+|||||++++..... ++ ..
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~--~~-~~ 90 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSR--EN-DE 90 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCccccc--cC-ee
Confidence 45688999999999999999999999999999998754 222267789999999999999999999964221 11 46
Q ss_pred EEEEEecCC-CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC-CCcEEEeecCccccccC
Q 007177 97 IYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFN 173 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~-~~~vKL~DFGla~~~~~ 173 (614)
++|+|||+. |+|.++++..+ .|+++.++.+.+||++||+|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999 69999999877 7999999999999999999999999999999999999999 79999999999987654
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC-ChhHHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-NVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~-~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
............||+.|||||++... ..-.+++|||||||++.||+||.+||... .....+-.|
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~i-------------- 235 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLI-------------- 235 (313)
T ss_pred ccccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHH--------------
Confidence 12221223457899999999999841 22335999999999999999999999763 222111111
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
.... . .......+++++++||.+||.+||++||||+++|+|||.+...
T Consensus 236 ------------g~~~-~--~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 236 ------------GRED-S--LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred ------------hccC-C--CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 1111 1 1133346899999999999999999999999999999997643
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=408.12 Aligned_cols=285 Identities=27% Similarity=0.424 Sum_probs=226.0
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC------CCcceeeeEecCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH------PDIVEIKHIMLPPS 90 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~H------pnIv~l~~v~~~~~ 90 (614)
.++|++++.||+|+||.||+|.+..+++.||||+++... ........|+.+++.++| ++|+.+++++..
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~-- 202 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN-- 202 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc--
Confidence 478999999999999999999999999999999996421 223345567777777654 458888887732
Q ss_pred CCCCCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeecCCCCcEEECCCC-----------
Q 007177 91 RRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANC----------- 158 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~----------- 158 (614)
+...+|||||++.++|.+++...+.+++..++.|+.||+.||.|||+ .|||||||||+|||++.++
T Consensus 203 --~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 203 --ETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred --CCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 33578999999999999999888889999999999999999999998 5999999999999998765
Q ss_pred -----cEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhH
Q 007177 159 -----KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH 233 (614)
Q Consensus 159 -----~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~ 233 (614)
.+||+|||++..... ..+..+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~------~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERH------SRTAIVSTRHYRSPEVVLG--LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred CCCCceEEECCCCccccCcc------ccccccCCccccCcHHhhc--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 499999998854221 1245689999999999987 689999999999999999999999999999999
Q ss_pred HHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccC---------CCC--CCCHHHHHHHHHhcCCCCCCCCCH
Q 007177 234 QLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQ---------KFP--NADPSALRLLERLLAFDPKDRPTA 302 (614)
Q Consensus 234 ~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~---------~~~--~~s~~l~dLI~~mL~~DP~~Rpsa 302 (614)
++..|...+|.+..+............++.......+..... .+. ..++.+.|||.+||++||++|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 999999999988776654433333333332221111110000 000 124678899999999999999999
Q ss_pred HHHHcCcccccCCc
Q 007177 303 EEALADPYFKGLSK 316 (614)
Q Consensus 303 ~eiL~hp~f~~~~~ 316 (614)
+|+|+||||..+..
T Consensus 433 ~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 433 RQMTTHPYVLKYYP 446 (467)
T ss_pred HHHhcCccccccCC
Confidence 99999999987644
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=381.26 Aligned_cols=254 Identities=30% Similarity=0.533 Sum_probs=224.7
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
...||++.+.||+|.||.|-+|++...|+.||||.|++. .....+.-.|.+||+||..|+||||+.+|++| ++.
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENk 125 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENK 125 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCC
Confidence 346899999999999999999999999999999999754 34556778899999999999999999999999 677
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
+.+.|||||.. |+|+++|...+.|+|.+++.|++||..|+.|+|.++++|||||.+|||+|.||.+||+||||+..+..
T Consensus 126 dKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 126 DKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred ceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 88999999998 79999999999999999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCccccccccCCccccCcccccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y-~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
..+++++||++.|.+||++.+ .+| ++.+|.||||++||.|+.|..||.|.+....+.+|....
T Consensus 206 ----~kfLqTFCGSPLYASPEIvNG--~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga---------- 269 (668)
T KOG0611|consen 206 ----KKFLQTFCGSPLYASPEIVNG--TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA---------- 269 (668)
T ss_pred ----ccHHHHhcCCcccCCccccCC--CCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc----------
Confidence 346789999999999999988 455 689999999999999999999999998765555543210
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~ 312 (614)
. .-|..+..+.-||+.||..+|++|.|+++|-+|-|++
T Consensus 270 -----------------Y-----rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 270 -----------------Y-----REPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred -----------------c-----cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 0 0134456789999999999999999999999999986
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=385.98 Aligned_cols=331 Identities=41% Similarity=0.764 Sum_probs=275.6
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RD 93 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~-~~ 93 (614)
...++|++++.||+|+||.||+|.+..++..||||++............+.+|+.+|+.++||||+++++++..... ..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 45778999999999999999999999999999999987544444445678899999999999999999999864422 22
Q ss_pred CCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 94 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 94 ~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
...+|+||||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 92 ~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 92 FHDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred cceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 346799999998899888864 5699999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
. .....++++|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.+....+..+....+.+..+....+
T Consensus 171 ~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 171 E------MTGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred C------ccccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 1 1334678999999988652 35889999999999999999999999999888888888888888777777766
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCCCCCccchhHH
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEF 333 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 333 (614)
.......+...+.......+...++++++.+.+||.+||+.||.+|||+.++|.||||+.+...+.++...+ +...+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~---~~~~~ 320 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPP---YDDSF 320 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCC---ccccH
Confidence 666666666665554444455556788999999999999999999999999999999998877655544333 44456
Q ss_pred HhhcCCHHHHHHHHHHHHHHhCc
Q 007177 334 ERRRVTKEDIRELIFREILEYHP 356 (614)
Q Consensus 334 e~~~~~~e~~~~~~~~ei~~~~~ 356 (614)
+....+.|+++.+.+.||+.++|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07880 321 DEVDQSLEEWKRLTFTEILSFQP 343 (343)
T ss_pred HhhccchHHHHHHHHHHHHhcCC
Confidence 77788899999999999998765
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-46 Score=395.41 Aligned_cols=262 Identities=32% Similarity=0.531 Sum_probs=227.5
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-ISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSR 91 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~-~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~ 91 (614)
......|++.+.||.|.||+||+|+++.||+.+|+|.+.+.... ..+...+.+|+.+|++|. |||||.++++|
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~----- 105 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF----- 105 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----
Confidence 34556899999999999999999999999999999999765332 224567889999999998 99999999999
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC----CcEEEeecC
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN----CKLKICDFG 166 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~----~~vKL~DFG 166 (614)
++...+|+|||+|. |+|++.|... .+++..+..++.||+.+++|||+.||+||||||+|+|+... +.+|++|||
T Consensus 106 e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 106 EDPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EcCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 56668999999999 6999999877 49999999999999999999999999999999999998543 479999999
Q ss_pred ccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCc
Q 007177 167 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 246 (614)
Q Consensus 167 la~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~ 246 (614)
++..... .......+||+.|+|||++.. ..|+..+||||+|+|+|.|++|.+||.+.+.......|.
T Consensus 185 la~~~~~----~~~~~~~~Gtp~y~APEvl~~--~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~------- 251 (382)
T KOG0032|consen 185 LAKFIKP----GERLHTIVGTPEYVAPEVLGG--RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL------- 251 (382)
T ss_pred CceEccC----CceEeeecCCccccCchhhcC--CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH-------
Confidence 9987654 223467899999999999986 689999999999999999999999999988665554332
Q ss_pred hhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 247 ~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
..........|++++..+++||.+||.+||.+|+|+.++|+|||++..
T Consensus 252 --------------------~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 252 --------------------RGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred --------------------cCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 222234456789999999999999999999999999999999999865
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-46 Score=383.02 Aligned_cols=275 Identities=29% Similarity=0.433 Sum_probs=229.0
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
.+.+.|++.++||.|..++||+|+...+++.||||++.-. ....+...+.+|+..|+.++||||++++..|. ..
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLE-kc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv-----v~ 96 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLE-KCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV-----VD 96 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehh-hhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE-----ec
Confidence 4567899999999999999999999999999999999743 23345788999999999999999999999994 44
Q ss_pred CcEEEEEecCC-CcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 95 KDIYVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
..+|+||.||. |+++++|+. ...+.|..+..|++++|+||.|||.+|-||||||+.||||+.+|.|||+|||.+...
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 66999999999 799999986 346999999999999999999999999999999999999999999999999998776
Q ss_pred cCCCCCcccc-ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 172 FNDTPTTIFW-TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 172 ~~~~~~~~~~-~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
.......... .+++||++|||||++...-..|+.|+||||||+...||.+|..||........+ +..+-|.|..-..
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL--l~tLqn~pp~~~t 254 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL--LLTLQNDPPTLLT 254 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH--HHHhcCCCCCccc
Confidence 6544333222 778999999999997665678999999999999999999999999877655443 4445555543222
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
.....+. ....+..++.+|..||+.||.+|||++++|+|+||+....
T Consensus 255 ~~~~~d~-------------------~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 255 SGLDKDE-------------------DKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred ccCChHH-------------------hhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 2211111 1234558999999999999999999999999999997543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=388.14 Aligned_cols=254 Identities=27% Similarity=0.435 Sum_probs=215.9
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
..+.|++.+.||+|+||.||+|.++.+++.||||++.... ........+.+|+.+|+.++||||+++++.+ .+.
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~ 90 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDE 90 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcC
Confidence 3578999999999999999999999999999999997432 2223456788999999999999999999998 455
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
+.+|+|||||. ++|.+.+...+.++++.++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred CEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 67999999998 59999999888899999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
.. ...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 171 ~~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~------------- 229 (329)
T PTZ00263 171 RT------FTLCGTPEYLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA------------- 229 (329)
T ss_pred Cc------ceecCChhhcCHHHHcC--CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc-------------
Confidence 21 23579999999999987 5789999999999999999999999988765444333311
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHHcCccccc
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKG 313 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~eiL~hp~f~~ 313 (614)
. ... ....++..+++||.+||+.||.+|++ ++++++||||.+
T Consensus 230 --------------~-~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 230 --------------G-RLK---FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred --------------C-CcC---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 0 011 11236789999999999999999996 799999999985
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=383.02 Aligned_cols=253 Identities=24% Similarity=0.394 Sum_probs=215.0
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
++|++++.||+|+||.||+|.++.+|+.||||++.... ........+.+|+.+|+.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCe
Confidence 47999999999999999999999999999999986432 1223456688999999999999999999887 45578
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 999999998 5999999988899999999999999999999999999999999999999999999999999997653221
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 156 ------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~--------------- 212 (291)
T cd05612 156 ------WTLCGTPEYLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA--------------- 212 (291)
T ss_pred ------ccccCChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------------
Confidence 23579999999999887 6789999999999999999999999988775544443321
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccC
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 314 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~eiL~hp~f~~~ 314 (614)
. ... .....++.+++||++||+.||.+|++ ++++++||||+.+
T Consensus 213 -----------~--~~~---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 213 -----------G--KLE---FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred -----------C--CcC---CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 0 001 11245789999999999999999995 9999999999864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=372.43 Aligned_cols=263 Identities=29% Similarity=0.485 Sum_probs=221.6
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-----Ch-HHHHHHHHHHHHHHhcC-CCCcceeeeEecCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-----HI-SDAARILREIKLLRLLR-HPDIVEIKHIMLPP 89 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-----~~-~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~ 89 (614)
...|.-.++||.|..++|.+|+++.+|..+|+|+|..... .. .-.....+|+.||+++. ||+|+.+.++|
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--- 92 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--- 92 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec---
Confidence 3467778999999999999999999999999999963211 11 12234568999999985 99999999999
Q ss_pred CCCCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcc
Q 007177 90 SRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 168 (614)
Q Consensus 90 ~~~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 168 (614)
+....+++|||+|. |.|++++.+.-.++|++.+.||+||++|+.|||..+||||||||+|||++++..+||+|||+|
T Consensus 93 --es~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 93 --ESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred --cCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEecccee
Confidence 44456899999999 899999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCccccCccccccc----CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCC
Q 007177 169 RVAFNDTPTTIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 244 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~----~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~ 244 (614)
+..... ..+++.||||.|+|||.+... ...|+..+|+|++|+|+|.||.|.+||......-.+..|+
T Consensus 171 ~~l~~G----ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Im----- 241 (411)
T KOG0599|consen 171 CQLEPG----EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIM----- 241 (411)
T ss_pred eccCCc----hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHH-----
Confidence 876433 346788999999999987542 2468999999999999999999999997654433333332
Q ss_pred CchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 245 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 245 p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
..+-..-+..|.+++...+|||.+||+.||.+|.|++|+|+||||..+.
T Consensus 242 ----------------------eGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 242 ----------------------EGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred ----------------------hcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 2233334567899999999999999999999999999999999997654
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=383.27 Aligned_cols=331 Identities=41% Similarity=0.797 Sum_probs=275.4
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRD 93 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~-~~~ 93 (614)
...++|.+.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++.... ...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 3457899999999999999999999999999999999765444445667889999999999999999999885432 233
Q ss_pred CCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 94 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 94 ~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
...+|++++++.++|.+++... .+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 94 ~~~~~lv~~~~~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 94 FNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred cccEEEEehhcccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 4568999999988998887654 699999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
. .....++.+|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.+.......+
T Consensus 173 ~------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 173 E------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred c------ccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 1 2345789999999987652 46888999999999999999999999999888888899998998888877777
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCCCCCccchhHH
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEF 333 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 333 (614)
.....+.++..+.......+...+...++.+.+||.+||..||.+||++.++|.||||+++...+.++... .++..+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~~---~~~~~~ 322 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD---PYDQSF 322 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccccCC---CccCcc
Confidence 66666667666655555555555567889999999999999999999999999999999887766666433 345555
Q ss_pred HhhcCCHHHHHHHHHHHHHHhCc
Q 007177 334 ERRRVTKEDIRELIFREILEYHP 356 (614)
Q Consensus 334 e~~~~~~e~~~~~~~~ei~~~~~ 356 (614)
..+.+..+++....|++...|-|
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~ 345 (345)
T cd07877 323 ESRDLLIDEWKSLTYDEVISFVP 345 (345)
T ss_pred hhcccCHHHHHHHHHHHHHhcCC
Confidence 66677778888899998876543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=402.32 Aligned_cols=256 Identities=25% Similarity=0.473 Sum_probs=222.9
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~ 93 (614)
...+|.++++||+|+||+|++|..+.+++.||||++++. .....+......|-.|+.... ||.++.++..| ++
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----QT 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----QT 440 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----cc
Confidence 346899999999999999999999999999999999864 234456777889999998885 99999999998 67
Q ss_pred CCcEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 94 FKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 94 ~~~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
..++|+||||+.| |+ ..+...+.|++..+++|+..|+.||.|||++||||||||.+|||+|.+|++||+|||+++...
T Consensus 441 ~~~l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred CCeEEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC
Confidence 7789999999995 74 444455679999999999999999999999999999999999999999999999999999755
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
..... ..++||||.|+|||++.+ ..|+.++|+|||||+|||||.|++||+|.++.+..+.|..-
T Consensus 520 ~~g~~---TsTfCGTpey~aPEil~e--~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d----------- 583 (694)
T KOG0694|consen 520 GQGDR---TSTFCGTPEFLAPEVLTE--QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND----------- 583 (694)
T ss_pred CCCCc---cccccCChhhcChhhhcc--CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-----------
Confidence 33333 267899999999999998 79999999999999999999999999999998888877420
Q ss_pred hhchhHHHHHHhhcccCCCcccCCC-CCCCHHHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKF-PNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 314 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~-~~~s~~l~dLI~~mL~~DP~~Rps-----a~eiL~hp~f~~~ 314 (614)
...+ -.+|.++.+++++||..||++|.. +++|..||||+.+
T Consensus 584 ---------------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 584 ---------------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred ---------------------CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence 1112 247889999999999999999974 6899999999976
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=386.80 Aligned_cols=250 Identities=26% Similarity=0.463 Sum_probs=210.9
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEe
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 102 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E 102 (614)
+.||+|+||.||+|.++.+|+.||||+++... ........+.+|+.+|+.++||||+++++.+ .+...+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 47999999999999999999999999997532 2234456778999999999999999999988 45567999999
Q ss_pred cCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCcccc
Q 007177 103 LME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 181 (614)
Q Consensus 103 ~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~ 181 (614)
|+. ++|.+.+...+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---~~ 152 (323)
T cd05571 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA---TM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC---cc
Confidence 998 59999998888999999999999999999999999999999999999999999999999999975322211 12
Q ss_pred ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHH
Q 007177 182 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRY 261 (614)
Q Consensus 182 ~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~ 261 (614)
...+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--------------------- 209 (323)
T cd05571 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------------- 209 (323)
T ss_pred cceecCccccChhhhcC--CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc---------------------
Confidence 34679999999999987 6799999999999999999999999987765444333211
Q ss_pred HHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 007177 262 LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 314 (614)
Q Consensus 262 l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~ 314 (614)
. .. .....+++.+.+||++||+.||++|| ++.++|+||||.++
T Consensus 210 -----~--~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 210 -----E--EI---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred -----C--CC---CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 0 00 11235788999999999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=379.09 Aligned_cols=291 Identities=35% Similarity=0.645 Sum_probs=235.0
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
++..++|++.+.||.|+||.||+|.++.+++.||+|.+..... ......+.+|+.+++.++||||+++++++ .+
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~ 75 (301)
T cd07873 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDII-----HT 75 (301)
T ss_pred CccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEE-----ec
Confidence 5667789999999999999999999999999999999864322 22234567899999999999999999998 44
Q ss_pred CCcEEEEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 94 FKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 94 ~~~~ylV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
...+|+||||+.++|.+.+.. ...+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++....
T Consensus 76 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 76 EKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred CCeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 567999999999999998875 3568999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.... ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+...++.|....+..
T Consensus 156 ~~~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (301)
T cd07873 156 IPTK---TYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231 (301)
T ss_pred CCCC---cccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh
Confidence 2221 12334678999999988652 4678899999999999999999999999999999999999999888776654
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
+......... .........+....+.+++.+.+||.+||+.||.+|||++|+|+||||+.+.
T Consensus 232 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 232 ILSNEEFKSY-NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred hhcccccccc-ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 3221100000 0000011111223356788999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=381.80 Aligned_cols=281 Identities=35% Similarity=0.604 Sum_probs=217.2
Q ss_pred EeEeeecCceEEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEE
Q 007177 23 QEVIGKGSYGVVCSAIDT--HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVV 100 (614)
Q Consensus 23 ~~~LG~G~~G~V~~a~d~--~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV 100 (614)
.++||+|+||+||+|.++ .+++.||+|.+.... ....+.+|+.+|+.++||||+++++++... ....+|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEE
Confidence 468999999999999865 467899999987532 123467899999999999999999988542 33568999
Q ss_pred EecCCCcHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEE----CCCCcEEEeecCc
Q 007177 101 FELMESDLHQVIKAN---------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA----NANCKLKICDFGL 167 (614)
Q Consensus 101 ~E~~~g~L~~~i~~~---------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi----~~~~~vKL~DFGl 167 (614)
|||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 999999999888632 258999999999999999999999999999999999999 4567899999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCh---------hHHHHHH
Q 007177 168 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV---------VHQLDLM 238 (614)
Q Consensus 168 a~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~---------~~~l~~i 238 (614)
++...............++|+.|+|||++.+. ..|+.++|||||||++|+|++|++||.+... .+++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 98654332222223456899999999988752 4689999999999999999999999976543 4678889
Q ss_pred HhhhCCCchhhhhhhhchhH-HHHHHhhcccC--CC----cccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 239 TDLLGTPSLDTISRVRNDKA-RRYLTSMRKKQ--PV----QFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 239 ~~~~g~p~~~~i~~~~~~~~-~~~l~~~~~~~--~~----~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
...+|.|....+........ ........... .. .+.......+..+.+||.+||++||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 99999988777665432110 01111111000 00 0111122346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=381.19 Aligned_cols=326 Identities=48% Similarity=0.828 Sum_probs=266.6
Q ss_pred CeEEEeEeeecCceEEEEEEECCC--CcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCC
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHT--GEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~t--g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~ 95 (614)
+|++.+.||+|+||.||++.+..+ +..||||++............+.+|+.+++.+ .||||+++++...... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 589999999999999999999888 89999999876544444566788999999999 5999999998754321 3346
Q ss_pred cEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 96 DIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 96 ~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
.+|+++|+++++|.+.+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 80 ELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred cEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 68999999999999999888889999999999999999999999999999999999999999999999999998654322
Q ss_pred CC-ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 176 PT-TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 176 ~~-~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
.. .......+||..|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...+|.|..+.+..+.
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred ccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 1122346789999999987652 468899999999999999999999999999999999999999999888877766
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCCCCCccchhHHH
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFE 334 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~e 334 (614)
......+...........+...++..+..+.+||.+||+.||.+|||+.++|.||||..+......+.|.......|+-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~- 317 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSFES- 317 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccCCccc-
Confidence 6655555555555555556666777899999999999999999999999999999999888776666665443333332
Q ss_pred hhcCCHHHHHHHHHH
Q 007177 335 RRRVTKEDIRELIFR 349 (614)
Q Consensus 335 ~~~~~~e~~~~~~~~ 349 (614)
+.+.++++..|..
T Consensus 318 --~~~~~~~~~~~~~ 330 (332)
T cd07857 318 --EDSMEELRDMIIE 330 (332)
T ss_pred --cccHHHHHHHHhh
Confidence 2345666666544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=387.93 Aligned_cols=262 Identities=26% Similarity=0.400 Sum_probs=214.3
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
++|++++.||+|+||.||+|.++.+++.||||++.+... .......+.+|+.++..++||||+++++.+ .+...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence 479999999999999999999999999999999975321 223345678899999999999999999998 45567
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|+|||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999998 5999999988899999999999999999999999999999999999999999999999999987542211
Q ss_pred CC--------------------------------ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCC
Q 007177 176 PT--------------------------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 223 (614)
Q Consensus 176 ~~--------------------------------~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~ 223 (614)
.. .......+||+.|+|||++.+ ..|+.++|||||||++|||++|.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--CCCCCchhhhhhHHHHHHHHhCC
Confidence 00 001124589999999999977 67999999999999999999999
Q ss_pred CCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCC---CC
Q 007177 224 PLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD---RP 300 (614)
Q Consensus 224 ~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~---Rp 300 (614)
+||.+.+..+.+..+.... ....+.. ...+++++++||.+|+. +|.+ ||
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~--------------------------~~~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~ 285 (363)
T cd05628 234 PPFCSETPQETYKKVMNWK--------------------------ETLIFPP-EVPISEKAKDLILRFCC-EWEHRIGAP 285 (363)
T ss_pred CCCCCCCHHHHHHHHHcCc--------------------------CcccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCC
Confidence 9998887665555443210 0111111 12478899999999886 5554 58
Q ss_pred CHHHHHcCcccccC
Q 007177 301 TAEEALADPYFKGL 314 (614)
Q Consensus 301 sa~eiL~hp~f~~~ 314 (614)
+++|+++||||+++
T Consensus 286 ~~~ei~~hp~f~~~ 299 (363)
T cd05628 286 GVEEIKTNPFFEGV 299 (363)
T ss_pred CHHHHhCCCCCCCC
Confidence 99999999999865
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=381.10 Aligned_cols=327 Identities=40% Similarity=0.748 Sum_probs=262.9
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~-~~~~ 94 (614)
...+|.+.+.||+|+||.||+|++..+|+.||||++............+.+|+.+++.++||||+++++++.... ..+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 357899999999999999999999999999999999764433334556789999999999999999999885442 2234
Q ss_pred CcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 95 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 95 ~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
..+|+|+||+..+|...+. ..++++.+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 93 ~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~ 170 (342)
T cd07879 93 QDFYLVMPYMQTDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE 170 (342)
T ss_pred ceEEEEecccccCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence 5689999999988877652 36899999999999999999999999999999999999999999999999998754221
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
.....++.+|+|||.+.+. ..++.++|+|||||++|+|++|+.||.+.+....+..+....|.+..+.+....
T Consensus 171 ------~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 171 ------MTGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred ------CCCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 2345788999999988652 458899999999999999999999999999888899999988888877776665
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCCCCCccchhHHH
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFE 334 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~e 334 (614)
......+...........+...++..++.+.+||.+||+.||++||+++++|.||||+.+...+.++...+ +....+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~~---~~~~~~ 320 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQP---YDDSLE 320 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCCc---ccchhh
Confidence 54444444443333334445556778899999999999999999999999999999998876544443332 222334
Q ss_pred hhcCCHHHHHHHHHHHHHHh
Q 007177 335 RRRVTKEDIRELIFREILEY 354 (614)
Q Consensus 335 ~~~~~~e~~~~~~~~ei~~~ 354 (614)
......+++...+|+|...+
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~ 340 (342)
T cd07879 321 NEKLSVDEWKKHIYKEVKSF 340 (342)
T ss_pred hhhCCHHHHHHHhhhhhhcc
Confidence 44566678888888876544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=383.50 Aligned_cols=261 Identities=26% Similarity=0.477 Sum_probs=219.4
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence 479999999999999999999999999999999975322 223456788999999999999999999988 45567
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|||||||+ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999998 59999998888899999999999999999999999999999999999999999999999999976533
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+.+..+.......
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---------- 217 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL---------- 217 (333)
T ss_pred ----ccCCcccCccccChhHhcC--CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc----------
Confidence 1234579999999999987 589999999999999999999999998887665554442211000
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
..+ ........+++++.+||.+||..+|.+||+++++++||||.++
T Consensus 218 ------------~~~-~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 218 ------------QRP-VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred ------------cCC-CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 000 0011113578899999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=387.73 Aligned_cols=262 Identities=28% Similarity=0.452 Sum_probs=215.4
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++.+ .+...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence 47999999999999999999999999999999997432 1223445677899999999999999999998 45567
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|||||||. ++|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999987542211
Q ss_pred CCc-----------------------------------cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHH
Q 007177 176 PTT-----------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 220 (614)
Q Consensus 176 ~~~-----------------------------------~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLl 220 (614)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC--CCCCCeeeeecchhHHHHhh
Confidence 000 00112479999999999876 67999999999999999999
Q ss_pred hCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 007177 221 TGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP 300 (614)
Q Consensus 221 tG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp 300 (614)
+|.+||.+.+..+.+..+... .....+. ....+++.+++||.+||. ||.+|+
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~--------------------------~~~~~~~-~~~~~s~~~~~li~~ll~-~p~~R~ 285 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINW--------------------------KETLQFP-DEVPLSPEAKDLIKRLCC-EAERRL 285 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcC--------------------------CCccCCC-CCCCCCHHHHHHHHHHcc-CHhhcC
Confidence 999999887765544433211 0011111 112468899999999997 999999
Q ss_pred C---HHHHHcCcccccC
Q 007177 301 T---AEEALADPYFKGL 314 (614)
Q Consensus 301 s---a~eiL~hp~f~~~ 314 (614)
+ ++++|+||||++.
T Consensus 286 ~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 286 GNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHHHhcCCCcCCC
Confidence 8 9999999999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=369.99 Aligned_cols=302 Identities=33% Similarity=0.529 Sum_probs=249.0
Q ss_pred cccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCC-
Q 007177 11 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPP- 89 (614)
Q Consensus 11 ~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~- 89 (614)
+....+.+.|+-+..||+|.||.||+|+.+++|+.||+|++.-..++..--...++|+++|..|+|+|++.+++++...
T Consensus 10 ~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 10 EPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (376)
T ss_pred CCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence 3445778899999999999999999999999999999998753323333345568999999999999999999987543
Q ss_pred --CCCCCCcEEEEEecCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecC
Q 007177 90 --SRRDFKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFG 166 (614)
Q Consensus 90 --~~~~~~~~ylV~E~~~g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFG 166 (614)
...+...+|+||++|+.||.-++... .+++..+++.++.+++.||.|||.+.|+|||+|+.|+||+.+|.+||+|||
T Consensus 90 Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred CCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccc
Confidence 33445669999999999999999765 579999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC-CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCC
Q 007177 167 LARVAFNDT-PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 245 (614)
Q Consensus 167 la~~~~~~~-~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p 245 (614)
+++.+.... .....++..+.|.||++||++.+. ..|+++.|||..|||++||+++.+.|.+.++.+++..|..++|..
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 997654322 223346778999999999999884 789999999999999999999999999999999999999999999
Q ss_pred chhhhhhhhchhHHHHHHh--hcccCCCcccCCCC--CCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 246 SLDTISRVRNDKARRYLTS--MRKKQPVQFSQKFP--NADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 246 ~~~~i~~~~~~~~~~~l~~--~~~~~~~~~~~~~~--~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
+.+.|..+.+-.....++. +.+........... .-++++.||+.+||..||.+|++++++|+|.||..
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 9999988766544433321 11111111111111 22678999999999999999999999999999964
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=390.28 Aligned_cols=262 Identities=25% Similarity=0.392 Sum_probs=213.8
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
++|++++.||+|+||.||+|.++.+++.||||++.... ........+.+|+.+|+.++||||+++++.+ .+...
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~ 75 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDN 75 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCE
Confidence 46999999999999999999999999999999987532 1233456788999999999999999999998 45567
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999998 5999999888889999999999999999999999999999999999999999999999999975321000
Q ss_pred C--------------------------------------------CccccccccCCccccCcccccccCCCCCCcccchh
Q 007177 176 P--------------------------------------------TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 211 (614)
Q Consensus 176 ~--------------------------------------------~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWS 211 (614)
. ........+||+.|+|||++.+ ..|+.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwS 233 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC--CCCCCeeeEEe
Confidence 0 0000123579999999999987 68999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHh
Q 007177 212 IGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERL 291 (614)
Q Consensus 212 LG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~m 291 (614)
|||++|||++|++||.+.+..+....+.... ....+ .....+++++.+||.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~--------------------------~~~~~-p~~~~~s~~~~~li~~l 286 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQMKVINWQ--------------------------TSLHI-PPQAKLSPEASDLIIKL 286 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHHHHHccC--------------------------CCcCC-CCcccCCHHHHHHHHHH
Confidence 9999999999999998877554443332110 00001 11245789999999998
Q ss_pred cCCCCCCCCC---HHHHHcCcccccC
Q 007177 292 LAFDPKDRPT---AEEALADPYFKGL 314 (614)
Q Consensus 292 L~~DP~~Rps---a~eiL~hp~f~~~ 314 (614)
+ .||.+|++ ++++++||||+.+
T Consensus 287 ~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 287 C-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred c-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 7 49999997 9999999999865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=389.34 Aligned_cols=263 Identities=24% Similarity=0.375 Sum_probs=213.3
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
+.|++++.||+|+||.||+|.++.+++.||||++... .........+.+|+.+|+.++||||+++++.+ .+...
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~ 75 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDN 75 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCE
Confidence 3699999999999999999999999999999999753 22334556788999999999999999999998 45567
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++++||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999998 5999999888889999999999999999999999999999999999999999999999999975421100
Q ss_pred CC--------------------------------------------ccccccccCCccccCcccccccCCCCCCcccchh
Q 007177 176 PT--------------------------------------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 211 (614)
Q Consensus 176 ~~--------------------------------------------~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWS 211 (614)
.. .......+||+.|+|||++.+ ..|+.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwS 233 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--KGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC--CCCCCccceee
Confidence 00 000123579999999999876 67999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHh
Q 007177 212 IGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERL 291 (614)
Q Consensus 212 LG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~m 291 (614)
||||+|||++|.+||.+.+..+....+..... ... ......+++++.+||.+|
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~~i~~~~~--------------------------~~~-~~~~~~~s~~~~dli~~l 286 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQLKVINWEN--------------------------TLH-IPPQVKLSPEAVDLITKL 286 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHHHHHcccc--------------------------ccC-CCCCCCCCHHHHHHHHHH
Confidence 99999999999999988775544433321100 000 111235789999999997
Q ss_pred cCC--CCCCCCCHHHHHcCcccccC
Q 007177 292 LAF--DPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 292 L~~--DP~~Rpsa~eiL~hp~f~~~ 314 (614)
|.. ++..|++++++|+||||+++
T Consensus 287 l~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 287 CCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred ccCcccccCCCCHHHHhcCcccCCC
Confidence 655 44459999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=381.52 Aligned_cols=329 Identities=43% Similarity=0.763 Sum_probs=266.3
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~ 94 (614)
..++|++.+.||.|+||.||+|.+..+|+.+|+|++...+........+.+|+.+++.+ +||||+++++++.. .+.
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence 35689999999999999999999999999999999876544555566778999999999 99999999998743 223
Q ss_pred CcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 95 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 95 ~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
..+|+||||+.++|.+++... .+++...+.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 82 KDIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred ceEEEEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 468999999999999999776 7899999999999999999999999999999999999999999999999999865433
Q ss_pred CCC--ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 175 TPT--TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 175 ~~~--~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
... ......++++.+|+|||++.+. ..++.++|+|||||++|+|++|++||.+....+.+..+....+.+..+.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred cccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 211 1233456899999999987652 4678899999999999999999999999999999999999999988877776
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCCCCCccchhH
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFE 332 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~ 332 (614)
+........+..........+...++.++..+.+||.+||+.||.+|||+.++|+||||+++.....++.........+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLD 319 (337)
T ss_pred HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCccCCcc
Confidence 66555555555555555555666677789999999999999999999999999999999988665555443322222222
Q ss_pred HHhhcCCHHHHHHHHHHH
Q 007177 333 FERRRVTKEDIRELIFRE 350 (614)
Q Consensus 333 ~e~~~~~~e~~~~~~~~e 350 (614)
+.+++...+.+..+|+|
T Consensus 320 -~~~~~~~~~~~~~~~~~ 336 (337)
T cd07852 320 -DNVKLSVAEYRNKLYEE 336 (337)
T ss_pred -ccceeeHHHHHhhhhhc
Confidence 33444455555555544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=367.85 Aligned_cols=278 Identities=31% Similarity=0.494 Sum_probs=228.7
Q ss_pred CCccccccCCCCCCeEEE-eEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceee
Q 007177 6 PEMEFFSEYGDASRYKIQ-EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIK 83 (614)
Q Consensus 6 ~~~~~~~~~~~~~rY~i~-~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~ 83 (614)
+.|+| .++...++|.|. ++||-|-.|.|..|.++.|++++|+|++.+ ..+..+|+++.-.. .|||||.++
T Consensus 50 ~~m~~-k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~Ii 121 (400)
T KOG0604|consen 50 SDMDF-KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSII 121 (400)
T ss_pred hhcch-hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEee
Confidence 45666 788888899885 689999999999999999999999998864 34456788876555 599999999
Q ss_pred eEecCCCCCCCCcEEEEEecCC-CcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC---C
Q 007177 84 HIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD--LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---N 157 (614)
Q Consensus 84 ~v~~~~~~~~~~~~ylV~E~~~-g~L~~~i~~~~~--lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~---~ 157 (614)
++|. +++.+..++.||||.|+ |+|+..|+.++. |+|.++..|++||..||.|||+.+|.||||||+|+|... |
T Consensus 122 dVye-Ns~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~n 200 (400)
T KOG0604|consen 122 DVYE-NSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPN 200 (400)
T ss_pred hhhh-hhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCC
Confidence 9984 34566788999999999 599999998775 999999999999999999999999999999999999864 5
Q ss_pred CcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHH
Q 007177 158 CKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 237 (614)
Q Consensus 158 ~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~ 237 (614)
..+||+|||+|+.... ...+.+-+.|++|.|||+++. .+|+..+|+||||||+|-||+|.+||.......
T Consensus 201 a~lKLtDfGFAK~t~~----~~~L~TPc~TPyYvaPevlg~--eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---- 270 (400)
T KOG0604|consen 201 APLKLTDFGFAKETQE----PGDLMTPCFTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---- 270 (400)
T ss_pred cceEecccccccccCC----CccccCCcccccccCHHHhCc--hhcCCCCCccchhHHHHHhhcCCCcccccCCcc----
Confidence 6799999999986442 223456789999999999987 789999999999999999999999997654211
Q ss_pred HHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcc
Q 007177 238 MTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 317 (614)
Q Consensus 238 i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~ 317 (614)
.+..+-. .++........+.|..+|..++|||++||..+|.+|.|+++++.|||+.+...+
T Consensus 271 -------ispgMk~------------rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~v 331 (400)
T KOG0604|consen 271 -------ISPGMKR------------RIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAV 331 (400)
T ss_pred -------CChhHHh------------HhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccC
Confidence 1111111 122233334456788999999999999999999999999999999999987665
Q ss_pred cCCC
Q 007177 318 EREP 321 (614)
Q Consensus 318 ~~~~ 321 (614)
...+
T Consensus 332 p~tp 335 (400)
T KOG0604|consen 332 PQTP 335 (400)
T ss_pred CCCC
Confidence 4443
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=375.82 Aligned_cols=264 Identities=27% Similarity=0.429 Sum_probs=223.7
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
..+.|++++.||.|.-|+||+|..+.++..+|+|++.+.. .......+...|-+||..++||.+..||..+ +..
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~ 149 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETD 149 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----ecc
Confidence 3467889999999999999999999999999999998643 2344567788999999999999999999998 667
Q ss_pred CcEEEEEecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 95 KDIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
..+|+|||||. |||+.+.+.. +.|+++.+++++..++.||+|||-.|||+|||||+||||-++|+|.|.||.|+...
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 78999999999 5999998764 47999999999999999999999999999999999999999999999999998432
Q ss_pred cC----------------------------------CC-------------------CCccccccccCCccccCcccccc
Q 007177 172 FN----------------------------------DT-------------------PTTIFWTDYVATRWYRAPELCGS 198 (614)
Q Consensus 172 ~~----------------------------------~~-------------------~~~~~~~~~vgt~~Y~APEvl~~ 198 (614)
.. .. ++......+|||-.|+|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 10 00 00011233699999999999998
Q ss_pred cCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCC
Q 007177 199 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFP 278 (614)
Q Consensus 199 ~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 278 (614)
...+.++|+|+||++|||||.|..||.|.+..+.+..|.. ++..|... +
T Consensus 310 --~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~----------------------------~~l~Fp~~-~ 358 (459)
T KOG0610|consen 310 --EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG----------------------------QPLKFPEE-P 358 (459)
T ss_pred --CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc----------------------------CCCcCCCC-C
Confidence 6889999999999999999999999999998777766632 12222222 3
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCC----HHHHHcCcccccCC
Q 007177 279 NADPSALRLLERLLAFDPKDRPT----AEEALADPYFKGLS 315 (614)
Q Consensus 279 ~~s~~l~dLI~~mL~~DP~~Rps----a~eiL~hp~f~~~~ 315 (614)
.++..++|||+++|.+||.+|.. |.||-+||||+++.
T Consensus 359 ~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVn 399 (459)
T KOG0610|consen 359 EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVN 399 (459)
T ss_pred cchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCC
Confidence 67789999999999999999998 99999999999863
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=389.23 Aligned_cols=262 Identities=26% Similarity=0.422 Sum_probs=213.4
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
++|.+++.||+|+||.||+|.++.+++.||||++.+.. ........+.+|+.+|+.++||||+++++.+ .+...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCe
Confidence 37999999999999999999999999999999986431 1223456778999999999999999999998 45567
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|||||||. ++|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999996321110
Q ss_pred CC------------c--------------------------------cccccccCCccccCcccccccCCCCCCcccchh
Q 007177 176 PT------------T--------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 211 (614)
Q Consensus 176 ~~------------~--------------------------------~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWS 211 (614)
.. . ......+||+.|+|||++.+ ..|+.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwS 233 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ--QGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc--CCCCCceeeEe
Confidence 00 0 00012479999999999876 67999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHh
Q 007177 212 IGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERL 291 (614)
Q Consensus 212 LG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~m 291 (614)
|||++|||++|.+||.+.+..+.+..+.... ....+ .....++.++.+||.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~--------------------------~~~~~-p~~~~~s~~~~dli~~l 286 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIINWR--------------------------ETLYF-PDDIHLSVEAEDLIRRL 286 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHccC--------------------------CccCC-CCCCCCCHHHHHHHHHH
Confidence 9999999999999998877655554443210 00111 11224688999999999
Q ss_pred cCCCCCCC---CCHHHHHcCcccccC
Q 007177 292 LAFDPKDR---PTAEEALADPYFKGL 314 (614)
Q Consensus 292 L~~DP~~R---psa~eiL~hp~f~~~ 314 (614)
|. +|.+| +++.|+|.||||++.
T Consensus 287 L~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 287 IT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 98 77765 599999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=371.38 Aligned_cols=259 Identities=25% Similarity=0.383 Sum_probs=211.6
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
.|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+|+.++|+||+.+++.+ .+.+.+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence 38899999999999999999999999999999874322 222334577999999999999999999988 445679
Q ss_pred EEEEecCC-CcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 98 YVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
|+|||||. ++|.+.+.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999998 589887754 336899999999999999999999999999999999999999999999999999764322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
. .....+||..|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 156 ~----~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~------------- 216 (285)
T cd05631 156 E----TVRGRVGTVGYMAPEVINN--EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR------------- 216 (285)
T ss_pred C----eecCCCCCCCccCHhhhcC--CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH-------------
Confidence 1 1234579999999999987 68999999999999999999999999876643222222110
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccCC
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGLS 315 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~eiL~hp~f~~~~ 315 (614)
+. . ........+++.+.+||++||+.||.+||+ ++++++||||.++.
T Consensus 217 ----------~~-~---~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 217 ----------VK-E---DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred ----------hh-c---ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 00 0 011223457889999999999999999997 89999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=384.36 Aligned_cols=262 Identities=31% Similarity=0.502 Sum_probs=218.0
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
++|.+++.||+|+||.||+|.+..+|+.||||+++.... .......+.+|+.+|..++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence 479999999999999999999999999999999975322 223456678999999999999999999988 45567
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999998 5999999888889999999999999999999999999999999999999999999999999997654332
Q ss_pred C--------------------------CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 007177 176 P--------------------------TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 229 (614)
Q Consensus 176 ~--------------------------~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~ 229 (614)
. ........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--TPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcC--CCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 0 0011234579999999999987 58999999999999999999999999888
Q ss_pred ChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC-HHHHHcC
Q 007177 230 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-AEEALAD 308 (614)
Q Consensus 230 ~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-a~eiL~h 308 (614)
+.......+..... ...+ .....+++.+.+||.+||. ||.+|++ ++++|+|
T Consensus 234 ~~~~~~~~i~~~~~--------------------------~~~~-p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETYNKIINWKE--------------------------SLRF-PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHHHHHhccCC--------------------------cccC-CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 75554444422100 0011 1112378999999999998 9999999 9999999
Q ss_pred cccccC
Q 007177 309 PYFKGL 314 (614)
Q Consensus 309 p~f~~~ 314 (614)
|||+++
T Consensus 286 p~~~~~ 291 (350)
T cd05573 286 PFFKGI 291 (350)
T ss_pred CCcCCC
Confidence 999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=367.34 Aligned_cols=282 Identities=38% Similarity=0.625 Sum_probs=229.4
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
.|++++.||.|++|.||+|.+..++..||||++............+.+|+.+++.++||||+++++++ .+...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVL-----MQESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEE-----eeCCeEE
Confidence 48999999999999999999999999999999875433333446678999999999999999999998 3456799
Q ss_pred EEEecCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 99 VVFELMESDLHQVIKAN---DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 99 lV~E~~~g~L~~~i~~~---~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+||||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred EEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 99999999998888643 468999999999999999999999999999999999999999999999999997543221
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
.......+++.|+|||++.+. ..++.++|+|||||++|+|++|++||.+.+..+.+..+...++.+....+.....
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 ---RVYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred ---ccccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 112334678999999988652 4578899999999999999999999999988888888888888776655543322
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
. ..+...........+......+++++.+||++||..||.+|||+.++|+||||
T Consensus 232 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 L--PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred h--HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 1 11211121212222233445689999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=387.86 Aligned_cols=262 Identities=26% Similarity=0.385 Sum_probs=213.9
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
++|++++.||+|+||.||+|.++.+++.||||++.+.. ........+.+|+.+|+.++||||+++++.+ .+.+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCE
Confidence 47999999999999999999999999999999986431 1223456678999999999999999999998 45568
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|+|||||+ ++|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999985321000
Q ss_pred C----------------------------------------CccccccccCCccccCcccccccCCCCCCcccchhHHHH
Q 007177 176 P----------------------------------------TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 215 (614)
Q Consensus 176 ~----------------------------------------~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~I 215 (614)
. ........+||+.|+|||++.+ ..++.++|||||||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvi 233 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC--CCCCcceeeeeccce
Confidence 0 0000123579999999999987 678999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCC
Q 007177 216 FAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 295 (614)
Q Consensus 216 l~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~D 295 (614)
+|+|++|+.||.+.+..+....+.... .... ......+++.+.+||.+|+ .|
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~~--------------------------~~~~-~~~~~~~s~~~~~li~~l~-~~ 285 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINWE--------------------------TTLH-IPSQAKLSREASDLILRLC-CG 285 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhccC--------------------------cccc-CCCCCCCCHHHHHHHHHHh-cC
Confidence 999999999998877654443332110 0000 1123467899999999987 49
Q ss_pred CCCCC---CHHHHHcCcccccC
Q 007177 296 PKDRP---TAEEALADPYFKGL 314 (614)
Q Consensus 296 P~~Rp---sa~eiL~hp~f~~~ 314 (614)
|.+|+ +++++|+||||+++
T Consensus 286 p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 286 AEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred HhhcCCCCCHHHHhCCCCcCCC
Confidence 99999 99999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=370.69 Aligned_cols=282 Identities=37% Similarity=0.596 Sum_probs=227.1
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
+|++.+.||+|+||.||+|.+..+|+.||+|.++...........+.+|+.+++.++||||+++++++ .+...+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence 69999999999999999999999999999999875322223335677899999999999999999988 4556799
Q ss_pred EEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007177 99 VVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 177 (614)
Q Consensus 99 lV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 177 (614)
+|+||++++|.+.+.. .+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++.......
T Consensus 76 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 76 LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 9999999999888865 56799999999999999999999999999999999999999999999999999976432211
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCC-CCCCChhHHHHHHHhhhCCCchhhhhhhhch
Q 007177 178 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256 (614)
Q Consensus 178 ~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~p-F~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~ 256 (614)
......++..|+|||++.+. ..++.++|||||||++|+|++|..| |.+.+..+.+..+...++.+....+......
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred --CcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 12345678999999988652 4578999999999999999998766 6777778888888888888876655433211
Q ss_pred hHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 257 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
....... .......+.+..+.+++.+.+||.+||..||.+|||++++|.||||
T Consensus 232 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 232 PDYKPYP--MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccccC--CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 1000000 0011112233456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=377.26 Aligned_cols=248 Identities=32% Similarity=0.500 Sum_probs=208.8
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecC
Q 007177 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM 104 (614)
Q Consensus 26 LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~ 104 (614)
||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+|+.++||||+++++.+ .+...+|+|||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence 799999999999999999999999987432 2334556788999999999999999999988 4556799999999
Q ss_pred C-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCcccccc
Q 007177 105 E-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD 183 (614)
Q Consensus 105 ~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~ 183 (614)
. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... ....
T Consensus 76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~ 152 (312)
T cd05585 76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNT 152 (312)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC---cccc
Confidence 8 59999998888899999999999999999999999999999999999999999999999999975432221 1234
Q ss_pred ccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHH
Q 007177 184 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLT 263 (614)
Q Consensus 184 ~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~ 263 (614)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 153 ~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~----------------------- 207 (312)
T cd05585 153 FCGTPEYLAPELLLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ----------------------- 207 (312)
T ss_pred ccCCcccCCHHHHcC--CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc-----------------------
Confidence 679999999999987 6799999999999999999999999988765443332211
Q ss_pred hhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC---CHHHHHcCcccccC
Q 007177 264 SMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP---TAEEALADPYFKGL 314 (614)
Q Consensus 264 ~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp---sa~eiL~hp~f~~~ 314 (614)
.+. .....+++.+.+||.+||..||.+|| ++.++|.||||...
T Consensus 208 -----~~~---~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 208 -----EPL---RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred -----CCC---CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 011 12245788999999999999999997 58999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=381.72 Aligned_cols=256 Identities=24% Similarity=0.383 Sum_probs=215.3
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCC-cEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTG-EKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg-~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
...++|++.+.||+|+||.||+|.++.++ ..||+|++.... ........+.+|+.+|+.++||||+++++++ .
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~ 101 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----K 101 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----E
Confidence 34568999999999999999999877665 689999986432 2233456788999999999999999999998 4
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
+...+|+|||||. |+|.+++..+..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 102 ~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 102 DESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 5567999999997 699999998889999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+..
T Consensus 182 ~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~----------- 242 (340)
T PTZ00426 182 DTR------TYTLCGTPEYIAPEILLN--VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE----------- 242 (340)
T ss_pred CCC------cceecCChhhcCHHHHhC--CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc-----------
Confidence 321 134579999999999976 6789999999999999999999999988765444333311
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 314 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~ 314 (614)
. .. ...+.+++.+.+||++||+.||.+|+ +++++++||||.++
T Consensus 243 ----------------~-~~---~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 243 ----------------G-II---YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred ----------------C-CC---CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 0 01 11234678999999999999999995 89999999999875
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=377.45 Aligned_cols=250 Identities=25% Similarity=0.460 Sum_probs=209.8
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEe
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 102 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E 102 (614)
+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++.+ .+...+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 47999999999999999999999999997532 2234556788999999999999999999988 45567999999
Q ss_pred cCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCcccc
Q 007177 103 LME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 181 (614)
Q Consensus 103 ~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~ 181 (614)
|++ ++|...+.....+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~---~~ 152 (328)
T cd05593 76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---TM 152 (328)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc---cc
Confidence 998 59999998888899999999999999999999999999999999999999999999999999875332211 12
Q ss_pred ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHH
Q 007177 182 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRY 261 (614)
Q Consensus 182 ~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~ 261 (614)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--------------------- 209 (328)
T cd05593 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------------- 209 (328)
T ss_pred ccccCCcCccChhhhcC--CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc---------------------
Confidence 34679999999999976 6789999999999999999999999987765443332210
Q ss_pred HHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 007177 262 LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 314 (614)
Q Consensus 262 l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~ 314 (614)
... .....+++.+.+||++||..||++|+ ++.++++||||.+.
T Consensus 210 -------~~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 210 -------EDI---KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred -------CCc---cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 001 11235788999999999999999997 89999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=380.89 Aligned_cols=260 Identities=28% Similarity=0.493 Sum_probs=229.8
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
.+++-|.+.+.||+|.|.+|-+|++.-||+.||||+|.+..........++.|+..|+.++|||||++|++. ...
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQ 89 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQ 89 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----ccc
Confidence 456789999999999999999999999999999999998766666777899999999999999999999998 556
Q ss_pred CcEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEE-CCCCcEEEeecCccccc
Q 007177 95 KDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA-NANCKLKICDFGLARVA 171 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi-~~~~~vKL~DFGla~~~ 171 (614)
..+|||+|+-+ |||+++|.++ ..+.|+.++.++.||+.|+.|+|+..+|||||||+|+++ ..-|-|||.|||++..+
T Consensus 90 TKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 90 TKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred ceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 77999999998 5999999765 479999999999999999999999999999999999865 66789999999999765
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCC-CcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~-~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
... ..+++.||+..|-|||++.+ ..|+ +++||||||+|||.|++|++||...++.+.+.+|++.-.+
T Consensus 170 ~PG----~kL~TsCGSLAYSAPEILLG--DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt------ 237 (864)
T KOG4717|consen 170 QPG----KKLTTSCGSLAYSAPEILLG--DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT------ 237 (864)
T ss_pred CCc----chhhcccchhhccCchhhhc--CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc------
Confidence 433 23578899999999999988 4554 7899999999999999999999999999999888763221
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
....++.+++|||..||..||++|.+.++|..|+|++....
T Consensus 238 -------------------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 238 -------------------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred -------------------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 12357889999999999999999999999999999997754
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=371.76 Aligned_cols=321 Identities=47% Similarity=0.856 Sum_probs=266.3
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
+...++|++++.||.|+||.||+|.++.+++.||||++............+.+|+.+++.++||||+++.+++.. .
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~ 81 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS----P 81 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec----C
Confidence 456788999999999999999999999999999999987544444455678899999999999999999998843 2
Q ss_pred CCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 94 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 94 ~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
....|+|+||++++|.++++. ..+++..+..++.||+.||.|||+.||+||||+|+|||++.++.+||+|||++.....
T Consensus 82 ~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 82 LEDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred CCcEEEEeehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 356899999999999888864 4589999999999999999999999999999999999999999999999999875322
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
. .....++..|+|||.+.+. ..++.++|+|||||++|+|++|++||++.+.......+.+.+|.+..+.+...
T Consensus 161 ~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 161 Q------MTGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred C------cCCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 1 1345678899999987542 46889999999999999999999999999988888889999999988887766
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCCCCCccchhHH
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEF 333 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 333 (614)
......+++.......+.+.....+.+++.+.+||.+||+.||++|||++++|.||||........++... .+++|.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~~--~~~~~~~ 311 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVAE--EKFDWSF 311 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCch--hhcCCch
Confidence 66555556655555556666666778899999999999999999999999999999998776654443322 2566777
Q ss_pred HhhcCCHHHHHHHHH
Q 007177 334 ERRRVTKEDIRELIF 348 (614)
Q Consensus 334 e~~~~~~e~~~~~~~ 348 (614)
+...+..+.|+-++|
T Consensus 312 ~~~~~~~~~~~~~~~ 326 (328)
T cd07856 312 NDADLPVDTWKVMMY 326 (328)
T ss_pred hcccCCHHHHHHHhc
Confidence 777777777765554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=375.33 Aligned_cols=250 Identities=26% Similarity=0.462 Sum_probs=210.0
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEe
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 102 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E 102 (614)
+.||+|+||.||+|.++.+|..||+|++..... .......+.+|+.+|+.++||||+++++.+ .+...+|||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence 479999999999999999999999999975322 233456677899999999999999999988 44567999999
Q ss_pred cCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCcccc
Q 007177 103 LME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 181 (614)
Q Consensus 103 ~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~ 181 (614)
||+ ++|...+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~ 152 (323)
T cd05595 76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC---cc
Confidence 998 59999998888899999999999999999999999999999999999999999999999999875322221 12
Q ss_pred ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHH
Q 007177 182 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRY 261 (614)
Q Consensus 182 ~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~ 261 (614)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~--------------------- 209 (323)
T cd05595 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------------------- 209 (323)
T ss_pred ccccCCcCcCCcccccC--CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------------
Confidence 34679999999999876 6789999999999999999999999987765444333311
Q ss_pred HHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 007177 262 LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 314 (614)
Q Consensus 262 l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~ 314 (614)
. .. .....+++.+.+||.+||..||++|+ ++.++|+||||.+.
T Consensus 210 -----~--~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 210 -----E--EI---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred -----C--CC---CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 0 00 11235788999999999999999998 99999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=369.47 Aligned_cols=295 Identities=41% Similarity=0.626 Sum_probs=235.3
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
...++|++.+.||.|+||.||+|.++.+|+.||+|+++...........+.+|+.+|+.++|+||+++++++... ..
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HL 80 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CC
Confidence 346789999999999999999999999999999999874333322234566899999999999999999998532 23
Q ss_pred CcEEEEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 95 KDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 95 ~~~ylV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
..+|+||||++++|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 81 DSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred CeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 56899999999999888875 35799999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
... ..+...++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+...++.+....+..+
T Consensus 161 ~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 161 PAK---PMTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred ccC---CCCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 221 12334568889999988652 46889999999999999999999999999999999999999998876665433
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcc
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 317 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~ 317 (614)
..-.....+. ........+...+...++.+.+||.+||.+||++|||++++|.||||++....
T Consensus 237 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 237 SDLPLVGKFT-LPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred hccccccccc-ccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 2211000000 00111112222344568899999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=376.45 Aligned_cols=262 Identities=24% Similarity=0.417 Sum_probs=215.6
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
++|++.+.||+|+||.||+|.++.+|+.||||+++.... .......+.+|+.+++.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence 479999999999999999999999999999999975422 223455677899999999999999999988 45567
Q ss_pred EEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 97 IYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
+|+|||||+ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999997 6999999876 67999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCccccccccCCccccCccccccc----CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~----~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
... .....+||+.|+|||++... ...++.++||||||||+|+|++|..||.+.+....+..+...
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--------- 224 (330)
T cd05601 156 KMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--------- 224 (330)
T ss_pred Cce--eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC---------
Confidence 221 12335799999999998631 146789999999999999999999999887765544443221
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
.....+ ...+.+++.+.+||.+||. ||.+|||++++++||||..+
T Consensus 225 -----------------~~~~~~-~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 225 -----------------QRFLKF-PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred -----------------CCccCC-CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 000111 1224578999999999998 99999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=380.07 Aligned_cols=262 Identities=27% Similarity=0.418 Sum_probs=214.9
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
+.|++++.||+|+||.||+|.++.+++.||||++.... ........+.+|+.+|..++||||+++++.+ .+...
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 46999999999999999999999999999999997432 1223456778899999999999999999988 45677
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|+|||||. ++|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999998 5999999888889999999999999999999999999999999999999999999999999987542211
Q ss_pred CC--------------------------------ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCC
Q 007177 176 PT--------------------------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 223 (614)
Q Consensus 176 ~~--------------------------------~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~ 223 (614)
.. .......+||+.|+|||++.+ ..|+.++|||||||++|||++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--CCCCCcceeccccceeeecccCC
Confidence 00 000123579999999999987 68999999999999999999999
Q ss_pred CCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC---
Q 007177 224 PLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP--- 300 (614)
Q Consensus 224 ~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp--- 300 (614)
+||.+.+..+.+..+... .....+.. ...+++.+++||.+|+. ||.+|+
T Consensus 234 ~Pf~~~~~~~~~~~i~~~--------------------------~~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~ 285 (360)
T cd05627 234 PPFCSETPQETYRKVMNW--------------------------KETLVFPP-EVPISEKAKDLILRFCT-DSENRIGSN 285 (360)
T ss_pred CCCCCCCHHHHHHHHHcC--------------------------CCceecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCC
Confidence 999887765554443211 00111111 12468899999999875 999998
Q ss_pred CHHHHHcCcccccC
Q 007177 301 TAEEALADPYFKGL 314 (614)
Q Consensus 301 sa~eiL~hp~f~~~ 314 (614)
+++++++||||+++
T Consensus 286 ~~~ei~~hp~f~~~ 299 (360)
T cd05627 286 GVEEIKSHPFFEGV 299 (360)
T ss_pred CHHHHhcCCCCCCC
Confidence 58999999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=373.71 Aligned_cols=261 Identities=25% Similarity=0.414 Sum_probs=209.9
Q ss_pred CeEEEeEeeecCceEEEEEEEC---CCCcEEEEEEecCcc--CChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCC
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIF--EHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~---~tg~~vAIK~i~~~~--~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~ 92 (614)
+|++++.||+|+||.||+|.+. .+++.||+|++.+.. ........+.+|+.+|+.++ ||||+.+++++ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence 4899999999999999998764 578999999987432 12234556788999999995 99999999988 4
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
+...+|+|||||. ++|.+.+.....++++.++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 5567999999998 599999988888999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
...... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||...........+.
T Consensus 156 ~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~------------ 220 (332)
T cd05614 156 LSEEKE--RTYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS------------ 220 (332)
T ss_pred cccCCC--ccccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH------------
Confidence 332221 12346799999999998752 357889999999999999999999997543221111110
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 314 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~ 314 (614)
..+....+ .....+++.+.+||.+||+.||++|| +++++|+||||++.
T Consensus 221 -----------~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 221 -----------RRILKCDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred -----------HHHhcCCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 00001110 12235788999999999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=369.11 Aligned_cols=281 Identities=35% Similarity=0.595 Sum_probs=215.0
Q ss_pred EeEeeecCceEEEEEEECC--CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEE
Q 007177 23 QEVIGKGSYGVVCSAIDTH--TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVV 100 (614)
Q Consensus 23 ~~~LG~G~~G~V~~a~d~~--tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV 100 (614)
...||+|+||.||+|.++. ++..||+|.+.... ....+.+|+.+|+.++||||+++++++... ....+|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEE
Confidence 4689999999999998654 66889999987532 223567899999999999999999988543 34578999
Q ss_pred EecCCCcHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEE----CCCCcEEEeecCc
Q 007177 101 FELMESDLHQVIKAN---------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA----NANCKLKICDFGL 167 (614)
Q Consensus 101 ~E~~~g~L~~~i~~~---------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi----~~~~~vKL~DFGl 167 (614)
|||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 79 FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 999999998887532 248899999999999999999999999999999999999 5667899999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCh---------hHHHHHH
Q 007177 168 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV---------VHQLDLM 238 (614)
Q Consensus 168 a~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~---------~~~l~~i 238 (614)
++...............++|+.|+|||++.+. ..++.++|||||||++|||++|.+||.+... ..++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 98754333222223456789999999988652 4688999999999999999999999976542 3567888
Q ss_pred HhhhCCCchhhhhhhhchhHH-HHHHhhccc--CCC----cccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 239 TDLLGTPSLDTISRVRNDKAR-RYLTSMRKK--QPV----QFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 239 ~~~~g~p~~~~i~~~~~~~~~-~~l~~~~~~--~~~----~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
...+|.+..+.+..+...... ......... ... .........+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 888888877776554321100 000000000 000 0011112356789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=371.96 Aligned_cols=255 Identities=24% Similarity=0.409 Sum_probs=212.9
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCC-CcceeeeEecCCCCCCCCc
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHP-DIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~Hp-nIv~l~~v~~~~~~~~~~~ 96 (614)
+|++++.||+|+||.||+|.++.+++.||||++..... .......+..|+.++..+.|+ +|+.+++++ .+...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence 48999999999999999999999999999999975322 234556778899999999765 578888887 44567
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|+|||||+ ++|.+.+.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999987532211
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-------------- 216 (324)
T cd05587 156 K---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH-------------- 216 (324)
T ss_pred C---ceeeecCCccccChhhhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------
Confidence 1 1234579999999999987 67899999999999999999999999887765554443210
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHHcCcccccC
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA-----EEALADPYFKGL 314 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa-----~eiL~hp~f~~~ 314 (614)
.. .....+++.+.+||.+||..||.+|++. +++++||||..+
T Consensus 217 --------------~~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 217 --------------NV---SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred --------------CC---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 00 1123578899999999999999999976 899999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=361.60 Aligned_cols=285 Identities=41% Similarity=0.705 Sum_probs=234.6
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
+|++.+.||.|+||.||+|.+..+|..||+|++............+.+|+.+++.++||||+++++++ .+...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence 69999999999999999999999999999999876443344556788999999999999999999998 3456799
Q ss_pred EEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007177 99 VVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 177 (614)
Q Consensus 99 lV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 177 (614)
+||||+.++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 76 ~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 76 LVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9999997799999865 45699999999999999999999999999999999999999999999999999986543322
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchh
Q 007177 178 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257 (614)
Q Consensus 178 ~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~ 257 (614)
.......++.+|+|||.+.+. ..++.++|||||||++|+|++|.++|.+.+....+..+...++.|....+.......
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred -CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 112345789999999988652 457899999999999999999999999999999999999988888776655432211
Q ss_pred HHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 007177 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312 (614)
Q Consensus 258 ~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~ 312 (614)
.... ..........+...+++.+..+.+||++||..||.+|||++++|+||||.
T Consensus 233 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 233 DYNK-ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhhc-ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0000 00111222233445567889999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=373.46 Aligned_cols=250 Identities=25% Similarity=0.429 Sum_probs=209.5
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCcEEEEE
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~~~ylV~ 101 (614)
+.||+|+||.||+|.++.+++.||||++.+.. ........+.+|+.++..+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 47999999999999999999999999987532 2233456677899998876 699999999998 4556799999
Q ss_pred ecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007177 102 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 180 (614)
Q Consensus 102 E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 180 (614)
|||+ ++|.+.+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~---~ 152 (320)
T cd05590 76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK---T 152 (320)
T ss_pred cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHH
Q 007177 181 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260 (614)
Q Consensus 181 ~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~ 260 (614)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~-------------------- 210 (320)
T cd05590 153 TSTFCGTPDYIAPEILQE--MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-------------------- 210 (320)
T ss_pred ccccccCccccCHHHHcC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc--------------------
Confidence 234579999999999886 6789999999999999999999999988876555444321
Q ss_pred HHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCH------HHHHcCcccccC
Q 007177 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA------EEALADPYFKGL 314 (614)
Q Consensus 261 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa------~eiL~hp~f~~~ 314 (614)
. .. .....+++++.+||.+||+.||.+|+++ +++++||||+.+
T Consensus 211 -------~-~~---~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 211 -------D-EV---VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred -------C-CC---CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 0 00 0112468899999999999999999998 999999999865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=361.61 Aligned_cols=282 Identities=39% Similarity=0.639 Sum_probs=229.9
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
.|++++.||.|++|.||+|.++.+|..||||++............+.+|+.+++.++||||+++++++ .+....|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence 48999999999999999999999999999999875433333445788999999999999999999987 4556799
Q ss_pred EEEecCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 99 VVFELMESDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 99 lV~E~~~g~L~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
+||||+.++|..++.. ...+++..++.++.||+.||+|||+.|++||||+|+||+++.++.+||+|||++........
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 9999999899888865 35689999999999999999999999999999999999999999999999999876432211
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhch
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~ 256 (614)
......++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+....+......
T Consensus 156 ---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 156 ---TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred ---ccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 12334678899999988652 44688999999999999999999999999998888889888888876554432221
Q ss_pred hHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 257 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
..+...........+....+.+++.+++||.+||+.||.+|||++++|+||||
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 232 --PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred --HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 11111122222222333345688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=374.79 Aligned_cols=250 Identities=27% Similarity=0.474 Sum_probs=209.3
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEe
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 102 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E 102 (614)
+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++.+ .+...+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 47999999999999999999999999997532 2233456678899999999999999999988 45567999999
Q ss_pred cCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007177 103 LME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 180 (614)
Q Consensus 103 ~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 180 (614)
|++ ++|...+.....+++..++.|+.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (325)
T cd05594 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---T 152 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---c
Confidence 998 5899999888889999999999999999999997 7999999999999999999999999999875332221 1
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHH
Q 007177 181 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260 (614)
Q Consensus 181 ~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~ 260 (614)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~-------------------- 210 (325)
T cd05594 153 MKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-------------------- 210 (325)
T ss_pred cccccCCcccCCHHHHcc--CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc--------------------
Confidence 234579999999999976 6789999999999999999999999988765444333210
Q ss_pred HHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 007177 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 314 (614)
Q Consensus 261 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~ 314 (614)
.... ....+++.+.+||++||+.||++|+ ++.++|+||||.++
T Consensus 211 --------~~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 211 --------EEIR---FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred --------CCCC---CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 0001 1134688999999999999999997 99999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=378.83 Aligned_cols=263 Identities=26% Similarity=0.381 Sum_probs=215.3
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
..++|++.+.||+|+||.||+|.++.+++.||+|++.+.. ........+.+|+.+|+.++||||+++++.+ .+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 4568999999999999999999999999999999996431 2223445577899999999999999999988 455
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
..+|+|||||+ |+|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 67999999998 5999988654 589999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCccccccccCCccccCccccccc--CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~--~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
... ......+||+.|+|||++.+. ...++.++|||||||++|||++|.+||.+.+....+..|..
T Consensus 195 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~----------- 261 (370)
T cd05596 195 NGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD----------- 261 (370)
T ss_pred CCc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHc-----------
Confidence 211 112346799999999998642 13488999999999999999999999988876554444321
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCC--CCCHHHHHcCccccc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD--RPTAEEALADPYFKG 313 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~--Rpsa~eiL~hp~f~~ 313 (614)
......+ .....++.++++||.+||..+|.+ |+|++++|+||||++
T Consensus 262 ---------------~~~~~~~-~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 262 ---------------HKNSLTF-PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred ---------------CCCcCCC-CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 0111111 122357899999999999999988 999999999999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=369.22 Aligned_cols=279 Identities=24% Similarity=0.387 Sum_probs=218.4
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|++++.||+|+||.||+|.+..++..||+|.+.... .......+.+|+++|+.++||||+++++++ .+...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~ 77 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGE 77 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECCE
Confidence 468999999999999999999999999999999987532 334456788999999999999999999998 34567
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
+|+||||++ ++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999 59999998888899999999999999999999986 6999999999999999999999999999765322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh--
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR-- 252 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~-- 252 (614)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+... .++.+..+....
T Consensus 158 ~-----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~----~~~~~~~~~~~~~~ 226 (331)
T cd06649 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA----IFGRPVVDGEEGEP 226 (331)
T ss_pred c-----cccCCCCcCcCCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HhcccccccccCCc
Confidence 1 234579999999999987 679999999999999999999999998766543322 222221110000
Q ss_pred ---------------------hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 253 ---------------------VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 253 ---------------------~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
.........+..+........ ....+++++++||.+||.+||++|||++++|+||||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 227 HSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKL--PNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cccCcccccccccccccccccccchhHHHHHHHHHhCCCcCC--CCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 000001111111111111110 112467899999999999999999999999999999
Q ss_pred ccC
Q 007177 312 KGL 314 (614)
Q Consensus 312 ~~~ 314 (614)
+..
T Consensus 305 ~~~ 307 (331)
T cd06649 305 KRS 307 (331)
T ss_pred hhc
Confidence 853
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=370.83 Aligned_cols=253 Identities=26% Similarity=0.442 Sum_probs=208.9
Q ss_pred eEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHH---HhcCCCCcceeeeEecCCCCCCCC
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLL---RLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL---~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
|++++.||+|+||.||+|.+..+++.||||+++... ........+.+|+.++ +.++||||+++++++ .+..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence 789999999999999999999999999999997532 1223445667777665 456799999999998 4556
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
.+|+|||||+ ++|...+.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 7999999999 588887754 46999999999999999999999999999999999999999999999999998753322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
.. .....+|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 155 ~~---~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~-------------- 215 (324)
T cd05589 155 GD---RTSTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-------------- 215 (324)
T ss_pred CC---cccccccCccccCHhHhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------
Confidence 21 1234679999999999887 6789999999999999999999999988776555443321
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 314 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~ 314 (614)
... .....+++.+.+||.+||+.||.+|| +++++++||||+++
T Consensus 216 -------------~~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 216 -------------DEV----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred -------------CCC----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 000 11235688999999999999999999 79999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=379.16 Aligned_cols=263 Identities=26% Similarity=0.387 Sum_probs=213.8
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
..++|++.+.||+|+||.||+|.++.+++.||+|++.+.. ........+.+|+.+++.++||||+++++.+ .+.
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDD 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence 3468999999999999999999999999999999986421 2233455677999999999999999999998 455
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
..+|+|||||. |+|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 77999999998 6999988654 589999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCccccccccCCccccCcccccccC--CCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~--~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
... ......+||+.|+|||++.+.. ..++.++|||||||++|+|++|.+||.+.+....+..|....
T Consensus 195 ~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~--------- 263 (370)
T cd05621 195 TGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK--------- 263 (370)
T ss_pred CCc--eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------
Confidence 211 1123567999999999986521 237899999999999999999999998887655544442211
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCC--CCCHHHHHcCccccc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD--RPTAEEALADPYFKG 313 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~--Rpsa~eiL~hp~f~~ 313 (614)
....+. ....++..+++||.+||..++.+ |++++|+|+||||+.
T Consensus 264 -----------------~~~~~p-~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 264 -----------------NSLNFP-EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred -----------------cccCCC-CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 111111 12356889999999999866544 899999999999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=370.18 Aligned_cols=264 Identities=25% Similarity=0.436 Sum_probs=214.2
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
++|++++.||+|+||.||++.++.+++.||||++.+. .........+.+|+.+++.++|+||+.+++++ .+...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence 4799999999999999999999999999999998742 12233455678899999999999999999998 45567
Q ss_pred EEEEEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 97 IYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999997 699999976 457999999999999999999999999999999999999999999999999998764332
Q ss_pred CCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~---~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
... .....+||+.|+|||++... ...++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~----------- 222 (331)
T cd05597 156 GTV--QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN----------- 222 (331)
T ss_pred CCc--cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHc-----------
Confidence 211 11234699999999998631 14578899999999999999999999988776555444321
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCC--CCCHHHHHcCcccccC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD--RPTAEEALADPYFKGL 314 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~--Rpsa~eiL~hp~f~~~ 314 (614)
......+....+.+++.+++||++||..++++ |++++++|+||||.++
T Consensus 223 ---------------~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 223 ---------------HKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred ---------------CCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 11112223334558899999999999765554 7899999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=371.02 Aligned_cols=250 Identities=26% Similarity=0.425 Sum_probs=209.8
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCcEEEEE
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~~~ylV~ 101 (614)
+.||+|+||.||+|.++.+++.||||++.... ........+..|..++..+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence 46999999999999999999999999987532 2233455677899999866 799999999998 4556799999
Q ss_pred ecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007177 102 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 180 (614)
Q Consensus 102 E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 180 (614)
|||+ ++|...+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (321)
T cd05591 76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---T 152 (321)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999975432221 1
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHH
Q 007177 181 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260 (614)
Q Consensus 181 ~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~ 260 (614)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~------------------- 211 (321)
T cd05591 153 TTTFCGTPDYIAPEILQE--LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD------------------- 211 (321)
T ss_pred ccccccCccccCHHHHcC--CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 244679999999999876 67999999999999999999999999988766655444210
Q ss_pred HHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-------CHHHHHcCcccccC
Q 007177 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-------TAEEALADPYFKGL 314 (614)
Q Consensus 261 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-------sa~eiL~hp~f~~~ 314 (614)
. . .....++.++.+||.+||+.||++|+ +++++++||||..+
T Consensus 212 --------~-~---~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 212 --------D-V---LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred --------C-C---CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 0 0 01123678999999999999999999 99999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=370.21 Aligned_cols=251 Identities=29% Similarity=0.498 Sum_probs=208.5
Q ss_pred EeEeeecCceEEEEEEEC---CCCcEEEEEEecCcc--CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 23 QEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIF--EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 23 ~~~LG~G~~G~V~~a~d~---~tg~~vAIK~i~~~~--~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
++.||+|+||.||+|.+. .+++.||||+++... ........+.+|+.+|+.++||||+++++.+ .+.+.+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeE
Confidence 368999999999999864 478899999987532 1223445677899999999999999999998 445679
Q ss_pred EEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 98 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
|+||||+. ++|.+.+...+.+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 76 YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred EEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999998 59999999888899999999999999999999999999999999999999999999999999875432221
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhch
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~ 256 (614)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+..
T Consensus 156 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~---------------- 214 (323)
T cd05584 156 ---VTHTFCGTIEYMAPEILMR--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK---------------- 214 (323)
T ss_pred ---cccccCCCccccChhhccC--CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc----------------
Confidence 1234579999999999876 5788999999999999999999999988765444433321
Q ss_pred hHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 007177 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 314 (614)
Q Consensus 257 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~ 314 (614)
.. . ...+.+++.+.+||.+||+.||.+|| +++++++||||...
T Consensus 215 ----------~~--~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 215 ----------GK--L---NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred ----------CC--C---CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 00 0 12245688999999999999999999 89999999999753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=371.42 Aligned_cols=250 Identities=28% Similarity=0.477 Sum_probs=207.0
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHH-HHHhcCCCCcceeeeEecCCCCCCCCcEEEEE
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIK-LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~-iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~ 101 (614)
+.||+|+||.||+|.++.+|+.||||++.... ........+.+|.. +++.++||||+++++.+ .+...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence 47999999999999999999999999987432 12233455666665 46789999999999988 4556799999
Q ss_pred ecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007177 102 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 180 (614)
Q Consensus 102 E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 180 (614)
|||. ++|...+..++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (323)
T cd05575 76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK---T 152 (323)
T ss_pred cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHH
Q 007177 181 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260 (614)
Q Consensus 181 ~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~ 260 (614)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~-------------------- 210 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN-------------------- 210 (323)
T ss_pred cccccCChhhcChhhhcC--CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc--------------------
Confidence 234579999999999877 6799999999999999999999999988765544433311
Q ss_pred HHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCH----HHHHcCcccccC
Q 007177 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA----EEALADPYFKGL 314 (614)
Q Consensus 261 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa----~eiL~hp~f~~~ 314 (614)
.. ....+.+++.+.+||.+||+.||.+||++ .++++||||..+
T Consensus 211 --------~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 211 --------KP---LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred --------CC---CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 00 11234678899999999999999999987 699999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=359.75 Aligned_cols=282 Identities=38% Similarity=0.681 Sum_probs=220.8
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
++|++.+.||+|+||.||+|.++.+|+.||+|++............+.+|+.+++.++||||+++++++ .+...+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEE
Confidence 479999999999999999999999999999999865432223345577999999999999999999998 445679
Q ss_pred EEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 98 YVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 98 ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
|+||||+++ .|..++.....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999999996 5555555666799999999999999999999999999999999999999999999999999986543221
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhch
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~ 256 (614)
......++.+|+|||++.+. ..++.++|+|||||++|+|++|.+||.+.+..+.+..+...++.............
T Consensus 156 ---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 156 ---DYTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred ---cccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 12345688999999988652 45788999999999999999999999998877777666655544332211111000
Q ss_pred hHHHHHHhhc---ccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 257 KARRYLTSMR---KKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 257 ~~~~~l~~~~---~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
.+...+. .....+....++.++..+.+||.+||..||++|||+.|+|.||||
T Consensus 232 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 232 ---QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ---cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000000 001111222345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=356.23 Aligned_cols=258 Identities=36% Similarity=0.602 Sum_probs=213.1
Q ss_pred eEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEE
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 99 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~yl 99 (614)
|++++.||+|+||+||++.+..+++.||+|++..............+|+.+++.++||||+++++++. +...+|+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQ-----DDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEE-----ESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccc-----ccccccc
Confidence 89999999999999999999999999999999865433334444567999999999999999999984 4677999
Q ss_pred EEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCc
Q 007177 100 VFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 178 (614)
Q Consensus 100 V~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~ 178 (614)
|||++.+ +|.+++.....+++..+..++.||++||.+||+.||+|+||||+||+++.++.++|+|||++...... .
T Consensus 76 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~---~ 152 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN---N 152 (260)
T ss_dssp EEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST---T
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---c
Confidence 9999997 99999987788999999999999999999999999999999999999999999999999999754111 1
Q ss_pred cccccccCCccccCccccc-ccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchh
Q 007177 179 IFWTDYVATRWYRAPELCG-SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257 (614)
Q Consensus 179 ~~~~~~vgt~~Y~APEvl~-~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~ 257 (614)
.......++..|+|||++. + ..++.++|+|||||++++|++|..||...+..+....+...........
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 222 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQG--KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS-------- 222 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTT--SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH--------
T ss_pred ccccccccccccccccccccc--ccccccccccccccccccccccccccccccchhhhhhhhhccccccccc--------
Confidence 2235568899999999987 4 6789999999999999999999999988754444444432221111000
Q ss_pred HHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 258 ~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
. ......+..+.+||.+||+.||++|||+.++++||||
T Consensus 223 -------~---------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 223 -------S---------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp -------T---------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred -------c---------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 0 0001123789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=361.62 Aligned_cols=286 Identities=41% Similarity=0.652 Sum_probs=234.3
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCC---hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH---ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~---~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
+|++.+.||.|+||.||+|.+..+++.||||++...... ......+.+|+.+++.++|+||+++++++ .+..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF-----GHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee-----ecCC
Confidence 589999999999999999999999999999999754322 22345667899999999999999999998 3456
Q ss_pred cEEEEEecCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 96 DIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 96 ~~ylV~E~~~g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
.+|+||||+.++|.+++.... .+++..+..++.||++||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 799999999889999998766 7999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
.. ......+++.|+|||.+.+. ..++.++|+|||||++|+|++|.++|.+.+..+.+..+...++.|....+....
T Consensus 156 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NR---KMTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred Cc---cccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 21 12334578899999987542 467899999999999999999999999999888888888888877665554322
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
... .+. ........+....+...+..+.+||.+||..||++|||+.|+|.||||.+...
T Consensus 232 ~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 232 SLP--DYV-EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred ccc--ccc-cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 211 111 11122233334456677899999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=368.66 Aligned_cols=250 Identities=25% Similarity=0.413 Sum_probs=206.7
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCcEEEEE
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~~~ylV~ 101 (614)
+.||+|+||.||+|.++.+|+.||+|+++.... .......+..|..++..+ +||||+++++.+ .+.+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 479999999999999999999999999975321 123445667788888754 899999999998 4556899999
Q ss_pred ecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007177 102 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 180 (614)
Q Consensus 102 E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 180 (614)
|||. ++|...+.....+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~ 152 (316)
T cd05620 76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---NR 152 (316)
T ss_pred CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC---Cc
Confidence 9998 5999999888889999999999999999999999999999999999999999999999999987432111 12
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHH
Q 007177 181 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260 (614)
Q Consensus 181 ~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~ 260 (614)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~-------------------- 210 (316)
T cd05620 153 ASTFCGTPDYIAPEILQG--LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV-------------------- 210 (316)
T ss_pred eeccCCCcCccCHHHHcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------------
Confidence 245679999999999987 6799999999999999999999999988765444333211
Q ss_pred HHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCH-HHHHcCcccccC
Q 007177 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA-EEALADPYFKGL 314 (614)
Q Consensus 261 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa-~eiL~hp~f~~~ 314 (614)
..+ .....++..+++||++||..||.+|+++ +++++||||+.+
T Consensus 211 -------~~~----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 211 -------DTP----HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred -------CCC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 000 1112467899999999999999999998 588999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=367.53 Aligned_cols=255 Identities=23% Similarity=0.399 Sum_probs=213.3
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCc
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
+|++++.||+|+||.||+|.++.+++.||||++.+... .......+..|..++..+ .|++|+.+++++ .+...
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 48999999999999999999999999999999975322 223445567788888877 488999999988 45567
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|+||||++ |+|.+.+.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999997543221
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-------------- 216 (323)
T cd05616 156 V---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-------------- 216 (323)
T ss_pred C---ccccCCCChhhcCHHHhcC--CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 1 1234679999999999987 67999999999999999999999999888765555444220
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccC
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 314 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~eiL~hp~f~~~ 314 (614)
.. .....++.++.+|+.+||+.||.+|++ ..++++||||+.+
T Consensus 217 --------------~~---~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 217 --------------NV---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred --------------CC---CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 00 111357889999999999999999997 4899999999854
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=347.24 Aligned_cols=259 Identities=26% Similarity=0.425 Sum_probs=224.3
Q ss_pred ccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007177 12 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 90 (614)
Q Consensus 12 ~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 90 (614)
+.....++|++++.||+|-||.||+|+.+.++.-||+|++.+... .......+.+|++|...|+||||+++|+.|
T Consensus 16 ~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f---- 91 (281)
T KOG0580|consen 16 TKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF---- 91 (281)
T ss_pred ccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe----
Confidence 344556789999999999999999999999999999999975422 222345678999999999999999999999
Q ss_pred CCCCCcEEEEEecCC-CcHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCc
Q 007177 91 RRDFKDIYVVFELME-SDLHQVIK--ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 167 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~-g~L~~~i~--~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGl 167 (614)
.+...+||++||.. |+|+..+. ....+++.....+++|++.||.|+|.++|+||||||+|+|++.++.+||+|||-
T Consensus 92 -hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGw 170 (281)
T KOG0580|consen 92 -HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGW 170 (281)
T ss_pred -eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCc
Confidence 56678999999998 79999998 567899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007177 168 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247 (614)
Q Consensus 168 a~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~ 247 (614)
+....... ..+.|||..|.+||...+ ..++..+|+|++|++.||++.|.+||...+..+.+.+|...
T Consensus 171 sV~~p~~k-----R~tlcgt~dyl~pEmv~~--~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~------ 237 (281)
T KOG0580|consen 171 SVHAPSNK-----RKTLCGTLDYLPPEMVEG--RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV------ 237 (281)
T ss_pred eeecCCCC-----ceeeecccccCCHhhcCC--CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc------
Confidence 97643222 256799999999999988 68999999999999999999999999888876666665321
Q ss_pred hhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 248 ~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
...+ ...++..+.|||.+||..+|.+|.+..|++.|||+..
T Consensus 238 ----------------------~~~~---p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 238 ----------------------DLKF---PSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ----------------------cccC---CcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 1111 1468899999999999999999999999999999864
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=359.70 Aligned_cols=287 Identities=36% Similarity=0.651 Sum_probs=227.1
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
||..++|++.+.||.|++|.||+|.++.+++.||||.+...... .....+.+|+.+++.++||||+++++++ .+
T Consensus 1 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~ 74 (291)
T cd07844 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDII-----HT 74 (291)
T ss_pred CCCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEE-----ec
Confidence 56778999999999999999999999999999999998743221 1223467899999999999999999998 45
Q ss_pred CCcEEEEEecCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 94 FKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 94 ~~~~ylV~E~~~g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
....|+||||+.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 75 KKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKS 154 (291)
T ss_pred CCeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccC
Confidence 5679999999999999988764 468999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-hhHHHHHHHhhhCCCchhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN-VVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~-~~~~l~~i~~~~g~p~~~~i~ 251 (614)
.... ......++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.. ..+++..+.+.++.+..+.+.
T Consensus 155 ~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 155 VPSK---TYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred CCCc---cccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhh
Confidence 2111 11233568889999988652 458899999999999999999999998776 667788888888887766654
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCC--HHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNAD--PSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s--~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
........... .........+...++.++ ..+.+||.+||+.||.+|||+.++|+||||
T Consensus 231 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 231 GVSSNPEFKPY-SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhhhccccccc-cccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 33211000000 000011112223334445 789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=359.73 Aligned_cols=288 Identities=36% Similarity=0.624 Sum_probs=229.8
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ 96 (614)
++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.+. ||||+++++++..........
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4799999999999999999999999999999998754333334456788999999995 699999999885544333345
Q ss_pred EEEEEecCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC-CCcEEEeecCcccc
Q 007177 97 IYVVFELMESDLHQVIKAN-----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARV 170 (614)
Q Consensus 97 ~ylV~E~~~g~L~~~i~~~-----~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~-~~~vKL~DFGla~~ 170 (614)
+|+||||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 8999999999998888642 35899999999999999999999999999999999999998 88999999999875
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
...... ..+...++++|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.|....+
T Consensus 161 ~~~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 161 FSIPVK---SYTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cCCCcc---ccCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 432211 11234678899999987642 45789999999999999999999999999988888888888888776554
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~ 312 (614)
.......... ......+..+....+.+++.+.+||.+||..||.+||+++|+|.||||+
T Consensus 237 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWH---EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchh---hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 3322211100 0111122222333467889999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=378.83 Aligned_cols=259 Identities=29% Similarity=0.441 Sum_probs=226.8
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|.+++++|+|+||.+++++++.++..|++|+|.-.............|+.++++++|||||.+++.|. .+...
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~ 78 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQL 78 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCce
Confidence 46899999999999999999999999999999999865455555557889999999999999999999983 33344
Q ss_pred EEEEEecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 97 IYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
+||||+||+ |+|.+.|+.. ..++++.+..|+.||+.||.|||+++|+|||||+.|||++.++.|||+|||+|+....
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 999999999 5999999764 3689999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
... +....+||+.|++||+|.+ .+|+.++|||||||++|||++-+++|.+.+....+.+|......|
T Consensus 159 ~~~---~a~tvvGTp~YmcPEil~d--~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P-------- 225 (426)
T KOG0589|consen 159 EDS---LASTVVGTPYYMCPEILSD--IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP-------- 225 (426)
T ss_pred chh---hhheecCCCcccCHHHhCC--CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC--------
Confidence 541 3356899999999999998 799999999999999999999999999999888887776543332
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
.....+.+++.||+.||..+|..||++.++|.+|.+...
T Consensus 226 ----------------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 226 ----------------------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred ----------------------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 223567899999999999999999999999999887643
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=368.17 Aligned_cols=264 Identities=25% Similarity=0.428 Sum_probs=214.6
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
++|++.+.||+|+||.||++.++.+++.||+|++.+.. ........+.+|+.++..++|+||+.+++.+ .+...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence 47999999999999999999999999999999986421 1223344577899999999999999999988 45567
Q ss_pred EEEEEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 97 IYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
+|+||||+. |+|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999998 699999976 467999999999999999999999999999999999999999999999999999764322
Q ss_pred CCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~---~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
.. ......+||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+.+..+.+..+..
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~----------- 222 (332)
T cd05623 156 GT--VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN----------- 222 (332)
T ss_pred Cc--ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhC-----------
Confidence 21 112335799999999988531 14688999999999999999999999988776555544421
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCC--CCCHHHHHcCcccccC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD--RPTAEEALADPYFKGL 314 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~--Rpsa~eiL~hp~f~~~ 314 (614)
......+......+++.+++||.+||..++.+ |++++++++||||.++
T Consensus 223 ---------------~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 223 ---------------HKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred ---------------CCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 11112233334567899999999999776554 6899999999999865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=370.31 Aligned_cols=251 Identities=27% Similarity=0.460 Sum_probs=210.0
Q ss_pred EeEeeecCceEEEEEEE---CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEE
Q 007177 23 QEVIGKGSYGVVCSAID---THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 99 (614)
Q Consensus 23 ~~~LG~G~~G~V~~a~d---~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~yl 99 (614)
++.||+|+||.||++.+ ..+|+.||+|++............+.+|+.+|+.++||||+++++++ .+...+|+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~l 75 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYL 75 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEE
Confidence 36799999999999876 45789999999976433334556678899999999999999999998 45567999
Q ss_pred EEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCc
Q 007177 100 VFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 178 (614)
Q Consensus 100 V~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~ 178 (614)
|||||+ ++|.+.+.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 76 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 999998 69999998888899999999999999999999999999999999999999999999999999976433211
Q ss_pred cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhH
Q 007177 179 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 258 (614)
Q Consensus 179 ~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~ 258 (614)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 154 -~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~------------------ 212 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK------------------ 212 (318)
T ss_pred -ceecccCChhhcCHHHHcC--CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc------------------
Confidence 1234679999999999876 5788999999999999999999999988775544433311
Q ss_pred HHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccC
Q 007177 259 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 314 (614)
Q Consensus 259 ~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~eiL~hp~f~~~ 314 (614)
. .. .....+++.+.+||++||+.||.+||+ +++++.||||..+
T Consensus 213 --------~--~~---~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 213 --------A--KL---GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred --------C--CC---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 0 00 112346889999999999999999999 7889999999854
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=378.14 Aligned_cols=281 Identities=23% Similarity=0.316 Sum_probs=219.4
Q ss_pred CCCeEEEeEeeecCceEEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDT--HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~--~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
..+|++++.||.|+||.||+|... .++..||+|.+... ....+|+.+|+.|+||||+++++.+ ...
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~-----~~~ 158 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAY-----RWK 158 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeE-----eeC
Confidence 347999999999999999999754 45678999988642 2345899999999999999999988 455
Q ss_pred CcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 95 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 95 ~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
..+|+|||++.++|.+++.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 159 ~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 159 STVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred CEEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 67999999999999999987788999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC---hhHHHHHHHhhhCCCchhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN---VVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~---~~~~l~~i~~~~g~p~~~~i~ 251 (614)
.. .......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.. ...++..+...++....+...
T Consensus 239 ~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 239 PD-TPQCYGWSGTLETNSPELLAL--DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred cc-cccccccccccCccCHhHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 22 112234679999999999986 679999999999999999999999997764 345666666666654433221
Q ss_pred hhhchhHHHHHHhhc--ccCCCcccCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 252 RVRNDKARRYLTSMR--KKQPVQFSQKF--PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~--~~~~~~~~~~~--~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
..... ....+.... .+.+......+ ...+.++.+||.+||.+||++|||+.|+|.||||..
T Consensus 316 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 316 NGSTN-LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred ccchh-HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 11111 111111111 11111111111 235678999999999999999999999999999975
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=359.52 Aligned_cols=297 Identities=33% Similarity=0.518 Sum_probs=229.0
Q ss_pred cCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-
Q 007177 13 EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR- 91 (614)
Q Consensus 13 ~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~- 91 (614)
-....++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 3455678999999999999999999999999999999986433333334456789999999999999999998865431
Q ss_pred --CCCCcEEEEEecCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcc
Q 007177 92 --RDFKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 168 (614)
Q Consensus 92 --~~~~~~ylV~E~~~g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 168 (614)
......|+||||+.++|.+.+.... .+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++
T Consensus 87 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 87 YNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred ccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 2345679999999999988886543 6899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC-ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007177 169 RVAFNDTPT-TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247 (614)
Q Consensus 169 ~~~~~~~~~-~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~ 247 (614)
......... ........++..|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+...++..+..+.|....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 765332211 1112345678899999987652 45788999999999999999999999999988888888888877665
Q ss_pred hhhhhhhchhHHHHHHhhcccCCCcc-cCC-CCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 248 DTISRVRNDKARRYLTSMRKKQPVQF-SQK-FPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 248 ~~i~~~~~~~~~~~l~~~~~~~~~~~-~~~-~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
+.+...........+.. ........ ... ....++.+.+||.+||..||.+|||++++|+||||
T Consensus 246 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 246 EVWPGVDKLELFKKMEL-PQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhcccccchhhhhhccC-CCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 54433321111110000 00000000 001 11246788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=365.90 Aligned_cols=250 Identities=26% Similarity=0.452 Sum_probs=206.0
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCcEEEEE
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~~~ylV~ 101 (614)
+.||+|+||.||+|.+..+++.||||+++.... .......+..|..++..+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 479999999999999999999999999975321 223445566777777654 799999999988 4456799999
Q ss_pred ecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007177 102 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 180 (614)
Q Consensus 102 E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 180 (614)
||++ ++|.+.+.....+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---~~ 152 (316)
T cd05592 76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GK 152 (316)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC---Cc
Confidence 9998 5999999888889999999999999999999999999999999999999999999999999997543222 12
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHH
Q 007177 181 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260 (614)
Q Consensus 181 ~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~ 260 (614)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-------------------- 210 (316)
T cd05592 153 ASTFCGTPDYIAPEILKG--QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-------------------- 210 (316)
T ss_pred cccccCCccccCHHHHcC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--------------------
Confidence 244679999999999987 5789999999999999999999999988776544433311
Q ss_pred HHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCH-HHHHcCcccccC
Q 007177 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA-EEALADPYFKGL 314 (614)
Q Consensus 261 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa-~eiL~hp~f~~~ 314 (614)
..+ .....++.++.+||.+||..||.+||++ ++++.||||..+
T Consensus 211 -------~~~----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 211 -------DRP----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred -------CCC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 000 0113467899999999999999999986 588899999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=372.65 Aligned_cols=264 Identities=26% Similarity=0.376 Sum_probs=213.6
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
-..++|++.+.||+|+||.||+|.++.+++.||+|++.... ........+.+|+.+++.++||||+++++.+ .+
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~ 114 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QD 114 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----Ec
Confidence 34579999999999999999999999999999999986421 2223445677899999999999999999998 45
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
...+|+|||||+ ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 567999999998 5899988654 58999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCccccccccCCccccCcccccccC--CCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~--~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
.... ......+||+.|+|||++.+.. ..++.++|||||||++|+|++|.+||.+.+.......|...
T Consensus 194 ~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--------- 262 (371)
T cd05622 194 KEGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH--------- 262 (371)
T ss_pred cCCc--ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC---------
Confidence 2211 1123467999999999986521 23889999999999999999999999887765544443211
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCC--CCCHHHHHcCccccc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD--RPTAEEALADPYFKG 313 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~--Rpsa~eiL~hp~f~~ 313 (614)
.....+. ....++..+++||.+||..++.+ |++++++++||||++
T Consensus 263 -----------------~~~~~~~-~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 263 -----------------KNSLTFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred -----------------CCcccCC-CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 1111111 23468899999999999844433 789999999999976
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=366.73 Aligned_cols=259 Identities=23% Similarity=0.409 Sum_probs=206.0
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCcEEEEE
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~~~ylV~ 101 (614)
++||+|+||.||+|.++.+++.||||+++.... .......+.+|+.+++.+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 479999999999999999999999999975422 233456678899999988 699999999998 4556799999
Q ss_pred ecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007177 102 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 180 (614)
Q Consensus 102 E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 180 (614)
|||+ ++|...+...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (329)
T cd05588 76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHH
Q 007177 181 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260 (614)
Q Consensus 181 ~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~ 260 (614)
....+||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||......+ .+.... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~----------~~~~~~--------~~~ 212 (329)
T cd05588 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD----------NPDQNT--------EDY 212 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceechHHHHHHHHHCCCCcccccccc----------cccccc--------hHH
Confidence 234679999999999987 678999999999999999999999996432110 000000 000
Q ss_pred HHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC------HHHHHcCcccccC
Q 007177 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT------AEEALADPYFKGL 314 (614)
Q Consensus 261 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps------a~eiL~hp~f~~~ 314 (614)
....+.. .... ....++..+.+||.+||+.||.+|+| ++++++||||..+
T Consensus 213 ~~~~~~~-~~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 213 LFQVILE-KQIR---IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred HHHHHHc-CCCC---CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 0011111 1111 12357889999999999999999987 7999999999754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=365.80 Aligned_cols=250 Identities=24% Similarity=0.437 Sum_probs=208.7
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCcEEEEE
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~~~ylV~ 101 (614)
+.||+|+||.||+|.++.++..||||++++.. ........+.+|+.+++.+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 47999999999999999999999999997532 2233456677899999888 699999999998 4556799999
Q ss_pred ecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007177 102 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 180 (614)
Q Consensus 102 E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 180 (614)
|||. ++|...+...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (318)
T cd05570 76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---T 152 (318)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHH
Q 007177 181 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260 (614)
Q Consensus 181 ~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~ 260 (614)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 153 ~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~-------------------- 210 (318)
T cd05570 153 TSTFCGTPDYIAPEILSY--QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE-------------------- 210 (318)
T ss_pred ccceecCccccCHHHhcC--CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc--------------------
Confidence 234579999999999987 6789999999999999999999999988775444333211
Q ss_pred HHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHHcCcccccC
Q 007177 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA-----EEALADPYFKGL 314 (614)
Q Consensus 261 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa-----~eiL~hp~f~~~ 314 (614)
... .....++..+.+||++||..||++|||+ .++++||||+..
T Consensus 211 -------~~~----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 211 -------DEV----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred -------CCC----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 000 0113467899999999999999999999 999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=364.09 Aligned_cols=281 Identities=32% Similarity=0.569 Sum_probs=226.6
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC--CCC----cceeeeEecCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR--HPD----IVEIKHIMLPP 89 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~--Hpn----Iv~l~~v~~~~ 89 (614)
...||.+++.+|+|.||.|..|.|..++..||||+++.. . ......+-|+++|+++. .|+ ++.+.+.|
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF--- 160 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-D--KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF--- 160 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-H--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh---
Confidence 468999999999999999999999999999999999853 1 22333456999999994 232 55555555
Q ss_pred CCCCCCcEEEEEecCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC-----------
Q 007177 90 SRRDFKDIYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA----------- 156 (614)
Q Consensus 90 ~~~~~~~~ylV~E~~~g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~----------- 156 (614)
+..+.+|||+|.++-++++++++++ +++..+++.+.+||+++++|||+.+++|.||||+|||+.+
T Consensus 161 --dyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 161 --DYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred --hccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence 5567899999999999999999876 6899999999999999999999999999999999999732
Q ss_pred ---------CCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 007177 157 ---------NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 227 (614)
Q Consensus 157 ---------~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~ 227 (614)
+..|||+|||.|+...... ...+.|+.|+|||++.+ -+++.++||||+||||+||.+|..+|+
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEViLg--LGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYRAPEVILG--LGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc------ceeeeccccCCchheec--cCcCCccCceeeeeEEEEeeccceecc
Confidence 2358999999998654333 34589999999999998 589999999999999999999999999
Q ss_pred CCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhccc---------------CCCcccCCCCCC---CHHHHHHHH
Q 007177 228 GKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKK---------------QPVQFSQKFPNA---DPSALRLLE 289 (614)
Q Consensus 228 g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~---------------~~~~~~~~~~~~---s~~l~dLI~ 289 (614)
+.++.+.+..|...+|..+..++.+.+ ..+|+...+-. .+.++....... ...+.|||+
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~---~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTR---KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhh---hHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 999999999999999988877776653 33333222111 111111111122 245889999
Q ss_pred HhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 290 RLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 290 ~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
+||.+||.+|+|+.|+|.||||+.+.
T Consensus 388 ~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred HHHccCccccccHHHHhcCHHhhcCC
Confidence 99999999999999999999998653
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=356.31 Aligned_cols=281 Identities=38% Similarity=0.672 Sum_probs=229.1
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
+|++.+.||.|++|.||+|.+..+|..||||++..... ......+.+|+.+++.++||||+++++.+ .+....|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVI-----HTENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeE-----eeCCcEE
Confidence 58999999999999999999999999999999875322 22345677899999999999999999998 4456789
Q ss_pred EEEecCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 99 VVFELMESDLHQVIKAN---DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 99 lV~E~~~g~L~~~i~~~---~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+||||++++|.+++... ..++++.+..++.||+.||.|||+.||+||||||+||++++++.+||+|||+++......
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 75 LVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred EEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 99999999999988754 358999999999999999999999999999999999999999999999999997543221
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
. ......++..|++||++.+. ..++.++|+|||||++|+|++|.+||.+.+..+.+..+....+.|....+..+..
T Consensus 155 ~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 155 N---TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred c---ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 1 12334678899999987652 4578899999999999999999999999999999999999888888777654432
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
. ..+................+.+++.+.++|.+||+.||.+||++.++|+||||
T Consensus 231 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 231 L--PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred C--chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 1 11111111111111222345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=357.47 Aligned_cols=288 Identities=38% Similarity=0.659 Sum_probs=230.6
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
++|++.+.||+|++|.||+|.++.+|+.||||++............+.+|+.+++.++||||+++++.+ .+....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeE
Confidence 579999999999999999999999999999999865433333345677899999999999999999998 445679
Q ss_pred EEEEecCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC-CCcEEEeecCccccccCC
Q 007177 98 YVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFND 174 (614)
Q Consensus 98 ylV~E~~~g~L~~~i~~~~~--lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~-~~~vKL~DFGla~~~~~~ 174 (614)
|+||||++++|.+.+..... +++..++.++.||+.||+|||+.||+||||+|+||+++. ++.+||+|||++......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 99999999999888866443 578889999999999999999999999999999999985 557999999999754322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
.. ..+...+++.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.|....+....
T Consensus 157 ~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 VR---TFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred cc---ccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 11 12345678999999988652 457899999999999999999999999998888888888888888766654322
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
.. ..+................+.+++.+.+||.+||..||++||+++++|+||||.++..
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 233 SL--PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred cc--hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 11 1111111111112222234678899999999999999999999999999999987643
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=359.68 Aligned_cols=287 Identities=40% Similarity=0.655 Sum_probs=231.4
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.+.|++.+.||.|+||.||+|.+..+++.++||.++...........+.+|+.+++.++||||+++++++... +...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~ 80 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDK 80 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCc
Confidence 4579999999999999999999999999999999975433333344567899999999999999999987432 2367
Q ss_pred EEEEEecCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
.|+||||+.++|.+++.... .+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 81 IYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99999999999999887644 59999999999999999999999999999999999999999999999999998654332
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
. ......+++.|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.+..+.+..+...++.|....+.....
T Consensus 161 ~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 161 K---PYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred c---ccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 1 12344678899999988652 3468899999999999999999999999999999999999998887766554321
Q ss_pred hhHHHHHHhhcccCCCcccCCCCC--CCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPN--ADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~--~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
-..... ..........+...++. +++.+.+||++||+.||++|||+.|+|.||||
T Consensus 237 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 237 LPGAKK-KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cchhcc-cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 100000 00011111222334554 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=365.92 Aligned_cols=298 Identities=40% Similarity=0.648 Sum_probs=228.5
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC---
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR--- 91 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~--- 91 (614)
...++|.+.+.||.|+||.||+|.++.+|..||+|++.... ......+.+|+.+|+.++||||+++++++.....
T Consensus 2 ~~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred CcCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 45689999999999999999999999999999999986532 2345668899999999999999999988754321
Q ss_pred ------CCCCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC-CCcEEEee
Q 007177 92 ------RDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICD 164 (614)
Q Consensus 92 ------~~~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~-~~~vKL~D 164 (614)
.+....|+||||++++|.+.+.. ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccccccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 12246899999999999888864 46999999999999999999999999999999999999974 55789999
Q ss_pred cCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCC
Q 007177 165 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 244 (614)
Q Consensus 165 FGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~ 244 (614)
||+++................++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99997643222211122334688899999987542 46888999999999999999999999988877776666655444
Q ss_pred CchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcc
Q 007177 245 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 317 (614)
Q Consensus 245 p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~ 317 (614)
+..+......+..... ..........++....+.++.++.+||.+||..||++|||++++|.||||+.+..+
T Consensus 238 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~ 309 (342)
T cd07854 238 VREEDRNELLNVIPSF-VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP 309 (342)
T ss_pred CChHHhhhhhhhhhhh-hhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence 4333322221111111 11011111222233445788999999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=360.14 Aligned_cols=296 Identities=37% Similarity=0.618 Sum_probs=232.5
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC--
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-- 91 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~-- 91 (614)
....++|++.+.||.|+||.||+|.++.+++.||||++............+.+|+++|+.++||||+++++++.....
T Consensus 4 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred CcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 344679999999999999999999999999999999986433322233456789999999999999999998754321
Q ss_pred -CCCCcEEEEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 92 -RDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 92 -~~~~~~ylV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
.....+|+||||+.++|...+.. ...+++..++.++.||++||.|||+.||+|+||||+|||++.++.+||+|||+++
T Consensus 84 ~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 84 KRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred cccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 23456899999999988888765 4479999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCC--------ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhh
Q 007177 170 VAFNDTPT--------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 241 (614)
Q Consensus 170 ~~~~~~~~--------~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~ 241 (614)
........ ....+...+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 65432211 1122345678999999987652 45889999999999999999999999999999999999888
Q ss_pred hCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 242 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 242 ~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
.+.+....+.....-..... .......+......+...++.+.+||.+||..||.+|||+.++|.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEG-VHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred hCCCChhhchhhhhcccccc-cccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 88776655433211000000 0001111222233445667889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=366.90 Aligned_cols=250 Identities=29% Similarity=0.501 Sum_probs=206.2
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHH-HHHhcCCCCcceeeeEecCCCCCCCCcEEEEE
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIK-LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~-iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~ 101 (614)
+.||+|+||.||+|.++.+|+.||||++..... .......+.+|.. +++.++||||+++++.+ .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence 469999999999999999999999999874321 2234455666665 46789999999999988 4556799999
Q ss_pred ecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007177 102 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 180 (614)
Q Consensus 102 E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 180 (614)
|||. ++|...+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---~ 152 (325)
T cd05604 76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---T 152 (325)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC---C
Confidence 9998 58999998888999999999999999999999999999999999999999999999999999875322221 1
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHH
Q 007177 181 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260 (614)
Q Consensus 181 ~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~ 260 (614)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~-------------------- 210 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRK--QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH-------------------- 210 (325)
T ss_pred cccccCChhhCCHHHHcC--CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc--------------------
Confidence 245679999999999987 6789999999999999999999999988765444333211
Q ss_pred HHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCH----HHHHcCcccccC
Q 007177 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA----EEALADPYFKGL 314 (614)
Q Consensus 261 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa----~eiL~hp~f~~~ 314 (614)
. . ....+..+..+.+||.+||..||.+||++ .++++||||...
T Consensus 211 ------~--~---~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 211 ------K--P---LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred ------C--C---ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 0 0 11234678899999999999999999976 699999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=363.66 Aligned_cols=255 Identities=23% Similarity=0.398 Sum_probs=211.9
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCc
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ 96 (614)
+|++.+.||+|+||.||+|.++.+|+.||||++.+... .......+..|+.++..+. |++|+.+++.+ .+...
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence 47899999999999999999999999999999975321 2334556778999998886 57788888887 44567
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|+||||++ ++|.+++...+.+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999987543221
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+...
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-------------- 216 (323)
T cd05615 156 V---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH-------------- 216 (323)
T ss_pred c---cccCccCCccccCHHHHcC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 1 1234579999999999876 67899999999999999999999999887765544443210
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccC
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 314 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~eiL~hp~f~~~ 314 (614)
.. .....++..+.+|+.+||+.||.+|++ .+++++||||..+
T Consensus 217 --------------~~---~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 217 --------------NV---SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred --------------CC---CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 00 112356789999999999999999997 5899999999865
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=364.73 Aligned_cols=264 Identities=24% Similarity=0.413 Sum_probs=214.4
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
++|++.+.||+|+||.||++.++.+++.||+|++.+.. ........+.+|+.++..++|+||+.+++.+ .+.+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 47999999999999999999999999999999987521 2223345577899999999999999999998 45577
Q ss_pred EEEEEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 97 IYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
+|+|||||. |+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999998 699999977 467999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~---~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
... .....+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~----------- 222 (331)
T cd05624 156 GTV--QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN----------- 222 (331)
T ss_pred Cce--eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc-----------
Confidence 211 12235799999999988642 13578899999999999999999999988776554444321
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCC--CCCHHHHHcCcccccC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD--RPTAEEALADPYFKGL 314 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~--Rpsa~eiL~hp~f~~~ 314 (614)
......+...+..+++.+++||.+||..++.+ |++++++++||||+++
T Consensus 223 ---------------~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 223 ---------------HEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred ---------------CCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 11112233444567899999999999976654 4699999999999853
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=352.56 Aligned_cols=274 Identities=26% Similarity=0.406 Sum_probs=227.1
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCcEEEEE
Q 007177 23 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 23 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~~ylV~ 101 (614)
.+.||+|+|+.|-.|+...+|.+||||+|.+. ..-...+++||++++.+.+ |+||++++++| +++..+||||
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FYLVf 155 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFYLVF 155 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEEEEE
Confidence 46899999999999999999999999999875 3345678999999999986 99999999999 7788899999
Q ss_pred ecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC---cEEEeecCccccccCCC--
Q 007177 102 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC---KLKICDFGLARVAFNDT-- 175 (614)
Q Consensus 102 E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~---~vKL~DFGla~~~~~~~-- 175 (614)
|-|. |.|...|.++.-|+|.++..++..|+.||.|||.+||.||||||+|||..... -||||||.|........
T Consensus 156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 9998 59999999999999999999999999999999999999999999999986554 48999999885432111
Q ss_pred --CCccccccccCCccccCccccc---ccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 176 --PTTIFWTDYVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 176 --~~~~~~~~~vgt~~Y~APEvl~---~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
..+..+.+.+|+..|||||+.. +....|+.++|.||||+|||.||.|++||.|.-..+ -.|
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d--------------CGW 301 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD--------------CGW 301 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc--------------CCc
Confidence 1233456678999999999753 333579999999999999999999999998864311 112
Q ss_pred hhh--hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcc
Q 007177 251 SRV--RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 317 (614)
Q Consensus 251 ~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~ 317 (614)
++- ...--..+++++...........|..+|.+++|||..+|..|+.+|.++.++|+|||++.....
T Consensus 302 drGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 302 DRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred cCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 111 1122345667776666666677899999999999999999999999999999999999987544
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=379.71 Aligned_cols=281 Identities=26% Similarity=0.320 Sum_probs=212.3
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
...|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+.+|+.|+||||+++++++. ..+.
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~-----~~~~ 234 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRV-----VGGL 234 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEE-----ECCE
Confidence 457999999999999999999999999999999643 223568999999999999999999873 4456
Q ss_pred EEEEEecCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
.|+|||++.++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 235 ~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 235 TCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 8999999999999988764 469999999999999999999999999999999999999999999999999998653322
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCC-CCCCC------hhHHHHHHHhhhCCCchh
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKN------VVHQLDLMTDLLGTPSLD 248 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~p-F~g~~------~~~~l~~i~~~~g~p~~~ 248 (614)
.. ......+||+.|+|||++.+ ..++.++||||||||||||++|..+ |.... ...++..+....+....+
T Consensus 315 ~~-~~~~~~~GT~~Y~APE~~~~--~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 315 ST-PFHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred cc-ccccccCCCcCCcCHHHHcC--CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 11 11234579999999999987 6799999999999999999998754 43321 123455555444332211
Q ss_pred hhhhhhchhHHHHHHhh----cccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 249 TISRVRNDKARRYLTSM----RKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 249 ~i~~~~~~~~~~~l~~~----~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
.-..........+.... ...........+..++..+.+||.+||++||.+|||+.|+|+||||+.
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 11110011111111111 011111111222356788999999999999999999999999999974
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=365.25 Aligned_cols=259 Identities=22% Similarity=0.407 Sum_probs=205.1
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCcEEEEE
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~~~ylV~ 101 (614)
+.||+|+||.||+|.++.+++.||+|++++.. ........+.+|+.++..+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence 47999999999999999999999999997542 2334456677899988776 799999999998 4556799999
Q ss_pred ecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007177 102 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 180 (614)
Q Consensus 102 E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 180 (614)
|||. ++|...+.....+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~---~ 152 (329)
T cd05618 76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---c
Confidence 9999 59999988888899999999999999999999999999999999999999999999999999975322211 1
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHH
Q 007177 181 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260 (614)
Q Consensus 181 ~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~ 260 (614)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... .+.. .....
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----------~~~~--------~~~~~ 212 (329)
T cd05618 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD----------NPDQ--------NTEDY 212 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceecccHHHHHHhhCCCCCccCCCcC----------Cccc--------ccHHH
Confidence 234679999999999987 678999999999999999999999995321100 0000 00000
Q ss_pred HHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC------HHHHHcCcccccC
Q 007177 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT------AEEALADPYFKGL 314 (614)
Q Consensus 261 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps------a~eiL~hp~f~~~ 314 (614)
....+.. ... .....++..+.+||.+||+.||++|++ ++++++||||+.+
T Consensus 213 ~~~~i~~-~~~---~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 213 LFQVILE-KQI---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHHhc-CCC---CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 0111111 111 122457889999999999999999998 5899999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=355.33 Aligned_cols=285 Identities=35% Similarity=0.638 Sum_probs=223.5
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+|+.++||||+++++++ .+....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence 479999999999999999999999999999999875433333455678999999999999999999998 455679
Q ss_pred EEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 98 YVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 98 ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
|+||||+++ .|..++.....+++..++.++.||+.||.|||+.||+|+||+|+||++++++.+||+|||++.......
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred EEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 999999996 566666666679999999999999999999999999999999999999999999999999997653322
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhch
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~ 256 (614)
...+.+.++.+|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+.............
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred --cccCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 123456789999999988652 45788999999999999999999999988877777777666555432211111100
Q ss_pred hHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 257 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
....................+++++..+.+|+.+||..||.+||++.++|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0000000000001111223356788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=374.51 Aligned_cols=257 Identities=29% Similarity=0.456 Sum_probs=221.1
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
....|..++.||+|+||.||+|+|..+++.||||++.-. ....+...+..|+.+|.+++++||.++|+.|+.+ .
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le-~~~deIediqqei~~Ls~~~~~~it~yygsyl~g-----~ 84 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE-EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG-----T 84 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechh-hcchhhHHHHHHHHHHHhcCcchHHhhhhheeec-----c
Confidence 345788889999999999999999999999999999743 3334567788999999999999999999999644 4
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
.++++||||. |++.++++....+.|.++..++++++.||.|||..+.+|||||+.|||+..+|.+||+|||.+......
T Consensus 85 ~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 85 KLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred cHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech
Confidence 5899999999 599999998888899999999999999999999999999999999999999999999999999876544
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
.. ...+++||++|||||++.. ..|+.++||||||++.+||++|.|||.....+..
T Consensus 165 ~~---rr~tfvGTPfwMAPEVI~~--~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-------------------- 219 (467)
T KOG0201|consen 165 VK---RRKTFVGTPFWMAPEVIKQ--SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-------------------- 219 (467)
T ss_pred hh---ccccccccccccchhhhcc--ccccchhhhhhhhHHHHHHhcCCCCCcccCcceE--------------------
Confidence 32 2367899999999999996 7999999999999999999999999977653222
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
+-.+.+..|..+.. .+++.+++||..||..||+.||+|.++|+|+|++.
T Consensus 220 -------lflIpk~~PP~L~~---~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 220 -------LFLIPKSAPPRLDG---DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred -------EEeccCCCCCcccc---ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 22223333333332 67889999999999999999999999999999986
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=353.71 Aligned_cols=281 Identities=41% Similarity=0.677 Sum_probs=230.0
Q ss_pred eEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEE
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 99 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~yl 99 (614)
|++.+.||.|++|.||+|.++.+|..||||++............+.+|+.+++.++||||+++++++ .+....|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-----~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-----HSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-----ccCCeEEE
Confidence 6789999999999999999999999999999875433333345678899999999999999999998 34567999
Q ss_pred EEecCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007177 100 VFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 177 (614)
Q Consensus 100 V~E~~~g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 177 (614)
||||++++|.+++.... .+++..+..++.||+.||.|||+.+++||||+|+||+++.++.+||+|||+++.......
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 99999999999997765 799999999999999999999999999999999999999999999999999975432211
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchh
Q 007177 178 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257 (614)
Q Consensus 178 ~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~ 257 (614)
......++..|+|||++.+. ..++.++|+|||||++|+|++|++||.+.+..+.+..+.+..++|....+......
T Consensus 155 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (283)
T cd07835 155 --TYTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL- 230 (283)
T ss_pred --ccCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc-
Confidence 11233568899999987652 35788999999999999999999999999988888888888888877665443221
Q ss_pred HHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 258 ~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
..+................+.++..+.+||.+||+.||.+|||++|++.||||
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 231 -PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred -hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 11111222222222333456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=363.89 Aligned_cols=251 Identities=24% Similarity=0.420 Sum_probs=206.5
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHh-cCCCCcceeeeEecCCCCCCCCcEEEEE
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRL-LRHPDIVEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~-L~HpnIv~l~~v~~~~~~~~~~~~ylV~ 101 (614)
+.||+|+||.||+|.+..+++.||||+++.... ..........|..++.. ++||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence 479999999999999999999999999975321 12334556678888875 4899999999998 4456799999
Q ss_pred ecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007177 102 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 180 (614)
Q Consensus 102 E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 180 (614)
||++ ++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (316)
T cd05619 76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA---K 152 (316)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC---c
Confidence 9998 69999998888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHH
Q 007177 181 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260 (614)
Q Consensus 181 ~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~ 260 (614)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~--------------------- 209 (316)
T cd05619 153 TCTFCGTPDYIAPEILLG--QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR--------------------- 209 (316)
T ss_pred eeeecCCccccCHHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH---------------------
Confidence 234579999999999876 678999999999999999999999998876544433321
Q ss_pred HHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHH-HHHcCcccccCC
Q 007177 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE-EALADPYFKGLS 315 (614)
Q Consensus 261 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~-eiL~hp~f~~~~ 315 (614)
...+. ....++..+.+||.+||+.||.+||++. ++++||||+.+.
T Consensus 210 ------~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 210 ------MDNPC----YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred ------hCCCC----CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 00000 1123678999999999999999999996 899999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=364.48 Aligned_cols=250 Identities=27% Similarity=0.448 Sum_probs=205.0
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHH-HHHhcCCCCcceeeeEecCCCCCCCCcEEEEE
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIK-LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~-iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~ 101 (614)
+.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+. +++.++||||+++++.+ .+...+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence 47999999999999999999999999987432 12233445566654 67889999999999988 4556799999
Q ss_pred ecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007177 102 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 180 (614)
Q Consensus 102 E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 180 (614)
|||+ ++|...+.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (321)
T cd05603 76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---T 152 (321)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC---c
Confidence 9998 59999888888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHH
Q 007177 181 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260 (614)
Q Consensus 181 ~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~ 260 (614)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-------------------- 210 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRK--EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH-------------------- 210 (321)
T ss_pred cccccCCcccCCHHHhcC--CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc--------------------
Confidence 234679999999999876 6789999999999999999999999988765444333211
Q ss_pred HHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCH----HHHHcCcccccC
Q 007177 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA----EEALADPYFKGL 314 (614)
Q Consensus 261 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa----~eiL~hp~f~~~ 314 (614)
.+. ...+..+..+.+||.+||+.||.+|+++ .++++|+||..+
T Consensus 211 --------~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 211 --------KPL---QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred --------CCC---CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 011 1224567899999999999999999875 599999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=356.97 Aligned_cols=252 Identities=23% Similarity=0.363 Sum_probs=203.5
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecC
Q 007177 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM 104 (614)
Q Consensus 26 LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~ 104 (614)
||+|+||+||+|.++.+++.||+|++..... .......+..|+.+|+.++||||+++.+++ .....+|+|||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 7999999999999999999999999874321 222345677899999999999999999988 4456799999999
Q ss_pred C-CcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCcc
Q 007177 105 E-SDLHQVIK----ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 179 (614)
Q Consensus 105 ~-g~L~~~i~----~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~ 179 (614)
+ ++|...+. .+..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--- 152 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--- 152 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc---
Confidence 8 58887774 235699999999999999999999999999999999999999999999999999976533221
Q ss_pred ccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHH
Q 007177 180 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKAR 259 (614)
Q Consensus 180 ~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~ 259 (614)
......||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||...........+.
T Consensus 153 ~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~-------------------- 210 (280)
T cd05608 153 KTKGYAGTPGFMAPELLQG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK-------------------- 210 (280)
T ss_pred cccccCCCcCccCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH--------------------
Confidence 1234579999999999987 678999999999999999999999997654321111110
Q ss_pred HHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 007177 260 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 314 (614)
Q Consensus 260 ~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~ 314 (614)
..+. ..+ ......+++.+.+|+.+||+.||++|| +++++++||||+++
T Consensus 211 ---~~~~-~~~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 211 ---QRIL-NDS---VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred ---Hhhc-ccC---CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 0000 001 112245788999999999999999999 88999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=364.87 Aligned_cols=249 Identities=29% Similarity=0.467 Sum_probs=205.4
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHH-HHHhcCCCCcceeeeEecCCCCCCCCcEEEEE
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIK-LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~-iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~ 101 (614)
+.||+|+||.||+|.+..+++.||+|++..... .......+.+|.. +++.++||||+++++.+ .+.+.+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence 479999999999999999999999999874321 1223344555554 56789999999999988 4556799999
Q ss_pred ecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007177 102 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 180 (614)
Q Consensus 102 E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 180 (614)
|||. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~---~ 152 (325)
T cd05602 76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---T 152 (325)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC---C
Confidence 9999 59999998888899999999999999999999999999999999999999999999999999975432221 1
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHH
Q 007177 181 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260 (614)
Q Consensus 181 ~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~ 260 (614)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-------------------- 210 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN-------------------- 210 (325)
T ss_pred cccccCCccccCHHHHcC--CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh--------------------
Confidence 245679999999999987 6789999999999999999999999988776544433311
Q ss_pred HHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHH----HHHcCccccc
Q 007177 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE----EALADPYFKG 313 (614)
Q Consensus 261 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~----eiL~hp~f~~ 313 (614)
.+ ....+.+++.+.+||.+||+.||.+|+++. ++++|+||..
T Consensus 211 --------~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 211 --------KP---LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred --------CC---cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 01 112356789999999999999999999875 8999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=354.74 Aligned_cols=258 Identities=26% Similarity=0.395 Sum_probs=210.3
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
.|++.+.||+|+||.||++.+..+++.||+|++..... .......+.+|+.+++.++||||+.+++.+ .+...+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence 48999999999999999999999999999999864322 222334567899999999999999999988 344579
Q ss_pred EEEEecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 98 YVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
|+|||||. ++|.+.+... ..+++..+..++.||+.||.|||+.||+||||||+||++++++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999998 5888877543 46999999999999999999999999999999999999999999999999999764322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
.. ....+|+..|+|||++.+ ..++.++||||+||++|+|++|..||.+.+.......+...
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~------------- 216 (285)
T cd05605 156 ET----IRGRVGTVGYMAPEVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR------------- 216 (285)
T ss_pred Cc----cccccCCCCccCcHHhcC--CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH-------------
Confidence 11 133478999999999876 67899999999999999999999999876643332222110
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 314 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~ 314 (614)
+... . ......+++.+.+||.+||..||++|| +++++++||||...
T Consensus 217 ----------~~~~-~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 217 ----------VKED-Q---EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred ----------hhhc-c---cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 0000 0 112245788999999999999999999 99999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=347.09 Aligned_cols=258 Identities=26% Similarity=0.432 Sum_probs=212.4
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCC---hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH---ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~---~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
+.|++.+.||+|++|.||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++ .+.
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccC
Confidence 4699999999999999999999999999999998643222 12345678999999999999999999998 445
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
..+|+|+||+. ++|.+.+.....+++..++.+++||+.||.|||+.||+||||+|+||+++.++.+||+|||+++....
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 68999999998 59999998888899999999999999999999999999999999999999999999999999976433
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
............++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------- 221 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISG--EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT------------- 221 (263)
T ss_pred cccccccccCCCcCccccCcceecc--CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc-------------
Confidence 2221111134568889999999987 5689999999999999999999999976544333222110
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
... .......++..+.+||.+||..||.+|||+.++|+||||
T Consensus 222 -------------~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 222 -------------QPT---NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred -------------cCC---CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 000 011223578899999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=369.96 Aligned_cols=258 Identities=26% Similarity=0.341 Sum_probs=204.6
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.+.|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++|+||+++++++ .+.+.
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~ 146 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGE 146 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCe
Confidence 467889999999999999999999999999999986432 233456788999999999999999999998 45577
Q ss_pred EEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|+|||||++ +|... ..+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 147 ~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 147 IQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999999995 66542 346788889999999999999999999999999999999999999999999998653221
Q ss_pred CCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~---~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
. .....+||..|+|||++... ...++.++|||||||++|||++|+.||......+....+.
T Consensus 223 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~------------- 286 (353)
T PLN00034 223 D---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC------------- 286 (353)
T ss_pred c---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH-------------
Confidence 1 12345799999999987431 1234568999999999999999999997433211111110
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
...... .......++..+++||.+||..||++|||+.|+|+||||.+-
T Consensus 287 -----------~~~~~~---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 287 -----------AICMSQ---PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred -----------HHhccC---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 000000 111234678899999999999999999999999999999864
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=367.93 Aligned_cols=277 Identities=24% Similarity=0.333 Sum_probs=209.2
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
..|++++.||+|+||.||+|.+..++..||+|+.... ....|+.+|+.++||||+++++++. .....
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 132 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLV-----SGAIT 132 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEE-----eCCee
Confidence 4699999999999999999999999999999975432 2356999999999999999999884 44568
Q ss_pred EEEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 98 YVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 98 ylV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
|+|||++.++|.+++.. ...+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 133 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 133 CMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred EEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 99999999999998865 4579999999999999999999999999999999999999999999999999997532221
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCC-CCCCCCCh---------hHHHHHHHhhhCCCc
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNV---------VHQLDLMTDLLGTPS 246 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~-~pF~g~~~---------~~~l~~i~~~~g~p~ 246 (614)
......||..|+|||++.+ ..|+.++|||||||++|||+++. ++|..... ...+..+...++...
T Consensus 212 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 286 (357)
T PHA03209 212 ---AFLGLAGTVETNAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHP 286 (357)
T ss_pred ---ccccccccccccCCeecCC--CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccCh
Confidence 1234579999999999987 67999999999999999999854 44443221 223333444444332
Q ss_pred hhhhhhhhchhHHHHHHhhcccCCCcccC----CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQ----KFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 247 ~~~i~~~~~~~~~~~l~~~~~~~~~~~~~----~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
..............++..... ...++.. ...+++..+.+||.+||++||.+|||+.|+|+||||+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 287 EEFPRDPGSRLVRGFIEYASL-ERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred hhcCCCCccHHHHHHHhhccc-CCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 221111111111122211110 0011111 123567788999999999999999999999999999863
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=351.78 Aligned_cols=280 Identities=39% Similarity=0.737 Sum_probs=222.7
Q ss_pred eEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCcEE
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
|++++.||+|+||.||+|.+..+++.||+|+++...... ......+|+.+++.+. ||||+++++++... ..+.+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEE
Confidence 788999999999999999999999999999987643332 2234567999998885 99999999998532 225789
Q ss_pred EEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007177 99 VVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 177 (614)
Q Consensus 99 lV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 177 (614)
+||||++++|.+.+.. ...+++..+..++.||+.||.|||+.||+||||||+||+++. +.+||+|||+++.......
T Consensus 77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 77 LVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 9999999999988876 357899999999999999999999999999999999999999 9999999999986543222
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchh
Q 007177 178 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257 (614)
Q Consensus 178 ~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~ 257 (614)
.....++..|+|||++... ..++.++|||||||++|+|++|.+||++.+..+.+..+.+.++.+............
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 155 ---YTEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred ---cCCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 2345688999999976432 457889999999999999999999999999988889998888887765533221111
Q ss_pred HHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 258 ~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
...+ .........+....+.++..+.+||.+||..||.+|||++++|+||||
T Consensus 231 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 231 HMNY--NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccc--cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0000 000000111112234678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=354.70 Aligned_cols=286 Identities=38% Similarity=0.673 Sum_probs=225.7
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
++|++.+.||.|+||.||+|.+..+++.||+|+++...........+.+|+.+++.++|+||+++++++. +.+..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR-----RKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEE-----ECCEE
Confidence 4799999999999999999999999999999998754444444567889999999999999999999983 45679
Q ss_pred EEEEecCCCcHHHH-HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 98 YVVFELMESDLHQV-IKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 98 ylV~E~~~g~L~~~-i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
|+||||+++++.+. +.....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++........
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 76 YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99999999755544 45556799999999999999999999999999999999999999999999999999987543322
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhch
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~ 256 (614)
.....++++.+|+|||++.+. ..++.++|+|||||++|+|++|.+||.+.+..+.+..+...++.............
T Consensus 156 --~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 156 --SPLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred --ccccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 122456789999999998762 37889999999999999999999999998888877777777766554433322111
Q ss_pred hHHHHHHhhcccCCCcccCCCCC-CCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 257 KARRYLTSMRKKQPVQFSQKFPN-ADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 257 ~~~~~l~~~~~~~~~~~~~~~~~-~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
....-...........+...++. ++..+.+||++||..||.+|||++++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00000000000011111122333 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=380.54 Aligned_cols=268 Identities=26% Similarity=0.382 Sum_probs=220.4
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC--
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-- 91 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~-- 91 (614)
....++|.+.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+|..++|+||+++++.+.....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 344589999999999999999999999999999999997654555667778899999999999999999887643321
Q ss_pred -CCCCcEEEEEecCC-CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeec
Q 007177 92 -RDFKDIYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 165 (614)
Q Consensus 92 -~~~~~~ylV~E~~~-g~L~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DF 165 (614)
.....+++||||+. |+|.+.+.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 11224789999999 699998864 346899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCC
Q 007177 166 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 245 (614)
Q Consensus 166 Gla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p 245 (614)
|+++........ ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..+..
T Consensus 188 Gls~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~--~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~----- 259 (496)
T PTZ00283 188 GFSKMYAATVSD-DVGRTFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA----- 259 (496)
T ss_pred ccCeeccccccc-cccccccCCcceeCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-----
Confidence 999865432211 11234679999999999987 6799999999999999999999999988765444333211
Q ss_pred chhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 246 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 246 ~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
.. .....+.+++.+.+||.+||..||.+||++.++|+|||++.+
T Consensus 260 ----------------------~~---~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 260 ----------------------GR---YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred ----------------------CC---CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 00 111234678899999999999999999999999999998754
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=362.37 Aligned_cols=283 Identities=23% Similarity=0.363 Sum_probs=216.2
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|++.+.||.|+||.||+|.+..++..+|+|.+.... .......+.+|+++|+.++||||+++++++. +.+.
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 77 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGE 77 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEE-----ECCE
Confidence 468999999999999999999999999999999887532 3344567889999999999999999999983 4567
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999998 59999998888899999999999999999999975 7999999999999999999999999999754322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHh-hhCCCchhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD-LLGTPSLDTISRV 253 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~-~~g~p~~~~i~~~ 253 (614)
. .....|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||...+..+....+.. ..+.+........
T Consensus 158 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred c-----cccCCCCccccCHHHhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 1 133578999999999977 5789999999999999999999999987654332221110 1111111000000
Q ss_pred hc----------------hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 254 RN----------------DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 254 ~~----------------~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
.. .........+.......+. ....+.++.+||.+||++||++|||++|+|.||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLP--SGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCC--CCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 00 0000111111111111110 12357889999999999999999999999999999853
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=363.60 Aligned_cols=255 Identities=31% Similarity=0.414 Sum_probs=209.3
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcE-EEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEK-VAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~-vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
.+.....+.+.||.|+||+||++.. .|.. ||||++............+.+|+.+|..|+|||||++++++..+.
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~--- 112 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP--- 112 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC---
Confidence 3445566777899999999999965 4666 999999865544455778999999999999999999999995432
Q ss_pred CCcEEEEEecCC-CcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC-eEeecCCCCcEEECCCC-cEEEeecCcc
Q 007177 94 FKDIYVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTAN-VYHRDLKPKNILANANC-KLKICDFGLA 168 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~g-IvHrDLKP~NILi~~~~-~vKL~DFGla 168 (614)
..++||||||. |+|.+++.. ...++...+..|+.||++||.|||+++ ||||||||+|||++.++ ++||||||++
T Consensus 113 -~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 113 -GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred -CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 16899999999 799999987 678999999999999999999999999 99999999999999998 9999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007177 169 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~ 248 (614)
+...... ...+...||+.|||||++.+....|+.++||||||++||||+||..||.+.........+.....+|
T Consensus 192 r~~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp--- 265 (362)
T KOG0192|consen 192 REKVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP--- 265 (362)
T ss_pred eeecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC---
Confidence 8754321 1224468999999999998411589999999999999999999999999988744433332111111
Q ss_pred hhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 249 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 249 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.+ ....++.+..|+++||..||.+||+..+++.
T Consensus 266 ---------------------~~-----p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 266 ---------------------PI-----PKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ---------------------CC-----CccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 11 1126789999999999999999999999865
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=366.11 Aligned_cols=250 Identities=26% Similarity=0.432 Sum_probs=203.4
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhc---CCCCcceeeeEecCCCCCCCCcEEEEE
Q 007177 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLL---RHPDIVEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 26 LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L---~HpnIv~l~~v~~~~~~~~~~~~ylV~ 101 (614)
||+|+||.||+|.++.+++.||||++.+.. ...........|..++..+ .||||+++++.+ .+...+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 799999999999999999999999986421 1223344566777777665 699999999998 4556799999
Q ss_pred ecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007177 102 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 180 (614)
Q Consensus 102 E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 180 (614)
||+. ++|.+.+...+.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~---~ 152 (330)
T cd05586 76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK---T 152 (330)
T ss_pred cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---C
Confidence 9998 59999998888999999999999999999999999999999999999999999999999999875332221 1
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHH
Q 007177 181 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260 (614)
Q Consensus 181 ~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~ 260 (614)
....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+.+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~-------------------- 211 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF-------------------- 211 (330)
T ss_pred ccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc--------------------
Confidence 2456799999999998652 4588999999999999999999999988765443333211
Q ss_pred HHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC----CHHHHHcCcccccC
Q 007177 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP----TAEEALADPYFKGL 314 (614)
Q Consensus 261 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp----sa~eiL~hp~f~~~ 314 (614)
. ...+. ...+++.+.+||++||..||.+|| +++++++||||...
T Consensus 212 -------~-~~~~~--~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 212 -------G-KVRFP--KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred -------C-CCCCC--CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 0 00010 123678999999999999999998 79999999999854
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=355.76 Aligned_cols=287 Identities=38% Similarity=0.617 Sum_probs=220.1
Q ss_pred CeEEEeEeeecCceEEEEEEECC--CCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTH--TGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~--tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
+|++.+.||+|+||.||+|.+.. ++..||||.+.... ........+.+|+.+++.++||||+++++.+... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 58999999999999999999988 89999999997532 1122335677899999999999999999998543 236
Q ss_pred cEEEEEecCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC----CCcEEEeecC
Q 007177 96 DIYVVFELMESDLHQVIKAN-----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA----NCKLKICDFG 166 (614)
Q Consensus 96 ~~ylV~E~~~g~L~~~i~~~-----~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~----~~~vKL~DFG 166 (614)
.+|+||||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 79999999999888877532 26899999999999999999999999999999999999999 8999999999
Q ss_pred ccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChh---------HHHHH
Q 007177 167 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV---------HQLDL 237 (614)
Q Consensus 167 la~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~---------~~l~~ 237 (614)
++................+++.+|+|||++.+. ..++.++|||||||++|+|++|++||.+.... ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 998654332212222345789999999987652 46789999999999999999999999876543 35566
Q ss_pred HHhhhCCCchhhhhhhhchhHHHHHHh--hcccCCCc------ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCc
Q 007177 238 MTDLLGTPSLDTISRVRNDKARRYLTS--MRKKQPVQ------FSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 309 (614)
Q Consensus 238 i~~~~g~p~~~~i~~~~~~~~~~~l~~--~~~~~~~~------~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp 309 (614)
+...++.+....+....... .+... ........ ....+...+..+.+||.+||+.||++|||+.|+++||
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~ 314 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMP--EYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHP 314 (316)
T ss_pred HHHHhCCCchhHHHHHhhcc--cchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCC
Confidence 66677766554443221110 11110 00000000 0111125678899999999999999999999999999
Q ss_pred cc
Q 007177 310 YF 311 (614)
Q Consensus 310 ~f 311 (614)
||
T Consensus 315 ~f 316 (316)
T cd07842 315 YF 316 (316)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=350.19 Aligned_cols=286 Identities=37% Similarity=0.617 Sum_probs=221.1
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
++..++|++++.||+|+||.||+|.++.+|..||||.+..... ......+.+|+.+|+.++|+||+++++++ .+
T Consensus 1 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~ 74 (291)
T cd07870 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDII-----HT 74 (291)
T ss_pred CCccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ec
Confidence 3566889999999999999999999999999999999864322 22233567899999999999999999998 34
Q ss_pred CCcEEEEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 94 FKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 94 ~~~~ylV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
....|+||||+.++|.+.+.. ...+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 75 KETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred CCeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 567999999999888877754 3568899999999999999999999999999999999999999999999999997543
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-hhHHHHHHHhhhCCCchhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN-VVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~-~~~~l~~i~~~~g~p~~~~i~ 251 (614)
.... ......++..|+|||.+.+. ..++.++|+|||||++|+|++|..||.+.+ ..+++..+...+|.|......
T Consensus 155 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 155 IPSQ---TYSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred CCCC---CCCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence 2211 12334678999999988652 457889999999999999999999997765 345666677777777655443
Q ss_pred hhhchhHHHHHHh-hcccCCCcccCCCC--CCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 252 RVRNDKARRYLTS-MRKKQPVQFSQKFP--NADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 252 ~~~~~~~~~~l~~-~~~~~~~~~~~~~~--~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
..... ..+... .....+..+...+. ..++.+.+||.+||..||.+|||++|+|.||||
T Consensus 231 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 231 GVSKL--PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhhhc--ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 32210 000000 00011111111222 236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=349.82 Aligned_cols=282 Identities=47% Similarity=0.766 Sum_probs=234.9
Q ss_pred eEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEE
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 99 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~yl 99 (614)
|++.+.||.|++|.||+|.+..+++.+++|.+............+.+|+.+|+.++||||+++++++ .+...+|+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-----RHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-----ccCCCEEE
Confidence 6788999999999999999999999999999876544444566788999999999999999999988 34467999
Q ss_pred EEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCc
Q 007177 100 VFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 178 (614)
Q Consensus 100 V~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~ 178 (614)
|+||++++|.+.+.. ...+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||.+.......
T Consensus 76 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--- 152 (283)
T cd05118 76 VFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--- 152 (283)
T ss_pred EEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence 999999999888876 4579999999999999999999999999999999999999999999999999997654332
Q ss_pred cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhH
Q 007177 179 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 258 (614)
Q Consensus 179 ~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~ 258 (614)
.......++.+|+|||.+.+. ..++.++|+|||||++|+|++|+.||++.+..+++..+...++.+....+...... .
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 230 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL-A 230 (283)
T ss_pred ccccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh-h
Confidence 122345688899999998762 37899999999999999999999999999999999999888888877665554331 1
Q ss_pred HHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 259 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 259 ~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
..................++.++..+.+||.+||..||.+||+++++|.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 11111122223333344556789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=358.79 Aligned_cols=258 Identities=21% Similarity=0.391 Sum_probs=206.2
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCcEEEEE
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~~~ylV~ 101 (614)
+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++..+ +||||+.+++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence 479999999999999999999999999975422 233456678999999888 599999999988 4556799999
Q ss_pred ecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007177 102 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 180 (614)
Q Consensus 102 E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 180 (614)
|||. ++|...+...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (327)
T cd05617 76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---T 152 (327)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHH
Q 007177 181 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260 (614)
Q Consensus 181 ~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~ 260 (614)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~--------------------~~~~ 210 (327)
T cd05617 153 TSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN--------------------TEDY 210 (327)
T ss_pred eecccCCcccCCHHHHCC--CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc--------------------cHHH
Confidence 234679999999999877 688999999999999999999999996432110000 0000
Q ss_pred HHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC------HHHHHcCcccccCC
Q 007177 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT------AEEALADPYFKGLS 315 (614)
Q Consensus 261 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps------a~eiL~hp~f~~~~ 315 (614)
....+ ...+.. ....++..+.+||.+||..||++|++ ++++++||||+.+.
T Consensus 211 ~~~~~-~~~~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 211 LFQVI-LEKPIR---IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred HHHHH-HhCCCC---CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 00011 111111 12346889999999999999999997 57999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=338.71 Aligned_cols=254 Identities=28% Similarity=0.465 Sum_probs=211.0
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
.|++++.||+|++|.||++.++.+++.||+|++............+.+|+.+++.++||||+++++.+. .....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence 499999999999999999999999999999999754444455667889999999999999999988763 2334689
Q ss_pred EEEecCC-CcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 99 VVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 99 lV~E~~~-g~L~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+||||+. ++|.+.+.. ...+++..++.++.||+.||.+||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999998 589998876 3458999999999999999999999999999999999999999999999999997653322
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
. ......+++.|+|||++.+ ..++.++|+|||||++++|++|+.||.+.+.......+..
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~--------------- 216 (257)
T cd08223 157 D---MASTLIGTPYYMSPELFSN--KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE--------------- 216 (257)
T ss_pred C---ccccccCCcCccChhHhcC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---------------
Confidence 1 2234578899999999877 6788999999999999999999999987664333222211
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
.. .......+++.+.+||.+||+.||++|||+.++|+||||
T Consensus 217 -----------~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 217 -----------GK----LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -----------cC----CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 011123577899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=350.04 Aligned_cols=256 Identities=28% Similarity=0.473 Sum_probs=223.8
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
.+.|.++++||+|.||.|-+|+.+.+++.||||++++... ...+....+.|-.+|+..+||.+..+.-.| +...
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccCc
Confidence 3568889999999999999999999999999999986532 344567778899999999999999998877 5667
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
.+|+||||.. |+|+..+.....++++..+++-..|+.||.|||+.+||.||||.+|+|+|.+|++||.||||++.....
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 7999999999 599999988889999999999999999999999999999999999999999999999999999865443
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
..+ ..++||||.|+|||++.. ..|+.++|+|.+|+++|||++|+.||...+.......|.-.
T Consensus 322 g~t---~kTFCGTPEYLAPEVleD--nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e------------- 383 (516)
T KOG0690|consen 322 GDT---TKTFCGTPEYLAPEVLED--NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME------------- 383 (516)
T ss_pred cce---eccccCChhhcCchhhcc--ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-------------
Confidence 333 367899999999999987 68999999999999999999999999998876666655210
Q ss_pred chhHHHHHHhhcccCCCcccCCCC-CCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFP-NADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 314 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~-~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~ 314 (614)
.-.|| .++++++.||..+|.+||++|. .+.||.+|+||..+
T Consensus 384 -------------------d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 384 -------------------DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred -------------------hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 01233 5899999999999999999996 67899999999875
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=358.85 Aligned_cols=293 Identities=39% Similarity=0.608 Sum_probs=233.5
Q ss_pred CCCCCCeEE-EeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHH------------HHHHHHHHHHHHhcCCCCcc
Q 007177 14 YGDASRYKI-QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISD------------AARILREIKLLRLLRHPDIV 80 (614)
Q Consensus 14 ~~~~~rY~i-~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~------------~~~i~~Ei~iL~~L~HpnIv 80 (614)
+...+||.. .+.||.|+||+||+|.++.+++.||||++......... ...+.+|+.+|+.++||||+
T Consensus 4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 83 (335)
T PTZ00024 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM 83 (335)
T ss_pred cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence 345678875 57799999999999999999999999998643221100 12467899999999999999
Q ss_pred eeeeEecCCCCCCCCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcE
Q 007177 81 EIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKL 160 (614)
Q Consensus 81 ~l~~v~~~~~~~~~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~v 160 (614)
++++++. .....|+||||+.++|.+++.....++++.+..++.||+.||.|||+.||+|+||||+|||++.++.+
T Consensus 84 ~~~~~~~-----~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 84 GLVDVYV-----EGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred eeeEEEe-----cCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCE
Confidence 9999983 44679999999999999999888889999999999999999999999999999999999999999999
Q ss_pred EEeecCccccccCCC-----------CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 007177 161 KICDFGLARVAFNDT-----------PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 229 (614)
Q Consensus 161 KL~DFGla~~~~~~~-----------~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~ 229 (614)
||+|||+++...... ..........++..|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999997654111 011112334578899999988653 45789999999999999999999999999
Q ss_pred ChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCc
Q 007177 230 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 309 (614)
Q Consensus 230 ~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp 309 (614)
+..+++..+...++.|....+....... .+ .......+..+...++..+..+.+||.+||..||.+|||++|+|.||
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKKLP--LY-TEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhhcc--cc-cccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 9999999999988888765443221100 00 00111122223334556788999999999999999999999999999
Q ss_pred ccccCC
Q 007177 310 YFKGLS 315 (614)
Q Consensus 310 ~f~~~~ 315 (614)
||+...
T Consensus 315 ~~~~~~ 320 (335)
T PTZ00024 315 YFKSDP 320 (335)
T ss_pred ccCCCC
Confidence 998653
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=347.24 Aligned_cols=281 Identities=42% Similarity=0.710 Sum_probs=233.7
Q ss_pred eEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEE
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 99 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~yl 99 (614)
|++.+.||+|.||.||+|.+..+++.||+|++............+.+|+.+++.++|+||+++++++. +...+|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence 67889999999999999999999999999999865433444566788999999999999999999883 4467999
Q ss_pred EEecCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCc
Q 007177 100 VFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 178 (614)
Q Consensus 100 V~E~~~g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~ 178 (614)
||||++++|.+++... ..+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||+++.......
T Consensus 76 v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 76 VFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred EecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 9999999999999876 5799999999999999999999999999999999999999999999999999976533221
Q ss_pred cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhH
Q 007177 179 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 258 (614)
Q Consensus 179 ~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~ 258 (614)
......++..|+|||.+.+. ..++.++|+|||||++++|++|.+||.+.+..+.+..+...++.+....+.......
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP- 230 (282)
T ss_pred -ccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc-
Confidence 12334567889999988652 478899999999999999999999999999999999999999988877665443321
Q ss_pred HHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 259 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 259 ~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
.+...............++..+..+.++|.+||..||++||++++++.||||
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 231 -DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred -cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1111111222223334566778899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=372.72 Aligned_cols=257 Identities=24% Similarity=0.338 Sum_probs=212.4
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCC-CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHT-GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~t-g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
...|.+.+.||+|++|.||+|.+..+ +..||+|++.. ........+.+|+.+|+.++||||+++++.+ ...+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-----~~~~ 138 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML--NDERQAAYARSELHCLAACDHFGIVKHFDDF-----KSDD 138 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----EECC
Confidence 34599999999999999999998888 78899997753 2334456677899999999999999999998 4456
Q ss_pred cEEEEEecCC-CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 96 DIYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
.+|||||||. ++|.+.+.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 139 ~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~ 218 (478)
T PTZ00267 139 KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQ 218 (478)
T ss_pred EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCcee
Confidence 7999999998 699887753 44689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
...... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 219 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~---------- 285 (478)
T PTZ00267 219 YSDSVS-LDVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY---------- 285 (478)
T ss_pred cCCccc-cccccccCCCccccCHhHhCC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------
Confidence 543221 112345679999999999987 6799999999999999999999999988765444433311
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
... ......+++.+.+||.+||..||++||+++++|.|+|++.
T Consensus 286 -----------------~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 286 -----------------GKY---DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred -----------------CCC---CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 000 0112357789999999999999999999999999999864
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=389.34 Aligned_cols=269 Identities=27% Similarity=0.391 Sum_probs=217.6
Q ss_pred cccccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecC
Q 007177 9 EFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLP 88 (614)
Q Consensus 9 ~~~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~ 88 (614)
.+.+.....++|++++.||.|+||.||+|.+..++..||+|++............+.+|+.+|+.|+||||++++++|..
T Consensus 4 ~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 4 KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred cccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 34455566689999999999999999999999999999999997654555667788999999999999999999998854
Q ss_pred CCCCCCCcEEEEEecCC-CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-------CeEeecCCCCcEEECC
Q 007177 89 PSRRDFKDIYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTA-------NVYHRDLKPKNILANA 156 (614)
Q Consensus 89 ~~~~~~~~~ylV~E~~~-g~L~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~-------gIvHrDLKP~NILi~~ 156 (614)
. ....+|||||||. ++|.++|.. ...+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 84 e---~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 84 K---ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred c---CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 2 3356899999999 599998865 35799999999999999999999985 4999999999999964
Q ss_pred -----------------CCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHH
Q 007177 157 -----------------NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 219 (614)
Q Consensus 157 -----------------~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eL 219 (614)
.+.+||+|||++........ ....+||+.|+|||++.+....++.++||||||||||+|
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~----~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYEL 236 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM----AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCcccccccccc----ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHH
Confidence 23589999999976532211 234579999999999865335688999999999999999
Q ss_pred HhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCC
Q 007177 220 LTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR 299 (614)
Q Consensus 220 ltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~R 299 (614)
++|..||...+...++.... ..... ......+..+.+||..||.+||.+|
T Consensus 237 LTGk~PF~~~~~~~qli~~l--------------------------k~~p~----lpi~~~S~eL~dLI~~~L~~dPeeR 286 (1021)
T PTZ00266 237 CSGKTPFHKANNFSQLISEL--------------------------KRGPD----LPIKGKSKELNILIKNLLNLSAKER 286 (1021)
T ss_pred HHCCCCCCcCCcHHHHHHHH--------------------------hcCCC----CCcCCCCHHHHHHHHHHhcCChhHC
Confidence 99999997765443322111 01111 1123467899999999999999999
Q ss_pred CCHHHHHcCcccccC
Q 007177 300 PTAEEALADPYFKGL 314 (614)
Q Consensus 300 psa~eiL~hp~f~~~ 314 (614)
|++.|+|.||||+.+
T Consensus 287 PSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 287 PSALQCLGYQIIKNV 301 (1021)
T ss_pred cCHHHHhccHHHhhc
Confidence 999999999999743
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=347.95 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=208.1
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
+|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+|+.++|+||+.+++.+ .+...+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEE
Confidence 47889999999999999999999999999999864322 222345577899999999999999999988 344679
Q ss_pred EEEEecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 98 YVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999998 5898888543 35899999999999999999999999999999999999999999999999998754322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
.. .....|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+..........
T Consensus 156 ~~----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~---------------- 213 (285)
T cd05630 156 QT----IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---------------- 213 (285)
T ss_pred cc----ccCCCCCccccChHHHcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH----------------
Confidence 11 123478999999999976 67899999999999999999999999765321111111
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccC
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 314 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~eiL~hp~f~~~ 314 (614)
...+.... ......+++.+.+||.+||+.||++||| ++|+++||||+.+
T Consensus 214 ----~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 214 ----ERLVKEVQ-------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred ----Hhhhhhhh-------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 00111000 0122456789999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=342.97 Aligned_cols=282 Identities=37% Similarity=0.623 Sum_probs=225.5
Q ss_pred eEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc---CCCCcceeeeEecCCCCCCCCc
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL---RHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L---~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
|++.+.||.|+||.||+|.++.++..||+|++............+.+|+.+++.+ .||||+++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999998999999999975433333345566788887766 5999999999986554333445
Q ss_pred EEEEEecCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 97 IYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 97 ~ylV~E~~~g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
+|++|||+.++|.+++.... .+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 99999999999998887643 5899999999999999999999999999999999999999999999999999775432
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
.. .....++..|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+..+.+..+.+..+.+....+....
T Consensus 161 ~~----~~~~~~~~~~~~PE~~~~--~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 161 MA----LTSVVVTLWYRAPEVLLQ--SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred cc----cccccccccccChHHhcc--CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 21 123457889999999877 578899999999999999999999999999988888888877766543332211
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
...... ........+....+.+++.+.+||.+||..||.+||+++++|.||||
T Consensus 235 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSS----FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhh----cccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 100000 11112222233445677899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=357.11 Aligned_cols=286 Identities=21% Similarity=0.283 Sum_probs=208.1
Q ss_pred EEeEeeec--CceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEE
Q 007177 22 IQEVIGKG--SYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 99 (614)
Q Consensus 22 i~~~LG~G--~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~yl 99 (614)
++++||+| +|++||++.++.+|+.||||++............+.+|+.+++.++||||+++++++. +.+..|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence 57889999 6789999999999999999999765444445566778999999999999999999983 4467999
Q ss_pred EEecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 100 VFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 100 V~E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
|||||+ ++|.+++..+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++++||+.+........
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999998 6999988653 4589999999999999999999999999999999999999999999999987654322111
Q ss_pred Cc----cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch-hhhh
Q 007177 177 TT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL-DTIS 251 (614)
Q Consensus 177 ~~----~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~-~~i~ 251 (614)
.. .......++..|+|||++.+....|+.++|||||||++|+|++|..||........+.... .+.... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~ 234 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL--NGTVPCLLDTT 234 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHh--cCCcccccccc
Confidence 00 0112235677899999987533468999999999999999999999998765433322221 111100 0000
Q ss_pred hhhchhHHH----------HHH--h---h-cccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 252 RVRNDKARR----------YLT--S---M-RKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 252 ~~~~~~~~~----------~l~--~---~-~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
....+.... +.. . . ..............+++.+.+||.+||+.||++|||++|+|+||||+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 000000000 000 0 0 0000000011223467899999999999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.41 Aligned_cols=282 Identities=25% Similarity=0.377 Sum_probs=215.5
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
++|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|+++++.++||||+++++.+ .+.+.+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAF-----YSDGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCEE
Confidence 36999999999999999999999999999999987532 334456788999999999999999999998 455679
Q ss_pred EEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 98 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
|+||||++ ++|.+++...+.+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 75 ~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred EEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999998 5999999888889999999999999999999997 699999999999999999999999999987543221
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh----h
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI----S 251 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i----~ 251 (614)
....++++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+............ .
T Consensus 155 -----~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
T cd06615 155 -----ANSFVGTRSYMSPERLQG--THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVS 227 (308)
T ss_pred -----cccCCCCcCccChhHhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCccccc
Confidence 234578999999999876 56889999999999999999999999876643322222111000000000 0
Q ss_pred -----hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 252 -----RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 252 -----~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
........+....+....+. ......++.++.+||.+||..||++|||+.++|+||||.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIVNEPPP--KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CCCCCccchhhHHHHHHHHhcCCCc--cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 00000001111111111110 11112367889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=348.97 Aligned_cols=292 Identities=37% Similarity=0.610 Sum_probs=229.2
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-----
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS----- 90 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~----- 90 (614)
..++|++.+.||+|+||.||+|.++.+|+.||||+++...........+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 457899999999999999999999999999999999754333333456778999999999999999999885432
Q ss_pred CCCCCcEEEEEecCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 91 RRDFKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
..+...+|+|+||++++|...+... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 1223479999999999888888754 469999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 170 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 170 ~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
....... .......++..|+|||.+.+. ..++.++|||||||++++|++|++||...+..+.+..+....+.+....
T Consensus 165 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (302)
T cd07864 165 LYNSEES--RPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241 (302)
T ss_pred cccCCcc--cccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 6543322 112233567889999987642 4578899999999999999999999999998888888888888776654
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
+..+............ ..........+..++..+.+||.+||..||.+|||++++|.||||
T Consensus 242 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 242 WPDVIKLPYFNTMKPK-KQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccc-cccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 4322111000000000 000011122345678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=344.82 Aligned_cols=283 Identities=40% Similarity=0.682 Sum_probs=228.4
Q ss_pred eEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEE
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 99 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~yl 99 (614)
|++.+.||.|+||.||+|.+..+++.+|+|++............+.+|+.+++.++||||+++++++.... ....|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 78999999999999999999999999999999865433444566889999999999999999999984321 367999
Q ss_pred EEecCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCc
Q 007177 100 VFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 178 (614)
Q Consensus 100 V~E~~~g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~ 178 (614)
||||++++|.+++... ..+++..++.++.||+.||+|||+.|++|+||||+||++++++.+||+|||++........
T Consensus 78 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-- 155 (287)
T cd07840 78 VFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-- 155 (287)
T ss_pred EeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--
Confidence 9999999999988765 5799999999999999999999999999999999999999999999999999986544321
Q ss_pred cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhH
Q 007177 179 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 258 (614)
Q Consensus 179 ~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~ 258 (614)
...+...++..|+|||.+.+. ..++.++|||||||++|+|++|+.||...+....+..+....+.+....+.....-.
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 233 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP- 233 (287)
T ss_pred ccccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch-
Confidence 112334678899999977642 467899999999999999999999999999888888888888887666554332210
Q ss_pred HHHHHhhccc--CCCcccCCCCCC-CHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 259 RRYLTSMRKK--QPVQFSQKFPNA-DPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 259 ~~~l~~~~~~--~~~~~~~~~~~~-s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
+....... ....+...+... ++.+.++|.+||..||.+||+++++++||||
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 234 --WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred --hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00000000 001111223333 8899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=345.69 Aligned_cols=253 Identities=24% Similarity=0.381 Sum_probs=200.9
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecC
Q 007177 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM 104 (614)
Q Consensus 26 LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~ 104 (614)
||+|+||.||++.++.+|+.||+|++...... ......+..|+.+|+.++||||+++++.+ .+...+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 79999999999999999999999998643221 22334456799999999999999999988 4556799999999
Q ss_pred C-CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCcccc
Q 007177 105 E-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 181 (614)
Q Consensus 105 ~-g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~ 181 (614)
. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ..
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~ 151 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TI 151 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc----ee
Confidence 8 58988876533 58899999999999999999999999999999999999999999999999987653321 12
Q ss_pred ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHH
Q 007177 182 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRY 261 (614)
Q Consensus 182 ~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~ 261 (614)
....|+..|+|||++.+ ..++.++|+|||||++|+|++|..||.+.........+. ...
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~-------------------~~~ 210 (277)
T cd05607 152 TQRAGTNGYMAPEILKE--EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK-------------------RRT 210 (277)
T ss_pred eccCCCCCccCHHHHcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH-------------------HHh
Confidence 34568999999999877 569999999999999999999999997643211100000 000
Q ss_pred HHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCH----HHHHcCcccccCC
Q 007177 262 LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA----EEALADPYFKGLS 315 (614)
Q Consensus 262 l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa----~eiL~hp~f~~~~ 315 (614)
.... .......+++++++||.+||+.||++||++ ++++.||||+.+.
T Consensus 211 ---~~~~----~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 211 ---LEDE----VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTIN 261 (277)
T ss_pred ---hccc----cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCC
Confidence 0000 111123578899999999999999999999 7788999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=343.51 Aligned_cols=260 Identities=26% Similarity=0.404 Sum_probs=209.7
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
...++|++.+.||+|+||.||+|.+..+++.||+|+++.. .......+.+|+.+++.++||||+++++.+ .+.
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~-----~~~ 78 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSY-----LRR 78 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EeC
Confidence 3456899999999999999999999999999999998743 223445677899999999999999999988 445
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
..+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.....
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 79 DKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 67999999998 59999998888999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCccccccccCCccccCcccccc-cCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~-~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
... ......|+..|+|||++.. ....++.++|+|||||++|+|++|..||........+..+..
T Consensus 159 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~------------ 223 (267)
T cd06645 159 TIA---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK------------ 223 (267)
T ss_pred ccc---ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc------------
Confidence 211 1234578999999998742 114688999999999999999999999865543222211100
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcc
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 310 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~ 310 (614)
....+..+ .....++..+.+||.+||..||++|||++++|+|||
T Consensus 224 -------------~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 224 -------------SNFQPPKL-KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred -------------cCCCCCcc-cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 00000000 111246778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=334.83 Aligned_cols=253 Identities=27% Similarity=0.436 Sum_probs=212.3
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
.|.+.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.+++.++||||+++++.+ .+.+..|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-----LDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-----ccCCEEE
Confidence 48899999999999999999999999999999875444456677888999999999999999999988 3446799
Q ss_pred EEEecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 99 VVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 99 lV~E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||+++......
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999998 5999998764 578999999999999999999999999999999999999999999999999988654322
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
. ......++.+|+|||++.+ ..++.++|+|||||++++|++|+.||...+.......+..
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 215 (256)
T cd08529 156 N---FANTIVGTPYYLSPELCED--KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR--------------- 215 (256)
T ss_pred c---hhhccccCccccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---------------
Confidence 1 1234568899999999887 5788999999999999999999999987764333322211
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
.. +......++..+.++|.+||+.+|++||++.++++|||+
T Consensus 216 ------------~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 216 ------------GV---FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ------------CC---CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 00 011112467899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=343.98 Aligned_cols=254 Identities=26% Similarity=0.473 Sum_probs=214.6
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
++|++.+.||+|+||.||++.+..+++.||+|++.... ........+.+|+++|+.++||||+++++.+ .+...
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCe
Confidence 47999999999999999999999999999999986432 2234456788999999999999999999998 45567
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+.||+|+||+|.|||++.++.+||+|||++......
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999996 799999988889999999999999999999999999999999999999999999999999999865433
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
.....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+..
T Consensus 155 -----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 212 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILS--KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--------------- 212 (290)
T ss_pred -----CCCCCCCccccChhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------
Confidence 123468899999999876 5788999999999999999999999987664333322210
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCC
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGLS 315 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~~ 315 (614)
. ... .....++.+.++|.+||..||.+|+ +++|+++||||+.+.
T Consensus 213 -----------~--~~~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 213 -----------G--KVR---FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred -----------C--Ccc---CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 0 011 1124578999999999999999999 999999999998653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=344.25 Aligned_cols=258 Identities=26% Similarity=0.403 Sum_probs=210.6
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
.|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+|+.++|+||+.+.+.+ .+...+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEE
Confidence 47889999999999999999999999999999864322 222345577899999999999999999988 445679
Q ss_pred EEEEecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 98 YVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
|+||||+. ++|...+... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999999 5888877543 36999999999999999999999999999999999999999999999999998754322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
. ......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||.+.........+...
T Consensus 156 ~----~~~~~~g~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~------------- 216 (285)
T cd05632 156 E----SIRGRVGTVGYMAPEVLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR------------- 216 (285)
T ss_pred C----cccCCCCCcCccChHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-------------
Confidence 1 1234578999999999876 67899999999999999999999999877654333322110
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccC
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 314 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~eiL~hp~f~~~ 314 (614)
.... . ......+++.+.+|+.+||+.||++||+ +++++.|+||+..
T Consensus 217 ----------~~~~-~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 217 ----------VLET-E---EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred ----------hhcc-c---cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 0000 0 1122457789999999999999999999 8999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=354.25 Aligned_cols=253 Identities=26% Similarity=0.455 Sum_probs=199.8
Q ss_pred CCeEEEeEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAID-----THTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d-----~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~ 91 (614)
++|++.+.||+|+||.||+|.+ ..+++.||+|+++.. ........+.+|+.+|+.+ +||||+++++++..
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 82 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTK--- 82 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecC---
Confidence 5899999999999999999975 245578999998743 2334456788999999999 89999999998742
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhC-------------------------------------------------------
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------- 115 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~------------------------------------------------------- 115 (614)
....+|+|||||+ |+|.+++...
T Consensus 83 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 83 -PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred -CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 2346899999999 6999988652
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCc
Q 007177 116 -------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 188 (614)
Q Consensus 116 -------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~ 188 (614)
..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++........ .......++.
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~ 240 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGSARLPL 240 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch-hcccCCCCCc
Confidence 24788899999999999999999999999999999999999999999999999865332211 1112234567
Q ss_pred cccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcc
Q 007177 189 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRK 267 (614)
Q Consensus 189 ~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~ 267 (614)
.|+|||++.+ ..++.++|||||||++|||++ |..||.+....+.+.... ..
T Consensus 241 ~y~aPE~~~~--~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~--------------------------~~ 292 (338)
T cd05102 241 KWMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL--------------------------KD 292 (338)
T ss_pred cccCcHHhhc--CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH--------------------------hc
Confidence 8999999876 678999999999999999997 999998765332221110 00
Q ss_pred cCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 268 KQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 268 ~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.... ......++.+.+||.+||..||.+|||+.++++
T Consensus 293 ~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 293 GTRM---RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0000 112356789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=343.65 Aligned_cols=264 Identities=23% Similarity=0.374 Sum_probs=212.7
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
....+.|++++.||.|+||.||+|.+..++..|++|.+... .......+.+|+.+++.++||||+++++.+. .
T Consensus 8 ~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 80 (292)
T cd06644 8 LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFY-----W 80 (292)
T ss_pred cCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----e
Confidence 34557899999999999999999999999999999998752 3445677889999999999999999999883 4
Q ss_pred CCcEEEEEecCCC-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 94 FKDIYVVFELMES-DLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 94 ~~~~ylV~E~~~g-~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
...+|+||||+++ +|..++.+ ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 81 ~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 81 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred CCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceec
Confidence 4679999999995 77776654 456899999999999999999999999999999999999999999999999998753
Q ss_pred cCCCCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~---~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~ 248 (614)
..... ......++..|+|||++.+. ...++.++|+|||||++|+|++|.+||...+.......+..
T Consensus 161 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~-------- 229 (292)
T cd06644 161 VKTLQ---RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-------- 229 (292)
T ss_pred ccccc---ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc--------
Confidence 32211 12345688899999988521 14578899999999999999999999977654332222210
Q ss_pred hhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 249 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 249 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
.. .+.......++..+.+||.+||..||.+||+++++|+||||..+.
T Consensus 230 ------------------~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 230 ------------------SE--PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred ------------------CC--CccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 00 001111235678899999999999999999999999999998654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=346.80 Aligned_cols=262 Identities=27% Similarity=0.451 Sum_probs=215.2
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.+|++.+.||.|+||.||+|.+..+++.||||.+...... ......+.+|+++|+.++||||+++++.+ .+...
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence 4799999999999999999999999999999999754222 23566788999999999999999999988 45567
Q ss_pred EEEEEecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 97 IYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
.|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999998 4999998754 5699999999999999999999999999999999999999999999999999875432
Q ss_pred CCCC--------------------------ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 007177 174 DTPT--------------------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 227 (614)
Q Consensus 174 ~~~~--------------------------~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~ 227 (614)
.... ......++||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--DGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--CCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 2110 011123578999999999876 578999999999999999999999998
Q ss_pred CCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC----HH
Q 007177 228 GKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT----AE 303 (614)
Q Consensus 228 g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps----a~ 303 (614)
+.+....+..+.. . ...+. ....+++.+.+||.+||..||++||| ++
T Consensus 234 ~~~~~~~~~~~~~--------------------------~--~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 234 GSNRDETFSNILK--------------------------K--EVTFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred CCchHHHHHHHhc--------------------------C--CccCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 8775444333211 0 01111 11236889999999999999999999 99
Q ss_pred HHHcCcccccCC
Q 007177 304 EALADPYFKGLS 315 (614)
Q Consensus 304 eiL~hp~f~~~~ 315 (614)
++|.||||++..
T Consensus 285 ~ll~~~~~~~~~ 296 (316)
T cd05574 285 EIKQHPFFRGVN 296 (316)
T ss_pred HHHcCchhhcCC
Confidence 999999998753
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=344.74 Aligned_cols=262 Identities=27% Similarity=0.438 Sum_probs=214.0
Q ss_pred ccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 12 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 12 ~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
+..+...+|++.+.||.|+||.||+|++..++..|++|.+.... ......+.+|+.+++.++||||+++++.+.
T Consensus 14 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~---- 87 (296)
T cd06654 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYL---- 87 (296)
T ss_pred ccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC--cchHHHHHHHHHHHHhCCCCCEeeEEEEEE----
Confidence 33455679999999999999999999999999999999987532 234566889999999999999999999884
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
+....|+||||+. ++|.+++.. ..+++.++..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~ 165 (296)
T cd06654 88 -VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (296)
T ss_pred -eCCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchh
Confidence 3457999999998 589998865 4689999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
...... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+..
T Consensus 166 ~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~---------- 230 (296)
T cd06654 166 ITPEQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---------- 230 (296)
T ss_pred cccccc---ccCcccCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc----------
Confidence 432211 1233478899999999876 5688999999999999999999999977654332221110
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
...........++..+.+||.+||..||++|||+.++|+||||...
T Consensus 231 ------------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 231 ------------------NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred ------------------CCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 0001111223567889999999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=337.73 Aligned_cols=260 Identities=25% Similarity=0.415 Sum_probs=207.7
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC---ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE---HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~---~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
..|++.+.||+|+||.||+|.+..++..|++|++..... .......+.+|+.+++.++||||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence 468999999999999999999999999999999864322 223456688999999999999999999987432 23
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
..+|+++||+. ++|.+.+.....+++...+.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 56899999998 59999998878899999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
............++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||........+..+.. .+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~-------- 225 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISG--EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QP-------- 225 (266)
T ss_pred ccccCCccccCCccccccCHHHhCC--CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CC--------
Confidence 2111111233468889999999876 5788999999999999999999999976543222211100 00
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~ 312 (614)
.. ......+++.+.+|| +||..||++||+++|+|+||||+
T Consensus 226 ---------------~~---~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 226 ---------------TN---PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ---------------CC---CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 00 011124577889999 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=389.62 Aligned_cols=263 Identities=26% Similarity=0.423 Sum_probs=227.5
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
.++|.|+++||+|+||.|.+++++.|++.||+|++++. ..+..+...|..|-.+|-.-..+=|+.++-.| +|..
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~~ 148 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDER 148 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCcc
Confidence 46799999999999999999999999999999999863 22345666788899999888888899998888 7889
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
++|+|||||. |||..++...+.++++.+++|+..|+.||.-||+.|+|||||||+|||+|..|+|||+|||.|-....+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 9999999998 699999998889999999999999999999999999999999999999999999999999999776543
Q ss_pred CCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~---~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
. .......||||.|.|||++... .+.|++.||+|||||++||||.|..||...+.++.+.+|++.
T Consensus 229 G--~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h---------- 296 (1317)
T KOG0612|consen 229 G--TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH---------- 296 (1317)
T ss_pred C--cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch----------
Confidence 3 3334567999999999998532 256999999999999999999999999999988888888642
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC---HHHHHcCcccccC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT---AEEALADPYFKGL 314 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps---a~eiL~hp~f~~~ 314 (614)
+..+.|.. -..+|+++++||.++|. +|..|.. ++++-.||||.++
T Consensus 297 ----------------k~~l~FP~-~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 297 ----------------KESLSFPD-ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred ----------------hhhcCCCc-ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence 22233332 23489999999999998 8889998 9999999999875
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=364.28 Aligned_cols=260 Identities=25% Similarity=0.414 Sum_probs=215.5
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
+-|.|+..||.|+||.||+|.++.++-..|.|+|.. ........++-||.||..++||+||++++.|+ ..+.+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy-----~enkL 104 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYY-----FENKL 104 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHh-----ccCce
Confidence 457899999999999999999999998899998864 34567788999999999999999999999984 44679
Q ss_pred EEEEecCCC-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 98 YVVFELMES-DLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 98 ylV~E~~~g-~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|+.|||.| -...++.. ...|++.+++.+++|+|.||+|||+++|||||||..|||++-+|.|+|+|||.+-...
T Consensus 105 wiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--- 181 (1187)
T KOG0579|consen 105 WILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--- 181 (1187)
T ss_pred EEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch---
Confidence 999999996 44444433 5579999999999999999999999999999999999999999999999999885432
Q ss_pred CCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~---~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.+......++|||+|||||+.... ..+|+.++||||||+.|.||.-+.||....+.+..+-+|.+
T Consensus 182 ~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK------------ 249 (1187)
T KOG0579|consen 182 STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK------------ 249 (1187)
T ss_pred hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh------------
Confidence 222233568999999999986431 25799999999999999999999999988887766655422
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
..|..+. ....++..+.|||.+||..||..||++.++|+||||++..
T Consensus 250 ---------------SePPTLl-qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 250 ---------------SEPPTLL-QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred ---------------cCCCccc-CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 1111111 1234677899999999999999999999999999998653
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=345.95 Aligned_cols=263 Identities=29% Similarity=0.443 Sum_probs=214.3
Q ss_pred cCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 13 EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 13 ~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
.-+..++|++++.||.|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++.+ .
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~ 86 (297)
T cd06656 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSY-----L 86 (297)
T ss_pred cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCCCCCEeeEEEEE-----e
Confidence 3455689999999999999999999999999999999986432 23446678999999999999999999998 3
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
.....|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 87 VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (297)
T ss_pred cCCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEc
Confidence 4567999999998 589888865 45899999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
..... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+....+..+.. .+.
T Consensus 166 ~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~------- 232 (297)
T cd06656 166 TPEQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGT------- 232 (297)
T ss_pred cCCcc---CcCcccCCccccCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCC-------
Confidence 32221 1234578899999999876 5788999999999999999999999977654322211100 000
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
+.......++..+.+||.+||..||.+||+++++|+||||+....
T Consensus 233 --------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 233 --------------------PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred --------------------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 011112346788999999999999999999999999999986544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=343.69 Aligned_cols=262 Identities=29% Similarity=0.486 Sum_probs=215.6
Q ss_pred cCC-CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 13 EYG-DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 13 ~~~-~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
+++ ...+|++.+.||.|+||.||+|++..+++.|+||.+... .......+.+|+.+++.++||||+++++.+
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~----- 85 (296)
T cd06655 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ--KQPKKELIINEILVMKELKNPNIVNFLDSF----- 85 (296)
T ss_pred hcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc--cCchHHHHHHHHHHHHhcCCCceeeeeeeE-----
Confidence 444 457899999999999999999999999999999998643 223456788999999999999999999998
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
.+...+|+|+||+. ++|..++... .+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++..
T Consensus 86 ~~~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~ 164 (296)
T cd06655 86 LVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164 (296)
T ss_pred ecCceEEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchh
Confidence 34567999999998 5888887654 699999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
....... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+....+..+..
T Consensus 165 ~~~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~---------- 229 (296)
T cd06655 165 ITPEQSK---RSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---------- 229 (296)
T ss_pred ccccccc---CCCcCCCccccCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------
Confidence 4332211 133468889999999876 5788999999999999999999999988765444332211
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
...........+++.+.+||.+||..||.+|||+.+++.||||+...
T Consensus 230 ------------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 230 ------------------NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred ------------------cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 00011112345788999999999999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=335.16 Aligned_cols=262 Identities=27% Similarity=0.419 Sum_probs=212.8
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
++|++.+.||.|+||.||+|.+..++..+++|++....... ....+.+|+.+|+.++|+||+++++.+ .+....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEE
Confidence 47999999999999999999999999999999987543222 667889999999999999999999988 445679
Q ss_pred EEEEecCC-CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 98 YVVFELME-SDLHQVIKAN---DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~~---~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
|+|||++. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||++++++.+||+|||++.....
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 99999998 5999998764 4589999999999999999999999999999999999999999999999999977554
Q ss_pred CCCCc-cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTT-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~-~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
..... ......+++..|+|||.+... ..++.++|+|||||++++|++|+.||...+....+..+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~----------- 222 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN----------- 222 (267)
T ss_pred CccccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC-----------
Confidence 32221 112345688999999998763 36889999999999999999999999766543322222110
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
..........+..+++.+.+||.+||..||.+|||++++|+||||
T Consensus 223 --------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 223 --------------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred --------------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 000111111234678899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=340.68 Aligned_cols=256 Identities=23% Similarity=0.360 Sum_probs=208.4
Q ss_pred eEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEE
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 99 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~yl 99 (614)
|++.+.||.|+||.||++.+..++..+++|.+... .......+.+|+.+++.++||||+++++.+. .....|+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~ 79 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWI 79 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEE
Confidence 78899999999999999999999999999998642 3345667889999999999999999999884 4467899
Q ss_pred EEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007177 100 VFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 177 (614)
Q Consensus 100 V~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 177 (614)
|+||+. ++|..++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence 999998 477777654 45799999999999999999999999999999999999999999999999999876432211
Q ss_pred ccccccccCCccccCcccccc---cCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 178 TIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 178 ~~~~~~~vgt~~Y~APEvl~~---~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
......++..|+|||++.. ....++.++|+|||||++|+|++|.+||...+.......+...
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~------------- 223 (282)
T cd06643 159 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS------------- 223 (282)
T ss_pred --ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc-------------
Confidence 1234578999999998742 1145788999999999999999999999876654433332110
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
... .......++..+.+||.+||..||.+||+++++|+||||..
T Consensus 224 --------------~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 224 --------------EPP-TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred --------------CCC-CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 000 00112346789999999999999999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=360.41 Aligned_cols=257 Identities=28% Similarity=0.551 Sum_probs=218.1
Q ss_pred CeEE--EeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 19 RYKI--QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 19 rY~i--~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
-|+| .++||+|.||+||-|+++++|+.||||+|.+..........+.+|+.||+.+.||.||.+.-.+ +....
T Consensus 563 vYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~er 637 (888)
T KOG4236|consen 563 VYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPER 637 (888)
T ss_pred HHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCce
Confidence 3554 4799999999999999999999999999987655555567788999999999999999998888 45567
Q ss_pred EEEEEecCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC---cEEEeecCccccc
Q 007177 97 IYVVFELMESDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC---KLKICDFGLARVA 171 (614)
Q Consensus 97 ~ylV~E~~~g~L~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~---~vKL~DFGla~~~ 171 (614)
+|+|||-+.||..+.|.+ .++|++..-++++.|||.||.|||-+||+|+||||+|||+.+.. .+||||||+|+..
T Consensus 638 vFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiI 717 (888)
T KOG4236|consen 638 VFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARII 717 (888)
T ss_pred EEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeec
Confidence 999999999999998854 56899999999999999999999999999999999999997653 6999999999987
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
.+.. +....+||+.|+|||++.. ..|+..-|+||+|+|+|--|.|..||....+.+. +|..
T Consensus 718 gEks----FRrsVVGTPAYLaPEVLrn--kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd--QIQN----------- 778 (888)
T KOG4236|consen 718 GEKS----FRRSVVGTPAYLAPEVLRN--KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND--QIQN----------- 778 (888)
T ss_pred chhh----hhhhhcCCccccCHHHHhh--ccccccccceeeeEEEEEEecccccCCCccchhH--Hhhc-----------
Confidence 5433 4456799999999999988 7899999999999999999999999965543221 1110
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
..-......|..+++++.|||..+|+..-.+|.|++..|.|||++++.
T Consensus 779 ----------------AaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 779 ----------------AAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred ----------------cccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 011122345788999999999999999999999999999999998754
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=336.27 Aligned_cols=256 Identities=28% Similarity=0.481 Sum_probs=209.7
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCCh-------HHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI-------SDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~-------~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
+|.+.+.||.|+||.||+|.+..++..||+|.+....... .....+.+|+.+++.++||||+++++.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----- 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS----- 75 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----
Confidence 5889999999999999999999999999999886432221 1235677999999999999999999987
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
.+....|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.|++||||+|+||+++.++.+||+|||+++.
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 76 LDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 44567899999998 49999998888899999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCc---cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007177 171 AFNDTPTT---IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247 (614)
Q Consensus 171 ~~~~~~~~---~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~ 247 (614)
........ .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+....+..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------- 226 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQ--TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE------- 226 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhcc--CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-------
Confidence 64221111 11123468889999999876 5788999999999999999999999987654332221110
Q ss_pred hhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 248 ~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
.........++..+.+||++||+.||.+||++.++|+||||
T Consensus 227 -----------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 227 -----------------------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred -----------------------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 00111223567899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=339.41 Aligned_cols=263 Identities=25% Similarity=0.402 Sum_probs=209.7
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~ 94 (614)
..++|.+.+.||+|+||.||+|.+..+++.+|+|.+.... .....+.+|+.+++.+ +||||+++++++........
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 3678999999999999999999999999999999986431 2345577899999998 79999999999865443344
Q ss_pred CcEEEEEecCC-CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 95 KDIYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
...|+||||++ ++|.++++. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 67999999998 589888753 4578999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCccccccccCCccccCcccccccC---CCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCc
Q 007177 170 VAFNDTPTTIFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 246 (614)
Q Consensus 170 ~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~---~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~ 246 (614)
........ .....++..|+|||++.... ..++.++|||||||++|+|++|++||...+....+..+..
T Consensus 177 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~------ 247 (291)
T cd06639 177 QLTSTRLR---RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR------ 247 (291)
T ss_pred hccccccc---ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc------
Confidence 64322211 12346889999999875421 2368899999999999999999999977654333322211
Q ss_pred hhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 007177 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312 (614)
Q Consensus 247 ~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~ 312 (614)
.....+ .....++..+.+||.+||..||.+||++.++|+||||+
T Consensus 248 ---------------------~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 248 ---------------------NPPPTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ---------------------CCCCCC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 000000 11124567899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=342.10 Aligned_cols=260 Identities=27% Similarity=0.421 Sum_probs=211.9
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|++++.||.|+||.||++.+..++..||+|.+.. ........+.+|+++++.++||||+++++.+. +...
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI--ESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENK 76 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEee--CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCe
Confidence 4579999999999999999999998999999999864 34455677889999999999999999999984 4467
Q ss_pred EEEEEecCCC-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 97 IYVVFELMES-DLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 97 ~ylV~E~~~g-~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++......
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 8999999995 898888764 46999999999999999999999999999999999999999999999999998764322
Q ss_pred CCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~---~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
... .....++..|+|||++... ...++.++|+|||||++|+|++|++||.+.+....+..+..
T Consensus 157 ~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------- 222 (280)
T cd06611 157 LQK---RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK----------- 222 (280)
T ss_pred ccc---cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc-----------
Confidence 211 1335688999999987521 13577899999999999999999999977654333222210
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
... +.......++..+.+||.+||..||.+||+++++|+||||...
T Consensus 223 ----------------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 223 ----------------SEP-PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred ----------------CCC-CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 000 0011123467899999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=335.78 Aligned_cols=257 Identities=25% Similarity=0.415 Sum_probs=209.0
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC----ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE----HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~----~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
+|++.+.||.|+||.||+|.+ .++..+|+|.+..... .......+.+|+.+|+.++|+||+++++.+ .+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence 588999999999999999986 4788999999864321 123345688999999999999999999998 445
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
..+|+||||+. ++|.+++.....+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.....
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 78999999998 59999998888899999999999999999999999999999999999999999999999999976422
Q ss_pred CC---CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 174 DT---PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 174 ~~---~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
.. ..........++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---------- 222 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINE--SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA---------- 222 (265)
T ss_pred ccccccccccccccCCCccccChhhhcC--CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh----------
Confidence 11 11122234578999999999876 5788999999999999999999999976553322211110
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
. ..........++..+.+||.+||..||.+||++.++|+||||
T Consensus 223 ----------------~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 223 ----------------H--RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ----------------c--cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0 001112234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=338.89 Aligned_cols=259 Identities=26% Similarity=0.391 Sum_probs=207.7
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++.+. +..
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~ 79 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SRE 79 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC--ccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCC
Confidence 346799999999999999999999999999999998643 2234456778999999999999999999883 446
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
.+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 80 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 80 KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 7899999999 599999988888999999999999999999999999999999999999999999999999999865322
Q ss_pred CCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~-~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
.. ......++..|+|||.+... ...++.++|+|||||++|+|++|+.||...+..+....+...
T Consensus 160 ~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~------------ 224 (267)
T cd06646 160 IA---KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS------------ 224 (267)
T ss_pred cc---ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC------------
Confidence 11 11335688999999987421 245788999999999999999999999654432211111000
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcc
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 310 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~ 310 (614)
...+.. ......++..+.+||++||..||++|||++++|+|+|
T Consensus 225 -------------~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 225 -------------NFQPPK-LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred -------------CCCCCC-CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 000000 0111346789999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=333.84 Aligned_cols=257 Identities=28% Similarity=0.417 Sum_probs=210.2
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
++|++.+.||.|+||.||+|.+..+++.+++|++... .......+.+|+.+++.++||||+++++.+ .+...+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~ 75 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKL 75 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC--chhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEE
Confidence 5799999999999999999999999999999998753 223567788999999999999999999988 445679
Q ss_pred EEEEecCCC-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 98 YVVFELMES-DLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 98 ylV~E~~~g-~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
|++|||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.......
T Consensus 76 ~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 76 WIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred EEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 999999995 899888776 689999999999999999999999999999999999999999999999999997654322
Q ss_pred CCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~-~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
. ......++..|+|||.+.+. ...++.++|+|||||++|+|++|.+||.+.+.......+....
T Consensus 156 ~---~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~------------ 220 (262)
T cd06613 156 A---KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSN------------ 220 (262)
T ss_pred h---ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc------------
Confidence 1 12345788899999998651 1268889999999999999999999998776544433221100
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcc
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 310 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~ 310 (614)
..+. .......++..+.+||++||..||.+|||+.++|.|+|
T Consensus 221 -------------~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 221 -------------FPPP-KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred -------------CCCc-cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0000 00111235678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=331.50 Aligned_cols=253 Identities=28% Similarity=0.487 Sum_probs=214.1
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
+|++++.||.|+||.|+.+.+..+++.+++|++............+.+|+.+|+.++|+||+++++++ .+...++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF-----MDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEE-----ecCCeEE
Confidence 69999999999999999999999999999999875544556667788999999999999999999998 4456799
Q ss_pred EEEecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 99 VVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 99 lV~E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|||||. ++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999998 5999999765 468999999999999999999999999999999999999999999999999997653322
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
. ......++..|+|||++.+ ..++.++|+|||||++++|++|..||.+.+..+....+..
T Consensus 156 ~---~~~~~~~~~~y~ape~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--------------- 215 (256)
T cd08221 156 S---MAETVVGTPYYMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--------------- 215 (256)
T ss_pred c---cccccCCCccccCHhhcCC--CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc---------------
Confidence 1 2234578999999999876 4688899999999999999999999987665444433311
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
.. +......++..+.++|.+||..||.+||++.++|+|||+
T Consensus 216 ------------~~---~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 216 ------------GN---YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ------------CC---CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 00 111114567899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=338.96 Aligned_cols=280 Identities=41% Similarity=0.731 Sum_probs=226.7
Q ss_pred eEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCcEE
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
|.+.+.||.|++|.||+|.+..+++.|+||++...... .+.....+|+..++.++ ||||+++++++ .+....|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-----~~~~~~~ 74 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVF-----RENDELY 74 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHh-----hcCCcEE
Confidence 78899999999999999999999999999998754332 23334567999999999 99999999988 3456799
Q ss_pred EEEecCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 99 VVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 99 lV~E~~~g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
+||||+.++|.+.+.... .+++..+..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 75 FVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred EEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 999999999999987764 789999999999999999999999999999999999999999999999999976543221
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhch
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~ 256 (614)
.....++..|+|||++.+. ..++.++|+|||||++++|++|++||++.+..+.+..+...++.|..+.+......
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 155 ----YTDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred ----cCCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 2346789999999988542 46789999999999999999999999999999999999998888876654321100
Q ss_pred hHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 257 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
. ...-..+...........++..+..+.+||++||..||.+|||++|++.||||
T Consensus 230 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 230 A-SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred h-ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0 00000111111122223344557899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=372.47 Aligned_cols=286 Identities=24% Similarity=0.308 Sum_probs=205.9
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCC-cEEEEEEe--------------cC-ccCChHHHHHHHHHHHHHHhcCCCCcc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTG-EKVAIKKI--------------HD-IFEHISDAARILREIKLLRLLRHPDIV 80 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg-~~vAIK~i--------------~~-~~~~~~~~~~i~~Ei~iL~~L~HpnIv 80 (614)
.++|++++.||+|+||.||+|..+... ..+++|.+ .+ ..........+.+|+.+|+.++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 368999999999999999998765432 22222211 11 111223345678999999999999999
Q ss_pred eeeeEecCCCCCCCCcEEEEEecCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEEC
Q 007177 81 EIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN-----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 155 (614)
Q Consensus 81 ~l~~v~~~~~~~~~~~~ylV~E~~~g~L~~~i~~~-----~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~ 155 (614)
++++++ .+....|+|+|++.++|.+++... .......++.|+.||+.||.|||++||+||||||+|||++
T Consensus 227 ~l~~~~-----~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 227 KIEEIL-----RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301 (501)
T ss_pred cEeEEE-----EECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 999998 445678999999999998887543 2345677889999999999999999999999999999999
Q ss_pred CCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCC-CCC--CChh
Q 007177 156 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPG--KNVV 232 (614)
Q Consensus 156 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~p-F~g--~~~~ 232 (614)
.++.+||+|||+++....... ......+||..|+|||++.+ ..|+.++|||||||++|||++|..+ |.+ .+..
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAG--DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred CCCCEEEEeCCCceecCcccc--cccccccCCcCCCCchhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 999999999999986543221 11234679999999999987 6799999999999999999998754 432 2344
Q ss_pred HHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcc-cCCCcccCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCc
Q 007177 233 HQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRK-KQPVQFSQKF--PNADPSALRLLERLLAFDPKDRPTAEEALADP 309 (614)
Q Consensus 233 ~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~-~~~~~~~~~~--~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp 309 (614)
.++..+...++.+..+.... ......++..... ..+..+...+ ..++..+.+||.+||++||++|||+.|+|+||
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDP--PCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHHHhcccChhhcCCc--HHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 55666655555443321110 0111122211110 0111111111 23567889999999999999999999999999
Q ss_pred cccc
Q 007177 310 YFKG 313 (614)
Q Consensus 310 ~f~~ 313 (614)
||..
T Consensus 456 ~f~~ 459 (501)
T PHA03210 456 LFSA 459 (501)
T ss_pred hhhc
Confidence 9975
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=337.86 Aligned_cols=260 Identities=24% Similarity=0.406 Sum_probs=207.6
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCC-CC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRR-DF 94 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~-~~ 94 (614)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.+ +||||+++++.+...... ..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 467999999999999999999999999999999986432 2345677899999998 699999999998644221 23
Q ss_pred CcEEEEEecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 95 KDIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
..+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 56899999998 5999988763 36899999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~---~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~ 248 (614)
..... ......|+..|+|||++.+. ...|+.++|+|||||++|+|++|..||...........+.
T Consensus 162 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~--------- 229 (272)
T cd06637 162 DRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP--------- 229 (272)
T ss_pred ccccc---cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh---------
Confidence 32211 12345789999999988531 1358889999999999999999999996544322221110
Q ss_pred hhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 249 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 249 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
... ........++..+.+||.+||..||.+|||+.+++.||||
T Consensus 230 ------------------~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 230 ------------------RNP--APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ------------------cCC--CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 000 0001123467899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=341.89 Aligned_cols=262 Identities=25% Similarity=0.411 Sum_probs=212.3
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
..|++.+.||+|+||.||++.+..+++.|++|.+..... .......+.+|+.+++.++||||+++++.+ .+...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence 369999999999999999999999999999999875322 223456788999999999999999999988 44567
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999998 4999999888889999999999999999999999999999999999999999999999999987421111
Q ss_pred CC------------ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhC
Q 007177 176 PT------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 243 (614)
Q Consensus 176 ~~------------~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g 243 (614)
.. ........++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+.+..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~--- 230 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS--- 230 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---
Confidence 00 001122467889999999876 5789999999999999999999999987664433322211
Q ss_pred CCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC---HHHHHcCcccccC
Q 007177 244 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT---AEEALADPYFKGL 314 (614)
Q Consensus 244 ~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps---a~eiL~hp~f~~~ 314 (614)
...........++..+.+||.+||+.||++||+ +.++|+||||...
T Consensus 231 -------------------------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 231 -------------------------DDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred -------------------------cccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 000111111257889999999999999999997 7999999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=335.40 Aligned_cols=261 Identities=25% Similarity=0.438 Sum_probs=210.2
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCC----hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH----ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~----~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
+|+..+.||+|+||.||++.+..+++.||+|++...... ......+.+|+++|+.++||||+++++++ .+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence 488899999999999999999999999999998743211 22356788999999999999999999998 455
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC-cEEEeecCcccccc
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAF 172 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~-~vKL~DFGla~~~~ 172 (614)
..+++||||+. ++|.+++...+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .+||+|||++....
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 67999999999 59999998888899999999999999999999999999999999999998776 59999999987654
Q ss_pred CCCCCc-cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 173 NDTPTT-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 173 ~~~~~~-~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
...... .......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------- 223 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI---------- 223 (268)
T ss_pred cccccCCccccccccccceeCHhHhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHH----------
Confidence 332111 11123468889999999876 57889999999999999999999999755433222222110
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~ 312 (614)
. . ..........+++.+.++|.+||..||.+|||+.++|+||||+
T Consensus 224 -------------~-~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 224 -------------A-S--ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred -------------h-c--cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 0 0 0001112235678999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=334.71 Aligned_cols=261 Identities=27% Similarity=0.446 Sum_probs=209.6
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCC-CCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSR-RDF 94 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~-~~~ 94 (614)
.++|++.+.||.|+||.||+|.++.+++.+++|++.... .....+.+|+.+++.+ .||||+++++.+..... .+.
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 478999999999999999999999999999999987432 2346688999999999 69999999999865443 345
Q ss_pred CcEEEEEecCCC-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 95 KDIYVVFELMES-DLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 95 ~~~ylV~E~~~g-~L~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
..+|+||||+++ +|.+++.. +..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 678999999994 88888764 3579999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCc
Q 007177 170 VAFNDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 246 (614)
Q Consensus 170 ~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~---~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~ 246 (614)
....... ......++..|+|||++... ...++.++||||||||+|+|++|.+||........+..+..
T Consensus 162 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------ 232 (275)
T cd06608 162 QLDSTLG---RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR------ 232 (275)
T ss_pred ecccchh---hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc------
Confidence 6432221 12345688999999987531 13578899999999999999999999976544333322211
Q ss_pred hhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 247 ~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
... ........++..+.+||.+||..||.+|||++++++|||+
T Consensus 233 ---------------------~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 233 ---------------------NPP-PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ---------------------cCC-CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 000 0001112367789999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=340.42 Aligned_cols=261 Identities=24% Similarity=0.416 Sum_probs=210.9
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
++|++++.||+|+||.||+|.+..++..||+|.+... ........+.+|+.+|+.++||||+++++.+. ..+.+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeE
Confidence 4799999999999999999999999999999998743 23344567889999999999999999999873 45679
Q ss_pred EEEEecCCC-cHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh-CCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 98 YVVFELMES-DLHQVIKAN---DDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 98 ylV~E~~~g-~L~~~i~~~---~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
|+||||+++ +|..++... ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999999995 888888763 379999999999999999999996 599999999999999999999999999987643
Q ss_pred CCCCCccccccccCCccccCccccccc----CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~----~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~ 248 (614)
... .....++..|+|||++.+. ...++.++|+|||||++|+|++|..||...........+..
T Consensus 155 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~-------- 221 (286)
T cd06622 155 ASL-----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA-------- 221 (286)
T ss_pred CCc-----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH--------
Confidence 221 1234688899999988542 12468899999999999999999999976543222221111
Q ss_pred hhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 249 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 249 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
+... ......+.+++++.+||.+||..||.+||++++++.||||.....
T Consensus 222 ----------------~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 222 ----------------IVDG---DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred ----------------Hhhc---CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 0011 111233457889999999999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=335.65 Aligned_cols=254 Identities=28% Similarity=0.478 Sum_probs=211.2
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
+|++.+.||.|+||.||+|.+..+++.||+|++..... .......+.+|++++++++||||+++++.+ .+....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 59999999999999999999999999999999975322 224567888999999999999999999987 455679
Q ss_pred EEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 98 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
|+|+||+. ++|.+.+.....+++..+..|+.||++||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999998 5999999887789999999999999999999999999999999999999999999999999997654332
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhch
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~ 256 (614)
......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.... ..+
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~------------------ 210 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCR--QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR-DQI------------------ 210 (258)
T ss_pred ---cccccCCChhhcCHHHHcc--cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH-HHH------------------
Confidence 1233568889999999876 5689999999999999999999999987663110 000
Q ss_pred hHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCH--HHHHcCccc
Q 007177 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA--EEALADPYF 311 (614)
Q Consensus 257 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa--~eiL~hp~f 311 (614)
...... ......+.++..+.++|.+||..||.+||++ +|+++||||
T Consensus 211 -----~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 211 -----RAKQET----ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -----HHHhcc----ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 000000 0111223467899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=331.15 Aligned_cols=253 Identities=25% Similarity=0.468 Sum_probs=211.0
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
+|++.+.||+|+||.||++.+..+|+.||+|.+............+.+|+.+++.++||||+++++.+ .+....|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 69999999999999999999999999999999875433445566788999999999999999999988 4556799
Q ss_pred EEEecCC-CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 99 VVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 99 lV~E~~~-g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+||||+. ++|.+.+.... .+++..+..|+.||+.||.|||++|++|+||+|+|||++.++.++|+|||++.......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999998 59999887643 58999999999999999999999999999999999999999999999999997654322
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
. ......++..|+|||++.+ ..++.++|+|||||++++|++|..||...+..+....+..
T Consensus 156 ~---~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--------------- 215 (256)
T cd08218 156 E---LARTCIGTPYYLSPEICEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--------------- 215 (256)
T ss_pred h---hhhhccCCccccCHHHhCC--CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc---------------
Confidence 1 1123468889999999877 5788899999999999999999999976654443332211
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
.. ........+..+.+||.+||+.||.+||++.++|+||||
T Consensus 216 -----------~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 216 -----------GS----YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -----------CC----CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 00 011123567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=332.31 Aligned_cols=260 Identities=25% Similarity=0.426 Sum_probs=208.9
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc---CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF---EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~---~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
..|++.+.||+|+||.||++.+..++..||||++.... ........+.+|+.+++.++||||+++++.+... ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---ME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CC
Confidence 57999999999999999999999999999999886321 1223456788999999999999999999987432 23
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
..+|+||||++ ++|.+++.....+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++....
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 56899999998 59999998877899999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
............++..|+|||++.+ ..++.++|+|||||++|+|++|+.||...+....+..+ ...+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~~-------- 225 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISG--EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI---ATQP-------- 225 (265)
T ss_pred ccccccccccCCCCccccChhhhcC--CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHH---hcCC--------
Confidence 2111111234568899999999876 57889999999999999999999999765433222111 1000
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~ 312 (614)
. .......++..+.++|.+||. +|++||+++++++|||+.
T Consensus 226 ----------------~--~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 226 ----------------T--NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ----------------C--CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 0 011123467789999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=338.24 Aligned_cols=258 Identities=23% Similarity=0.391 Sum_probs=205.0
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
++|++++.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+|+.++||||+++++.+. .....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 74 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFF-----VENRI 74 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----ECCEE
Confidence 36899999999999999999999999999999986432 2334567889999999999999999999983 44678
Q ss_pred EEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 98 YVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 98 ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
++||||+++ +|... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.......
T Consensus 75 ~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 75 SICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred EEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 999999995 55433 357899999999999999999999999999999999999999999999999997653222
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhch
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~ 256 (614)
....++|..|+|||++.+ ..++.++|+|||||++|+|++|..||......+... ..
T Consensus 150 ----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~---------~~--------- 205 (279)
T cd06619 150 ----AKTYVGTNAYMAPERISG--EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL---------MP--------- 205 (279)
T ss_pred ----ccCCCCChhhcCceeecC--CCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc---------ch---------
Confidence 234578999999999986 578999999999999999999999996532111000 00
Q ss_pred hHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 257 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
......+...... .......++++.+||.+||..||.+||+++++|.||||...
T Consensus 206 --~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 206 --LQLLQCIVDEDPP--VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred --HHHHHHHhccCCC--CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 0000000000000 11123467899999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=330.67 Aligned_cols=261 Identities=30% Similarity=0.457 Sum_probs=213.0
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
||++.+.||+|+||.||+|.+..++..|++|.++...........+.+|+.+++.++|+||+++++.. .+...++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence 69999999999999999999999999999999976544445678899999999999999999999987 4456799
Q ss_pred EEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007177 99 VVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 177 (614)
Q Consensus 99 lV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 177 (614)
+|+||+. ++|.+++.....+++..++.|+.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.........
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999998 599999988778999999999999999999999999999999999999999999999999999875433322
Q ss_pred ccc-cccccCCccccCcccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 178 TIF-WTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 178 ~~~-~~~~vgt~~Y~APEvl~~~~-~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
... .....++..|+|||++.+.. ..++.++|||||||++++|++|+.||.+.+..........
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~--------------- 220 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG--------------- 220 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh---------------
Confidence 111 22356788999999987631 2378899999999999999999999976532211111100
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
. ........+..+++.+.+||.+||+.||.+|||+++++.|||+
T Consensus 221 -----------~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 221 -----------A-GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred -----------c-CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0 0011111233458899999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=359.36 Aligned_cols=263 Identities=27% Similarity=0.457 Sum_probs=226.6
Q ss_pred cCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 13 EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 13 ~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
+-...+-|.+.+.||+|.|+.|.+|++..|+..||||.|++...+....+.+.+|+++|+.|+|||||+++.++ .
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~-----~ 125 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI-----E 125 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee-----e
Confidence 34456789999999999999999999999999999999998877777777899999999999999999999999 5
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
....+|+||||+. |++++++.+++...+..++.++.|++.|++|||+++|||||||.+|||++.+..+||+|||++..+
T Consensus 126 t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 126 TEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred ecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceee
Confidence 5677999999998 699999999999999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
... ....+++|++.|.|||++.+. ...++.+|+||+|++||-|+.|..||.|.+-...-...
T Consensus 206 ~~~----~~lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv------------- 267 (596)
T KOG0586|consen 206 DYG----LMLQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV------------- 267 (596)
T ss_pred ccc----ccccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCcccccccchh-------------
Confidence 432 245678999999999999885 45578999999999999999999999987632211110
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
++.+-.++ --++-++.+||+++|..+|.+|++.+++..|.|......
T Consensus 268 -------------l~gk~rIp-----~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 268 -------------LRGKYRIP-----FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred -------------eeeeeccc-----ceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence 11111111 135678999999999999999999999999999986544
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=330.05 Aligned_cols=255 Identities=32% Similarity=0.525 Sum_probs=212.7
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
+|++.+.||.|+||.||+|.+..++..||+|.+...........++.+|+.+++.++||||+++++.+... ....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence 58999999999999999999999999999999876545556677888999999999999999999977432 335689
Q ss_pred EEEecCC-CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCeEeecCCCCcEEECCCCcEEEeecCcc
Q 007177 99 VVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIH-----TANVYHRDLKPKNILANANCKLKICDFGLA 168 (614)
Q Consensus 99 lV~E~~~-g~L~~~i~~----~~~lse~~~~~i~~QIl~aL~yLH-----s~gIvHrDLKP~NILi~~~~~vKL~DFGla 168 (614)
++|||++ ++|.+++.. ...+++..+..++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999998 599988865 457999999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007177 169 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~ 248 (614)
........ ......++..|+|||.+.+ ..++.++|+||||+++++|++|..||...+.......+.
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------- 223 (265)
T cd08217 158 KILGHDSS---FAKTYVGTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK--------- 223 (265)
T ss_pred ccccCCcc---cccccccCCCccChhhhcC--CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh---------
Confidence 87543321 1234578999999999877 568899999999999999999999998766333222211
Q ss_pred hhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 249 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 249 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
... +.......+..+.+|+.+||..||.+||++.++|+|||+
T Consensus 224 ------------------~~~---~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 224 ------------------EGK---FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ------------------cCC---CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 110 111223567899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=356.32 Aligned_cols=268 Identities=27% Similarity=0.404 Sum_probs=209.2
Q ss_pred cccccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEec
Q 007177 9 EFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIML 87 (614)
Q Consensus 9 ~~~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~ 87 (614)
++++-- ...|++++.||+|+.+.||++... ....||+|++.....+.....-+.+||.+|.+|+ |.+|++|+++-.
T Consensus 354 ~~i~Vk--g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv 430 (677)
T KOG0596|consen 354 EIIKVK--GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV 430 (677)
T ss_pred eeEEEC--cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence 444443 467999999999999999999753 3456788877765566777888999999999996 999999999863
Q ss_pred CCCCCCCCcEEEEEecCCCcHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecC
Q 007177 88 PPSRRDFKDIYVVFELMESDLHQVIKANDD-LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFG 166 (614)
Q Consensus 88 ~~~~~~~~~~ylV~E~~~g~L~~~i~~~~~-lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFG 166 (614)
.++.+|||||+-+-||..+|+.... +..-.++++.+|||.|++++|..||||.||||.|+|+- .|.+||+|||
T Consensus 431 -----~d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFG 504 (677)
T KOG0596|consen 431 -----TDGYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFG 504 (677)
T ss_pred -----cCceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeec
Confidence 4678999999999999999987654 33358899999999999999999999999999999875 4589999999
Q ss_pred ccccccCCCCCccccccccCCccccCcccccccC---------CCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHH
Q 007177 167 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF---------SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 237 (614)
Q Consensus 167 la~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~---------~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~ 237 (614)
.|.....+.. .+.....+||..||+||.+.... -+.++++||||||||||+|+.|++||.... +++.+
T Consensus 505 IA~aI~~DTT-sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aK 581 (677)
T KOG0596|consen 505 IANAIQPDTT-SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAK 581 (677)
T ss_pred hhcccCcccc-ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHH
Confidence 9988765543 34456689999999999874321 136789999999999999999999994432 12222
Q ss_pred HHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 238 MTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 238 i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
+.. .......+.|....++ .++.++++.||.+||++|||+.++|+|||++.
T Consensus 582 l~a-----------------------I~~P~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 582 LHA-----------------------ITDPNHEIEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred HHh-----------------------hcCCCccccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 211 1111122233222221 24999999999999999999999999999875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=325.98 Aligned_cols=289 Identities=31% Similarity=0.606 Sum_probs=234.8
Q ss_pred ccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCC
Q 007177 12 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPS 90 (614)
Q Consensus 12 ~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~ 90 (614)
-.+|..++|++++.+|+|.|+.||.|++..++++++||+++. ...+.+.||++||+.|+ ||||++++++..++.
T Consensus 32 i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~ 106 (338)
T KOG0668|consen 32 IDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPE 106 (338)
T ss_pred eeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCcc
Confidence 357888999999999999999999999999999999999874 56678999999999997 999999999987653
Q ss_pred CCCCCcEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC-CcEEEeecCcc
Q 007177 91 RRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLA 168 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~-~~vKL~DFGla 168 (614)
.....+||||++. |...+.. .|+.-+++++++|||.||.|||+.||.|||+||.|++||.. -.++|+|+|||
T Consensus 107 ---SktpaLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 107 ---SKTPSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred ---ccCchhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchH
Confidence 3456899999995 6666553 58999999999999999999999999999999999999865 47999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCC-CCCCChhHHHHHHHhhhCCCch
Q 007177 169 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKNVVHQLDLMTDLLGTPSL 247 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~p-F~g~~~~~~l~~i~~~~g~p~~ 247 (614)
..+..... ..-.+.+++|--||++... ..|+.+-|+|||||+|+.|+..+.| |.|.++.+|+.+|.+.+|+...
T Consensus 181 EFYHp~~e----YnVRVASRyfKGPELLVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el 255 (338)
T KOG0668|consen 181 EFYHPGKE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDEL 255 (338)
T ss_pred hhcCCCce----eeeeeehhhcCCchheeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHH
Confidence 87643322 2335889999999999874 7899999999999999999997655 6899999999999999998643
Q ss_pred hh-hhhhhchhHHHHHHhhcccCCCcccCCC-----CCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 248 DT-ISRVRNDKARRYLTSMRKKQPVQFSQKF-----PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 248 ~~-i~~~~~~~~~~~l~~~~~~~~~~~~~~~-----~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
.. +.+..-+-..++-..+.......|.... .-+++++.|||.++|..|-.+|+||.|++.||||..+.+
T Consensus 256 ~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~ 330 (338)
T KOG0668|consen 256 YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVRE 330 (338)
T ss_pred HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHH
Confidence 22 3333333233333333333333333222 235799999999999999999999999999999986544
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=337.12 Aligned_cols=256 Identities=29% Similarity=0.446 Sum_probs=212.0
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
++|++.+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++.+. +...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeE
Confidence 47999999999999999999999999999999987532 2345567889999999999999999999883 44679
Q ss_pred EEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 98 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
|+|+||+. ++|.+++... .+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||+++.......
T Consensus 75 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 99999998 5899998765 799999999999999999999999999999999999999999999999999987643321
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhch
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~ 256 (614)
......++..|+|||++.+ ..++.++|+|||||++|+|++|.+||...+....+..+.
T Consensus 154 ---~~~~~~~~~~y~~PE~~~~--~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~----------------- 211 (274)
T cd06609 154 ---KRNTFVGTPFWMAPEVIKQ--SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP----------------- 211 (274)
T ss_pred ---ccccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh-----------------
Confidence 1234578889999999887 568999999999999999999999997655332222111
Q ss_pred hHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 257 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
......+. ...+++.+.++|.+||..||++|||++++++||||...
T Consensus 212 ----------~~~~~~~~--~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 212 ----------KNNPPSLE--GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred ----------hcCCCCCc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 00010010 11267889999999999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=335.05 Aligned_cols=258 Identities=26% Similarity=0.451 Sum_probs=203.7
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHH-HHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKL-LRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~i-L~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
++|++++.||+|+||.||+|.++.+|+.||||.++...... ....+..|+.+ ++.+.||||+++++.+. ....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~ 74 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGD 74 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCc
Confidence 46999999999999999999999999999999997643332 33456667665 66778999999999983 4467
Q ss_pred EEEEEecCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 97 IYVVFELMESDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 97 ~ylV~E~~~g~L~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
+|+||||++++|.+++.. ...+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++...
T Consensus 75 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 75 VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred EEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999988887754 34689999999999999999999997 9999999999999999999999999999765
Q ss_pred cCCCCCccccccccCCccccCccccccc--CCCCCCcccchhHHHHHHHHHhCCCCCCCCC-hhHHHHHHHhhhCCCchh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN-VVHQLDLMTDLLGTPSLD 248 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~--~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~-~~~~l~~i~~~~g~p~~~ 248 (614)
..... .+...++..|+|||++.+. ...++.++|+|||||++|+|++|+.||.... ..+.+..+.
T Consensus 155 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------- 221 (283)
T cd06617 155 VDSVA----KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV--------- 221 (283)
T ss_pred ccccc----cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH---------
Confidence 32211 1234688899999987542 1357889999999999999999999996432 111111110
Q ss_pred hhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 249 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 249 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
. .....+ ....++.++.+||.+||..||.+||+++++++||||...
T Consensus 222 --------------~----~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 222 --------------E----EPSPQL--PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred --------------h----cCCCCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 0 000000 012467899999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=346.89 Aligned_cols=253 Identities=26% Similarity=0.445 Sum_probs=214.8
Q ss_pred eEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEE
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 99 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~yl 99 (614)
|.+++.||+|+||.|++|+++.+|..+|||++.- .++.+.+.+||.||++++.|++|++|+.|+ ...+++|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYF-----K~sDLWI 105 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYF-----KHSDLWI 105 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhc-----cCCceEe
Confidence 6688999999999999999999999999999864 478899999999999999999999999884 4467999
Q ss_pred EEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007177 100 VFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 177 (614)
Q Consensus 100 V~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 177 (614)
|||||+ |++.++++. +.+|++.++..+++..|.||+|||...-+|||||..|||++.+|+.||+|||.|-.+.+.
T Consensus 106 VMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--- 182 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--- 182 (502)
T ss_pred ehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh---
Confidence 999999 899999975 568999999999999999999999999999999999999999999999999999765432
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchh
Q 007177 178 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257 (614)
Q Consensus 178 ~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~ 257 (614)
.....+.+||+.|||||++.. ..|+.++||||||+...||..|++||..-..+..+-.|
T Consensus 183 MAKRNTVIGTPFWMAPEVI~E--IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI------------------- 241 (502)
T KOG0574|consen 183 MAKRNTVIGTPFWMAPEVIEE--IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI------------------- 241 (502)
T ss_pred HHhhCccccCcccccHHHHHH--hccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-------------------
Confidence 223356789999999999987 68999999999999999999999999654432221111
Q ss_pred HHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 258 ~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
....+..| .....+|.++.|||++||.+.|++|.|+.++++|||+++.
T Consensus 242 --------PT~PPPTF-~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 242 --------PTKPPPTF-KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred --------cCCCCCCC-CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 11111111 1222467899999999999999999999999999999864
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=328.06 Aligned_cols=252 Identities=28% Similarity=0.468 Sum_probs=209.6
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
+|++.+.||+|+||.||+|.+..++..+|||.+............+.+|+.+|+.++||||+++++.+ .+...++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence 69999999999999999999999999999999976544445667888999999999999999999987 3456799
Q ss_pred EEEecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC-cEEEeecCccccccCC
Q 007177 99 VVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAFND 174 (614)
Q Consensus 99 lV~E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~-~vKL~DFGla~~~~~~ 174 (614)
+||||++ ++|.+++... ..+++..+..++.|++.||+|||++||+|+||||+||+++.++ .+||+|||++......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999998 5999999763 3589999999999999999999999999999999999998654 6899999999865433
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
.. .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+..
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-------------- 215 (256)
T cd08220 156 SK----AYTVVGTPCYISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-------------- 215 (256)
T ss_pred cc----ccccccCCcccCchhccC--CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh--------------
Confidence 21 123468889999999876 5688999999999999999999999977664433322211
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
. ........+++.+.+||.+||..||.+|||+.|+|+||||
T Consensus 216 -------------~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 216 -------------G---TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred -------------c---CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 0 0111123467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=335.51 Aligned_cols=267 Identities=24% Similarity=0.416 Sum_probs=210.3
Q ss_pred cccCC-CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecC
Q 007177 11 FSEYG-DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLP 88 (614)
Q Consensus 11 ~~~~~-~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~ 88 (614)
++... ..++|++++.||+|+||.||+|.++.+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 44443 5689999999999999999999999999999999886421 2234577899999999 69999999998865
Q ss_pred CCCCCCCcEEEEEecCC-CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEe
Q 007177 89 PSRRDFKDIYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 163 (614)
Q Consensus 89 ~~~~~~~~~ylV~E~~~-g~L~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~ 163 (614)
....+...+|+||||++ ++|.+++.. ...+++..++.++.||+.||.|||+.+|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence 44445567999999998 588887752 3568999999999999999999999999999999999999999999999
Q ss_pred ecCccccccCCCCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 007177 164 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 240 (614)
Q Consensus 164 DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~---~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~ 240 (614)
|||+++....... ......|++.|+|||++... ...++.++|||||||++|+|++|+.||...+....+..+.
T Consensus 167 dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~- 242 (286)
T cd06638 167 DFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP- 242 (286)
T ss_pred cCCceeecccCCC---ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc-
Confidence 9999876532211 12334689999999987531 1458899999999999999999999997665433221110
Q ss_pred hhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 241 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 241 ~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
....... .....++..+.+||.+||+.||.+|||+.|+|+|+||
T Consensus 243 --------------------------~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 243 --------------------------RNPPPTL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred --------------------------ccCCCcc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 0000000 0112346789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=331.24 Aligned_cols=252 Identities=30% Similarity=0.506 Sum_probs=208.5
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
++|++.+.||.|+||.||+|.+..++..|++|.+... .....+.+|+.+++.++||||+++++.+. +...+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~ 73 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDL 73 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcE
Confidence 5799999999999999999999998999999998743 22677889999999999999999999884 44679
Q ss_pred EEEEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 98 YVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
|+++||+. ++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 74 ~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 74 WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred EEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 99999999 599998865 4578999999999999999999999999999999999999999999999999998654322
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
. ......++..|+|||++.+ ..++.++||||||||+|+|++|++||...+.......+.
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~---------------- 212 (256)
T cd06612 154 A---KRNTVIGTPFWMAPEVIQE--IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP---------------- 212 (256)
T ss_pred c---ccccccCCccccCHHHHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc----------------
Confidence 1 1123457889999999877 578999999999999999999999997655432221110
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
. ...........++..+.+||.+||+.||.+|||+.|+|.||||
T Consensus 213 -----------~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 213 -----------N-KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred -----------c-CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 0 0000111123467889999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=332.11 Aligned_cols=262 Identities=26% Similarity=0.470 Sum_probs=209.2
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCC--------hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH--------ISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 90 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~--------~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 90 (614)
+|.+.+.||.|+||.||+|.+..+|+.||+|.+...... ....+.+.+|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~---- 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE---- 77 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence 689999999999999999999999999999988532111 11234577899999999999999999987
Q ss_pred CCCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 91 RRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
.+...+|+||||+. ++|.+.+...+.+++..++.++.||+.||.|||+.|++||||+|+||+++.++.+||+|||+++
T Consensus 78 -~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 78 -TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred -ccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 44567999999998 5999999888889999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 170 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 170 ~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
....... ........++..|+|||++......++.++|+|||||++++|++|..||...+....+..+..
T Consensus 157 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------- 226 (272)
T cd06629 157 KSDDIYD-NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN--------- 226 (272)
T ss_pred ccccccc-ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc---------
Confidence 6432211 111234568889999999876323478999999999999999999999965443222111100
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
............+.++..+.+||.+||..||.+|||++++|+||||
T Consensus 227 ----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 227 ----------------KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ----------------cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0011111122335678899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.46 Aligned_cols=262 Identities=24% Similarity=0.405 Sum_probs=208.7
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCC-C
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSR-R 92 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~-~ 92 (614)
...++|++.+.||.|+||.||+|.+..+++.+|+|.+... ......+..|+.+++.+ +||||+++++.+..... .
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 3457899999999999999999999999999999998642 23445678899999988 69999999998854321 2
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
....+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 3467899999998 5999988753 458899999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCc
Q 007177 170 VAFNDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 246 (614)
Q Consensus 170 ~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~---~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~ 246 (614)
....... ......++..|+|||++... ...++.++|+|||||++|+|++|..||........+..+.
T Consensus 170 ~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~------- 239 (282)
T cd06636 170 QLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP------- 239 (282)
T ss_pred hhhcccc---CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh-------
Confidence 5432111 12345789999999987521 1468889999999999999999999996654322221110
Q ss_pred hhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 247 ~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
.. .........++..+.+||.+||..||.+|||+.|+|+||||
T Consensus 240 --------------------~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 240 --------------------RN--PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred --------------------hC--CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 00 00111123567899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=327.25 Aligned_cols=254 Identities=29% Similarity=0.502 Sum_probs=209.8
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC---ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE---HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~---~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
||+..+.||+|+||.||+|.+..++..|++|.+..... .......+.+|+.+++.++||||+++++.+ .+..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence 68889999999999999999998999999999864321 123456788999999999999999999987 4456
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
.+|+|+||++ ++|.+++.....+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 7999999998 499999988888999999999999999999999999999999999999999999999999998765433
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
. ......++..|++||.+... ..++.++|+|||||++|+|++|..||...........+...
T Consensus 156 ~----~~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~------------- 217 (258)
T cd06632 156 S----FAKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS------------- 217 (258)
T ss_pred c----cccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc-------------
Confidence 2 12345688999999988652 23889999999999999999999999765532222211100
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
.......+.+++.+.+||.+||..||.+||++.++|.|||+
T Consensus 218 ----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 218 ----------------KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ----------------ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 01112234578899999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=333.54 Aligned_cols=257 Identities=28% Similarity=0.478 Sum_probs=210.2
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
++|++.+.||.|+||.||+|.++.+++.+|+|.+..... ......+.+|+++++.++||||+++++.+. ....+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFY-----NNGDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeee-----cCCEE
Confidence 368899999999999999999999999999999875432 345567889999999999999999999883 44679
Q ss_pred EEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 98 YVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
|+|+||+. ++|.+++... ..+++..+..++.||+.||.|||+ .|++|+||||+||+++.++.+||+|||++......
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999 6999999876 789999999999999999999999 99999999999999999999999999998764322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCh--hHHHHHHHhhhCCCchhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~--~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.. ....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+. .....
T Consensus 155 ~~-----~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---------------- 211 (265)
T cd06605 155 LA-----KTFVGTSSYMAPERIQG--NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE---------------- 211 (265)
T ss_pred Hh-----hcccCChhccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHH----------------
Confidence 11 12568889999999877 5789999999999999999999999966431 00000
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCC-CCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPN-ADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~-~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
.+......... ..... +++.+.+||.+||..||++|||+.+++.||||+.+
T Consensus 212 --------~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 212 --------LLQYIVNEPPP---RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred --------HHHHHhcCCCC---CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 01111011110 11111 68899999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=337.06 Aligned_cols=259 Identities=22% Similarity=0.336 Sum_probs=200.1
Q ss_pred CCCeEEEeEeeecCceEEEEEEECC----------------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTH----------------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 80 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~----------------tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv 80 (614)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+|..++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 4689999999999999999997532 34479999987532 334456788999999999999999
Q ss_pred eeeeEecCCCCCCCCcEEEEEecCC-CcHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHhC
Q 007177 81 EIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAND-------------------DLTREHYQFFLYQLLRALKYIHTA 140 (614)
Q Consensus 81 ~l~~v~~~~~~~~~~~~ylV~E~~~-g~L~~~i~~~~-------------------~lse~~~~~i~~QIl~aL~yLHs~ 140 (614)
++++++. +....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.
T Consensus 83 ~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 83 RLLGVCV-----DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred EEEEEEe-----cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 9999983 4456899999998 59999886532 367788999999999999999999
Q ss_pred CeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHH
Q 007177 141 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 220 (614)
Q Consensus 141 gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLl 220 (614)
||+||||||+|||++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY-RIQGRAVLPIRWMAWECILM--GKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred CccccCcchhheEEcCCccEEECCCccceecccCcee-EecCcCCCCccccCHHHHhc--CCCCchhhhHHHHHHHHHHH
Confidence 9999999999999999999999999999765332211 11123355778999999876 57999999999999999998
Q ss_pred h--CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCC
Q 007177 221 T--GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD 298 (614)
Q Consensus 221 t--G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~ 298 (614)
+ +..||.+.+..+.+..+...+ . ......+....+.++..+.+|+.+||..||++
T Consensus 235 ~~~~~~p~~~~~~~~~~~~~~~~~--------------------~---~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~ 291 (304)
T cd05096 235 MLCKEQPYGELTDEQVIENAGEFF--------------------R---DQGRQVYLFRPPPCPQGLYELMLQCWSRDCRE 291 (304)
T ss_pred HccCCCCCCcCCHHHHHHHHHHHh--------------------h---hccccccccCCCCCCHHHHHHHHHHccCCchh
Confidence 7 567887766544433321110 0 00001111123456789999999999999999
Q ss_pred CCCHHHHHc
Q 007177 299 RPTAEEALA 307 (614)
Q Consensus 299 Rpsa~eiL~ 307 (614)
|||++++.+
T Consensus 292 RPs~~~i~~ 300 (304)
T cd05096 292 RPSFSDIHA 300 (304)
T ss_pred CcCHHHHHH
Confidence 999999943
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=359.09 Aligned_cols=267 Identities=28% Similarity=0.466 Sum_probs=223.4
Q ss_pred ccccccCCCCCCe-EEEeEeeecCceEEEEEEECCCCcEEEEEEec--CccCChHHHHHHHHHHHHHHhcCCCCcceeee
Q 007177 8 MEFFSEYGDASRY-KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHPDIVEIKH 84 (614)
Q Consensus 8 ~~~~~~~~~~~rY-~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~--~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~ 84 (614)
...+-+....+|| ++..+||+|+|-+||+|.|..+|..||+-.++ +........+++..|+.+|+.|+||||+++|+
T Consensus 29 ~~~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~ 108 (632)
T KOG0584|consen 29 ESEFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYD 108 (632)
T ss_pred cccccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeee
Confidence 3445555666777 56789999999999999999999999987654 33455667799999999999999999999999
Q ss_pred EecCCCCCCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeecCCCCcEEECCC-CcE
Q 007177 85 IMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANAN-CKL 160 (614)
Q Consensus 85 v~~~~~~~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILi~~~-~~v 160 (614)
.+.+.. ...+.+|+|+|. |+|.+++++.+.++.+.++.|++|||+||.|||+.. |+|||||.+||||+.+ |.|
T Consensus 109 SW~d~~---n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~V 185 (632)
T KOG0584|consen 109 SWVDTD---NKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEV 185 (632)
T ss_pred heecCC---CceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCce
Confidence 997643 367899999998 899999999999999999999999999999999986 9999999999999876 799
Q ss_pred EEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 007177 161 KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 240 (614)
Q Consensus 161 KL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~ 240 (614)
||+|+|||........ ...+|||.|||||+... .|++.+||||||++++||+|+..||......-|+.+-.
T Consensus 186 KIGDLGLAtl~r~s~a-----ksvIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV- 256 (632)
T KOG0584|consen 186 KIGDLGLATLLRKSHA-----KSVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKV- 256 (632)
T ss_pred eecchhHHHHhhcccc-----ceeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHH-
Confidence 9999999987543322 33689999999999874 89999999999999999999999998776655543321
Q ss_pred hhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 241 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 241 ~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
....+|..|... -++++++||.+||.. ..+|+|+.|+|.||||..-
T Consensus 257 ------------------------~SGiKP~sl~kV---~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 257 ------------------------TSGIKPAALSKV---KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ------------------------HcCCCHHHhhcc---CCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 122333333322 268999999999999 8999999999999999853
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=340.22 Aligned_cols=258 Identities=27% Similarity=0.501 Sum_probs=209.8
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
+.|.....||.|+||.||++.+..++..||||++... .......+.+|+.+++.++||||+++++.+. .....
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~ 94 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDEL 94 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeE
Confidence 4566678899999999999999999999999998642 2344566889999999999999999999873 44678
Q ss_pred EEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 98 YVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 98 ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
|+||||+++ +|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 95 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 95 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred EEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 999999985 78887754 5699999999999999999999999999999999999999999999999999875432221
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhch
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~ 256 (614)
......++..|+|||.+.+ ..++.++|+|||||++|||++|+.||.+.+....+..+...
T Consensus 174 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--------------- 233 (292)
T cd06658 174 ---KRKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN--------------- 233 (292)
T ss_pred ---cCceeecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------------
Confidence 1234578999999999876 57889999999999999999999999876644333222110
Q ss_pred hHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 257 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
+ .. ........+..+.+||.+||..||.+|||++++|+||||.....
T Consensus 234 --------~----~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 234 --------L----PP-RVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred --------C----CC-ccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 0 00 00112346788999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=356.57 Aligned_cols=264 Identities=27% Similarity=0.412 Sum_probs=220.5
Q ss_pred cccccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEec
Q 007177 9 EFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIML 87 (614)
Q Consensus 9 ~~~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~ 87 (614)
+.|...+.-..|.-++.||.|+||.||.|+|..+.+.||||++.... ........|+.|+..|++|+|||++.+.++|+
T Consensus 17 ~LF~k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL 96 (948)
T KOG0577|consen 17 DLFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL 96 (948)
T ss_pred HHHccCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee
Confidence 34555566678888999999999999999999999999999997543 23445678999999999999999999999996
Q ss_pred CCCCCCCCcEEEEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecC
Q 007177 88 PPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFG 166 (614)
Q Consensus 88 ~~~~~~~~~~ylV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFG 166 (614)
-. ...|||||||-|+-.+++.- ..++.+.++..|+.+.|.||.|||+.+.||||||..|||+++.|.|||+|||
T Consensus 97 re-----~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFG 171 (948)
T KOG0577|consen 97 RE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFG 171 (948)
T ss_pred cc-----chHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeecccc
Confidence 43 45799999999866666643 3579999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCC
Q 007177 167 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 245 (614)
Q Consensus 167 la~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~-~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p 245 (614)
.|..... ...++|||+|||||++... .+.|+-++||||||++..||.-.+||+...+.+..+.-|-.
T Consensus 172 SAsi~~P-------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ----- 239 (948)
T KOG0577|consen 172 SASIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----- 239 (948)
T ss_pred chhhcCc-------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh-----
Confidence 9976432 2457999999999987532 36799999999999999999999999888776666555522
Q ss_pred chhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 246 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 246 ~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
...|. + .-+.+|..++.|+..||++-|.+|||.+++|.|+|...
T Consensus 240 ---------------------NesPt-L--qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 240 ---------------------NESPT-L--QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred ---------------------cCCCC-C--CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 11111 1 12456889999999999999999999999999999864
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=333.19 Aligned_cols=258 Identities=28% Similarity=0.518 Sum_probs=211.5
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
..|...+.||.|++|.||++.+..++..+++|++... .......+.+|+.+++.++||||+++++.+. .....
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~ 91 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDEL 91 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeE
Confidence 4566678999999999999999999999999998642 2234556889999999999999999999884 44568
Q ss_pred EEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 98 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
|+|+||+. ++|.+++.. ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++........
T Consensus 92 ~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 92 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 99999998 599998877 5799999999999999999999999999999999999999999999999998875433222
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhch
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~ 256 (614)
. .....|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+....+..+..
T Consensus 171 ~---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~---------------- 229 (285)
T cd06648 171 R---RKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRD---------------- 229 (285)
T ss_pred c---cccccCCccccCHHHhcC--CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHh----------------
Confidence 1 133568999999999876 5789999999999999999999999977665444332211
Q ss_pred hHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 257 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
.. .........++..+.+||.+||..||++|||+.++|+||||+....
T Consensus 230 -----------~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 230 -----------NL-PPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred -----------cC-CCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 00 0111112346789999999999999999999999999999987553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=336.39 Aligned_cols=262 Identities=27% Similarity=0.457 Sum_probs=205.8
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ 96 (614)
+.|...+.||+|+||.||++.+..++..||||++...... .....+.+|+.++.++. ||||+++++++. +...
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-----~~~~ 77 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALF-----REGD 77 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-----cCCc
Confidence 4577788999999999999999999999999998754222 45567889999999996 999999999873 4466
Q ss_pred EEEEEecCCCcHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 97 IYVVFELMESDLHQVIK-----ANDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 97 ~ylV~E~~~g~L~~~i~-----~~~~lse~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
.|++|||+..+|.++.. ....+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 78 CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 89999999976555432 245799999999999999999999974 999999999999999999999999999976
Q ss_pred ccCCCCCccccccccCCccccCcccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~-~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
....... ....++..|+|||++.+.. ..++.++|||||||++|+|++|+.||...+. ....+....
T Consensus 158 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~------- 224 (288)
T cd06616 158 LVDSIAK----TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVV------- 224 (288)
T ss_pred hccCCcc----ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhc-------
Confidence 5432211 2336888999999987521 2688999999999999999999999976541 111111100
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
....+.........++..+.+||.+||..||.+|||++++++||||+..
T Consensus 225 ----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 225 ----------------KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred ----------------CCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 0011111112224578899999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=326.12 Aligned_cols=259 Identities=31% Similarity=0.476 Sum_probs=213.9
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
..|++.+.||.|++|.||+|.+..+++.|+||++...... .....+.+|+..++.++||||+++++.+. .....
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 74 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEI 74 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeE
Confidence 3689999999999999999999999999999998754322 45677889999999999999999999984 44679
Q ss_pred EEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 98 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
|+||||++ ++|.+++.....+++..+..++.||+.||.|||+ .|++||||+|+||+++.++.++|+|||++.......
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999 6999999888889999999999999999999999 999999999999999999999999999998654332
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
.. .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.....+.+.
T Consensus 155 ~~---~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~---------------- 213 (264)
T cd06623 155 DQ---CNTFVGTVTYMSPERIQG--ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ---------------- 213 (264)
T ss_pred Cc---ccceeecccccCHhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH----------------
Confidence 21 124568889999999877 578899999999999999999999997764211111110
Q ss_pred hhHHHHHHhhcccCCCcccCCCCC-CCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPN-ADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~-~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
.+...... ..... ++..+.+||.+||..+|.+|||++++|+||||+..
T Consensus 214 --------~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 214 --------AICDGPPP---SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred --------HHhcCCCC---CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 01111111 11223 67899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=336.29 Aligned_cols=260 Identities=28% Similarity=0.461 Sum_probs=212.3
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++.+.||.|+||.||++.+..++..||+|.+... .......+.+|+.+++.++||||+++++.+ .+..
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~ 89 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSY-----LVGD 89 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhhee-----eeCC
Confidence 357999999999999999999999999999999998642 233456788999999999999999999988 3445
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
..|+|+||++ ++|.+++... .+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred cEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 7899999998 5999988654 5899999999999999999999999999999999999999999999999998754322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
.. ......+++.|++||.+.+ ..++.++|+|||||++|+|++|..||...+..+++..+..
T Consensus 169 ~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-------------- 229 (293)
T cd06647 169 QS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-------------- 229 (293)
T ss_pred cc---ccccccCChhhcCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc--------------
Confidence 21 1233568899999999876 5788999999999999999999999977654333221100
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
. ..+.......++..+.+||++||..||.+||++++++.|+||+....
T Consensus 230 -------------~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 230 -------------N-GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred -------------C-CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence 0 00001112346778999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=328.85 Aligned_cols=252 Identities=19% Similarity=0.270 Sum_probs=202.2
Q ss_pred CCCCeEEEeEeeecCceEEEEEEEC---CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~---~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
+..+|++.+.||+|+||.||+|.++ ..+..||+|.++... .......+.+|+.+|+.++||||+++++++.
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----- 76 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVIT----- 76 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----
Confidence 3467999999999999999999765 355689999987542 2334567889999999999999999999984
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
.....|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||.+..
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 77 RGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred cCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 4456899999998 5899888764 5799999999999999999999999999999999999999999999999998765
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
....... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+.+.
T Consensus 157 ~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-------- 224 (266)
T cd05064 157 DKSEAIY--TTMSGKSPVLWAAPEAIQY--HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-------- 224 (266)
T ss_pred ccccchh--cccCCCCceeecCHHHHhh--CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC--------
Confidence 3221111 0112235678999999876 688999999999999999775 99999887655444433211
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
... .....++..+.+|+.+||+.||.+||+++++++
T Consensus 225 -------------------~~~---~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 225 -------------------FRL---PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred -------------------CCC---CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 001 112456788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=333.04 Aligned_cols=246 Identities=21% Similarity=0.254 Sum_probs=201.1
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCccCChH-HHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEe
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHIS-DAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 102 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~-~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E 102 (614)
..||+|++|.||+|.. +|+.||||+++....... ....+.+|+.+|+.++||||+++++++.... .+...+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 5799999999999976 689999999976433222 2466779999999999999999999885411 22457899999
Q ss_pred cCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007177 103 LME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 180 (614)
Q Consensus 103 ~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 180 (614)
||. |+|.+++.....+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----
Confidence 999 5999999988889999999999999999999998 599999999999999999999999999998643221
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHH
Q 007177 181 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260 (614)
Q Consensus 181 ~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~ 260 (614)
...+++..|+|||++.+....|+.++|||||||++|||++|..||.+.+..+....+....
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~------------------ 238 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKN------------------ 238 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC------------------
Confidence 2346889999999987644679999999999999999999999998876554443332110
Q ss_pred HHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 261 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.... .....++.+.+||.+||+.||++|||++++|+
T Consensus 239 --------~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 239 --------NSLK---LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred --------CCCC---CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 0111 11256789999999999999999999999986
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=325.23 Aligned_cols=249 Identities=28% Similarity=0.452 Sum_probs=206.4
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
+|++.+.||.|+||.||++.++.++..||+|.++... .......+.+|+.+++.++||||+++++.+ .+...+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEE
Confidence 5899999999999999999999999999999986432 234567788999999999999999999998 4556799
Q ss_pred EEEecCC-CcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 99 VVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 99 lV~E~~~-g~L~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+||||++ ++|.+++.. ...++++.+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 9999998 599988865 3458999999999999999999999999999999999999999999999999997653322
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
. ......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+....+..+..
T Consensus 155 ~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~--------------- 214 (255)
T cd08219 155 A---YACTYVGTPYYVPPEIWEN--MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ--------------- 214 (255)
T ss_pred c---ccccccCCccccCHHHHcc--CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc---------------
Confidence 1 1234578999999999876 5789999999999999999999999987664333322211
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.. +......++..+.+||.+||..||.+|||+.++|+-
T Consensus 215 ------------~~---~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 215 ------------GS---YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ------------CC---CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00 011123467789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=318.09 Aligned_cols=266 Identities=25% Similarity=0.398 Sum_probs=211.9
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
..+.+||+|.+.||+|+|+.|+++....+++.||+|++.... ..+....++|+...++++|||++++++..+......
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 356789999999999999999999999999999999998643 567788899999999999999999998776554445
Q ss_pred CCcEEEEEecCC-CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeecCCCCcEEECCCCcEEEeecC
Q 007177 94 FKDIYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANANCKLKICDFG 166 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILi~~~~~vKL~DFG 166 (614)
....||+++|.. |+|.+.|.. ...++|.++..|+.+|++||++||+.. ++||||||.|||+.+++.++|.|||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence 667999999998 899998864 236999999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCC------CccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 007177 167 LARVAFNDTP------TTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMT 239 (614)
Q Consensus 167 la~~~~~~~~------~~~~~~~~vgt~~Y~APEvl~~~-~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~ 239 (614)
.+....-... .-..|.....|..|+|||++.-. ....++++|||||||+||.|+.|..||. .+.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe---------~~~ 245 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFE---------RIY 245 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcch---------HHh
Confidence 9976421111 11224445678899999987431 2457899999999999999999999992 222
Q ss_pred hhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 240 DLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 240 ~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
...|.-.... ......+... ..+|..+.+||+.||+.||.+||++.++|.+
T Consensus 246 ~~GgSlaLAv-----------------~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 246 QQGGSLALAV-----------------QNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred hcCCeEEEee-----------------eccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 2112111100 0011112222 2378899999999999999999999999874
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=364.80 Aligned_cols=257 Identities=24% Similarity=0.429 Sum_probs=205.3
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeE-ecCCCCCC-
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHI-MLPPSRRD- 93 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v-~~~~~~~~- 93 (614)
..+++|.++|.+|+|+.||+|.+...|..||+|++-.. +......+.+||.+|++|+ |+|||.+++. ........
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 34688999999999999999999988899999998753 5667788899999999997 9999999993 33332222
Q ss_pred CCcEEEEEecCC-CcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeecCCCCcEEECCCCcEEEeecCcc
Q 007177 94 FKDIYVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANANCKLKICDFGLA 168 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILi~~~~~vKL~DFGla 168 (614)
.-.++|+||||. |.|.+++.. ...|+|.+++.|++|+++||.+||... |||||||-|||||+.++..||||||.|
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 356899999999 699999974 346999999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCc---cccc---cccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhh
Q 007177 169 RVAFNDTPTT---IFWT---DYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 241 (614)
Q Consensus 169 ~~~~~~~~~~---~~~~---~~vgt~~Y~APEvl~~~-~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~ 241 (614)
.-........ .... ....|+.|||||+|.-. ....++|+|||+|||+||-||....||.+......+
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl------ 267 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL------ 267 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE------
Confidence 7533222111 0001 12578999999987421 146899999999999999999999999765321110
Q ss_pred hCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 242 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 242 ~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.....| ..+++++..+++||..||+.||.+||++-+++.+
T Consensus 268 --------------------------ng~Y~~-P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 268 --------------------------NGNYSF-PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred --------------------------eccccC-CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 001111 2246789999999999999999999999999874
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=335.04 Aligned_cols=262 Identities=26% Similarity=0.396 Sum_probs=212.7
Q ss_pred cccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCC
Q 007177 11 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPP 89 (614)
Q Consensus 11 ~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~ 89 (614)
+.......+|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~-- 85 (307)
T cd06607 8 FSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL-- 85 (307)
T ss_pred hcCCCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE--
Confidence 334455578999999999999999999999999999999986432 23344567889999999999999999999984
Q ss_pred CCCCCCcEEEEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcc
Q 007177 90 SRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 168 (614)
Q Consensus 90 ~~~~~~~~ylV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 168 (614)
+....|+||||+.++|.+++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++
T Consensus 86 ---~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~ 162 (307)
T cd06607 86 ---REHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSA 162 (307)
T ss_pred ---eCCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcc
Confidence 4456899999999998888764 457999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007177 169 RVAFNDTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~-~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~ 247 (614)
...... ....++..|+|||++.+. ...++.++|||||||++|+|++|.+||.+.+....+..+..
T Consensus 163 ~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~------- 228 (307)
T cd06607 163 SLVSPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------- 228 (307)
T ss_pred eecCCC-------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-------
Confidence 754221 234688899999987421 24688999999999999999999999977664433222210
Q ss_pred hhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 248 ~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
..... .....++..+.+||.+||..||.+||++.+++.||||..
T Consensus 229 --------------------~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 229 --------------------NDSPT--LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred --------------------CCCCC--CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 00000 001235678999999999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=327.30 Aligned_cols=249 Identities=24% Similarity=0.421 Sum_probs=205.8
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecC
Q 007177 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM 104 (614)
Q Consensus 26 LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~ 104 (614)
||.|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++.+ .+...+|+||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence 6999999999999999999999999975432 223456788999999999999999999987 4556799999999
Q ss_pred C-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCcccccc
Q 007177 105 E-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD 183 (614)
Q Consensus 105 ~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~ 183 (614)
+ ++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++....... ....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----~~~~ 151 (262)
T cd05572 76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWT 151 (262)
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----cccc
Confidence 8 6999999888889999999999999999999999999999999999999999999999999998654332 1123
Q ss_pred ccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCh--hHHHHHHHhhhCCCchhhhhhhhchhHHHH
Q 007177 184 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLMTDLLGTPSLDTISRVRNDKARRY 261 (614)
Q Consensus 184 ~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~--~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~ 261 (614)
..++..|++||.+.+ ..++.++|+|||||++|+|++|..||..... .+....+..
T Consensus 152 ~~~~~~~~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------- 208 (262)
T cd05572 152 FCGTPEYVAPEIILN--KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK--------------------- 208 (262)
T ss_pred ccCCcCccChhHhcC--CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc---------------------
Confidence 468899999999876 5788999999999999999999999977652 222211110
Q ss_pred HHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccC
Q 007177 262 LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 314 (614)
Q Consensus 262 l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~eiL~hp~f~~~ 314 (614)
...... .....++.+.+||.+||..||.+||+ ++|+++||||+++
T Consensus 209 -----~~~~~~---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 209 -----GNGKLE---FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred -----cCCCCC---CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 001111 11234789999999999999999999 9999999999865
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=324.84 Aligned_cols=253 Identities=29% Similarity=0.498 Sum_probs=208.5
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
+|.+.+.||.|+||.||++.++.+|..+|+|.+............+.+|+.+++.++|+||+++++.+ .+....|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence 68999999999999999999999999999999875333334556778999999999999999999988 4456799
Q ss_pred EEEecCC-CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC-cEEEeecCccccccCC
Q 007177 99 VVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAFND 174 (614)
Q Consensus 99 lV~E~~~-g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~-~vKL~DFGla~~~~~~ 174 (614)
+|+||+. ++|.+++.... .+++..+..++.||+.||.|||+.+|+|+||||+||++++++ .+||+|||.+......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999998 59999887643 479999999999999999999999999999999999999886 4699999999765432
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
... .....|++.|+|||++.+ ..++.++|+|||||++++|++|..||...+..+.+..+..
T Consensus 156 ~~~---~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------- 216 (257)
T cd08225 156 MEL---AYTCVGTPYYLSPEICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-------------- 216 (257)
T ss_pred ccc---ccccCCCccccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--------------
Confidence 211 123468889999998876 5788999999999999999999999977654333221110
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
..+....+.++..+.++|.+||..+|++|||+.++|+||||
T Consensus 217 ----------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 217 ----------------GYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ----------------ccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 01112234577899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=337.70 Aligned_cols=257 Identities=28% Similarity=0.504 Sum_probs=210.2
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
.-|.....||.|+||.||+|.+..++..||||++... .......+.+|+.+++.++||||+++++.+ ......
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~ 93 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHQNVVEMYKSY-----LVGEEL 93 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec--ccchHHHHHHHHHHHHhCCCCchhhhhhhe-----eeCCeE
Confidence 4456667899999999999999999999999998643 223345678999999999999999999988 345679
Q ss_pred EEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 98 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
|+||||++ ++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 94 ~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred EEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 99999999 488877654 5699999999999999999999999999999999999999999999999999875433221
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhch
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~ 256 (614)
......++..|+|||++.+ ..++.++|+|||||++|+|++|+.||...+..+.+..+..
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---------------- 231 (297)
T cd06659 173 ---KRKSLVGTPYWMAPEVISR--TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---------------- 231 (297)
T ss_pred ---cccceecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc----------------
Confidence 1234578999999999876 5789999999999999999999999987665444332210
Q ss_pred hHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 257 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
...........++..+.++|.+||+.||.+||+++++++||||.+..
T Consensus 232 ------------~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 232 ------------SPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred ------------cCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 01111122345788999999999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=332.05 Aligned_cols=252 Identities=26% Similarity=0.378 Sum_probs=197.6
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHH---hcCCCCcceeeeEecCCCCCCCCcEEEE
Q 007177 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-ISDAARILREIKLLR---LLRHPDIVEIKHIMLPPSRRDFKDIYVV 100 (614)
Q Consensus 25 ~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~-~~~~~~i~~Ei~iL~---~L~HpnIv~l~~v~~~~~~~~~~~~ylV 100 (614)
.||+|+||.||++.+..+++.+|+|.+...... ........+|..+++ ...||||+.+++.+. ..+..|+|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-----TPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-----cCCeEEEE
Confidence 489999999999999999999999998654322 122233345554444 347999999999883 44578999
Q ss_pred EecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCcc
Q 007177 101 FELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 179 (614)
Q Consensus 101 ~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~ 179 (614)
|||+. ++|.+++...+.+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 99999 5999999888889999999999999999999999999999999999999999999999999987543221
Q ss_pred ccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHH
Q 007177 180 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKAR 259 (614)
Q Consensus 180 ~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~ 259 (614)
.....|+..|+|||.+... ..++.++|||||||++|+|++|..||.+........ +
T Consensus 152 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~--------------------- 207 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-I--------------------- 207 (279)
T ss_pred -ccCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-H---------------------
Confidence 1234689999999988631 468899999999999999999999997643211100 0
Q ss_pred HHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCC
Q 007177 260 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGLS 315 (614)
Q Consensus 260 ~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~~ 315 (614)
........ ....+.+++.+.+||.+||..||.+|+ |++++++||||+++.
T Consensus 208 ---~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 208 ---DRMTLTVN---VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred ---HHHhhcCC---cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 00000000 112345788999999999999999999 699999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=344.36 Aligned_cols=260 Identities=27% Similarity=0.440 Sum_probs=214.8
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
.+.|..-++||+|+||.||-|..+.||+-||+|++.+... ........++|-.||.+++.+.||.+--.| +..+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-----eTkd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-----ETKD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----cCCC
Confidence 3567888999999999999999999999999999864322 222334567999999999999999998887 5667
Q ss_pred cEEEEEecCC-CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 96 DIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
.+|+|+.+|+ |||+-.|...+ .|+++.+.+++.+|+.||.+||+.+||+|||||+|||+|+.|+|+|+|+|||....
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 8999999999 59999887765 79999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
...+ .+..+||..|||||++.+ ..|+...|+|||||+||||+.|+.||.....-...
T Consensus 339 ~g~~----~~~rvGT~GYMAPEvl~n--e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~----------------- 395 (591)
T KOG0986|consen 339 EGKP----IRGRVGTVGYMAPEVLQN--EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR----------------- 395 (591)
T ss_pred CCCc----cccccCcccccCHHHHcC--CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH-----------------
Confidence 4433 245699999999999998 67999999999999999999999999654321111
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 314 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~ 314 (614)
+. ++.+....+..+ ....|+++++|.+.+|+.||++|. .++++-+||||+++
T Consensus 396 ---eE----vdrr~~~~~~ey---~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 396 ---EE----VDRRTLEDPEEY---SDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred ---HH----HHHHHhcchhhc---ccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 00 111111222222 245789999999999999999997 67899999999976
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=328.48 Aligned_cols=256 Identities=32% Similarity=0.550 Sum_probs=212.9
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~ 95 (614)
++|.+.+.||.|+||.||+|.+..++..||+|++.... ........+.+|+.+++.++ ||||+++++++ .+..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCc
Confidence 47999999999999999999999999999999987532 23344567889999999998 99999999987 4556
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
.+|+|||++. ++|.+++...+.+++..++.|+.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 7999999996 799999998888999999999999999999999999999999999999999999999999999865433
Q ss_pred CCC-----------------ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHH
Q 007177 175 TPT-----------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 237 (614)
Q Consensus 175 ~~~-----------------~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~ 237 (614)
... ........++..|+|||++.. ..++.++|+|||||++++|++|..||...+....+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCC--CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 211 011233467889999998876 5688899999999999999999999987764333322
Q ss_pred HHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCH----HHHHcCccc
Q 007177 238 MTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA----EEALADPYF 311 (614)
Q Consensus 238 i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa----~eiL~hp~f 311 (614)
+.. . .. .....+++.+.+||.+||..||.+|||+ +++|+||||
T Consensus 234 ~~~--------------------------~--~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILK--------------------------L--EY---SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHh--------------------------c--CC---CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 210 0 00 1123457899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=331.20 Aligned_cols=252 Identities=27% Similarity=0.392 Sum_probs=203.4
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecC
Q 007177 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM 104 (614)
Q Consensus 26 LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~ 104 (614)
||+|+||.||+|.+..+|+.||+|++..... .......+.+|+++|+.++||||+++++.+ ...+.+|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 6899999999999999999999999864322 222345567899999999999999999988 4456799999999
Q ss_pred C-CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCcccc
Q 007177 105 E-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 181 (614)
Q Consensus 105 ~-g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~ 181 (614)
+ ++|.+.+.... .+++..+..++.||+.||.|||+.|++||||+|+||+++.++.+||+|||++....... ..
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~----~~ 151 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK----KI 151 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC----cc
Confidence 9 59999987755 79999999999999999999999999999999999999999999999999987643211 12
Q ss_pred ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHH
Q 007177 182 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRY 261 (614)
Q Consensus 182 ~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~ 261 (614)
....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.........+..
T Consensus 152 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------------- 208 (277)
T cd05577 152 KGRAGTPGYMAPEVLQG--EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR--------------------- 208 (277)
T ss_pred ccccCCCCcCCHHHhcC--CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh---------------------
Confidence 33467889999999876 5688999999999999999999999977653211111100
Q ss_pred HHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCC
Q 007177 262 LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGLS 315 (614)
Q Consensus 262 l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~~ 315 (614)
.. ... .....+..++.+.+||.+||+.||.+|| ++.++++||||..+.
T Consensus 209 --~~-~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 209 --RT-LEM---AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred --cc-ccc---cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence 00 000 1112345688999999999999999999 999999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=323.23 Aligned_cols=259 Identities=25% Similarity=0.432 Sum_probs=209.7
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc---CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF---EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~---~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
..|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.++||||+++++.+... +.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CC
Confidence 47999999999999999999999999999999875321 1234456788999999999999999999987432 23
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
..+++||||+. ++|.+.+...+.+++..++.|+.||+.||.|||+.|++|+||||+||+++.++.++|+|||+++....
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 56899999998 58999998877899999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
........+...++..|+|||++.+ ..++.++|+|||||++|+|++|++||........+..+ ...+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~------- 226 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISG--EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI---ATQPT------- 226 (264)
T ss_pred ccccCccccccCCcccccCHhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH---HcCCC-------
Confidence 2211112234578999999999876 56889999999999999999999999765443322211 11110
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
.......+++.+.++|.+||. +|..||++.++|.|||.
T Consensus 227 -------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 227 -------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred -------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 011234578899999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=319.47 Aligned_cols=253 Identities=31% Similarity=0.530 Sum_probs=212.5
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
+|.+.+.||.|+||.||++.+..++..|++|++............+.+|+++++.++|||++++.+.+. +....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-----EKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-----cCCEEE
Confidence 689999999999999999999999999999999765445566778889999999999999999999884 336799
Q ss_pred EEEecCCC-cHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 99 VVFELMES-DLHQVIKAN----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 99 lV~E~~~g-~L~~~i~~~----~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
+|+|++++ +|.+.+... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 99999985 999988763 6799999999999999999999999999999999999999999999999999986544
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
... ......+++.|+|||.+.+ ..++.++|+||+|+++++|++|..||...+.......+.
T Consensus 156 ~~~---~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-------------- 216 (258)
T cd08215 156 TVD---LAKTVVGTPYYLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL-------------- 216 (258)
T ss_pred Ccc---eecceeeeecccChhHhcc--CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh--------------
Confidence 321 1234578899999998876 568899999999999999999999997765332222111
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
... +.......+..+.+++.+||..||.+|||+.++|+||||
T Consensus 217 -------------~~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 217 -------------KGQ---YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred -------------cCC---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 111 111122567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=329.54 Aligned_cols=253 Identities=23% Similarity=0.362 Sum_probs=204.9
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCC-----cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTG-----EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg-----~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
..+|++.+.||+|+||.||+|.+...+ ..||+|.+... ........+.+|+.+|+.++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~---- 78 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT---- 78 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC-CCHHHHHHHHHHHHHHHhcCCcccceEEEEEc----
Confidence 357999999999999999999876655 67999998743 23344567889999999999999999999883
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEE
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA 154 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~----------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi 154 (614)
+....|++|||++ ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+
T Consensus 79 -~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~ 157 (283)
T cd05048 79 -KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV 157 (283)
T ss_pred -CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE
Confidence 4456899999998 6999999764 458889999999999999999999999999999999999
Q ss_pred CCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhH
Q 007177 155 NANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVH 233 (614)
Q Consensus 155 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~ 233 (614)
+.++.+||+|||+++....... ........+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~ 234 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADY-YRVQSKSLLPVRWMPPEAILY--GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE 234 (283)
T ss_pred cCCCcEEECCCcceeecccccc-ccccCCCcccccccCHHHhcc--CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999999999976432221 111234467888999999876 578999999999999999998 999998876543
Q ss_pred HHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 234 QLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 234 ~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
....+.. .... .....+++++.+|+.+||+.||.+||++.+++++
T Consensus 235 ~~~~i~~---------------------------~~~~---~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 235 VIEMIRS---------------------------RQLL---PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHHc---------------------------CCcC---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3332211 1111 1123578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=330.96 Aligned_cols=255 Identities=26% Similarity=0.390 Sum_probs=210.4
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
..|+..+.||.|+||.||+|.+..++..||||.+... ........+.+|+.+++.+.||||+++++.+ .+....
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 77 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKGTKL 77 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCEE
Confidence 4688899999999999999999999999999998743 2234567788999999999999999999998 445679
Q ss_pred EEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 98 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
|+||||++ ++|.+++.. +.+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 78 ~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 78 WIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999998 489988865 5699999999999999999999999999999999999999999999999999976533221
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhch
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~ 256 (614)
......++..|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+.......+.
T Consensus 157 ---~~~~~~~~~~y~apE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~----------------- 214 (277)
T cd06640 157 ---KRNTFVGTPFWMAPEVIQQ--SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP----------------- 214 (277)
T ss_pred ---ccccccCcccccCHhHhcc--CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-----------------
Confidence 1233468889999999876 568899999999999999999999997665433222110
Q ss_pred hHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 257 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
... .......++..+.+||.+||..||++||+++++|+|+||...
T Consensus 215 ----------~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 215 ----------KNN---PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ----------cCC---CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 000 011223456789999999999999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=325.55 Aligned_cols=250 Identities=26% Similarity=0.420 Sum_probs=201.1
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHH-HhcCCCCcceeeeEecCCCCCCCCcEEEEE
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLL-RLLRHPDIVEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL-~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~ 101 (614)
+.||.|+||.||+|.+..+|+.||+|.+..... .......+..|..++ ..++||||+++++.+ .....+|+|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence 679999999999999999999999999864321 122233445555544 455899999999998 4456799999
Q ss_pred ecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007177 102 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 180 (614)
Q Consensus 102 E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 180 (614)
||+. ++|.+++...+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||+++....
T Consensus 77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 149 (260)
T cd05611 77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------- 149 (260)
T ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875432
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHH
Q 007177 181 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260 (614)
Q Consensus 181 ~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~ 260 (614)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+....+..+..
T Consensus 150 ~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------------- 207 (260)
T cd05611 150 NKKFVGTPDYLAPETILG--VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS-------------------- 207 (260)
T ss_pred cccCCCCcCccChhhhcC--CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--------------------
Confidence 123468889999999877 4589999999999999999999999987765433332211
Q ss_pred HHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC---CHHHHHcCcccccC
Q 007177 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP---TAEEALADPYFKGL 314 (614)
Q Consensus 261 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp---sa~eiL~hp~f~~~ 314 (614)
............+++.+.++|.+||+.||.+|| +++|+|.||||+++
T Consensus 208 -------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 208 -------RRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred -------cccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence 000011112235788999999999999999999 55899999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=318.72 Aligned_cols=253 Identities=32% Similarity=0.534 Sum_probs=213.9
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
+|++.+.||+|++|.||++.+..+++.|++|.+............+.+|+++++.++||||+++++++ .+....|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSI-----ETSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEE-----EeCCEEE
Confidence 58999999999999999999999999999999987654445677889999999999999999999988 3446799
Q ss_pred EEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007177 99 VVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 177 (614)
Q Consensus 99 lV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 177 (614)
+|||++++ +|.+++.....+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 76 IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred EEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999985 99999988888999999999999999999999999999999999999999999999999999875433221
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchh
Q 007177 178 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257 (614)
Q Consensus 178 ~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~ 257 (614)
.....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.
T Consensus 156 ---~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~------------------ 212 (254)
T cd06627 156 ---DASVVGTPYWMAPEVIEM--SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV------------------ 212 (254)
T ss_pred ---ccccccchhhcCHhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh------------------
Confidence 233468889999999876 458899999999999999999999997655332221110
Q ss_pred HHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 258 ~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
.. ........++..+.++|.+||..||++|||+.++|.||||
T Consensus 213 ---------~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 213 ---------QD---DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ---------cc---CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 00 1111234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=323.80 Aligned_cols=251 Identities=29% Similarity=0.454 Sum_probs=200.2
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEe
Q 007177 23 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 102 (614)
Q Consensus 23 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E 102 (614)
...||+|+||.||+|.+..++..|++|.+... .......+.+|+.+++.++|+||+++++++ .+...+|+|+|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e 85 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSD-----SENGFFKIFME 85 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeee-----ccCCEEEEEEe
Confidence 35899999999999999999999999988753 334566788999999999999999999988 34467999999
Q ss_pred cCC-CcHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC-CCcEEEeecCccccccCCCCC
Q 007177 103 LME-SDLHQVIKAN-DDL--TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFNDTPT 177 (614)
Q Consensus 103 ~~~-g~L~~~i~~~-~~l--se~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~-~~~vKL~DFGla~~~~~~~~~ 177 (614)
|+. ++|.+++... ..+ ++..+..++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~- 164 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP- 164 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-
Confidence 998 5999998764 445 88889999999999999999999999999999999976 67899999999876532221
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchh
Q 007177 178 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257 (614)
Q Consensus 178 ~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~ 257 (614)
......++..|+|||++.+....++.++|+||||+++|+|++|.+||............
T Consensus 165 --~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~------------------- 223 (268)
T cd06624 165 --CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK------------------- 223 (268)
T ss_pred --ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-------------------
Confidence 12334688899999998653345889999999999999999999999654321110000
Q ss_pred HHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 258 ~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
..... ........+++.+.+|+.+||..+|.+|||+.+++.||||
T Consensus 224 -----~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 224 -----VGMFK----IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -----hhhhc----cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 00000 0011223567899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=327.29 Aligned_cols=263 Identities=25% Similarity=0.412 Sum_probs=207.6
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
++|++.+.||.|++|.||+|.+..+++.||+|.+... .......++.+|+++|+.++||||+++++++... +...+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTD-PNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecC-CchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeE
Confidence 4799999999999999999999999999999998743 2234567788999999999999999999988432 33568
Q ss_pred EEEEecCC-CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 98 YVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999998 588877643 3468999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCh--hHHHHHHHhhhCCCchhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~--~~~l~~i~~~~g~p~~~~i 250 (614)
.... ....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||..... ....+..
T Consensus 157 ~~~~-----~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------ 217 (287)
T cd06621 157 NSLA-----GTFTGTSFYMAPERIQG--KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL------------ 217 (287)
T ss_pred cccc-----ccccCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH------------
Confidence 2211 23457889999999876 6789999999999999999999999976532 0001100
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCC---CCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKF---PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~---~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
.++. ......+.... ...++.+.+||.+||..||.+|||+.|++.||||+...
T Consensus 218 ---------~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 218 ---------SYIV---NMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred ---------HHHh---cCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 0000 00000011000 12457899999999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=345.16 Aligned_cols=253 Identities=25% Similarity=0.400 Sum_probs=198.7
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCC-----cEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTG-----EKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 90 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg-----~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~ 90 (614)
.++|++.+.||+|+||.||+|++..+| ..||||+++... .......+.+|+.+|+.+ +||||+++++.+
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~---- 111 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGAC---- 111 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEe----
Confidence 357999999999999999999865443 579999997542 234456788999999999 899999999988
Q ss_pred CCCCCcEEEEEecCC-CcHHHHHHhC------------------------------------------------------
Q 007177 91 RRDFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 115 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~-g~L~~~i~~~------------------------------------------------------ 115 (614)
.+...+|+|||||. |+|.+++...
T Consensus 112 -~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 112 -THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred -cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 44567899999998 6999888542
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCcc
Q 007177 116 ----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 179 (614)
Q Consensus 116 ----------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~ 179 (614)
..++++.+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~- 269 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV- 269 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee-
Confidence 247888999999999999999999999999999999999999999999999997654332211
Q ss_pred ccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhH
Q 007177 180 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 258 (614)
Q Consensus 180 ~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~ 258 (614)
......++..|+|||++.+ ..++.++|||||||++|+|++ |..||........+..+..
T Consensus 270 ~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~------------------ 329 (374)
T cd05106 270 VKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK------------------ 329 (374)
T ss_pred eccCCCCccceeCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHH------------------
Confidence 1122335567999999876 679999999999999999997 9999976543222211110
Q ss_pred HHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 259 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 259 ~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
...... ....+++++.+||.+||+.||.+|||++++++
T Consensus 330 --------~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 330 --------RGYQMS---RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred --------cccCcc---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000000 11235789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=347.25 Aligned_cols=245 Identities=28% Similarity=0.433 Sum_probs=202.9
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
.+++++.||+|.||.||.|.... ...||+|.++.. ......+++|+++|+.|+|+|||++++++. ....+|
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~-----~~~piy 277 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCT-----KQEPIY 277 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC-CCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEe-----cCCceE
Confidence 35567899999999999996532 238999999853 233456779999999999999999999993 334699
Q ss_pred EEEecCC-CcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 99 VVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 99 lV~E~~~-g~L~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
||||||. |+|.++++. ...+...+...|+.||++|++||+++++|||||-..||||+++..+||+|||||+...++.
T Consensus 278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 9999999 899999987 4579999999999999999999999999999999999999999999999999999544433
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
.+.. ...--..-|.|||.+.. ..++.++||||||++|+||+| |+.||++.+..+.+..+......|
T Consensus 358 Y~~~--~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp--------- 424 (468)
T KOG0197|consen 358 YTAS--EGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP--------- 424 (468)
T ss_pred eeec--CCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC---------
Confidence 3221 11122335889999986 789999999999999999999 899999999888887764432222
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHH
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 306 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL 306 (614)
...++++.+.+|+..||+.+|++|||++.+.
T Consensus 425 ---------------------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 425 ---------------------RPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ---------------------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 1246888999999999999999999999664
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=317.26 Aligned_cols=259 Identities=28% Similarity=0.452 Sum_probs=213.3
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
+|.+.+.||+|++|.||+|.+..++..|++|++............+.+|+.+++.++||||+++++.+.... ...+|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 588999999999999999999999999999999765444456778899999999999999999999884331 26789
Q ss_pred EEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007177 99 VVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 177 (614)
Q Consensus 99 lV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 177 (614)
+|+|+++ ++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+.........
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999996 699999988778999999999999999999999999999999999999999999999999999876544321
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchh
Q 007177 178 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257 (614)
Q Consensus 178 ~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~ 257 (614)
.......++..|++||.+.+ ..++.++|+|||||++|+|++|..||...+. ....+...
T Consensus 158 -~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~---------------- 216 (260)
T cd06606 158 -EGTGSVRGTPYWMAPEVIRG--EEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKI---------------- 216 (260)
T ss_pred -ccccCCCCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhc----------------
Confidence 01133468889999999876 4588999999999999999999999977651 11111110
Q ss_pred HHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 258 ~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
.. ...........+..+.+||.+||..||.+||++.++|.||||
T Consensus 217 --------~~--~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 217 --------GS--SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred --------cc--cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 00 011112223457899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=331.30 Aligned_cols=266 Identities=26% Similarity=0.394 Sum_probs=211.0
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|++++.||+|+||.||++.+..+|..||+|++... ........+.+|+++++.++||||+++++.+. +...
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~ 77 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG-AKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENN 77 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec-CcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCE
Confidence 35799999999999999999999999999999988643 22344567889999999999999999999983 4467
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+||+++.++.++|+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999 5899999888889999999999999999999997 69999999999999999999999999998654222
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
.. ...+++..|+|||++.+ ..++.++|||||||++|+|++|..||...+........
T Consensus 158 ~~-----~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~---------------- 214 (284)
T cd06620 158 IA-----DTFVGTSTYMSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD---------------- 214 (284)
T ss_pred cc-----CccccCcccCCHHHHcc--CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhh----------------
Confidence 11 23478999999999876 57889999999999999999999999865532110000
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
.......+..+.......+. ...++..+.+||.+||..||.+|||++|+++|+||..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 215 PMGILDLLQQIVQEPPPRLP--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred hhHHHHHHHHHhhccCCCCC--chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 00000111111111111110 1136678999999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=327.05 Aligned_cols=257 Identities=30% Similarity=0.484 Sum_probs=209.0
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC---CCCcceeeeEecCCCCCCCC
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR---HPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~v~~~~~~~~~~ 95 (614)
.|++.+.||.|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++ ||||+++++.+ .+..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~-----~~~~ 75 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSY-----LKGP 75 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeee-----eeCC
Confidence 5888999999999999999999999999999987532 2344567889999999986 99999999988 3456
Q ss_pred cEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 96 DIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 96 ~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
..|+||||+.+ +|.+++... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 76 RLWIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EEEEEEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 78999999984 898888654 7999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
.. ......|+..|+|||.+.+. ..++.++|+|||||++|+|++|..||.+.+.......+.
T Consensus 155 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~--------------- 215 (277)
T cd06917 155 SS---KRSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP--------------- 215 (277)
T ss_pred cc---ccccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc---------------
Confidence 21 12345789999999987642 457889999999999999999999997765432221110
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
...+..+. ...++.++.+|+.+||..||.+||++.+++.|+||+...
T Consensus 216 ------------~~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 216 ------------KSKPPRLE--DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred ------------cCCCCCCC--cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 00000000 112678999999999999999999999999999997643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=323.12 Aligned_cols=253 Identities=31% Similarity=0.518 Sum_probs=206.7
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecC
Q 007177 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM 104 (614)
Q Consensus 26 LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~ 104 (614)
||.|+||.||+|.+..+|+.+++|.+.... ........+.+|+.+++.++||||+++++.+ .+....|+|+||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 689999999999999999999999986432 1224556788999999999999999999887 4556799999999
Q ss_pred C-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCC-----c
Q 007177 105 E-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT-----T 178 (614)
Q Consensus 105 ~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~-----~ 178 (614)
. ++|.+++...+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++......... .
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 8 599999988778999999999999999999999999999999999999999999999999998764332110 1
Q ss_pred cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhH
Q 007177 179 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 258 (614)
Q Consensus 179 ~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~ 258 (614)
.......++..|++||.+.. ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------------ 215 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN------------------ 215 (265)
T ss_pred ccccCcccCccccCHHHhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------------
Confidence 11234568889999999876 5688899999999999999999999977664433332211
Q ss_pred HHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCH---HHHHcCcccccC
Q 007177 259 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA---EEALADPYFKGL 314 (614)
Q Consensus 259 ~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa---~eiL~hp~f~~~ 314 (614)
....+.. ...++..+.+||.+||+.||.+|||+ .++|+||||+++
T Consensus 216 ----------~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 216 ----------GKIEWPE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred ----------CCcCCCc-cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 0011111 11247899999999999999999999 999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=322.81 Aligned_cols=249 Identities=23% Similarity=0.449 Sum_probs=203.7
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
...|.+.+.||+|+||.||+|.++.+++.||+|.+... ......+.+|+.+|+.++||||+++++++ .....
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 76 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPP 76 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEE-----cCCCC
Confidence 34699999999999999999999999999999998742 23456788999999999999999999988 34567
Q ss_pred EEEEEecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 97 IYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 899999998 6999998764 3589999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||++.+..+....+..
T Consensus 157 ~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~------------ 220 (263)
T cd05052 157 DTYTA--HAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------------ 220 (263)
T ss_pred ceeec--cCCCCCccccCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC------------
Confidence 32111 111234567999998876 678899999999999999998 9999988765444333211
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.... .....+++.+.+||.+||..||.+|||+.++++
T Consensus 221 ---------------~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 221 ---------------GYRM---ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ---------------CCCC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0000 112356789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=328.11 Aligned_cols=251 Identities=27% Similarity=0.399 Sum_probs=197.1
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEecCccCCh-HHHHHHHHHH---HHHHhcCCCCcceeeeEecCCCCCCCCcEEEE
Q 007177 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI-SDAARILREI---KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVV 100 (614)
Q Consensus 25 ~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~-~~~~~i~~Ei---~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV 100 (614)
.||+|+||.||+|.+..+++.||||.+....... ........|. .+++...||+|+.+++.+ .+...+|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence 4899999999999999999999999987532221 1122233343 445556799999999988 445679999
Q ss_pred EecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCcc
Q 007177 101 FELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 179 (614)
Q Consensus 101 ~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~ 179 (614)
|||+. ++|.+++...+.+++..++.|+.||+.||.|||+.+|+||||||+||+++.++.+||+|||++.......
T Consensus 76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 99998 5899999888889999999999999999999999999999999999999999999999999987543221
Q ss_pred ccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHH
Q 007177 180 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKAR 259 (614)
Q Consensus 180 ~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~ 259 (614)
....+|+..|+|||++.+. ..++.++||||+||++|+|++|..||.+..........
T Consensus 152 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~--------------------- 208 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--------------------- 208 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---------------------
Confidence 1234789999999998642 46889999999999999999999999765321111000
Q ss_pred HHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 007177 260 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 314 (614)
Q Consensus 260 ~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~ 314 (614)
. ....... ......+..+.+||.+||..||.+|| +++++++||||+..
T Consensus 209 ~----~~~~~~~---~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 209 R----MTLTMAV---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred H----HhhccCC---CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 0 0000011 12234688999999999999999999 99999999999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=338.93 Aligned_cols=286 Identities=20% Similarity=0.262 Sum_probs=206.3
Q ss_pred eEeeec--CceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEE
Q 007177 24 EVIGKG--SYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 24 ~~LG~G--~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~ 101 (614)
..||+| +||+||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++ .....+|+||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEEE
Confidence 456776 999999999999999999999875444445567888999999999999999999998 3456789999
Q ss_pred ecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCc
Q 007177 102 ELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 178 (614)
Q Consensus 102 E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~ 178 (614)
||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++||+.+..........
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 9999 5999988764 358999999999999999999999999999999999999999999999998664332211110
Q ss_pred -cc---cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 179 -IF---WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 179 -~~---~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
.. .....++..|+|||++.+....++.++|||||||++|+|++|.+||.+......+..+.. +.+.........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 236 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLK--GPPYSPLDITTF 236 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhc--CCCCCCcccccc
Confidence 00 011234567999999876434588999999999999999999999988765444333322 111100000000
Q ss_pred chhHHH-------HH----Hhhcc-----cCC-Ccc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 255 NDKARR-------YL----TSMRK-----KQP-VQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 255 ~~~~~~-------~l----~~~~~-----~~~-~~~-~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
...... +. ..... ... ... .......++.+.+||.+||..||++|||++|+|+||||+.+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 000000 00 00000 000 000 0112245678999999999999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=343.87 Aligned_cols=253 Identities=26% Similarity=0.393 Sum_probs=198.8
Q ss_pred CCeEEEeEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAID-----THTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d-----~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~ 91 (614)
++|++.+.||+|+||.||+|.+ ..++..||||+++... .......+.+|+.+|+.+ +||||+++++.+
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~----- 108 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGAC----- 108 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeee-----
Confidence 4799999999999999999964 3466789999987432 234456788999999999 799999999998
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhCC------------------------------------------------------
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKAND------------------------------------------------------ 116 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~~------------------------------------------------------ 116 (614)
.+....|+|||||+ |+|.+++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 44556899999999 69998886421
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 117 ---------------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 117 ---------------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
.++++.+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 47888999999999999999999999999999999999999999999999998654322
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+......+..+..
T Consensus 269 ~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~-------------- 331 (375)
T cd05104 269 NYV-VKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK-------------- 331 (375)
T ss_pred ccc-ccCCCCCCcceeChhHhcC--CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH--------------
Confidence 111 1112335567999999876 679999999999999999998 8999977653322211110
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
..... ......+.++.+||.+||..||++|||+.|+++.
T Consensus 332 ------------~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 332 ------------EGYRM---LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred ------------hCccC---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 00000 0112356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=331.65 Aligned_cols=255 Identities=28% Similarity=0.405 Sum_probs=208.0
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
+.|++.+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++.+. +....
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCce
Confidence 45778899999999999999999999999999987432 2334567889999999999999999999883 45679
Q ss_pred EEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 98 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++........
T Consensus 78 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999999 588888764 5699999999999999999999999999999999999999999999999999976432211
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhch
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~ 256 (614)
......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~------------------ 213 (277)
T cd06642 157 ---KRNTFVGTPFWMAPEVIKQ--SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI------------------ 213 (277)
T ss_pred ---hhhcccCcccccCHHHhCc--CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh------------------
Confidence 1123468889999999877 57889999999999999999999999655432222111
Q ss_pred hHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 257 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
..... ......++..+.+||.+||..||.+||++.++|+||||..+
T Consensus 214 ---------~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 214 ---------PKNSP---PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred ---------hcCCC---CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 00000 11112467789999999999999999999999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=321.91 Aligned_cols=256 Identities=21% Similarity=0.351 Sum_probs=203.6
Q ss_pred eEEEeEeeecCceEEEEEEECCC---CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CCCC
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHT---GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RDFK 95 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~t---g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~-~~~~ 95 (614)
|++++.||+|+||.||+|.+..+ +..||||+++...........+.+|+.+|+.++||||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67899999999999999987653 4789999998654445566778999999999999999999998765432 3345
Q ss_pred cEEEEEecCC-CcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcc
Q 007177 96 DIYVVFELME-SDLHQVIKAN------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 168 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 168 (614)
..++||||+. ++|..++... ..+++..+..++.||+.||.|||+.||+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 6899999998 6998887432 36899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCch
Q 007177 169 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSL 247 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~ 247 (614)
+......... ......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+..+.++.+..
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~------- 230 (273)
T cd05035 161 KKIYSGDYYR-QGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH------- 230 (273)
T ss_pred eecccccccc-ccccccCCccccCHhhccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------
Confidence 8654322111 1112234567999999876 678999999999999999999 8999987665443332211
Q ss_pred hhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 248 ~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
... .......+..+.+|+.+||+.||.+|||+.+++++
T Consensus 231 --------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 231 --------------------GNR---LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred --------------------CCC---CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 101 11224567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=326.04 Aligned_cols=260 Identities=21% Similarity=0.356 Sum_probs=204.7
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 90 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~-----tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 90 (614)
..++|++.+.||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--- 79 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVS--- 79 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc---
Confidence 45789999999999999999997652 34579999886432 2334456789999999999999999999883
Q ss_pred CCCCCcEEEEEecCC-CcHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCc
Q 007177 91 RRDFKDIYVVFELME-SDLHQVIKAN----------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK 159 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~-g~L~~~i~~~----------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~ 159 (614)
+....|+||||+. ++|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 80 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 80 --KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred --CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc
Confidence 4456899999998 6999999652 23467788999999999999999999999999999999999999
Q ss_pred EEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 007177 160 LKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLM 238 (614)
Q Consensus 160 vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i 238 (614)
+||+|||+++......... ......++..|+|||.+.+ ..++.++|+|||||++|||++ |..||.+.+..+.+..+
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~--~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYR-KGGKGLLPVRWMAPESLKD--GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234 (288)
T ss_pred EEECcCCcccccccccccc-ccCCCcccccccCHHHhcc--CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999998643322111 1122345677999999876 578999999999999999998 78899776654433322
Q ss_pred HhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc------Ccccc
Q 007177 239 TDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA------DPYFK 312 (614)
Q Consensus 239 ~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~------hp~f~ 312 (614)
.. .... ......++.+.+|+.+||+.||++|||+.++++ ||||.
T Consensus 235 ~~---------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~ 284 (288)
T cd05061 235 MD---------------------------GGYL---DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284 (288)
T ss_pred Hc---------------------------CCCC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence 11 0000 111245688999999999999999999999987 89998
Q ss_pred cC
Q 007177 313 GL 314 (614)
Q Consensus 313 ~~ 314 (614)
++
T Consensus 285 ~~ 286 (288)
T cd05061 285 EV 286 (288)
T ss_pred CC
Confidence 65
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=314.30 Aligned_cols=251 Identities=29% Similarity=0.502 Sum_probs=208.4
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
.|.+.+.||.|++|.||++.+..+++.+++|++..... .....+.+|+.+++.++||||+++++.+. .....|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 73 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYL-----KKDELW 73 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEE
Confidence 48899999999999999999999999999999975422 45677889999999999999999999883 346789
Q ss_pred EEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 99 VVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 99 lV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
+++||++ ++|.+++... ..+++..+..++.||+.||.+||+.|++||||+|+||+++.++.+||+|||++........
T Consensus 74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 9999999 6999998776 5799999999999999999999999999999999999999999999999999976543321
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhch
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~ 256 (614)
.....++..|++||.+.+ ..++.++|+|||||++|+|++|..||...+....+..+..
T Consensus 154 ----~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------- 211 (253)
T cd05122 154 ----RNTMVGTPYWMAPEVING--KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---------------- 211 (253)
T ss_pred ----ccceecCCcccCHHHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----------------
Confidence 133568889999999876 4688999999999999999999999977654333322211
Q ss_pred hHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcc
Q 007177 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 310 (614)
Q Consensus 257 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~ 310 (614)
...........++..+.++|.+||..||.+|||+.++|+|||
T Consensus 212 ------------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 212 ------------NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ------------cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 000000011124788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=325.32 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=203.6
Q ss_pred CCCeEEEeEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~-----tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
.++|.+.+.||+|+||.||+|.+.. ++..||||.++... .......+.+|+++|+.++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---- 78 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCT---- 78 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEe----
Confidence 4579999999999999999998753 45789999987542 2234567889999999999999999999984
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKAND--------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA 156 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~~--------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~ 156 (614)
.....|+||||+. ++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 79 -~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~ 157 (280)
T cd05049 79 -EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY 157 (280)
T ss_pred -cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence 3467999999998 59999997542 4789999999999999999999999999999999999999
Q ss_pred CCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHH
Q 007177 157 NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQL 235 (614)
Q Consensus 157 ~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l 235 (614)
++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~ 234 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI 234 (280)
T ss_pred CCeEEECCcccceecccCcce-ecCCCCcccceecChhhhcc--CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999999764332211 11123356788999999876 679999999999999999998 99999877654443
Q ss_pred HHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 236 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 236 ~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
..+.. .. .......++..+.+|+.+||..||.+||+++|+++
T Consensus 235 ~~~~~---------------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 235 ECITQ---------------------------GR---LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHc---------------------------CC---cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 33311 00 01112356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=334.60 Aligned_cols=275 Identities=24% Similarity=0.294 Sum_probs=201.4
Q ss_pred CceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecCC-CcH
Q 007177 30 SYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDL 108 (614)
Q Consensus 30 ~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~-g~L 108 (614)
++|.||++.++.+++.||||++............+.+|+.+|+.++||||+++++++. +....|++|||+. ++|
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~-----~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI-----VDSELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee-----cCCeEEEEEeccCCCCH
Confidence 4456677777889999999999765445567788999999999999999999999883 4466899999999 689
Q ss_pred HHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCC----ccccc
Q 007177 109 HQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT----TIFWT 182 (614)
Q Consensus 109 ~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~----~~~~~ 182 (614)
.+++... ..+++..+..+++||+.||+|||++||+||||||+|||++.++.+||+|||.+......... .....
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 9988753 46899999999999999999999999999999999999999999999999998754322211 11123
Q ss_pred cccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHH
Q 007177 183 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYL 262 (614)
Q Consensus 183 ~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l 262 (614)
...++..|+|||++.+....|+.++|+||+||++|+|++|..||........+.. ...+..... +... ......
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~--~~~~~~~~~-~~~~---~~~~~~ 240 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCL-LDKS---TYPLYE 240 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhccCccc-cccC---chhhhc
Confidence 3467888999999876334688999999999999999999999987654332211 111111000 0000 000000
Q ss_pred Hhhcc--------cCCCcc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 263 TSMRK--------KQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 263 ~~~~~--------~~~~~~-~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
..+.. ...... ......++..+.+||.+||..||.+|||++++|+||||+.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00000 000000 011123467889999999999999999999999999998765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=320.47 Aligned_cols=245 Identities=22% Similarity=0.340 Sum_probs=197.9
Q ss_pred EeeecCceEEEEEEE--CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEe
Q 007177 25 VIGKGSYGVVCSAID--THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 102 (614)
Q Consensus 25 ~LG~G~~G~V~~a~d--~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E 102 (614)
.||+|+||.||+|.+ +.++..+|+|+++...........+.+|+.+|+.++||||+++++++. ....++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence 589999999999964 457789999998755444455677889999999999999999999862 235799999
Q ss_pred cCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCcccc
Q 007177 103 LME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 181 (614)
Q Consensus 103 ~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~ 181 (614)
|+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 76 LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999 6899999887889999999999999999999999999999999999999999999999999997654332211111
Q ss_pred ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHH
Q 007177 182 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260 (614)
Q Consensus 182 ~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~ 260 (614)
....++..|+|||.+.. ..++.++|+|||||++|||++ |..||.+.+..+....+..
T Consensus 156 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~-------------------- 213 (257)
T cd05116 156 THGKWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-------------------- 213 (257)
T ss_pred CCCCCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC--------------------
Confidence 22234578999998875 578899999999999999997 9999987665444333311
Q ss_pred HHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 261 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.... ......++.+.+||.+||+.||.+||++++|..
T Consensus 214 -------~~~~---~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 214 -------GERM---ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred -------CCCC---CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 1111 112357889999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=318.37 Aligned_cols=251 Identities=28% Similarity=0.447 Sum_probs=210.3
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
+|++.+.||.|+||.||++.+..+++.+++|++............+.+|+.+++.++||||+++++++. +....|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL-----DGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc-----cCCEEE
Confidence 589999999999999999999999999999999765444556677889999999999999999999884 346799
Q ss_pred EEEecCC-CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 99 VVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 99 lV~E~~~-g~L~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
+||||++ ++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 9999998 589988865 35689999999999999999999999999999999999999999999999999987644
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
.. .....++..|++||.+.+ ..++.++|+||||+++++|++|+.||...+.......+..
T Consensus 156 ~~-----~~~~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------- 215 (256)
T cd08530 156 NM-----AKTQIGTPHYMAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR------------- 215 (256)
T ss_pred CC-----cccccCCccccCHHHHCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------------
Confidence 31 123468889999999876 6788999999999999999999999987664332222110
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
. .+.......+.+++++|.+||..+|++|||+.++|+||++
T Consensus 216 --------------~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 216 --------------G---KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred --------------C---CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 0 0111112467889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=350.00 Aligned_cols=252 Identities=32% Similarity=0.525 Sum_probs=209.1
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecC
Q 007177 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM 104 (614)
Q Consensus 25 ~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~ 104 (614)
+||+|.||+||.|+|..|....|||.|.. ......+.+..||.+.++|+|.|||++++.+ ...+.+-|.||-+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe--kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqV 654 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE--KDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQV 654 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccc--ccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecC
Confidence 79999999999999999999999999974 3345677889999999999999999999987 5556788999999
Q ss_pred C-CcHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEEC-CCCcEEEeecCccccccCCCCCcc
Q 007177 105 E-SDLHQVIKAN-DDL--TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN-ANCKLKICDFGLARVAFNDTPTTI 179 (614)
Q Consensus 105 ~-g~L~~~i~~~-~~l--se~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~-~~~~vKL~DFGla~~~~~~~~~~~ 179 (614)
+ |+|..++... +++ .|..+-++.+|||+||+|||.+.|||||||-+|+||+ -.|.+||.|||-++....-.+.+
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T- 733 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT- 733 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccc-
Confidence 8 5999999764 667 7889999999999999999999999999999999996 47899999999998876555433
Q ss_pred ccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHH
Q 007177 180 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKAR 259 (614)
Q Consensus 180 ~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~ 259 (614)
.++.||..|||||++......|+.++|||||||.+.||.||+|||... |.|...+..
T Consensus 734 --ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El-------------gspqAAMFk-------- 790 (1226)
T KOG4279|consen 734 --ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL-------------GSPQAAMFK-------- 790 (1226)
T ss_pred --cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec-------------CChhHhhhh--------
Confidence 567899999999999765678999999999999999999999999553 222221110
Q ss_pred HHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 260 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 260 ~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
-.+-+..| .....++.+++.||.+|+..||.+||+|.++|.+||++.-
T Consensus 791 ---VGmyKvHP----~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 791 ---VGMYKVHP----PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred ---hcceecCC----CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 00001100 1112467789999999999999999999999999999864
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=325.99 Aligned_cols=263 Identities=22% Similarity=0.388 Sum_probs=209.1
Q ss_pred CeEEEeEeeecCceEEEEEEEC---CCCcEEEEEEecCcc--CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCC
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIF--EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~---~tg~~vAIK~i~~~~--~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~ 92 (614)
.|++.+.||.|+||.||+|.+. .+|..||+|.+.... ........+.+|+.+|+.+ +|+||+.+++.+ +
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 4899999999999999999875 478999999987431 1223446678899999999 599999999888 4
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
....+|+||||+. ++|.+++.....+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++...
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 4567899999999 599999988888999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
...... ......|+..|+|||.+.+....++.++|||||||++|+|++|..||...........+.
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~------------ 221 (290)
T cd05613 156 HEDEVE--RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS------------ 221 (290)
T ss_pred cccccc--ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHH------------
Confidence 322211 123457899999999987533457889999999999999999999996543221111111
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGLS 315 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~~ 315 (614)
..+....+ .....+++.+.+|+++||..||.+|| ++++++.||||+.+.
T Consensus 222 -----------~~~~~~~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 222 -----------RRILKSEP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred -----------HHhhccCC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 11101100 11234678999999999999999997 899999999998653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=364.07 Aligned_cols=148 Identities=24% Similarity=0.434 Sum_probs=133.8
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
.++|.+++.||.|+||.||+|.+..+++.||||+++.. .........+.+|+.+++.++||||+++++++ ....
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECC
Confidence 46899999999999999999999999999999999743 22334456788999999999999999999887 4556
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
.+|||||||. ++|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 7999999997 6999999888889999999999999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=321.82 Aligned_cols=256 Identities=22% Similarity=0.381 Sum_probs=202.4
Q ss_pred eEEEeEeeecCceEEEEEEECCCCc--EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CCCCc
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTGE--KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RDFKD 96 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg~--~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~-~~~~~ 96 (614)
|.+.+.||+|+||.||+|.+..++. .+|+|.++...........+.+|+.+|+.++||||+++++.+..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3578899999999999999877775 69999987654555667788899999999999999999998754321 22346
Q ss_pred EEEEEecCC-CcHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 97 IYVVFELME-SDLHQVIKA------NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~------~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
.++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 799999998 699888742 2348899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchh
Q 007177 170 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLD 248 (614)
Q Consensus 170 ~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~ 248 (614)
......... ......+++.|++||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 161 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~--------- 228 (272)
T cd05075 161 KIYNGDYYR-QGRIAKMPVKWIAIESLAD--RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR--------- 228 (272)
T ss_pred ccCccccee-cCCcccCCcccCCHHHccC--CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---------
Confidence 654322111 1122345678999999887 678999999999999999999 899998765433332221
Q ss_pred hhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 249 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 249 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
..... ...+.++..+.+||.+||+.||.+|||+++++++
T Consensus 229 ------------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 229 ------------------QGNRL---KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred ------------------cCCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11111 1123567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=323.44 Aligned_cols=254 Identities=20% Similarity=0.360 Sum_probs=201.6
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 90 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~-----tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 90 (614)
..++|++.+.||+|+||.||+|.++. ++..||||++... ........+.+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~---- 78 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVV---- 78 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE----
Confidence 45689999999999999999998652 4567999998643 2334556788999999999999999999988
Q ss_pred CCCCCcEEEEEecCC-CcHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCc
Q 007177 91 RRDFKDIYVVFELME-SDLHQVIKAND----------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK 159 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~-g~L~~~i~~~~----------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~ 159 (614)
.+....|+||||+. ++|.+++.... .++...+..++.||+.||.|||+.|++||||||+|||++.++.
T Consensus 79 -~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 79 -SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred -cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC
Confidence 44467899999998 59999986532 3577889999999999999999999999999999999999999
Q ss_pred EEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 007177 160 LKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLM 238 (614)
Q Consensus 160 vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i 238 (614)
+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+
T Consensus 158 ~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYR-KGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234 (277)
T ss_pred EEECCCCCccccCCcceee-cCCCCccCHhhcChhHhhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999987543322111 1122345778999999876 678999999999999999998 78999877654443322
Q ss_pred HhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 239 TDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 239 ~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.. .... ......++.+.+|+.+||+.||.+|||+.|++++
T Consensus 235 ~~---------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 235 ME---------------------------GGLL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred Hc---------------------------CCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11 0000 1113467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=330.87 Aligned_cols=261 Identities=25% Similarity=0.390 Sum_probs=211.9
Q ss_pred ccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007177 12 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 90 (614)
Q Consensus 12 ~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 90 (614)
........|...+.||+|+||.||+|.+..++..|+||++..... .......+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~---- 90 (313)
T cd06633 15 YKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCY---- 90 (313)
T ss_pred ccCCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEE----
Confidence 334444568888999999999999999999999999999864322 233456788999999999999999999998
Q ss_pred CCCCCcEEEEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 91 RRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
.+....|+||||+.++|.+.+.. ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.
T Consensus 91 -~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~ 169 (313)
T cd06633 91 -LKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSAS 169 (313)
T ss_pred -EeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCc
Confidence 44567899999999998888765 4568999999999999999999999999999999999999999999999999986
Q ss_pred cccCCCCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007177 170 VAFNDTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248 (614)
Q Consensus 170 ~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~-~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~ 248 (614)
.... .....++..|+|||++... ...++.++|+|||||++|+|++|.+||...+....+..+..
T Consensus 170 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-------- 234 (313)
T cd06633 170 KSSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------- 234 (313)
T ss_pred ccCC-------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--------
Confidence 4221 1235688899999987421 14688899999999999999999999977765444333211
Q ss_pred hhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 249 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 249 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
...+ ....+.++..+.+||.+||+.||.+||++.++|.||||..
T Consensus 235 ------------------~~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 235 ------------------NDSP---TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred ------------------cCCC---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 0000 0112345678999999999999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=323.84 Aligned_cols=254 Identities=26% Similarity=0.402 Sum_probs=208.5
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
-|++.+.||.|+||.||+|.+..++..||||.+... ........+.+|+.+++.++||||+++++.+ .+....|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 78 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLW 78 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc-cchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeEE
Confidence 478899999999999999999999999999988643 2233456788999999999999999999998 4456799
Q ss_pred EEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007177 99 VVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 177 (614)
Q Consensus 99 lV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 177 (614)
+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 79 lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 79 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999998 488888764 4689999999999999999999999999999999999999999999999999876432211
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchh
Q 007177 178 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257 (614)
Q Consensus 178 ~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~ 257 (614)
......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 157 --~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----------------- 215 (277)
T cd06641 157 --KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK----------------- 215 (277)
T ss_pred --hhccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc-----------------
Confidence 1233568889999999876 5778899999999999999999999976554332222110
Q ss_pred HHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 258 ~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
.. .......++..+.++|.+||..||.+||++.++++||||...
T Consensus 216 ----------~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 216 ----------NN---PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ----------CC---CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 00 011123467889999999999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=324.59 Aligned_cols=247 Identities=22% Similarity=0.363 Sum_probs=196.8
Q ss_pred CCeEEEeEe--eecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007177 18 SRYKIQEVI--GKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 18 ~rY~i~~~L--G~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~ 94 (614)
+.|.+.+.+ |.|+||.||++.++.++..+|+|.+....... .|+..+..+ +||||+++++.+. ..
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~-----~~ 81 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVT-----TL 81 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEe-----cC
Confidence 456666665 99999999999999999999999986431111 133333323 6999999999984 44
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC-cEEEeecCcccccc
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAF 172 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~-~vKL~DFGla~~~~ 172 (614)
+.+|+||||++ ++|.+++..+..++++.++.++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++....
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 57999999998 69999998888899999999999999999999999999999999999999998 99999999987643
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHH-HHHHHhhhCCCchhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ-LDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~-l~~i~~~~g~p~~~~i~ 251 (614)
.. ....++..|+|||++.+ ..++.++|+|||||++|+|++|..||........ +..+
T Consensus 162 ~~-------~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~------------- 219 (267)
T PHA03390 162 TP-------SCYDGTLDYFSPEKIKG--HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL------------- 219 (267)
T ss_pred CC-------ccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHH-------------
Confidence 22 22468889999999976 6789999999999999999999999975542210 0100
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC-HHHHHcCccccc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-AEEALADPYFKG 313 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-a~eiL~hp~f~~ 313 (614)
.... ......++..++.+.+||.+||+.||.+|++ ++++|+||||++
T Consensus 220 ----------~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 220 ----------LKRQ-----QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred ----------HHhh-----cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 0000 0111223468899999999999999999996 699999999963
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=325.91 Aligned_cols=260 Identities=32% Similarity=0.508 Sum_probs=214.8
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
-+....|++.+.||.|+||.||++.+..++..|++|++..... ....+.+|+.+++.++|+||+++++.+. .
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~ 86 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYL-----V 86 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEE-----E
Confidence 3556779999999999999999999998999999999975322 4567889999999999999999999984 3
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
....|+|+||++ ++|.+++.... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++...
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 467999999999 69999998876 8999999999999999999999999999999999999999999999999998654
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
..... ......++..|++||.+.+ ..++.++|+||||||+|+|++|..||...+.......+..
T Consensus 167 ~~~~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~----------- 230 (286)
T cd06614 167 TKEKS---KRNSVVGTPYWMAPEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT----------- 230 (286)
T ss_pred ccchh---hhccccCCcccCCHhHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Confidence 32211 1123357889999999876 5789999999999999999999999977654433222211
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
... ........++..+.+||.+||+.||.+|||+.++|+|+||+..
T Consensus 231 ----------------~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 231 ----------------KGI-PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred ----------------cCC-CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 000 0111123467899999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=336.73 Aligned_cols=254 Identities=25% Similarity=0.420 Sum_probs=200.7
Q ss_pred CCeEEEeEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~-----tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~ 91 (614)
++|++.+.||.|+||.||+|.+.. +++.||+|+++... .......+.+|+.+++.+ +||||+++++.+..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~--- 82 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTK--- 82 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEec---
Confidence 589999999999999999997543 45789999987532 234456788999999999 79999999998743
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhC-------------------------------------------------------
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------- 115 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~------------------------------------------------------- 115 (614)
....+|+||||+. ++|.+++...
T Consensus 83 -~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 83 -PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred -CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 3457899999999 5898888542
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCcc
Q 007177 116 ------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 189 (614)
Q Consensus 116 ------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~ 189 (614)
..++++.+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ .......++..
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~-~~~~~~~~~~~ 240 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARLPLK 240 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch-hhccCCCCCcc
Confidence 25789999999999999999999999999999999999999999999999999875432211 11223456678
Q ss_pred ccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhccc
Q 007177 190 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKK 268 (614)
Q Consensus 190 Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~ 268 (614)
|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.+.... ...
T Consensus 241 y~aPE~~~~--~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~--------------------------~~~ 292 (337)
T cd05054 241 WMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL--------------------------KEG 292 (337)
T ss_pred ccCcHHhcC--CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH--------------------------hcc
Confidence 999999877 689999999999999999997 999998754322221111 000
Q ss_pred CCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 269 QPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 269 ~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
... ......++.+.+|+.+||+.+|++||+++|+++|
T Consensus 293 ~~~---~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 293 TRM---RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CCC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 000 0112457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=320.61 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=202.6
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
++|++.+.||+|+||.||+|.+..+++.||||++... .........+.+|+.+|+.++||||+++++.+. +.+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI-----EDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE-----ECCe
Confidence 5899999999999999999999999999999988642 223344567889999999999999999999883 4467
Q ss_pred EEEEEecCC-CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 97 IYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
.|+|+||++ ++|.+++.. ...++++.+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 899999999 588887753 345899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChh-HHHHHHHhhhCCCchhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~-~~l~~i~~~~g~p~~~~i 250 (614)
..... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...... ..+...
T Consensus 157 ~~~~~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~------------ 219 (267)
T cd08228 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK------------ 219 (267)
T ss_pred cchhH---HHhcCCCCccccChhhhcc--CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH------------
Confidence 32221 1234568889999999876 57889999999999999999999999654321 111110
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
+..... ........+..+.+||.+||..||.+||++.++|+.
T Consensus 220 --------------~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 220 --------------IEQCDY--PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred --------------HhcCCC--CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 000000 001112456789999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.61 Aligned_cols=283 Identities=33% Similarity=0.535 Sum_probs=226.5
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC------CCcceeeeEecCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH------PDIVEIKHIMLPP 89 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~H------pnIv~l~~v~~~~ 89 (614)
..+||.+....|+|-||.|+.|.|..-|..||||+|.+. ..-.+.=++|++||+.|.. -++++++..|
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F--- 503 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF--- 503 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh---
Confidence 357999999999999999999999999999999999853 2333445689999999962 3688887777
Q ss_pred CCCCCCcEEEEEecCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC-CcEEEeec
Q 007177 90 SRRDFKDIYVVFELMESDLHQVIKAND---DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDF 165 (614)
Q Consensus 90 ~~~~~~~~ylV~E~~~g~L~~~i~~~~---~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~-~~vKL~DF 165 (614)
...+++|||||-+.-+|.++++.-+ .|....+..++.||+.||..|-.+||+|.||||+|||++.. ..+|||||
T Consensus 504 --~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 504 --KHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred --hhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccC
Confidence 4557899999999999999998744 68999999999999999999999999999999999999875 46899999
Q ss_pred CccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCC
Q 007177 166 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 245 (614)
Q Consensus 166 Gla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p 245 (614)
|.|.....+. .+.|..+++|+|||++.+ -.|+..+|+||+||+||||.||+.+|+|.++.+.+...+++-|..
T Consensus 582 GSA~~~~ene-----itPYLVSRFYRaPEIiLG--~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~ 654 (752)
T KOG0670|consen 582 GSASFASENE-----ITPYLVSRFYRAPEIILG--LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF 654 (752)
T ss_pred cccccccccc-----ccHHHHHHhccCcceeec--CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence 9997765443 367889999999999999 689999999999999999999999999999999999999999988
Q ss_pred chhhhhhhhc----------------hhH--HHHHHhhcccCC-Cccc------CCCC----CCCHHHHHHHHHhcCCCC
Q 007177 246 SLDTISRVRN----------------DKA--RRYLTSMRKKQP-VQFS------QKFP----NADPSALRLLERLLAFDP 296 (614)
Q Consensus 246 ~~~~i~~~~~----------------~~~--~~~l~~~~~~~~-~~~~------~~~~----~~s~~l~dLI~~mL~~DP 296 (614)
+..++.+-.- +.. +....-+....| ..+. +..+ .+-..+++||.+||..||
T Consensus 655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP 734 (752)
T KOG0670|consen 655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP 734 (752)
T ss_pred cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence 7766643210 000 000000000001 0000 0011 122468899999999999
Q ss_pred CCCCCHHHHHcCccccc
Q 007177 297 KDRPTAEEALADPYFKG 313 (614)
Q Consensus 297 ~~Rpsa~eiL~hp~f~~ 313 (614)
.+|.|+.++|.||||+.
T Consensus 735 ~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 735 EKRITVNQALKHPFITE 751 (752)
T ss_pred hhcCCHHHHhcCCcccC
Confidence 99999999999999974
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=333.11 Aligned_cols=259 Identities=25% Similarity=0.408 Sum_probs=222.3
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~ 92 (614)
..+.+|.++.+||+|+||.|.+|..+.+.+.||||++++.. ....+..-.+.|-++|.... -|.++.+...| +
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF-----Q 420 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF-----Q 420 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-----h
Confidence 34567899999999999999999999999999999998643 23345555667888887764 67888888887 5
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
..+.+|+||||+. |||...|+.-+.+.|..+.+++..|+-||-|||++||+.||||.+|||++.+|++||.|||+++..
T Consensus 421 TmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 421 TMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred hhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 6677999999999 599999999999999999999999999999999999999999999999999999999999999864
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
.-+..++ .+++|||.|+|||++.- .+|+.++|+||+|++|||||.|++||.|.++.+....|++..-
T Consensus 501 i~~~~TT---kTFCGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv-------- 567 (683)
T KOG0696|consen 501 IFDGVTT---KTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV-------- 567 (683)
T ss_pred ccCCcce---eeecCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC--------
Confidence 3333332 57899999999999875 7999999999999999999999999999999888887754211
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHHcCcccccC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA-----EEALADPYFKGL 314 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa-----~eiL~hp~f~~~ 314 (614)
.....+|.++.++.+.+|...|.+|... .+|-.||||+.+
T Consensus 568 -----------------------syPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 568 -----------------------SYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred -----------------------cCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence 1224678999999999999999999744 788899999865
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=320.02 Aligned_cols=254 Identities=27% Similarity=0.411 Sum_probs=203.9
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~---~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
+..+|++.+.||+|+||.||+|.++.++. .+|+|.++... .......+.+|+.+|+.++||||+++++++ .
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~ 75 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----T 75 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----e
Confidence 35689999999999999999998875554 69999887532 234456788999999999999999999998 3
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
+....|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++.
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 76 KSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred cCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 4467899999998 5999998764 4689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
...............++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~------- 226 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY------- 226 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhcc--CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC-------
Confidence 5433221111122233567999999876 578999999999999999886 999998776544443332110
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.. .....+++.+.+|+.+||+.+|.+||++.++++
T Consensus 227 --------------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 227 --------------------RL---PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred --------------------cC---CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 00 112346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=315.93 Aligned_cols=246 Identities=25% Similarity=0.427 Sum_probs=203.7
Q ss_pred eEeeecCceEEEEEEECCC---CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEE
Q 007177 24 EVIGKGSYGVVCSAIDTHT---GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVV 100 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~t---g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV 100 (614)
+.||+|+||.||+|.+... +..|++|.+....... ....+.+|+.+++.++|+||+++++++. +...+|+|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeec-----CCCceEEE
Confidence 4799999999999999866 8899999998643332 4678889999999999999999999984 35679999
Q ss_pred EecCC-CcHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 101 FELME-SDLHQVIKAN---------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 101 ~E~~~-g~L~~~i~~~---------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
|||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||.+..
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccc
Confidence 99996 7999999875 7899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
...... ........++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 155 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--------- 222 (262)
T cd00192 155 VYDDDY-YRKKTGGKLPIRWMAPESLKD--GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK--------- 222 (262)
T ss_pred cccccc-cccccCCCcCccccCHHHhcc--CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---------
Confidence 543321 111234567889999999876 578999999999999999999 6999988765444433321
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.. .......+++++.+++.+||..||.+|||++|++++
T Consensus 223 ------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 223 ------------------GY---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ------------------CC---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 00 011223568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=328.50 Aligned_cols=256 Identities=28% Similarity=0.518 Sum_probs=208.8
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
.|.....||+|+||.||++.+..+++.||||++... .......+.+|+.+++.++|+||+++++.+ .+....|
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 93 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELW 93 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEE-----EeCCEEE
Confidence 344457899999999999999999999999998642 233456688999999999999999999988 3456799
Q ss_pred EEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007177 99 VVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 177 (614)
Q Consensus 99 lV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 177 (614)
+||||+++ +|.+++. ...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 94 lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~- 171 (292)
T cd06657 94 VVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 171 (292)
T ss_pred EEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-
Confidence 99999985 7887764 45689999999999999999999999999999999999999999999999999875433221
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchh
Q 007177 178 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257 (614)
Q Consensus 178 ~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~ 257 (614)
......++..|++||.+.+ ..++.++|+||+||++|+|++|..||.+.+....+..+..
T Consensus 172 --~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~----------------- 230 (292)
T cd06657 172 --RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD----------------- 230 (292)
T ss_pred --cccccccCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------------
Confidence 1233568899999999876 5788999999999999999999999987765443332211
Q ss_pred HHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 258 ~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
..+..+ .....+++.+.++|.+||..||.+||++.++|+||||....
T Consensus 231 ----------~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 231 ----------NLPPKL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred ----------hCCccc-CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 001111 12245688999999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=322.17 Aligned_cols=252 Identities=21% Similarity=0.384 Sum_probs=201.1
Q ss_pred CCeEEEeEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~-----tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
++|.+.+.||+|+||.||+|.+.. ++..|++|.+... ........+.+|+.+++.++|+||+++++++.
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----- 79 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFNHQNIVRLIGVSF----- 79 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----
Confidence 579999999999999999999887 7788999988643 22334456889999999999999999999873
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC---cEE
Q 007177 93 DFKDIYVVFELME-SDLHQVIKAND-------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC---KLK 161 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~~-------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~---~vK 161 (614)
+....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+|||++.++ .+|
T Consensus 80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceE
Confidence 3456799999997 59999997653 489999999999999999999999999999999999998765 599
Q ss_pred EeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHh
Q 007177 162 ICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTD 240 (614)
Q Consensus 162 L~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~ 240 (614)
|+|||+++......... .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 160 l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~ 236 (277)
T cd05036 160 IADFGMARDIYRASYYR-KGGRAMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236 (277)
T ss_pred eccCccccccCCcccee-cCCCCCccHhhCCHHHHhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999998653221110 1112233567999999876 679999999999999999997 9999988765443332211
Q ss_pred hhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 241 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 241 ~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.... .....++..+.+|+.+||+.||++|||+.++|+|
T Consensus 237 ---------------------------~~~~---~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 237 ---------------------------GGRL---DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred ---------------------------CCcC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0000 1123567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=318.18 Aligned_cols=249 Identities=24% Similarity=0.377 Sum_probs=201.7
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++++.||+|+||.||+|.+. ++..||+|.+... ......+.+|+.+++.++|+||+++++.+ .+..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 74 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEE 74 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCC
Confidence 3568999999999999999999864 5678999987642 22456788999999999999999999987 3456
Q ss_pred cEEEEEecCC-CcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 96 DIYVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
..|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++....
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05072 75 PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE 154 (261)
T ss_pred CcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecC
Confidence 6899999997 699999865 3468899999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
..... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 155 ~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~---------- 220 (261)
T cd05072 155 DNEYT--AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG---------- 220 (261)
T ss_pred CCcee--ccCCCccceecCCHHHhcc--CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC----------
Confidence 32211 1122345678999999876 578899999999999999998 99999877654443332110
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
... .....++..+.+|+.+||..||++|||++++++
T Consensus 221 -----------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 221 -----------------YRM---PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred -----------------CCC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 000 122356789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=317.56 Aligned_cols=248 Identities=25% Similarity=0.389 Sum_probs=200.2
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|++.+.||+|+||.||++..+ ++..+|+|.+.... .....+.+|+.+|+.++||||+++++++ .+...
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 73 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVC-----TQQKP 73 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEE-----ccCCC
Confidence 467999999999999999999765 45689999876432 2245678899999999999999999988 34466
Q ss_pred EEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 97 IYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
+|+||||++ ++|.+++... +.+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 74 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 74 LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 899999998 6999988753 46899999999999999999999999999999999999999999999999999765322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
.... .....++..|+|||++.+ ..++.++|+|||||++|+|++ |+.||...+..+.+..+...
T Consensus 154 ~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~------------ 217 (256)
T cd05114 154 EYTS--SSGAKFPVKWSPPEVFNF--SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG------------ 217 (256)
T ss_pred ceec--cCCCCCchhhCChhhccc--CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC------------
Confidence 2111 122345567999999876 578999999999999999999 89999887765555444221
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
..... ....+..+.+|+.+||..||.+|||++++++
T Consensus 218 ---------------~~~~~---~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 218 ---------------FRLYR---PKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ---------------CCCCC---CCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00000 1124678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=328.97 Aligned_cols=252 Identities=23% Similarity=0.376 Sum_probs=201.2
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcE----EEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEK----VAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~----vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
..+|++.+.||+|+||.||+|.+..+++. ||||+++.. .......++.+|+.+++.++||||+++++.+..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~---- 80 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLT---- 80 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC----
Confidence 45799999999999999999998766664 899998643 233456678899999999999999999998843
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
...++|+||+. |+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 81 --~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 81 --STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred --CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccc
Confidence 24689999998 6999999874 4689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
........ ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....+....+ .
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~-~--------- 225 (316)
T cd05108 159 LGADEKEY-HAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-E--------- 225 (316)
T ss_pred ccCCCcce-eccCCccceeecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-h---------
Confidence 54322211 1122334667999999876 678999999999999999997 99999776543322111 0
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
..... ...+..+..+.+|+.+||..||.+||++.+++.+
T Consensus 226 -----------------~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 226 -----------------KGERL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred -----------------CCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00011 1123466789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=325.65 Aligned_cols=262 Identities=24% Similarity=0.398 Sum_probs=206.4
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~ 94 (614)
..+.|++.+.||+|+||.||+|.+..++..||||.++.... ......+.+|+.++..+. ||||+++++.+ .+.
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~ 86 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYF-----ITD 86 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheee-----ecC
Confidence 34679999999999999999999999999999999975422 234456777887776664 99999999998 445
Q ss_pred CcEEEEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 95 KDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 95 ~~~ylV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
..+|+||||+.+.|..++.. ...+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++....
T Consensus 87 ~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 87 SDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred CeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 67999999999888887765 4578999999999999999999997 599999999999999999999999999987643
Q ss_pred CCCCCccccccccCCccccCcccccccC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCh-hHHHHHHHhhhCCCchhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-VHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~--~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~-~~~l~~i~~~~g~p~~~~ 249 (614)
.... .....++..|+|||.+.+.. ..++.++|||||||++|+|++|+.||..... .+.+..+..
T Consensus 167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--------- 233 (296)
T cd06618 167 DSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ--------- 233 (296)
T ss_pred CCCc----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc---------
Confidence 2221 12235778899999986531 3478899999999999999999999965332 111111110
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
.....+ .....++.++.+||.+||..||.+||++++++.||||....
T Consensus 234 ------------------~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 234 ------------------EEPPSL-PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred ------------------CCCCCC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 000000 11124678899999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=327.79 Aligned_cols=259 Identities=27% Similarity=0.404 Sum_probs=210.6
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
.+.-..|...+.||+|+||.||++.+..++..||+|++.... ........+.+|+.+++.++|||++++++++.
T Consensus 21 ~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----- 95 (317)
T cd06635 21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL----- 95 (317)
T ss_pred CCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----
Confidence 344455899999999999999999999999999999986432 23344567889999999999999999999983
Q ss_pred CCCcEEEEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 93 DFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 93 ~~~~~ylV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
+....|+||||+.|+|.+.+.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++...
T Consensus 96 ~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~ 175 (317)
T cd06635 96 REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA 175 (317)
T ss_pred eCCeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCcccc
Confidence 4456899999999988887754 456999999999999999999999999999999999999999999999999998653
Q ss_pred cCCCCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~-~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
... ....++..|+|||++... ...++.++|+|||||++|+|++|.+||.+.+....+..+...
T Consensus 176 ~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--------- 239 (317)
T cd06635 176 SPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--------- 239 (317)
T ss_pred CCc-------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc---------
Confidence 221 234688899999987421 246889999999999999999999999776544433332210
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
..+ ......+++.+.+||.+||+.||.+||++.++++|+|+..
T Consensus 240 -----------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 240 -----------------ESP---TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -----------------cCC---CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 000 0111246778999999999999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=316.44 Aligned_cols=245 Identities=23% Similarity=0.392 Sum_probs=194.6
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEec
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFEL 103 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E~ 103 (614)
+.||+|+||.||+|.++.+++.||+|.+.... .......+.+|+.+|+.++||||+++++++ .+...+|+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCCCCeEEEEee
Confidence 46999999999999999999999999886532 233456788999999999999999999998 344678999999
Q ss_pred CC-CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCcccc
Q 007177 104 ME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 181 (614)
Q Consensus 104 ~~-g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~ 181 (614)
+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......... ..
T Consensus 75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~ 153 (252)
T cd05084 75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS-TG 153 (252)
T ss_pred ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccc-cC
Confidence 98 59999987643 68999999999999999999999999999999999999999999999999987543221111 01
Q ss_pred ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHH
Q 007177 182 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260 (614)
Q Consensus 182 ~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~ 260 (614)
.....+..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+.
T Consensus 154 ~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~--------------------- 210 (252)
T cd05084 154 GMKQIPVKWTAPEALNY--GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE--------------------- 210 (252)
T ss_pred CCCCCceeecCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH---------------------
Confidence 11123456999999876 578999999999999999997 889996654332222111
Q ss_pred HHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 261 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
..... ......+..+.+|+.+||..||.+|||+.++++
T Consensus 211 ------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 211 ------QGVRL---PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred ------cCCCC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00011 112345789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=321.85 Aligned_cols=252 Identities=22% Similarity=0.389 Sum_probs=201.8
Q ss_pred CCeEEEeEeeecCceEEEEEEEC----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDT----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
..|++.+.||+|+||.||+|.+. .++..|++|.+... ........+.+|+.+++.++||||+++++++ ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~ 78 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-NNPQQWGEFQQEASLMAELHHPNIVCLLGVV-----TQ 78 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE-----ec
Confidence 57899999999999999999853 35678999998753 2334456788999999999999999999988 34
Q ss_pred CCcEEEEEecCC-CcHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEEC
Q 007177 94 FKDIYVVFELME-SDLHQVIKAN-----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 155 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~-----------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~ 155 (614)
....|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 456899999998 5999988532 2478899999999999999999999999999999999999
Q ss_pred CCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHH
Q 007177 156 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQ 234 (614)
Q Consensus 156 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~ 234 (614)
.++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|+|||||++|||++ |..||.+.+..+.
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYR-VQPKSLLPIRWMPPEAIMY--GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235 (283)
T ss_pred CCCcEEeccccccccccCCccee-cccCCCccceecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999998653322111 1123345677999999876 578999999999999999998 9999987664333
Q ss_pred HHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 235 LDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 235 l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
...+. ..... .....+++.+.+|+.+||+.||.+||++.+++++
T Consensus 236 ~~~~~---------------------------~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 236 IEMVR---------------------------KRQLL---PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHH---------------------------cCCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 33221 11111 1223567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=322.26 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=201.6
Q ss_pred CCeEEEeEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~-----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
..|.+.+.||.|+||.||++.+. .++..+|+|.+... .......+.+|+.+|+.++||||+++++++.
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----- 77 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCV----- 77 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----
Confidence 56999999999999999999853 34567999988753 3345667889999999999999999999983
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC
Q 007177 93 DFKDIYVVFELME-SDLHQVIKAND-------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC 158 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~~-------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~ 158 (614)
+...+|+||||+. ++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||+++++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 78 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 157 (288)
T ss_pred cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 4467899999998 69999987543 489999999999999999999999999999999999999999
Q ss_pred cEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 007177 159 KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDL 237 (614)
Q Consensus 159 ~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~ 237 (614)
.+||+|||+++....... ........++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..
T Consensus 158 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~ 234 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234 (288)
T ss_pred cEEeccCCccccccCCce-eecCCCCCccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999976533221 111223446778999999876 578999999999999999998 9999977765444333
Q ss_pred HHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 238 MTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 238 i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
+.. .... ......+..+.+|+.+||+.||.+|||+.+++.
T Consensus 235 i~~---------------------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 235 ITQ---------------------------GRVL---QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHc---------------------------CCcC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 311 1111 111246789999999999999999999999955
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=326.03 Aligned_cols=259 Identities=25% Similarity=0.391 Sum_probs=209.7
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
....+|...+.||+|+||.||+|+++.++..+|||.+... ........++.+|+.+++.++|+||+++++++. .
T Consensus 12 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 86 (308)
T cd06634 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----R 86 (308)
T ss_pred CcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE-----c
Confidence 3455688899999999999999999999999999998643 223344567889999999999999999999884 3
Q ss_pred CCcEEEEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 94 FKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 94 ~~~~ylV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
....|+||||+.++|.+.+.. ...+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++....
T Consensus 87 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 87 EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred CCeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 456899999999988887754 4568999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~-~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
.. ....++..|+|||.+.+. ...++.++|||||||++|+|++|..||...+..+.+..+..
T Consensus 167 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~----------- 228 (308)
T cd06634 167 PA-------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----------- 228 (308)
T ss_pred Cc-------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh-----------
Confidence 21 234688899999987531 14578899999999999999999999976544333222110
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
...+ .......+..+.+||++||..+|.+||+++++++|||+...
T Consensus 229 ---------------~~~~---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 229 ---------------NESP---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ---------------cCCC---CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 0000 01123467789999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=316.39 Aligned_cols=245 Identities=21% Similarity=0.323 Sum_probs=196.8
Q ss_pred eEeeecCceEEEEEEECCCC---cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEE
Q 007177 24 EVIGKGSYGVVCSAIDTHTG---EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVV 100 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg---~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV 100 (614)
+.||+|+||.||+|....++ ..+|+|.+...... .....+.+|+.+|+.+.||||+++++++. ....++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEE
Confidence 47999999999999876555 78999998754332 45667889999999999999999999763 2357999
Q ss_pred EecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCcc
Q 007177 101 FELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 179 (614)
Q Consensus 101 ~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~ 179 (614)
|||+. ++|.+++.....+++..+..++.||+.||.|||..|++|+||||+|||++.++.+||+|||+++..........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99998 69999998888899999999999999999999999999999999999999999999999999986543322111
Q ss_pred ccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhH
Q 007177 180 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 258 (614)
Q Consensus 180 ~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~ 258 (614)
......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~------------------ 213 (257)
T cd05060 154 ATTAGRWPLKWYAPECINY--GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES------------------ 213 (257)
T ss_pred cccCccccccccCHHHhcC--CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc------------------
Confidence 1111223457999999876 678999999999999999997 9999977654433322211
Q ss_pred HHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 259 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 259 ~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
... ......++..+.+||.+||..||++||++.++++
T Consensus 214 ---------~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 214 ---------GER---LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ---------CCc---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 000 1122356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=316.91 Aligned_cols=253 Identities=25% Similarity=0.376 Sum_probs=203.1
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCC---CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHT---GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~t---g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
.++|++.+.||+|+||.||+|.++.+ ...||||.++... .......+.+|+.+++.++||||+++++.+ .+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 76 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TK 76 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ec
Confidence 46799999999999999999988654 4579999887532 334456788999999999999999999988 34
Q ss_pred CCcEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
....|+||||+. ++|.+++... +.+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++..
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 466899999998 5999998764 46899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
....... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+....
T Consensus 157 ~~~~~~~-~~~~~~~~~~y~~Pe~~~~--~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-------- 225 (266)
T cd05033 157 EDSEATY-TTKGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY-------- 225 (266)
T ss_pred cccccce-eccCCCCCccccChhhhcc--CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC--------
Confidence 4221111 1112334678999999876 578999999999999999998 999997665444333331110
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
..+ .....++.+.+|+.+||+.||.+||++++++++
T Consensus 226 -------------------~~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 226 -------------------RLP---PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred -------------------CCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000 113467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=324.26 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=199.1
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCc--EEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGE--KVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~--~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~ 94 (614)
++|++.+.||+|+||.||+|.++.++. .+++|.++.. ........+.+|+.++.++ +||||+++++.+ .+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~ 75 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENR 75 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccC
Confidence 579999999999999999999887775 4788887632 3334566788999999999 799999999988 445
Q ss_pred CcEEEEEecCC-CcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC
Q 007177 95 KDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN 157 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~----------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~ 157 (614)
..+|+||||+. ++|.+++.... .+++..++.|+.||+.||+|||+.||+||||||+|||++.+
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~ 155 (297)
T cd05089 76 GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN 155 (297)
T ss_pred CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC
Confidence 67899999998 69999996532 48899999999999999999999999999999999999999
Q ss_pred CcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHH
Q 007177 158 CKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLD 236 (614)
Q Consensus 158 ~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~ 236 (614)
+.+||+|||++........ ......+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 156 ~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~ 229 (297)
T cd05089 156 LASKIADFGLSRGEEVYVK----KTMGRLPVRWMAIESLNY--SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229 (297)
T ss_pred CeEEECCcCCCccccceec----cCCCCcCccccCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999864321111 011123456999999876 578999999999999999997 999998776544333
Q ss_pred HHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 237 LMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 237 ~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.+.. ... ......++..+.+||.+||..||.+|||++++++.
T Consensus 230 ~~~~---------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 230 KLPQ---------------------------GYR---MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHhc---------------------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2211 000 01123577899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=315.96 Aligned_cols=248 Identities=25% Similarity=0.392 Sum_probs=200.6
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|++.+.||+|+||.||+|.+. ++..||+|.++... .....+.+|+.+++.++||||+++++++ ...+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 75 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEP 75 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCC
Confidence 357999999999999999999875 45789999987532 2345678999999999999999999987 34466
Q ss_pred EEEEEecCC-CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 97 IYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
.|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 899999996 79999997654 689999999999999999999999999999999999999999999999999987642
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
..... ......+..|+|||++.+ ..++.++|+|||||++|+|++ |+.||.+.+....+..+...
T Consensus 156 ~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~----------- 220 (261)
T cd05068 156 DIYEA--REGAKFPIKWTAPEAALY--NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG----------- 220 (261)
T ss_pred Ccccc--cCCCcCceeccCcccccc--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------
Confidence 22111 111223457999999876 678999999999999999999 99999887654444333210
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
... ......+..+.+|+.+||+.||.+||++.++++
T Consensus 221 ----------------~~~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 221 ----------------YRM---PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ----------------CCC---CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 000 112346789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=347.25 Aligned_cols=243 Identities=32% Similarity=0.506 Sum_probs=202.6
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~ 95 (614)
...|.+...+|.|+|++|-.|.++.++..+++|++.+. .....+|+.++... +||||+++.+++ .+..
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~------~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~ 389 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR------ADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGK 389 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc------ccccccccchhhhhcCCCcceeeccee-----cCCc
Confidence 45688888899999999999999999999999999764 12234577555544 699999999999 6778
Q ss_pred cEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEE-CCCCcEEEeecCccccccC
Q 007177 96 DIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA-NANCKLKICDFGLARVAFN 173 (614)
Q Consensus 96 ~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi-~~~~~vKL~DFGla~~~~~ 173 (614)
++|+|||++.| .|.+.|.....+. .++..|++||+.||.|||++|||||||||+|||+ ++.++++|||||.++....
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred eeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 89999999995 7777777666555 7888999999999999999999999999999999 6889999999999987644
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
. +...+-|..|.|||++.. ..|+++|||||||++||+||+|+.||........ |...++.+.
T Consensus 469 ~------~~tp~~t~~y~APEvl~~--~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e---i~~~i~~~~------- 530 (612)
T KOG0603|consen 469 S------CDTPALTLQYVAPEVLAI--QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE---IHTRIQMPK------- 530 (612)
T ss_pred h------hcccchhhcccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCccccCCchHH---HHHhhcCCc-------
Confidence 3 233467889999999986 7999999999999999999999999977654411 211122221
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
++ ..+|..++|||+.||++||.+|+++.+++.||||
T Consensus 531 -------------------~s---~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 531 -------------------FS---ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -------------------cc---cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 11 4689999999999999999999999999999999
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.15 Aligned_cols=259 Identities=22% Similarity=0.313 Sum_probs=203.8
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCC----------------cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTG----------------EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 80 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg----------------~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv 80 (614)
.++|++++.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+.+|+.++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 358999999999999999999876544 458999987532 234567788999999999999999
Q ss_pred eeeeEecCCCCCCCCcEEEEEecCC-CcHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCC
Q 007177 81 EIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAND-----------DLTREHYQFFLYQLLRALKYIHTANVYHRDLK 148 (614)
Q Consensus 81 ~l~~v~~~~~~~~~~~~ylV~E~~~-g~L~~~i~~~~-----------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLK 148 (614)
++++++. +....++|||++. ++|.+++.... .+++..+..++.||+.||.|||+.||+|||||
T Consensus 83 ~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk 157 (296)
T cd05051 83 RLLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157 (296)
T ss_pred EEEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence 9999883 4467899999998 59999987655 68999999999999999999999999999999
Q ss_pred CCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh--CCCCC
Q 007177 149 PKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLF 226 (614)
Q Consensus 149 P~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt--G~~pF 226 (614)
|+||+++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~~p~ 234 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYY-RVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEILTLCREQPY 234 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcce-eecCcCCCCceecCHHHhhc--CCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence 99999999999999999999764332211 11223456778999999876 578999999999999999998 67888
Q ss_pred CCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHH
Q 007177 227 PGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 306 (614)
Q Consensus 227 ~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL 306 (614)
...+..+.+..+...+.. ..........+.++.++.+|+.+||+.||.+|||+.+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~ 291 (296)
T cd05051 235 EHLTDQQVIENAGHFFRD-----------------------DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIH 291 (296)
T ss_pred CCcChHHHHHHHHhcccc-----------------------ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHH
Confidence 766554443333211100 000111112235678999999999999999999999996
Q ss_pred c
Q 007177 307 A 307 (614)
Q Consensus 307 ~ 307 (614)
+
T Consensus 292 ~ 292 (296)
T cd05051 292 L 292 (296)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=317.52 Aligned_cols=252 Identities=21% Similarity=0.356 Sum_probs=202.1
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCC-----cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTG-----EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg-----~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
.++|.+.+.||+|+||.||+|.++..+ ..||+|.+... ........+.+|+.+|+.++||||+++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~---- 79 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS---- 79 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc-cCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc----
Confidence 468999999999999999999886544 78999998643 23344567889999999999999999999983
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcE
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKAND----------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKL 160 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~~----------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~v 160 (614)
+....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+
T Consensus 80 -~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 80 -TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred -CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence 4467899999998 69999986532 36788999999999999999999999999999999999999999
Q ss_pred EEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 007177 161 KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMT 239 (614)
Q Consensus 161 KL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~ 239 (614)
||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 159 kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 235 (277)
T cd05032 159 KIGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235 (277)
T ss_pred EECCcccchhhccCccc-ccCCCCCccccccCHHHHhc--CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence 99999999765432211 11123456778999999876 578999999999999999998 999998776543332221
Q ss_pred hhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 240 DLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 240 ~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
..... ......+..+.+||.+||+.||++|||+.++++
T Consensus 236 ---------------------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 236 ---------------------------DGGHL---DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred ---------------------------cCCCC---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 01011 112335789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=315.84 Aligned_cols=253 Identities=25% Similarity=0.398 Sum_probs=202.7
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~---~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
.++|...+.||+|+||.||+|.++.++. .+++|++.... .......+.+|+.+++.++||||+++.+++ .+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 77 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TK 77 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----cc
Confidence 4578999999999999999999877665 69999886432 334566788999999999999999999998 44
Q ss_pred CCcEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
....|+||||++ ++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 567899999999 5899888764 57899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
...............+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~-------- 227 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF-------- 227 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhc--CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC--------
Confidence 432221111111223457999999876 578999999999999999997 999997766544443332110
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
..+ .....+..+.+|+.+||..||.+||++.++++
T Consensus 228 -------------------~~~---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 228 -------------------RLP---APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -------------------CCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 011 11245778999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=325.08 Aligned_cols=250 Identities=25% Similarity=0.382 Sum_probs=198.7
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcE--EEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEK--VAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~--vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~ 93 (614)
.+.|++.+.||+|+||.||+|.++.++.. +++|.++.. ........+.+|+.++..+ +||||+++++++ .+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~ 79 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EH 79 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CC
Confidence 45799999999999999999998887764 577776642 2234456788999999999 899999999998 44
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC
Q 007177 94 FKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA 156 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~----------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~ 156 (614)
...+|+||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 159 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC
Confidence 567999999998 69999987542 4789999999999999999999999999999999999999
Q ss_pred CCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHH
Q 007177 157 NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQL 235 (614)
Q Consensus 157 ~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l 235 (614)
++.+||+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 233 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 233 (303)
T ss_pred CCcEEeCccccCcccchhhh----cccCCCcccccCHHHHhc--cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH
Confidence 99999999999864221111 011224567999998876 568899999999999999998 99999776644333
Q ss_pred HHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 236 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 236 ~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
..+. .... .......++.+.+||.+||+.||.+||+++++|.+
T Consensus 234 ~~~~---------------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 234 EKLP---------------------------QGYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHHh---------------------------cCCc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2221 0000 01122467889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.80 Aligned_cols=253 Identities=26% Similarity=0.438 Sum_probs=202.2
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCC-----cEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTG-----EKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 90 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg-----~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~ 90 (614)
.++|++.+.||+|+||.||++.+...+ ..+|+|.+.... .......+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~---- 85 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC---- 85 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence 467999999999999999999876443 689999987532 334556788999999999 799999999988
Q ss_pred CCCCCcEEEEEecCC-CcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEE
Q 007177 91 RRDFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL 153 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~-g~L~~~i~~~----------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NIL 153 (614)
.....+|+||||+. ++|..++... ..+++..+..++.||+.||.|||+.||+||||||+|||
T Consensus 86 -~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 86 -TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred -cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 34456899999998 6999998642 46899999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChh
Q 007177 154 ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVV 232 (614)
Q Consensus 154 i~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~ 232 (614)
++.++.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYR-KTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred EcCCCeEEeCcccccccccccccee-ccCCCCCCccccCHHHhcc--CCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 9999999999999998654322111 1122234567999999876 678999999999999999997 99999877654
Q ss_pred HHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 233 HQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 233 ~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
+....+.. ... .......+..+.+|+.+||..||++|||+.++|++
T Consensus 242 ~~~~~~~~---------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 242 ELFKLLKE---------------------------GYR---MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHc---------------------------CCc---CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 43332211 000 01123567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=315.80 Aligned_cols=249 Identities=21% Similarity=0.324 Sum_probs=199.3
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|.+.+.||+|+||.||++.+.. +..+|||.+.... .....+.+|+.+++.++||||+++++++. +...
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 73 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRP 73 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCC
Confidence 4579999999999999999997643 4569999887432 22356889999999999999999999983 3456
Q ss_pred EEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 97 IYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++.....
T Consensus 74 ~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 74 IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred cEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 899999998 5899998764 46899999999999999999999999999999999999999999999999998765432
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
.... .....++..|++||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 154 ~~~~--~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~------------ 217 (256)
T cd05113 154 EYTS--SVGSKFPVRWSPPEVLLY--SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG------------ 217 (256)
T ss_pred ceee--cCCCccChhhCCHHHHhc--CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC------------
Confidence 2111 112235567999999876 578999999999999999998 99999776654433333110
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.... .....+..+.+|+.+||..||.+||++.+++.+
T Consensus 218 ---------------~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 218 ---------------LRLY---RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ---------------CCCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0010 112356889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=358.89 Aligned_cols=256 Identities=27% Similarity=0.382 Sum_probs=202.5
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
++|++++.||+|+||.||+|.+..+|+.||||++..... ......++.+|+.+++.++||||+++++++ .+.+.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-----~d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-----SDGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-----eeCCE
Confidence 689999999999999999999999999999999975432 233456788999999999999999999988 45567
Q ss_pred EEEEEecCC-CcHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEee
Q 007177 97 IYVVFELME-SDLHQVIKAN-----------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 164 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~-----------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~D 164 (614)
.|+|||||+ ++|.+++... ..++...+..++.||+.||.|||+.||+||||||+|||++.++.+||+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence 999999998 5999888641 2355677889999999999999999999999999999999999999999
Q ss_pred cCccccccCCCC---------------CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 007177 165 FGLARVAFNDTP---------------TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 229 (614)
Q Consensus 165 FGla~~~~~~~~---------------~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~ 229 (614)
||+++....... ........+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--VPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--CCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 999986521110 0001123579999999999877 67899999999999999999999999775
Q ss_pred ChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 230 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 230 ~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
+....... ... ..+... ..+..+++.+.+++.+||..||++|++..+.|.+
T Consensus 235 ~~~ki~~~--~~i-------------------------~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 235 KGRKISYR--DVI-------------------------LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred chhhhhhh--hhc-------------------------cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 43221110 000 000000 1124678899999999999999999877666654
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=316.99 Aligned_cols=249 Identities=23% Similarity=0.364 Sum_probs=199.5
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
..+|++.+.||+|+||.||++.++ ++..+|+|++..... ....+.+|+.+++.++||||+++++++ .+...
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 73 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRP 73 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCc
Confidence 456899999999999999999875 467899999864322 234577899999999999999999987 34456
Q ss_pred EEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 97 IYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
.|+||||++ ++|.+++..+ ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++...+.
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 74 IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred eEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 899999998 5899998764 46899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
.... .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+..
T Consensus 154 ~~~~--~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~------------- 216 (256)
T cd05059 154 QYTS--SQGTKFPVKWAPPEVFDY--SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA------------- 216 (256)
T ss_pred cccc--cCCCCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc-------------
Confidence 2111 111223457999999876 678999999999999999999 8999977665443332211
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.... ......+..+.+|+.+||..+|++|||+.++++.
T Consensus 217 --------------~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 217 --------------GYRL---YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred --------------CCcC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0000 1123468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=315.95 Aligned_cols=247 Identities=27% Similarity=0.388 Sum_probs=198.2
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|++.+.||+|+||.||+|.+..+ ..||+|++..... ....+.+|+.+++.++||||+++++.+. ...
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~ 74 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEP 74 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEEC------CCC
Confidence 46899999999999999999988665 4699999875322 2346788999999999999999998762 234
Q ss_pred EEEEEecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 97 IYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
.|+||||+. ++|.+++... ..++++.+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 799999998 5999999763 3589999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
..... .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.+..+..
T Consensus 155 ~~~~~--~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~------------ 218 (262)
T cd05071 155 NEYTA--RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER------------ 218 (262)
T ss_pred ccccc--ccCCcccceecCHhHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc------------
Confidence 22111 112345678999998876 578999999999999999999 8899987664443333211
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.... .....++..+.+||.+||+.||.+||++.++++
T Consensus 219 ---------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 219 ---------------GYRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ---------------CCCC---CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0000 112346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=314.13 Aligned_cols=253 Identities=28% Similarity=0.454 Sum_probs=202.3
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
++|++.+.||.|+||.||+|.+..+|+.||+|.++.. .........+.+|+++++.++|+||+++++.+. +...
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence 5899999999999999999999999999999998642 223334667889999999999999999999984 4467
Q ss_pred EEEEEecCC-CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 97 IYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
.|+||||++ ++|..++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||+++..
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 899999998 599988864 345899999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
..... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...... .. .+
T Consensus 157 ~~~~~---~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~-~~------------- 216 (267)
T cd08224 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LY-SL------------- 216 (267)
T ss_pred cCCCc---ccceecCCccccCHHHhcc--CCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HH-HH-------------
Confidence 32221 1233568889999999876 57899999999999999999999999654311 00 00
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
...+......+ ......+..+.++|.+||..||.+|||+.++++
T Consensus 217 ----------~~~~~~~~~~~--~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 217 ----------CKKIEKCDYPP--LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ----------HhhhhcCCCCC--CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00000000000 011246778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=318.72 Aligned_cols=268 Identities=24% Similarity=0.343 Sum_probs=199.1
Q ss_pred CCe-EEEeEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 18 SRY-KIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 18 ~rY-~i~~~LG~G~~G~V~~a~----d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
+|| ++++.||+|+||+||++. ...++..||+|.+.... .......+.+|+.+|+.++||||+++++.+.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~ 78 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSE---Q 78 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---C
Confidence 466 999999999999998864 34578899999987532 22345677899999999999999999998743 2
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
+...+|+||||+. ++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 3356899999999 5898888764 5999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
..............++..|+|||.+.+ ..++.++|||||||++|+|++|..||...... +..+. .... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~---~~~~-~--- 226 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKE--NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMI---GPKQ-G--- 226 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcc--cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhh---cccc-c---
Confidence 432221111122345667999999876 57899999999999999999999998554311 11110 0000 0
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
..........+...... ......+..+.+|+.+||..||.+|||++++++
T Consensus 227 ---~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 227 ---QMTVVRLIELLERGMRL---PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred ---ccchhhhhhhhhcCCCC---CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00000011111111111 112356789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=317.25 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=200.5
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~----~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
..+|++.+.||.|+||+||+|.+..++. .||+|.+... ........+.+|+.+++.+.||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---- 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT---- 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC----
Confidence 4579999999999999999999877776 4899988643 233445678899999999999999999998843
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
...++++||++ |+|.+++..+ +.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 81 --~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 81 --STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred --CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceee
Confidence 34689999998 6999998764 4699999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
....... .......++..|+|||.+.+ ..++.++|||||||++|||++ |..||...........+.
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~---------- 225 (279)
T cd05109 159 LDIDETE-YHADGGKVPIKWMALESILH--RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE---------- 225 (279)
T ss_pred cccccce-eecCCCccchhhCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH----------
Confidence 5432211 11122345677999999876 578999999999999999998 899997655332222111
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
..... ...+..+..+.+|+.+||..||++||++.+++.
T Consensus 226 -----------------~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 226 -----------------KGERL---PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred -----------------CCCcC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11011 112456789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=322.02 Aligned_cols=253 Identities=21% Similarity=0.319 Sum_probs=201.9
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCC-----CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHT-----GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~t-----g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
..+|++.+.||+|+||.||+|.+..+ +..||||+++... .......+.+|+.++..++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~---- 78 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVT---- 78 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc----
Confidence 34688999999999999999987543 5789999997542 2234466889999999999999999999983
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEE
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA 154 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~----------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi 154 (614)
+...+++++||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+
T Consensus 79 -~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~ 157 (283)
T cd05091 79 -KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV 157 (283)
T ss_pred -CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe
Confidence 4456899999998 5898888532 347888999999999999999999999999999999999
Q ss_pred CCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhH
Q 007177 155 NANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVH 233 (614)
Q Consensus 155 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~ 233 (614)
++++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 234 (283)
T cd05091 158 FDKLNVKISDLGLFREVYAADYY-KLMGNSLLPIRWMSPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 234 (283)
T ss_pred cCCCceEecccccccccccchhe-eeccCccCCccccCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 99999999999998865322211 11223456778999999876 578999999999999999998 889998876554
Q ss_pred HHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 234 QLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 234 ~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.+..+... ... ......+..+.+|+.+||+.||.+||++.++++.
T Consensus 235 ~~~~i~~~---------------------------~~~---~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 235 VIEMIRNR---------------------------QVL---PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHHHcC---------------------------CcC---CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 44443211 000 1123567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=317.06 Aligned_cols=248 Identities=24% Similarity=0.401 Sum_probs=203.9
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
...|++++.||.|+||.||+|.+.. +..+++|++... .......+.+|+.+|+.++||||+++++.+ .+...
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 76 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVC-----SVGEP 76 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeE-----ecCCC
Confidence 3469999999999999999999987 889999998753 233456788999999999999999999988 34456
Q ss_pred EEEEEecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 97 IYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
.|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 899999998 5999999753 4689999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.... .....++..|++||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+....
T Consensus 157 ~~~~---~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~---------- 221 (261)
T cd05148 157 DVYL---SSDKKIPYKWTAPEAASH--GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY---------- 221 (261)
T ss_pred cccc---ccCCCCceEecCHHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC----------
Confidence 2211 123345678999999876 578899999999999999998 899998877554444332100
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.. ......++.+.+++.+||..||.+|||+.++++
T Consensus 222 -----------------~~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 222 -----------------RM---PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred -----------------cC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00 112456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=319.98 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=201.3
Q ss_pred CCCeEEEeEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~-----tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
..+|.+.+.||+|+||.||+|.+.. ++..+++|.+... .......+.+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----- 76 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVC----- 76 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEE-----
Confidence 3569999999999999999997543 4556999988642 234456788999999999999999999998
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEE
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA 154 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~~----------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi 154 (614)
.+....++||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~ 156 (291)
T cd05094 77 GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV 156 (291)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE
Confidence 34466899999998 69999997542 38899999999999999999999999999999999999
Q ss_pred CCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhH
Q 007177 155 NANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVH 233 (614)
Q Consensus 155 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~ 233 (614)
+.++.+||+|||++........ ........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 233 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 233 (291)
T ss_pred ccCCcEEECCCCcccccCCCce-eecCCCCCcceeecChHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999976443221 111233457788999999876 678999999999999999998 999997766544
Q ss_pred HHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 234 QLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 234 ~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.+..+.. .. ........+..+.+|+.+||..||++|||+.++++
T Consensus 234 ~~~~~~~---------------------------~~---~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 234 VIECITQ---------------------------GR---VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHHhC---------------------------CC---CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 3332211 00 01112345778999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=339.91 Aligned_cols=264 Identities=26% Similarity=0.414 Sum_probs=214.2
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
.+-|..++.||-|+||.||++....|...||+|.+.+. .........+..|-.||..-+++-||+||-.| +|.+
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkd 702 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKD 702 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCC
Confidence 34578899999999999999998899999999998643 33344566778899999999999999999988 7888
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC-
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN- 173 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~- 173 (614)
++|+||||+. ||+..+|-..+-|.|+.+++++..|.+|+.+.|..|+|||||||+|||||.+|+|||.|||||.-+..
T Consensus 703 nLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 703 NLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred ceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999 59999999999999999999999999999999999999999999999999999999999999953211
Q ss_pred --------CCCC----c--------------------------cccccccCCccccCcccccccCCCCCCcccchhHHHH
Q 007177 174 --------DTPT----T--------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 215 (614)
Q Consensus 174 --------~~~~----~--------------------------~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~I 215 (614)
.... . +.....+||+.|+|||++.. ..|+..||+||.|||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r--~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR--TGYTQLCDWWSVGVI 860 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc--cCccccchhhHhhHH
Confidence 0000 0 00123589999999999987 789999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCC
Q 007177 216 FAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 295 (614)
Q Consensus 216 l~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~D 295 (614)
||||+.|++||......+...++..+ +.++. .....++|+++.+||.++.. +
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv~nw-----------------~~~l~----------~~~~~~ls~e~~~li~kLc~-s 912 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKVINW-----------------RNFLH----------IPYQGNLSKEALDLIQKLCC-S 912 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeeeeeh-----------------hhccc----------cccccccCHHHHHHHHHHhc-C
Confidence 99999999999776644333222211 01110 01124789999999998665 7
Q ss_pred CCCCC---CHHHHHcCcccccCC
Q 007177 296 PKDRP---TAEEALADPYFKGLS 315 (614)
Q Consensus 296 P~~Rp---sa~eiL~hp~f~~~~ 315 (614)
+++|+ .++|+-.||||+++.
T Consensus 913 ad~RLGkng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 913 ADSRLGKNGADQVKAHPFFKGID 935 (1034)
T ss_pred hhhhhcccchhhhhcCccccccc
Confidence 88886 567899999999874
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=314.11 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=202.6
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~---~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
.+.|++.+.||+|+||.||+|.++.+++ .||||.+... ........+.+|+.+++.++||||+++++.+ .+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~ 76 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TK 76 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CC
Confidence 4579999999999999999999887765 5999998753 2344567889999999999999999999988 44
Q ss_pred CCcEEEEEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
....|+||||++ ++|.+++.. .+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++...
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 566899999998 589988875 356899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCccccccc--cCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchh
Q 007177 172 FNDTPTTIFWTDY--VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLD 248 (614)
Q Consensus 172 ~~~~~~~~~~~~~--vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~ 248 (614)
............. ..+..|+|||.+.+ ..++.++|||||||++|||++ |..||...+..+....+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~------- 227 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD------- 227 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhcc--CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-------
Confidence 4322211111111 12457999999876 678999999999999999886 99999776654443333110
Q ss_pred hhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 249 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 249 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
...+ .....+..+.+|+.+||..||.+||++++++.
T Consensus 228 --------------------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 228 --------------------YRLP---PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred --------------------CcCC---CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0111 12356778999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=320.41 Aligned_cols=258 Identities=22% Similarity=0.365 Sum_probs=200.1
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCC--------------cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceee
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTG--------------EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 83 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg--------------~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~ 83 (614)
.+|++.+.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+++|+.++||||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 58999999999999999999875432 358999987532 234456788999999999999999999
Q ss_pred eEecCCCCCCCCcEEEEEecCC-CcHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCC
Q 007177 84 HIMLPPSRRDFKDIYVVFELME-SDLHQVIKAND------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPK 150 (614)
Q Consensus 84 ~v~~~~~~~~~~~~ylV~E~~~-g~L~~~i~~~~------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~ 150 (614)
+.+. .....|+|||||. ++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+
T Consensus 84 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 158 (295)
T cd05097 84 GVCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATR 158 (295)
T ss_pred EEEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChh
Confidence 9983 4456899999998 59999886432 3688899999999999999999999999999999
Q ss_pred cEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh--CCCCCCC
Q 007177 151 NILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPG 228 (614)
Q Consensus 151 NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt--G~~pF~g 228 (614)
|||++.++.+||+|||++......... .......++..|+|||++.+ ..++.++|+|||||++|+|++ |..||..
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcce-eccCcCcCceeecChhhhcc--CCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999999764322211 11122345678999998876 578999999999999999988 6678877
Q ss_pred CChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 229 KNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 229 ~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.+..+.+..+... +.. .....+....+..++.+.+|+.+||..||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~--------------------~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 236 LSDEQVIENTGEF--------------------FRN---QGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cChHHHHHHHHHh--------------------hhh---ccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 6654443332111 000 0000111223456789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=315.37 Aligned_cols=247 Identities=26% Similarity=0.375 Sum_probs=198.9
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|++.+.||+|+||.||+|.+. ++..+|+|.+..... ....+.+|+.+|+.++||||+++++++. ...
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~ 74 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS------EEP 74 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC------CCC
Confidence 457999999999999999999765 566799999875322 2345889999999999999999998762 234
Q ss_pred EEEEEecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 97 IYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
.|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||++++++.+||+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 799999998 5999998753 3589999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
..... .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+...
T Consensus 155 ~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~----------- 219 (260)
T cd05070 155 NEYTA--RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG----------- 219 (260)
T ss_pred ccccc--ccCCCCCccccChHHHhc--CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------
Confidence 22111 122345667999998876 578999999999999999999 89999877655444433210
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
... ......+..+.+|+.+||..||.+|||++++++
T Consensus 220 ----------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 220 ----------------YRM---PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred ----------------CCC---CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 000 112356788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=336.15 Aligned_cols=253 Identities=25% Similarity=0.388 Sum_probs=198.8
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCC-----CcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHT-----GEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPS 90 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~t-----g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~ 90 (614)
.++|++++.||+|+||.||+|.+... +..||||++... ........+.+|+.+|+.+. ||||+++++++
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~---- 110 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGAC---- 110 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE----
Confidence 46788999999999999999987433 347999999753 23344567899999999996 99999999998
Q ss_pred CCCCCcEEEEEecCC-CcHHHHHHhC------------------------------------------------------
Q 007177 91 RRDFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 115 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~-g~L~~~i~~~------------------------------------------------------ 115 (614)
.+...+|||||||. |+|.+++..+
T Consensus 111 -~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 111 -TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred -ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 44567999999998 6998887542
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEE
Q 007177 116 ------------------------------------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL 153 (614)
Q Consensus 116 ------------------------------------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NIL 153 (614)
..+++..+..++.||+.||.|||+.||+||||||+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil 269 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence 24788889999999999999999999999999999999
Q ss_pred ECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChh
Q 007177 154 ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVV 232 (614)
Q Consensus 154 i~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~ 232 (614)
++.++.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||++....
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYV-SKGSTFLPVKWMAPESIFD--NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred EeCCCEEEEEeCCcceecccccccc-ccCCcCCCcceEChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 9999999999999998654322111 1123356778999999876 678999999999999999997 99999765432
Q ss_pred HHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 233 HQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 233 ~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
+.+... +...... .....++..+.+|+.+||..||++|||+.++.+
T Consensus 347 ~~~~~~--------------------------~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 347 STFYNK--------------------------IKSGYRM---AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHH--------------------------HhcCCCC---CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 221111 0000000 112356789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=316.23 Aligned_cols=253 Identities=26% Similarity=0.419 Sum_probs=202.5
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
++|++.+.||.|+||.||+|.+..++..+|||.+.... ........+.+|+.+++.++||||+++++.+. +.+.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence 47899999999999999999999999999999886432 23344567889999999999999999999883 4467
Q ss_pred EEEEEecCC-CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 97 IYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
.|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 999999998 489888863 346899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
..... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+...... . +
T Consensus 157 ~~~~~---~~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~-~------------- 216 (267)
T cd08229 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-S-L------------- 216 (267)
T ss_pred ccCCc---ccccccCCcCccCHHHhcC--CCccchhhHHHHHHHHHHHHhCCCCcccccchHH-H-H-------------
Confidence 33221 1234568899999999876 5788999999999999999999999976532110 0 0
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
...+.... .........++.+.+||.+||..||.+|||+.++++
T Consensus 217 ----------~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 217 ----------CKKIEQCD--YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ----------hhhhhcCC--CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 00000000 001112346789999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=359.65 Aligned_cols=264 Identities=32% Similarity=0.479 Sum_probs=204.9
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-------
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS------- 90 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~------- 90 (614)
..|+.++.||+|+||.||+|+++-+|..||||+|.-.. ......++.+|+++|.+|+|||||+++..+....
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 45677899999999999999999999999999998655 5667788999999999999999999987652100
Q ss_pred ----------------------------------------------C--------------------CC-----------
Q 007177 91 ----------------------------------------------R--------------------RD----------- 93 (614)
Q Consensus 91 ----------------------------------------------~--------------------~~----------- 93 (614)
. ++
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0 00
Q ss_pred ----------------------C--------CcEEEEEecCCCcH-HHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhCC
Q 007177 94 ----------------------F--------KDIYVVFELMESDL-HQVIKANDDL-TREHYQFFLYQLLRALKYIHTAN 141 (614)
Q Consensus 94 ----------------------~--------~~~ylV~E~~~g~L-~~~i~~~~~l-se~~~~~i~~QIl~aL~yLHs~g 141 (614)
. ..+||=||||+.+| .++|..+... ....++.+++||++||.|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0 24799999999655 5555555433 47888999999999999999999
Q ss_pred eEeecCCCCcEEECCCCcEEEeecCcccccc------C---------CCCCccccccccCCccccCcccccccC-CCCCC
Q 007177 142 VYHRDLKPKNILANANCKLKICDFGLARVAF------N---------DTPTTIFWTDYVATRWYRAPELCGSFF-SKYTP 205 (614)
Q Consensus 142 IvHrDLKP~NILi~~~~~vKL~DFGla~~~~------~---------~~~~~~~~~~~vgt~~Y~APEvl~~~~-~~y~~ 205 (614)
||||||||.||++++++.|||+|||+|.... . ........|..+||..|+|||++.+.. ..|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999998721 0 011122457789999999999998742 26999
Q ss_pred cccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcc-cCCCCCCCHHH
Q 007177 206 AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSA 284 (614)
Q Consensus 206 ~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~s~~l 284 (614)
|+||||||+||+||+. ||... ++... .+..++ ...+++ ...|.+--+.-
T Consensus 798 KiDmYSLGIVlFEM~y---PF~Ts--MERa~------------------------iL~~LR-~g~iP~~~~f~~~~~~~e 847 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGTS--MERAS------------------------ILTNLR-KGSIPEPADFFDPEHPEE 847 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCch--HHHHH------------------------HHHhcc-cCCCCCCcccccccchHH
Confidence 9999999999999985 46432 22222 223333 222222 23344455677
Q ss_pred HHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 007177 285 LRLLERLLAFDPKDRPTAEEALADPYFK 312 (614)
Q Consensus 285 ~dLI~~mL~~DP~~Rpsa~eiL~hp~f~ 312 (614)
..+|+.||+.||.+||||.|+|++.||-
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 8999999999999999999999999986
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=312.59 Aligned_cols=249 Identities=27% Similarity=0.420 Sum_probs=201.9
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|.+.+.||.|+||.||+|.+. ++..||||.+.... .....+.+|+.+++.++||||+++++++ .+..
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 74 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEE 74 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCC
Confidence 4568999999999999999999875 45789999987432 2345688999999999999999999987 3445
Q ss_pred cEEEEEecCC-CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 96 DIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
..|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....
T Consensus 75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceecc
Confidence 6899999998 59999997643 68999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
...... ......+..|+|||.+.+ ..++.++|+|||||++|+|++ |+.||.+.+....+..+.....
T Consensus 155 ~~~~~~--~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~-------- 222 (261)
T cd05034 155 DDEYTA--REGAKFPIKWTAPEAANY--GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR-------- 222 (261)
T ss_pred chhhhh--hhccCCCccccCHHHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 321111 112234567999999876 578999999999999999998 9999988765555444322110
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.......+..+.+++.+||..||.+||+++++++
T Consensus 223 ----------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 223 ----------------------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0111235778999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=312.83 Aligned_cols=247 Identities=26% Similarity=0.387 Sum_probs=199.6
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|+++++||+|+||.||+|.++ +++.||+|.+..... ....+.+|+.+++.++||||+++++++. ...
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~ 74 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT------QEP 74 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCC
Confidence 467999999999999999999864 578899999875322 3456889999999999999999998862 235
Q ss_pred EEEEEecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 97 IYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
.|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 899999998 6999988653 3689999999999999999999999999999999999999999999999999976542
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
..... .....++..|+|||.+.. ..++.++|||||||++|+|++ |++||.+.+..+....+....
T Consensus 155 ~~~~~--~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------- 220 (260)
T cd05067 155 NEYTA--REGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY---------- 220 (260)
T ss_pred CCccc--ccCCcccccccCHHHhcc--CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC----------
Confidence 21111 122345678999999876 578899999999999999998 999998876544443331110
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.. ......+.++.+||.+||..||++|||++++++
T Consensus 221 -----------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 221 -----------------RM---PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -----------------CC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00 112346778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=310.94 Aligned_cols=258 Identities=24% Similarity=0.406 Sum_probs=209.9
Q ss_pred eEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCcEE
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
.+++..||.|+.|.||+++.+.+|...|||.+.+. .+..+.++++..+.++... .+|+||+++++|... .+++
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n-----~dV~ 167 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN-----TDVF 167 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC-----chHH
Confidence 34677899999999999999999999999999865 4556788999999887655 489999999999544 4588
Q ss_pred EEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 99 VVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 99 lV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
|.||.|..-+..+++. .++++|..+-.+...++.||.||.. +||+|||+||+|||+|+.|.+||||||.+-...+...
T Consensus 168 IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 168 ICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 9999999766666554 4579999999999999999999985 5899999999999999999999999999976543322
Q ss_pred CccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCC-hhHHHHHHHhhhCCCchhhhhhhh
Q 007177 177 TTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN-VVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~-~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~-~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
.+...|-+.|||||.+.-. ...|+-.+|+||||+.++||.||+.||++.+ +.+.+.+|.+
T Consensus 248 ----htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-------------- 309 (391)
T KOG0983|consen 248 ----HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-------------- 309 (391)
T ss_pred ----cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh--------------
Confidence 2345788999999988542 4679999999999999999999999999864 4444444422
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
..+ +.-..-...|+.+.+|+..||++|+.+||...++|+|||+....
T Consensus 310 -------------~eP-P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 310 -------------EEP-PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred -------------cCC-CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 111 11111224789999999999999999999999999999998654
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=319.48 Aligned_cols=263 Identities=23% Similarity=0.403 Sum_probs=206.0
Q ss_pred CeEEEeEeeecCceEEEEEEEC---CCCcEEEEEEecCcc--CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCC
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIF--EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~---~tg~~vAIK~i~~~~--~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~ 92 (614)
.|++.+.||+|+||.||++.+. .+++.||||.+++.. ........+.+|+.+++.+ +||||+++++.+ .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence 4899999999999999999864 467899999987431 1223445678999999999 599999999887 4
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
....+|+||||+. ++|.+.+.....+++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||+++..
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 4467899999998 599999987778999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
....... .....++..|+|||.+.+.....+.++|+||||+++|+|++|..||...........+.
T Consensus 156 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~------------ 221 (288)
T cd05583 156 LAEEEER--AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEIS------------ 221 (288)
T ss_pred ccccccc--cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHH------------
Confidence 4322111 12346888999999987632347889999999999999999999996543221111110
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC---HHHHHcCcccccCC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT---AEEALADPYFKGLS 315 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps---a~eiL~hp~f~~~~ 315 (614)
.... ... ......+++.+.+||.+||+.||++||| +.++|+||||+.+.
T Consensus 222 -------~~~~----~~~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 222 -------RRIL----KSK----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred -------HHHH----ccC----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 0010 000 1112346789999999999999999998 57789999998763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=315.59 Aligned_cols=269 Identities=23% Similarity=0.389 Sum_probs=201.0
Q ss_pred CCeEEEeEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~----d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
.+|++++.||+|+||.||+|. +..++..||||++... .......+.+|+.+|+.++||||+++++++... +
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---G 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---C
Confidence 479999999999999999997 4567889999998753 334566788999999999999999999987443 2
Q ss_pred CCcEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
...+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 346899999997 6999998764 46899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
..............++..|+|||++.+ ..++.++|||||||++|||++|..++...... ... ..+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~----~~~~~~~~~-- 229 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMR----MMGNDKQGQ-- 229 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhcc--CCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhh----hcccccccc--
Confidence 432221111112234456999999876 57899999999999999999998776443211 111 111110000
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.........+...... .....++..+.+||.+||..||++|||+.++++
T Consensus 230 ----~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 230 ----MIVYHLIELLKNNGRL---PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred ----cchHHHHHHHhcCCcC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0000111111111111 123457789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=321.38 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=200.5
Q ss_pred CCCeEEEeEeeecCceEEEEEEECC-------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTH-------TGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLP 88 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~-------tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~ 88 (614)
.++|.+.+.||+|+||.||+|.+.. +...+|+|.++.. ........+.+|+.+++.+ +||||+++++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~-- 93 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC-- 93 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC-CChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE--
Confidence 4789999999999999999998643 2346999998753 2334556788999999999 799999999998
Q ss_pred CCCCCCCcEEEEEecCC-CcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCc
Q 007177 89 PSRRDFKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKN 151 (614)
Q Consensus 89 ~~~~~~~~~ylV~E~~~-g~L~~~i~~~~----------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~N 151 (614)
.+...+|+||||+. ++|.+++.... .+++..++.++.||+.||+|||+.|++||||||+|
T Consensus 94 ---~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 170 (307)
T cd05098 94 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN 170 (307)
T ss_pred ---ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence 34467899999998 69999997642 48889999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCC
Q 007177 152 ILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 230 (614)
Q Consensus 152 ILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~ 230 (614)
||++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchh-hccccCCCccceeChHHhcc--CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 99999999999999998764322111 01112234567999999876 578999999999999999998 889997765
Q ss_pred hhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 231 VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 231 ~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
..+....+. .... .......+.++.+||.+||..+|.+|||+.+++++
T Consensus 248 ~~~~~~~~~---------------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 248 VEELFKLLK---------------------------EGHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHH---------------------------cCCC---CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 433222211 1111 11223567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=310.00 Aligned_cols=245 Identities=30% Similarity=0.500 Sum_probs=203.9
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecC
Q 007177 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM 104 (614)
Q Consensus 26 LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~ 104 (614)
||.|+||.||++.+..+++.|++|.+..... .......+.+|+.+++.++||||+++++.+ .+...+|+||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 6999999999999998999999999875422 223556788999999999999999999887 4567799999999
Q ss_pred C-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCcccccc
Q 007177 105 E-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD 183 (614)
Q Consensus 105 ~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~ 183 (614)
. ++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~ 152 (250)
T cd05123 76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNT 152 (250)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC---cccC
Confidence 5 79999998888899999999999999999999999999999999999999999999999999976543321 1234
Q ss_pred ccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHH
Q 007177 184 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLT 263 (614)
Q Consensus 184 ~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~ 263 (614)
..++..|++||.+.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 153 ~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~----------------------- 207 (250)
T cd05123 153 FCGTPEYLAPEVLLG--KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK----------------------- 207 (250)
T ss_pred CcCCccccChHHhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-----------------------
Confidence 568889999999876 5678899999999999999999999977654222222110
Q ss_pred hhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCH---HHHHcCccc
Q 007177 264 SMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA---EEALADPYF 311 (614)
Q Consensus 264 ~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa---~eiL~hp~f 311 (614)
... ......+..+.+||++||..||.+||++ +++++||||
T Consensus 208 -----~~~---~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 208 -----DPL---RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred -----CCC---CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 001 1112347889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=313.76 Aligned_cols=252 Identities=29% Similarity=0.475 Sum_probs=201.9
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc---CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF---EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~---~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
||.+.+.||+|+||.||++.+..++..+++|.++... ........+.+|+.+++.++||||+++++.+. +..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-----ERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-----cCC
Confidence 6999999999999999999998888777777765322 12234456778999999999999999999873 445
Q ss_pred cEEEEEecCC-CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 96 DIYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
..|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++. +.+||+|||++..
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceee
Confidence 6899999998 488887753 457999999999999999999999999999999999999975 5699999999976
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
....... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+..
T Consensus 155 ~~~~~~~---~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~---------- 219 (260)
T cd08222 155 LMGSCDL---ATTFTGTPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE---------- 219 (260)
T ss_pred cCCCccc---ccCCCCCcCccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc----------
Confidence 5432221 123467889999998865 5788899999999999999999999976654333222110
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
. ........++..+.+||.+||..||.+||++.++|+||||
T Consensus 220 ----------------~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 220 ----------------G----PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ----------------C----CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 0 0111123567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=316.64 Aligned_cols=251 Identities=22% Similarity=0.355 Sum_probs=200.6
Q ss_pred CCCeEEEeEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~-----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
..+|.+.+.||+|+||.||++... .++..+|+|.+... .......+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---- 77 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCT---- 77 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEe----
Confidence 457899999999999999999643 35668999988753 3445667889999999999999999999883
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEEC
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKAND---------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 155 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~~---------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~ 155 (614)
+....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++
T Consensus 78 -~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 78 -EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG 156 (280)
T ss_pred -cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc
Confidence 4456899999998 69999987643 488999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHH
Q 007177 156 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQ 234 (614)
Q Consensus 156 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~ 234 (614)
+++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||......+.
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 233 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILY--RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA 233 (280)
T ss_pred CCCCEEECCCCceeEcCCCcee-ecCCCccccccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH
Confidence 9999999999999754322211 11122345678999998876 578999999999999999998 9999977665443
Q ss_pred HHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 235 LDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 235 l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
+..+.. .... .....+++.+.+||.+||+.||.+||+++++++
T Consensus 234 ~~~~~~---------------------------~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 234 IECITQ---------------------------GREL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHHc---------------------------CccC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 332211 0010 112356788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=310.61 Aligned_cols=243 Identities=24% Similarity=0.405 Sum_probs=197.3
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
..+|++.+.||+|+||.||++.. .|..||+|.+... .....+.+|+.+++.++|+||+++++++. .+...
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~ 74 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGG 74 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEE----cCCCc
Confidence 45799999999999999999965 4788999988642 23456889999999999999999998763 23456
Q ss_pred EEEEEecCC-CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 97 IYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
.|+||||++ ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 899999998 59999997654 488999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.. ....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+.
T Consensus 155 ~~------~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~------------- 213 (256)
T cd05082 155 TQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE------------- 213 (256)
T ss_pred cC------CCCccceeecCHHHHcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-------------
Confidence 22 12234567999999876 578999999999999999997 999997665433322221
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.... ....+.+++.+.+||.+||..||++|||+.++++
T Consensus 214 --------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 214 --------------KGYK---MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred --------------cCCC---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1100 1122457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=309.64 Aligned_cols=243 Identities=26% Similarity=0.433 Sum_probs=200.3
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
...|++.+.||.|+||.||+|.+. |+.||+|++.... ....++.+|+.+++.++|+||+++++++. +...
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 74 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS---TAAQAFLAEASVMTTLRHPNLVQLLGVVL-----QGNP 74 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccch---hHHHHHHHHHHHHHhcCCcceeeeEEEEc-----CCCC
Confidence 457999999999999999999764 8899999997542 25677899999999999999999999984 3567
Q ss_pred EEEEEecCC-CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 97 IYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
.|+||||++ ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc
Confidence 899999999 59999998765 699999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
... ....+..|+|||.+.. ..++.++|+|||||++|+|++ |..||...+..+....+.
T Consensus 155 ~~~------~~~~~~~~~ape~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~------------- 213 (256)
T cd05039 155 GQD------SGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE------------- 213 (256)
T ss_pred ccc------cCCCcccccCchhhcC--CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-------------
Confidence 211 2234567999998876 578899999999999999997 999997665433322221
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.... .......++.+.+||.+||..+|.+|||+.++++
T Consensus 214 --------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 214 --------------KGYR---MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred --------------cCCC---CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0000 0112346789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=311.22 Aligned_cols=247 Identities=28% Similarity=0.383 Sum_probs=197.9
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|++.+.||+|+||.||+|.+..+ ..+|+|.+.... .....+.+|+.+++.++||||+++++++. ...
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~ 74 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEP 74 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCC
Confidence 46799999999999999999987655 469999876432 22356788999999999999999998872 234
Q ss_pred EEEEEecCC-CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 97 IYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
.|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+|+||||+||++++++.+||+|||+++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 799999998 59999997643 488999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 155 ~~~~~--~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~------------ 218 (260)
T cd05069 155 NEYTA--RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER------------ 218 (260)
T ss_pred Ccccc--cCCCccchhhCCHHHhcc--CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------------
Confidence 22111 122345677999998876 578999999999999999999 9999987665444333211
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.... ......+..+.+|+.+||..||.+||+++++++
T Consensus 219 ---------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 219 ---------------GYRM---PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ---------------CCCC---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0000 112356789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=370.31 Aligned_cols=261 Identities=29% Similarity=0.395 Sum_probs=213.9
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
|++-...||.|.||.||.|++..||+..|+|.|+-..........+.+|.++|..|+|||+|+++++=. ....+|
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv-----HRekv~ 1310 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV-----HREKVY 1310 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee-----cHHHHH
Confidence 566778999999999999999999999999998754344445566789999999999999999999863 345689
Q ss_pred EEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC-
Q 007177 99 VVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP- 176 (614)
Q Consensus 99 lV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~- 176 (614)
|.||||+ |+|.+++...+...|-..+.+..|++.||.|||+.|||||||||.|||++.+|.+|++|||.|+...+...
T Consensus 1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 9999999 69999998877777888889999999999999999999999999999999999999999999998765542
Q ss_pred CccccccccCCccccCcccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~-~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
....+..+.||+.|||||++.+.. .....+.|||||||++.||+||+.||...+..=++ |.++
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI--My~V-------------- 1454 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI--MYHV-------------- 1454 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH--HhHH--------------
Confidence 223356789999999999987632 34667999999999999999999999766532222 2111
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
...... +....+|++.+|||.+||..||++|+++.|+|+|-|-+.
T Consensus 1455 ----------~~gh~P---q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1455 ----------AAGHKP---QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred ----------hccCCC---CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 011111 111248899999999999999999999999999988653
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=318.80 Aligned_cols=254 Identities=25% Similarity=0.412 Sum_probs=202.7
Q ss_pred CCCCeEEEeEeeecCceEEEEEEEC-------CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEec
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDT-------HTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIML 87 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~-------~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~ 87 (614)
...+|.+.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.+ +||||+++++.+
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~- 90 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC- 90 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEE-
Confidence 3568999999999999999999752 234579999887432 234567788999999999 799999999998
Q ss_pred CCCCCCCCcEEEEEecCC-CcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCC
Q 007177 88 PPSRRDFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPK 150 (614)
Q Consensus 88 ~~~~~~~~~~ylV~E~~~-g~L~~~i~~~----------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~ 150 (614)
.....+|+||||+. ++|.+++... ..++...+..++.||+.||.|||++||+||||||+
T Consensus 91 ----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 91 ----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred ----ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 34467899999998 5999998753 24778889999999999999999999999999999
Q ss_pred cEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 007177 151 NILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 229 (614)
Q Consensus 151 NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~ 229 (614)
|||++.++.+||+|||+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred eEEEcCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999865432211 11123345678999999876 578999999999999999998 88999877
Q ss_pred ChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 230 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 230 ~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
+..+....+.. .... .....++..+.+||.+||..+|.+|||+.++|+.
T Consensus 244 ~~~~~~~~~~~---------------------------~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 244 PVEELFKLLKE---------------------------GHRM---DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CHHHHHHHHHc---------------------------CCcC---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 65444433211 0000 1123567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=318.77 Aligned_cols=252 Identities=26% Similarity=0.396 Sum_probs=200.3
Q ss_pred CCeEEEeEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~-----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~ 91 (614)
++|.+.+.||+|+||.||+|.+. .++..||+|.++... .......+.+|+.+++.+ +||||+++++.+
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~----- 108 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGAC----- 108 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEE-----
Confidence 47999999999999999999752 345689999987532 234456788999999999 799999999988
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcc
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 168 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 168 (614)
...+.+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 34456899999998 69999997643 3899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCch
Q 007177 169 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSL 247 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~ 247 (614)
+......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+.+.....
T Consensus 189 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~------- 258 (302)
T cd05055 189 RDIMNDSNYV-VKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK------- 258 (302)
T ss_pred ccccCCCcee-ecCCCCcccccCCHhhhcc--CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH-------
Confidence 7654322111 1122346778999999876 578999999999999999998 9999977654322211110
Q ss_pred hhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 248 ~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
..... ......++.+.+|+.+||..||++|||+.|+++
T Consensus 259 -------------------~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 259 -------------------EGYRM---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred -------------------cCCcC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00000 112346789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=319.69 Aligned_cols=251 Identities=25% Similarity=0.420 Sum_probs=199.9
Q ss_pred CCeEEEeEeeecCceEEEEEEECC-------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTH-------TGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPP 89 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~-------tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~ 89 (614)
++|.+.+.||+|+||.||+|.+.. ....+|+|.++... .......+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 88 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCT-- 88 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc--
Confidence 589999999999999999997642 34579999887532 334566788999999999 6999999999883
Q ss_pred CCCCCCcEEEEEecCC-CcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcE
Q 007177 90 SRRDFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNI 152 (614)
Q Consensus 90 ~~~~~~~~ylV~E~~~-g~L~~~i~~~----------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NI 152 (614)
+...+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||
T Consensus 89 ---~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 89 ---QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 4456899999998 6999999653 3488999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCh
Q 007177 153 LANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNV 231 (614)
Q Consensus 153 Li~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~ 231 (614)
|++.++.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYK-KTSNGRLPVKWMAPEALFD--RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred EEcCCCcEEEcccccccccccccccc-ccccCCCCccccCHHHHcc--CCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999997653221111 0111234467999999876 678999999999999999999 8999987765
Q ss_pred hHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 232 VHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 232 ~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.+.+..+.. ... ......++..+.+||.+||..||++|||+.++++
T Consensus 243 ~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 243 EELFKLLRE---------------------------GHR---MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHc---------------------------CCC---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 444433211 000 0112456789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=310.73 Aligned_cols=244 Identities=21% Similarity=0.336 Sum_probs=193.0
Q ss_pred EeeecCceEEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEe
Q 007177 25 VIGKGSYGVVCSAIDT--HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 102 (614)
Q Consensus 25 ~LG~G~~G~V~~a~d~--~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E 102 (614)
.||+|+||.||+|.+. .++..||+|++... ........+.+|+.+|+.++||||+++++++. ....|+|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e 74 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVME 74 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEE
Confidence 3899999999999765 44567999998753 23344567889999999999999999999872 235899999
Q ss_pred cCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007177 103 LME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 180 (614)
Q Consensus 103 ~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 180 (614)
|++ ++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++...........
T Consensus 75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 998 599998875 457999999999999999999999999999999999999999999999999999754333221111
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHH
Q 007177 181 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKAR 259 (614)
Q Consensus 181 ~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~ 259 (614)
.+...++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 155 ~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------------------- 212 (257)
T cd05115 155 RSAGKWPLKWYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-------------------- 212 (257)
T ss_pred cCCCCCCcccCCHHHHcc--CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH--------------------
Confidence 122233567999998876 578999999999999999996 999997766544332221
Q ss_pred HHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 260 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 260 ~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
..... ...+..++++.+||.+||..||++||++.++++
T Consensus 213 -------~~~~~---~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 213 -------QGKRL---DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred -------CCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11111 112356789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=309.40 Aligned_cols=246 Identities=22% Similarity=0.354 Sum_probs=198.0
Q ss_pred eEeeecCceEEEEEEECC-CCc--EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEE
Q 007177 24 EVIGKGSYGVVCSAIDTH-TGE--KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVV 100 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~-tg~--~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV 100 (614)
+.||+|+||.||+|.+.. .+. .||||.+...... .....+.+|+.+++.++||||+++++.+. + ...|+|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEE
Confidence 468999999999998865 333 6999999864333 55678889999999999999999999883 3 678999
Q ss_pred EecCC-CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007177 101 FELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 177 (614)
Q Consensus 101 ~E~~~-g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 177 (614)
|||++ ++|.+.+.... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||+++........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99997 69999997754 6899999999999999999999999999999999999999999999999999876432221
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhch
Q 007177 178 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256 (614)
Q Consensus 178 ~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~ 256 (614)
........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~--------------- 216 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRT--RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE--------------- 216 (257)
T ss_pred eecccCCCCCceecCHHHhcc--cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc---------------
Confidence 111122456778999999876 578999999999999999998 99999776655443333110
Q ss_pred hHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 257 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.... ......+..+.+|+.+||..+|++|||+.++++
T Consensus 217 -----------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 217 -----------GERL---ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred -----------CCcC---CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 0000 011245778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=314.27 Aligned_cols=251 Identities=23% Similarity=0.347 Sum_probs=198.4
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~----~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
.++|++++.||+|+||+||+|.+..++. .+++|.+... ........+..|+.+++.+.||||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~----- 79 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP----- 79 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-----
Confidence 3579999999999999999999887776 4777776532 22234466778899999999999999999872
Q ss_pred CCCcEEEEEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
....++|+||+. ++|.+++.. ...+++..+..|+.||+.||.|||+.|++||||||+|||++.++.+||+|||+++.
T Consensus 80 -~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 80 -GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred -CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 234789999998 799999976 45789999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
...... ........++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.......+.+.
T Consensus 159 ~~~~~~-~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~---------- 225 (279)
T cd05111 159 LYPDDK-KYFYSEHKTPIKWMALESILF--GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE---------- 225 (279)
T ss_pred ccCCCc-ccccCCCCCcccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH----------
Confidence 543221 112234456778999999876 579999999999999999998 999998765433222211
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
...... .....+..+.+++.+||..||.+|||+.|+++
T Consensus 226 -----------------~~~~~~---~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 226 -----------------KGERLA---QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -----------------CCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 111111 11124568899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=327.15 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=198.1
Q ss_pred CCCeEEEeEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAID-----THTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 90 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d-----~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~ 90 (614)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++... .......+.+|+.+|..+ +||||+++++.+..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-- 82 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK-- 82 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeec--
Confidence 35899999999999999999984 3567899999997532 234456788999999999 68999999998742
Q ss_pred CCCCCcEEEEEecCC-CcHHHHHHhC------------------------------------------------------
Q 007177 91 RRDFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 115 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~-g~L~~~i~~~------------------------------------------------------ 115 (614)
....+|+|||||+ |+|.+++...
T Consensus 83 --~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 83 --PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred --CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 3356899999999 6999888642
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccccc
Q 007177 116 -------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 182 (614)
Q Consensus 116 -------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~ 182 (614)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~ 239 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV-RKG 239 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchh-hcC
Confidence 136778889999999999999999999999999999999999999999999997653222111 112
Q ss_pred cccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHH
Q 007177 183 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRY 261 (614)
Q Consensus 183 ~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~ 261 (614)
...++..|+|||++.+ ..++.++|||||||++|+|++ |..||++......+...
T Consensus 240 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~----------------------- 294 (343)
T cd05103 240 DARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR----------------------- 294 (343)
T ss_pred CCCCCcceECcHHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH-----------------------
Confidence 2345667999999876 678999999999999999997 99999775432221111
Q ss_pred HHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 262 LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 262 l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
+....... .....++.+.+++.+||+.||.+|||+.++++|
T Consensus 295 ---~~~~~~~~---~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 295 ---LKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ---HhccCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00000000 012356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=314.52 Aligned_cols=248 Identities=28% Similarity=0.455 Sum_probs=195.5
Q ss_pred EEEeEeeecCceEEEEEEEC----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 21 KIQEVIGKGSYGVVCSAIDT----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 21 ~i~~~LG~G~~G~V~~a~d~----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
++.+.||.|+||.||+|... ..+..|+||.++. .........+.+|+++|+.++||||+++++++. ....
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-----~~~~ 75 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-----ENEP 75 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-----SSSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccc-----cccc
Confidence 57899999999999999887 3456899999964 244456788999999999999999999999995 3344
Q ss_pred EEEEEecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 97 IYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
+++|||||. |+|.+++... ..+++..+..|+.||+.||.|||+.+|+|+||+++|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999998 6999999887 6799999999999999999999999999999999999999999999999999987632
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.... ...........|+|||.+.. ..++.++||||||+++|||++ |+.||...+..+....+.+.
T Consensus 156 ~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~----------- 221 (259)
T PF07714_consen 156 KSKY-KNDSSQQLPLRYLAPEVLKD--GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQG----------- 221 (259)
T ss_dssp SSSE-EESTTSESGGGGS-HHHHHH--SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTT-----------
T ss_pred cccc-cccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccc-----------
Confidence 2211 11223356678999999876 568999999999999999999 78999877655444433110
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
... .....++..+.+||..||..||++|||++++++
T Consensus 222 ----------------~~~---~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 222 ----------------QRL---PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ----------------EET---TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ----------------ccc---eeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 001 112346788999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=315.93 Aligned_cols=250 Identities=23% Similarity=0.397 Sum_probs=197.8
Q ss_pred CeEEEeEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~-----tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
+|++.+.||+|+||.||+|.+.. ....+++|.+... ........+.+|+.+|+.++||||+++++.+ ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 74 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN-ASSSELRDLLSEFNLLKQVNHPHVIKLYGAC-----SQ 74 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC-CCHHHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ec
Confidence 58899999999999999998753 2356888888643 2234567788999999999999999999988 34
Q ss_pred CCcEEEEEecCC-CcHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCC
Q 007177 94 FKDIYVVFELME-SDLHQVIKAN------------------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLK 148 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~------------------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLK 148 (614)
....|+|+||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+|||||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik 154 (290)
T cd05045 75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA 154 (290)
T ss_pred CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence 456899999999 6999888642 247889999999999999999999999999999
Q ss_pred CCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCC
Q 007177 149 PKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFP 227 (614)
Q Consensus 149 P~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~ 227 (614)
|+|||+++++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++++|++ |..||.
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYV-KRSKGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccchh-cccCCCCCccccCHHHHcc--CCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 999999999999999999997653322111 1122245678999998876 578999999999999999998 999998
Q ss_pred CCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 228 GKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 228 g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
+.........+.. . ... ......+..+.+|+.+||+.||++||++.++++
T Consensus 232 ~~~~~~~~~~~~~---------------------------~--~~~-~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 232 GIAPERLFNLLKT---------------------------G--YRM-ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCCHHHHHHHHhC---------------------------C--CCC-CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 7764433322210 0 000 012346789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=322.26 Aligned_cols=252 Identities=25% Similarity=0.412 Sum_probs=200.5
Q ss_pred CCeEEEeEeeecCceEEEEEEECCC-------CcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHT-------GEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPP 89 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~t-------g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~ 89 (614)
.+|++++.||+|+||.||+|.+... +..||+|.++.. ........+.+|+.+++.+ +||||+++++.+.
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 88 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 88 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc--
Confidence 4799999999999999999986432 236899988743 2334567788999999999 7999999999983
Q ss_pred CCCCCCcEEEEEecCC-CcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcE
Q 007177 90 SRRDFKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNI 152 (614)
Q Consensus 90 ~~~~~~~~ylV~E~~~-g~L~~~i~~~~----------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NI 152 (614)
....+|+||||+. ++|.+++.... .++...+..++.||+.||.|||++||+||||||+||
T Consensus 89 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 89 ---QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 4456899999998 59999987532 477888999999999999999999999999999999
Q ss_pred EECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCh
Q 007177 153 LANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNV 231 (614)
Q Consensus 153 Li~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~ 231 (614)
|++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEcCCCcEEECCcccceeccccccc-ccccCCCcCceEcCHHHhcc--CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999765332211 11122334567999999876 678999999999999999998 8999988765
Q ss_pred hHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 232 VHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 232 ~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.+....+.. ... .......+..+.+||.+||..+|.+|||+.++|++
T Consensus 243 ~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 243 EELFKLLKE---------------------------GHR---MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHc---------------------------CCC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 444333211 000 01123567789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=314.11 Aligned_cols=270 Identities=24% Similarity=0.367 Sum_probs=203.1
Q ss_pred CCeEEEeEeeecCceEEEEEEE----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAID----THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d----~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
.-|++++.||+|+||.||+|.. +.++..||+|.++.. ........+.+|+.+|+.++||||+++++++... +
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~ 79 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKEIEILRNLYHENIVKYKGICTED---G 79 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---C
Confidence 3479999999999999999974 467889999998743 2334456788999999999999999999987432 2
Q ss_pred CCcEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
....|+||||++ ++|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 356899999997 5999998664 35899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
..............++..|+|||++.+ ..++.++|||||||++|+|+++..|+.... ....+..+....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~ellt~~~~~~~~~-----~~~~~~~~~~~~~~~- 231 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQ--SKFYIASDVWSFGVTLYELLTYCDSESSPM-----TLFLKMIGPTHGQMT- 231 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhcc--CCCCccccchhhhhhhhhhhcCCCCCcccc-----chhhhhccccccccc-
Confidence 433221112234557778999999876 578999999999999999999876653321 111111121111100
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.......+..... ...+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 232 ------~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 232 ------VTRLVRVLEEGKR---LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ------HHHHHHHHHcCcc---CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0011111111111 12234678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=311.29 Aligned_cols=254 Identities=20% Similarity=0.349 Sum_probs=203.0
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECC----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTH----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~----tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
..++|++.+.||+|+||.||+|.+.. ++..|++|.+... ........+.+|+.+|+.++||||+++++++...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-- 80 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-- 80 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence 35689999999999999999999876 3578999988643 3455667788999999999999999999987432
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEE
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKAN--------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKI 162 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~--------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL 162 (614)
....++++||+. ++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||
T Consensus 81 --~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 81 --GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred --CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEE
Confidence 356799999998 6999988653 45899999999999999999999999999999999999999999999
Q ss_pred eecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhh
Q 007177 163 CDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDL 241 (614)
Q Consensus 163 ~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~ 241 (614)
+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|++++ |+.||...+..+....+..
T Consensus 159 ~d~g~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~- 234 (280)
T cd05043 159 TDNALSRDLFPMDYHC-LGDNENRPVKWMALESLVN--KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD- 234 (280)
T ss_pred CCCCCcccccCCceEE-eCCCCCcchhccCHHHHhc--CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc-
Confidence 9999998654322111 1122345677999999876 578999999999999999998 9999977654332222110
Q ss_pred hCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 242 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 242 ~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.... .....+++.+.+++.+||..||++|||+.++++
T Consensus 235 --------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 235 --------------------------GYRL---AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred --------------------------CCCC---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0000 112345788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=305.90 Aligned_cols=248 Identities=29% Similarity=0.485 Sum_probs=201.7
Q ss_pred eEEEeEeeecCceEEEEEEECCCC----cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTG----EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg----~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
+++.+.||.|+||.||+|.+..++ ..||+|++... ........+..|+.+|+.++|+||+++++.+. +.+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~ 74 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED-ADEQQIEEFLREARIMRKLDHPNIVKLLGVCT-----EEE 74 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC-CChHHHHHHHHHHHHHHhcCCCchheEEEEEc-----CCC
Confidence 357899999999999999998766 88999999653 22235678889999999999999999999983 446
Q ss_pred cEEEEEecCC-CcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 96 DIYVVFELME-SDLHQVIKANDD--LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~--lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
..|+|||++. ++|.+++..... +++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++....
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 7999999998 599999976554 9999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
....... ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||...+..+....+..
T Consensus 155 ~~~~~~~--~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~----------- 219 (258)
T smart00219 155 DDDYYKK--KGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK----------- 219 (258)
T ss_pred ccccccc--ccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-----------
Confidence 4321111 11236788999999865 678999999999999999998 8899977655444333211
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.... ......+..+.+++.+||..||.+|||+.|+++
T Consensus 220 ----------------~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 220 ----------------GYRL---PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ----------------CCCC---CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 1011 112336789999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=309.05 Aligned_cols=251 Identities=25% Similarity=0.424 Sum_probs=201.3
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCC---CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHT---GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~t---g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
..+|.+.+.||.|+||.||+|.+... ...|+||...... .......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----- 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE----- 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----
Confidence 35699999999999999999987654 3468999886432 23456678899999999999999999998732
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
...|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++..
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 79 -NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeec
Confidence 34689999998 69999997644 5899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
..... ...+...++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.+..+.+..+..
T Consensus 158 ~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~---------- 223 (270)
T cd05056 158 EDESY--YKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN---------- 223 (270)
T ss_pred ccccc--eecCCCCccccccChhhhcc--CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc----------
Confidence 43311 11122234567999998876 578999999999999999986 9999988775544433211
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.... ...+.++..+.+||.+||..||.+|||+.+++..
T Consensus 224 -----------------~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 224 -----------------GERL---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred -----------------CCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0011 1234578899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=314.58 Aligned_cols=258 Identities=23% Similarity=0.370 Sum_probs=197.5
Q ss_pred CCeEEEeEeeecCceEEEEEEECC----------------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcce
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTH----------------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVE 81 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~----------------tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~ 81 (614)
++|++.+.||+|+||.||+|.+.. ++..||+|++... ........+.+|+.+|+.++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 579999999999999999985432 3457999998743 23344567889999999999999999
Q ss_pred eeeEecCCCCCCCCcEEEEEecCC-CcHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCC
Q 007177 82 IKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAND-----------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKP 149 (614)
Q Consensus 82 l~~v~~~~~~~~~~~~ylV~E~~~-g~L~~~i~~~~-----------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP 149 (614)
+++++. +....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp 158 (296)
T cd05095 84 LLAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLAT 158 (296)
T ss_pred EEEEEe-----cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCCh
Confidence 999883 3456899999998 69999987542 367788999999999999999999999999999
Q ss_pred CcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh--CCCCCC
Q 007177 150 KNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFP 227 (614)
Q Consensus 150 ~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt--G~~pF~ 227 (614)
+|||++.++.+||+|||+++......... ......++..|++||++.+ ..++.++|+|||||++|||++ |..||.
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYR-IQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCccee-ccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 99999999999999999997643322111 1122344677999998765 578999999999999999998 778887
Q ss_pred CCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 228 GKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 228 g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
..+..+.+.... .++..... .........+++.+.+|+.+||..||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~--------------------~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 236 QLSDEQVIENTG--------------------EFFRDQGR---QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ccChHHHHHHHH--------------------HHHhhccc---cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 665433332211 01110000 0011112346689999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=339.98 Aligned_cols=279 Identities=20% Similarity=0.274 Sum_probs=187.9
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCC----CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHT----GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS- 90 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~t----g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~- 90 (614)
..++|++.+.||+|+||.||+|.+..+ +..||||++..... .....+| .++...+.++..+...+....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 457899999999999999999999998 99999999864211 1111111 122222333433333322211
Q ss_pred CCCCCcEEEEEecCC-CcHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCeEeecCCC
Q 007177 91 RRDFKDIYVVFELME-SDLHQVIKANDD--------------------LTREHYQFFLYQLLRALKYIHTANVYHRDLKP 149 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~-g~L~~~i~~~~~--------------------lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP 149 (614)
..+...+++|+||++ ++|.+++..... ..+..+..|+.||+.||.|||+.||+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 145567999999999 589988865421 12345678999999999999999999999999
Q ss_pred CcEEECC-CCcEEEeecCccccccCCCCCccccccccCCccccCcccccccC--------------------CCCCCccc
Q 007177 150 KNILANA-NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF--------------------SKYTPAID 208 (614)
Q Consensus 150 ~NILi~~-~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~--------------------~~y~~~~D 208 (614)
+|||++. ++.+||+|||+|+....... .....+++|+.|+|||.+.... ..++.++|
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 9999986 57899999999975432221 1224578999999999653210 13455679
Q ss_pred chhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCccc---CCCCCCCHHHH
Q 007177 209 IWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFS---QKFPNADPSAL 285 (614)
Q Consensus 209 IWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~~s~~l~ 285 (614)
|||||||||||+++. |+..+...++..+....+....... ............ +.+...+..+.
T Consensus 362 VwSlGviL~el~~~~--~~~~~~~~~~~~~l~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~d~~~~~~~ 427 (566)
T PLN03225 362 IYSAGLIFLQMAFPN--LRSDSNLIQFNRQLKRNDYDLVAWR------------KLVEPRASPDLRRGFEVLDLDGGAGW 427 (566)
T ss_pred cHHHHHHHHHHHhCc--CCCchHHHHHHHHHHhcCCcHHHHH------------HhhccccchhhhhhhhhccccchHHH
Confidence 999999999999865 4444444455444443333211111 000011000101 11222345677
Q ss_pred HHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 286 RLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 286 dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
+||.+||++||++|||+.++|+||||++...
T Consensus 428 dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 428 ELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred HHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 9999999999999999999999999987543
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=314.23 Aligned_cols=267 Identities=17% Similarity=0.191 Sum_probs=195.5
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCC---CcEEEEEEecCccCChH-H--------HHHHHHHHHHHHhcCCCCccee
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHT---GEKVAIKKIHDIFEHIS-D--------AARILREIKLLRLLRHPDIVEI 82 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~t---g~~vAIK~i~~~~~~~~-~--------~~~i~~Ei~iL~~L~HpnIv~l 82 (614)
...++|++.+.||+|+||.||+|.+..+ +..+|+|+......... + ......++..+..+.|+||+.+
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3457999999999999999999998877 66777776432211110 0 0112234445566789999999
Q ss_pred eeEecCCCCCCCCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEE
Q 007177 83 KHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKI 162 (614)
Q Consensus 83 ~~v~~~~~~~~~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL 162 (614)
++...... ......|+++|++..++.+.+......++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||
T Consensus 89 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKR-CRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEec-CCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 98653321 11224588999988888888876666789999999999999999999999999999999999999999999
Q ss_pred eecCccccccCCCCCc----cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 007177 163 CDFGLARVAFNDTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLM 238 (614)
Q Consensus 163 ~DFGla~~~~~~~~~~----~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i 238 (614)
+|||+|+......... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+....+...
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 9999998653222111 11123479999999999887 67999999999999999999999999877432221111
Q ss_pred HhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 239 TDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 239 ~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.. ..++..+.... ...++.++.+.++++.|+..||++||+.+++++
T Consensus 246 ~~------------------~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 246 AK------------------CDFIKRLHEGK-----IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hH------------------HHHHHHhhhhh-----hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 00 01111111110 123456788999999999999999999999875
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=306.27 Aligned_cols=248 Identities=25% Similarity=0.400 Sum_probs=199.3
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++.+.||+|+||.||++.+. .+..+|+|.+... ......+.+|+.+++.++|+||+++++.+. + .
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~-~ 73 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-E 73 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEc-----C-C
Confidence 3578999999999999999999754 4567999988642 234567889999999999999999999873 2 4
Q ss_pred cEEEEEecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 96 DIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
..|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++....
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 5899999998 6999999763 357888999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
...... .....++..|+|||++.. ..++.++|+|||||++|+|++ |..||.+.+..+....+..
T Consensus 154 ~~~~~~--~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~----------- 218 (260)
T cd05073 154 DNEYTA--REGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER----------- 218 (260)
T ss_pred CCCccc--ccCCcccccccCHhHhcc--CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC-----------
Confidence 221111 122345667999999876 578999999999999999998 9999987765444333211
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
... .......+..+.+++.+||..||++||++.++++
T Consensus 219 ----------------~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 219 ----------------GYR---MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ----------------CCC---CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 000 1122456789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=333.35 Aligned_cols=234 Identities=26% Similarity=0.417 Sum_probs=194.8
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEe
Q 007177 23 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 102 (614)
Q Consensus 23 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E 102 (614)
++.||.|+.|.||+++. .++.||||+++.. -..+|+-|++|+||||+.+++++.. ...+|||||
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtq-----sPcyCIiME 192 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQ-----SPCYCIIME 192 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecC-----CceeEEeee
Confidence 57899999999999954 5889999998642 1247888999999999999999944 356899999
Q ss_pred cCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCcccc
Q 007177 103 LME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 181 (614)
Q Consensus 103 ~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~ 181 (614)
||. |-|.+++++...++......|..+|+.|++|||.+.|||||||.-||||+.+..|||+|||-++..... .+ .
T Consensus 193 fCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-ST---k 268 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-ST---K 268 (904)
T ss_pred ccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hh---h
Confidence 999 899999999999999999999999999999999999999999999999999999999999999865433 21 1
Q ss_pred ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHH
Q 007177 182 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRY 261 (614)
Q Consensus 182 ~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~ 261 (614)
-.++||..|||||++.. .+.++|+|||||||+|||||||..||..-+ +...|.. .|.
T Consensus 269 MSFaGTVaWMAPEvIrn--ePcsEKVDIwSfGVVLWEmLT~EiPYkdVd---ssAIIwG-VGs----------------- 325 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRN--EPCSEKVDIWSFGVVLWEMLTGEIPYKDVD---SSAIIWG-VGS----------------- 325 (904)
T ss_pred hhhhhhHhhhCHHHhhc--CCcccccceehhHHHHHHHHhcCCCccccc---hheeEEe-ccC-----------------
Confidence 34789999999999998 789999999999999999999999995533 2121111 011
Q ss_pred HHhhcccCCCcccCCC-CCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 262 LTSMRKKQPVQFSQKF-PNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 262 l~~~~~~~~~~~~~~~-~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
..+.-.. ..+++.++=||+.||.-.|..||++.++|.|
T Consensus 326 ---------NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 326 ---------NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred ---------CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 0111111 2456778889999999999999999999999
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=306.19 Aligned_cols=250 Identities=26% Similarity=0.417 Sum_probs=199.8
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
+..+|++.+.||.|+||.||++.+. .+..+|+|.+..... ....+.+|+++++.++||||+++++.+ .+..
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~ 72 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERS 72 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCC
Confidence 3568999999999999999999875 467899998874322 234578899999999999999999988 4445
Q ss_pred cEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 96 DIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
..|+||||+. ++|.+++... ..++++.+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||+++....
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 7899999998 5898888764 4689999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
..... .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||........+..+..
T Consensus 153 ~~~~~--~~~~~~~~~~~aPe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------ 216 (256)
T cd05112 153 DQYTS--STGTKFPVKWSSPEVFSF--SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA------------ 216 (256)
T ss_pred Ccccc--cCCCccchhhcCHhHhcc--CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC------------
Confidence 22111 112235568999999876 578899999999999999998 9999977664443332211
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
...... ....+..+.+|+.+||+.||++|||+.+++++
T Consensus 217 ---------------~~~~~~---~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 217 ---------------GFRLYK---PRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ---------------CCCCCC---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 000000 11246789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=312.63 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=199.8
Q ss_pred CCCeEEEeEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~-----tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
.++|++.+.||.|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~----- 77 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVC----- 77 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEE-----
Confidence 4579999999999999999998753 67889999987532 233456688999999999999999999988
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCC
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKAND----------------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLK 148 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~~----------------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLK 148 (614)
.+....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.|++|||||
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~ 157 (288)
T cd05050 78 AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA 157 (288)
T ss_pred cCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 34456899999999 59999986432 47888899999999999999999999999999
Q ss_pred CCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCC
Q 007177 149 PKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFP 227 (614)
Q Consensus 149 P~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~ 227 (614)
|+|||++.++.+||+|||+++......... .......+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYK-ASENDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred HhheEecCCCceEECccccceecccCcccc-ccCCCccChhhcCHHHHhc--CCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999987643322111 0112234567999999876 678999999999999999997 888987
Q ss_pred CCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 228 GKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 228 g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
+.+..+.+..+.. .... ......+..+.+||.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~---------------------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 235 GMAHEEVIYYVRD---------------------------GNVL---SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCCHHHHHHHHhc---------------------------CCCC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7655433322211 0000 112346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=309.51 Aligned_cols=252 Identities=22% Similarity=0.379 Sum_probs=201.2
Q ss_pred CCeEEEeEeeecCceEEEEEEECCC-----CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHT-----GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~t-----g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
++|++++.||.|+||.||+|..+.+ .+.|++|.+... ........+.+|+.+|+.++||||+++++.+ .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 78 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----R 78 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----C
Confidence 5799999999999999999987643 457999987642 2223456788999999999999999999988 4
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEE
Q 007177 93 DFKDIYVVFELME-SDLHQVIKAND---------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKI 162 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~~---------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL 162 (614)
+....|+||||++ ++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEE
Confidence 4466899999998 69999998765 6999999999999999999999999999999999999999999999
Q ss_pred eecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhh
Q 007177 163 CDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDL 241 (614)
Q Consensus 163 ~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~ 241 (614)
+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+....+..+..
T Consensus 159 ~~~~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~- 233 (275)
T cd05046 159 SLLSLSKDVYNSEY--YKLRNALIPLRWLAPEAVQE--DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA- 233 (275)
T ss_pred cccccccccCcccc--cccCCceeEEeecChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc-
Confidence 99999875432221 11233456778999998876 567889999999999999998 8889976544332222110
Q ss_pred hCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 242 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 242 ~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
....+ ......+..+.+++.+||..||.+|||+.+++.+
T Consensus 234 ---------------------------~~~~~-~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 234 ---------------------------GKLEL-PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred ---------------------------CCcCC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 00011 1123567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=309.30 Aligned_cols=251 Identities=25% Similarity=0.375 Sum_probs=201.1
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~----~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
..+|++.+.||+|+||.||+|.++.+|+ .+|+|.+.... .......+.+|+.+|+.++||||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS---- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence 4689999999999999999999877765 58999886542 23455678899999999999999999998843
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
...++||||+. ++|.+++..+ ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 81 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 81 --SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred --CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 46899999998 6999998764 4699999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
........ ......++..|+|||.+.. ..++.++|+|||||++|||++ |..||.+.+..+....+.
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---------- 225 (279)
T cd05057 159 LDVDEKEY-HAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE---------- 225 (279)
T ss_pred ccCcccce-ecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh----------
Confidence 54222111 1111223567999998875 578899999999999999998 999998765433322221
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
...... .....+..+.+++.+||..||.+||++.++++
T Consensus 226 -----------------~~~~~~---~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 226 -----------------KGERLP---QPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred -----------------CCCCCC---CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 111111 11235678999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=307.93 Aligned_cols=228 Identities=25% Similarity=0.356 Sum_probs=185.6
Q ss_pred cCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecCC-Cc
Q 007177 29 GSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SD 107 (614)
Q Consensus 29 G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~-g~ 107 (614)
|.||.||+|.++.+++.||+|++.... ...+|...+....||||+++++.+ .+....|+||||++ ++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCC
Confidence 889999999999999999999997531 123444555556799999999987 44567999999999 59
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCC
Q 007177 108 LHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 187 (614)
Q Consensus 108 L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt 187 (614)
|.+.+.....+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....... ....++
T Consensus 72 L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~------~~~~~~ 145 (237)
T cd05576 72 LWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC------DGEAVE 145 (237)
T ss_pred HHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc------ccCCcC
Confidence 99999887789999999999999999999999999999999999999999999999999886543221 223567
Q ss_pred ccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcc
Q 007177 188 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRK 267 (614)
Q Consensus 188 ~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~ 267 (614)
..|+|||.+.+ ..++.++|+||+||++|+|++|..||...... + ..
T Consensus 146 ~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~---------------------------~~ 191 (237)
T cd05576 146 NMYCAPEVGGI--SEETEACDWWSLGAILFELLTGKTLVECHPSG-----I---------------------------NT 191 (237)
T ss_pred ccccCCcccCC--CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c---------------------------cc
Confidence 78999999876 57889999999999999999999887432110 0 00
Q ss_pred cCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHHcCccc
Q 007177 268 KQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA-----EEALADPYF 311 (614)
Q Consensus 268 ~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa-----~eiL~hp~f 311 (614)
.... ...+.+++.+.+||.+||+.||.+|+++ +++++||||
T Consensus 192 ~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 192 HTTL---NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cccc---CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 0000 1113467899999999999999999986 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=308.21 Aligned_cols=251 Identities=22% Similarity=0.302 Sum_probs=188.6
Q ss_pred eEeeecCceEEEEEEECC--CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEE
Q 007177 24 EVIGKGSYGVVCSAIDTH--TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~--tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~ 101 (614)
+.||+|+||.||+|.... ....+++|.+... ........+.+|+.+++.++||||+++++.+. +....|+||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~ 74 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVL 74 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEE
Confidence 369999999999996433 4457888877643 23344566789999999999999999999883 445689999
Q ss_pred ecCC-CcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 102 ELME-SDLHQVIKAND-----DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 102 E~~~-g~L~~~i~~~~-----~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch
Confidence 9998 69999987643 24677889999999999999999999999999999999999999999999986532221
Q ss_pred CCccccccccCCccccCccccccc-----CCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~-----~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
... ......++..|+|||++... ...++.++|||||||++|||++ |..||......+.+..+....
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~------- 226 (269)
T cd05042 155 YYI-TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ------- 226 (269)
T ss_pred hee-ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhcc-------
Confidence 110 01223456779999987431 1357889999999999999999 788997766544433321110
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
....+.......++..+.+++..|+ .||.+|||++++++
T Consensus 227 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 227 ------------------DIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ------------------CccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 0011111122356788899999998 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=318.27 Aligned_cols=286 Identities=29% Similarity=0.473 Sum_probs=218.0
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-----C---CCcceeeeEecCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-----H---PDIVEIKHIMLPP 89 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-----H---pnIv~l~~v~~~~ 89 (614)
+||.+.++||-|.|++||+|.|..+.+.||+|+++.. ....+..+.||++|++++ | ..||+|++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 7999999999999999999999999999999999842 234456678999999884 3 2599999998665
Q ss_pred CCCCCCcEEEEEecCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHh-CCeEeecCCCCcEEECCC---------
Q 007177 90 SRRDFKDIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANAN--------- 157 (614)
Q Consensus 90 ~~~~~~~~ylV~E~~~g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~--------- 157 (614)
. .+..++|+|||+++.+|..+|+.. ..++...++.|++|||.||.|||. +||||.||||+|||+..+
T Consensus 155 G-pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 155 G-PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred C-CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhh
Confidence 4 577899999999999999999864 469999999999999999999996 699999999999996211
Q ss_pred --C-----------------------------------------------------------------------------
Q 007177 158 --C----------------------------------------------------------------------------- 158 (614)
Q Consensus 158 --~----------------------------------------------------------------------------- 158 (614)
+
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence 0
Q ss_pred ------------------------------------------------------------------------------cE
Q 007177 159 ------------------------------------------------------------------------------KL 160 (614)
Q Consensus 159 ------------------------------------------------------------------------------~v 160 (614)
+|
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 01
Q ss_pred EEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC------ChhHH
Q 007177 161 KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK------NVVHQ 234 (614)
Q Consensus 161 KL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~------~~~~~ 234 (614)
||+|||-|.-. ...+|+-+.|+.|+||||+.+ ..|+..+||||++|++|||+||..+|... .+.+.
T Consensus 394 KIaDlGNACW~------~khFT~DIQTRQYRapEVllG--sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH 465 (590)
T KOG1290|consen 394 KIADLGNACWV------HKHFTEDIQTRQYRAPEVLLG--SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH 465 (590)
T ss_pred EEeeccchhhh------hhhhchhhhhhhccCcceeec--CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence 11111111100 011244578999999999998 79999999999999999999999999543 36788
Q ss_pred HHHHHhhhCCCchhhhhhhhchhHHHHHHhh------cccCCCcccC------CCC-CCCHHHHHHHHHhcCCCCCCCCC
Q 007177 235 LDLMTDLLGTPSLDTISRVRNDKARRYLTSM------RKKQPVQFSQ------KFP-NADPSALRLLERLLAFDPKDRPT 301 (614)
Q Consensus 235 l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~------~~~~~~~~~~------~~~-~~s~~l~dLI~~mL~~DP~~Rps 301 (614)
+..|++++|..+...... ...-+.|+... .+-++-++.. .|+ ....++.|||.-||+++|++|||
T Consensus 466 iA~i~ELLG~iPr~ia~~--Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~t 543 (590)
T KOG1290|consen 466 IALIMELLGKIPRKIALG--GKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPT 543 (590)
T ss_pred HHHHHHHHhhccHHHHhc--CcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccccc
Confidence 999999999987765432 22233444322 1112222111 111 12345789999999999999999
Q ss_pred HHHHHcCcccccCCcc
Q 007177 302 AEEALADPYFKGLSKV 317 (614)
Q Consensus 302 a~eiL~hp~f~~~~~~ 317 (614)
|.++|+|||++.+...
T Consensus 544 A~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 544 AAQCLKHPWLNPVAGP 559 (590)
T ss_pred HHHHhcCccccCCCCC
Confidence 9999999999977654
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=308.94 Aligned_cols=242 Identities=25% Similarity=0.387 Sum_probs=191.5
Q ss_pred eEeeecCceEEEEEEECCCCc--EEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCcEEEE
Q 007177 24 EVIGKGSYGVVCSAIDTHTGE--KVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVV 100 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~--~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~~~ylV 100 (614)
+.||+|+||.||+|.++.++. .+++|.++.. ........+.+|+.+++.+ +||||+++++.+. ....+|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv 74 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLA 74 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEE
Confidence 468999999999999988876 4688887642 2234456788999999999 7999999999983 44568999
Q ss_pred EecCC-CcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEe
Q 007177 101 FELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 163 (614)
Q Consensus 101 ~E~~~-g~L~~~i~~~~----------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~ 163 (614)
|||+. ++|.+++.... .++++.+..++.||+.||+|||+.|++||||||+|||++.++.+||+
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~ 154 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 154 (270)
T ss_pred EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence 99998 69999987543 47899999999999999999999999999999999999999999999
Q ss_pred ecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhh
Q 007177 164 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLL 242 (614)
Q Consensus 164 DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~ 242 (614)
|||++........ ......+..|+|||++.. ..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 155 dfgl~~~~~~~~~----~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~--- 225 (270)
T cd05047 155 DFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP--- 225 (270)
T ss_pred CCCCccccchhhh----ccCCCCccccCChHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh---
Confidence 9999863221110 111233567999999876 678999999999999999997 999997765433332221
Q ss_pred CCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 243 g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
..... ......+..+.+|+.+||..||.+|||+++++.
T Consensus 226 ------------------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 226 ------------------------QGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ------------------------CCCCC---CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 00000 112346788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=302.67 Aligned_cols=244 Identities=24% Similarity=0.417 Sum_probs=194.1
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEec
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFEL 103 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E~ 103 (614)
++||.|+||.||+|... ++..+|+|++.... .......+.+|+.+++.++||||+++++++ ......|+||||
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVC-----TQRQPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEE-----ecCCccEEEEEC
Confidence 47999999999999864 68899999987543 233445688999999999999999999988 344568999999
Q ss_pred CC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCcccc
Q 007177 104 ME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 181 (614)
Q Consensus 104 ~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~ 181 (614)
+. ++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.......... .
T Consensus 74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~--~ 151 (250)
T cd05085 74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS--S 151 (250)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc--C
Confidence 98 6999888653 468999999999999999999999999999999999999999999999999987543221111 0
Q ss_pred ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHH
Q 007177 182 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260 (614)
Q Consensus 182 ~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~ 260 (614)
....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~-------------------- 209 (250)
T cd05085 152 GLKQIPIKWTAPEALNY--GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-------------------- 209 (250)
T ss_pred CCCCCcccccCHHHhcc--CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc--------------------
Confidence 11234567999999876 578899999999999999998 9999987764433222211
Q ss_pred HHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 261 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
... ......++..+.+|+.+||..||++||++.++++.
T Consensus 210 -------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 210 -------GYR---MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred -------CCC---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 000 11223567899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=303.90 Aligned_cols=244 Identities=26% Similarity=0.413 Sum_probs=195.1
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEec
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFEL 103 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E~ 103 (614)
+.||.|+||.||+|.+.. ++.|++|++...... .....+.+|+++++.++||||+++++++ .+....|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEc
Confidence 479999999999999877 999999998754332 3556788999999999999999999988 445678999999
Q ss_pred CC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCcccc
Q 007177 104 ME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 181 (614)
Q Consensus 104 ~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~ 181 (614)
+. ++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......... ..
T Consensus 74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~ 152 (251)
T cd05041 74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV-SD 152 (251)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee-cc
Confidence 97 589998865 4468999999999999999999999999999999999999999999999999997643221110 00
Q ss_pred ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHH
Q 007177 182 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260 (614)
Q Consensus 182 ~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~ 260 (614)
.....+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.........+..
T Consensus 153 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-------------------- 210 (251)
T cd05041 153 GLKQIPIKWTAPEALNY--GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-------------------- 210 (251)
T ss_pred ccCcceeccCChHhhcc--CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc--------------------
Confidence 11233556999999876 578999999999999999998 8899977664333222211
Q ss_pred HHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 261 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.... ......+..+.+|+.+||..+|.+|||++|+|+
T Consensus 211 -------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 211 -------GYRM---PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -------CCCC---CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0000 011245779999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=307.83 Aligned_cols=256 Identities=21% Similarity=0.368 Sum_probs=200.7
Q ss_pred eEEEeEeeecCceEEEEEEECC---CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC-CC
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD-FK 95 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~---tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~-~~ 95 (614)
|.+.+.||+|+||.||+|.++. ++..||||.+............+.+|+.+|+.++||||+++++++....... ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6788999999999999998643 5789999999865555566778899999999999999999999886543222 22
Q ss_pred cEEEEEecCC-CcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcc
Q 007177 96 DIYVVFELME-SDLHQVIKAN------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 168 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 168 (614)
..++++||+. ++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 3578999998 6888876432 24789999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCch
Q 007177 169 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSL 247 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~ 247 (614)
+........ .......++..|++||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+..
T Consensus 161 ~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~--~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~------- 230 (273)
T cd05074 161 KKIYSGDYY-RQGCASKLPVKWLALESLAD--NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK------- 230 (273)
T ss_pred ccccCCcce-ecCCCccCchhhcCHhHHhc--CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc-------
Confidence 865322111 11122345677999998876 578899999999999999999 8999977665433322211
Q ss_pred hhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 248 ~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.... ...+..+..+.+|+.+||..+|.+|||+.+++.+
T Consensus 231 --------------------~~~~---~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 231 --------------------GNRL---KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred --------------------CCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0000 1113467899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=327.47 Aligned_cols=253 Identities=24% Similarity=0.361 Sum_probs=199.6
Q ss_pred CCeEEEeEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSR 91 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~-----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~ 91 (614)
++|.+.+.||+|+||.||+|.+. .+++.||+|+++... .......+.+|+.+|..+. ||||+++++.+.
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~---- 111 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACT---- 111 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc----
Confidence 56888999999999999999853 355689999997542 2334557889999999997 999999999983
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhCC------------------------------------------------------
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKAND------------------------------------------------------ 116 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~~------------------------------------------------------ 116 (614)
..+.+|+|||||. |+|.+++..+.
T Consensus 112 -~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 112 -KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred -cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 4456899999999 69999986532
Q ss_pred --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcE
Q 007177 117 --------------------------------------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNI 152 (614)
Q Consensus 117 --------------------------------------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NI 152 (614)
.+++..+..|+.||+.||.|||+.||+||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 356778889999999999999999999999999999
Q ss_pred EECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCh
Q 007177 153 LANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNV 231 (614)
Q Consensus 153 Li~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~ 231 (614)
|++.++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.....
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYI-SKGSTFLPLKWMAPESIFN--NLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccc-cCCCcCCCCceeChHHhcC--CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 99999999999999998643222111 1123356788999999876 578999999999999999998 8999977554
Q ss_pred hHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 232 VHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 232 ~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.+.+..... ..... .....++..+.+|+.+||..||.+||+++++|..
T Consensus 348 ~~~~~~~~~--------------------------~~~~~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 348 NEQFYNAIK--------------------------RGYRM---AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred hHHHHHHHH--------------------------cCCCC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 333221110 00000 1123567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=305.32 Aligned_cols=251 Identities=20% Similarity=0.286 Sum_probs=188.9
Q ss_pred eEeeecCceEEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEE
Q 007177 24 EVIGKGSYGVVCSAIDT--HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~--~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~ 101 (614)
+.||+|+||.||+|... .++..+|+|++..... ......+.+|+.+++.++||||+++++.+ .+...+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~ 74 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQC-----TEVTPYLLVM 74 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCCCcEEEE
Confidence 46899999999999754 3557899999875432 23445788999999999999999999988 3445689999
Q ss_pred ecCC-CcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 102 ELME-SDLHQVIKAND-----DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 102 E~~~-g~L~~~i~~~~-----~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
||++ ++|.+++.... .+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||+++......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 9999 69999986532 35677888999999999999999999999999999999999999999999997543221
Q ss_pred CCccccccccCCccccCcccccccC-----CCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~-----~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
. ........++..|+|||++.+.. ..++.++|||||||++|||++ |..||......+.+.....
T Consensus 155 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------- 224 (269)
T cd05087 155 Y-YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR--------- 224 (269)
T ss_pred e-eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh---------
Confidence 1 11112345778899999986421 136789999999999999996 9999977654333221100
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
. ..............++.+.+|+++|+ .||.+|||+++++.
T Consensus 225 --------------~--~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 225 --------------E--QQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred --------------c--ccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 0 00000111111245678899999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=310.28 Aligned_cols=238 Identities=18% Similarity=0.286 Sum_probs=186.7
Q ss_pred eEeeecCceEEEEEEECCCCc-------EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 24 EVIGKGSYGVVCSAIDTHTGE-------KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~-------~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
+.||.|+||.||+|.++.++. .+++|.+... .......+.+|+.+|+.++||||+++++.+. +...
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~ 73 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCV-----CGDE 73 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEE-----eCCC
Confidence 469999999999998866554 3888887542 2334567788999999999999999999984 3456
Q ss_pred EEEEEecCC-CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCc--------EEEeecC
Q 007177 97 IYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK--------LKICDFG 166 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~--------vKL~DFG 166 (614)
.++||||+. |+|.+++..++ .+++..+..++.||+.||.|||++||+||||||+|||++.++. +|++|||
T Consensus 74 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 74 SIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 899999998 58999997654 5899999999999999999999999999999999999987764 6999999
Q ss_pred ccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhC-CCCCCCCChhHHHHHHHhhhCCC
Q 007177 167 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLMTDLLGTP 245 (614)
Q Consensus 167 la~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG-~~pF~g~~~~~~l~~i~~~~g~p 245 (614)
++...... ....++..|+|||++.+. ..++.++|||||||++|+|++| .+||...+........
T Consensus 154 ~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~------- 218 (258)
T cd05078 154 ISITVLPK-------EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY------- 218 (258)
T ss_pred cccccCCc-------hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-------
Confidence 98654321 234678889999998752 4578999999999999999998 4666554432221110
Q ss_pred chhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 246 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 246 ~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
. ... ......+..+.+||.+||+.||++|||++++++.
T Consensus 219 -----------------~---~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 219 -----------------E---DRH-----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred -----------------H---ccc-----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 0 000 0112345789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=304.29 Aligned_cols=248 Identities=23% Similarity=0.384 Sum_probs=190.9
Q ss_pred eEeeecCceEEEEEEECC---CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEE
Q 007177 24 EVIGKGSYGVVCSAIDTH---TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVV 100 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~---tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV 100 (614)
+.||+|+||.||+|.+.. .+..||||.+... ........+.+|+.+++.++||||+++++++.. .....|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEE
Confidence 468999999999998653 3457999988642 233456778899999999999999999997643 23457999
Q ss_pred EecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCc
Q 007177 101 FELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 178 (614)
Q Consensus 101 ~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~ 178 (614)
|||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.........
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99998 6999998764 356788889999999999999999999999999999999999999999999997643321111
Q ss_pred -cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhch
Q 007177 179 -IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256 (614)
Q Consensus 179 -~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~ 256 (614)
.......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||...+..+....+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~----------------- 216 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL----------------- 216 (262)
T ss_pred ecccccCcCCccccChhHhcc--CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-----------------
Confidence 11122345678999999876 578999999999999999999 567786655433222111
Q ss_pred hHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 257 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
....... ....++.+.+|+.+||..||++||++.++++.
T Consensus 217 ----------~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 217 ----------QGRRLLQ---PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred ----------cCCCCCC---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0111111 12356789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=303.48 Aligned_cols=240 Identities=25% Similarity=0.448 Sum_probs=195.7
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
++|++.+.||+|+||.||++. .+++.||+|.+... .....+.+|+.+++.++||||+++++.+.. ...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~ 73 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILH------NGL 73 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCc
Confidence 579999999999999999985 57889999998643 234568899999999999999999998732 236
Q ss_pred EEEEecCC-CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 98 YVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 99999998 59999997643 5889999999999999999999999999999999999999999999999998754322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
. .....+..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||.+.+..+....+..
T Consensus 154 ~------~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------- 212 (254)
T cd05083 154 V------DNSKLPVKWTAPEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK------------- 212 (254)
T ss_pred C------CCCCCCceecCHHHhcc--CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-------------
Confidence 1 12234567999998876 578899999999999999997 9999987764433222210
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.... .....+++.+.+|+.+||..+|.+||++++++.
T Consensus 213 --------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 213 --------------GYRM---EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred --------------CCCC---CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000 112356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=306.33 Aligned_cols=238 Identities=21% Similarity=0.285 Sum_probs=184.6
Q ss_pred eEeeecCceEEEEEEECC------------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 24 EVIGKGSYGVVCSAIDTH------------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~------------tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
+.||+|+||.||+|.... ....+++|.+... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~---- 74 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCV---- 74 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe----
Confidence 468999999999997432 2236888987642 2334557788999999999999999999984
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCc-------EEE
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK-------LKI 162 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~-------vKL 162 (614)
+....++||||++ ++|..++.. ...+++..+..|+.||+.||.|||+.||+||||||+|||++.++. +|+
T Consensus 75 -~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 75 -RDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred -cCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 3355799999999 577777765 456999999999999999999999999999999999999987654 899
Q ss_pred eecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHH-hCCCCCCCCChhHHHHHHHhh
Q 007177 163 CDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL-TGKPLFPGKNVVHQLDLMTDL 241 (614)
Q Consensus 163 ~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLl-tG~~pF~g~~~~~~l~~i~~~ 241 (614)
+|||++...... ....++..|+|||++... ..++.++|||||||++|+|+ .|..||.+....+... +
T Consensus 154 ~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~--- 221 (262)
T cd05077 154 SDPGIPITVLSR-------QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-F--- 221 (262)
T ss_pred CCCCCCccccCc-------ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-H---
Confidence 999998654321 234678889999988632 57899999999999999998 5888887654322111 0
Q ss_pred hCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 242 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 242 ~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.. . .. ......++++.+||.+||+.||.+||++.+||++
T Consensus 222 --------------------~~---~--~~---~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 222 --------------------YE---G--QC---MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred --------------------Hh---c--Cc---cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 00 0 00 0112245688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=311.77 Aligned_cols=252 Identities=24% Similarity=0.369 Sum_probs=199.6
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~----~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
..+|++.+.||+|+||.||+|.+..+|. .||+|.+... ........+.+|+.+++.++||||+++++.+..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---- 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET-TGPKANVEFMDEALIMASMDHPHLVRLLGVCLS---- 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC----
Confidence 3578999999999999999999888776 4788887643 223334567899999999999999999998843
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
...++|+||+. |+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 81 --~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 81 --PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred --CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccc
Confidence 23579999998 69999987654 689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
....... .......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+....+.
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~---------- 225 (303)
T cd05110 159 LEGDEKE-YNADGGKMPIKWMALECIHY--RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE---------- 225 (303)
T ss_pred ccCcccc-cccCCCccccccCCHHHhcc--CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----------
Confidence 5332211 11223345678999999876 678999999999999999997 899997765332222111
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
..... ...+..+..+.+++.+||..||++||+++++++.
T Consensus 226 -----------------~~~~~---~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 226 -----------------KGERL---PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred -----------------CCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01111 1123456789999999999999999999999774
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=328.95 Aligned_cols=258 Identities=24% Similarity=0.400 Sum_probs=224.2
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
.+..+++..||-|+||.|=++.-......+|+|++++.. -.......+..|-.||..++.|.||++|..| ++.+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~k 493 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSK 493 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccch
Confidence 456788899999999999988766665569999987642 2334556788999999999999999999988 7889
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
++|++||-|= |+|+..+..++.|.+..+++++.-+++|+.|||++|||+|||||+|++++.+|-+||.|||+|+.....
T Consensus 494 yvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999986 699999999999999999999999999999999999999999999999999999999999999987655
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
..+ .++|||+.|.|||++.+ ...+.++|.||||+++||||+|.+||.+-+.+..++.|.+.+..
T Consensus 574 ~KT----wTFcGTpEYVAPEIILn--KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~---------- 637 (732)
T KOG0614|consen 574 RKT----WTFCGTPEYVAPEIILN--KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK---------- 637 (732)
T ss_pred Cce----eeecCCcccccchhhhc--cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh----------
Confidence 433 56899999999999987 68899999999999999999999999999998888887542211
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccC
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 314 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~eiL~hp~f~~~ 314 (614)
. .....++..+.+||+++-..+|.+|.. +.+|-+|.||.++
T Consensus 638 ----------------i---~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 638 ----------------I---EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred ----------------h---hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 0 111246778999999999999999985 8999999999875
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=304.94 Aligned_cols=245 Identities=27% Similarity=0.406 Sum_probs=193.5
Q ss_pred eEeeecCceEEEEEEECCCC------cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 24 EVIGKGSYGVVCSAIDTHTG------EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg------~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
+.||+|+||.||+|.++... ..+|||.+... ........+.+|+.+|+.++||||+++++++. +....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 74 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG-ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQ 74 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc-cchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCe
Confidence 36999999999999876543 68999988643 22234567889999999999999999999883 44568
Q ss_pred EEEEecCC-CcHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC-----cEEEee
Q 007177 98 YVVFELME-SDLHQVIKAN-------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-----KLKICD 164 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~~-------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~-----~vKL~D 164 (614)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+++|+||||+|||++.++ .+||+|
T Consensus 75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence 99999998 6999998642 3478899999999999999999999999999999999999887 899999
Q ss_pred cCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhC
Q 007177 165 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLG 243 (614)
Q Consensus 165 FGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g 243 (614)
||+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+..
T Consensus 155 fg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~--- 228 (269)
T cd05044 155 FGLARDIYKSDYYR-KEGEGLLPVRWMAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA--- 228 (269)
T ss_pred cccccccccccccc-cCcccCCCccccCHHHHcc--CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc---
Confidence 99997653322111 1122345678999999876 678999999999999999998 9999987665443332210
Q ss_pred CCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 244 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 244 ~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.... .....++..+.+||.+||..+|.+||+++++++
T Consensus 229 ------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 229 ------------------------GGRL---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ------------------------CCcc---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0000 122356788999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=328.14 Aligned_cols=257 Identities=23% Similarity=0.310 Sum_probs=203.7
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
...+...+.+.||+|+||+||+|.+- -.||||+++-........+.|.+|+..|++-+|.||+-+.+++..+.
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~---- 461 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP---- 461 (678)
T ss_pred cCHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc----
Confidence 34467789999999999999999653 36999999877677778899999999999999999999999885432
Q ss_pred CcEEEEEecCCC-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 95 KDIYVVFELMES-DLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 95 ~~~ylV~E~~~g-~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
+.||+.+|+| +|+.+|.. ...|.......|+.||++|+.|||.++|||||||..|||+.++++|||+||||+....
T Consensus 462 --~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 462 --LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred --eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 4999999997 89888864 3468888999999999999999999999999999999999999999999999997532
Q ss_pred CCCCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~-~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
-- .....+..-.|...|||||++... ..+|++.+|||||||++|||++|..||.. +..+|+--+ .|+
T Consensus 540 ~w-~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqIifm---VGr------- 607 (678)
T KOG0193|consen 540 RW-SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQIIFM---VGR------- 607 (678)
T ss_pred ee-ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhheEEE---ecc-------
Confidence 11 111112334577889999998532 25799999999999999999999999984 333333111 111
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
............+.+.++++|+..||.+++++||.+.+||.
T Consensus 608 ---------------G~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 608 ---------------GYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ---------------cccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 00011122223456679999999999999999999999987
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=307.46 Aligned_cols=237 Identities=20% Similarity=0.259 Sum_probs=184.0
Q ss_pred EeeecCceEEEEEEECCC------------------------CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcc
Q 007177 25 VIGKGSYGVVCSAIDTHT------------------------GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 80 (614)
Q Consensus 25 ~LG~G~~G~V~~a~d~~t------------------------g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv 80 (614)
.||+|+||.||+|....+ ...|++|++... .......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 589999999999974321 235889988642 233455678899999999999999
Q ss_pred eeeeEecCCCCCCCCcEEEEEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC
Q 007177 81 EIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC 158 (614)
Q Consensus 81 ~l~~v~~~~~~~~~~~~ylV~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~ 158 (614)
++++++. +....|+|||||+ ++|..++.. .+.+++..+..++.||+.||.|||+.||+||||||+|||++.++
T Consensus 80 ~~~~~~~-----~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 80 FVHGVCV-----RGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred eEEEEEE-----eCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence 9999984 3456899999999 588888865 45789999999999999999999999999999999999997643
Q ss_pred -------cEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHH-hCCCCCCCCC
Q 007177 159 -------KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL-TGKPLFPGKN 230 (614)
Q Consensus 159 -------~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLl-tG~~pF~g~~ 230 (614)
.+||+|||++...... ....++..|+|||.+.+. ..++.++|||||||++|||+ +|..||.+..
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cccCccceeeecCCccccccccc-------cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 4899999988643221 223577889999988653 56899999999999999985 6999997654
Q ss_pred hhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 231 VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 231 ~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
..+....+ . .... .....++.+.+||.+||+.||++|||+.++|++
T Consensus 227 ~~~~~~~~------------------------~---~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 227 PSEKERFY------------------------E---KKHR-----LPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred hHHHHHHH------------------------H---hccC-----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 32221110 0 0000 011245689999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=318.29 Aligned_cols=270 Identities=27% Similarity=0.419 Sum_probs=213.9
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-----ChHHHHHHHHHHHHHHhcCCCCcceeeeEecC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-----HISDAARILREIKLLRLLRHPDIVEIKHIMLP 88 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-----~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~ 88 (614)
-...+||-++..||+|+|+.||+|.|....+.||+|+-.-... +....+...+|..|.+.|.||.||++|++|..
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 4567899999999999999999999999999999997542211 12223456799999999999999999999843
Q ss_pred CCCCCCCcEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeecCCCCcEEEC---CCCcEEE
Q 007177 89 PSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILAN---ANCKLKI 162 (614)
Q Consensus 89 ~~~~~~~~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILi~---~~~~vKL 162 (614)
+...+|-|+|||+| ||.-+++.+..++|.+++.|+.||+.||.||.... |||-||||.|||+. .-|.+||
T Consensus 539 ----DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 539 ----DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred ----ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEe
Confidence 34568999999997 89999999999999999999999999999999875 99999999999984 3478999
Q ss_pred eecCccccccCCCCCc----cccccccCCccccCcccccc--cCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHH
Q 007177 163 CDFGLARVAFNDTPTT----IFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 236 (614)
Q Consensus 163 ~DFGla~~~~~~~~~~----~~~~~~vgt~~Y~APEvl~~--~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~ 236 (614)
.||||++...++.... .......||.||++||.+.- ...+.+.++||||+|||||.++.|+.||...-....
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd-- 692 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD-- 692 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--
Confidence 9999999876654432 12234689999999997632 134678899999999999999999999955432111
Q ss_pred HHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 007177 237 LMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312 (614)
Q Consensus 237 ~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~ 312 (614)
|.. +- .+.+.....|.. -|-+++++++||++||++--++|..+.++-.||||.
T Consensus 693 -ILq--------------------eN-TIlkAtEVqFP~-KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 693 -ILQ--------------------EN-TILKATEVQFPP-KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred -HHh--------------------hh-chhcceeccCCC-CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 100 00 011112222222 256899999999999999999999999999999996
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=301.32 Aligned_cols=236 Identities=19% Similarity=0.273 Sum_probs=186.9
Q ss_pred eEeeecCceEEEEEEECCCC----------cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 24 EVIGKGSYGVVCSAIDTHTG----------EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg----------~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
+.||+|+||.||+|.+..++ ..+++|.+.... .....+.+|+.+|+.++||||+++++.+..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR----- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-----
Confidence 46999999999999998777 357888765421 125778899999999999999999998743
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC-------cEEEee
Q 007177 94 FKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-------KLKICD 164 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~-------~vKL~D 164 (614)
...|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|
T Consensus 73 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 73 -DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 44699999999 69999998765 799999999999999999999999999999999999999887 799999
Q ss_pred cCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhC
Q 007177 165 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLG 243 (614)
Q Consensus 165 FGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g 243 (614)
||++...... ....++..|+|||++.+....++.++|||||||++|+|++ |..||...+..+......
T Consensus 152 fg~a~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---- 220 (259)
T cd05037 152 PGIPITVLSR-------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---- 220 (259)
T ss_pred CCcccccccc-------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh----
Confidence 9999765331 2235667899999987622368899999999999999999 577776654221111110
Q ss_pred CCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 244 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 244 ~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
..... .......+.+||.+||..||.+|||+.++|+
T Consensus 221 -----------------------~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 221 -----------------------DQHRL-----PMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -----------------------cCCCC-----CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00000 0112268899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=303.79 Aligned_cols=269 Identities=24% Similarity=0.395 Sum_probs=201.8
Q ss_pred CCeEEEeEeeecCceEEEEEEEC----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDT----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
..|++.+.||+|+||.||+|... .+++.||||++...... .....+.+|+++++.++||||+++++++... +
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---~ 79 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKP---G 79 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecC---C
Confidence 46889999999999999999854 34789999999754332 3566788999999999999999999987432 2
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
....|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+.||+|+||||+||+++.++.+||+|||++...
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 456899999998 59999997654 6999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
..............++..|++||.+.+ ..++.++|||||||++++|++|..||....... ....+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~~~~---- 228 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRT--SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMIGIAQG---- 228 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHcc--CCCCcccchHHHhhhhheeeccCCCcccccchh-----ccccccccc----
Confidence 432221111122345567999998876 578899999999999999999999886543211 011111000
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
..........+....... .....+..+.+|+.+||..||.+|||+.|+++
T Consensus 229 ---~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 229 ---QMIVTRLLELLKEGERLP---RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred ---cccHHHHHHHHHcCCcCC---CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000111111111111111 12345678999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=330.17 Aligned_cols=264 Identities=25% Similarity=0.420 Sum_probs=218.8
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~ 93 (614)
+..+.|+|.++||.|.||.||++.++.++...|+|+....... -..+..|+++|+.+. |||++.++++|.-.....
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~---deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE---EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc---cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 3456799999999999999999999999999999988754332 345677999999885 999999999997666667
Q ss_pred CCcEEEEEecCC-CcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
.+.++||||||. |+..++++. ...+.|+.+.+|++.+|.||.+||.+.++|||||-.|||++.++.|||+|||++..
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 788999999999 688888865 45799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~---~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~ 247 (614)
.... .....+.+||++|||||+|... ...|+..+|+||||++..||--|.||+...-.+..+-.|
T Consensus 173 ldsT---~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I--------- 240 (953)
T KOG0587|consen 173 LDST---VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--------- 240 (953)
T ss_pred eecc---cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---------
Confidence 6432 2233567999999999998643 235788999999999999999999999665433222211
Q ss_pred hhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 007177 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312 (614)
Q Consensus 248 ~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~ 312 (614)
.+.|.+-...+..++..+.+||..||.+|..+||+..++|.|||++
T Consensus 241 -------------------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 241 -------------------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred -------------------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 1222222334556788999999999999999999999999999997
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=298.94 Aligned_cols=250 Identities=20% Similarity=0.301 Sum_probs=187.2
Q ss_pred eEeeecCceEEEEEEECCC--CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEE
Q 007177 24 EVIGKGSYGVVCSAIDTHT--GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~t--g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~ 101 (614)
+.||+|+||.||++....+ ...+++|.+... ........+.+|+.+++.++||||+++++.+. +....|+||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~ 74 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVF 74 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEE
Confidence 3699999999999975433 335677776542 22345667899999999999999999999884 445689999
Q ss_pred ecCC-CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 102 ELME-SDLHQVIKAN----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 102 E~~~-g~L~~~i~~~----~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
|||+ ++|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++........
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh
Confidence 9999 6999998753 2466778889999999999999999999999999999999999999999999864321111
Q ss_pred CccccccccCCccccCccccccc-----CCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 177 TTIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~-----~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
........++..|+|||++... ...++.++|||||||++|||++ |.+||...+..+.+..+..
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~---------- 223 (268)
T cd05086 155 -IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK---------- 223 (268)
T ss_pred -hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh----------
Confidence 0111235678899999987531 1245789999999999999997 5778877665444433211
Q ss_pred hhhhchhHHHHHHhhcccCCCcc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
......+ ......+++.+.+|+..|| .||.+||+++++++
T Consensus 224 ----------------~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 224 ----------------DQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ----------------hcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0000001 1112346788999999999 68999999999965
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=299.85 Aligned_cols=250 Identities=26% Similarity=0.448 Sum_probs=199.7
Q ss_pred CeEEEeEeeecCceEEEEEEECC-CCcEEEEEEecCcc--------CChHHHHHHHHHHHHHHh-cCCCCcceeeeEecC
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTH-TGEKVAIKKIHDIF--------EHISDAARILREIKLLRL-LRHPDIVEIKHIMLP 88 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~-tg~~vAIK~i~~~~--------~~~~~~~~i~~Ei~iL~~-L~HpnIv~l~~v~~~ 88 (614)
.|++.+.||+|+||.||++.+.. +++.+|+|.+.... .......++.+|+.++.. ++||||+++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-- 78 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF-- 78 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence 38899999999999999999987 67899999885321 223345667789998865 7999999999998
Q ss_pred CCCCCCCcEEEEEecCCC-cHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeecCCCCcEEECCCCcEEE
Q 007177 89 PSRRDFKDIYVVFELMES-DLHQVIK----ANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKI 162 (614)
Q Consensus 89 ~~~~~~~~~ylV~E~~~g-~L~~~i~----~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL 162 (614)
.+....|+||||+++ +|.+++. ....+++..++.++.||+.||.|||+ .||+|+||+|+|||++.++.+||
T Consensus 79 ---~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l 155 (269)
T cd08528 79 ---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI 155 (269)
T ss_pred ---ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEE
Confidence 445679999999984 8877763 24469999999999999999999996 78999999999999999999999
Q ss_pred eecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhh
Q 007177 163 CDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242 (614)
Q Consensus 163 ~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~ 242 (614)
+|||++....... ......++..|++||.+.+ ..++.++|+|||||++|+|++|.+||...+.......+....
T Consensus 156 ~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~ 229 (269)
T cd08528 156 TDFGLAKQKQPES----KLTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229 (269)
T ss_pred ecccceeeccccc----ccccccCcccCcChhhhcC--CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhcc
Confidence 9999997654332 2244578889999999876 568999999999999999999999997665433332221100
Q ss_pred CCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 243 g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
..+. .....++.+.+||.+||..||.+||++.|+.++
T Consensus 230 ---------------------------~~~~--~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 230 ---------------------------YEPL--PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ---------------------------CCcC--CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 0000 112457899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=332.04 Aligned_cols=248 Identities=27% Similarity=0.429 Sum_probs=206.7
Q ss_pred CeEEEeEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~-----tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
.-++.+.||+|+||+||+|.-.. ....||||.+++. ......+.|.||+.+|..|+|||||++++++ .+
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC-----~~ 560 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVC-----RE 560 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----cc
Confidence 45678999999999999996533 3346999999864 3333567899999999999999999999999 55
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCC----------C----CCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC
Q 007177 94 FKDIYVVFELME-SDLHQVIKAND----------D----LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC 158 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~----------~----lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~ 158 (614)
.+-+|+|||||. |||++++..+. + |+..+...|+.||+.|+.||-++.+|||||-..|+||.++-
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 667999999999 89999997532 3 88999999999999999999999999999999999999999
Q ss_pred cEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 007177 159 KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDL 237 (614)
Q Consensus 159 ~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~ 237 (614)
.|||+|||+++...+.+.-.....+ .-...||+||-|.- ++|+.++||||+||+|||+++ |.-||.|.++.+.++.
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t-~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~ 717 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNT-LLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC 717 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCc-eeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence 9999999999986554432211111 22346999998875 799999999999999999998 8999999999888877
Q ss_pred HHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 007177 238 MTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 305 (614)
Q Consensus 238 i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~ei 305 (614)
|.. ... -+...+.+.++.+|+..||+.+|++||++.||
T Consensus 718 i~~---------------------------g~l---L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 718 IRA---------------------------GQL---LSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred HHc---------------------------CCc---ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 643 111 12234688899999999999999999999998
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=297.76 Aligned_cols=259 Identities=25% Similarity=0.417 Sum_probs=208.3
Q ss_pred EEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHH-hcCCCCcceeeeEecCCCCCCCCcEEEE
Q 007177 22 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLR-LLRHPDIVEIKHIMLPPSRRDFKDIYVV 100 (614)
Q Consensus 22 i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~-~L~HpnIv~l~~v~~~~~~~~~~~~ylV 100 (614)
-+..||.|+||+|++-.++.+|+..|||.|..... ..+.++++.|+.... .-++||||++|++.+ .+++.+|.
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F-----~EGdcWiC 141 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALF-----SEGDCWIC 141 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh-----cCCceeee
Confidence 35689999999999999999999999999986533 456778889997654 456999999999983 45779999
Q ss_pred EecCCCcHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 101 FELMESDLHQVIK-----ANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 101 ~E~~~g~L~~~i~-----~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
||+|+-+|..+.+ ....++|..+-.|.--.+.||.||.. .+|||||+||+|||++..|.|||||||.+-.+.+.
T Consensus 142 MELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 142 MELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred HHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 9999976655543 34579999999999999999999975 58999999999999999999999999999765433
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-hhHHHHHHHhhhCCCchhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN-VVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~-~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
.. -+--.|-+.|||||.+......|+-++|+||||+.|||+.||..|+.+.+ ..+|+..+. .|.|+.
T Consensus 222 iA----kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv--~gdpp~------ 289 (361)
T KOG1006|consen 222 IA----KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV--IGDPPI------ 289 (361)
T ss_pred HH----hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH--cCCCCe------
Confidence 22 23347899999999997654569999999999999999999999997765 334444332 222211
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
..++...-+.+..+..+|.-||.+|-.+||...+++++||++...
T Consensus 290 -----------------l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 290 -----------------LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred -----------------ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 111222235788999999999999999999999999999998654
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=310.31 Aligned_cols=260 Identities=26% Similarity=0.436 Sum_probs=193.1
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC-c
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK-D 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~-~ 96 (614)
+.|.-...||+|+||.||+|.-. +|..||||++....... ...+.+|+.+|..++|||+|+++++|. +.+ .
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~-----e~~~~ 146 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCL-----EGGEH 146 (361)
T ss_pred hCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEe-----cCCce
Confidence 45666689999999999999764 44899999887543221 445999999999999999999999994 334 5
Q ss_pred EEEEEecCC-CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 97 IYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTAN---VYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~g---IvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
.+||+|||. |+|.+.+.... .|+|.....|+.++++||+|||... |||||||++|||+|.+...||+|||+|+.
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~ 226 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL 226 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc
Confidence 899999999 79999997655 8999999999999999999999865 99999999999999999999999999965
Q ss_pred ccCCCCCccccccc-cCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC---hhHHHHHHHhhhCCCc
Q 007177 171 AFNDTPTTIFWTDY-VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN---VVHQLDLMTDLLGTPS 246 (614)
Q Consensus 171 ~~~~~~~~~~~~~~-vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~---~~~~l~~i~~~~g~p~ 246 (614)
.... ... .... .||..|++||.+.. ...+.++||||||++|.||++|+.+..... ..........
T Consensus 227 ~~~~-~~~--~~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~------ 295 (361)
T KOG1187|consen 227 GPEG-DTS--VSTTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP------ 295 (361)
T ss_pred CCcc-ccc--eeeecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH------
Confidence 4331 111 1112 79999999999876 678999999999999999999998876532 1111111111
Q ss_pred hhhhhhhhchhHHHHHHhhcccCCCcccCCCC--CCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFP--NADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 247 ~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~--~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.+......++++..... ..++ ..-..+..+..+|++.+|++||+..|+++
T Consensus 296 -----~~~~~~~~eiiD~~l~~------~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 296 -----LLEEGKLREIVDPRLKE------GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred -----HHHCcchhheeCCCccC------CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 11111111111100000 0011 01123567888999999999999999754
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=324.46 Aligned_cols=208 Identities=31% Similarity=0.479 Sum_probs=176.0
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRD 93 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~-~~~ 93 (614)
+...-+...+.||+|+||.||+++++.+|+.||||.++... ......+..+|+++|++|+|||||+++++=.+.. .-.
T Consensus 10 ~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 10 GENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred CCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence 45567888999999999999999999999999999998643 4566778889999999999999999998743221 001
Q ss_pred CCcEEEEEecCC-CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEEC--CCC--cEEEeec
Q 007177 94 FKDIYVVFELME-SDLHQVIKAN---DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN--ANC--KLKICDF 165 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~---~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~--~~~--~vKL~DF 165 (614)
...-.+|||||. |+|...+.+. ..|++.++..++..+..||.|||++||+||||||.||++- .+| .-|||||
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 234589999999 6999999753 3699999999999999999999999999999999999963 334 4699999
Q ss_pred CccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 007177 166 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 228 (614)
Q Consensus 166 Gla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g 228 (614)
|.|+...++. .++..+||+.|++||+.... ..|+..+|.|||||++|++.||..||-.
T Consensus 169 G~Arel~d~s----~~~S~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 169 GAARELDDNS----LFTSLVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred cccccCCCCC----eeeeecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 9999875544 45778999999999998742 6899999999999999999999999944
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=297.22 Aligned_cols=265 Identities=23% Similarity=0.417 Sum_probs=213.8
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~ 94 (614)
...|.++++||+|+|..|.++..++|.+-||+|++++. +....+..=+..|-.+..+- +||.+|.+...| +.+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf-----qte 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF-----QTE 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-----ccc
Confidence 36799999999999999999999999999999999865 33444555566777777766 599999999988 566
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
..+++|.||++ |+|.-.++....|++++++++...|+.||.|||+.||+.||||.+|+|++..|++||.|+|.++....
T Consensus 324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 67999999999 59988888888999999999999999999999999999999999999999999999999999987555
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
+..++ .+++|||.|.|||++.+ ..|+..+|+|+||++++||+.|+.||.- .|....
T Consensus 404 ~gd~t---stfcgtpnyiapeilrg--eeygfsvdwwalgvlmfemmagrspfdi-------------vgm~n~------ 459 (593)
T KOG0695|consen 404 PGDTT---STFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDI-------------VGMDNP------ 459 (593)
T ss_pred CCccc---ccccCCCcccchhhhcc--cccCceehHHHHHHHHHHHHcCCCCcce-------------ecCCCc------
Confidence 44433 57899999999999998 7999999999999999999999999931 111100
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC------CHHHHHcCcccccC
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP------TAEEALADPYFKGL 314 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp------sa~eiL~hp~f~~~ 314 (614)
...-+.|+-.+...+.+.+ ...+|-.+..+|+..|.+||++|. ...++-.|+||+.+
T Consensus 460 -d~ntedylfqvilekqiri---prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 460 -DMNTEDYLFQVILEKQIRI---PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred -ccchhHHHHHHHhhhcccc---cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 0111222222211111111 124566778899999999999996 56899999999855
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=314.88 Aligned_cols=251 Identities=23% Similarity=0.359 Sum_probs=202.5
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCc---E-EEEEEecC-ccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGE---K-VAIKKIHD-IFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~---~-vAIK~i~~-~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
++-.+.+.||+|+||.||+|.-+..+. . ||||..+. ..........+++|.++|++|+|||||++|++..
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~----- 231 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV----- 231 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc-----
Confidence 344566899999999999997765432 3 89998875 3355667888999999999999999999999984
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
...-+|||||+|. |+|.++++.++ .++..+...++++.+.||.|||+++++||||-..|+|++.++.+||+|||+++.
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 4455999999999 59999999887 499999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
........ ...-....|+|||.+.. ..|+.++||||+||++||+++ |..||++....+....|..-
T Consensus 312 ~~~~~~~~---~~~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~-------- 378 (474)
T KOG0194|consen 312 GSQYVMKK---FLKKLPIRWLAPETLNT--GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN-------- 378 (474)
T ss_pred Ccceeecc---ccccCcceecChhhhcc--CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc--------
Confidence 42111000 01123456999999987 589999999999999999999 88899999877665555210
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.-+.. .....+.++..++.+|+..||++|||+.++.+
T Consensus 379 ------------------~~r~~---~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 379 ------------------GYRMP---IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ------------------CccCC---CCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 00011 11245667889999999999999999999855
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=282.11 Aligned_cols=242 Identities=40% Similarity=0.650 Sum_probs=197.9
Q ss_pred CceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecCCC-cH
Q 007177 30 SYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DL 108 (614)
Q Consensus 30 ~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~g-~L 108 (614)
+||.||+|.+..+|+.+++|++........ ...+.+|+..++.++|+||+++++.+. .....++++|++++ +|
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFE-----DEDKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhhee-----eCCEEEEEEeCCCCCCH
Confidence 589999999998999999999875322211 577889999999999999999999884 33678999999996 99
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCc
Q 007177 109 HQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 188 (614)
Q Consensus 109 ~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~ 188 (614)
.+++.....+++..+..++.+++.+|.|||+.||+|+||+|+||+++.++.++|+|||++....... ......++.
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~ 150 (244)
T smart00220 75 FDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTP 150 (244)
T ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCc
Confidence 9999877679999999999999999999999999999999999999999999999999998764432 123456888
Q ss_pred cccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHH-HHHHHhhhCCCchhhhhhhhchhHHHHHHhhcc
Q 007177 189 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ-LDLMTDLLGTPSLDTISRVRNDKARRYLTSMRK 267 (614)
Q Consensus 189 ~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~-l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~ 267 (614)
.|++||.+.+ ..++.++|+||||+++++|++|..||......+. +..+.
T Consensus 151 ~~~~pE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~---------------------------- 200 (244)
T smart00220 151 EYMAPEVLLG--KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG---------------------------- 200 (244)
T ss_pred CCCCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh----------------------------
Confidence 9999999875 5788899999999999999999999977332222 11110
Q ss_pred cCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 268 KQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 268 ~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
............++..+.+++.+||..||++||++.++++||||
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 201 KPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 11111111112267899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=329.68 Aligned_cols=252 Identities=23% Similarity=0.397 Sum_probs=206.7
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCC-C----cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHT-G----EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~t-g----~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
...-.+.+.||+|+||.||.|.-... | ..||||.+.+. .+..+...|++|..+|+.++|||||+++++++.
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~--- 766 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD--- 766 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC---
Confidence 34567899999999999999975542 2 24999999864 456778899999999999999999999999965
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEe
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKAN-------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 163 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~-------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~ 163 (614)
....+|++|||+ |||..+|++. ..|+..+...|+.||++|++||+++++|||||-..|+|++....+||+
T Consensus 767 --~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 767 --SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred --CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEc
Confidence 345799999999 6999999875 369999999999999999999999999999999999999999999999
Q ss_pred ecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhh
Q 007177 164 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLL 242 (614)
Q Consensus 164 DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~ 242 (614)
|||+|+............. -.-...|||||.+.. ..++.++|||||||+|||+++ |..||++.+..+.+.......
T Consensus 845 DFGlArDiy~~~yyr~~~~-a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg 921 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGE-AMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG 921 (1025)
T ss_pred ccchhHhhhhchheeccCc-cccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC
Confidence 9999995443332221111 112236999999987 689999999999999999999 899999998876655332210
Q ss_pred CCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 243 g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
. -...+.++..+.+|+..||+.+|++||++..|++
T Consensus 922 ---------------------------R---L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 ---------------------------R---LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ---------------------------c---cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 0 1122457778899999999999999999999987
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=310.24 Aligned_cols=278 Identities=18% Similarity=0.262 Sum_probs=189.1
Q ss_pred CCCCeEEEeEeeecCceEEEEEEEC----------------CCCcEEEEEEecCccCChH------------HHHHHHHH
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDT----------------HTGEKVAIKKIHDIFEHIS------------DAARILRE 67 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~----------------~tg~~vAIK~i~~~~~~~~------------~~~~i~~E 67 (614)
..++|++.++||+|+||+||+|.+. ..++.||||++........ .......|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3568999999999999999999752 3456799999864211100 01123357
Q ss_pred HHHHHhcCCCCc-----ceeeeEecCCC---CCCCCcEEEEEecCC-CcHHHHHHhC-----------------------
Q 007177 68 IKLLRLLRHPDI-----VEIKHIMLPPS---RRDFKDIYVVFELME-SDLHQVIKAN----------------------- 115 (614)
Q Consensus 68 i~iL~~L~HpnI-----v~l~~v~~~~~---~~~~~~~ylV~E~~~-g~L~~~i~~~----------------------- 115 (614)
+.++..++|.++ +++++++.... ..+....||||||++ ++|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776554 55666553321 112356899999999 5888887532
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcc
Q 007177 116 -DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 194 (614)
Q Consensus 116 -~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE 194 (614)
..+++..++.|+.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++......... .....+|+.|+|||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~g~~tp~Y~aPE 380 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN--PLYGMLDPRYSPPE 380 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC--ccccCCCcceeChh
Confidence 124567788999999999999999999999999999999999999999999997543221111 11224578999999
Q ss_pred cccccCC------------------CCC--CcccchhHHHHHHHHHhCCC-CCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 195 LCGSFFS------------------KYT--PAIDIWSIGCIFAEVLTGKP-LFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 195 vl~~~~~------------------~y~--~~~DIWSLG~Il~eLltG~~-pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
++..... .|+ .+.||||+|||+|+|++|.. ||.+....+... ...
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~--------------~~~ 446 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTEL--------------RQY 446 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHH--------------hhc
Confidence 8753110 122 34799999999999999874 775432211100 000
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCC---CCCCCHHHHHcCccccc
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDP---KDRPTAEEALADPYFKG 313 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP---~~Rpsa~eiL~hp~f~~ 313 (614)
.++ ... +... ......+. .+...++.++||+.+||..+| .+|+|++|+|+||||..
T Consensus 447 ~~~-~~~-~r~~-~~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 447 DND-LNR-WRMY-KGQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cch-HHH-HHhh-cccCCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 000 000 1111 11222332 466789999999999999876 68999999999999963
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=317.32 Aligned_cols=246 Identities=31% Similarity=0.453 Sum_probs=191.5
Q ss_pred EeEeeecCce-EEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCcEEEE
Q 007177 23 QEVIGKGSYG-VVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDIYVV 100 (614)
Q Consensus 23 ~~~LG~G~~G-~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~~ylV 100 (614)
.+++|.|+-| .||+|. -.|+.||||.+-. .-.....+||.+|+.-+ |||||+++..- .+...+||.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIa 581 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGV--YEGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIA 581 (903)
T ss_pred HHHcccCCCCcEEEEEe--eCCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEE
Confidence 4688999887 568995 4688999998753 33446679999999885 99999998875 666789999
Q ss_pred EecCCCcHHHHHHhC-CC---CCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC---CC--cEEEeecCccccc
Q 007177 101 FELMESDLHQVIKAN-DD---LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---NC--KLKICDFGLARVA 171 (614)
Q Consensus 101 ~E~~~g~L~~~i~~~-~~---lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~---~~--~vKL~DFGla~~~ 171 (614)
.|+|..+|.+++... .. ........++.|++.||++||+.+||||||||+||||+. ++ .++|+|||+++..
T Consensus 582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999999999999874 11 122455789999999999999999999999999999976 34 6899999999987
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhC-CCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG-~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
..+...-....+..||..|+|||++.+ ..-+.++|||||||++|+.++| ..||...- ..+ ..|..
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~--~~~~~avDiFslGCvfyYvltgG~HpFGd~~-~R~-~NIl~---------- 727 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLRE--DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL-ERQ-ANILT---------- 727 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhc--cccCcccchhhcCceEEEEecCCccCCCchH-Hhh-hhhhc----------
Confidence 666554444566789999999999987 4556799999999999999996 88994432 111 11110
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~ 312 (614)
....+...-+..+.++.|||.+||.+||..||+|.++|.||+|=
T Consensus 728 ------------------~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 728 ------------------GNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred ------------------CccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 01111122222233899999999999999999999999999994
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=311.40 Aligned_cols=261 Identities=27% Similarity=0.413 Sum_probs=223.0
Q ss_pred ccccccCCCCCCeEEEeEeeecCceEEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeee
Q 007177 8 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKH 84 (614)
Q Consensus 8 ~~~~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~---~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~ 84 (614)
..+|+...+++...|.++||.|.||.||+++.+..|+ .||||.++.- ........|+.|..||-+++||||++|.+
T Consensus 619 vreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEG 697 (996)
T KOG0196|consen 619 VREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEG 697 (996)
T ss_pred HHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEE
Confidence 4567777888999999999999999999999887775 6999999853 44556778999999999999999999999
Q ss_pred EecCCCCCCCCcEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEE
Q 007177 85 IMLPPSRRDFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKI 162 (614)
Q Consensus 85 v~~~~~~~~~~~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL 162 (614)
+. ...+-+.||+|||+ |.|..+++.+ +.|+..++..+++.|+.|++||-+.|.|||||-..|||++.+-.+|+
T Consensus 698 VV-----Tks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKV 772 (996)
T KOG0196|consen 698 VV-----TKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKV 772 (996)
T ss_pred EE-----ecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEe
Confidence 98 34466899999999 8999999875 47999999999999999999999999999999999999999999999
Q ss_pred eecCccccccCCCCCccccccccC--CccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 007177 163 CDFGLARVAFNDTPTTIFWTDYVA--TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMT 239 (614)
Q Consensus 163 ~DFGla~~~~~~~~~~~~~~~~vg--t~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~ 239 (614)
+||||+|...++.+... ++.-| ...|.|||.+.- ++++.++|+||+|+++||.++ |..||...++.+.+..|.
T Consensus 773 sDFGLSRvledd~~~~y--tt~GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe 848 (996)
T KOG0196|consen 773 SDFGLSRVLEDDPEAAY--TTLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE 848 (996)
T ss_pred ccccceeecccCCCccc--cccCCccceeecChhHhhh--cccCchhhccccceEEEEecccCCCcccccchHHHHHHHH
Confidence 99999997765553321 22222 246899999875 789999999999999999876 999999999988888886
Q ss_pred hhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 240 DLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 240 ~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
+-...|.. .+++..+..|+..||++|-.+||.+.||+++
T Consensus 849 ~gyRLPpP------------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 849 QGYRLPPP------------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred hccCCCCC------------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 65554432 4677889999999999999999999999874
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=291.43 Aligned_cols=285 Identities=28% Similarity=0.449 Sum_probs=213.7
Q ss_pred CCCeEEEeEeeecCceEEEEEEECC---CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~---tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~ 92 (614)
...|.++++||.|.|++||++.+.. ..+.||+|.+... +...++.+|+++|..+. +.||+++.+.+ +
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~-----r 105 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCF-----R 105 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhh-----c
Confidence 3568899999999999999999887 7889999998743 44567999999999995 99999999988 6
Q ss_pred CCCcEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC-CcEEEeecCcccc
Q 007177 93 DFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARV 170 (614)
Q Consensus 93 ~~~~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~-~~vKL~DFGla~~ 170 (614)
..+...+|+||++. +..+++. .++..+++.+++.++.||.++|.+|||||||||+|+|.+.. ++-.|+|||||..
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred cCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 77789999999995 5555554 37789999999999999999999999999999999999764 5689999999962
Q ss_pred ccCC--------------CC-----------------Cc----------cccccccCCccccCcccccccCCCCCCcccc
Q 007177 171 AFND--------------TP-----------------TT----------IFWTDYVATRWYRAPELCGSFFSKYTPAIDI 209 (614)
Q Consensus 171 ~~~~--------------~~-----------------~~----------~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DI 209 (614)
.... .. .. ...-...||+.|+|||++... ..-+.++||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiDi 261 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAIDI 261 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCccce
Confidence 1000 00 00 001124799999999998764 677889999
Q ss_pred hhHHHHHHHHHhCCCCC-CCCChhHHHHHHHhhhCCCchhhhhhhhch----------hHHHH---H-----HhhcccCC
Q 007177 210 WSIGCIFAEVLTGKPLF-PGKNVVHQLDLMTDLLGTPSLDTISRVRND----------KARRY---L-----TSMRKKQP 270 (614)
Q Consensus 210 WSLG~Il~eLltG~~pF-~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~----------~~~~~---l-----~~~~~~~~ 270 (614)
||.|+|+..++++..|| ...++.+.+..|...+|.-...-....... .+.+. + ..+.+...
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 99999999999998775 566777788888877775432221111110 11111 1 11111111
Q ss_pred -CcccCCCCC-CCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 271 -VQFSQKFPN-ADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 271 -~~~~~~~~~-~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
.-....|.+ .+..+.||+.+||..||.+|.|++++|+||||...
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 011122223 45589999999999999999999999999999854
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=294.79 Aligned_cols=257 Identities=24% Similarity=0.356 Sum_probs=203.9
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
++..+++.||+|.||.|.+|.-. .+.+||+|+++.. ........+.+||++|.+|+||||+++++++... +-+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-----ePi 610 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPD-ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-----DPL 610 (807)
T ss_pred hheehhhhhcCcccceeEEEEec-CceEEEEeecCcc-cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-----Cch
Confidence 45778999999999999999643 3689999999853 3333457899999999999999999999999543 458
Q ss_pred EEEEecCC-CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 98 YVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
++|+|||+ |||.+++.++. .+..+....|+.||+.|++||.+.++|||||-+.|+|++.++++||+|||.++.....
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999 89999998873 3455666779999999999999999999999999999999999999999999976554
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh--CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt--G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
...... ...+-...|||+|.+.. ++++.++|+|++|+.+||+++ ...||....+.+..+..-.++..+....
T Consensus 691 ~yy~vq-gr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~--- 764 (807)
T KOG1094|consen 691 DYYRVQ-GRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV--- 764 (807)
T ss_pred Cceeee-cceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce---
Confidence 432221 22455678999997765 689999999999999999765 6789987776665555444333322111
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.....+-++..+.+|+.+||..|-++||+++++-.
T Consensus 765 --------------------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 765 --------------------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred --------------------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 11122345678889999999999999999999843
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=295.70 Aligned_cols=244 Identities=27% Similarity=0.477 Sum_probs=197.0
Q ss_pred EeEeeecCceEEEEEEECC--CCc--EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 23 QEVIGKGSYGVVCSAIDTH--TGE--KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 23 ~~~LG~G~~G~V~~a~d~~--tg~--~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
.+.||.|.||.||.|+-.. .|+ .||||..+.. ....+.+.|+.|..+|+.++||||+++++++.. .-.+
T Consensus 394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d-~t~d~tekflqEa~iMrnfdHphIikLIGv~~e------~P~W 466 (974)
T KOG4257|consen 394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD-CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE------QPMW 466 (974)
T ss_pred HHhhcCCcccceeeeEecccccCcceeeeeehhccC-CChhhHHHHHHHHHHHHhCCCcchhheeeeeec------ccee
Confidence 4689999999999997432 233 5899987753 334557889999999999999999999999843 4479
Q ss_pred EEEecCC-CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 99 VVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 99 lV~E~~~-g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
||||++. |.|..+++.+. .|+......+++||+.||.|||+.++|||||-..|||+.+...|||+||||++....+..
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence 9999999 89999998754 689999999999999999999999999999999999999999999999999998755443
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
... +...-..-|||||-+.- +.++.++|+|.||+++||++. |..||.|-.+.+.+..|.+
T Consensus 547 Yka--S~~kLPIKWmaPESINf--RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn--------------- 607 (974)
T KOG4257|consen 547 YKA--SRGKLPIKWMAPESINF--RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN--------------- 607 (974)
T ss_pred hhc--cccccceeecCccccch--hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC---------------
Confidence 221 11122345999998863 789999999999999999886 9999988765544433311
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
... ....+++++.+..|+.+||++||.+||++.++..
T Consensus 608 ------------GeR---lP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 608 ------------GER---LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred ------------CCC---CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 111 1234688999999999999999999999988743
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=299.41 Aligned_cols=255 Identities=25% Similarity=0.391 Sum_probs=208.4
Q ss_pred CCeEEEeEeeecCceEEEEEEECCC-Cc--EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHT-GE--KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~t-g~--~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
++.++.+.||+|.||+||+|.++.- |+ .||||.++...... ....|++|+.+|..|+|||+++||++++.
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~------ 182 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD------ 182 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc------
Confidence 3455678999999999999987753 33 59999998654332 67789999999999999999999999964
Q ss_pred CcEEEEEecCC-CcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 95 KDIYVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
.-+.+|||++. |+|++.+.+ ...|.......|+.||+.|+.||.++++|||||-..|||+-....||||||||.+.+
T Consensus 183 qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceecc
Confidence 33689999999 799999876 346888889999999999999999999999999999999999989999999999987
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
........+....-....|+|||.+.. ..++.++|+|++||.+|||++ |+.||.|.+..+.+.+|-+.
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~--------- 331 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRH--RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG--------- 331 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhcc--ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc---------
Confidence 665543333233334456999999987 789999999999999999998 78999999987777665210
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
. .-...+.++..+.+++..||..+|.+|||+..|.+.-++
T Consensus 332 ------------------e---rLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 332 ------------------E---RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred ------------------c---cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 0 011224577889999999999999999999988654333
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=288.83 Aligned_cols=245 Identities=24% Similarity=0.442 Sum_probs=204.2
Q ss_pred eEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEE
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 99 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~yl 99 (614)
..+..+||.|.||.||.++++.-...||||.++ ++......|+.|..+|+.++|||+|+++++|. .+.-+||
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK---EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT-----~EpPFYI 340 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----HEPPFYI 340 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhh---hcchhHHHHHHHHHHHHhhcCccHHHHhhhhc-----cCCCeEE
Confidence 345679999999999999999999999999987 34567889999999999999999999999994 3445899
Q ss_pred EEecCC-CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 100 VFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 100 V~E~~~-g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
|+|||. |+|.+++.+.. .++.-...+++.||..|+.||..+++|||||-..|+|+.++..|||+||||++....+..
T Consensus 341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 999998 89999998754 477777889999999999999999999999999999999999999999999998876655
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
+.. ...-...-|.|||-+.- ..++.++|+|+||++|||+.| |..||+|-+..+.+..+.+-+
T Consensus 421 TAH--AGAKFPIKWTAPEsLAy--NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy------------- 483 (1157)
T KOG4278|consen 421 TAH--AGAKFPIKWTAPESLAY--NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY------------- 483 (1157)
T ss_pred ecc--cCccCcccccCcccccc--cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc-------------
Confidence 432 11122345899998763 678999999999999999998 889999987655554442210
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHH
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 306 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL 306 (614)
+. .....+++.+.+|++.||++.|.+||++.|+-
T Consensus 484 ----------RM-------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 484 ----------RM-------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred ----------cc-------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 00 11236788999999999999999999999983
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=292.25 Aligned_cols=200 Identities=25% Similarity=0.411 Sum_probs=175.4
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc------CChHHHHHHHHHHHHHHhcC---CCCcceeeeEecC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF------EHISDAARILREIKLLRLLR---HPDIVEIKHIMLP 88 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~------~~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~v~~~ 88 (614)
..|..++.+|.|+||.|++|+++.+...|+||.|.+.. -.......+--||.||..|+ |+||++++++|
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF-- 638 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF-- 638 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee--
Confidence 56899999999999999999999999999999997531 11122334668999999997 99999999999
Q ss_pred CCCCCCCcEEEEEecCC-C-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecC
Q 007177 89 PSRRDFKDIYVVFELME-S-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFG 166 (614)
Q Consensus 89 ~~~~~~~~~ylV~E~~~-g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFG 166 (614)
++.+++||+||--+ | ||+++|..+..++|.+++.|++|+..|+++||+.||||||||-+|+.++.+|-+||+|||
T Consensus 639 ---Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 639 ---EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred ---ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeecc
Confidence 78889999999988 5 999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 007177 167 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 228 (614)
Q Consensus 167 la~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g 228 (614)
.|....+.. ...++||..|.|||++++. ...+..-|||+||++||.++....||..
T Consensus 716 saa~~ksgp-----fd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 716 SAAYTKSGP-----FDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred chhhhcCCC-----cceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 997654332 3457999999999999983 3346789999999999999999999853
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=296.58 Aligned_cols=263 Identities=27% Similarity=0.405 Sum_probs=217.3
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
.-..+|+++..+|.|.||.||+|+|+.+++..|+|+++- ....+..-+..||-+++..+||||+.+++.|+. .
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkL--ep~dd~~~iqqei~~~~dc~h~nivay~gsylr-----~ 84 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKL--EPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR-----R 84 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeec--cCCccccccccceeeeecCCCcChHHHHhhhhh-----h
Confidence 456789999999999999999999999999999999984 334466777889999999999999999998853 3
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
..++|+||||+ |+|.+...-.++|++.++.+..+..++||+|||+.|=+|||||-.|||+++.|.+||.|||.+-.+..
T Consensus 85 dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred cCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh
Confidence 45899999999 58888888889999999999999999999999999999999999999999999999999998865432
Q ss_pred CCCCccccccccCCccccCcccc-cccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl-~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
+......++||++|||||+. .+....|...+|||++|+.-.|+-.-++|-...-.+..+..+++-...|
T Consensus 165 ---ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qp------- 234 (829)
T KOG0576|consen 165 ---TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQP------- 234 (829)
T ss_pred ---hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCC-------
Confidence 22334678999999999975 3334689999999999999999988888765555444444443322221
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
..+.. -...++.+.+|++.+|..+|++|||++.+|.|||...
T Consensus 235 ------------------p~lkD-k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 235 ------------------PTLKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred ------------------CcccC-CccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 11111 1245778999999999999999999999999999864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=316.35 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=184.7
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
..|...+.||+|+||.||+|.++.++..||||++...... ...|+.+|+.++||||+++++++. +....
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~-----~~~~~ 758 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCR-----SEKGA 758 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEE-----cCCCC
Confidence 3456678999999999999999999999999998743211 124688999999999999999984 34568
Q ss_pred EEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 98 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH---TANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLH---s~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
|+|||||+ |+|.++++ .+++.....|+.||+.||.||| +.+|+||||||+||+++.++..+++ ||.......
T Consensus 759 ~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred EEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 99999998 69999986 3899999999999999999999 6799999999999999999888776 665543221
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChh-HHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~-~~l~~i~~~~g~p~~~~i~~ 252 (614)
. ....+|+.|+|||++.+ ..|+.++|||||||++|||++|+.||...... ..+.......
T Consensus 835 ~-------~~~~~t~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~---------- 895 (968)
T PLN00113 835 D-------TKCFISSAYVAPETRET--KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYC---------- 895 (968)
T ss_pred C-------CCccccccccCcccccC--CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHh----------
Confidence 1 22368899999999886 67999999999999999999999999532210 0010000000
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
........+++. ...... ........++.+|+.+||+.||++|||+.|+++.
T Consensus 896 ~~~~~~~~~~~~---~~~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 896 YSDCHLDMWIDP---SIRGDV-SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cCccchhheeCc---cccCCC-CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 000000000000 000000 0001112356789999999999999999999874
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=273.46 Aligned_cols=269 Identities=24% Similarity=0.327 Sum_probs=202.5
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHh--cCCCCcceeeeEecCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRL--LRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~--L~HpnIv~l~~v~~~~~~~~ 93 (614)
...-.++.+.||+|.||.||+|. -+++.||||++.. .+.+.+.+|-.|.+. ++|+||++++..-...+ .+
T Consensus 208 ~l~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~ 279 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-AD 279 (534)
T ss_pred cCCchhhHHHhhcCccceeehhh--ccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCC-cc
Confidence 34556788999999999999994 4679999999863 566777888888765 57999999988754433 23
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CeEeecCCCCcEEECCCCcEEEe
Q 007177 94 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA---------NVYHRDLKPKNILANANCKLKIC 163 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~---------gIvHrDLKP~NILi~~~~~vKL~ 163 (614)
...++||+||.+ |+|.++++.+ .+++.....++..|++||+|||+. .|+|||||..||||..|++.-|+
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 567999999998 8999999887 499999999999999999999964 59999999999999999999999
Q ss_pred ecCccccccCCCCCccccccccCCccccCcccccccCCCCC-----CcccchhHHHHHHHHHhCCCCCC-CCChhHHHHH
Q 007177 164 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYT-----PAIDIWSIGCIFAEVLTGKPLFP-GKNVVHQLDL 237 (614)
Q Consensus 164 DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~-----~~~DIWSLG~Il~eLltG~~pF~-g~~~~~~l~~ 237 (614)
|||||..+....+.. .....+||+.|||||++.+- -... ...||||+|.+|+||++....+. +....-++.-
T Consensus 359 DFGLAl~~~p~~~~~-d~~~qVGT~RYMAPEvLEga-inl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf 436 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQG-DTHGQVGTRRYMAPEVLEGA-INLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF 436 (534)
T ss_pred ccceeEEecCCCCCc-chhhhhhhhhhcCHHHHhhh-cccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence 999998876443332 23347999999999999763 2222 36999999999999999876653 3332223333
Q ss_pred HHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCC--CCHHHHHHHHHhcCCCCCCCCCHHHH
Q 007177 238 MTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPN--ADPSALRLLERLLAFDPKDRPTAEEA 305 (614)
Q Consensus 238 i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~--~s~~l~dLI~~mL~~DP~~Rpsa~ei 305 (614)
-.++...|+.+.+..+- ++++....+...|.. .-..+.+.++.||..|++-|.|+.=+
T Consensus 437 e~evG~hPt~e~mq~~V----------V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 437 EAEVGNHPTLEEMQELV----------VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred hHHhcCCCCHHHHHHHH----------HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 33445566666554321 122222333333332 23468899999999999999998543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=249.93 Aligned_cols=209 Identities=25% Similarity=0.442 Sum_probs=172.6
Q ss_pred eEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHh-cCCCCcceeeeEecCCCCCCCCcEE
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRL-LRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~-L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
...+..||+|+||+|-+.++..+|...|+|.+..... ....+++++|+.+... ..+|.+|.+|+.+ ..+.+++
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~-----~regdvw 121 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGAL-----FREGDVW 121 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhh-----hccccEE
Confidence 3446789999999999999999999999999986543 4556778899987654 5799999999987 5667899
Q ss_pred EEEecCCCcHHHH----HHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 99 VVFELMESDLHQV----IKANDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 99 lV~E~~~g~L~~~----i~~~~~lse~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
|.||.|..+|..+ ++..+.++|..+-.|+..++.||.|||++ .|+|||+||+||||+.+|+||+||||.+-.+.+
T Consensus 122 IcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 122 ICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred EeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 9999999877654 45677899999999999999999999975 899999999999999999999999999976544
Q ss_pred CCCCccccccccCCccccCccccccc--CCCCCCcccchhHHHHHHHHHhCCCCCCC-CChhHHHHHH
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KNVVHQLDLM 238 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~--~~~y~~~~DIWSLG~Il~eLltG~~pF~g-~~~~~~l~~i 238 (614)
.... +--.|.-.|||||.+... ...|+-++||||||+.+.||.+++.||+. .+..+|+..+
T Consensus 202 SiAk----t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 202 SIAK----TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred hhHH----HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence 3322 223577889999987532 24699999999999999999999999865 3455665554
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=259.71 Aligned_cols=267 Identities=27% Similarity=0.419 Sum_probs=204.7
Q ss_pred ccccccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEe
Q 007177 8 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIM 86 (614)
Q Consensus 8 ~~~~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~ 86 (614)
++........+.|.|.+.||+|.||.+.+|.++.++..+++|.+... ......+.+|...--.|. |.||+.-|++.
T Consensus 14 ~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~va 90 (378)
T KOG1345|consen 14 MEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVA 90 (378)
T ss_pred cccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHH
Confidence 44555667778999999999999999999999999999999999864 345677889988766664 89999999987
Q ss_pred cCCCCCCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEEC-CC-CcEEEe
Q 007177 87 LPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN-AN-CKLKIC 163 (614)
Q Consensus 87 ~~~~~~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~-~~-~~vKL~ 163 (614)
+ +..+.+.+++||++ |||..-+...+ +.|...+.++.|++.||.|+|++++||||||.+||||- .| -+||||
T Consensus 91 F----qt~d~YvF~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlc 165 (378)
T KOG1345|consen 91 F----QTSDAYVFVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLC 165 (378)
T ss_pred h----hcCceEEEeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEee
Confidence 4 44567889999999 89999887654 89999999999999999999999999999999999983 33 379999
Q ss_pred ecCccccccCCCCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 007177 164 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 240 (614)
Q Consensus 164 DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~---~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~ 240 (614)
|||+.+..+..... .--+..|.+||++... .-..++..|+|.||+|+|.+|+|.+||......++
T Consensus 166 DFG~t~k~g~tV~~------~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~------ 233 (378)
T KOG1345|consen 166 DFGLTRKVGTTVKY------LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK------ 233 (378)
T ss_pred ecccccccCceehh------hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc------
Confidence 99998764322111 1234469999987532 12357789999999999999999999974432221
Q ss_pred hhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCC---CCHHHHHcCccc
Q 007177 241 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR---PTAEEALADPYF 311 (614)
Q Consensus 241 ~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~R---psa~eiL~hp~f 311 (614)
...++.... ++........|...++.+..+.++-|..++++| .++......-|.
T Consensus 234 ----------------~Y~~~~~w~-~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 234 ----------------PYWEWEQWL-KRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred ----------------hHHHHHHHh-cccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 112222222 222224556677889999999999999999999 444444444444
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-29 Score=240.19 Aligned_cols=212 Identities=38% Similarity=0.637 Sum_probs=182.1
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecCC
Q 007177 26 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME 105 (614)
Q Consensus 26 LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~ 105 (614)
||.|++|.||++.+..+++.+++|++....... ....+.+|+.+++.++|++|+++++.+. .....+++||++.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFE-----DENHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeee-----cCCeEEEEEecCC
Confidence 689999999999998889999999987532221 3567889999999999999999999984 3367899999999
Q ss_pred -CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC-CCcEEEeecCccccccCCCCCccccc
Q 007177 106 -SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFNDTPTTIFWT 182 (614)
Q Consensus 106 -g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~-~~~vKL~DFGla~~~~~~~~~~~~~~ 182 (614)
++|.+++... ..+++..+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~ 151 (215)
T cd00180 75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLK 151 (215)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhh
Confidence 6999999876 57999999999999999999999999999999999999999 89999999999976543321 123
Q ss_pred cccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHH
Q 007177 183 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYL 262 (614)
Q Consensus 183 ~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l 262 (614)
...+...|++||.+... ..++.+.|+|+||+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 34678889999998762 2788899999999999999
Q ss_pred HhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCc
Q 007177 263 TSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 309 (614)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp 309 (614)
..+.+++.+||..||.+||+++++++|+
T Consensus 188 -------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2567899999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-30 Score=263.96 Aligned_cols=266 Identities=26% Similarity=0.369 Sum_probs=194.9
Q ss_pred cccccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHH--hcCCCCcceeeeEe
Q 007177 9 EFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLR--LLRHPDIVEIKHIM 86 (614)
Q Consensus 9 ~~~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~--~L~HpnIv~l~~v~ 86 (614)
.++-....+.+..+.+.||+|.||.||+| +..|+.||||++.. .+.....||.+|.+ .|+|+||+.++..=
T Consensus 202 plLVQRTiarqI~L~e~IGkGRyGEVwrG--~wrGe~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILgFIaaD 274 (513)
T KOG2052|consen 202 PLLVQRTIARQIVLQEIIGKGRFGEVWRG--RWRGEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILGFIAAD 274 (513)
T ss_pred hhHhHHhhhheeEEEEEecCccccceeec--cccCCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhhhhhcc
Confidence 34444556788999999999999999999 56799999999874 33445566666665 56999999998764
Q ss_pred cCCCCCCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeEeecCCCCcEEECCC
Q 007177 87 LPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA--------NVYHRDLKPKNILANAN 157 (614)
Q Consensus 87 ~~~~~~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~--------gIvHrDLKP~NILi~~~ 157 (614)
.... ..-..+|||++|.+ |+|++++.. ..++.+....+++.++.||++||.. .|.|||||..||||.++
T Consensus 275 ~~~~-gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn 352 (513)
T KOG2052|consen 275 NKDN-GSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 352 (513)
T ss_pred ccCC-CceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence 3222 33467999999999 899999988 5699999999999999999999953 49999999999999999
Q ss_pred CcEEEeecCccccccCCCCC-ccccccccCCccccCccccccc-----CCCCCCcccchhHHHHHHHHHhC---------
Q 007177 158 CKLKICDFGLARVAFNDTPT-TIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLTG--------- 222 (614)
Q Consensus 158 ~~vKL~DFGla~~~~~~~~~-~~~~~~~vgt~~Y~APEvl~~~-----~~~y~~~~DIWSLG~Il~eLltG--------- 222 (614)
+.+-|+|+|||....++... .+.....+||-.|||||++.+. +..| ..+||||||.+++|+...
T Consensus 353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesy-k~ADIYafgLVlWEiarRc~~ggi~ee 431 (513)
T KOG2052|consen 353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESY-KRADIYAFGLVLWEIARRCESGGIVEE 431 (513)
T ss_pred CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhh-hHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence 99999999999876655432 2344567999999999998652 1112 358999999999999863
Q ss_pred -CCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCC--HHHHHHHHHhcCCCCCCC
Q 007177 223 -KPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNAD--PSALRLLERLLAFDPKDR 299 (614)
Q Consensus 223 -~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s--~~l~dLI~~mL~~DP~~R 299 (614)
++||.+--. ..|+.+.+.++-- . ++....+...|.+.+ ..+-.|++.||..+|.-|
T Consensus 432 y~~Pyyd~Vp-----------~DPs~eeMrkVVC------v----~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aR 490 (513)
T KOG2052|consen 432 YQLPYYDVVP-----------SDPSFEEMRKVVC------V----QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAAR 490 (513)
T ss_pred hcCCcccCCC-----------CCCCHHHHhccee------e----cccCCCCCcccccCHHHHHHHHHHHHhhcCCchhh
Confidence 355543211 2233333222110 0 111122233343322 234578999999999999
Q ss_pred CCHHHH
Q 007177 300 PTAEEA 305 (614)
Q Consensus 300 psa~ei 305 (614)
.||-.+
T Consensus 491 ltALri 496 (513)
T KOG2052|consen 491 LTALRI 496 (513)
T ss_pred hHHHHH
Confidence 998766
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-29 Score=285.06 Aligned_cols=247 Identities=27% Similarity=0.465 Sum_probs=197.1
Q ss_pred EEEeEeeecCceEEEEEEECC-------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCC
Q 007177 21 KIQEVIGKGSYGVVCSAIDTH-------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 21 ~i~~~LG~G~~G~V~~a~d~~-------tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~ 92 (614)
.+.+.||+|.||.||+|.-.. ....||||.++..... .+...+..|+++|+.+. ||||+.+++.+..
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~---- 373 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ---- 373 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc----
Confidence 567799999999999996331 1457999999876554 77888999999999985 9999999999843
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEEC
Q 007177 93 DFKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 155 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~~----------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~ 155 (614)
.+.+++|+|||. |+|.++++.+. .|+..+...|.+||+.|+.||++.++|||||-..|||+.
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 567999999999 89999998765 389999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCccccccCCCCCccccccccC--CccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCC-h
Q 007177 156 ANCKLKICDFGLARVAFNDTPTTIFWTDYVA--TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN-V 231 (614)
Q Consensus 156 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~vg--t~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~-~ 231 (614)
.+..+||+|||+|+.......... ..-.+ ...|||||.+.. ..|+.++||||+|++||||++ |..||++-. .
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~--~~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRT--KSSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred CCCEEEEccccceeccCCCCceEe--cCCCCccceeecCHHHhcc--CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 999999999999996544332221 11112 234999999987 689999999999999999998 889998843 2
Q ss_pred hHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 232 VHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 232 ~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.+.+..+ +..... .....+++++.+|++.||+.+|++||++.++..
T Consensus 529 ~~l~~~l---------------------------~~G~r~---~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 529 EELLEFL---------------------------KEGNRM---EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHHH---------------------------hcCCCC---CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 2222211 111111 112346889999999999999999999999854
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=303.26 Aligned_cols=208 Identities=16% Similarity=0.190 Sum_probs=147.9
Q ss_pred hcCC-CCcceeeeEecCCCC--CCCCcEEEEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCC
Q 007177 73 LLRH-PDIVEIKHIMLPPSR--RDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLK 148 (614)
Q Consensus 73 ~L~H-pnIv~l~~v~~~~~~--~~~~~~ylV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLK 148 (614)
.++| +||..+++.+..... .....++++||+++++|+++|.. ...+++.+++.|++||++||.|||++||+|||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 3445 577777776532211 12246888999999999999975 3469999999999999999999999999999999
Q ss_pred CCcEEECCCC-------------------cEEEeecCccccccCCCC-------------CccccccccCCccccCcccc
Q 007177 149 PKNILANANC-------------------KLKICDFGLARVAFNDTP-------------TTIFWTDYVATRWYRAPELC 196 (614)
Q Consensus 149 P~NILi~~~~-------------------~vKL~DFGla~~~~~~~~-------------~~~~~~~~vgt~~Y~APEvl 196 (614)
|+||||+..+ .+||+|||+++....... ........+||++|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 9999996544 455566666543211000 00001224689999999998
Q ss_pred cccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCC
Q 007177 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQK 276 (614)
Q Consensus 197 ~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~ 276 (614)
.+ ..|+.++||||||||||||++|.+||..... .+..+.. .. + + ..
T Consensus 188 ~~--~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~-------------------~~---~----~----~~ 233 (793)
T PLN00181 188 NG--SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRH-------------------RV---L----P----PQ 233 (793)
T ss_pred cc--CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHH-------------------hh---c----C----hh
Confidence 87 6799999999999999999999888753211 1111100 00 0 0 00
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 277 FPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 277 ~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
+....+...+++.+||+.||.+||++.|+|+||||...
T Consensus 234 ~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 234 ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred hhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 01123466789999999999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=238.62 Aligned_cols=200 Identities=38% Similarity=0.652 Sum_probs=172.6
Q ss_pred eEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEE
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 99 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~yl 99 (614)
|.+.+.||.|++|.||++.+..+++.+++|.+...... .....+.+|+..++.++|+|++++++.+. .....++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-----~~~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFE-----DPEPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeee-----cCCceEE
Confidence 67889999999999999999988999999999754222 25678889999999999999999999873 3467899
Q ss_pred EEecCCC-cHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007177 100 VFELMES-DLHQVIKANDD-LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 177 (614)
Q Consensus 100 V~E~~~g-~L~~~i~~~~~-lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 177 (614)
++|++.+ +|.+++..... +++..+..++.|++.+|.+||+.+++|+||+|.||+++.++.++|+|||++.........
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred EEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999996 99999988766 899999999999999999999999999999999999999999999999999876543211
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 007177 178 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 228 (614)
Q Consensus 178 ~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g 228 (614)
......++..|++||.+.+ ...++.++|+|+||+++++|++|+.||..
T Consensus 155 --~~~~~~~~~~~~~pe~~~~-~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 --LLKTVKGTPFYLAPEVLLG-GKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred --cccceeccCCcCCHhHhcC-CCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 1234567888999999832 26788899999999999999999999977
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=268.57 Aligned_cols=246 Identities=25% Similarity=0.396 Sum_probs=198.3
Q ss_pred EEeEeeecCceEEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 22 IQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 22 i~~~LG~G~~G~V~~a~d~~tg~----~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
..++||.|+||+||++...-.|+ +||||++... ........+++|.-+|..|+|||+++|++++.... +
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------~ 772 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------L 772 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------H
Confidence 45799999999999998876665 6888887642 44455678999999999999999999999986543 6
Q ss_pred EEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 98 YVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
-||++||. |.|.++++.+ +.+..+....|.+||++|++|||.++++||||-..||||.+-.++||.|||+++....+.
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 79999999 7999999764 579999999999999999999999999999999999999999999999999999865543
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
... .....-..+-|||-|.+.. ..|+.++||||+||.+|||+| |..|+.+....+.-+.+.
T Consensus 853 ~ey-~~~~gK~pikwmale~i~~--~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle--------------- 914 (1177)
T KOG1025|consen 853 KEY-SAPGGKVPIKWMALESIRI--RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE--------------- 914 (1177)
T ss_pred ccc-cccccccCcHHHHHHHhhc--cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh---------------
Confidence 321 1111223345788887765 789999999999999999998 999998887544332221
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
+... -...+..+-++.-++.+||..|+..||+++++..
T Consensus 915 ------------~geR---LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 915 ------------KGER---LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ------------cccc---CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 1111 1223567788999999999999999999998754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-29 Score=280.54 Aligned_cols=267 Identities=28% Similarity=0.353 Sum_probs=203.8
Q ss_pred EEEeEeeecCceEEEEEEECCCCcEEEEEEecC---ccCChHHH-HHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 21 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHD---IFEHISDA-ARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 21 ~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~---~~~~~~~~-~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
....++|.|++|.|+.+......+.++.|.... ........ ..+..|+.+-..|.||||+..+..+.. ...
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~-----~~~ 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE-----IDG 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh-----ccc
Confidence 346789999999888888877777777776541 11222222 237788888899999999888877633 333
Q ss_pred EEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 97 IYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 97 ~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
.+-+||||++||+.++...+.++..++..++.||+.||+|||+.||.||||||+|++++.+|.+||||||.+....-+..
T Consensus 396 ~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 396 ILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred chhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 44559999999999999988899999999999999999999999999999999999999999999999999987543332
Q ss_pred C-ccccccccCCccccCcccccccCCCCCC-cccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 177 T-TIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 177 ~-~~~~~~~vgt~~Y~APEvl~~~~~~y~~-~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
. .....+.+|+..|+|||++.+ ..|++ ..||||.|+++..|++|+.||.-....++... ..
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~--~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-----------~~---- 538 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTG--KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-----------TN---- 538 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccc--cccCcchhhhhhccceEEEEecCCCccccccccccchh-----------hh----
Confidence 2 244567899999999999987 56665 69999999999999999999965543322110 00
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
.+. ............+..++...+.+|.+||+.||.+|.|+++||+++||+.+..
T Consensus 539 -----~~~--~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 539 -----NYS--DQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred -----ccc--cccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 000 0001111112233456678899999999999999999999999999997653
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=223.05 Aligned_cols=165 Identities=22% Similarity=0.286 Sum_probs=127.3
Q ss_pred CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccccccc
Q 007177 106 SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY 184 (614)
Q Consensus 106 g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~ 184 (614)
|+|.+++... ..++++.++.|++||+.||.|||+.+ ||+|||++.++.+|+ ||+++..... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--------~~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE--------QS 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc--------cC
Confidence 6899999874 46999999999999999999999998 999999999999999 9999765332 12
Q ss_pred cCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHH-HHHHHhhhCCCchhhhhhhhchhHHHHHH
Q 007177 185 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ-LDLMTDLLGTPSLDTISRVRNDKARRYLT 263 (614)
Q Consensus 185 vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~-l~~i~~~~g~p~~~~i~~~~~~~~~~~l~ 263 (614)
.||+.|+|||++.+ ..|+.++|||||||++|||++|+.||........ +..+..
T Consensus 65 ~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~----------------------- 119 (176)
T smart00750 65 RVDPYFMAPEVIQG--QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN----------------------- 119 (176)
T ss_pred CCcccccChHHhcC--CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHH-----------------------
Confidence 68999999999987 6899999999999999999999999966543211 111111
Q ss_pred hhcccCCCcccCCCCCCCH--HHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 007177 264 SMRKKQPVQFSQKFPNADP--SALRLLERLLAFDPKDRPTAEEALADPYFK 312 (614)
Q Consensus 264 ~~~~~~~~~~~~~~~~~s~--~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~ 312 (614)
.+....+.. ......++. .+.+||.+||..||.+||++.++++|+|+.
T Consensus 120 ~~~~~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 120 GMPADDPRD-RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HhccCCccc-cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 000000000 000111222 689999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-25 Score=224.24 Aligned_cols=265 Identities=34% Similarity=0.520 Sum_probs=205.6
Q ss_pred eEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChH-HHHHHHHHHHHHHhcCCC-CcceeeeEecCCCCCCCCcE
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHIS-DAARILREIKLLRLLRHP-DIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~-~~~~i~~Ei~iL~~L~Hp-nIv~l~~v~~~~~~~~~~~~ 97 (614)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +|+++++.+. .....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEE
Confidence 889999999999999999887 8899999986554443 567788999999999988 7999999983 33448
Q ss_pred EEEEecCCC-cHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC-cEEEeecCcccccc
Q 007177 98 YVVFELMES-DLHQVIKAND---DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAF 172 (614)
Q Consensus 98 ylV~E~~~g-~L~~~i~~~~---~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~-~vKL~DFGla~~~~ 172 (614)
+++++++.+ ++.+++.... .+++.....++.|++.++.|+|+.|++||||||+||+++..+ .++++|||+++...
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 999999994 8887777664 799999999999999999999999999999999999999998 79999999998554
Q ss_pred CCCCCc---cccccccCCccccCcccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCh---hHHHHHHHhhhCCC
Q 007177 173 NDTPTT---IFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV---VHQLDLMTDLLGTP 245 (614)
Q Consensus 173 ~~~~~~---~~~~~~vgt~~Y~APEvl~~~~-~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~---~~~l~~i~~~~g~p 245 (614)
...... ......+||.+|++||.+.+.. ..+....|+||+|++++++++|..||..... .............+
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 333221 1346678999999999987631 3678899999999999999999999877764 22222222111111
Q ss_pred chhhhhhhhchhHHHHHHhhcccCCCcccCCC-CCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 246 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKF-PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 246 ~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
. ......... ......+.+++.+|+..+|..|.+..+...++|....
T Consensus 234 ~----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 234 S----------------------LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred c----------------------cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 0 000000000 1123578899999999999999999999998776544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=231.36 Aligned_cols=169 Identities=20% Similarity=0.201 Sum_probs=130.2
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECC-CCcEEEEEEecCccC---ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTH-TGEKVAIKKIHDIFE---HISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 90 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~-tg~~vAIK~i~~~~~---~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 90 (614)
...++|.+.+.||+|+||+||+|.++. ++..||||++..... .......+.+|+++|+.|+|+||+..+..+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 446789999999999999999998876 677889998753211 233456688999999999999998533221
Q ss_pred CCCCCcEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecC-CCCcEEECCCCcEEEeecCcc
Q 007177 91 RRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDL-KPKNILANANCKLKICDFGLA 168 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDL-KP~NILi~~~~~vKL~DFGla 168 (614)
+..|||||||+| +|. .+.. .. ...++.|++.+|.|||+.||+|||| ||+|||++.++.+||+|||+|
T Consensus 91 ----~~~~LVmE~~~G~~L~-~~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLH-LARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred ----CCcEEEEEccCCCCHH-HhCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 247999999996 675 2211 11 1568899999999999999999999 999999999999999999999
Q ss_pred ccccCCCCCc-----cccccccCCccccCcccccc
Q 007177 169 RVAFNDTPTT-----IFWTDYVATRWYRAPELCGS 198 (614)
Q Consensus 169 ~~~~~~~~~~-----~~~~~~vgt~~Y~APEvl~~ 198 (614)
+......... ...+...+++.|+|||.+..
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 8754332111 11245678888999998854
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-25 Score=224.06 Aligned_cols=252 Identities=19% Similarity=0.340 Sum_probs=199.5
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCC-----cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTG-----EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg-----~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
.|+++.-.+-+|.||.||.|+.+... +.|.+|.++.. ........++.|--+|..+.|||+..+.++.. +
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~i----e 358 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSI----E 358 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEe----e
Confidence 56778889999999999999765432 34667766643 34456678889999999999999999999985 3
Q ss_pred CCCcEEEEEecCC-CcHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEe
Q 007177 93 DFKDIYVVFELME-SDLHQVIKA--------NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 163 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~--------~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~ 163 (614)
+...-++++.+++ |+|..++.. ...++..+...++.||..|+.|||+.||||.||-..|.+|++.-.+||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 4556789999999 899999872 1247778888899999999999999999999999999999999999999
Q ss_pred ecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhh
Q 007177 164 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLL 242 (614)
Q Consensus 164 DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~ 242 (614)
|=.++|..+..+.... ....-...-||+||.+.. ..|+.++|+||||++||||++ |+.|+..-+..+....+.+
T Consensus 439 DsaLSRDLFP~DYhcL-GDnEnRPvkWMslEal~n--~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd-- 513 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCL-GDNENRPVKWMSLEALQN--SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD-- 513 (563)
T ss_pred cchhccccCccccccc-CCCCCCcccccCHHHHhh--hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc--
Confidence 9999998776554321 112234456999999987 789999999999999999998 8899876665444333321
Q ss_pred CCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 243 g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
...+.+ .-++++++..++--||+.+|++||+.+|+..
T Consensus 514 ---------------------------GyRlaQ-P~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 514 ---------------------------GYRLAQ-PFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ---------------------------cceecC-CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 111111 1378899999999999999999999999854
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-23 Score=221.24 Aligned_cols=256 Identities=21% Similarity=0.237 Sum_probs=190.6
Q ss_pred CeEEEeEeeecCceEEEEEEECCCC-cEEEEEEecCccCChHHHHHHHHHHHHHHhcCC----CCcceeeeEecCCCCCC
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTG-EKVAIKKIHDIFEHISDAARILREIKLLRLLRH----PDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg-~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~H----pnIv~l~~v~~~~~~~~ 93 (614)
+|++.+.||+|+||.||.|.+..++ +.+|+|.......... ..+..|+.+|..+.. .++..+++... ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----ST 92 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEecc----CC
Confidence 8999999999999999999988775 6788888764322111 156678888888863 57888877763 24
Q ss_pred CCcEEEEEecCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC-----CcEEEeecC
Q 007177 94 FKDIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-----CKLKICDFG 166 (614)
Q Consensus 94 ~~~~ylV~E~~~g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~-----~~vKL~DFG 166 (614)
...-||||++++.+|.++.... +.++...+..|+.|++.+|.+||+.|++||||||+|+++... ..+.|.|||
T Consensus 93 ~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 93 EDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred CceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 4567999999999999988654 579999999999999999999999999999999999999765 469999999
Q ss_pred ccc--cccCCCCC----ccc-cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 007177 167 LAR--VAFNDTPT----TIF-WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMT 239 (614)
Q Consensus 167 la~--~~~~~~~~----~~~-~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~ 239 (614)
+++ ........ ... ...+.||..|.++....+ ...+++.|+||++.++.+|+.|..||.+.........+.
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCC--CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 998 43222211 101 134569999999999887 688999999999999999999999997765433322221
Q ss_pred hhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 240 DLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 240 ~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.. ...... .......+..+..+...+-..+...+|....+...
T Consensus 251 ~~-----------------------~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 251 KD-----------------------PRKLLT---DRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HH-----------------------hhhhcc---ccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 10 000000 00222344567777777777888889988877554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=212.03 Aligned_cols=206 Identities=22% Similarity=0.337 Sum_probs=169.0
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ 96 (614)
=.|+++++||+|+||+.+.+.+.-+++.||||.-... +++-.+..|....+.|. .++|...|-+- .+..+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~ 98 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKY 98 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeec-----cccch
Confidence 4699999999999999999999999999999976532 44556667888888775 78888876543 45556
Q ss_pred EEEEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC-----cEEEeecCcccc
Q 007177 97 IYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-----KLKICDFGLARV 170 (614)
Q Consensus 97 ~ylV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~-----~vKL~DFGla~~ 170 (614)
-.||+|+++.+|.+++.- ...|+.+.+..++.|++.-++|+|++.+|.|||||+|+||..-+ .|.|+|||+|+.
T Consensus 99 NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 99 NILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 689999999877777754 34699999999999999999999999999999999999996543 589999999998
Q ss_pred ccCCCCC-cccc---ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHH
Q 007177 171 AFNDTPT-TIFW---TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ 234 (614)
Q Consensus 171 ~~~~~~~-~~~~---~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~ 234 (614)
+.+.... .+.+ ....||..||+-....+ ..-+...|+-|||.+|.+.|.|..||.|......
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG--rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn 244 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN 244 (449)
T ss_pred hcCccccccCccccccccccceeeeEeecccc--chhhhhhhHHHhhhhhhhhccCCCccccccCcch
Confidence 7654322 2222 33579999999998887 6778999999999999999999999998754433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=200.82 Aligned_cols=256 Identities=23% Similarity=0.314 Sum_probs=190.5
Q ss_pred ccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC-CCcceeeeEecCCC
Q 007177 12 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH-PDIVEIKHIMLPPS 90 (614)
Q Consensus 12 ~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~H-pnIv~l~~v~~~~~ 90 (614)
.+....++|++++.||+|+||.+|+|....+|+.||||+-.....+ -.+..|.++.+.|++ ..|..+..+.
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~---- 80 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYG---- 80 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhc----
Confidence 4556788999999999999999999999999999999987654332 246678899998874 5666666655
Q ss_pred CCCCCcEEEEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC--CC-cEEEeecC
Q 007177 91 RRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA--NC-KLKICDFG 166 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~--~~-~vKL~DFG 166 (614)
.+..+-.+|||+++.+|.+++.- ...++...+.-++-|++.-|+|+|..+++||||||+|+|..- .+ .+.|+|||
T Consensus 81 -~e~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFG 159 (341)
T KOG1163|consen 81 -TEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFG 159 (341)
T ss_pred -cccccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEecc
Confidence 34456689999999887777753 346999999999999999999999999999999999999743 33 58999999
Q ss_pred ccccccCCCCCc-c---ccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhh
Q 007177 167 LARVAFNDTPTT-I---FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242 (614)
Q Consensus 167 la~~~~~~~~~~-~---~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~ 242 (614)
+|+.+.+..... + ..+...||..|.+-....+ ..-+...|+-|+|.+|..+..|..||.|.......++.
T Consensus 160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g--~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy---- 233 (341)
T KOG1163|consen 160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG--IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY---- 233 (341)
T ss_pred chhhhccccccccCccccCCccceeeeehhhhhhhh--hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH----
Confidence 999875443221 1 1244689999999887665 45678899999999999999999999987543333222
Q ss_pred CCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 007177 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT 301 (614)
Q Consensus 243 g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps 301 (614)
-....++...+........+.++.-.|.-|-..--++-|.
T Consensus 234 -------------------EkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 234 -------------------EKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred -------------------HHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 1112233444444455566667666666654443333343
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-24 Score=241.52 Aligned_cols=252 Identities=28% Similarity=0.405 Sum_probs=188.7
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCc--cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI--FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~--~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.|...+.||++.|=.|++|.+. .| .|+||++-+. ........+.++|++ ...++|||.+.+..+. ...+.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence 7889999999999999999764 34 4999998543 233445666667777 6678999999987765 45567
Q ss_pred EEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc--CC
Q 007177 97 IYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF--ND 174 (614)
Q Consensus 97 ~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~--~~ 174 (614)
.|||-+|...+|++.|..+.-|..-+.+.|+.||+.||.-+|..||+|+|||.+||||++=..+.|.||..-+... .+
T Consensus 96 AylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 8999999999999999988889999999999999999999999999999999999999998899999998776532 22
Q ss_pred CC--CccccccccCCccccCccccccc--------CCC-CCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhh
Q 007177 175 TP--TTIFWTDYVATRWYRAPELCGSF--------FSK-YTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLL 242 (614)
Q Consensus 175 ~~--~~~~~~~~vgt~~Y~APEvl~~~--------~~~-y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~ 242 (614)
.+ ...++.+-..-..|.|||.+... ... .+++-||||+||+++||++ |+|||.-. |+-....
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~-- 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYRS-- 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHhc--
Confidence 22 22223333334479999976431 012 5788999999999999988 78999321 1111100
Q ss_pred CCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 243 g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
......+..++.+ -+..++.||..|++.||.+|.+|++.|+-
T Consensus 250 ----------~~~~~~e~~Le~I--------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 250 ----------GNADDPEQLLEKI--------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ----------cCccCHHHHHHhC--------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0011112222222 13478999999999999999999999985
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-24 Score=233.22 Aligned_cols=239 Identities=25% Similarity=0.409 Sum_probs=195.5
Q ss_pred EeeecCceEEEEEEE---CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCcEEEE
Q 007177 25 VIGKGSYGVVCSAID---THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDIYVV 100 (614)
Q Consensus 25 ~LG~G~~G~V~~a~d---~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~~ylV 100 (614)
++|.|+||.|+++.. ...|.-+|+|+.++.............|-.++...+ ||.++++...+ +....+|++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf-----qt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF-----QTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee-----ccccchhHh
Confidence 479999999988742 235667999998865444444445556888888887 99999999888 566779999
Q ss_pred EecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCcc
Q 007177 101 FELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 179 (614)
Q Consensus 101 ~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~ 179 (614)
+++..| +|+..+.....+.+...+.+...++.++.++|+.+|+|||+|++||+++.+|++|+.|||+++......
T Consensus 76 ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred hhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 999985 999999888889999999999999999999999999999999999999999999999999998754332
Q ss_pred ccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHh-hhCCCchhhhhhhhchhH
Q 007177 180 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD-LLGTPSLDTISRVRNDKA 258 (614)
Q Consensus 180 ~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~-~~g~p~~~~i~~~~~~~~ 258 (614)
..|||..|||||++. ....++|.||+|++.++|++|..||.+ +....|.. .++
T Consensus 152 ---~~cgt~eymApEI~~----gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~--------------- 205 (612)
T KOG0603|consen 152 ---IACGTYEYRAPEIIN----GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELE--------------- 205 (612)
T ss_pred ---hcccchhhhhhHhhh----ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccC---------------
Confidence 128999999999986 367899999999999999999999977 23333321 010
Q ss_pred HHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccCC
Q 007177 259 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGLS 315 (614)
Q Consensus 259 ~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~eiL~hp~f~~~~ 315 (614)
.....+..+.+++..|+..+|..|.- ++|+++|++|+.+.
T Consensus 206 -----------------~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~ 250 (612)
T KOG0603|consen 206 -----------------MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSID 250 (612)
T ss_pred -----------------CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeee
Confidence 11245678999999999999999964 58999999998764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-23 Score=234.97 Aligned_cols=228 Identities=28% Similarity=0.437 Sum_probs=172.5
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
.....|..++.|..|+||.||+++|+.+...+|+ ++++. .-+ || ||..+-+
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq-------~li------lR-----nilt~a~---------- 130 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQ-------NLI------LR-----NILTFAG---------- 130 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhh-ccccc-------chh------hh-----ccccccC----------
Confidence 3456799999999999999999999999999999 44431 011 11 1222211
Q ss_pred CcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 95 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 95 ~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
+.++| ||-...++..+.++.+. +.+++|||+-||+|||+||+|+||+.-|++|+.|||+.+.....
T Consensus 131 -npfvv-----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 131 -NPFVV-----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred -Cccee-----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 12333 55555666656666443 78999999999999999999999999999999999999764322
Q ss_pred CCCc-----------cc-cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhh
Q 007177 175 TPTT-----------IF-WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242 (614)
Q Consensus 175 ~~~~-----------~~-~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~ 242 (614)
..+. .+ -...+||+.|+|||++.. ..|+..+|+|++|+|+||.+.|+.||.|+...+.+.....-
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr--qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd- 273 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD- 273 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhh--hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh-
Confidence 2111 11 123489999999999986 68999999999999999999999999999877766554321
Q ss_pred CCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC---CHHHHHcCcccccCC
Q 007177 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP---TAEEALADPYFKGLS 315 (614)
Q Consensus 243 g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp---sa~eiL~hp~f~~~~ 315 (614)
.+.|.+......+++++||..+|+.+|..|. .+-++.+|+||+.+.
T Consensus 274 ---------------------------~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LD 322 (1205)
T KOG0606|consen 274 ---------------------------DIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLD 322 (1205)
T ss_pred ---------------------------hccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecc
Confidence 1223333456788999999999999999994 677888999998764
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.2e-22 Score=198.20 Aligned_cols=176 Identities=13% Similarity=0.121 Sum_probs=134.2
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHH-HHH------HHHHHHHHHhcCCCCcceeeeEecCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISD-AAR------ILREIKLLRLLRHPDIVEIKHIMLPP 89 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~-~~~------i~~Ei~iL~~L~HpnIv~l~~v~~~~ 89 (614)
.++|+++++||.|+||.||++.+ ++..+|||++......... ..+ +.+|+..+.++.||+|..+.+.+...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 58999999999999999999644 4778999999754333222 223 46899999999999999999886543
Q ss_pred CCC---CCCcEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeec
Q 007177 90 SRR---DFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 165 (614)
Q Consensus 90 ~~~---~~~~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DF 165 (614)
... -.+..+|||||++| +|.++. .+++ ..+.+|+.+|..||..|++||||||+||+++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 221 13568999999997 787763 2333 3466999999999999999999999999999988 999999
Q ss_pred CccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHH
Q 007177 166 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 220 (614)
Q Consensus 166 Gla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLl 220 (614)
|..+......... .+... ..|+.++|+||||+.+..+.
T Consensus 179 g~~~~~~e~~a~d---------------~~vle--r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAKD---------------RIDLE--RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhHH---------------HHHHH--hHhcccccccceeEeehHHH
Confidence 9886542211110 02232 45778999999999988764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.3e-22 Score=201.31 Aligned_cols=240 Identities=20% Similarity=0.272 Sum_probs=152.8
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCC----------CCcceeeeEec
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRH----------PDIVEIKHIML 87 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~H----------pnIv~l~~v~~ 87 (614)
.+...+.||.|+++.||.+.|..||+.+|+|++.... ......+.+.+|.-....+.+ -.++-.+++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 5677889999999999999999999999999975332 222345556666544433322 12333333322
Q ss_pred CCCC-------C--CCC---cEEEEEecCCCcHHHHHHh---CCCC----CHHHHHHHHHHHHHHHHHHHhCCeEeecCC
Q 007177 88 PPSR-------R--DFK---DIYVVFELMESDLHQVIKA---NDDL----TREHYQFFLYQLLRALKYIHTANVYHRDLK 148 (614)
Q Consensus 88 ~~~~-------~--~~~---~~ylV~E~~~g~L~~~i~~---~~~l----se~~~~~i~~QIl~aL~yLHs~gIvHrDLK 148 (614)
.... . ..- +.+++|+-+.+||.+++.. .... .......+..|+++.+++||+.||+|+|||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 1110 0 011 4578999999998888642 2222 222234566899999999999999999999
Q ss_pred CCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCccccccc------CCCCCCcccchhHHHHHHHHHhC
Q 007177 149 PKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEVLTG 222 (614)
Q Consensus 149 P~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~------~~~y~~~~DIWSLG~Il~eLltG 222 (614)
|+|+|++.+|.++|+||+.....+... .....+..|.+||+.... .-.++.+.|.|+||+++|.|+||
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRY------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEE------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred eeeEEEcCCCCEEEcChHHHeecCcee------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999999887643221 112345779999976431 13578899999999999999999
Q ss_pred CCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCC
Q 007177 223 KPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR 299 (614)
Q Consensus 223 ~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~R 299 (614)
..||........ ....|...- ++++.+++||..||+.||.+|
T Consensus 247 ~lPf~~~~~~~~----------------------------------~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEAD----------------------------------PEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGST----------------------------------SGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCcccc----------------------------------ccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999965532100 000233333 788899999999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.7e-22 Score=194.01 Aligned_cols=140 Identities=21% Similarity=0.255 Sum_probs=109.2
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHH------------------------HHHHHHHHHHHHhcCCCC
Q 007177 23 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISD------------------------AARILREIKLLRLLRHPD 78 (614)
Q Consensus 23 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~------------------------~~~i~~Ei~iL~~L~Hpn 78 (614)
.+.||+|++|.||+|.+. +|+.||||+++........ .....+|+.+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 8999999999743211100 112345999999998887
Q ss_pred cceeeeEecCCCCCCCCcEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCeEeecCCCCcEEECC
Q 007177 79 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI-HTANVYHRDLKPKNILANA 156 (614)
Q Consensus 79 Iv~l~~v~~~~~~~~~~~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yL-Hs~gIvHrDLKP~NILi~~ 156 (614)
+.....+.. ...||||||++| ++...+.....++++.+..++.||+.+|.+| |+.||+||||||+|||++
T Consensus 81 v~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~- 152 (190)
T cd05147 81 IPCPEPILL-------KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCCcEEEe-------cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence 744333221 123899999996 5554444556799999999999999999999 799999999999999998
Q ss_pred CCcEEEeecCccccc
Q 007177 157 NCKLKICDFGLARVA 171 (614)
Q Consensus 157 ~~~vKL~DFGla~~~ 171 (614)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.9e-21 Score=186.15 Aligned_cols=142 Identities=23% Similarity=0.193 Sum_probs=111.8
Q ss_pred EEeEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----------------------H--HHHHHHHHHHHHHhcCCC
Q 007177 22 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI----------------------S--DAARILREIKLLRLLRHP 77 (614)
Q Consensus 22 i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~----------------------~--~~~~i~~Ei~iL~~L~Hp 77 (614)
+.+.||+|++|.||+|.+. +|+.||||+++...... . ....+.+|+..+..+.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 89999999987532110 0 012235799999999999
Q ss_pred CcceeeeEecCCCCCCCCcEEEEEecCCCc-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeecCCCCcEEEC
Q 007177 78 DIVEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILAN 155 (614)
Q Consensus 78 nIv~l~~v~~~~~~~~~~~~ylV~E~~~g~-L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~ 155 (614)
+|.....+... ..||||||++|. +.........+++..+..++.|++.+|.+||+ .||+||||||+|||++
T Consensus 80 ~i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~ 152 (190)
T cd05145 80 GVPVPEPILLK-------KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH 152 (190)
T ss_pred CCCCceEEEec-------CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence 88555444311 238999999963 43333344568899999999999999999999 9999999999999998
Q ss_pred CCCcEEEeecCcccccc
Q 007177 156 ANCKLKICDFGLARVAF 172 (614)
Q Consensus 156 ~~~~vKL~DFGla~~~~ 172 (614)
++.++|+|||++....
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 8899999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-21 Score=198.02 Aligned_cols=199 Identities=27% Similarity=0.365 Sum_probs=144.9
Q ss_pred CCCCcceeeeEecCC----------------------CCCCCCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHH
Q 007177 75 RHPDIVEIKHIMLPP----------------------SRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLR 132 (614)
Q Consensus 75 ~HpnIv~l~~v~~~~----------------------~~~~~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~ 132 (614)
+|||||++...|.+. .......+|+||.....+|++++-.+. .+.....-++.|+++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~-~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH-RSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC-CchHHHHHHHHHHHH
Confidence 599999998877421 123345699999999999999997664 777888899999999
Q ss_pred HHHHHHhCCeEeecCCCCcEEE--CCCC--cEEEeecCccccccCCC---CCccccccccCCccccCcccccccCCC---
Q 007177 133 ALKYIHTANVYHRDLKPKNILA--NANC--KLKICDFGLARVAFNDT---PTTIFWTDYVATRWYRAPELCGSFFSK--- 202 (614)
Q Consensus 133 aL~yLHs~gIvHrDLKP~NILi--~~~~--~vKL~DFGla~~~~~~~---~~~~~~~~~vgt~~Y~APEvl~~~~~~--- 202 (614)
|+.|||.+||.|||||.+|||+ ++|+ .+.|+|||.+-...+.. +.....-+..|.-..||||+.....++
T Consensus 353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av 432 (598)
T KOG4158|consen 353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV 432 (598)
T ss_pred HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence 9999999999999999999997 4443 48999999885422211 111112344577889999987532111
Q ss_pred -CCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCC
Q 007177 203 -YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNAD 281 (614)
Q Consensus 203 -y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s 281 (614)
.-.++|.|+.|.+-||++....||.+.-.... +. +.| +...+......++
T Consensus 433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-------------~~---------r~Y-------qe~qLPalp~~vp 483 (598)
T KOG4158|consen 433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-------------DT---------RTY-------QESQLPALPSRVP 483 (598)
T ss_pred eccchhhhhhhhhhHHHHhccCCcccccchhee-------------ch---------hhh-------hhhhCCCCcccCC
Confidence 12479999999999999999999987443211 00 001 1112222334678
Q ss_pred HHHHHHHHHhcCCCCCCCCCHH
Q 007177 282 PSALRLLERLLAFDPKDRPTAE 303 (614)
Q Consensus 282 ~~l~dLI~~mL~~DP~~Rpsa~ 303 (614)
+.+++|+..+|+.||.+|+++.
T Consensus 484 p~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 484 PVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred hHHHHHHHHHhcCCccccCCcc
Confidence 9999999999999999999864
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.2e-20 Score=179.90 Aligned_cols=191 Identities=16% Similarity=0.054 Sum_probs=138.8
Q ss_pred EEeEeeecCceEEEEEEECCCCcEEEEEEecCccC--ChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCcEE
Q 007177 22 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE--HISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 22 i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~--~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
+...|++|+||+|+++.. .+.+++.+.+..... .......+.+|+++|++|. |++|.++++. ...|
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~~~ 74 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DGRH 74 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cCEE
Confidence 578999999999998854 677888777764322 1112335779999999996 5889998874 2369
Q ss_pred EEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecC-CCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 99 VVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDL-KPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 99 lV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDL-KP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
++|||+.| +|.+.+.. . ...++.|++.+|.+||+.||+|||| ||+|||++.++.++|+|||+|........
T Consensus 75 lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred EEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 99999997 66544321 1 2357899999999999999999999 79999999999999999999985432221
Q ss_pred Ccccc----------ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Q 007177 177 TTIFW----------TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 230 (614)
Q Consensus 177 ~~~~~----------~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~ 230 (614)
....+ .-...++.|++|+...-....--...++++.|+-+|.++|+..++.+.+
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 00000 0013577788888543211222356789999999999999998876654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-19 Score=178.07 Aligned_cols=136 Identities=21% Similarity=0.247 Sum_probs=107.0
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-----CCCCcceeeeEecCCCCCCCCcE
Q 007177 23 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-----RHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 23 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-----~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
.+.||+|+||.||. +..++.. +||++... .......+.+|+.+++.| .||||+++++++.... ..+.+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~--~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHR--GDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecc--ccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEE
Confidence 47899999999995 7777766 69988642 122456789999999999 5799999999995532 22344
Q ss_pred E-EEEecCC---CcHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhCCeEeecCCCCcEEECCC----CcEEEeecCcc
Q 007177 98 Y-VVFELME---SDLHQVIKANDDLTREHYQFFLYQLLRAL-KYIHTANVYHRDLKPKNILANAN----CKLKICDFGLA 168 (614)
Q Consensus 98 y-lV~E~~~---g~L~~~i~~~~~lse~~~~~i~~QIl~aL-~yLHs~gIvHrDLKP~NILi~~~----~~vKL~DFGla 168 (614)
| +|+||++ ++|.++++.. .+++. ..++.|++.++ +|||+++|+||||||+|||++.+ +.++|+||+.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 7899955 5999999764 46666 46788999888 89999999999999999999743 37999995544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.7e-20 Score=197.61 Aligned_cols=255 Identities=24% Similarity=0.365 Sum_probs=166.7
Q ss_pred CCeEEEeEeeecCceEEEEEEECCC---CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeee-------Eec
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHT---GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKH-------IML 87 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~t---g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~-------v~~ 87 (614)
..+.+.+..+..+++.+....-... .+.+.-+..+. .+........+++-.+....|-+..-+.+ .+.
T Consensus 244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~--d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~ 321 (516)
T KOG1033|consen 244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADV--DSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSK 321 (516)
T ss_pred ccccccccccccccCCchhhhhcccchhhhhccchhhhc--cchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcc
Confidence 4455566666666666655433222 22232222221 12233444556666555554443333333 111
Q ss_pred CCCCCCCCcEEEEEecCC-CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEe
Q 007177 88 PPSRRDFKDIYVVFELME-SDLHQVIKAND---DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 163 (614)
Q Consensus 88 ~~~~~~~~~~ylV~E~~~-g~L~~~i~~~~---~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~ 163 (614)
........++||.|++|. .+|.++|..+. ..+....+.++.||..|+.| +|.+|||+||.||++..++.+||.
T Consensus 322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIg 398 (516)
T KOG1033|consen 322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIG 398 (516)
T ss_pred ccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhh
Confidence 111222346899999999 69999997543 46777889999999999999 999999999999999999999999
Q ss_pred ecCccccccCCC---CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 007177 164 DFGLARVAFNDT---PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 240 (614)
Q Consensus 164 DFGla~~~~~~~---~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~ 240 (614)
|||+........ +.....+..+||.|||+||.+.+ ..|+.++||||||+||+||+.- |.. ..+...
T Consensus 399 DFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g--~~y~~kvdIyaLGlil~EL~~~---f~T--~~er~~---- 467 (516)
T KOG1033|consen 399 DFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG--QQYSEKVDIYALGLILAELLIQ---FST--QFERIA---- 467 (516)
T ss_pred hhhheeecccCCcccchhhhhhhcccccccCCHHHHhh--hhhhhhcchhhHHHHHHHHHHH---hcc--HHHHHH----
Confidence 999997655443 11223466799999999999998 7899999999999999999972 111 001110
Q ss_pred hhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 241 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 241 ~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
.+..++. -.+...+..-.+.-.+|+..||...|.+||++.+.--|.|.
T Consensus 468 --------------------t~~d~r~---g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 468 --------------------TLTDIRD---GIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred --------------------hhhhhhc---CCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 1111111 11111112223566799999999999999988777777764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.3e-19 Score=179.94 Aligned_cols=144 Identities=18% Similarity=0.140 Sum_probs=111.4
Q ss_pred CeEEEeEeeecCceEEEEEE-ECCCCcEEEEEEecCccCCh--------------------H--HHHHHHHHHHHHHhcC
Q 007177 19 RYKIQEVIGKGSYGVVCSAI-DTHTGEKVAIKKIHDIFEHI--------------------S--DAARILREIKLLRLLR 75 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~-d~~tg~~vAIK~i~~~~~~~--------------------~--~~~~i~~Ei~iL~~L~ 75 (614)
-|.+.+.||+|+||.||+|. +..+|+.||||+++...... . ....+.+|+.++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47899999999999999998 77899999999987431100 0 1123568999999997
Q ss_pred CCCcceeeeEecCCCCCCCCcEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-eEeecCCCCcEE
Q 007177 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN-VYHRDLKPKNIL 153 (614)
Q Consensus 76 HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~g-IvHrDLKP~NIL 153 (614)
+. ++.+..++.. ...|+||||++| +|.........+.+..+..++.||+.+|.+||+.| |+||||||+||+
T Consensus 109 ~~-~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 109 EA-GVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred hc-CCCCCeeeEe------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 53 2322233311 124899999997 55555444456777778899999999999999999 999999999999
Q ss_pred ECCCCcEEEeecCcccc
Q 007177 154 ANANCKLKICDFGLARV 170 (614)
Q Consensus 154 i~~~~~vKL~DFGla~~ 170 (614)
++ ++.++|+|||++..
T Consensus 182 i~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 182 VH-DGKVVIIDVSQSVE 197 (237)
T ss_pred EE-CCCEEEEEChhhhc
Confidence 99 88999999999864
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-18 Score=201.25 Aligned_cols=193 Identities=24% Similarity=0.316 Sum_probs=152.2
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC---CCCcceeeeEecCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR---HPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~v~~~~~~~~ 93 (614)
...|.|.+.||+|+||.||+|.+.+ |+.||+|+-+... ...++--.+++.+|+ -+.|..+...+..
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~-----~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~----- 765 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPN-----PWEFYICLQVMERLKPQMLPSIMHISSAHVF----- 765 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCC-----ceeeeehHHHHHhhchhhhcchHHHHHHHcc-----
Confidence 4579999999999999999999877 9999999876431 112222334444444 2344444444422
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC-------CCcEEEeec
Q 007177 94 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-------NCKLKICDF 165 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~-------~~~vKL~DF 165 (614)
.+..+||+||.+ |+|.+++..++.+++..+.+|..|||+.|..||..+|||+||||+|+||.. +--++|+||
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 234689999999 899999998889999999999999999999999999999999999999842 235999999
Q ss_pred CccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCC
Q 007177 166 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 223 (614)
Q Consensus 166 Gla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~ 223 (614)
|.+....--... ..+...++|-.+-.+|...| ..|+..+|.|.|.-+++.||.|+
T Consensus 846 G~siDm~lfp~~-~~F~~~~~td~f~C~EM~~g--rpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 846 GRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREG--RPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ccceeeeEcCCC-cEEeeeeccccchhHHHhcC--CCCchhhhhHHHHHHHHHHHHHH
Confidence 999764322222 23455678888999999988 79999999999999999999997
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.9e-18 Score=167.42 Aligned_cols=136 Identities=22% Similarity=0.268 Sum_probs=110.2
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEecCccCCh------HHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 23 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI------SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 23 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~------~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
++.||+|++|.||+|.+ .|..+++|+........ ....++.+|+.++..+.|++|.....++. +...
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~ 73 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV-----DPEN 73 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE-----eCCC
Confidence 36799999999999976 77889999865322211 12346778999999999998876665552 2345
Q ss_pred EEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 97 IYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 97 ~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
.++||||++| +|.+++..... ....++.+|+.+|.+||+.|++|+||+|.|||++ ++.++|+|||++..
T Consensus 74 ~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 74 FIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 7899999986 89888865432 7889999999999999999999999999999999 78999999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-19 Score=204.71 Aligned_cols=265 Identities=25% Similarity=0.349 Sum_probs=207.7
Q ss_pred CCCeEEEeEeeecCceEEEEEEECC-CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTH-TGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~-tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~ 94 (614)
...|.+.+.||+|+|+.|-++.... +...+|.|.+............+..|..+-+.+. |+|++.+++.. .+.
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCC
Confidence 5679999999999999998887644 3446777777654333444556667888888887 99999999887 444
Q ss_pred CcEEEEEecCC-CcHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCeEeecCCCCcEEECCCC-cEEEeecCccc
Q 007177 95 KDIYVVFELME-SDLHQVI-KAND-DLTREHYQFFLYQLLRALKYIH-TANVYHRDLKPKNILANANC-KLKICDFGLAR 169 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i-~~~~-~lse~~~~~i~~QIl~aL~yLH-s~gIvHrDLKP~NILi~~~~-~vKL~DFGla~ 169 (614)
...++++++.. ++++..+ .... ..+...+..++.|+..+|.|+| ..++.||||||+|.+++.++ .+|+.|||+|.
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhc
Confidence 56899999987 4888888 5544 6788899999999999999999 99999999999999999999 99999999998
Q ss_pred cccCCCCCccccccccC-CccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007177 170 VAFNDTPTTIFWTDYVA-TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248 (614)
Q Consensus 170 ~~~~~~~~~~~~~~~vg-t~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~ 248 (614)
...............+| ++.|.|||...+. ....+..|+||+|+++.-+++|..||......+.
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-------------- 238 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-------------- 238 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCccccccccc--------------
Confidence 86652222333456688 9999999998763 3557889999999999999999999865443221
Q ss_pred hhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 249 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 249 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
.+...+..+ ...-...|..++..+.+++.++|..+|..|.+.+++-.+||+..
T Consensus 239 -----------~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 239 -----------RYSSWKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred -----------cceeecccc-cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 111111111 11123346778899999999999999999999999999999987
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-18 Score=171.17 Aligned_cols=242 Identities=16% Similarity=0.226 Sum_probs=182.2
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
+...++-+|.+...|..|++ +..|..+++|++.-..-.......+..|.-.|+.+.||||+.+++.+..+ .++
T Consensus 190 ~~lnl~tkl~e~hsgelwrg--rwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnl 262 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRG--RWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNL 262 (448)
T ss_pred hhhhhhhhhccCCCcccccc--cccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCc
Confidence 34456678899999999999 56788888898864433334455677899999999999999999998444 568
Q ss_pred EEEEecCC-CcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCC--eEeecCCCCcEEECCCCcEEEe--ecCcccc
Q 007177 98 YVVFELME-SDLHQVIKANDD--LTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANANCKLKIC--DFGLARV 170 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~~~~--lse~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILi~~~~~vKL~--DFGla~~ 170 (614)
.++..||. |+|+.++..... +...++..|+..|++|++|||+.. |.---|....++||++.+.+|. |--++..
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq 342 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ 342 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee
Confidence 99999999 899999976543 567788999999999999999975 4444678889999998766553 3222211
Q ss_pred ccCCCCCccccccccCCccccCcccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~-~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
.....-.+.|++||.+.... ...-.++|+|||.++++||.|...||...+.++.-.+|
T Consensus 343 ----------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki----------- 401 (448)
T KOG0195|consen 343 ----------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI----------- 401 (448)
T ss_pred ----------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh-----------
Confidence 12234567899999886521 12345799999999999999999999887765443322
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 305 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~ei 305 (614)
.++.++. ...|.++.....|+.-|+..||.+||.++.+
T Consensus 402 -----------aleglrv-------~ippgis~hm~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 402 -----------ALEGLRV-------HIPPGISRHMNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred -----------hhccccc-------cCCCCccHHHHHHHHHHhcCCCCcCCCccee
Confidence 1122221 2346889999999999999999999998776
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.8e-17 Score=160.65 Aligned_cols=131 Identities=27% Similarity=0.380 Sum_probs=102.2
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEecCc-cCC-----hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEH-----ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 25 ~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~-----~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
.||+|+||.||++. .+|..+++|+.... ... .....++.+|+.+++.+.|+++....-+.. +....+
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-----DPDNKT 73 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-----ECCCCE
Confidence 38999999999997 46789999986432 111 112456779999999999876544333332 223468
Q ss_pred EEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 99 VVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 99 lV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
+||||++| +|.+.+..... .++.||+.+|.+||+.|++|+||+|.||+++ ++.++|+|||++..
T Consensus 74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999985 88887754321 7899999999999999999999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.1e-17 Score=159.88 Aligned_cols=137 Identities=22% Similarity=0.204 Sum_probs=105.8
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCCh--------------------HHHHHHHHHHHHHHhcCCCC
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI--------------------SDAARILREIKLLRLLRHPD 78 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~--------------------~~~~~i~~Ei~iL~~L~Hpn 78 (614)
.|.+.+.||.|+||.||++.+. +|+.||||++....... .......+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888999999999999999874 79999999876321100 01123567999999998775
Q ss_pred c--ceeeeEecCCCCCCCCcEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEEC
Q 007177 79 I--VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 155 (614)
Q Consensus 79 I--v~l~~v~~~~~~~~~~~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~ 155 (614)
+ ...++ ....++||||++| +|..... ......++.+|+.++.++|+.||+||||||+||+++
T Consensus 95 i~v~~~~~---------~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~ 159 (198)
T cd05144 95 FPVPKPID---------WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD 159 (198)
T ss_pred CCCCceee---------cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc
Confidence 3 33322 1335899999996 6655432 145678899999999999999999999999999999
Q ss_pred CCCcEEEeecCccccc
Q 007177 156 ANCKLKICDFGLARVA 171 (614)
Q Consensus 156 ~~~~vKL~DFGla~~~ 171 (614)
.++.++|+|||++...
T Consensus 160 ~~~~~~liDfg~~~~~ 175 (198)
T cd05144 160 DDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCcEEEEECCccccC
Confidence 9999999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=180.09 Aligned_cols=139 Identities=22% Similarity=0.290 Sum_probs=108.0
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEec-CccCC-----hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEH-----ISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 90 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~-~~~~~-----~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 90 (614)
...|...+.||+|+||.||++... +..+++|+.. +.... .....++.+|+.+|+.++|++|+........
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-- 407 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD-- 407 (535)
T ss_pred ccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--
Confidence 344567899999999999999754 4445555432 21111 1234568899999999999999876655432
Q ss_pred CCCCCcEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 91 RRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
....++||||++| +|.+++. ....++.||+.+|.+||+.||+||||||+|||+ .++.++|+|||+++
T Consensus 408 ---~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 408 ---PEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred ---CCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 2346899999985 8888875 357789999999999999999999999999999 67799999999998
Q ss_pred cc
Q 007177 170 VA 171 (614)
Q Consensus 170 ~~ 171 (614)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 64
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.7e-16 Score=172.38 Aligned_cols=210 Identities=23% Similarity=0.312 Sum_probs=151.4
Q ss_pred HHhcCCCCcceeeeEecCCCCCCCCcEEEEEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCe-EeecC
Q 007177 71 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANV-YHRDL 147 (614)
Q Consensus 71 L~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gI-vHrDL 147 (614)
|+.+.|.|+.++++....+ ..+++|.+||. |+|.+.+.. .-.++.-....+++.|+.||.|||..-| +|+.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence 4678999999999998644 67899999999 899999987 4468888889999999999999998877 99999
Q ss_pred CCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccC--C---CCCCcccchhHHHHHHHHHhC
Q 007177 148 KPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF--S---KYTPAIDIWSIGCIFAEVLTG 222 (614)
Q Consensus 148 KP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~--~---~y~~~~DIWSLG~Il~eLltG 222 (614)
+..|.+++....+||.|||+........... ......-...|.|||++.+.. . .-+.+.||||+|+|++|+++.
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~-~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPE-AHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred ccccceeeeeEEEEechhhhccccccccccc-ccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999987653211000 011112334689999987521 1 146779999999999999999
Q ss_pred CCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCH
Q 007177 223 KPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 302 (614)
Q Consensus 223 ~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa 302 (614)
..||........-+.+... ++........+.-.......+.+..++..||..+|.+||++
T Consensus 155 ~~~~~~~~~~~~~~eii~~--------------------~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~ 214 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILR--------------------VKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSI 214 (484)
T ss_pred cCccccccccCChHHHHHH--------------------HHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccH
Confidence 9999774422111111100 00000000000001111445589999999999999999999
Q ss_pred HHHH
Q 007177 303 EEAL 306 (614)
Q Consensus 303 ~eiL 306 (614)
+++-
T Consensus 215 ~~i~ 218 (484)
T KOG1023|consen 215 EQIR 218 (484)
T ss_pred HHHH
Confidence 9984
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.7e-16 Score=151.08 Aligned_cols=137 Identities=24% Similarity=0.253 Sum_probs=97.7
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHH----------------------HHHHHHHHHhcCCCC--
Q 007177 23 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR----------------------ILREIKLLRLLRHPD-- 78 (614)
Q Consensus 23 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~----------------------i~~Ei~iL~~L~Hpn-- 78 (614)
.+.||+|+||.||+|.+. +|+.||||++............ ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999876 8999999998643221111111 135666666664433
Q ss_pred cceeeeEecCCCCCCCCcEEEEEecCCC-cHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeecCCCCcEEEC
Q 007177 79 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLH-QVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILAN 155 (614)
Q Consensus 79 Iv~l~~v~~~~~~~~~~~~ylV~E~~~g-~L~-~~i~~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~ 155 (614)
+.+++.. ...++||||+++ .+. ..+.... . ...++.++.+++.++.++|. .||+||||||+||+++
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD 149 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence 3333332 235899999996 221 1121111 1 16788999999999999999 9999999999999999
Q ss_pred CCCcEEEeecCcccccc
Q 007177 156 ANCKLKICDFGLARVAF 172 (614)
Q Consensus 156 ~~~~vKL~DFGla~~~~ 172 (614)
++.++|+|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=5.3e-16 Score=168.74 Aligned_cols=257 Identities=25% Similarity=0.250 Sum_probs=202.2
Q ss_pred CCeEEEeEeee--cCceEEEEEEE--CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCC
Q 007177 18 SRYKIQEVIGK--GSYGVVCSAID--THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 18 ~rY~i~~~LG~--G~~G~V~~a~d--~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~ 92 (614)
.++.+.+.+|. |.+|.||.+.. ..++..+|+|+-+..+.......+-++|+.-.+.++ |+|.++.+..+ +
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----e 188 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----E 188 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----c
Confidence 35678899999 99999999988 889999999986655554455556677888877775 99999977766 5
Q ss_pred CCCcEEEEEecCCCcHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHhCCeEeecCCCCcEEECCC-CcEEEeecC
Q 007177 93 DFKDIYVVFELMESDLHQVIKANDD-LTREHYQFFLYQLLR----ALKYIHTANVYHRDLKPKNILANAN-CKLKICDFG 166 (614)
Q Consensus 93 ~~~~~ylV~E~~~g~L~~~i~~~~~-lse~~~~~i~~QIl~----aL~yLHs~gIvHrDLKP~NILi~~~-~~vKL~DFG 166 (614)
+.+.+|+-+|+|+.+|..+...... +++..++.++.+.+. ||.++|+.+++|-|+||.||++..+ ..++++|||
T Consensus 189 ~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 189 GSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred cCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 6677999999999999988877655 889999999999999 9999999999999999999999999 889999999
Q ss_pred ccccccCCCCCcccc--ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC--ChhHHHHHHHhhh
Q 007177 167 LARVAFNDTPTTIFW--TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK--NVVHQLDLMTDLL 242 (614)
Q Consensus 167 la~~~~~~~~~~~~~--~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~--~~~~~l~~i~~~~ 242 (614)
+............+. ...-|...|++||++.+ -++...||++||.++.+-.++..++... +.+.++..+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~---- 341 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG---- 341 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc----
Confidence 998765544222111 11246667999999886 6889999999999999999987766544 332222111
Q ss_pred CCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 243 g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
..-.+.....+..+...+..|+..||..|++++.+++|+++...
T Consensus 342 ----------------------------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 342 ----------------------------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred ----------------------------cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 01112223455666779999999999999999999999998743
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.6e-15 Score=148.85 Aligned_cols=139 Identities=21% Similarity=0.280 Sum_probs=103.6
Q ss_pred eEee-ecCceEEEEEEECCCCcEEEEEEecCcc------C-----ChHHHHHHHHHHHHHHhcCCCCc--ceeeeEecCC
Q 007177 24 EVIG-KGSYGVVCSAIDTHTGEKVAIKKIHDIF------E-----HISDAARILREIKLLRLLRHPDI--VEIKHIMLPP 89 (614)
Q Consensus 24 ~~LG-~G~~G~V~~a~d~~tg~~vAIK~i~~~~------~-----~~~~~~~i~~Ei~iL~~L~HpnI--v~l~~v~~~~ 89 (614)
..|| .|+.|+||.+.. .+..++||.+.... . ......++.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4677 788888888855 37889999874210 0 11234567899999999998875 5565553221
Q ss_pred CCCCCCcEEEEEecCCC--cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCc
Q 007177 90 SRRDFKDIYVVFELMES--DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 167 (614)
Q Consensus 90 ~~~~~~~~ylV~E~~~g--~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGl 167 (614)
. ......++|||+++| +|.+++.. ..++++. +.||+.+|.+||++||+||||||+|||++.++.++|+|||.
T Consensus 115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 115 H-GLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred c-CcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 1 111123599999995 88888765 3566543 57899999999999999999999999999999999999998
Q ss_pred ccc
Q 007177 168 ARV 170 (614)
Q Consensus 168 a~~ 170 (614)
++.
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 865
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.2e-14 Score=133.28 Aligned_cols=131 Identities=24% Similarity=0.219 Sum_probs=107.1
Q ss_pred EEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC--CCcceeeeEecCCCCCCCCcEEE
Q 007177 22 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH--PDIVEIKHIMLPPSRRDFKDIYV 99 (614)
Q Consensus 22 i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~H--pnIv~l~~v~~~~~~~~~~~~yl 99 (614)
+++.||.|.++.||++.+. +..+++|.+..... ...+.+|+.+++.++| .++.+++.... ..+..|+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~-----~~~~~~~ 70 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGE-----SDGWSYL 70 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcC-----CCCccEE
Confidence 4688999999999999864 37899998865322 4567889999999976 58888877662 3356899
Q ss_pred EEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 100 VFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA---NVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 100 V~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~---gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
+|||+.+ .+..+ +......++.+++.+|++||.. +++|+||+|+||+++.++.++++|||++..
T Consensus 71 v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 71 LMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9999986 34332 5566778899999999999985 699999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.3e-13 Score=151.58 Aligned_cols=184 Identities=23% Similarity=0.352 Sum_probs=137.6
Q ss_pred eEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEE
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 99 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~yl 99 (614)
|.+ +..+-++.+..-.|..+.++.+|.|.+.+.... .....+.+-++-|+.|+||||+++++.+ +..+.+||
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~yl 86 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYL 86 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEE
Confidence 555 444444444322466778899999998875422 3455677889999999999999999988 56678999
Q ss_pred EEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCc
Q 007177 100 VFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH-TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 178 (614)
Q Consensus 100 V~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLH-s~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~ 178 (614)
|+|.+. .|..++++ ++...+...++||+.||.||| .++++|++|.-+.|+|+..|+.||++|.++.........
T Consensus 87 vTErV~-Pl~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~- 161 (690)
T KOG1243|consen 87 VTERVR-PLETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP- 161 (690)
T ss_pred Eeeccc-cHHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc-
Confidence 999986 34444443 447888999999999999997 789999999999999999999999999998764332210
Q ss_pred cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhC
Q 007177 179 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 222 (614)
Q Consensus 179 ~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG 222 (614)
.....---.|..|+.+.. .. -..|.|-|||+++|++.|
T Consensus 162 --~~~~~~~~s~~~P~~~~~--s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 162 --AKSLYLIESFDDPEEIDP--SE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cccchhhhcccChhhcCc--cc--cchhhhhHHHHHHHHhCc
Confidence 111122223677776653 12 458999999999999998
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.50 E-value=8.1e-15 Score=166.75 Aligned_cols=264 Identities=23% Similarity=0.267 Sum_probs=195.0
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
.+.+.+.+.+-+|+++.++.+.-..+|..+++|+..... ....+...+..+-.++-...+|-++...--+ .-..
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~rs 877 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCRS 877 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCCC
Confidence 355778889999999999999887888777777654321 1111233344444444444556666543332 2335
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
..+||++|+. ++|...+...+..+++-++.++..+..+++|||+..+.|||++|.|+|+..+++.++.|||........
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred CcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccc
Confidence 6899999998 599999988888999999999999999999999999999999999999999999999999844332111
Q ss_pred CCCc----------------------------cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCC
Q 007177 175 TPTT----------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 226 (614)
Q Consensus 175 ~~~~----------------------------~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF 226 (614)
.+.. ..-...++|+.|.+||.+.+ ......+|+|++|++++|.++|.+||
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg--~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG--RRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc--ccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0000 00123478999999999887 56788999999999999999999999
Q ss_pred CCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHH---
Q 007177 227 PGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE--- 303 (614)
Q Consensus 227 ~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~--- 303 (614)
...........| .....++.......++.+.+++.++|..+|.+|..+.
T Consensus 1036 na~tpq~~f~ni----------------------------~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~ 1087 (1205)
T KOG0606|consen 1036 NAETPQQIFENI----------------------------LNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAA 1087 (1205)
T ss_pred CCcchhhhhhcc----------------------------ccCCCCCCCCccccChhhhhhhhhhhccCchhccCccccc
Confidence 776644333222 1222333333345688999999999999999998887
Q ss_pred HHHcCcccccCC
Q 007177 304 EALADPYFKGLS 315 (614)
Q Consensus 304 eiL~hp~f~~~~ 315 (614)
++-.|++|+...
T Consensus 1088 e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1088 EVKGHPFFQDVD 1099 (1205)
T ss_pred ccccCCccCCCC
Confidence 888999998753
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=5.1e-14 Score=142.59 Aligned_cols=247 Identities=19% Similarity=0.203 Sum_probs=160.8
Q ss_pred EEEEEEECCCCcEEEEEEecCccCChHHHH--HHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecCC-CcHH
Q 007177 33 VVCSAIDTHTGEKVAIKKIHDIFEHISDAA--RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLH 109 (614)
Q Consensus 33 ~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~--~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~-g~L~ 109 (614)
.||++.+...|.+|+.-.+.....+.-..+ ....-+.-|-++-|-|||+++.++.+...++...+.++.|||+ |+|.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 356666666666665554432111111111 1111123344567999999999887766667778999999999 7999
Q ss_pred HHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeecCCCCcEEECCCCcEEEeecCcc--ccccCCCCCcccc
Q 007177 110 QVIKA----NDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANANCKLKICDFGLA--RVAFNDTPTTIFW 181 (614)
Q Consensus 110 ~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILi~~~~~vKL~DFGla--~~~~~~~~~~~~~ 181 (614)
+++++ ...+.....++|+.||+.||.|||+.. |+|+++..+.|++..+|-+|++--.-. ......... ...
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~-~Ek 239 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTRE-AEK 239 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhH-hhh
Confidence 98865 346889999999999999999999986 999999999999999998887632211 111100000 000
Q ss_pred ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCC-CCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHH
Q 007177 182 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260 (614)
Q Consensus 182 ~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~p-F~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~ 260 (614)
.-..+-+.|.+||.=.. .+.+-++|||++|+...+|..+..- -.+.+....-..| .+
T Consensus 240 ~~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~i--------------------a~ 297 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGTT--TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENI--------------------AN 297 (458)
T ss_pred hccccCCccccCCcCcc--cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhh--------------------hh
Confidence 11245678999996433 4556789999999999999877632 1111111000000 00
Q ss_pred HHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 261 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
. .+..-.+.-++++.+||+-.|..||++.++|.||.+-.+..
T Consensus 298 ~--------------i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhs 339 (458)
T KOG1266|consen 298 V--------------IIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHS 339 (458)
T ss_pred h--------------eeeccCccccCcCcccccCCCCCCcchhhhhcCceeeecch
Confidence 0 01112234567999999999999999999999999766554
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.37 E-value=5.8e-13 Score=148.20 Aligned_cols=141 Identities=19% Similarity=0.277 Sum_probs=96.7
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCC---------------------------h-----HHHHHHH-
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH---------------------------I-----SDAARIL- 65 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~---------------------------~-----~~~~~i~- 65 (614)
.|.. +.||+|++|.||+|+.+.+|+.||||+++..... . .-...+.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3554 7899999999999999888999999999743110 0 0112223
Q ss_pred -----HHHHHHHhc----CCCCcceeeeEecCCCCCCCCcEEEEEecCCC-cHHHH--HHhCC----CCCHHHHHHHHHH
Q 007177 66 -----REIKLLRLL----RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQV--IKAND----DLTREHYQFFLYQ 129 (614)
Q Consensus 66 -----~Ei~iL~~L----~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~g-~L~~~--i~~~~----~lse~~~~~i~~Q 129 (614)
+|...+.++ .+.+.+.+-+++. +..+..+||||||+| .+.++ +...+ .+.+..+..++.|
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~----d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYW----DYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeec----ccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 333333333 2444444445542 223456899999996 77653 33333 3556666667777
Q ss_pred HHHHHHHHHhCCeEeecCCCCcEEECCCC----cEEEeecCccccc
Q 007177 130 LLRALKYIHTANVYHRDLKPKNILANANC----KLKICDFGLARVA 171 (614)
Q Consensus 130 Il~aL~yLHs~gIvHrDLKP~NILi~~~~----~vKL~DFGla~~~ 171 (614)
|+ ..|++|+|+||.||+++.++ .++++|||++...
T Consensus 276 if-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 276 VF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 66 48999999999999999988 9999999998754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.35 E-value=5.8e-12 Score=138.21 Aligned_cols=140 Identities=21% Similarity=0.261 Sum_probs=94.3
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCccCChH--H------------------------------------HHHHH
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHIS--D------------------------------------AARIL 65 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~--~------------------------------------~~~i~ 65 (614)
+.||.|++|.||+|+.+ +|+.||||+.+......- + .-.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999864 799999999863211000 0 00133
Q ss_pred HHHHHHHhc----CCCCcceeeeEecCCCCCCCCcEEEEEecCCC-cHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHH
Q 007177 66 REIKLLRLL----RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAN-DDLTREHYQFFLYQLLR-ALKYIH 138 (614)
Q Consensus 66 ~Ei~iL~~L----~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~g-~L~~~i~~~-~~lse~~~~~i~~QIl~-aL~yLH 138 (614)
+|...+..+ +|.+-+.+-.++.. .....+|||||++| +|.++.... ..+. ...++.+++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~----~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWD----RTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehh----hcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH
Confidence 445444444 34444444444422 12346999999996 676665422 1222 2345566665 467899
Q ss_pred hCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 139 TANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 139 s~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
..|++|+|+||.||+++.++.++|+|||++...
T Consensus 275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred hCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999999999999999999999999999998654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.32 E-value=1e-11 Score=121.27 Aligned_cols=139 Identities=22% Similarity=0.274 Sum_probs=99.8
Q ss_pred EeEeeecCceEEEEEEECC------CCcEEEEEEecCc---cCC-----------------hHHHHHHH----HHHHHHH
Q 007177 23 QEVIGKGSYGVVCSAIDTH------TGEKVAIKKIHDI---FEH-----------------ISDAARIL----REIKLLR 72 (614)
Q Consensus 23 ~~~LG~G~~G~V~~a~d~~------tg~~vAIK~i~~~---~~~-----------------~~~~~~i~----~Ei~iL~ 72 (614)
...||.|--+.||.|.... .+..+|||+.+.. +.. ......+. +|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999997653 3579999987411 100 11122233 8999999
Q ss_pred hcCC--CCcceeeeEecCCCCCCCCcEEEEEecCCCc-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCeEeecCC
Q 007177 73 LLRH--PDIVEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFLYQLLRALKYI-HTANVYHRDLK 148 (614)
Q Consensus 73 ~L~H--pnIv~l~~v~~~~~~~~~~~~ylV~E~~~g~-L~~~i~~~~~lse~~~~~i~~QIl~aL~yL-Hs~gIvHrDLK 148 (614)
++.. -++..++.+ ..-+|||||++++ +..-......++++....++.|++.+|..| |..||||+||+
T Consensus 82 rl~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 8853 455555543 2348999999863 322112223466677888899999999998 89999999999
Q ss_pred CCcEEECCCCcEEEeecCccccc
Q 007177 149 PKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 149 P~NILi~~~~~vKL~DFGla~~~ 171 (614)
+.|||+. ++.+.|+|||.+...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 468999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.5e-12 Score=119.57 Aligned_cols=126 Identities=18% Similarity=0.164 Sum_probs=92.7
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcc-eeeeEecCCCCCCCCcEEEEE
Q 007177 23 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV-EIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 23 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv-~l~~v~~~~~~~~~~~~ylV~ 101 (614)
++.|+.|.++.||++... +..|++|....... ....+.+|+.+++.+.+.+++ +++... . ...++||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~--~~~~lv~ 70 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD-----P--ETGVLIT 70 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe-----C--CCCeEEE
Confidence 577899999999999754 78899998764321 122456899999988655543 444432 1 1247999
Q ss_pred ecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCe-----EeecCCCCcEEECCCCcEEEeecCccc
Q 007177 102 ELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV-----YHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 102 E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gI-----vHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
|+++| ++.+. .. ....++.+++++|..||+.++ +|+|++|.||+++ ++.++|+|||.+.
T Consensus 71 e~i~G~~l~~~-----~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 71 EFIEGSELLTE-----DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EecCCCccccc-----cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 99997 44322 01 123467899999999999985 9999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.8e-12 Score=138.89 Aligned_cols=250 Identities=21% Similarity=0.209 Sum_probs=179.8
Q ss_pred CCCeEEEeEeeecCceEEEEEEEC-CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDT-HTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~-~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~ 94 (614)
..+|..+..||.|.|+.|+.+.-. .++..|++|.+.+......+...-+.|+.+...+ .|.++++.+..+ ...
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-----~~~ 338 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW-----SQL 338 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc-----ccc
Confidence 356778999999999999887644 5778999999876655555544556777777766 499999987777 344
Q ss_pred CcEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC-CcEEEeecCcccccc
Q 007177 95 KDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARVAF 172 (614)
Q Consensus 95 ~~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~-~~vKL~DFGla~~~~ 172 (614)
...||=.|||++ ++...+.-...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||.+....
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 567899999984 444333333458888999999999999999999999999999999999886 788999999886411
Q ss_pred CCCCCccccccccCCcccc-CcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYR-APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~-APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
-. ......+-++. ..|++... ..+..+.|++|||.-+.+.+++.+.-...+.... |
T Consensus 419 ~~------~~~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~---i------------- 475 (524)
T KOG0601|consen 419 FS------SGVFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT---I------------- 475 (524)
T ss_pred ee------cccccccccccccchhhccc-cccccccccccccccccccccCcccCccccccee---e-------------
Confidence 00 11122333444 35555543 5678899999999999999998865433221100 0
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~ 312 (614)
... .....+....++..+.+.|+..|++.|+.+.++..|.=|.
T Consensus 476 ---------------~~~---~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 476 ---------------RSG---DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ---------------ecc---cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 000 0011233346788899999999999999999998887654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.9e-09 Score=115.71 Aligned_cols=215 Identities=18% Similarity=0.225 Sum_probs=156.8
Q ss_pred ceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecCC--CcH
Q 007177 31 YGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDL 108 (614)
Q Consensus 31 ~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~--g~L 108 (614)
-.+.|+|....+|..|++|.++.... ........-++.++++.|+|||.+.+++.... -++..+++|++|.+ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchH
Confidence 35679999999999999999942111 11112233467889999999999999997544 34567899999998 478
Q ss_pred HHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 109 HQVIKA---------------NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 109 ~~~i~~---------------~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
.++.-. +...+|+.+|.|+.||..||.+||+.|+..+-|.|.+||++.+.+++|...|.......
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 776522 23478899999999999999999999999999999999999999999999888766554
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCC-CCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~p-F~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
+.. |.+.+ -.+-|.=.||.+++.|.||..- +........ .
T Consensus 446 d~~-----------------~~le~-----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s--~--------------- 486 (655)
T KOG3741|consen 446 DPT-----------------EPLES-----QQQNDLRDLGLLLLALATGTENSNRTDSTQSS--H--------------- 486 (655)
T ss_pred CCC-----------------cchhH-----HhhhhHHHHHHHHHHHhhcccccccccchHHH--H---------------
Confidence 431 11221 2357888999999999999621 111110000 0
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
++ ...+.++.+++++|.-+...++++ -+++++|.|
T Consensus 487 ---------~~-----------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 487 ---------LT-----------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ---------HH-----------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 00 112456778899999998888877 789999876
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=9.9e-10 Score=108.35 Aligned_cols=142 Identities=17% Similarity=0.245 Sum_probs=102.2
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC--CCcceeeeEecCCCCCCCCcEEEEE
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH--PDIVEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~H--pnIv~l~~v~~~~~~~~~~~~ylV~ 101 (614)
+.|+.|..+.||++... +|+.+++|........ .....+.+|+.+++.+.+ .++.+++...... ...+..|+||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEEE
Confidence 67899999999999764 3689999987643211 134567899999999975 3456666654221 1123568999
Q ss_pred ecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 007177 102 ELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHT----------------------------------------- 139 (614)
Q Consensus 102 E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs----------------------------------------- 139 (614)
|+++| ++.+.+.. ..++++....++.+++++|..||+
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99997 45443321 346777777777888888877773
Q ss_pred ---------------CCeEeecCCCCcEEECC--CCcEEEeecCcccc
Q 007177 140 ---------------ANVYHRDLKPKNILANA--NCKLKICDFGLARV 170 (614)
Q Consensus 140 ---------------~gIvHrDLKP~NILi~~--~~~vKL~DFGla~~ 170 (614)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 56789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.9e-09 Score=101.06 Aligned_cols=143 Identities=22% Similarity=0.303 Sum_probs=104.2
Q ss_pred EEeEeeecCceEEEEEEECCCCcEEEEEEec-CccCC-----hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 22 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEH-----ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 22 i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~-~~~~~-----~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
.+..|-+|+-+.|+++ ...|+.++||.-. +...+ .-...+..+|+++|.++.--.|.-..=++. |..
T Consensus 11 ~l~likQGAEArv~~~--~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~-----D~~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRG--SFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFI-----DTY 83 (229)
T ss_pred cceeeeccceeeEeee--ccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEE-----ecC
Confidence 6788999999999999 4579998888643 22222 224567889999998875333322222221 222
Q ss_pred cEEEEEecCCC--cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC---cEEEeecCcc
Q 007177 96 DIYVVFELMES--DLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC---KLKICDFGLA 168 (614)
Q Consensus 96 ~~ylV~E~~~g--~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~---~vKL~DFGla 168 (614)
.-.|+|||.+| ++.+++.... ....+-...++.+|-+.|.-||.++|||+||..+||++..++ .+.|+|||++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 34799999998 8888887642 333344478999999999999999999999999999997665 3589999998
Q ss_pred ccc
Q 007177 169 RVA 171 (614)
Q Consensus 169 ~~~ 171 (614)
...
T Consensus 164 ~~s 166 (229)
T KOG3087|consen 164 SVS 166 (229)
T ss_pred hcc
Confidence 754
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.98 E-value=7.4e-09 Score=106.34 Aligned_cols=143 Identities=13% Similarity=0.080 Sum_probs=95.5
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEecCccCCh---------HHHHHHHHHHHHHHhcCCCCccee--eeEecCCCCCC
Q 007177 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI---------SDAARILREIKLLRLLRHPDIVEI--KHIMLPPSRRD 93 (614)
Q Consensus 25 ~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~---------~~~~~i~~Ei~iL~~L~HpnIv~l--~~v~~~~~~~~ 93 (614)
.+-......|+++. ..|+.|.||......... .......+|+..+..|..-+|... +.+........
T Consensus 29 ~v~~~~~rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 29 VFRELEGRRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred EEecCCCceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 33333333455653 467889999764321110 001136688888877743333222 22221111111
Q ss_pred CCcEEEEEecCCC--cHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC-------CCcEEE
Q 007177 94 FKDIYVVFELMES--DLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-------NCKLKI 162 (614)
Q Consensus 94 ~~~~ylV~E~~~g--~L~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~-------~~~vKL 162 (614)
....|||||++++ +|.+++.. ....++.....++.+|...+.-||.+||+|+||++.|||++. +..+.|
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L 186 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSV 186 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEE
Confidence 3457899999996 78888864 345667788899999999999999999999999999999975 467999
Q ss_pred eecCccc
Q 007177 163 CDFGLAR 169 (614)
Q Consensus 163 ~DFGla~ 169 (614)
+||+.+.
T Consensus 187 IDl~r~~ 193 (268)
T PRK15123 187 IDLHRAQ 193 (268)
T ss_pred EECCccc
Confidence 9999875
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.8e-10 Score=126.04 Aligned_cols=151 Identities=25% Similarity=0.371 Sum_probs=112.0
Q ss_pred HHHHHHHh-CCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCcccccc--------ccCCccccCcccccccCCC
Q 007177 132 RALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD--------YVATRWYRAPELCGSFFSK 202 (614)
Q Consensus 132 ~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~--------~vgt~~Y~APEvl~~~~~~ 202 (614)
.|+.|+|. .++||++|.|++|.++.++.+||+.|+++....+... ..+.. ......|.|||++.+ ..
T Consensus 110 dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~--~p~~~yd~~lp~~~~~~~~f~apE~~~~--~~ 185 (700)
T KOG2137|consen 110 DGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE--YPFSEYDPPLPLLLQPHLNFLAPEYLLG--TT 185 (700)
T ss_pred chhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc--cccccCCCCCChhhccCcccccchhhcc--cc
Confidence 89999995 6899999999999999999999999999876544221 11111 234567999999987 57
Q ss_pred CCCcccchhHHHHHHHHH-hCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCC
Q 007177 203 YTPAIDIWSIGCIFAEVL-TGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNAD 281 (614)
Q Consensus 203 y~~~~DIWSLG~Il~eLl-tG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s 281 (614)
.+.++|++||||++|.+. .|+..|.+.+.......-...+ .......-.+++
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~---------------------------~~~~~~~s~~~p 238 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL---------------------------NAGAFGYSNNLP 238 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc---------------------------ccccccccccCc
Confidence 789999999999999999 5777765554221111100000 000011125788
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 282 PSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 282 ~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
+++++=|.++|..|+..||++.+++..|||.+
T Consensus 239 ~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D 270 (700)
T KOG2137|consen 239 SELRESLKKLLNGDSAVRPTLDLLLSIPFFSD 270 (700)
T ss_pred HHHHHHHHHHhcCCcccCcchhhhhcccccCC
Confidence 99999999999999999999999999999975
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4e-09 Score=100.45 Aligned_cols=131 Identities=21% Similarity=0.309 Sum_probs=93.2
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEe-cCccCChH-----HHHHHHHHHHHHHhcCCC--CcceeeeEecCCCCCCCC
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKI-HDIFEHIS-----DAARILREIKLLRLLRHP--DIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i-~~~~~~~~-----~~~~i~~Ei~iL~~L~Hp--nIv~l~~v~~~~~~~~~~ 95 (614)
..+++|+-+.++.+.. -|..+++|.= .+...++. ...+..+|..+|..+.-- +..-++++. ..
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD-------~~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD-------PD 72 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc-------CC
Confidence 4578999999998843 4556677753 23222222 345677899999887532 333344443 23
Q ss_pred cEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 96 DIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 96 ~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
...|+|||.+| .|.+.+... ...+++.+=.-+.-||.+||+|+||.++||++..+. +.++||||+...
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 35799999998 566677654 145667777777889999999999999999998775 999999999753
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.3e-08 Score=100.62 Aligned_cols=129 Identities=22% Similarity=0.310 Sum_probs=92.5
Q ss_pred CCCcEEEEEEecCccC-----ChHHHHHHHHHHHHHHhcCCCC--cceeeeEecCCCCCCCCcEEEEEecCCC--cHHHH
Q 007177 41 HTGEKVAIKKIHDIFE-----HISDAARILREIKLLRLLRHPD--IVEIKHIMLPPSRRDFKDIYVVFELMES--DLHQV 111 (614)
Q Consensus 41 ~tg~~vAIK~i~~~~~-----~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~~~~~~~~~~ylV~E~~~g--~L~~~ 111 (614)
..++.|.+|....... ..-...+..+|...+..|..-. ..+.+.+..... ......|||+|++++ +|.++
T Consensus 30 ~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~ 108 (206)
T PF06293_consen 30 LVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDL 108 (206)
T ss_pred ccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHH
Confidence 3456677775432211 1133456778888887775322 223333322211 112456899999996 79999
Q ss_pred HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC---cEEEeecCcccc
Q 007177 112 IKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC---KLKICDFGLARV 170 (614)
Q Consensus 112 i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~---~vKL~DFGla~~ 170 (614)
+.....++......++.++...+.-||.+||+|+|+++.|||++.++ .+.|+||+.++.
T Consensus 109 ~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 109 LQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 98755578888899999999999999999999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.2e-08 Score=99.34 Aligned_cols=128 Identities=27% Similarity=0.295 Sum_probs=83.2
Q ss_pred EEEEEEECCCCcEEEEEEecCc----------------cC--------ChHHHHHHHHHHHHHHhcCCC--CcceeeeEe
Q 007177 33 VVCSAIDTHTGEKVAIKKIHDI----------------FE--------HISDAARILREIKLLRLLRHP--DIVEIKHIM 86 (614)
Q Consensus 33 ~V~~a~d~~tg~~vAIK~i~~~----------------~~--------~~~~~~~i~~Ei~iL~~L~Hp--nIv~l~~v~ 86 (614)
.||.|.. .+|..+|+|+.+.. +. .........+|.+.|..+..- ++.+++.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888876 46789999986411 00 011224467899999999755 456665543
Q ss_pred cCCCCCCCCcEEEEEecCC--CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCeEeecCCCCcEEECCCCcEEEe
Q 007177 87 LPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQLLRALKY-IHTANVYHRDLKPKNILANANCKLKIC 163 (614)
Q Consensus 87 ~~~~~~~~~~~ylV~E~~~--g~L~~~i~~~~~lse~~~~~i~~QIl~aL~y-LHs~gIvHrDLKP~NILi~~~~~vKL~ 163 (614)
.-+|||||++ |.....+.... ++.+....++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+
T Consensus 80 ---------~~~ivME~I~~~G~~~~~l~~~~-~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---------RNVIVMEYIGEDGVPLPRLKDVD-LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---------TTEEEEE--EETTEEGGCHHHCG-GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE-
T ss_pred ---------CCEEEEEecCCCccchhhHHhcc-ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEE
Confidence 2379999999 63223333221 2355677888899885555 689999999999999999888 99999
Q ss_pred ecCcccccc
Q 007177 164 DFGLARVAF 172 (614)
Q Consensus 164 DFGla~~~~ 172 (614)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=4.1e-08 Score=98.79 Aligned_cols=136 Identities=27% Similarity=0.296 Sum_probs=101.4
Q ss_pred eEEEeEeeecCceEEEEEEECCCCcEEEEEEec-------Cc---------cCChH----HHHHHHHHHHHHHhcCCC--
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-------DI---------FEHIS----DAARILREIKLLRLLRHP-- 77 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~-------~~---------~~~~~----~~~~i~~Ei~iL~~L~Hp-- 77 (614)
+.+...||-|--|.||.|.+. .|.++|||.=+ +. ..+.+ ......+|.++|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 457789999999999999875 68999999632 00 01111 123356899999998644
Q ss_pred CcceeeeEecCCCCCCCCcEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC
Q 007177 78 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA 156 (614)
Q Consensus 78 nIv~l~~v~~~~~~~~~~~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~ 156 (614)
.+.+.++ -+...+|||+.+| .|... ++..+....++..|++-+.-+-..||||+|+.+=|||++.
T Consensus 172 ~VP~P~~---------~nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 172 KVPKPIA---------WNRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCCccc---------cccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence 4544433 2457899999998 33332 2346667778888888888878999999999999999999
Q ss_pred CCcEEEeecCcccc
Q 007177 157 NCKLKICDFGLARV 170 (614)
Q Consensus 157 ~~~vKL~DFGla~~ 170 (614)
||.+.++||-.+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999987754
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.6e-07 Score=92.34 Aligned_cols=141 Identities=17% Similarity=0.154 Sum_probs=101.5
Q ss_pred eecCceEEEEEEECCCCcEEEEEEecCc----cCChHHHHHHHHHHHHHHhcCCCC--cceeeeEecCCCCCCCCcEEEE
Q 007177 27 GKGSYGVVCSAIDTHTGEKVAIKKIHDI----FEHISDAARILREIKLLRLLRHPD--IVEIKHIMLPPSRRDFKDIYVV 100 (614)
Q Consensus 27 G~G~~G~V~~a~d~~tg~~vAIK~i~~~----~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~~~~~~~~~~ylV 100 (614)
|+|+.|-|+.... .|+.+-+|.-.+. ...+.-...+.+|+..|+.|..-+ +.++. ++........-.-+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 5588888888743 4557888976421 111234566889999998886333 33332 1111111123347899
Q ss_pred EecCCC--cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCc--EEEeecCcccc
Q 007177 101 FELMES--DLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK--LKICDFGLARV 170 (614)
Q Consensus 101 ~E~~~g--~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~--vKL~DFGla~~ 170 (614)
+|-++| +|.+++... .+.++.....++.++...|.-||+.|+.|+|+-+.|||++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998884 999888653 34677888899999999999999999999999999999987777 99999997764
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=4.2e-07 Score=95.87 Aligned_cols=261 Identities=17% Similarity=0.168 Sum_probs=158.6
Q ss_pred EEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcce----eeeEecCCCCCCCCc
Q 007177 21 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVE----IKHIMLPPSRRDFKD 96 (614)
Q Consensus 21 ~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~----l~~v~~~~~~~~~~~ 96 (614)
...+.||+|+-+.+|-.-. -...+.|+....-- ........| +...-.||.+-. -.... .+. +....
T Consensus 14 ~~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Ppp--a~~aqk~a~--la~~p~~p~~~~rvaWPqa~L-~G~-~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPP--AAQAQKVAE--LAATPDAPLLNYRVAWPQATL-HGG-RRGKV 84 (637)
T ss_pred CCCccccCCccceeeecch---hhchhheeecCCCc--hHHHHHHHH--hccCCCCcchhhhhcccHHHh-hCC-Cccce
Confidence 3567899999999986622 22345577764311 111111111 112224554332 11111 111 12223
Q ss_pred EEEEEecCCC--cHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcc
Q 007177 97 IYVVFELMES--DLHQVIKA------NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 168 (614)
Q Consensus 97 ~ylV~E~~~g--~L~~~i~~------~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 168 (614)
+-++|..+.| .++.++.. .....++.+.+..+.|+.+.+-||..|.+-+|+.++|+|+++++.|.|.|=..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 7788888875 55555532 224678888999999999999999999999999999999999999999986544
Q ss_pred ccccCCCCCccccccccCCccccCccccc-ccC--CCCCCcccchhHHHHHHHHHhC-CCCCCCCChhHHHHHHHhhhCC
Q 007177 169 RVAFNDTPTTIFWTDYVATRWYRAPELCG-SFF--SKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLMTDLLGT 244 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~~vgt~~Y~APEvl~-~~~--~~y~~~~DIWSLG~Il~eLltG-~~pF~g~~~~~~l~~i~~~~g~ 244 (614)
....+ .......+|...|.+||+-. +.+ -.-+...|.|.||+++++||.| +.||.|-.. +.. .+.
T Consensus 165 qi~~n----g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~------~~~-ap~ 233 (637)
T COG4248 165 QINAN----GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPL------ISD-APN 233 (637)
T ss_pred eeccC----CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccc------cCC-CCC
Confidence 33221 22234568999999999643 111 2346679999999999999997 999987431 000 011
Q ss_pred CchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCC--CCCCCCHHH
Q 007177 245 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD--PKDRPTAEE 304 (614)
Q Consensus 245 p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~D--P~~Rpsa~e 304 (614)
|-+..|....--.+. +.-...++.+.+--|.-+++.+..|+.+|+..- +.-|||++-
T Consensus 234 p~E~~Ia~g~f~ya~---~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 234 PLETDIAHGRFAYAS---DQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred cchhhhhcceeeech---hccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 111111110000000 011123334444445568899999999999853 458999854
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.63 E-value=3e-07 Score=90.76 Aligned_cols=143 Identities=20% Similarity=0.263 Sum_probs=89.9
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHH-HHH------HHHHHHHHHhcCC---CCcceeeeEe
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISD-AAR------ILREIKLLRLLRH---PDIVEIKHIM 86 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~-~~~------i~~Ei~iL~~L~H---pnIv~l~~v~ 86 (614)
.++|++.+++-......|.+. ..+|+.+++|........... ... ..+++..+..+.. -.+..++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 568999999999888877766 456889999987643211110 111 1233343333332 2222222222
Q ss_pred cCCCCCCCCcEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeec
Q 007177 87 LPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 165 (614)
Q Consensus 87 ~~~~~~~~~~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DF 165 (614)
.-....--...++||||++| .|.+.. .+++. +...|..+|.-||+.|++|+|..|.|++++.+ .++++||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~----~i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE----DIDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch----hcCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEEC
Confidence 11111222345689999998 555442 13332 34567778899999999999999999999865 4999999
Q ss_pred Ccccc
Q 007177 166 GLARV 170 (614)
Q Consensus 166 Gla~~ 170 (614)
+..+.
T Consensus 179 ~~k~~ 183 (229)
T PF06176_consen 179 QGKRM 183 (229)
T ss_pred ccccc
Confidence 87653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.4e-06 Score=101.89 Aligned_cols=207 Identities=17% Similarity=0.219 Sum_probs=144.0
Q ss_pred HHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh
Q 007177 61 AARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHT 139 (614)
Q Consensus 61 ~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs 139 (614)
.....-|+..+..+.|+|++.++.+-+..-... ..+.+..++|.. ++...+..-+.++.+..+.+..++++||.|+|+
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 344445677778889999999988765432211 234556678885 888999888899999999999999999999999
Q ss_pred CCeEeecCCCC---cEEECCCCcEEEe--ecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHH
Q 007177 140 ANVYHRDLKPK---NILANANCKLKIC--DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGC 214 (614)
Q Consensus 140 ~gIvHrDLKP~---NILi~~~~~vKL~--DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~ 214 (614)
....|.-|... +--++.++.+.+. ||+..+........ ....-...+.++|.............|+|++|.
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~----~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS----FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccc----hhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 96666655555 4445666777777 88888765433221 122344557788877653233344579999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCH-HHHHHHHHhcC
Q 007177 215 IFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADP-SALRLLERLLA 293 (614)
Q Consensus 215 Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~-~l~dLI~~mL~ 293 (614)
++..+..|..+-.-.. .+ ....+..+. ...+++.+|+.
T Consensus 381 l~~~~~~~~~i~~~~~------~~-----------------------------------~~~l~~~~~~~~~d~~~~~~~ 419 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSA------VP-----------------------------------VSLLDVLSTSELLDALPKCLD 419 (1351)
T ss_pred HHhhhhhcCccccccc------ch-----------------------------------hhhhccccchhhhhhhhhhcc
Confidence 9999998774321100 00 001111121 67889999999
Q ss_pred CCCCCCCCHHHHHcCccccc
Q 007177 294 FDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 294 ~DP~~Rpsa~eiL~hp~f~~ 313 (614)
-|+++|+++.++|.|+|.+-
T Consensus 420 ~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 420 EDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred hhhhhccchhhhhhchhccc
Confidence 99999999999999999864
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.31 E-value=7.8e-06 Score=80.81 Aligned_cols=139 Identities=19% Similarity=0.226 Sum_probs=79.9
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC--cceeeeEecCCCCCCCCcEEEE
Q 007177 23 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD--IVEIKHIMLPPSRRDFKDIYVV 100 (614)
Q Consensus 23 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~~~~~~~~~~ylV 100 (614)
++.|+.|..+.||++.... ..+++|..... .....+.+|..+++.|.... +.+++...... ......+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~--~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD--EFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET--EETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccc--cccccceEE
Confidence 5789999999999997654 59999987642 45567778999998885332 44555432111 223347999
Q ss_pred EecCCC-cHHH----------------HHH---hC----CCCCHHH------HHHH---------------HHHHHH-HH
Q 007177 101 FELMES-DLHQ----------------VIK---AN----DDLTREH------YQFF---------------LYQLLR-AL 134 (614)
Q Consensus 101 ~E~~~g-~L~~----------------~i~---~~----~~lse~~------~~~i---------------~~QIl~-aL 134 (614)
|++++| .+.. .+. .. ..+.... ...+ ...+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 999997 4444 111 11 0111000 0000 011111 23
Q ss_pred HHHH-------hCCeEeecCCCCcEEEC-CCCcEEEeecCccc
Q 007177 135 KYIH-------TANVYHRDLKPKNILAN-ANCKLKICDFGLAR 169 (614)
Q Consensus 135 ~yLH-------s~gIvHrDLKP~NILi~-~~~~vKL~DFGla~ 169 (614)
..++ ...++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3333 24599999999999999 66667899999774
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.28 E-value=9.3e-06 Score=81.53 Aligned_cols=132 Identities=19% Similarity=0.215 Sum_probs=79.0
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC--cceeeeEecCCCCCCCCcEEEEE
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD--IVEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~~~~~~~~~~ylV~ 101 (614)
..||.|..+.||+. .+..+++|...... ....+.+|.++++.+..-. +.+++++. .+.+...+||
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~ 73 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIY 73 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeee
Confidence 57899999999984 25578888876421 2345688999998886332 45555554 2334467899
Q ss_pred ecCCCc--HHHHH---------------------HhC--CCCCHHH-HHHHHHHH----------HH-HHHHHH----hC
Q 007177 102 ELMESD--LHQVI---------------------KAN--DDLTREH-YQFFLYQL----------LR-ALKYIH----TA 140 (614)
Q Consensus 102 E~~~g~--L~~~i---------------------~~~--~~lse~~-~~~i~~QI----------l~-aL~yLH----s~ 140 (614)
|+++|. +...+ ..- ....... ...+-.+| .. ...+|. ..
T Consensus 74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~ 153 (226)
T TIGR02172 74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS 153 (226)
T ss_pred eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence 999983 11111 000 0111111 01111011 11 111222 12
Q ss_pred CeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 141 NVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 141 gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
.++|+|+.|.||+++.++ +.|+||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 478999999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.1e-05 Score=90.03 Aligned_cols=140 Identities=20% Similarity=0.318 Sum_probs=87.6
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCccCC---------------------------hH----H-HHH------HH
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH---------------------------IS----D-AAR------IL 65 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~---------------------------~~----~-~~~------i~ 65 (614)
+.|+.++-|.||+|+-+ +|+.||||+.+..... .. + .+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 78999999999999875 4999999987422111 00 0 011 23
Q ss_pred HHHHHHHhc----CCCCcceeeeEecCCCCCCCCcEEEEEecCCC-cHHHH--HHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 007177 66 REIKLLRLL----RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQV--IKANDDLTREHYQFFLYQLLRALKYIH 138 (614)
Q Consensus 66 ~Ei~iL~~L----~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~g-~L~~~--i~~~~~lse~~~~~i~~QIl~aL~yLH 138 (614)
+|...+..+ ++..-+.+=.+|.. -.+.-.|+|||++| .+.+. +++ ..++.+.+...+.++. +.-+-
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we----~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~ 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWE----YTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLL 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehh----ccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHH
Confidence 444444443 33333444455532 22445899999998 45544 444 3344333322222211 12233
Q ss_pred hCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 139 TANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 139 s~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
..|++|.|.+|.||+++.+|++.+.|||.....
T Consensus 283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred hcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 489999999999999999999999999988654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.12 E-value=4.7e-07 Score=99.86 Aligned_cols=244 Identities=15% Similarity=0.117 Sum_probs=164.1
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC-cceeeeEecCCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD-IVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn-Iv~l~~v~~~~~~~~~~ 95 (614)
..-|.....+++|+++.+++.+...+...+ .+++... ....-++++|.+++||| .+..++ +.+.+.
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~-----d~~~E~ 307 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLE-----DYDGED 307 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccc-----cCCccc
Confidence 344667778899999999999876665555 6666532 23345889999999999 433333 336677
Q ss_pred cEEEEEecCCCc--HHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 96 DIYVVFELMESD--LHQVI-KANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 96 ~~ylV~E~~~g~--L~~~i-~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
...++++++.+. ....+ ...-.+.+-+...+.+.-+++|++||+.-=+||| ||+..+ +..|..||+....+.
T Consensus 308 ~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 308 YLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLT 382 (829)
T ss_pred ccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccC
Confidence 889999999842 22111 1112344555666777788899999998778998 777655 579999999887654
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
... ..+...+|+.++|||+... ..+....|.|++|.--.+|--|-+|-...- ..+.. .|...
T Consensus 383 ~~~----~~~t~~~~~~~~~pev~~~--~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~----~g~~p------ 444 (829)
T KOG0576|consen 383 RTM----KPRTAIGTPEPLAPEVIQE--NTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPM----IGNGP------ 444 (829)
T ss_pred ccc----ccccCCCCCCCCCchhhcc--cccccCCCccCCCcchhhcCCCCCCCCCCc--cccCC----CCCCC------
Confidence 332 2345689999999999887 689999999999987777777777654311 00000 00000
Q ss_pred hhchhHHHHHHhhcccCCCccc--CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFS--QKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~--~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
....+. ..|... .-.++...||..-|..|+....++.|.+|++-
T Consensus 445 ----------------~s~~L~~~~aw~~~--~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 445 ----------------NSPMLTDKSAWSPV--FHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred ----------------CccccchhhhcCcc--cccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 000000 111111 11257788999999999999999999999864
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.12 E-value=2.4e-05 Score=78.35 Aligned_cols=137 Identities=20% Similarity=0.144 Sum_probs=92.6
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCccCC--------------------hHHHHH--HHHHHHHHHhcC--CCCc
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH--------------------ISDAAR--ILREIKLLRLLR--HPDI 79 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~--------------------~~~~~~--i~~Ei~iL~~L~--HpnI 79 (614)
..|+.|--+.||+|.. .++..+|+|+.+..... ...... ..+|+.-|+++. +=.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3666778889999964 56889999998522100 000111 246777777764 3334
Q ss_pred ceeeeEecCCCCCCCCcEEEEEecCCCcH--HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeecCCCCcEEECC
Q 007177 80 VEIKHIMLPPSRRDFKDIYVVFELMESDL--HQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANA 156 (614)
Q Consensus 80 v~l~~v~~~~~~~~~~~~ylV~E~~~g~L--~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~ 156 (614)
.+.+.+. +-.|||||++.+. .=.++ .-++..+++..+..++++.+.-|-. .|+||+||+.=|||+.
T Consensus 133 P~Pi~~~---------~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~- 201 (268)
T COG1718 133 PEPIAFR---------NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH- 201 (268)
T ss_pred CCceeec---------CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-
Confidence 4443332 2479999998431 00111 1134555788888999999998877 9999999999999999
Q ss_pred CCcEEEeecCcccccc
Q 007177 157 NCKLKICDFGLARVAF 172 (614)
Q Consensus 157 ~~~vKL~DFGla~~~~ 172 (614)
++.+.|+|||.|....
T Consensus 202 ~~~p~iID~~QaV~~~ 217 (268)
T COG1718 202 DGEPYIIDVSQAVTID 217 (268)
T ss_pred CCeEEEEECccccccC
Confidence 7799999999987543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.07 E-value=1.7e-05 Score=75.53 Aligned_cols=131 Identities=19% Similarity=0.252 Sum_probs=92.7
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
.-++.+.|++|.+|.||++. ..|..+|+|+-+. ++....+..|.++|..+.--++..=+-.| +..+
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~----ds~r~~l~kEakiLeil~g~~~~p~vy~y--------g~~~ 88 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGE--WRGGEVALKVRRR----DSPRRNLEKEAKILEILAGEGVTPEVYFY--------GEDF 88 (201)
T ss_pred hhhhhhhhhcccccEEEEee--ccCceEEEEEecC----CcchhhHHHHHHHHHHhhhcCCCceEEEe--------chhh
Confidence 34567899999999999995 4677999998653 34456688899999998866665432222 2345
Q ss_pred EEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCC-CCcEEECCCCcEEEeecCcccc
Q 007177 99 VVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLK-PKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 99 lV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLK-P~NILi~~~~~vKL~DFGla~~ 170 (614)
+.|||..| .|.+.-.. .+. .-+..+++..--|-..||-|..|. |..+++-.++.+.|+||..|+.
T Consensus 89 i~me~i~G~~L~~~~~~---~~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 89 IRMEYIDGRPLGKLEIG---GDR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcCcchhhhhhc---ccH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 77999998 66554321 122 334556666666888999999997 5555544555899999999874
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.96 E-value=8.2e-05 Score=75.11 Aligned_cols=71 Identities=15% Similarity=0.091 Sum_probs=46.3
Q ss_pred eEeeecCc-eEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCcEEEEE
Q 007177 24 EVIGKGSY-GVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 24 ~~LG~G~~-G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~~ylV~ 101 (614)
+.|..|.+ ..||++.. .+..+++|...... ...+.+|+.+++.+. +--+.++++... ..+.-++||
T Consensus 4 ~~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~lv~ 71 (244)
T cd05150 4 ERVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGS-----DDGRAWLLT 71 (244)
T ss_pred eecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEe-----cCCccEEEE
Confidence 34556665 78898854 34678888775421 345678999998884 434555665542 223468999
Q ss_pred ecCCC
Q 007177 102 ELMES 106 (614)
Q Consensus 102 E~~~g 106 (614)
|+++|
T Consensus 72 e~i~G 76 (244)
T cd05150 72 SAVPG 76 (244)
T ss_pred EeeCC
Confidence 99987
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.92 E-value=8.6e-05 Score=82.70 Aligned_cols=139 Identities=24% Similarity=0.306 Sum_probs=86.8
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEecCccCCh-----------------------------HHHHH------HHHH
Q 007177 23 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI-----------------------------SDAAR------ILRE 67 (614)
Q Consensus 23 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~-----------------------------~~~~~------i~~E 67 (614)
-+.||.-+.|.|++|+.+. |+.||||+-+...... .-.+. +.+|
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 4689999999999998766 9999999865322211 00111 2233
Q ss_pred HHHH----HhcCCCCc---ceeeeEecCCCCCCCCcEEEEEecCCC----cHHHHHHhCCCCCHHHHHHHHHHHHHHH-H
Q 007177 68 IKLL----RLLRHPDI---VEIKHIMLPPSRRDFKDIYVVFELMES----DLHQVIKANDDLTREHYQFFLYQLLRAL-K 135 (614)
Q Consensus 68 i~iL----~~L~HpnI---v~l~~v~~~~~~~~~~~~ylV~E~~~g----~L~~~i~~~~~lse~~~~~i~~QIl~aL-~ 135 (614)
.+-. +.+.|-++ |.+-.+|.. -...-.|+||||+| || +.|.+.+ ++...+.. .+.++. .
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~----~st~RVLtME~~~G~~i~Dl-~~i~~~g-i~~~~i~~---~l~~~~~~ 315 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWD----LSTKRVLTMEYVDGIKINDL-DAIDKRG-ISPHDILN---KLVEAYLE 315 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhh----cCcceEEEEEecCCccCCCH-HHHHHcC-CCHHHHHH---HHHHHHHH
Confidence 3322 33345551 223333321 12346899999996 55 4555554 55554333 333322 2
Q ss_pred HHHhCCeEeecCCCCcEEECC----CCcEEEeecCccccc
Q 007177 136 YIHTANVYHRDLKPKNILANA----NCKLKICDFGLARVA 171 (614)
Q Consensus 136 yLHs~gIvHrDLKP~NILi~~----~~~vKL~DFGla~~~ 171 (614)
-|-..|++|.|-.|.||++.. ++.+.+.|||+....
T Consensus 316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred HHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 244578999999999999984 678999999998754
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.92 E-value=6.1e-05 Score=73.74 Aligned_cols=141 Identities=26% Similarity=0.325 Sum_probs=95.8
Q ss_pred CccccccCCCCCCeEEEeEeeecCc-eEEEEEEECCCCcEEEEEEecC-----------ccC-Ch-------HHHHHHHH
Q 007177 7 EMEFFSEYGDASRYKIQEVIGKGSY-GVVCSAIDTHTGEKVAIKKIHD-----------IFE-HI-------SDAARILR 66 (614)
Q Consensus 7 ~~~~~~~~~~~~rY~i~~~LG~G~~-G~V~~a~d~~tg~~vAIK~i~~-----------~~~-~~-------~~~~~i~~ 66 (614)
...-|+.. ...++.++.||.|.- |.||++. -.|+.||+|++.. .+. .. .....+..
T Consensus 28 KL~~F~~h--~~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ 103 (207)
T PF13095_consen 28 KLEPFTHH--GDDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNC 103 (207)
T ss_pred CcCCcCCC--CCcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHH
Confidence 34445553 378999999999999 9999995 4688999999421 000 00 12234667
Q ss_pred HHHHHHhc---CCCCc--ceeeeEecCCC-------------CCCCCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHH
Q 007177 67 EIKLLRLL---RHPDI--VEIKHIMLPPS-------------RRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLY 128 (614)
Q Consensus 67 Ei~iL~~L---~HpnI--v~l~~v~~~~~-------------~~~~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~ 128 (614)
|....-+| .+.++ |++++.+.-.. ........||.||....- .++.++ +.
T Consensus 104 ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~~~----~~ 171 (207)
T PF13095_consen 104 ECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQIRD----IP 171 (207)
T ss_pred HHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccchhH----HH
Confidence 77665555 45666 88888774321 011223467888877532 233333 46
Q ss_pred HHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcc
Q 007177 129 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 168 (614)
Q Consensus 129 QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 168 (614)
+|++-|..+|..||+-+|+++.|.. .=||+|||.+
T Consensus 172 ~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 172 QMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 7788888899999999999999986 3489999965
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00015 Score=86.27 Aligned_cols=146 Identities=16% Similarity=0.299 Sum_probs=89.4
Q ss_pred EEeEeeecCceEEEEEEECCCC--cEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCc--ceeeeEecCCCCCCCCc
Q 007177 22 IQEVIGKGSYGVVCSAIDTHTG--EKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDI--VEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 22 i~~~LG~G~~G~V~~a~d~~tg--~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnI--v~l~~v~~~~~~~~~~~ 96 (614)
-++.|+.|.++.+|+......+ ..+++|+..... .......+.+|+.+|+.|. |.+| .+++..+.+. ...+.
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~-~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~ 118 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGK-LLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGT 118 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCc-cCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCC
Confidence 3678899999999998664432 467888764321 1122346789999999996 6664 6666655332 12345
Q ss_pred EEEEEecCCCcH-HH--------------------HHH---hCC----C---------CCHHHHHHHHHH----------
Q 007177 97 IYVVFELMESDL-HQ--------------------VIK---AND----D---------LTREHYQFFLYQ---------- 129 (614)
Q Consensus 97 ~ylV~E~~~g~L-~~--------------------~i~---~~~----~---------lse~~~~~i~~Q---------- 129 (614)
.|+||||++|.. .+ .+. .-. . +...++..|..+
T Consensus 119 ~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~ 198 (822)
T PLN02876 119 AFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKP 198 (822)
T ss_pred ceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCC
Confidence 789999998742 10 111 100 0 111233333222
Q ss_pred -----HHHHHHHHHh-----------CCeEeecCCCCcEEECCC-Cc-EEEeecCcccc
Q 007177 130 -----LLRALKYIHT-----------ANVYHRDLKPKNILANAN-CK-LKICDFGLARV 170 (614)
Q Consensus 130 -----Il~aL~yLHs-----------~gIvHrDLKP~NILi~~~-~~-vKL~DFGla~~ 170 (614)
+...+.+|.. ..+||+|+++.|||++.+ +. +-|.||+++..
T Consensus 199 ~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 199 PRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred CCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 2233556632 359999999999999853 33 57999999875
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00026 Score=71.24 Aligned_cols=31 Identities=32% Similarity=0.486 Sum_probs=26.0
Q ss_pred CCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 140 ANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 140 ~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
.+++|+|+.+.|||++.+...-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3589999999999998765567999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00022 Score=77.73 Aligned_cols=177 Identities=24% Similarity=0.339 Sum_probs=120.8
Q ss_pred HHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 007177 59 SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 138 (614)
Q Consensus 59 ~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLH 138 (614)
.....++-...+|+.+.|+|....+++.... -....+|||+++.+|.+.++.+. +-.....
T Consensus 24 ~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~----~~r~IVV~e~~~~Sled~~~~~~-l~~~s~~-------------- 84 (725)
T KOG1093|consen 24 PNSIQILGRFQYLKSLQHDNLCQYLDFSRGK----HERVIVVMEHYTMSLEDILKTGN-LKDESLL-------------- 84 (725)
T ss_pred CcHHHHhhhhHHHHhhcCccceeeEeeecCc----cceEEEEehhhccchHHHHHhcc-cchhhhc--------------
Confidence 3456677888999999999999998876432 23389999999999999887654 3222211
Q ss_pred hCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHH
Q 007177 139 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 218 (614)
Q Consensus 139 s~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~e 218 (614)
..|+.|- || ++.+| -++ +. | | ....+++||||+|.|+.+
T Consensus 85 ~~~~~~~-----~~-------~~~td-~~~-------------t~------~--~-------~~~~pKsdVwsl~~i~~e 123 (725)
T KOG1093|consen 85 AHGVLHL-----NI-------IYITD-HFL-------------TK------Y--P-------SPIGPKSDVWSLGFIILE 123 (725)
T ss_pred cccccee-----hh-------hhccc-ccc-------------cc------C--C-------CCCCcchhhhhHHHHHHH
Confidence 2222222 22 23333 000 00 1 1 112258999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCC
Q 007177 219 VLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD 298 (614)
Q Consensus 219 LltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~ 298 (614)
+..|...|......+++..|......+..-.+-..... . ...++....+++.+|+-..|..
T Consensus 124 l~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~---~----------------~~~~d~~~~~~~~~c~~~~~~i 184 (725)
T KOG1093|consen 124 LYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHL---I----------------QLLADKKRLPLLKKCLWLEPII 184 (725)
T ss_pred HHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHH---H----------------HHhhhHhHHHHhccCCcccccc
Confidence 99999999999999998888776655543332211110 0 0134567789999999999999
Q ss_pred CCCHHHHHcCcccccC
Q 007177 299 RPTAEEALADPYFKGL 314 (614)
Q Consensus 299 Rpsa~eiL~hp~f~~~ 314 (614)
||...++.+++-|...
T Consensus 185 r~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 185 RPLPMELSKRCSFTEV 200 (725)
T ss_pred ccchhHHhcCccHHHH
Confidence 9999999999998754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00074 Score=66.35 Aligned_cols=128 Identities=20% Similarity=0.263 Sum_probs=89.4
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCcc--------------CChHHHHHHHHHHHHHHhcC------CCCcceee
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF--------------EHISDAARILREIKLLRLLR------HPDIVEIK 83 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~--------------~~~~~~~~i~~Ei~iL~~L~------HpnIv~l~ 83 (614)
..||+|+.-.||.- . ......||++.... ..........+|+.....+. +..|.+++
T Consensus 7 ~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 57899999888765 3 34456788886532 11123455667777766665 78899999
Q ss_pred eEecCCCCCCCCcEEEEEecCC---C----cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC
Q 007177 84 HIMLPPSRRDFKDIYVVFELME---S----DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA 156 (614)
Q Consensus 84 ~v~~~~~~~~~~~~ylV~E~~~---g----~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~ 156 (614)
+.. ++....-+|+|... | +|.++++.. .+++ .+ ...+-+-..||-..+|+.+||+|.||++..
T Consensus 84 G~v-----eT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 84 GFV-----ETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEE-----ecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEe
Confidence 998 45566789998863 2 788888554 4666 33 333445557889999999999999999854
Q ss_pred CC----cEEEee
Q 007177 157 NC----KLKICD 164 (614)
Q Consensus 157 ~~----~vKL~D 164 (614)
+. .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 32 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.58 E-value=1.7e-05 Score=94.82 Aligned_cols=157 Identities=18% Similarity=0.129 Sum_probs=117.0
Q ss_pred HHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecCC-CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHH
Q 007177 62 ARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAN----DDLTREHYQFFLYQLLRALKY 136 (614)
Q Consensus 62 ~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~-g~L~~~i~~~----~~lse~~~~~i~~QIl~aL~y 136 (614)
+..+.|...++...|+++.....-..+ .+....|+++++|. |+++..|-+. .++.+.-+.....+.+.+..-
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~p---s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~ 1350 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPP---SESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNV 1350 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCC---CCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccch
Confidence 334456666677789998876655433 33456799999998 7999988643 234444444444444777777
Q ss_pred HHhCC-----eEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchh
Q 007177 137 IHTAN-----VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 211 (614)
Q Consensus 137 LHs~g-----IvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWS 211 (614)
+|+.. .+|++||+-|.+|..+-.+|++++|+.+.... ...+....++++.|++|++... -.++.++|+|.
T Consensus 1351 ~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp---~~sf~Gl~l~sp~~v~qli~N~--ik~t~rsdilr 1425 (2724)
T KOG1826|consen 1351 ILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP---VLSFFGLELCSPIYVLQLIKNE--IKFTKRSDILR 1425 (2724)
T ss_pred hhhcccCCccchhhhhhhhccceecCCcccccccccccccCc---hHhhhhhhhCCHHHHHHHHHHH--HhhhhHHHHHH
Confidence 77642 69999999999999999999999999984322 2233455678889999998776 57888899999
Q ss_pred HHHHHHHHHhCCCCC
Q 007177 212 IGCIFAEVLTGKPLF 226 (614)
Q Consensus 212 LG~Il~eLltG~~pF 226 (614)
.||.+|++..|..+|
T Consensus 1426 ~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1426 RSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHHHhcccHHH
Confidence 999999999988777
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00098 Score=66.71 Aligned_cols=72 Identities=11% Similarity=0.179 Sum_probs=45.4
Q ss_pred EeEeeecCceEEEEEEECC-CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC-cceeeeEecCCCCCCCCcEEEE
Q 007177 23 QEVIGKGSYGVVCSAIDTH-TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD-IVEIKHIMLPPSRRDFKDIYVV 100 (614)
Q Consensus 23 ~~~LG~G~~G~V~~a~d~~-tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn-Iv~l~~v~~~~~~~~~~~~ylV 100 (614)
++.|..|-...+|++.... .++.|++|+...... ......+|+.+++.+.... ..+++... .+ .+|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~~----~~l 70 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATF-----QN----GLI 70 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEe-----CC----cEE
Confidence 5678889899999996433 357899997653211 1122347888988885333 34444332 11 379
Q ss_pred EecCCC
Q 007177 101 FELMES 106 (614)
Q Consensus 101 ~E~~~g 106 (614)
|||++|
T Consensus 71 ~e~i~G 76 (235)
T cd05157 71 YEFIPG 76 (235)
T ss_pred EEeeCC
Confidence 999886
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0021 Score=69.71 Aligned_cols=77 Identities=21% Similarity=0.201 Sum_probs=53.0
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEecCcc----C-ChHHHHHHHHHHHHHHhcC---CCCcceeeeEecCCCCCCC
Q 007177 23 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF----E-HISDAARILREIKLLRLLR---HPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 23 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~----~-~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~v~~~~~~~~~ 94 (614)
.+.||.|.+..||++.+...++.++||.-.... . ......+...|...|+.+. ...+.+++.+- .
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-------~ 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-------E 103 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-------C
Confidence 478999999999999886444689999753111 1 1234567778888888763 24566666652 2
Q ss_pred CcEEEEEecCCC
Q 007177 95 KDIYVVFELMES 106 (614)
Q Consensus 95 ~~~ylV~E~~~g 106 (614)
...++|||++++
T Consensus 104 ~~~~lVME~L~~ 115 (401)
T PRK09550 104 ELAVTVMEDLSD 115 (401)
T ss_pred CCCEEEEecCCC
Confidence 346899999974
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0011 Score=69.65 Aligned_cols=153 Identities=16% Similarity=0.141 Sum_probs=85.9
Q ss_pred ccccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC--cceeeeEec
Q 007177 10 FFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD--IVEIKHIML 87 (614)
Q Consensus 10 ~~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~ 87 (614)
++..|+. +....++.++.|....+|++.. ++..+++|+..... ....+..|+.+++.|.... +.+++....
T Consensus 15 ~l~~y~~-~~~~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~ 87 (307)
T TIGR00938 15 FLDGYDL-GELLSLKGIAEGVENSNYLLTT--DVGRYILTLYEKRV----KAEELPFFLALTTHLAARGLPVPKPVKSRD 87 (307)
T ss_pred HHHhcCC-CCceeccccCCccccceEEEEe--CCCcEEEEEecCCC----CHHHHHHHHHHHHHHHHCCCCCCccccCCC
Confidence 3445543 3455677888888889998853 34468888765421 1234556778887775322 333333110
Q ss_pred CC-CCCCCCcEEEEEecCCCc-H-----H------HHH---H-hCCCC--------CHHHH-----H----------HHH
Q 007177 88 PP-SRRDFKDIYVVFELMESD-L-----H------QVI---K-ANDDL--------TREHY-----Q----------FFL 127 (614)
Q Consensus 88 ~~-~~~~~~~~ylV~E~~~g~-L-----~------~~i---~-~~~~l--------se~~~-----~----------~i~ 127 (614)
.. .....+..++|+||++|. + . ..+ . ....+ ..... . ...
T Consensus 88 g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~ 167 (307)
T TIGR00938 88 GRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMG 167 (307)
T ss_pred CCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHH
Confidence 00 001235578999998861 1 1 011 0 00111 00000 0 001
Q ss_pred HHHHHHHHHHHh-------CCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 128 YQLLRALKYIHT-------ANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 128 ~QIl~aL~yLHs-------~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
..+...+.++.. .++||+|+.+.||+++.++.+.|+||+.+.
T Consensus 168 ~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 168 AELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 122334555542 689999999999999998877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00065 Score=66.23 Aligned_cols=98 Identities=22% Similarity=0.223 Sum_probs=78.1
Q ss_pred HHHHHHHHhcCC-CCcceeeeEecCCCCCCCCcEEEEEecCC-CcHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHh
Q 007177 65 LREIKLLRLLRH-PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQV---IKANDDLTREHYQFFLYQLLRALKYIHT 139 (614)
Q Consensus 65 ~~Ei~iL~~L~H-pnIv~l~~v~~~~~~~~~~~~ylV~E~~~-g~L~~~---i~~~~~lse~~~~~i~~QIl~aL~yLHs 139 (614)
..|.-+|+.|.+ +++.++++.+ + -++|.||.. +++... +..--..+++....|+.++++.+.+|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C--------G-~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC--------G-RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC--------C-CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 358889999976 6999999987 2 267889998 444321 1111246899999999999999999998
Q ss_pred ---CCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 140 ---ANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 140 ---~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
..+.-.|++|+|+-+++++++|++|...+...
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 45888999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.00075 Score=68.74 Aligned_cols=132 Identities=16% Similarity=0.236 Sum_probs=74.7
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCc-ceeeeEecCCCCCCCCcEEEEEec
Q 007177 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI-VEIKHIMLPPSRRDFKDIYVVFEL 103 (614)
Q Consensus 25 ~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnI-v~l~~v~~~~~~~~~~~~ylV~E~ 103 (614)
.+..|-.+.+|+.. .++..+++|......... .....+|..+|+.+..-.+ .+++... . -++||||
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~ 69 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEW 69 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEe
Confidence 35678888899885 457788898754321111 0124678899988864333 2333322 1 2689999
Q ss_pred CCC-cHH--------------HHHHh---C----CCCCH-HHHHHHHHHH---------HHHHHHHHh--------CCeE
Q 007177 104 MES-DLH--------------QVIKA---N----DDLTR-EHYQFFLYQL---------LRALKYIHT--------ANVY 143 (614)
Q Consensus 104 ~~g-~L~--------------~~i~~---~----~~lse-~~~~~i~~QI---------l~aL~yLHs--------~gIv 143 (614)
++| .+. +.+.+ . ..++. ..+..+..++ ...+..+-. ..++
T Consensus 70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 986 221 11111 0 11121 1222322222 111222221 2589
Q ss_pred eecCCCCcEEECCCCcEEEeecCcccc
Q 007177 144 HRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 144 HrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
|+|+.|.||+++.++ +.|+||+.|..
T Consensus 150 H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 150 HMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 999999999999877 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0055 Score=64.09 Aligned_cols=79 Identities=13% Similarity=0.102 Sum_probs=52.8
Q ss_pred eEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC---CCcceeeeEecCCCCCCCCc
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH---PDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~H---pnIv~l~~v~~~~~~~~~~~ 96 (614)
-.-.+.||.|..+.||...+. +..+++|..+. ......+.+|...|+.|.. -.+.++++++... ...+.
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~--~~~g~ 87 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDS--QGNPMPLMARS----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE--QSPGP 87 (297)
T ss_pred hheeeecCCccceeEEEEEcC--CCCEEEEEecc----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC--CcCCC
Confidence 344678999999999998532 23566776432 1123467889999988853 3567777665332 12345
Q ss_pred EEEEEecCCC
Q 007177 97 IYVVFELMES 106 (614)
Q Consensus 97 ~ylV~E~~~g 106 (614)
-|||||+++|
T Consensus 88 ~~LVmE~i~G 97 (297)
T PRK10593 88 DVLLLERLRG 97 (297)
T ss_pred eEEEEeccCC
Confidence 7999999885
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0036 Score=65.81 Aligned_cols=30 Identities=30% Similarity=0.306 Sum_probs=26.0
Q ss_pred CCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 140 ANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 140 ~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 389999999999999876556899999875
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0018 Score=67.28 Aligned_cols=149 Identities=15% Similarity=0.075 Sum_probs=85.0
Q ss_pred ccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC--cceeeeEecCC
Q 007177 12 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD--IVEIKHIMLPP 89 (614)
Q Consensus 12 ~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~~ 89 (614)
..|+. +...-++.|..|....+|++.. .+..+++|+... .....+..|+.++..|.+-. +.+++... .+
T Consensus 9 ~~y~~-~~~~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~-~g 79 (296)
T cd05153 9 ADYDL-GELLSFEGISAGIENTNYFVTT--DSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADR-DG 79 (296)
T ss_pred HHcCC-CchhheecccCccccceEEEEe--CCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCC-CC
Confidence 34442 2333367788888889999853 345788998753 12345677888888885332 34433311 00
Q ss_pred C--CCCCCcEEEEEecCCC-cH--------HHHHH-------hCCCCCH--------HHHH------------HHHHHHH
Q 007177 90 S--RRDFKDIYVVFELMES-DL--------HQVIK-------ANDDLTR--------EHYQ------------FFLYQLL 131 (614)
Q Consensus 90 ~--~~~~~~~ylV~E~~~g-~L--------~~~i~-------~~~~lse--------~~~~------------~i~~QIl 131 (614)
. ....+..++|+++++| .+ .++.+ ....+.. .... .....+.
T Consensus 80 ~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 159 (296)
T cd05153 80 EYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLA 159 (296)
T ss_pred cEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHH
Confidence 0 0123457899999986 21 11100 0000000 0000 0111123
Q ss_pred HHHHHHHh-------CCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 132 RALKYIHT-------ANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 132 ~aL~yLHs-------~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
.++.++.. .+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 160 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 160 DELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 34445443 479999999999999998777899999774
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0031 Score=65.74 Aligned_cols=72 Identities=15% Similarity=0.099 Sum_probs=44.4
Q ss_pred EeEeeecCceEEEEEEECC------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCc-ceeeeEecCCCCCCCC
Q 007177 23 QEVIGKGSYGVVCSAIDTH------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI-VEIKHIMLPPSRRDFK 95 (614)
Q Consensus 23 ~~~LG~G~~G~V~~a~d~~------tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnI-v~l~~v~~~~~~~~~~ 95 (614)
++.|..|-...||++.... +++.+++|+..... .......+|+.+++.+....+ .+++..+. +
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-----~-- 72 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFP-----N-- 72 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeC-----C--
Confidence 4567778788899886433 25789999875422 122345688888888853333 34444331 1
Q ss_pred cEEEEEecCCC
Q 007177 96 DIYVVFELMES 106 (614)
Q Consensus 96 ~~ylV~E~~~g 106 (614)
.+|+||++|
T Consensus 73 --~~v~e~i~G 81 (302)
T cd05156 73 --GRIEEFIPS 81 (302)
T ss_pred --CchhheeCC
Confidence 257888775
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.001 Score=69.07 Aligned_cols=136 Identities=19% Similarity=0.222 Sum_probs=94.2
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecC---ccC---------------ChHHHH--HHHHHHHHHHhcC-CC
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHD---IFE---------------HISDAA--RILREIKLLRLLR-HP 77 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~---~~~---------------~~~~~~--~i~~Ei~iL~~L~-Hp 77 (614)
-|.+++.||-|.-+-||.+.+ ..|...++|.=.- .|. ..-... ...+|+..|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 366889999999999999976 4578888884210 000 011112 2357888888875 32
Q ss_pred C-cceeeeEecCCCCCCCCcEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEEC
Q 007177 78 D-IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 155 (614)
Q Consensus 78 n-Iv~l~~v~~~~~~~~~~~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~ 155 (614)
. +.+. -+.+..++|||++.| .|.++-.- ..+..+...|..-+.-|-..|+||+|..-=||+++
T Consensus 172 fpVPkp---------iD~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 172 FPVPKP---------IDHNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCCc---------ccccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEe
Confidence 2 2222 244568999999997 66654321 12334556666677789999999999999999999
Q ss_pred CCCcEEEeecCcccc
Q 007177 156 ANCKLKICDFGLARV 170 (614)
Q Consensus 156 ~~~~vKL~DFGla~~ 170 (614)
+++.++++||-....
T Consensus 237 dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMVS 251 (465)
T ss_pred cCCCEEEeechHhhc
Confidence 999999999986643
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.011 Score=62.27 Aligned_cols=145 Identities=17% Similarity=0.197 Sum_probs=82.7
Q ss_pred eEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC--cceeeeEecCCCCCCCCcE
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD--IVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~~~~~~~~~~ 97 (614)
-.+++.+..|....+|...+. ++++++. ...............+|+.+++.+.--. +...+.++.... .+..
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~---~g~p 100 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY---LGTP 100 (321)
T ss_pred CceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC---CCCc
Confidence 345666656655566666554 7888888 3322233445666778888888774322 222333332211 3567
Q ss_pred EEEEecCCC-cHH------------------HHHHhC--------------CCCCHHHHHHHHHHH--------------
Q 007177 98 YVVFELMES-DLH------------------QVIKAN--------------DDLTREHYQFFLYQL-------------- 130 (614)
Q Consensus 98 ylV~E~~~g-~L~------------------~~i~~~--------------~~lse~~~~~i~~QI-------------- 130 (614)
|.||++++| .+. +++..- +.....++..+..+.
T Consensus 101 f~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 101 FYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred eEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 999999987 211 111100 001111222222222
Q ss_pred HHHHHHHHhC--------CeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 131 LRALKYIHTA--------NVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 131 l~aL~yLHs~--------gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
..-..||+.+ .++|+|+++.||+++.++.+=|+||+++..
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 1223344332 489999999999999998899999999875
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0099 Score=63.48 Aligned_cols=82 Identities=17% Similarity=0.109 Sum_probs=53.5
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEec----Cc-cCChHHHHHHHHHHHHHHhcC--CC-CcceeeeEecCCCCCCCCc
Q 007177 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIH----DI-FEHISDAARILREIKLLRLLR--HP-DIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 25 ~LG~G~~G~V~~a~d~~tg~~vAIK~i~----~~-~~~~~~~~~i~~Ei~iL~~L~--Hp-nIv~l~~v~~~~~~~~~~~ 96 (614)
.||.|....||++.+...++.++||.-. .. ........+..-|...|+... .| .+.+++.+ +...
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-------D~e~ 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-------DTEM 74 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-------cccc
Confidence 5799999999999875444689999743 11 122345567778888887764 34 45555543 3344
Q ss_pred EEEEEecCCC--cHHHHHH
Q 007177 97 IYVVFELMES--DLHQVIK 113 (614)
Q Consensus 97 ~ylV~E~~~g--~L~~~i~ 113 (614)
..+|||+++. .|.+.+.
T Consensus 75 ~~~vMEdL~~~~ilR~~Li 93 (370)
T TIGR01767 75 AVTVMEDLSHHKIARKGLI 93 (370)
T ss_pred ceehHhhCccchHHHHHHH
Confidence 5799999963 4545443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.01 Score=64.11 Aligned_cols=89 Identities=21% Similarity=0.169 Sum_probs=58.7
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEec----CccCChHHHHHHHHHHHHHHhcC--CC-CcceeeeEecCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAARILREIKLLRLLR--HP-DIVEIKHIMLPP 89 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~----~~~~~~~~~~~i~~Ei~iL~~L~--Hp-nIv~l~~v~~~~ 89 (614)
.+.+. .+.||.|.-..||++.+...++.|+||.-. ..........+..-|...|+.+. .| .+.+++.+
T Consensus 29 ~~~~~-~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~---- 103 (409)
T PRK12396 29 AKGLQ-CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF---- 103 (409)
T ss_pred cccce-eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE----
Confidence 34444 678999999999999875446789999642 11122445677788899998764 34 45555543
Q ss_pred CCCCCCcEEEEEecCCC--cHHHHHH
Q 007177 90 SRRDFKDIYVVFELMES--DLHQVIK 113 (614)
Q Consensus 90 ~~~~~~~~ylV~E~~~g--~L~~~i~ 113 (614)
+.....+|||+++. .|.+.+.
T Consensus 104 ---D~e~~~~vMEdL~~~~ilR~~Li 126 (409)
T PRK12396 104 ---DSVMNCCVMEDLSDHTILRTALI 126 (409)
T ss_pred ---CcHHhhHHHHhCcccHHHHHHHH
Confidence 33456789999863 4555443
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.023 Score=59.34 Aligned_cols=29 Identities=24% Similarity=0.381 Sum_probs=25.6
Q ss_pred CCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 140 ANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 140 ~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57999999999999987 578999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.037 Score=57.33 Aligned_cols=30 Identities=30% Similarity=0.529 Sum_probs=25.4
Q ss_pred CeEeecCCCCcEEECCCCc-EEEeecCcccc
Q 007177 141 NVYHRDLKPKNILANANCK-LKICDFGLARV 170 (614)
Q Consensus 141 gIvHrDLKP~NILi~~~~~-vKL~DFGla~~ 170 (614)
.++|+|++|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 56999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.042 Score=57.65 Aligned_cols=30 Identities=17% Similarity=0.128 Sum_probs=27.7
Q ss_pred CeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 141 NVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 141 gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
++||+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.025 Score=59.97 Aligned_cols=140 Identities=22% Similarity=0.275 Sum_probs=92.5
Q ss_pred EEeEeeecCceEEEEEEECCCCcEEEEEEecCcc----------------------CChHHHHHH--HHHHHHHHhcCCC
Q 007177 22 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF----------------------EHISDAARI--LREIKLLRLLRHP 77 (614)
Q Consensus 22 i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~----------------------~~~~~~~~i--~~Ei~iL~~L~Hp 77 (614)
|-..|..|--..||.|.. .+|..+|||+++... .++...-++ ..|+.-|.+|..-
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 445677888889999964 578889999875210 011112222 3577777777655
Q ss_pred CcceeeeEecCCCCCCCCcEEEEEecCCCcHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHH-HhCCeEeecCCCCcEEEC
Q 007177 78 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVI-KANDDLTREHYQFFLYQLLRALKYI-HTANVYHRDLKPKNILAN 155 (614)
Q Consensus 78 nIv~l~~v~~~~~~~~~~~~ylV~E~~~g~L~~~i-~~~~~lse~~~~~i~~QIl~aL~yL-Hs~gIvHrDLKP~NILi~ 155 (614)
.|.-..-+++ ....|||++++.+=+-.- ...-.++...+..+-.|++.-+.-| |.+++||.||.==|+|+-
T Consensus 227 GIP~PePIlL-------k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 227 GIPCPEPILL-------KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCCceee-------ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE
Confidence 5443333332 335799999984322111 1223577778877777777777665 678999999999999985
Q ss_pred CCCcEEEeecCcccc
Q 007177 156 ANCKLKICDFGLARV 170 (614)
Q Consensus 156 ~~~~vKL~DFGla~~ 170 (614)
+ |.|.|+|.+.+..
T Consensus 300 d-G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 300 D-GKLYIIDVSQSVE 313 (520)
T ss_pred C-CEEEEEEcccccc
Confidence 4 5899999987754
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.075 Score=57.84 Aligned_cols=76 Identities=16% Similarity=0.165 Sum_probs=50.4
Q ss_pred EEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-----ChHHHHHHHHHHHHHHhcC---CCCcceeeeEecCCCCCC
Q 007177 22 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-----HISDAARILREIKLLRLLR---HPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 22 i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-----~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~v~~~~~~~~ 93 (614)
..+.||.|....||+..+ .+..++||.-..... ......+...|...|+.+. ...+.+++.+..
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de------ 107 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR------ 107 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC------
Confidence 467899999999999876 345689997541111 1124455566777777664 246777777652
Q ss_pred CCcEEEEEecCCC
Q 007177 94 FKDIYVVFELMES 106 (614)
Q Consensus 94 ~~~~ylV~E~~~g 106 (614)
...+++||++++
T Consensus 108 -d~~vlvME~L~~ 119 (418)
T PLN02756 108 -TMALIGMRYLEP 119 (418)
T ss_pred -CCCEEEEeecCC
Confidence 335789999975
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.085 Score=56.40 Aligned_cols=139 Identities=15% Similarity=0.141 Sum_probs=77.3
Q ss_pred CCeEEEeEeeecCceEEEEEEECC----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCc-ceeeeEecCCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTH----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI-VEIKHIMLPPSRR 92 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~----tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnI-v~l~~v~~~~~~~ 92 (614)
+... ++.|..|-...+|++.... +++.|++|+...... .... ..+|+.+++.+..-++ .++++.+ .
T Consensus 37 ~~~~-i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~--~~id-R~~E~~~~~~l~~~gl~P~~~~~~-----~ 107 (344)
T PLN02236 37 EALQ-VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE--LFFD-RDDEIRTFECMSRHGQGPRLLGRF-----P 107 (344)
T ss_pred CcEE-EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC--eeec-hHHHHHHHHHHHHcCCCCceEEEE-----C
Confidence 3444 4556668888999986422 346899998764211 1112 2578888888864333 2344443 1
Q ss_pred CCCcEEEEEecCCC-cHH-----------HH---HH---hCC------CCCHHHHHHHHHHHH-----------------
Q 007177 93 DFKDIYVVFELMES-DLH-----------QV---IK---AND------DLTREHYQFFLYQLL----------------- 131 (614)
Q Consensus 93 ~~~~~ylV~E~~~g-~L~-----------~~---i~---~~~------~lse~~~~~i~~QIl----------------- 131 (614)
+ ..|.||+++ +|. .+ +. ... ....+.+..++.++.
T Consensus 108 ~----g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~ 183 (344)
T PLN02236 108 N----GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLE 183 (344)
T ss_pred C----ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHH
Confidence 1 147888764 221 11 11 000 111233334432221
Q ss_pred HHHHHH----H----hCCeEeecCCCCcEEECC-CCcEEEeecCccc
Q 007177 132 RALKYI----H----TANVYHRDLKPKNILANA-NCKLKICDFGLAR 169 (614)
Q Consensus 132 ~aL~yL----H----s~gIvHrDLKP~NILi~~-~~~vKL~DFGla~ 169 (614)
..+..| . ...++|+||++.|||++. ++.+.|+||..|.
T Consensus 184 ~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 184 DEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 111112 1 235899999999999976 4689999998774
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.064 Score=56.97 Aligned_cols=28 Identities=32% Similarity=0.444 Sum_probs=24.8
Q ss_pred eEeecCCCCcEEECC-CCcEEEeecCccc
Q 007177 142 VYHRDLKPKNILANA-NCKLKICDFGLAR 169 (614)
Q Consensus 142 IvHrDLKP~NILi~~-~~~vKL~DFGla~ 169 (614)
++|.||.+.|||+++ ++.++++||+.|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 799999999999975 5789999999774
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.69 E-value=0.33 Score=52.68 Aligned_cols=29 Identities=31% Similarity=0.326 Sum_probs=24.3
Q ss_pred CCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 140 ANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 140 ~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
..++|.||-+.|||.+++ .++++||..|.
T Consensus 227 ~VfCHNDL~~gNIL~~~~-~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ-GIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecCC-CEEEEEecccc
Confidence 468999999999997654 69999998763
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.22 E-value=0.37 Score=50.23 Aligned_cols=74 Identities=15% Similarity=0.108 Sum_probs=43.3
Q ss_pred eEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC--C-CCcceeeeEecCCCCCCCCc
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR--H-PDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~--H-pnIv~l~~v~~~~~~~~~~~ 96 (614)
-+-.+.|+.|....+|+.. .+++.+.+|.-.. .....+..|..-|+.|. . -.+.+++.+-.. .+.
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~-----~~~ 86 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY-----DDD 86 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE------SSC
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee-----cCC
Confidence 4456789999999999985 7788999997652 22345667888888774 2 235555555422 223
Q ss_pred EEEEEecCC
Q 007177 97 IYVVFELME 105 (614)
Q Consensus 97 ~ylV~E~~~ 105 (614)
-||||||++
T Consensus 87 ~fLlle~l~ 95 (288)
T PF03881_consen 87 AFLLLEFLE 95 (288)
T ss_dssp CEEEEE---
T ss_pred ceEEEEeec
Confidence 499999986
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.26 E-value=0.16 Score=53.97 Aligned_cols=74 Identities=23% Similarity=0.365 Sum_probs=57.2
Q ss_pred CCCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 93 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 93 ~~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
+..+.|++|++-.+.|.- ++ .-..+++..|+++-+..+.-+..+ .+-||||...||||+ +|.|-|+||-++|..
T Consensus 297 e~~y~yl~~kdhgt~is~-ik---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 297 ETLYLYLHFKDHGTPISI-IK---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred CceEEEEEEecCCceeee-ee---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence 345688999988875432 22 234667788888877777766654 589999999999999 999999999999854
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.01 E-value=0.36 Score=48.13 Aligned_cols=100 Identities=20% Similarity=0.239 Sum_probs=63.8
Q ss_pred EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecCCC--cHHHHHHhCCCCCHHH
Q 007177 45 KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES--DLHQVIKANDDLTREH 122 (614)
Q Consensus 45 ~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~g--~L~~~i~~~~~lse~~ 122 (614)
...+|++....-.. ...-+.++..++.++. .|+++.. .+.-.+-++.|.|.. .+.
T Consensus 87 ~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~N-------Dn~~~yGvIlE~Cy~~~i~~------------- 143 (308)
T PF07387_consen 87 PLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKN-------DNNYKYGVILERCYKIKINF------------- 143 (308)
T ss_pred hhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeec-------CCCceeEEEEeeccCcccch-------------
Confidence 45566665322221 2233467788877653 5666652 233456799999973 111
Q ss_pred HHHHHHHHHHHHHHHHh--CCeEeecCCCCcEEECCCCcEEEeecCcc
Q 007177 123 YQFFLYQLLRALKYIHT--ANVYHRDLKPKNILANANCKLKICDFGLA 168 (614)
Q Consensus 123 ~~~i~~QIl~aL~yLHs--~gIvHrDLKP~NILi~~~~~vKL~DFGla 168 (614)
..++.-=+.+|.-.|+ .+.+|+|-.|+||+-|+.|.+||.|-+..
T Consensus 144 -~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 144 -SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred -hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 1111222456777884 46999999999999999999999998754
|
The function of this family is unknown. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=91.33 E-value=0.19 Score=52.95 Aligned_cols=75 Identities=25% Similarity=0.312 Sum_probs=45.3
Q ss_pred EEEEEecCCCc---HHHHH-HhCCC-CCHHHHHHHHHHHHHHHHHH---H-hCCeEeecCCCCcEEECCC----------
Q 007177 97 IYVVFELMESD---LHQVI-KANDD-LTREHYQFFLYQLLRALKYI---H-TANVYHRDLKPKNILANAN---------- 157 (614)
Q Consensus 97 ~ylV~E~~~g~---L~~~i-~~~~~-lse~~~~~i~~QIl~aL~yL---H-s~gIvHrDLKP~NILi~~~---------- 157 (614)
-.|||.+...+ +.... .+.|- .-.+-+++++.||+.-.--+ - -.+++|-||||+|||+-+.
T Consensus 246 nIIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~ 325 (434)
T PF05445_consen 246 NIIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGN 325 (434)
T ss_pred cEEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECC
Confidence 35888886532 21111 12222 22455688888887543223 1 3469999999999997332
Q ss_pred --------CcEEEeecCccccc
Q 007177 158 --------CKLKICDFGLARVA 171 (614)
Q Consensus 158 --------~~vKL~DFGla~~~ 171 (614)
-.++|.||.+++..
T Consensus 326 ~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 326 RNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred eEEEecccceeeecccCHHHhc
Confidence 12577888888764
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=91.20 E-value=0.31 Score=50.27 Aligned_cols=45 Identities=31% Similarity=0.384 Sum_probs=33.9
Q ss_pred HHHHHHHHHHHHHhC--CeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 126 FLYQLLRALKYIHTA--NVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 126 i~~QIl~aL~yLHs~--gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
.+..+-.++.-+|.. =++|+|+.|+|+|.++.+.++|+||..|..
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 344444444444443 489999999999999999999999987753
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.03 E-value=0.17 Score=49.30 Aligned_cols=28 Identities=25% Similarity=0.394 Sum_probs=25.1
Q ss_pred eEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 142 VYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 142 IvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
.+|+|+.|.||++++++ ++|+||+.|..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 69999999999998877 99999998853
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=90.62 E-value=0.34 Score=47.65 Aligned_cols=30 Identities=40% Similarity=0.594 Sum_probs=21.5
Q ss_pred CeEeecCCCCcEEE-CCCCcEEEeecCcccc
Q 007177 141 NVYHRDLKPKNILA-NANCKLKICDFGLARV 170 (614)
Q Consensus 141 gIvHrDLKP~NILi-~~~~~vKL~DFGla~~ 170 (614)
-++|.||.|.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 58999999999999 8889999999998854
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=90.49 E-value=3.9 Score=41.26 Aligned_cols=77 Identities=16% Similarity=0.188 Sum_probs=45.0
Q ss_pred eEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEE
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 99 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~yl 99 (614)
.+-.+.+..|.--..|...+ ...+|.+|+-. ......+..|+.-|+.|.--|-+.+-.++..+ ...++.|+
T Consensus 18 i~er~~v~gG~inea~~v~d--g~~~~FvK~n~-----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G--~~~~~syl 88 (286)
T COG3001 18 IKEREEVSGGDINEAWRLRD--GTDPFFVKCNQ-----REQLSMFTAEADGLELLARSNTITVPKVIAVG--ASRDHSYL 88 (286)
T ss_pred hhcccccCCccccceeEeec--CCcceEEEecc-----hhhHHHHHHHHHHHHHHHhcCCccccceEEec--CCCCeeEE
Confidence 33344554454444454432 23468888643 24456677888888887655533333333222 34577899
Q ss_pred EEecCC
Q 007177 100 VFELME 105 (614)
Q Consensus 100 V~E~~~ 105 (614)
||||++
T Consensus 89 Vle~L~ 94 (286)
T COG3001 89 VLEYLP 94 (286)
T ss_pred EEeecc
Confidence 999997
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.25 E-value=6.3 Score=43.66 Aligned_cols=28 Identities=32% Similarity=0.672 Sum_probs=23.9
Q ss_pred CeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 141 NVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 141 gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
.++|.|+-+.|||.+.++ ++|+||..|.
T Consensus 285 VfCHNDl~~~NiL~~~~~-l~LIDfEYAg 312 (442)
T PTZ00296 285 VFCHNDLQENNIINTNKC-LRLIDFEYSG 312 (442)
T ss_pred eEEeCCCCccceeecCCC-EEEEeecccc
Confidence 489999999999987554 9999998763
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 614 | ||||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-83 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-83 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-79 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-79 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-79 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-79 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-79 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-79 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-79 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-79 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-79 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-79 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-79 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-79 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-79 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-79 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-78 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-78 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-78 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-78 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-78 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-78 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-77 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-77 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-77 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-75 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-72 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-71 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-71 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-69 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-69 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-69 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-69 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-69 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-69 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-69 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-69 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-69 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-69 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-69 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-69 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-69 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-69 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-69 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-69 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-69 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-69 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-69 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-69 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-68 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-68 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-68 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-68 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-68 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-68 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-68 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-68 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-68 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-68 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-68 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-68 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-68 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-68 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-68 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-68 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-68 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-68 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-68 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-68 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-68 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-68 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-68 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-68 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-68 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-68 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-68 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-68 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-67 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-67 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-67 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-67 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-67 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-67 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-67 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-67 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-67 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-67 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-66 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-66 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-65 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-65 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-64 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-63 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-63 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-61 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-59 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-55 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-51 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-51 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-51 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-51 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-50 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-50 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-50 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-50 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-50 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-50 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-50 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-50 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-50 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-50 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-50 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-50 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-50 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-50 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-50 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-50 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-50 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-50 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-49 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-49 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-49 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-49 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-49 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-49 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-49 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-48 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-48 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-48 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-48 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-47 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-47 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-44 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-44 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-44 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-41 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-41 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-41 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-41 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-41 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-41 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-41 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-41 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-41 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-41 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-41 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-41 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-41 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-41 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-41 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-41 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-41 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-41 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-41 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-41 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-41 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-40 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-40 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-40 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-40 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-40 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-40 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-40 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-40 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-40 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-40 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-40 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-40 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-40 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-40 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-40 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-39 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-39 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-39 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-39 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-38 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-37 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-37 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-37 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-37 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-37 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-37 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-37 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-37 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-37 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-37 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-37 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-37 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-37 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-37 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-36 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-36 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-36 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-36 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-36 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-36 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-36 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-36 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-36 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-36 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-36 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-36 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-34 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-33 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-32 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-32 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-32 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-32 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-32 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-32 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-32 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-32 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-32 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-32 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-32 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-32 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-29 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-29 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-29 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-28 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-27 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-26 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-24 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-24 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-24 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-24 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-24 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-24 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-24 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-24 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-24 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-24 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-24 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-24 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 6e-24 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 6e-24 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 7e-24 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 7e-24 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 7e-24 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 7e-24 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 7e-24 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 8e-24 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 8e-24 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 8e-24 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-23 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-23 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-23 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-23 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-23 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-23 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 8e-23 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-22 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-22 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-22 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-21 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-21 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-21 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-21 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-21 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-21 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-20 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-20 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-20 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-20 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 8e-20 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 9e-20 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 9e-20 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-19 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-19 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-19 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-19 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-19 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-19 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-18 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-18 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-18 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-18 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-18 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-18 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-18 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-17 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-17 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-17 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-17 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-17 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-16 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-16 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-16 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-16 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-16 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-16 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-16 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-16 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-15 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-15 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-15 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-15 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-15 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-15 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-15 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-15 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-15 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-15 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-15 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-15 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-14 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-14 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-14 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-14 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-14 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-14 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-14 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-14 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-14 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-14 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-14 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-14 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-14 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-14 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-14 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-14 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-14 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 9e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-13 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-13 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-13 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-13 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-13 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-13 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-13 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-13 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-13 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-12 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-12 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-12 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-12 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-12 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-12 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-12 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-11 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-10 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-10 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-10 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-10 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-09 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-09 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-09 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-08 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-08 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-08 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 5e-08 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 5e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-06 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 9e-06 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 1e-05 |
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 614 | |||
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 0.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 0.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 0.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 0.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 0.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 0.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 0.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 0.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 0.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 0.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 0.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-180 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-164 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-152 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 1e-150 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-143 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-133 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-120 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-112 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-103 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-103 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 1e-102 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-102 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-102 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-101 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-101 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-101 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-100 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-100 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 9e-99 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 4e-86 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 5e-80 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-66 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-66 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 1e-63 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-63 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-63 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-62 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 2e-62 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 1e-61 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 6e-60 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-59 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 8e-59 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 8e-58 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 9e-58 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-57 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 5e-57 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 8e-57 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-56 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-56 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 4e-56 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-55 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 5e-54 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 1e-53 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 6e-53 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 6e-53 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 9e-53 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-52 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-52 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 5e-52 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 8e-52 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 3e-51 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 4e-51 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 6e-51 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 1e-50 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-50 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 5e-50 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 7e-50 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-49 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-49 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-49 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 2e-49 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 4e-49 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 1e-48 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-48 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 3e-48 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 5e-48 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 5e-48 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-47 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-47 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-47 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 3e-47 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 5e-47 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 5e-47 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 7e-47 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-46 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 4e-46 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 6e-46 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 7e-46 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-45 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 1e-45 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-45 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 2e-45 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 3e-45 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 3e-45 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 7e-45 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-44 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-44 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 4e-44 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 4e-44 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 5e-44 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-43 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 3e-43 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 4e-43 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 5e-43 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 1e-42 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-42 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-42 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 6e-42 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 6e-42 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 7e-42 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-41 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-41 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-41 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 5e-41 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 6e-39 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 7e-39 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 8e-39 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-38 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 3e-38 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 7e-38 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 8e-38 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 8e-38 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-37 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-37 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-37 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 8e-37 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 1e-36 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-36 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-36 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-36 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-36 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-36 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-36 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 3e-36 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 6e-36 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 7e-36 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-34 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 5e-34 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 9e-34 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-33 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-32 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 3e-32 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 4e-32 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-31 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-31 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 2e-31 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-31 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 7e-31 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 5e-30 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-29 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-29 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 3e-29 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 4e-29 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 5e-29 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 7e-29 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 8e-29 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-28 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 6e-28 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 8e-28 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 1e-27 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-27 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 3e-27 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 3e-27 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 4e-27 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 5e-27 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 7e-27 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 9e-27 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-26 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 1e-26 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-26 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 1e-26 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-26 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-26 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 4e-26 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 4e-26 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 4e-26 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 5e-26 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 9e-26 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-25 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-25 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-25 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-25 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 2e-25 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-25 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 4e-25 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 5e-25 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-24 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-24 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-24 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 3e-24 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 4e-24 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 4e-24 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 1e-23 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-23 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-23 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 4e-23 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 4e-23 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 7e-23 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 8e-23 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-22 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-22 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-22 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 5e-22 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 9e-22 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 9e-22 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-21 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-21 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 5e-20 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 7e-20 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 9e-20 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-19 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 3e-19 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-18 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 4e-18 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 6e-18 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-17 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 2e-17 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 5e-17 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 7e-17 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-16 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 2e-16 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 3e-16 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 4e-16 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 7e-16 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 7e-16 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-15 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-15 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 4e-15 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-14 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 4e-14 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 6e-14 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-13 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 7e-13 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 4e-12 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-11 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-09 |
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 573 bits (1479), Expect = 0.0
Identities = 164/356 (46%), Positives = 225/356 (63%), Gaps = 5/356 (1%)
Query: 3 QNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 62
PEM + RY IG+G+YG+VCSA D +VAIKKI FEH +
Sbjct: 12 AAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQ 70
Query: 63 RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH 122
R LREIK+L RH +I+ I I+ P+ KD+Y+V +LME+DL++++K L+ +H
Sbjct: 71 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDH 129
Query: 123 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 182
+FLYQ+LR LKYIH+ANV HRDLKP N+L N C LKICDFGLARVA D T F T
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 183 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242
+YVATRWYRAPE+ + YT +IDIWS+GCI AE+L+ +P+FPGK+ + QL+ + +L
Sbjct: 190 EYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248
Query: 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 302
G+PS + ++ + N KAR YL S+ K V +++ FPNAD AL LL+++L F+P R
Sbjct: 249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 308
Query: 303 EEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQL 358
E+ALA PY + EP + +F+ E + KE ++ELIF E + P
Sbjct: 309 EQALAHPYLEQYYDPSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETARFQPGY 362
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 569 bits (1470), Expect = 0.0
Identities = 148/355 (41%), Positives = 221/355 (62%), Gaps = 13/355 (3%)
Query: 8 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 67
M Y +S ++++ ++G+G+YGVVCSA TGE VAIKKI + F+ A R LRE
Sbjct: 1 MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLRE 59
Query: 68 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 127
IK+L+ +H +I+ I +I P S +F ++Y++ ELM++DLH+VI L+ +H Q+F+
Sbjct: 60 IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM-LSDDHIQYFI 118
Query: 128 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND-------TPTTIF 180
YQ LRA+K +H +NV HRDLKP N+L N+NC LK+CDFGLAR+ T
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 181 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 240
++VATRWYRAPE+ + +KY+ A+D+WS GCI AE+ +P+FPG++ HQL L+
Sbjct: 179 MVEFVATRWYRAPEVMLT-SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237
Query: 241 LLGTPSLD-TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR 299
++GTP D + + + +AR Y+ S+ + FP +P + LL+R+L FDP R
Sbjct: 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKR 297
Query: 300 PTAEEALADPYFKGLSKVEREPSCQPISKMEFEF--ERRRVTKEDIRELIFREIL 352
TA+EAL PY + EP +PI FEF + +T +D+++LI+ EI
Sbjct: 298 ITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 570 bits (1471), Expect = 0.0
Identities = 134/420 (31%), Positives = 211/420 (50%), Gaps = 53/420 (12%)
Query: 3 QNSPEMEFFSEYGD----ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI 58
+S + + Y I+ +IG+GSYG V A D +T + VAIKK++ +FE +
Sbjct: 7 HSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDL 66
Query: 59 SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDL 118
D RILREI +L L+ I+ + +++P F ++Y+V E+ +SDL ++ K L
Sbjct: 67 IDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFL 126
Query: 119 TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 178
T EH + LY LL +IH + + HRDLKP N L N +C +K+CDFGLAR ++ T
Sbjct: 127 TEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186
Query: 179 I-------------------FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 219
I T +V TRWYRAPEL YT +IDIWS GCIFAE+
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI-LLQENYTKSIDIWSTGCIFAEL 245
Query: 220 LTG-----------KPLFPG-----------------KNVVHQLDLMTDLLGTPSLDTIS 251
L PLFPG K+ QL+++ +++GTP+ D +
Sbjct: 246 LNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLK 305
Query: 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311
+ + +Y+ ++P+ QK+P+ + LLE +L F+P R T ++AL PY
Sbjct: 306 NINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365
Query: 312 KGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGTERTNF 371
K + K + E + F+ + +++ +R + +E+ +HP+L+ + NF
Sbjct: 366 KDVRKKKLENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPELVIPSVFTIHENNF 424
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 549 bits (1416), Expect = 0.0
Identities = 136/386 (35%), Positives = 217/386 (56%), Gaps = 43/386 (11%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-H 76
+Y++ + +GKG+YG+V +ID TGE VA+KKI D F++ +DA R REI +L L H
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 136
+IV + +++ + +D+Y+VF+ ME+DLH VI+AN L H Q+ +YQL++ +KY
Sbjct: 69 ENIVNLLNVLRAD---NDRDVYLVFDYMETDLHAVIRANI-LEPVHKQYVVYQLIKVIKY 124
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARV------------------AFNDTPTT 178
+H+ + HRD+KP NIL NA C +K+ DFGL+R N
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 179 IFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 237
TDYVATRWYRAPE L GS +KYT ID+WS+GCI E+L GKP+FPG + ++QL+
Sbjct: 185 PILTDYVATRWYRAPEILLGS--TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242
Query: 238 MTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKF----------------PNAD 281
+ ++ PS + + +++ A+ + S+++K ++ S K + +
Sbjct: 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN 302
Query: 282 PSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKE 341
AL LL++LL F+P R +A +AL P+ EP+C I + + + + +
Sbjct: 303 EEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPIN-DNVKHSID 361
Query: 342 DIRELIFREILEYHPQLLKDYMNGTE 367
D R L++ EI +L+ + +
Sbjct: 362 DYRNLVYSEISRRKRELISNKHQNVQ 387
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 545 bits (1406), Expect = 0.0
Identities = 120/349 (34%), Positives = 178/349 (51%), Gaps = 20/349 (5%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHD---------IFEHISDAARILREI 68
S Y +Q I GSYG VC+ +D+ G VAIK++ + I R+LREI
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 69 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD-LTREHYQFFL 127
+LL HP+I+ ++ I + +Y+V ELM +DL QVI ++ +H Q+F+
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 128 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 187
Y +L L +H A V HRDL P NIL N + ICDF LAR D T YV
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA----NKTHYVTH 196
Query: 188 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247
RWYRAPEL F +T +D+WS GC+ AE+ K LF G +QL+ + +++GTP +
Sbjct: 197 RWYRAPELVMQ-FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 248 DTISRVRNDKARRYL-TSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 306
+ + + AR YL S+ ++ P ADP AL L+ ++L F+P+ R + E+AL
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315
Query: 307 ADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYH 355
PYF+ L F F+ D+ ++ E+ ++
Sbjct: 316 RHPYFESLFDPLDLTEGLSE---RFHFDESVTDVYDMHKIFTAEVERFN 361
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 544 bits (1404), Expect = 0.0
Identities = 134/341 (39%), Positives = 208/341 (60%), Gaps = 12/341 (3%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
+ Y+ + +G G+YG VCSA+D TG KVAIKK++ F+ A R RE++LL+ +RH
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84
Query: 78 DIVEIKHIMLP-PSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 136
+++ + + P + DF D Y+V M +DL +++K L + QF +YQ+L+ L+Y
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRY 143
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 196
IH A + HRDLKP N+ N +C+LKI DFGLAR A ++ T YV TRWYRAPE+
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE------MTGYVVTRWYRAPEVI 197
Query: 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256
++ +YT +DIWS+GCI AE++TGK LF G + + QL + + GTP + + R+++D
Sbjct: 198 LNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256
Query: 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316
+A+ Y+ + + + F+ NA P A+ LLE++L D + R TA EALA PYF+ L
Sbjct: 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316
Query: 317 VEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQ 357
E EP Q + F+ T ++ + + ++E+L + P
Sbjct: 317 TEDEPQVQKY---DDSFDDVDRTLDEWKRVTYKEVLSFKPP 354
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 543 bits (1401), Expect = 0.0
Identities = 133/340 (39%), Positives = 199/340 (58%), Gaps = 12/340 (3%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
Y +G G+YG VCSAID +GEKVAIKK+ F+ A R RE+ LL+ ++H
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 78 DIVEIKHIMLPPSR-RDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 136
+++ + + P S R+F D Y+V M++DL +++ + E Q+ +YQ+L+ LKY
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--FSEEKIQYLVYQMLKGLKY 141
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 196
IH+A V HRDLKP N+ N +C+LKI DFGLAR A + T YV TRWYRAPE+
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MTGYVVTRWYRAPEVI 195
Query: 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256
S+ Y +DIWS+GCI AE+LTGK LF GK+ + QL + + G P + + ++ +
Sbjct: 196 LSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254
Query: 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316
A+ Y+ S+ + F+Q FP A P A LLE++L D R TA +AL P+F+
Sbjct: 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314
Query: 317 VEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 356
E E Q + E ++T ++ ++ I++EI+ + P
Sbjct: 315 PEEETEAQQ--PFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 543 bits (1401), Expect = 0.0
Identities = 140/411 (34%), Positives = 206/411 (50%), Gaps = 57/411 (13%)
Query: 3 QNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 62
+ S++ RY+I+ +IG GSYG VC A D VAIKKI +FE + D
Sbjct: 38 PTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK 97
Query: 63 RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH 122
RILREI +L L H +V++ I++P F ++YVV E+ +SD ++ + LT H
Sbjct: 98 RILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELH 157
Query: 123 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA----------- 171
+ LY LL +KY+H+A + HRDLKP N L N +C +K+CDFGLAR
Sbjct: 158 IKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLP 217
Query: 172 -------------FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 218
+ T +V TRWYRAPEL YT AID+WSIGCIFAE
Sbjct: 218 ISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-QENYTEAIDVWSIGCIFAE 276
Query: 219 VLT-----------GKPLFPGKNVV--------------------HQLDLMTDLLGTPSL 247
+L PLFPG + QL+++ ++LGTPS
Sbjct: 277 LLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSE 336
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
+ I + + A+RY+ K++ +++FP + A+ LL+R+L F+P R T E LA
Sbjct: 337 EDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA 396
Query: 308 DPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQL 358
P+FK + E E + ++ F + + + +R +EI YHP++
Sbjct: 397 HPFFKEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYHPEI 446
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 537 bits (1385), Expect = 0.0
Identities = 138/349 (39%), Positives = 211/349 (60%), Gaps = 13/349 (3%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
RY+ +G G+YG VC+A DT TG +VA+KK+ F+ I A R RE++LL+ ++H
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 78 DIVEIKHIMLPP-SRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 136
+++ + + P S +F D+Y+V LM +DL+ ++K LT +H QF +YQ+LR LKY
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKY 147
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 196
IH+A++ HRDLKP N+ N +C+LKI DFGLAR + T YVATRWYRAPE+
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD------EMTGYVATRWYRAPEIM 201
Query: 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256
++ Y +DIWS+GCI AE+LTG+ LFPG + + QL L+ L+GTP + + ++ ++
Sbjct: 202 LNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260
Query: 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316
AR Y+ S+ + + F+ F A+P A+ LLE++L D R TA +ALA YF
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320
Query: 317 VEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLK-DYMN 364
+ EP P + E R + ++ + L + E++ + P L + M
Sbjct: 321 PDDEPVADPY---DQSLESRDLLIDEWKSLTYDEVISFVPPPLDQEEME 366
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 530 bits (1367), Expect = 0.0
Identities = 133/446 (29%), Positives = 220/446 (49%), Gaps = 56/446 (12%)
Query: 1 MLQNSPEMEFFS-EYGDA-----SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI 54
M ++ + +F+S E GD+ RY+ + IG G+ G+VC+A D VAIKK+
Sbjct: 39 MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 98
Query: 55 FEHISDAARILREIKLLRLLRHPDIVEIKHIMLP-PSRRDFKDIYVVFELMESDLHQVIK 113
F++ + A R RE+ L++ + H +I+ + ++ P + +F+D+Y+V ELM+++L QVI+
Sbjct: 99 FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ 158
Query: 114 ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173
+L E + LYQ+L +K++H+A + HRDLKP NI+ ++C LKI DFGLAR A
Sbjct: 159 M--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-- 214
Query: 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH 233
T+ T YV TR+YRAPE+ Y +DIWS+GCI E++ K LFPG++ +
Sbjct: 215 --GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYID 270
Query: 234 QLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNA------------D 281
Q + + + LGTP + + ++ R Y+ + K + F + FP++
Sbjct: 271 QWNKVIEQLGTPCPEFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKA 329
Query: 282 PSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKE 341
A LL ++L DP R + ++AL PY P + + + R T E
Sbjct: 330 SQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE-APPPQIYDKQLDEREHTIE 388
Query: 342 DIRELIFREILEYHPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPE 401
+ +ELI++E++ + + G P
Sbjct: 389 EWKELIYKEVMNSEEKTKNGVVKGQPS---------------------------PSGAAV 421
Query: 402 RKHVSLPRSTIVHSNTVPPKEQQNLS 427
SLP S+ V+ + +Q S
Sbjct: 422 NSSESLPPSSSVNDISSMSTDQTLAS 447
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 522 bits (1347), Expect = 0.0
Identities = 124/374 (33%), Positives = 201/374 (53%), Gaps = 29/374 (7%)
Query: 3 QNSPEMEFFS-EYGDA-----SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE 56
++ + F+S E GD+ RY+ + IG G+ G+VC+A D VAIKK+ F+
Sbjct: 4 RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 63
Query: 57 HISDAARILREIKLLRLLRHPDIVEIKHIMLPP-SRRDFKDIYVVFELMESDLHQVIKAN 115
+ + A R RE+ L++ + H +I+ + ++ P S +F+D+Y+V ELM+++L QVI+
Sbjct: 64 NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM- 122
Query: 116 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175
+L E + LYQ+L +K++H+A + HRDLKP NI+ ++C LKI DFGLAR A
Sbjct: 123 -ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---- 177
Query: 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 235
T+ T YV TR+YRAPE+ Y +DIWS+GCI E++ G LFPG + + Q
Sbjct: 178 GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW 235
Query: 236 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNA------------DPS 283
+ + + LGTP + + ++ R Y+ + K F + FP+
Sbjct: 236 NKVIEQLGTPCPEFMKKL-QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQ 294
Query: 284 ALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDI 343
A LL ++L D R + +EAL PY + P + + + R T E+
Sbjct: 295 ARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAP-PPKIPDKQLDEREHTIEEW 353
Query: 344 RELIFREILEYHPQ 357
+ELI++E+++
Sbjct: 354 KELIYKEVMDLEHH 367
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 512 bits (1321), Expect = e-180
Identities = 120/315 (38%), Positives = 172/315 (54%), Gaps = 15/315 (4%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 76
SRY + +G G G+V SA+D ++VAIKKI + LREIK++R L H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRLDH 67
Query: 77 PDIVEIKHIMLPPSRR---------DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 127
+IV++ I+ P + + +Y+V E ME+DL V++ L EH + F+
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP-LLEEHARLFM 126
Query: 128 YQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFNDTPTTIFWTDYVA 186
YQLLR LKYIH+ANV HRDLKP N+ N + LKI DFGLAR+ ++ +
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 187 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 246
T+WYR+P L S + YT AID+W+ GCIFAE+LTGK LF G + + Q+ L+ + +
Sbjct: 187 TKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245
Query: 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 306
+ + + Y+ + + +Q P A+ LE++L F P DR TAEEAL
Sbjct: 246 EEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEAL 304
Query: 307 ADPYFKGLSKVEREP 321
+ PY S EP
Sbjct: 305 SHPYMSIYSFPMDEP 319
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 472 bits (1218), Expect = e-164
Identities = 112/366 (30%), Positives = 178/366 (48%), Gaps = 27/366 (7%)
Query: 1 MLQNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISD 60
M N+ + R++++ + G+G++G V + TG VAIKK+ +
Sbjct: 6 MSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRF 62
Query: 61 AARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY--VVFELMESDLHQVIK----A 114
R L+ ++ L +L HP+IV+++ RD +DIY VV E + LH+ +
Sbjct: 63 RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122
Query: 115 NDDLTREHYQFFLYQLLRALKYIH--TANVYHRDLKPKNILAN-ANCKLKICDFGLARVA 171
+ FL+QL+R++ +H + NV HRD+KP N+L N A+ LK+CDFG A+
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
Query: 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 231
P Y+ +R+YRAPEL YT A+DIWS+GCIFAE++ G+P+F G N
Sbjct: 183 SPSEPNV----AYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS 237
Query: 232 VHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKF----PNADPSALRL 287
QL + +LG PS + + ++ L + + +S F A L
Sbjct: 238 AGQLHEIVRVLGCPSREVLRKLNPSHTDVDL---YNSKGIPWSNVFSDHSLKDAKEAYDL 294
Query: 288 LERLLAFDPKDRPTAEEALADPYFKGL-SKVEREPSCQPISKMEFEFERR--RVTKEDIR 344
L LL + P++R EAL PYF L + P+ + + + F F V E +
Sbjct: 295 LSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQK 354
Query: 345 ELIFRE 350
+ R+
Sbjct: 355 AKLVRK 360
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 442 bits (1139), Expect = e-152
Identities = 116/376 (30%), Positives = 194/376 (51%), Gaps = 31/376 (8%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
Y +VIG GS+GVV A + E VAIKK+ D RE++++R+++HP
Sbjct: 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVL------QDKRFKNRELQIMRIVKHP 92
Query: 78 DIVEIKHIMLPPS-RRDFKDIYVVFELMESDLHQVI----KANDDLTREHYQFFLYQLLR 132
++V++K ++D + +V E + +++ K + + ++YQLLR
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 133 ALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 191
+L YIH+ + HRD+KP+N+L + LK+ DFG A++ P Y+ +R+YR
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV----SYICSRYYR 208
Query: 192 APELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250
APEL G+ + YT IDIWS GC+ AE++ G+PLFPG++ + QL + +LGTPS + I
Sbjct: 209 APELIFGA--TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266
Query: 251 SRVRNDKARRYLTSMRKKQPVQFSQKF-PNADPSALRLLERLLAFDPKDRPTAEEALADP 309
+ + + +P FS+ F P P A+ L+ RLL + P R TA EAL P
Sbjct: 267 KTMNPNYMEHKF---PQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323
Query: 310 YFKGLSKVE-REPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGTER 368
+F L E R P+ + + + F + + + +R + ++ H + + G +
Sbjct: 324 FFDELRTGEARMPNGRELPPL-FNWTKE---ELSVRPDLISRLVPQHAE-AELLSRGIDV 378
Query: 369 TNFLYPSAVDQFRKQF 384
NF P ++ +
Sbjct: 379 HNFQ-PIPLESLKVTL 393
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 436 bits (1124), Expect = e-150
Identities = 99/383 (25%), Positives = 178/383 (46%), Gaps = 67/383 (17%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 76
+ +Y + + +G GS+G+VC D +G++ A+KK+ D RE+ ++++L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDH 59
Query: 77 PDIVEIKHIM---------------------------------LPPSRRDFKDIYVVFEL 103
+I+++ + + K + V+ E
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 104 MESDLHQVI----KANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-C 158
+ LH+V+ ++ + ++YQL RA+ +IH+ + HRD+KP+N+L N+
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 159 KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFA 217
LK+CDFG A+ P+ Y+ +R+YRAPEL G+ ++YTP+ID+WSIGC+F
Sbjct: 180 TLKLCDFGSAKKLIPSEPSV----AYICSRFYRAPELMLGA--TEYTPSIDLWSIGCVFG 233
Query: 218 EVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKF 277
E++ GKPLF G+ + QL + ++GTP+ + + R+ + + +
Sbjct: 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRF---PTLKAKDWRKIL 290
Query: 278 PNADPS-ALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKME------ 330
P PS A+ LLE++L ++P R EA+A P+F L +
Sbjct: 291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNI 350
Query: 331 ---FEF---ERRRVTKEDIRELI 347
F F E + + ++
Sbjct: 351 PQLFNFSPYELSIIPGNVLNRIL 373
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 421 bits (1083), Expect = e-143
Identities = 106/339 (31%), Positives = 173/339 (51%), Gaps = 25/339 (7%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
Y +VIG GS+GVV A +GE VAIKK+ D RE++++R L H +
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 108
Query: 79 IVEIKHIMLPPS-RRDFKDIYVVFELMESDLHQVIK----ANDDLTREHYQFFLYQLLRA 133
IV +++ ++D + +V + + +++V + A L + + ++YQL R+
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 134 LKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 192
L YIH+ + HRD+KP+N+L + + LK+CDFG A+ P Y+ +R+YRA
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV----SYICSRYYRA 224
Query: 193 PELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251
PEL G+ + YT +ID+WS GC+ AE+L G+P+FPG + V QL + +LGTP+ + I
Sbjct: 225 PELIFGA--TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282
Query: 252 RVRNDKARRYLTSMRKKQPVQFSQKF-PNADPSALRLLERLLAFDPKDRPTAEEALADPY 310
+ + + + +++ F P P A+ L RLL + P R T EA A +
Sbjct: 283 EMNPNYTEFKF---PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339
Query: 311 FKGLSKVE-REPSCQPISKM-EFEFERRRVTKEDIRELI 347
F L + P+ + + F + LI
Sbjct: 340 FDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILI 378
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 392 bits (1009), Expect = e-133
Identities = 91/315 (28%), Positives = 159/315 (50%), Gaps = 24/315 (7%)
Query: 13 EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLR 72
E+G+ Y++ +G+G Y V AI+ EKV +K + + +I REIK+L
Sbjct: 31 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILE 85
Query: 73 LLR-HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLL 131
LR P+I+ + I+ P V + +D Q+ + LT +F++Y++L
Sbjct: 86 NLRGGPNIITLADIVKDPV--SRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEIL 140
Query: 132 RALKYIHTANVYHRDLKPKNILAN-ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 190
+AL Y H+ + HRD+KP N++ + + KL++ D+GLA + VA+R++
Sbjct: 141 KALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----EYNVRVASRYF 196
Query: 191 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLMTDLLGTPSL-D 248
+ PEL + Y ++D+WS+GC+ A ++ K P F G + QL + +LGT L D
Sbjct: 197 KGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255
Query: 249 TISRVRNDKARRYLTSMRKKQPVQFSQKFPN-----ADPSALRLLERLLAFDPKDRPTAE 303
I + + R+ + + ++ + + P AL L++LL +D + R TA
Sbjct: 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 315
Query: 304 EALADPYFKGLSKVE 318
EA+ PYF + K +
Sbjct: 316 EAMEHPYFYTVVKDQ 330
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 358 bits (921), Expect = e-120
Identities = 104/306 (33%), Positives = 162/306 (52%), Gaps = 12/306 (3%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
+Y+ IG+GSYGVV + TG+ VAIKK + + LREI++L+ L+HP+
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYI 137
+V + + R + +++VFE + + + + + +Q L+A+ +
Sbjct: 64 LVNLLEVF-----RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LC 196
H N HRD+KP+NIL + +K+CDFG AR P+ + D VATRWYR+PE L
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFAR-LLTG-PSDYY-DDEVATRWYRSPELLV 175
Query: 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256
G ++Y P +D+W+IGC+FAE+L+G PL+PGK+ V QL L+ LG +
Sbjct: 176 GD--TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233
Query: 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316
+ + + KFPN AL LL+ L DP +R T E+ L PYF+ + +
Sbjct: 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293
Query: 317 VEREPS 322
+E
Sbjct: 294 IEDLAK 299
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 338 bits (870), Expect = e-112
Identities = 94/296 (31%), Positives = 154/296 (52%), Gaps = 12/296 (4%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
+Y+ ++G+GSYG+V + TG VAIKK + + +REIKLL+ LRH +
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYI 137
+V + + + K Y+VFE ++ + ++ + L + Q +L+Q++ + +
Sbjct: 86 LVNLLEVC-----KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC- 196
H+ N+ HRD+KP+NIL + + +K+CDFG AR P ++ D VATRWYRAPEL
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAA-PGEVY-DDEVATRWYRAPELLV 197
Query: 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256
G KY A+D+W+IGC+ E+ G+PLFPG + + QL + LG +
Sbjct: 198 GD--VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255
Query: 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312
+ K+ +++P + L ++ L DP RP E L +F+
Sbjct: 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 313 bits (805), Expect = e-103
Identities = 99/309 (32%), Positives = 142/309 (45%), Gaps = 30/309 (9%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI-----LREIKLLR 72
SRY+ IG G+YG V A D H+G VA+K + + +RE+ LLR
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VPNGGGGGGGLPISTVREVALLR 66
Query: 73 LLR---HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA--NDDLTREHYQFFL 127
L HP++V + + + +VFE ++ DL + L E + +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 128 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 187
Q LR L ++H + HRDLKP+NIL + +K+ DFGLAR ++ T V T
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMA---LTPVVVT 182
Query: 188 RWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 246
WYRAPE L S Y +D+WS+GCIFAE+ KPLF G + QL + DL+G P
Sbjct: 183 LWYRAPEVLLQS---TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239
Query: 247 LDT---ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE 303
D + + + P P + S +LL +L F+P R +A
Sbjct: 240 EDDWPRDVSLPR-------GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF 292
Query: 304 EALADPYFK 312
AL Y
Sbjct: 293 RALQHSYLH 301
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 311 bits (800), Expect = e-102
Identities = 120/319 (37%), Positives = 171/319 (53%), Gaps = 24/319 (7%)
Query: 5 SPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI 64
S E G +Y+ E +G+G+YGVV A D+ G VA+K+I + +
Sbjct: 8 SSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR--LDAEDEGIPS 64
Query: 65 --LREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTRE 121
+REI LL+ L HP+IV + ++ + +VFE ME DL +V+ L
Sbjct: 65 TAIREISLLKELHHPNIVSLIDVIHSERC-----LTLVFEFMEKDLKKVLDENKTGLQDS 119
Query: 122 HYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 181
+ +LYQLLR + + H + HRDLKP+N+L N++ LK+ DFGLAR AF P +
Sbjct: 120 QIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR-AFGI-PVRSY- 176
Query: 182 TDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 240
T V T WYRAP+ L GS KY+ ++DIWSIGCIFAE++TGKPLFPG QL +
Sbjct: 177 THEVVTLWYRAPDVLMGS--KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFS 234
Query: 241 LLGTPSLDT---ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPK 297
+LGTP+ + + K R + + + +S P + LL +L FDP
Sbjct: 235 ILGTPNPREWPQVQELPLWKQRTF----QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPN 290
Query: 298 DRPTAEEALADPYFKGLSK 316
R +A +A+ PYFK L
Sbjct: 291 KRISARDAMNHPYFKDLDP 309
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = e-102
Identities = 114/301 (37%), Positives = 164/301 (54%), Gaps = 19/301 (6%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRH 76
+Y E IG+G+YGVV A + GE A+KKI E + +REI +L+ L+H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR--LEKEDEGIPSTTIREISILKELKH 59
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALK 135
+IV++ ++ R + +VFE ++ DL +++ L + FL QLL +
Sbjct: 60 SNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 136 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE- 194
Y H V HRDLKP+N+L N +LKI DFGLAR AF P + T + T WYRAP+
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLAR-AFGI-PVRKY-THEIVTLWYRAPDV 171
Query: 195 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254
L GS KY+ IDIWS+GCIFAE++ G PLFPG + QL + +LGTP+ V
Sbjct: 172 LMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314
+ +Y + +P+ + D S + LL ++L DP R TA++AL YFK
Sbjct: 230 --ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287
Query: 315 S 315
+
Sbjct: 288 N 288
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 311 bits (800), Expect = e-102
Identities = 109/333 (32%), Positives = 161/333 (48%), Gaps = 25/333 (7%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARI--LREIKLLRL 73
A RY+ + +G+G + V A D +T + VAIKKI D LREIKLL+
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 74 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD-LTREHYQFFLYQLLR 132
L HP+I+ + S I +VF+ ME+DL +IK N LT H + ++ L+
Sbjct: 69 LSHPNIIGLLDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 192
L+Y+H + HRDLKP N+L + N LK+ DFGLA+ +F P + T V TRWYRA
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK-SFGS-PNRAY-THQVVTRWYRA 180
Query: 193 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT-- 249
PE L G+ Y +D+W++GCI AE+L P PG + + QL + + LGTP+ +
Sbjct: 181 PELLFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238
Query: 250 -ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308
+ + + + + + F A L L++ L F+P R TA +AL
Sbjct: 239 DMCSLPDYV------TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292
Query: 309 PYFKGLSKVEREPSCQPISKMEFEFERRRVTKE 341
YF P E + +
Sbjct: 293 KYFSNRPG-PTPGCQLPRPNCPVETLKEQSNPA 324
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 311 bits (798), Expect = e-101
Identities = 111/329 (33%), Positives = 168/329 (51%), Gaps = 26/329 (7%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 77
Y + +G+G+Y V T VA+K+I + E A +RE+ LL+ L+H
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA--IREVSLLKDLKHA 60
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKY 136
+IV + I+ + +VFE ++ DL Q + + + + + FL+QLLR L Y
Sbjct: 61 NIVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-L 195
H V HRDLKP+N+L N +LK+ DFGLAR A + PT + + V T WYR P+ L
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLAR-AKSI-PTKTY-DNEVVTLWYRPPDIL 172
Query: 196 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT---ISR 252
GS + Y+ ID+W +GCIF E+ TG+PLFPG V QL + +LGTP+ +T I
Sbjct: 173 LGS--TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230
Query: 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312
K Y K + P D LL +LL F+ ++R +AE+A+ P+F
Sbjct: 231 NEEFKTYNY----PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286
Query: 313 GL----SKVEREPSCQPISKMEFEFERRR 337
L K+ S + +++ + E
Sbjct: 287 SLGERIHKLPDTTSIFALKEIQLQKEASL 315
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 308 bits (791), Expect = e-101
Identities = 112/303 (36%), Positives = 163/303 (53%), Gaps = 19/303 (6%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRH 76
+Y+ E IG+G+YG V A + T E VA+K++ + + LREI LL+ L+H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKH 60
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALK 135
+IV + ++ + + +VFE + DL + + N DL E + FL+QLL+ L
Sbjct: 61 KNIVRLHDVLHSDKK-----LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 136 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE- 194
+ H+ NV HRDLKP+N+L N N +LK+ +FGLAR AF P + + V T WYR P+
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR-AFGI-PVRCY-SAEVVTLWYRPPDV 172
Query: 195 LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253
L G+ Y+ +ID+WS GCIFAE+ G+PLFPG +V QL + LLGTP+ + +
Sbjct: 173 LFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313
K Y P + + LL+ LL +P R +AEEAL PYF
Sbjct: 231 T--KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
Query: 314 LSK 316
Sbjct: 289 FCP 291
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 309 bits (794), Expect = e-101
Identities = 110/340 (32%), Positives = 161/340 (47%), Gaps = 28/340 (8%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRL 73
+ S+Y+ IG+G++G V A TG+KVA+KK+ E+ + I LREIK+L+L
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALREIKILQL 72
Query: 74 LRHPDIVEIKHIM---LPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQ 129
L+H ++V + I P R IY+VF+ E DL ++ T + +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 130 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY---VA 186
LL L YIH + HRD+K N+L + LK+ DFGLAR AF+ Y V
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR-AFSL-AKNSQPNRYTNRVV 190
Query: 187 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 245
T WYR PE L G Y P ID+W GCI AE+ T P+ G HQL L++ L G+
Sbjct: 191 TLWYRPPELLLGE--RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248
Query: 246 SLDT---ISRVRNDKARRYLTSMRKKQPVQFSQKFPN--ADPSALRLLERLLAFDPKDRP 300
+ + + + K Q + + DP AL L+++LL DP R
Sbjct: 249 TPEVWPNVDNYELYEKLEL----VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 304
Query: 301 TAEEALADPYFKGL---SKVEREPSCQPISKMEFEFERRR 337
+++AL +F S ++ S S E+ RR
Sbjct: 305 DSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRR 344
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 307 bits (788), Expect = e-100
Identities = 112/309 (36%), Positives = 166/309 (53%), Gaps = 29/309 (9%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLR 75
RY+ +G+G+YG V AIDT T E VAIK+I EH + +RE+ LL+ L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR--LEHEEEGVPGTAIREVSLLKELQ 91
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALK 135
H +I+E+K ++ R ++++FE E+DL + + N D++ + FLYQL+ +
Sbjct: 92 HRNIIELKSVIHHNHR-----LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 136 YIHTANVYHRDLKPKNILANANCK-----LKICDFGLARVAFNDTPTTIFWTDYVATRWY 190
+ H+ HRDLKP+N+L + + LKI DFGLAR AF P F T + T WY
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGI-PIRQF-THEIITLWY 203
Query: 191 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 249
R PE L GS Y+ ++DIWSI CI+AE+L PLFPG + + QL + ++LG P T
Sbjct: 204 RPPEILLGS--RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261
Query: 250 ---ISRVRNDKARRYLTSMRKKQPVQFSQKFPNA-DPSALRLLERLLAFDPKDRPTAEEA 305
++ + + + S K + + D L LL +L DP R +A+ A
Sbjct: 262 WPGVTALPD-----WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNA 316
Query: 306 LADPYFKGL 314
L PYF
Sbjct: 317 LEHPYFSHN 325
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 306 bits (786), Expect = e-100
Identities = 98/326 (30%), Positives = 155/326 (47%), Gaps = 34/326 (10%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDT-HTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLL 74
+Y+ IG+G+YG V A D + G VA+K++ + + + +RE+ +LR L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRHL 68
Query: 75 R---HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA--NDDLTREHYQFFLYQ 129
HP++V + + + +VFE ++ DL + + E + ++Q
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 130 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 189
LLR L ++H+ V HRDLKP+NIL ++ ++K+ DFGLAR ++ T V T W
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMA---LTSVVVTLW 184
Query: 190 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248
YRAPE L S Y +D+WS+GCIFAE+ KPLF G + V QL + D++G P +
Sbjct: 185 YRAPEVLLQS---SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241
Query: 249 T---ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 305
+ + K + + D LL + L F+P R +A A
Sbjct: 242 DWPRDVALPR-------QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 306 LADPYFKGLSKVEREPSCQPISKMEF 331
L+ PYF+ L C+
Sbjct: 295 LSHPYFQDL------ERCKENLDSHL 314
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 302 bits (777), Expect = 9e-99
Identities = 108/314 (34%), Positives = 171/314 (54%), Gaps = 33/314 (10%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLR 75
+S++K E +G G+Y V ++ TG VA+K++ D E A +REI L++ L+
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA--IREISLMKELK 61
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN------DDLTREHYQFFLYQ 129
H +IV + ++ ++ + +VFE M++DL + + + L ++F +Q
Sbjct: 62 HENIVRLYDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 130 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 189
LL+ L + H + HRDLKP+N+L N +LK+ DFGLAR AF P F + V T W
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGI-PVNTF-SSEVVTLW 173
Query: 190 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248
YRAP+ L GS Y+ +IDIWS GCI AE++TGKPLFPG N QL L+ D++GTP+
Sbjct: 174 YRAPDVLMGS--RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231
Query: 249 T---ISRVRNDKARRYLTSMRKKQPVQFSQKFPNA-----DPSALRLLERLLAFDPKDRP 300
++++ Y +++++ P Q D + + L LL +P R
Sbjct: 232 LWPSVTKLPK-----YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL 286
Query: 301 TAEEALADPYFKGL 314
+A++AL P+F
Sbjct: 287 SAKQALHHPWFAEY 300
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 4e-86
Identities = 111/361 (30%), Positives = 169/361 (46%), Gaps = 53/361 (14%)
Query: 21 KIQEVIGKGSYGVVCSAI--DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
+G+G+YG V A D + A+K+I IS +A REI LLR L+HP+
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG--TGISMSA--CREIALLRELKHPN 79
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD---------LTREHYQFFLYQ 129
++ ++ + L + + ++++F+ E DL +IK + L R + LYQ
Sbjct: 80 VISLQKVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 130 LLRALKYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTTIF-WTDY 184
+L + Y+H V HRDLKP NIL ++KI D G AR FN +
Sbjct: 137 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLADLDPV 195
Query: 185 VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN---------VVHQ 234
V T WYRAPE L G+ YT AIDIW+IGCIFAE+LT +P+F + Q
Sbjct: 196 VVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253
Query: 235 LDLMTDLLGTPSLDT---------ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSAL 285
LD + +++G P+ S + D R T+ + ++ + D A
Sbjct: 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYME--KHKVKPDSKAF 311
Query: 286 RLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQP-ISKMEFEFERRRVTKEDIR 344
LL++LL DP R T+E+A+ DPYF E + + + +R E+
Sbjct: 312 HLLQKLLTMDPIKRITSEQAMQDPYFL-----EDPLPTSDVFAGCQIPYPKREFLTEEEP 366
Query: 345 E 345
+
Sbjct: 367 D 367
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 5e-80
Identities = 92/400 (23%), Positives = 151/400 (37%), Gaps = 67/400 (16%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLR-LLRHP 77
+ ++V+G G+ G + VA+K+I +D RE++LLR HP
Sbjct: 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFAD-----REVQLLRESDEHP 78
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY-QFFLYQLLRALKY 136
+++ + +D + Y+ EL + L + ++ D L Q L +
Sbjct: 79 NVIRYFC-----TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 137 IHTANVYHRDLKPKNIL-----ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 191
+H+ N+ HRDLKP NIL A+ K I DFGL + + + T +
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 192 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 249
APE L T +DI+S GC+F V++ G F
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF----------------------- 230
Query: 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 309
+R + + + D A L+E+++A DP+ RP+A+ L P
Sbjct: 231 -----GKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285
Query: 310 YFKGLSK-----------VEREPSCQPISKMEFEFERRRVTKEDIRELIFREILE----- 353
+F L K +E+E PI K + E R V K D RE I +
Sbjct: 286 FFWSLEKQLQFFQDVSDRIEKESLDGPIVK-QLERGGRAVVKMDWRENITVPLQTDLRKF 344
Query: 354 --YHPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENV 391
Y ++D + Y + R+ L ++
Sbjct: 345 RTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGTLPDDF 384
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 1e-66
Identities = 96/331 (29%), Positives = 155/331 (46%), Gaps = 46/331 (13%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 76
A RY++ +VIGKGS+G V A D + VA+K + + + A EI++L LR
Sbjct: 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAE--EIRILEHLRK 152
Query: 77 PDIVEIKHIMLPPSRRDFKD-IYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLRA 133
D +++ F++ I + FEL+ +L+++IK N + + F + +L+
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 134 LKYIHTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 191
L +H + H DLKP+NIL +K+ DFG + + T Y+ +R+YR
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE-HQRVYT-----YIQSRFYR 266
Query: 192 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250
APE + G+ +Y ID+WS+GCI AE+LTG PL PG++ QL M +LLG PS +
Sbjct: 267 APEVILGA---RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323
Query: 251 SRVRN-------------------DKARRYLTSMRKK----QPVQFSQKFPNADPSALR- 286
+ L R + + S+++ NA
Sbjct: 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDP 383
Query: 287 ----LLERLLAFDPKDRPTAEEALADPYFKG 313
L++ L +DP R T +AL P+ +
Sbjct: 384 LFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 220 bits (561), Expect = 2e-66
Identities = 54/352 (15%), Positives = 93/352 (26%), Gaps = 61/352 (17%)
Query: 1 MLQNSPEMEFFSEYGDASR-YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHI 58
+ + E S R K+ E + G VV D E A+K
Sbjct: 44 VWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSR 103
Query: 59 SDAARILREIKLLRLLRHPDIVEI-------------------KHIMLPPSRRDFK--DI 97
S+ R+ L E L P + D+ +
Sbjct: 104 SELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANY 163
Query: 98 YVVFELMESDLHQVIKANDDLTREHY-------QFFLYQLLRALKYIHTANVYHRDLKPK 150
++ DL + D + QL+R + + + H P
Sbjct: 164 LLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPD 223
Query: 151 NILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 210
N+ + +L + D P + Y E + + +T A++ W
Sbjct: 224 NLFIMPDGRLMLGDVSALWKVGTRGPAS------SVPVTYAPREFLNASTATFTHALNAW 277
Query: 211 SIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQP 270
+G V F + L P D+++
Sbjct: 278 QLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLA------------------- 318
Query: 271 VQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPS 322
L+ R L FD + R EA+ P F +++ E S
Sbjct: 319 ---FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL---QLQNEIS 364
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 1e-63
Identities = 70/341 (20%), Positives = 139/341 (40%), Gaps = 59/341 (17%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 76
+ + + +G G++G V + A+K + +I + + +A+I E +L+ +++
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKI--EADILKKIQN 90
Query: 77 PDIVEIKHIMLPPSRRDFKD-IYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLRA 133
D + +I+ + + D + ++FE + L+++I N+ E + + ++L+A
Sbjct: 91 DD-INNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 134 LKYIHTANVYHRDLKPKNIL-------------------------ANANCKLKICDFGLA 168
L Y+ ++ H DLKP+NIL + +K+ DFG A
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 169 RVAF-NDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 226
F +D + + TR YRAPE + + + D+WS GC+ AE+ TG LF
Sbjct: 210 --TFKSDYHGS-----IINTRQYRAPEVILNL---GWDVSSDMWSFGCVLAELYTGSLLF 259
Query: 227 PGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYL-------------TSMRKKQPVQF 273
+ L +M ++ + + +Y+ +S+ + V+
Sbjct: 260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKK 319
Query: 274 SQKFPNA--DPSALRLLERLLAFDPKDRPTAEEALADPYFK 312
L +L DP RP+ E L + +
Sbjct: 320 CLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 1e-63
Identities = 71/305 (23%), Positives = 110/305 (36%), Gaps = 47/305 (15%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP- 77
Y I + IG G V ++ + AIK ++ EI L L+
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 78 -DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 136
I+ + + IY+V E DL+ +K + + + +L A+
Sbjct: 88 DKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 142
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL- 195
IH + H DLKP N L + LK+ DFG+A DT T++ V T Y PE
Sbjct: 143 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT-TSVVKDSQVGTVNYMPPEAI 200
Query: 196 --------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247
G SK +P D+WS+GCI + GK F +
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI--------------INQI 246
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
+ + + ++F + +L+ L DPK R + E LA
Sbjct: 247 SKLHAI-----------IDPNHEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
Query: 308 DPYFK 312
PY +
Sbjct: 293 HPYVQ 297
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 1e-63
Identities = 92/336 (27%), Positives = 150/336 (44%), Gaps = 51/336 (15%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 76
RY+I +IGKGS+G V A D E VAIK I + + + A+I E++LL L+
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQI--EVRLLELMNK 109
Query: 77 PDIVEIKHIMLPPSRRDFKD-IYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLRA 133
D +I+ F++ + +VFE++ +L+ +++ + ++ + F Q+ A
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 134 LKYIHT--ANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 189
L ++ T ++ H DLKP+NIL +KI DFG + Y+ +R+
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRIYQ-----YIQSRF 223
Query: 190 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 249
YR+PE+ Y AID+WS+GCI E+ TG+PLF G N V Q++ + ++LG P
Sbjct: 224 YRSPEVL--LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281
Query: 250 I--------------------------SRVRNDKARRYLTSMRKKQ---PVQFSQKFPNA 280
+ R R L ++ + P
Sbjct: 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGH 341
Query: 281 DPSALR----LLERLLAFDPKDRPTAEEALADPYFK 312
+ L+ R+L +DPK R AL +FK
Sbjct: 342 TVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 1e-62
Identities = 94/344 (27%), Positives = 144/344 (41%), Gaps = 51/344 (14%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTG-EKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
RY+I +G+G++G V +D G +VA+K I ++ +AAR+ EI +L+ ++
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARL--EINVLKKIK 74
Query: 76 HPDIVEIKHIMLPPSRRDFKD-IYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLR 132
D +L +F + + FEL+ + + +K N+ H + YQL
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134
Query: 133 ALKYIHTANVYHRDLKPKNIL-------------------ANANCKLKICDFGLARVAF- 172
AL+++H + H DLKP+NIL + N +++ DFG A F
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFD 192
Query: 173 NDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 231
++ TT VATR YR PE + + D+WSIGCI E G LF
Sbjct: 193 HEHHTT-----IVATRHYRPPEVILEL---GWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244
Query: 232 VHQLDLMTDLLGTPSLDTISRVR------NDKARRYLTSMRKKQPVQFSQKFPNA----- 280
L +M +LG I R R S + + + +
Sbjct: 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDS 304
Query: 281 --DPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPS 322
L+ R+L FDP R T EAL P+F GL+ ER
Sbjct: 305 LEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFH 348
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 2e-62
Identities = 92/339 (27%), Positives = 149/339 (43%), Gaps = 53/339 (15%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTG-EKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
++RY+I + +G+G++G V ID G VA+K + ++ + +AAR EI++L L
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARS--EIQVLEHLN 69
Query: 76 HPDIVEIKHIMLPPSRRDFKD-IYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLR 132
D + + I +VFEL+ + IK N +H + YQ+ +
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICK 129
Query: 133 ALKYIHTANVYHRDLKPKNIL-------------------ANANCKLKICDFGLARVAF- 172
++ ++H+ + H DLKP+NIL N +K+ DFG A +
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYD 187
Query: 173 NDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 231
++ +T V+TR YRAPE + ++ D+WSIGCI E G +FP +
Sbjct: 188 DEHHST-----LVSTRHYRAPEVILAL---GWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239
Query: 232 VHQLDLMTDLLGTPSLDTISRVRNDK--------------ARRYLTSMRKKQPVQFSQKF 277
L +M +LG I + R K A RY++ K +F
Sbjct: 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK-EFMLSQ 298
Query: 278 PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316
L++++L +DP R T EAL P+F L K
Sbjct: 299 DVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 1e-61
Identities = 73/331 (22%), Positives = 116/331 (35%), Gaps = 49/331 (14%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP- 77
Y I + IG G V ++ + AIK ++ EI L L+
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 78 -DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 136
I+ + + IY+V E DL+ +K + + + +L A+
Sbjct: 69 DKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 123
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL- 195
IH + H DLKP N L + LK+ DFG+A DT T++ V T Y PE
Sbjct: 124 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT-TSVVKDSQVGTVNYMPPEAI 181
Query: 196 --------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247
G SK +P D+WS+GCI + GK F
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK------------ 229
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPN-ADPSALRLLERLLAFDPKDRPTAEEAL 306
+ +FP+ + +L+ L DPK R + E L
Sbjct: 230 -----------------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272
Query: 307 ADPYFKGLSKVEREPSCQPISKMEFEFERRR 337
A PY + + + + +M++ +
Sbjct: 273 AHPYVQIQTHPVNQMAKGTTEEMKYVLGQLV 303
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 6e-60
Identities = 75/335 (22%), Positives = 126/335 (37%), Gaps = 49/335 (14%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
+RY + +G G + V A D VA+K + + ++AA EIKLL+ +
Sbjct: 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAED--EIKLLQRVN 73
Query: 76 HPDIVEIKHIMLPPSRR-----DFKDIYV-----VFELMESDLHQVIKANDD--LTREHY 123
D + + + + K VFE++ +L +IK + + +
Sbjct: 74 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 133
Query: 124 QFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCK------LKICDFGLARVAFNDTP 176
+ QLL L Y+H + H D+KP+N+L +KI D G A
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY- 192
Query: 177 TTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV---- 231
T+ + TR YR+PE L G+ + DIWS C+ E++TG LF
Sbjct: 193 -----TNSIQTREYRSPEVLLGA---PWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244
Query: 232 --VHQLDLMTDLLGTPSLDTISRVR----------NDKARRYLTSMRKKQPVQFSQKFPN 279
+ + +LLG + + + L + + KF
Sbjct: 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 304
Query: 280 ADPSALR-LLERLLAFDPKDRPTAEEALADPYFKG 313
+ + L +L DP+ R A + P+ K
Sbjct: 305 DEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-59
Identities = 79/376 (21%), Positives = 126/376 (33%), Gaps = 57/376 (15%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP- 77
Y I + IG G V ++ + AIK ++ EI L L+
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 78 -DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 136
I+ + + IY+V E DL+ +K + + + +L A+
Sbjct: 116 DKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL- 195
IH + H DLKP N L + LK+ DFG+A DT T++ V Y PE
Sbjct: 171 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT-TSVVKDSQVGAVNYMPPEAI 228
Query: 196 --------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247
G SK +P D+WS+GCI + GK F +
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI--------------INQI 274
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
+ + + ++F + +L+ L DPK R + E LA
Sbjct: 275 SKLHAI-----------IDPNHEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLA 320
Query: 308 DPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGTE 367
PY +++ P Q E K + +L+ + K
Sbjct: 321 HPYV----QIQTHPVNQMAKGTTEEM------KYVLGQLVGLNSPNSILKAAKTLYEHYS 370
Query: 368 RTNFLYPSAVDQFRKQ 383
S+ F K+
Sbjct: 371 GGESHNSSSSKTFEKK 386
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 8e-59
Identities = 78/318 (24%), Positives = 124/318 (38%), Gaps = 56/318 (17%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 76
AS ++ V+G+G++G V A + AIKKI E + IL E+ LL L H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTE--EKLSTILSEVMLLASLNH 61
Query: 77 PDIVEIKH--------IMLPPSRRDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFF 126
+V + + + +++ E E L+ +I + N + R+ Y
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 127 LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW----- 181
Q+L AL YIH+ + HRDLKP NI + + +KI DFGLA+
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 182 ------TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 235
T + T Y A E+ Y ID++S+G IF E++ P G V+
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDG-TGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVN-- 236
Query: 236 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFP-NADPSALRLLERLLAF 294
++ L + ++F F N +++ L+
Sbjct: 237 -ILKKL-------------------------RSVSIEFPPDFDDNKMKVEKKIIRLLIDH 270
Query: 295 DPKDRPTAEEALADPYFK 312
DP RP A L +
Sbjct: 271 DPNKRPGARTLLNSGWLP 288
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 8e-58
Identities = 90/307 (29%), Positives = 136/307 (44%), Gaps = 49/307 (15%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH------DIFEHISDAARILREIKLLR 72
Y + + +G G+ G V A + T +KVAI+ I A + EI++L+
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 73 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLL 131
L HP I++IK+ D +D Y+V ELME +L + N L + + YQ+L
Sbjct: 196 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 132 RALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 188
A++Y+H + HRDLKP+N+L +C +KI DFG +++ + T
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTP 305
Query: 189 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247
Y APE L + Y A+D WS+G I L+G P F L
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----------K 354
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 306
D I + +Y F + + AL L+++LL DPK R T EEAL
Sbjct: 355 DQI------TSGKY----------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 398
Query: 307 ADPYFKG 313
P+ +
Sbjct: 399 RHPWLQD 405
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 9e-58
Identities = 59/314 (18%), Positives = 113/314 (35%), Gaps = 26/314 (8%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
+ + +++G+G+ V TG+ AIK + + +RE ++L+ L H +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAN---DDLTREHYQFFLYQLLRAL 134
IV++ I + + ++ E L+ V++ L + L ++ +
Sbjct: 69 IVKLFAIEEETTT---RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 135 KYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 190
++ + HR++KP NI+ + K+ DFG AR +D T Y
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL----YGTEEY 181
Query: 191 RAPEL------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF-PGKNVVHQLDLMTDLLG 243
P++ KY +D+WSIG F TG F P + ++M ++
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 244 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE 303
IS V+ + S S +L +L D + +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGFD 298
Query: 304 EALADPYFKGLSKV 317
+ A+
Sbjct: 299 QFFAETSDILHRGN 312
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-57
Identities = 71/324 (21%), Positives = 122/324 (37%), Gaps = 55/324 (16%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
+ ++ + +G+G +GVV A + AIK+I + +++RE+K L L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHP 63
Query: 78 DIVEIKH-------IMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQF---F 126
IV + +Y+ +L +L + +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 127 LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT---------PT 177
Q+ A++++H+ + HRDLKP NI + +K+ DFGL D P
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 178 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 237
T V T+ Y +PE + Y+ +DI+S+G I E+L P V
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY--PFSTQMERV----- 234
Query: 238 MTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPK 297
T++ VRN K F F P +++ +L+ P
Sbjct: 235 ----------RTLTDVRNLK---------------FPPLFTQKYPCEYVMVQDMLSPSPM 269
Query: 298 DRPTAEEALADPYFKGLSKVEREP 321
+RP A + + F+ L +
Sbjct: 270 ERPEAINIIENAVFEDLDFPGKTV 293
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 5e-57
Identities = 75/319 (23%), Positives = 113/319 (35%), Gaps = 63/319 (19%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 76
+K E+IG G +G V A G+ IK++ + + RE+K L L H
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNEKAEREVKALAKLDH 63
Query: 77 PDIVEIKH-----------IMLPPSRRDFKDIYVVFELMES-DLHQVIKA--NDDLTREH 122
+IV SR K +++ E + L Q I+ + L +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 123 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 182
Q+ + + YIH+ + +RDLKP NI ++KI DFGL ND T
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS-- 181
Query: 183 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDL 241
T Y +PE S Y +D++++G I AE+L F L
Sbjct: 182 --KGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL------ 231
Query: 242 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT 301
F +K LL++LL+ P+DRP
Sbjct: 232 -----------------------RDGIISDIFDKKEKT-------LLQKLLSKKPEDRPN 261
Query: 302 AEEALADPYFKGLSKVERE 320
E L S + E
Sbjct: 262 TSEILRTLTVWKKSPEKNE 280
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 8e-57
Identities = 71/297 (23%), Positives = 105/297 (35%), Gaps = 46/297 (15%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIK-LLRLLRH 76
++ +G GSYG V G A+K+ F D AR L E+ ++ +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY-QFFLYQLLRALK 135
P V ++ + + +Y+ EL L Q +A E +L L AL
Sbjct: 117 PCCVRLEQ-----AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA 171
Query: 136 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 195
++H+ + H D+KP NI + K+ DFGL + Y APEL
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ----EGDPRYMAPEL 227
Query: 196 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255
Y A D++S+G EV L G QL
Sbjct: 228 LQG---SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL-------------------- 264
Query: 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312
+ P +F+ +L +L DPK R TAE LA P +
Sbjct: 265 ---------RQGYLPPEFTAGLS---SELRSVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-56
Identities = 74/332 (22%), Positives = 134/332 (40%), Gaps = 47/332 (14%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRH 76
+Y + IG+GS+G T G + IK+I+ +S R RE+ +L ++H
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEIN--ISRMSSKEREESRREVAVLANMKH 82
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIK-ANDDLTREHY-QFFLYQLLRA 133
P+IV+ + S + +Y+V + E DL + I L +E + Q+ A
Sbjct: 83 PNIVQYRE-----SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA 137
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 193
LK++H + HRD+K +NI + +++ DFG+ARV T + T +Y +P
Sbjct: 138 LKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL---NSTVELARACIGTPYYLSP 194
Query: 194 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253
E+C + Y DIW++GC+ E+ T K F + M +L + ++
Sbjct: 195 EICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGS-------MKNL--------VLKI 237
Query: 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313
+ + +S + L+ +L +P+DRP+ L +
Sbjct: 238 ISGSFPPV--------SLHYSYDLRS-------LVSQLFKRNPRDRPSVNSILEKGFIAK 282
Query: 314 LSKVEREPSCQPISKMEFEFERRRVTKEDIRE 345
+ P F + +
Sbjct: 283 RIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKR 314
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-56
Identities = 83/306 (27%), Positives = 128/306 (41%), Gaps = 52/306 (16%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRH 76
Y++ IG GSYG G+ + K++ + +++A + ++ E+ LLR L+H
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD--YGSMTEAEKQMLVSEVNLLRELKH 64
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIK----ANDDLTREHYQFFLYQLL 131
P+IV ++ R +Y+V E E DL VI L E + QL
Sbjct: 65 PNIVRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 132 RALKYIHTAN-----VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA 186
ALK H + V HRDLKP N+ + +K+ DFGLAR+ T F +V
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL---NHDTSFAKTFVG 178
Query: 187 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 246
T +Y +PE Y DIWS+GC+ E+ P F + +L
Sbjct: 179 TPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFS-------QKEL----- 224
Query: 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 306
++R K RR P ++S + ++ R+L RP+ EE L
Sbjct: 225 ---AGKIREGKFRRI--------PYRYSDELNE-------IITRMLNLKDYHRPSVEEIL 266
Query: 307 ADPYFK 312
+P
Sbjct: 267 ENPLIL 272
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 4e-56
Identities = 90/307 (29%), Positives = 133/307 (43%), Gaps = 49/307 (15%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH------DIFEHISDAARILREIKLLR 72
Y + + +G G+ G V A + T +KVAIK I A + EI++L+
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 73 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLL 131
L HP I++IK+ D +D Y+V ELME +L + N L + + YQ+L
Sbjct: 71 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 132 RALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 188
A++Y+H + HRDLKP+N+L +C +KI DFG +++ + T
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTP 180
Query: 189 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247
Y APE L + Y A+D WS+G I L+G P F L
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----------K 229
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 306
D I F + + AL L+++LL DPK R T EEAL
Sbjct: 230 DQI----------------TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273
Query: 307 ADPYFKG 313
P+ +
Sbjct: 274 RHPWLQD 280
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-55
Identities = 67/357 (18%), Positives = 129/357 (36%), Gaps = 28/357 (7%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
+ + +++G+G+ V TG+ AIK + + +RE ++L+ L H +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAN---DDLTREHYQFFLYQLLRAL 134
IV++ I + + ++ E L+ V++ L + L ++ +
Sbjct: 69 IVKLFAIEEETTT---RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 135 KYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 190
++ + HR++KP NI+ + K+ DFG AR +D T Y
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL----YGTEEY 181
Query: 191 RAPEL------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF-PGKNVVHQLDLMTDLLG 243
P++ KY +D+WSIG F TG F P + ++M ++
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 244 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE 303
IS V+ + S S +L +L D + +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGFD 298
Query: 304 EALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREI-LEYHPQLL 359
+ A+ V S Q ++ + T EL++++ + Q L
Sbjct: 299 QFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYN-TATIFHELVYKQTKIISSNQEL 354
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 5e-54
Identities = 84/339 (24%), Positives = 128/339 (37%), Gaps = 61/339 (17%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 77
RY +GKG + D T E A K + + ++ EI + R L H
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 136
+V D ++VV EL L ++ K LT +++L Q++ +Y
Sbjct: 102 HVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 156
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND---------TPTTIFWTDYVAT 187
+H V HRDLK N+ N + ++KI DFGLA D TP +Y+
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP------NYI-- 208
Query: 188 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247
APE+ ++ +D+WSIGCI +L GKP F +
Sbjct: 209 ----APEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--------------- 247
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
+T R++ Y P + P A L++++L DP RPT E L
Sbjct: 248 ETYLRIKK---NEY------SIPKHIN-------PVAASLIQKMLQTDPTARPTINELLN 291
Query: 308 DPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIREL 346
D +F R P F + + + L
Sbjct: 292 DEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPL 330
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 1e-53
Identities = 82/317 (25%), Positives = 124/317 (39%), Gaps = 62/317 (19%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 77
RY +GKG + D T E A K + + ++ EI + R L H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 136
+V D ++VV EL L ++ K LT +++L Q++ +Y
Sbjct: 76 HVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 130
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND---------TPTTIFWTDYVAT 187
+H V HRDLK N+ N + ++KI DFGLA D TP +Y+
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP------NYI-- 182
Query: 188 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247
APE+ ++ +D+WSIGCI +L GKP F +
Sbjct: 183 ----APEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--------------- 221
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
+T R++ Y P + P A L++++L DP RPT E L
Sbjct: 222 ETYLRIKK---NEY------SIPKHIN-------PVAASLIQKMLQTDPTARPTINELLN 265
Query: 308 DPYF-KGLSKVEREPSC 323
D +F G +C
Sbjct: 266 DEFFTSGYIPARLPITC 282
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 6e-53
Identities = 97/376 (25%), Positives = 160/376 (42%), Gaps = 66/376 (17%)
Query: 2 LQNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISD 60
LQ +P M S+ G + Y+ + +G G+YG V D T + AIK I S
Sbjct: 20 LQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS 79
Query: 61 AARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLT 119
+++L E+ +L+LL HP+I+++ D ++ Y+V E + +L I
Sbjct: 80 NSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFN 134
Query: 120 REHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTP 176
+ Q+L + Y+H N+ HRDLKP+N+L + +KI DFGL+ V F +
Sbjct: 135 EVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV-FENQK 193
Query: 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 236
+ + T +Y APE+ KY D+WSIG I +L G P F G+
Sbjct: 194 K---MKERLGTAYYIAPEV---LRKKYDEKCDVWSIGVILFILLAGYPPFGGQT------ 241
Query: 237 LMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFD 295
+ + +K F S ++ N A L++++L FD
Sbjct: 242 ----------------------DQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFD 279
Query: 296 PKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFE----FERRR-------------- 337
+ R +A++AL P+ K + + P E F+ +
Sbjct: 280 SQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKL 339
Query: 338 VTKEDIREL--IFREI 351
++E+ +EL IFR I
Sbjct: 340 TSQEETKELTDIFRHI 355
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 6e-53
Identities = 73/304 (24%), Positives = 128/304 (42%), Gaps = 53/304 (17%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLR 75
+ ++I++ IG+G + V A G VA+KK+ IF+ + AR ++EI LL+ L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV-QIFDLMDAKARADCIKEIDLLKQLN 90
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFF-------- 126
HP++++ S + ++ +V EL ++ DL ++IK ++ +
Sbjct: 91 HPNVIKYYA-----SFIEDNELNIVLELADAGDLSRMIKHF----KKQKRLIPERTVWKY 141
Query: 127 LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA 186
QL AL+++H+ V HRD+KP N+ A +K+ D GL R + T V
Sbjct: 142 FVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTAAHSLVG 198
Query: 187 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 246
T +Y +PE + Y DIWS+GC+ E+ + F G D + S
Sbjct: 199 TPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYG-----------DKMNLYS 245
Query: 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 306
L ++ + +S++ L+ + DP+ RP
Sbjct: 246 L--CKKIEQCDYPPLPSD-------HYSEELRQ-------LVNMCINPDPEKRPDVTYVY 289
Query: 307 ADPY 310
Sbjct: 290 DVAK 293
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 9e-53
Identities = 84/334 (25%), Positives = 140/334 (41%), Gaps = 47/334 (14%)
Query: 2 LQNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHIS 59
L +P M + RYK Q V+GKGS+G V D TG++ A+K I + +
Sbjct: 9 LHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKT 68
Query: 60 DAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDL 118
D +LRE++LL+ L HP+I+++ D Y+V E+ +L I +
Sbjct: 69 DKESLLREVQLLKQLDHPNIMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRF 123
Query: 119 TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDT 175
+ + Q+L + Y+H + HRDLKP+N+L + + ++I DFGL+ F +
Sbjct: 124 SEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH-FEAS 182
Query: 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 235
D + T +Y APE+ Y D+WS G I +L+G P F G N
Sbjct: 183 KK---MKDKIGTAYYIAPEV---LHGTYDEKCDVWSTGVILYILLSGCPPFNGAN----- 231
Query: 236 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAF 294
+ +K F ++ SA L+ ++L +
Sbjct: 232 -----------------------EYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTY 268
Query: 295 DPKDRPTAEEALADPYFKGLSKVEREPSCQPISK 328
P R +A +AL + + +K + +
Sbjct: 269 VPSMRISARDALDHEWIQTYTKEQISVDVPSLDN 302
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-52
Identities = 93/333 (27%), Positives = 138/333 (41%), Gaps = 48/333 (14%)
Query: 3 QNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA 61
+S E G A RY I ++GKGS+G V D T ++ A+K I+ D
Sbjct: 6 HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65
Query: 62 ARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTR 120
+ ILRE++LL+ L HP+I+++ I+ D Y+V EL +L I +
Sbjct: 66 STILREVELLKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSE 120
Query: 121 EHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPT 177
+ Q+ + Y+H N+ HRDLKP+NIL +C +KI DFGL+ F
Sbjct: 121 HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC-FQQNTK 179
Query: 178 TIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 236
D + T +Y APE L G Y D+WS G I +L+G P F GKN
Sbjct: 180 ---MKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKN------ 226
Query: 237 LMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFD 295
+ + F ++ A L+ ++L F
Sbjct: 227 ----------------------EYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFH 264
Query: 296 PKDRPTAEEALADPYFKGLSKVEREPSCQPISK 328
P R TA + L P+ + S S P +
Sbjct: 265 PSLRITATQCLEHPWIQKYSSETPTISDLPSLE 297
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-52
Identities = 84/347 (24%), Positives = 129/347 (37%), Gaps = 81/347 (23%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI---HDIFEHISDAARILREIKLLRLL 74
+Y ++ IG+GSYGVV AI+ T AIK + + D RI E++L++ L
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 75 RHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQF-------- 125
HP+I + + D + I +V EL L + D +
Sbjct: 86 HHPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 126 --------------------------------FLYQLLRALKYIHTANVYHRDLKPKNIL 153
+ Q+ AL Y+H + HRD+KP+N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 154 --ANANCKLKICDFGLAR-VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 210
N + ++K+ DFGL++ + T T ++ APE+ + Y P D W
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 211 SIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQP 270
S G + +L G FPG N DTIS+V +
Sbjct: 261 SAGVLLHLLLMGAVPFPGVN---------------DADTISQV-------------LNKK 292
Query: 271 VQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316
+ F + + P A LL LL + +R A AL P+ S
Sbjct: 293 LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 5e-52
Identities = 94/324 (29%), Positives = 141/324 (43%), Gaps = 48/324 (14%)
Query: 2 LQNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISD 60
+S E G A RY I ++GKGS+G V D T ++ A+K I+ D
Sbjct: 5 HHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64
Query: 61 AARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLT 119
+ ILRE++LL+ L HP+I+++ I+ D Y+V EL +L I +
Sbjct: 65 TSTILREVELLKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFS 119
Query: 120 REHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTP 176
+ Q+ + Y+H N+ HRDLKP+NIL +C +KI DFGL+ +T
Sbjct: 120 EHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT- 178
Query: 177 TTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 235
D + T +Y APE L G Y D+WS G I +L+G P F GKN +
Sbjct: 179 ---KMKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKN---EY 228
Query: 236 DLMTD-LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 294
D++ G + D ++ A L+ ++L F
Sbjct: 229 DILKRVETGKYAFD-------------------------LPQWRTISDDAKDLIRKMLTF 263
Query: 295 DPKDRPTAEEALADPYFKGLSKVE 318
P R TA + L P+ + S E
Sbjct: 264 HPSLRITATQCLEHPWIQKYSSEE 287
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 8e-52
Identities = 78/357 (21%), Positives = 131/357 (36%), Gaps = 68/357 (19%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLR-LLRH 76
+ ++++G GS G V + G VA+K++ F I L EIKLL H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDI-----ALMEIKLLTESDDH 68
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQF-------FLYQ 129
P+++ + +Y+ EL +L ++++ + L Q
Sbjct: 69 PNVIRYYCSE-----TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 130 LLRALKYIHTANVYHRDLKPKNIL-------------ANANCKLKICDFGLAR-VAFNDT 175
+ + ++H+ + HRDLKP+NIL N ++ I DFGL + + +
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 176 PTTIFWTDYVATRWYRAPEL-----CGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 229
+ T +RAPEL + T +IDI+S+GC+F +L+ GK F K
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243
Query: 230 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLE 289
S + + A L+
Sbjct: 244 Y-----------------SRESNIIRGI---------FSLDEMKCLHDRSLIAEATDLIS 277
Query: 290 RLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIREL 346
+++ DP RPTA + L P F SK + +S E E R + +
Sbjct: 278 QMIDHDPLKRPTAMKVLRHPLFWPKSK--KLEFLLKVSD-RLEIENRDPPSALLMKF 331
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 3e-51
Identities = 83/302 (27%), Positives = 125/302 (41%), Gaps = 49/302 (16%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
Y ++ IG+GS+G V A+ T + A KKI + D R +EI++++ L HP
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK--YFVEDVDRFKQEIEIMKSLDHP 66
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 136
+I+ + D DIY+V EL +L + + + +L A+ Y
Sbjct: 67 NIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAY 121
Query: 137 IHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 193
H NV HRDLKP+N L + + LK+ DFGLA V T +Y +P
Sbjct: 122 CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK----MMRTKVGTPYYVSP 177
Query: 194 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL-GTPSLDTIS 251
+ L G Y P D WS G + +L G P F ++M + GT +
Sbjct: 178 QVLEG----LYGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEVMLKIREGTFTFP--- 227
Query: 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311
+ + N P A L+ RLL PK R T+ +AL +F
Sbjct: 228 ----------------------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF 265
Query: 312 KG 313
+
Sbjct: 266 EK 267
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 4e-51
Identities = 77/316 (24%), Positives = 131/316 (41%), Gaps = 50/316 (15%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRH 76
++I +GKG +G V A + + +A+K + E ++ RE+++ LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALK 135
P+I+ + D +Y++ E +++ ++ + ++ +L AL
Sbjct: 69 PNILRLYGYF-----HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 136 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT-DYVATRWYRAPE 194
Y H+ V HRD+KP+N+L + +LKI DFG + A + T + T DY+ PE
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL------PPE 177
Query: 195 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254
+ + +D+WS+G + E L GKP F +T R+
Sbjct: 178 MIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---------------ETYKRIS 220
Query: 255 NDKARRYLTSMRKKQPVQFSQKFPN-ADPSALRLLERLLAFDPKDRPTAEEALADPYF-K 312
V+F FP+ A L+ RLL +P RP E L P+
Sbjct: 221 R---------------VEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263
Query: 313 GLSKVEREPSCQPISK 328
SK + + SK
Sbjct: 264 NSSKPSNCQNKESASK 279
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 6e-51
Identities = 90/338 (26%), Positives = 132/338 (39%), Gaps = 59/338 (17%)
Query: 2 LQNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI--------- 51
+ +P M + G Y +G G+YG V + + + AIK I
Sbjct: 19 IAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGR 78
Query: 52 --HDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DL 108
D I EI LL+ L HP+I+++ + D K Y+V E E +L
Sbjct: 79 YSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGEL 133
Query: 109 HQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDF 165
+ I + Q+L + Y+H N+ HRD+KP+NIL N+ +KI DF
Sbjct: 134 FEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193
Query: 166 GLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 224
GL+ F+ D + T +Y APE L KY D+WS G I +L G P
Sbjct: 194 GLSSF-FSKDYK---LRDRLGTAYYIAPEVLKK----KYNEKCDVWSCGVIMYILLCGYP 245
Query: 225 LFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPS 283
F G+N D I +V K F + N
Sbjct: 246 PFGGQNDQ---------------DIIKKVEKGK-------------YYFDFNDWKNISDE 277
Query: 284 ALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREP 321
A L++ +L +D R TAEEAL + K + +
Sbjct: 278 AKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKS 315
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-50
Identities = 96/463 (20%), Positives = 164/463 (35%), Gaps = 38/463 (8%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
++++E +G G +G V I TGE+VAIK+ + R EI++++ L HP+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQC-RQELSPKNRERWCLEIQIMKKLNHPN 73
Query: 79 IVEIKHIMLPPSRRDFKD-IYVVFELMES-DLHQVIKANDD---LTREHYQFFLYQLLRA 133
+V + + + D + E E DL + + ++ L + L + A
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 134 LKYIHTANVYHRDLKPKNILANANCK---LKICDFGLARVAFNDTPTTIFWTDYVATRWY 190
L+Y+H + HRDLKP+NI+ + KI D G A+ T F V T Y
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF----VGTLQY 189
Query: 191 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250
APEL KYT +D WS G + E +TG F Q +
Sbjct: 190 LAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV----REKSNEH 243
Query: 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 310
V +D S P S R L+ +L + + R T +
Sbjct: 244 IVVYDDLTGAVKFSSVLPTPNHLS---GILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300
Query: 311 FKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREI-----LEYHPQLLKDYMNG 365
F+ L + ++ + VT+ + + + + + Q L
Sbjct: 301 FQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQELLQASGL 360
Query: 366 TER-----TNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPP 420
T ++ V R+ L V P+ + P S V P
Sbjct: 361 ALNSAQPLTQYVIDCTVIDGRQGEGDLIFLFDNRKTVYEPQISLPAHPES--VSIVLQDP 418
Query: 421 KEQQNLSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPL 463
K + R+ +++ + + +R L Q+ +
Sbjct: 419 KRPLTYTHLRRVWGQIWQ----TIRALKEDCARLLQGQRTSMV 457
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-50
Identities = 84/318 (26%), Positives = 137/318 (43%), Gaps = 56/318 (17%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
Y ++E +GKG++ VV + TG + A K I+ D ++ RE ++ R L+HP
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQ-----FFLYQLL 131
+IV + + ++ Y+VF+L+ +L + I A RE Y + Q+L
Sbjct: 66 NIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVA-----REFYSEADASHCIQQIL 115
Query: 132 RALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 188
++ Y H+ + HR+LKP+N+L +K+ DFGLA ND+ W + T
Sbjct: 116 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSE---AWHGFAGTP 171
Query: 189 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD-LLGTPS 246
Y +PE L Y+ +DIW+ G I +L G P F ++ Q L G
Sbjct: 172 GYLSPEVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAYD 225
Query: 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 306
S ++ P A L++ +L +PK R TA++AL
Sbjct: 226 YP-------------------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQAL 260
Query: 307 ADPYFKGLSKVEREPSCQ 324
P+ +V Q
Sbjct: 261 KVPWICNRERVASAIHRQ 278
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 5e-50
Identities = 69/300 (23%), Positives = 121/300 (40%), Gaps = 42/300 (14%)
Query: 18 SRY-KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 76
R+ K IG+GS+ V +DT T +VA ++ D S+ R E ++L+ L+H
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH 84
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALK 135
P+IV + K I +V ELM S L +K + + + + Q+L+ L+
Sbjct: 85 PNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143
Query: 136 YIHTAN--VYHRDLKPKNILANA-NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 192
++HT + HRDLK NI +KI D GLA + + T + A
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPE----FM-A 198
Query: 193 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252
PE+ KY ++D+++ G E+ T + + Q+
Sbjct: 199 PEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI----------------- 238
Query: 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312
Y +P F + A P ++E + + +R + ++ L +F+
Sbjct: 239 --------YRRVTSGVKPASFDK---VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 7e-50
Identities = 75/303 (24%), Positives = 132/303 (43%), Gaps = 56/303 (18%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 77
+K+ ++GKGS+ V A HTG +VAIK I R+ E+K+ L+HP
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND-DLTREHYQFFLYQLLRALK 135
I+E+ + D +Y+V E+ + ++++ +K + + F++Q++ +
Sbjct: 72 SILELYNYF-----EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 136 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT-----DYVATRWY 190
Y+H+ + HRDL N+L N +KI DFGLA P +T +Y+
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA--TQLKMPHEKHYTLCGTPNYI----- 179
Query: 191 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250
+PE+ S + D+WS+GC+F +L G+P F V +T+
Sbjct: 180 -SPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK---------------NTL 221
Query: 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPN-ADPSALRLLERLLAFDPKDRPTAEEALADP 309
++V + + P+ A L+ +LL +P DR + L P
Sbjct: 222 NKVVL---------------ADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264
Query: 310 YFK 312
+
Sbjct: 265 FMS 267
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-49
Identities = 77/318 (24%), Positives = 130/318 (40%), Gaps = 51/318 (16%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-------HDIFEHISDAARILREIKL 70
Y+ +E++G+G VV I T ++ A+K I E L+E+ +
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 71 LRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLY 128
LR + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 77 LRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131
Query: 129 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 188
LL + +H N+ HRDLKP+NIL + + +K+ DFG + + T
Sbjct: 132 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE----KLREVCGTP 187
Query: 189 WYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD-LLG 243
Y APE + S Y +D+WS G I +L G P F + Q+ ++ + G
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLMLRMIMSG 244
Query: 244 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE 303
S ++ + + L+ R L P+ R TAE
Sbjct: 245 NYQFG-------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAE 279
Query: 304 EALADPYFKGLSKVEREP 321
EALA P+F+ E
Sbjct: 280 EALAHPFFQQYVVEEVRH 297
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-49
Identities = 79/323 (24%), Positives = 136/323 (42%), Gaps = 54/323 (16%)
Query: 1 MLQNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHIS 59
+S E G + + +G G++G V + +G + IK I +
Sbjct: 4 HHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTI-NKDRSQV 62
Query: 60 DAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDL 118
+I EI++L+ L HP+I++I + D+ ++Y+V E E +L + I +
Sbjct: 63 PMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQA- 116
Query: 119 TREHY-----QFFLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARV 170
+ + Q++ AL Y H+ +V H+DLKP+NIL + + +KI DFGLA +
Sbjct: 117 RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176
Query: 171 AFNDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 229
+D T+ T Y APE T DIWS G + +LTG F G
Sbjct: 177 FKSDE----HSTNAAGTALYMAPEVFKR----DVTFKCDIWSAGVVMYFLLTGCLPFTGT 228
Query: 230 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLE 289
+ + ++ + ++ + P A+ LL+
Sbjct: 229 S-LEEV-----------QQKA----------------TYKEPNYAVECRPLTPQAVDLLK 260
Query: 290 RLLAFDPKDRPTAEEALADPYFK 312
++L DP+ RP+A + L +FK
Sbjct: 261 QMLTKDPERRPSAAQVLHHEWFK 283
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-49
Identities = 76/313 (24%), Positives = 126/313 (40%), Gaps = 49/313 (15%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRH 76
+ I +GKG +G V A + +A+K + E ++ REI++ LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALK 135
P+I+ + + D K IY++ E +L++ ++ + + F+ +L AL
Sbjct: 74 PNILRMYNYF-----HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128
Query: 136 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT-DYVATRWYRAPE 194
Y H V HRD+KP+N+L +LKI DFG + A + T+ T DY+ PE
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL------PPE 182
Query: 195 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254
+ + +D+W G + E L G P F + +T R+
Sbjct: 183 MIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT---------------ETHRRIV 225
Query: 255 NDKARRYLTSMRKKQPVQFSQKFPN-ADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313
N V KFP + L+ +LL + P R + + P+ K
Sbjct: 226 N---------------VDL--KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268
Query: 314 LSKVEREPSCQPI 326
S+ P Q
Sbjct: 269 NSRRVLPPVYQST 281
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 4e-49
Identities = 96/386 (24%), Positives = 158/386 (40%), Gaps = 65/386 (16%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
Y ++E +GKG++ VV + TG + A K I+ D ++ RE ++ R L+HP
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQ-----FFLYQLL 131
+IV + + ++ Y+VF+L+ +L + I A RE Y + Q+L
Sbjct: 89 NIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVA-----REFYSEADASHCIQQIL 138
Query: 132 RALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 188
++ Y H+ + HR+LKP+N+L +K+ DFGLA ND+ W + T
Sbjct: 139 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSE---AWHGFAGTP 194
Query: 189 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD-LLGTPS 246
Y +PE L Y+ +DIW+ G I +L G P F ++ Q L G
Sbjct: 195 GYLSPEVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAYD 248
Query: 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 306
S ++ P A L++ +L +PK R TA++AL
Sbjct: 249 YP-------------------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQAL 283
Query: 307 ADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIF--REILEYHPQLLKDYMN 364
P+ +V Q +F RR K I + R + LL
Sbjct: 284 KVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTMIATRNLSNLGRNLLNKKEQ 343
Query: 365 GTERTNFLYPSAVDQFRKQFAHLEEN 390
G PS + + + +++N
Sbjct: 344 GP-------PSTIKESSESSQTIDDN 362
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-48
Identities = 64/303 (21%), Positives = 106/303 (34%), Gaps = 43/303 (14%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
Y + +G+G + V H G A+K+I + D RE + RL HP+
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI--LCHEQQDREEAQREADMHRLFNHPN 87
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKA----NDDLTREHYQFFLYQLLRA 133
I+ + L R + +++ + L I+ + LT + + L + R
Sbjct: 88 ILRLVAYCLR-ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT------IFWTDYVAT 187
L+ IH HRDLKP NIL + + D G A + W T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 188 RWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 246
YRAPEL D+WS+GC+ ++ G+ +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF--------------QK 252
Query: 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 306
D+++ ++ + Q + S LL ++ DP RP L
Sbjct: 253 GDSVALAVQNQ-------LSIPQSPRHSSALWQ-------LLNSMMTVDPHQRPHIPLLL 298
Query: 307 ADP 309
+
Sbjct: 299 SQL 301
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-48
Identities = 77/315 (24%), Positives = 129/315 (40%), Gaps = 49/315 (15%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAARILREIKLLRL 73
Y++ E +G G + +V TG++ A K I I RE+ +LR
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 74 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLR 132
+RHP+I+ + I + D+ ++ EL+ +L + + LT + FL Q+L
Sbjct: 65 IRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD 119
Query: 133 ALKYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 188
+ Y+H+ + H DLKP+NI+ N ++K+ DFG+A + + T
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE----FKNIFGTP 175
Query: 189 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248
+ APE+ + D+WSIG I +L+G F G+ + + +
Sbjct: 176 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGET---KQETL---------T 221
Query: 249 TISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
IS V D F + F N A + RLL DPK R T ++L
Sbjct: 222 NISAVNYD----------------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265
Query: 308 DPYFKGLSKVEREPS 322
+ K + +
Sbjct: 266 HSWIKAIRRRNVRGE 280
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-48
Identities = 84/331 (25%), Positives = 135/331 (40%), Gaps = 55/331 (16%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
Y++ E +GKG++ VV + G++ A I+ D ++ RE ++ RLL+HP
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHY-----QFFLYQLL 131
+IV + + + Y++F+L+ +L + I A RE+Y + Q+L
Sbjct: 71 NIVRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVA-----REYYSEADASHCIQQIL 120
Query: 132 RALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 188
A+ + H V HR+LKP+N+L +K+ DFGLA + W + T
Sbjct: 121 EAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA---WFGFAGTP 177
Query: 189 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD-LLGTPS 246
Y +PE L Y +D+W+ G I +L G P F ++ Q L G
Sbjct: 178 GYLSPEVLRK---DPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLYQQIKAGAYD 231
Query: 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 306
S ++ P A L+ ++L +P R TA EAL
Sbjct: 232 FP-------------------------SPEWDTVTPEAKDLINKMLTINPSKRITAAEAL 266
Query: 307 ADPYFKGLSKVEREPSCQPISKMEFEFERRR 337
P+ S V Q +F RR
Sbjct: 267 KHPWISHRSTVASCMHRQETVDCLKKFNARR 297
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 5e-48
Identities = 79/323 (24%), Positives = 127/323 (39%), Gaps = 49/323 (15%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAARILREIKLLRL 73
Y E +G G + VV + TG + A K I I RE+ +L+
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 74 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLR 132
++HP+++ + + + D+ ++ EL+ +L + + LT E FL Q+L
Sbjct: 71 IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 133 ALKYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 188
+ Y+H+ + H DLKP+NI+ ++KI DFGLA + + T
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIFGTP 181
Query: 189 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248
+ APE+ + D+WSIG I +L+G F G T L
Sbjct: 182 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT-----KQET-------LA 227
Query: 249 TISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
+S V + F + F N A + RLL DPK R T +++L
Sbjct: 228 NVSAVNYE----------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 308 DPYFKGLSKVEREPSCQPISKME 330
P+ K + ME
Sbjct: 272 HPWIKPKDTQQALSRKASAVNME 294
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 5e-48
Identities = 55/336 (16%), Positives = 121/336 (36%), Gaps = 50/336 (14%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH---------------DIFEHISDAAR 63
Y+I + +G + + + A+KK D S
Sbjct: 32 DYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 64 ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREH 122
E++++ +++ + + I+ ++ ++Y+++E ME+ + + + L + +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGII-----TNYDEVYIIYEYMENDSILKFDEYFFVLDKNY 144
Query: 123 YQ--------FFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFN 173
+ +L + YIH N+ HRD+KP NIL + N ++K+ DFG + +
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204
Query: 174 DTPTTIFWT-DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 232
T +++ PE + S +DIWS+G + F K +
Sbjct: 205 KKIKGSRGTYEFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258
Query: 233 HQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLL 292
+L + I + + + + + L+ L
Sbjct: 259 VEL-----------FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFL 307
Query: 293 AFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISK 328
+P +R T+E+AL + + + + + K
Sbjct: 308 RKNPAERITSEDALKHEWLADTNIEDLREFSKELYK 343
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-47
Identities = 74/333 (22%), Positives = 132/333 (39%), Gaps = 49/333 (14%)
Query: 8 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAAR 63
ME F + Y I E +G G + +V + TG + A K I
Sbjct: 2 MEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 64 ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREH 122
I RE+ +LR + H +++ + + + D+ ++ EL+ +L + + L+ E
Sbjct: 62 IEREVSILRQVLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEE 116
Query: 123 YQFFLYQLLRALKYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTT 178
F+ Q+L + Y+HT + H DLKP+NI+ +K+ DFGLA +
Sbjct: 117 ATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-- 174
Query: 179 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLM 238
+ + T + APE+ + D+WSIG I +L+G F G + + +
Sbjct: 175 --FKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETL 227
Query: 239 TDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPK 297
I+ V D F + F + A + +LL + +
Sbjct: 228 ---------ANITSVSYD----------------FDEEFFSHTSELAKDFIRKLLVKETR 262
Query: 298 DRPTAEEALADPYFKGLSKVEREPSCQPISKME 330
R T +EAL P+ + + + + +E
Sbjct: 263 KRLTIQEALRHPWITPVDNQQAMVRRESVVNLE 295
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-47
Identities = 72/367 (19%), Positives = 123/367 (33%), Gaps = 104/367 (28%)
Query: 17 ASR----YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLR 72
ASR ++ + +G+G +GVV A + AIK+I + +++RE+K L
Sbjct: 1 ASRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALA 59
Query: 73 LLRHPDIV-------------------------------------------------EIK 83
L HP IV
Sbjct: 60 KLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS 119
Query: 84 HIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQ---FFLYQLLRALKY 136
+ ++ M+ +L + L + Q+ A+++
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND---------TPTTIFWTDYVAT 187
+H+ + HRDLKP NI + +K+ DFGL D P T V T
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 188 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247
+ Y +PE + Y+ +DI+S+G I E+L V
Sbjct: 240 KLYMSPEQIHG--NNYSHKVDIFSLGLILFELLY--SFSTQMERVR-------------- 281
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
I+ VRN ++F F P +++ +L+ P +RP A + +
Sbjct: 282 -IITDVRN---------------LKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325
Query: 308 DPYFKGL 314
+ F+ L
Sbjct: 326 NAIFENL 332
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-47
Identities = 74/313 (23%), Positives = 125/313 (39%), Gaps = 60/313 (19%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI------HDIFEHISDAARILREIKLL 71
+Y ++VIG+G VV + TG + A+K + + RE +L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 72 RLLR-HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQ----- 124
R + HP I+ + +++VF+LM +L + +
Sbjct: 154 RQVAGHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYLTE-----KVALSEKETR 203
Query: 125 FFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY 184
+ LL A+ ++H N+ HRDLKP+NIL + N ++++ DFG + +
Sbjct: 204 SIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH-LEPGE---KLREL 259
Query: 185 VATRWYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 240
T Y APE L S Y +D+W+ G I +L G P F + Q+ ++
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILMLRM 316
Query: 241 -LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR 299
+ G S ++ + + L+ RLL DP+ R
Sbjct: 317 IMEGQYQFS-------------------------SPEWDDRSSTVKDLISRLLQVDPEAR 351
Query: 300 PTAEEALADPYFK 312
TAE+AL P+F+
Sbjct: 352 LTAEQALQHPFFE 364
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 3e-47
Identities = 73/323 (22%), Positives = 128/323 (39%), Gaps = 49/323 (15%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAARILREIKLLRL 73
Y I E +G G + +V + TG + A K I I RE+ +LR
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 74 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLR 132
+ HP+I+ + + + D+ ++ EL+ +L + + L+ E F+ Q+L
Sbjct: 72 VLHPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 133 ALKYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 188
+ Y+HT + H DLKP+NI+ +K+ DFGLA + + + T
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE----FKNIFGTP 182
Query: 189 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248
+ APE+ + D+WSIG I +L+G F G + + +
Sbjct: 183 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETL---------A 228
Query: 249 TISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
I+ V D F + F A + +LL + + R T +EAL
Sbjct: 229 NITAVSYD----------------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272
Query: 308 DPYFKGLSKVEREPSCQPISKME 330
P+ + + + + +E
Sbjct: 273 HPWITPVDTQQAMVRRESVVNLE 295
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 5e-47
Identities = 71/307 (23%), Positives = 126/307 (41%), Gaps = 42/307 (13%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
+ + + +G+G+YG V A++ T E VA+K I D+ + I +EI + ++L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI 137
+V+ + Y+ E +L I+ + + Q F +QL+ + Y+
Sbjct: 67 VVKFYGHRREGN-----IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
H + HRD+KP+N+L + LKI DFGLA V + + T Y APEL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPELLK 180
Query: 198 SFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256
++ +D+WS G + +L G+ + D
Sbjct: 181 R--REFHAEPVDVWSCGIVLTAMLAGELPW-----------------------------D 209
Query: 257 KARRYLTSMRKKQPVQFSQ-KFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF-KGL 314
+ + + + D + L LL ++L +P R T + D ++ K L
Sbjct: 210 QPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269
Query: 315 SKVEREP 321
K + P
Sbjct: 270 KKGAKRP 276
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 5e-47
Identities = 82/338 (24%), Positives = 132/338 (39%), Gaps = 63/338 (18%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI---HDIFEHISDAARILREIKLLRLL 74
Y++ EVIGKG + VV I+ TG++ A+K + + RE + +L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 75 RHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFF------- 126
+HP IVE+ +Y+VFE M+ +DL I R F
Sbjct: 84 KHPHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVK-----RADAGFVYSEAVAS 133
Query: 127 --LYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFW 181
+ Q+L AL+Y H N+ HRD+KP +L + +K+ FG+A
Sbjct: 134 HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV---A 190
Query: 182 TDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 240
V T + APE + Y +D+W G I +L+G F G +L
Sbjct: 191 GGRVGTPHFMAPEVVKR---EPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERL----- 240
Query: 241 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDR 299
+ I + + + +++ + SA L+ R+L DP +R
Sbjct: 241 ------FEGIIKGK----------------YKMNPRQWSHISESAKDLVRRMLMLDPAER 278
Query: 300 PTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRR 337
T EAL P+ K + + + +F RR
Sbjct: 279 ITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARR 316
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 7e-47
Identities = 67/326 (20%), Positives = 131/326 (40%), Gaps = 74/326 (22%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI------------------------HDI 54
+Y +++ IGKGSYGVV A + + A+K +
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 55 FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIK 113
+ ++ +EI +L+ L HP++V++ ++ P+ +Y+VFEL+ + +V
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNE---DHLYMVFELVNQGPVMEVPT 130
Query: 114 A---NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170
++D R ++Q L++ ++Y+H + HRD+KP N+L + +KI DFG++
Sbjct: 131 LKPLSEDQARFYFQ----DLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS-- 184
Query: 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGK 229
+ V T + APE ++ A+D+W++G + G+ F +
Sbjct: 185 NEFKGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243
Query: 230 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKK---QPVQFSQKFPNADPSALR 286
++ + K Q ++F P+
Sbjct: 244 RIM-------------------------------CLHSKIKSQALEFP-DQPDIAEDLKD 271
Query: 287 LLERLLAFDPKDRPTAEEALADPYFK 312
L+ R+L +P+ R E P+
Sbjct: 272 LITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-46
Identities = 78/341 (22%), Positives = 132/341 (38%), Gaps = 66/341 (19%)
Query: 19 RYKI-QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLL-RLLRH 76
Y++ ++V+G G G V TG+K A+K + D+ + +E+ +
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-------YDSPKARQEVDHHWQASGG 81
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQF-------FLY 128
P IV I + + + ++ E ME +L I+ R F +
Sbjct: 82 PHIVCILDVYENMHHGK-RCLLIIMECMEGGELFSRIQE-----RGDQAFTEREAAEIMR 135
Query: 129 QLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYV 185
+ A++++H+ N+ HRD+KP+N+L + LK+ DFG A+ + T
Sbjct: 136 DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-----C 190
Query: 186 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 245
T +Y APE+ G KY + D+WS+G I +L G P F M
Sbjct: 191 YTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM------- 241
Query: 246 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNAD-----PSALRLLERLLAFDPKDRP 300
R+ + Q+ FPN + A +L+ LL DP +R
Sbjct: 242 -------------------KRRIRLGQYG--FPNPEWSEVSEDAKQLIRLLLKTDPTERL 280
Query: 301 TAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKE 341
T + + P+ V + P E + V +E
Sbjct: 281 TITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWDEVKEE 321
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-46
Identities = 81/339 (23%), Positives = 149/339 (43%), Gaps = 54/339 (15%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
Y++ + IGKG++ V A TG +VAIK I + + ++ RE++++++L HP+
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI 137
IV++ ++ K +Y++ E ++ + A+ + + + Q++ A++Y
Sbjct: 76 IVKLFEVIETE-----KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 130
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
H + HRDLK +N+L +A+ +KI DFG + F Y APEL
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF----CGAPPYAAPEL-- 184
Query: 198 SFFS--KYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254
F KY P +D+WS+G I +++G F G+N+ L
Sbjct: 185 --FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-------------KEL------- 222
Query: 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK-G 313
R + + + P S LL+R L +P R T E+ + D + G
Sbjct: 223 ----RERVLRGKYRIPFYMS-------TDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271
Query: 314 LSKVEREPSCQPISKMEFEF-----ERRRVTKEDIRELI 347
+ E +P +P + + ++E+I+E +
Sbjct: 272 HEEDELKPFVEPELDISDQKRIDIMVGMGYSQEEIQESL 310
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-46
Identities = 73/306 (23%), Positives = 123/306 (40%), Gaps = 57/306 (18%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
++++ +G+G+ +V T + A+K + + D + EI +L L HP
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVL----KKTVDKKIVRTEIGVLLRLSHP 108
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHY-----QFFLYQLL 131
+I+++K I +I +V EL+ +L I + +Y + Q+L
Sbjct: 109 NIIKLKEIF-----ETPTEISLVLELVTGGELFDRIVE-----KGYYSERDAADAVKQIL 158
Query: 132 RALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 188
A+ Y+H + HRDLKP+N+L + LKI DFGL+++ + T
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV----LMKTVCGTP 214
Query: 189 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247
Y APE L G Y P +D+WS+G I +L G F + +
Sbjct: 215 GYCAPEILRG---CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM-----------F 260
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
I + + +A L+ +L+ DPK R T +AL
Sbjct: 261 RRILNCEYYFISPW---------------WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305
Query: 308 DPYFKG 313
P+ G
Sbjct: 306 HPWVTG 311
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 7e-46
Identities = 72/318 (22%), Positives = 127/318 (39%), Gaps = 46/318 (14%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
+ + + +G+G+YG V A++ T E VA+K I D+ + I +EI + ++L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI 137
+V+ + Y+ E +L I+ + + Q F +QL+ + Y+
Sbjct: 67 VVKFYGHRREGN-----IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
H + HRD+KP+N+L + LKI DFGLA V + + T Y APEL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPEL-- 178
Query: 198 SFFS--KYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254
++ +D+WS G + +L G+ +
Sbjct: 179 --LKRREFHAEPVDVWSCGIVLTAMLAGELPW---------------------------- 208
Query: 255 NDKARRYLTSMRKKQPVQFSQ-KFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF-K 312
D+ + + + D + L LL ++L +P R T + D ++ K
Sbjct: 209 -DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267
Query: 313 GLSKVEREPSCQPISKME 330
L K + P E
Sbjct: 268 PLKKGAKRPRVTSGGVSE 285
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-45
Identities = 74/314 (23%), Positives = 130/314 (41%), Gaps = 44/314 (14%)
Query: 19 RYKIQ-EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-H 76
Y++Q +V+G+G++ V + I+ T ++ A+K I + +R+ RE+++L + H
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEK--QPGHIRSRVFREVEMLYQCQGH 70
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHY-----QFFLYQL 130
+++E+ + Y+VFE M + I R H+ + +
Sbjct: 71 RNVLELIEFF-----EEEDRFYLVFEKMRGGSILSHIHK-----RRHFNELEASVVVQDV 120
Query: 131 LRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARV----AFNDTPTTIFWTD 183
AL ++H + HRDLKP+NIL N +KICDF L +T
Sbjct: 121 ASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 184 YVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 240
+ Y APE+ S Y D+WS+G I +L+G P F G+ +
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240
Query: 241 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDR 299
++ K +F + + + +A L+ +LL D K R
Sbjct: 241 ACPACQNMLFESIQEGK-------------YEFPDKDWAHISCAAKDLISKLLVRDAKQR 287
Query: 300 PTAEEALADPYFKG 313
+A + L P+ +G
Sbjct: 288 LSAAQVLQHPWVQG 301
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-45
Identities = 77/352 (21%), Positives = 139/352 (39%), Gaps = 60/352 (17%)
Query: 2 LQNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA 61
+++SP F+ Y + +G+GS+ + + + + A+K I
Sbjct: 1 MKDSP---FYQHY---DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RME 49
Query: 62 ARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLT 119
A +EI L+L HP+IV++ + D ++V EL+ +L + IK
Sbjct: 50 ANTQKEITALKLCEGHPNIVKLHEVF-----HDQLHTFLVMELLNGGELFERIKK----- 99
Query: 120 REHY-----QFFLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVA 171
++H+ + + +L+ A+ ++H V HRDLKP+N+L N N ++KI DFG AR+
Sbjct: 100 KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159
Query: 172 FNDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 230
D T Y APE L + Y + D+WS+G I +L+G+ F +
Sbjct: 160 PPDNQP---LKTPCFTLHYAAPELLNQ---NGYDESCDLWSLGVILYTMLSGQVPFQSHD 213
Query: 231 VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLE 289
+++ +++ F + + N A L++
Sbjct: 214 RSLTCTSAVEIM--------KKIKKGD-------------FSFEGEAWKNVSQEAKDLIQ 252
Query: 290 RLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKE 341
LL DP R + + + S++ P P K
Sbjct: 253 GLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKA 304
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-45
Identities = 49/348 (14%), Positives = 96/348 (27%), Gaps = 82/348 (23%)
Query: 7 EMEFFSEYGDASR-YKIQEVIGKGSYGVVCSAIDTHTGEKVAIK---------------- 49
SE G+ R V+G+ A D TGE +
Sbjct: 61 PFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQM 120
Query: 50 -------KIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 102
++ ++ A LR I L++ P ++ + L + ++
Sbjct: 121 KEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP 180
Query: 103 LMESDLHQVIKANDDLTREHYQF-------FLYQLLRALKYIHTANVYHRDLKPKNILAN 155
M+S+L + + H Q++R L +H + H L+P +I+ +
Sbjct: 181 RMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD 240
Query: 156 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL---------CGSFFSKYTPA 206
+ + F V + +R + PEL + T +
Sbjct: 241 QRGGVFLTGFEHL-VRDGARVVS------SVSRGFEPPELEARRATISYHRDRRTLMTFS 293
Query: 207 IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMR 266
D W++G + + +
Sbjct: 294 FDAWALGLVIYWIWCADLPITKDAA----------------------------LGGSEWI 325
Query: 267 KKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314
+ LLE L + +DR +A+ P ++ L
Sbjct: 326 FRSCKNIP-------QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-45
Identities = 69/328 (21%), Positives = 127/328 (38%), Gaps = 46/328 (14%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
Y I E +G G++GVV ++ TG K I+ + D + EI ++ L HP
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHP 108
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELME-SDLH-QVIKANDDLTREHYQFFLYQLLRALK 135
++ + D ++ ++ E + +L ++ + ++ ++ Q LK
Sbjct: 109 KLINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 163
Query: 136 YIHTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 193
++H ++ H D+KP+NI+ +KI DFGLA P I AT + AP
Sbjct: 164 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVT-TATAEFAAP 219
Query: 194 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253
E+ D+W+IG + +L+G F G++ + +T+ V
Sbjct: 220 EIVD--REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---------------ETLQNV 262
Query: 254 RNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312
+ +F F + P A ++ LL +P+ R T +AL P+ K
Sbjct: 263 KRCD-------------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 309
Query: 313 GLSKVEREPSCQPISKMEFEFERRRVTK 340
G + + +
Sbjct: 310 GDHSNLTSRIPSSRYNKIRQKIKEKYAD 337
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-45
Identities = 64/318 (20%), Positives = 121/318 (38%), Gaps = 52/318 (16%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI--HDIFEHISDAARILREIKLLRLLRH 76
+Y + +++G+GSYG V +D+ T + A+K + + + A + +EI+LLR LRH
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIK--ANDDLTREHYQFFLYQLLRAL 134
+++++ ++ + + +Y+V E + +++ + QL+ L
Sbjct: 66 KNVIQLVDVLYNEEK---QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 135 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT-----DYVATRW 189
+Y+H+ + H+D+KP N+L LKI G+A T +
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ---- 178
Query: 190 YRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248
PE+ + ++ +DIWS G + TG F G N+ L
Sbjct: 179 --PPEIA-NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-------------YKL- 221
Query: 249 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308
+ P P LL+ +L ++P R + +
Sbjct: 222 ----------FENIGKGSYAIPGDCG-------PPLSDLLKGMLEYEPAKRFSIRQIRQH 264
Query: 309 PYF-KGLSKVEREPSCQP 325
+F K E P
Sbjct: 265 SWFRKKHPPAEAPVPIPP 282
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-45
Identities = 57/325 (17%), Positives = 101/325 (31%), Gaps = 71/325 (21%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLL-RLLR 75
+ + E IG G +G V + G AIK+ D LRE+ L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTR----EHYQFFLYQL 130
H +V + + + + E L I N + + L Q+
Sbjct: 70 HSHVVRYFS-----AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 131 LRALKYIHTANVYHRDLKPKNIL-------------------ANANCKLKICDFGLARVA 171
R L+YIH+ ++ H D+KP NI A+ KI D G
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR- 183
Query: 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 231
+ + A E+ ++ + P DI+++ +PL +
Sbjct: 184 ISSPQV------EEGDSRFLANEVLQENYT-HLPKADIFALALTVVCAAGAEPLPRNGDQ 236
Query: 232 VHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERL 291
H++ R+ + + Q LL+ +
Sbjct: 237 WHEI------------------------------RQGRLPRIPQVLS---QEFTELLKVM 263
Query: 292 LAFDPKDRPTAEEALADPYFKGLSK 316
+ DP+ RP+A + S+
Sbjct: 264 IHPDPERRPSAMALVKHSVLLSASR 288
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-44
Identities = 81/366 (22%), Positives = 134/366 (36%), Gaps = 63/366 (17%)
Query: 9 EFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREI 68
+Y +V+G G G V + T EK A+K + D + RE+
Sbjct: 58 AIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREV 105
Query: 69 KLL-RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQF- 125
+L R + P IV I + K + +V E ++ +L I+ R F
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQD-----RGDQAFT 159
Query: 126 ------FLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTP 176
+ + A++Y+H+ N+ HRD+KP+N+L N LK+ DFG A+ +
Sbjct: 160 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219
Query: 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 236
T T +Y APE+ G KY + D+WS+G I +L G P F + +
Sbjct: 220 ----LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 273
Query: 237 LMTD--LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 294
M +G + ++ L+ LL
Sbjct: 274 GMKTRIRMGQYEFP-------------------------NPEWSEVSEEVKMLIRNLLKT 308
Query: 295 DPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEY 354
+P R T E + P+ +KV + P E + V +E L +
Sbjct: 309 EPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYE 368
Query: 355 HPQLLK 360
++ K
Sbjct: 369 QIKIKK 374
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-44
Identities = 78/305 (25%), Positives = 126/305 (41%), Gaps = 61/305 (20%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 77
Y + + +G G++G V TG KVA+K ++ + +I REI+ L+L RHP
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 136
I+++ ++ P+ D ++V E + +L I + + + Q+L A+ Y
Sbjct: 72 HIIKLYQVISTPT-----DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND--------TPTTIFWTDYVATR 188
H V HRDLKP+N+L +A+ KI DFGL+ + + +P
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN----------- 175
Query: 189 WYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247
Y APE+ Y P +DIWS G I +L G F ++V P+L
Sbjct: 176 -YAAPEVISG--RLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-------------PTL 219
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
+ + P + S LL +L DP R T ++
Sbjct: 220 -----------FKKIRGGVFYIPEYLN-------RSVATLLMHMLQVDPLKRATIKDIRE 261
Query: 308 DPYFK 312
+FK
Sbjct: 262 HEWFK 266
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-44
Identities = 49/348 (14%), Positives = 92/348 (26%), Gaps = 71/348 (20%)
Query: 1 MLQNSPEMEFFSEYGDASR-YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHI 58
+ SE G+ R V+G+ A D TGE + +
Sbjct: 60 LWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS 119
Query: 59 SDAARILREIKLLRLLR----------------------HPDIVEIKHIMLPPSRRDFKD 96
+ ++ E+ LRLLR P ++ + L
Sbjct: 120 NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLS 179
Query: 97 IYVVFELMESDLHQVIKANDDLTREHYQ-------FFLYQLLRALKYIHTANVYHRDLKP 149
+ ++ M+S+L + + H Q++R L +H + H L+P
Sbjct: 180 RFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRP 239
Query: 150 KNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC---GSFFSKYTPA 206
+I+ + + + F A A + + T A
Sbjct: 240 VDIVLDQRGGVFLTGFEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFA 297
Query: 207 IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMR 266
D W++G + + +
Sbjct: 298 FDTWTLGLAIYWIWCADLPNTDDAAL---------------GGSEWIFRSCKN------- 335
Query: 267 KKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314
P LLE L + +DR +A+ P ++ L
Sbjct: 336 ----------IP---QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 165 bits (418), Expect = 4e-44
Identities = 69/325 (21%), Positives = 125/325 (38%), Gaps = 46/325 (14%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
Y I E +G G++GVV + TG A K + H SD + +EI+ + +LRHP
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHP 214
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELME-SDL-HQVIKANDDLTREHYQFFLYQLLRALK 135
+V + D ++ +++E M +L +V ++ ++ + ++ Q+ + L
Sbjct: 215 TLVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 269
Query: 136 YIHTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 193
++H N H DLKP+NI+ + +LK+ DFGL T + AP
Sbjct: 270 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS----VKVTTGTAEFAAP 325
Query: 194 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD-LLGTPSLDTISR 252
E+ D+WS+G + +L+G F G+N + + + ++D
Sbjct: 326 EVAE--GKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DDETLRNVKSCDWNMD---- 376
Query: 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312
F + +LL DP R T +AL P+
Sbjct: 377 ---------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415
Query: 313 GLSKVEREPSCQPISKMEFEFERRR 337
+ R+ + +
Sbjct: 416 PGNAPGRDSQIPSSRYTKIRDSIKT 440
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-44
Identities = 79/323 (24%), Positives = 127/323 (39%), Gaps = 60/323 (18%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIK-LLRLLRHP 77
Y+++E IG GSY V I T + A+K I EI+ LLR +HP
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK------SKRDPTEEIEILLRYGQHP 76
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHY-----QFFLYQLL 131
+I+ +K + D K +YVV ELM+ +L I ++ + L+ +
Sbjct: 77 NIITLKDVY-----DDGKYVYVVTELMKGGELLDKILR-----QKFFSEREASAVLFTIT 126
Query: 132 RALKYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 187
+ ++Y+H V HRDLKP NIL + ++ICDFG A+ T
Sbjct: 127 KTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL---RAENGLLMTPCYT 183
Query: 188 RWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 246
+ APE L Y A DIWS+G + +LTG F +++
Sbjct: 184 ANFVAPEVLER---QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA------- 233
Query: 247 LDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEA 305
R+ + K + + +A L+ ++L DP R TA
Sbjct: 234 -----RIGSGK-------------FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALV 275
Query: 306 LADPYFKGLSKVEREPSCQPISK 328
L P+ ++ + + +
Sbjct: 276 LRHPWIVHWDQLPQYQLNRQDAP 298
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-43
Identities = 63/305 (20%), Positives = 128/305 (41%), Gaps = 49/305 (16%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
+Y I E +G+G +G+V ++T + + K + +D + +EI +L + RH
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHR 61
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELME-SDLH-QVIKANDDLTREHYQFFLYQLLRALK 135
+I+ + +++ ++FE + D+ ++ + +L +++Q+ AL+
Sbjct: 62 NILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 136 YIHTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 193
++H+ N+ H D++P+NI+ + +KI +FG AR + Y AP
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN----FRLLFTAPEYYAP 172
Query: 194 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD-LLGTPSLDTIS 251
E + A D+WS+G + +L+G F + ++ + + + D
Sbjct: 173 EVHQHDV---VSTATDMWSLGTLVYVLLSGINPFLAET---NQQIIENIMNAEYTFD--- 223
Query: 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311
+ F A+ ++RLL + K R TA EAL P+
Sbjct: 224 ----------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261
Query: 312 KGLSK 316
K +
Sbjct: 262 KQKIE 266
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-43
Identities = 85/304 (27%), Positives = 134/304 (44%), Gaps = 60/304 (19%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 77
Y I+E +G+GS+G V A T +KVA+K I + + R+ REI L+LLRHP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 137
I+++ ++ P DI +V E +L I +T + + F Q++ A++Y
Sbjct: 70 HIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFND--------TPTTIFWTDYVATRW 189
H + HRDLKP+N+L + N +KI DFGL+ + + +P
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN------------ 172
Query: 190 YRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248
Y APE+ Y P +D+WS G + +L G+ F + + P+L
Sbjct: 173 YAAPEVING--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI-------------PNL- 216
Query: 249 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308
+ + S P S P A L+ R++ DP R T +E D
Sbjct: 217 ----------FKKVNSCVYVMPDFLS-------PGAQSLIRRMIVADPMQRITIQEIRRD 259
Query: 309 PYFK 312
P+F
Sbjct: 260 PWFN 263
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 4e-43
Identities = 93/393 (23%), Positives = 148/393 (37%), Gaps = 64/393 (16%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
RY + IG G++GV D T E VA+K I D + REI R LRHP+
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIER--GAAID-ENVQREIINHRSLRHPN 77
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI 137
IV K ++L P+ + ++ E +L++ I + + +FF QLL + Y
Sbjct: 78 IVRFKEVILTPT-----HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYC 132
Query: 138 HTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFNDT-PTTIFWTDYVATRWYRAPE 194
H+ + HRDLK +N L + +LKICDFG ++ + + P + V T Y APE
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-----TVGTPAYIAPE 187
Query: 195 LCGSFFS--KYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251
+ +Y D+WS G +L G F TI
Sbjct: 188 V----LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR-----------KTIQ 232
Query: 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNAD---PSALRLLERLLAFDPKDRPTAEEALAD 308
R+ + V++ P+ P L+ R+ DP R + E
Sbjct: 233 RILS---------------VKY--SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275
Query: 309 PYF-KGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGTE 367
+F K L S E E + + + I ++I P + ++
Sbjct: 276 SWFLKNLPADLMNESNTGSQFQEPEQPMQSL--DTIMQIISEAT---IPAVRNRCLDDFM 330
Query: 368 RTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPP 400
N D + E ++ SG ++
Sbjct: 331 TDNLD---LDDDMDDFDSESEIDIDSSGEIVYA 360
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-43
Identities = 71/315 (22%), Positives = 118/315 (37%), Gaps = 49/315 (15%)
Query: 12 SEYGDASR-YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKL 70
EY + Q +G+GS+G V D TG + A+KK+ E E+
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRV-----EELVA 103
Query: 71 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLY 128
L P IV + + R+ + + EL+E S L Q+IK L + ++L
Sbjct: 104 CAGLSSPRIVPLYG-----AVREGPWVNIFMELLEGGS-LGQLIKQMGCLPEDRALYYLG 157
Query: 129 QLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLA-RVAFNDTPTTIFWTDYVA 186
Q L L+Y+HT + H D+K N+L +++ + +CDFG A + + ++ DY+
Sbjct: 158 QALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 187 -TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 245
T + APE+ +DIWS C+ +L G + Q L
Sbjct: 218 GTETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPW------TQYFRGPLCLKIA 269
Query: 246 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 305
S R + P + P + ++ L +P R +A E
Sbjct: 270 SEPPPIR---------------EIPPSCA-------PLTAQAIQEGLRKEPVHRASAMEL 307
Query: 306 LADPYFKGLSKVERE 320
+
Sbjct: 308 RRKVGKALQEVGGLK 322
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-42
Identities = 74/347 (21%), Positives = 120/347 (34%), Gaps = 84/347 (24%)
Query: 9 EFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREI 68
+Y +V+G G G V + T EK A+K + D + RE+
Sbjct: 14 AIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKM-------LQDCPKARREV 61
Query: 69 KLL-RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQF- 125
+L R + P IV I + K + +V E ++ +L I+ R F
Sbjct: 62 ELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQD-----RGDQAFT 115
Query: 126 ------FLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTP 176
+ + A++Y+H+ N+ HRD+KP+N+L N LK+ DFG
Sbjct: 116 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------- 166
Query: 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 236
A E G KY + D+WS+G I +L G P F + +
Sbjct: 167 ---------------AKETTG---EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 208
Query: 237 LMTD--LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 294
M +G + ++ L+ LL
Sbjct: 209 GMKTRIRMGQYEFP-------------------------NPEWSEVSEEVKMLIRNLLKT 243
Query: 295 DPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKE 341
+P R T E + P+ +KV + P E + V +E
Sbjct: 244 EPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEE 290
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-42
Identities = 71/328 (21%), Positives = 119/328 (36%), Gaps = 62/328 (18%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAARILREIKLLRL 73
+ Y++ ++GKG +G V + +VAIK I + +SD+ E+ LL
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 74 LR----HPDIVEIKHIMLPPSRRDFKDIYVVFELMES--DLHQVIKANDDLTREHYQFFL 127
+ HP ++ + + +V E DL I L + F
Sbjct: 91 VGAGGGHPGVIRLLDWFETQ-----EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145
Query: 128 YQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFNDTPTTIFWTDYVA 186
Q++ A+++ H+ V HRD+K +NIL + K+ DFG + TD+
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG----ALLHDEPY-TDFDG 200
Query: 187 TRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 245
TR Y PE +Y +WS+G + +++ G F
Sbjct: 201 TRVYSPPEWIS--RHQYHALPATVWSLGILLYDMVCGDIPF------------------- 239
Query: 246 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 305
+ + + P S P L+ R LA P RP+ EE
Sbjct: 240 --ERDQEILEAELH---------FPAHVS-------PDCCALIRRCLAPKPSSRPSLEEI 281
Query: 306 LADPYFK-GLSKVEREPSCQPISKMEFE 332
L DP+ + V PS + + +
Sbjct: 282 LLDPWMQTPAEDVPLNPSKGGPAPLAWS 309
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-42
Identities = 68/305 (22%), Positives = 117/305 (38%), Gaps = 59/305 (19%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAARILREIKLLRLL 74
+Y++ ++G G +G V S I VAIK + + + + R+ E+ LL+ +
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 75 RH--PDIVEIKHIMLPPSRRDFKDIYVVFELMES--DLHQVIKANDDLTREHYQFFLYQL 130
++ + P ++ E E DL I L E + F +Q+
Sbjct: 104 SSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 158
Query: 131 LRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARVAFNDTPTTIFWTDYVATRW 189
L A+++ H V HRD+K +NIL + N +LK+ DFG T++ TD+ TR
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG----ALLKDTVY-TDFDGTRV 213
Query: 190 YRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248
Y PE + +Y + +WS+G + +++ G F +
Sbjct: 214 YSPPEWIR--YHRYHGRSAAVWSLGILLYDMVCGDIPF---------------------E 250
Query: 249 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308
+ + + S L+ LA P DRPT EE
Sbjct: 251 HDEEIIRGQVFF---------RQRVS-------SECQHLIRWCLALRPSDRPTFEEIQNH 294
Query: 309 PYFKG 313
P+ +
Sbjct: 295 PWMQD 299
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 6e-42
Identities = 74/314 (23%), Positives = 128/314 (40%), Gaps = 52/314 (16%)
Query: 18 SRYKI--QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
S Y + E++G G +G V +T TG K+A K I + D + EI ++ L
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT--RGMKDKEEVKNEISVMNQLD 144
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLH-QVIKANDDLTREHYQFFLYQLLRA 133
H +++++ DI +V E ++ +L ++I + +LT F+ Q+
Sbjct: 145 HANLIQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEG 199
Query: 134 LKYIHTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFNDTP-TTIFWTDYVATRWY 190
++++H + H DLKP+NIL ++KI DFGLAR F T +
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPE-----F 254
Query: 191 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 249
APE + F + D+WS+G I +L+G F G N +T
Sbjct: 255 LAPEVVNYDF---VSFPTDMWSVGVIAYMLLSGLSPFLGDNDA---------------ET 296
Query: 250 ISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308
++ + + ++F + A + +LL + R +A EAL
Sbjct: 297 LNNILACR-------------WDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343
Query: 309 PYFKGLSKVEREPS 322
P+ R +
Sbjct: 344 PWLSDHKLHSRLSA 357
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-42
Identities = 78/316 (24%), Positives = 122/316 (38%), Gaps = 57/316 (18%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
+ + V+GKG+YG+V + D ++AIK+I + + EI L + L+
Sbjct: 20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLK 77
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLYQLL 131
H +IV+ S + I + E + S L + + F+ Q+L
Sbjct: 78 HKNIVQYLG-----SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132
Query: 132 RALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFNDTPT------TIFWTDY 184
LKY+H + HRD+K N+L N + LKI DFG ++ P T+ +
Sbjct: 133 EGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYM-- 190
Query: 185 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 244
APE+ Y A DIWS+GC E+ TGKP P + M
Sbjct: 191 -------APEIIDKGPRGYGKAADIWSLGCTIIEMATGKP--PFYELGEPQAAM------ 235
Query: 245 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFP-NADPSALRLLERLLAFDPKDRPTAE 303
+ M K P + P + A + + DP R A
Sbjct: 236 ----------------FKVGMFKVHP-----EIPESMSAEAKAFILKCFEPDPDKRACAN 274
Query: 304 EALADPYFKGLSKVER 319
+ L D + K SK ++
Sbjct: 275 DLLVDEFLKVSSKKKK 290
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 7e-42
Identities = 71/307 (23%), Positives = 124/307 (40%), Gaps = 54/307 (17%)
Query: 18 SRYKIQ-EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 76
+ Y + + +G+G + VV I TG++ A K + A IL EI +L L +
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 77 -PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHY-----QFFLYQ 129
P ++ + + + +I ++ E ++ + E + Q
Sbjct: 88 CPRVINLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELA---EMVSENDVIRLIKQ 139
Query: 130 LLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVA 186
+L + Y+H N+ H DLKP+NIL +KI DFG++R + + +
Sbjct: 140 ILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE----LREIMG 195
Query: 187 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 246
T Y APE+ + T A D+W+IG I +LT F G++ +
Sbjct: 196 TPEYLAPEILN--YDPITTATDMWNIGIIAYMLLTHTSPFVGED---NQETY-------- 242
Query: 247 LDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEA 305
IS+V V + + F + A ++ LL +P+ RPTAE
Sbjct: 243 -LNISQVN----------------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEIC 285
Query: 306 LADPYFK 312
L+ + +
Sbjct: 286 LSHSWLQ 292
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 61/308 (19%), Positives = 114/308 (37%), Gaps = 56/308 (18%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HP 77
R +++ V+ +G + V A D +G + A+K++ + I++E+ ++ L HP
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL--LSNEEEKNRAIIQEVCFMKKLSGHP 86
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELME---SDLHQVI---KANDDLTREHYQFFLYQLL 131
+IV+ L E L + + ++ L+ + YQ
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 132 RALKYIHTAN--VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA--- 186
RA++++H + HRDLK +N+L + +K+CDFG A + +
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 187 ------TRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLM 238
T YR PE+ +S DIW++GCI + + F +
Sbjct: 207 EITRNTTPMYRTPEII-DLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------ 259
Query: 239 TDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD 298
R+ N K Y F + L+ +L +P++
Sbjct: 260 -------------RIVNGK---Y----SIPPHDTQYTVFHS-------LIRAMLQVNPEE 292
Query: 299 RPTAEEAL 306
R + E +
Sbjct: 293 RLSIAEVV 300
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 71/354 (20%), Positives = 129/354 (36%), Gaps = 72/354 (20%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI------HDIFEHISDAARILREIKLLR 72
+Y +G G++G V +A+D ++V +K I D + ++ EI +L
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 73 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES--DLHQVIKANDDLTREHYQFFLYQL 130
+ H +I+++ I + +V E S DL I + L + QL
Sbjct: 85 RVEHANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 131 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 190
+ A+ Y+ ++ HRD+K +NI+ + +K+ DFG A +F+T + T Y
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYT-FCGTIEY 195
Query: 191 RAPELCGSFFS--KYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247
APE+ Y P +++WS+G L T +
Sbjct: 196 CAPEV----LMGNPYRGPELEMWSLGVT---------------------LYTLVFEENPF 230
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
+ P S + L+ LL P+ R T E+ +
Sbjct: 231 CELEET---VEAAI------HPPYLVS-------KELMSLVSGLLQPVPERRTTLEKLVT 274
Query: 308 DPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKD 361
DP+ QP++ ++ +E + ++ LE + L D
Sbjct: 275 DPWVT-----------QPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSD 317
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 69/354 (19%), Positives = 120/354 (33%), Gaps = 52/354 (14%)
Query: 3 QNSPEMEFFSEYGD-ASRYKIQEVIGKG--SYGVVCSAIDTHTGEKVAIKKI---HDIFE 56
+ + S + Y++ VIGKG V A TGE V +++I E
Sbjct: 9 MENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE 68
Query: 57 HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKA 114
++ + E+ + +L HP+IV + + + +++VV M S +I
Sbjct: 69 MVTF---LQGELHVSKLFNHPNIVPYRATFIADN-----ELWVVTSFMAYGS-AKDLICT 119
Query: 115 --NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFG----LA 168
D + + L +L+AL YIH HR +K +IL + + K+ + +
Sbjct: 120 HFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179
Query: 169 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP---- 224
F V + +PE+ Y DI+S+G E+ G
Sbjct: 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239
Query: 225 ------LF------------PGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMR 266
L +L + S + S + S
Sbjct: 240 MPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPS 299
Query: 267 KKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVERE 320
FS F + +E+ L +P RP+A L +FK + + E
Sbjct: 300 HPYHRTFSPHFHH-------FVEQCLQRNPDARPSASTLLNHSFFKQIKRRASE 346
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 5e-41
Identities = 95/450 (21%), Positives = 162/450 (36%), Gaps = 83/450 (18%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 77
Y + + +G G++G V TG KVA+K ++ + +I REI+ L+L RHP
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 136
I+++ ++ P DI++V E + +L I N L + + Q+L + Y
Sbjct: 77 HIIKLYQVISTP-----SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND--------TPTTIFWTDYVATR 188
H V HRDLKP+N+L +A+ KI DFGL+ + + +P
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN----------- 180
Query: 189 WYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247
Y APE+ Y P +DIWS G I +L G F +V P+L
Sbjct: 181 -YAAPEVISG--RLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-------------PTL 224
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
+ + P + PS + LL+ +L DP R T ++
Sbjct: 225 -----------FKKICDGIFYTPQYLN-------PSVISLLKHMLQVDPMKRATIKDIRE 266
Query: 308 DPYFKGLSKVEREPSCQPISKMEFEFERRR-------VTKEDIRELIFREILEYHPQ--- 357
+FK P S + E + ++E++ ++ +
Sbjct: 267 HEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNR--NHQDPLAV 324
Query: 358 ---LLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVH 414
L+ D + A D + PER + +
Sbjct: 325 AYHLIIDN-------RRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRAR 377
Query: 415 SNTVPPKEQQNLSRDRQAAEEVFNKNSKES 444
Q++ + + A+ S+
Sbjct: 378 HTLDELNPQKSKHQGVRKAKWHLGIRSQSR 407
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-39
Identities = 61/312 (19%), Positives = 117/312 (37%), Gaps = 45/312 (14%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIK-LLRL 73
+ + + +G G+ G V TG +A+K++ + + RIL ++ +L+
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK--EENKRILMDLDVVLKS 80
Query: 74 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY-QFFLYQLLR 132
P IV+ + + D+++ ELM + ++ K E +++
Sbjct: 81 HDCPYIVQCFGTFITNT-----DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVK 135
Query: 133 ALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 191
AL Y+ V HRD+KP NIL + ++K+CDFG++ + Y
Sbjct: 136 ALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD----DKAKDRSAGCAAYM 191
Query: 192 APE---LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248
APE Y D+WS+G E+ TG+ + +
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK--------------TDFE 237
Query: 249 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308
+++V ++ + FS F + ++ L D + RP + L
Sbjct: 238 VLTKVLQEEPP------LLPGHMGFSGDFQS-------FVKDCLTKDHRKRPKYNKLLEH 284
Query: 309 PYFKGLSKVERE 320
+ K +E +
Sbjct: 285 SFIKRYETLEVD 296
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 7e-39
Identities = 81/297 (27%), Positives = 135/297 (45%), Gaps = 44/297 (14%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
+Y E IG+G+ G V +A+D TG++VAI++++ + I+ EI ++R ++P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNP 77
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 136
+IV S +++VV E + L V+ + + L+AL++
Sbjct: 78 NIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEF 131
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 196
+H+ V HRD+K NIL + +K+ DFG TP + V T ++ APE+
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 197 GSFFSKYTPAIDIWSIGCIFA-EVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255
Y P +DIWS+G I A E++ G+P + +N + L L+ GTP L
Sbjct: 189 TR--KAYGPKVDIWSLG-IMAIEMIEGEPPYLNENPLRALYLIAT-NGTPEL-------- 236
Query: 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312
+ P + S F + L R L D + R +A+E L + K
Sbjct: 237 ------------QNPEKLSAIFRD-------FLNRCLEMDVEKRGSAKELLQHQFLK 274
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 8e-39
Identities = 82/329 (24%), Positives = 138/329 (41%), Gaps = 42/329 (12%)
Query: 1 MLQNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISD 60
M ++S + + + Y++QEVIG G+ VV +A EKVAIK+I ++ + +
Sbjct: 1 MSEDSSALPWSI---NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTS 56
Query: 61 AARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKAND 116
+L+EI+ + HP+IV + ++++V +L+ D+ + I A
Sbjct: 57 MDELLKEIQAMSQCHHPNIVSYYTSFVVKD-----ELWLVMKLLSGGSVLDIIKHIVAKG 111
Query: 117 D-----LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR-- 169
+ L L ++L L+Y+H HRD+K NIL + ++I DFG++
Sbjct: 112 EHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171
Query: 170 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 229
D +V T + APE+ Y DIWS G E+ TG +
Sbjct: 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQ-VRGYDFKADIWSFGITAIELATGAAPY--- 227
Query: 230 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLE 289
H+ M L+ T +ND K+ ++ + F ++
Sbjct: 228 ---HKYPPMKVLMLTL--------QNDPPSLETGVQDKEMLKKYGKSFRK-------MIS 269
Query: 290 RLLAFDPKDRPTAEEALADPYFKGLSKVE 318
L DP+ RPTA E L +F+ E
Sbjct: 270 LCLQKDPEKRPTAAELLRHKFFQKAKNKE 298
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 72/329 (21%), Positives = 130/329 (39%), Gaps = 47/329 (14%)
Query: 2 LQNSPEMEFFSEYG---DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI 58
+++S +++ E A K IG+G+YG V + +G+ +A+K+I
Sbjct: 3 IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDE 61
Query: 59 SDAARILREIK-LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM----ESDLHQVIK 113
+ ++L ++ ++R P IV+ + D ++ ELM + V
Sbjct: 62 KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG-----DCWICMELMSTSFDKFYKYVYS 116
Query: 114 ANDDLTREHY-QFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVA 171
DD+ E ++AL ++ + HRD+KP NIL + + +K+CDFG++
Sbjct: 117 VLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176
Query: 172 FNDTPTTIFWTDYVATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 229
+ +I T R Y APE + Y D+WS+G E+ TG+ +P
Sbjct: 177 VD----SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232
Query: 230 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLE 289
N D +++V + + + +FS F N +
Sbjct: 233 N--------------SVFDQLTQVVKGDPPQ----LSNSEEREFSPSFIN-------FVN 267
Query: 290 RLLAFDPKDRPTAEEALADPYFKGLSKVE 318
L D RP +E L P+ +
Sbjct: 268 LCLTKDESKRPKYKELLKHPFILMYEERA 296
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 74/297 (24%), Positives = 127/297 (42%), Gaps = 44/297 (14%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
IG+GS G+VC A + H+G +VA+K + + E+ ++R +H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHF 102
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 136
++VE+ S ++++V+ E ++ L ++ L E +L+AL Y
Sbjct: 103 NVVEMYK-----SYLVGEELWVLMEFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAY 156
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 196
+H V HRD+K +IL + ++K+ DFG + V T ++ APE+
Sbjct: 157 LHAQGVIHRDIKSDSILLTLDGRVKLSDFG---FCAQISKDVPKRKSLVGTPYWMAPEVI 213
Query: 197 GSFFSKYTPAIDIWSIGCIFA-EVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255
S Y +DIWS+G I E++ G+P + + V + + D P L
Sbjct: 214 SR--SLYATEVDIWSLG-IMVIEMVDGEPPYFSDSPVQAMKRLRD-SPPPKL-------- 261
Query: 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312
K + S + LER+L DP++R TA+E L P+
Sbjct: 262 ------------KNSHKVSPVLRD-------FLERMLVRDPQERATAQELLDHPFLL 299
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 7e-38
Identities = 88/356 (24%), Positives = 140/356 (39%), Gaps = 68/356 (19%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
D +++EV+G+G++GVVC A + VAIK+I S+ + E++ L +
Sbjct: 6 DYKEIEVEEVVGRGAFGVVCKA--KWRAKDVAIKQIESE----SERKAFIVELRQLSRVN 59
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVI---KANDDLTREHYQFFLYQLL 131
HP+IV++ L P + +V E E L+ V+ + T H + Q
Sbjct: 60 HPNIVKLYGACLNP-------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 132 RALKYIHTAN---VYHRDLKPKNILANANCK-LKICDFGLARVAFNDTPTTIFWTDYVAT 187
+ + Y+H+ + HRDLKP N+L A LKICDFG A T+ +
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM------TNNKGS 166
Query: 188 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247
+ APE+ S Y+ D++S G I EV+T + F +G P+
Sbjct: 167 AAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDE-------------IGGPAF 211
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPTAEEAL 306
+ V N +P P + L+ R + DP RP+ EE +
Sbjct: 212 RIMWAVHNG-----------TRP-----PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIV 255
Query: 307 A-----DPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQ 357
YF G + + P + E RV +R H +
Sbjct: 256 KIMTHLMRYFPGADEPLQYPCQHSLPPG----EDGRVEPYVDFAEFYRLWSVDHGE 307
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 8e-38
Identities = 68/302 (22%), Positives = 110/302 (36%), Gaps = 62/302 (20%)
Query: 21 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-----DIFEHISDAARILREIKLLRLLR 75
+ ++ IGKG +G+V VAIK + E I RE+ ++ L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVI-KANDDLTREHYQFFLYQLLRA 133
HP+IV++ +M P +V E + DL+ + + + +
Sbjct: 82 HPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 134 LKYIHTAN--VYHRDLKPKNIL-----ANANCKLKICDFGLARVAFNDTPT---TIFWTD 183
++Y+ N + HRDL+ NI NA K+ DFGL++ + + W
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWM- 193
Query: 184 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 243
APE G+ YT D +S I +LTG+ F +
Sbjct: 194 --------APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK---------- 235
Query: 244 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPTA 302
+ I+ +R + R P P P LR ++E + DPK RP
Sbjct: 236 ---IKFINMIREEGLR----------P-----TIPEDCPPRLRNVIELCWSGDPKKRPHF 277
Query: 303 EE 304
Sbjct: 278 SY 279
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-38
Identities = 82/374 (21%), Positives = 136/374 (36%), Gaps = 91/374 (24%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 76
RY + +G G + V + D + VA+K + EH ++ A EI+LL+ +R+
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETAL--DEIRLLKSVRN 92
Query: 77 PDIVEIKHIMLPPSRRDFKD-------IYVVFELMESDLHQVIKANDD--LTREHYQFFL 127
D + M+ DFK I +VFE++ L + I ++ L + +
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKII 152
Query: 128 YQLLRALKYIHT-ANVYHRDLKPKNILANAN----------------------------- 157
Q+L+ L Y+HT + H D+KP+NIL + N
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 158 --------------------CKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
K+KI D G A + T + TR YR+ E+
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWV-HKHFTED-----IQTRQYRSLEVL- 265
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN------VVHQLDLMTDLLGTPSLDTIS 251
S Y DIWS C+ E+ TG LF + + L+ +LLG I
Sbjct: 266 -IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324
Query: 252 RVRNDKARRYLTS---MRKKQPVQFSQ---------KFPNAD-PSALRLLERLLAFDPKD 298
++ + T ++ ++ ++ + L +L P+
Sbjct: 325 --AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEK 382
Query: 299 RPTAEEALADPYFK 312
R TA E L P+
Sbjct: 383 RATAAECLRHPWLN 396
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 71/319 (22%), Positives = 125/319 (39%), Gaps = 30/319 (9%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
++ +G G+ GVV +G +A K IH + + +I+RE+++L
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQIIRELQVLHECN 89
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFLYQLLRAL 134
P IV +I + E M+ L QV+K + + +++ L
Sbjct: 90 SPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 144
Query: 135 KYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 193
Y+ + HRD+KP NIL N+ ++K+CDFG++ + + +V TR Y +P
Sbjct: 145 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSP 199
Query: 194 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252
E L G + Y+ DIWS+G E+ G+ P + + + + +T R
Sbjct: 200 ERLQG---THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256
Query: 253 VRNDKARRYLTSMRKKQPV---QFSQKFPNADPSALRLLERLLAF----------DPKDR 299
R M + P+ + N P L L F +P +R
Sbjct: 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 316
Query: 300 PTAEEALADPYFKGLSKVE 318
++ + + K E
Sbjct: 317 ADLKQLMVHAFIKRSDAEE 335
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 67/307 (21%), Positives = 123/307 (40%), Gaps = 50/307 (16%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIK-LLRLL 74
A + +G+G+YGVV +G+ +A+K+I + R+L ++ +R +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTV 63
Query: 75 RHPDIVEIKHIMLPPSRRDFKDIYVVFELM----ESDLHQVIKANDDLTREHYQFFLYQL 130
P V + D+++ ELM + QVI + + +
Sbjct: 64 DCPFTVTFYGALFREG-----DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 131 LRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 189
++AL+++H+ +V HRD+KP N+L NA ++K+CDFG++ + + +
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD----DVAKDIDAGCKP 174
Query: 190 YRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT--P 245
Y APE Y+ DIWS+G E+ + FP + + ++ P
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEPSP 232
Query: 246 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 305
L +FS +F + + L + K+RPT E
Sbjct: 233 QLP---------------------ADKFSAEFVD-------FTSQCLKKNSKERPTYPEL 264
Query: 306 LADPYFK 312
+ P+F
Sbjct: 265 MQHPFFT 271
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 75/321 (23%), Positives = 128/321 (39%), Gaps = 65/321 (20%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLR-LLR 75
A +++ E++G G+YG V TG+ AIK + + + I +EI +L+
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE---IKQEINMLKKYSH 79
Query: 76 HPDIVEIKHIMLPPSRRDFKD-IYVVFELME----SDLHQVIKANDDLTREHYQFFLYQL 130
H +I + + D +++V E +DL + K N L E + ++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREI 138
Query: 131 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA---------RVAFNDTPTTIFW 181
LR L ++H V HRD+K +N+L N ++K+ DFG++ R F TP +W
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP---YW 195
Query: 182 TDYVATRWYRAPE--LCGSFF-SKYTPAIDIWSIGCIFA-EVLTGKPLFPGKNVVHQLDL 237
APE C + Y D+WS+G I A E+ G P + + L L
Sbjct: 196 M---------APEVIACDENPDATYDFKSDLWSLG-ITAIEMAEGAPPLCDMHPMRALFL 245
Query: 238 MTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPK 297
+ P L + ++S+KF + +E L +
Sbjct: 246 IPR-NPAPRL---------------------KSKKWSKKFQS-------FIESCLVKNHS 276
Query: 298 DRPTAEEALADPYFKGLSKVE 318
RP E+ + P+ +
Sbjct: 277 QRPATEQLMKHPFIRDQPNER 297
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-37
Identities = 77/305 (25%), Positives = 131/305 (42%), Gaps = 50/305 (16%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
+ + E +G+GSYG V AI TG+ VAIK++ + + + I++EI +++ P
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDLQE---IIKEISIMQQCDSPH 85
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLYQLLRAL 134
+V+ + D+++V E SD+ ++ N LT + L L+ L
Sbjct: 86 VVKYYGSYFKNT-----DLWIVMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGL 138
Query: 135 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 194
+Y+H HRD+K NIL N K+ DFG VA T T + T ++ APE
Sbjct: 139 EYLHFMRKIHRDIKAGNILLNTEGHAKLADFG---VAGQLTDTMAKRNTVIGTPFWMAPE 195
Query: 195 LCGSFFSKYTPAIDIWSIGCIFA-EVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253
+ Y DIWS+G I A E+ GKP + + + + ++ P+
Sbjct: 196 VIQE--IGYNCVADIWSLG-ITAIEMAEGKPPYADIHPMRAIFMIPT-NPPPTF------ 245
Query: 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313
++P +S F + +++ L P+ R TA + L P+ +
Sbjct: 246 --------------RKPELWSDNFTD-------FVKQCLVKSPEQRATATQLLQHPFVRS 284
Query: 314 LSKVE 318
V
Sbjct: 285 AKGVS 289
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 74/305 (24%), Positives = 122/305 (40%), Gaps = 56/305 (18%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLR 75
+ IG GS+G V A D E VAIKK+ + I++E++ L+ LR
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY-QFFLYQLLRAL 134
HP+ ++ + L ++V E +++ + +E + L+ L
Sbjct: 113 HPNTIQYRGCYLREH-----TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 135 KYIHTANVYHRDLKPKNILANANCKLKICDFGLA-----RVAFNDTPTTIFWTDYVATRW 189
Y+H+ N+ HRD+K NIL + +K+ DFG A +F TP +W
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTP---YWM------- 217
Query: 190 YRAPEL-CGSFFSKYTPAIDIWSIGCIFA-EVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247
APE+ +Y +D+WS+G I E+ KP N + L + +P+L
Sbjct: 218 --APEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQ-NESPAL 273
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
Q +S+ F N ++ L P+DRPT+E L
Sbjct: 274 ---------------------QSGHWSEYFRN-------FVDSCLQKIPQDRPTSEVLLK 305
Query: 308 DPYFK 312
+
Sbjct: 306 HRFVL 310
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 44/345 (12%), Positives = 95/345 (27%), Gaps = 72/345 (20%)
Query: 19 RYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRL 73
+ ++G+G++ V A D +K +K + + + ++ L+
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP--ANPWEFYIGTQLMERLKP 123
Query: 74 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIK-----ANDDLTREHYQFFL 127
++ L +V EL L I + + F
Sbjct: 124 SMQHMFMKFYSAHLFQ-----NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 128 YQLLRALKYIHTANVYHRDLKPKNIL-----------ANANCKLKICDFGLARVAFNDTP 176
++L ++ +H + H D+KP N + + + L + D G +
Sbjct: 179 MRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238
Query: 177 TTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 235
TIF T ++ E L + ID + + +L G +
Sbjct: 239 GTIFTAK-CETSGFQCVEMLSN---KPWNYQIDYFGVAATVYCMLFGTYMK--------- 285
Query: 236 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 295
+ +P ++ P+ D +L
Sbjct: 286 -------------------------VKNEGGECKPEGLFRRLPHLDMWN-EFFHVMLNIP 319
Query: 296 PKDRPTAEEALA---DPYFKGLSKVEREPSCQPISKMEFEFERRR 337
+ + L F+ + + + E +R R
Sbjct: 320 DCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSR 364
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 69/339 (20%), Positives = 120/339 (35%), Gaps = 55/339 (16%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
S EV+GKG +G TGE + +K++ E L+E+K++R L
Sbjct: 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE--ETQRTFLKEVKVMRCLE 65
Query: 76 HPDIVE-IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQLLR 132
HP++++ I + + + E ++ L +IK+ D F +
Sbjct: 66 HPNVLKFIGVLYKDK------RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS 119
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT-----------PTTIFW 181
+ Y+H+ N+ HRDL N L N + + DFGLAR+ ++ P
Sbjct: 120 GMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 182 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 241
V ++ APE+ Y +D++S G + E++ P
Sbjct: 180 YTVVGNPYWMAPEMIN--GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM------- 230
Query: 242 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT 301
D + + P PN PS + R DP+ RP+
Sbjct: 231 --------------DFGLNVRGFLDRYCP-------PNCPPSFFPITVRCCDLDPEKRPS 269
Query: 302 AEE---ALADPYFKGLSKVEREPSCQPISKMEFEFERRR 337
+ L + P + + + +E RR
Sbjct: 270 FVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWETYRRG 308
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 63/288 (21%), Positives = 112/288 (38%), Gaps = 49/288 (17%)
Query: 21 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 80
I+E IG GS+G V A G VA+K + + H LRE+ +++ LRHP+IV
Sbjct: 40 NIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 81 EIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD---LTREHYQFFLYQLLRALKY 136
+ P + +V E + L++++ + L Y + + + Y
Sbjct: 98 LFMGAVTQPPN-----LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 137 IHTAN--VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 194
+H N + HR+LK N+L + +K+CDFGL+R+ + ++ T + APE
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS---KSAAGTPEWMAPE 209
Query: 195 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254
+ D++S G I E+ T + + N ++ V
Sbjct: 210 VLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLN---------------PAQVVAAVG 252
Query: 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPT 301
R + P + ++E +P RP+
Sbjct: 253 FKCKR----------L-----EIPRNLNPQVAAIIEGCWTNEPWKRPS 285
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 74/324 (22%), Positives = 130/324 (40%), Gaps = 77/324 (23%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 76
++I +G G++G V A + TG A K I + + + + EI++L H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI-ET-KSEEELEDYIVEIEILATCDH 75
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLYQLLR 132
P IV++ ++++ E + +++ + LT Q Q+L
Sbjct: 76 PYIVKLLGAYYHDG-----KLWIMIEFCPGGAVDAI--MLELDRGLTEPQIQVVCRQMLE 128
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA---------RVAFNDTPTTIFWTD 183
AL ++H+ + HRDLK N+L +++ DFG++ R +F TP +W
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP---YWM- 184
Query: 184 YVATRWYRAPELCGSFFSK---YTPAIDIWSIGCIFA-EVLTGKPLFPGKNVVHQLDLMT 239
APE+ K Y DIWS+G I E+ +P P H+L+ M
Sbjct: 185 --------APEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEP--P----HHELNPMR 229
Query: 240 DLL-----GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 294
LL P+L P ++S +F + L+ L
Sbjct: 230 VLLKIAKSDPPTL--------------------LTPSKWSVEFRD-------FLKIALDK 262
Query: 295 DPKDRPTAEEALADPYFKGLSKVE 318
+P+ RP+A + L P+ ++ +
Sbjct: 263 NPETRPSAAQLLEHPFVSSITSNK 286
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 61/287 (21%), Positives = 109/287 (37%), Gaps = 38/287 (13%)
Query: 21 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 80
+ + IG GS+G V G+ VA+K ++ E+ +LR RH +I+
Sbjct: 27 TVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 81 EIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD-LTREHYQFFLYQLLRALKYIH 138
P + +V + E S L+ + A++ + Q R + Y+H
Sbjct: 84 LFMGYSTAP------QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 139 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCG 197
++ HRDLK NI + + +KI DFGLA + + + + + APE +
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE-KSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257
+ Y+ D+++ G + E++TG+ + N Q+ I V
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--------------IEMVGRGS 242
Query: 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 304
L+ +R N RL+ L +RP+
Sbjct: 243 LSPDLSKVR-----------SNCPKRMKRLMAECLKKKRDERPSFPR 278
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-36
Identities = 64/314 (20%), Positives = 116/314 (36%), Gaps = 53/314 (16%)
Query: 21 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 80
+I E+IGKG +G V GE VAI+ I ++ RE+ R RH ++V
Sbjct: 36 EIGELIGKGRFGQVYHG--RWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 81 E-IKHIMLPPSRRDFKDIYVVFELME-SDLHQVI-KANDDLTREHYQFFLYQLLRALKYI 137
+ M PP + ++ L + L+ V+ A L + ++++ + Y+
Sbjct: 93 LFMGACMSPP------HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR--APEL 195
H + H+DLK KN+ + N K+ I DFGL ++ + W APE+
Sbjct: 147 HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 196 -------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248
++ D++++G I+ E+ + F + +
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP----------------AE 249
Query: 249 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308
I + L+ +L AF+ ++RPT + +
Sbjct: 250 AIIWQMGTGMKPNLSQ-------------IGMGKEISDILLFCWAFEQEERPTFTKLMD- 295
Query: 309 PYFKGLSKVEREPS 322
+ L K R S
Sbjct: 296 -MLEKLPKRNRRLS 308
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-36
Identities = 81/319 (25%), Positives = 124/319 (38%), Gaps = 79/319 (24%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 76
+ E IGKGS+G V ID T + VAIK I D+ E + I +EI +L
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDS 79
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLYQLLR 132
P + + L + ++++ E + DL + L L ++L+
Sbjct: 80 PYVTKYYGSYLKDT-----KLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILK 130
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA---------RVAFNDTPTTIFWTD 183
L Y+H+ HRD+K N+L + + ++K+ DFG+A R F TP FW
Sbjct: 131 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTP---FWM- 186
Query: 184 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-EVLTGKPLFPGKNVVHQLDLMTDLL 242
APE+ S Y DIWS+G I A E+ G+P +L M L
Sbjct: 187 --------APEVIKQ--SAYDSKADIWSLG-ITAIELARGEPPH------SELHPMKVLF 229
Query: 243 -----GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPK 297
P+L+ +S+ +E L +P
Sbjct: 230 LIPKNNPPTLEG----------------------NYSKPLKE-------FVEACLNKEPS 260
Query: 298 DRPTAEEALADPYFKGLSK 316
RPTA+E L + +K
Sbjct: 261 FRPTAKELLKHKFILRNAK 279
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 72/300 (24%), Positives = 118/300 (39%), Gaps = 62/300 (20%)
Query: 21 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRHPD 78
++E+IG G +G V A G++VA+K + + +E KL +L+HP+
Sbjct: 10 TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 79 IVEIKHI-MLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 136
I+ ++ + + P ++ +V E L++V+ + + + Q+ R + Y
Sbjct: 68 IIALRGVCLKEP------NLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNY 120
Query: 137 IHTANVY---HRDLKPKNIL--------ANANCKLKICDFGLARVAFNDTPTTIFWTDYV 185
+H + HRDLK NIL +N LKI DFGLAR T +
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGA--- 177
Query: 186 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 245
W APE+ + S ++ D+WS G + E+LTG+ F G +
Sbjct: 178 -YAW-MAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGID--------------- 218
Query: 246 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPTAEE 304
L V +K P+ P L+E DP RP+
Sbjct: 219 GLAVAYGVAMNKLA----------L-----PIPSTCPEPFAKLMEDCWNPDPHSRPSFTN 263
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 71/308 (23%), Positives = 130/308 (42%), Gaps = 57/308 (18%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHP 77
+K +++G+GS+ V A + T + AIK + I + + + RE ++ L HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHP 90
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELME-----SDLHQVIKANDDLTREHYQFFLYQLLR 132
V++ + +D + +Y + + ++ ++ TR F+ +++
Sbjct: 91 FFVKLYF-----TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTR----FYTAEIVS 141
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 192
AL+Y+H + HRDLKP+NIL N + ++I DFG A+V ++ + +V T Y +
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGTAQYVS 200
Query: 193 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252
PEL + D+W++GCI +++ G P F N +
Sbjct: 201 PELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNE---------------YLIFQK 243
Query: 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT------AEEAL 306
+ + F +KF P A L+E+LL D R
Sbjct: 244 IIKLE-------------YDFPEKF---FPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 287
Query: 307 ADPYFKGL 314
A P+F+ +
Sbjct: 288 AHPFFESV 295
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 9e-34
Identities = 40/288 (13%), Positives = 89/288 (30%), Gaps = 50/288 (17%)
Query: 21 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 80
+ + G + G + +K + + E LR+ HP+++
Sbjct: 13 NFLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 81 EIKHIMLPPSRRDFKDIYVVFELMES-DLHQVI--KANDDLTREHYQFFLYQLLRALKYI 137
+ P ++ M L+ V+ N + + F + R + ++
Sbjct: 71 PVLGACQSPPAPHP---TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 138 HTAN--VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT-TIFWTDYVATRWYRAPE 194
HT + L ++++ + + +I + + W APE
Sbjct: 128 HTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWV---------APE 178
Query: 195 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253
L + D+WS + E++T + F + +++ +V
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS---------------NMEIGMKV 223
Query: 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT 301
+ +R P P P +L++ + DP RP
Sbjct: 224 ALEG-------LRPTIP-------PGISPHVSKLMKICMNEDPAKRPK 257
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 79/324 (24%), Positives = 117/324 (36%), Gaps = 37/324 (11%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
A + ++ + IGKG YG V GEKVA+K E S EI L+R
Sbjct: 35 IAKQIQMVKQIGKGRYGEVWMG--KWRGEKVAVKVFFTT-EEASWFRE--TEIYQTVLMR 89
Query: 76 HPDIVE-IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRA 133
H +I+ I + +Y++ + E+ L+ +K+ L + Y +
Sbjct: 90 HENILGFIAADIKGTGSW--TQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSG 146
Query: 134 LKYIHTANVY--------HRDLKPKNILANANCKLKICDFGLARVAFNDT-PTTIFWTDY 184
L ++HT HRDLK KNIL N I D GLA +DT I
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206
Query: 185 VATRWYRAPE-LCGSFFSKYTPA---IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 240
V T+ Y PE L S + + D++S G I EV G +QL
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG-GIVEEYQLPYHDL 265
Query: 241 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP 300
+ PS + + + K R +L+ A +P R
Sbjct: 266 VPSDPSYEDMREIVCIKKLR--------PSFPNRWSSDECLRQMGKLMTECWAHNPASRL 317
Query: 301 TAEEALADPYFKGLSKVEREPSCQ 324
TA K L+K+ +
Sbjct: 318 TALRVK-----KTLAKMSESQDIK 336
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 76/329 (23%), Positives = 122/329 (37%), Gaps = 47/329 (14%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
A +QE IGKG +G V GE+VA+K R EI +LR
Sbjct: 40 IARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS--REERSWFR-EAEIYQTVMLR 94
Query: 76 HPDIV-----EIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQ 129
H +I+ + K +++V + E L + +T E
Sbjct: 95 HENILGFIAADNKDNGTWT------QLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALS 147
Query: 130 LLRALKYIHTA--------NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT-TIF 180
L ++H + HRDLK KNIL N I D GLA + T T I
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 207
Query: 181 WTDYVATRWYRAPE-LCGSFFSKYTPA---IDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 236
V T+ Y APE L S K+ + DI+++G +F E+ + G + +QL
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLP 266
Query: 237 LMTDLLGTPSLDTISR-VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 295
+ PS++ + + V K R + + + A +++ +
Sbjct: 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCE---------ALRVMAKIMRECWYAN 317
Query: 296 PKDRPTAEEALADPYFKGLSKVEREPSCQ 324
R TA K LS++ ++ +
Sbjct: 318 GAARLTALRIK-----KTLSQLSQQEGIK 341
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 78/299 (26%), Positives = 121/299 (40%), Gaps = 52/299 (17%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA---ARILREIKLLRLLR 75
Y+++ ++G+G G V A DT VA+K + + SD R+ RE + L+
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSE--TLSSDPVFRTRMQREARTAGRLQ 92
Query: 76 HPDIVEIKHIMLPPSRRDFKDI----YVVFELME-SDLHQVIKANDDLTREHYQFFLYQL 130
P +V I DF +I YV L+ DL +++ L + Q+
Sbjct: 93 EPHVVPI---------HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQI 143
Query: 131 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 190
AL H A HRD+KP+NIL +A+ + DFG+A A D T V T +Y
Sbjct: 144 GSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGN-TVGTLYY 201
Query: 191 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250
APE S T DI+++ C+ E LTG P + G D +
Sbjct: 202 MAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQG-------------------DQL 240
Query: 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-PTAEEALAD 308
S ++ + S P + ++ R +A +P+DR T + A
Sbjct: 241 S-----VMGAHINQ----AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAA 290
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 43/295 (14%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHPDIVEI 82
IGKGS+G VC T + A+K ++ E ++ + +E+++++ L HP +V +
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER-NEVRNVFKELQIMQGLEHPFLVNL 80
Query: 83 KHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN 141
+ S +D +D+++V +L+ DL ++ N E + F+ +L+ AL Y+
Sbjct: 81 WY-----SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR 135
Query: 142 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFF 200
+ HRD+KP NIL + + + I DF +A + +T T T+ Y APE
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM----AGTKPYMAPEMFSSRKG 191
Query: 201 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260
+ Y+ A+D WS+G E+L G+ + +R+ + +
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPY-------------------------HIRSSTSSK 226
Query: 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-PTAEEALADPYFKGL 314
+ + V + + + LL++LL +P R + PY +
Sbjct: 227 EIVHTFETTVVTYPSAW---SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 82/307 (26%), Positives = 123/307 (40%), Gaps = 62/307 (20%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA---ARILREIKLLRL 73
RYKI + +G G V A DT KVAIK I R RE+
Sbjct: 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFI--PPREKEETLKRFEREVHNSSQ 67
Query: 74 LRHPDIVEIKHIMLPPSRRDF----KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLY 128
L H +IV + D Y+V E +E L + I+++ L+ + F
Sbjct: 68 LSHQNIVSM---------IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTN 118
Query: 129 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYV-AT 187
Q+L +K+ H + HRD+KP+NIL ++N LKI DFG+A+ A ++T T T++V T
Sbjct: 119 QILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQ--TNHVLGT 175
Query: 188 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-----HQLDLMTDLL 242
Y +PE DI+SIG + E+L G+P F G+ V H
Sbjct: 176 VQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH--------- 224
Query: 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-T 301
++ P + + S ++ R D +R T
Sbjct: 225 ----------------------IQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKT 262
Query: 302 AEEALAD 308
+E D
Sbjct: 263 IQEMKDD 269
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-31
Identities = 73/312 (23%), Positives = 116/312 (37%), Gaps = 59/312 (18%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTH-TGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
A +Y+++ I G G + A+D + G V +K + + A + E + L +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA-EAQAMAMAERQFLAEVV 137
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRAL 134
HP IV+I + + R Y+V E + L + L +L ++L AL
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPAL 195
Query: 135 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 194
Y+H+ + + DLKP+NI+ +LK+ D G N T ++APE
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGYLY------GTPGFQAPE 247
Query: 195 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254
+ + T A DI+++G A + P G+ V + L S
Sbjct: 248 IVR---TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYG------ 298
Query: 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-TAEEALADPYFKG 313
RLL R + DP+ R TAEE A
Sbjct: 299 -------------------------------RLLRRAIDPDPRQRFTTAEEMSAQ----- 322
Query: 314 LSKVEREPSCQP 325
L+ V RE Q
Sbjct: 323 LTGVLREVVAQD 334
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 64/306 (20%), Positives = 110/306 (35%), Gaps = 42/306 (13%)
Query: 21 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 80
+ E +GKG YG V + GE VA+K R E+ +LRH +I+
Sbjct: 11 TLLECVGKGRYGEVWRG--SWQGENVAVKIFSS--RDEKSWFR-ETELYNTVMLRHENIL 65
Query: 81 -----EIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRAL 134
++ ++++ E L+ ++ L + + L
Sbjct: 66 GFIASDMTSRHSST------QLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGL 118
Query: 135 KYIHTANVY--------HRDLKPKNILANANCKLKICDFGLARV-AFNDTPTTIFWTDYV 185
++H HRDLK KNIL N + I D GLA + + + + V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 186 ATRWYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 241
T+ Y APE L + +DIW+ G + EV G ++ +
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN-GIVEDYKPPFYDVV 237
Query: 242 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRP 300
PS + + +V +R P ++ F + ++L L++ +P R
Sbjct: 238 PNDPSFEDMRKVVCVDQQR---------PNIPNRWFSDPTLTSLAKLMKECWYQNPSARL 288
Query: 301 TAEEAL 306
TA
Sbjct: 289 TALRIK 294
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 7e-31
Identities = 79/306 (25%), Positives = 125/306 (40%), Gaps = 55/306 (17%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA---ARILREIKLLRL 73
+ RY++ E++G G V A D VA+K + + D R RE +
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA--DLARDPSFYLRFRREAQNAAA 68
Query: 74 LRHPDIVEI--------KHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQ 124
L HP IV + LP Y+V E ++ L ++ +T +
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLP---------YIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 125 FFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY 184
+ +AL + H + HRD+KP NI+ +A +K+ DFG+AR A D+ ++ T
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR-AIADSGNSVTQTAA 178
Query: 185 V-ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 243
V T Y +PE D++S+GC+ EVLTG+P F G + V +
Sbjct: 179 VIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-SVAYQ----- 230
Query: 244 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-TA 302
VR D P+ S + ++ + LA +P++R TA
Sbjct: 231 --------HVRED-------------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTA 269
Query: 303 EEALAD 308
E AD
Sbjct: 270 AEMRAD 275
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 69/305 (22%), Positives = 115/305 (37%), Gaps = 34/305 (11%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
+ ++ EV +G +G V A E VA+K + + E+ L ++
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKA--QLLNEYVAVKIF---PIQDKQSWQNEYEVYSLPGMK 76
Query: 76 HPDIVE-IKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRA 133
H +I++ I S D++++ E L +KAN ++ + R
Sbjct: 77 HENILQFIGAEKRGTSVD--VDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARG 133
Query: 134 LKYIHTANVY----------HRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD 183
L Y+H HRD+K KN+L N I DFGLA F +
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK-FEAGKSAGDTHG 192
Query: 184 YVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 240
V TR Y APE+ +F ID++++G + E+ + G + L +
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252
Query: 241 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSAL-RLLERLLAFDPKDR 299
+ PSL+ + V K +R PV +A + L +E D + R
Sbjct: 253 IGQHPSLEDMQEVVVHKKKR---------PVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 300 PTAEE 304
+A
Sbjct: 304 LSAGC 308
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 27/219 (12%)
Query: 16 DASRYKIQEVIGKGSYGVVCSA----IDTHTGEKVAIKKIHDIFEHISDAARILREIKLL 71
+ K + +GKG++G V + +TGE VA+KK+ REI++L
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEIL 65
Query: 72 RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQ 129
+ L+H +IV+ K + RR+ + ++ E + L ++ + + + + Q
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122
Query: 130 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-- 187
+ + ++Y+ T HRDL +NIL ++KI DFGL +V D +
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF------FKVKEP 176
Query: 188 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
WY APE SK++ A D+WS G + E+ T
Sbjct: 177 GESPIFWY-APE--SLTESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 27/219 (12%)
Query: 16 DASRYKIQEVIGKGSYGVVCSA----IDTHTGEKVAIKKIHDIFEHISDAARILREIKLL 71
+ K + +GKG++G V + +TGE VA+KK+ REI++L
Sbjct: 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEIL 96
Query: 72 RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQ 129
+ L+H +IV+ K + RR+ + ++ E + L ++ + + + + Q
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 153
Query: 130 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-- 187
+ + ++Y+ T HRDL +NIL ++KI DFGL +V D Y
Sbjct: 154 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY------YKVKEP 207
Query: 188 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
WY APE SK++ A D+WS G + E+ T
Sbjct: 208 GESPIFWY-APE--SLTESKFSVASDVWSFGVVLYELFT 243
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-29
Identities = 67/320 (20%), Positives = 124/320 (38%), Gaps = 59/320 (18%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIKKI--HDIFEHISDAARILREIKLLRLLRHPDIVEI 82
V+G+G +G V + TG+ A KK+ + + + E K+L + IV +
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKR-KGYQGAMVEKKILAKVHSRFIVSL 250
Query: 83 KHIMLPPSRRDFKDIYVVFELMES-DL----HQVIKANDDLTREHYQFFLYQLLRALKYI 137
+ + + +V +M D+ + V + N F+ Q++ L+++
Sbjct: 251 AYAFETKTD-----LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTDYVATRWYRAPEL 195
H N+ +RDLKP+N+L + + ++I D GLA A Y T + APEL
Sbjct: 306 HQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-----YAGTPGFMAPEL 360
Query: 196 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255
+Y ++D +++G E++ + F + + + RV
Sbjct: 361 LLG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ-----------RVLE 407
Query: 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALADPY 310
V + KF P++ E LL DP+ R + + P
Sbjct: 408 Q-------------AVTYPDKFS---PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451
Query: 311 FKGLS--KVER---EPSCQP 325
F+ +S ++E P P
Sbjct: 452 FRDISWRQLEAGMLTPPFVP 471
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-29
Identities = 64/303 (21%), Positives = 119/303 (39%), Gaps = 49/303 (16%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHPDIVEI 82
VIG+G++ V TG+ A+K ++ D+ + + + E +L I ++
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR-GEVSCFREERDVLVNGDRRWITQL 126
Query: 83 KHIMLPPSRRDFKDIYVVFELMES-DL-HQVIKANDDLTREHYQFFLYQLLRALKYIHTA 140
+ +D +Y+V E DL + K + + E +F+L +++ A+ +H
Sbjct: 127 HF-----AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL 181
Query: 141 NVYHRDLKPKNILANANCKLKICDFGLA-RVAFNDTPTTIFWTDYVATRWYRAPEL---- 195
HRD+KP NIL + +++ DFG ++ + T + V T Y +PE+
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS--LV-AVGTPDYLSPEILQAV 238
Query: 196 -CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254
G Y P D W++G E+ G+ F + +T ++
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA---------------ETYGKI- 282
Query: 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR---PTAEEALADPYF 311
+ K+ + A ++RLL P+ R A + P+F
Sbjct: 283 ----------VHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFF 331
Query: 312 KGL 314
GL
Sbjct: 332 FGL 334
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 5e-29
Identities = 68/301 (22%), Positives = 130/301 (43%), Gaps = 47/301 (15%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHPDIVEI 82
VIG+G++G V + + A+K ++ ++ + ++ A E +L I +
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR-AETACFREERDVLVNGDSKWITTL 139
Query: 83 KHIMLPPSRRDFKDIYVVFELMES-DL-HQVIKANDDLTREHYQFFLYQLLRALKYIHTA 140
+ + +D ++Y+V + DL + K D L E +F+L +++ A+ +H
Sbjct: 140 HY-----AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL 194
Query: 141 NVYHRDLKPKNILANANCKLKICDFGLA-RVAFNDTPTTIFWTDYVATRWYRAPEL---C 196
+ HRD+KP NIL + N +++ DFG ++ + T + V T Y +PE+
Sbjct: 195 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS--SV-AVGTPDYISPEILQAM 251
Query: 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256
+Y P D WS+G E+L G+ F +++V +T ++
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---------------ETYGKI--- 293
Query: 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR---PTAEEALADPYFKG 313
M K+ QF + + +A L+ RL+ + R E+ P+F G
Sbjct: 294 --------MNHKERFQFPTQVTDVSENAKDLIRRLIC-SREHRLGQNGIEDFKKHPFFSG 344
Query: 314 L 314
+
Sbjct: 345 I 345
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 7e-29
Identities = 75/343 (21%), Positives = 123/343 (35%), Gaps = 63/343 (18%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-------DIFEHISDAARILREIKLLRLLRHP 77
+IG+G +G V TG+ A+K + + +L + P
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD---CP 252
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 136
IV + + P + + + +LM DLH + + + +F+ +++ L++
Sbjct: 253 FIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 196
+H V +RDLKP NIL + + ++I D GLA P V T Y APE+
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYMAPEVL 362
Query: 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256
Y + D +S+GC+ ++L G F R
Sbjct: 363 QK-GVAYDSSADWFSLGCMLFKLLRGHSPF-------------------------RQHKT 396
Query: 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALADPYF 311
K + + M V+ F P LLE LL D R A+E P+F
Sbjct: 397 KDKHEIDRMTLTMAVELPDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453
Query: 312 KGL--SKVER---EPSCQPISKM---EFEFERRRVTKEDIREL 346
+ L V P P F+ +ED + +
Sbjct: 454 RSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGI 496
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-29
Identities = 78/344 (22%), Positives = 136/344 (39%), Gaps = 59/344 (17%)
Query: 3 QNSPEMEFFSEYGDASRYKIQE-------VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DI 54
+S F ++ R + + V+GKG +G VC+ TG+ A KK+
Sbjct: 162 LDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR 221
Query: 55 FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DL--HQV 111
+ A L E ++L + +V + + + +V LM DL H
Sbjct: 222 IKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA-----LCLVLTLMNGGDLKFHIY 276
Query: 112 IKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171
F+ ++ L+ +H + +RDLKP+NIL + + ++I D GLA
Sbjct: 277 HMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336
Query: 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 231
V T Y APE+ + +YT + D W++GC+ E++ G+ F +
Sbjct: 337 PEGQTIKGR----VGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 390
Query: 232 VHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERL 291
+ + + + K+ P ++S++F P A L +L
Sbjct: 391 KIKREEVER------------------------LVKEVPEEYSERFS---PQARSLCSQL 423
Query: 292 LAFDPKDR-----PTAEEALADPYFKGLS--KVER---EPSCQP 325
L DP +R +A E P FK L+ ++ EP +P
Sbjct: 424 LCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKP 467
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 30/221 (13%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAAR--ILREIK 69
+ K +G+G +G V +TGE+VA+K + + +EI+
Sbjct: 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK---PESGGNHIADLKKEIE 75
Query: 70 LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFL 127
+LR L H +IV+ K I I ++ E + S L + + N + + + +
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNG---IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA 132
Query: 128 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 187
Q+ + + Y+ + HRDL +N+L + ++KI DFGL + D Y
Sbjct: 133 VQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY------YTVK 186
Query: 188 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
WY APE SK+ A D+WS G E+LT
Sbjct: 187 DDRDSPVFWY-APE--CLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 33/234 (14%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
D S + IG G +G+V + KVAIK I E + E +++ L
Sbjct: 6 DPSELTFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIR---EGAMSEEDFIEEAEVMMKLS 61
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQLLRA 133
HP +V++ + L + I +V E ME L ++ E +
Sbjct: 62 HPKLVQLYGVCL-----EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 116
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT------ 187
+ Y+ A V HRDL +N L N +K+ DFG+ R +D Y ++
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--------QYTSSTGTKFP 168
Query: 188 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 236
+W +PE FS+Y+ D+WS G + EV + GK + ++ VV +
Sbjct: 169 VKWA-SPE--VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 57/237 (24%), Positives = 107/237 (45%), Gaps = 37/237 (15%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
+ + ++ +G G YG V + VA+K + E + L+E +++ ++
Sbjct: 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIK 67
Query: 76 HPDIVEIKHIML--PPSRRDFKDIYVVFELMES-DLHQVIKAND--DLTREHYQFFLYQL 130
HP++V++ + PP Y++ E M +L ++ + +++ + Q+
Sbjct: 68 HPNLVQLLGVCTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 120
Query: 131 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTD 183
A++Y+ N HRDL +N L N +K+ DFGL+R+ DT T I WT
Sbjct: 121 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT- 179
Query: 184 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 236
APE ++K++ D+W+ G + E+ T G +PG + V L+
Sbjct: 180 --------APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 1e-27
Identities = 76/341 (22%), Positives = 132/341 (38%), Gaps = 60/341 (17%)
Query: 21 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE--IKLLRLLRHPD 78
K+ E+IG+G YG V + VA+K ++ + E I + L+ H +
Sbjct: 16 KLLELIGRGRYGAVYKG--SLDERPVAVKVFSF-----ANRQNFINEKNIYRVPLMEHDN 68
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI 137
I + + +V E + L + + + + + R L Y+
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH-SVTRGLAYL 127
Query: 138 HTANVY---------HRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY---- 184
HT HRDL +N+L + I DFGL+ + D
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187
Query: 185 -VATRWYRAPE-LCGSF----FSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVV-HQLD 236
V T Y APE L G+ +D++++G I+ E+ LFPG++V +Q+
Sbjct: 188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247
Query: 237 LMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNA---DPSALRLLERLL- 292
T++ P+ + + + + + +R P KFP A + A+R L+ +
Sbjct: 248 FQTEVGNHPTFEDMQVLVSREKQR---------P-----KFPEAWKENSLAVRSLKETIE 293
Query: 293 ---AFDPKDRPTA---EEALADPYFKGLSKVEREPSCQPIS 327
D + R TA EE +A + + ER S P +
Sbjct: 294 DCWDQDAEARLTAQXAEERMA----ELMMIWERNKSVSPTA 330
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 27/219 (12%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLL 71
+ K +GKG++G V +TG VA+K++ REI++L
Sbjct: 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH--SGPDQQRDFQREIQIL 78
Query: 72 RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQ 129
+ L IV+ + + P R + + +V E + S L ++ + L + Q
Sbjct: 79 KALHSDFIVKYRGVSYGPGR---QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 135
Query: 130 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-- 187
+ + ++Y+ + HRDL +NIL + +KI DFGLA++ D YV
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY------YVVREP 189
Query: 188 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
WY APE + ++ D+WS G + E+ T
Sbjct: 190 GQSPIFWY-APE--SLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 72/304 (23%), Positives = 125/304 (41%), Gaps = 47/304 (15%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHP 77
Y++ +VIG+G++G V T + A+K + ++ + SD+A E ++ P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR-SDSAFFWEERDIMAFANSP 129
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKY 136
+V++ + + +D + +Y+V E M DL ++ N D+ + +F+ +++ AL
Sbjct: 130 WVVQLFY-----AFQDDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLALDA 183
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLA-RVAFNDTPTTIFWTDYVATRWYRAPE- 194
IH+ HRD+KP N+L + + LK+ DFG ++ T V T Y +PE
Sbjct: 184 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC--DT-AVGTPDYISPEV 240
Query: 195 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253
Y D WS+G E+L G F ++V T S++
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---------------GTYSKI 285
Query: 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR---PTAEEALADPY 310
M K + F + A L+ L D + R EE +
Sbjct: 286 -----------MNHKNSLTFP-DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLF 332
Query: 311 FKGL 314
FK
Sbjct: 333 FKND 336
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 56/249 (22%), Positives = 103/249 (41%), Gaps = 36/249 (14%)
Query: 4 NSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEK----VAIKKIHDIFEHIS 59
N + E + +K +V+G G++G V + GEK VAIK++ +
Sbjct: 5 NQALLRILKE----TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-K 59
Query: 60 DAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD- 117
IL E ++ + +P + + I L + + ++ +LM L ++ + D
Sbjct: 60 ANKEILDEAYVMASVDNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDN 113
Query: 118 LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 177
+ ++ + Q+ + + Y+ + HRDL +N+L +KI DFGLA++ +
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 178 TIFWTDYVAT------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 230
Y A +W A E YT D+WS G E++T G + G
Sbjct: 174 ------YHAEGGKVPIKWM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224
Query: 231 ---VVHQLD 236
+ L+
Sbjct: 225 ASEISSILE 233
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 4e-27
Identities = 51/234 (21%), Positives = 93/234 (39%), Gaps = 33/234 (14%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
+ + +G G +GVV VA+K I E +E + + L
Sbjct: 6 KREEITLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIK---EGSMSEDEFFQEAQTMMKLS 61
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND-DLTREHYQFFLYQLLRA 133
HP +V+ + IY+V E + + L ++++ L Y +
Sbjct: 62 HPKLVKFYGVCS-----KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG 116
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT------ 187
+ ++ + HRDL +N L + + +K+ DFG+ R +D YV++
Sbjct: 117 MAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD--------QYVSSVGTKFP 168
Query: 188 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 236
+W APE + KY+ D+W+ G + EV + GK + VV ++
Sbjct: 169 VKWS-APE--VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 5e-27
Identities = 59/231 (25%), Positives = 106/231 (45%), Gaps = 31/231 (13%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
+ K+ + IGKG +G V + G KVA+K I + + A L E ++ LR
Sbjct: 19 NMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND----ATAQAFLAEASVMTQLR 72
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND--DLTREHYQFFLYQLLR 132
H ++V++ +++ + +Y+V E M L +++ L + F +
Sbjct: 73 HSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 128
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF---WTDYVATRW 189
A++Y+ N HRDL +N+L + + K+ DFGL + A + T WT
Sbjct: 129 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------- 181
Query: 190 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQLD 236
APE K++ D+WS G + E+ + G+ +P K+VV +++
Sbjct: 182 --APE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 66/238 (27%), Positives = 107/238 (44%), Gaps = 33/238 (13%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAARI--LREIKL 70
DA+ I +V+G G +G VCS +K VAIK + ++ R L E +
Sbjct: 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASI 99
Query: 71 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLY 128
+ HP+I+ ++ ++ K + +V E ME+ L ++ +D T L
Sbjct: 100 MGQFDHPNIIRLEGVVT-----KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 129 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT- 187
+ +KY+ HRDL +NIL N+N K+ DFGL RV +D Y
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-----EAAYTTRG 209
Query: 188 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 236
RW +PE + K+T A D+WS G + EV++ G+ + + V+ +D
Sbjct: 210 GKIPIRWT-SPE--AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 54/239 (22%), Positives = 94/239 (39%), Gaps = 34/239 (14%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAI---DTHTGEKVAIKKIH-DIFEHISDAARILREIKLL 71
++ E +G GS+GVV + VA+K + D+ +RE+ +
Sbjct: 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 75
Query: 72 RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQ 129
L H +++ + ++L P + +V EL L ++ + + Q
Sbjct: 76 HSLDHRNLIRLYGVVLTPP------MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 130 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-- 187
+ + Y+ + HRDL +N+L +KI DFGL R + YV
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH------YVMQEH 183
Query: 188 -----RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 236
W APE S ++ A D W G E+ T G+ + G N ++H++D
Sbjct: 184 RKVPFAWC-APE---SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 63/238 (26%), Positives = 105/238 (44%), Gaps = 33/238 (13%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARI--LREIKL 70
+ASR I+++IG G G VC G+ VAIK + ++ R L E +
Sbjct: 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLSEASI 103
Query: 71 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLY 128
+ HP+I+ ++ ++ + +V E ME+ L ++ +D T L
Sbjct: 104 MGQFDHPNIIRLEGVVT-----RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR 158
Query: 129 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT- 187
+ ++Y+ HRDL +N+L ++N K+ DFGL+RV +D Y T
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA-----YTTTG 213
Query: 188 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 236
RW APE F ++ A D+WS G + EVL G+ + V+ ++
Sbjct: 214 GKIPIRWT-APE--AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 40/240 (16%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARI--LREIKL 70
R ++ IG+G +G V I VAIK SD+ R L+E
Sbjct: 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALT 69
Query: 71 LRLLRHPDIVEIKHIML-PPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFL 127
+R HP IV++ ++ P ++++ EL +L ++ L +
Sbjct: 70 MRQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122
Query: 128 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 187
YQL AL Y+ + HRD+ +N+L ++N +K+ DFGL+R + Y
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------TYYKA 174
Query: 188 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 236
+W APE F ++T A D+W G E+L G F G V+ +++
Sbjct: 175 SKGKLPIKWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 51/238 (21%), Positives = 93/238 (39%), Gaps = 34/238 (14%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLL 71
+ + +V+G G +G V + GE V IK I D S A + + +
Sbjct: 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA-VTDHMLAI 69
Query: 72 RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQ 129
L H IV + + S + +V + + L ++ + L + + Q
Sbjct: 70 GSLDHAHIVRLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123
Query: 130 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-- 187
+ + + Y+ + HR+L +N+L + ++++ DFG+A + D +
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-------DKQLLYSE 176
Query: 188 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 236
+W A E F KYT D+WS G E++T G + G V L+
Sbjct: 177 AKTPIKWM-ALE--SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 53/227 (23%), Positives = 94/227 (41%), Gaps = 25/227 (11%)
Query: 21 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRHPD 78
+ E IG+G++G V S VA+K E + + L+E ++L+ HP+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR---ETLPPDLKAKFLQEARILKQYSHPN 173
Query: 79 IVEIKHIML--PPSRRDFKDIYVVFELMES-DLHQVIKAND-DLTREHYQFFLYQLLRAL 134
IV + + P IY+V EL++ D ++ L + + +
Sbjct: 174 IVRLIGVCTQKQP-------IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGM 226
Query: 135 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 194
+Y+ + HRDL +N L LKI DFG++R + V +W APE
Sbjct: 227 EYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT-APE 285
Query: 195 LCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 236
+ + +Y+ D+WS G + E + G +P + ++
Sbjct: 286 ---ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-26
Identities = 54/235 (22%), Positives = 104/235 (44%), Gaps = 33/235 (14%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
+ + ++ +G G YG V + VA+K + E + L+E +++ ++
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIK 274
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND--DLTREHYQFFLYQLLR 132
HP++V++ + Y++ E M +L ++ + +++ + Q+
Sbjct: 275 HPNLVQLLGVCT-----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 329
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTDYV 185
A++Y+ N HR+L +N L N +K+ DFGL+R+ DT T I WT
Sbjct: 330 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT--- 386
Query: 186 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQLD 236
APE ++K++ D+W+ G + E+ T G +PG V L+
Sbjct: 387 ------APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 54/228 (23%), Positives = 97/228 (42%), Gaps = 29/228 (12%)
Query: 23 QEVIGKGSYGVVCSAIDTHTGE--KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 80
+ +G G++G V VA+K + + + +L E +++ L +P IV
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 81 EIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHT 139
+ I S +V E+ E L++ ++ N + ++ ++Q+ +KY+
Sbjct: 82 RMIGICEAES------WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 140 ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-------RWYRA 192
+N HRDL +N+L KI DFGL++ D Y A +WY A
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY------YKAQTHGKWPVKWY-A 188
Query: 193 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 236
PE + K++ D+WS G + E + G+ + G V L+
Sbjct: 189 PE--CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 54/240 (22%), Positives = 102/240 (42%), Gaps = 40/240 (16%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARI--LREIKL 70
+ ++G+G +G V + T+ VA+K + + + + E +
Sbjct: 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVI 66
Query: 71 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLY 128
++ L HP IV++ I+ +++ EL +L ++ N + L +
Sbjct: 67 MKNLDHPHIVKLIGIIEEEP------TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 129 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT- 187
Q+ +A+ Y+ + N HRD+ +NIL + +K+ DFGL+R ++ DY
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE--------DYYKAS 172
Query: 188 ------RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 236
+W +PE S F ++T A D+W E+L+ GK F V+ L+
Sbjct: 173 VTRLPIKWM-SPE---SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 228
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 63/240 (26%), Positives = 109/240 (45%), Gaps = 36/240 (15%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK----VAIKKIHDIFEHISDAARI--LREIK 69
S Q+VIG G +G V + + K VAIK + ++ R+ L E
Sbjct: 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAG 98
Query: 70 LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFL 127
++ H +I+ ++ ++ +K + ++ E ME+ L + ++ D + L
Sbjct: 99 IMGQFSHHNIIRLEGVIS-----KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 153
Query: 128 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 187
+ +KY+ N HRDL +NIL N+N K+ DFGL+RV +D Y +
Sbjct: 154 RGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-----EATYTTS 208
Query: 188 ------RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 236
RW APE + + K+T A D+WS G + EV+T G+ + + V+ ++
Sbjct: 209 GGKIPIRWT-APE---AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 52/235 (22%), Positives = 93/235 (39%), Gaps = 35/235 (14%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGE-KVAIKKIHDIFEHISDAARILREIKLLRLL 74
D + +G G +GVV G+ VAIK I E + E K++ L
Sbjct: 22 DPKDLTFLKELGTGQFGVVKYG--KWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNL 76
Query: 75 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQLLR 132
H +V++ + + I+++ E M + L ++ + +
Sbjct: 77 SHEKLVQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 131
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT----- 187
A++Y+ + HRDL +N L N +K+ DFGL+R +D +Y ++
Sbjct: 132 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--------EYTSSVGSKF 183
Query: 188 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 236
RW PE +SK++ DIW+ G + E+ + GK + +
Sbjct: 184 PVRWS-PPE--VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-26
Identities = 60/235 (25%), Positives = 102/235 (43%), Gaps = 35/235 (14%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
+++ +G+G +G V T +VAIK + L+E ++++ LR
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLR 237
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLR 132
H +V++ ++ + IY+V E M L +K L Q+
Sbjct: 238 HEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 291
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTDYV 185
+ Y+ N HRDL+ NIL N K+ DFGLAR+ ++ T I WT
Sbjct: 292 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT--- 348
Query: 186 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQLD 236
APE + + ++T D+WS G + E+ T G+ +PG + V+ Q++
Sbjct: 349 ------APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 55/215 (25%), Positives = 84/215 (39%), Gaps = 30/215 (13%)
Query: 21 KIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLL 74
K +G+G +G V + TGE VA+K + R +EI +LR L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK---ADAGPQHRSGWKQEIDILRTL 90
Query: 75 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRA 133
H I++ K + +V E + L + + + F Q+
Sbjct: 91 YHEHIIKYKGCCEDAGA---ASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEG 146
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT------ 187
+ Y+H + HRDL +N+L + + +KI DFGLA+ Y
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY------YRVREDGDSP 200
Query: 188 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
WY APE K+ A D+WS G E+LT
Sbjct: 201 VFWY-APE--CLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 56/249 (22%), Positives = 103/249 (41%), Gaps = 36/249 (14%)
Query: 4 NSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEK----VAIKKIHDIFEHIS 59
N + E + +K +V+G G++G V + GEK VAIK++ +
Sbjct: 5 NQALLRILKE----TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-K 59
Query: 60 DAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD- 117
IL E ++ + +P + + I L + + ++ +LM L ++ + D
Sbjct: 60 ANKEILDEAYVMASVDNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDN 113
Query: 118 LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 177
+ ++ + Q+ + + Y+ + HRDL +N+L +KI DFGLA++ +
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 178 TIFWTDYVAT------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 230
Y A +W A E YT D+WS G E++T G + G
Sbjct: 174 ------YHAEGGKVPIKWM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224
Query: 231 ---VVHQLD 236
+ L+
Sbjct: 225 ASEISSILE 233
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 72/312 (23%), Positives = 126/312 (40%), Gaps = 71/312 (22%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHP 77
++I +G GS+G V H G A+K K + E +L ++ HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL-KQVEHTNDERLMLSIVTHP 66
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELME-----SDLHQVIKANDDLTREHYQFFLYQLLR 132
I+ + + +D + I+++ + +E S L + + + + + F+ ++
Sbjct: 67 FIIRMWG-----TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAK----FYAAEVCL 117
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT-----DYVAT 187
AL+Y+H+ ++ +RDLKP+NIL + N +KI DFG A+ + T +T DY+
Sbjct: 118 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYI-- 170
Query: 188 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247
APE+ + Y +ID WS G + E+L G F N + +L
Sbjct: 171 ----APEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSN---TMKTYEKIL----- 216
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTA 302
++F F + LL RL+ D R
Sbjct: 217 --------------------NAELRFPPFF---NEDVKDLLSRLITRDLSQRLGNLQNGT 253
Query: 303 EEALADPYFKGL 314
E+ P+FK +
Sbjct: 254 EDVKNHPWFKEV 265
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-25
Identities = 60/235 (25%), Positives = 102/235 (43%), Gaps = 35/235 (14%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
+++ +G+G +G V T +VAIK + L+E ++++ LR
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLR 320
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLR 132
H +V++ ++ + IY+V E M L +K L Q+
Sbjct: 321 HEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 374
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTDYV 185
+ Y+ N HRDL+ NIL N K+ DFGLAR+ ++ T I WT
Sbjct: 375 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT--- 431
Query: 186 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQLD 236
APE + + ++T D+WS G + E+ T G+ +PG + V+ Q++
Sbjct: 432 ------APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 63/287 (21%), Positives = 116/287 (40%), Gaps = 56/287 (19%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHP 77
+ + +G GS+G V +G A+K + + L E ++L+ + P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRILQAVNFP 101
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELME-----SDLHQVIKANDDLTREHYQFFLYQLLR 132
+V+++ S +D ++Y+V E + S L ++ + ++ R F+ Q++
Sbjct: 102 FLVKLEF-----SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR----FYAAQIVL 152
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 192
+Y+H+ ++ +RDLKP+N+L + +++ DFG A+ T WT T A
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WT-LCGTPEALA 206
Query: 193 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252
PE+ S Y A+D W++G + E+ G P F + +
Sbjct: 207 PEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQP---------------IQIYEK 249
Query: 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR 299
+ + K V+F F LL LL D R
Sbjct: 250 IVSGK-------------VRFPSHF---SSDLKDLLRNLLQVDLTKR 280
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 54/231 (23%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 22 IQEVIGKGSYGVVCSAIDTHTGE--KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 79
+G G++G V + + VAIK + E ++RE +++ L +P I
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE-MMREAQIMHQLDNPYI 72
Query: 80 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQLLRALKYI 137
V + + + + +V E+ LH+ + + + + L+Q+ +KY+
Sbjct: 73 VRLIGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 126
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-------RWY 190
N HRDL +N+L KI DFGL++ D Y A +WY
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY------YTARSAGKWPLKWY 180
Query: 191 RAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 236
APE F K++ D+WS G E L+ G+ + V+ ++
Sbjct: 181 -APE---CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 58/228 (25%), Positives = 105/228 (46%), Gaps = 25/228 (10%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
+ K+ + IGKG +G V + G KVA+K I + A L E ++ LR
Sbjct: 191 NMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIK---NDATAQA-FLAEASVMTQLR 244
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND--DLTREHYQFFLYQLLR 132
H ++V++ +++ + +Y+V E M L +++ L + F +
Sbjct: 245 HSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 300
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 192
A++Y+ N HRDL +N+L + + K+ DFGL + A + T +W A
Sbjct: 301 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWT-A 354
Query: 193 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQLD 236
PE K++ D+WS G + E+ + G+ +P K+VV +++
Sbjct: 355 PE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 58/240 (24%), Positives = 101/240 (42%), Gaps = 35/240 (14%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAARILREIKLLR 72
+ EVIG+G +G V K A+K ++ I + I + ++ L E +++
Sbjct: 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMK 81
Query: 73 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND-DLTREHYQFFLYQL 130
HP+++ + I L VV M+ DL I+ + T + F Q+
Sbjct: 82 DFSHPNVLSLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137
Query: 131 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT--- 187
+ +KY+ + HRDL +N + + +K+ DFGLAR ++ +Y +
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--------MYDKEYYSVHNK 189
Query: 188 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 236
+W A E K+T D+WS G + E++T G P +P N + L
Sbjct: 190 TGAKLPVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 246
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 62/236 (26%), Positives = 99/236 (41%), Gaps = 37/236 (15%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
K+ E +G G +G V KVA+K + + L E L++ L+
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYYNGHT-KVAVKSLK---QGSMSPDAFLAEANLMKQLQ 66
Query: 76 HPDIVEIKHIML-PPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLL 131
H +V + ++ P IY++ E ME+ L +K LT Q+
Sbjct: 67 HQRLVRLYAVVTQEP-------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 132 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT---- 187
+ +I N HRDL+ NIL + KI DFGLAR+ ++ +Y A
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN--------EYTAREGAK 171
Query: 188 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 236
+W APE + +T D+WS G + E++T G+ +PG V+ L+
Sbjct: 172 FPIKWT-APE--AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 49/244 (20%), Positives = 93/244 (38%), Gaps = 35/244 (14%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLR 72
D + + +++G+G +G V KVA+K + + L E ++
Sbjct: 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMK 91
Query: 73 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAN------DDLTREHYQF 125
HP+++ + + + S + V+ M+ DLH + + + +
Sbjct: 92 DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 126 FLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD-Y 184
F+ + ++Y+ N HRDL +N + + + + DFGL++ I+ D Y
Sbjct: 152 FMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK--------IYSGDYY 203
Query: 185 VAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VV 232
+W A E S YT D+W+ G E+ T G +PG +
Sbjct: 204 RQGRIAKMPVKWI-AIE---SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259
Query: 233 HQLD 236
L
Sbjct: 260 DYLL 263
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 77/307 (25%), Positives = 126/307 (41%), Gaps = 64/307 (20%)
Query: 25 VIGKGSYG---VVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHPDI 79
V+GKG YG V +TG+ A+K K I + D A E +L ++HP I
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 80 VEIKHIMLPPSRRDFKDIYVVF------ELMESDLHQVIKANDDLTREHYQFFLYQLLRA 133
V++ + + +Y++ EL + ++ + F+L ++ A
Sbjct: 84 VDLIYAFQTGGK-----LYLILEYLSGGELF---MQ--LEREGIFMEDTACFYLAEISMA 133
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 193
L ++H + +RDLKP+NI+ N +K+ DFGL + + +D T + T Y AP
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT---HTFCGTIEYMAP 190
Query: 194 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252
E L S + A+D WS+G + ++LTG P F G+N
Sbjct: 191 EILMR---SGHNRAVDWWSLGALMYDMLTGAPPFTGEN---------------------- 225
Query: 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR----PT-AEEALA 307
R+ K + A LL++LL + R P A E A
Sbjct: 226 ------RKKTIDKILKCKLNLPPYLT---QEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276
Query: 308 DPYFKGL 314
P+F+ +
Sbjct: 277 HPFFRHI 283
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 62/235 (26%), Positives = 102/235 (43%), Gaps = 35/235 (14%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
K+++ +G G +G V A KVA+K + L E +++ L+
Sbjct: 186 PRESLKLEKKLGAGQFGEVWMATYNKHT-KVAVKTMK---PGSMSVEAFLAEANVMKTLQ 241
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLR 132
H +V++ ++ + IY++ E M L +K+++ F Q+
Sbjct: 242 HDKLVKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 295
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTDYV 185
+ +I N HRDL+ NIL +A+ KI DFGLARV ++ T I WT
Sbjct: 296 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT--- 352
Query: 186 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQLD 236
APE F +T D+WS G + E++T G+ +PG V+ L+
Sbjct: 353 ------APE--AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 3e-24
Identities = 54/230 (23%), Positives = 97/230 (42%), Gaps = 31/230 (13%)
Query: 22 IQEVIGKGSYGVVCSAIDTHTGE--KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 79
+G G++G V + + VAIK + E +D ++RE +++ L +P I
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYI 398
Query: 80 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQLLRALKYI 137
V + + + + +V E+ LH+ + + + + L+Q+ +KY+
Sbjct: 399 VRLIGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 452
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-------RWY 190
N HR+L +N+L KI DFGL++ D Y A +WY
Sbjct: 453 EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY------YTARSAGKWPLKWY 506
Query: 191 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 236
APE F K++ D+WS G E L+ G+ + V+ ++
Sbjct: 507 -APE--CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 56/240 (23%), Positives = 101/240 (42%), Gaps = 35/240 (14%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAARILREIKLLR 72
+ EVIG+G +G V K A+K ++ I + I + ++ L E +++
Sbjct: 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMK 145
Query: 73 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND-DLTREHYQFFLYQL 130
HP+++ + I L VV M+ DL I+ + T + F Q+
Sbjct: 146 DFSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201
Query: 131 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT--- 187
+ +K++ + HRDL +N + + +K+ DFGLAR ++ ++ +
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--------MYDKEFDSVHNK 253
Query: 188 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 236
+W A E K+T D+WS G + E++T G P +P N + L
Sbjct: 254 TGAKLPVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 65/258 (25%), Positives = 106/258 (41%), Gaps = 44/258 (17%)
Query: 4 NSPEMEFFSEY---GDASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEH 57
+S + + + VIGKG +GVV + + AIK + I E
Sbjct: 4 DSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE- 62
Query: 58 ISDAARILREIKLLRLLRHPDIVEIKHIML---PPSRRDFKDIYVVFELMES-DLHQVIK 113
+ LRE L+R L HP+++ + IML +V+ M DL Q I+
Sbjct: 63 MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL-------PHVLLPYMCHGDLLQFIR 115
Query: 114 AND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172
+ + T + F Q+ R ++Y+ HRDL +N + + + +K+ DFGLAR
Sbjct: 116 SPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD-- 173
Query: 173 NDTPTTIFWTDYVAT----------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT- 221
I +Y + +W A E ++T D+WS G + E+LT
Sbjct: 174 ------ILDREYYSVQQHRHARLPVKWT-ALE--SLQTYRFTTKSDVWSFGVLLWELLTR 224
Query: 222 GKPLFPGKN---VVHQLD 236
G P + + + H L
Sbjct: 225 GAPPYRHIDPFDLTHFLA 242
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 40/240 (16%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAARI--LREIKL 70
R ++ IG+G +G V I VAIK SD+ R L+E
Sbjct: 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK---NCTSDSVREKFLQEALT 444
Query: 71 LRLLRHPDIVEIKHIML-PPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFL 127
+R HP IV++ ++ P ++++ EL +L ++ L +
Sbjct: 445 MRQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497
Query: 128 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 187
YQL AL Y+ + HRD+ +N+L ++N +K+ DFGL+R + Y
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------TYYKA 549
Query: 188 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 236
+W APE F ++T A D+W G E+L G F G V+ +++
Sbjct: 550 SKGKLPIKWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 54/244 (22%), Positives = 100/244 (40%), Gaps = 34/244 (13%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLR 72
++ + ++GKG +G V A KVA+K + SD LRE ++
Sbjct: 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK 80
Query: 73 LLRHPDIVEIKHIMLPP-SRRDFKDIYVVFELMES-DLHQVIKAN------DDLTREHYQ 124
HP + ++ + L ++ V+ M+ DLH + A+ +L +
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140
Query: 125 FFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY 184
F+ + ++Y+ + N HRDL +N + + + + DFGL+R I+ DY
Sbjct: 141 RFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK--------IYSGDY 192
Query: 185 --------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VV 232
+ +W A E + YT D+W+ G E++T G+ + G +
Sbjct: 193 YRQGCASKLPVKWL-ALE--SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY 249
Query: 233 HQLD 236
+ L
Sbjct: 250 NYLI 253
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 70/299 (23%), Positives = 126/299 (42%), Gaps = 52/299 (17%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHPDIVEI 82
++GKG++G V + TG A+K + I + A + E ++L+ RHP + +
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-DEVAHTVTESRVLQNTRHPFLTAL 70
Query: 83 KHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN 141
K+ R + V E +L + T E +F+ +++ AL+Y+H+ +
Sbjct: 71 KYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 142 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFF 200
V +RD+K +N++ + + +KI DFGL + +D T + T Y APE L
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED--- 179
Query: 201 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260
+ Y A+D W +G + E++ G+ F ++
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----------------------------HE 211
Query: 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALADPYFKGL 314
L + + ++F + P A LL LL DPK R A+E + +F +
Sbjct: 212 RLFELILMEEIRFPRTLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-23
Identities = 64/297 (21%), Positives = 114/297 (38%), Gaps = 51/297 (17%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRL-LRHPDIVE 81
++GKGS+G V A T + AIK K + D + E ++L L HP +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD-DDVECTMVEKRVLSLAWEHPFLTH 82
Query: 82 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 140
+ ++ V E + DL I++ F+ +++ L+++H+
Sbjct: 83 MFCTFQTKEN-----LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 137
Query: 141 NVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTDYVATRWYRAPELCGS 198
+ +RDLK NIL + + +KI DFG+ + + + T + T Y APE+
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-----FCGTPDYIAPEILLG 192
Query: 199 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 258
KY ++D WS G + E+L G+ F G++
Sbjct: 193 --QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---------------------------- 222
Query: 259 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-PTAEEALADPYFKGL 314
L + + + A LL +L +P+ R + P F+ +
Sbjct: 223 EEELFHSIRMDNPFYPRWLE---KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-23
Identities = 36/291 (12%), Positives = 66/291 (22%), Gaps = 65/291 (22%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLR 75
RY++ G A+DT +VA+ + L L +
Sbjct: 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID 89
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRAL 134
P + + ++ VV E + L +V + + + L A
Sbjct: 90 KPGVARVLDVV-----HTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAA 142
Query: 135 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 194
H A V P + + + + + A
Sbjct: 143 DAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDA----------------------- 179
Query: 195 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254
P DI IG +L + P V L
Sbjct: 180 ---------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ--------- 221
Query: 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 305
P++ + + + R + D R +
Sbjct: 222 ---------------PIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-23
Identities = 38/244 (15%), Positives = 77/244 (31%), Gaps = 40/244 (16%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGE-------KVAIKKIHDIFEHISDAARILREI 68
E +G+G++ + + G+ +V +K + H + +
Sbjct: 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK--AHRNYSESFFEAA 63
Query: 69 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFF 126
++ L H +V + + + +V E ++ L +K N + +
Sbjct: 64 SMMSKLSHKHLVLNYGVCV-----CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV 118
Query: 127 LYQLLRALKYIHTANVYHRDLKPKNIL--------ANANCKLKICDFGLARVAFNDTPTT 178
QL A+ ++ + H ++ KNIL +K+ D G++
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK---- 174
Query: 179 IFWTDY--VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VV 232
D W PE C A D WS G E+ + G + +
Sbjct: 175 ----DILQERIPWV-PPE-CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL 228
Query: 233 HQLD 236
+
Sbjct: 229 QFYE 232
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 8e-23
Identities = 70/307 (22%), Positives = 123/307 (40%), Gaps = 66/307 (21%)
Query: 25 VIGKGSYG---VVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHPDI 79
V+G+GS+G +V + + A+K K + D R E +L + HP I
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR--DRVRTKMERDILVEVNHPFI 88
Query: 80 VEIKHIMLPPSRRDFKDIYVVF------ELMESDLHQVIKANDDLTREHYQFFLYQLLRA 133
V++ + + +Y++ +L + L + + ++ + F+L +L A
Sbjct: 89 VKLHYAFQTEGK-----LYLILDFLRGGDLF-TRLSKEVMFTEEDVK----FYLAELALA 138
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 193
L ++H+ + +RDLKP+NIL + +K+ DFGL++ + + + T Y AP
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA---YSFCGTVEYMAP 195
Query: 194 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252
E + +T + D WS G + E+LTG F GK+
Sbjct: 196 EVVNR---RGHTQSADWWSFGVLMFEMLTGTLPFQGKD---------------------- 230
Query: 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALA 307
R+ +M K + Q P A LL L +P +R EE
Sbjct: 231 ------RKETMTMILKAKLGMPQFLS---PEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281
Query: 308 DPYFKGL 314
+F +
Sbjct: 282 HSFFSTI 288
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 72/299 (24%), Positives = 125/299 (41%), Gaps = 51/299 (17%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHPDIVEI 82
++GKG++G V + TG A+K K I + A L E ++L+ RHP + +
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK-DEVAHTLTENRVLQNSRHPFLTAL 213
Query: 83 KHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA- 140
K+ R + V E +L + + + +F+ +++ AL Y+H+
Sbjct: 214 KYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 268
Query: 141 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF 200
NV +RDLK +N++ + + +KI DFGL + D T + T Y APE+
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVLED-- 323
Query: 201 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 260
+ Y A+D W +G + E++ G+ F ++
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----------------------------HE 355
Query: 261 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR----PT-AEEALADPYFKGL 314
L + + ++F + P A LL LL DPK R A+E + +F G+
Sbjct: 356 KLFELILMEEIRFPRTLG---PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 70/318 (22%), Positives = 124/318 (38%), Gaps = 54/318 (16%)
Query: 15 GDASRYKIQE-----VIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILRE 67
G +Q+ VIG+GSY V T A+K K + + D + E
Sbjct: 1 GAMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD-EDIDWVQTE 59
Query: 68 IK-LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQF 125
+ HP +V + SR ++ V E + DL ++ L EH +F
Sbjct: 60 KHVFEQASNHPFLVGLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARF 114
Query: 126 FLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTD 183
+ ++ AL Y+H + +RDLK N+L ++ +K+ D+G+ + + DT +T
Sbjct: 115 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST----- 169
Query: 184 YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242
+ T Y APE L G Y ++D W++G + E++ G+ F D
Sbjct: 170 FCGTPNYIAPEILRG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------ 220
Query: 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR--- 299
YL + ++ ++ + A +L+ L DPK+R
Sbjct: 221 -------------QNTEDYLFQVILEKQIRIPRSLS---VKAASVLKSFLNKDPKERLGC 264
Query: 300 ---PTAEEALADPYFKGL 314
+ P+F+ +
Sbjct: 265 HPQTGFADIQGHPFFRNV 282
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 59/302 (19%), Positives = 111/302 (36%), Gaps = 57/302 (18%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIK-LLRLLRHPDIVE 81
V+GKGS+G V + T E A+K K + + D + E + L + P + +
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD-DDVECTMVEKRVLALPGKPPFLTQ 406
Query: 82 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 140
+ R +Y V E + DL I+ H F+ ++ L ++ +
Sbjct: 407 LHSCFQTMDR-----LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 141 NVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTDYVATRWYRAPE-LCG 197
+ +RDLK N++ ++ +KI DFG+ + + T T + T Y APE +
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-----FCGTPDYIAPEIIAY 516
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257
Y ++D W+ G + E+L G+ F G++
Sbjct: 517 ---QPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------------------------- 546
Query: 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALADPYFK 312
L + V + + A+ + + L+ P R + +F+
Sbjct: 547 -EDELFQSIMEHNVAYPKSMS---KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 602
Query: 313 GL 314
+
Sbjct: 603 YI 604
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 5e-22
Identities = 62/305 (20%), Positives = 112/305 (36%), Gaps = 63/305 (20%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIK-LLRLLRHPDIVE 81
V+GKGS+G V + T E A+K K + + D + E + L + P + +
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD-DDVECTMVEKRVLALPGKPPFLTQ 85
Query: 82 IKHIMLPPSRRDFKDIYVVFE------LMESDLHQVIKANDDLTREHYQFFLYQLLRALK 135
+ R +Y V E LM H I+ H F+ ++ L
Sbjct: 86 LHSCFQTMDR-----LYFVMEYVNGGDLM---YH--IQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 136 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE- 194
++ + + +RDLK N++ ++ +KI DFG+ + D TT + T Y APE
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT---KTFCGTPDYIAPEI 192
Query: 195 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254
+ Y ++D W+ G + E+L G+ F G++
Sbjct: 193 IAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEGED------------------------ 225
Query: 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR----PT-AEEALADP 309
L + V + + A+ + + L+ P R P +
Sbjct: 226 ----EDELFQSIMEHNVAYPKSMS---KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 278
Query: 310 YFKGL 314
+F+ +
Sbjct: 279 FFRYI 283
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 9e-22
Identities = 64/302 (21%), Positives = 127/302 (42%), Gaps = 46/302 (15%)
Query: 25 VIGKGSYG---VVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRH-PD 78
V+G G+YG +V TG+ A+K + I + E ++L +R P
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI 137
+V + + ++ ++++ + + +L + + T Q ++ +++ AL+++
Sbjct: 121 LVTLHYAFQTETK-----LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHL 175
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
H + +RD+K +NIL ++N + + DFGL++ D + + T Y AP++
Sbjct: 176 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA-YD-FCGTIEYMAPDIVR 233
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257
S + A+D WS+G + E+LTG F
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG------------------------EKN 269
Query: 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR----PT-AEEALADPYFK 312
++ ++ K + Q+ A L++RLL DPK R P A+E +F+
Sbjct: 270 SQAEISRRILKSEPPYPQEMS---ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 326
Query: 313 GL 314
+
Sbjct: 327 KI 328
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 9e-22
Identities = 67/303 (22%), Positives = 120/303 (39%), Gaps = 49/303 (16%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIK-LLRLLRHPDIVE 81
VIG+GSY V T A++ K + + D + E + HP +V
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD-EDIDWVQTEKHVFEQASNHPFLVG 117
Query: 82 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 140
+ SR ++ V E + DL ++ L EH +F+ ++ AL Y+H
Sbjct: 118 LHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 172
Query: 141 NVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTDYVATRWYRAPE-LCG 197
+ +RDLK N+L ++ +K+ D+G+ + + DT +T + T Y APE L G
Sbjct: 173 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-----FCGTPNYIAPEILRG 227
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257
Y ++D W++G + E++ G+ F D
Sbjct: 228 ---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-------------------QN 265
Query: 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR------PTAEEALADPYF 311
YL + ++ ++ + A +L+ L DPK+R + P+F
Sbjct: 266 TEDYLFQVILEKQIRIPRSLS---VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322
Query: 312 KGL 314
+ +
Sbjct: 323 RNV 325
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 70/304 (23%), Positives = 113/304 (37%), Gaps = 60/304 (19%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIK-LLRLLRHPDIVE 81
V+GKGS+G V A TG+ A+K K I + D + E + L HP + +
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD-DDVECTMTEKRILSLARNHPFLTQ 88
Query: 82 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 140
+ P R ++ V E + DL I+ + +F+ +++ AL ++H
Sbjct: 89 LFCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK 143
Query: 141 NVYHRDLKPKNILANANCKLKICDFGLA--RVAFNDTPTTIFWT-DYVATRWYRAPE-LC 196
+ +RDLK N+L + K+ DFG+ + T T T DY+ APE L
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYI------APEILQ 197
Query: 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256
Y PA+D W++G + E+L G F +N
Sbjct: 198 E---MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-------------------------- 228
Query: 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR------PTAEEALADPY 310
L V + A +L+ + +P R L P+
Sbjct: 229 --EDDLFEAILNDEVVYPTWLH---EDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283
Query: 311 FKGL 314
FK +
Sbjct: 284 FKEI 287
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 75/305 (24%), Positives = 118/305 (38%), Gaps = 64/305 (20%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIK-LLRLLRHPDIVE 81
VIGKGS+G V A A+K + I + + I+ E LL+ ++HP +V
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVG 103
Query: 82 IKHIMLPPSRRDFKDIYVVF------ELMESDLHQVIKANDDLTREHYQFFLYQLLRALK 135
+ + +Y V EL H ++ +F+ ++ AL
Sbjct: 104 LHFSFQTADK-----LYFVLDYINGGELF---YH--LQRERCFLEPRARFYAAEIASALG 153
Query: 136 YIHTANVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTDYVATRWYRAP 193
Y+H+ N+ +RDLKP+NIL ++ + + DFGL + + N T +T + T Y AP
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-----FCGTPEYLAP 208
Query: 194 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253
E+ Y +D W +G + E+L G P F +N M D
Sbjct: 209 EVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT----AEMYD------------- 249
Query: 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR----PTAEEALADP 309
+P+Q SA LLE LL D R E +
Sbjct: 250 -----------NILNKPLQLKPNIT---NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHV 295
Query: 310 YFKGL 314
+F +
Sbjct: 296 FFSLI 300
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 58/256 (22%), Positives = 101/256 (39%), Gaps = 55/256 (21%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARI--LREI 68
++ +G+G++G V A VA+K + + S++AR RE
Sbjct: 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREA 94
Query: 69 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD---------- 117
+LL +L+H IV + + + + +VFE M DL++ ++++
Sbjct: 95 ELLTMLQHQHIVRFFGVCT-----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149
Query: 118 -----LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172
L Q+ + Y+ + HRDL +N L +KI DFG++R
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD-- 207
Query: 173 NDTPTTIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK 223
I+ TDY RW PE + K+T D+WS G + E+ T GK
Sbjct: 208 ------IYSTDYYRVGGRTMLPIRWM-PPE--SILYRKFTTESDVWSFGVVLWEIFTYGK 258
Query: 224 PLFPGKN---VVHQLD 236
+ + + +
Sbjct: 259 QPWYQLSNTEAIDCIT 274
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 65/257 (25%), Positives = 106/257 (41%), Gaps = 56/257 (21%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARI--LREI 68
++ +G+G++G V A T VA+K + D + AAR RE
Sbjct: 13 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREA 68
Query: 69 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAN------------ 115
+LL L+H IV+ + D + +VFE M+ DL++ ++A+
Sbjct: 69 ELLTNLQHEHIVKFYGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123
Query: 116 ----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171
+L Q+ + Y+ + + HRDL +N L AN +KI DFG++R
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD- 182
Query: 172 FNDTPTTIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-G 222
++ TDY RW PE + K+T D+WS G I E+ T G
Sbjct: 183 -------VYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFTYG 232
Query: 223 KPLFPGKN---VVHQLD 236
K + + V+ +
Sbjct: 233 KQPWFQLSNTEVIECIT 249
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 89.9 bits (222), Expect = 9e-20
Identities = 51/349 (14%), Positives = 89/349 (25%), Gaps = 75/349 (21%)
Query: 11 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH------DIFEHISDAARI 64
FS + + E IG+G +G V I HT VAIK I H I
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEI 70
Query: 65 LREIKLLRLL---------RHPDIVEIKHIML-------------------------PPS 90
L EI + + L R + + + P
Sbjct: 71 LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130
Query: 91 RRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKP 149
+++V E + + + L+QL +L + HRDL
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHW 190
Query: 150 KNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDI 209
N+L K+ + + + YT +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQV------------------SIIDYTLSRLE 232
Query: 210 WSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK-------ARRYL 262
+F +V + LF G +Q D + L+ + + +
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDG-DYQFD-IYRLMKKENNNRWGEYHPYSNVLWLHYLTDKM 290
Query: 263 TSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311
+ + +L F +A + L
Sbjct: 291 LKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 50/238 (21%), Positives = 88/238 (36%), Gaps = 51/238 (21%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARI--LREI 68
S + E +G+ +G V + VAIK + + R E
Sbjct: 7 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEA 63
Query: 69 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAN------------ 115
L L+HP++V + ++ + + ++F DLH+ +
Sbjct: 64 MLRARLQHPNVVCLLGVVT-----KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 116 ----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171
L + + Q+ ++Y+ + +V H+DL +N+L +KI D GL R
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE- 177
Query: 172 FNDTPTTIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
++ DY RW APE + K++ DIWS G + EV +
Sbjct: 178 -------VYAADYYKLLGNSLLPIRWM-APE--AIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 51/242 (21%), Positives = 93/242 (38%), Gaps = 56/242 (23%)
Query: 21 KIQEVIGKGSYGVVCSAIDTHTGE-----KVAIKKIHDIFEHISDAARI--LREIKLLRL 73
+ +G+GS+G+V + + +VAIK ++ E S RI L E +++
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKE 84
Query: 74 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAN----------DDLTREH 122
+V + ++ + V+ ELM DL +++ +
Sbjct: 85 FNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 123 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 182
++ + Y++ HRDL +N + + +KI DFG+ R I+ T
Sbjct: 140 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--------IYET 191
Query: 183 DYVATRWYR------------APELCGS-FFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 228
DY YR +PE S +T D+WS G + E+ T + + G
Sbjct: 192 DY-----YRKGGKGLLPVRWMSPE---SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 243
Query: 229 KN 230
+
Sbjct: 244 LS 245
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 50/251 (19%), Positives = 88/251 (35%), Gaps = 49/251 (19%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARI--LREI 68
+ +G G++G V + + +VA+K + E S+ + L E
Sbjct: 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEA 84
Query: 69 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFL 127
++ H +IV + L +++ ELM DL ++ + +
Sbjct: 85 LIISKFNHQNIVRCIGVSL-----QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 128 YQLL-------RALKYIHTANVYHRDLKPKNILANA---NCKLKICDFGLARVAFNDTPT 177
LL +Y+ + HRD+ +N L KI DFG+AR
Sbjct: 140 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD------- 192
Query: 178 TIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 228
I+ Y +W PE +T D WS G + E+ + G +P
Sbjct: 193 -IYRASYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 248
Query: 229 KN---VVHQLD 236
K+ V+ +
Sbjct: 249 KSNQEVLEFVT 259
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 40/168 (23%), Positives = 70/168 (41%), Gaps = 32/168 (19%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARIL-REIKLLRLLR 75
+++ + IG G++G + + +T E VAIK E + A L E + + L
Sbjct: 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLG 62
Query: 76 H-PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFF-------- 126
I ++ + K +V EL+ L +DL + F
Sbjct: 63 SGDGIPQVYY-----FGPCGKYNAMVLELLGPSL-------EDLFDLCDRTFSLKTVLMI 110
Query: 127 LYQLLRALKYIHTANVYHRDLKPKNIL-----ANANCKLKICDFGLAR 169
QL+ ++Y+H+ N+ +RD+KP+N L + I DF LA+
Sbjct: 111 AIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 61/254 (24%), Positives = 101/254 (39%), Gaps = 63/254 (24%)
Query: 3 QNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEK--VAIKKIHDIFEHISD 60
+N+P+ + D + K Q+VIG+G++G V A G + AIK++ E+ S
Sbjct: 11 KNNPDPTIYPVL-DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASK 66
Query: 61 AARI--LREIKLL-RLLRHPDIVEIKHIML------PPSRRDFKDIYVVFELMES-DLHQ 110
E+++L +L HP+I+ +L +Y+ E +L
Sbjct: 67 DDHRDFAGELEVLCKLGHHPNIIN----LLGACEHRGY-------LYLAIEYAPHGNLLD 115
Query: 111 VIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA 154
++ + L+ + F + R + Y+ HRDL +NIL
Sbjct: 116 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 175
Query: 155 NANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-------RWYRAPELCGSFFSKYTPAI 207
N KI DFGL+R + YV RW A E +S YT
Sbjct: 176 GENYVAKIADFGLSR--GQEV--------YVKKTMGRLPVRWM-AIE--SLNYSVYTTNS 222
Query: 208 DIWSIGCIFAEVLT 221
D+WS G + E+++
Sbjct: 223 DVWSYGVLLWEIVS 236
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 50/251 (19%), Positives = 88/251 (35%), Gaps = 49/251 (19%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARI--LREI 68
+ +G G++G V + + +VA+K + E S+ + L E
Sbjct: 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEA 125
Query: 69 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFL 127
++ H +IV + L +++ ELM DL ++ + +
Sbjct: 126 LIISKFNHQNIVRCIGVSL-----QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180
Query: 128 YQLL-------RALKYIHTANVYHRDLKPKNILANA---NCKLKICDFGLARVAFNDTPT 177
LL +Y+ + HRD+ +N L KI DFG+AR
Sbjct: 181 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD------- 233
Query: 178 TIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 228
I+ Y +W PE +T D WS G + E+ + G +P
Sbjct: 234 -IYRAGYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289
Query: 229 KN---VVHQLD 236
K+ V+ +
Sbjct: 290 KSNQEVLEFVT 300
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 62/252 (24%), Positives = 108/252 (42%), Gaps = 52/252 (20%)
Query: 18 SRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARI--LREIKL 70
R K+ + +G+G++G V A T T VA+K + E + + + E+K+
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 83
Query: 71 L-RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAN------------- 115
L + H ++V +L + + V+ E + +L +++
Sbjct: 84 LIHIGHHLNVVN----LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 116 ---DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172
D LT EH + +Q+ + ++++ + HRDL +NIL + +KICDFGLAR
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD-- 197
Query: 173 NDTPTTIFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK 223
I+ YV +W APE F YT D+WS G + E+ + G
Sbjct: 198 ------IYKDPDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLLWEIFSLGA 248
Query: 224 PLFPGKNVVHQL 235
+PG + +
Sbjct: 249 SPYPGVKIDEEF 260
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 18/160 (11%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARIL-REIKLLRLLR 75
+RY++ IG GS+G + D GE+VAIK E + L E K+ ++++
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQ 62
Query: 76 H-PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRA 133
I I+ + +V EL+ L + + + Q++
Sbjct: 63 GGVGIPTIRW-----CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISR 117
Query: 134 LKYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLAR 169
++YIH+ N HRD+KP N L N + I DFGLA+
Sbjct: 118 IEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAK 156
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 33/168 (19%), Positives = 66/168 (39%), Gaps = 21/168 (12%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
++ + + IG G +G++ A T+ EK A + E+ + + E+K + + D
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK--VEY-QENGPLFSELKFYQRVAKKD 94
Query: 79 IVEIKHIMLPPSRRDFKDIY--------------VVFELMESDLHQVIKANDDLTREHYQ 124
++ Y +V E + DL ++ N +
Sbjct: 95 CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVL 154
Query: 125 FFLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLAR 169
++L L+YIH H D+K N+L N + ++ + D+GL+
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-QVYLADYGLSY 201
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 54/251 (21%), Positives = 95/251 (37%), Gaps = 73/251 (29%)
Query: 18 SRYKIQEVIGKGSYGVVCSA----IDTHTGE-KVAIKKIHDIFEHISDAARI--LREIKL 70
+ + IG+G++G V A + + VA+K + E S + RE L
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAAL 103
Query: 71 LRLLRHPDIVEIKHIML--PPSRRDFKDIYVVFELMES-DLHQVIKANDD---------- 117
+ +P+IV++ + P + ++FE M DL++ +++
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKP-------MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156
Query: 118 --------------LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 163
L+ Q+ + Y+ HRDL +N L N +KI
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 216
Query: 164 DFGLARVAFNDTPTTIFWTDYVATRWYR------------APELCGS-FFSKYTPAIDIW 210
DFGL+R I+ DY Y+ PE S F+++YT D+W
Sbjct: 217 DFGLSRN--------IYSADY-----YKADGNDAIPIRWMPPE---SIFYNRYTTESDVW 260
Query: 211 SIGCIFAEVLT 221
+ G + E+ +
Sbjct: 261 AYGVVLWEIFS 271
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 40/168 (23%), Positives = 71/168 (42%), Gaps = 32/168 (19%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARIL-REIKLLRLLR 75
YK+ IG+GS+GV+ + ++VAIK FE A L E + +LL
Sbjct: 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-----FEPRRSDAPQLRDEYRTYKLLA 63
Query: 76 H-PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL------- 127
I + + ++ +V +L+ L ++ +F +
Sbjct: 64 GCTGIPNVYY-----FGQEGLHNVLVIDLLGPSLEDLLDLCG------RKFSVKTVAMAA 112
Query: 128 YQLLRALKYIHTANVYHRDLKPKNIL------ANANCKLKICDFGLAR 169
Q+L ++ IH ++ +RD+KP N L NAN + + DFG+ +
Sbjct: 113 KQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNAN-MIYVVDFGMVK 159
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 57/255 (22%), Positives = 96/255 (37%), Gaps = 61/255 (23%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGE-----KVAIKKIHDIFEHISDAARI--LREIKL 70
+ + + +G G++G V A G+ KVA+K + + + E+K+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKI 102
Query: 71 L-RLLRHPDIVEIKHIML------PPSRRDFKDIYVVFELME---------------SDL 108
+ L +H +IV +L P + V+ E
Sbjct: 103 MSHLGQHENIVN----LLGACTHGGP-------VLVITEYCCYGDLLNFLRRKSRVLETD 151
Query: 109 HQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 168
AN + F Q+ + + ++ + N HRD+ +N+L KI DFGLA
Sbjct: 152 PAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
Query: 169 RVAFNDTPTTIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 221
R ND ++Y+ +W APE F YT D+WS G + E+ +
Sbjct: 212 RDIMND-------SNYIVKGNARLPVKWM-APE--SIFDCVYTVQSDVWSYGILLWEIFS 261
Query: 222 -GKPLFPGKNVVHQL 235
G +PG V +
Sbjct: 262 LGLNPYPGILVNSKF 276
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 60/270 (22%), Positives = 105/270 (38%), Gaps = 79/270 (29%)
Query: 18 SRYKIQEVIGKGSYGVVCSA----IDTHTGE-KVAIKKIHDIFEHISDAARI--LREIKL 70
+ + +G+G +G V A + G VA+K + E+ S + L E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNV 79
Query: 71 LRLLRHPDIVEIKHIML------PPSRRDFKDIYVVFELMES-DLHQVIKAN-------- 115
L+ + HP +++ + P + ++ E + L ++ +
Sbjct: 80 LKQVNHPHVIK----LYGACSQDGP-------LLLIVEYAKYGSLRGFLRESRKVGPGYL 128
Query: 116 ----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK 159
LT F +Q+ + ++Y+ + HRDL +NIL K
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK 188
Query: 160 LKICDFGLARVAFNDTPTTIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIW 210
+KI DFGL+R ++ D YV +W A E S F YT D+W
Sbjct: 189 MKISDFGLSRD--------VYEEDSYVKRSQGRIPVKWM-AIE---SLFDHIYTTQSDVW 236
Query: 211 SIGCIFAEVLT--GKPLFPG---KNVVHQL 235
S G + E++T G P +PG + + + L
Sbjct: 237 SFGVLLWEIVTLGGNP-YPGIPPERLFNLL 265
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 66/290 (22%), Positives = 115/290 (39%), Gaps = 81/290 (27%)
Query: 1 MLQNSPEMEFFSEYG---------DASRYKIQEVIGKGSYGVVCSA----IDTHTGE--- 44
++P + SEY + + + +G+G +G V A ID +
Sbjct: 55 STADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAV 114
Query: 45 KVAIKKIHDIFEHISDAARI--LREIKLL-RLLRHPDIVEIKHIML------PPSRRDFK 95
VA+K + + ++ + E++++ + +H +I+ +L P
Sbjct: 115 TVAVKMLK---DDATEKDLSDLVSEMEMMKMIGKHKNIIN----LLGACTQDGP------ 161
Query: 96 DIYVVFELMES-DLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIH 138
+YV+ E +L + ++A + +T + YQL R ++Y+
Sbjct: 162 -LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA 220
Query: 139 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD-YVAT-------RWY 190
+ HRDL +N+L N +KI DFGLAR I D Y T +W
Sbjct: 221 SQKCIHRDLAARNVLVTENNVMKIADFGLARD--------INNIDYYKKTTNGRLPVKWM 272
Query: 191 RAPELCGS-FFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQL 235
APE + F YT D+WS G + E+ T G +PG + + L
Sbjct: 273 -APE---ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 318
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 62/264 (23%), Positives = 108/264 (40%), Gaps = 72/264 (27%)
Query: 18 SRYKIQEVIGKGSYGVVCSA----IDTHTGE---KVAIKKIHDIFEHISDAARI--LREI 68
+ + + +G+G++G V A ID + VA+K + + ++ + E+
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 91
Query: 69 KLL-RLLRHPDIVEIKHIML------PPSRRDFKDIYVVFELMES-DLHQVIKAN----- 115
+++ + +H +I+ +L P +YV+ E +L + ++A
Sbjct: 92 EMMKMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLRARRPPGM 140
Query: 116 -----------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 164
+ +T + YQL R ++Y+ + HRDL +N+L N +KI D
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD 200
Query: 165 FGLARVAFNDTPTTIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCI 215
FGLAR I D Y T +W APE + F YT D+WS G +
Sbjct: 201 FGLARD--------INNIDYYKKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVL 248
Query: 216 FAEVLT-GK---PLFPGKNVVHQL 235
E+ T G P P + + L
Sbjct: 249 MWEIFTLGGSPYPGIPVEELFKLL 272
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 64/260 (24%), Positives = 94/260 (36%), Gaps = 67/260 (25%)
Query: 18 SRYKIQEVIGKGSYGVV--CSAIDTHTGE---KVAIKKIHDIFEHISDAARI--LREIKL 70
+R + +G G++G V +A + VA+K + R + E+K+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKV 79
Query: 71 L-RLLRHPDIVEIKHIML------PPSRRDFKDIYVVFELMES-DLHQVIKAN------- 115
L L H +IV +L P V+ E DL ++
Sbjct: 80 LSYLGNHMNIVN----LLGACTIGGP-------TLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 116 -----------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 164
L E F YQ+ + + ++ + N HRDL +NIL KICD
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 188
Query: 165 FGLARVAFNDTPTTIFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIF 216
FGLAR I YV +W APE F YT D+WS G
Sbjct: 189 FGLARD--------IKNDSNYVVKGNARLPVKWM-APESI--FNCVYTFESDVWSYGIFL 237
Query: 217 AEVLT-GKPLFPGKNVVHQL 235
E+ + G +PG V +
Sbjct: 238 WELFSLGSSPYPGMPVDSKF 257
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 61/264 (23%), Positives = 107/264 (40%), Gaps = 72/264 (27%)
Query: 18 SRYKIQEVIGKGSYGVV--CSAIDTHTGE-----KVAIKKIHDIFEHISDAARI--LREI 68
R + + +G+G++G V AI + KVA+K + ++ + E+
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEM 125
Query: 69 KLL-RLLRHPDIVEIKHIML------PPSRRDFKDIYVVFELMES-DLHQVIKAN----- 115
+++ + +H +I+ +L P +YV+ E +L + ++A
Sbjct: 126 EMMKMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLQARRPPGL 174
Query: 116 -----------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 164
+ L+ + YQ+ R ++Y+ + HRDL +N+L + +KI D
Sbjct: 175 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 234
Query: 165 FGLARVAFNDTPTTIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCI 215
FGLAR I D Y T +W APE + F YT D+WS G +
Sbjct: 235 FGLARD--------IHHIDYYKKTTNGRLPVKWM-APE---ALFDRIYTHQSDVWSFGVL 282
Query: 216 FAEVLT-GK---PLFPGKNVVHQL 235
E+ T G P P + + L
Sbjct: 283 LWEIFTLGGSPYPGVPVEELFKLL 306
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 77.4 bits (190), Expect = 4e-15
Identities = 38/166 (22%), Positives = 72/166 (43%), Gaps = 30/166 (18%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARIL-REIKLLRLLR 75
+++++ IG GS+G + + T E+VAIK E++ L E K+ R+L+
Sbjct: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKIYRILQ 60
Query: 76 -HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFF-------- 126
I ++ + +V +L+ L +DL +
Sbjct: 61 GGTGIPNVRW-----FGVEGDYNVLVMDLLGPSL-------EDLFNFCSRKLSLKTVLML 108
Query: 127 LYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLAR 169
Q++ ++++H+ + HRD+KP N L ++ I DFGLA+
Sbjct: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 64/266 (24%), Positives = 104/266 (39%), Gaps = 74/266 (27%)
Query: 18 SRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARI--LREIKL 70
+ +V+G G++G V +A T +VA+K + E + R + E+K+
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKM 101
Query: 71 L-RLLRHPDIVEIKHIML------PPSRRDFKDIYVVFELME------------------ 105
+ +L H +IV +L P IY++FE
Sbjct: 102 MTQLGSHENIVN----LLGACTLSGP-------IYLIFEYCCYGDLLNYLRSKREKFSED 150
Query: 106 ------SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK 159
+ + + LT E F YQ+ + ++++ + HRDL +N+L
Sbjct: 151 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV 210
Query: 160 LKICDFGLAR-VAFNDTPTTIFWTDYVAT-------RWYRAPELCGSFF-SKYTPAIDIW 210
+KICDFGLAR + + YV +W APE S F YT D+W
Sbjct: 211 VKICDFGLARDIMSDSN--------YVVRGNARLPVKWM-APE---SLFEGIYTIKSDVW 258
Query: 211 SIGCIFAEVLT-GKPLFPGKNVVHQL 235
S G + E+ + G +PG V
Sbjct: 259 SYGILLWEIFSLGVNPYPGIPVDANF 284
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 35/175 (20%), Positives = 67/175 (38%), Gaps = 32/175 (18%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
+K+ IG+G +G + A D ++ E V + SD + E+K + P+
Sbjct: 36 AWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 79 IVEIKHIMLPPSRRDFKDIY--------------VVFELMESDLHQVIKANDDLTREHYQ 124
++ + ++ + SDL ++ +AN +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA------KR 148
Query: 125 FFL-------YQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLAR 169
F ++L L+YIH H D+K N+L N + ++ + D+GLA
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD-QVYLVDYGLAY 202
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 6e-14
Identities = 58/240 (24%), Positives = 89/240 (37%), Gaps = 86/240 (35%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIKKI-------HDIFEHISDAARILREIKLLRLLRHP 77
+IG G +G V + G KVA+K+ + F EI+ L RHP
Sbjct: 46 LIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEF---------ETEIETLSFCRHP 95
Query: 78 DIV-------EIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQL 130
+V E ++L +++ ME N +L + H LY
Sbjct: 96 HLVSLIGFCDERNEMIL------------IYKYME---------NGNL-KRH----LYGS 129
Query: 131 L-------------------RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171
R L Y+HT + HRD+K NIL + N KI DFG+++
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 172 FNDTPTTIFWTDYVATRW-----YRAPELCGSFFS--KYTPAIDIWSIGCIFAEVLTGKP 224
T +++T Y PE +F + T D++S G + EVL +
Sbjct: 190 TELDQT------HLSTVVKGTLGYIDPE----YFIKGRLTEKSDVYSFGVVLFEVLCARS 239
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 73.0 bits (178), Expect = 2e-13
Identities = 94/640 (14%), Positives = 180/640 (28%), Gaps = 190/640 (29%)
Query: 38 IDTHTGE-KVAIKKIHDIFE----------HISDAAR-ILREIKLLRLLRHPDIVEIKHI 85
+D TGE + K I +FE + D + IL + EI HI
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSK------------EEIDHI 54
Query: 86 MLPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQL--------LRALKY 136
++ +F + S ++++ +++ R +Y+F + + + Y
Sbjct: 55 IMSKDAVS--GTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMY 112
Query: 137 IHTANVYHRD-----------LKPKNILANANCKLK----ICDFG--------LARVAFN 173
I + + D L+P L A +L+ + G +A
Sbjct: 113 IEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCL 172
Query: 174 DTPTT------IFWTDYVATRWYRAPE--------LCGSFFSKYTPAIDIWSIGCIFAEV 219
IFW + + +PE L +T D S +
Sbjct: 173 SYKVQCKMDFKIFW---LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS 229
Query: 220 LTGKP--LFPGKNVVHQLDLMTDLLGTPSLDTI---SRV----RNDKARRYLTSMRKKQP 270
+ + L K + L ++ ++ + + ++ R + +L++
Sbjct: 230 IQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHI 289
Query: 271 VQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA-DPYFKGLSKVEREPSCQPISKM 329
LL + L P+D P E L +P + I++
Sbjct: 290 SLDHHSMTLTPDEVKSLLLKYLDCRPQDLP--REVLTTNPRRLSI-----------IAES 336
Query: 330 EFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGTERT--NFLYPSAVDQFRKQFAHL 387
IR+ + + + D + + N L P ++RK F L
Sbjct: 337 -------------IRDGLAT--WDNWKHVNCDKLTTIIESSLNVLEP---AEYRKMFDRL 378
Query: 388 EENVGKSGPVIPPERKHVSLPRSTIV----HSNTVPPKEQQNLSRDRQAAEEVFNKNSKE 443
+ P +P + N E K KE
Sbjct: 379 ---------SVFPP--SAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVE----KQPKE 423
Query: 444 SE-GIP-------------ANLSRTLPAQQRFPLAKPGKVVGPVV--------------- 474
S IP L R++ P + P
Sbjct: 424 STISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKN 483
Query: 475 --PYENASVRRDAY-DPRTF----IRSTVLPQAIPAAYC--------YRKSSTGKQEMDS 519
E ++ R + D R F IR + Y+ +
Sbjct: 484 IEHPERMTLFRMVFLDFR-FLEQKIRHDSTAWNASGSILNTLQQLKFYKPYIC-DNDPKY 541
Query: 520 EREMPSQVKHVPQCG---MAAKFATDI---AINMDSNPFF 553
ER + + + +P+ + +K+ TD+ A+ + F
Sbjct: 542 ERLVNAILDFLPKIEENLICSKY-TDLLRIALMAEDEAIF 580
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 25/180 (13%), Positives = 60/180 (33%), Gaps = 42/180 (23%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTG--------EKVAIKKIHDIFEHISDAARILREIKL 70
++K++ + + G++ A T T +K ++K + R+ E
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-----LDAKD--GRLFNEQNF 95
Query: 71 L-RLLRHPDIVEIKHIMLPPS----------RRDFKDIYVVFELMESDLHQVIKANDDLT 119
R + + + K + P K ++V + L + +
Sbjct: 96 FQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHV 155
Query: 120 REHYQFFL-------YQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLAR 169
+LL AL+++H H ++ +NI + + ++ + +G A
Sbjct: 156 -----LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQS-QVTLAGYGFAF 209
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 42/140 (30%), Positives = 65/140 (46%), Gaps = 18/140 (12%)
Query: 104 MESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 163
+E + D LT EH + +Q+ + ++++ + HRDL +NIL + +KIC
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 235
Query: 164 DFGLARVAFNDTPTTIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIF 216
DFGLAR + D DYV +W APE F YT D+WS G +
Sbjct: 236 DFGLARDIYKD-------PDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLL 285
Query: 217 AEVLT-GKPLFPGKNVVHQL 235
E+ + G +PG + +
Sbjct: 286 WEIFSLGASPYPGVKIDEEF 305
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 55/234 (23%), Positives = 90/234 (38%), Gaps = 73/234 (31%)
Query: 25 VIGKGSYGVV-CSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRHPDIV- 80
+G+G +GVV ++ VA+KK+ + + ++ + +EIK++ +H ++V
Sbjct: 38 KMGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 81 ------EIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLL--- 131
+ + L V+ M N L L L
Sbjct: 95 LLGFSSDGDDLCL------------VYVYMP---------NGSL-----LDRLSCLDGTP 128
Query: 132 ---------------RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176
+ ++H + HRD+K NIL + KI DFGLAR +
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 177 TTIFWTDYVATRW-----YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 224
T + +R Y APE L G + TP DI+S G + E++TG P
Sbjct: 189 T------VMTSRIVGTTAYMAPEALRG----EITPKSDIYSFGVVLLEIITGLP 232
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 46/223 (20%), Positives = 88/223 (39%), Gaps = 51/223 (22%)
Query: 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV---- 80
++G+G +G V G VA+K++ + + E++++ + H +++
Sbjct: 37 ILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRG 94
Query: 81 ---EIKHIMLPPSRRDFKDIYVVFELM-----ESDLHQVIKANDDL---TREHYQFFLYQ 129
+L V+ M S L + ++ L R +
Sbjct: 95 FCMTPTERLL------------VYPYMANGSVASCLRERPESQPPLDWPKR-------QR 135
Query: 130 LL----RALKYIH---TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 182
+ R L Y+H + HRD+K NIL + + + DFGLA++ + T + T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVT-T 193
Query: 183 DYVATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 223
T + APE G K + D++ G + E++TG+
Sbjct: 194 AVRGTIGHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQ 232
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 614 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.25 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.11 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.04 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.75 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.5 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.41 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.2 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.17 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.05 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.96 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.77 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.49 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.41 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.2 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.05 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.99 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.96 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.94 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.75 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.71 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.7 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.63 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.41 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.4 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.15 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.13 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.28 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-67 Score=564.46 Aligned_cols=340 Identities=49% Similarity=0.878 Sum_probs=299.4
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCC-CCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPP-SRR 92 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~-~~~ 92 (614)
+...++|++++.||+|+||+||+|+++.+|+.||||++++.........++++|+.+|+.|+|||||++++++... .+.
T Consensus 50 ~~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 50 FDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp CCCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred CCCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence 4556799999999999999999999999999999999987766777788899999999999999999999998654 345
Q ss_pred CCCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 93 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 93 ~~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
+.+.+|||||||+|+|.++|..++.+++.+++.|++||+.||.|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus 130 ~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 130 EFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp TCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred cCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 66789999999999999999999999999999999999999999999999999999999999999999999999998654
Q ss_pred CCC-CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 173 NDT-PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 173 ~~~-~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
... ......++++||++|||||++.+. ..|+.++||||||||+|||++|++||.+.+..+++..|....|.|+...+.
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred cCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 322 122334678999999999998763 467999999999999999999999999999999999999999999999988
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCCCCCccchh
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEF 331 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~~~~~~~~~ 331 (614)
.........++..+....+.++...+++++++++|||.+||++||.+|||++|+|+||||+.+.....++.+.+ .+++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~~~~--~~~~ 366 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAP--PFDF 366 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCCCSS--CCCC
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccCCCC--CCCC
Confidence 88888888888888888888888889999999999999999999999999999999999999888777776554 3456
Q ss_pred HHHhhcCCHHHHHHHHHHHHHHhCc
Q 007177 332 EFERRRVTKEDIRELIFREILEYHP 356 (614)
Q Consensus 332 ~~e~~~~~~e~~~~~~~~ei~~~~~ 356 (614)
.++...++.+++++.+++|+.++|.
T Consensus 367 ~~~~~~~~~~~~k~~i~~ei~~~~~ 391 (398)
T 4b99_A 367 AFDREALTRERIKEAIVAEIEDFHA 391 (398)
T ss_dssp HHHHSCCCHHHHHHHHHHHHHHHHH
T ss_pred ccchhhcCHHHHHHHHHHHHHHHHH
Confidence 7778889999999999999998875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-60 Score=501.30 Aligned_cols=257 Identities=28% Similarity=0.495 Sum_probs=222.8
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
.+|++++.||+|+||+||+|+++.+|+.||||+++.... .....+.+|+.+|+.|+|||||++++++ .+.+.+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~ 146 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDEL 146 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence 569999999999999999999999999999999974322 2345678999999999999999999999 455779
Q ss_pred EEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 98 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
|||||||+ |+|.+++.. +.+++++++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.......
T Consensus 147 ~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp EEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 99999999 599998876 4699999999999999999999999999999999999999999999999999987643322
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhch
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~ 256 (614)
..+..+||++|||||++.+ ..|+.++||||||||+|||++|++||.+.+..+.+..|....
T Consensus 226 ---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-------------- 286 (346)
T 4fih_A 226 ---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-------------- 286 (346)
T ss_dssp ---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS--------------
T ss_pred ---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC--------------
Confidence 2356799999999999987 689999999999999999999999999988777766553211
Q ss_pred hHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 257 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
.+....+..+|+++++||.+||+.||++|||++|+|+||||+...
T Consensus 287 --------------~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 287 --------------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp --------------CCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred --------------CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 111123456899999999999999999999999999999998643
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-60 Score=494.77 Aligned_cols=259 Identities=27% Similarity=0.464 Sum_probs=225.2
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+++|+.|+|||||++++++ ++.+
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~ 105 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDE 105 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence 457999999999999999999999999999999997432 1223356789999999999999999999999 5667
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
.+|||||||+ |+|.++|+..+.+++.+++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 106 ~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 8999999999 599999999889999999999999999999999999999999999999999999999999999876433
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
.. .....+.+||+.|||||++.+ ..|+.++||||||||||+|++|++||.+.+..+.+..|...
T Consensus 186 ~~-~~~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~------------- 249 (311)
T 4aw0_A 186 SK-QARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL------------- 249 (311)
T ss_dssp TT-CCCBCCCCSCGGGCCHHHHHH--SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-------------
T ss_pred CC-cccccCcccCcccCCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------------
Confidence 22 223456799999999999987 68999999999999999999999999998877666665321
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHH------HHcCcccccC
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE------ALADPYFKGL 314 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~e------iL~hp~f~~~ 314 (614)
... ....+++++++||.+||+.||++|||++| +++||||+++
T Consensus 250 ---------------~~~---~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 250 ---------------EYD---FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp ---------------CCC---CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred ---------------CCC---CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 111 12357899999999999999999999987 5899999876
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-60 Score=501.40 Aligned_cols=259 Identities=25% Similarity=0.447 Sum_probs=221.1
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
...++|++++.||+|+||+||+|+++.+|+.||||++............+.+|+.+|+.|+|||||++++++ .+.
T Consensus 21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-----~~~ 95 (350)
T 4b9d_A 21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-----EEN 95 (350)
T ss_dssp SCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EET
T ss_pred CcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-----EEC
Confidence 345799999999999999999999999999999999987656666778899999999999999999999999 456
Q ss_pred CcEEEEEecCC-CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 95 KDIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
+.+|||||||+ |+|.++|...+ .+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+..
T Consensus 96 ~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 175 (350)
T 4b9d_A 96 GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175 (350)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceee
Confidence 78999999998 59999997643 5799999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
... ....+..+||++|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..|...
T Consensus 176 ~~~---~~~~~~~~GT~~YmAPE~l~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~---------- 240 (350)
T 4b9d_A 176 NST---VELARACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG---------- 240 (350)
T ss_dssp CHH---HHHHHHHHSCCTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT----------
T ss_pred cCC---cccccccCCCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC----------
Confidence 321 112345789999999999987 68999999999999999999999999999877776655321
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
.+...+..+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus 241 --------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 241 --------------------SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp --------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred --------------------CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 011234568999999999999999999999999999999974
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-59 Score=482.90 Aligned_cols=255 Identities=31% Similarity=0.536 Sum_probs=207.3
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
.++|++++.||+|+||+||+|.++.+|+.||||++++.... .....++.+|+.+|+.|+|||||++++++ .+.+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECC
Confidence 46899999999999999999999999999999999754322 23356788999999999999999999999 5567
Q ss_pred cEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 96 DIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 96 ~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
.+|||||||+|+|.+.+..++.+++.+++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 87 ~~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 87 EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999998654322
Q ss_pred CCccccccccCCccccCcccccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y-~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
...+.+||+.|||||++.+ ..| +.++|||||||++|+|++|++||.+.+....+..|...
T Consensus 167 ----~~~~~~GT~~Y~APE~~~~--~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~------------- 227 (275)
T 3hyh_A 167 ----FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG------------- 227 (275)
T ss_dssp ------------CTTSCHHHHSS--SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-------------
T ss_pred ----ccCCeeECcccCChhhhcC--CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC-------------
Confidence 2345789999999999987 454 68999999999999999999999988765555444220
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
.. .....+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus 228 ---------------~~---~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 228 ---------------VY---TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp ---------------CC---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred ---------------CC---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 11 112457899999999999999999999999999999973
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-58 Score=502.26 Aligned_cols=350 Identities=37% Similarity=0.691 Sum_probs=300.8
Q ss_pred ccccccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEec
Q 007177 8 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIML 87 (614)
Q Consensus 8 ~~~~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~ 87 (614)
-+.+..+...++|++++.||+|+||.||+|.++.+++.||||++...........++.+|+.+|+.++||||+++++++.
T Consensus 16 ~Q~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 16 FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp TTCGGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred hcCCCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 44567778889999999999999999999999999999999999887777788889999999999999999999999997
Q ss_pred CCCCCCCCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCc
Q 007177 88 PPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 167 (614)
Q Consensus 88 ~~~~~~~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGl 167 (614)
.........+|+|||||+++|.+++.....+++.+++.|++||+.||+|||+.||+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp CSCTTTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred cCCCCcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 76655667899999999999999999988899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCC-------------------ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-------
Q 007177 168 ARVAFNDTPT-------------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT------- 221 (614)
Q Consensus 168 a~~~~~~~~~-------------------~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt------- 221 (614)
++........ ....+.++||++|+|||++... ..|+.++||||||||+|||++
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhccccccc
Confidence 9875433221 0234678999999999986442 579999999999999999997
Q ss_pred ----CCCCCCCCC-----------------hhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCC
Q 007177 222 ----GKPLFPGKN-----------------VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNA 280 (614)
Q Consensus 222 ----G~~pF~g~~-----------------~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 280 (614)
|.++|++.+ ..+++..|.+.+|.|..+.+..+.......++..+....+..+...++.+
T Consensus 255 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (432)
T 3n9x_A 255 DPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSI 334 (432)
T ss_dssp SGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTS
T ss_pred ccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCC
Confidence 677787765 47899999999999999999999999999999988888888888889999
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCCCCCccchhHHHhhcCCHHHHHHHHHHHHHHhCchhh
Q 007177 281 DPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLL 359 (614)
Q Consensus 281 s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~~~e~~~~~~~~ei~~~~~~~~ 359 (614)
++.+.+||.+||++||++|||++|+|+||||+++.....++.+.......|+ +...++.+++++.+++|+..++|+..
T Consensus 335 s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~~~~~ 412 (432)
T 3n9x_A 335 SDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPELV 412 (432)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSC-TTCCCCHHHHHHHHHHHHHHHCTTCC
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChh-hcccCCHHHHHHHHHHHHHHhCcccc
Confidence 9999999999999999999999999999999998876666544322222222 22568899999999999999999754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-58 Score=508.07 Aligned_cols=347 Identities=40% Similarity=0.738 Sum_probs=288.3
Q ss_pred ccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 12 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 12 ~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
..+...++|++++.||+|+||+||+|.++.+++.||||++...........++.+|+.+|+.|+||||+++++++.....
T Consensus 47 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 47 SDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp SSCCSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred CcCccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence 34566789999999999999999999999999999999998777777788899999999999999999999999977766
Q ss_pred CCCCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 92 RDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 92 ~~~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
++...+|+|||||+++|.+++.....+++.+++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 127 ~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 127 EKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp TTCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred ccCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 67788999999999999999999889999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCC------------------------ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh------
Q 007177 172 FNDTPT------------------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT------ 221 (614)
Q Consensus 172 ~~~~~~------------------------~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt------ 221 (614)
...... ....+.++||++|+|||++... ..|+.++||||||||||||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 432211 1234667899999999986432 579999999999999999998
Q ss_pred -----CCCCCCCCC--------------------hhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCC
Q 007177 222 -----GKPLFPGKN--------------------VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQK 276 (614)
Q Consensus 222 -----G~~pF~g~~--------------------~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~ 276 (614)
|.++|+|.+ ..+++..|.+.+|.|..+.+..+.......++..+.......+...
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 889998876 3789999999999999999999999999999998888888888999
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCCCCCccchhHHHhhcCCHHHHHHHHHHHHHHhCc
Q 007177 277 FPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 356 (614)
Q Consensus 277 ~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~~~e~~~~~~~~ei~~~~~ 356 (614)
++.+++++.+||.+||.+||++|||++|+|+||||+++.....++.........|+ +...++.+++++.+++|+..|++
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~~ 444 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYHP 444 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSC-TTSCCCHHHHHHHHHHHHTTTCT
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCcc-ccccCCHHHHHHHHHHHHHHhCc
Confidence 99999999999999999999999999999999999998776655544322222222 23467899999999999999998
Q ss_pred hhhh
Q 007177 357 QLLK 360 (614)
Q Consensus 357 ~~~~ 360 (614)
....
T Consensus 445 ~~~~ 448 (458)
T 3rp9_A 445 EIQL 448 (458)
T ss_dssp TCCC
T ss_pred cccC
Confidence 7543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-59 Score=503.00 Aligned_cols=258 Identities=28% Similarity=0.488 Sum_probs=223.7
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|++++.||+|+||.||+|+++.+|+.||||++.... ......+.+|+.+|+.|+|||||++++++ .+.+.
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~ 222 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDE 222 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EECCE
Confidence 357999999999999999999999999999999997532 23345688999999999999999999999 45567
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|||||||+ |+|.++++.. .+++.+++.|++||+.||.|||++|||||||||+||||+.+|.+||+|||+|+......
T Consensus 223 ~~iVmEy~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp EEEEEECCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred EEEEEeCCCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 999999999 5999998764 69999999999999999999999999999999999999999999999999998764332
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
. ..+..+||++|||||++.+ ..|+.++||||||||+|||++|++||.+.+..+.+..|....
T Consensus 302 ~---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~------------- 363 (423)
T 4fie_A 302 P---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL------------- 363 (423)
T ss_dssp C---CBCCCEECTTTCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-------------
T ss_pred c---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-------------
Confidence 2 2356799999999999987 689999999999999999999999999988777766553210
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
.+....+..+|+++++||.+||+.||++|||++|+|+||||+...
T Consensus 364 ---------------~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 364 ---------------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp ---------------CCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ---------------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 111233567899999999999999999999999999999998643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=478.17 Aligned_cols=261 Identities=26% Similarity=0.375 Sum_probs=219.4
Q ss_pred CCCCe-EEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 16 DASRY-KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 16 ~~~rY-~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
..+|| ++.+.||+|+||+||+|.++.++..||||++...........++.+|+.+|+.|+|||||++++++.... ...
T Consensus 23 ~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~ 101 (290)
T 3fpq_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGK 101 (290)
T ss_dssp TTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTE
T ss_pred CCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCC
Confidence 34566 7888999999999999999999999999999866566667788999999999999999999999985322 234
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeecCCCCcEEECC-CCcEEEeecCcccc
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANA-NCKLKICDFGLARV 170 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILi~~-~~~vKL~DFGla~~ 170 (614)
..+|||||||+ |+|.+++...+.+++..++.|+.||+.||.|||++| |+||||||+|||++. ++.+||+|||+|+.
T Consensus 102 ~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred cEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 56899999999 699999999889999999999999999999999999 999999999999985 78999999999985
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
.... .....+||+.|||||++.+ .|+.++|||||||+||||++|++||.+.+...++......
T Consensus 182 ~~~~-----~~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~--------- 244 (290)
T 3fpq_A 182 KRAS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS--------- 244 (290)
T ss_dssp CCTT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT---------
T ss_pred CCCC-----ccCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc---------
Confidence 4322 2346799999999999864 6999999999999999999999999876654443322110
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
...+ .......++++++||.+||+.||++|||++|+|+||||++
T Consensus 245 ----------------~~~~---~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 245 ----------------GVKP---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ----------------TCCC---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ----------------CCCC---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 0011 1112346789999999999999999999999999999974
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-59 Score=486.88 Aligned_cols=259 Identities=27% Similarity=0.446 Sum_probs=216.5
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEEC---CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~---~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
.+.++|++++.||+|+||+||+|++. .+++.||||++++......+..++.+|+.+|+.|+|||||++++++
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~----- 95 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF----- 95 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-----
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----
Confidence 34578999999999999999999884 4678999999975433333344678899999999999999999999
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
.+.+.+|||||||+ |+|.++|...+.+++.+++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 96 ~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 96 QTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 45678999999999 69999999988999999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
...... .....+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|...
T Consensus 176 ~~~~~~---~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--------- 241 (304)
T 3ubd_A 176 SIDHEK---KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA--------- 241 (304)
T ss_dssp -----C---CCCSCCCCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------
T ss_pred ccCCCc---cccccccCcccCCHHHhcc--CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC---------
Confidence 433222 2345789999999999987 68999999999999999999999999998877766665321
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccC
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 314 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~eiL~hp~f~~~ 314 (614)
.. .....+|+++++||.+||+.||++||| ++|+|+||||+++
T Consensus 242 -------------------~~---~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 242 -------------------KL---GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp -------------------CC---CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred -------------------CC---CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 01 112457899999999999999999998 5899999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=478.29 Aligned_cols=334 Identities=40% Similarity=0.756 Sum_probs=285.1
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RR 92 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~-~~ 92 (614)
+...++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++.... ..
T Consensus 21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 45668999999999999999999999999999999999876666677788999999999999999999999996652 23
Q ss_pred CCCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 93 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 93 ~~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
+...+|+|||||+++|.+++.. ..+++.+++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 101 DFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp TCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cCceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 4567899999998899999977 569999999999999999999999999999999999999999999999999998753
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.. .+.+++|++|+|||++.+. ..|+.++||||||||+|+|++|++||.+.+..+++..|...+|.|..+.+..
T Consensus 180 ~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 180 SE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp SS------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cc------cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 22 2456899999999998753 5799999999999999999999999999999999999999999999999999
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCCCCCccchhH
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFE 332 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~ 332 (614)
+.......++..+.......+...++.+++.+.+||.+||.+||.+|||++|+|+||||+.+...+.++...+ +++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~---~~~~ 329 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQK---YDDS 329 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCCC---CCCC
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCCC---CCCC
Confidence 9999999999988888888888889999999999999999999999999999999999999988777766553 4556
Q ss_pred HHhhcCCHHHHHHHHHHHHHHhCchh
Q 007177 333 FERRRVTKEDIRELIFREILEYHPQL 358 (614)
Q Consensus 333 ~e~~~~~~e~~~~~~~~ei~~~~~~~ 358 (614)
++....+.+++++.+++|++.++++.
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (367)
T 1cm8_A 330 FDDVDRTLDEWKRVTYKEVLSFKPPR 355 (367)
T ss_dssp -----CCHHHHHHHHHHHHHTCCC--
T ss_pred hhhhcCCHHHHHHHHHHHHHHhcccc
Confidence 67778889999999999999998863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-58 Score=481.04 Aligned_cols=258 Identities=25% Similarity=0.346 Sum_probs=217.8
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.+.|++.+.||+|+||+||+|+++.+|+.||||+++.... ..+|+.+|+.|+|||||++++++ .+...
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~-----~~~~~ 124 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAV-----REGPW 124 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEE-----EETTE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence 4579999999999999999999999999999999975321 24799999999999999999998 45577
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC-cEEEeecCccccccCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAFND 174 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~-~vKL~DFGla~~~~~~ 174 (614)
+|||||||+ |+|.++|+..+.+++.+++.|+.||+.||.|||++|||||||||+||||+.+| ++||+|||+|+....+
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999 59999999988999999999999999999999999999999999999999987 6999999999876543
Q ss_pred CCCc--cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 175 TPTT--IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 175 ~~~~--~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.... ......+||+.|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..|..
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~------------ 270 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS------------ 270 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH------------
T ss_pred CcccceecCCccccCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc------------
Confidence 2211 11234689999999999987 6899999999999999999999999988776554444422
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHH-------------HcCcccccCCc
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA-------------LADPYFKGLSK 316 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~ei-------------L~hp~f~~~~~ 316 (614)
.+.++...++.+++.+.+||.+||+.||.+|||+.|+ |+|||+..+.+
T Consensus 271 ----------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 271 ----------------EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp ----------------SCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred ----------------CCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 1223334567899999999999999999999999997 57999987643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=480.69 Aligned_cols=339 Identities=39% Similarity=0.744 Sum_probs=273.6
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~ 95 (614)
.++|++++.||+|+||.||+|.++.+|+.||||++...........++.+|+.+|+.+. ||||+++++++... +..
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~ 84 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDR 84 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCC
Confidence 36899999999999999999999999999999999877777788889999999999997 99999999998542 345
Q ss_pred cEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 96 DIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 96 ~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
.+|+|||||+++|.+++... .+++.+++.+++||+.||+|||+.||+||||||+|||++.++.+||+|||+|+......
T Consensus 85 ~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 85 DVYLVFDYMETDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp CEEEEEECCSEEHHHHHHHT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEEEEecccCcCHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 79999999999999999874 69999999999999999999999999999999999999999999999999998653211
Q ss_pred ------------------CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHH
Q 007177 176 ------------------PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 237 (614)
Q Consensus 176 ------------------~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~ 237 (614)
......+.++||++|+|||++.+. ..|+.++||||||||+|||++|++||++.+..+++..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 112234567999999999998753 5789999999999999999999999999999999999
Q ss_pred HHhhhCCCchhhhhhhhchhHHHHHHhhcccC---CCcccCCC-------------CCCCHHHHHHHHHhcCCCCCCCCC
Q 007177 238 MTDLLGTPSLDTISRVRNDKARRYLTSMRKKQ---PVQFSQKF-------------PNADPSALRLLERLLAFDPKDRPT 301 (614)
Q Consensus 238 i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~---~~~~~~~~-------------~~~s~~l~dLI~~mL~~DP~~Rps 301 (614)
|...++.|..+.+..+.......++..+.... ...+...+ ..+++.+.+||.+||++||.+|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 99999999999988877777666666554433 22222222 278899999999999999999999
Q ss_pred HHHHHcCcccccCCcccCCCCCCCCccchhHHHhhcCCHHHHHHHHHHHHHHhCchhhhh
Q 007177 302 AEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKD 361 (614)
Q Consensus 302 a~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~~~e~~~~~~~~ei~~~~~~~~~~ 361 (614)
++|+|+||||+.+.....++.+.......+. +....+.+++++.+++++.+++++...+
T Consensus 323 ~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (388)
T 3oz6_A 323 ANDALKHPFVSIFHNPNEEPNCDHIITIPIN-DNVKHSIDDYRNLVYSEISRRKRELISN 381 (388)
T ss_dssp HHHHTTSTTTTTTCCGGGCCCCSSCCCCC-------CCHHHHHHHHHHHHHHHHHHHTCC
T ss_pred HHHHhCCHHHHHhcCCccCCCCCCCCCCCcc-ccccCCHHHHHHHHHHHHHHhhhhhhhh
Confidence 9999999999999887777776554333332 2346788999999999999988876543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-57 Score=480.18 Aligned_cols=285 Identities=27% Similarity=0.451 Sum_probs=224.9
Q ss_pred CCCeEEEeEeeecCceEEEEEEEC---CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~---~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~ 92 (614)
.++|++++.||+|+||+||+|.++ .+++.||||++... ....++.+|+++|+.+ +||||+++++++ +
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~-----~ 90 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCF-----R 90 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEE-----E
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEE-----E
Confidence 468999999999999999999875 46789999998653 2345678999999998 699999999999 4
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC-CcEEEeecCcccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARV 170 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~-~~vKL~DFGla~~ 170 (614)
+.+.+|||||||+ ++|.++++ .+++.+++.|++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 5678999999998 69999984 59999999999999999999999999999999999999877 7999999999976
Q ss_pred ccCCCCC-------------------------ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCC
Q 007177 171 AFNDTPT-------------------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 225 (614)
Q Consensus 171 ~~~~~~~-------------------------~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~p 225 (614)
....... ....+..+||++|+|||++.+. ..|+.++||||+|||+|||++|++|
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCCC
Confidence 4332110 1123456899999999998762 4689999999999999999999988
Q ss_pred C-CCCChhHHHHHHHhhhCCCchhhhhhhhc-----------hhHHHHHHhhccc------------CCCcccCCCCCCC
Q 007177 226 F-PGKNVVHQLDLMTDLLGTPSLDTISRVRN-----------DKARRYLTSMRKK------------QPVQFSQKFPNAD 281 (614)
Q Consensus 226 F-~g~~~~~~l~~i~~~~g~p~~~~i~~~~~-----------~~~~~~l~~~~~~------------~~~~~~~~~~~~s 281 (614)
| .+.++.+++..|...+|++.......... .........+... ........|..+|
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 7 66788999999999999765443322110 1111111111100 0111224567899
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 282 PSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 282 ~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
++++|||.+||++||++|+|++|+|+||||+++
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999999876
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-56 Score=476.87 Aligned_cols=334 Identities=41% Similarity=0.799 Sum_probs=281.8
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCC-CCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPP-SRR 92 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~-~~~ 92 (614)
+...++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++... ...
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 4456899999999999999999999999999999999987666677788899999999999999999999998654 223
Q ss_pred CCCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 93 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 93 ~~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
+...+|+|||+++++|.+++.. ..+++..++.+++||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 105 EFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp GCCCCEEEEECCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred cCCeEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 4567899999999999998876 569999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.. .+.++||++|+|||++.+. ..|+.++||||||||+|+|++|++||.+.+..+++..|...+|.|..+.+..
T Consensus 184 ~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 184 DE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp -------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred cc------CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 22 2456899999999998753 5789999999999999999999999999999999999999999999999999
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCCCCCccchhH
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFE 332 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~ 332 (614)
+.......++..+.......+...++..++.+.+||.+||++||.+|||++|+|+||||+.+.....++...+ +++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~---~~~~ 333 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP---YDQS 333 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCCC---CCGG
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCCC---CCcc
Confidence 9998899999888877777888888999999999999999999999999999999999999888777766554 4566
Q ss_pred HHhhcCCHHHHHHHHHHHHHHhCchh
Q 007177 333 FERRRVTKEDIRELIFREILEYHPQL 358 (614)
Q Consensus 333 ~e~~~~~~e~~~~~~~~ei~~~~~~~ 358 (614)
++......+++++++++|+..++|..
T Consensus 334 ~~~~~~~~~~~~~~~~~e~~~~~~~~ 359 (367)
T 2fst_X 334 LESRDLLIDEWKSLTYDEVISFVPPP 359 (367)
T ss_dssp GSSCCCCHHHHHHHHHHHHHHCCCCC
T ss_pred hhhccCCHHHHHHHHHHHHHHhccCc
Confidence 67778899999999999999998874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-55 Score=482.26 Aligned_cols=331 Identities=35% Similarity=0.667 Sum_probs=265.7
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~-~~~ 94 (614)
..++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++..... .+.
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3579999999999999999999999999999999998776677778889999999999999999999999966532 455
Q ss_pred CcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 95 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 95 ~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
..+|||||||+++|.+.+.. .+++.+++.|++||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 140 ~~~~lv~E~~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 140 QDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217 (464)
T ss_dssp CEEEEEEECCSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred CeEEEEEeCCCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence 78999999999999988854 4999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
. ..+.++||++|+|||++.+ ..|+.++||||||||+|||++|++||.+.+..+++..|...+|.|..+.+..+.
T Consensus 218 ~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 218 F----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp C----CC----CCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred c----ccCCCcccccccCHHHHcC--CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 2 2356789999999999987 689999999999999999999999999999999999999999999998887764
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCC------------CHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCC
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNA------------DPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPS 322 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~------------s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~ 322 (614)
.....++..........+...++.. ++++++||.+||.+||++|||++|+|+||||+.+........
T Consensus 292 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~~ 370 (464)
T 3ttj_A 292 -PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEA 370 (464)
T ss_dssp -HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHSC
T ss_pred -hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcccccC
Confidence 4455555544444444444444332 578999999999999999999999999999998765433221
Q ss_pred CCCCccchhHHHhhcCCHHHHHHHHHHHHHHhCc
Q 007177 323 CQPISKMEFEFERRRVTKEDIRELIFREILEYHP 356 (614)
Q Consensus 323 ~~~~~~~~~~~e~~~~~~e~~~~~~~~ei~~~~~ 356 (614)
. +....++.++....+.+++++.+++|+..++.
T Consensus 371 ~-~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~ 403 (464)
T 3ttj_A 371 P-PPQIYDKQLDEREHTIEEWKELIYKEVMNSEE 403 (464)
T ss_dssp C-C-----------CCCHHHHHHHHHHHHHC---
T ss_pred C-CCccCCcchhhccCCHHHHHHHHHHHHHHhhh
Confidence 1 11234556677788899999999999876544
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-54 Score=456.41 Aligned_cols=341 Identities=47% Similarity=0.830 Sum_probs=291.7
Q ss_pred cCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 13 EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 13 ~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
.+...++|++++.||+|+||.||+|.+..++..||||++... ........+.+|+.+|+.++||||+++++++......
T Consensus 22 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 100 (364)
T ss_dssp BCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred eccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence 356678999999999999999999999999999999999742 3455667889999999999999999999999776655
Q ss_pred CCCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 93 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 93 ~~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
....+|+||||++++|.++++.. .+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~~iv~e~~~~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 101 QMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp TCCCEEEEEECCSEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEcccCcCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 66789999999999999999764 59999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
............+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+...+|.|..+.+..
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 443333334567899999999987542 4689999999999999999999999999999999999999999999999988
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCCCCCccchhH
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFE 332 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~ 332 (614)
..+.....+...........+...++++++.+.+||.+||+.||.+|||++|+|+||||+.+.....++.... .+.+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~--~~~~~ 336 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFD 336 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSS--CCCCC
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCCCC--cCCcc
Confidence 8888888888877777777777888899999999999999999999999999999999998866554443322 23444
Q ss_pred HHhhcCCHHHHHHHHHHHHHHhCchh
Q 007177 333 FERRRVTKEDIRELIFREILEYHPQL 358 (614)
Q Consensus 333 ~e~~~~~~e~~~~~~~~ei~~~~~~~ 358 (614)
.+...+.++++++++++|...+++..
T Consensus 337 ~~~~~~~~~~~~~~~~~e~~~~~~~~ 362 (364)
T 3qyz_A 337 MELDDLPKEKLKELIFEETARFQPGY 362 (364)
T ss_dssp -----CCHHHHHHHHHHHTGGGCC--
T ss_pred cccccCCHHHHHHHHHHHHHHhhhhc
Confidence 56667889999999999998888753
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-56 Score=459.88 Aligned_cols=262 Identities=26% Similarity=0.445 Sum_probs=200.4
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-------
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR------- 91 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~------- 91 (614)
+|++++.||+|+||+||+|+++.+|+.||||+++.. .......++.+|+.+|+.|+|||||++++++.....
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC-SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 589999999999999999999999999999999743 234456788999999999999999999999864321
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhCCCC---CHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCc
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKANDDL---TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 167 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~~~l---se~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGl 167 (614)
.+...+|||||||+ |+|.+++.....+ .+..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 12345899999998 6999999876543 4566899999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCc---------cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 007177 168 ARVAFNDTPTT---------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLM 238 (614)
Q Consensus 168 a~~~~~~~~~~---------~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i 238 (614)
|+......... ...+..+||+.|||||++.+ ..|+.++||||||||||||++ ||.+.. +....+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~~ 237 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY---PFSTQM--ERVRTL 237 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcC--CCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHHH
Confidence 98764432211 12345689999999999987 689999999999999999996 675432 222222
Q ss_pred HhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 239 TDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 239 ~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
...... .+...++..++.+.+||++||+.||++|||++|+|+||||+++.
T Consensus 238 ~~~~~~---------------------------~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 238 TDVRNL---------------------------KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHTT---------------------------CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHhcC---------------------------CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 211110 11112233467889999999999999999999999999998763
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=481.39 Aligned_cols=260 Identities=26% Similarity=0.425 Sum_probs=227.1
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|++++.||+|+||+||+|.++.+|+.||||++.. ....+...+.+|+.+|+.|+|||||++++++ .+...
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~ 228 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNE 228 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--CSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEec--cchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCE
Confidence 3689999999999999999999999999999999975 3455667889999999999999999999999 56678
Q ss_pred EEEEEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC--CcEEEeecCcccccc
Q 007177 97 IYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN--CKLKICDFGLARVAF 172 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~--~~vKL~DFGla~~~~ 172 (614)
+|||||||+ |+|+++|.. .+.|++.+++.|++||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 999999998 599999864 4679999999999999999999999999999999999999854 899999999998764
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
... .....+||++|||||++.+ ..|+.++||||||||||||++|.+||.+.+..+.+..|......
T Consensus 309 ~~~----~~~~~~GT~~y~APEv~~~--~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~-------- 374 (573)
T 3uto_A 309 PKQ----SVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN-------- 374 (573)
T ss_dssp TTS----EEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--------
T ss_pred CCC----ceeeeEECccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCC--------
Confidence 322 2356789999999999987 68999999999999999999999999999887777666432111
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
.....++.+|+++++||.+||++||.+|||++|+|+||||+....
T Consensus 375 -------------------~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 375 -------------------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp -------------------CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred -------------------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 112345678999999999999999999999999999999987544
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-52 Score=443.54 Aligned_cols=330 Identities=41% Similarity=0.760 Sum_probs=281.3
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RD 93 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~-~~ 93 (614)
...++|.+.+.||+|+||.||+|.++.+|+.||||++............+.+|+.+|+.++||||+++++++..... ..
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 34579999999999999999999999999999999998766666677889999999999999999999999965432 22
Q ss_pred CCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 94 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 94 ~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
...+|+||||+.++|.+.+. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 119 ~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 119 FYDFYLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCCCEEEEECCCEEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred ceeEEEEEccccccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 33459999999999988874 3599999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
. ....+||++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....|.|..+.+..+
T Consensus 197 ~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 269 (371)
T 4exu_A 197 E------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 269 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred C------cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence 2 2446799999999998753 57899999999999999999999999999999999999999999999998888
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCC-CCCccchhH
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSC-QPISKMEFE 332 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~-~~~~~~~~~ 332 (614)
.......++..+.......+...++.+++.+.+||.+||+.||.+|||++|+|+||||+.+.....+... +++. ..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~---~~ 346 (371)
T 4exu_A 270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFD---DS 346 (371)
T ss_dssp SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCC---CT
T ss_pred hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccCcC---cc
Confidence 8777778887777766667777788899999999999999999999999999999999988665444332 2222 22
Q ss_pred HHhhcCCHHHHHHHHHHHHHHhCc
Q 007177 333 FERRRVTKEDIRELIFREILEYHP 356 (614)
Q Consensus 333 ~e~~~~~~e~~~~~~~~ei~~~~~ 356 (614)
.+....+.+++++.+++|+.+|+|
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~ 370 (371)
T 4exu_A 347 LEHEKLTVDEWKQHIYKEIVNFSP 370 (371)
T ss_dssp TSSCCCCHHHHHHHHHHHHHHCCC
T ss_pred hhhcccchHHHHHHHHHHHHhccc
Confidence 345667889999999999999876
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=440.68 Aligned_cols=266 Identities=23% Similarity=0.344 Sum_probs=217.8
Q ss_pred ccccccCCCCCCeEEEeEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCccee
Q 007177 8 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEI 82 (614)
Q Consensus 8 ~~~~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~-----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l 82 (614)
++-|......++|.+.+.||+|+||.||+|.+. .++..||||+++. ......+.+.+|+.+|++|+|||||++
T Consensus 3 ~d~~~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l 80 (299)
T 4asz_A 3 MDTFVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD--ASDNARKDFHREAELLTNLQHEHIVKF 80 (299)
T ss_dssp GGGSCCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS--CCHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred chhhhcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC--CChHHHHHHHHHHHHHHhCCCCCCccE
Confidence 344555555678999999999999999999865 3678899999975 344566789999999999999999999
Q ss_pred eeEecCCCCCCCCcEEEEEecCC-CcHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCC
Q 007177 83 KHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAN-------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLK 148 (614)
Q Consensus 83 ~~v~~~~~~~~~~~~ylV~E~~~-g~L~~~i~~~-------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLK 148 (614)
++++ .+.+.+|||||||+ |+|.++|... ..+++.++..|+.||+.||.|||+++|+|||||
T Consensus 81 ~g~~-----~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlK 155 (299)
T 4asz_A 81 YGVC-----VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLA 155 (299)
T ss_dssp EEEE-----CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEE-----eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccC
Confidence 9999 44567999999999 6999999764 369999999999999999999999999999999
Q ss_pred CCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCC
Q 007177 149 PKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFP 227 (614)
Q Consensus 149 P~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~ 227 (614)
|+|||++.++.+||+|||+|+........ ......+||+.|||||++.+ ..|+.++|||||||+||||+| |+.||.
T Consensus 156 p~NILl~~~~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~--~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~ 232 (299)
T 4asz_A 156 TRNCLVGENLLVKIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWY 232 (299)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCE-EETTTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred HhhEEECCCCcEEECCcccceecCCCCce-eecCceecChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999865433221 11233569999999999987 689999999999999999998 899999
Q ss_pred CCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 228 GKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 228 g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
+.+..+.+..+... ... .....+++++.+||.+||+.||++|||++++
T Consensus 233 ~~~~~~~~~~i~~~---------------------------~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i-- 280 (299)
T 4asz_A 233 QLSNNEVIECITQG---------------------------RVL---QRPRTCPQEVYELMLGCWQREPHMRKNIKGI-- 280 (299)
T ss_dssp TSCHHHHHHHHHHT---------------------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--
T ss_pred CCCHHHHHHHHHcC---------------------------CCC---CCCccchHHHHHHHHHHcCCChhHCcCHHHH--
Confidence 98876655544321 001 1224578999999999999999999999999
Q ss_pred CcccccCC
Q 007177 308 DPYFKGLS 315 (614)
Q Consensus 308 hp~f~~~~ 315 (614)
|+||+.+.
T Consensus 281 ~~~L~~~~ 288 (299)
T 4asz_A 281 HTLLQNLA 288 (299)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 45776553
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-53 Score=477.03 Aligned_cols=260 Identities=25% Similarity=0.365 Sum_probs=214.2
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc----CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF----EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~----~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
.++|+++++||+|+||.||+|+++.+|+.||||++++.. ..........+++.+++.++|||||+++++| +
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f-----~ 262 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H 262 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE-----E
Confidence 467999999999999999999999999999999996431 1112222233446677778999999999999 5
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
+...+|||||||. |+|.++|...+.|++..+++|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+..
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 6678999999999 599999999899999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
.... ....+||+.|||||++.+. ..|+.++||||||||||||++|.+||.+.+..+....+..
T Consensus 343 ~~~~-----~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~----------- 405 (689)
T 3v5w_A 343 SKKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----------- 405 (689)
T ss_dssp SSCC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH-----------
T ss_pred CCCC-----CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-----------
Confidence 4332 2456999999999998641 5799999999999999999999999987543222111100
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccCC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGLS 315 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~eiL~hp~f~~~~ 315 (614)
... ... ..+..+|+++++||.+||+.||.+|++ ++||++||||+++.
T Consensus 406 -------------i~~-~~~---~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id 457 (689)
T 3v5w_A 406 -------------TLT-MAV---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457 (689)
T ss_dssp -------------HHH-CCC---CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred -------------hcC-CCC---CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence 000 011 223568999999999999999999998 89999999999863
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=434.44 Aligned_cols=337 Identities=43% Similarity=0.800 Sum_probs=278.2
Q ss_pred cCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 13 EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 13 ~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
.+...++|++.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+|+.++||||+++++++......
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE 84 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence 345678999999999999999999999999999999999642 3445567788999999999999999999998766556
Q ss_pred CCCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 93 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 93 ~~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
+...+|+||||++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 85 NFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp TCCCEEEEECCCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEeccCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 6688999999999999999976 469999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCc-------cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCC
Q 007177 173 NDTPTT-------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 245 (614)
Q Consensus 173 ~~~~~~-------~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p 245 (614)
...... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+++..+....|.|
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 322111 112346899999999987542 578999999999999999999999999999999999999999988
Q ss_pred chhh-hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCCC
Q 007177 246 SLDT-ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQ 324 (614)
Q Consensus 246 ~~~~-i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~~ 324 (614)
.... ...........++..+.......+...++.+++.+.+||.+||..||.+|||++|+|+||||+.+.....++...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~ 322 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGE 322 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCCC
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccccC
Confidence 7443 333344445556555554444555566778999999999999999999999999999999999887766655555
Q ss_pred CCcc--chhHHHhhcCCHHHHHHHHHHHHH
Q 007177 325 PISK--MEFEFERRRVTKEDIRELIFREIL 352 (614)
Q Consensus 325 ~~~~--~~~~~e~~~~~~e~~~~~~~~ei~ 352 (614)
++.. +++......++.+++++++++|+.
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 2b9h_A 323 PIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352 (353)
T ss_dssp CCCGGGGGGGCCSSCCCHHHHHHHHHHHHT
T ss_pred CCCcceeeecchhhcCCHHHHHHHHHHHhh
Confidence 5543 444556667889999999999974
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=436.30 Aligned_cols=259 Identities=23% Similarity=0.290 Sum_probs=209.4
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
...+++++.+.||+|+||+||+|... ..||||+++.........+.+.+|+.+|+.|+|||||++++++. .
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~------~ 103 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT------K 103 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------S
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE------C
Confidence 34578999999999999999999653 36999999865556667788999999999999999999999873 2
Q ss_pred CcEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 95 KDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
+.+|||||||+ |+|.++|... ..+++.++..|+.||+.||.|||++|||||||||+|||+++++.+||+|||+|+...
T Consensus 104 ~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 104 DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 35799999999 6999999764 579999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~-~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
.... ....+..+||+.|||||++.+. ...|+.++|||||||+||||++|+.||.+.+....+..+...
T Consensus 184 ~~~~-~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~---------- 252 (307)
T 3omv_A 184 RWSG-SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGR---------- 252 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHT----------
T ss_pred cCCc-ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhc----------
Confidence 3222 1223456899999999998642 246999999999999999999999999887765554433211
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
......+...++++++.+.+||.+||+.||++|||+.|++++
T Consensus 253 ---------------~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 253 ---------------GYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp ---------------TCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred ---------------CCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 111112234456789999999999999999999999988654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=434.78 Aligned_cols=330 Identities=40% Similarity=0.755 Sum_probs=280.5
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~-~~~ 94 (614)
..++|.+.+.||+|+||.||+|.++.+|+.||||++............+.+|+.+|+.++||||+++++++..... ...
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 3578999999999999999999999999999999998766666667888999999999999999999999865421 123
Q ss_pred CcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 95 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 95 ~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
..+|+||||++++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 179 (353)
T 3coi_A 102 YDFYLVMPFMQTDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179 (353)
T ss_dssp CCCEEEEECCSEEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred eeEEEEeccccCCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence 45699999999999887743 5999999999999999999999999999999999999999999999999999764322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
....++|+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+++..+....|.|..+.+..+.
T Consensus 180 ------~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 180 ------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp ----------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred ------ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 2346799999999988753 578999999999999999999999999999999999999999999999888888
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCCCCCccchhHHH
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFE 334 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~e 334 (614)
......++..+.......+...++.+++.+.+||.+||..||.+|||++++|+||||+.+...+.+..... .+....+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~--~~~~~~~ 330 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ--PFDDSLE 330 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSS--CCCCTTT
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCC--CCccchh
Confidence 77777787777766666777778889999999999999999999999999999999998876554433221 2233445
Q ss_pred hhcCCHHHHHHHHHHHHHHhCc
Q 007177 335 RRRVTKEDIRELIFREILEYHP 356 (614)
Q Consensus 335 ~~~~~~e~~~~~~~~ei~~~~~ 356 (614)
....+.+++++.+++++.++++
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 3coi_A 331 HEKLTVDEWKQHIYKEIVNFSP 352 (353)
T ss_dssp TCCCCHHHHHHHHHHHHHTCCC
T ss_pred hccCCHHHHHHHHHHHHHhhcc
Confidence 6678899999999999988765
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=427.63 Aligned_cols=299 Identities=38% Similarity=0.632 Sum_probs=240.9
Q ss_pred CCccccccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeE
Q 007177 6 PEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 85 (614)
Q Consensus 6 ~~~~~~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v 85 (614)
+..+-....+..++|++++.||+|+||.||+|.+. +|+.||+|++............+.+|+.+|+.++||||++++++
T Consensus 9 ~~~~~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 87 (311)
T 3niz_A 9 SGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87 (311)
T ss_dssp ------CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccceeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 34455566788899999999999999999999985 58999999997654444455778899999999999999999999
Q ss_pred ecCCCCCCCCcEEEEEecCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEee
Q 007177 86 MLPPSRRDFKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 164 (614)
Q Consensus 86 ~~~~~~~~~~~~ylV~E~~~g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~D 164 (614)
+ .+...+|+|||||+++|.+.+.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|
T Consensus 88 ~-----~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~D 162 (311)
T 3niz_A 88 I-----HSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLAD 162 (311)
T ss_dssp E-----CCSSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred E-----ccCCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEcc
Confidence 8 4556799999999999999887654 599999999999999999999999999999999999999999999999
Q ss_pred cCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCC
Q 007177 165 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 244 (614)
Q Consensus 165 FGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~ 244 (614)
||+++....... .....++|+.|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+.+..+...++.
T Consensus 163 fg~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 238 (311)
T 3niz_A 163 FGLARAFGIPVR---SYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGT 238 (311)
T ss_dssp CTTCEETTSCCC------CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCC
T ss_pred CcCceecCCCcc---cccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCC
Confidence 999987543222 22446789999999998652 46899999999999999999999999999999999999999999
Q ss_pred CchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 245 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 245 p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
+....+.......... ...........+....+.+++++.+||.+||++||++|||++|+|+||||+++.
T Consensus 239 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 239 PNPREWPQVQELPLWK-QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp CCTTTSGGGTTSHHHH-SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred CChHHhhhhhccchhh-hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 9877765543321110 000111112223334567899999999999999999999999999999999764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=439.28 Aligned_cols=330 Identities=35% Similarity=0.661 Sum_probs=256.3
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~-~~~~ 94 (614)
..++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++.... ..+.
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 357999999999999999999999999999999999866566667788999999999999999999999986542 2345
Q ss_pred CcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 95 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 95 ~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
..+|+|||||+++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 103 QDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp CEEEEEEECCSEEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred cceEEEEEcCCCCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 5799999999999999986 35999999999999999999999999999999999999999999999999999865322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..+++..+...+|.|..+.+..+.
T Consensus 181 ~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 181 F----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp -------------CTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred c----ccCCceecCCccCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 1 2345689999999999987 679999999999999999999999999999999999999999999887776553
Q ss_pred chhHHHHHHhhcccCCCcccCCCCC------------CCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCC
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPN------------ADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPS 322 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~------------~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~ 322 (614)
. ....++..........+...++. .++.+++||.+||..||.+|||++|+|+||||+.+........
T Consensus 255 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~ 333 (371)
T 2xrw_A 255 P-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEA 333 (371)
T ss_dssp H-HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTC
T ss_pred h-HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCC
Confidence 2 22333332222222222221211 1567999999999999999999999999999987654321111
Q ss_pred CCCCccchhHHHhhcCCHHHHHHHHHHHHHHhC
Q 007177 323 CQPISKMEFEFERRRVTKEDIRELIFREILEYH 355 (614)
Q Consensus 323 ~~~~~~~~~~~e~~~~~~e~~~~~~~~ei~~~~ 355 (614)
..+ .......+.+..+.+++++++++++..+.
T Consensus 334 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (371)
T 2xrw_A 334 PPP-KIPDKQLDEREHTIEEWKELIYKEVMDLE 365 (371)
T ss_dssp CCC-CCCTTTTCCCCCCHHHHHHHHHHHHHHHC
T ss_pred CCC-CCCChhhccccCcHHHHHHHHHHHHHHHh
Confidence 111 11123345566788999999999997754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=433.79 Aligned_cols=252 Identities=22% Similarity=0.343 Sum_probs=204.8
Q ss_pred CCCeEEEeEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~-----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
..+|.+.+.||+|+||+||+|..+ .++..||||+++. ......+.+.+|+.+|+.|+|||||++++++
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~----- 112 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTMLQHQHIVRFFGVC----- 112 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC--CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence 357899999999999999999865 3688999999975 3455667899999999999999999999999
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEEC
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKAN---------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 155 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~---------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~ 155 (614)
.+...+|||||||+ |+|.+++... ..+++.++..|+.||+.||.|||+.+||||||||+|||++
T Consensus 113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 44567999999999 6999999753 3599999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHH
Q 007177 156 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQ 234 (614)
Q Consensus 156 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~ 234 (614)
.++.+||+|||+|+........ ...+..+||+.|||||++.+ ..|+.++|||||||+||||+| |+.||.+.+..+.
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~--~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~ 269 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269 (329)
T ss_dssp TTTEEEECCCC-----------------CCCCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH
T ss_pred CCCcEEEcccccceeccCCCcc-eecCcccccccccChhhhcC--CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999999865433221 12245679999999999987 689999999999999999998 8999999887666
Q ss_pred HHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 235 LDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 235 l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
+..+... ... .....+++++.+|+.+||+.||++|||++|++++
T Consensus 270 ~~~i~~g---------------------------~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 270 IDCITQG---------------------------REL---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHT---------------------------CCC---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHHcC---------------------------CCC---CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 5554321 011 1124578999999999999999999999999764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=429.07 Aligned_cols=255 Identities=21% Similarity=0.314 Sum_probs=210.7
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAID-----THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPP 89 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d-----~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~ 89 (614)
...+++++++.||+|+||+||+|.. ..+++.||||+++... .....+.+.+|+.+|++|+|||||++++++.
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-- 99 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVT-- 99 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE--
Confidence 3456799999999999999999985 3467899999997542 2234567899999999999999999999994
Q ss_pred CCCCCCcEEEEEecCC-CcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcE
Q 007177 90 SRRDFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNI 152 (614)
Q Consensus 90 ~~~~~~~~ylV~E~~~-g~L~~~i~~~----------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NI 152 (614)
+...+|||||||+ |+|.++|... ..+++..+..|+.||+.||.|||+++||||||||+||
T Consensus 100 ---~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NI 176 (308)
T 4gt4_A 100 ---KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNV 176 (308)
T ss_dssp ---SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ---ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccce
Confidence 4466899999999 6999999653 3589999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCh
Q 007177 153 LANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNV 231 (614)
Q Consensus 153 Li~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~ 231 (614)
||++++.+||+|||+|+........ ...+..+||+.|||||++.+ ..|+.++|||||||+||||+| |..||.+.+.
T Consensus 177 Ll~~~~~~Ki~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~--~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~ 253 (308)
T 4gt4_A 177 LVYDKLNVKISDLGLFREVYAADYY-KLLGNSLLPIRWMAPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 253 (308)
T ss_dssp EECGGGCEEECCSCCBCGGGGGGCB-CSSSSSCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH
T ss_pred EECCCCCEEECCcccceeccCCCce-eEecccccCCcccCHHHHhC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999875433221 12345689999999999987 689999999999999999998 8999999887
Q ss_pred hHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 232 VHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 232 ~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.+.+..+... ... ....++++.+.+|+.+||+.||.+|||+.||+++
T Consensus 254 ~~~~~~i~~~---------------------------~~~---~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 254 QDVVEMIRNR---------------------------QVL---PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHHHTT---------------------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcC---------------------------CCC---CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6665544221 111 1234678899999999999999999999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=416.91 Aligned_cols=287 Identities=36% Similarity=0.594 Sum_probs=237.8
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
++|++++.||+|+||.||+|.++.+++.||||++............+.+|+.+|+.++||||+++++++ .+...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEE-----EeCCEE
Confidence 589999999999999999999999999999999986555556667888999999999999999999998 455679
Q ss_pred EEEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 98 YVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 98 ylV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
|+|||||+++|.+.+.. .+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 99999999988887765 56899999999999999999999999999999999999999999999999999986543221
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCC-CCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~p-F~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|..| |.+.+..+++..+...++.|..+.+.....
T Consensus 157 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 157 ---CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ---cccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 22456899999999998762 4489999999999999999977655 888888999999999999998876654332
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
... +................+.+++.+++||.+||+.||++|||++|+|+||||+++.
T Consensus 233 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 233 LPD--YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp STT--CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred ccc--ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 100 0000000111222334567899999999999999999999999999999998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=422.23 Aligned_cols=263 Identities=27% Similarity=0.472 Sum_probs=227.0
Q ss_pred ccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 12 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 12 ~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
++....++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++
T Consensus 9 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~----- 83 (328)
T 3fe3_A 9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI----- 83 (328)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred ccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----
Confidence 344556789999999999999999999999999999999987666677788899999999999999999999998
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
.+.+.+|+|||||+ ++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 163 (328)
T 3fe3_A 84 ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNE 163 (328)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred EECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence 45577999999997 69999998888999999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y-~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
..... .....+||++|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 164 ~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-------- 229 (328)
T 3fe3_A 164 FTVGG----KLDAFCGAPPYAAPELFQG--KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-------- 229 (328)
T ss_dssp GSSSC----GGGTTSSSGGGCCHHHHHT--CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------
T ss_pred cCCCC----ccccccCCcceeCcccccC--CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------
Confidence 54322 2356789999999999987 454 57999999999999999999999998866555544220
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
... ....+++.+.+||.+||..||.+|||++|+|+||||+....
T Consensus 230 ------------------~~~-----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 230 ------------------KYR-----IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp ------------------CCC-----CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred ------------------CCC-----CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 000 11246889999999999999999999999999999987543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=416.22 Aligned_cols=284 Identities=38% Similarity=0.638 Sum_probs=233.4
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
++|++++.||+|+||.||+|.+ .+|+.||||++............+.+|+.+|+.++||||+++++++ .+...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEE-----ccCCeE
Confidence 5899999999999999999998 6799999999975433333346678999999999999999999998 345679
Q ss_pred EEEEecCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 98 YVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 98 ylV~E~~~g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
|+||||++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 999999999999999864 6799999999999999999999999999999999999999999999999999986542221
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhch
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~ 256 (614)
.....++|+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....+......
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ---ccccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 12445789999999998652 46899999999999999999999999999999999999999998876655433211
Q ss_pred hHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 257 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
..+........+..+......+++.+.+||.+||+.||++|||++|+|+||||++
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 232 --PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp --TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred --cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0111111222333444556678999999999999999999999999999999985
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=423.04 Aligned_cols=302 Identities=35% Similarity=0.541 Sum_probs=227.0
Q ss_pred CCCCCCccccccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcce
Q 007177 2 LQNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVE 81 (614)
Q Consensus 2 ~~~~~~~~~~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~ 81 (614)
|+++............++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+|+.++||||++
T Consensus 18 Gp~s~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 97 (329)
T 3gbz_A 18 GPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIE 97 (329)
T ss_dssp --------------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCC
T ss_pred CCCcceeccCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcce
Confidence 44555555556666778999999999999999999999999999999999765444444567789999999999999999
Q ss_pred eeeEecCCCCCCCCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEEC-----C
Q 007177 82 IKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN-----A 156 (614)
Q Consensus 82 l~~v~~~~~~~~~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~-----~ 156 (614)
+++++ .+...+|||||||+++|.+++.....+++..++.|+.||+.||.|||++||+||||||+|||++ .
T Consensus 98 ~~~~~-----~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~ 172 (329)
T 3gbz_A 98 LKSVI-----HHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASE 172 (329)
T ss_dssp EEEEE-----EETTEEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----
T ss_pred EEEEE-----ecCCEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCc
Confidence 99998 4556799999999999999999998999999999999999999999999999999999999994 4
Q ss_pred CCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHH
Q 007177 157 NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 236 (614)
Q Consensus 157 ~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~ 236 (614)
++.+||+|||+++....... .....++|+.|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+..+.+.
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 248 (329)
T 3gbz_A 173 TPVLKIGDFGLARAFGIPIR---QFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF 248 (329)
T ss_dssp CCEEEECCTTHHHHHC--------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred cceEEECcCCCccccCCccc---ccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHH
Confidence 55699999999987543221 12445789999999998762 458999999999999999999999999999999999
Q ss_pred HHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCC-CCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 237 LMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQK-FPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 237 ~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
.+...++.|....+........ +...........+... ...+++++.+||.+||+.||.+|||++|+|+||||++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 249 KIFEVLGLPDDTTWPGVTALPD--WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp HHHHHHCCCCTTTSTTGGGSTT--CCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred HHHHHhCCCchhhhhhhhhhhh--hhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 9999999887766543321100 0000000000000000 01267899999999999999999999999999999865
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=429.59 Aligned_cols=256 Identities=24% Similarity=0.402 Sum_probs=210.8
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCC-----cEEEEEEecCccCChHHHHHHHHHHHHHHhcCC-CCcceeeeEecCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTG-----EKVAIKKIHDIFEHISDAARILREIKLLRLLRH-PDIVEIKHIMLPP 89 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg-----~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~H-pnIv~l~~v~~~~ 89 (614)
..++|++++.||+|+||+||+|.+..++ +.||||+++.. ........+.+|+.+|+.++| ||||++++++..
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~- 139 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK- 139 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC-
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe-
Confidence 3468999999999999999999876543 57999999753 334556789999999999975 899999999843
Q ss_pred CCCCCCcEEEEEecCC-CcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcE
Q 007177 90 SRRDFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNI 152 (614)
Q Consensus 90 ~~~~~~~~ylV~E~~~-g~L~~~i~~~----------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NI 152 (614)
+...+|||||||+ |+|.++|+.. ..+++.++..|+.||+.||.|||+++||||||||+||
T Consensus 140 ---~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 140 ---PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ---TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ---cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 2356899999999 6999999753 3489999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCh
Q 007177 153 LANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNV 231 (614)
Q Consensus 153 Li~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~ 231 (614)
|++.++.+||+|||+|+....+... ......+||+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+.+.
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~--~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred eeCCCCCEEECcchhhhhcccCCCc-eeeccccccccccCHHHHhc--CCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999876543322 22345689999999999987 689999999999999999998 9999998765
Q ss_pred hHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 232 VHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 232 ~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.+.+..+.. ..... .....+++++.+||.+||+.||++|||+.|+++|
T Consensus 294 ~~~~~~~i~--------------------------~g~~~---~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 294 DEEFCRRLK--------------------------EGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp SHHHHHHHH--------------------------HTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHH--------------------------cCCCC---CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 443332211 00011 1123578999999999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=420.17 Aligned_cols=332 Identities=36% Similarity=0.662 Sum_probs=262.7
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC---------ChHHHHHHHHHHHHHHhcCCCCcceeeeE
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE---------HISDAARILREIKLLRLLRHPDIVEIKHI 85 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~---------~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v 85 (614)
...++|++++.||+|+||.||+|.+.. |..||||++..... .......+.+|+.+|+.++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 346799999999999999999999865 99999999864322 22345788999999999999999999999
Q ss_pred ecCCCCCCCCcEEEEEecCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEee
Q 007177 86 MLPPSRRDFKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 164 (614)
Q Consensus 86 ~~~~~~~~~~~~ylV~E~~~g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~D 164 (614)
+..........+|+|||||+++|.+.+.... .+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 8665545566899999999999999987654 699999999999999999999999999999999999999999999999
Q ss_pred cCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCC
Q 007177 165 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 244 (614)
Q Consensus 165 FGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~ 244 (614)
||+++....... ....++|++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.
T Consensus 178 fg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 178 FNLAREDTADAN----KTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp TTC-------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cCcccccccccc----cceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 999975433222 2446799999999988753 56899999999999999999999999999999999999999999
Q ss_pred CchhhhhhhhchhHHHHHHhhccc-CCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCC
Q 007177 245 PSLDTISRVRNDKARRYLTSMRKK-QPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSC 323 (614)
Q Consensus 245 p~~~~i~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~ 323 (614)
|..+.+..........++...... ....+....+..++.+.+||.+||+.||.+|||++|+|+||||+.+.........
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~ 332 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEG 332 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTT
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccccc
Confidence 998887766665555554332222 2223334456789999999999999999999999999999999987543322211
Q ss_pred CCCccchhHHHhhcCCHHHHHHHHHHHHHHhC
Q 007177 324 QPISKMEFEFERRRVTKEDIRELIFREILEYH 355 (614)
Q Consensus 324 ~~~~~~~~~~e~~~~~~e~~~~~~~~ei~~~~ 355 (614)
. ...+.++....+..++++.++.|+.+++
T Consensus 333 ~---~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 361 (362)
T 3pg1_A 333 L---SERFHFDESVTDVYDMHKIFTAEVERFN 361 (362)
T ss_dssp C---CCCCCCCTTCCCHHHHHHHHHHHHHHHC
T ss_pred c---ccccChhhhhhhHHHHHHHHHHHHHHhc
Confidence 1 1123444566678899999999988764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=416.22 Aligned_cols=289 Identities=34% Similarity=0.559 Sum_probs=234.1
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCC---hHHHHHHHHHHHHHHhc---CCCCcceeeeEecCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH---ISDAARILREIKLLRLL---RHPDIVEIKHIMLPP 89 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~---~~~~~~i~~Ei~iL~~L---~HpnIv~l~~v~~~~ 89 (614)
..++|++++.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+++.+ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357999999999999999999999999999999998643211 11123455677777666 499999999998655
Q ss_pred CCCCCCcEEEEEecCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCc
Q 007177 90 SRRDFKDIYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 167 (614)
Q Consensus 90 ~~~~~~~~ylV~E~~~g~L~~~i~~~~~--lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGl 167 (614)
.......+|+||||++++|.+++..... +++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp CSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred CCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 4333446899999999999999987654 99999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007177 168 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247 (614)
Q Consensus 168 a~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~ 247 (614)
++....... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.+..
T Consensus 167 a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 167 ARIYSYQMA----LTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp TTTSTTCCC----SGGGGCCCSSCCHHHHHT--SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred ccccCCCcc----cCCccccccccCchHHcC--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 986543222 245689999999999976 67999999999999999999999999999999999999999999887
Q ss_pred hhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 248 ~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
..+........ .......+..+....+.+++.+.+||.+||++||.+|||++|+|+||||++.
T Consensus 241 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 241 DDWPRDVSLPR----GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp TTSCSSCSSCG----GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hhccchhhccc----cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 76543221110 0111222333344567889999999999999999999999999999999853
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=412.06 Aligned_cols=292 Identities=35% Similarity=0.621 Sum_probs=231.6
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++ .+...
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVF-----RRKRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhhee-----ecCCe
Confidence 4689999999999999999999999999999999976555555567788999999999999999999998 44567
Q ss_pred EEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|+|||||++ +|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999995 777788778889999999999999999999999999999999999999999999999999998654322
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
. .....+||++|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++............
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 157 D---YYDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp ------------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred c---ccCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 1 22456799999999998652 5689999999999999999999999999999999999988888766544332211
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcc
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 317 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~ 317 (614)
.....................++++++.+.+||.+||+.||.+|||++|+|+||||+++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 11000000000001111222356789999999999999999999999999999999987654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=423.09 Aligned_cols=269 Identities=27% Similarity=0.436 Sum_probs=228.7
Q ss_pred ccccccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----HHHHHHHHHHHHHHhcCCCCcceee
Q 007177 8 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI----SDAARILREIKLLRLLRHPDIVEIK 83 (614)
Q Consensus 8 ~~~~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~----~~~~~i~~Ei~iL~~L~HpnIv~l~ 83 (614)
|+.+......++|++++.||+|+||.||+|.++.+|+.||||+++...... .....+.+|+.+|+.++||||++++
T Consensus 2 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~ 81 (361)
T 2yab_A 2 METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81 (361)
T ss_dssp --CCBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cccccCCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEE
Confidence 345566667788999999999999999999999999999999997543221 1346788999999999999999999
Q ss_pred eEecCCCCCCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC----
Q 007177 84 HIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC---- 158 (614)
Q Consensus 84 ~v~~~~~~~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~---- 158 (614)
+++ .+...+|+|||||. ++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++
T Consensus 82 ~~~-----~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~ 156 (361)
T 2yab_A 82 DVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIP 156 (361)
T ss_dssp EEE-----ECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSC
T ss_pred EEE-----EeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCcc
Confidence 998 45577999999997 69999998888999999999999999999999999999999999999998877
Q ss_pred cEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 007177 159 KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLM 238 (614)
Q Consensus 159 ~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i 238 (614)
.+||+|||+++...... .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..|
T Consensus 157 ~vkl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i 230 (361)
T 2yab_A 157 HIKLIDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230 (361)
T ss_dssp CEEECCCSSCEECCTTC----CCCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred CEEEEecCCceEcCCCC----ccccCCCCccEECchHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 79999999998754332 1245689999999999986 68999999999999999999999999998877666655
Q ss_pred HhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 239 TDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 239 ~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
....... ....|..+++.+++||.+||..||.+|||++|+|+||||+.+
T Consensus 231 ~~~~~~~---------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 231 TAVSYDF---------------------------DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp HTTCCCC---------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred HhcCCCC---------------------------CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 4321111 112346788999999999999999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=421.16 Aligned_cols=288 Identities=35% Similarity=0.626 Sum_probs=233.2
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
++|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+|+.++||||+++++++ .+...+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEE-----ECSSCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEE-----eeCCEE
Confidence 589999999999999999999999999999999974321 11222455899999999999999999998 455679
Q ss_pred EEEEecCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 98 YVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 98 ylV~E~~~g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
|+|||||+++|.+++...+ .+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 76 TLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred EEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 9999999999999987754 599999999999999999999999999999999999999999999999999976432221
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhch
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~ 256 (614)
.....+||++|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+..+++..+...++.|....+......
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 156 ---TYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp ----------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred ---ccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 22445789999999998652 56899999999999999999999999999999999999999999988877655433
Q ss_pred hHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 257 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
...... .............++.+++.+.+||.+||+.||.+|||++|+|+||||..+..
T Consensus 232 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 232 EEFKTY-NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHHHT-CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred hhhccc-ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 221111 11111222223345678999999999999999999999999999999998754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=418.85 Aligned_cols=288 Identities=34% Similarity=0.615 Sum_probs=221.9
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|++++.||+|+||.||+|.++.+|+.||||+++... .......+.+|+.+|+.++||||+++++++ .+.+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 77 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENK 77 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCe
Confidence 468999999999999999999999999999999997432 222345678999999999999999999998 45567
Q ss_pred EEEEEecCCCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 97 IYVVFELMESDLHQVIKAN------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 97 ~ylV~E~~~g~L~~~i~~~------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
+|+|||||+++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 78 LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 9999999999999998753 3599999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
...... .....++|+.|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+++..+.+..|.|....+
T Consensus 158 ~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 158 FGIPVN---TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp TTSCCC---CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred cCCCcc---cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence 543222 12445799999999998752 46899999999999999999999999999999999999999999877665
Q ss_pred hhhhchhHHHHHHhhcccCCCcc-----cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQF-----SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~-----~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
....... .+...+....+..+ ......+++.+.+||.+||+.||.+|||++|+|+||||+++..
T Consensus 234 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 234 PSVTKLP--KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp GGGGGCT--TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhhhhhh--hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 4432110 00000000000000 0112357889999999999999999999999999999998754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=425.75 Aligned_cols=287 Identities=36% Similarity=0.660 Sum_probs=234.0
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~-~~~~ 95 (614)
..+|++++.||+|+||.||+|.+..+++ ||+|++..... ...+|+.+|+.++||||+++++++..... .+..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 3579999999999999999999987766 88888754211 12379999999999999999999865432 3445
Q ss_pred cEEEEEecCCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEEC-CCCcEEEeecCcccc
Q 007177 96 DIYVVFELMESDLHQVIK----ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN-ANCKLKICDFGLARV 170 (614)
Q Consensus 96 ~~ylV~E~~~g~L~~~i~----~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~-~~~~vKL~DFGla~~ 170 (614)
.+|+|||||++++...+. ....+++..++.|++||+.||.|||+.||+||||||+|||++ .++.+||+|||+++.
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 589999999987766554 356899999999999999999999999999999999999999 799999999999987
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
...... ...+++|++|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+++..|...+|+|..+.+
T Consensus 192 ~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 192 LIAGEP----NVSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp CCTTCC----CCSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccCCCC----CcccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 543322 2456899999999998652 46999999999999999999999999999999999999999999998877
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCC-CCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCccc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKF-PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 318 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~ 318 (614)
.......... .+....+.++...+ +.+++++.+||.+||++||.+|||+.|+|+||||+.+....
T Consensus 267 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 332 (394)
T 4e7w_A 267 KTMNPNYMEH---KFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGE 332 (394)
T ss_dssp HHHCGGGSSS---CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSC
T ss_pred HhhChhhhhh---ccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccc
Confidence 6543221100 11112222333333 35889999999999999999999999999999999886544
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=426.53 Aligned_cols=287 Identities=34% Similarity=0.627 Sum_probs=232.4
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~-~~~~~~ 96 (614)
.+|++++.||+|+||.||+|.++.+|+.||||++.... ....+|+.+|+.|+||||+++++++.... ..+...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 36999999999999999999999999999999986431 12347999999999999999999885432 133445
Q ss_pred EEEEEecCCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC-CcEEEeecCccccc
Q 007177 97 IYVVFELMESDLHQVIK----ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARVA 171 (614)
Q Consensus 97 ~ylV~E~~~g~L~~~i~----~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~-~~vKL~DFGla~~~ 171 (614)
+++|||||+++|.+++. ....+++..++.|++||+.||.|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 128 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 78999999998877764 35679999999999999999999999999999999999999965 57899999999875
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
..... ...++||++|+|||++.+. ..|+.++||||||||+|||++|++||.+.+..+++..|...+|+|..+.+.
T Consensus 208 ~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 208 VRGEP----NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CTTCC----CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCC----ceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 43322 2456899999999998652 479999999999999999999999999999999999999999999987775
Q ss_pred hhhchhHHHHHHhhcccCCCcccCC-CCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCccc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQK-FPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 318 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~ 318 (614)
........ + .+.......+... .+.+++++.+||.+||.+||.+|||++|+|+||||+.+....
T Consensus 283 ~~~~~~~~-~--~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 347 (420)
T 1j1b_A 283 EMNPNYTE-F--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 347 (420)
T ss_dssp HHCSCCCC-C--CCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred hhChhhhh-h--ccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccccc
Confidence 43211000 0 0000111111111 246789999999999999999999999999999999876543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=430.54 Aligned_cols=261 Identities=27% Similarity=0.474 Sum_probs=224.8
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|++++.||+|+||.||+|.++.+|+.||+|++........+...+.+|+.+|+.|+||||+++++++ .+.+.
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~~ 84 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEGH 84 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSSE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECCE
Confidence 4579999999999999999999999999999999986555555677889999999999999999999998 55678
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEEC---CCCcEEEeecCcccccc
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN---ANCKLKICDFGLARVAF 172 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~---~~~~vKL~DFGla~~~~ 172 (614)
+|+|||||. |+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 999999998 59999999999999999999999999999999999999999999999998 45789999999997654
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.... .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..+..
T Consensus 165 ~~~~---~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~------------ 227 (444)
T 3soa_A 165 GEQQ---AWFGFAGTPGYLSPEVLRK--DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA------------ 227 (444)
T ss_dssp TTCC---BCCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH------------
T ss_pred CCCc---eeecccCCcccCCHHHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh------------
Confidence 3322 2345789999999999987 6899999999999999999999999998876665555432
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
.........|+.+++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 228 ---------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 228 ---------------GAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp ---------------TCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred ---------------CCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 11112234567889999999999999999999999999999999854
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=433.46 Aligned_cols=259 Identities=31% Similarity=0.511 Sum_probs=217.5
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
++|++++.||+|+||.||+|.++.++..||||++............+.+|+.+|+.++||||+++++++ .+...+
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~~ 111 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRNY 111 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCEE
Confidence 479999999999999999999999999999999976543344456788999999999999999999998 455779
Q ss_pred EEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC---CcEEEeecCccccccC
Q 007177 98 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN---CKLKICDFGLARVAFN 173 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~---~~vKL~DFGla~~~~~ 173 (614)
|+|||||. ++|.+.+.....+++..++.|+.||+.||.|||+.||+||||||+|||++.+ +.+||+|||+++....
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 99999998 5999999888889999999999999999999999999999999999999764 4599999999987543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
.. .....+||++|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+...
T Consensus 192 ~~----~~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~------------ 252 (494)
T 3lij_A 192 QK----KMKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKG------------ 252 (494)
T ss_dssp TB----CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------------
T ss_pred Cc----cccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence 32 2345689999999999864 6899999999999999999999999998876665555321
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
........|..+++.+++||.+||+.||.+|||++|+|+||||+...
T Consensus 253 ---------------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 253 ---------------KYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp ---------------CCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred ---------------CCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 11112234567899999999999999999999999999999998653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=411.52 Aligned_cols=257 Identities=25% Similarity=0.454 Sum_probs=220.0
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
.++|++++.||+|+||.||+|.++.+|+.||||++++... .......+.+|+.+|+.++||||+++++++ .+..
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCC
Confidence 4689999999999999999999999999999999974311 122356688999999999999999999998 4556
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
.+|+|||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 7999999998 599999988888999999999999999999999999999999999999999999999999999864322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
.. .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+.......|..
T Consensus 159 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~-------------- 219 (337)
T 1o6l_A 159 GA---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-------------- 219 (337)
T ss_dssp TC---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------------
T ss_pred CC---cccccccChhhCChhhhcC--CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc--------------
Confidence 22 2345689999999999987 6899999999999999999999999988876555444421
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 314 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~ 314 (614)
. ... ....+++++.+||.+||+.||.+|| +++|+++||||+++
T Consensus 220 ------------~--~~~---~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 220 ------------E--EIR---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp ------------C--CCC---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ------------C--CCC---CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 0 011 1235789999999999999999999 99999999999865
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=418.04 Aligned_cols=258 Identities=24% Similarity=0.416 Sum_probs=216.9
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~ 93 (614)
..++|++++.||+|+||.||+|.++.+|+.||||++++.. ........+.+|+.+|+.+ +||||+++++++ .+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~ 95 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QT 95 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----Ee
Confidence 3578999999999999999999999999999999997531 1223456678999999988 699999999998 45
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
...+|+|||||. ++|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 567999999998 5999999988899999999999999999999999999999999999999999999999999998533
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..|...
T Consensus 176 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------- 239 (353)
T 3txo_A 176 CNGV---TTATFCGTPDYIAPEILQE--MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND----------- 239 (353)
T ss_dssp C------------CCGGGCCHHHHHH--HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred cCCc---cccccCCCcCeEChhhcCC--CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------
Confidence 2221 2345689999999999987 57999999999999999999999999998877666655321
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCH------HHHHcCcccccC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA------EEALADPYFKGL 314 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa------~eiL~hp~f~~~ 314 (614)
... ....+++.+.+||.+||+.||.+||++ +|+++||||+++
T Consensus 240 -----------------~~~---~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 240 -----------------EVV---YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp -----------------CCC---CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred -----------------CCC---CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 011 113478899999999999999999999 999999999875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=419.41 Aligned_cols=286 Identities=32% Similarity=0.674 Sum_probs=231.1
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC----
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR---- 91 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~---- 91 (614)
..++|++++.||+|+||.||+|.+..+|+.||||++..... ...+|+.+|+.++||||+++++++.....
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 35689999999999999999999999999999999864321 12379999999999999999999854432
Q ss_pred -----------------------------CCCCcEEEEEecCCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH
Q 007177 92 -----------------------------RDFKDIYVVFELMESDLHQVIK----ANDDLTREHYQFFLYQLLRALKYIH 138 (614)
Q Consensus 92 -----------------------------~~~~~~ylV~E~~~g~L~~~i~----~~~~lse~~~~~i~~QIl~aL~yLH 138 (614)
.+...+|+|||||+++|.+.+. ....+++..++.|++||+.||.|||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp -------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3345689999999998777765 3568999999999999999999999
Q ss_pred hCCeEeecCCCCcEEEC-CCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHH
Q 007177 139 TANVYHRDLKPKNILAN-ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA 217 (614)
Q Consensus 139 s~gIvHrDLKP~NILi~-~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~ 217 (614)
+.||+||||||+|||++ .++.+||+|||+++....... ....++|+.|+|||++.+. ..|+.++|||||||++|
T Consensus 159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC----CCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHH
T ss_pred HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC----CcCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHH
Confidence 99999999999999997 688999999999986543322 2456789999999988762 45899999999999999
Q ss_pred HHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCC-CCCCHHHHHHHHHhcCCCC
Q 007177 218 EVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKF-PNADPSALRLLERLLAFDP 296 (614)
Q Consensus 218 eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~s~~l~dLI~~mL~~DP 296 (614)
+|++|++||.+.+..+++..+...+|.|..+.+.......... .........+...+ ...++.+.+||.+||+.||
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEV---RFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--C---CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccc---cCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 9999999999999999999999999999988775543211000 00001111112222 3478899999999999999
Q ss_pred CCCCCHHHHHcCcccccCC
Q 007177 297 KDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 297 ~~Rpsa~eiL~hp~f~~~~ 315 (614)
.+|||+.|+|+||||+.+.
T Consensus 311 ~~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 311 DLRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp GGSCCHHHHHTSGGGHHHH
T ss_pred hhCCCHHHHhcCHHHHHHH
Confidence 9999999999999998764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=432.67 Aligned_cols=262 Identities=33% Similarity=0.532 Sum_probs=222.2
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++++.||+|+||.||+|.++.+++.||||++............+.+|+.+|+.++||||+++++++ .+..
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~ 94 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSS 94 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcCC
Confidence 34689999999999999999999999999999999965433333456788999999999999999999998 4557
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEEC---CCCcEEEeecCccccc
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN---ANCKLKICDFGLARVA 171 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~---~~~~vKL~DFGla~~~ 171 (614)
.+|+|||||. ++|.+.+.....+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 7999999998 59999998888899999999999999999999999999999999999995 4567999999999865
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
.... .....+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+....
T Consensus 175 ~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--------- 238 (486)
T 3mwu_A 175 QQNT----KMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK--------- 238 (486)
T ss_dssp CCC--------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC---------
T ss_pred CCCC----ccCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------
Confidence 4332 2345689999999999875 59999999999999999999999999988776665553311
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
.......|..+++.+++||.+||+.||.+|||+.++|+||||+....
T Consensus 239 ------------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 239 ------------------YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp ------------------CCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred ------------------CCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 11112234568899999999999999999999999999999987643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=415.53 Aligned_cols=259 Identities=28% Similarity=0.491 Sum_probs=223.7
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
++|++.+.||+|+||.||+|.++.+|+.||+|++............+.+|+.+|+.|+||||+++++++ .+....
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~ 103 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESFH 103 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCEE
Confidence 579999999999999999999999999999999986555666778899999999999999999999998 455779
Q ss_pred EEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC---cEEEeecCccccccC
Q 007177 98 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC---KLKICDFGLARVAFN 173 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~---~vKL~DFGla~~~~~ 173 (614)
|+|||||. ++|.+.+.....+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++.....
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp EEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 99999998 59999998888899999999999999999999999999999999999998654 599999999986543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
.. .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+....+..+...
T Consensus 184 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~------------ 245 (362)
T 2bdw_A 184 SE----AWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG------------ 245 (362)
T ss_dssp CC----SCCCSCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------------
T ss_pred Cc----ccccCCCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC------------
Confidence 22 2345689999999999987 68999999999999999999999999988765555444321
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
........|..+++.+.+||.+||..||.+|||++++|+||||...
T Consensus 246 ---------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 246 ---------------AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp ---------------CCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred ---------------CCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 1111123345688999999999999999999999999999999754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=414.18 Aligned_cols=299 Identities=34% Similarity=0.537 Sum_probs=237.2
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC--
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-- 91 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~-- 91 (614)
.+..++|++++.||+|+||.||+|.++.+|+.||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 13 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY 92 (351)
T ss_dssp SCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred cccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence 456789999999999999999999999999999999997554444445567899999999999999999999864321
Q ss_pred -CCCCcEEEEEecCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 92 -RDFKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 92 -~~~~~~ylV~E~~~g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
...+.+|+|||||+++|.+.+... ..+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp ----CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 124578999999999998888764 579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC-CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007177 170 VAFNDTP-TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248 (614)
Q Consensus 170 ~~~~~~~-~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~ 248 (614)
....... ........+||+.|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+..+++..+....+.+..+
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 6542221 12223556899999999988652 468999999999999999999999999999999999999999988777
Q ss_pred hhhhhhchhHHHHHHhhcccCCCcccCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 249 TISRVRNDKARRYLTSMRKKQPVQFSQKF--PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 249 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~--~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
.+...........+..... ....+...+ ...++.+.+||.+||+.||++|||++|+|+||||+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKG-QKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSS-CCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred hccccccchhhcccccccc-cccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 6554432211000000000 000000000 0136789999999999999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=415.88 Aligned_cols=297 Identities=22% Similarity=0.290 Sum_probs=222.5
Q ss_pred CCCCCeEEEeEeeec--CceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 15 GDASRYKIQEVIGKG--SYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G--~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
+..++|++++.||+| +||.||+|.++.+|+.||||++............+.+|+.+|+.++||||+++++++.
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----- 96 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI----- 96 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE-----
Confidence 556799999999999 9999999999999999999999866555666778889999999999999999999984
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
+.+.+|+|||||+ ++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence 4567999999998 6999999875 679999999999999999999999999999999999999999999999999986
Q ss_pred cccCCCCC----ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCC-
Q 007177 170 VAFNDTPT----TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT- 244 (614)
Q Consensus 170 ~~~~~~~~----~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~- 244 (614)
........ .......+||+.|+|||++.+....|+.++||||||||+|+|++|++||.+.+..+.+..+....-.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 256 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence 54322111 1112234799999999998764357899999999999999999999999988766655443221100
Q ss_pred -------Cchhhhhhhh----chhHHHHHH---hhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcc
Q 007177 245 -------PSLDTISRVR----NDKARRYLT---SMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 310 (614)
Q Consensus 245 -------p~~~~i~~~~----~~~~~~~l~---~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~ 310 (614)
+......... .......+. .............+..+++.+.+||.+||+.||.+|||++|+|+|||
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~ 336 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 336 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence 0000000000 000000000 00000111112234568899999999999999999999999999999
Q ss_pred cccCCc
Q 007177 311 FKGLSK 316 (614)
Q Consensus 311 f~~~~~ 316 (614)
|+.+..
T Consensus 337 f~~~~~ 342 (389)
T 3gni_B 337 FKQIKR 342 (389)
T ss_dssp GGGC--
T ss_pred HHHHhh
Confidence 998754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=403.49 Aligned_cols=259 Identities=28% Similarity=0.459 Sum_probs=218.9
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
...++|++++.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+|+.++||||+++++++. +.
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~ 89 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYL-----VG 89 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEE-----EC
Confidence 445789999999999999999999999999999999864322 23456789999999999999999999984 44
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
..+|+|||||+ ++|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 67999999997 6999999775 599999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+....+..+.... .+
T Consensus 169 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~-------- 234 (297)
T 3fxz_A 169 EQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TP-------- 234 (297)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHHC--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-SC--------
T ss_pred ccc---ccCCccCCcCccChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CC--------
Confidence 322 2245689999999999987 689999999999999999999999998887655554432110 00
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
.......+++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 235 -------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 235 -------------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp -------------------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -------------------CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 011123578899999999999999999999999999999854
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=402.70 Aligned_cols=300 Identities=39% Similarity=0.627 Sum_probs=235.8
Q ss_pred cCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC--
Q 007177 13 EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-- 90 (614)
Q Consensus 13 ~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~-- 90 (614)
.+...++|++++.||+|+||.||+|.+..+++.||||++.. ........+.+|+.+|+.++||||+++++++....
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL--TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ 83 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEEC--CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEec--CChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence 45567899999999999999999999999999999999874 34556678899999999999999999999885432
Q ss_pred -------CCCCCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEEC-CCCcEEE
Q 007177 91 -------RRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN-ANCKLKI 162 (614)
Q Consensus 91 -------~~~~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~-~~~~vKL 162 (614)
..+...+|+||||++++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 84 LTDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CCC----CCSCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccccccccCceeEEeeccCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence 134567999999999999999864 5699999999999999999999999999999999999997 5679999
Q ss_pred eecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhh
Q 007177 163 CDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242 (614)
Q Consensus 163 ~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~ 242 (614)
+|||+++................+|++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999998754332222223455789999999987642 578999999999999999999999999999988888888877
Q ss_pred CCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcc
Q 007177 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 317 (614)
Q Consensus 243 g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~ 317 (614)
..+..+........ ...++..........+...++.+++.+.+||.+||+.||.+|||++|+|+||||+.+.-.
T Consensus 242 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 242 PVVHEEDRQELLSV-IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp CCCCHHHHHHHHTT-SCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred CCCchhhhhhhhhc-CcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 77665554433221 111222222223333444567889999999999999999999999999999999976543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=405.91 Aligned_cols=258 Identities=25% Similarity=0.434 Sum_probs=222.0
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++++.||+|+||.||+|.++.+++.||+|.+... ..+...+.+|+.+|+.++||||+++++++ .+..
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~ 74 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESF-----ESME 74 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETT
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEE-----ecCC
Confidence 457899999999999999999999999999999998742 34556788999999999999999999998 4556
Q ss_pred cEEEEEecCC-CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC--CCcEEEeecCccccc
Q 007177 96 DIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA--NCKLKICDFGLARVA 171 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~--~~~vKL~DFGla~~~ 171 (614)
.+|+|||||+ ++|.+.+.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++..
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 7999999998 59999997654 7999999999999999999999999999999999999987 789999999999875
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......+
T Consensus 155 ~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------ 222 (321)
T 1tki_A 155 KPGD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF------ 222 (321)
T ss_dssp CTTC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC------
T ss_pred CCCC----ccccccCChhhcCcHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCC------
Confidence 4322 2245679999999999987 568999999999999999999999999988776666554322111
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
....++.+++++.+||.+||..||.+|||++|+|+||||+..
T Consensus 223 ---------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 223 ---------------------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ---------------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ---------------------ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 112345788999999999999999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=410.84 Aligned_cols=289 Identities=36% Similarity=0.584 Sum_probs=231.5
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCCh---HHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI---SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~---~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
..++|++++.||+|+||.||+|.+..+|+.||||++....... .....+.+|+.+|+.++||||+++++++ .
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 82 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----G 82 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE-----e
Confidence 4578999999999999999999999999999999997432211 1124678999999999999999999998 4
Q ss_pred CCCcEEEEEecCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 93 DFKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 93 ~~~~~ylV~E~~~g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
+...+|+|||||+++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 83 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 83 HKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp CTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred eCCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 456789999999999999987653 6999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
..... .....++|++|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+..+++..+....+.|..+.+.
T Consensus 163 ~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 163 GSPNR---AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp TSCCC---CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred cCCcc---cCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 43221 23456899999999998652 468999999999999999999999999999999999999999998776654
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
...... .++ ........++...+..+++.+.+||.+||..||.+|||++|+|+||||++...
T Consensus 239 ~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 239 DMCSLP--DYV-TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp STTSST--TCC-CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred hhccCc--ccc-cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 432110 000 00011112223345678899999999999999999999999999999987543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=426.71 Aligned_cols=320 Identities=26% Similarity=0.362 Sum_probs=245.9
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCCh-----------HHHHHHHHHHHHHHhcCCCCcceee
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI-----------SDAARILREIKLLRLLRHPDIVEIK 83 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~-----------~~~~~i~~Ei~iL~~L~HpnIv~l~ 83 (614)
...++|++++.||+|+||.||+|.++.++..||||++....... .....+.+|+.+|+.|+||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 34578999999999999999999999999999999997542211 2346788999999999999999999
Q ss_pred eEecCCCCCCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC---c
Q 007177 84 HIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC---K 159 (614)
Q Consensus 84 ~v~~~~~~~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~---~ 159 (614)
+++ .+...+|||||||+ ++|.+.+.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++ .
T Consensus 113 ~~~-----~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 113 DVF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEE-----ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred EEE-----EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence 998 45678999999998 59999998888899999999999999999999999999999999999998876 6
Q ss_pred EEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 007177 160 LKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMT 239 (614)
Q Consensus 160 vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~ 239 (614)
+||+|||+++...... .....+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+.
T Consensus 188 ~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 260 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY----KLRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE 260 (504)
T ss_dssp EEECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEEEECCCCEEcCCCC----ccccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999998654332 2345689999999999874 68999999999999999999999999988776666553
Q ss_pred hhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccC
Q 007177 240 DLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVER 319 (614)
Q Consensus 240 ~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~ 319 (614)
..... .....|..+++.+++||.+||++||.+|||++|+|+||||+.......
T Consensus 261 ~~~~~---------------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~ 313 (504)
T 3q5i_A 261 KGKYY---------------------------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNIN 313 (504)
T ss_dssp HCCCC---------------------------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCC
T ss_pred cCCCC---------------------------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhccc
Confidence 31111 111234678999999999999999999999999999999987543210
Q ss_pred CCCCCCCccchhHHHhhcCCHHHHHHHHHHHHHHhCch-hhhhhccccccccccChhHHHHHHHHHHHHhhhc
Q 007177 320 EPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQ-LLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENV 391 (614)
Q Consensus 320 ~~~~~~~~~~~~~~e~~~~~~e~~~~~~~~ei~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~f~~l~~~~ 391 (614)
... ...+ ......+..+... .++..........++.+....++++.|+.+|.++
T Consensus 314 --------~~~---------~~~~-~~~~~~~~~~~~~~kl~~a~l~~i~~~~~~~~~~~~l~~~F~~~D~d~ 368 (504)
T 3q5i_A 314 --------KSD---------QKTL-CGALSNMRKFEGSQKLAQAAILFIGSKLTTLEERKELTDIFKKLDKNG 368 (504)
T ss_dssp --------GGG---------HHHH-HHHHHHHHHCCCCSHHHHHHHHHHHHHTSCHHHHHHHHHHHHHHCTTC
T ss_pred --------ccc---------hhhH-HHHHHHHHHHHHHHHHHHHHHHHhhccCCcHHHHHHHHHHHHeeCCCC
Confidence 000 0001 1112223333322 1222111122234456778899999999999983
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=405.11 Aligned_cols=263 Identities=28% Similarity=0.440 Sum_probs=223.4
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----HHHHHHHHHHHHHHhcCCCCcceeeeEecCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI----SDAARILREIKLLRLLRHPDIVEIKHIMLPP 89 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~----~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~ 89 (614)
....++|++.+.||+|+||.||+|.++.+|+.||||++....... .....+.+|+.+|+.++||||+++++++
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--- 83 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY--- 83 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE---
Confidence 344568999999999999999999999999999999997543221 1356788999999999999999999998
Q ss_pred CCCCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC----cEEEee
Q 007177 90 SRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC----KLKICD 164 (614)
Q Consensus 90 ~~~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~----~vKL~D 164 (614)
.+...+|+|||||+ ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|
T Consensus 84 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 84 --ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp --ECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred --EeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 45567999999997 59999998888899999999999999999999999999999999999999887 799999
Q ss_pred cCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCC
Q 007177 165 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 244 (614)
Q Consensus 165 FGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~ 244 (614)
||+++....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 162 fg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 235 (326)
T 2y0a_A 162 FGLAHKIDFGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235 (326)
T ss_dssp CTTCEECCTTSC----CCCCCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC
T ss_pred CCCCeECCCCCc----cccccCCcCcCCceeecC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC
Confidence 999987543221 244679999999999976 67999999999999999999999999988876665554332111
Q ss_pred CchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 245 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 245 p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
. ....++.+++.+.+||.+||..||.+|||++|+|+||||+..
T Consensus 236 ~---------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 236 F---------------------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp C---------------------------CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred c---------------------------CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 1 112235678999999999999999999999999999999753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=418.09 Aligned_cols=282 Identities=32% Similarity=0.545 Sum_probs=232.0
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc------CCCCcceeeeEecC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL------RHPDIVEIKHIMLP 88 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L------~HpnIv~l~~v~~~ 88 (614)
....+|++++.||+|+||.||+|.+..+++.||||++... ......+.+|+.+|+.+ .|+||+++++.+
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~-- 168 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF-- 168 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE--
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec--
Confidence 3457899999999999999999999999999999999742 34456677888888877 577999999998
Q ss_pred CCCCCCCcEEEEEecCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCc--EEEee
Q 007177 89 PSRRDFKDIYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK--LKICD 164 (614)
Q Consensus 89 ~~~~~~~~~ylV~E~~~g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~--vKL~D 164 (614)
.....+|+|||||+++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++.++. +||+|
T Consensus 169 ---~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 169 ---TFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp ---EETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECC
T ss_pred ---ccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEee
Confidence 3446799999999999999998754 4999999999999999999999999999999999999999987 99999
Q ss_pred cCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCC
Q 007177 165 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 244 (614)
Q Consensus 165 FGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~ 244 (614)
||+++..... ....+||+.|+|||++.+ ..|+.++||||||||+|||++|.+||.+.+..+++..+...+|.
T Consensus 246 FG~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~ 317 (429)
T 3kvw_A 246 FGSSCYEHQR------VYTYIQSRFYRAPEVILG--ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGM 317 (429)
T ss_dssp CTTCEETTCC------CCSSCSCGGGCCHHHHHT--BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred cccceecCCc------ccccCCCCCccChHHHhC--CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 9999764322 234689999999999987 67999999999999999999999999999999999999999999
Q ss_pred CchhhhhhhhchhHHHHHHhhcccC-----------------------------CCcccCC-CCCCCHHHHHHHHHhcCC
Q 007177 245 PSLDTISRVRNDKARRYLTSMRKKQ-----------------------------PVQFSQK-FPNADPSALRLLERLLAF 294 (614)
Q Consensus 245 p~~~~i~~~~~~~~~~~l~~~~~~~-----------------------------~~~~~~~-~~~~s~~l~dLI~~mL~~ 294 (614)
|..+.+..... ...++....... ...+... ....++.+.+||.+||++
T Consensus 318 p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~ 395 (429)
T 3kvw_A 318 PSQKLLDASKR--AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEW 395 (429)
T ss_dssp CCHHHHHTBTT--HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCS
T ss_pred CCHHHHHhhhh--hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCC
Confidence 99887654322 122211100000 0000001 123478899999999999
Q ss_pred CCCCCCCHHHHHcCcccccC
Q 007177 295 DPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 295 DP~~Rpsa~eiL~hp~f~~~ 314 (614)
||++|||++|+|+||||+..
T Consensus 396 dP~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 396 DPAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp STTTSCCHHHHHTSTTTC--
T ss_pred ChhhCCCHHHHhCChhhccC
Confidence 99999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=409.73 Aligned_cols=291 Identities=32% Similarity=0.568 Sum_probs=232.2
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
+...++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++ .+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 95 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC-----KK 95 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEe-----ec
Confidence 3456799999999999999999999999999999999976555555667788999999999999999999998 45
Q ss_pred CCcEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 94 FKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 94 ~~~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
...+|+||||+++ +|.+++.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred CCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 5679999999996 566666667789999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.... .....+||++|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+.........
T Consensus 176 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 176 APGE---VYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred CCcc---ccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 3221 12446799999999998762 4689999999999999999999999999999999999988888766544322
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
........-...............++.+++.+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 2111000000000001111222345678999999999999999999999999999999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=403.59 Aligned_cols=254 Identities=26% Similarity=0.468 Sum_probs=219.7
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
.++|++++.||+|+||.||+|.++.+|+.||||++++... .......+.+|+.+|+.++||||+++++++ .+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCC
Confidence 4689999999999999999999999999999999974311 112345678899999999999999999998 4557
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
.+|+|||||+ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 7999999998 599999999889999999999999999999999999999999999999999999999999999865332
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..|...
T Consensus 160 ------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------------- 218 (318)
T 1fot_A 160 ------TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA------------- 218 (318)
T ss_dssp ------BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-------------
T ss_pred ------cccccCCccccCHhHhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Confidence 134589999999999987 67999999999999999999999999988776655554320
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 314 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~ 314 (614)
. .. ..+.+++++.+||.+||..||.+|| +++++++||||+++
T Consensus 219 -------------~--~~---~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 219 -------------E--LR---FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp -------------C--CC---CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred -------------C--CC---CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 0 01 1235788999999999999999999 99999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=408.28 Aligned_cols=273 Identities=23% Similarity=0.236 Sum_probs=195.1
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
+.+|.+.+.||+|+||+||+|.+ +|+.||||+++.. ........+|+..+..|+|||||++++++.... .....
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~ 75 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQ 75 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceE
Confidence 46799999999999999999976 6899999999742 122222345666677889999999999985432 12246
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeEeecCCCCcEEECCCCcEEEeecCc
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA--------NVYHRDLKPKNILANANCKLKICDFGL 167 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~--------gIvHrDLKP~NILi~~~~~vKL~DFGl 167 (614)
+|||||||+ |+|.++++.. .++++.+..|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 899999999 6999999765 599999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCCCCc-cccccccCCccccCcccccccC----CCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhh
Q 007177 168 ARVAFNDTPTT-IFWTDYVATRWYRAPELCGSFF----SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242 (614)
Q Consensus 168 a~~~~~~~~~~-~~~~~~vgt~~Y~APEvl~~~~----~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~ 242 (614)
|+......... ......+||++|||||++.+.. ..|+.++|||||||+||||++|.+||........
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~-------- 226 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL-------- 226 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC--------
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc--------
Confidence 98765433221 1223468999999999986521 1367899999999999999999988755432110
Q ss_pred CCCchhhhhhhhchhHHHHHHhhcc-cCCCcccCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 243 GTPSLDTISRVRNDKARRYLTSMRK-KQPVQFSQKF--PNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 243 g~p~~~~i~~~~~~~~~~~l~~~~~-~~~~~~~~~~--~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
|....... ..........+.. .....+...+ ...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 227 --p~~~~~~~--~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 227 --PYYDLVPS--DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp --TTTTTSCS--SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred --cchhcccc--cchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 10000000 0000011111111 1111111111 1233568899999999999999999999763
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=406.45 Aligned_cols=283 Identities=22% Similarity=0.407 Sum_probs=230.4
Q ss_pred ccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-----CCCcceeeeEe
Q 007177 12 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-----HPDIVEIKHIM 86 (614)
Q Consensus 12 ~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-----HpnIv~l~~v~ 86 (614)
......++|++++.||+|+||.||+|.+..+++.||||++.. .........+|+.+|+.+. ||||+++++++
T Consensus 29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~ 105 (360)
T 3llt_A 29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF 105 (360)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence 334456899999999999999999999999999999999974 2345566778999999997 99999999998
Q ss_pred cCCCCCCCCcEEEEEecCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC--------
Q 007177 87 LPPSRRDFKDIYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-------- 156 (614)
Q Consensus 87 ~~~~~~~~~~~ylV~E~~~g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~-------- 156 (614)
. ....+|+|||||+++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++.
T Consensus 106 ~-----~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 106 M-----YYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp E-----ETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred e-----ECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccccc
Confidence 4 446799999999889999998754 5999999999999999999999999999999999999975
Q ss_pred -----------------CCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHH
Q 007177 157 -----------------NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 219 (614)
Q Consensus 157 -----------------~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eL 219 (614)
++.+||+|||+++...... ...+||+.|+|||++.+ ..|+.++|||||||++|+|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH------GSIINTRQYRAPEVILN--LGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC------CSCCSCGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHH
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCCCC------cCccCcccccCcHHHcC--CCCCCccchHHHHHHHHHH
Confidence 7889999999998643322 34579999999999987 6799999999999999999
Q ss_pred HhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccC-----------------CCCCCCH
Q 007177 220 LTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQ-----------------KFPNADP 282 (614)
Q Consensus 220 ltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~-----------------~~~~~s~ 282 (614)
++|+.||.+.+..+.+..+....+.+....+..........++..... ...+.. .....++
T Consensus 253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (360)
T 3llt_A 253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDEL--KLAWPENASSINSIKHVKKCLPLYKIIKHE 330 (360)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTT--EECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccc--eecCcccccchhhhhhhhhcccccccchHH
Confidence 999999999999999999999888877665543322111111000000 000000 0012347
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 007177 283 SALRLLERLLAFDPKDRPTAEEALADPYFK 312 (614)
Q Consensus 283 ~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~ 312 (614)
.+.+||.+||+.||.+|||++|+|+||||+
T Consensus 331 ~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 331 LFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 788999999999999999999999999995
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=428.02 Aligned_cols=261 Identities=30% Similarity=0.493 Sum_probs=223.7
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
.++|++.+.||+|+||.||+|.++.+|+.||||++..... .......+.+|+.+|+.++||||+++++++ .+..
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDKG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence 4689999999999999999999999999999999964322 234567788999999999999999999998 4567
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEE---CCCCcEEEeecCccccc
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA---NANCKLKICDFGLARVA 171 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi---~~~~~vKL~DFGla~~~ 171 (614)
.+|+|||||. ++|.+.+.....+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 8999999998 5999999998899999999999999999999999999999999999999 56789999999999865
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
.... .....+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+....
T Consensus 180 ~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--------- 243 (484)
T 3nyv_A 180 EASK----KMKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK--------- 243 (484)
T ss_dssp CCCC----SHHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred cccc----ccccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC---------
Confidence 4332 1245689999999999875 68999999999999999999999999988776665553311
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
.......|..+++.+++||.+||+.||.+|||++|+|+||||+....
T Consensus 244 ------------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 244 ------------------YTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp ------------------CCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred ------------------CCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 11112234568899999999999999999999999999999987643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=409.49 Aligned_cols=257 Identities=32% Similarity=0.511 Sum_probs=215.0
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCCh-HHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI-SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
..++|++++.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+|+.++||||+++++++ .+.
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~ 81 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI-----TTP 81 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeC
Confidence 3478999999999999999999999999999999987432111 1234688999999999999999999998 445
Q ss_pred CcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 95 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 95 ~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
..+|+||||++|+|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 82 TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp SEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred CEEEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 67999999999999999988889999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCccccccccCCccccCcccccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y-~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
. .....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+.....
T Consensus 162 ~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~------------------ 217 (336)
T 3h4j_B 162 N----FLKTSCGSPNYAAPEVING--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF------------------ 217 (336)
T ss_dssp B----TTCCCTTSTTTSCGGGSCC--SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB------------------
T ss_pred c----ccccccCCcCcCCHHHHcC--CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH------------------
Confidence 2 2345689999999999976 344 78999999999999999999999775432111
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
.............+++.+.+||.+||..||.+|||++|+|+||||+.-
T Consensus 218 -------------~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 218 -------------KKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp -------------CCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred -------------HHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 000011111223578999999999999999999999999999999853
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=409.72 Aligned_cols=260 Identities=24% Similarity=0.403 Sum_probs=220.0
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~ 92 (614)
-..++|++++.||+|+||.||+|.++.+|+.||||++++... .......+.+|..+|+.+ +||||+++++++ .
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~ 88 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----Q 88 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----E
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----E
Confidence 346789999999999999999999999999999999975311 112345677899999876 899999999998 4
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
+...+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 89 TKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 5567999999998 599999998888999999999999999999999999999999999999999999999999999854
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
..... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..|..
T Consensus 169 ~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~----------- 232 (345)
T 1xjd_A 169 MLGDA---KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM----------- 232 (345)
T ss_dssp CCTTC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----------
T ss_pred ccCCC---cccCCCCCcccCChhhhcC--CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh-----------
Confidence 32221 1345789999999999987 6799999999999999999999999998887665554421
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHH-HHHcCcccccCC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE-EALADPYFKGLS 315 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~-eiL~hp~f~~~~ 315 (614)
..+ .....+++.+.+||.+||..||.+||++. ++++||||+++.
T Consensus 233 ----------------~~~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 233 ----------------DNP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp ----------------CCC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred ----------------CCC----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 000 11134789999999999999999999998 999999998763
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=387.70 Aligned_cols=264 Identities=28% Similarity=0.495 Sum_probs=226.5
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|++++.||+|+||.||+|.++.+|+.||+|++............+.+|+.+++.++||||+++++++ .+...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCCE
Confidence 5789999999999999999999999999999999986655666778889999999999999999999998 45567
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCc---EEEeecCcccccc
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK---LKICDFGLARVAF 172 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~---vKL~DFGla~~~~ 172 (614)
.|+||||+. ++|.+.+.....+++..+..++.||+.||.|||+.||+||||||+|||++.++. +||+|||++....
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 899999998 599999988888999999999999999999999999999999999999987665 9999999997654
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 160 ~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~----------- 222 (284)
T 3kk8_A 160 DSE----AWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG----------- 222 (284)
T ss_dssp SSC----BCCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----------
T ss_pred cCc----cccCCCCCcCCcCchhhcC--CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhc-----------
Confidence 322 1244679999999999987 67899999999999999999999999888765555444221
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCccc
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 318 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~ 318 (614)
........+..+++.+.+||.+||+.||.+|||++|+|+||||++.....
T Consensus 223 ----------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 272 (284)
T 3kk8_A 223 ----------------AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA 272 (284)
T ss_dssp ----------------CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGG
T ss_pred ----------------cccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHH
Confidence 11112233467889999999999999999999999999999998765543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=403.85 Aligned_cols=267 Identities=22% Similarity=0.402 Sum_probs=216.8
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~ 94 (614)
.++|++++.||+|+||.||+|.++.+++.||||++.+.. ........+.+|+.+|+.+ +||||+++++++ .+.
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTE 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----EeC
Confidence 468999999999999999999999999999999997543 3445567788999999987 899999999998 455
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
..+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 77999999998 59999998888899999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||......+... .
T Consensus 163 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----------~------ 221 (345)
T 3a8x_A 163 PGD---TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD----------Q------ 221 (345)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------------------
T ss_pred CCC---cccccCCCccccCccccCC--CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc----------c------
Confidence 221 2345689999999999987 689999999999999999999999996532111000 0
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCH------HHHHcCcccccCC
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA------EEALADPYFKGLS 315 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa------~eiL~hp~f~~~~ 315 (614)
.........+... ... ....+++.+.+||.+||+.||.+||++ +|+++||||+++.
T Consensus 222 --~~~~~~~~~i~~~-~~~---~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 222 --NTEDYLFQVILEK-QIR---IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp ---CHHHHHHHHHHC-CCC---CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred --ccHHHHHHHHHcC-CCC---CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 0000001111111 111 123578999999999999999999995 8999999998753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=400.83 Aligned_cols=261 Identities=28% Similarity=0.472 Sum_probs=211.8
Q ss_pred cCCCCCCeEEEeEeeecCceEEEEEEEC---CCCcEEEEEEecCccC--ChHHHHHHHHHHHHHHhcCCCCcceeeeEec
Q 007177 13 EYGDASRYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIFE--HISDAARILREIKLLRLLRHPDIVEIKHIML 87 (614)
Q Consensus 13 ~~~~~~rY~i~~~LG~G~~G~V~~a~d~---~tg~~vAIK~i~~~~~--~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~ 87 (614)
+.-..++|++++.||+|+||.||+|.+. .+|+.||||++++... .......+.+|+.+|+.++||||+++++++
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~- 90 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF- 90 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE-
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE-
Confidence 3445678999999999999999999985 6899999999975422 223455678999999999999999999998
Q ss_pred CCCCCCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecC
Q 007177 88 PPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFG 166 (614)
Q Consensus 88 ~~~~~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFG 166 (614)
.+.+.+|+|||||+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 91 ----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 166 (327)
T 3a62_A 91 ----QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFG 166 (327)
T ss_dssp ----ECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred ----EcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCC
Confidence 45567999999998 5999999988889999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCc
Q 007177 167 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 246 (614)
Q Consensus 167 la~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~ 246 (614)
+++....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 167 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~----- 236 (327)
T 3a62_A 167 LCKESIHDGT---VTHTFCGTIEYMAPEILMR--SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC----- 236 (327)
T ss_dssp CC-------------CTTSSCCTTSCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-----
T ss_pred cccccccCCc---cccccCCCcCccCHhhCcC--CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC-----
Confidence 9976432221 1245689999999999977 67899999999999999999999999988776655544321
Q ss_pred hhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 007177 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 314 (614)
Q Consensus 247 ~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~ 314 (614)
. . ...+.+++.+.+||.+||..||.+|| +++|+|+||||+++
T Consensus 237 ---------------------~--~---~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 237 ---------------------K--L---NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp ---------------------C--C---CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred ---------------------C--C---CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 0 0 11245788999999999999999999 89999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=413.05 Aligned_cols=267 Identities=21% Similarity=0.396 Sum_probs=214.9
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~ 93 (614)
..++|++++.||+|+||.||+|.++.+++.||||++++... .......+.+|..+|+.+ +||||+++++++ .+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~ 124 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QT 124 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----EC
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----EE
Confidence 34689999999999999999999999999999999975432 233445678899999877 899999999998 45
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
...+|+|||||. |+|..++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 125 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 125 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 577999999998 5999999988899999999999999999999999999999999999999999999999999998633
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+....+....
T Consensus 205 ~~~~---~~~~~~gt~~Y~aPE~l~~--~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~--------------- 264 (396)
T 4dc2_A 205 RPGD---TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--------------- 264 (396)
T ss_dssp CTTC---CBCCCCBCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC---------------------
T ss_pred cCCC---ccccccCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch---------------
Confidence 2222 2355789999999999987 6899999999999999999999999975432111000
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCH------HHHHcCcccccC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA------EEALADPYFKGL 314 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa------~eiL~hp~f~~~ 314 (614)
.........+.. ... .....+++.+.+||++||+.||.+||++ +|+++||||+++
T Consensus 265 ---~~~~~~~~~i~~-~~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 265 ---NTEDYLFQVILE-KQI---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp ---CCHHHHHHHHHH-CCC---CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred ---hhHHHHHHHHhc-ccc---CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 000000111111 111 1223578999999999999999999985 899999999876
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=423.20 Aligned_cols=266 Identities=24% Similarity=0.414 Sum_probs=222.8
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
..++|++++.||+|+||.||+|.++.+++.||||++.+... .......+.+|+.+|..++||||+++++++ .+.
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~ 146 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QDD 146 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----ECS
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeC
Confidence 34689999999999999999999999999999999974211 111123377899999999999999999998 456
Q ss_pred CcEEEEEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 95 KDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
..+|||||||. |+|.+++.. .+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+...
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence 77999999997 699999987 5689999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~---~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
.... ......+||++|+|||++... ...|+.++|||||||++|||++|++||.+.+..+.+..|....
T Consensus 227 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------- 297 (437)
T 4aw2_A 227 EDGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK------- 297 (437)
T ss_dssp TTSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-------
T ss_pred cCCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc-------
Confidence 3322 123446899999999998621 1568999999999999999999999999998877776664310
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCC--CCCHHHHHcCcccccC
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD--RPTAEEALADPYFKGL 314 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~--Rpsa~eiL~hp~f~~~ 314 (614)
....+...+..+++++++||++||..+|++ |++++|+++||||+++
T Consensus 298 -------------------~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 298 -------------------ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp -------------------HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred -------------------ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 012233344678999999999999999988 9999999999999875
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=407.00 Aligned_cols=258 Identities=22% Similarity=0.385 Sum_probs=219.5
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~ 93 (614)
..++|++++.||+|+||.||+|.++.+|+.||||++++... .......+.+|..+|..+ +||||+++++++ .+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----EC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----Ec
Confidence 35789999999999999999999999999999999975311 112345678899999887 799999999998 45
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
...+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 577999999998 5999999988889999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|...
T Consensus 173 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------- 236 (353)
T 2i0e_A 173 WDGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH----------- 236 (353)
T ss_dssp CTTC---CBCCCCSCGGGCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred cCCc---ccccccCCccccChhhhcC--CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-----------
Confidence 2221 2245689999999999987 68999999999999999999999999988876665554320
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 314 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~ 314 (614)
... ....+++++.+||.+||..||.+|| +++++++||||+++
T Consensus 237 -----------------~~~---~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 237 -----------------NVA---YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp -----------------CCC---CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred -----------------CCC---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 011 1235789999999999999999999 47999999999865
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=396.16 Aligned_cols=291 Identities=33% Similarity=0.572 Sum_probs=236.8
Q ss_pred CCCCeEEEeEeeecCceEEEEEEEC-CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc---CCCCcceeeeEecCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDT-HTGEKVAIKKIHDIFEHISDAARILREIKLLRLL---RHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~-~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L---~HpnIv~l~~v~~~~~~ 91 (614)
..++|++++.||+|+||.||+|.+. .+|+.||||++............+.+|+.+++.+ +||||+++++++.....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3478999999999999999999995 6789999999874433222223455777777666 89999999999854333
Q ss_pred CCCCcEEEEEecCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 92 RDFKDIYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 92 ~~~~~~ylV~E~~~g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
.....+|+||||++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 3557799999999999999998754 49999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 170 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 170 ~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.|....
T Consensus 169 ~~~~~----~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 169 IYSFQ----MALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCCGG----GGGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cccCC----CCccccccccceeCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 64322 12345679999999999987 5799999999999999999999999999999999999999999887666
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
+........ ..........+...++.+++.+.+||.+||..||.+|||++|+|+||||+++..
T Consensus 243 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 243 WPRDVALPR----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp SCTTCSSCG----GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred Cccccccch----hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 543211100 001112223344556788999999999999999999999999999999997754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=405.67 Aligned_cols=256 Identities=22% Similarity=0.401 Sum_probs=220.8
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
...++|++++.||+|+||.||+|.++.+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++ .+
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~ 112 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KD 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----Ec
Confidence 34578999999999999999999999999999999996431 1112346788999999999999999999998 45
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
...+|+|||||+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 113 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceecc
Confidence 567999999997 6999999988889999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
... ...+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..|...
T Consensus 193 ~~~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------- 253 (350)
T 1rdq_E 193 GRT------WTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----------- 253 (350)
T ss_dssp SCB------CCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred CCc------ccccCCccccCHHHhcC--CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC-----------
Confidence 321 34589999999999987 67999999999999999999999999988766655554320
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 314 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~eiL~hp~f~~~ 314 (614)
... ....+++.+.+||.+||+.||.+||+ ++|+++||||+++
T Consensus 254 -----------------~~~---~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 254 -----------------KVR---FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp -----------------CCC---CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred -----------------CCC---CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 011 12357899999999999999999998 9999999999865
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=409.59 Aligned_cols=260 Identities=29% Similarity=0.449 Sum_probs=213.4
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc---CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF---EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~---~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
.++|++.+.||+|+||.||+|.++.+|+.||||++.... ........+.+|+.+|+.++||||+++++++ .+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~ 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY-----SS 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence 357999999999999999999999999999999986321 1111356788999999999999999999998 44
Q ss_pred CCcEEEEEecCC-CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCc---EEEeec
Q 007177 94 FKDIYVVFELME-SDLHQVIKAN----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK---LKICDF 165 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~----~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~---vKL~DF 165 (614)
...+|+|||||+ ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+||
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 567999999999 5998877542 35899999999999999999999999999999999999987654 999999
Q ss_pred CccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCC
Q 007177 166 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 245 (614)
Q Consensus 166 Gla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p 245 (614)
|+++....... .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|..||.+.+. +.+..+..
T Consensus 178 g~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~----- 246 (351)
T 3c0i_A 178 GVAIQLGESGL---VAGGRVGTPHFMAPEVVKR--EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIK----- 246 (351)
T ss_dssp TTCEECCTTSC---BCCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHH-----
T ss_pred cceeEecCCCe---eecCCcCCcCccCHHHHcC--CCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHc-----
Confidence 99987543321 2245689999999999987 6789999999999999999999999987532 22222211
Q ss_pred chhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 246 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 246 ~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
.........|+.+++.+.+||.+||..||.+|||++|+|+||||+..
T Consensus 247 ----------------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 247 ----------------------GKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp ----------------------TCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred ----------------------CCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 11111112345688999999999999999999999999999999854
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=416.03 Aligned_cols=291 Identities=34% Similarity=0.582 Sum_probs=216.6
Q ss_pred CCCeEE-EeEeeecCceEEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 17 ASRYKI-QEVIGKGSYGVVCSAIDT--HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 17 ~~rY~i-~~~LG~G~~G~V~~a~d~--~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
.+.|++ .++||+|+||.||+|.++ .+++.||||++..... ...+.+|+.+|+.|+||||+++++++... +
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~ 91 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSH---A 91 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEET---T
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecC---C
Confidence 356777 458999999999999966 5788999999975322 23577999999999999999999998542 3
Q ss_pred CCcEEEEEecCCCcHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEE----CCCCcE
Q 007177 94 FKDIYVVFELMESDLHQVIKAN---------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA----NANCKL 160 (614)
Q Consensus 94 ~~~~ylV~E~~~g~L~~~i~~~---------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi----~~~~~v 160 (614)
...+|||||||+++|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+|||+ +.++.+
T Consensus 92 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 92 DRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp TTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred CCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence 4679999999999999988632 249999999999999999999999999999999999999 677899
Q ss_pred EEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCh---------
Q 007177 161 KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--------- 231 (614)
Q Consensus 161 KL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~--------- 231 (614)
||+|||+++...............+||++|+|||++.+. ..|+.++||||||||+|+|++|.+||.+.+.
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 999999998764432222233557899999999998762 4589999999999999999999999987765
Q ss_pred hHHHHHHHhhhCCCchhhhhhhhchhH-HHHHHhhcccCCC--c----ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 007177 232 VHQLDLMTDLLGTPSLDTISRVRNDKA-RRYLTSMRKKQPV--Q----FSQKFPNADPSALRLLERLLAFDPKDRPTAEE 304 (614)
Q Consensus 232 ~~~l~~i~~~~g~p~~~~i~~~~~~~~-~~~l~~~~~~~~~--~----~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~e 304 (614)
.+++..|...+|.|....+..+..... ............. . +.......++.+.+||.+||++||.+|||++|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 488999999999998877765533211 1111111110000 0 01112344788999999999999999999999
Q ss_pred HHcCcccccCC
Q 007177 305 ALADPYFKGLS 315 (614)
Q Consensus 305 iL~hp~f~~~~ 315 (614)
+|+||||+...
T Consensus 331 ~L~hp~f~~~~ 341 (405)
T 3rgf_A 331 AMQDPYFLEDP 341 (405)
T ss_dssp HHTSGGGTSSS
T ss_pred HhcChhhccCC
Confidence 99999998654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=395.63 Aligned_cols=267 Identities=26% Similarity=0.437 Sum_probs=225.5
Q ss_pred cccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----HHHHHHHHHHHHHHhcCCCCcceeeeEe
Q 007177 11 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI----SDAARILREIKLLRLLRHPDIVEIKHIM 86 (614)
Q Consensus 11 ~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~----~~~~~i~~Ei~iL~~L~HpnIv~l~~v~ 86 (614)
+......++|++.+.||+|+||.||+|.++.+|+.||||++....... .....+.+|+.+|+.++||||+++++++
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (321)
T 2a2a_A 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY 84 (321)
T ss_dssp CBCSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 444455678999999999999999999999999999999997542221 1356788999999999999999999998
Q ss_pred cCCCCCCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC----cEE
Q 007177 87 LPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC----KLK 161 (614)
Q Consensus 87 ~~~~~~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~----~vK 161 (614)
.+...+|+|||||+ ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+|
T Consensus 85 -----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~k 159 (321)
T 2a2a_A 85 -----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159 (321)
T ss_dssp -----ECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred -----ecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEE
Confidence 45567999999997 59999999888899999999999999999999999999999999999999888 799
Q ss_pred EeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhh
Q 007177 162 ICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 241 (614)
Q Consensus 162 L~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~ 241 (614)
|+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 160 l~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 233 (321)
T 2a2a_A 160 LIDFGLAHEIEDGVE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233 (321)
T ss_dssp ECCCTTCEECCTTCC----CCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred EccCccceecCcccc----ccccCCCCCccCcccccC--CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 999999987543321 244579999999999876 67899999999999999999999999988876666555332
Q ss_pred hCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 242 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 242 ~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
..... ...+..+++.+.+||.+||..||.+|||++|+|+||||+...
T Consensus 234 ~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 234 SYDFD---------------------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp CCCCC---------------------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred ccccC---------------------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 11111 112356788999999999999999999999999999998653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=401.58 Aligned_cols=264 Identities=25% Similarity=0.379 Sum_probs=215.1
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++++.||+|+||.||+|.++.+++.||||++..... ......+.+|+.+++.++||||+++++++ .+..
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~ 78 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHR-----REGN 78 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCC
Confidence 35689999999999999999999999999999999864321 22345678999999999999999999998 4556
Q ss_pred cEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 96 DIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 96 ~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
..|+|||||++ +|.+++.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred eEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 79999999984 99999988888999999999999999999999999999999999999999999999999999865322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
.. .......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..........
T Consensus 159 ~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-------------- 222 (323)
T 3tki_A 159 NR-ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-------------- 222 (323)
T ss_dssp TE-ECCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH--------------
T ss_pred Cc-ccccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--------------
Confidence 21 1223456899999999998762 2347789999999999999999999987654322111100
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
.. ......+..+++.+.+||.+||..||.+|||++|+|+||||+...
T Consensus 223 -----------~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 223 -----------EK---KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp -----------TT---CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred -----------cc---cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 00 111122356789999999999999999999999999999998653
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=403.42 Aligned_cols=292 Identities=33% Similarity=0.584 Sum_probs=224.5
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC--CCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR--RDF 94 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~--~~~ 94 (614)
.++|++.+.||+|+||.||+|.++.+|+.||||++.... ....+..+|+..++.++||||+++++++..... ...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 468999999999999999999999999999999986432 222345678888899999999999999864322 223
Q ss_pred CcEEEEEecCCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH--hCCeEeecCCCCcEEECC-CCcEEEeecCc
Q 007177 95 KDIYVVFELMESDLHQVIK----ANDDLTREHYQFFLYQLLRALKYIH--TANVYHRDLKPKNILANA-NCKLKICDFGL 167 (614)
Q Consensus 95 ~~~ylV~E~~~g~L~~~i~----~~~~lse~~~~~i~~QIl~aL~yLH--s~gIvHrDLKP~NILi~~-~~~vKL~DFGl 167 (614)
..+|+|||||+++|.+.+. ....+++..++.++.||+.||.||| +.||+||||||+|||++. ++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 3488999999998776654 4567999999999999999999999 999999999999999996 89999999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007177 168 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247 (614)
Q Consensus 168 a~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~ 247 (614)
++....... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+...++.|..
T Consensus 179 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3e3p_A 179 AKKLSPSEP----NVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253 (360)
T ss_dssp CBCCCTTSC----CCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ceecCCCCC----cccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence 986543322 2346789999999998652 45899999999999999999999999999999999999999999988
Q ss_pred hhhhhhhchhHHHHHHhhcccCCCcccCC----CCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccC
Q 007177 248 DTISRVRNDKARRYLTSMRKKQPVQFSQK----FPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVER 319 (614)
Q Consensus 248 ~~i~~~~~~~~~~~l~~~~~~~~~~~~~~----~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~ 319 (614)
+.+..+....... .........+... ....++.+.+||.+||+.||.+|||+.|+|+||||+++.....
T Consensus 254 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 326 (360)
T 3e3p_A 254 EVLRKLNPSHTDV---DLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT 326 (360)
T ss_dssp HHHHHHCTTCCCG---GGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred HHHHhcccchhhc---cccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence 7765543211000 0001111122222 2236789999999999999999999999999999998865443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=409.56 Aligned_cols=263 Identities=25% Similarity=0.454 Sum_probs=218.3
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
..++|++++.||+|+||.||+|.++.+++.||||++.+.. ........+.+|+.+|+.++||||+++++++ .+.
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~ 87 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QDE 87 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeC
Confidence 4578999999999999999999999999999999986431 1122346788999999999999999999998 455
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
..+|+|||||. |+|.+++.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 67999999997 59999999988999999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~-~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.. .....+||+.|+|||++.+. ...|+.++|||||||++|+|++|..||.+.+.......+.
T Consensus 168 ~~----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~------------- 230 (384)
T 4fr4_A 168 ET----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH------------- 230 (384)
T ss_dssp TC----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH-------------
T ss_pred CC----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH-------------
Confidence 22 23557899999999998642 1458999999999999999999999998654322211110
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC-HHHHHcCcccccCC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-AEEALADPYFKGLS 315 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-a~eiL~hp~f~~~~ 315 (614)
.+.. .. ......+++.+.+||.+||+.||.+||+ ++++++||||+++.
T Consensus 231 -----------~~~~-~~---~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 231 -----------TFET-TV---VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp -----------HHHH-CC---CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred -----------HHhh-cc---cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence 0000 01 1122457899999999999999999998 99999999998763
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=403.04 Aligned_cols=257 Identities=29% Similarity=0.454 Sum_probs=213.1
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~ 95 (614)
.++|++++.||+|+||.||+|.++.+|+.||||++.+... ...+|+.+|..+ +||||+++++++ .+..
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~ 89 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVY-----DDGK 89 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEE-----ECSS
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEE-----EcCC
Confidence 4579999999999999999999999999999999975432 234688888877 799999999998 4567
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC----CcEEEeecCcccc
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN----CKLKICDFGLARV 170 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~----~~vKL~DFGla~~ 170 (614)
.+|+|||||+ ++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||+..+ +.+||+|||+++.
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 8999999998 5999999988899999999999999999999999999999999999998543 3599999999986
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCh---hHHHHHHHhhhCCCch
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV---VHQLDLMTDLLGTPSL 247 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~---~~~l~~i~~~~g~p~~ 247 (614)
...... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+... .+.+..+
T Consensus 170 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i--------- 235 (342)
T 2qr7_A 170 LRAENG---LLMTPCYTANFVAPEVLER--QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI--------- 235 (342)
T ss_dssp CBCTTC---CBCCSSCCSSCCCHHHHHH--HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH---------
T ss_pred CcCCCC---ceeccCCCccccCHHHhcC--CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH---------
Confidence 543322 1245689999999999876 5688999999999999999999999976432 1122111
Q ss_pred hhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 248 ~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
...........|+.+++.+++||.+||..||++|||++++|+||||.++..
T Consensus 236 ------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~ 286 (342)
T 2qr7_A 236 ------------------GSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286 (342)
T ss_dssp ------------------HHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred ------------------ccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence 111222223456789999999999999999999999999999999987543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=402.40 Aligned_cols=262 Identities=28% Similarity=0.414 Sum_probs=204.2
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
....++|++++.||+|+||.||+|.++.+++.||||++..... ....+.+|+.+++.++||||+++++++. +
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~ 87 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVIL-----T 87 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEe-----e
Confidence 4567899999999999999999999999999999999975322 2245779999999999999999999984 4
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCc--EEEeecCcccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK--LKICDFGLARV 170 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~--vKL~DFGla~~ 170 (614)
...+|+|||||. ++|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 88 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 88 PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred CCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 567999999997 599999988888999999999999999999999999999999999999987765 99999999975
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCC-cccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~-~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
..... .....+||++|+|||++.+ ..++. ++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 168 ~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~--------- 232 (361)
T 3uc3_A 168 SVLHS----QPKSTVGTPAYIAPEVLLR--QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ--------- 232 (361)
T ss_dssp -----------------CTTSCHHHHHC--SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH---------
T ss_pred ccccC----CCCCCcCCCCcCChhhhcC--CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH---------
Confidence 32221 1234579999999999876 45554 49999999999999999999987654322222111
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
.+... ...+ .....+++.+.+||.+||+.||.+|||++|+|+||||...
T Consensus 233 --------------~~~~~-~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 233 --------------RILSV-KYSI-PDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp --------------HHHTT-CCCC-CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred --------------HHhcC-CCCC-CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 00000 0001 1123578999999999999999999999999999999654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=395.11 Aligned_cols=288 Identities=31% Similarity=0.598 Sum_probs=226.1
Q ss_pred cCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCC
Q 007177 13 EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSR 91 (614)
Q Consensus 13 ~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~ 91 (614)
+++..++|++++.||+|+||.||+|.+..+++.||||+++.. ....+.+|+.+|+.++ ||||+++++++...
T Consensus 31 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~-- 103 (330)
T 3nsz_A 31 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDP-- 103 (330)
T ss_dssp CCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT--
T ss_pred cccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccC--
Confidence 455668999999999999999999999999999999999742 2456889999999997 99999999998542
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC-cEEEeecCccc
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLAR 169 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~-~vKL~DFGla~ 169 (614)
.....|+||||+. ++|.+++. .+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+++
T Consensus 104 -~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 104 -VSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp -TTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred -CCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 2467899999999 58888874 499999999999999999999999999999999999999777 89999999998
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCC-CCCChhHHHHHHHhhhCCCchh
Q 007177 170 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF-PGKNVVHQLDLMTDLLGTPSLD 248 (614)
Q Consensus 170 ~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF-~g~~~~~~l~~i~~~~g~p~~~ 248 (614)
....... ....++|+.|+|||++.+. ..++.++|||||||++|+|++|..|| .+.+..+++..+...++.+...
T Consensus 180 ~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~ 254 (330)
T 3nsz_A 180 FYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 254 (330)
T ss_dssp ECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred EcCCCCc----cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhh
Confidence 6543322 2345799999999998653 56899999999999999999999888 5566777888887777754332
Q ss_pred hhh-hhhchhHHHHHHhhcccCCCcccCC-----CCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 249 TIS-RVRNDKARRYLTSMRKKQPVQFSQK-----FPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 249 ~i~-~~~~~~~~~~l~~~~~~~~~~~~~~-----~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
... .........+...........+... ...+++.+.+||.+||+.||.+|||++|+|+||||+++.+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred hHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 211 1110001111111111111112111 1237899999999999999999999999999999997653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=407.06 Aligned_cols=259 Identities=27% Similarity=0.454 Sum_probs=212.8
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHH-HHhcCCCCcceeeeEecCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKL-LRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~i-L~~L~HpnIv~l~~v~~~~~~~ 92 (614)
...++|++++.||+|+||.||+|.++.+++.||||++++... .......+.+|..+ ++.++||||+++++++ .
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~ 109 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----Q 109 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----E
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----E
Confidence 345789999999999999999999999999999999975432 23345567778776 5778999999999998 4
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
+...+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++..
T Consensus 110 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 110 TADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred eCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 5578999999998 599999998888999999999999999999999999999999999999999999999999999864
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
..... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..|...
T Consensus 190 ~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~---------- 254 (373)
T 2r5t_A 190 IEHNS---TTSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK---------- 254 (373)
T ss_dssp BCCCC---CCCSBSCCCCCCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS----------
T ss_pred ccCCC---ccccccCCccccCHHHhCC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc----------
Confidence 33222 1245689999999999987 68999999999999999999999999988876665554320
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCH----HHHHcCcccccC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA----EEALADPYFKGL 314 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa----~eiL~hp~f~~~ 314 (614)
.. ...+.+++.+.+||.+||+.||.+||++ +++++||||+++
T Consensus 255 ------------------~~---~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 255 ------------------PL---QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp ------------------CC---CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred ------------------cc---CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 11 1124678999999999999999999986 799999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=406.80 Aligned_cols=258 Identities=27% Similarity=0.442 Sum_probs=220.6
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|++++.||+|+||.||+|.++.+|+.||+|++... ...+...+.+|+.+|+.|+||||+++++++ .+...
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 122 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYE 122 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----EeCCE
Confidence 46899999999999999999999999999999999753 234556788999999999999999999998 45577
Q ss_pred EEEEEecCC-CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC--CCcEEEeecCcccccc
Q 007177 97 IYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA--NCKLKICDFGLARVAF 172 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~--~~~vKL~DFGla~~~~ 172 (614)
+|+|||||. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++...
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 999999998 59999987654 7999999999999999999999999999999999999974 4679999999998754
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 203 ~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~----------- 265 (387)
T 1kob_A 203 PDEI----VKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC----------- 265 (387)
T ss_dssp TTSC----EEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC-----------
T ss_pred CCcc----eeeeccCCCccCchhccC--CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------
Confidence 3321 234579999999999987 67899999999999999999999999998876665554321
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
........+..+++.+.+||.+||..||.+|||++|+|+||||++.
T Consensus 266 ----------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 266 ----------------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp ----------------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ----------------CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 1111123456789999999999999999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=415.73 Aligned_cols=265 Identities=25% Similarity=0.365 Sum_probs=219.8
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
...++|++++.||+|+||.||+|.++.+++.||+|++++... .......+.+|+.+|+.++||||+++++++ .+
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~ 140 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QD 140 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EE
Confidence 345789999999999999999999999999999999964210 111223477899999999999999999998 45
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
...+|||||||+ |+|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence 677999999997 5999998764 69999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCccccccccCCccccCcccccccCC--CCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFS--KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~--~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
... .......+||+.|+|||++.+... .|+.++|||||||++|||++|++||.+.+..+.+..|.....
T Consensus 220 ~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~------- 290 (410)
T 3v8s_A 220 KEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN------- 290 (410)
T ss_dssp TTS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-------
T ss_pred cCC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc-------
Confidence 322 112345789999999999876211 278999999999999999999999999887777666643100
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCC--CCCHHHHHcCcccccC
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD--RPTAEEALADPYFKGL 314 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~--Rpsa~eiL~hp~f~~~ 314 (614)
...+ ..+..+++++++||.+||..+|.+ |++++|+++||||+++
T Consensus 291 -------------------~~~~-p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 291 -------------------SLTF-PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp -------------------HCCC-CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred -------------------cccC-CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 0001 123468999999999999999988 9999999999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=390.89 Aligned_cols=261 Identities=25% Similarity=0.471 Sum_probs=209.0
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCC------------------------hHHHHHHHHHHHHH
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH------------------------ISDAARILREIKLL 71 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~------------------------~~~~~~i~~Ei~iL 71 (614)
..++|++.+.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+|
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 357899999999999999999999999999999998643211 11235688999999
Q ss_pred HhcCCCCcceeeeEecCCCCCCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCC
Q 007177 72 RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPK 150 (614)
Q Consensus 72 ~~L~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~ 150 (614)
+.++||||+++++++... ....+|+|||||+ ++|.+++ ....+++..++.++.||+.||.|||+.||+||||||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp HTCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HhCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 999999999999998542 2467999999998 5777654 3457999999999999999999999999999999999
Q ss_pred cEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 007177 151 NILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFS-KYTPAIDIWSIGCIFAEVLTGKPLFPGK 229 (614)
Q Consensus 151 NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~-~y~~~~DIWSLG~Il~eLltG~~pF~g~ 229 (614)
|||++.++.+||+|||+++....... .....+||+.|+|||++.+... .++.++|||||||++|+|++|..||.+.
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA---LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC---EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HEEECCCCCEEEecCCCccccccccc---cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 99999999999999999986543221 2345689999999999876311 1477899999999999999999999887
Q ss_pred ChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCc
Q 007177 230 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 309 (614)
Q Consensus 230 ~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp 309 (614)
+.......+.. . ...+ ...+.+++.+.+||.+||+.||.+|||++|+|+||
T Consensus 244 ~~~~~~~~~~~--------------------------~--~~~~-~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp 294 (298)
T 2zv2_A 244 RIMCLHSKIKS--------------------------Q--ALEF-PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294 (298)
T ss_dssp SHHHHHHHHHH--------------------------C--CCCC-CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred cHHHHHHHHhc--------------------------c--cCCC-CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence 65443332211 0 0011 12356889999999999999999999999999999
Q ss_pred ccc
Q 007177 310 YFK 312 (614)
Q Consensus 310 ~f~ 312 (614)
||+
T Consensus 295 ~~~ 297 (298)
T 2zv2_A 295 WVT 297 (298)
T ss_dssp HHH
T ss_pred ccc
Confidence 996
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=392.63 Aligned_cols=252 Identities=27% Similarity=0.310 Sum_probs=208.6
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
++|++++.||+|+||.||+|.++.+|+.||||++..............+|+..+..+ +||||+++++++ .+.+.
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~-----~~~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW-----EEGGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE-----EeCCE
Confidence 579999999999999999999999999999999887656666666777777776655 899999999998 45567
Q ss_pred EEEEEecCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|+|||||+++|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred EEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 9999999999999988764 469999999999999999999999999999999999999999999999999997654322
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
. .....||+.|+|||++.+ .++.++|||||||++|||++|..||.+......+ ..
T Consensus 212 ~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~---~~--------------- 266 (311)
T 3p1a_A 212 A----GEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL---RQ--------------- 266 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHH---TT---------------
T ss_pred C----CcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH---hc---------------
Confidence 2 234579999999999875 6899999999999999999998777554322111 00
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
.. ........+++.+.+||.+||+.||++|||++|+|+||||++
T Consensus 267 -----------~~---~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 267 -----------GY---LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp -----------TC---CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred -----------cC---CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 00 001112457899999999999999999999999999999974
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=399.55 Aligned_cols=263 Identities=26% Similarity=0.465 Sum_probs=195.1
Q ss_pred CeEEE---eEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCC
Q 007177 19 RYKIQ---EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 19 rY~i~---~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~ 94 (614)
+|++. +.||+|+||.||+|.++.+++.||||++... ....+.+|+.+|+.+. ||||+++++++ .+.
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~ 78 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVF-----HDQ 78 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcC
Confidence 46664 7899999999999999999999999999742 3456778999999997 99999999998 455
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC---cEEEeecCcccc
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC---KLKICDFGLARV 170 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~---~vKL~DFGla~~ 170 (614)
..+|+|||||+ ++|.+++.....+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 77999999998 59999999998999999999999999999999999999999999999997765 899999999986
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
...... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+.....
T Consensus 159 ~~~~~~---~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--------------- 218 (325)
T 3kn6_A 159 KPPDNQ---PLKTPCFTLHYAAPELLNQ--NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC--------------- 218 (325)
T ss_dssp CCC---------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C---------------
T ss_pred cCCCCC---cccccCCCcCccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc---------------
Confidence 433221 2345678999999999987 67999999999999999999999999875431100
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
......+..+...........|..+++++++||.+||..||.+|||++|+|+||||++...
T Consensus 219 -----~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 219 -----TSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp -----CCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred -----ccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 0001111222222222222334568999999999999999999999999999999987543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=413.33 Aligned_cols=266 Identities=23% Similarity=0.353 Sum_probs=218.8
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
-..++|++++.||+|+||.||+|.++.+|+.||||++++.. ........+.+|+.+|..++||||+++++++ .+
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~ 132 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QD 132 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----EC
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----ee
Confidence 34578999999999999999999999999999999997421 1112234477899999999999999999998 55
Q ss_pred CCcEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
...+|||||||. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++..
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~ 212 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL 212 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheec
Confidence 678999999997 6999999874 47999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCccccccccCCccccCccccccc-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCc
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 246 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~-----~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~ 246 (614)
..... ......+||+.|+|||++... ...|+.++|||||||++|||++|++||.+.+..+.+..|....
T Consensus 213 ~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~---- 286 (412)
T 2vd5_A 213 RADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK---- 286 (412)
T ss_dssp CTTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH----
T ss_pred cCCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----
Confidence 43322 112346899999999998621 1468999999999999999999999999988777666654210
Q ss_pred hhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCC---CCHHHHHcCcccccC
Q 007177 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR---PTAEEALADPYFKGL 314 (614)
Q Consensus 247 ~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~R---psa~eiL~hp~f~~~ 314 (614)
....+......+++++++||++||. ||.+| ++++|+++||||+++
T Consensus 287 ----------------------~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 287 ----------------------EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp ----------------------HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred ----------------------cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 0011112234688999999999999 99998 599999999999876
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=416.21 Aligned_cols=258 Identities=26% Similarity=0.458 Sum_probs=211.4
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
..++|++++.||+|+||.||+|.++.+|+.||||++.... ........+.+|+.+|+.++||||+++++++ .+.
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~-----~~~ 220 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTH 220 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE-----EET
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE-----eeC
Confidence 3468999999999999999999999999999999997432 2233456678999999999999999999998 445
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
+.+|||||||+ ++|.+++.....+++..++.|+.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++...
T Consensus 221 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 221 DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp TEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred CEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 67999999998 5999999888899999999999999999999998 999999999999999999999999999998643
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+.......+...
T Consensus 301 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------- 364 (446)
T 4ejn_A 301 KDGA---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME----------- 364 (446)
T ss_dssp C--------CCSSSCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred CCCc---ccccccCCccccCHhhcCC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC-----------
Confidence 2221 2345789999999999977 68999999999999999999999999988766555544210
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 314 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~ 314 (614)
.. .....+++.+.+||.+||+.||.+|| +++|+|+||||+++
T Consensus 365 -----------------~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 365 -----------------EI---RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp -----------------CC---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred -----------------CC---CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 00 11235789999999999999999999 99999999999976
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=389.31 Aligned_cols=284 Identities=31% Similarity=0.531 Sum_probs=230.3
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEE-CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC------cceeeeEec
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAID-THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD------IVEIKHIML 87 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d-~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn------Iv~l~~v~~ 87 (614)
...++|++++.||+|+||.||+|.+ ..+++.||||+++.. ......+.+|+.+++.++|++ |+++++++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~- 86 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF- 86 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE-
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc-
Confidence 3467999999999999999999998 568899999999742 345567889999999887654 99999988
Q ss_pred CCCCCCCCcEEEEEecCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC---------
Q 007177 88 PPSRRDFKDIYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA--------- 156 (614)
Q Consensus 88 ~~~~~~~~~~ylV~E~~~g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~--------- 156 (614)
.+.+.+|+|||||+++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 87 ----~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 87 ----EHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp ----EETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred ----ccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence 4456799999999989999998765 6899999999999999999999999999999999999987
Q ss_pred ----------CCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCC
Q 007177 157 ----------NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 226 (614)
Q Consensus 157 ----------~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF 226 (614)
++.+||+|||+++...... ...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf 234 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEHH------STLVSTRHYRAPEVILA--LGWSQPCDVWSIGCILIEYYLGFTVF 234 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSCC------CSSCSCGGGCCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccccccCCCceEeeCcccccCcccc------ccccCCccccChHHhhC--CCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 6689999999998643221 34579999999999987 67999999999999999999999999
Q ss_pred CCCChhHHHHHHHhhhCCCchhhhhhhhch--------------hHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhc
Q 007177 227 PGKNVVHQLDLMTDLLGTPSLDTISRVRND--------------KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLL 292 (614)
Q Consensus 227 ~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~--------------~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL 292 (614)
.+.+..+.+..+....+.+....+...... ....+..... .....+.......++.+.+||.+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~L 313 (339)
T 1z57_A 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRAC-KPLKEFMLSQDVEHERLFDLIQKML 313 (339)
T ss_dssp CCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHC-CCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcC-cchhhhcccchhhHHHHHHHHHHHh
Confidence 999999999999988888776665443211 0111111110 0111111112234578899999999
Q ss_pred CCCCCCCCCHHHHHcCcccccCC
Q 007177 293 AFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 293 ~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
+.||.+|||++|+|+||||+.+.
T Consensus 314 ~~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 314 EYDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp CSSTTTSCCHHHHTTSGGGGGGG
T ss_pred CcCcccccCHHHHhcCHHHHHHh
Confidence 99999999999999999998754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=385.50 Aligned_cols=257 Identities=30% Similarity=0.489 Sum_probs=210.2
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++.+.||+|+||.||+|.++.++..||+|++..... ......+.+|+.+|+.++||||+++++++ .+..
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 93 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYH 93 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecCC
Confidence 34689999999999999999999999999999999975432 23456788999999999999999999998 4556
Q ss_pred cEEEEEecCC-CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEE---CCCCcEEEeecCc
Q 007177 96 DIYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA---NANCKLKICDFGL 167 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi---~~~~~vKL~DFGl 167 (614)
.+|+|||||+ ++|.+.+.. ...+++..++.|+.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~ 173 (285)
T 3is5_A 94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGL 173 (285)
T ss_dssp EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence 7999999998 499988854 3679999999999999999999999999999999999999 4567899999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007177 168 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247 (614)
Q Consensus 168 a~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~ 247 (614)
+........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 174 a~~~~~~~~----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~------- 239 (285)
T 3is5_A 174 AELFKSDEH----STNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY------- 239 (285)
T ss_dssp CCC--------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------
T ss_pred ceecCCccc----CcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc-------
Confidence 976543221 234579999999999864 689999999999999999999999988775444333211
Q ss_pred hhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 248 ~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
....+......+++.+.+||.+||+.||++|||++|+|+||||++
T Consensus 240 ---------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 240 ---------------------KEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ---------------------CCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ---------------------CCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 011111223457899999999999999999999999999999975
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=381.66 Aligned_cols=258 Identities=31% Similarity=0.476 Sum_probs=220.2
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++.+.||+|+||.||+|.++.++..||+|++..... .....+.+|+.+|+.++||||+++++++ .+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~ 79 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNT 79 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCC
Confidence 34679999999999999999999999999999999975432 2356788999999999999999999998 4556
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEE---CCCCcEEEeecCccccc
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA---NANCKLKICDFGLARVA 171 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi---~~~~~vKL~DFGla~~~ 171 (614)
.+|+|||||+ ++|.+.+.....+++..++.|+.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 80 DIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 7999999998 5999999888889999999999999999999999999999999999999 78889999999999765
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 160 ~~~~----~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------ 226 (277)
T 3f3z_A 160 KPGK----MMRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTF------ 226 (277)
T ss_dssp CTTS----CBCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------
T ss_pred cCcc----chhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC------
Confidence 4322 1244579999999999875 58999999999999999999999999887766655543321111
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
....+..+++.+.+||.+||+.||.+|||+.++|+||||++.
T Consensus 227 ---------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 227 ---------------------PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp ---------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred ---------------------CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 112234678999999999999999999999999999999854
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=382.46 Aligned_cols=262 Identities=25% Similarity=0.349 Sum_probs=219.1
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
.....|++.+.||+|+||.||+|.+..++..||+|++............+.+|+.+|+.++||||+++++++.... .+.
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~ 101 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGK 101 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSC
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCC
Confidence 4456799999999999999999999999999999999876666677888999999999999999999999875432 345
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeecCCCCcEEEC-CCCcEEEeecCcccc
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILAN-ANCKLKICDFGLARV 170 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILi~-~~~~vKL~DFGla~~ 170 (614)
..+|+||||++ ++|.+++.....+++..++.|+.||+.||.|||+.| |+||||||+|||++ .++.+||+|||++..
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 67999999997 599999998888999999999999999999999999 99999999999998 788999999999975
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+......
T Consensus 182 ~~~~~-----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--------- 244 (290)
T 1t4h_A 182 KRASF-----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS--------- 244 (290)
T ss_dssp CCTTS-----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT---------
T ss_pred ccccc-----cccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc---------
Confidence 43221 234579999999998874 6899999999999999999999999876544333221110
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
...+ .......++.+.+||.+||..||.+|||++|+|+||||++
T Consensus 245 ----------------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 245 ----------------GVKP---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ----------------TCCC---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ----------------cCCc---cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 0001 1112345689999999999999999999999999999985
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=398.20 Aligned_cols=257 Identities=27% Similarity=0.452 Sum_probs=203.3
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|++.+.||+|+||.||+|.++.+++.||||++... .....+.+|+.+|+.++||||+++++++ .+...
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~ 122 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHPNIIKLKEIF-----ETPTE 122 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----hhHHHHHHHHHHHHhCCCCCCcceeeeE-----ecCCe
Confidence 46799999999999999999999999999999999753 2345677899999999999999999998 44567
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC---CCcEEEeecCcccccc
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---NCKLKICDFGLARVAF 172 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~---~~~vKL~DFGla~~~~ 172 (614)
+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++...
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999998 599999988888999999999999999999999999999999999999975 8899999999998653
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhH-HHHHHHhhhCCCchhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~-~l~~i~~~~g~p~~~~i~ 251 (614)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... .+..+.
T Consensus 203 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~------------ 264 (349)
T 2w4o_A 203 HQV----LMKTVCGTPGYCAPEILRG--CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL------------ 264 (349)
T ss_dssp --------------CGGGSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHH------------
T ss_pred ccc----ccccccCCCCccCHHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHH------------
Confidence 322 1244679999999999987 679999999999999999999999997765433 222221
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
..........++.++..+.+||.+||..||++|||++|+|+||||.+..
T Consensus 265 ---------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 265 ---------------NCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp ---------------TTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred ---------------hCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 1111222344567899999999999999999999999999999998643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=395.79 Aligned_cols=268 Identities=29% Similarity=0.451 Sum_probs=216.0
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc---CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF---EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~---~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
.++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|+.++||||+++++++ .+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~ 99 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-----ED 99 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh-----cc
Confidence 467999999999999999999999999999999986431 1234567889999999999999999999998 45
Q ss_pred CCcEEEEEecCC-CcHHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHH
Q 007177 94 FKDIYVVFELME-SDLHQVIKA----------------------------------------NDDLTREHYQFFLYQLLR 132 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~----------------------------------------~~~lse~~~~~i~~QIl~ 132 (614)
...+|+|||||+ ++|.+++.. ...+++..++.|+.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 567999999997 699998842 112467889999999999
Q ss_pred HHHHHHhCCeEeecCCCCcEEECCCC--cEEEeecCccccccCCCC-CccccccccCCccccCcccccccCCCCCCcccc
Q 007177 133 ALKYIHTANVYHRDLKPKNILANANC--KLKICDFGLARVAFNDTP-TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDI 209 (614)
Q Consensus 133 aL~yLHs~gIvHrDLKP~NILi~~~~--~vKL~DFGla~~~~~~~~-~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DI 209 (614)
||.|||+.||+||||||+|||++.++ .+||+|||+++....... .........||+.|+|||++.+....++.++||
T Consensus 180 ~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 99999999999999999999998776 899999999986543221 111234567999999999986543578999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHH
Q 007177 210 WSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLE 289 (614)
Q Consensus 210 WSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~ 289 (614)
|||||++|+|++|..||.+.+..+.+..+.... .......+..+++.+.+||.
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~li~ 312 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKK---------------------------LCFENPNYNVLSPLARDLLS 312 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------------------------CCTTSGGGGGSCHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcc---------------------------cccCCcccccCCHHHHHHHH
Confidence 999999999999999999988766655543211 11111223457889999999
Q ss_pred HhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 290 RLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 290 ~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
+||+.||.+|||+.++|+||||+++..
T Consensus 313 ~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 313 NLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp HHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred HHcCCChhHCCCHHHHhcChhhccChH
Confidence 999999999999999999999997654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=412.84 Aligned_cols=262 Identities=29% Similarity=0.482 Sum_probs=220.9
Q ss_pred ccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007177 12 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 90 (614)
Q Consensus 12 ~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 90 (614)
......++|.+++.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+|+.++||||+++++++
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~---- 85 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI---- 85 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE----
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE----
Confidence 334456799999999999999999999999999999999974311 112345788999999999999999999998
Q ss_pred CCCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 91 RRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
.+...+|+|||||+ ++|.+++..++.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 86 -~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~ 164 (476)
T 2y94_A 86 -STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN 164 (476)
T ss_dssp -ECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred -EECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchh
Confidence 44567999999997 5999999888899999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 170 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 170 ~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
...... .....+||+.|+|||++.+. ..++.++||||||||+|+|++|..||.+.+....+..+....
T Consensus 165 ~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------- 232 (476)
T 2y94_A 165 MMSDGE----FLRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI------- 232 (476)
T ss_dssp ECCTTC----CBCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC-------
T ss_pred hccccc----cccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-------
Confidence 754322 23456899999999999862 234789999999999999999999998877655554442210
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
. .....+++.+.+||.+||..||.+|||++|+++||||+..
T Consensus 233 ---------------------~---~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 233 ---------------------F---YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp ---------------------C---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ---------------------c---CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 0 1113478899999999999999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=397.66 Aligned_cols=283 Identities=27% Similarity=0.406 Sum_probs=225.7
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC--------CCCcceeeeEecC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR--------HPDIVEIKHIMLP 88 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~--------HpnIv~l~~v~~~ 88 (614)
.++|++++.||+|+||.||+|.+..+++.||||++.. .......+.+|+.+|+.++ ||||+++++.+..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec---CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 4799999999999999999999999999999999974 2345667889999999986 7889999998853
Q ss_pred CCCCCCCcEEEEEecCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CeEeecCCCCcEEECCCC-------
Q 007177 89 PSRRDFKDIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANC------- 158 (614)
Q Consensus 89 ~~~~~~~~~ylV~E~~~g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILi~~~~------- 158 (614)
.. .+...+|+|||||+++|.+.+... ..+++..++.|+.||+.||.|||++ ||+||||||+|||++.++
T Consensus 113 ~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 113 SG-VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EE-TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred cC-CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 21 244679999999999888888664 4699999999999999999999998 999999999999999775
Q ss_pred ------------------------------------------cEEEeecCccccccCCCCCccccccccCCccccCcccc
Q 007177 159 ------------------------------------------KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 196 (614)
Q Consensus 159 ------------------------------------------~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl 196 (614)
.+||+|||+++..... ....+||+.|+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCHHHH
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCChhh
Confidence 7999999999865432 2345799999999999
Q ss_pred cccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC------hhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCC
Q 007177 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN------VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQP 270 (614)
Q Consensus 197 ~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~------~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~ 270 (614)
.+ ..|+.++|||||||++|+|++|..||.+.+ ..+++..+...+|.+....+...... ..++........
T Consensus 266 ~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~ 341 (397)
T 1wak_A 266 IG--SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS--KEFFTKKGDLKH 341 (397)
T ss_dssp HT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTG--GGTBCTTSSBSS
T ss_pred cC--CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccc--ccccCCcccccc
Confidence 87 579999999999999999999999998765 56788889999998877655322111 000000000000
Q ss_pred Ccc-------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 271 VQF-------------SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 271 ~~~-------------~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
..- .......++.+.+||.+||+.||++|||++|+|+||||++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 000 0001123467899999999999999999999999999973
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=396.09 Aligned_cols=280 Identities=32% Similarity=0.531 Sum_probs=226.8
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CC-----CcceeeeEecCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HP-----DIVEIKHIMLPPS 90 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-Hp-----nIv~l~~v~~~~~ 90 (614)
.++|++.+.||+|+||.||+|.+..+++.||||+++. .......+.+|+.+++.++ |+ +|+.+++.+.
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~--- 126 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM--- 126 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE---
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec---cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec---
Confidence 4789999999999999999999999999999999974 2344566778999998885 55 3899999883
Q ss_pred CCCCCcEEEEEecCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEeecCCCCcEEEC--CCCcEEEee
Q 007177 91 RRDFKDIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIH--TANVYHRDLKPKNILAN--ANCKLKICD 164 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLH--s~gIvHrDLKP~NILi~--~~~~vKL~D 164 (614)
....+|||||||+++|.+++... ..+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+|
T Consensus 127 --~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 127 --FRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp --ETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred --cCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 44679999999999999999875 46999999999999999999999 57999999999999995 477899999
Q ss_pred cCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCC
Q 007177 165 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 244 (614)
Q Consensus 165 FGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~ 244 (614)
||+++..... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+++..|...++.
T Consensus 205 FG~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 276 (382)
T 2vx3_A 205 FGSSCQLGQR------IYQYIQSRFYRSPEVLLG--MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276 (382)
T ss_dssp CTTCEETTCC------CCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred ccCceecccc------cccccCCccccChHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999875332 234689999999999987 57999999999999999999999999999999999999999999
Q ss_pred CchhhhhhhhchhHHHHHHhhcccCC---------Cccc-CCC------------------C-------CCCHHHHHHHH
Q 007177 245 PSLDTISRVRNDKARRYLTSMRKKQP---------VQFS-QKF------------------P-------NADPSALRLLE 289 (614)
Q Consensus 245 p~~~~i~~~~~~~~~~~l~~~~~~~~---------~~~~-~~~------------------~-------~~s~~l~dLI~ 289 (614)
|....+.... ....++..+..... ..+. ... . ..++.+++||.
T Consensus 277 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 354 (382)
T 2vx3_A 277 PPAHILDQAP--KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLIL 354 (382)
T ss_dssp CCHHHHTTCT--THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHH
T ss_pred CCHHHHHhhH--HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHH
Confidence 9877665322 22233222211000 0000 000 0 00147899999
Q ss_pred HhcCCCCCCCCCHHHHHcCcccccC
Q 007177 290 RLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 290 ~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
+||++||++|||++|+|+||||++.
T Consensus 355 ~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 355 RMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HhcCCChhhCCCHHHHhcCcccccC
Confidence 9999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=392.22 Aligned_cols=262 Identities=25% Similarity=0.424 Sum_probs=206.2
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC------
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR------ 91 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~------ 91 (614)
++|++++.||+|+||.||+|.++.+|+.||||++.... .......+.+|+.+|+.|+||||+++++++.....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 47999999999999999999999999999999997532 33456778999999999999999999998754321
Q ss_pred ----------------------------------------------CCCCcEEEEEecCC-CcHHHHHHhCCC---CCHH
Q 007177 92 ----------------------------------------------RDFKDIYVVFELME-SDLHQVIKANDD---LTRE 121 (614)
Q Consensus 92 ----------------------------------------------~~~~~~ylV~E~~~-g~L~~~i~~~~~---lse~ 121 (614)
.....+|+|||||+ ++|.+++..... .++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 12234899999998 499999987643 5666
Q ss_pred HHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCc---------cccccccCCccccC
Q 007177 122 HYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT---------IFWTDYVATRWYRA 192 (614)
Q Consensus 122 ~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~---------~~~~~~vgt~~Y~A 192 (614)
.++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......... ......+||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 789999999999999999999999999999999999999999999998765432111 12244679999999
Q ss_pred cccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCc
Q 007177 193 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQ 272 (614)
Q Consensus 193 PEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~ 272 (614)
||++.+ ..++.++|||||||++|+|++|..|+.. ....+..... ..
T Consensus 245 PE~~~~--~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~---------------------------~~ 290 (332)
T 3qd2_B 245 PEQIHG--NNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRN---------------------------LK 290 (332)
T ss_dssp HHHHHC--CCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHT---------------------------TC
T ss_pred hHHhcC--CCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhc---------------------------cC
Confidence 999987 6899999999999999999998766521 1111111000 01
Q ss_pred ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 273 FSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 273 ~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
+...+...++.+.+||.+||+.||++|||++|+|+||||+++
T Consensus 291 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 291 FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 111122346788999999999999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=380.96 Aligned_cols=257 Identities=26% Similarity=0.440 Sum_probs=215.4
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
.++|++++.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++ .+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 82 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDAT 82 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-----ecCC
Confidence 4689999999999999999999999999999999864211 111245678999999999999999999998 4556
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
..|+||||++ ++|.+.+.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 7999999999 599999988888999999999999999999999999999999999999999999999999998654322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 163 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 223 (279)
T 3fdn_A 163 R-----RTDLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE------------ 223 (279)
T ss_dssp ----------CCCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC------------
T ss_pred c-----ccccCCCCCccCHhHhcc--CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC------------
Confidence 2 234579999999999887 678999999999999999999999998887655554442210
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
. .....+++.+.+||.+||..||.+|||++|+|+||||+....
T Consensus 224 ----------------~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 224 ----------------F---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp ----------------C---CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred ----------------C---CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 0 112346789999999999999999999999999999987543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=384.04 Aligned_cols=258 Identities=29% Similarity=0.464 Sum_probs=217.6
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.+|+.++||||+++++++ .+...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 80 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIY-----ESTTH 80 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhc-----ccCCE
Confidence 468999999999999999999999999999999997532 22345678999999999999999999998 45567
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEE---CCCCcEEEeecCcccccc
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA---NANCKLKICDFGLARVAF 172 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi---~~~~~vKL~DFGla~~~~ 172 (614)
+|+|||||+ ++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999998 5999999888889999999999999999999999999999999999999 778899999999997543
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+....
T Consensus 161 ~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~---------- 223 (304)
T 2jam_A 161 NG-----IMSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY---------- 223 (304)
T ss_dssp CB-----TTHHHHSCCCBCCTTTBSS--CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC----------
T ss_pred CC-----ccccccCCCCccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC----------
Confidence 22 1234579999999999987 679999999999999999999999998877655554443211
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
.......+..+++.+.+||.+||..||.+|||++|+|+||||++..
T Consensus 224 -----------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 224 -----------------YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp -----------------CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred -----------------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 1111233457889999999999999999999999999999998653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=389.65 Aligned_cols=280 Identities=25% Similarity=0.392 Sum_probs=209.6
Q ss_pred CCCeEEE-eEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007177 17 ASRYKIQ-EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 17 ~~rY~i~-~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~ 94 (614)
.++|++. +.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+|+.+ +||||+++++++ .+.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~-----~~~ 83 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFF-----EEE 83 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EET
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeC
Confidence 5689995 78999999999999999999999999997542 23356788999999885 799999999998 345
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCc---EEEeecCcccc
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK---LKICDFGLARV 170 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~---vKL~DFGla~~ 170 (614)
+.+|+|||||+ ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++..
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 67999999998 699999988888999999999999999999999999999999999999998776 99999999976
Q ss_pred ccCCCC----CccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhC
Q 007177 171 AFNDTP----TTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 243 (614)
Q Consensus 171 ~~~~~~----~~~~~~~~vgt~~Y~APEvl~~~---~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g 243 (614)
...... ........+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+..+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-------- 235 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG-------- 235 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC--------
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc--------
Confidence 432211 11112345799999999998631 134788999999999999999999999876532100
Q ss_pred CCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 244 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 244 ~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
-...+. ........+..+...........+..+++.+.+||.+||..||.+|||++|+|+||||++..
T Consensus 236 ~~~~~~----~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 236 WDRGEA----CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp C----C----CHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred cccccc----chhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 000000 00000111111212111111223456889999999999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=387.59 Aligned_cols=255 Identities=28% Similarity=0.494 Sum_probs=214.4
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
.|...+.||+|+||.||+|.++.+|+.||||++.... ......+.+|+.+|+.++||||+++++++. .....|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~ 118 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYL-----VGEELW 118 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEE-----ECCEEE
Confidence 4888999999999999999999999999999987432 233556889999999999999999999984 446799
Q ss_pred EEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007177 99 VVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 177 (614)
Q Consensus 99 lV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 177 (614)
+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 119 lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 197 (321)
T 2c30_A 119 VLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 197 (321)
T ss_dssp EEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred EEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc
Confidence 9999998 588888754 56999999999999999999999999999999999999999999999999999865433221
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchh
Q 007177 178 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257 (614)
Q Consensus 178 ~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~ 257 (614)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 198 ---~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~--------------- 257 (321)
T 2c30_A 198 ---RKSLVGTPYWMAPEVISR--SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP--------------- 257 (321)
T ss_dssp ---BCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS---------------
T ss_pred ---cccccCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---------------
Confidence 245689999999999977 678999999999999999999999998877655544332210
Q ss_pred HHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 258 ~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
.+.......+++.+.+||.+||+.||++|||++|+|+||||...
T Consensus 258 -------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 258 -------------PPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp -------------CCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred -------------CCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 00011123568899999999999999999999999999999854
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=399.17 Aligned_cols=257 Identities=28% Similarity=0.416 Sum_probs=213.2
Q ss_pred CCeEE--EeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 18 SRYKI--QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 18 ~rY~i--~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
+.|.+ .+.||+|+||.||+|.+..+|+.||+|+++.. .......+.+|+.+|+.|+||||+++++++ .+..
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~ 159 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKN 159 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECC
Confidence 34555 67899999999999999999999999999753 335567889999999999999999999998 4556
Q ss_pred cEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEE--CCCCcEEEeecCccccc
Q 007177 96 DIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA--NANCKLKICDFGLARVA 171 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi--~~~~~vKL~DFGla~~~ 171 (614)
.+|||||||+ ++|.+.+... ..+++..++.|+.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++..
T Consensus 160 ~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 160 DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 7999999998 5998888654 469999999999999999999999999999999999999 56788999999999875
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
..... ....+||+.|+|||++.+ ..++.++||||||||+|+|++|..||.+.+..+.+..+......
T Consensus 240 ~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~------- 306 (373)
T 2x4f_A 240 KPREK----LKVNFGTPEFLAPEVVNY--DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD------- 306 (373)
T ss_dssp CTTCB----CCCCCSSCTTCCHHHHTT--CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-------
T ss_pred CCccc----cccccCCCcEeChhhccC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-------
Confidence 43321 234579999999999876 67899999999999999999999999998877776665432111
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
.....++.+++++.+||.+||+.||.+|||++|+|+||||++.
T Consensus 307 --------------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 307 --------------------LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp --------------------SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred --------------------CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 1123346789999999999999999999999999999999854
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=404.77 Aligned_cols=259 Identities=28% Similarity=0.443 Sum_probs=205.3
Q ss_pred CCCCeEEE-eEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHH-HhcCCCCcceeeeEecCCCCCC
Q 007177 16 DASRYKIQ-EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLL-RLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 16 ~~~rY~i~-~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL-~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
..++|.+. +.||+|+||.||+|.++.+|+.||||++... ..+.+|+.++ +.++||||+++++++.... .+
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~ 130 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY-AG 130 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TT
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cC
Confidence 44678877 7999999999999999999999999999642 3466888887 4558999999999874311 23
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC---CCcEEEeecCc
Q 007177 94 FKDIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---NCKLKICDFGL 167 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~---~~~vKL~DFGl 167 (614)
...+|||||||+ |+|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++. ++.+||+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 567999999998 59999998754 5999999999999999999999999999999999999998 78899999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhH----HHHHHHhhhC
Q 007177 168 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH----QLDLMTDLLG 243 (614)
Q Consensus 168 a~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~----~l~~i~~~~g 243 (614)
++...... .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|..||.+.+... ....+
T Consensus 211 a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----- 279 (400)
T 1nxk_A 211 AKETTSHN----SLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----- 279 (400)
T ss_dssp CEECC---------------CTTCCGGGSCC--CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH-----
T ss_pred ccccCCCC----ccccCCCCCCccCHhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH-----
Confidence 98653222 2345689999999999976 689999999999999999999999998765321 11111
Q ss_pred CCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 244 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 244 ~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
...........|..+++++.+||.+||..||.+|||++|+|+||||.+..
T Consensus 280 ----------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 280 ----------------------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp ----------------------HHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred ----------------------HcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 01111111234567899999999999999999999999999999998643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=386.33 Aligned_cols=284 Identities=31% Similarity=0.520 Sum_probs=229.1
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCC-cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC------cceeeeEecC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTG-EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD------IVEIKHIMLP 88 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg-~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn------Iv~l~~v~~~ 88 (614)
..++|++++.||+|+||.||+|.+..++ ..||||+++. .......+.+|+.+|+.++|++ |+.+++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~-- 91 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF-- 91 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE--
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc---cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee--
Confidence 4589999999999999999999998877 6899999974 2345567788999999997766 88888887
Q ss_pred CCCCCCCcEEEEEecCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEE------------
Q 007177 89 PSRRDFKDIYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA------------ 154 (614)
Q Consensus 89 ~~~~~~~~~ylV~E~~~g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi------------ 154 (614)
...+.+|||||||+++|.+.+.... .+++..++.|+.||+.||.|||++||+||||||+|||+
T Consensus 92 ---~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 92 ---NFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp ---EETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred ---eeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence 4456799999999999988887654 69999999999999999999999999999999999999
Q ss_pred -------CCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 007177 155 -------NANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 227 (614)
Q Consensus 155 -------~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~ 227 (614)
+.++.+||+|||+++...... ...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEHH------TTIVATRHYRPPEVILE--LGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSCC------CSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccCCCcEEEeecCccccccccc------cCCcCCCcccCCeeeec--CCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 567899999999998643222 34579999999999987 689999999999999999999999999
Q ss_pred CCChhHHHHHHHhhhCCCchhhhhhhhchh--------------HHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcC
Q 007177 228 GKNVVHQLDLMTDLLGTPSLDTISRVRNDK--------------ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLA 293 (614)
Q Consensus 228 g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~--------------~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~ 293 (614)
+.+..+.+..+....+.++...+....... ..+++..... ............++.+.+||.+||.
T Consensus 241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK-PLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC-CGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCC-cccccccccchhHHHHHHHHHHHhc
Confidence 999999999999999888776654432211 1111111100 0000011112235678999999999
Q ss_pred CCCCCCCCHHHHHcCcccccCCc
Q 007177 294 FDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 294 ~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
.||.+|||++|+|+||||+++..
T Consensus 320 ~dP~~Rpt~~e~l~hp~f~~~~~ 342 (355)
T 2eu9_A 320 FDPAQRITLAEALLHPFFAGLTP 342 (355)
T ss_dssp SSTTTSCCHHHHTTSGGGGGCCH
T ss_pred CChhhCcCHHHHhcChhhcCCCh
Confidence 99999999999999999997653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=392.38 Aligned_cols=269 Identities=25% Similarity=0.404 Sum_probs=222.3
Q ss_pred cccccCCCCCCeEEE-eEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEe
Q 007177 9 EFFSEYGDASRYKIQ-EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIM 86 (614)
Q Consensus 9 ~~~~~~~~~~rY~i~-~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~ 86 (614)
.|-......++|.+. +.||+|+||.||+|.++.+++.||||++............+.+|+.+|+.+. ||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 333333445679888 8999999999999999999999999999865544455677889999999995 69999999998
Q ss_pred cCCCCCCCCcEEEEEecCCC-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC---CCcE
Q 007177 87 LPPSRRDFKDIYVVFELMES-DLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---NCKL 160 (614)
Q Consensus 87 ~~~~~~~~~~~ylV~E~~~g-~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~---~~~v 160 (614)
.+...+|+|||||.+ +|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+|||++. ++.+
T Consensus 99 -----~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 99 -----ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp -----ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCE
T ss_pred -----EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcE
Confidence 455679999999985 999888543 67999999999999999999999999999999999999988 7899
Q ss_pred EEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 007177 161 KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 240 (614)
Q Consensus 161 KL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~ 240 (614)
||+|||+++....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+..
T Consensus 174 kL~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 247 (327)
T 3lm5_A 174 KIVDFGMSRKIGHACE----LREIMGTPEYLAPEILNY--DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ 247 (327)
T ss_dssp EECCGGGCEEC-------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEeeCccccccCCccc----cccccCCcCccCCeeecC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHh
Confidence 9999999987543321 234679999999999986 6899999999999999999999999999887666554433
Q ss_pred hhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 241 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 241 ~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
... ......+..+++.+.+||.+||+.||.+|||++++|+||||+++.
T Consensus 248 ~~~---------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 248 VNV---------------------------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp TCC---------------------------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred ccc---------------------------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 211 112234567889999999999999999999999999999998764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=391.54 Aligned_cols=271 Identities=24% Similarity=0.346 Sum_probs=217.1
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
....++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.... .
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 86 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-P 86 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-T
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-C
Confidence 3456789999999999999999999999999999999976433 3445667889999999999999999999885432 1
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
.....|+|||||+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 2234699999998 599999998888999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
.............+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~---------- 234 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE---------- 234 (311)
T ss_dssp ---------------CCTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC----------
T ss_pred cccccccccccccCcCcccCCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC----------
Confidence 443332222344679999999999987 68999999999999999999999999988765554333221
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
...........+++.+.+||.+||+.||.+||++.++|.|+|++..
T Consensus 235 -----------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 235 -----------------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp -----------------CCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -----------------CCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 1111222345688999999999999999999999999999999754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=393.60 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=216.8
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
...++|++++.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+|+.++||||+++++++. +
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~ 125 (348)
T 1u5q_A 51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----R 125 (348)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----E
T ss_pred chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----E
Confidence 3346799999999999999999999999999999999754322 334567889999999999999999999984 4
Q ss_pred CCcEEEEEecCCCcHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 94 FKDIYVVFELMESDLHQVIK-ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 94 ~~~~ylV~E~~~g~L~~~i~-~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
....|+|||||.|+|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 126 ~~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 126 EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp TTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred CCeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 46799999999999988885 45679999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~-~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
.. ...+||+.|+|||++.+. ...++.++|||||||++|||++|.+||.+.+....+..+...
T Consensus 206 ~~-------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~---------- 268 (348)
T 1u5q_A 206 PA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---------- 268 (348)
T ss_dssp SB-------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----------
T ss_pred CC-------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc----------
Confidence 21 345799999999988421 257899999999999999999999999887765554433210
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
..+. .....+++.+.+||.+||+.||.+|||++++|+||||..
T Consensus 269 ----------------~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 269 ----------------ESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp ----------------CCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ----------------CCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 0110 112356889999999999999999999999999999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=391.15 Aligned_cols=262 Identities=26% Similarity=0.348 Sum_probs=209.0
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC--CCcceeeeEecCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH--PDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~H--pnIv~l~~v~~~~~~~~ 93 (614)
..++|++++.||+|+||.||+|.+ .+++.||||++............+.+|+.+|+.++| |||+++++++ .+
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~ 80 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----IT 80 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE-----ee
Confidence 456899999999999999999987 468899999997655566667888999999999986 9999999998 45
Q ss_pred CCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 94 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 94 ~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
...+|||||++.++|.+++.....+++.+++.|+.||+.||.|||+.||+||||||+|||++ ++.+||+|||+++....
T Consensus 81 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 81 DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp SSEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred CCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 56799999988889999999999999999999999999999999999999999999999997 67899999999986543
Q ss_pred CCCCccccccccCCccccCccccccc---------CCCCCCcccchhHHHHHHHHHhCCCCCCCCChh-HHHHHHHhhhC
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLDLMTDLLG 243 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~---------~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~-~~l~~i~~~~g 243 (614)
... .......+||+.|+|||++.+. ...|+.++|||||||++|+|++|+.||.+.... ..+..+
T Consensus 160 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~----- 233 (343)
T 3dbq_A 160 DTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI----- 233 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH-----
T ss_pred ccc-cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHH-----
Confidence 322 1123456899999999998531 146889999999999999999999999764321 111111
Q ss_pred CCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 244 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 244 ~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
+...... ......+..+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 234 ---------------------~~~~~~~---~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 234 ---------------------IDPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp ---------------------HCTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ---------------------hcCCccc---CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 0011111 1123456789999999999999999999999999999853
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=378.05 Aligned_cols=260 Identities=28% Similarity=0.471 Sum_probs=217.7
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----HHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI----SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~----~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
++|++++.||+|+||.||+|.+..+|+.||+|+++...... .....+.+|+.+|+.++||||+++++++ .+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF-----EN 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhee-----cC
Confidence 47999999999999999999999999999999987532221 1356788999999999999999999998 44
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC----cEEEeecCcc
Q 007177 94 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC----KLKICDFGLA 168 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~----~vKL~DFGla 168 (614)
....|+||||++ ++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 567999999997 69999998888899999999999999999999999999999999999998877 8999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007177 169 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~ 248 (614)
........ .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 160 ~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--- 230 (283)
T 3bhy_A 160 HKIEAGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF--- 230 (283)
T ss_dssp EECC------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC---
T ss_pred eeccCCCc----ccccCCCcCccCcceecC--CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCC---
Confidence 86543221 234579999999999876 678999999999999999999999999887666555443211111
Q ss_pred hhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 249 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 249 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
....++.+++.+.+||.+||..||.+|||++++|+||||+.+.
T Consensus 231 ------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 231 ------------------------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp ------------------------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred ------------------------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 1122356788999999999999999999999999999998764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=406.00 Aligned_cols=254 Identities=17% Similarity=0.210 Sum_probs=202.2
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHH---HHhcCCCCcceee-------eE
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKL---LRLLRHPDIVEIK-------HI 85 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~i---L~~L~HpnIv~l~-------~v 85 (614)
.++|++.+.||+|+||.||+|.++.+|+.||||++... .........+.+|+.+ |+.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 47899999999999999999999999999999999743 2334466778899954 5555799999998 54
Q ss_pred ecCCCC-------CCCC-----cEEEEEecCCCcHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhCCeEeec
Q 007177 86 MLPPSR-------RDFK-----DIYVVFELMESDLHQVIKANDDLTR-------EHYQFFLYQLLRALKYIHTANVYHRD 146 (614)
Q Consensus 86 ~~~~~~-------~~~~-----~~ylV~E~~~g~L~~~i~~~~~lse-------~~~~~i~~QIl~aL~yLHs~gIvHrD 146 (614)
+..... .+.. ..|||||||+|+|.+++...+.+++ ..+..|+.||+.||.|||+.||+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 432210 0111 3899999999999999987655655 78888999999999999999999999
Q ss_pred CCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCC-----------CCCCcccchhHHHH
Q 007177 147 LKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFS-----------KYTPAIDIWSIGCI 215 (614)
Q Consensus 147 LKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~-----------~y~~~~DIWSLG~I 215 (614)
|||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+ . .|+.++|||||||+
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~--~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEAR--RATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHH--HTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC------cccCCCC-cCccChhhhcc--cccccccccccccCChhhhHHHHHHH
Confidence 999999999999999999999985322 2244577 99999999876 4 68999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCC
Q 007177 216 FAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 295 (614)
Q Consensus 216 l~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~D 295 (614)
+|||++|+.||.+.+....+. .....++.+++.+.+||.+||..|
T Consensus 303 l~elltg~~Pf~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~li~~~L~~d 347 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSE-----------------------------------WIFRSCKNIPQPVRALLEGFLRYP 347 (377)
T ss_dssp HHHHHHSSCCC------CCSG-----------------------------------GGGSSCCCCCHHHHHHHHHHTCSS
T ss_pred HHHHHHCCCCCcccccccchh-----------------------------------hhhhhccCCCHHHHHHHHHHcCCC
Confidence 999999999997654321110 011223578899999999999999
Q ss_pred CCCCCCHHHHHcCcccccC
Q 007177 296 PKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 296 P~~Rpsa~eiL~hp~f~~~ 314 (614)
|.+|||+.|+|+||||+.+
T Consensus 348 p~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 348 KEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp GGGCCCHHHHHTSHHHHHH
T ss_pred chhCCCHHHHhhChHHHHH
Confidence 9999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=376.46 Aligned_cols=263 Identities=29% Similarity=0.428 Sum_probs=223.5
Q ss_pred cCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 13 EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 13 ~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
.....++|.+.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~----- 84 (294)
T 2rku_A 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF----- 84 (294)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----
T ss_pred CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee-----
Confidence 3456789999999999999999999999999999999987543 3345567788999999999999999999998
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
.+.+.+|+||||++ ++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 85 EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 164 (294)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCcee
Confidence 45567999999999 69999998888899999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 165 ~~~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------- 229 (294)
T 2rku_A 165 VEYDGER---KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK---------- 229 (294)
T ss_dssp CCSTTCC---BCCCCSCCSSCCHHHHTT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT----------
T ss_pred cccCccc---cccccCCCCcCCcchhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh----------
Confidence 5432221 234679999999999877 5789999999999999999999999988775544333211
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
. .. .....+++.+.+||.+||+.||.+|||++|+|+||||.....
T Consensus 230 -----------------~-~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 230 -----------------N-EY---SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp -----------------T-CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred -----------------c-cC---CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence 0 00 112357889999999999999999999999999999986543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=425.76 Aligned_cols=258 Identities=22% Similarity=0.384 Sum_probs=221.7
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~ 93 (614)
..++|++++.||+|+||.||+|.++.+++.||||++++.. ........+.+|..+|..+ +||+|+.+++++ .+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence 3578999999999999999999999999999999997431 1122345678899999887 699999999998 55
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
...+|||||||+ |+|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+||||+.++++||+|||+++...
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred CCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 678999999998 5999999988899999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.... .....+||+.|+|||++.+ ..|+.++||||||||+|||++|.+||.+.+..+.+..|...
T Consensus 494 ~~~~---~~~~~~GT~~Y~APE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~----------- 557 (674)
T 3pfq_A 494 WDGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH----------- 557 (674)
T ss_dssp CTTC---CBCCCCSCSSSCCHHHHTC--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS-----------
T ss_pred cCCc---ccccccCCCcccCHhhhcC--CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-----------
Confidence 3222 1345789999999999987 68999999999999999999999999998877766665321
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHHcCcccccC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA-----EEALADPYFKGL 314 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa-----~eiL~hp~f~~~ 314 (614)
.. .....+++++.+||++||+.||.+||++ +||++||||+++
T Consensus 558 -----------------~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 558 -----------------NV---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp -----------------CC---CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred -----------------CC---CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 01 1123578999999999999999999997 999999999976
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=404.98 Aligned_cols=261 Identities=32% Similarity=0.524 Sum_probs=205.2
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC------ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE------HISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 90 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~------~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 90 (614)
.++|.+.+.||+|+||.||+|.++.+++.||||++..... .......+.+|+.+|+.++||||+++++++.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--- 210 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--- 210 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence 4689999999999999999999999999999999874321 1122235789999999999999999999873
Q ss_pred CCCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC---cEEEeecC
Q 007177 91 RRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC---KLKICDFG 166 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~---~vKL~DFG 166 (614)
...+|+|||||. ++|.+.+.....+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 211 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 211 ---AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp ---SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred ---cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecc
Confidence 235799999998 59999998888999999999999999999999999999999999999997554 59999999
Q ss_pred ccccccCCCCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCC
Q 007177 167 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 245 (614)
Q Consensus 167 la~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~-~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p 245 (614)
+++...... .....+||+.|+|||++.+. ...|+.++|||||||++|+|++|.+||.+......+....
T Consensus 288 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i------ 357 (419)
T 3i6u_A 288 HSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI------ 357 (419)
T ss_dssp TTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHH------
T ss_pred cceecCCCc----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHH------
Confidence 998754322 22456899999999998531 2568889999999999999999999998754322221111
Q ss_pred chhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 246 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 246 ~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
...........+..+++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus 358 --------------------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 358 --------------------TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp --------------------HTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred --------------------hcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 011111122334678899999999999999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=385.39 Aligned_cols=263 Identities=29% Similarity=0.423 Sum_probs=223.7
Q ss_pred cCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 13 EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 13 ~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
.....++|.+.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----- 110 (335)
T 2owb_A 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF----- 110 (335)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----
T ss_pred CcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----
Confidence 3455679999999999999999999999999999999987543 3445667788999999999999999999998
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
.+.+.+|+|||||+ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 111 EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 190 (335)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCcee
Confidence 45567999999999 59999998888899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 191 ~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------- 256 (335)
T 2owb_A 191 VEYDGER---KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--------- 256 (335)
T ss_dssp CCSTTCC---BCCCCSCCSSCCHHHHHT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT---------
T ss_pred cccCccc---ccccCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC---------
Confidence 5432221 234679999999999877 67899999999999999999999999887755444333110
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
.. .....+++.+.+||.+||+.||.+|||++|+|+||||.....
T Consensus 257 -------------------~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 257 -------------------EY---SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp -------------------CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred -------------------CC---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 00 112357889999999999999999999999999999986543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=375.37 Aligned_cols=251 Identities=21% Similarity=0.288 Sum_probs=208.3
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.++..+ +||||+++++++ .+...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~-----~~~~~ 85 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW-----AEDDH 85 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE-----EETTE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee-----ecCCe
Confidence 579999999999999999999999999999999987655566777889999999999 899999999998 34567
Q ss_pred EEEEEecCCC-cHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC--------------
Q 007177 97 IYVVFELMES-DLHQVIKAN----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-------------- 157 (614)
Q Consensus 97 ~ylV~E~~~g-~L~~~i~~~----~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~-------------- 157 (614)
+|+|||||++ +|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999985 999999764 679999999999999999999999999999999999999844
Q ss_pred -----CcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChh
Q 007177 158 -----CKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 232 (614)
Q Consensus 158 -----~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~ 232 (614)
..+||+|||++....... ...||+.|+|||++.+. ..++.++|||||||++|+|++|.++|......
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-------~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 237 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-------VEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-------CCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH
T ss_pred ccCCceEEEEcccccccccCCcc-------ccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhHH
Confidence 479999999998654322 23599999999998762 35678999999999999999999887554321
Q ss_pred HHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 007177 233 HQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312 (614)
Q Consensus 233 ~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~ 312 (614)
. .+. .. ........+++.+.+||.+||..||.+|||++|+|+||||.
T Consensus 238 ~---~~~---------------------------~~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 284 (289)
T 1x8b_A 238 H---EIR---------------------------QG---RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284 (289)
T ss_dssp H---HHH---------------------------TT---CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred H---HHH---------------------------cC---CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence 1 110 00 01122346789999999999999999999999999999998
Q ss_pred cC
Q 007177 313 GL 314 (614)
Q Consensus 313 ~~ 314 (614)
..
T Consensus 285 ~~ 286 (289)
T 1x8b_A 285 SA 286 (289)
T ss_dssp --
T ss_pred hh
Confidence 53
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=378.24 Aligned_cols=261 Identities=23% Similarity=0.380 Sum_probs=199.0
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++++.||+|+||.||+|.+..+|+.||||++............+.++..+++.++||||+++++++. +.+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----~~~ 79 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-----REG 79 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-----ccC
Confidence 357899999999999999999999999999999999764333333344445555678889999999999984 456
Q ss_pred cEEEEEecCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 96 DIYVVFELMESDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 96 ~~ylV~E~~~g~L~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
..|+|||||+++|.+++.. ...+++..++.|+.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 7999999999988777653 56899999999999999999999998 999999999999999999999999999976
Q ss_pred ccCCCCCccccccccCCccccCcccccc--cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCh-hHHHHHHHhhhCCCch
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-VHQLDLMTDLLGTPSL 247 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~--~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~-~~~l~~i~~~~g~p~~ 247 (614)
...... .....||+.|+|||++.. ....++.++|||||||++|+|++|..||..... ...+..+..
T Consensus 160 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------- 228 (290)
T 3fme_A 160 LVDDVA----KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE------- 228 (290)
T ss_dssp --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH-------
T ss_pred cccccc----ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc-------
Confidence 543322 123479999999999631 115689999999999999999999999976432 222221111
Q ss_pred hhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 248 ~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
...+ ......+++.+.+||.+||+.||++|||++|+|+||||+..
T Consensus 229 -------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 229 -------------------EPSP---QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp -------------------SCCC---CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred -------------------cCCC---CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 1001 11123578899999999999999999999999999999853
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=377.45 Aligned_cols=259 Identities=25% Similarity=0.415 Sum_probs=218.9
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
-..++|++.+.||+|+||.||+|.+..++..||||++..... .......+.+|+.+++.++||||+++++++ .+
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 85 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF-----HD 85 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE-----Ec
Confidence 345689999999999999999999999999999999864211 111235688999999999999999999998 45
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
...+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 567999999998 5999999888889999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
... .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 166 ~~~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----------- 227 (284)
T 2vgo_A 166 SLR-----RRTMCGTLDYLPPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV----------- 227 (284)
T ss_dssp SSC-----BCCCCSCGGGCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-----------
T ss_pred ccc-----cccccCCCCcCCHHHhcc--CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc-----------
Confidence 221 134579999999999987 67899999999999999999999999887765544333210
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
.. ...+.+++.+.+||.+||..||.+|||++++|+||||+....
T Consensus 228 -----------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 228 -----------------DL---KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp -----------------CC---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred -----------------cc---CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 00 112457889999999999999999999999999999986543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=379.09 Aligned_cols=266 Identities=29% Similarity=0.346 Sum_probs=215.4
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
...++|++++.||+|+||.||+|.+..++..||+|++.... .......++.+|+.+++.++||||+++++++ .+
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~ 82 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EE 82 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----EC
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----ee
Confidence 34578999999999999999999999999999999986432 3445567889999999999999999999998 45
Q ss_pred CCcEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 94 FKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 94 ~~~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
.+.+|+|||||++ +|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 83 DDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred CCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 6779999999985 999999988899999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..........
T Consensus 163 ~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~------------ 226 (294)
T 4eqm_A 163 ETSLT--QTNHVLGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ------------ 226 (294)
T ss_dssp --------------CCSSCCHHHHHT--CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS------------
T ss_pred ccccc--ccCccccCccccCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh------------
Confidence 32211 1234579999999999887 6789999999999999999999999988875444322211
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
...+.......+.+++.+.+||.+||+.||.+||+..+.|.+.|..-+.
T Consensus 227 --------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 227 --------------DSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp --------------SCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred --------------ccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 1111111233467889999999999999999999666667777755443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=388.76 Aligned_cols=259 Identities=28% Similarity=0.492 Sum_probs=217.1
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCC--h----HHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH--I----SDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 90 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~--~----~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~ 90 (614)
++|++.+.||+|+||.||+|.++.+|+.||||++...... . .....+.+|+.+|+.+ +||||+++++++
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~---- 169 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY---- 169 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE----
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE----
Confidence 5799999999999999999999999999999998653221 1 1245678999999999 799999999998
Q ss_pred CCCCCcEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 91 RRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
......|+|||||++ +|.+++.....+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 170 -~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 170 -ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp -EBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred -eeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 445679999999985 999999888889999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCccccccccCCccccCccccccc----CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCC
Q 007177 170 VAFNDTPTTIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 245 (614)
Q Consensus 170 ~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~----~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p 245 (614)
....... ....+||+.|+|||++.+. ...|+.++|||||||++|+|++|..||.+.+....+..+......
T Consensus 249 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~- 323 (365)
T 2y7j_A 249 HLEPGEK----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQ- 323 (365)
T ss_dssp ECCTTCC----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-
T ss_pred ccCCCcc----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-
Confidence 6543321 2456899999999988531 135889999999999999999999999887765555444321111
Q ss_pred chhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 007177 246 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312 (614)
Q Consensus 246 ~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~ 312 (614)
.....|...++.+.+||.+||..||++|||++++|+||||+
T Consensus 324 --------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 324 --------------------------FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp --------------------------CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred --------------------------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 11122356788999999999999999999999999999997
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=375.94 Aligned_cols=265 Identities=28% Similarity=0.445 Sum_probs=220.6
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC---C----hHHHHHHHHHHHHHHhcC-CCCcceeeeEe
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE---H----ISDAARILREIKLLRLLR-HPDIVEIKHIM 86 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~---~----~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~ 86 (614)
+..++|++.+.||+|+||.||+|.++.+|+.||||++..... . ......+.+|+.+|+.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 456799999999999999999999999999999999964321 1 123456789999999996 99999999998
Q ss_pred cCCCCCCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeec
Q 007177 87 LPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 165 (614)
Q Consensus 87 ~~~~~~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DF 165 (614)
.+...+|+||||++ ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+||
T Consensus 94 -----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 94 -----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp -----ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred -----ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecc
Confidence 45577999999998 599999998888999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCccccccccCCccccCcccccc----cCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhh
Q 007177 166 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGS----FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 241 (614)
Q Consensus 166 Gla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~----~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~ 241 (614)
|++........ .....+|+.|+|||++.+ ....++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 169 g~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (298)
T 1phk_A 169 GFSCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244 (298)
T ss_dssp TTCEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred cchhhcCCCcc----cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence 99986543221 244679999999998752 1246889999999999999999999999887765554444221
Q ss_pred hCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 242 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 242 ~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
. .......+..+++.+.+||.+||..||.+|||++|+|+||||++..
T Consensus 245 ~---------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 245 N---------------------------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp C---------------------------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred C---------------------------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 1 1111123346788999999999999999999999999999998653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=395.57 Aligned_cols=260 Identities=26% Similarity=0.354 Sum_probs=208.6
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC--CCCcceeeeEecCCCCCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR--HPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~--HpnIv~l~~v~~~~~~~~~~ 95 (614)
.+|++++.||+|+||.||+|.+.. ++.||||++............+.+|+.+|+.|+ ||||+++++++. ...
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-----~~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----cCC
Confidence 469999999999999999998865 899999999765555667788999999999997 599999999884 445
Q ss_pred cEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 96 DIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 96 ~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
.+|||||+++++|.+++.....+++.+++.|+.||+.||.|||+.||+||||||+|||++ ++.+||+|||+++......
T Consensus 130 ~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 130 YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 699999977789999999988999999999999999999999999999999999999995 5799999999998654322
Q ss_pred CCccccccccCCccccCccccccc---------CCCCCCcccchhHHHHHHHHHhCCCCCCCCCh-hHHHHHHHhhhCCC
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-VHQLDLMTDLLGTP 245 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~---------~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~-~~~l~~i~~~~g~p 245 (614)
. .......+||+.|+|||++.+. ...|+.++||||||||+|+|++|.+||.+... ...+..+.
T Consensus 209 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~------ 281 (390)
T 2zmd_A 209 T-SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII------ 281 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH------
T ss_pred c-cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh------
Confidence 1 1123456899999999998641 13689999999999999999999999976532 12221111
Q ss_pred chhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 246 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 246 ~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
....... .....+..+.+||.+||..||.+|||++|+|+||||+..
T Consensus 282 --------------------~~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 282 --------------------DPNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp --------------------CTTSCCC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred --------------------CccccCC---CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 0111111 112346789999999999999999999999999999854
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=392.71 Aligned_cols=250 Identities=23% Similarity=0.380 Sum_probs=211.5
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCCh------HHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI------SDAARILREIKLLRLLRHPDIVEIKHIMLPPS 90 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~------~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 90 (614)
.++|++++.||+|+||.||+|.++.+++.||||++....... .....+.+|+.+|+.++||||+++++++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~---- 98 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF---- 98 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE----
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence 368999999999999999999999999999999997542211 1334567899999999999999999998
Q ss_pred CCCCCcEEEEEecCC-C-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcc
Q 007177 91 RRDFKDIYVVFELME-S-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 168 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~-g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 168 (614)
.+.+.+|+||||+. | +|.+++.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 99 -~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 99 -ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp -ECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred -eeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 45677999999986 5 99999999889999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007177 169 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y-~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~ 247 (614)
+....... ....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||......
T Consensus 178 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------- 236 (335)
T 3dls_A 178 AYLERGKL----FYTFCGTIEYCAPEVLMG--NPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------- 236 (335)
T ss_dssp EECCTTCC----BCEECSCGGGCCHHHHTT--CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------
T ss_pred eECCCCCc----eeccCCCccccChhhhcC--CCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------
Confidence 87543322 234679999999999876 444 78999999999999999999999653210
Q ss_pred hhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 248 ~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
... .......+++.+.+||.+||..||++|||++++|+||||++.
T Consensus 237 -----------------~~~-----~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 237 -----------------VEA-----AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp -----------------TTT-----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred -----------------Hhh-----ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 000 001123478899999999999999999999999999999853
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=380.53 Aligned_cols=269 Identities=22% Similarity=0.370 Sum_probs=214.7
Q ss_pred cccccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecC
Q 007177 9 EFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLP 88 (614)
Q Consensus 9 ~~~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~ 88 (614)
..-......++|++++.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+|+.++||||+++++++.
T Consensus 10 ~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~- 86 (302)
T 2j7t_A 10 HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYY- 86 (302)
T ss_dssp CCBSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred ccccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeee-
Confidence 3344456778999999999999999999999999999999998753 2234567889999999999999999999984
Q ss_pred CCCCCCCcEEEEEecCCC-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecC
Q 007177 89 PSRRDFKDIYVVFELMES-DLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFG 166 (614)
Q Consensus 89 ~~~~~~~~~ylV~E~~~g-~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFG 166 (614)
+...+|+|||||++ +|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus 87 ----~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 162 (302)
T 2j7t_A 87 ----HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFG 162 (302)
T ss_dssp ----CC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCH
T ss_pred ----eCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECC
Confidence 44579999999985 88888765 5679999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCccccccccCCccccCcccccc---cCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhC
Q 007177 167 LARVAFNDTPTTIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 243 (614)
Q Consensus 167 la~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~---~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g 243 (614)
++....... .......||+.|+|||++.. ....++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 163 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-- 237 (302)
T 2j7t_A 163 VSAKNLKTL---QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-- 237 (302)
T ss_dssp HHHHHHHHH---HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--
T ss_pred CCccccccc---cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc--
Confidence 986432111 01133579999999998731 1157889999999999999999999999887765444333211
Q ss_pred CCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 244 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 244 ~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
..+ .......++..+.+||.+||..||.+|||++++|+||||+.+.
T Consensus 238 ------------------------~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 238 ------------------------DPP--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp ------------------------CCC--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ------------------------CCc--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 000 0011234678999999999999999999999999999998654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=375.24 Aligned_cols=261 Identities=26% Similarity=0.397 Sum_probs=215.4
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
++|++++.||+|+||.||+|.++.+++.||||++.... .......+.+|+.+++.++||||+++++++ .+....
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 80 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ 80 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG-CTTHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETTEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc-chhhhHHHHHHHHHHHhcCCCCceeeeeEE-----EcCCEE
Confidence 57999999999999999999999999999999987432 223456788999999999999999999998 445678
Q ss_pred EEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 98 YVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 98 ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
|+||||+++ +|.+++.....+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 999999985 9999998777899999999999999999999999999999999999999999999999999976533221
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHH-HHHHhhhCCCchhhhhhhhc
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL-DLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l-~~i~~~~g~p~~~~i~~~~~ 255 (614)
........||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..... ..+.
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------- 222 (276)
T 2yex_A 161 -ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK---------------- 222 (276)
T ss_dssp -ECCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH----------------
T ss_pred -hhcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh----------------
Confidence 1123456799999999998762 23477899999999999999999999876543221 1110
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
.. ......+..+++.+.+||.+||..||.+|||++|+|+||||++..
T Consensus 223 -----------~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 223 -----------EK--KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp -----------TT--CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred -----------hc--ccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 00 011122346788999999999999999999999999999998653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=375.73 Aligned_cols=257 Identities=28% Similarity=0.476 Sum_probs=192.3
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++ .+..
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDSN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECSS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccCC
Confidence 4689999999999999999999999999999999864211 111246788999999999999999999998 4556
Q ss_pred cEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 96 DIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
.+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 7999999998 5999999875 5799999999999999999999999999999999999999999999999999986542
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+.+..+
T Consensus 165 ~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------------- 224 (278)
T 3cok_A 165 PHEK---HYTLCGTPNYISPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV--------------- 224 (278)
T ss_dssp --------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C---------------
T ss_pred CCCc---ceeccCCCCcCCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH---------------
Confidence 2211 134578999999999876 57899999999999999999999999876543322111
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
.. .. ......++..+.+||.+||..||.+|||++++|+||||...
T Consensus 225 ------------~~-~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 225 ------------VL-AD---YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp ------------CS-SC---CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred ------------hh-cc---cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 00 00 11223578899999999999999999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=377.57 Aligned_cols=267 Identities=22% Similarity=0.403 Sum_probs=217.4
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC--ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE--HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~--~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
.++|++++.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+|+.++||||+++++++.. .+.
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence 4789999999999999999999999999999999974311 12345678899999999999999999999843 234
Q ss_pred CcEEEEEecCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 95 KDIYVVFELMESDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 95 ~~~ylV~E~~~g~L~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
..+|+|||||+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 81 QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp -CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 57899999999888888876 4579999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
..... .......||+.|+|||++.+....++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 161 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~------------ 227 (305)
T 2wtk_C 161 PFAAD-DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK------------ 227 (305)
T ss_dssp TTCSS-CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH------------
T ss_pred ccccc-cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc------------
Confidence 32221 12245679999999999876323357899999999999999999999988775544433321
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCccc
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 318 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~ 318 (614)
. .. .....+++.+.+||.+||..||.+|||++|+|+||||+......
T Consensus 228 ---------------~-~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 228 ---------------G-SY---AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp ---------------C-CC---CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred ---------------C-CC---CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence 0 00 11235788999999999999999999999999999998765443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=397.75 Aligned_cols=269 Identities=17% Similarity=0.150 Sum_probs=195.6
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc--CCCCcceee-------eEec
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL--RHPDIVEIK-------HIML 87 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L--~HpnIv~l~-------~v~~ 87 (614)
.+|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 449999999999999999999999999999999986543 234456677886555555 699988755 3332
Q ss_pred CCCCC------------CCCcEEEEEecCCCcHHHHHHhCC-CCCHHHH------HHHHHHHHHHHHHHHhCCeEeecCC
Q 007177 88 PPSRR------------DFKDIYVVFELMESDLHQVIKAND-DLTREHY------QFFLYQLLRALKYIHTANVYHRDLK 148 (614)
Q Consensus 88 ~~~~~------------~~~~~ylV~E~~~g~L~~~i~~~~-~lse~~~------~~i~~QIl~aL~yLHs~gIvHrDLK 148 (614)
..... ....+|||||||+++|.+++...+ .+.+... ..++.||+.||.|||++||+|||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 22110 114589999999999999998642 3444444 5777999999999999999999999
Q ss_pred CCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 007177 149 PKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 228 (614)
Q Consensus 149 P~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g 228 (614)
|+|||++.++.+||+|||+++...... ....+|+.|+|||++.+....|+.++|||||||++|+|++|+.||.+
T Consensus 222 p~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 222 PDNLFIMPDGRLMLGDVSALWKVGTRG------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp GGGEEECTTSCEEECCGGGEEETTCEE------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred HHHEEECCCCCEEEEecceeeecCCCc------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999998653211 13467799999999875324689999999999999999999999987
Q ss_pred CChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 229 KNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 229 ~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
...... ..+.... .............++.+++.+.+||.+||+.||++|||++++|+|
T Consensus 296 ~~~~~~-------------~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 296 VTPGIK-------------GSWKRPS---------LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp CCTTCT-------------TCCCBCC---------TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred cCcccc-------------cchhhhh---------hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 642100 0000000 000001111112245789999999999999999999999999999
Q ss_pred cccccC
Q 007177 309 PYFKGL 314 (614)
Q Consensus 309 p~f~~~ 314 (614)
|||+++
T Consensus 354 p~f~~~ 359 (371)
T 3q60_A 354 PEFLQL 359 (371)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=415.76 Aligned_cols=262 Identities=27% Similarity=0.414 Sum_probs=216.5
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
...++|++++.||+|+||.||+|.++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++ .+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~ 255 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ET 255 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----ee
Confidence 345689999999999999999999999999999999964311 112345678999999999999999999998 45
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
...+|+|||||. |+|.+++...+ .+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEeccccee
Confidence 568999999997 69999998754 499999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
...... ....+||+.|+|||++.+ ..|+.++||||||||+|||++|.+||.+.+.......+.
T Consensus 336 ~~~~~~----~~~~~GT~~Y~APEvl~~--~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~----------- 398 (576)
T 2acx_A 336 VPEGQT----IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE----------- 398 (576)
T ss_dssp CCTTCC----EECCCSCGGGCCHHHHTT--CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH-----------
T ss_pred cccCcc----ccccCCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH-----------
Confidence 543221 244689999999999987 679999999999999999999999998764321111110
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 314 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~ 314 (614)
..+.. .+. .....+++.+++||.+||+.||.+|| +++|+++||||+++
T Consensus 399 ---------~~i~~----~~~---~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 399 ---------RLVKE----VPE---EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp ---------HHHHH----CCC---CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred ---------HHhhc----ccc---cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 00110 111 11246789999999999999999999 89999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=377.55 Aligned_cols=260 Identities=33% Similarity=0.549 Sum_probs=219.5
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++ .+...
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 95 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSS 95 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE-----eCCCe
Confidence 3689999999999999999999999999999999976544445567889999999999999999999998 44567
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC---CcEEEeecCcccccc
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN---CKLKICDFGLARVAF 172 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~---~~vKL~DFGla~~~~ 172 (614)
+|+||||+. ++|.+.+.....+++..++.++.||+.||.|||+.||+||||||+|||++.+ +.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 999999998 5999999887889999999999999999999999999999999999999764 469999999998654
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.... .....+|+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 176 ~~~~----~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------- 237 (287)
T 2wei_A 176 QNTK----MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG----------- 237 (287)
T ss_dssp CCSS----CSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred CCCc----cccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------
Confidence 3321 234468999999999875 5899999999999999999999999988765554443221
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
........+..+++.+.+||.+||..||.+|||++|+|+||||++..
T Consensus 238 ----------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 238 ----------------KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp ----------------CCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred ----------------CCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 00111123456789999999999999999999999999999998654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=387.54 Aligned_cols=287 Identities=24% Similarity=0.360 Sum_probs=224.6
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-----------CCCcceeee
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-----------HPDIVEIKH 84 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-----------HpnIv~l~~ 84 (614)
..++|++++.||+|+||.||+|.+..+++.||||++.. .......+.+|+.+|+.++ ||||+++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 35799999999999999999999999999999999974 2345567789999998886 899999999
Q ss_pred EecCCCCCCCCcEEEEEecCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CeEeecCCCCcEEEC------
Q 007177 85 IMLPPSRRDFKDIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILAN------ 155 (614)
Q Consensus 85 v~~~~~~~~~~~~ylV~E~~~g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILi~------ 155 (614)
++.... .+...+++|||+++++|.+++... ..+++..++.|+.||+.||.|||+. ||+||||||+|||++
T Consensus 94 ~~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 94 HFNHKG-PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEEEE-TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred HhhccC-CCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence 985432 233478999999988999999863 4599999999999999999999998 999999999999994
Q ss_pred CCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-----
Q 007177 156 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN----- 230 (614)
Q Consensus 156 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~----- 230 (614)
.++.+||+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CcceEEEcccccccccCCC------CCCCCCCccccCcHHHhC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 4447999999999865432 234579999999999987 679999999999999999999999998765
Q ss_pred -hhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCccc-------------CCCCCCCHHHHHHHHHhcCCCC
Q 007177 231 -VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFS-------------QKFPNADPSALRLLERLLAFDP 296 (614)
Q Consensus 231 -~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~-------------~~~~~~s~~l~dLI~~mL~~DP 296 (614)
..+.+..+...+|.++...+..... ...++............ ......++.+.+||.+||+.||
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKY--TRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTT--HHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccch--hhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence 5677888888888887665543221 11111100000000000 0112345788999999999999
Q ss_pred CCCCCHHHHHcCcccccCCc
Q 007177 297 KDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 297 ~~Rpsa~eiL~hp~f~~~~~ 316 (614)
.+|||++|+|+||||++...
T Consensus 323 ~~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 323 RKRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp TTCBCHHHHHTCGGGTTCTT
T ss_pred cccCCHHHHhhChhhhcccC
Confidence 99999999999999997644
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=389.84 Aligned_cols=284 Identities=22% Similarity=0.339 Sum_probs=220.0
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++++.||+|+||.||+|.+..++..||+|++... ........+.+|+.+|+.++||||+++++++. +.+
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~ 104 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDG 104 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE-----ETT
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE-----ECC
Confidence 457899999999999999999999999999999999754 24455678899999999999999999999984 456
Q ss_pred cEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 96 DIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 96 ~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
.+|+|||||++ +|.+++...+.+++..+..|+.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 105 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 79999999985 9999999888899999999999999999999996 999999999999999999999999999976432
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh---
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI--- 250 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i--- 250 (614)
.. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+............
T Consensus 185 ~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 185 SM-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp HC---------CCCCTTCCHHHHTT--CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred cc-----ccCCCCCCCeECHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 21 234579999999999987 67999999999999999999999999887755433222111110000000
Q ss_pred ------------hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 251 ------------SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 251 ------------~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
...........+..+........ ....++.++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKL--PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCCC--CTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCCC--CcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 00000011112222222111111 123478899999999999999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=408.78 Aligned_cols=262 Identities=23% Similarity=0.348 Sum_probs=215.4
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
..++|++++.||+|+||.||+|.++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++ .+.
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~ 257 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ETK 257 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----eeC
Confidence 34789999999999999999999999999999999974321 112345688999999999999999999998 455
Q ss_pred CcEEEEEecCC-CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 95 KDIYVVFELME-SDLHQVIKAN----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~----~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
..+|+|||||+ ++|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceee
Confidence 77999999998 5999999763 369999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 170 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 170 ~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
........ ....+||+.|+|||++.+ ..|+.++||||||||+|||++|.+||.+.+.......+..
T Consensus 338 ~~~~~~~~---~~~~~GT~~Y~APE~l~~--~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~--------- 403 (543)
T 3c4z_A 338 ELKAGQTK---TKGYAGTPGFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ--------- 403 (543)
T ss_dssp ECCTTCCC---BCCCCSCTTTSCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH---------
T ss_pred eccCCCcc---cccccCCccccChhhhcC--CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH---------
Confidence 75433221 244689999999999987 6899999999999999999999999987642111111100
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccC
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 314 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~eiL~hp~f~~~ 314 (614)
..+ .. .. .....+++.+.+||.+||+.||.+||+ ++++++||||+++
T Consensus 404 ----------~i~----~~-~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 404 ----------RVL----EQ-AV---TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp ----------HHH----HC-CC---CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred ----------HHh----hc-cc---CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 000 00 11 112467899999999999999999995 5899999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=382.47 Aligned_cols=260 Identities=33% Similarity=0.541 Sum_probs=208.7
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC------ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE------HISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 90 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~------~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 90 (614)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 86 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 86 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence 3579999999999999999999999999999999975321 11223457899999999999999999999832
Q ss_pred CCCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCc---EEEeecC
Q 007177 91 RRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK---LKICDFG 166 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~---vKL~DFG 166 (614)
...|+||||++ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 87 ----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 87 ----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp ----SSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred ----CceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 23899999998 499999988889999999999999999999999999999999999999987664 9999999
Q ss_pred ccccccCCCCCccccccccCCccccCcccccc-cCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHH-HHHHhhhCC
Q 007177 167 LARVAFNDTPTTIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL-DLMTDLLGT 244 (614)
Q Consensus 167 la~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~-~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l-~~i~~~~g~ 244 (614)
+++..... .......||+.|+|||++.+ ....++.++|||||||++|+|++|..||.+......+ ..+..
T Consensus 163 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---- 234 (322)
T 2ycf_A 163 HSKILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS---- 234 (322)
T ss_dssp TCEECCCC----HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH----
T ss_pred cceecccc----cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh----
Confidence 99865322 11234579999999998742 1257899999999999999999999999775432211 11111
Q ss_pred CchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 245 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 245 p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
.........+..+++.+.+||.+||..||.+|||++++|+||||++
T Consensus 235 -----------------------~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 235 -----------------------GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp -----------------------TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred -----------------------CccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 0111112234567899999999999999999999999999999974
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=379.75 Aligned_cols=284 Identities=27% Similarity=0.401 Sum_probs=195.1
Q ss_pred CCCCCCCccccccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcc
Q 007177 1 MLQNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 80 (614)
Q Consensus 1 m~~~~~~~~~~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv 80 (614)
|.+.++...+ ....++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++||||+
T Consensus 1 m~~~s~~~p~---~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~ 76 (303)
T 2vwi_A 1 MSEDSSALPW---SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIV 76 (303)
T ss_dssp ---------------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBC
T ss_pred CCCccccccc---ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEe
Confidence 4444443332 344679999999999999999999999999999999986432 123456788999999999999999
Q ss_pred eeeeEecCCCCCCCCcEEEEEecCC-CcHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCc
Q 007177 81 EIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKA--------NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKN 151 (614)
Q Consensus 81 ~l~~v~~~~~~~~~~~~ylV~E~~~-g~L~~~i~~--------~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~N 151 (614)
++++++. +...+|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|
T Consensus 77 ~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~N 151 (303)
T 2vwi_A 77 SYYTSFV-----VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGN 151 (303)
T ss_dssp CEEEEEE-----SSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGG
T ss_pred eEEEEEe-----ecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 9999984 4456999999997 599999874 4569999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecCccccccCCCC--CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 007177 152 ILANANCKLKICDFGLARVAFNDTP--TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 229 (614)
Q Consensus 152 ILi~~~~~vKL~DFGla~~~~~~~~--~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~ 229 (614)
||++.++.+||+|||++........ .........||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.
T Consensus 152 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~ 230 (303)
T 2vwi_A 152 ILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKY 230 (303)
T ss_dssp EEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred EEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccC
Confidence 9999999999999999976543221 11112345799999999998642 36899999999999999999999999887
Q ss_pred ChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCc
Q 007177 230 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 309 (614)
Q Consensus 230 ~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp 309 (614)
+....+...... .+.. .............+++.+.+||.+||+.||.+|||++++|+||
T Consensus 231 ~~~~~~~~~~~~--~~~~-------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 289 (303)
T 2vwi_A 231 PPMKVLMLTLQN--DPPS-------------------LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHK 289 (303)
T ss_dssp CGGGHHHHHHTS--SCCC-------------------TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTST
T ss_pred chhhHHHHHhcc--CCCc-------------------cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 765544322111 0000 0000111223456789999999999999999999999999999
Q ss_pred ccccCC
Q 007177 310 YFKGLS 315 (614)
Q Consensus 310 ~f~~~~ 315 (614)
||+...
T Consensus 290 ~~~~~~ 295 (303)
T 2vwi_A 290 FFQKAK 295 (303)
T ss_dssp TC----
T ss_pred hhhcCC
Confidence 998653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=368.96 Aligned_cols=257 Identities=29% Similarity=0.475 Sum_probs=207.7
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
..++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++ .+.
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 83 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI-----STP 83 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE-----ecC
Confidence 45789999999999999999999999999999999864211 112245788999999999999999999998 445
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
..+|+||||++ ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 67999999998 59999998888899999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCccccccccCCccccCcccccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y-~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.. ......+|+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 164 ~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------------ 225 (276)
T 2h6d_A 164 GE----FLRTSCGSPNYAAPEVISG--RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG------------ 225 (276)
T ss_dssp -----------------CCTGGGTT--SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------------
T ss_pred Cc----ceecccCCccccCHHHHcC--CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc------------
Confidence 22 1234578999999999876 343 6899999999999999999999988765444333311
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
. .. .....++..+.+||.+||+.||.+|||++++|+||||++.
T Consensus 226 ---------------~-~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 226 ---------------G-VF---YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp ---------------C-CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ---------------C-cc---cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 0 00 1113467899999999999999999999999999999753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=375.22 Aligned_cols=258 Identities=27% Similarity=0.458 Sum_probs=210.1
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++++.||+|+||.||+|.+..+|+.||||++... .....+.+|+.+|+.++||||+++++++. +..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 97 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGSYF-----KNT 97 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT----SCCHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETT
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch----HHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCC
Confidence 357899999999999999999999999999999999753 23456889999999999999999999984 446
Q ss_pred cEEEEEecCCC-cHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 96 DIYVVFELMES-DLHQVIK-ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 96 ~~ylV~E~~~g-~L~~~i~-~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
.+|+||||+++ +|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 78999999985 9999987 456799999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 178 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------- 239 (314)
T 3com_A 178 TMA---KRNTVIGTPFWMAPEVIQE--IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT------------- 239 (314)
T ss_dssp TBS---CBCCCCSCGGGCCHHHHSS--SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------------
T ss_pred hcc---ccCccCCCCCccChhhcCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc-------------
Confidence 221 1234579999999999887 5789999999999999999999999987765443322211
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
..... ......+++.+.+||.+||..||.+|||++++|+||||+...
T Consensus 240 --------------~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 240 --------------NPPPT-FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp --------------SCCCC-CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred --------------CCCcc-cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 00000 011234678999999999999999999999999999998643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=370.92 Aligned_cols=259 Identities=30% Similarity=0.473 Sum_probs=216.1
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|++++.||+|+||.||+|.++.+++.||+|++............+.+|+.+|+.++||||+++++++.. .....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCCce
Confidence 468999999999999999999999999999999998655556677789999999999999999999998743 23457
Q ss_pred EEEEEecCCC-cHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----eEeecCCCCcEEECCCCcEEEeecC
Q 007177 97 IYVVFELMES-DLHQVIKAN----DDLTREHYQFFLYQLLRALKYIHTAN-----VYHRDLKPKNILANANCKLKICDFG 166 (614)
Q Consensus 97 ~ylV~E~~~g-~L~~~i~~~----~~lse~~~~~i~~QIl~aL~yLHs~g-----IvHrDLKP~NILi~~~~~vKL~DFG 166 (614)
+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999985 999998653 34999999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCc
Q 007177 167 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 246 (614)
Q Consensus 167 la~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~ 246 (614)
+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 162 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~------ 230 (279)
T 2w5a_A 162 LARILNHDT---SFAKTFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE------ 230 (279)
T ss_dssp HHHHC---C---HHHHHHHSCCTTCCHHHHHC--C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------
T ss_pred hheeecccc---ccccccCCCccccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh------
Confidence 998654322 11234578999999999877 5789999999999999999999999988775444433321
Q ss_pred hhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 247 ~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
.. +......+++.+.+||.+||..||.+|||++|+|+|+|+..
T Consensus 231 ---------------------~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 231 ---------------------GK---FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp ---------------------TC---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred ---------------------cc---cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 00 01122357889999999999999999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=391.69 Aligned_cols=263 Identities=24% Similarity=0.385 Sum_probs=211.6
Q ss_pred CCeEEEeEeeecCceEEEEEEEC---CCCcEEEEEEecCccC--ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIFE--HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~---~tg~~vAIK~i~~~~~--~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~ 91 (614)
++|++++.||+|+||.||+|.+. .+++.||||+++.... .......+.+|+.+|+.+ .||||+++++++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~----- 128 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF----- 128 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE-----
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE-----
Confidence 68999999999999999999984 5899999999874321 112334566899999999 699999999998
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
.+...+|||||||+ ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 44567999999998 59999999888899999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
...... ......+||+.|+|||++.+....++.++|||||||++|+|++|..||...........+..
T Consensus 209 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~---------- 276 (355)
T 1vzo_A 209 FVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---------- 276 (355)
T ss_dssp CCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH----------
T ss_pred cccCCC--CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH----------
Confidence 532221 12345689999999999875334688999999999999999999999976543222111110
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 314 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~ 314 (614)
... ... ......+++.+.+||.+||..||.+|| |++|+|+||||+.+
T Consensus 277 ---------~~~----~~~----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 277 ---------RIL----KSE----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp ---------HHH----HCC----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred ---------HHh----ccC----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 010 000 112346788999999999999999999 99999999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=375.05 Aligned_cols=266 Identities=23% Similarity=0.404 Sum_probs=211.2
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCC-
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSR- 91 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~- 91 (614)
-...++|++++.||+|+||.||+|.+..+|+.||||++.... .....+.+|+.+|+.+ +||||+++++++.....
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 456789999999999999999999999999999999986432 2345678999999998 79999999999865321
Q ss_pred CCCCcEEEEEecCCC-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcc
Q 007177 92 RDFKDIYVVFELMES-DLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 168 (614)
Q Consensus 92 ~~~~~~ylV~E~~~g-~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 168 (614)
.....+|+|||||++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 124679999999985 999999864 47999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCC
Q 007177 169 RVAFNDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 245 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~---~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p 245 (614)
........ ......||+.|+|||++... ...++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 177 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----- 248 (326)
T 2x7f_A 177 AQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR----- 248 (326)
T ss_dssp C----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-----
T ss_pred eecCcCcc---ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc-----
Confidence 76532211 12345799999999998621 14688999999999999999999999988765544333211
Q ss_pred chhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 246 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 246 ~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
...+ ......+++.+.+||.+||..||.+|||++++|+||||++.
T Consensus 249 ---------------------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 249 ---------------------NPAP---RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp ---------------------SCCC---CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred ---------------------Cccc---cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 0000 11124578899999999999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=373.41 Aligned_cols=256 Identities=25% Similarity=0.381 Sum_probs=206.2
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++.+.||+|+||.||+|.+ +|..||||++............+.+|+.+|+.++||||+++++++ .+..
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 107 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-----TQPP 107 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSTT
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence 346899999999999999999976 688999999987655666778899999999999999999999998 4445
Q ss_pred cEEEEEecCC-CcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCC--eEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 96 DIYVVFELME-SDLHQVIKANDD---LTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~---lse~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
.+|+|||||+ ++|.+++..... +++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 6899999998 599999987653 999999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 170 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 170 ~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 188 ~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~-------- 254 (309)
T 3p86_A 188 LKASTFL---SSKSAAGTPEWMAPEVLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-------- 254 (309)
T ss_dssp -----------------CCTTSCHHHHTT--CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS--------
T ss_pred ccccccc---ccccCCCCccccChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--------
Confidence 5433221 1234679999999999987 67899999999999999999999999887765444333110
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc--Ccccc
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA--DPYFK 312 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~--hp~f~ 312 (614)
... ......+++.+.+||.+||..||.+|||++++++ ++|++
T Consensus 255 ------------------~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 255 ------------------CKR---LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp ------------------CCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred ------------------CCC---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 001 1123467899999999999999999999999987 45554
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=377.13 Aligned_cols=258 Identities=23% Similarity=0.339 Sum_probs=212.3
Q ss_pred ccCCCCCCeEEEeEeeecCceEEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecC
Q 007177 12 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLP 88 (614)
Q Consensus 12 ~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~---~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~ 88 (614)
...-..++|++.+.||+|+||.||+|.+..++. .||||+++.. ........+.+|+.+|+.++||||+++++++
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-- 119 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVV-- 119 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE--
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE--
Confidence 344456899999999999999999999987665 4999999753 2445567889999999999999999999998
Q ss_pred CCCCCCCcEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecC
Q 007177 89 PSRRDFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFG 166 (614)
Q Consensus 89 ~~~~~~~~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFG 166 (614)
.+...+|+|||||+ ++|.+++... ..+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus 120 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 196 (325)
T 3kul_A 120 ---TRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFG 196 (325)
T ss_dssp ---CGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred ---EeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCC
Confidence 44567899999998 5999999764 579999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCC
Q 007177 167 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTP 245 (614)
Q Consensus 167 la~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p 245 (614)
+++................+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+....
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~--- 271 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF--RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY--- 271 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC---
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC---
Confidence 99876544333323344567889999999976 578999999999999999999 999998887665554442211
Q ss_pred chhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 246 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 246 ~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.. .....+++.+.+||.+||..||.+|||+.++++
T Consensus 272 ------------------------~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 272 ------------------------RL---PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp ------------------------CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CC---CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 00 122457889999999999999999999999987
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=375.29 Aligned_cols=278 Identities=21% Similarity=0.353 Sum_probs=211.0
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
...++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+|+.++||||+++++++... +.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~ 81 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TT 81 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TT
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CC
Confidence 446789999999999999999999999999999999975321 22356678999999999999999999988543 23
Q ss_pred CcEEEEEecCC-CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEE----CCCCcEEEeecC
Q 007177 95 KDIYVVFELME-SDLHQVIKAND---DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA----NANCKLKICDFG 166 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~---~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi----~~~~~vKL~DFG 166 (614)
..+|+|||||+ ++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 47899999998 69999998644 39999999999999999999999999999999999999 788889999999
Q ss_pred ccccccCCCCCccccccccCCccccCccccccc------CCCCCCcccchhHHHHHHHHHhCCCCCCCCChh-HHHHHHH
Q 007177 167 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLDLMT 239 (614)
Q Consensus 167 la~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~------~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~-~~l~~i~ 239 (614)
+++....... ....+||+.|+|||++... ...++.++|||||||++|+|++|..||...... .....+.
T Consensus 162 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 162 AARELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp TCEECCTTCC----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred CceecCCCCc----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 9987544322 2345799999999987521 157899999999999999999999999754321 1112222
Q ss_pred hhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCC-------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcc
Q 007177 240 DLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQK-------FPNADPSALRLLERLLAFDPKDRPTAEEALADPY 310 (614)
Q Consensus 240 ~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~-------~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~ 310 (614)
..+.......+..+... ......+... ...++..+.+||.+||+.||++|||++|+|+||-
T Consensus 238 ~~~~~~p~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 238 KIITGKPSGAISGVQKA----------ENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHHHCCTTCCEEEECS----------TTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred HHhcCCCcccchhhhcc----------cCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 21111111111110000 0011111111 1234567899999999999999999999999974
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=367.43 Aligned_cols=257 Identities=26% Similarity=0.407 Sum_probs=216.4
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
....+|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+|+.++||||+++++++. +.
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 92 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KD 92 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cC
Confidence 334679999999999999999999999999999999975422 234677889999999999999999999984 44
Q ss_pred CcEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 95 KDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 95 ~~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
..+|+||||+++ +|.+++.. +.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 93 TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp TEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 679999999985 89988864 5799999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+....+..+..
T Consensus 172 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------- 233 (303)
T 3a7i_A 172 TQI---KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK------------- 233 (303)
T ss_dssp TBC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------------
T ss_pred ccc---ccCccCCCcCccCHHHHhc--CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc-------------
Confidence 221 1245679999999999987 6789999999999999999999999987765443332211
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
... ......++..+.+||.+||..||.+|||++++|+||||..
T Consensus 234 --------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 234 --------------NNP---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp --------------SCC---CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred --------------CCC---CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 111 1123467889999999999999999999999999999975
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=373.89 Aligned_cols=268 Identities=22% Similarity=0.346 Sum_probs=196.8
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 90 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~---~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 90 (614)
....++|++++.||+|+||.||+|.+..++. .||||+++...........+.+|+.+|+.++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3456789999999999999999999887775 8999999865445566788999999999999999999999986542
Q ss_pred CC-CCCcEEEEEecCCC-cHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEE
Q 007177 91 RR-DFKDIYVVFELMES-DLHQVIKAND------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKI 162 (614)
Q Consensus 91 ~~-~~~~~ylV~E~~~g-~L~~~i~~~~------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL 162 (614)
.. .....|+|||||.+ +|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEE
Confidence 21 12235999999994 9999986532 5999999999999999999999999999999999999999999999
Q ss_pred eecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhh
Q 007177 163 CDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDL 241 (614)
Q Consensus 163 ~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~ 241 (614)
+|||+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...
T Consensus 179 ~Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 255 (323)
T 3qup_A 179 ADFGLSRKIYSGDYY-RQGCASKLPVKWLALESLAD--NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255 (323)
T ss_dssp CCCCC------------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred eeccccccccccccc-cccccccCcccccCchhhcC--CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence 999999865433221 11233457888999999887 679999999999999999999 99999888766555443221
Q ss_pred hCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC-------HHHHHcCcccccC
Q 007177 242 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-------AEEALADPYFKGL 314 (614)
Q Consensus 242 ~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-------a~eiL~hp~f~~~ 314 (614)
. .....+.+++.+.+||.+||..||.+||| ++++++|||+...
T Consensus 256 ---------------------------~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 256 ---------------------------N---RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp ---------------------------C---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred ---------------------------C---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 0 01123467889999999999999999999 7888899999753
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=369.59 Aligned_cols=263 Identities=21% Similarity=0.332 Sum_probs=195.3
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++++.||+|+||.||+|.++.+|+.||||++............+.++..+++.++||||+++++++. +..
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~~ 97 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TNT 97 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cCC
Confidence 456899999999999999999999999999999999754333333334445556788889999999999984 456
Q ss_pred cEEEEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 96 DIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 96 ~~ylV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
.+|+||||+++.+..+... ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 98 DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 7999999997666666654 56799999999999999999999995 999999999999999999999999999976543
Q ss_pred CCCCccccccccCCccccCcccccc---cCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-hhHHHHHHHhhhCCCchhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN-VVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~---~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~-~~~~l~~i~~~~g~p~~~~ 249 (614)
... .....+|+.|+|||++.. ....++.++|||||||++|+|++|..||.... ..+.+..+..
T Consensus 178 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------- 244 (318)
T 2dyl_A 178 DKA----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--------- 244 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH---------
T ss_pred Ccc----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc---------
Confidence 221 234579999999999852 11568899999999999999999999997643 2222222211
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
... ........+++.+.+||.+||..||.+|||++++|+||||+++.
T Consensus 245 ------------------~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 245 ------------------EEP-PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp ------------------SCC-CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred ------------------cCC-CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 111 11112346789999999999999999999999999999998653
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=378.54 Aligned_cols=273 Identities=20% Similarity=0.333 Sum_probs=212.8
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCCh---------------HHHHHHHHHHHHHHhcCCCCcce
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI---------------SDAARILREIKLLRLLRHPDIVE 81 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~---------------~~~~~i~~Ei~iL~~L~HpnIv~ 81 (614)
.++|++++.||+|+||.||+|.+ +|+.||||++....... .....+.+|+.+|+.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 47899999999999999999998 89999999986432111 11267889999999999999999
Q ss_pred eeeEecCCCCCCCCcEEEEEecCCC-cHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeecCCCCc
Q 007177 82 IKHIMLPPSRRDFKDIYVVFELMES-DLHQV------IKA--NDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKN 151 (614)
Q Consensus 82 l~~v~~~~~~~~~~~~ylV~E~~~g-~L~~~------i~~--~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~N 151 (614)
+++++ .+.+.+|+|||||++ +|.++ +.. ...+++..++.++.||+.||.|||+ .||+||||||+|
T Consensus 108 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGII-----TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp CSEEE-----ESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred EEEEE-----eeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 99998 345679999999995 99988 655 5679999999999999999999999 999999999999
Q ss_pred EEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCC-cccchhHHHHHHHHHhCCCCCCCCC
Q 007177 152 ILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEVLTGKPLFPGKN 230 (614)
Q Consensus 152 ILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~-~~DIWSLG~Il~eLltG~~pF~g~~ 230 (614)
||++.++.+||+|||++...... ......||+.|+|||++.+. ..++. ++|||||||++|+|++|..||.+.+
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEcCCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999865432 22456799999999998762 25666 9999999999999999999998877
Q ss_pred h-hHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCc
Q 007177 231 V-VHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 309 (614)
Q Consensus 231 ~-~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp 309 (614)
. .+....+.......... .... ...............+++.+.+||.+||+.||.+|||++|+|+||
T Consensus 257 ~~~~~~~~i~~~~~~~~~~-~~~~-----------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 257 SLVELFNNIRTKNIEYPLD-RNHF-----------LYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp CSHHHHHHHTSCCCCCCCS-SSSS-----------TTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred cHHHHHHHHhccCcCCccc-hhhh-----------hccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 6 44444332211000000 0000 000000001112256889999999999999999999999999999
Q ss_pred ccccC
Q 007177 310 YFKGL 314 (614)
Q Consensus 310 ~f~~~ 314 (614)
||++.
T Consensus 325 ~f~~~ 329 (348)
T 2pml_X 325 WLADT 329 (348)
T ss_dssp GGTTC
T ss_pred cccCC
Confidence 99864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=375.14 Aligned_cols=263 Identities=26% Similarity=0.434 Sum_probs=193.0
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHH-HHHhcCCCCcceeeeEecCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIK-LLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~-iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
..++|++++.||+|+||.||+|.++.+|+.||||++.... .......+.+|+. +++.++||||+++++++. +.
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~ 93 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----RE 93 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CS
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eC
Confidence 4578999999999999999999999999999999997542 3344555666766 677789999999999984 45
Q ss_pred CcEEEEEecCCCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeecCCCCcEEECCCCcEEEeecCcc
Q 007177 95 KDIYVVFELMESDLHQVIKA-----NDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLA 168 (614)
Q Consensus 95 ~~~ylV~E~~~g~L~~~i~~-----~~~lse~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILi~~~~~vKL~DFGla 168 (614)
+..|+||||++++|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 94 GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp SEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred CceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 67999999999998888863 56799999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCccccCccccccc--CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCc
Q 007177 169 RVAFNDTPTTIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 246 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~--~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~ 246 (614)
+....... .....||+.|+|||++... ...++.++|||||||++|+|++|..||.+.+.... .+
T Consensus 174 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~-------- 239 (327)
T 3aln_A 174 GQLVDSIA----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--QL-------- 239 (327)
T ss_dssp CC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------------
T ss_pred eecccccc----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--HH--------
Confidence 76543221 2334799999999998321 15689999999999999999999999976542110 00
Q ss_pred hhhhhhhhchhHHHHHHhhcccCCCcc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 247 LDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 247 ~~~i~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
..+.......+ ...+..+++.+.+||.+||..||.+|||+.++|+||||...
T Consensus 240 ----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 240 ----------------TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp ----------------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ----------------HHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 00001111111 12335688999999999999999999999999999999754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=377.19 Aligned_cols=253 Identities=25% Similarity=0.414 Sum_probs=209.6
Q ss_pred CCCeEEEeEeeecCceEEEEEEEC-------CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDT-------HTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLP 88 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~-------~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~ 88 (614)
.++|++++.||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+|+.+ +||||+++++++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-- 156 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-- 156 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE--
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE--
Confidence 468999999999999999999875 34567999999754 3345667899999999999 899999999998
Q ss_pred CCCCCCCcEEEEEecCC-CcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCc
Q 007177 89 PSRRDFKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKN 151 (614)
Q Consensus 89 ~~~~~~~~~ylV~E~~~-g~L~~~i~~~~----------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~N 151 (614)
.+.+.+|+|||||+ |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|
T Consensus 157 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 157 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp ---CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred ---ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 44567899999998 59999998653 48999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCC
Q 007177 152 ILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 230 (614)
Q Consensus 152 ILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~ 230 (614)
||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..|+.++|||||||++|||++ |..||.+.+
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTT-CTTTTTTSCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEECCCCCEEEccccCCcccCcccce-ecccCCCcccceECHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999999865433221 11234567889999999877 679999999999999999999 999998877
Q ss_pred hhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 231 VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 231 ~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
..+.+..+.. ... ......+++.+.+||.+||..||.+|||+.|++++
T Consensus 311 ~~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 311 VEELFKLLKE---------------------------GHR---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GGGHHHHHHT---------------------------TCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhc---------------------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5544433311 000 11224678899999999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=374.68 Aligned_cols=267 Identities=26% Similarity=0.407 Sum_probs=188.6
Q ss_pred cccCCCCCCeEEEe-EeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHH-HHHHhcCCCCcceeeeEecC
Q 007177 11 FSEYGDASRYKIQE-VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREI-KLLRLLRHPDIVEIKHIMLP 88 (614)
Q Consensus 11 ~~~~~~~~rY~i~~-~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei-~iL~~L~HpnIv~l~~v~~~ 88 (614)
...+...++|++++ .||+|+||.||+|.++.+|+.||||++... .. ..+|+ ..++.+.||||+++++++..
T Consensus 21 ~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~----~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 21 PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PK----ARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HH----HHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HH----HHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 34466678999965 699999999999999999999999998642 11 22233 34567799999999999843
Q ss_pred CCCCCCCcEEEEEecCCC-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC---CcEEE
Q 007177 89 PSRRDFKDIYVVFELMES-DLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN---CKLKI 162 (614)
Q Consensus 89 ~~~~~~~~~ylV~E~~~g-~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~---~~vKL 162 (614)
.. .+...+|+|||||++ +|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++.+ +.+||
T Consensus 94 ~~-~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl 172 (336)
T 3fhr_A 94 MH-HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKL 172 (336)
T ss_dssp EE-TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEE
T ss_pred cc-CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEE
Confidence 21 224568999999985 9999998764 69999999999999999999999999999999999999864 45999
Q ss_pred eecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhh
Q 007177 163 CDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242 (614)
Q Consensus 163 ~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~ 242 (614)
+|||+++...... ....++|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.
T Consensus 173 ~Dfg~~~~~~~~~-----~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--- 242 (336)
T 3fhr_A 173 TDFGFAKETTQNA-----LQTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK--- 242 (336)
T ss_dssp CCCTTCEEC-----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred eccccceeccccc-----cccCCCCcCccChhhhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---
Confidence 9999998654322 234578999999999876 578899999999999999999999997765322211110
Q ss_pred CCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 243 g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
..+...........+..+++.+.+||.+||..||.+|||++|+|+||||++..
T Consensus 243 --------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 243 --------------------RRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp ----------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred --------------------HhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 00001111112234567899999999999999999999999999999998653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=370.68 Aligned_cols=260 Identities=24% Similarity=0.421 Sum_probs=210.9
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++.+.||+|+||.||+|.+..+++.||+|++.. ........+.+|+.+|+.++||||+++++++. +..
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~ 80 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY-----KDK 80 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETT
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe-----cCC
Confidence 35689999999999999999999999999999999864 34566778999999999999999999999984 456
Q ss_pred cEEEEEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 96 DIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
..|+|||||+ ++|.+++.. ...+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 81 RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred eeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 7999999998 599999987 56799999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCc-----------cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhh
Q 007177 174 DTPTT-----------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242 (614)
Q Consensus 174 ~~~~~-----------~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~ 242 (614)
..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~-------- 230 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING--RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM-------- 230 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT--------
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH--------
Confidence 32211 01124689999999999987 6899999999999999999999999976432100
Q ss_pred CCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 243 g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
.. .......+.. ...+.+++.+.+||.+||+.||.+|||++++++ |++.+
T Consensus 231 ------~~----~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l 280 (310)
T 3s95_A 231 ------DF----GLNVRGFLDR----------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL 280 (310)
T ss_dssp ------TS----SBCHHHHHHH----------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred ------HH----hhhhhccccc----------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence 00 0001111111 112467889999999999999999999999987 55543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=362.89 Aligned_cols=262 Identities=28% Similarity=0.419 Sum_probs=202.6
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-------
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS------- 90 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~------- 90 (614)
++|++++.||+|+||.||+|.+..+|+.||||++.. .......+.+|+.+|+.++||||+++++++....
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 579999999999999999999999999999999964 2345677889999999999999999999875421
Q ss_pred -CCCCCcEEEEEecCC-CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCc
Q 007177 91 -RRDFKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 167 (614)
Q Consensus 91 -~~~~~~~ylV~E~~~-g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGl 167 (614)
..+...+|+|||||+ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 123567999999998 59999998644 688999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC-----------CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC-ChhHHH
Q 007177 168 ARVAFNDTP-----------TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-NVVHQL 235 (614)
Q Consensus 168 a~~~~~~~~-----------~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~-~~~~~l 235 (614)
+........ .........||+.|+|||++.+. ..++.++|||||||++|+|++ ||... +..+.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 976532210 01122456799999999998752 468999999999999999998 45322 111111
Q ss_pred HHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 236 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 236 ~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
..+ ...............++.+.+||.+||..||.+|||++++|+||||+.
T Consensus 239 ~~~---------------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 239 KKL---------------------------RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHH---------------------------HSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred Hhc---------------------------cccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 111 111111111223456788999999999999999999999999999974
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=367.17 Aligned_cols=264 Identities=26% Similarity=0.343 Sum_probs=208.6
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC--CCCcceeeeEecCCCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR--HPDIVEIKHIMLPPSR 91 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~--HpnIv~l~~v~~~~~~ 91 (614)
....++|++++.||+|+||.||+|.+. +++.||||++............+.+|+.+|+.++ ||||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~---- 98 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI---- 98 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE----
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee----
Confidence 345578999999999999999999885 5889999999765555667788999999999997 599999999983
Q ss_pred CCCCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 92 RDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 92 ~~~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
+...+|+|||++.++|.+++.....+++..++.|+.||+.||.|||+.||+||||||+|||++ ++.+||+|||+++..
T Consensus 99 -~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 99 -TDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 176 (313)
T ss_dssp -CSSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-
T ss_pred -cCCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccc
Confidence 456799999987789999999988999999999999999999999999999999999999996 479999999999865
Q ss_pred cCCCCCccccccccCCccccCccccccc---------CCCCCCcccchhHHHHHHHHHhCCCCCCCCChh-HHHHHHHhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLDLMTDL 241 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~---------~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~-~~l~~i~~~ 241 (614)
..... ........||+.|+|||++.+. ...++.++|||||||++|+|++|..||...... ..+..+
T Consensus 177 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~--- 252 (313)
T 3cek_A 177 QPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI--- 252 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH---
T ss_pred cCccc-cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH---
Confidence 43322 1122345799999999998641 136888999999999999999999999765321 111111
Q ss_pred hCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 242 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 242 ~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
+...... ......+..+.+||.+||..||.+|||++|+|+||||+..
T Consensus 253 -----------------------~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 253 -----------------------IDPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp -----------------------HCTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred -----------------------Hhccccc---CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 0011111 1123457889999999999999999999999999999854
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=362.43 Aligned_cols=258 Identities=28% Similarity=0.415 Sum_probs=204.2
Q ss_pred eEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEE
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 99 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~yl 99 (614)
|.....||+|+||.||+|.+..++..||||++... .......+.+|+.+++.++||||+++++++ .+.+.+|+
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l 96 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSF-----SENGFIKI 96 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEE-----EETTEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEE-----EeCCcEEE
Confidence 33344899999999999999999999999998753 234456788999999999999999999998 34567999
Q ss_pred EEecCC-CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC-CCcEEEeecCccccccCC
Q 007177 100 VFELME-SDLHQVIKAND---DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFND 174 (614)
Q Consensus 100 V~E~~~-g~L~~~i~~~~---~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~-~~~vKL~DFGla~~~~~~ 174 (614)
||||++ ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++......
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999997 69999997652 4679999999999999999999999999999999999987 889999999999865432
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
.. ......||+.|+|||++.+....++.++|||||||++|+|++|..||.+..........
T Consensus 177 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---------------- 237 (295)
T 2clq_A 177 NP---CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK---------------- 237 (295)
T ss_dssp -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH----------------
T ss_pred CC---cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh----------------
Confidence 21 12345799999999998653234889999999999999999999999654322111000
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
...... .......+++.+.+||.+||..||++|||++++|+||||+...
T Consensus 238 --------~~~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 238 --------VGMFKV----HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp --------HHHHCC----CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred --------hccccc----cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 000000 0122346789999999999999999999999999999998543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=374.81 Aligned_cols=256 Identities=25% Similarity=0.406 Sum_probs=209.7
Q ss_pred CCCCeEEEeEeeecCceEEEEEE-----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPP 89 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~-----d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~ 89 (614)
..++|++++.||+|+||.||+|. +..+++.||||+++.. ........+.+|+.+|+.+ +||||+++++++..
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~- 97 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK- 97 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec-
Confidence 35789999999999999999998 5567789999999753 3345567789999999999 79999999999843
Q ss_pred CCCCCCcEEEEEecCC-CcHHHHHHhCCC---------------------------------------------------
Q 007177 90 SRRDFKDIYVVFELME-SDLHQVIKANDD--------------------------------------------------- 117 (614)
Q Consensus 90 ~~~~~~~~ylV~E~~~-g~L~~~i~~~~~--------------------------------------------------- 117 (614)
....+|+|||||. |+|.+++.....
T Consensus 98 ---~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 98 ---PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ---TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred ---CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 2345899999999 599999986543
Q ss_pred ---------------CCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccccc
Q 007177 118 ---------------LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 182 (614)
Q Consensus 118 ---------------lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~ 182 (614)
+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++........ ....
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~ 253 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKG 253 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC-EEC-
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc-hhcc
Confidence 899999999999999999999999999999999999999999999999999865433221 2234
Q ss_pred cccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHH
Q 007177 183 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRY 261 (614)
Q Consensus 183 ~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~ 261 (614)
...||+.|+|||++.+ ..|+.++|||||||++|+|++ |..||.+.+..+.+......
T Consensus 254 ~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-------------------- 311 (359)
T 3vhe_A 254 DARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE-------------------- 311 (359)
T ss_dssp -CEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH--------------------
T ss_pred ccCCCceeEChhhhcC--CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc--------------------
Confidence 5678999999999876 689999999999999999998 99999887654433222110
Q ss_pred HHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 262 LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 262 l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
... ......+++.+.+||.+||+.||.+|||++|+++|
T Consensus 312 ------~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 312 ------GTR---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CCC---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 001 11123578899999999999999999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=380.90 Aligned_cols=257 Identities=21% Similarity=0.309 Sum_probs=210.5
Q ss_pred CCCeEEEeEeeecCceEEEEEE-----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~-----d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
.++|++++.||+|+||.||+|. +..++..||||+++.. ........+.+|+.+|+.++||||+++++++.
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~---- 144 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSL---- 144 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe----
Confidence 4689999999999999999999 4567889999999743 34455667889999999999999999999984
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC---cE
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKAND-------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC---KL 160 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~~-------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~---~v 160 (614)
+....|+|||||. ++|.+++.... .+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 145 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 145 -QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp -SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred -cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 4456799999997 59999997643 599999999999999999999999999999999999999655 59
Q ss_pred EEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 007177 161 KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMT 239 (614)
Q Consensus 161 KL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~ 239 (614)
||+|||+++........ .......+|+.|+|||++.+ ..|+.++|||||||++|||++ |..||.+.+..+.+..+.
T Consensus 224 kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYY-RKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp EECCCHHHHHHHHHSSC-TTCCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred EECCCcccccccccccc-ccCCCcCCcccEECHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999864322211 11234568999999999876 679999999999999999998 999999887665554442
Q ss_pred hhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 007177 240 DLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312 (614)
Q Consensus 240 ~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~ 312 (614)
... . ......+++.+.+||.+||+.||.+|||++++++|.|+.
T Consensus 301 ~~~---------------------------~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 SGG---------------------------R---MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTC---------------------------C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCC---------------------------C---CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 210 0 011245788999999999999999999999999998764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=360.33 Aligned_cols=252 Identities=26% Similarity=0.414 Sum_probs=199.0
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCC---CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHT---GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~t---g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
..++|++.+.||+|+||.||+|.+..+ +..||+|++... ........+.+|+.+|+.++||||+++++++.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----- 86 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----- 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-----
Confidence 346899999999999999999998754 456999998753 34455677899999999999999999999872
Q ss_pred CCCcEEEEEecCCC-cHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 93 DFKDIYVVFELMES-DLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 93 ~~~~~ylV~E~~~g-~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
.+..|+||||+++ +|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 2457999999995 9999998654 699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+...
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~-------- 233 (281)
T 1mp8_A 166 MEDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-------- 233 (281)
T ss_dssp ---------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT--------
T ss_pred cCccccc--ccccCCCcccccChhhccc--CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC--------
Confidence 5432211 1233457789999999876 678999999999999999996 99999887765554443210
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.. ....+.+++.+.+||.+||..||.+|||+.+++++
T Consensus 234 -------------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 234 -------------------ER---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp -------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01 11235678999999999999999999999999774
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=373.54 Aligned_cols=254 Identities=26% Similarity=0.418 Sum_probs=211.1
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----HHHHHHHHHHHHHHhcC--CCCcceeeeEec
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI----SDAARILREIKLLRLLR--HPDIVEIKHIML 87 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~----~~~~~i~~Ei~iL~~L~--HpnIv~l~~v~~ 87 (614)
....++|++++.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+|+.++ ||||+++++++
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~- 117 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF- 117 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE-
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE-
Confidence 345688999999999999999999999999999999997532211 12245668999999996 59999999998
Q ss_pred CCCCCCCCcEEEEEecCC--CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEEC-CCCcEEEee
Q 007177 88 PPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN-ANCKLKICD 164 (614)
Q Consensus 88 ~~~~~~~~~~ylV~E~~~--g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~-~~~~vKL~D 164 (614)
.+...+|+|||++. ++|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++ .++.+||+|
T Consensus 118 ----~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 118 ----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp ----ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred ----ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence 45567999999997 69999999888899999999999999999999999999999999999999 778999999
Q ss_pred cCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCC
Q 007177 165 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 244 (614)
Q Consensus 165 FGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~ 244 (614)
||+++...... .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+. +.
T Consensus 194 fg~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~----- 256 (320)
T 3a99_A 194 FGSGALLKDTV-----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------II----- 256 (320)
T ss_dssp CTTCEECCSSC-----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH-----
T ss_pred Ccccccccccc-----ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhh------hh-----
Confidence 99998754322 2345799999999998752 2347889999999999999999999965321 00
Q ss_pred CchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 245 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 245 p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
. .. . .....+++.+.+||.+||..||.+|||++|+|+||||++..
T Consensus 257 ------------------~---~~--~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 257 ------------------R---GQ--V---FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp ------------------H---CC--C---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ------------------c---cc--c---cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 0 00 0 11245788999999999999999999999999999998653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=356.89 Aligned_cols=250 Identities=25% Similarity=0.388 Sum_probs=207.8
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++++.||+|+||.||+|.+. ++..||+|++...... ...+.+|+.+|+.++||||+++++++ .+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQA 78 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSS
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCC
Confidence 4568999999999999999999986 5778999999854322 35688999999999999999999998 4456
Q ss_pred cEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 96 DIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
.+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 7999999998 5999999754 4699999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 159 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~---------- 224 (269)
T 4hcu_A 159 DQY--TSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF---------- 224 (269)
T ss_dssp HHH--HSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC----------
T ss_pred ccc--ccccCcccccccCCHHHhcC--CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc----------
Confidence 211 11233467888999999876 679999999999999999999 999998887655554442210
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
. .......++.+.+||.+||+.||.+|||+.++++|
T Consensus 225 -----------------~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 225 -----------------R---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp -----------------C---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------c---CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0 01123468899999999999999999999999886
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=364.09 Aligned_cols=254 Identities=22% Similarity=0.387 Sum_probs=211.3
Q ss_pred CCCCeEEEeEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 90 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~-----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 90 (614)
..++|++.+.||+|+||.||+|.+. .++..||||++... ........+.+|+.+|+.++||||+++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~---- 95 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGAC---- 95 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE----
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEE----
Confidence 3578999999999999999999883 45689999999753 3455667889999999999999999999998
Q ss_pred CCCCCcEEEEEecCC-CcHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCeEee
Q 007177 91 RRDFKDIYVVFELME-SDLHQVIKANDD------------------------LTREHYQFFLYQLLRALKYIHTANVYHR 145 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~-g~L~~~i~~~~~------------------------lse~~~~~i~~QIl~aL~yLHs~gIvHr 145 (614)
.+...+|+|||||. ++|.+++..... +++..++.++.||+.||.|||++||+||
T Consensus 96 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 96 -SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred -ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 44566899999998 699999987543 8999999999999999999999999999
Q ss_pred cCCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCC
Q 007177 146 DLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 224 (614)
Q Consensus 146 DLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~ 224 (614)
||||+|||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSY-VKRSQGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCE-ECSSCCCSCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccchheEEEcCCCCEEEccccccccccccccc-eeccCCCCcccccChhhhcC--CCcCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999865433221 11234567889999999876 578999999999999999999 999
Q ss_pred CCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 007177 225 LFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 304 (614)
Q Consensus 225 pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~e 304 (614)
||.+.+.......+.. .. .......+++.+.+||.+||+.||.+|||+++
T Consensus 252 p~~~~~~~~~~~~~~~---------------------------~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 301 (314)
T 2ivs_A 252 PYPGIPPERLFNLLKT---------------------------GH---RMERPDNCSEEMYRLMLQCWKQEPDKRPVFAD 301 (314)
T ss_dssp SSTTCCGGGHHHHHHT---------------------------TC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCHHHHHHHhhc---------------------------CC---cCCCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 9988775544433311 00 11223467899999999999999999999999
Q ss_pred HHcC
Q 007177 305 ALAD 308 (614)
Q Consensus 305 iL~h 308 (614)
++++
T Consensus 302 l~~~ 305 (314)
T 2ivs_A 302 ISKD 305 (314)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=361.60 Aligned_cols=259 Identities=18% Similarity=0.228 Sum_probs=209.5
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~ 94 (614)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+.+|+.+++.+ +|+||+.+++++ .+.
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~ 78 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEG 78 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EET
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCC
Confidence 4578999999999999999999999999999999986432 223577899999999 799999999988 455
Q ss_pred CcEEEEEecCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCc-----EEEeecCcc
Q 007177 95 KDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK-----LKICDFGLA 168 (614)
Q Consensus 95 ~~~ylV~E~~~g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~-----vKL~DFGla 168 (614)
...|+||||+.++|.+++...+ .+++..+..|+.||+.||.|||+.||+||||||+|||++.++. +||+|||++
T Consensus 79 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 79 LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 6799999999889999998754 5999999999999999999999999999999999999987776 999999999
Q ss_pred ccccCCCCCc----cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCC
Q 007177 169 RVAFNDTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 244 (614)
Q Consensus 169 ~~~~~~~~~~----~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~ 244 (614)
+......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~-- 234 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG-- 234 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH--
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH--
Confidence 8765432211 11245679999999999887 678999999999999999999999998854322221111100
Q ss_pred CchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 245 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 245 p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
. ...........+.+++.+.+||.+||+.||.+|||++++++.
T Consensus 235 ------------------~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 235 ------------------E---KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp ------------------H---HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred ------------------h---hccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 0 000111222345678999999999999999999999999763
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=370.24 Aligned_cols=257 Identities=19% Similarity=0.222 Sum_probs=205.8
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~ 94 (614)
..++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+|+.| +||||+++++++ .+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~-----~~~ 77 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFG-----PCG 77 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEE-----EET
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEE-----ecC
Confidence 45789999999999999999999999999999999864321 23577899999999 899999999998 445
Q ss_pred CcEEEEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCc-----EEEeecCcc
Q 007177 95 KDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK-----LKICDFGLA 168 (614)
Q Consensus 95 ~~~ylV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~-----vKL~DFGla 168 (614)
...|+||||+.++|.+++.. ...+++..+..|+.||+.||.|||+.||+||||||+|||++.++. +||+|||++
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 78 KYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred CccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 67899999998899999986 467999999999999999999999999999999999999999887 999999999
Q ss_pred ccccCCCCCcc----ccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCC
Q 007177 169 RVAFNDTPTTI----FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 244 (614)
Q Consensus 169 ~~~~~~~~~~~----~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~ 244 (614)
+.......... .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+....+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~-- 233 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLG--KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG-- 233 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH--
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcC--CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH--
Confidence 87543322110 1245689999999999987 679999999999999999999999998865333222221100
Q ss_pred CchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 245 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 245 p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
. .....+........+ .+.+||..||..||.+||+++++++
T Consensus 234 ------------------~---~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 234 ------------------D---TKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp ------------------H---HHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ------------------h---hhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0 000001111112233 8999999999999999999999865
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=362.75 Aligned_cols=256 Identities=27% Similarity=0.370 Sum_probs=201.7
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
...++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++ .+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~ 105 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG-----EI 105 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE-----ee
Confidence 345789999999999999999999999999999999975432 334457788999999999999999999998 34
Q ss_pred CCcEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 94 FKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 94 ~~~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
.+.+|+||||+++ +|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 106 DGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp TTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 5679999999985 999999988889999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.
T Consensus 186 ~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~------------- 248 (309)
T 2h34_A 186 DEKL--TQLGNTVGTLYYMAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN------------- 248 (309)
T ss_dssp -------------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH-------------
T ss_pred cccc--ccccccCCCcCccCHHHHcC--CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc-------------
Confidence 3221 12234579999999999877 678999999999999999999999998765432211110
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-CHHHHHc
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-TAEEALA 307 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-sa~eiL~ 307 (614)
..........+.+++.+.+||.+||..||++|| +++++++
T Consensus 249 ---------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 249 ---------------QAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp ---------------SCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ---------------cCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 111112233467889999999999999999999 8888765
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=362.85 Aligned_cols=271 Identities=21% Similarity=0.354 Sum_probs=207.0
Q ss_pred CCCCeEEEeEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~----d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
..++|++++.||+|+||.||+|. +..+++.||||++.. ........+.+|+.+|+.++||||+++++++...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 83 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA-- 83 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH--
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 45789999999999999999998 667899999999975 3445667889999999999999999999988432
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
+...+|+|||||+ ++|.+++.... .+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 84 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 84 -GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp -HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred -CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 2245899999997 59999998754 59999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 170 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 170 ~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
................++..|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~ 235 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPPA-----EFMRMIGNDKQGQ 235 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH-----HHHHHHCTTCCTH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcC--CCCChHHHHHHHHHHHHHHHhcccccCCChH-----HHHhhhcCccccc
Confidence 76443322222334567888999999887 6799999999999999999999999865432 1111222221111
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
. ........+...... .....+++.+.+||.+||+.||.+|||++|+++
T Consensus 236 ~------~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 236 M------IVFHLIELLKNNGRL---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp H------HHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred h------hHHHHHHHHhccCcC---CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1 011111222222111 123467899999999999999999999999976
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=354.67 Aligned_cols=250 Identities=20% Similarity=0.313 Sum_probs=207.3
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++++.||+|+||.||+|.+. ++..||+|++..... ....+.+|+.+|+.++||||+++++++ .+..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~ 76 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEY 76 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSS
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCC
Confidence 3568999999999999999999775 577899999975432 235688999999999999999999998 4556
Q ss_pred cEEEEEecCC-CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 96 DIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
.+|+||||++ ++|.+++...+ .+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 77 PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 7999999997 58999997654 599999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 157 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~----------- 221 (268)
T 3sxs_A 157 DQYV--SSVGTKFPVKWSAPEVFHY--FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG----------- 221 (268)
T ss_dssp TCEE--ECCSCCCCGGGCCHHHHHH--SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-----------
T ss_pred hhhh--cccCCCcCcccCCHHHHhc--cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcC-----------
Confidence 3221 1234456788999999876 578999999999999999999 99999887765544433210
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
... ......++.+.+||.+||+.||.+|||+.++|++
T Consensus 222 ----------------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 222 ----------------HRL---YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ----------------CCC---CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCC---CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 1113467899999999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=357.65 Aligned_cols=251 Identities=21% Similarity=0.314 Sum_probs=206.1
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
-..++|++++.||+|+||.||+|.+. ++..||||++...... ...+.+|+.+|+.++||||+++++++ .+.
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~ 91 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQ 91 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEE-----CSS
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEE-----ecC
Confidence 45679999999999999999999875 6778999999854322 35688999999999999999999998 455
Q ss_pred CcEEEEEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 95 KDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
..+|+|||||+ ++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 67999999997 699999976 5679999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 172 ~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-------- 239 (283)
T 3gen_A 172 DDEY--TSSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-------- 239 (283)
T ss_dssp CHHH--HSTTSTTSCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--------
T ss_pred cccc--ccccCCccCcccCCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC--------
Confidence 2211 11233457788999999886 578999999999999999998 9999988776555544422110
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
. ......++.+.+||.+||+.||.+|||++++|+|
T Consensus 240 -------------------~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 240 -------------------L---YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp -------------------C---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------------C---CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0 1123457899999999999999999999999886
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=366.13 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=209.7
Q ss_pred CCCCeEEEeEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 90 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~-----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 90 (614)
..++|++++.||+|+||.||+|.+. .+++.||||+++.. ........+.+|+.+|+.++||||+++++++
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~---- 119 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVC---- 119 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE----
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE----
Confidence 4578999999999999999999987 35589999999754 2344567789999999999999999999998
Q ss_pred CCCCCcEEEEEecCC-CcHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEee
Q 007177 91 RRDFKDIYVVFELME-SDLHQVIKAN------------------------DDLTREHYQFFLYQLLRALKYIHTANVYHR 145 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~-g~L~~~i~~~------------------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHr 145 (614)
.+...+|+|||||+ ++|.+++... ..+++..++.|+.||+.||.|||+.||+||
T Consensus 120 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 120 -AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred -ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 44567899999998 5999999764 569999999999999999999999999999
Q ss_pred cCCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCC
Q 007177 146 DLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 224 (614)
Q Consensus 146 DLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~ 224 (614)
||||+|||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccc-cccCCCcccceecChhhhcc--CCcCcccccHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999865332211 11234568899999999876 579999999999999999999 999
Q ss_pred CCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 007177 225 LFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 304 (614)
Q Consensus 225 pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~e 304 (614)
||.+.+..+....+.. ... ......+++.+.+||.+||..||.+|||+.+
T Consensus 276 p~~~~~~~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 325 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRD---------------------------GNI---LACPENCPLELYNLMRLCWSKLPADRPSFCS 325 (343)
T ss_dssp TTTTSCHHHHHHHHHT---------------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cCCCCChHHHHHHHhC---------------------------CCc---CCCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 9988776544433321 111 1122457889999999999999999999999
Q ss_pred HHcC
Q 007177 305 ALAD 308 (614)
Q Consensus 305 iL~h 308 (614)
++++
T Consensus 326 ~~~~ 329 (343)
T 1luf_A 326 IHRI 329 (343)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=357.69 Aligned_cols=255 Identities=21% Similarity=0.304 Sum_probs=208.1
Q ss_pred CCCCCeEEEe-EeeecCceEEEEEEE--CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 15 GDASRYKIQE-VIGKGSYGVVCSAID--THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 15 ~~~~rY~i~~-~LG~G~~G~V~~a~d--~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
-+.++|++.+ .||+|+||.||+|.+ ..+++.||||+++...........+.+|+.+++.++||||+++++++.
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---- 88 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE---- 88 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE----
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC----
Confidence 4457899998 999999999999954 567889999999865444455678899999999999999999999882
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
....|+||||++ ++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 89 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 89 --AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp --SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred --CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 245899999998 59999999988899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
...............+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--------- 235 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK--------- 235 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---------
T ss_pred eccCCCcccccccCCCCceeeChHHhcc--CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---------
Confidence 6443332222233456788999999876 578899999999999999999 9999988776444333211
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
... ......+++.+.+||.+||..||.+|||+.++++
T Consensus 236 ------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 236 ------------------GER---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ------------------TCC---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001 1122467899999999999999999999999976
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=365.73 Aligned_cols=253 Identities=26% Similarity=0.414 Sum_probs=202.0
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----HHHHHHHHHHHHHHhc----CCCCcceeeeEe
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI----SDAARILREIKLLRLL----RHPDIVEIKHIM 86 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~----~~~~~i~~Ei~iL~~L----~HpnIv~l~~v~ 86 (614)
...++|++.+.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+++.+ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34578999999999999999999999999999999997532211 2334456899999998 899999999998
Q ss_pred cCCCCCCCCcEEEEEec-CC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEEC-CCCcEEEe
Q 007177 87 LPPSRRDFKDIYVVFEL-ME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN-ANCKLKIC 163 (614)
Q Consensus 87 ~~~~~~~~~~~ylV~E~-~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~-~~~~vKL~ 163 (614)
.+....|+|||+ +. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+
T Consensus 108 -----~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 108 -----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp ----------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEEC
T ss_pred -----ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEE
Confidence 344668999999 55 69999999888899999999999999999999999999999999999999 88999999
Q ss_pred ecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhC
Q 007177 164 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 243 (614)
Q Consensus 164 DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g 243 (614)
|||+++...... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+... +.
T Consensus 183 dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~---- 246 (312)
T 2iwi_A 183 DFGSGALLHDEP-----YTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQE------IL---- 246 (312)
T ss_dssp CCSSCEECCSSC-----BCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH----
T ss_pred EcchhhhcccCc-----ccccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hh----
Confidence 999998754322 2446799999999998752 2334589999999999999999999965321 00
Q ss_pred CCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 244 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 244 ~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
. .. ......+++.+.+||.+||..||++|||++|+|+||||+...
T Consensus 247 -------------------~---~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 247 -------------------E---AE-----LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp -------------------H---TC-----CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred -------------------h---hc-----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 0 00 011245788999999999999999999999999999998643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=357.36 Aligned_cols=265 Identities=22% Similarity=0.268 Sum_probs=202.4
Q ss_pred ccccccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEec
Q 007177 8 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIML 87 (614)
Q Consensus 8 ~~~~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~ 87 (614)
..+-...-..++|++.+.||+|+||.||+|.+. ..||||+++...........+.+|+.+|+.++||||++++++.
T Consensus 14 ~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~- 89 (289)
T 3og7_A 14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 89 (289)
T ss_dssp ----CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred CCCCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence 334444566789999999999999999999653 3599999987666667778899999999999999999999965
Q ss_pred CCCCCCCCcEEEEEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeec
Q 007177 88 PPSRRDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 165 (614)
Q Consensus 88 ~~~~~~~~~~ylV~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DF 165 (614)
....+++|||||+ ++|.+++.. ...+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+||
T Consensus 90 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Df 164 (289)
T 3og7_A 90 -----TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDF 164 (289)
T ss_dssp -----CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCC
T ss_pred -----cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccc
Confidence 2345799999998 599999854 456999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCC
Q 007177 166 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 244 (614)
Q Consensus 166 Gla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~-~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~ 244 (614)
|+++....... ........||+.|+|||++... ...++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 165 g~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--- 240 (289)
T 3og7_A 165 GLATEKSRWSG-SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR--- 240 (289)
T ss_dssp C-------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH---
T ss_pred eeccccccccc-cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc---
Confidence 99976432221 1123446799999999988521 156888999999999999999999999887655444333211
Q ss_pred CchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 245 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 245 p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
......+......+++.+.+||.+||..||.+|||++++++
T Consensus 241 ----------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 241 ----------------------GSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp ----------------------TSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------cccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11122233344578899999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=370.48 Aligned_cols=254 Identities=24% Similarity=0.403 Sum_probs=211.1
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCC-------CcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEec
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHT-------GEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIML 87 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~t-------g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~ 87 (614)
..++|++.+.||+|+||.||+|.+..+ +..||||++... ........+.+|+.+|+.+ +||||+++++++
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~- 144 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC- 144 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeee-
Confidence 347899999999999999999997543 357999999754 3455667889999999999 899999999998
Q ss_pred CCCCCCCCcEEEEEecCC-CcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCC
Q 007177 88 PPSRRDFKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPK 150 (614)
Q Consensus 88 ~~~~~~~~~~ylV~E~~~-g~L~~~i~~~~----------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~ 150 (614)
.+.+.+|+|||||+ ++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+
T Consensus 145 ----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 145 ----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220 (382)
T ss_dssp ----CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred ----ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence 44566899999998 59999998754 4999999999999999999999999999999999
Q ss_pred cEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 007177 151 NILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 229 (614)
Q Consensus 151 NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~ 229 (614)
|||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTT-CCCTTCCCGGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eEEEcCCCcEEEcccCccccccccccc-ccccCCCCCcceeCHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999865432211 11234567889999999887 689999999999999999999 99999888
Q ss_pred ChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 230 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 230 ~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
+..+....+.. ... ......+++.+.+||.+||+.||.+|||++|++++
T Consensus 298 ~~~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 298 PVEELFKLLKE---------------------------GHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CHHHHHHHHHT---------------------------TCC---CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHc---------------------------CCC---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 76554433321 101 11124578899999999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=362.68 Aligned_cols=261 Identities=24% Similarity=0.350 Sum_probs=205.4
Q ss_pred ccccCCCCCCeEEEeEeeecCceEEEEEEECCCC----cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeE
Q 007177 10 FFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTG----EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 85 (614)
Q Consensus 10 ~~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg----~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v 85 (614)
.|...-..++|.+.+.||+|+||.||+|.+..++ ..||||++... ........+.+|+.+|+.++||||++++++
T Consensus 36 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 114 (333)
T 1mqb_A 36 KFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGV 114 (333)
T ss_dssp --CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 3445566789999999999999999999887654 35999999753 234556678899999999999999999999
Q ss_pred ecCCCCCCCCcEEEEEecCCC-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEe
Q 007177 86 MLPPSRRDFKDIYVVFELMES-DLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 163 (614)
Q Consensus 86 ~~~~~~~~~~~~ylV~E~~~g-~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~ 163 (614)
+ .+...+|||||||++ +|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+
T Consensus 115 ~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~ 189 (333)
T 1mqb_A 115 I-----SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVS 189 (333)
T ss_dssp E-----CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred E-----ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEEC
Confidence 8 455679999999985 999999764 579999999999999999999999999999999999999999999999
Q ss_pred ecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhh
Q 007177 164 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLL 242 (614)
Q Consensus 164 DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~ 242 (614)
|||+++................+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~- 266 (333)
T 1mqb_A 190 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG- 266 (333)
T ss_dssp CCCC-----------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-
T ss_pred CCCcchhhccccccccccCCCCccccccCchhccc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC-
Confidence 99999875443322222233456889999999876 679999999999999999998 99999887765444333211
Q ss_pred CCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 243 g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
... .....+++.+.+||.+||+.||.+||++.+++++
T Consensus 267 --------------------------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 267 --------------------------FRL---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp --------------------------CCC---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --------------------------CcC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 1123578899999999999999999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=353.18 Aligned_cols=251 Identities=22% Similarity=0.327 Sum_probs=204.1
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHH-----HHHHHHHHHHHhcCCCCcceeeeEecCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA-----ARILREIKLLRLLRHPDIVEIKHIMLPP 89 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~-----~~i~~Ei~iL~~L~HpnIv~l~~v~~~~ 89 (614)
-..++|++.+.||+|+||.||+|.+..+++.||||++.......... ..+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 34679999999999999999999999999999999986433222111 6788999999999999999999998432
Q ss_pred CCCCCCcEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeecCCCCcEEECCCCc-----E
Q 007177 90 SRRDFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANANCK-----L 160 (614)
Q Consensus 90 ~~~~~~~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILi~~~~~-----v 160 (614)
.++||||+. ++|.+.+... ..+++..+..++.||+.||.|||+.| |+||||||+|||++.++. +
T Consensus 96 -------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 96 -------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp -------TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred -------CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeE
Confidence 279999998 6998888654 47999999999999999999999999 999999999999988776 9
Q ss_pred EEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHH--HHHH
Q 007177 161 KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ--LDLM 238 (614)
Q Consensus 161 KL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~--l~~i 238 (614)
||+|||+++..... .....||+.|+|||++.+....++.++|||||||++|+|++|..||.+.+..+. ...+
T Consensus 169 kl~Dfg~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 242 (287)
T 4f0f_A 169 KVADFGLSQQSVHS------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242 (287)
T ss_dssp EECCCTTCBCCSSC------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH
T ss_pred EeCCCCcccccccc------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH
Confidence 99999999753321 244679999999999854335688999999999999999999999977653222 1111
Q ss_pred HhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 239 TDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 239 ~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.. ... .......+++.+.+||.+||+.||.+|||++++++
T Consensus 243 ~~--------------------------~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 243 RE--------------------------EGL---RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HH--------------------------SCC---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hc--------------------------cCC---CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 000 11223467899999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=387.03 Aligned_cols=258 Identities=28% Similarity=0.404 Sum_probs=195.1
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.+|.+.+.||+|+||.||. ....+|+.||||++..... ..+.+|+.+|+.+ +||||+++++++ .+...
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~ 92 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTE-----KDRQF 92 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEE-----EETTE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCE
Confidence 4699999999999999764 4467899999999964321 2246899999999 799999999988 45567
Q ss_pred EEEEEecCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC-----CCcEEEeecCcccc
Q 007177 97 IYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-----NCKLKICDFGLARV 170 (614)
Q Consensus 97 ~ylV~E~~~g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~-----~~~vKL~DFGla~~ 170 (614)
+|||||||+++|.+++.... .+.+..+..|+.||+.||.|||+.||+||||||+|||++. ...+||+|||+++.
T Consensus 93 ~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 93 QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 99999999999999998654 4666678899999999999999999999999999999953 23588999999987
Q ss_pred ccCCCCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLD 248 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~-~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~ 248 (614)
..............+||++|+|||++.+. ...++.++||||||||+|+|++ |..||...... +...+ .+..
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-~~~~~---~~~~--- 245 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-QANIL---LGAC--- 245 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-HHHHH---TTCC---
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-HHHHH---hccC---
Confidence 65433222233557899999999998642 2467889999999999999999 89999554322 21111 1110
Q ss_pred hhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 249 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 249 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
...........+..+.+||.+||+.||.+|||++++|+||||..+
T Consensus 246 ---------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 246 ---------------------SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp ---------------------CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred ---------------------CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 011111112235568999999999999999999999999999764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=356.03 Aligned_cols=251 Identities=22% Similarity=0.423 Sum_probs=212.0
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
-..++|++.+.||+|+||.||+|.+..++..||||++... ......+.+|+.+|+.++||||+++++++ .+.
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~ 81 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TRE 81 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSS
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccC
Confidence 4567899999999999999999999999999999999742 34567788999999999999999999998 455
Q ss_pred CcEEEEEecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 95 KDIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
..+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 67999999999 6999999874 35999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+...
T Consensus 162 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~--------- 228 (288)
T 3kfa_A 162 TGDTYT--AHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------- 228 (288)
T ss_dssp CSSSSE--EETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT---------
T ss_pred cCCccc--cccCCccccCcCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc---------
Confidence 433221 2234467889999999876 678999999999999999999 99999887755444333210
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.. ......+++.+.+||.+||..||.+|||++++++
T Consensus 229 ------------------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 229 ------------------YR---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CC---CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 00 1122467889999999999999999999999976
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=368.47 Aligned_cols=275 Identities=22% Similarity=0.240 Sum_probs=208.1
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
-..++|++++.||+|+||.||+|.+. ++.||||++... ........+|+.+|+.++||||+++++++.... ...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~ 94 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVD 94 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSS
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCC
Confidence 34578999999999999999999775 789999999642 234455667999999999999999999985432 123
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------CeEeecCCCCcEEECCCCcEEEe
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA----------NVYHRDLKPKNILANANCKLKIC 163 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~----------gIvHrDLKP~NILi~~~~~vKL~ 163 (614)
..+|+|||||+ ++|.+++... .+++..++.|+.||+.||.|||+. ||+||||||+|||++.++.+||+
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred ceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 56899999998 5999999775 599999999999999999999999 99999999999999999999999
Q ss_pred ecCccccccCCCCCccccccccCCccccCcccccccC---CCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 007177 164 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 240 (614)
Q Consensus 164 DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~---~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~ 240 (614)
|||+++........ ......+||+.|+|||++.+.. ..++.++|||||||++|||++|+.||.+......+.....
T Consensus 174 DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 174 DFGLALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCTTCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred cCCcccccccccCc-cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 99999875443221 1224468999999999987521 2456688999999999999999999988654333222222
Q ss_pred hhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCC--CCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 241 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFP--NADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 241 ~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~--~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
..+.|....+... . ........+...+. ..++.+.+||.+||+.||++|||++|+++
T Consensus 253 ~~~~~~~~~~~~~--------~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 253 IGQHPSLEDMQEV--------V--VHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HCSSCCHHHHHHH--------H--TTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccCCchhhhhhh--------h--hcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 3333333222111 0 01111111112221 12356999999999999999999999976
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=362.94 Aligned_cols=259 Identities=22% Similarity=0.348 Sum_probs=191.9
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCC---CC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPS---RR 92 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~---~~ 92 (614)
..+|++.+.||+|+||.||+|.+..+++.||||++.. ........+.+|+.+|+.+. ||||+++++++.... ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS--NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecC--CchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 4589999999999999999999999999999999854 34456677889999999996 999999999985332 13
Q ss_pred CCCcEEEEEecCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeecCCCCcEEECCCCcEEEeecCc
Q 007177 93 DFKDIYVVFELMESDLHQVIKA---NDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANANCKLKICDFGL 167 (614)
Q Consensus 93 ~~~~~ylV~E~~~g~L~~~i~~---~~~lse~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILi~~~~~vKL~DFGl 167 (614)
+...+|+|||||+|+|.+++.. .+.+++..++.|+.||+.||.|||+.| |+||||||+|||++.++.+||+|||+
T Consensus 105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 4556899999999999998865 567999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCc---------cccccccCCccccCcccccc-cCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHH
Q 007177 168 ARVAFNDTPTT---------IFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 237 (614)
Q Consensus 168 a~~~~~~~~~~---------~~~~~~vgt~~Y~APEvl~~-~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~ 237 (614)
++......... .......||+.|+|||++.. ....++.++|||||||++|+|++|..||.+......+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 98754332211 01124569999999999831 115688999999999999999999999976543221110
Q ss_pred HHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcc
Q 007177 238 MTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 310 (614)
Q Consensus 238 i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~ 310 (614)
... .......++.+.+||.+||+.||.+|||++|+++|-+
T Consensus 265 ------------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 265 ------------------------------KYS---IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp -------------------------------CC---CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred ------------------------------ccc---CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 000 0112345678999999999999999999999998743
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=360.18 Aligned_cols=261 Identities=20% Similarity=0.299 Sum_probs=202.6
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECC---CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~---tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
-..++|++.+.||+|+||.||+|.+.. ++..||||+++...........+.+|+.+|+.++||||+++++++.....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 345789999999999999999998765 55689999998655566677889999999999999999999999876544
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEee
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKA------NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 164 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~------~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~D 164 (614)
......|+||||++ ++|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECS
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEee
Confidence 44456799999999 599999843 35699999999999999999999999999999999999999999999999
Q ss_pred cCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhC
Q 007177 165 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLG 243 (614)
Q Consensus 165 FGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g 243 (614)
||+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+...
T Consensus 191 fg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-- 265 (313)
T 3brb_A 191 FGLSKKIYSGDYY-RQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG-- 265 (313)
T ss_dssp CSCC-----------------CCGGGSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT--
T ss_pred cCcceeccccccc-CcccccCCCccccCchhhcC--CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC--
Confidence 9999865432211 11233467889999999977 689999999999999999999 99999887765544333210
Q ss_pred CCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 244 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 244 ~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.. ......+++.+.+||.+||..||.+|||+.+++++
T Consensus 266 -------------------------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 266 -------------------------HR---LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp -------------------------CC---CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CC---CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 11224678899999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=358.40 Aligned_cols=254 Identities=26% Similarity=0.378 Sum_probs=209.6
Q ss_pred CCCeEEEeEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAID-----THTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 90 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d-----~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~ 90 (614)
.++|++.+.||+|+||.||+|.+ ..+++.||||++... ........+.+|+.+|+.+ +||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--- 97 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACT--- 97 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe---
Confidence 46899999999999999999985 457789999999753 3345567889999999999 8999999999983
Q ss_pred CCCCCcEEEEEecCCC-cHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCc
Q 007177 91 RRDFKDIYVVFELMES-DLHQVIKAND------------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKN 151 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~g-~L~~~i~~~~------------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~N 151 (614)
+.+..|+|||||++ +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|
T Consensus 98 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 98 --IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp --SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred --cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 44568999999985 9999998754 48999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCC
Q 007177 152 ILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 230 (614)
Q Consensus 152 ILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~ 230 (614)
||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+..
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EEEcCCCCEEEccccccccccccccc-eeccCCCCcceeeChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 99999999999999999876543321 12234567889999999876 679999999999999999998 999998876
Q ss_pred hhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 231 VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 231 ~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
....+..+... ... ......+++.+.+||.+||..||.+|||++|++++
T Consensus 253 ~~~~~~~~~~~--------------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 253 VDSKFYKMIKE--------------------------GFR---MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SSHHHHHHHHH--------------------------TCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhHHHHHhcc--------------------------CCC---CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 54333222110 000 01124578899999999999999999999999874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=373.96 Aligned_cols=259 Identities=25% Similarity=0.381 Sum_probs=199.8
Q ss_pred cccCCCCCCeEEEeEeeecCceEEEEEEEC---CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEec
Q 007177 11 FSEYGDASRYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIML 87 (614)
Q Consensus 11 ~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~---~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~ 87 (614)
|...-..++|++.+.||+|+||.||+|.++ .++..||||+++.. ........+.+|+.+|+.++||||+++++++
T Consensus 38 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~- 115 (373)
T 2qol_A 38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVV- 115 (373)
T ss_dssp TSCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred HHhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-
Confidence 344455678999999999999999999876 46778999999753 2445567899999999999999999999998
Q ss_pred CCCCCCCCcEEEEEecCC-CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeec
Q 007177 88 PPSRRDFKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 165 (614)
Q Consensus 88 ~~~~~~~~~~ylV~E~~~-g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DF 165 (614)
.+...+|+|||||+ ++|.+++...+ .+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+||
T Consensus 116 ----~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df 191 (373)
T 2qol_A 116 ----TKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDF 191 (373)
T ss_dssp ----CSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred ----eeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcC
Confidence 34567899999997 69999998754 6999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCC
Q 007177 166 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGT 244 (614)
Q Consensus 166 Gla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~ 244 (614)
|+++................++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+....
T Consensus 192 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~-- 267 (373)
T 2qol_A 192 GLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY-- 267 (373)
T ss_dssp ----------------------CTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE--
T ss_pred ccccccccCCccceeccCCCcCCCccChhhhcc--CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--
Confidence 999876443222211223345778999999986 689999999999999999998 999998877654443332110
Q ss_pred CchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 245 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 245 p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
. ......++..+.+||.+||+.||.+||+++++++
T Consensus 268 -----------------------~-----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 268 -----------------------R-----LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp -----------------------E-----CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------C-----CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 0 0112356789999999999999999999999976
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=364.19 Aligned_cols=256 Identities=25% Similarity=0.391 Sum_probs=206.9
Q ss_pred CCCCeEEEeEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPP 89 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~-----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~ 89 (614)
..++|++.+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+|+.+ +||||+++++++.
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-- 119 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACT-- 119 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe--
Confidence 3478999999999999999999973 466789999997532 234456788999999999 8999999999984
Q ss_pred CCCCCCcEEEEEecCC-CcHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEee
Q 007177 90 SRRDFKDIYVVFELME-SDLHQVIKAND-----------------------DLTREHYQFFLYQLLRALKYIHTANVYHR 145 (614)
Q Consensus 90 ~~~~~~~~ylV~E~~~-g~L~~~i~~~~-----------------------~lse~~~~~i~~QIl~aL~yLHs~gIvHr 145 (614)
+.+.+|+|||||+ ++|.+++.... .+++..+..|+.||+.||.|||+.||+||
T Consensus 120 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 120 ---LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp ---SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred ---eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 4456899999998 59999998653 37999999999999999999999999999
Q ss_pred cCCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCC
Q 007177 146 DLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 224 (614)
Q Consensus 146 DLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~ 224 (614)
||||+|||++.++.+||+|||++......... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccc-eeccCccCccCccCHHHhcc--CCCChhHhHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999866443322 12234567889999999876 679999999999999999998 999
Q ss_pred CCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 007177 225 LFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 304 (614)
Q Consensus 225 pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~e 304 (614)
||.+.+....+..+.. .... ......+++.+.+||.+||..||.+|||+.+
T Consensus 274 p~~~~~~~~~~~~~~~--------------------------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 324 (344)
T 1rjb_A 274 PYPGIPVDANFYKLIQ--------------------------NGFK---MDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 324 (344)
T ss_dssp SSTTCCCSHHHHHHHH--------------------------TTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CcccCCcHHHHHHHHh--------------------------cCCC---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 9988764433322211 0000 1112356889999999999999999999999
Q ss_pred HHcCc
Q 007177 305 ALADP 309 (614)
Q Consensus 305 iL~hp 309 (614)
+++|.
T Consensus 325 l~~~l 329 (344)
T 1rjb_A 325 LTSFL 329 (344)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=357.67 Aligned_cols=257 Identities=19% Similarity=0.239 Sum_probs=203.3
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
...++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++|++++..+..+. .+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~ 77 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCG----AEG 77 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEE----EET
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeec----CCC
Confidence 44578999999999999999999999999999999876432 2234778999999999988887777663 344
Q ss_pred CcEEEEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEE---CCCCcEEEeecCcccc
Q 007177 95 KDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA---NANCKLKICDFGLARV 170 (614)
Q Consensus 95 ~~~ylV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi---~~~~~vKL~DFGla~~ 170 (614)
...|+||||+.++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++.
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 78 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred CceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 67899999998899999985 4579999999999999999999999999999999999999 7889999999999987
Q ss_pred ccCCCCCc----cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhH---HHHHHHhhhC
Q 007177 171 AFNDTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH---QLDLMTDLLG 243 (614)
Q Consensus 171 ~~~~~~~~----~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~---~l~~i~~~~g 243 (614)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+... .+..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--- 232 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE--- 232 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH---
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcC--CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhc---
Confidence 65432211 11235689999999999987 679999999999999999999999998754321 1111110
Q ss_pred CCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 244 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 244 ~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.....+.......+++.+.+||.+||+.||.+|||++++++
T Consensus 233 -----------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 233 -----------------------KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -----------------------HHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -----------------------ccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 00001112223567889999999999999999999999987
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=366.32 Aligned_cols=261 Identities=20% Similarity=0.317 Sum_probs=207.6
Q ss_pred ccccccCCCCCCeEEEeEeeecCceEEEEEEECCCCcE----EEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceee
Q 007177 8 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEK----VAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 83 (614)
Q Consensus 8 ~~~~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~----vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~ 83 (614)
|+.+...-..++|++++.||+|+||.||+|.+..+++. ||+|.+.... .......+.+|+.+++.++||||++++
T Consensus 3 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~ 81 (325)
T 3kex_A 3 MKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLL 81 (325)
T ss_dssp -CCCCCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEE
T ss_pred hHHHHhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEE
Confidence 34444555667899999999999999999999988876 7777765321 112234567899999999999999999
Q ss_pred eEecCCCCCCCCcEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEE
Q 007177 84 HIMLPPSRRDFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLK 161 (614)
Q Consensus 84 ~v~~~~~~~~~~~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vK 161 (614)
+++. ....|+|||||. ++|.+++... +.+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+|
T Consensus 82 ~~~~------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~k 155 (325)
T 3kex_A 82 GLCP------GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQ 155 (325)
T ss_dssp EEEC------BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEE
T ss_pred EEEc------CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEE
Confidence 9873 345899999998 6999999774 5799999999999999999999999999999999999999999999
Q ss_pred EeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHh
Q 007177 162 ICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTD 240 (614)
Q Consensus 162 L~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~ 240 (614)
|+|||+++........ .......+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 156 l~Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 232 (325)
T 3kex_A 156 VADFGVADLLPPDDKQ-LLYSEAKTPIKWMALESIHF--GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232 (325)
T ss_dssp ECSCSGGGGSCCCTTC-CC-----CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT
T ss_pred ECCCCcccccCccccc-ccccCCCCcccccChHHhcc--CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc
Confidence 9999999876433222 22345578889999999976 679999999999999999999 9999988765444333321
Q ss_pred hhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 241 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 241 ~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.... .....+++.+.+||.+||..||.+|||+.++++|
T Consensus 233 ---------------------------~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 233 ---------------------------GERL---AQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ---------------------------TCBC---CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ---------------------------CCCC---CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0011 1112356788999999999999999999999886
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=349.55 Aligned_cols=250 Identities=14% Similarity=0.196 Sum_probs=207.7
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++.+.||+|+||.||+|.+. +..||||++............+.+|+.+|+.++||||+++++++... +..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~ 82 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAP 82 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSS
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCC
Confidence 4568999999999999999999874 88999999987655666778899999999999999999999998543 236
Q ss_pred cEEEEEecCC-CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 96 DIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
.+|+|||||+ ++|.+++.... .+++..+..|+.||+.||.|||+.| |+||||||+|||++.++.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 7899999998 59999998765 4899999999999999999999999 99999999999999999999999988754
Q ss_pred ccCCCCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~-~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
... ....+|+.|+|||++.+. ...++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 163 ~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-------- 226 (271)
T 3kmu_A 163 FQS--------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE-------- 226 (271)
T ss_dssp TSC--------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHS--------
T ss_pred ecc--------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhc--------
Confidence 221 234789999999998752 123344899999999999999999999887765544333211
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
... ......+++.+.+||.+||+.||.+|||++++++
T Consensus 227 ------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 227 ------------------GLR---PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ------------------CCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 1123467899999999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=353.80 Aligned_cols=256 Identities=20% Similarity=0.246 Sum_probs=206.3
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+.+|+.+++.++|++++..+..+. .+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~ 78 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCG----AEGD 78 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEE----EETT
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCcccccc----CCCC
Confidence 457899999999999999999999999999999998653222 35789999999999988777776653 3446
Q ss_pred cEEEEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEE---CCCCcEEEeecCccccc
Q 007177 96 DIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA---NANCKLKICDFGLARVA 171 (614)
Q Consensus 96 ~~ylV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi---~~~~~vKL~DFGla~~~ 171 (614)
..|+||||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 79 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 79 YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 7899999998899999974 4579999999999999999999999999999999999999 47889999999999875
Q ss_pred cCCCCCc----cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChh---HHHHHHHhhhCC
Q 007177 172 FNDTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV---HQLDLMTDLLGT 244 (614)
Q Consensus 172 ~~~~~~~----~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~---~~l~~i~~~~g~ 244 (614)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.. ..+..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--- 233 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK--- 233 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH---
T ss_pred cccccccccccccccccccccccCChhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc---
Confidence 5433211 11245689999999999987 67999999999999999999999999874421 122222110
Q ss_pred CchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 245 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 245 p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
....+.......+++.+.+||.+||+.||.+|||++++++
T Consensus 234 -----------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 234 -----------------------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -----------------------HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -----------------------ccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 0001111223567899999999999999999999999976
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=355.23 Aligned_cols=273 Identities=23% Similarity=0.365 Sum_probs=210.8
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPP 89 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~----d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~ 89 (614)
.-...+|++++.||+|+||.||+|. +..+++.||||++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 3445679999999999999999998 57789999999997532 223456788999999999999999999998542
Q ss_pred CCCCCCcEEEEEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCc
Q 007177 90 SRRDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 167 (614)
Q Consensus 90 ~~~~~~~~ylV~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGl 167 (614)
+...+|+||||++ ++|.+++.. ...+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 96 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 96 ---GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp -----CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred ---CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccc
Confidence 2356899999998 599999954 56799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007177 168 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247 (614)
Q Consensus 168 a~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~ 247 (614)
+.................+|..|+|||++.+ ..++.++|||||||++|+|++|..||... ...+....+....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~ 245 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQ--SKFYIASDVWSFGVTLHELLTYCDSDSSP-----MALFLKMIGPTHG 245 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSH-----HHHHHHHHCSCCG
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecC--CCCCcchhHHHHHHHHHHHHHccCCCcch-----hhHHhhccCCccc
Confidence 9876544332233345678899999999876 57889999999999999999999886432 1222222222211
Q ss_pred hhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 248 ~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.. ........+...... ...+.+++.+.+||.+||+.||.+|||++++++
T Consensus 246 ~~-------~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 246 QM-------TVTRLVNTLKEGKRL---PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp GG-------HHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred cc-------CHHHHHHHHhccCCC---CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 11 111222222222222 223568899999999999999999999999976
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=364.16 Aligned_cols=253 Identities=22% Similarity=0.367 Sum_probs=199.9
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEE----EEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKV----AIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~v----AIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
..++|++++.||+|+||.||+|.+..+++.+ |+|.+... ........+.+|+.+|+.++||||+++++++..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 88 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLT--- 88 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEES---
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec---
Confidence 4568999999999999999999998888754 77776532 222345678899999999999999999999853
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
...++|+|++. ++|.+++.. ...+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 89 ---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 89 ---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp ---SSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred ---CCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCccee
Confidence 23789999998 699999977 4579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchh
Q 007177 170 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLD 248 (614)
Q Consensus 170 ~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~ 248 (614)
........ .......+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 166 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-------- 234 (327)
T 3poz_A 166 LLGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------- 234 (327)
T ss_dssp HHTTTCC--------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT--------
T ss_pred EccCCccc-ccccCCCccccccChHHhcc--CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc--------
Confidence 76433321 12234467889999999887 689999999999999999999 9999988765444333211
Q ss_pred hhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 249 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 249 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.... ...+..+..+.+||.+||+.||.+|||+.+++++
T Consensus 235 -------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 235 -------------------GERL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -------------------TCCC---CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred -------------------CCCC---CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0001 1224567899999999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=360.48 Aligned_cols=254 Identities=19% Similarity=0.357 Sum_probs=210.0
Q ss_pred CCCCeEEEeEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 90 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~-----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 90 (614)
..++|++.+.||+|+||.||+|.++ .+++.||||++... ........+.+|+.+|+.++||||+++++++
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~---- 97 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVV---- 97 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE----
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE----
Confidence 3478999999999999999999876 46788999999753 3345566788999999999999999999998
Q ss_pred CCCCCcEEEEEecCC-CcHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCc
Q 007177 91 RRDFKDIYVVFELME-SDLHQVIKAN----------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK 159 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~-g~L~~~i~~~----------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~ 159 (614)
.+....|+|||||+ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 98 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 98 -SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred -ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence 34456899999998 5999998652 35799999999999999999999999999999999999999999
Q ss_pred EEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 007177 160 LKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLM 238 (614)
Q Consensus 160 vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i 238 (614)
+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus 177 ~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 253 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253 (322)
T ss_dssp EEECCTTCCCGGGGGGCE-EGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred EEECcCcccccccccccc-ccccCCCCCCCccChhhhcc--CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence 999999999865432211 11233467889999999876 678999999999999999999 89999887765444333
Q ss_pred HhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 239 TDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 239 ~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.. .. .......+++.+.+||.+||..||.+|||+.|+++|
T Consensus 254 ~~---------------------------~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 254 ME---------------------------GG---LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HT---------------------------TC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred Hc---------------------------CC---cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 21 00 111234678899999999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=372.69 Aligned_cols=253 Identities=23% Similarity=0.383 Sum_probs=207.5
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++.+.||+|+||.||+|.++.+++.||||+++.. ........+.+|+.+|+.++||||+++++++ .+..
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~ 185 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQ 185 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE-----CSSS
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----ecCC
Confidence 356899999999999999999999999999999998753 2334456788999999999999999999998 3445
Q ss_pred cEEEEEecCC-CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 96 DIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
.+|+|||||+ ++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 6899999998 69999997653 699999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
..... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+..
T Consensus 266 ~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~------------ 330 (377)
T 3cbl_A 266 GVYAA-SGGLRQVPVKWTAPEALNY--GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK------------ 330 (377)
T ss_dssp SEEEC-CSSCCEEEGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHT------------
T ss_pred Cceee-cCCCCCCCcCcCCHhHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------------
Confidence 21110 0111235678999999876 578999999999999999998 9999988775444333211
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.... .....+++.+.+||.+||+.||.+|||++++++
T Consensus 331 ---------------~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 331 ---------------GGRL---PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ---------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1111 112346789999999999999999999999976
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=364.53 Aligned_cols=273 Identities=22% Similarity=0.333 Sum_probs=214.4
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPP 89 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~----d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~ 89 (614)
.-..++|++++.||+|+||.||+|. +..+++.||||++... .......+.+|+.+|+.++||||+++++++..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 95 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYG- 95 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEec-
Confidence 3445689999999999999999998 5678999999999753 44556778999999999999999999998753
Q ss_pred CCCCCCcEEEEEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCc
Q 007177 90 SRRDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 167 (614)
Q Consensus 90 ~~~~~~~~ylV~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGl 167 (614)
.+...+|+|||||+ ++|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 96 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 96 --PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp --SSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred --CCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccc
Confidence 24467999999997 699999976 45699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007177 168 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247 (614)
Q Consensus 168 a~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~ 247 (614)
++................+|..|+|||++.+ ..++.++|||||||++|+|++|..||........ .......
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----~~~~~~~- 245 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSD--NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL-----RMMGCER- 245 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-----HHCC----
T ss_pred ceecccCCccceeeccCCccccccCHHHhcc--CCCChHHhHHHHHHHHHHHHhCCCCCccccchhh-----hhccccc-
Confidence 9876544333333345678999999999876 5789999999999999999999999965432111 0000000
Q ss_pred hhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 248 ~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
...........+...... ...+.+++.+.+||.+||+.||.+|||+++++++
T Consensus 246 ------~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 246 ------DVPALSRLLELLEEGQRL---PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp -------CCHHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------ccccHHHHHHHhhcccCC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000111122222222211 2235678999999999999999999999999765
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=356.61 Aligned_cols=246 Identities=17% Similarity=0.279 Sum_probs=201.2
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCC-------cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTG-------EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLP 88 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg-------~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~ 88 (614)
..++|++.+.||+|+||.||+|.+..++ ..||+|++... .......+.+|+.+|+.++||||+++++++.
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~- 82 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCV- 82 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC-
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-
Confidence 3568999999999999999999998877 47999998753 2344567889999999999999999999984
Q ss_pred CCCCCCCcEEEEEecCC-CcHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCc-------
Q 007177 89 PSRRDFKDIYVVFELME-SDLHQVIKANDD-LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK------- 159 (614)
Q Consensus 89 ~~~~~~~~~ylV~E~~~-g~L~~~i~~~~~-lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~------- 159 (614)
+....|+|||||+ ++|.+++..... +++..+..|+.||+.||.|||+.||+||||||+|||++.++.
T Consensus 83 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 83 ----CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp ----CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred ----eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccc
Confidence 4456799999998 699999987654 999999999999999999999999999999999999998887
Q ss_pred -EEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhC-CCCCCCCChhHHHHH
Q 007177 160 -LKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDL 237 (614)
Q Consensus 160 -vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG-~~pF~g~~~~~~l~~ 237 (614)
+||+|||++...... ....+|+.|+|||++.+. ..++.++|||||||++|+|++| .+||...+.......
T Consensus 159 ~~kl~Dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~ 230 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK-------DILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230 (289)
T ss_dssp EEEECCCCSCTTTSCH-------HHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred eeeeccCcccccccCc-------cccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH
Confidence 999999998654221 234588899999998752 4689999999999999999995 555555443322211
Q ss_pred HHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 238 MTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 238 i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.. .. .......++.+.+||.+||+.||.+|||++++++|
T Consensus 231 ~~---------------------------~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 231 YE---------------------------DR-----HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HH---------------------------TT-----CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hh---------------------------cc-----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 10 00 01123456789999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=352.57 Aligned_cols=255 Identities=22% Similarity=0.328 Sum_probs=209.3
Q ss_pred CCCeEEEe-EeeecCceEEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 17 ASRYKIQE-VIGKGSYGVVCSAIDT--HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 17 ~~rY~i~~-~LG~G~~G~V~~a~d~--~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
.++|.+.+ .||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+|+.++||||+++++++.
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------ 80 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------ 80 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEec------
Confidence 45788877 9999999999999864 46788999999754 34456778999999999999999999999982
Q ss_pred CCcEEEEEecCCC-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 94 FKDIYVVFELMES-DLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 94 ~~~~ylV~E~~~g-~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
...+|+||||+++ +|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 2358999999995 999998653 46999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
..............+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~---------- 228 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---------- 228 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT----------
T ss_pred ccCcceeeccccccccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc----------
Confidence 433322222233457889999999876 578999999999999999998 9999988765444433311
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 310 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~ 310 (614)
... ....+.+++.+.+||.+||..||.+|||++++++|.+
T Consensus 229 -----------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 229 -----------------GKR---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp -----------------TCC---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred -----------------CCc---CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 001 1123467899999999999999999999999998744
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=357.49 Aligned_cols=256 Identities=25% Similarity=0.414 Sum_probs=209.3
Q ss_pred CCCCeEEEeEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAID-----THTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPP 89 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d-----~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~ 89 (614)
..++|++.+.||+|+||.||+|.+ ..+++.||||++... ........+.+|+.+|+.+ +||||+++++++..
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 102 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK- 102 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC-
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec-
Confidence 457899999999999999999985 457789999999754 3344566789999999999 69999999999843
Q ss_pred CCCCCCcEEEEEecCC-CcHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcE
Q 007177 90 SRRDFKDIYVVFELME-SDLHQVIKANDD----------------LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNI 152 (614)
Q Consensus 90 ~~~~~~~~ylV~E~~~-g~L~~~i~~~~~----------------lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NI 152 (614)
....+|+|||||+ ++|.+++..... +++..+..++.||+.||.|||+.||+||||||+||
T Consensus 103 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 103 ---PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ---TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ---CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 2345899999999 599999987654 89999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCh
Q 007177 153 LANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNV 231 (614)
Q Consensus 153 Li~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~ 231 (614)
|++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred EECCCCCEEECCCccccccccCccc-eeccCCCcceeecCchhhcc--ccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 9999999999999999865433221 22234568899999999876 679999999999999999998 9999987664
Q ss_pred hHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 232 VHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 232 ~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.+.+..... ..... .....+++.+.+||.+||..||.+|||++++++|
T Consensus 257 ~~~~~~~~~--------------------------~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 257 DEEFCRRLK--------------------------EGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp SHHHHHHHH--------------------------HTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHhc--------------------------cCccC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 333221111 01111 1123578899999999999999999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=355.50 Aligned_cols=250 Identities=27% Similarity=0.423 Sum_probs=195.4
Q ss_pred cccccCCCCCCeEEE-eEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHH-HhcCCCCcceeeeEe
Q 007177 9 EFFSEYGDASRYKIQ-EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLL-RLLRHPDIVEIKHIM 86 (614)
Q Consensus 9 ~~~~~~~~~~rY~i~-~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL-~~L~HpnIv~l~~v~ 86 (614)
..+......++|.+. +.||+|+||.||+|.++.+++.||||++.. ...+.+|+.++ +.++||||+++++++
T Consensus 8 ~~~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~ 80 (299)
T 3m2w_A 8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVY 80 (299)
T ss_dssp CCCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred ccCcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhh
Confidence 344555566788887 789999999999999999999999999864 23466888888 666899999999988
Q ss_pred cCCCCCCCCcEEEEEecCCC-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC---CCcE
Q 007177 87 LPPSRRDFKDIYVVFELMES-DLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---NCKL 160 (614)
Q Consensus 87 ~~~~~~~~~~~ylV~E~~~g-~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~---~~~v 160 (614)
.... .+...+|+|||||++ +|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++. ++.+
T Consensus 81 ~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~ 159 (299)
T 3m2w_A 81 ENLY-AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL 159 (299)
T ss_dssp EEEE-TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCE
T ss_pred hhhc-CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcE
Confidence 4311 235679999999985 9999998764 6999999999999999999999999999999999999998 7889
Q ss_pred EEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 007177 161 KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 240 (614)
Q Consensus 161 KL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~ 240 (614)
||+|||++.... + ..|+.++|||||||++|+|++|..||.+.+.......+..
T Consensus 160 kl~Dfg~a~~~~-------------------------~--~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 212 (299)
T 3m2w_A 160 KLTDFGFAKETT-------------------------G--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 212 (299)
T ss_dssp EECCCTTCEECT-------------------------T--CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC
T ss_pred EEeccccccccc-------------------------c--ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH
Confidence 999999986421 1 3577899999999999999999999977653221100000
Q ss_pred hhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 241 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 241 ~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
.+...........+..+++.+.+||.+||+.||.+|||++|+|+||||++...
T Consensus 213 -----------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 213 -----------------------RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp -----------------------SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred -----------------------HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 00000000011122567899999999999999999999999999999987544
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=347.90 Aligned_cols=249 Identities=27% Similarity=0.430 Sum_probs=194.5
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCC--hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH--ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~--~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
..++|++.+.||+|+||.||+|.+. +..||||++...... ......+.+|+.+++.++||||+++++++ .+
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 77 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-----LK 77 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CC
T ss_pred chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ec
Confidence 4578999999999999999999874 889999998753222 12346788999999999999999999998 44
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeecCCCCcEEECC--------CCcEE
Q 007177 94 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN---VYHRDLKPKNILANA--------NCKLK 161 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~g---IvHrDLKP~NILi~~--------~~~vK 161 (614)
....|+||||++ ++|.+++. ...+++..++.++.||+.||.|||+.| |+||||||+|||++. ++.+|
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 78 EPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp C--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred CCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceE
Confidence 566899999998 58888775 557999999999999999999999999 999999999999986 67899
Q ss_pred EeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhh
Q 007177 162 ICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 241 (614)
Q Consensus 162 L~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~ 241 (614)
|+|||+++....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 157 l~Dfg~~~~~~~~~~-----~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~- 228 (271)
T 3dtc_A 157 ITDFGLAREWHRTTK-----MSAAGAYAWMAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM- 228 (271)
T ss_dssp ECCCCC------------------CCGGGSCHHHHHH--CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT-
T ss_pred EccCCcccccccccc-----cCCCCccceeCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc-
Confidence 999999976543222 23579999999999877 6789999999999999999999999988775444332211
Q ss_pred hCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 242 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 242 ~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.... ......+++.+.+||.+||..||.+|||++|++++
T Consensus 229 -------------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 229 -------------------------NKLA---LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp -------------------------SCCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCCC---CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 0101 11224578899999999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=347.43 Aligned_cols=250 Identities=25% Similarity=0.385 Sum_probs=207.2
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
+.++|++.+.||+|+||.||+|.+. ++..||+|++...... ...+.+|+.+++.++||||+++++++. +..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 76 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQA 76 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSS
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCC
Confidence 4578999999999999999999986 6788999999864332 356889999999999999999999983 445
Q ss_pred cEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 96 DIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
.+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 77 PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp SCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence 6899999998 5999999775 5689999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.. ........++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 157 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~----------- 221 (267)
T 3t9t_A 157 DQ--YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG----------- 221 (267)
T ss_dssp HH--HHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-----------
T ss_pred cc--ccccccccccccccChhhhcC--CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC-----------
Confidence 11 111233467888999999976 578999999999999999999 89999887765544433210
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
... ......++.+.+||.+||..||.+|||+++++++
T Consensus 222 ----------------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 222 ----------------FRL---YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ----------------CCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CcC---CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 000 1123467899999999999999999999999874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=358.95 Aligned_cols=254 Identities=25% Similarity=0.408 Sum_probs=208.5
Q ss_pred CCCCeEEEeEeeecCceEEEEEEEC-------CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEec
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDT-------HTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIML 87 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~-------~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~ 87 (614)
..++|++.+.||+|+||.||+|.+. .++..||||++... ........+.+|+.+|+.+ +||||+++++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~- 110 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC- 110 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE-
Confidence 3478999999999999999999986 46678999999754 3445667889999999999 899999999998
Q ss_pred CCCCCCCCcEEEEEecCC-CcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCC
Q 007177 88 PPSRRDFKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPK 150 (614)
Q Consensus 88 ~~~~~~~~~~ylV~E~~~-g~L~~~i~~~~----------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~ 150 (614)
.+.+.+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+
T Consensus 111 ----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 111 ----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp ----CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred ----ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 34567899999998 59999998654 3899999999999999999999999999999999
Q ss_pred cEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 007177 151 NILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 229 (614)
Q Consensus 151 NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~ 229 (614)
|||++.++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSS-EECCSCCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eEEEcCCCCEEEcccccccccccccc-ccccCCCCcccceeChHHhcC--CCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 99999999999999999986543321 111233467889999999876 578999999999999999999 99999887
Q ss_pred ChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 230 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 230 ~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
+..+....+... .. ......+++.+.+||.+||..||.+|||+++++++
T Consensus 264 ~~~~~~~~~~~~---------------------------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 264 PVEELFKLLKEG---------------------------HR---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CHHHHHHHHHHT---------------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhcC---------------------------CC---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 755444333210 00 11224678899999999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=361.17 Aligned_cols=258 Identities=21% Similarity=0.317 Sum_probs=206.9
Q ss_pred CCCCeEEEeEeeecCceEEEEEE-----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 90 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~-----d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 90 (614)
..++|++++.||+|+||.||+|. +..++..||||++... ........+.+|+.+|+.++||||+++++++.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--- 103 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSL--- 103 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc---
Confidence 45799999999999999999998 5678889999999743 34456677889999999999999999999984
Q ss_pred CCCCCcEEEEEecCC-CcHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC---Cc
Q 007177 91 RRDFKDIYVVFELME-SDLHQVIKAND-------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN---CK 159 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~-g~L~~~i~~~~-------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~---~~ 159 (614)
+....|+|||||+ ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.+ ..
T Consensus 104 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 104 --QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp --SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred --CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence 4456799999997 69999998753 48999999999999999999999999999999999999844 46
Q ss_pred EEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 007177 160 LKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLM 238 (614)
Q Consensus 160 vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i 238 (614)
+||+|||+++......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 258 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYR-KGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258 (327)
T ss_dssp EEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred EEECccccccccccccccc-cCCCcCCCcceeCHhHhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence 9999999997654322211 1234568899999999876 678999999999999999998 99999887765444333
Q ss_pred HhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 007177 239 TDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312 (614)
Q Consensus 239 ~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~ 312 (614)
... .. ......+++.+.+||.+||..||.+|||++++++|.|+-
T Consensus 259 ~~~---------------------------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 TSG---------------------------GR---MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HTT---------------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcC---------------------------CC---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 210 00 112246788999999999999999999999999998864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=351.98 Aligned_cols=259 Identities=23% Similarity=0.373 Sum_probs=197.4
Q ss_pred CCCCCCCccccccC---CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCC
Q 007177 1 MLQNSPEMEFFSEY---GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77 (614)
Q Consensus 1 m~~~~~~~~~~~~~---~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hp 77 (614)
||.+.+..+.+... -..++|++.+.||+|+||.||+|.+ +|+.||||+++.. .....+.+|+.+++.++||
T Consensus 1 mg~s~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~ 74 (278)
T 1byg_A 1 MGGSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHS 74 (278)
T ss_dssp --------------CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCT
T ss_pred CCCCccchhhhhhccccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch----hHHHHHHHHHHHHHhCCCC
Confidence 78876666655442 4458999999999999999999976 4889999998753 2456788999999999999
Q ss_pred CcceeeeEecCCCCCCCCcEEEEEecCCC-cHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEE
Q 007177 78 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA 154 (614)
Q Consensus 78 nIv~l~~v~~~~~~~~~~~~ylV~E~~~g-~L~~~i~~~~~--lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi 154 (614)
||+++++++.. ....+|+||||+++ +|.+++..... +++..+..++.||+.||.|||+.||+||||||+|||+
T Consensus 75 ~iv~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~ 150 (278)
T 1byg_A 75 NLVQLLGVIVE----EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV 150 (278)
T ss_dssp TBCCEEEEECC----C--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CEeeEEEEEEc----CCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE
Confidence 99999998743 33468999999985 99999976543 8999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhH
Q 007177 155 NANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVH 233 (614)
Q Consensus 155 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~ 233 (614)
+.++.+||+|||++....... ....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+
T Consensus 151 ~~~~~~~l~Dfg~~~~~~~~~------~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 222 (278)
T 1byg_A 151 SEDNVAKVSDFGLTKEASSTQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222 (278)
T ss_dssp CTTSCEEECCCCC------------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG
T ss_pred eCCCcEEEeeccccccccccc------cCCCccccccCHHHhCC--CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999997643321 22357889999999876 678999999999999999998 999998776544
Q ss_pred HHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 234 QLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 234 ~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
....+.. ... ......+++.+.+||.+||..||.+|||+.++++
T Consensus 223 ~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 223 VVPRVEK---------------------------GYK---MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHTT---------------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhc---------------------------CCC---CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 4333211 100 1123467899999999999999999999999976
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=350.49 Aligned_cols=252 Identities=23% Similarity=0.376 Sum_probs=204.2
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECC---CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~---tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+... ........+.+|+.+|+.++||||+++++++..
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---- 84 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE---- 84 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS----
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC----
Confidence 34689999999999999999998654 3346999998754 244566788999999999999999999999732
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
...|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 85 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 85 --EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred --CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 34699999999 5999999764 4699999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+...
T Consensus 163 ~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~-------- 230 (281)
T 3cc6_A 163 IEDEDYY--KASVTRLPIKWMSPESINF--RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-------- 230 (281)
T ss_dssp C-----------CCCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT--------
T ss_pred ccccccc--ccccCCCCcceeCchhhcc--CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC--------
Confidence 5432211 1233457889999999876 678999999999999999998 99999876655444333211
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
... .....+++.+.+||.+||..||.+|||+.|++++
T Consensus 231 -------------------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 231 -------------------DRL---PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp -------------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCC---CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 001 1123578899999999999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=365.68 Aligned_cols=269 Identities=16% Similarity=0.159 Sum_probs=203.0
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCC-----CcEEEEEEecCccCChHH---------HHHHHHHHHHHHhcCCCCcce
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHT-----GEKVAIKKIHDIFEHISD---------AARILREIKLLRLLRHPDIVE 81 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~t-----g~~vAIK~i~~~~~~~~~---------~~~i~~Ei~iL~~L~HpnIv~ 81 (614)
..++|++++.||+|+||.||+|.+..+ ++.||||++......... ...+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 345899999999999999999998765 578999998643211110 012345666777888999999
Q ss_pred eeeEecCCCCCCCCcEEEEEecCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEEC--CCC
Q 007177 82 IKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN--ANC 158 (614)
Q Consensus 82 l~~v~~~~~~~~~~~~ylV~E~~~g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~--~~~ 158 (614)
+++++.... .+...+|||||||+++|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEE-TTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeecc-CCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 999985432 223568999999977999999876 6799999999999999999999999999999999999998 889
Q ss_pred cEEEeecCccccccCCCCCc----cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHH
Q 007177 159 KLKICDFGLARVAFNDTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ 234 (614)
Q Consensus 159 ~vKL~DFGla~~~~~~~~~~----~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~ 234 (614)
.+||+|||+++......... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 99999999997654322111 11234569999999999987 5799999999999999999999999986443322
Q ss_pred HHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 235 LDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 235 l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
......... .......+.... ...++++.+.+||..||..||.+||+++++++
T Consensus 270 ~~~~~~~~~-----------~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 270 YVRDSKIRY-----------RENIASLMDKCF---------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHH-----------HHCHHHHHHHHS---------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHh-----------hhhHHHHHHHhc---------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 221111000 001111111100 01467889999999999999999999999976
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=357.01 Aligned_cols=255 Identities=24% Similarity=0.373 Sum_probs=208.4
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCc-----EEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGE-----KVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPP 89 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~-----~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~ 89 (614)
..++|++.+.||+|+||.||+|.+..++. .||+|++... ........+.+|+.+|+.+ +||||+++++++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--- 119 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST-AHADEKEALMSELKIMSHLGQHENIVNLLGAC--- 119 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc-cChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE---
Confidence 45789999999999999999999987665 7999999754 3345567789999999999 899999999998
Q ss_pred CCCCCCcEEEEEecCCC-cHHHHHHh--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEE
Q 007177 90 SRRDFKDIYVVFELMES-DLHQVIKA--------------NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA 154 (614)
Q Consensus 90 ~~~~~~~~ylV~E~~~g-~L~~~i~~--------------~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi 154 (614)
.+...+|+|||||++ +|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||+
T Consensus 120 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 120 --THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp --CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred --ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 344668999999984 99999864 3458999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhH
Q 007177 155 NANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVH 233 (614)
Q Consensus 155 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~ 233 (614)
+.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.....
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNY-IVKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTS-EECSSCEECGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred CCCCeEEECccccccccccccce-eecCCCCCCccccCHHHhcc--CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 99999999999999865443321 12234467889999999876 679999999999999999998 999998876443
Q ss_pred HHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 234 QLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 234 ~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.+..+... .... ......++.+.+||.+||+.||.+|||+++++++
T Consensus 275 ~~~~~~~~--------------------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 275 KFYKLVKD--------------------------GYQM---AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHHHH--------------------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhc--------------------------CCCC---CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 33222110 0000 1123467899999999999999999999999873
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=366.19 Aligned_cols=266 Identities=15% Similarity=0.160 Sum_probs=201.8
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECC---CCcEEEEEEecCccCChHH---------HHHHHHHHHHHHhcCCCCcceee
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKIHDIFEHISD---------AARILREIKLLRLLRHPDIVEIK 83 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~---tg~~vAIK~i~~~~~~~~~---------~~~i~~Ei~iL~~L~HpnIv~l~ 83 (614)
..++|++++.||+|+||.||+|.+.. ++..||||++......... ...+.+|+.+++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 45789999999999999999999987 7889999998753211111 12356788999999999999999
Q ss_pred eEecCCCCCCCCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC--cEE
Q 007177 84 HIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC--KLK 161 (614)
Q Consensus 84 ~v~~~~~~~~~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~--~vK 161 (614)
+++.... .+...+|+|||||.++|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEF-KGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEES-SSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred ccccccc-CCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 9985422 2356799999999779999998877899999999999999999999999999999999999998887 999
Q ss_pred EeecCccccccCCCC----CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCh--hHHH
Q 007177 162 ICDFGLARVAFNDTP----TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQL 235 (614)
Q Consensus 162 L~DFGla~~~~~~~~----~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~--~~~l 235 (614)
|+|||+++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+... ....
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 999999986543211 1112245689999999999987 5799999999999999999999999965321 1111
Q ss_pred HHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 236 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKF--PNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 236 ~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~--~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
....... ...+..+.... ..+++.+.+||.+||..||.+|||++++++.
T Consensus 272 ~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 272 TAKTNLL------------------------DELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHH------------------------HTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHhhc------------------------ccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 1111100 00011111111 2678899999999999999999999999873
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=375.90 Aligned_cols=262 Identities=26% Similarity=0.359 Sum_probs=194.1
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~ 93 (614)
...+.|.+.+.||+|+||+||.+ ...+|+.||||++... ....+.+|+.+|+.+ +||||+++++++ .+
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~ 80 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSE-----TT 80 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEE-----EC
T ss_pred hhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEE-----ec
Confidence 34567888899999999999875 4568999999998642 234567899999876 899999999988 45
Q ss_pred CCcEEEEEecCCCcHHHHHHhCCCC-------CHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC---------
Q 007177 94 FKDIYVVFELMESDLHQVIKANDDL-------TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN--------- 157 (614)
Q Consensus 94 ~~~~ylV~E~~~g~L~~~i~~~~~l-------se~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~--------- 157 (614)
...+|||||||+++|.+++...... ++..+..|+.||+.||.|||+.||+||||||+|||++.+
T Consensus 81 ~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~ 160 (434)
T 2rio_A 81 DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT 160 (434)
T ss_dssp SSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred CCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccccc
Confidence 5779999999999999999876433 233457799999999999999999999999999999754
Q ss_pred ----CcEEEeecCccccccCCCCC-ccccccccCCccccCccccccc-----CCCCCCcccchhHHHHHHHHHh-CCCCC
Q 007177 158 ----CKLKICDFGLARVAFNDTPT-TIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLT-GKPLF 226 (614)
Q Consensus 158 ----~~vKL~DFGla~~~~~~~~~-~~~~~~~vgt~~Y~APEvl~~~-----~~~y~~~~DIWSLG~Il~eLlt-G~~pF 226 (614)
+.+||+|||+++........ .......+||+.|+|||++.+. ...++.++|||||||++|||++ |..||
T Consensus 161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 240 (434)
T 2rio_A 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240 (434)
T ss_dssp CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence 48999999999876443221 1122346899999999998641 1468999999999999999999 99999
Q ss_pred CCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHH
Q 007177 227 PGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 306 (614)
Q Consensus 227 ~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL 306 (614)
.+..... ..+... .. ..... .......+++++.+||.+||+.||.+|||+.++|
T Consensus 241 ~~~~~~~--~~i~~~--~~---------------------~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil 294 (434)
T 2rio_A 241 GDKYSRE--SNIIRG--IF---------------------SLDEM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294 (434)
T ss_dssp CSTTTHH--HHHHHT--CC---------------------CCCCC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCchhhH--HHHhcC--CC---------------------Ccccc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHH
Confidence 7654322 111110 00 00000 0000123457899999999999999999999999
Q ss_pred cCccccc
Q 007177 307 ADPYFKG 313 (614)
Q Consensus 307 ~hp~f~~ 313 (614)
+||||..
T Consensus 295 ~hp~f~~ 301 (434)
T 2rio_A 295 RHPLFWP 301 (434)
T ss_dssp TSGGGSC
T ss_pred hCCccCC
Confidence 9999964
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=356.31 Aligned_cols=263 Identities=24% Similarity=0.311 Sum_probs=197.3
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHh--cCCCCcceeeeEecCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRL--LRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~--L~HpnIv~l~~v~~~~~~~~ 93 (614)
..++|++++.||+|+||.||+|.+ +++.||||++.. .....+.+|.+++.. ++||||+++++++.... ..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~ 77 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSS-----RDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HS 77 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TT
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecc-----ccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CC
Confidence 467899999999999999999976 689999999864 234455677777776 78999999999864322 34
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCeEeecCCCCcEEECCCCcEEEee
Q 007177 94 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH--------TANVYHRDLKPKNILANANCKLKICD 164 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLH--------s~gIvHrDLKP~NILi~~~~~vKL~D 164 (614)
...+|+|||||+ ++|.++++. ..+++..+..|+.||+.||.||| +.||+||||||+|||++.++.+||+|
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred CceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEee
Confidence 466899999998 599999954 56999999999999999999999 99999999999999999999999999
Q ss_pred cCccccccCCCCCc-cccccccCCccccCcccccccCC----CCCCcccchhHHHHHHHHHhC----------CCCCCCC
Q 007177 165 FGLARVAFNDTPTT-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTG----------KPLFPGK 229 (614)
Q Consensus 165 FGla~~~~~~~~~~-~~~~~~vgt~~Y~APEvl~~~~~----~y~~~~DIWSLG~Il~eLltG----------~~pF~g~ 229 (614)
||+++......... ......+||+.|+|||++.+... .++.++|||||||++|||++| ..||.+.
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99997654433221 11234589999999999876211 345789999999999999999 8888553
Q ss_pred ChhH-HHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 230 NVVH-QLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 230 ~~~~-~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
...+ ....+. ............+........++.+.+||.+||+.||.+|||++++++
T Consensus 237 ~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 237 VPNDPSFEDMR--------------------KVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SCSSCCHHHHH--------------------HHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCcchhhhh--------------------HHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 2110 000000 000000000011100011224567999999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=351.34 Aligned_cols=256 Identities=26% Similarity=0.425 Sum_probs=197.4
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
+...++|++.+.||+|+||.||+|.+..+|+.||||++... .........+.+|+.+|+.++||||+++++++.
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----- 102 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI----- 102 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----
Confidence 34557899999999999999999999999999999999753 234556678889999999999999999999984
Q ss_pred CCCcEEEEEecCCC-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCc
Q 007177 93 DFKDIYVVFELMES-DLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 167 (614)
Q Consensus 93 ~~~~~ylV~E~~~g-~L~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGl 167 (614)
+...+|+||||+++ +|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 182 (310)
T ss_dssp ETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--
T ss_pred cCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccc
Confidence 44679999999995 99998864 45799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChh--HHHHHHHhhhCCC
Q 007177 168 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLMTDLLGTP 245 (614)
Q Consensus 168 a~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~--~~l~~i~~~~g~p 245 (614)
++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... .....+
T Consensus 183 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------- 250 (310)
T 2wqm_A 183 GRFFSSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI------- 250 (310)
T ss_dssp -------------------CCSSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHH-------
T ss_pred eeeecCCCc---cccccCCCeeEeChHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHh-------
Confidence 976543221 1234578999999999887 67899999999999999999999999765321 111111
Q ss_pred chhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 246 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 246 ~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
...... ......+++.+.+||.+||..||.+|||+++++++
T Consensus 251 --------------------~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 251 --------------------EQCDYP--PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp --------------------HTTCSC--CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------hcccCC--CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 000000 01124578899999999999999999999999873
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=359.17 Aligned_cols=253 Identities=22% Similarity=0.355 Sum_probs=200.7
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEE----EEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKV----AIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 90 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~v----AIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~ 90 (614)
-..++|++++.||+|+||.||+|.+..+++.+ |+|.+... ........+.+|+.+|+.++||||+++++++..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 88 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-- 88 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES--
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec--
Confidence 44678999999999999999999999888765 66666532 223345678899999999999999999999853
Q ss_pred CCCCCcEEEEEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcc
Q 007177 91 RRDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 168 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 168 (614)
...++|+|++. ++|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 89 ----~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 89 ----STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp ----SSEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred ----CCceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 23789999998 699999876 457999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCch
Q 007177 169 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSL 247 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~ 247 (614)
+........ .......+|+.|+|||++.+ ..|+.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 165 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~------- 234 (327)
T 3lzb_A 165 KLLGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK------- 234 (327)
T ss_dssp ----------------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-------
T ss_pred eEccCcccc-ccccCCCccccccCHHHHcC--CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-------
Confidence 875433221 12234467889999999987 689999999999999999999 9999988776554433321
Q ss_pred hhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 248 ~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
... ....+.+++.+.+||.+||..||.+|||++|+|+
T Consensus 235 --------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 235 --------------------GER---LPQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp --------------------TCC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCC---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 111 1122457889999999999999999999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=349.49 Aligned_cols=255 Identities=23% Similarity=0.368 Sum_probs=204.2
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCC---cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTG---EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg---~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
...+|++.+.||+|+||.||+|.+..++ ..||+|.+... ........+.+|+.+|+.++||||+++++++. .
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~ 97 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----R 97 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC----C
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE----c
Confidence 3457999999999999999999875443 35899998753 34556678899999999999999999999864 3
Q ss_pred CCCcEEEEEecCCC-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 93 DFKDIYVVFELMES-DLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 93 ~~~~~ylV~E~~~g-~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
+.+..|+|||||++ +|.+++.. ...+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 98 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 98 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred CCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccc
Confidence 34568999999995 99999976 44689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCC-CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchh
Q 007177 171 AFNDTP-TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLD 248 (614)
Q Consensus 171 ~~~~~~-~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~ 248 (614)
...... .........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~------- 248 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG------- 248 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT-------
T ss_pred ccccchhccccccCCCCCccccChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC-------
Confidence 543221 1112344578889999999977 679999999999999999999 67888777655444333210
Q ss_pred hhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 249 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 249 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
... .....+++.+.+||.+||..||.+|||++++++
T Consensus 249 --------------------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 249 --------------------RRL---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp --------------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 112346789999999999999999999999987
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=360.48 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=203.8
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEE--EEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKV--AIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~v--AIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~ 93 (614)
.++|++.+.||+|+||.||+|.++.++..+ |||.+... ........+.+|+.+|+.+ +||||+++++++ .+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~ 97 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EH 97 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEE-----EE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceee-----ee
Confidence 478999999999999999999999888865 99988743 2334456788999999999 899999999998 44
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC
Q 007177 94 FKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA 156 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~----------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~ 156 (614)
.+.+|+||||++ ++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 177 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence 567999999997 59999997654 6999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHH
Q 007177 157 NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQL 235 (614)
Q Consensus 157 ~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l 235 (614)
++.+||+|||+++...... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 178 ~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~ 251 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251 (327)
T ss_dssp GGCEEECCTTCEESSCEEC----CC----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred CCeEEEcccCcCccccccc----cccCCCCCccccChhhhcc--ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH
Confidence 9999999999997432211 1123457889999999876 578999999999999999998 99999887754443
Q ss_pred HHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 236 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 236 ~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
..+.. ... ......+++.+.+||.+||..||.+|||+++++++
T Consensus 252 ~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 252 EKLPQ---------------------------GYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHGGG---------------------------TCC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhc---------------------------CCC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 32211 100 11224578899999999999999999999999886
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=365.80 Aligned_cols=268 Identities=24% Similarity=0.326 Sum_probs=206.9
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
....++|++.+.||+|+||.||+|.+ .+++.||||++... .......+.+|+.+|+.++||||+++++++ .+
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 106 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFC-----DE 106 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEEC-----CC
T ss_pred HHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cC
Confidence 34568999999999999999999986 46899999998753 234567788999999999999999999998 44
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcc
Q 007177 94 FKDIYVVFELME-SDLHQVIKAND----DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 168 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~----~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 168 (614)
.+.+|+|||||+ ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence 567899999998 59999886543 5899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007177 169 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~ 248 (614)
+........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+..
T Consensus 187 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~-------- 255 (321)
T 2qkw_B 187 KKGTELDQT-HLSTVVKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW-------- 255 (321)
T ss_dssp EECSSSSCC-CCBCCCEEETTTCCHHHHHH--CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHH--------
T ss_pred ccccccccc-ccccccCCCccccCHHHhcC--CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHH--------
Confidence 864332221 12234568999999999876 5789999999999999999999999977543221111000
Q ss_pred hhhhhhchhHHHHHHh--hccc-CCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCc
Q 007177 249 TISRVRNDKARRYLTS--MRKK-QPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 309 (614)
Q Consensus 249 ~i~~~~~~~~~~~l~~--~~~~-~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp 309 (614)
....... +... .+.......+..+..+.+|+.+||+.||++|||+.|+|++.
T Consensus 256 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 256 ---------AVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp ---------THHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ---------hhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 0000000 0000 00000111123456789999999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=346.74 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=203.7
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~---~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
-+|.+.+.||+|+||.||+|.+..++. .||+|++... ........+.+|+.+|+.++||||+++++++... .
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~ 95 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP----E 95 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----S
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC----C
Confidence 357788999999999999998766554 7999998753 3445667889999999999999999999998432 2
Q ss_pred CcEEEEEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 95 KDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
...|+||||+. ++|.+++.. ...+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 33589999997 699999987 4568999999999999999999999999999999999999999999999999997643
Q ss_pred CCCC-CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 173 NDTP-TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 173 ~~~~-~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
.... .........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~--------- 244 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQT--YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG--------- 244 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTT--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT---------
T ss_pred CCcccccccCcCCCCCccccChhhhcc--CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC---------
Confidence 3211 1112234578899999999987 678999999999999999999 55666665544443332211
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
... .....+++.+.+||.+||..||.+|||++++++.
T Consensus 245 ------------------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 245 ------------------RRL---PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp ------------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCC---CCCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 111 1123567899999999999999999999999873
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=356.54 Aligned_cols=262 Identities=24% Similarity=0.390 Sum_probs=204.9
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++++.||+|+||.||+|.+..+|+.||||++.. ........+.+|+.+++.++||||+++++++.... ....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~ 103 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKH 103 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec--CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCc
Confidence 35789999999999999999999999999999999864 34456778889999999999999999999885321 2345
Q ss_pred cEEEEEecCCC-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 96 DIYVVFELMES-DLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 96 ~~ylV~E~~~g-~L~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
..|+|||||.+ +|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 78999999995 99999875 46799999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCc------cccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhC
Q 007177 171 AFNDTPTT------IFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 243 (614)
Q Consensus 171 ~~~~~~~~------~~~~~~vgt~~Y~APEvl~~~-~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g 243 (614)
........ ..+....||+.|+|||++.+. ...++.++|||||||++|+|++|..||.......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---------- 253 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---------- 253 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT----------
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc----------
Confidence 43211110 112334679999999998652 1237889999999999999999999994311000
Q ss_pred CCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 244 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 244 ~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
+....... .... ....+.+++.+.+||.+||+.||.+|||+++++++
T Consensus 254 ------------~~~~~~~~---~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 254 ------------DSVALAVQ---NQLS---IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp ------------SCHHHHHH---CC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------chhhHHhh---ccCC---CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 00000000 1000 11234678999999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=364.67 Aligned_cols=257 Identities=14% Similarity=0.173 Sum_probs=201.8
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCC--------CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceee-----
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHT--------GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK----- 83 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~t--------g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~----- 83 (614)
.++|++.+.||+|+||.||+|.+..+ ++.||||++... ..+.+|+.+|+.++||||++++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 57999999999999999999999884 889999998743 3577999999999999999843
Q ss_pred ----------eEecCCCCCCCCcEEEEEecCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCc
Q 007177 84 ----------HIMLPPSRRDFKDIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKN 151 (614)
Q Consensus 84 ----------~v~~~~~~~~~~~~ylV~E~~~g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~N 151 (614)
+++. .+...+|+|||||.++|.+++... ..+++..+..|+.||+.||.|||+.||+||||||+|
T Consensus 114 ~~~~~i~~~~~~~~----~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N 189 (352)
T 2jii_A 114 TPLLAIPTCMGFGV----HQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN 189 (352)
T ss_dssp CTTCSCCCCCEEEE----ETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred CCccCccchhhccc----cCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence 3331 234678999999977999999886 789999999999999999999999999999999999
Q ss_pred EEECCCC--cEEEeecCccccccCCCCC----ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCC
Q 007177 152 ILANANC--KLKICDFGLARVAFNDTPT----TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 225 (614)
Q Consensus 152 ILi~~~~--~vKL~DFGla~~~~~~~~~----~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~p 225 (614)
||++.++ .+||+|||+++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--CGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999998 8999999999765432211 111234589999999999987 5799999999999999999999999
Q ss_pred CCCCC-hhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 007177 226 FPGKN-VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 304 (614)
Q Consensus 226 F~g~~-~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~e 304 (614)
|.+.. ....+..... .+... ..........+..+++.+.+||.+||..||.+|||+++
T Consensus 268 f~~~~~~~~~~~~~~~-------------------~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 326 (352)
T 2jii_A 268 WTNCLPNTEDIMKQKQ-------------------KFVDK--PGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAM 326 (352)
T ss_dssp TGGGTTCHHHHHHHHH-------------------HHHHS--CCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred cccCCcCHHHHHHHHH-------------------hccCC--hhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHH
Confidence 97754 2222111110 00000 00000111123467899999999999999999999999
Q ss_pred HHc
Q 007177 305 ALA 307 (614)
Q Consensus 305 iL~ 307 (614)
+++
T Consensus 327 l~~ 329 (352)
T 2jii_A 327 LRN 329 (352)
T ss_dssp HHH
T ss_pred HHH
Confidence 977
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=375.07 Aligned_cols=262 Identities=18% Similarity=0.188 Sum_probs=199.1
Q ss_pred ccccCCCC-CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCC-CCcce-----
Q 007177 10 FFSEYGDA-SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRH-PDIVE----- 81 (614)
Q Consensus 10 ~~~~~~~~-~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~H-pnIv~----- 81 (614)
+.++.+.. ..|.+.+.||+|+||+||+|.+..+|+.||||++.... ........+.+|+.+++.++| .|+..
T Consensus 69 ~~s~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~ 148 (413)
T 3dzo_A 69 VESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 148 (413)
T ss_dssp EEESSSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHT
T ss_pred EeccCCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhc
Confidence 33343333 34899999999999999999999999999999987332 222235678899999999987 32211
Q ss_pred ----eeeEec------------CCCCCCCCcEEEEEecCCCcHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHH
Q 007177 82 ----IKHIML------------PPSRRDFKDIYVVFELMESDLHQVIKA-------NDDLTREHYQFFLYQLLRALKYIH 138 (614)
Q Consensus 82 ----l~~v~~------------~~~~~~~~~~ylV~E~~~g~L~~~i~~-------~~~lse~~~~~i~~QIl~aL~yLH 138 (614)
..++.. .........++++|+++.++|.+++.. ...+++..+..|+.||+.||.|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 228 (413)
T 3dzo_A 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 228 (413)
T ss_dssp CBCCCCEEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccchhhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 111111 111111345899999999999998851 234788899999999999999999
Q ss_pred hCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccc--------cCCCCCCcccch
Q 007177 139 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS--------FFSKYTPAIDIW 210 (614)
Q Consensus 139 s~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~--------~~~~y~~~~DIW 210 (614)
++||+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++.+ ....|+.++|||
T Consensus 229 ~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw 301 (413)
T 3dzo_A 229 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301 (413)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred hCCcccCCcccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence 999999999999999999999999999998764322 244577 99999999831 114588899999
Q ss_pred hHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHH
Q 007177 211 SIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLER 290 (614)
Q Consensus 211 SLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~ 290 (614)
||||++|+|++|+.||.+.+..+... .....+..+++.+.+||.+
T Consensus 302 SlGvil~elltg~~Pf~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~li~~ 346 (413)
T 3dzo_A 302 TLGLAIYWIWCADLPNTDDAALGGSE-----------------------------------WIFRSCKNIPQPVRALLEG 346 (413)
T ss_dssp HHHHHHHHHHHSSCCCCTTGGGSCSG-----------------------------------GGGSSCCCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCcchhhhHH-----------------------------------HHHhhcccCCHHHHHHHHH
Confidence 99999999999999997765321110 0111234678999999999
Q ss_pred hcCCCCCCCCCHHHHHcCccccc
Q 007177 291 LLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 291 mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
||+.||++|||+.++|+||||+.
T Consensus 347 ~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 347 FLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HccCChhhCcCHHHHHhCHHHHH
Confidence 99999999999999999999974
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=347.59 Aligned_cols=248 Identities=29% Similarity=0.380 Sum_probs=204.6
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-------
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS------- 90 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~------- 90 (614)
++|++++.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.+|+.++||||+++++++....
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 57999999999999999999999999999999997532 24668999999999999999999874311
Q ss_pred ----CCCCCcEEEEEecCCC-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEe
Q 007177 91 ----RRDFKDIYVVFELMES-DLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 163 (614)
Q Consensus 91 ----~~~~~~~ylV~E~~~g-~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~ 163 (614)
......+|+|||||++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 1224568999999995 999999754 579999999999999999999999999999999999999999999999
Q ss_pred ecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhC
Q 007177 164 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 243 (614)
Q Consensus 164 DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g 243 (614)
|||++........ .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ..
T Consensus 165 Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~--------- 227 (284)
T 2a19_B 165 DFGLVTSLKNDGK----RTRSKGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETS--KF--------- 227 (284)
T ss_dssp CCTTCEESSCCSC----CCCCCSCCTTSCHHHHHC--SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HH---------
T ss_pred cchhheecccccc----ccccCCcccccChhhhcc--CCCcchhhhHHHHHHHHHHHhcCCcchhHH--HH---------
Confidence 9999987544322 234579999999999887 678999999999999999999998873211 00
Q ss_pred CCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 007177 244 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312 (614)
Q Consensus 244 ~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~ 312 (614)
...+... .....+++.+.+||.+||..||.+|||+.|+++|.|.-
T Consensus 228 ------------------~~~~~~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 228 ------------------FTDLRDG------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp ------------------HHHHHTT------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------------------HHHhhcc------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0001110 01234678999999999999999999999999998754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=346.08 Aligned_cols=248 Identities=26% Similarity=0.375 Sum_probs=204.7
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++++.||+|+||.||+|.+. ++..||||++..... ....+.+|+.+|+.++||||+++++++. ..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~ 80 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVT------QE 80 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC------SS
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEc------CC
Confidence 3478999999999999999999875 567899999975322 3456889999999999999999999873 23
Q ss_pred cEEEEEecCC-CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 96 DIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
..|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 4799999997 69999986543 69999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
..... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+...
T Consensus 161 ~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~---------- 226 (279)
T 1qpc_A 161 DNEYT--AREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---------- 226 (279)
T ss_dssp SSCEE--CCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT----------
T ss_pred Ccccc--cccCCCCccCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc----------
Confidence 33211 1233457888999999876 578999999999999999999 99999887765544333210
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.. ......+++.+.+||.+||..||++|||++++++
T Consensus 227 -----------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 227 -----------------YR---MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp -----------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------cC---CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 0112457889999999999999999999999976
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=350.28 Aligned_cols=260 Identities=21% Similarity=0.332 Sum_probs=201.4
Q ss_pred cccCCCCCCeEEEeEeeecCceEEEEEEECC-CCc--EEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEe
Q 007177 11 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTH-TGE--KVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIM 86 (614)
Q Consensus 11 ~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~-tg~--~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~ 86 (614)
.+..-..++|++++.||+|+||.||+|.+.. ++. .||||+++... ........+.+|+.+++.++||||+++++++
T Consensus 11 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (291)
T 1u46_A 11 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 90 (291)
T ss_dssp CCEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 3344556799999999999999999998643 333 68999987532 2334567889999999999999999999998
Q ss_pred cCCCCCCCCcEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEee
Q 007177 87 LPPSRRDFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 164 (614)
Q Consensus 87 ~~~~~~~~~~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~D 164 (614)
... ..++||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|
T Consensus 91 ~~~------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~D 164 (291)
T 1u46_A 91 LTP------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGD 164 (291)
T ss_dssp CSS------SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECC
T ss_pred ccC------CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcc
Confidence 432 3799999998 6999998764 5699999999999999999999999999999999999999999999999
Q ss_pred cCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhC
Q 007177 165 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLG 243 (614)
Q Consensus 165 FGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g 243 (614)
||++.................+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+...
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-- 240 (291)
T 1u46_A 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE-- 240 (291)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS--
T ss_pred ccccccccccccchhhhccCCCCceeeCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc--
Confidence 9999876544332222334567889999999876 578899999999999999999 99999888765544433211
Q ss_pred CCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 244 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 244 ~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
... ......+++.+.+||.+||..||.+|||+.++++
T Consensus 241 ------------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 241 ------------------------GER---LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp ------------------------CCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CCC---CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 000 1122467899999999999999999999999987
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=378.70 Aligned_cols=250 Identities=22% Similarity=0.430 Sum_probs=209.4
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
...+|++.+.||+|+||.||+|.++.++..||||+++... .....+.+|+.+|+.++||||+++++++ .+..
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~-----~~~~ 289 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREP 289 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSS
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEE-----ecCC
Confidence 3467999999999999999999999999999999997532 2356788999999999999999999998 3446
Q ss_pred cEEEEEecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 96 DIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
.+|||||||. ++|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 6899999998 6999999864 459999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
..... ......++..|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+....+..
T Consensus 370 ~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~----------- 434 (495)
T 1opk_A 370 GDTYT--AHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----------- 434 (495)
T ss_dssp TCCEE--CCTTCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-----------
T ss_pred CCcee--ecCCCcCCcceeCHhHHhc--CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----------
Confidence 33211 1223456788999999876 578999999999999999999 9999988775544433311
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
... ......+++.+.+||.+||+.||.+|||+.++++
T Consensus 435 ----------------~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 435 ----------------DYR---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp ----------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCC---CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 000 0122467889999999999999999999999976
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=368.73 Aligned_cols=245 Identities=24% Similarity=0.393 Sum_probs=203.4
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
...++|++++.||+|+||.||+|.+. |+.||||+++... ....+.+|+.+|+.++||||+++++++.. ..
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~ 259 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVE----EK 259 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEEC----TT
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEc----CC
Confidence 34578999999999999999999774 7899999997532 45678899999999999999999999743 23
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 95 KDIYVVFELME-SDLHQVIKANDD--LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~--lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
..+|||||||+ |+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 46999999998 599999987543 799999999999999999999999999999999999999999999999999854
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
.... ....++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+..
T Consensus 340 ~~~~------~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~---------- 401 (450)
T 1k9a_A 340 SSTQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---------- 401 (450)
T ss_dssp C------------CCCTTTSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT----------
T ss_pred cccc------cCCCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----------
Confidence 3221 22357889999999976 689999999999999999998 9999988765544433321
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
... ......+++.+.+||.+||..||.+|||+.++++
T Consensus 402 -----------------~~~---~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 402 -----------------GYK---MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp -----------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCC---CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 000 1122467899999999999999999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=355.13 Aligned_cols=269 Identities=23% Similarity=0.334 Sum_probs=206.7
Q ss_pred CCCe-EEEeEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 17 ASRY-KIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 17 ~~rY-~i~~~LG~G~~G~V~~a~----d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
.++| ++++.||+|+||.||++. +..+++.||||+++.. ........+.+|+.+|+.++||||+++++++...
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 105 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA-- 105 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC--
Confidence 3455 999999999999998774 4458899999999854 3445667789999999999999999999998542
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
+...+|+|||||+ ++|.+++... .+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 106 -~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 106 -GAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp -TTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred -CCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 2467899999998 5999999765 499999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
...............+|..|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-----~~~~~~~~~~~~- 255 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKE--YKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-----FLELIGIAQGQM- 255 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-----HHHHHCSCCHHH-
T ss_pred ccccccccccccCCCCCceeeChHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCcccccchh-----hhhhhcccccch-
Confidence 6543332222345578899999999876 57889999999999999999999999654321 111111111100
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
........+...... .....+++.+.+||.+||+.||.+|||++|+++
T Consensus 256 ------~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 256 ------TVLRLTELLERGERL---PRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp ------HHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------hHHHHHHHHhcccCC---CCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 011111111111111 223467899999999999999999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=369.98 Aligned_cols=273 Identities=22% Similarity=0.369 Sum_probs=206.8
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
...++|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+|+.++||||+++++++... +.
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~ 81 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TT 81 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TT
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CC
Confidence 346789999999999999999999999999999999975321 22356678999999999999999999998543 23
Q ss_pred CcEEEEEecCC-CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEE----CCCCcEEEeecC
Q 007177 95 KDIYVVFELME-SDLHQVIKAND---DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA----NANCKLKICDFG 166 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~---~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi----~~~~~vKL~DFG 166 (614)
...|+|||||+ ++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 46899999998 59999997543 39999999999999999999999999999999999999 778889999999
Q ss_pred ccccccCCCCCccccccccCCccccCccccccc------CCCCCCcccchhHHHHHHHHHhCCCCCCCCC----hhHHHH
Q 007177 167 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN----VVHQLD 236 (614)
Q Consensus 167 la~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~------~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~----~~~~l~ 236 (614)
+++...... .....+||+.|+|||++.+. ...|+.++|||||||++|+|++|+.||.+.. ..+.+.
T Consensus 162 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 162 AARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp GCEECCCGG----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred CceEccCCC----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 998653322 22446799999999987531 0357789999999999999999999996533 222222
Q ss_pred HHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCC-------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 237 LMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQK-------FPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 237 ~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~-------~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.+.. +.|. ..+...... ......+... ...+++.+.+||.+||+.||++|||+++++++
T Consensus 238 ~~~~--~~p~-~~~~~~~~~----------~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 238 KIIT--GKPS-GAISGVQKA----------ENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHHH--SCCT-TCCEEEECS----------TTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred HHhc--CCCc-ccchhheec----------cCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 2221 2221 111111000 0011111111 12345678899999999999999999998653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=359.29 Aligned_cols=271 Identities=20% Similarity=0.307 Sum_probs=204.8
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
....++|++.+.||+|+||.||+|.+ .+|+.||||++...... .....+.+|+.+|+.++||||+++++++. +
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~ 98 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCM-----T 98 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEEC-----C
T ss_pred HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEe-----c
Confidence 34567999999999999999999974 46899999999753211 12235789999999999999999999984 4
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeecCCCCcEEECCCCcEEEeec
Q 007177 94 FKDIYVVFELME-SDLHQVIKAND----DLTREHYQFFLYQLLRALKYIHTA---NVYHRDLKPKNILANANCKLKICDF 165 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~----~lse~~~~~i~~QIl~aL~yLHs~---gIvHrDLKP~NILi~~~~~vKL~DF 165 (614)
....|+|||||. ++|.+++.... .+++..+..|+.||+.||.|||+. ||+||||||+|||++.++.+||+||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Df 178 (326)
T 3uim_A 99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 178 (326)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCC
T ss_pred CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccC
Confidence 456799999998 59999998643 499999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-----hhHHHHHHHh
Q 007177 166 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN-----VVHQLDLMTD 240 (614)
Q Consensus 166 Gla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~-----~~~~l~~i~~ 240 (614)
|+++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .......+..
T Consensus 179 g~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 179 GLAKLMDYKDT--HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp SSCEECCSSSS--CEECCCCSCGGGCCHHHHHH--SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccccccCcccc--cccccccCCcCccCHHHhcc--CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 99986543222 22344579999999999876 578999999999999999999999995311 1111111110
Q ss_pred hhCCCchhhhhhhhchhHHHHHHhhcccCCCcc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 241 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 241 ~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
.+....... ...... .......+..+.+|+.+||+.||.+|||+.|+|+|-+-..
T Consensus 255 ~~~~~~~~~------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 255 LLKEKKLEA------------------LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TTSSCCSTT------------------SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred Hhhchhhhh------------------hcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 000000000 000000 0111123467899999999999999999999999865433
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=383.90 Aligned_cols=250 Identities=21% Similarity=0.310 Sum_probs=203.5
Q ss_pred eEEE-eEeeecCceEEEEEEE--CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 20 YKIQ-EVIGKGSYGVVCSAID--THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 20 Y~i~-~~LG~G~~G~V~~a~d--~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
+.+. +.||+|+||.||+|.+ +.+++.||||+++...........+.+|+.+|+.|+||||+++++++. ...
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~------~~~ 443 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------AES 443 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE------SSS
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------cCC
Confidence 4443 4899999999999954 456789999999865555556678999999999999999999999883 234
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|||||||. ++|.+++.....+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 444 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred EEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 899999998 5999999998899999999999999999999999999999999999999999999999999998765433
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
......+...+|..|+|||++.+ ..|+.++|||||||++|||++ |+.||.+.+..+....+...
T Consensus 524 ~~~~~~~~~~~t~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~------------- 588 (635)
T 4fl3_A 524 NYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG------------- 588 (635)
T ss_dssp -----------CGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------------
T ss_pred cccccccCCCCceeeeChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-------------
Confidence 22222334467889999999976 689999999999999999998 99999988765554444221
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
... .....+++.+.+||.+||..||++|||++++++
T Consensus 589 --------------~~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 589 --------------ERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp --------------CCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------------CCC---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 111 122457889999999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=371.40 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=205.6
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++.+.||+|+||.||+|.+. ++..||||+++... .....+.+|+.+|+.|+||||+++++++. ..
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~ 255 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT------KE 255 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SS
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CC
Confidence 4568999999999999999999885 46789999997532 23567889999999999999999999983 24
Q ss_pred cEEEEEecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 96 DIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
.+|||||||. |+|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 5899999998 6999999754 368999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
.... .......++..|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+.+..+....
T Consensus 336 ~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~--------- 402 (454)
T 1qcf_A 336 DNEY--TAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY--------- 402 (454)
T ss_dssp CHHH--HTTCSSSSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC---------
T ss_pred CCce--eccCCCcccccccCHHHhcc--CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---------
Confidence 2211 11123356788999999976 679999999999999999999 999999887665554432210
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.. .....+++.+.+||.+||..||.+|||++++++
T Consensus 403 ------------------~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 403 ------------------RM---PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ------------------CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CC---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 00 112357889999999999999999999999976
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=355.99 Aligned_cols=281 Identities=22% Similarity=0.290 Sum_probs=199.1
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHH--HHhcCCCCcceeeeEecCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKL--LRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~i--L~~L~HpnIv~l~~v~~~~~~~ 92 (614)
-..++|++++.||+|+||.||+|.+ +++.||||++... ....+..|..+ +..++||||+++++.+......
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 4567999999999999999999965 6899999998642 22333444444 4568999999999865443334
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CeEeecCCCCcEEECCCCcEEE
Q 007177 93 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA---------NVYHRDLKPKNILANANCKLKI 162 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~---------gIvHrDLKP~NILi~~~~~vKL 162 (614)
+...+|+|||||+ ++|.+++.... +++..+..|+.||+.||.|||+. ||+||||||+|||++.++.+||
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred CCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 5567899999997 59999997654 69999999999999999999999 9999999999999999999999
Q ss_pred eecCccccccCCCC-----CccccccccCCccccCcccccccC-----CCCCCcccchhHHHHHHHHHhCCCCC-CCCCh
Q 007177 163 CDFGLARVAFNDTP-----TTIFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAEVLTGKPLF-PGKNV 231 (614)
Q Consensus 163 ~DFGla~~~~~~~~-----~~~~~~~~vgt~~Y~APEvl~~~~-----~~y~~~~DIWSLG~Il~eLltG~~pF-~g~~~ 231 (614)
+|||+++....... ........+||+.|+|||++.+.. ..++.++|||||||++|||++|..|| ++...
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999986543221 111223467999999999987521 24567899999999999999996554 44332
Q ss_pred hHHHHHHH-hhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCC---CCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 232 VHQLDLMT-DLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPN---ADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 232 ~~~l~~i~-~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~---~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.+....+. .....|..+.+. .... .......+...++. +++.+.+||.+||..||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~--------~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQ--------VLVS--REKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHH--------HHHT--TSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hHHHHhhhcccCCCchHHHHH--------hhhc--ccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 11111111 111122211111 1111 11112222222222 4567999999999999999999999955
Q ss_pred ------Cccccc
Q 007177 308 ------DPYFKG 313 (614)
Q Consensus 308 ------hp~f~~ 313 (614)
++|-++
T Consensus 312 ~L~~ll~~~~~~ 323 (336)
T 3g2f_A 312 RMAELMMIWERN 323 (336)
T ss_dssp HHHHHHHCCCC-
T ss_pred HHHHHHHHHHhc
Confidence 566543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=348.49 Aligned_cols=268 Identities=22% Similarity=0.317 Sum_probs=205.6
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc--CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF--EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~--~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
|.....|...+.||+|+||.||+|.+ ++..||||++.... ........+.+|+.+|+.++||||+++++++
T Consensus 27 f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~----- 99 (307)
T 2nru_A 27 FDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS----- 99 (307)
T ss_dssp TCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred cccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEE-----
Confidence 44445566679999999999999975 68899999987532 2334567788999999999999999999998
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCc
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKA---NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 167 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~---~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGl 167 (614)
.+....|+||||++ ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~ 179 (307)
T 2nru_A 100 SDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGL 179 (307)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred ecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 34467899999997 699999874 34699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007177 168 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247 (614)
Q Consensus 168 a~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~ 247 (614)
++........ .......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+....+..+.........
T Consensus 180 ~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 255 (307)
T 2nru_A 180 ARASEKFAQT-VMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEK 255 (307)
T ss_dssp CEECCSCSSC-EECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSC
T ss_pred cccccccccc-ccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhh
Confidence 9865432221 12234579999999999875 5789999999999999999999999876543322222211100000
Q ss_pred hhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 248 ~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
....++ . ..+.......+..+.+||.+||..||.+|||+++++++
T Consensus 256 ---------~~~~~~---~----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 256 ---------TIEDYI---D----KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp ---------CHHHHS---C----SSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------hhhhhc---c----ccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000000 0 00111112345678999999999999999999999874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=347.25 Aligned_cols=244 Identities=30% Similarity=0.454 Sum_probs=194.3
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
+.++|++.+.||+|+||.||+|.+. ++.||||++.. ......+.+|+.+|+.++||||+++++++. +
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~ 72 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACL-------N 72 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-------T
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------C
Confidence 4568999999999999999999764 78999999864 245677889999999999999999999873 2
Q ss_pred cEEEEEecCC-CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEeecCCCCcEEECCCCc-EEEeecCc
Q 007177 96 DIYVVFELME-SDLHQVIKAND---DLTREHYQFFLYQLLRALKYIHT---ANVYHRDLKPKNILANANCK-LKICDFGL 167 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~---~lse~~~~~i~~QIl~aL~yLHs---~gIvHrDLKP~NILi~~~~~-vKL~DFGl 167 (614)
..|+||||++ ++|.+++.... .+++..+..++.||+.||.|||+ +||+||||||+|||++.++. +||+|||+
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~ 152 (307)
T 2eva_A 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152 (307)
T ss_dssp TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence 3699999998 59999998765 47899999999999999999999 89999999999999998886 79999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007177 168 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247 (614)
Q Consensus 168 a~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~ 247 (614)
+...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .+
T Consensus 153 ~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~--------- 214 (307)
T 2eva_A 153 ACDIQTH------MTNNKGSAAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IM--------- 214 (307)
T ss_dssp ------------------CCTTSSCHHHHTC--CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HH---------
T ss_pred ccccccc------cccCCCCCceEChhhhCC--CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HH---------
Confidence 9754322 133469999999999987 68999999999999999999999999754321110 00
Q ss_pred hhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 248 ~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
....... .......+++.+.+||.+||+.||.+|||+++++++
T Consensus 215 ---------------~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 215 ---------------WAVHNGT---RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp ---------------HHHHTTC---CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------HHHhcCC---CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0000111 112235678899999999999999999999999873
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=360.67 Aligned_cols=254 Identities=22% Similarity=0.359 Sum_probs=196.3
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCC---cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTG---EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg---~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
.+|++.+.||+|+||.||+|.+..++ ..||+|.++.. ........+.+|+.+|+.++||||+++++++.. ..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~ 163 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SE 163 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC----CS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc----CC
Confidence 46889999999999999999875433 46899998753 344567789999999999999999999998742 33
Q ss_pred CcEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 95 KDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
+..|+|||||+ ++|.+++... ..+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 56799999998 5999999864 458999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCC-ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 173 NDTPT-TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 173 ~~~~~-~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
..... ........+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~---------- 311 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---------- 311 (373)
T ss_dssp --------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT----------
T ss_pred ccccccccccCCCCCcccccChHHhcC--CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc----------
Confidence 32211 111234567889999999876 689999999999999999999 7889987765444333211
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.... .....+++.+.+||.+||..||.+|||+++++++
T Consensus 312 -----------------~~~~---~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 312 -----------------GRRL---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp -----------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0000 1123578899999999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=358.35 Aligned_cols=246 Identities=15% Similarity=0.165 Sum_probs=195.1
Q ss_pred CCCCeEEEeEeeecCceEEEEE-----EECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC---CCCcceeeeEec
Q 007177 16 DASRYKIQEVIGKGSYGVVCSA-----IDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR---HPDIVEIKHIML 87 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a-----~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~v~~ 87 (614)
..++|.+.+.||+|+||.||+| .+..+++.||||++... ....+.+|+.+++.++ |+||+.+++++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~- 136 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAH- 136 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE-
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheee-
Confidence 3578999999999999999999 47788999999999752 2345677888888887 99999999998
Q ss_pred CCCCCCCCcEEEEEecCC-CcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC-----
Q 007177 88 PPSRRDFKDIYVVFELME-SDLHQVIKA-----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA----- 156 (614)
Q Consensus 88 ~~~~~~~~~~ylV~E~~~-g~L~~~i~~-----~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~----- 156 (614)
...+..|||||||+ |+|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.
T Consensus 137 ----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 137 ----LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp ----ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC
T ss_pred ----ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCc
Confidence 34567899999998 699999973 457999999999999999999999999999999999999998
Q ss_pred ------CCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Q 007177 157 ------NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 230 (614)
Q Consensus 157 ------~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~ 230 (614)
++.+||+|||+|+....... ....+..+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||....
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~ 289 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPK-GTIFTAKCETSGFQCVEMLSN--KPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCT-TEEECCSSCTTSCCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred cccccccCCEEEeeCchhhhhhccCC-CceeeeecCCCCCCChHHhcC--CCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence 89999999999976432222 223456789999999999987 579999999999999999999999995433
Q ss_pred hhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCc
Q 007177 231 VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 309 (614)
Q Consensus 231 ~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp 309 (614)
.... .....+... ..++.+.+|+..||+.+|.+|++..+.|.+.
T Consensus 290 ~~~~---------------------------------~~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 290 GGEC---------------------------------KPEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp TTEE---------------------------------EECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred CCce---------------------------------eechhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 1000 000000011 2356788999999999999997655555543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=347.75 Aligned_cols=271 Identities=21% Similarity=0.355 Sum_probs=209.1
Q ss_pred CCCCeEEEeEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~----d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~ 91 (614)
..++|++++.||+|+||.||+|. +..+++.||||++... .......+.+|+.+|+.++||||+++++++...
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 114 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA-- 114 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec--
Confidence 45679999999999999999998 4678999999999753 345567889999999999999999999988543
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
+...+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 115 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 115 -GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred -CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 2346899999998 5999999875 469999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 170 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 170 ~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
................++..|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+....+......
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~~~~~~~-----~~~~~~~~~~~~~~ 266 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPP-----AEFMRMIGNDKQGQ 266 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHHTTCGGGSHH-----HHHHHHHCTTCCTH
T ss_pred hccccccccccccCCCCceeEECchhhcC--CCCCchhhHHHHHHHHHHHHhcCCCCCCCH-----HHHHHhhccccchh
Confidence 76543322222234567888999999876 578899999999999999999999885432 11112222222111
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.. .......+...... .....+++.+.+||.+||..||.+|||+.++++
T Consensus 267 ~~------~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 267 MI------VFHLIELLKNNGRL---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HH------HHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hh------HHHHHHHhhcCCCC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 10 01111111111111 123467899999999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=368.52 Aligned_cols=259 Identities=18% Similarity=0.251 Sum_probs=204.5
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+++++.|+|++++..+..+. .+..
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~ 76 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFG----VEGD 76 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEE----EETT
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEE----eeCC
Confidence 357899999999999999999999999999999988643222 24778999999998765554444442 3456
Q ss_pred cEEEEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEE---CCCCcEEEeecCccccc
Q 007177 96 DIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA---NANCKLKICDFGLARVA 171 (614)
Q Consensus 96 ~~ylV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi---~~~~~vKL~DFGla~~~ 171 (614)
..|||||||.++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++..
T Consensus 77 ~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 77 YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 7899999998899999985 5679999999999999999999999999999999999999 68889999999999876
Q ss_pred cCCCCCc----cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007177 172 FNDTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247 (614)
Q Consensus 172 ~~~~~~~----~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~ 247 (614)
....... ......+||+.|+|||++.+ ..++.++||||||||||||++|+.||.+.........+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i------ 228 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI------ 228 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH------
T ss_pred cCCccccccccccccccCCCccccCHHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH------
Confidence 5433211 11235689999999999987 67999999999999999999999999886543332222110
Q ss_pred hhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 248 ~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
..... ..........+++++.+||.+||..||++||+++++++
T Consensus 229 ------~~~~~-----------~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 229 ------SEKKV-----------ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp ------HHHHH-----------HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ------hhccc-----------cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00000 00111122456889999999999999999999999866
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=365.30 Aligned_cols=248 Identities=26% Similarity=0.380 Sum_probs=200.5
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++.+.||+|+||.||+|.+.. +..||||+++.... ....+.+|+.+|+.|+||||+++++++.. .
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~ 251 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------E 251 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------S
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC------C
Confidence 44689999999999999999999865 46799999975332 24568899999999999999999999832 4
Q ss_pred cEEEEEecCC-CcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 96 DIYVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
.+|||||||. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 5899999998 599999964 3469999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
...... .....++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+...
T Consensus 332 ~~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~---------- 397 (452)
T 1fmk_A 332 DNEYTA--RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---------- 397 (452)
T ss_dssp -------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT----------
T ss_pred CCceec--ccCCcccccccCHhHHhc--CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC----------
Confidence 322111 123456788999999876 679999999999999999999 99999988765554443211
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
... ...+.+++.+.+||.+||..||.+|||++++++
T Consensus 398 -----------------~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 398 -----------------YRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp -----------------CCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 000 112457889999999999999999999999987
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=350.10 Aligned_cols=266 Identities=27% Similarity=0.352 Sum_probs=194.0
Q ss_pred cccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHh--cCCCCcceeeeEecC
Q 007177 11 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRL--LRHPDIVEIKHIMLP 88 (614)
Q Consensus 11 ~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~--L~HpnIv~l~~v~~~ 88 (614)
.......++|++++.||+|+||.||+|.+. ++.||||++... ......+|.+++.. ++||||+++++++..
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 333444578999999999999999999874 899999998642 23344556666654 489999999999854
Q ss_pred CCCCCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeEeecCCCCcEEECCCCc
Q 007177 89 PSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA--------NVYHRDLKPKNILANANCK 159 (614)
Q Consensus 89 ~~~~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~--------gIvHrDLKP~NILi~~~~~ 159 (614)
.. .....+|+|||||+ ++|.++++.. .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.
T Consensus 103 ~~-~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 103 GT-GSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp SC-GGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CC-CCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 32 12367999999998 4999999765 699999999999999999999999 9999999999999999999
Q ss_pred EEEeecCccccccCCCCCc-cccccccCCccccCcccccccCCCCCCc------ccchhHHHHHHHHHhC----------
Q 007177 160 LKICDFGLARVAFNDTPTT-IFWTDYVATRWYRAPELCGSFFSKYTPA------IDIWSIGCIFAEVLTG---------- 222 (614)
Q Consensus 160 vKL~DFGla~~~~~~~~~~-~~~~~~vgt~~Y~APEvl~~~~~~y~~~------~DIWSLG~Il~eLltG---------- 222 (614)
+||+|||+++......... ......+||+.|+|||++.+ ..++.. +|||||||++|||++|
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE--SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTT--CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhccc--ccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 9999999997654332211 11234689999999999876 344444 9999999999999999
Q ss_pred CCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCC--CCCCCHHHHHHHHHhcCCCCCCCC
Q 007177 223 KPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQK--FPNADPSALRLLERLLAFDPKDRP 300 (614)
Q Consensus 223 ~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~--~~~~s~~l~dLI~~mL~~DP~~Rp 300 (614)
..||......+ +.... ...... . ......+... ...+++.+.+||.+||+.||.+||
T Consensus 259 ~~p~~~~~~~~-----------~~~~~--------~~~~~~-~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 317 (337)
T 3mdy_A 259 QLPYHDLVPSD-----------PSYED--------MREIVC-I-KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL 317 (337)
T ss_dssp CCTTTTTSCSS-----------CCHHH--------HHHHHT-T-SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSC
T ss_pred cccHhhhcCCC-----------Cchhh--------hHHHHh-h-hccCccccccchhhHHHHHHHHHHHHhhhhChhhCC
Confidence 55664432100 00000 000000 0 0001111111 123556799999999999999999
Q ss_pred CHHHHHcC
Q 007177 301 TAEEALAD 308 (614)
Q Consensus 301 sa~eiL~h 308 (614)
|++++++|
T Consensus 318 s~~ell~~ 325 (337)
T 3mdy_A 318 TALRVKKT 325 (337)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999886
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=375.22 Aligned_cols=252 Identities=21% Similarity=0.333 Sum_probs=200.7
Q ss_pred CCCeEEEe-EeeecCceEEEEEEECC--CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 17 ASRYKIQE-VIGKGSYGVVCSAIDTH--TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 17 ~~rY~i~~-~LG~G~~G~V~~a~d~~--tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
.++|.+.+ .||+|+||.||+|.++. ++..||||+++... .......+.+|+.+|+.++||||+++++++..
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----- 407 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----- 407 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-----
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-----
Confidence 44566666 89999999999998763 55679999997542 23456778999999999999999999999842
Q ss_pred CCcEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
..+|||||||. |+|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 35899999998 5999998654 46999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
..............+++.|+|||++.+ ..|+.++|||||||++|||++ |..||.+.+..+....+..
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~---------- 554 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---------- 554 (613)
T ss_dssp C--------------CCTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT----------
T ss_pred cCCCceeeeccCCCCccceeCHhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc----------
Confidence 433221111122346688999999976 689999999999999999998 9999998876555444321
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
... ......+++.+.+||.+||..||.+||+++++++
T Consensus 555 -----------------~~~---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 555 -----------------GKR---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp -----------------TCC---CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred -----------------CCC---CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 101 1122457899999999999999999999999854
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=388.72 Aligned_cols=284 Identities=25% Similarity=0.335 Sum_probs=211.3
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCC-CCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPP-SRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~-~~~~~~ 95 (614)
.++|++.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+|+.++||||+++++++... ......
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 47899999999999999999999999999999998753 3455667889999999999999999999987542 122356
Q ss_pred cEEEEEecCC-CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCc---EEEeecCcc
Q 007177 96 DIYVVFELME-SDLHQVIKAND---DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK---LKICDFGLA 168 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~---~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~---vKL~DFGla 168 (614)
..|+|||||+ ++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++.++. +||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 7899999997 59999998754 5999999999999999999999999999999999999997765 999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007177 169 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248 (614)
Q Consensus 169 ~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~ 248 (614)
........ ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......+... .......
T Consensus 172 ~~~~~~~~----~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~---i~~~~~~ 242 (676)
T 3qa8_A 172 KELDQGEL----CTEFVGTLQYLAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK---VREKSNE 242 (676)
T ss_dssp CBTTSCCC----CCCCCSCCTTCSSCSSCC--SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT---CC-----
T ss_pred cccccccc----cccccCCcccCChHHhcc--CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh---hhcccch
Confidence 87543322 245689999999999987 68999999999999999999999999776432221100 0000000
Q ss_pred hhhhhhchhHHHHHHhhcccCC-CcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 249 TISRVRNDKARRYLTSMRKKQP-VQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 249 ~i~~~~~~~~~~~l~~~~~~~~-~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
.+....... ........ .........+++.+.+||.+||.+||++|||++++|+||||+.+.
T Consensus 243 ~~~~~~~l~-----g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~ 305 (676)
T 3qa8_A 243 HIVVYDDLT-----GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305 (676)
T ss_dssp -CCSCCCCS-----SSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred hhhhhhhhc-----cccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence 000000000 00000000 001112234678899999999999999999999999999998654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=371.98 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=205.5
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
...++|++.+.||+|+||.||+|.+.. +..||||+++.... ....+.+|+.+|+.|+||||+++++++..
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~------ 333 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------ 333 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee------
Confidence 345689999999999999999998865 46799999985432 24568899999999999999999999832
Q ss_pred CcEEEEEecCC-CcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 95 KDIYVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
..+|||||||. ++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 45899999998 599999964 346999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
..... .......++..|+|||++.. ..++.++|||||||+||||++ |..||.+.+..+.+..+...
T Consensus 414 ~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~--------- 480 (535)
T 2h8h_A 414 EDNEY--TARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG--------- 480 (535)
T ss_dssp CCHHH--HTTCSTTSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT---------
T ss_pred CCCce--ecccCCcCcccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---------
Confidence 32111 11123456788999999876 679999999999999999999 99999988765554443211
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
... .....+++.+.+||.+||..||++|||++++++.
T Consensus 481 ------------------~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 481 ------------------YRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp ------------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 000 1124578899999999999999999999999873
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=346.18 Aligned_cols=255 Identities=20% Similarity=0.241 Sum_probs=200.7
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
...++|++.+.||+|+||.||+|.+.. .+|+|+++...........+.+|+.+++.++||||+++++++. +.
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 101 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM-----SP 101 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE-----CS
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cC
Confidence 456899999999999999999998753 4999999754333334456778999999999999999999984 44
Q ss_pred CcEEEEEecCC-CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 95 KDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
..+|+||||++ ++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++ ++.+||+|||+++...
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 56999999998 59999997654 699999999999999999999999999999999999998 6799999999987643
Q ss_pred CCCC--CccccccccCCccccCccccccc-------CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhC
Q 007177 173 NDTP--TTIFWTDYVATRWYRAPELCGSF-------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 243 (614)
Q Consensus 173 ~~~~--~~~~~~~~vgt~~Y~APEvl~~~-------~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g 243 (614)
.... .........||+.|+|||++.+. ...++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~--- 257 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT--- 257 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHT---
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc---
Confidence 2111 11122345689999999998642 13578999999999999999999999988775544333211
Q ss_pred CCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 244 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 244 ~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
... .......++..+.+||.+||..||.+|||++++++
T Consensus 258 ------------------------~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 258 ------------------------GMK--PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp ------------------------TCC--CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred ------------------------CCC--CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 000 01112356789999999999999999999999987
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=363.13 Aligned_cols=258 Identities=19% Similarity=0.172 Sum_probs=193.5
Q ss_pred ccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC------ChHHHHHHHHHHHHHHhcC---------C
Q 007177 12 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE------HISDAARILREIKLLRLLR---------H 76 (614)
Q Consensus 12 ~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~------~~~~~~~i~~Ei~iL~~L~---------H 76 (614)
...-..++|++++.||+|+||.||+|.+ +|+.||||++..... .......+.+|+.+|+.|+ |
T Consensus 14 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h 91 (336)
T 2vuw_A 14 SHCLPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRT 91 (336)
T ss_dssp HHHSCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBC
T ss_pred hhhcccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccC
Confidence 3344567899999999999999999987 689999999975421 2223467889999998886 7
Q ss_pred CCcceeeeEecCC-------------------------CCCCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHH
Q 007177 77 PDIVEIKHIMLPP-------------------------SRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQL 130 (614)
Q Consensus 77 pnIv~l~~v~~~~-------------------------~~~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QI 130 (614)
|||+++.+++... ...+...+|||||||. |++.+.+.. ..+++..++.|++||
T Consensus 92 ~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 92 EGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQL 170 (336)
T ss_dssp CCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHH
T ss_pred CchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHH
Confidence 7777777664211 0113578999999997 555555533 568999999999999
Q ss_pred HHHHHHHH-hCCeEeecCCCCcEEECCCC--------------------cEEEeecCccccccCCCCCccccccccCCcc
Q 007177 131 LRALKYIH-TANVYHRDLKPKNILANANC--------------------KLKICDFGLARVAFNDTPTTIFWTDYVATRW 189 (614)
Q Consensus 131 l~aL~yLH-s~gIvHrDLKP~NILi~~~~--------------------~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~ 189 (614)
+.||.||| +.||+||||||+|||++.++ .+||+|||+|+..... ..+||+.
T Consensus 171 ~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--------~~~gt~~ 242 (336)
T 2vuw_A 171 TASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------EEECCCC
T ss_pred HHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--------cEEEeec
Confidence 99999999 99999999999999999887 8999999999875422 2479999
Q ss_pred ccCcccccccCCCCCCcccchhHHHH-HHHHHhCCCCCCCCChhH-HHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcc
Q 007177 190 YRAPELCGSFFSKYTPAIDIWSIGCI-FAEVLTGKPLFPGKNVVH-QLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRK 267 (614)
Q Consensus 190 Y~APEvl~~~~~~y~~~~DIWSLG~I-l~eLltG~~pF~g~~~~~-~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~ 267 (614)
|+|||++.+. .+.++||||||++ .++++.|..||.+..... ....+ +... .
T Consensus 243 y~aPE~~~g~---~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~-----------------------~~~~-~ 295 (336)
T 2vuw_A 243 SMDEDLFTGD---GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKM-----------------------LKQM-T 295 (336)
T ss_dssp TTCSGGGCCC---SSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHH-----------------------HHTC-C
T ss_pred ccChhhhcCC---CccceehhhhhCCCCcccccccCCCcchhhhhHHHHhh-----------------------hhhh-c
Confidence 9999999862 3889999998777 778889999984321101 11111 1000 0
Q ss_pred cCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHH-cCcccc
Q 007177 268 KQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL-ADPYFK 312 (614)
Q Consensus 268 ~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL-~hp~f~ 312 (614)
.........++.+++++++||++||++| |++|+| +||||+
T Consensus 296 ~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 296 FKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp CSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred cCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 1111111223456789999999999987 999999 999995
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=344.46 Aligned_cols=261 Identities=24% Similarity=0.291 Sum_probs=198.4
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHh--cCCCCcceeeeEecCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRL--LRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~--L~HpnIv~l~~v~~~~~~~~~ 94 (614)
.++|++.+.||+|+||.||+|.+ +|+.||||++.. .....+.+|+++++. ++||||+++++++.... ...
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc-----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-Ccc
Confidence 46899999999999999999987 589999999864 234567789999987 78999999999985442 222
Q ss_pred CcEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCeEeecCCCCcEEECCCCcEEEeec
Q 007177 95 KDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIH--------TANVYHRDLKPKNILANANCKLKICDF 165 (614)
Q Consensus 95 ~~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLH--------s~gIvHrDLKP~NILi~~~~~vKL~DF 165 (614)
..+|+||||+++ +|.+++... .+++..+..++.||+.||.||| +.||+||||||+|||++.++.+||+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred ceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 479999999995 999999764 6999999999999999999999 899999999999999999999999999
Q ss_pred CccccccCCCCCc-cccccccCCccccCcccccccCC----CCCCcccchhHHHHHHHHHhC----------CCCCCCCC
Q 007177 166 GLARVAFNDTPTT-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTG----------KPLFPGKN 230 (614)
Q Consensus 166 Gla~~~~~~~~~~-~~~~~~vgt~~Y~APEvl~~~~~----~y~~~~DIWSLG~Il~eLltG----------~~pF~g~~ 230 (614)
|+++......... .......||+.|+|||++.+... .++.++|||||||++|+|++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 9998765433211 12244579999999999875211 233689999999999999999 67776542
Q ss_pred hhH-HHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 231 VVH-QLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKF--PNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 231 ~~~-~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~--~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
..+ ....+. ..+ ........+...+ ...++.+.+||.+||+.||.+|||++++++
T Consensus 272 ~~~~~~~~~~--------------------~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~ 329 (342)
T 1b6c_B 272 PSDPSVEEMR--------------------KVV--CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329 (342)
T ss_dssp CSSCCHHHHH--------------------HHH--TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cCcccHHHHH--------------------HHH--HHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 110 000000 000 0000111111111 123457899999999999999999999988
Q ss_pred C
Q 007177 308 D 308 (614)
Q Consensus 308 h 308 (614)
|
T Consensus 330 ~ 330 (342)
T 1b6c_B 330 T 330 (342)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=370.88 Aligned_cols=250 Identities=26% Similarity=0.424 Sum_probs=204.9
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCC---CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHT---GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~t---g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
.++|++.+.||+|+||.||+|.+..+ +..||||++... ........+.+|+.+|+.++||||+++++++.
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------ 461 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------ 461 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC------
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe------
Confidence 46899999999999999999998654 457999998753 34455678899999999999999999999873
Q ss_pred CCcEEEEEecCC-CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
.+.+|+|||||+ ++|.+++.... .+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 235799999999 69999998654 6999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
...... ......+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+...
T Consensus 542 ~~~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~--------- 608 (656)
T 2j0j_A 542 EDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--------- 608 (656)
T ss_dssp CC------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT---------
T ss_pred CCCcce--eccCCCCCcceeCHHHhcC--CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---------
Confidence 432211 1233467889999999976 689999999999999999997 99999988766555444221
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
... ...+.+++.+.+||.+||..||.+|||+.++++
T Consensus 609 ------------------~~~---~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 609 ------------------ERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp ------------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCC---CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 011 123467899999999999999999999999976
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=331.36 Aligned_cols=229 Identities=17% Similarity=0.096 Sum_probs=186.7
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
..++|++.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+++.++||||+++++++ .+.
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~ 103 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV-----HTR 103 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EET
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE-----EEC
Confidence 457899999999999999999999999999999999865332 45567889999999999999999999998 345
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
+..|+|||||+ ++|.++++.. ..+.++..|+.||+.||.|||+.||+||||||+|||++.++.+||+++|
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred CcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 67999999998 5999998543 5677889999999999999999999999999999999999999998554
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
|++ .++.++|||||||++|+|++|+.||.+.+..+.+.....
T Consensus 175 ----------------~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~------------- 216 (286)
T 3uqc_A 175 ----------------TMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER------------- 216 (286)
T ss_dssp ----------------CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB-------------
T ss_pred ----------------ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH-------------
Confidence 222 368899999999999999999999988764221100000
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.............+.+++.+.+||.+||+.||++| |++|+++.
T Consensus 217 -----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 217 -----------DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp -----------CTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred -----------HhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 00111112223346789999999999999999999 99999873
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=373.65 Aligned_cols=246 Identities=26% Similarity=0.368 Sum_probs=199.5
Q ss_pred CCCeEEEeEeeecCceEEEEEEECC-CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTH-TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~-tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
.++|++++.||+|+||.||+|.+.. +|+.||||++... ........+.+|+.+|+.++||||+++++++.........
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 4799999999999999999999976 7899999998753 3344556788999999999999999999998654332223
Q ss_pred cEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 96 DIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 96 ~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
..|||||||+| +|.+++.. .+++..++.|+.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.....
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 37999999984 88887754 69999999999999999999999999999999999999886 8999999999865332
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
...+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.... +.+..
T Consensus 235 -------~~~~gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~~------- 287 (681)
T 2pzi_A 235 -------GYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPED------- 287 (681)
T ss_dssp -------SCCCCCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCTT-------
T ss_pred -------CccCCCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCcccccc----------ccccc-------
Confidence 34579999999999875 4588999999999999999999998653210 00000
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
......++.+.+||.+||+.||.+||+..++|.|+|+.-
T Consensus 288 --------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 288 --------------------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp --------------------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --------------------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 000113568899999999999999999999999998754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-33 Score=314.74 Aligned_cols=187 Identities=18% Similarity=0.127 Sum_probs=134.8
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEecCccC--------ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCC
Q 007177 25 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE--------HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 25 ~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~--------~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~~~~~ 95 (614)
.++.|+.|.+..++....|+.|++|++.+... .....+.+.+|+++|+++ .|+||+++++++ ++..
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence 45677777777777778899999999964321 123456688999999999 699999999998 6778
Q ss_pred cEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 96 DIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 96 ~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
.+|||||||+| +|.++|...+.+++. .|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 89999999996 999999999889875 47899999999999999999999999999999999999999999875433
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCC
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 225 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~p 225 (614)
.. ..+..+||+.|+|||++.+ .+..++|+||+|+++++|.++..+
T Consensus 393 ~~---~~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CS---WPTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -C---CSHHHHHHHHHHHHHHC--------------------CCCCTTHHH
T ss_pred Cc---cccCceechhhccHHHhCC---CCCCcccccccccchhhhccccch
Confidence 22 2345789999999999976 567789999999999988766533
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=266.70 Aligned_cols=187 Identities=20% Similarity=0.278 Sum_probs=142.5
Q ss_pred EEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCC-h-----HHHHHHHHHHHHHHhcCCCCcc--eeeeEecCCCCC
Q 007177 21 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-I-----SDAARILREIKLLRLLRHPDIV--EIKHIMLPPSRR 92 (614)
Q Consensus 21 ~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~-~-----~~~~~i~~Ei~iL~~L~HpnIv--~l~~v~~~~~~~ 92 (614)
...+.||+|+||.||+| ...+..+++|+....... . ...+++.+|+++|+.++||||+ .++++.
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~------ 410 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD------ 410 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE------
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe------
Confidence 45679999999999999 566889999987532221 1 1245688999999999999999 555542
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
....|||||||+ ++|.+++.. +..|+.||+.||.|||++||+||||||+|||++. .+||+|||+++..
T Consensus 411 -~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 411 -LDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp -TTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred -CCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 234599999998 699999865 6789999999999999999999999999999998 9999999999876
Q ss_pred cCCCCCc----cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCC
Q 007177 172 FNDTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 226 (614)
Q Consensus 172 ~~~~~~~----~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF 226 (614)
....... ......+||++|+|||++......|+..+|+||..+-..+.+.++.+|
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 4321111 012456899999999999764457888999999999888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.3e-24 Score=220.48 Aligned_cols=160 Identities=18% Similarity=0.179 Sum_probs=122.4
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----------------HHHHHHHHHHHHHHhcCCCCcce
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI----------------SDAARILREIKLLRLLRHPDIVE 81 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~----------------~~~~~i~~Ei~iL~~L~HpnIv~ 81 (614)
..|.+.+.||+|+||.||+|.+ .+|+.||||+++...... .....+.+|+.+|+.++ | ++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 4566779999999999999999 889999999996321110 23566889999999999 4 55
Q ss_pred eeeEecCCCCCCCCcEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcE
Q 007177 82 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKL 160 (614)
Q Consensus 82 l~~v~~~~~~~~~~~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~v 160 (614)
+.+++. .+..|+|||||+| +|.+ +. ......++.||+.||.|||+.||+||||||+|||++ ++.+
T Consensus 166 v~~~~~------~~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~v 231 (282)
T 1zar_A 166 VPKVYA------WEGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGI 231 (282)
T ss_dssp SCCEEE------EETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEE
T ss_pred cCeEEe------ccceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcE
Confidence 555542 1346999999985 8887 42 134567999999999999999999999999999999 9999
Q ss_pred EEeecCccccccCCCCCccccccccCCccccCccccccc--------CCCCCCcccchh
Q 007177 161 KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF--------FSKYTPAIDIWS 211 (614)
Q Consensus 161 KL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~--------~~~y~~~~DIWS 211 (614)
||+|||+|+. +..++|||++... ...|+..+|+|.
T Consensus 232 kl~DFG~a~~----------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 232 WIIDFPQSVE----------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp EECCCTTCEE----------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EEEECCCCeE----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 9999999863 3347889986430 123455566654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.5e-20 Score=190.37 Aligned_cols=140 Identities=17% Similarity=0.143 Sum_probs=110.1
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcE--EEEEEecCccCC----------------------hHHHHHHHHHHHHHHh
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEK--VAIKKIHDIFEH----------------------ISDAARILREIKLLRL 73 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~--vAIK~i~~~~~~----------------------~~~~~~i~~Ei~iL~~ 73 (614)
.-|.+.+.||+|+||.||+|.+..+|+. ||||+++..... ......+.+|+.+|+.
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3488999999999999999998778999 999987542111 0112357899999999
Q ss_pred cCCCCc--ceeeeEecCCCCCCCCcEEEEEecCC--C----cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCeEe
Q 007177 74 LRHPDI--VEIKHIMLPPSRRDFKDIYVVFELME--S----DLHQVIKANDDLTREHYQFFLYQLLRALKYIH-TANVYH 144 (614)
Q Consensus 74 L~HpnI--v~l~~v~~~~~~~~~~~~ylV~E~~~--g----~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLH-s~gIvH 144 (614)
|.|++| ..+++. ...||||||++ | .|.+.+.. +++..+..++.||+.||.||| +.||+|
T Consensus 127 l~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givH 194 (258)
T 1zth_A 127 AKEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVH 194 (258)
T ss_dssp HHHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEEC
T ss_pred HHhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 988764 333322 24589999995 2 67766432 345678899999999999999 999999
Q ss_pred ecCCCCcEEECCCCcEEEeecCccccc
Q 007177 145 RDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 145 rDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999988 8999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.2e-16 Score=170.29 Aligned_cols=138 Identities=17% Similarity=0.177 Sum_probs=99.1
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC---------------ChHH---HHH--HHHHHHHHHhcCCCC
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE---------------HISD---AAR--ILREIKLLRLLRHPD 78 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~---------------~~~~---~~~--i~~Ei~iL~~L~Hpn 78 (614)
-|.+.+.||.|++|.||+|.+. +|+.||||+++.... .... ..+ ..+|+..|.+|.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4999999999999999999874 699999998752110 0000 111 235777777775544
Q ss_pred cceeeeEecCCCCCCCCcEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC
Q 007177 79 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN 157 (614)
Q Consensus 79 Iv~l~~v~~~~~~~~~~~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~ 157 (614)
+.-..-+. ....+|||||++| .|.++. ..+....++.||+.+|.+||++|||||||||.|||++.+
T Consensus 175 v~vp~p~~-------~~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 175 FPVPEPIA-------QSRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE 241 (397)
T ss_dssp CSCCCEEE-------EETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE
T ss_pred CCCCeeee-------ccCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC
Confidence 32211111 1123799999996 665432 223456788999999999999999999999999999887
Q ss_pred C----------cEEEeecCcccc
Q 007177 158 C----------KLKICDFGLARV 170 (614)
Q Consensus 158 ~----------~vKL~DFGla~~ 170 (614)
+ .+.|+||+.+..
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCcccccccccceEEEEeCCccc
Confidence 6 389999998754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=1.9e-11 Score=122.81 Aligned_cols=137 Identities=12% Similarity=0.121 Sum_probs=106.3
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCcE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
.|.+...++.|+.+.||++.. .+..+++|....... .....+.+|+.+|+.|. +..+.++++... +.+..
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~ 85 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGWS 85 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEE
T ss_pred cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCce
Confidence 588999999999999999964 368999999864221 11235788999999985 667778888763 34668
Q ss_pred EEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 007177 98 YVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHT------------------------------------- 139 (614)
Q Consensus 98 ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs------------------------------------- 139 (614)
|+|||+++| +|.+.+ .+......++.++..+|..||+
T Consensus 86 ~lv~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEEEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999997 676542 1223345788999999999998
Q ss_pred ----------------------CCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 140 ----------------------ANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 140 ----------------------~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
..++|+|++|.|||++.+..+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876566799999774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.12 E-value=2.4e-10 Score=113.68 Aligned_cols=134 Identities=15% Similarity=0.078 Sum_probs=96.4
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC--cceeeeEecCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD--IVEIKHIMLPPSRRDF 94 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~~~~~~~ 94 (614)
...|.+....+.|..+.||++. ..+|..+++|..... ....+.+|+.+|+.+.+.+ +.+++.... +.
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~ 87 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVT-----EA 87 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CS
T ss_pred cCCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEecc-----CC
Confidence 3457765554566779999995 456788999987642 1234678999999886444 455777652 33
Q ss_pred CcEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 007177 95 KDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN-------------------------------- 141 (614)
Q Consensus 95 ~~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~g-------------------------------- 141 (614)
+..|+|||+++| +| . . .... ...++.++...|..||+..
T Consensus 88 ~~~~~v~e~i~G~~l-~-~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDL-L-S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD 159 (264)
T ss_dssp SCEEEEEECCSSEET-T-T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred CCCEEEEEecCCccc-C-c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence 568999999997 55 3 1 1122 2356778888888888754
Q ss_pred --------------------------eEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 142 --------------------------VYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 142 --------------------------IvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.11 E-value=1.3e-10 Score=119.59 Aligned_cols=184 Identities=18% Similarity=0.270 Sum_probs=120.9
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCC--cceeeeEecCCCCCCCCcEEE
Q 007177 23 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPD--IVEIKHIMLPPSRRDFKDIYV 99 (614)
Q Consensus 23 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-Hpn--Iv~l~~v~~~~~~~~~~~~yl 99 (614)
++.++.|....||++. ..+++|+... ......+.+|+.+|+.+. +.. +.+++.... ........|+
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~--~~~~~~~~~~ 93 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGM--PSETYQMSFA 93 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECC--CCSSCSCSCE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecC--CCCCCCcceE
Confidence 4569999999999872 5689998653 244567889999999884 333 233333221 1112234589
Q ss_pred EEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 007177 100 VFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHT--------------------------------------- 139 (614)
Q Consensus 100 V~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs--------------------------------------- 139 (614)
|||+++| .|..... ..++.++...++.|+...|..||+
T Consensus 94 vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp EEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred EEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9999997 5544332 247888888899999999998886
Q ss_pred -------------------CCeEeecCCCCcEEECC--CCcEEEeecCccccccCCCCCccccccccCCccc---cCccc
Q 007177 140 -------------------ANVYHRDLKPKNILANA--NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY---RAPEL 195 (614)
Q Consensus 140 -------------------~gIvHrDLKP~NILi~~--~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y---~APEv 195 (614)
..++|+|++|.||+++. +..+.|+||+.+...... . +......+ ..|+.
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~--~-----Dl~~~~~~~~~~~~~~ 244 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD--N-----DFISLMEDDEEYGMEF 244 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT--H-----HHHTTCCTTTSCCHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH--H-----HHHHHHhhccccCHHH
Confidence 13799999999999988 456889999998653211 0 11111111 23332
Q ss_pred ccccCCCCC------------CcccchhHHHHHHHHHhCCCCC
Q 007177 196 CGSFFSKYT------------PAIDIWSIGCIFAEVLTGKPLF 226 (614)
Q Consensus 196 l~~~~~~y~------------~~~DIWSLG~Il~eLltG~~pF 226 (614)
.......|. ...+.|++|.+++.+.+|.++|
T Consensus 245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 211101111 1258999999999999998766
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.04 E-value=7e-10 Score=116.82 Aligned_cols=144 Identities=13% Similarity=0.211 Sum_probs=104.3
Q ss_pred eEEEeEeeecCceEEEEEEECCCCcEEEEEEec--CccCChHHHHHHHHHHHHHHhcC--CCCcceeeeEecCCCCCCCC
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLR--HPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~--~~~~~~~~~~~i~~Ei~iL~~L~--HpnIv~l~~v~~~~~~~~~~ 95 (614)
..-++.|+.|.++.||++.. .+..+++|+.. .. ........+.+|+.+|+.|. +..+.+++...... ...+
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~-~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g 114 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKS-KLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIG 114 (359)
T ss_dssp CCEEEECCC-CCSCEEEEEC--SSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTS
T ss_pred CceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCC-CCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccC
Confidence 33467899999999999864 35688888765 21 11123456789999999997 45577887776432 1224
Q ss_pred cEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 007177 96 DIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHT----------------------------------- 139 (614)
Q Consensus 96 ~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs----------------------------------- 139 (614)
..|+|||+++| .+.+. ....+++.+...++.++...|..||+
T Consensus 115 ~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 115 RAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp SCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred CeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 57999999997 44321 12347888889999999999999997
Q ss_pred -----------------------CCeEeecCCCCcEEECCCCc--EEEeecCcccc
Q 007177 140 -----------------------ANVYHRDLKPKNILANANCK--LKICDFGLARV 170 (614)
Q Consensus 140 -----------------------~gIvHrDLKP~NILi~~~~~--vKL~DFGla~~ 170 (614)
..++|+|++|.|||++.++. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36999999999999997753 69999999864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=1.5e-06 Score=89.61 Aligned_cols=133 Identities=22% Similarity=0.220 Sum_probs=91.9
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCC---CcceeeeEecCCCCCCCCcEEE
Q 007177 23 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP---DIVEIKHIMLPPSRRDFKDIYV 99 (614)
Q Consensus 23 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hp---nIv~l~~v~~~~~~~~~~~~yl 99 (614)
++.++.|....||+. |..+++|+... ......+.+|..+|+.|.+. .+.+++.... ...+..|+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~ 90 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFV 90 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEE
Confidence 456899999999988 57788998532 23456788999999999753 2344444432 12345789
Q ss_pred EEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 007177 100 VFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA-------------------------------------- 140 (614)
Q Consensus 100 V~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~-------------------------------------- 140 (614)
|||+++| .|....- ..++..+...+..++...|..||+.
T Consensus 91 v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 91 GYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp EEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred EEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 9999997 5544221 1345555556666666666665542
Q ss_pred ----------------------CeEeecCCCCcEEECC---CCc-EEEeecCcccc
Q 007177 141 ----------------------NVYHRDLKPKNILANA---NCK-LKICDFGLARV 170 (614)
Q Consensus 141 ----------------------gIvHrDLKP~NILi~~---~~~-vKL~DFGla~~ 170 (614)
.++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999987 455 48999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=2.3e-06 Score=85.71 Aligned_cols=133 Identities=18% Similarity=0.222 Sum_probs=94.0
Q ss_pred eEeeecCce-EEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCcEEEEE
Q 007177 24 EVIGKGSYG-VVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 24 ~~LG~G~~G-~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~~ylV~ 101 (614)
+.+..|..| .||+......+..+++|.-.. .....+.+|..+|+.|. +-.+.+++.+. .+.+..|+||
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~-----~~~~~~~lvm 99 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFI-----RTPDDAWLLT 99 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEEEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEE-----EECCeEEEEE
Confidence 345556555 689987777788899997653 34567889999999885 32355566655 3345689999
Q ss_pred ecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 007177 102 ELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA---------------------------------------- 140 (614)
Q Consensus 102 E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~---------------------------------------- 140 (614)
|+++| ++.+..... ......+..++...|.-||+.
T Consensus 100 e~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (272)
T 4gkh_A 100 TAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP 175 (272)
T ss_dssp ECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred EeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence 99997 666554321 223345666677777777742
Q ss_pred ------------------CeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 141 ------------------NVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 141 ------------------gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 179999999999999877777999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=6.1e-06 Score=87.81 Aligned_cols=78 Identities=17% Similarity=0.083 Sum_probs=48.8
Q ss_pred EEeEeeecCceEEEEEEECCCCcEEEEEEecCccC--C---hHHHHHHHHHHHHHHhcCC--CC-cceeeeEecCCCCCC
Q 007177 22 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE--H---ISDAARILREIKLLRLLRH--PD-IVEIKHIMLPPSRRD 93 (614)
Q Consensus 22 i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~--~---~~~~~~i~~Ei~iL~~L~H--pn-Iv~l~~v~~~~~~~~ 93 (614)
-.+.||.|..+.||++.+..++..++||....... . .....++.+|..+|+.+.. |. +.+++...
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d------- 106 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD------- 106 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-------
Confidence 36789999999999997666678999998653211 0 0123456789999988742 33 33454432
Q ss_pred CCcEEEEEecCCC
Q 007177 94 FKDIYVVFELMES 106 (614)
Q Consensus 94 ~~~~ylV~E~~~g 106 (614)
....++|||++++
T Consensus 107 ~~~~~lvmE~l~g 119 (397)
T 2olc_A 107 TEMAVTVMEDLSH 119 (397)
T ss_dssp TTTTEEEECCCTT
T ss_pred CCccEEEEEeCCC
Confidence 1224899999986
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.05 E-value=1.3e-05 Score=82.64 Aligned_cols=30 Identities=23% Similarity=0.345 Sum_probs=27.4
Q ss_pred CCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 140 ANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 140 ~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 679999999999999888899999999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.77 E-value=1.3e-05 Score=83.72 Aligned_cols=85 Identities=8% Similarity=0.138 Sum_probs=52.5
Q ss_pred eEEEeEe-eecCceEEEEEEECC------CCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcC-C--CCcceeeeEecC
Q 007177 20 YKIQEVI-GKGSYGVVCSAIDTH------TGEKVAIKKIHDIFE-HISDAARILREIKLLRLLR-H--PDIVEIKHIMLP 88 (614)
Q Consensus 20 Y~i~~~L-G~G~~G~V~~a~d~~------tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~-H--pnIv~l~~v~~~ 88 (614)
....+.| +.|....+|++.... ++..+++|....... .......+.+|+.+|+.|. + -.+.+++.....
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3446778 889999999886431 266889997653210 0001134678888888774 3 346666666532
Q ss_pred CCCCCCCcEEEEEecCCC
Q 007177 89 PSRRDFKDIYVVFELMES 106 (614)
Q Consensus 89 ~~~~~~~~~ylV~E~~~g 106 (614)
.. ..+..|+|||+++|
T Consensus 102 ~~--~~g~~~~v~e~l~G 117 (357)
T 3ats_A 102 GD--VLGTPFFLMDYVEG 117 (357)
T ss_dssp ST--TTSSCEEEEECCCC
T ss_pred CC--ccCCceEEEEecCC
Confidence 21 12446899999986
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00057 Score=73.19 Aligned_cols=32 Identities=13% Similarity=0.269 Sum_probs=28.3
Q ss_pred HhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 138 HTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 138 Hs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
+...++|+|++|.|||++.++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 467899999999999998876 99999998864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00036 Score=71.11 Aligned_cols=68 Identities=12% Similarity=0.002 Sum_probs=42.1
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCc-ceeeeEecCCCCCCCCcEEEEE
Q 007177 23 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI-VEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 23 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnI-v~l~~v~~~~~~~~~~~~ylV~ 101 (614)
++.|+.|....+|++ ..+++|+..... .......+|+.+++.+..-.+ .+++... . ..-++|+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~--~~~~~v~ 86 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVD-----P--ATGVMVT 86 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC-----T--TTCCEEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEE-----C--CCCEEEE
Confidence 788999999999999 568888876421 111123468888877753223 3444432 1 1236899
Q ss_pred ecC-CC
Q 007177 102 ELM-ES 106 (614)
Q Consensus 102 E~~-~g 106 (614)
||+ +|
T Consensus 87 e~i~~g 92 (301)
T 3dxq_A 87 RYIAGA 92 (301)
T ss_dssp ECCTTC
T ss_pred eecCCC
Confidence 999 65
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0023 Score=65.35 Aligned_cols=150 Identities=13% Similarity=0.101 Sum_probs=80.3
Q ss_pred ccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC--cceeeeEecCC
Q 007177 12 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD--IVEIKHIMLPP 89 (614)
Q Consensus 12 ~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~~ 89 (614)
..|+. +...-++.|+.|....+|++... +..+++|..... .....+..|+.+++.|.... +.+++... .+
T Consensus 17 ~~~~~-~~~~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~-~g 88 (322)
T 2ppq_A 17 TQYDV-GSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRK-DG 88 (322)
T ss_dssp TTBCC-CCEEEEEEECC---EEEEEEEES--SCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBT-TC
T ss_pred HhCCC-CcceEeeccCCCcccceEEEEeC--CccEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCCcccCCC-CC
Confidence 34554 34445677888998999998643 336889988642 12234557888887774222 22222210 00
Q ss_pred C--CCCCCcEEEEEecCCCc-H-----H----------HHHHhCCC--------CCHHHHHHH---------------HH
Q 007177 90 S--RRDFKDIYVVFELMESD-L-----H----------QVIKANDD--------LTREHYQFF---------------LY 128 (614)
Q Consensus 90 ~--~~~~~~~ylV~E~~~g~-L-----~----------~~i~~~~~--------lse~~~~~i---------------~~ 128 (614)
. ....+..++||++++|. + . .+-..... ......... -.
T Consensus 89 ~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~ 168 (322)
T 2ppq_A 89 ELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLRE 168 (322)
T ss_dssp CSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHH
T ss_pred CEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHH
Confidence 0 00124578999999862 1 0 01011111 111111110 01
Q ss_pred HHHHHHHHHHh-------CCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 129 QLLRALKYIHT-------ANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 129 QIl~aL~yLHs-------~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
.+...+.+++. .+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 169 ~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 169 EIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 13344555542 369999999999999887666899999775
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0024 Score=65.78 Aligned_cols=74 Identities=16% Similarity=0.104 Sum_probs=54.0
Q ss_pred EEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC---CCCcceeeeEecCCCCCCCCcE
Q 007177 21 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR---HPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 21 ~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
.-.+.|+.|....+|+... ++..+++|..... ....+.+|...|+.|. ...+.+++.... ..+..
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~ 106 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHS 106 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCce
Confidence 3467899999999999863 5678899976532 3556788999998884 245666666542 23568
Q ss_pred EEEEecCCC
Q 007177 98 YVVFELMES 106 (614)
Q Consensus 98 ylV~E~~~g 106 (614)
|+|||+++|
T Consensus 107 ~lvme~l~G 115 (312)
T 3jr1_A 107 FLLLEALNK 115 (312)
T ss_dssp EEEEECCCC
T ss_pred EEEEEeccC
Confidence 999999985
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0066 Score=61.17 Aligned_cols=76 Identities=12% Similarity=0.016 Sum_probs=51.8
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCC---CcceeeeEecCCCCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP---DIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hp---nIv~l~~v~~~~~~~~~ 94 (614)
.+..-++.+|.|..+.||++.. .+|+.|++|+...... .....+.+|...|+.|..- .+.+++..-
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-------- 83 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-------- 83 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--------
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEecc--------
Confidence 3566688999999999999964 5789999998653211 1123467899999988522 233444321
Q ss_pred CcEEEEEecCC
Q 007177 95 KDIYVVFELME 105 (614)
Q Consensus 95 ~~~ylV~E~~~ 105 (614)
.-++|||++.
T Consensus 84 -~~~lv~e~l~ 93 (288)
T 3f7w_A 84 -DRTLAMEWVD 93 (288)
T ss_dssp -TTEEEEECCC
T ss_pred -CceEEEEeec
Confidence 2378999987
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0069 Score=58.85 Aligned_cols=96 Identities=18% Similarity=0.134 Sum_probs=65.2
Q ss_pred cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHH-HhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCCccccccc
Q 007177 107 DLHQVIKA-NDDLTREHYQFFLYQLLRALKYI-HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY 184 (614)
Q Consensus 107 ~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yL-Hs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~ 184 (614)
+|.++++. +.+++|++++.+++|.+.+|.-+ +.+.-..+=+.|..|++..+|.|-+.+ ..+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------------
Confidence 79999876 56899999999999999998876 222222334457899999999987774 2111
Q ss_pred cCCccccCcccccccCCCCCCcccchhHHHHHHHHHh
Q 007177 185 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 221 (614)
Q Consensus 185 vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt 221 (614)
.....+.+||... ...+.+.=|+|||+++|.-+-
T Consensus 98 ~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---------CCSS---SSSCHHHHHHHHHHHHHHHHT
T ss_pred ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhh
Confidence 0122356888764 245678889999999999885
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0029 Score=65.12 Aligned_cols=32 Identities=25% Similarity=0.424 Sum_probs=27.6
Q ss_pred hCCeEeecCCCCcEEECCC----CcEEEeecCcccc
Q 007177 139 TANVYHRDLKPKNILANAN----CKLKICDFGLARV 170 (614)
Q Consensus 139 s~gIvHrDLKP~NILi~~~----~~vKL~DFGla~~ 170 (614)
...++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3479999999999999875 6799999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0087 Score=64.34 Aligned_cols=72 Identities=14% Similarity=0.130 Sum_probs=48.3
Q ss_pred EEeEeeecCceEEEEEEECC-------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCc-ceeeeEecCCCCCC
Q 007177 22 IQEVIGKGSYGVVCSAIDTH-------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI-VEIKHIMLPPSRRD 93 (614)
Q Consensus 22 i~~~LG~G~~G~V~~a~d~~-------tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnI-v~l~~v~~~~~~~~ 93 (614)
-++.|+.|....||++.... ++..+++|+.... .. ...+.+|+.+++.|...++ .++++.+ .+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~--~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~ 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET--ESHLVAESVIFTLLSERHLGPKLYGIF-----SG 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC--HHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc--HHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC
Confidence 35678899999999997642 3578999987431 11 1345579999988853333 5566554 11
Q ss_pred CCcEEEEEecCCC
Q 007177 94 FKDIYVVFELMES 106 (614)
Q Consensus 94 ~~~~ylV~E~~~g 106 (614)
.+|+||++|
T Consensus 148 ----g~v~e~l~G 156 (429)
T 1nw1_A 148 ----GRLEEYIPS 156 (429)
T ss_dssp ----EEEECCCCE
T ss_pred ----CEEEEEeCC
Confidence 289999975
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0058 Score=62.52 Aligned_cols=137 Identities=17% Similarity=0.113 Sum_probs=76.2
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC--cceeeeEecCCC--CCCCCcEEE
Q 007177 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD--IVEIKHIMLPPS--RRDFKDIYV 99 (614)
Q Consensus 24 ~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~~~--~~~~~~~yl 99 (614)
..|+ |....||++.. .+|+.+++|....... ....+..|+.+++.|.... +.+++.. .+. ....+..++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFA 104 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEE
Confidence 4566 77889998743 3466899999863211 2345667888888775222 3333332 111 011345688
Q ss_pred EEecCCCc-H-----HH------HH---H---hC------CCCCHHHH----------------------HHHHHHHHHH
Q 007177 100 VFELMESD-L-----HQ------VI---K---AN------DDLTREHY----------------------QFFLYQLLRA 133 (614)
Q Consensus 100 V~E~~~g~-L-----~~------~i---~---~~------~~lse~~~----------------------~~i~~QIl~a 133 (614)
||++++|. + .. .+ . .. ..++.... ...+.+++..
T Consensus 105 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 184 (328)
T 1zyl_A 105 VFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAA 184 (328)
T ss_dssp EEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHH
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHH
Confidence 99999861 1 11 01 0 10 01121111 1111222222
Q ss_pred HHHH----HhCCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 134 LKYI----HTANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 134 L~yL----Hs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
+.-+ ....++|+|+++.|||++ + .+.|+||+.+.
T Consensus 185 l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 185 VTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 2222 234589999999999998 4 89999999774
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0033 Score=65.80 Aligned_cols=73 Identities=7% Similarity=-0.009 Sum_probs=42.5
Q ss_pred EEeEeeecCceEEEEEEECC--------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC-cceeeeEecCCCCC
Q 007177 22 IQEVIGKGSYGVVCSAIDTH--------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD-IVEIKHIMLPPSRR 92 (614)
Q Consensus 22 i~~~LG~G~~G~V~~a~d~~--------tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn-Iv~l~~v~~~~~~~ 92 (614)
-++.|+.|....+|++.... .+..+++|+..... .......+|..+|+.|...+ ..+++... .
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~ 108 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF-----N 108 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec-----C
Confidence 35678889889999997543 13688888765321 11112357888888875333 34555543 1
Q ss_pred CCCcEEEEEecCCC
Q 007177 93 DFKDIYVVFELMES 106 (614)
Q Consensus 93 ~~~~~ylV~E~~~g 106 (614)
-++||||++|
T Consensus 109 ----~~~v~e~i~G 118 (369)
T 3c5i_A 109 ----GGRIEEWLYG 118 (369)
T ss_dssp ----TEEEEECCCS
T ss_pred ----CcEEEEEecC
Confidence 1689999986
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.63 E-value=0.011 Score=62.58 Aligned_cols=138 Identities=12% Similarity=0.167 Sum_probs=81.0
Q ss_pred CeEEEeEeeecCceEEEEEEECC-------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCC
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTH-------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPS 90 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~-------tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~ 90 (614)
... ++.|..|....+|++.... ++..|++|+..... .....+.+|..+++.|. +.-..+++..+
T Consensus 52 ~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~---- 123 (379)
T 3feg_A 52 ELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVF---- 123 (379)
T ss_dssp GCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEE----
T ss_pred ceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEc----
Confidence 344 4678788888999987532 35789999864311 12345568999998885 33335555554
Q ss_pred CCCCCcEEEEEecCCC-cH-----------HHH---HH---hC-----CCC--CHHHHHHHHHHHHH-------------
Q 007177 91 RRDFKDIYVVFELMES-DL-----------HQV---IK---AN-----DDL--TREHYQFFLYQLLR------------- 132 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~g-~L-----------~~~---i~---~~-----~~l--se~~~~~i~~QIl~------------- 132 (614)
.+ -+||||++| .| ..+ +. .. ... -...+..|+.++..
T Consensus 124 -~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~ 198 (379)
T 3feg_A 124 -PE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLE 198 (379)
T ss_dssp -TT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHH
T ss_pred -CC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhh
Confidence 22 299999985 21 111 11 11 111 23556666655432
Q ss_pred ------HHHHHH----h----CCeEeecCCCCcEEECCC----CcEEEeecCccc
Q 007177 133 ------ALKYIH----T----ANVYHRDLKPKNILANAN----CKLKICDFGLAR 169 (614)
Q Consensus 133 ------aL~yLH----s----~gIvHrDLKP~NILi~~~----~~vKL~DFGla~ 169 (614)
.+..|. . ..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 199 ~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 199 MYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred hHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 233332 2 258999999999999876 789999999874
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.41 E-value=0.06 Score=58.32 Aligned_cols=72 Identities=19% Similarity=0.198 Sum_probs=46.0
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCc-ceeeeEecCCCCCCCCcEEEEE
Q 007177 23 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI-VEIKHIMLPPSRRDFKDIYVVF 101 (614)
Q Consensus 23 ~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnI-v~l~~v~~~~~~~~~~~~ylV~ 101 (614)
++.|+.|-...+|++.....+..+++|+......... ...+|+.+|+.|...++ .+++..+ .+ .+||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i---dR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~ 180 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII---NREREKKISCILYNKNIAKKIYVFF-----TN----GRIE 180 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS---CHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc---CHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEE
Confidence 5678899999999997654457899998753211111 12479999998875444 4566655 11 2599
Q ss_pred ecCCC
Q 007177 102 ELMES 106 (614)
Q Consensus 102 E~~~g 106 (614)
||++|
T Consensus 181 e~I~G 185 (458)
T 2qg7_A 181 EFMDG 185 (458)
T ss_dssp ECCCS
T ss_pred EeeCC
Confidence 99975
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.40 E-value=0.012 Score=60.96 Aligned_cols=31 Identities=19% Similarity=0.310 Sum_probs=27.7
Q ss_pred CCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 140 ANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 140 ~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888899999988764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.13 E-value=0.25 Score=52.26 Aligned_cols=29 Identities=31% Similarity=0.427 Sum_probs=24.7
Q ss_pred eEeecCCCCcEEE------CCCCcEEEeecCcccc
Q 007177 142 VYHRDLKPKNILA------NANCKLKICDFGLARV 170 (614)
Q Consensus 142 IvHrDLKP~NILi------~~~~~vKL~DFGla~~ 170 (614)
++|+|+.+.|||+ +.+..++|+||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4456799999998853
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.28 E-value=1 Score=47.97 Aligned_cols=73 Identities=10% Similarity=-0.035 Sum_probs=45.8
Q ss_pred EEeEeeecCceEEEEEEECC-------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCC
Q 007177 22 IQEVIGKGSYGVVCSAIDTH-------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 22 i~~~LG~G~~G~V~~a~d~~-------tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~ 93 (614)
-++.|..|....+|++.... .+..|++++....... .....+|..+++.|. +.-..++++.+ .
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~---~idR~~E~~~l~~L~~~gi~P~l~~~~-----~- 144 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK---FYDSKVELDVFRYLSNINIAPNIIADF-----P- 144 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C---CCCHHHHHHHHHHHHHTTSSCCEEEEE-----T-
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch---hcCHHHHHHHHHHHHhcCCCCCEEEEc-----C-
Confidence 35678888889999997642 1578999986432111 112347888888775 32234454433 1
Q ss_pred CCcEEEEEecCCC
Q 007177 94 FKDIYVVFELMES 106 (614)
Q Consensus 94 ~~~~ylV~E~~~g 106 (614)
-++||||++|
T Consensus 145 ---~~~I~efI~G 154 (424)
T 3mes_A 145 ---EGRIEEFIDG 154 (424)
T ss_dssp ---TEEEEECCCS
T ss_pred ---CCEEEEEeCC
Confidence 1689999986
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 614 | ||||
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-98 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-90 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-89 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-78 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-77 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-75 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-73 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-72 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-72 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-72 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-70 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-69 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-68 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-68 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-68 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-67 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-67 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-67 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-66 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-66 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-66 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-65 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-65 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-65 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-64 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-64 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-62 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-59 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-59 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-58 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-57 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-56 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-55 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-53 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-50 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-50 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-49 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-49 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-49 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-48 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-48 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-47 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-47 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-43 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-43 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-43 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-41 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-25 |
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 301 bits (772), Expect = 3e-98
Identities = 160/342 (46%), Positives = 219/342 (64%), Gaps = 5/342 (1%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 76
RY IG+G+YG+VCSA D +VAIKKI FEH + R LREIK+L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRH 65
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 136
+I+ I I+ P+ KD+Y+V LM +DL++++K L+ +H +FLYQ+LR LKY
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKY 124
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 196
IH+ANV HRDLKP N+L N C LKICDFGLARVA D T F T+YVATRWYRAPE+
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256
+ YT +IDIWS+GCI AE+L+ +P+FPGK+ + QL+ + +LG+PS + ++ + N
Sbjct: 185 LNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316
KAR YL S+ K V +++ FPNAD AL LL+++L F+P R E+ALA PY +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
Query: 317 VEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQL 358
EP + +F+ E + KE ++ELIF E + P
Sbjct: 304 PSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETARFQPGY 343
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 280 bits (716), Expect = 8e-90
Identities = 138/346 (39%), Positives = 211/346 (60%), Gaps = 12/346 (3%)
Query: 12 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLL 71
+ + RY+ +G G+YG VC+A DT TG +VA+KK+ F+ I A R RE++LL
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 72 RLLRHPDIVEIKHIMLPP-SRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQL 130
+ ++H +++ + + P S +F D+Y+V LM +DL+ ++K LT +H QF +YQ+
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQI 130
Query: 131 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 190
LR LKYIH+A++ HRDLKP N+ N +C+LKI DFGLAR T T YVATRWY
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMTGYVATRWY 184
Query: 191 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250
RAPE+ + + Y +DIWS+GCI AE+LTG+ LFPG + + QL L+ L+GTP + +
Sbjct: 185 RAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 310
++ ++ AR Y+ S+ + + F+ F A+P A+ LLE++L D R TA +ALA Y
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303
Query: 311 FKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 356
F + EP P + FE R + ++ + L + E++ + P
Sbjct: 304 FAQYHDPDDEPVADPY---DQSFESRDLLIDEWKSLTYDEVISFVP 346
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 277 bits (710), Expect = 6e-89
Identities = 134/340 (39%), Positives = 210/340 (61%), Gaps = 12/340 (3%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
+ Y+ + +G G+YG VCSA+D TG KVAIKK++ F+ A R RE++LL+ +RH
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 78 DIVEIKHIMLPP-SRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 136
+++ + + P + DF D Y+V M +DL +++K ++ L + QF +YQ+L+ L+Y
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRY 136
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 196
IH A + HRDLKP N+ N +C+LKI DFGLAR A ++ T YV TRWYRAPE+
Sbjct: 137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM------TGYVVTRWYRAPEVI 190
Query: 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256
+ + +YT +DIWS+GCI AE++TGK LF G + + QL + + GTP + + R+++D
Sbjct: 191 LN-WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249
Query: 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316
+A+ Y+ + + + F+ NA P A+ LLE++L D + R TA EALA PYF+ L
Sbjct: 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309
Query: 317 VEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 356
E EP Q + F+ T ++ + + ++E+L + P
Sbjct: 310 TEDEPQVQKY---DDSFDDVDRTLDEWKRVTYKEVLSFKP 346
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (635), Expect = 8e-78
Identities = 118/354 (33%), Positives = 192/354 (54%), Gaps = 23/354 (6%)
Query: 12 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLL 71
S + RY+ + IG G+ G+VC+A D VAIKK+ F++ + A R RE+ L+
Sbjct: 11 STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70
Query: 72 RLLRHPDIVEIKHIMLPPSR-RDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQL 130
+ + H +I+ + ++ P +F+D+Y+V ELM+++L QVI+ D E + LYQ+
Sbjct: 71 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYLLYQM 128
Query: 131 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 190
L +K++H+A + HRDLKP NI+ ++C LKI DFGLAR A T YV TR+Y
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----TPYVVTRYY 184
Query: 191 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250
RAPE+ Y +DIWS+GCI E++ K LFPG++ + Q + + + LGTP + +
Sbjct: 185 RAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242
Query: 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNA------------DPSALRLLERLLAFDPKD 298
++ R Y+ + K + F + FP++ A LL ++L DP
Sbjct: 243 KKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 299 RPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREIL 352
R + ++AL PY + P + + + R T E+ +ELI++E++
Sbjct: 302 RISVDDALQHPYINVWYDPAEVEAPPP-QIYDKQLDEREHTIEEWKELIYKEVM 354
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (627), Expect = 4e-77
Identities = 104/301 (34%), Positives = 152/301 (50%), Gaps = 7/301 (2%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
S+Y+ IG+G++G V A TG+KVA+KK+ E LREIK+L+LL+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 78 DIVEIKHIML---PPSRRDFKDIYVVFELMESDLHQV-IKANDDLTREHYQFFLYQLLRA 133
++V + I P R IY+VF+ E DL + T + + LL
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR-VAFNDTPTTIFWTDYVATRWYRA 192
L YIH + HRD+K N+L + LK+ DFGLAR + +T+ V T WYR
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 193 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252
PEL Y P ID+W GCI AE+ T P+ G HQL L++ L G+ + +
Sbjct: 190 PELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 253 VRNDKARRYLTSMR-KKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311
V N + L ++ +K+ V+ K DP AL L+++LL DP R +++AL +F
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308
Query: 312 K 312
Sbjct: 309 W 309
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (617), Expect = 3e-75
Identities = 101/330 (30%), Positives = 165/330 (50%), Gaps = 19/330 (5%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
Y +VIG GS+GVV A +GE VAIKK+ D RE++++R L H +
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRKLDHCN 74
Query: 79 IVEIKHIMLPP-SRRDFKDIYVVFELMESDLHQVI----KANDDLTREHYQFFLYQLLRA 133
IV +++ ++D + +V + + +++V +A L + + ++YQL R+
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 134 LKYIHTANVYHRDLKPKNILANANCKL-KICDFGLARVAFNDTPTTIFWTDYVATRWYRA 192
L YIH+ + HRD+KP+N+L + + + K+CDFG A+ P Y+ +R+YRA
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP----NVSYICSRYYRA 190
Query: 193 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252
PEL YT +ID+WS GC+ AE+L G+P+FPG + V QL + +LGTP+ + I
Sbjct: 191 PELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312
+ + ++ + P P A+ L RLL + P R T EA A +F
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKV--FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307
Query: 313 GLSKVEREPSCQPISKMEFEFERRRVTKED 342
L + + F F + ++
Sbjct: 308 ELRDPNVKLPNGRDTPALFNFTTQELSSNP 337
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (601), Expect = 3e-73
Identities = 64/310 (20%), Positives = 121/310 (39%), Gaps = 28/310 (9%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
++ +G G+ GVV +G +A K IH + + +I+RE+++L P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRNQIIRELQVLHECNSPY 65
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI 137
IV +I + E M+ L QV+K + + +++ L Y+
Sbjct: 66 IVGFYGAF-----YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 138 HTAN-VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 196
+ + HRD+KP NIL N+ ++K+CDFG++ + + +V TR Y +PE
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERL 175
Query: 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256
+ Y+ DIWS+G E+ G+ P + + + + +T R R
Sbjct: 176 --QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 257 KARRYLTSMRKKQPVQFSQKFPNA-------------DPSALRLLERLLAFDPKDRPTAE 303
M + P+ + + + L +P +R +
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 304 EALADPYFKG 313
+ + + K
Sbjct: 294 QLMVHAFIKR 303
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (592), Expect = 3e-72
Identities = 111/300 (37%), Positives = 164/300 (54%), Gaps = 13/300 (4%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
++ E IG+G+YGVV A + TGE VA+KKI E + +REI LL+ L HP+
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKY 136
IV++ ++ +Y+VFE + DL + + A+ + + +L+QLL+ L +
Sbjct: 63 IVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 196
H+ V HRDLKP+N+L N +K+ DFGLAR +T V T WYRAPE+
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEIL 174
Query: 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256
Y+ A+DIWS+GCIFAE++T + LFPG + + QL + LGTP D +
Sbjct: 175 LG-CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP--DEVVWPGVT 231
Query: 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316
Y S K FS+ P D LL ++L +DP R +A+ ALA P+F+ ++K
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 3e-72
Identities = 97/306 (31%), Positives = 152/306 (49%), Gaps = 16/306 (5%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHT-GEKVAIKKIHDIFEHISDAARILREIKLLRLL--- 74
+Y+ IG+G+YG V A D G VA+K++ +RE+ +LR L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 75 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLR 132
HP++V + + + +VFE ++ DL + + + E + ++QLLR
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 192
L ++H+ V HRDLKP+NIL ++ ++K+ DFGLAR+ T V T WYRA
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA----LTSVVVTLWYRA 183
Query: 193 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252
PE+ S Y +D+WS+GCIFAE+ KPLF G + V QL + D++G P + R
Sbjct: 184 PEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312
+ + K + + D LL + L F+P R +A AL+ PYF+
Sbjct: 242 DVALPRQAF----HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
Query: 313 GLSKVE 318
L + +
Sbjct: 298 DLERCK 303
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 7e-72
Identities = 98/305 (32%), Positives = 150/305 (49%), Gaps = 18/305 (5%)
Query: 24 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA---RILREIKLLRLLRHPDIV 80
+ +G+G + V A D +T + VAIKKI + LREIKLL+ L HP+I+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 81 EIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFLYQLLRALKYIHT 139
+ +I +VF+ ME+D + + LT H + ++ L+ L+Y+H
Sbjct: 64 GLLDAF-----GHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 140 ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF 199
+ HRDLKP N+L + N LK+ DFGLA+ + +T V TRWYRAPEL
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA---YTHQVVTRWYRAPELL-FG 174
Query: 200 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKAR 259
Y +D+W++GCI AE+L P PG + + QL + + LGTP+ + + +
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 260 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVER 319
+ + + F A L L++ L F+P R TA +AL YF ++
Sbjct: 235 ---VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS--NRPGP 289
Query: 320 EPSCQ 324
P CQ
Sbjct: 290 TPGCQ 294
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 226 bits (576), Expect = 5e-70
Identities = 106/295 (35%), Positives = 155/295 (52%), Gaps = 13/295 (4%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
+Y E IG+G+YGVV A + + GE A+KKI E + +REI +L+ L+H +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 137
IV++ ++ K + +VFE + + + L + FL QLL + Y
Sbjct: 62 IVKLYDVI-----HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
H V HRDLKP+N+L N +LKI DFGLAR +T + T WYRAP++
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK---YTHEIVTLWYRAPDVLM 173
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257
KY+ IDIWS+GCIFAE++ G PLFPG + QL + +LGTP+ V +
Sbjct: 174 G-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT--E 230
Query: 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312
+Y + +P+ + D S + LL ++L DP R TA++AL YFK
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (570), Expect = 4e-69
Identities = 104/297 (35%), Positives = 148/297 (49%), Gaps = 11/297 (3%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
+Y+ E IG+G+YG V A + T E VA+K++ + + LREI LL+ L+H +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 138
IV + ++ D K V + N DL E + FL+QLL+ L + H
Sbjct: 63 IVRLHDVL----HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 139 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 198
+ NV HRDLKP+N+L N N +LK+ +FGLAR + V T WYR P++
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY---SAEVVTLWYRPPDVLFG 175
Query: 199 FFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257
Y+ +ID+WS GCIFAE+ PLFPG +V QL + LLGTP+ + + K
Sbjct: 176 -AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM--TK 232
Query: 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314
Y P + + LL+ LL +P R +AEEAL PYF
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 3e-68
Identities = 67/295 (22%), Positives = 118/295 (40%), Gaps = 37/295 (12%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
+ + + +G+G+YG V A++ T E VA+K + D+ + I +EI + ++L H +
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHEN 64
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMESDLH-QVIKANDDLTREHYQFFLYQLLRALKYI 137
+V+ + Y+ E I+ + + Q F +QL+ + Y+
Sbjct: 65 VVKFYGHRREGNI-----QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
H + HRD+KP+N+L + LKI DFGLA V F T Y APEL
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257
+ +D+WS G + +L G+ + + Q
Sbjct: 179 R-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--------------------- 216
Query: 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312
K+ + + D + L LL ++L +P R T + D ++
Sbjct: 217 -------SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 3e-68
Identities = 70/294 (23%), Positives = 125/294 (42%), Gaps = 40/294 (13%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
+Y E IG+G+ G V +A+D TG++VAI++++ + I+ EI ++R ++P+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 138
IV +++VV E + + + + L+AL+++H
Sbjct: 79 IVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 139 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 198
+ V HRD+K NIL + +K+ DFG + + V T ++ APE+
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTR 190
Query: 199 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 258
Y P +DIWS+G + E++ G+P + +N + L
Sbjct: 191 --KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL----------------------- 225
Query: 259 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312
YL + +Q +K L R L D + R +A+E L + K
Sbjct: 226 --YLIATNGTPELQNPEKLS---AIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 221 bits (563), Expect = 9e-68
Identities = 79/327 (24%), Positives = 138/327 (42%), Gaps = 43/327 (13%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
Y ++V+G G++ V A D T + VAIK I + EI +L ++HP+
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPN 68
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYI 137
IV + I +Y++ +L+ +L I T ++Q+L A+KY+
Sbjct: 69 IVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 123
Query: 138 HTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 194
H + HRDLKP+N+L + + K+ I DFGL+++ + + T Y APE
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS----TACGTPGYVAPE 179
Query: 195 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254
+ Y+ A+D WSIG I +L G P F +N +
Sbjct: 180 VLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE------------------ 219
Query: 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314
+ K + S + + SA + L+ DP+ R T E+AL P+ G
Sbjct: 220 ---------QILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270
Query: 315 SKVEREPSCQPISKMEFEFERRRVTKE 341
+ +++ +++ F + + +
Sbjct: 271 TALDKNIHQSVSEQIKKNFAKSKWKQA 297
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 220 bits (562), Expect = 2e-67
Identities = 93/314 (29%), Positives = 159/314 (50%), Gaps = 26/314 (8%)
Query: 13 EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLR 72
E+G+ Y++ +G+G Y V AI+ EKV +K + + + +I REIK+L
Sbjct: 30 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILE 84
Query: 73 LLR-HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQL 130
LR P+I+ + I+ P R +VFE + +D Q+ + LT +F++Y++
Sbjct: 85 NLRGGPNIITLADIVKDPVSRT---PALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEI 138
Query: 131 LRALKYIHTANVYHRDLKPKNIL-ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 189
L+AL Y H+ + HRD+KP N++ + + KL++ D+GLA + VA+R+
Sbjct: 139 LKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE----YNVRVASRY 194
Query: 190 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLMTDLLGTPSLD 248
++ PEL + Y ++D+WS+GC+ A ++ K P F G + QL + +LGT L
Sbjct: 195 FKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253
Query: 249 TISRVRNDKARRYLTSMRKKQPVQFSQKF------PNADPSALRLLERLLAFDPKDRPTA 302
N + + + + ++F P AL L++LL +D + R TA
Sbjct: 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313
Query: 303 EEALADPYFKGLSK 316
EA+ PYF + K
Sbjct: 314 REAMEHPYFYTVVK 327
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 6e-67
Identities = 72/333 (21%), Positives = 145/333 (43%), Gaps = 48/333 (14%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
+Y I E +G+G +G+V ++T + + K + +D + +EI +L + RH +
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRN 62
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND-DLTREHYQFFLYQLLRALKY 136
I+ + +++ ++FE + D+ + I + +L +++Q+ AL++
Sbjct: 63 ILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117
Query: 137 IHTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 194
+H+ N+ H D++P+NI+ + +KI +FG AR + +T Y APE
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT----APEYYAPE 173
Query: 195 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254
+ + A D+WS+G + +L+G F + ++ + + T
Sbjct: 174 VHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD-------- 223
Query: 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314
+ F A+ ++RLL + K R TA EAL P+ K
Sbjct: 224 -------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK-- 262
Query: 315 SKVEREPSCQPISKMEFEFERRRVTKEDIRELI 347
K+ER S + I ++ + K+D+ ++
Sbjct: 263 QKIER-VSTKVIRTLKHRRYYHTLIKKDLNMVV 294
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 218 bits (556), Expect = 8e-67
Identities = 77/352 (21%), Positives = 136/352 (38%), Gaps = 52/352 (14%)
Query: 6 PEM-EFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAAR 63
P++ E F + + IG GS+G V A D E VAIKK+ +
Sbjct: 2 PDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 64 ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREH 122
I++E++ L+ LRHP+ ++ + L ++V E S + L
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKKPLQEVE 116
Query: 123 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 182
+ L+ L Y+H+ N+ HRD+K NIL + +K+ DFG A +
Sbjct: 117 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------N 169
Query: 183 DYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 241
+V T ++ APE + +Y +D+WS+G E+ KP N + L +
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--- 226
Query: 242 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT 301
+ + P S + ++ L P+DRPT
Sbjct: 227 -----------------------AQNESPALQSGHWS---EYFRNFVDSCLQKIPQDRPT 260
Query: 302 AEEALADPYFKGLSKVEREPS-CQPISKMEFEF--ERRRVTKEDIRELIFRE 350
+E L + ER P+ + + + E + +++++F+E
Sbjct: 261 SEVLLKHRFVLR----ERPPTVIMDLIQRTKDAVRELDNLQYRKMKKILFQE 308
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 216 bits (551), Expect = 2e-66
Identities = 74/307 (24%), Positives = 126/307 (41%), Gaps = 49/307 (15%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA-------ARILREIKLL 71
Y+ +E++G+G VV I T ++ A+K I A L+E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 72 RLLR-HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQ 129
R + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 64 RKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 118
Query: 130 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 189
LL + +H N+ HRDLKP+NIL + + +K+ DFG + + T
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL----REVCGTPS 174
Query: 190 YRAPELC----GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 245
Y APE+ Y +D+WS G I +L G P F + + L +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM-------- 226
Query: 246 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 305
+ S ++ + + L+ R L P+ R TAEEA
Sbjct: 227 -------------------IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
Query: 306 LADPYFK 312
LA P+F+
Sbjct: 268 LAHPFFQ 274
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 218 bits (556), Expect = 3e-66
Identities = 72/335 (21%), Positives = 127/335 (37%), Gaps = 47/335 (14%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
Y I E +G G++GVV + TG A K + H SD + +EI+ + +LRHP
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHPT 84
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVI-KANDDLTREHYQFFLYQLLRALKY 136
+V + D ++ +++E M +L + + ++ ++ + ++ Q+ + L +
Sbjct: 85 LVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 139
Query: 137 IHTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 194
+H N H DLKP+NI+ + +LK+ DFGL T + APE
Sbjct: 140 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV----KVTTGTAEFAAPE 195
Query: 195 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254
+ D+WS+G + +L+G F G+N L +
Sbjct: 196 VA--EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD-------- 245
Query: 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314
F + +LL DP R T +AL P+
Sbjct: 246 -------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286
Query: 315 SKVERE---PSCQPISKMEFEFERRRVTKEDIREL 346
+ R+ PS + + + E + L
Sbjct: 287 NAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPL 321
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 6e-66
Identities = 68/298 (22%), Positives = 117/298 (39%), Gaps = 45/298 (15%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRH 76
++I +GKG +G V A + + +A+K + E ++ RE+++ LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALK 135
P+I+ + D +Y++ E +++ ++ + ++ +L AL
Sbjct: 66 PNILRLYGYF-----HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 120
Query: 136 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 195
Y H+ V HRD+KP+N+L + +LKI DFG + A + TT T Y PE+
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDYLPPEM 175
Query: 196 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255
+ +D+WS+G + E L GKP F ++ + T
Sbjct: 176 IEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--------- 224
Query: 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313
A L+ RLL +P RP E L P+
Sbjct: 225 ----------------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 3e-65
Identities = 84/350 (24%), Positives = 141/350 (40%), Gaps = 46/350 (13%)
Query: 19 RYKI-QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIK-LLRLLRH 76
YK+ +V+G G G V + T EK A+K + D + RE++ R +
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQC 64
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLRA 133
P IV I + K + +V E ++ +L I+ D T + + A
Sbjct: 65 PHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 134 LKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 190
++Y+H+ N+ HRD+KP+N+L N LK+ DFG A+ + T T +Y
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY----TPYY 179
Query: 191 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250
APE+ G KY + D+WS+G I +L G P F + + M
Sbjct: 180 VAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------------ 225
Query: 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 310
T +R Q + ++ L+ LL +P R T E + P+
Sbjct: 226 -----------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 274
Query: 311 FKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLK 360
+KV + P ++ + ER KE++ + ++Y +K
Sbjct: 275 IMQSTKVPQTPLHTSRV-LKEDKERWEDVKEEMTSALATMRVDYEQIKIK 323
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 3e-65
Identities = 61/300 (20%), Positives = 106/300 (35%), Gaps = 43/300 (14%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
++I +G G++G V A + T A K I + + + EI +L HP+
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYMVEIDILASCDHPN 70
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVI--KANDDLTREHYQFFLYQLLRALKY 136
IV++ +++++ E + + LT Q Q L AL Y
Sbjct: 71 IVKLLDAF-----YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNY 125
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 196
+H + HRDLK NIL + +K+ DFG++ ++ T ++ APE+
Sbjct: 126 LHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR---DSFIGTPYWMAPEVV 182
Query: 197 GSFFSK---YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253
SK Y D+WS+G E+ +P N + L +
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-------------- 228
Query: 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313
K + + L++ L + R T + L P+
Sbjct: 229 --------------KSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 215 bits (549), Expect = 4e-65
Identities = 74/336 (22%), Positives = 130/336 (38%), Gaps = 45/336 (13%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
Y I E +G G++GVV ++ TG K I+ + D + EI ++ L HP
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHPK 87
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD-LTREHYQFFLYQLLRALKY 136
++ + D ++ ++ E + +L I A D ++ ++ Q LK+
Sbjct: 88 LINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 142
Query: 137 IHTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 194
+H ++ H D+KP+NI+ +KI DFGLA D AT + APE
Sbjct: 143 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV----KVTTATAEFAAPE 198
Query: 195 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254
+ D+W+IG + +L+G F G++ + L + D
Sbjct: 199 IVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED------ 250
Query: 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG- 313
F + P A ++ LL +P+ R T +AL P+ KG
Sbjct: 251 ---------------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289
Query: 314 LSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFR 349
S + +K+ + + + + I R
Sbjct: 290 HSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGR 325
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 2e-64
Identities = 68/297 (22%), Positives = 120/297 (40%), Gaps = 41/297 (13%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 79
K IG+GS+ V +DT T +VA ++ D S+ R E ++L+ L+HP+I
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 80 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIH 138
V + K I +V ELM S L +K + + + + Q+L+ L+++H
Sbjct: 71 VRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 139 TAN--VYHRDLKPKNIL-ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 195
T + HRDLK NI +KI D GLA + + + T + APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-----IGTPEFMAPEM 184
Query: 196 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255
+ KY ++D+++ G E+ T + + Q+
Sbjct: 185 ---YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-------------------- 221
Query: 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312
Y +P F A P ++E + + +R + ++ L +F+
Sbjct: 222 -----YRRVTSGVKPASFD---KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 4e-64
Identities = 82/304 (26%), Positives = 122/304 (40%), Gaps = 48/304 (15%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 76
A Y++ IG GSYG G+ + K++ ++ ++ E+ LLR L+H
Sbjct: 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 62
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD----LTREHYQFFLYQLL 131
P+IV ++ R +Y+V E E DL VI L E + QL
Sbjct: 63 PNIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119
Query: 132 RALKYIH-----TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA 186
ALK H V HRDLKP N+ + +K+ DFGLAR+ +DT +V
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA---KAFVG 176
Query: 187 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 246
T +Y +PE Y DIWS+GC+ E+ P F +
Sbjct: 177 TPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG---------- 224
Query: 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 306
++R K RR P ++S ++ R+L RP+ EE L
Sbjct: 225 -----KIREGKFRRI--------PYRYS-------DELNEIITRMLNLKDYHRPSVEEIL 264
Query: 307 ADPY 310
+P
Sbjct: 265 ENPL 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 3e-62
Identities = 73/305 (23%), Positives = 127/305 (41%), Gaps = 47/305 (15%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 77
+K +++G+GS+ V A + T + AIK + + + RE ++ L HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKY 136
V++ +D + +Y + +L + I+ +F+ +++ AL+Y
Sbjct: 69 FFVKLYFTF-----QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 196
+H + HRDLKP+NIL N + ++I DFG A+V ++ +V T Y +PEL
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA-RANSFVGTAQYVSPELL 182
Query: 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256
+ D+W++GCI +++ G P F N +
Sbjct: 183 TE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI------------------ 222
Query: 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA------LADPY 310
K F +KF P A L+E+LL D R EE A P+
Sbjct: 223 ----------IKLEYDFPEKFF---PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
Query: 311 FKGLS 315
F+ ++
Sbjct: 270 FESVT 274
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 1e-59
Identities = 60/295 (20%), Positives = 106/295 (35%), Gaps = 38/295 (12%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
+ + + IG GS+G V VA+K ++ E+ +LR R
Sbjct: 6 PDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD-LTREHYQFFLYQLLRA 133
H +I+ + +V + E S L+ + + Q +
Sbjct: 63 HVNILLFMGYS------TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 193
+ Y+H ++ HRDLK NI + + +KI DFGLA V + + F + + AP
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMAP 175
Query: 194 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252
E + + Y+ D+++ G + E++TG+ + N Q+ M
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV------------- 222
Query: 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
R S+ N + RL+ L +RP + LA
Sbjct: 223 ------------GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 6e-59
Identities = 73/304 (24%), Positives = 118/304 (38%), Gaps = 47/304 (15%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAARILREIKLLRLL 74
Y E +G G + VV + TG + A K I I RE+ +L+ +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 75 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFLYQLLRA 133
+HP+++ + + + D+ ++ EL+ L + + LT E FL Q+L
Sbjct: 71 QHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 134 LKYIHTANVYHRDLKPKNILAN----ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 189
+ Y+H+ + H DLKP+NI+ ++KI DFGLA + T
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPE 181
Query: 190 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 249
+ APE+ D+WSIG I +L+G F G L ++ +
Sbjct: 182 FVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE--- 236
Query: 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 309
+ F N A + RLL DPK R T +++L P
Sbjct: 237 ------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 272
Query: 310 YFKG 313
+ K
Sbjct: 273 WIKP 276
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 194 bits (494), Expect = 4e-58
Identities = 71/293 (24%), Positives = 118/293 (40%), Gaps = 33/293 (11%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 77
RY++ E++G G V A D VA+K + D+ S R RE + L HP
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 78 DIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKY 136
IV + + Y+V E ++ L ++ +T + + +AL +
Sbjct: 68 AIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 137 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 196
H + HRD+KP NI+ +A +K+ DFG+AR + + + T Y +PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 197 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256
D++S+GC+ EVLTG+P F G + V
Sbjct: 187 RG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV----------------- 227
Query: 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-TAEEALAD 308
++ P+ S + ++ + LA +P++R TA E AD
Sbjct: 228 ----------REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 1e-57
Identities = 69/307 (22%), Positives = 119/307 (38%), Gaps = 57/307 (18%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAARILREIKLLR 72
S+Y++ ++G G +G V S I VAIK + + + + R+ E+ LL+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 73 LLR--HPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLY 128
+ ++ + P ++ E E DL I L E + F +
Sbjct: 63 KVSSGFSGVIRLLDWFERPDS-----FVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 129 QLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARVAFNDTPTTIFWTDYVAT 187
Q+L A+++ H V HRD+K +NIL + N +LK+ DFG + + +TD+ T
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGT 172
Query: 188 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247
R Y PE + + + +WS+G + +++ G F +
Sbjct: 173 RVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------------- 216
Query: 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
+ V F Q+ L+ LA P DRPT EE
Sbjct: 217 -------------------IRGQVFFRQRVS---SECQHLIRWCLALRPSDRPTFEEIQN 254
Query: 308 DPYFKGL 314
P+ + +
Sbjct: 255 HPWMQDV 261
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-56
Identities = 61/300 (20%), Positives = 116/300 (38%), Gaps = 45/300 (15%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLL-RLLRH 76
+ + +++GKGS+G V A T + AIK + D+ D + E ++L H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALK 135
P + + + ++++ V E + DL I++ F+ +++ L+
Sbjct: 63 PFLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 117
Query: 136 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 195
++H+ + +RDLK NIL + + +KI DFG+ + + T Y APE+
Sbjct: 118 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPEI 174
Query: 196 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255
KY ++D WS G + E+L G+ F G++
Sbjct: 175 LLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH------------------- 213
Query: 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE-EALADPYFKGL 314
+ + + A LL +L +P+ R + P F+ +
Sbjct: 214 ---------SIRMDNPFYPRWLE---KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 1e-55
Identities = 68/302 (22%), Positives = 129/302 (42%), Gaps = 48/302 (15%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPD 78
+ +++GKG++G V + TG A+K + ++ + A + E ++L+ RHP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFLYQLLRALKYI 137
+ +K+ R + V E L + T E +F+ +++ AL+Y+
Sbjct: 67 LTALKYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
H+ +V +RD+K +N++ + + +KI DFGL + +D T + T Y APE+
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF---CGTPEYLAPEVLE 178
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257
+ Y A+D W +G + E++ G+ F ++ +L+
Sbjct: 179 D--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------------------- 217
Query: 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFK 312
+ ++F + P A LL LL DPK R A+E + +F
Sbjct: 218 ---------LMEEIRFPRTLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
Query: 313 GL 314
+
Sbjct: 266 SI 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 184 bits (469), Expect = 2e-53
Identities = 67/306 (21%), Positives = 116/306 (37%), Gaps = 49/306 (16%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAARILREIKLLRLL 74
+ + +IG+G +G V TG+ A+K + + + + A + L+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 75 RHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRA 133
P IV + + P + + + +LM DLH + + + +F+ +++
Sbjct: 65 DCPFIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 119
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 193
L+++H V +RDLKP NIL + + ++I D GLA P T Y AP
Sbjct: 120 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG-----THGYMAP 174
Query: 194 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253
E+ Y + D +S+GC+ ++L G F + ++
Sbjct: 175 EVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--------------- 218
Query: 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALAD 308
M V+ F P LLE LL D R A+E
Sbjct: 219 ----------RMTLTMAVELPDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265
Query: 309 PYFKGL 314
P+F+ L
Sbjct: 266 PFFRSL 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 181 bits (460), Expect = 9e-53
Identities = 80/359 (22%), Positives = 145/359 (40%), Gaps = 64/359 (17%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPD 78
++I +G GS+G V H G A+K + +I + E +L ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYI 137
I+ + +D + I+++ + +E +L +++ + +F+ ++ AL+Y+
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 138 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 197
H+ ++ +RDLKP+NIL + N +KI DFG A+ + T Y APE+
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPDYIAPEVVS 174
Query: 198 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257
+ Y +ID WS G + E+L G F N + + +
Sbjct: 175 T--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------------------- 213
Query: 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALADPYFK 312
++F F LL RL+ D R E+ P+FK
Sbjct: 214 ---------LNAELRFPPFFN---EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261
Query: 313 G------LSKVEREPSCQPISKMEF---EFERRRVTKEDIRELIFREILEYHPQLLKDY 362
LS+ P PI + + +F++ +EDI + E + + L +D+
Sbjct: 262 EVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKY--PEEDINYGVQGE--DPYADLFRDF 316
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 1e-51
Identities = 62/295 (21%), Positives = 115/295 (38%), Gaps = 52/295 (17%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
+ K+ + IGKG +G V + G KVA+K I + + A L E ++ LR
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND----ATAQAFLAEASVMTQLR 58
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD--LTREHYQFFLYQLLR 132
H ++V++ +++ + +Y+V E M L +++ L + F +
Sbjct: 59 HSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 192
A++Y+ N HRDL +N+L + + K+ DFGL + A + T + A
Sbjct: 115 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTA 168
Query: 193 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251
PE K++ D+WS G + E+ + G+ +P + D +
Sbjct: 169 PEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---------------DVVP 211
Query: 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 306
RV + P P+ +++ D RP+ +
Sbjct: 212 RVEKGY--------KMDAP-------DGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 3e-50
Identities = 57/309 (18%), Positives = 116/309 (37%), Gaps = 46/309 (14%)
Query: 16 DASRYKIQE-VIGKGSYGVVCSAI--DTHTGEKVAIKKIHDIFEHISDAARILREIKLLR 72
D +++ +G G++G V + VA+K + + + +L E +++
Sbjct: 4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 63
Query: 73 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLL 131
L +P IV + I + + +V E+ E L++ ++ N + ++ ++Q+
Sbjct: 64 QLDNPYIVRMIGIC------EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 117
Query: 132 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 191
+KY+ +N HRDL +N+L KI DFGL++ D T +
Sbjct: 118 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 192 APELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250
APE K++ D+WS G + E + G+ + G +
Sbjct: 178 APECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM------------- 222
Query: 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE---ALA 307
+ K + + P L+ +D ++RP L
Sbjct: 223 --------------LEKGERMGCPAGCP---REMYDLMNLCWTYDVENRPGFAAVELRLR 265
Query: 308 DPYFKGLSK 316
+ Y+ +++
Sbjct: 266 NYYYDVVNE 274
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 5e-50
Identities = 59/308 (19%), Positives = 124/308 (40%), Gaps = 46/308 (14%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKIH--DIFEHISDAARILREIKLLRL 73
+++ +V+G G+YG V TG+ A+K + I + E ++L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 74 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLR 132
+R + + L + + ++++ + + +L + + T Q ++ +++
Sbjct: 85 IRQSPFL----VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 140
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 192
AL+++H + +RD+K +NIL ++N + + DFGL++ F T + +
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFVADETERAYDFCGTIEYMAP 199
Query: 193 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252
+ G S + A+D WS+G + E+LTG F + +
Sbjct: 200 DIVRGG-DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-------------- 244
Query: 253 VRNDKARRYLTSMRKKQPVQFSQKFP-NADPSALRLLERLLAFDPKDRP-----TAEEAL 306
++ ++ +P A L++RLL DPK R A+E
Sbjct: 245 --------------SRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290
Query: 307 ADPYFKGL 314
+F+ +
Sbjct: 291 EHLFFQKI 298
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-49
Identities = 70/316 (22%), Positives = 113/316 (35%), Gaps = 55/316 (17%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
+++ +G+G +G V T VAIK + L+E ++++ LR
Sbjct: 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKLR 70
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELME---SDLHQVIKANDDLTREHYQFFLYQLLR 132
H +V++ ++ + IY+V E M + L Q+
Sbjct: 71 HEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 192
+ Y+ N HRDL+ NIL N K+ DFGLAR+ ++ T + A
Sbjct: 125 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR--QGAKFPIKWTA 182
Query: 193 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251
PE ++T D+WS G + E+ T G+ +PG LD + P
Sbjct: 183 PEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 240
Query: 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA--DP 309
S L+ + +P++RPT E A +
Sbjct: 241 ------------------------------ESLHDLMCQCWRKEPEERPTFEYLQAFLED 270
Query: 310 YFKGLSKVEREPSCQP 325
YF EP QP
Sbjct: 271 YFTST-----EPQYQP 281
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (441), Expect = 1e-49
Identities = 57/317 (17%), Positives = 115/317 (36%), Gaps = 58/317 (18%)
Query: 3 QNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDA 61
QN+ +++ ++ + +G GS+G V +G A+K + +
Sbjct: 35 QNTAQLD---------QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI 85
Query: 62 ARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTRE 121
L E ++L+ + P +V+++ + + V+ + ++ ++ +
Sbjct: 86 EHTLNEKRILQAVNFPFLVKLEFSF----KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 122 HYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 181
H +F+ Q++ +Y+H+ ++ +RDLKP+N+L + +++ DFG A+ T T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGT 201
Query: 182 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 241
APE+ S Y A+D W++G + E+ G P F + +
Sbjct: 202 P------EALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE----- 248
Query: 242 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-- 299
V+F F LL LL D R
Sbjct: 249 -----------------------KIVSGKVRFPSHFS---SDLKDLLRNLLQVDLTKRFG 282
Query: 300 ---PTAEEALADPYFKG 313
+ +F
Sbjct: 283 NLKNGVNDIKNHKWFAT 299
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (437), Expect = 1e-49
Identities = 71/321 (22%), Positives = 122/321 (38%), Gaps = 51/321 (15%)
Query: 11 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAARILRE 67
F++ D S KI++VIG G +G VCS G++ VAIK + + L E
Sbjct: 19 FAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDFLSE 77
Query: 68 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD--LTREHYQF 125
++ HP+++ ++ ++ + + ++ E ME+ +D T
Sbjct: 78 ASIMGQFDHPNVIHLEGVVTKSTP-----VMIITEFMENGSLDSFLRQNDGQFTVIQLVG 132
Query: 126 FLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT--PTTIFWTD 183
L + +KY+ N HRDL +NIL N+N K+ DFGL+R +DT PT
Sbjct: 133 MLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 192
Query: 184 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLL 242
+ AP + K+T A D+WS G + EV++ G+ + ++ +
Sbjct: 193 GKIPIRWTAP--EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY 250
Query: 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 302
P + +L+ D RP
Sbjct: 251 RLPPPMDCP------------------------------SALHQLMLDCWQKDRNHRPKF 280
Query: 303 EEALADPYFKGLSKVEREPSC 323
+ + L K+ R P+
Sbjct: 281 GQIVNT-----LDKMIRNPNS 296
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (434), Expect = 2e-49
Identities = 53/305 (17%), Positives = 98/305 (32%), Gaps = 44/305 (14%)
Query: 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 78
RY++ IG GS+G + D GE+VAIK +H ++ E K+ ++++
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGV 63
Query: 79 IVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYI 137
+ + +V EL+ S + + + Q++ ++YI
Sbjct: 64 GIPTIRW----CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 138 HTANVYHRDLKPKNILAN---ANCKLKICDFGLARVAFNDTPTTIFW----TDYVATRWY 190
H+ N HRD+KP N L + I DFGLA+ + + T Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 191 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250
+ + + D+ S+G + G + G
Sbjct: 180 ASINTH--LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA------------------- 218
Query: 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE---EALA 307
K ++Y KK L + D+P +
Sbjct: 219 ----ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
Query: 308 DPYFK 312
+ + +
Sbjct: 275 NLFHR 279
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 3e-49
Identities = 67/304 (22%), Positives = 112/304 (36%), Gaps = 30/304 (9%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 76
A +QE IGKG +G V GE+VA+K + EI +LRH
Sbjct: 2 ARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRH 56
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALK 135
+I+ + + +++V + E L + +T E L
Sbjct: 57 ENILGFIAADNKDNG-TWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLA 114
Query: 136 YIHTA--------NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-IFWTDYVA 186
++H + HRDLK KNIL N I D GLA + T T I V
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 187 TRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 242
T+ Y APE+ + + DI+++G +F E+ + G + +QL +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233
Query: 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 302
PS++ + +V ++ R + + A +++ + R TA
Sbjct: 234 SDPSVEEMRKVVCEQKLRP--------NIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285
Query: 303 EEAL 306
Sbjct: 286 LRIK 289
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 170 bits (432), Expect = 5e-49
Identities = 47/298 (15%), Positives = 96/298 (32%), Gaps = 43/298 (14%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 76
YK+ IG+GS+GV+ + ++VAIK SDA ++ E + +LL
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLAG 59
Query: 77 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD-LTREHYQFFLYQLLRALK 135
+ + ++ +V +L+ L ++ + + Q+L ++
Sbjct: 60 CTGIPNVYYFG----QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115
Query: 136 YIHTANVYHRDLKPKNILANANC-----KLKICDFGLARVAFNDTPTTIFW----TDYVA 186
IH ++ +RD+KP N L + + DFG+ + + +
Sbjct: 116 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 187 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 246
T Y + + + D+ ++G +F L G + G
Sbjct: 176 TARYMSINTH--LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-------------- 219
Query: 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 304
++Y KKQ + + + P +
Sbjct: 220 ---------TNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDY 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-48
Identities = 64/309 (20%), Positives = 118/309 (38%), Gaps = 48/309 (15%)
Query: 19 RYKIQEV-IGKGSYGVVCSAIDTHTGEK--VAIKKIHDIFEHISDAARILREIKLLRLLR 75
I ++ +G G++G V + ++ VAIK + E +D ++RE +++ L
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLD 67
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRA 133
+P IV + + + + +V E+ LH+ + +++ + L+Q+
Sbjct: 68 NPYIVRLIGVC------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 193
+KY+ N HRDL +N+L KI DFGL++ D + + AP
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181
Query: 194 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252
E K++ D+WS G E L+ G+ + + ++
Sbjct: 182 ECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---------------GPEVMAF 224
Query: 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE---ALADP 309
+ K R + P P P L+ + +DRP +
Sbjct: 225 IEQGK--------RMECP-------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
Query: 310 YFKGLSKVE 318
Y+ SKVE
Sbjct: 270 YYSLASKVE 278
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 5e-48
Identities = 68/323 (21%), Positives = 124/323 (38%), Gaps = 69/323 (21%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGE-----KVAIKKIHDIFEHISDAARILREIKL 70
+ +V+G G++G V +A + +VA+K + + + S+ ++ E+K+
Sbjct: 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKM 93
Query: 71 L-RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD----------- 117
+ +L H +IV + IY++FE DL +++ +
Sbjct: 94 MTQLGSHENIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148
Query: 118 ------------LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 165
LT E F YQ+ + ++++ + HRDL +N+L +KICDF
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 208
Query: 166 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 224
GLAR +D+ + + APE F YT D+WS G + E+ + G
Sbjct: 209 GLARDIMSDSNYVVRGN-ARLPVKWMAPESL--FEGIYTIKSDVWSYGILLWEIFSLGVN 265
Query: 225 LFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSA 284
+PG V + ++N + QP A
Sbjct: 266 PYPGIPVDANFYKL--------------IQNGF--------KMDQP-------FYATEEI 296
Query: 285 LRLLERLLAFDPKDRPTAEEALA 307
+++ AFD + RP+ +
Sbjct: 297 YIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 169 bits (429), Expect = 6e-48
Identities = 66/340 (19%), Positives = 114/340 (33%), Gaps = 47/340 (13%)
Query: 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 77
+RY + +G G + V A D VA+K + EIKLL+ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDA 69
Query: 78 DIVE------------IKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQF 125
D + + H + + + + +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 126 FLYQLLRALKYIHTA-NVYHRDLKPKNILANAN------CKLKICDFGLARVAFNDTPTT 178
QLL L Y+H + H D+KP+N+L ++KI D G A
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---- 185
Query: 179 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV------V 232
+T+ + TR YR+PE+ + + DIWS C+ E++TG LF
Sbjct: 186 --YTNSIQTREYRSPEVL--LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241
Query: 233 HQLDLMTDLLGTPSLDTISRVRNDK----ARRYLTSMRKKQPVQFSQKF-------PNAD 281
+ + +LLG + + + +R L ++ K + +
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301
Query: 282 PSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREP 321
L +L DP+ R A + P+ K +E
Sbjct: 302 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR 341
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 7e-48
Identities = 56/296 (18%), Positives = 104/296 (35%), Gaps = 46/296 (15%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
D + +G G +GVV VAIK I E + E K++ L
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLS 57
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQLLRA 133
H +V++ + + I+++ E M L+ + + + + A
Sbjct: 58 HEKLVQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 112
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 193
++Y+ + HRDL +N L N +K+ DFGL+R +D T+ + P
Sbjct: 113 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS--SVGSKFPVRWSPP 170
Query: 194 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252
E+ SK++ DIW+ G + E+ + GK + + +
Sbjct: 171 EVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-------------- 214
Query: 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308
+R +P A ++ +RPT + L++
Sbjct: 215 ---------AQGLRLYRP-------HLASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 1e-47
Identities = 57/295 (19%), Positives = 105/295 (35%), Gaps = 44/295 (14%)
Query: 19 RYKIQEVIGKGSYGVVCSAI---DTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLL 74
++ E +G GS+GVV + VA+K + D+ +RE+ + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 75 RHPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQLLR 132
H +++ + ++L P + +V EL S L ++ K + Q+
Sbjct: 69 DHRNLIRLYGVVLTP------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 192
+ Y+ + HRDL +N+L +KI DFGL R + + + A
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 193 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251
PE + ++ A D W G E+ T G+ + G N +
Sbjct: 183 PESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---------------QILH 225
Query: 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 306
++ + R + + ++ + A P+DRPT
Sbjct: 226 KIDKEGER--------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 1e-47
Identities = 65/302 (21%), Positives = 111/302 (36%), Gaps = 50/302 (16%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
K+ E +G G +G V + KVA+K + + L E L++ L+
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQ 66
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDL---HQVIKANDDLTREHYQFFLYQLLR 132
H +V + ++ + IY++ E ME+ + LT Q+
Sbjct: 67 HQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 192
+ +I N HRDL+ NIL + KI DFGLAR+ ++ T + A
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA--REGAKFPIKWTA 178
Query: 193 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251
PE + +T D+WS G + E++T G+ +PG + +
Sbjct: 179 PEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER----------- 225
Query: 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA--DP 309
R +P N +L+ P+DRPT + + +
Sbjct: 226 ------------GYRMVRP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266
Query: 310 YF 311
+F
Sbjct: 267 FF 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (420), Expect = 2e-47
Identities = 56/292 (19%), Positives = 114/292 (39%), Gaps = 40/292 (13%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
+ + ++ +G G YG V + VA+K + E + L+E +++ ++
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIK 71
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALK 135
HP++V++ + ++ + + L + +++ + Q+ A++
Sbjct: 72 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAME 129
Query: 136 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 195
Y+ N HRDL +N L N +K+ DFGL+R+ DT T + APE
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA--HAGAKFPIKWTAPES 187
Query: 196 CGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254
+K++ D+W+ G + E+ T G +PG ++ +L
Sbjct: 188 LAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL----------------- 228
Query: 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 306
+ K ++ + P L+ ++P DRP+ E
Sbjct: 229 ----------LEKDYRMERPEGCP---EKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 7e-47
Identities = 67/294 (22%), Positives = 110/294 (37%), Gaps = 46/294 (15%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
D S + IG G +G+V +KVAIK I E + E +++ L
Sbjct: 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLS 58
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQLLRA 133
HP +V++ + L + I +VFE ME + E +
Sbjct: 59 HPKLVQLYGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 113
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 193
+ Y+ A V HRDL +N L N +K+ DFG+ R +D T+ T + +P
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT--KFPVKWASP 171
Query: 194 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252
E+ FS+Y+ D+WS G + EV + GK + ++ ++ +
Sbjct: 172 EVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-------------- 215
Query: 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 306
T R +P A +++ P+DRP L
Sbjct: 216 ---------STGFRLYKP-------RLASTHVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 4e-45
Identities = 61/298 (20%), Positives = 112/298 (37%), Gaps = 43/298 (14%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK----VAIKKIHDIFEHISDAARILREIKLL 71
S Q+VIG G +G V + + K VAIK + + L E ++
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIM 63
Query: 72 RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQ 129
H +I+ ++ ++ +K + ++ E ME + + + + + + L
Sbjct: 64 GQFSHHNIIRLEGVI-----SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 118
Query: 130 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 189
+ +KY+ N HRDL +NIL N+N K+ DFGL+RV +D T +
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 190 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 249
+ APE K+T A D+WS G + EV+T + H++
Sbjct: 179 WTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-------------- 222
Query: 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
M+ + + +L+ + + RP + ++
Sbjct: 223 ---------------MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 6e-45
Identities = 65/346 (18%), Positives = 123/346 (35%), Gaps = 58/346 (16%)
Query: 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLLR 72
+ +K +V+G G++G V + GE VAIK++ + ++ IL E ++
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMA 66
Query: 73 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLR 132
+ +P + + I L + + + L V + D++ ++ + Q+ +
Sbjct: 67 SVDNPHVCRLLGICLTSTVQ----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 122
Query: 133 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 192
+ Y+ + HRDL +N+L +KI DFGLA++ + A
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL-LGAEEKEYHAEGGKVPIKWMA 181
Query: 193 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251
E YT D+WS G E++T G + G ++
Sbjct: 182 LESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK----------- 228
Query: 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311
R QP P ++ + D RP E + +
Sbjct: 229 ------------GERLPQP-------PICTIDVYMIMVKCWMIDADSRPKFRELIIE--- 266
Query: 312 KGLSKVEREPSC----------QPISKMEFEFERRRVTKEDIRELI 347
SK+ R+P S + F R + +ED+ +++
Sbjct: 267 --FSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVV 310
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 1e-44
Identities = 71/299 (23%), Positives = 112/299 (37%), Gaps = 47/299 (15%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHT---GEKVAIKKIHDIFEHISDAARILREIKLLR 72
R ++ IG+G +G V I VAIK + S + L+E +R
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFLQEALTMR 63
Query: 73 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQL 130
HP IV++ ++ ++++ EL + L + YQL
Sbjct: 64 QFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 117
Query: 131 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 190
AL Y+ + HRD+ +N+L ++N +K+ DFGL+R + T + +
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA--SKGKLPIKW 175
Query: 191 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 249
APE ++T A D+W G E+L G F G D
Sbjct: 176 MAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---------------DV 218
Query: 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308
I R+ N + R P PN P+ L+ + A+DP RP E A
Sbjct: 219 IGRIENGE--------RLPMP-------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 4e-44
Identities = 65/313 (20%), Positives = 111/313 (35%), Gaps = 63/313 (20%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK--VAIKKIHDIFEHISDAARILREIKLL-R 72
D + K Q+VIG+G++G V A G + AIK++ + D E+++L +
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCK 66
Query: 73 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD-------------- 117
L HP+I+ + +Y+ E +L ++ +
Sbjct: 67 LGHHPNIINLLGACEHRGY-----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 118 --LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175
L+ + F + R + Y+ HRDL +NIL N KI DFGL+R
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
Query: 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQ 234
T+ + A E S YT D+WS G + E+++ G + G
Sbjct: 182 KKTMG----RLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 235
Query: 235 LDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 294
+ + R ++P N D L+ +
Sbjct: 236 YEKLPQ-----------------------GYRLEKP-------LNCDDEVYDLMRQCWRE 265
Query: 295 DPKDRPTAEEALA 307
P +RP+ + L
Sbjct: 266 KPYERPSFAQILV 278
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 1e-43
Identities = 66/317 (20%), Positives = 114/317 (35%), Gaps = 64/317 (20%)
Query: 16 DASRYKIQEVIGKGSYGVVCSA-----IDTHTGEKVAIKKIHDIFEHISDAARILREIKL 70
+R + +G G++G V A I + VA+K + H+++ ++ E+K+
Sbjct: 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMSELKV 79
Query: 71 L-RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD----------- 117
L L H +IV + V+ E DL ++ D
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGP-----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 118 -------LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170
L E F YQ+ + + ++ + N HRDL +NIL KICDFGLAR
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 229
ND+ + + +W + YT D+WS G E+ + G +PG
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFN---CVYTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 230 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLE 289
V + M +++ + + P +++
Sbjct: 252 PVDSKFYKM--------------------------IKEGFRMLSPEHAP---AEMYDIMK 282
Query: 290 RLLAFDPKDRPTAEEAL 306
DP RPT ++ +
Sbjct: 283 TCWDADPLKRPTFKQIV 299
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (393), Expect = 1e-43
Identities = 56/320 (17%), Positives = 105/320 (32%), Gaps = 70/320 (21%)
Query: 18 SRYKIQEVIGKGSYGVVCSA-----IDTHTGEKVAIKKIHDIFEHISDAARILREIKLLR 72
+ + IG+G++G V A + VA+K + + A RE L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMA 71
Query: 73 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD-------------- 117
+P+IV++ + + ++FE M DL++ +++
Sbjct: 72 EFDNPNIVKLLGVCAVGKP-----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 118 ----------LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 167
L+ Q+ + Y+ HRDL +N L N +KI DFGL
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 168 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLF 226
+R ++ D + RW + + +YT D+W+ G + E+ + G +
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYN---RYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 227 PGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALR 286
G + + R + + P
Sbjct: 244 YGMAHEEVIYYV---------------------------RDGNILACPENCP---LELYN 273
Query: 287 LLERLLAFDPKDRPTAEEAL 306
L+ + P DRP+
Sbjct: 274 LMRLCWSKLPADRPSFCSIH 293
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 1e-43
Identities = 60/296 (20%), Positives = 107/296 (36%), Gaps = 44/296 (14%)
Query: 19 RYKIQEVIGKGSYGVVCSAID---THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 75
EVIG+G +G V A+K ++ I I + ++ L E +++
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFS 86
Query: 76 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQ--FFLYQLLRA 133
HP+++ + I L R VV M+ + N+ F Q+ +
Sbjct: 87 HPNVLSLLGICL----RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 142
Query: 134 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR-VAFNDTPTTIFWTDYVATRWYRA 192
+K++ + HRDL +N + + +K+ DFGLAR + + + T + A
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 193 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251
E + K+T D+WS G + E++T G P +P N
Sbjct: 203 LESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------------------- 241
Query: 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307
D L R QP ++ + + RP+ E ++
Sbjct: 242 ----DITVYLLQGRRLLQP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 9e-42
Identities = 53/323 (16%), Positives = 109/323 (33%), Gaps = 62/323 (19%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKL 70
+ + +G+GS+G+V + +VAIK +++ + L E +
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASV 76
Query: 71 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD----------LT 119
++ +V + ++ V+ ELM DL +++ +
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131
Query: 120 REHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 179
++ + Y++ HRDL +N + + +KI DFG+ R +T
Sbjct: 132 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYR 190
Query: 180 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLM 238
+ + +PE +T D+WS G + E+ T + + G + L +
Sbjct: 191 KGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248
Query: 239 TDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD 298
+ K N L+ ++PK
Sbjct: 249 ME------------------------------GGLLDKPDNCPDMLFELMRMCWQYNPKM 278
Query: 299 RPTAEEALA------DPYFKGLS 315
RP+ E ++ +P F+ +S
Sbjct: 279 RPSFLEIISSIKEEMEPGFREVS 301
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-41
Identities = 60/319 (18%), Positives = 114/319 (35%), Gaps = 65/319 (20%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGE-------KVAIKKIHDIFEHISDAARILREI 68
R + + +G+G++G V A + KVA+K + D + ++ E+
Sbjct: 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEM 69
Query: 69 KLL-RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIK------------- 113
+++ + +H +I+ + +YV+ E +L + ++
Sbjct: 70 EMMKMIGKHKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 124
Query: 114 ---ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170
+ L+ + YQ+ R ++Y+ + HRDL +N+L + +KI DFGLAR
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 229
+ + +W L YT D+WS G + E+ T G +PG
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241
Query: 230 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLE 289
V L+ + R +P N ++
Sbjct: 242 PVEELFKLLKE-----------------------GHRMDKP-------SNCTNELYMMMR 271
Query: 290 RLLAFDPKDRPTAEEALAD 308
P RPT ++ + D
Sbjct: 272 DCWHAVPSQRPTFKQLVED 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-41
Identities = 64/314 (20%), Positives = 114/314 (36%), Gaps = 59/314 (18%)
Query: 16 DASRYKIQEVIGKGSYGVVCSAID-----THTGEKVAIKKIHDIFEHISDAARILREIKL 70
R K+ + +G+G++G V A T T VA+K + + H A + L
Sbjct: 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70
Query: 71 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAN-------------- 115
+ + H ++V + P + V+ E + +L +++
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 116 --DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173
D LT EH + +Q+ + ++++ + HRDL +NIL + +KICDFGLAR +
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVV 232
D + +W + YT D+WS G + E+ + +PG +
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 233 HQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLL 292
+ RR R + P P + +
Sbjct: 244 EEF----------------------CRRLKEGTRMRAP-------DYTTPEMYQTMLDCW 274
Query: 293 AFDPKDRPTAEEAL 306
+P RPT E +
Sbjct: 275 HGEPSQRPTFSELV 288
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 101 bits (252), Expect = 2e-25
Identities = 27/210 (12%), Positives = 62/210 (29%), Gaps = 30/210 (14%)
Query: 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH--------DIFEHISDAARILREIKLL 71
I +++G+G V + + +K +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 72 RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLL 131
+ +++ + +P ++ V+ EL+++ ++ E+ L +L
Sbjct: 61 ARNEFRALQKLQGLAVPK-VYAWEGNAVLMELIDAKELYRVR------VENPDEVLDMIL 113
Query: 132 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD-YVATRWY 190
+ + + H DL N+L + + I DF + + I D ++
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVL-VSEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172
Query: 191 RAPELCGSFFSKYTPAIDIWSIGCIFAEVL 220
Y DI S +L
Sbjct: 173 S---------RTYRTEKDINS---AIDRIL 190
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 614 | |||
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.32 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.76 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.55 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.64 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.57 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.41 |
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-59 Score=496.47 Aligned_cols=332 Identities=40% Similarity=0.763 Sum_probs=279.9
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RR 92 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~-~~ 92 (614)
+...++|++++.||+|+||+||+|.++.+|+.||||+++.........+.+.+|+.+|+.++|||||++++++.... ..
T Consensus 14 ~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~ 93 (346)
T d1cm8a_ 14 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 93 (346)
T ss_dssp ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred eecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccc
Confidence 34568999999999999999999999999999999999876666677888999999999999999999999997653 23
Q ss_pred CCCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 93 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 93 ~~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
....+|||||||+.+|..+++. +.+++..++.|++||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 94 ~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 94 DFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp TCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEecccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence 4557899999998888887765 469999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.. .+..+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+....+.+..+.+..
T Consensus 173 ~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 173 SE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp SS------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred Cc------cccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 32 2456899999999998763 4678999999999999999999999999999999999999999999999988
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCCCCCccchhH
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFE 332 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~ 332 (614)
........+...+.......+...+++++++++|||.+||..||.+|||++|+|+||||+.+...+.++..+.+ ++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~~~---~~~ 322 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKY---DDS 322 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCCCC---CCC
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCCCC---CCc
Confidence 88887778887777777777888888999999999999999999999999999999999998877777665533 344
Q ss_pred HHhhcCCHHHHHHHHHHHHHHhCc
Q 007177 333 FERRRVTKEDIRELIFREILEYHP 356 (614)
Q Consensus 333 ~e~~~~~~e~~~~~~~~ei~~~~~ 356 (614)
++....+.+++++++++|+++++|
T Consensus 323 ~~~~~~~~~e~k~~~~~e~~~~~~ 346 (346)
T d1cm8a_ 323 FDDVDRTLDEWKRVTYKEVLSFKP 346 (346)
T ss_dssp -----CCHHHHHHHHHHHHHTCCC
T ss_pred hhhhhcCHHHHHHHHHHHhhcCCC
Confidence 555667889999999999999876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-58 Score=484.00 Aligned_cols=340 Identities=47% Similarity=0.826 Sum_probs=285.6
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
|....||++++.||+|+||+||+|.++.+|+.||||++... .......++.+|+.+|+.|+||||+++++++.......
T Consensus 4 ~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 4 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp CCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred cCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh-cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence 45667999999999999999999999999999999999753 34556778899999999999999999999997776666
Q ss_pred CCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 94 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 94 ~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
...+||++++++++|.++++.. .+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 83 ~~~~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 83 MKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp CCCEEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred cceEEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 6778999988889999999765 699999999999999999999999999999999999999999999999999987544
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
...........+||+.|+|||++... ..|+.++||||+||++|+|++|++||.+.+..++...+...++.+........
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 43333334567899999999998653 57899999999999999999999999999999999999999999998887776
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCCCCCccchhHH
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEF 333 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 333 (614)
..................++...++++++++++||.+||+.||.+|||++|+|+||||+.......++.... ...++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~~~--~~~~~~ 318 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFDM 318 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSS--CC----
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccccC--ccCCCh
Confidence 666666777767777777777888999999999999999999999999999999999998766655554332 234555
Q ss_pred HhhcCCHHHHHHHHHHHHHHhCchh
Q 007177 334 ERRRVTKEDIRELIFREILEYHPQL 358 (614)
Q Consensus 334 e~~~~~~e~~~~~~~~ei~~~~~~~ 358 (614)
+......+++++++++|...++|+.
T Consensus 319 ~~~~~~~~~l~~l~~~e~~~~~~~~ 343 (345)
T d1pmea_ 319 ELDDLPKEKLKELIFEETARFQPGY 343 (345)
T ss_dssp ----CCHHHHHHHHHHHSGGGSTTT
T ss_pred hhhhCCHHHHHHHHHHHHHhcCCCC
Confidence 6677889999999999999988864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-57 Score=478.97 Aligned_cols=332 Identities=41% Similarity=0.809 Sum_probs=285.1
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-C
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-R 92 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~-~ 92 (614)
+...+||++++.||+|+||+||+|+++.+|+.||||++++.........++.+|+.+|+.|+||||+++++++..... +
T Consensus 14 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~ 93 (348)
T d2gfsa1 14 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 93 (348)
T ss_dssp EEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred ccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccc
Confidence 344679999999999999999999999999999999998776677778889999999999999999999999876543 3
Q ss_pred CCCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 93 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 93 ~~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
+...+|+++++++++|.+++.. +.+++.+++.|++||+.||+|||++||+||||||+|||++.++.+|++|||++....
T Consensus 94 ~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 94 EFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp TCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred cCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC
Confidence 3445666666666899998854 569999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.. .....||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......|....+.+..+....
T Consensus 173 ~~------~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 173 DE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp GG------GSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cc------cccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 22 2456899999999987763 4578999999999999999999999999999999999999999999888877
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCCCCCCccchhH
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFE 332 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~~~~~~~~~~~ 332 (614)
........+...+.......+...+.+++++++|||.+||+.||.+|||++|+|+||||+++.....++...+. ++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~~---~~~ 322 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY---DQS 322 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCCC---CCG
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCCC---CCc
Confidence 77777777777666666666777788999999999999999999999999999999999998887777766544 456
Q ss_pred HHhhcCCHHHHHHHHHHHHHHhCc
Q 007177 333 FERRRVTKEDIRELIFREILEYHP 356 (614)
Q Consensus 333 ~e~~~~~~e~~~~~~~~ei~~~~~ 356 (614)
++......+++++++++|++++.|
T Consensus 323 ~~~~~~~~~~~k~~~~~e~~~~~p 346 (348)
T d2gfsa1 323 FESRDLLIDEWKSLTYDEVISFVP 346 (348)
T ss_dssp GGGCCCCHHHHHHHHHHHHHTCCC
T ss_pred ccchhcCHHHHHHHHHHHhhccCC
Confidence 778889999999999999998776
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-58 Score=470.02 Aligned_cols=260 Identities=25% Similarity=0.403 Sum_probs=216.0
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|++++.||+|+||+||+|+++.+|+.||||+++.... ....+.+.+|+.+|+.++||||+++++++ .+.+.
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~-----~~~~~ 77 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHR-----REGNI 77 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEE-----EETTE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeee-----ccCce
Confidence 3579999999999999999999999999999999975321 22345688999999999999999999999 45577
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|||||||+ |+|.+++..++.+++.+++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred eEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999998 5999999888899999999999999999999999999999999999999999999999999998754332
Q ss_pred CCccccccccCCccccCcccccccCCC-CCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~-y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
. ....+..+||+.|+|||++.+ .. ++.++|||||||++|||++|++||.+.+..........
T Consensus 158 ~-~~~~~~~~GT~~Y~APE~~~~--~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~-------------- 220 (271)
T d1nvra_ 158 R-ERLLNKMCGTLPYVAPELLKR--REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-------------- 220 (271)
T ss_dssp E-ECCBCCCCSCGGGSCTHHHHC--SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH--------------
T ss_pred c-cccccceeeCcCccCHhHhcC--CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh--------------
Confidence 2 122356789999999999876 44 46789999999999999999999987664333222110
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
........++.+++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 221 --------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 221 --------------EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp --------------TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred --------------cCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 011122234568899999999999999999999999999999974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-57 Score=460.95 Aligned_cols=253 Identities=26% Similarity=0.446 Sum_probs=219.7
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++ .+.+.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECCE
Confidence 579999999999999999999999999999999864321 122345688999999999999999999999 45677
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|||||||+ |+|.+++...+.+++.+++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred EEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 999999999 6999999988899999999999999999999999999999999999999999999999999997654322
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+...
T Consensus 161 -----~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-------------- 219 (263)
T d2j4za1 161 -----RTTLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------------- 219 (263)
T ss_dssp -----CEETTEEGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--------------
T ss_pred -----ccccCCCCcccCHHHHcC--CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------------
Confidence 244689999999999987 67999999999999999999999999998876665554221
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
... ....+++++++||.+||+.||++|||++|+|+||||+.
T Consensus 220 --------------~~~---~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 220 --------------EFT---FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp --------------CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred --------------CCC---CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 011 12357899999999999999999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-57 Score=467.60 Aligned_cols=256 Identities=28% Similarity=0.448 Sum_probs=219.7
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|++++.||+|+||+||+|.++.+|+.||||+++.... ...+.+.+|+.+|+.++||||+++++++ .+.+.
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~ 91 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSY-----LVGDE 91 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEE-----EECCE
Confidence 4689999999999999999999999999999999875322 2346788999999999999999999999 45567
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|||||||+ |+|.+++..+ .+++.+++.|++||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~ivmEy~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp EEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEEEecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999999 5999888764 69999999999999999999999999999999999999999999999999998754332
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+.... .
T Consensus 171 ~---~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~----------- 233 (293)
T d1yhwa1 171 S---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-T----------- 233 (293)
T ss_dssp C---CBCCCCSCGGGCCHHHHSS--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-S-----------
T ss_pred c---cccccccCCCccChhhhcC--CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-C-----------
Confidence 2 2345689999999999987 689999999999999999999999999888766655443210 0
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
+....++.+++.+++||.+||+.||.+|||++|+|+||||+.
T Consensus 234 ----------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 234 ----------------PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp ----------------CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred ----------------CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 001223457899999999999999999999999999999974
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-56 Score=456.22 Aligned_cols=259 Identities=26% Similarity=0.375 Sum_probs=217.7
Q ss_pred CCCe-EEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 17 ASRY-KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY-~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
.+|| ++.+.||+|+||+||+|.++.++..||+|++............+.+|+++|+.|+||||+++++++.... .+..
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~ 85 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKK 85 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCC
Confidence 3456 7888999999999999999999999999999876556667788999999999999999999999985432 3346
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeecCCCCcEEEC-CCCcEEEeecCccccc
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILAN-ANCKLKICDFGLARVA 171 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILi~-~~~~vKL~DFGla~~~ 171 (614)
.+|||||||+ |+|.+++.....+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||+|+..
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 7899999998 599999998889999999999999999999999999 99999999999997 4789999999999764
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+......+......
T Consensus 166 ~~~-----~~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~---------- 227 (270)
T d1t4ha_ 166 RAS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS---------- 227 (270)
T ss_dssp CTT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT----------
T ss_pred cCC-----ccCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc----------
Confidence 322 1245689999999999864 6999999999999999999999999876654433222110
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~ 312 (614)
...+. ......++++.+||.+||+.||++|||++|+|+||||+
T Consensus 228 ---------------~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 228 ---------------GVKPA---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ---------------TCCCG---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ---------------CCCCc---ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 00111 12235688999999999999999999999999999996
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-57 Score=467.75 Aligned_cols=283 Identities=34% Similarity=0.553 Sum_probs=230.6
Q ss_pred EEeEeeecCceEEEEEEECCCCcEEEEEEecCccCCh---HHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007177 22 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI---SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 98 (614)
Q Consensus 22 i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~---~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~y 98 (614)
.+++||+|+||+||+|+++.+|+.||||+++...... .....+.+|+.+|+.++|||||++++++ .+.+.+|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCcee
Confidence 5789999999999999999999999999997532221 1235688999999999999999999999 4556799
Q ss_pred EEEecCCCcHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007177 99 VVFELMESDLHQVI-KANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 177 (614)
Q Consensus 99 lV~E~~~g~L~~~i-~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 177 (614)
||||||.+++...+ ..+..+++..++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus 77 ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred ehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 99999997554444 44667999999999999999999999999999999999999999999999999999865433222
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhchh
Q 007177 178 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 257 (614)
Q Consensus 178 ~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~ 257 (614)
....+||++|+|||++... ..|+.++|||||||++|||++|.+||.+.+..+++..|.+.+|+|..+.+.......
T Consensus 157 ---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 157 ---YTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp ---CCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred ---ccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 2456899999999988652 568999999999999999999999999999999999999999999887665432211
Q ss_pred HHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 258 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 258 ~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
... ........++...++.+++++++||.+||+.||++|||++|+|+||||++...
T Consensus 233 ~~~---~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 233 DYV---TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp TCC---CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred hhh---hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence 000 01112223334456778999999999999999999999999999999986543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-56 Score=456.23 Aligned_cols=257 Identities=30% Similarity=0.476 Sum_probs=210.4
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
+++|++++.||+|+||.||+|+++.+|+.||||++..........+.+.+|+++|+.++||||+++++++... ..+.
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCE
Confidence 4679999999999999999999999999999999987655666778899999999999999999999988532 3456
Q ss_pred EEEEEecCC-CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----eEeecCCCCcEEECCCCcEEEeecC
Q 007177 97 IYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTAN-----VYHRDLKPKNILANANCKLKICDFG 166 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~----~~~lse~~~~~i~~QIl~aL~yLHs~g-----IvHrDLKP~NILi~~~~~vKL~DFG 166 (614)
+|||||||+ |+|.+++.. +..+++..++.|+.||+.||+|||+.| |+||||||+|||++.++.+||+|||
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG 159 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 159 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence 899999998 599998853 467999999999999999999999976 9999999999999999999999999
Q ss_pred ccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCc
Q 007177 167 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 246 (614)
Q Consensus 167 la~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~ 246 (614)
+|+....... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|..
T Consensus 160 ~a~~~~~~~~---~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~------ 228 (269)
T d2java1 160 LARILNHDTS---FAKAFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE------ 228 (269)
T ss_dssp HHHHC--------------CCCSCCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH------
T ss_pred ceeecccCCC---ccccCCCCcccCCHHHHcC--CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc------
Confidence 9987643322 2345789999999999987 6899999999999999999999999998877655544422
Q ss_pred hhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccc
Q 007177 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 311 (614)
Q Consensus 247 ~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f 311 (614)
. .+......+|+++.+||.+||+.||++|||++|+|+|||+
T Consensus 229 ---------------------~---~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 229 ---------------------G---KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ---------------------T---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ---------------------C---CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 0 0112234678999999999999999999999999999996
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-56 Score=464.16 Aligned_cols=260 Identities=30% Similarity=0.469 Sum_probs=208.4
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++++.||+|+||+||+|.++.+|+.||||++...... .....+.+|+.+|+.|+||||+++++++ .+.+
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~ 80 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGG 80 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECC
Confidence 346799999999999999999999999999999999754322 2345678999999999999999999998 5567
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEEC---CCCcEEEeecCccccc
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN---ANCKLKICDFGLARVA 171 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~---~~~~vKL~DFGla~~~ 171 (614)
.+|||||||+ |+|.++|...+.+++.+++.|+.||+.||.|||++||+||||||+|||+. .++.+||+|||+|+..
T Consensus 81 ~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred EEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 8999999998 69999999988999999999999999999999999999999999999995 5789999999999865
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
.... .....+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+....+..
T Consensus 161 ~~~~----~~~~~~GT~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~----------- 223 (307)
T d1a06a_ 161 DPGS----VLSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK----------- 223 (307)
T ss_dssp ----------------CTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHT-----------
T ss_pred cCCC----eeeeeeeCccccCcHHHcC--CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhc-----------
Confidence 4322 1245689999999999987 6899999999999999999999999998887666555432
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
.........++++|+++.+||.+||+.||.+|||++|+|+||||++.
T Consensus 224 ----------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 224 ----------------AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp ----------------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred ----------------cCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 11111223456789999999999999999999999999999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-56 Score=457.46 Aligned_cols=266 Identities=28% Similarity=0.438 Sum_probs=226.6
Q ss_pred cccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCC----hHHHHHHHHHHHHHHhcCCCCcceeeeEe
Q 007177 11 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH----ISDAARILREIKLLRLLRHPDIVEIKHIM 86 (614)
Q Consensus 11 ~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~----~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~ 86 (614)
|......++|++++.||+|+||+||+|+++.+|+.||||++++.... ....+.+.+|+.+|+.|+|||||++++++
T Consensus 3 ~~~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~ 82 (293)
T d1jksa_ 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY 82 (293)
T ss_dssp CBCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 33444567899999999999999999999999999999999643221 12356788999999999999999999999
Q ss_pred cCCCCCCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC----cEE
Q 007177 87 LPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC----KLK 161 (614)
Q Consensus 87 ~~~~~~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~----~vK 161 (614)
.+...+|||||||+ |+|.++|...+.+++..++.|++||+.||+|||+.||+||||||+|||++.++ .+|
T Consensus 83 -----~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vk 157 (293)
T d1jksa_ 83 -----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 157 (293)
T ss_dssp -----ECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEE
T ss_pred -----EECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceE
Confidence 56678999999999 69999999888999999999999999999999999999999999999998776 499
Q ss_pred EeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhh
Q 007177 162 ICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 241 (614)
Q Consensus 162 L~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~ 241 (614)
|+|||+|+...... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..|...
T Consensus 158 l~DfG~a~~~~~~~----~~~~~~~t~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~ 231 (293)
T d1jksa_ 158 IIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231 (293)
T ss_dssp ECCCTTCEECTTSC----BCSCCCCCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT
T ss_pred ecchhhhhhcCCCc----cccccCCCCcccCHHHHcC--CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhc
Confidence 99999998754322 2245689999999999987 68999999999999999999999999998887776665432
Q ss_pred hCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 242 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 242 ~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
.... ....++++|+.+++||++||+.||.+|||++|+|+||||+..
T Consensus 232 ~~~~---------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 232 NYEF---------------------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp CCCC---------------------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred CCCC---------------------------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 1111 112235688999999999999999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-57 Score=474.84 Aligned_cols=283 Identities=22% Similarity=0.356 Sum_probs=218.7
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|++++.||+|+||+||+|+++.+|+.||||+++... .......+.+|+.+|+.++|||||++++++ .+...
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~ 78 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGE 78 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-----ECSSE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence 457999999999999999999999999999999997542 334567889999999999999999999999 45567
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
+|||||||+ |+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+.....
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999 5999999988899999999999999999999997 59999999999999999999999999999875432
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhH-HHHHHHhhhCCCchhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~-~l~~i~~~~g~p~~~~i~~~ 253 (614)
. .+.++||++|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+ +...+....|.+........
T Consensus 159 ~-----~~~~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 159 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp T-----C---CCSSCCCCHHHHHC--SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred c-----cccccCCccccCchHHcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence 2 245699999999999987 689999999999999999999999998876433 22223333332221110000
Q ss_pred h--------------chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 254 R--------------NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 254 ~--------------~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
. .......+..+....+..+. ...+|++++|||.+||++||++|||++|+|+||||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCCC--BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccCc--cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0 00011111111111111111 12368899999999999999999999999999999853
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-56 Score=468.13 Aligned_cols=327 Identities=35% Similarity=0.661 Sum_probs=255.8
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~-~~~ 94 (614)
..++|++++.||+|+||+||+|+++.+|+.||||++...........++.+|+.+|++++||||+++++++..... ++.
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 3478999999999999999999999999999999998776667777889999999999999999999999965432 456
Q ss_pred CcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 95 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 95 ~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
..+|+|||||.+++.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++.....
T Consensus 95 ~~~~iv~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 95 QDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp CEEEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred ceeEEEEeccchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 7899999999998887774 46999999999999999999999999999999999999999999999999998865432
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
. ..+..++|+.|+|||++.+ ..|+.++||||+||++|+|++|++||.+.+...++..+...++.+..+.+....
T Consensus 173 ~----~~~~~~~t~~y~aPE~l~~--~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 173 F----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp ------------CCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred c----ccccccccccccChhhhcC--CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 2 2355689999999999987 689999999999999999999999999999999999999999999888776653
Q ss_pred chhHHHHHHhhcccCCCcccCCC------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcccCCCC
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKF------------PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPS 322 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~------------~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~~~~~~ 322 (614)
. ....+...........+...+ ...++++++||++||.+||++||||+|+|+||||+.....+....
T Consensus 247 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~~ 325 (355)
T d2b1pa1 247 P-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEA 325 (355)
T ss_dssp H-HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHTC
T ss_pred h-hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccccC
Confidence 2 233333332222211111111 124678999999999999999999999999999997654333222
Q ss_pred CCCCccchhHHHhhcCCHHHHHHHHHHHHH
Q 007177 323 CQPISKMEFEFERRRVTKEDIRELIFREIL 352 (614)
Q Consensus 323 ~~~~~~~~~~~e~~~~~~e~~~~~~~~ei~ 352 (614)
..+ ...+.+.++++.+.++|+++|++|++
T Consensus 326 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (355)
T d2b1pa1 326 PPP-QIYDKQLDEREHTIEEWKELIYKEVM 354 (355)
T ss_dssp CCC--------CCCCCCHHHHHHHHHHHHH
T ss_pred CCC-CCCCcchhhhhcCHHHHHHHHHHHhc
Confidence 222 22344667788899999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=461.80 Aligned_cols=259 Identities=27% Similarity=0.468 Sum_probs=219.4
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
.++|++++.||+|+||+||+|.++.+|+.||||++.+.. ........+.+|+++|+.++||||+++++++ .+.+
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~ 81 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDE 81 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSS
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECC
Confidence 357999999999999999999999999999999997431 1222346788999999999999999999998 5567
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
.+|||||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 82 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC
Confidence 8999999999 599999999889999999999999999999999999999999999999999999999999999875433
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..|...
T Consensus 162 ~~~-~~~~~~~GT~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~------------- 225 (288)
T d1uu3a_ 162 SKQ-ARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL------------- 225 (288)
T ss_dssp ---------CCCCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT-------------
T ss_pred Ccc-cccccccCCccccCceeecc--CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC-------------
Confidence 221 22345689999999999987 68999999999999999999999999998876666555320
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHH------HHcCcccccC
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE------ALADPYFKGL 314 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~e------iL~hp~f~~~ 314 (614)
... ....+++++++||++||+.||++|||++| +++||||+++
T Consensus 226 ---------------~~~---~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 226 ---------------EYD---FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp ---------------CCC---CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred ---------------CCC---CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 011 12357899999999999999999999987 5889999876
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-56 Score=460.86 Aligned_cols=289 Identities=38% Similarity=0.632 Sum_probs=238.5
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
++|++++.||+|+||+||+|.++.+|+.||||+++...........+.+|+++|++++||||+++++++ .+...+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-----~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc-----ccccce
Confidence 589999999999999999999999999999999975433333456788999999999999999999999 455779
Q ss_pred EEEEecCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 98 YVVFELMESDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 98 ylV~E~~~g~L~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
|+|||||.+++.+.+.. ...+++..++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||+|+......
T Consensus 77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99999999887776644 4569999999999999999999999999999999999999999999999999998754332
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
. .....+||+.|+|||++... ..++.++|||||||++|+|++|+.||.+.+..+++..+....+.|....+.....
T Consensus 157 ~---~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 157 R---TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp B---CTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred c---cceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 2 23556899999999987663 4568899999999999999999999999999999999999999988776654322
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcc
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 317 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~ 317 (614)
.. .+...........+...++.+++++++||.+||..||++|||++|+|+||||+++.++
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 233 MP--DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp ST--TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cc--ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 11 1111111222233334567889999999999999999999999999999999987553
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=460.92 Aligned_cols=258 Identities=23% Similarity=0.345 Sum_probs=218.1
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
+.|++++.||+|+||.||+|.++.+|+.||||+++.. .....+.+.+|+++|+.|+|||||++++++ .+.+.+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~~ 84 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNL 84 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCeE
Confidence 4699999999999999999999999999999999753 234456788999999999999999999998 455679
Q ss_pred EEEEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 98 YVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 98 ylV~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
|||||||+ |+|.+++.. .+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 85 ~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 85 WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 99999998 599998765 5579999999999999999999999999999999999999999999999999997543211
Q ss_pred CCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~---~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
......+||+.|+|||++... ...|+.++|||||||++|||++|++||.+.+..+.+..+...
T Consensus 165 ---~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~----------- 230 (288)
T d2jfla1 165 ---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS----------- 230 (288)
T ss_dssp ---HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS-----------
T ss_pred ---ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------
Confidence 122456899999999998431 256899999999999999999999999998876666554321
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
.+ +.......+++++++||.+||+.||.+|||++|+|+||||+.
T Consensus 231 ----------------~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 231 ----------------EP-PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp ----------------CC-CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred ----------------CC-CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 00 111223467899999999999999999999999999999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-56 Score=465.27 Aligned_cols=257 Identities=25% Similarity=0.452 Sum_probs=223.5
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
.++|++++.||+|+||.||+|+++.+|+.||||++++... .......+.+|+.+|+.++||||+++++++ .+..
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----cccc
Confidence 3579999999999999999999999999999999975321 222456788999999999999999999999 5667
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
.+|+|||||+ |+|.+++...+.++++.++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred ccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 8999999999 699999999999999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
.. .....+||++|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+..
T Consensus 159 ~~---~~~~~~GT~~Y~aPE~~~~--~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~-------------- 219 (337)
T d1o6la_ 159 GA---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-------------- 219 (337)
T ss_dssp TC---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------------
T ss_pred Cc---ccccceeCHHHhhhhhccC--CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc--------------
Confidence 22 2356789999999999987 6899999999999999999999999999887655544422
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccC
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 314 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~eiL~hp~f~~~ 314 (614)
. .. ..+..+|+++++||.+||++||.+|++ ++|+|+||||+++
T Consensus 220 -------------~-~~---~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 220 -------------E-EI---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp -------------C-CC---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred -------------C-CC---CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 0 11 123468999999999999999999994 9999999999865
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.5e-56 Score=467.49 Aligned_cols=261 Identities=26% Similarity=0.420 Sum_probs=225.3
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++++.||+|+||.||+|.++.+|+.||||++... ...+.+.+.+|+.+|+.|+|||||++++++ .+.+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~ 96 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDN 96 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----EETT
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECC
Confidence 346899999999999999999999999999999999753 445667889999999999999999999998 4567
Q ss_pred cEEEEEecCC-CcHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC--CCcEEEeecCccccc
Q 007177 96 DIYVVFELME-SDLHQVIK-ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA--NCKLKICDFGLARVA 171 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~-~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~--~~~vKL~DFGla~~~ 171 (614)
.+|||||||+ |+|.+++. ..+.+++.+++.|++||+.||.|||++||+||||||+|||++. ++.+||+|||+|+..
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 8999999998 59999985 4557999999999999999999999999999999999999964 578999999999875
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
..... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..|......+
T Consensus 177 ~~~~~----~~~~~gT~~Y~aPEv~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------ 244 (350)
T d1koaa2 177 DPKQS----VKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM------ 244 (350)
T ss_dssp CTTSC----EEEECSCTTTCCHHHHHT--CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS------
T ss_pred ccccc----cceecCcccccCHHHHcC--CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------
Confidence 43322 345689999999999987 689999999999999999999999999998877776664322111
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
....++.+++++++||.+||+.||++|||++|+|+||||+....
T Consensus 245 ---------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 245 ---------------------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp ---------------------CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred ---------------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 12234568899999999999999999999999999999987644
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-56 Score=457.37 Aligned_cols=290 Identities=33% Similarity=0.582 Sum_probs=238.1
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCC-CcEEEEEEecCccCChHHHHHHHHHHHHHHhc---CCCCcceeeeEecCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHT-GEKVAIKKIHDIFEHISDAARILREIKLLRLL---RHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~t-g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L---~HpnIv~l~~v~~~~~~~ 92 (614)
.++|++++.||+|+||+||+|++..+ ++.||||+++...........+.+|+.+|+.| +||||+++++++......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999999766 56799999975433333334566788877766 799999999998655445
Q ss_pred CCCcEEEEEecCCCcHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 93 DFKDIYVVFELMESDLHQVIK--ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 93 ~~~~~ylV~E~~~g~L~~~i~--~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
....+|++||+|++++..+.. ....+++..++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 567899999999976555443 345699999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 171 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 171 ~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
.... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+++..|...+|.|....+
T Consensus 166 ~~~~----~~~~~~~gT~~Y~APE~~~~--~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 166 YSFQ----MALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCGG----GGGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hccc----ccCCCcccChhhcCcchhcC--CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 4322 23356789999999999987 68999999999999999999999999999999999999999999987766
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 316 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~ 316 (614)
......... .............+..+++.+++||.+||++||++|||++|+|+||||+++..
T Consensus 240 ~~~~~~~~~----~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 240 PRDVALPRQ----AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp CTTCSSCGG----GSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccchhh----hhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 433221110 11122333444556788999999999999999999999999999999998754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.5e-55 Score=465.87 Aligned_cols=260 Identities=27% Similarity=0.427 Sum_probs=225.2
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++++.||+|+||.||+|+++.+|+.||||+++.. ...+...+.+|+.+|+.|+||||+++++++ .+..
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~ 99 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKY 99 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSS
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECC
Confidence 345799999999999999999999999999999999753 344567788999999999999999999999 5567
Q ss_pred cEEEEEecCC-CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEEC--CCCcEEEeecCccccc
Q 007177 96 DIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN--ANCKLKICDFGLARVA 171 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~--~~~~vKL~DFGla~~~ 171 (614)
.+|||||||+ |+|.+.+...+ .+++.+++.|++||+.||+|||++||+||||||+|||++ .++.+||+|||+|+..
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceec
Confidence 8999999999 69998876544 699999999999999999999999999999999999998 5789999999999876
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
..... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|....
T Consensus 180 ~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--------- 244 (352)
T d1koba_ 180 NPDEI----VKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD--------- 244 (352)
T ss_dssp CTTSC----EEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC---------
T ss_pred CCCCc----eeeccCcccccCHHHHcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------
Confidence 43322 245689999999999987 689999999999999999999999999998877766654321
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
.......++++++++++||.+||+.||.+|||++|+|+||||++..
T Consensus 245 ------------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 245 ------------------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp ------------------CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred ------------------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 1112334578899999999999999999999999999999998643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-55 Score=457.28 Aligned_cols=256 Identities=25% Similarity=0.369 Sum_probs=217.9
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..+|++++.||+|+||+||+|+++.+|+.||||+++..... ....+.+.+|+.+|+.|+|||||++++++ .+..
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~ 88 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREH 88 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETT
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEE-----EECC
Confidence 34699999999999999999999999999999999754333 34456789999999999999999999998 4456
Q ss_pred cEEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 96 DIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 96 ~~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
.+|||||||.+ +|..++..++.+++.+++.|++||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 89 ~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp EEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 79999999995 6666677778899999999999999999999999999999999999999999999999999976432
Q ss_pred CCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~-~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
....+||+.|+|||++.+. ...|+.++|||||||++|||++|..||.+.+..+.+..+..
T Consensus 168 ------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~------------- 228 (309)
T d1u5ra_ 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------- 228 (309)
T ss_dssp ------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------------
T ss_pred ------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-------------
Confidence 1346899999999998642 24689999999999999999999999998877666554422
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
...+. .....+|+.+++||.+||+.||.+|||++|+|+||||..
T Consensus 229 -------------~~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 229 -------------NESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp -------------SCCCC---CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred -------------CCCCC---CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 11111 112457899999999999999999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.2e-55 Score=448.83 Aligned_cols=284 Identities=38% Similarity=0.638 Sum_probs=235.9
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
+||++++.||+|+||+||+|+++ +|+.||||+++..........++.+|+.+|+.++||||+++++.+ .+.+.+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeec-----ccCCce
Confidence 68999999999999999999985 789999999976543344457889999999999999999999999 455679
Q ss_pred EEEEecCCCcHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 98 YVVFELMESDLHQVI-KANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 98 ylV~E~~~g~L~~~i-~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
|++||++.+.+...+ ...+.+++..++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 999999997555555 5567899999999999999999999999999999999999999999999999999987543322
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhch
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 256 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~ 256 (614)
.....++++.|+|||++.+. ..++.++|||||||++|||++|++||.+.+..+++..+...+|.|....+......
T Consensus 156 ---~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ---ccceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence 22445799999999998753 56799999999999999999999999999999999999999999987776543221
Q ss_pred hHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 257 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 257 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
.++..........++....+.+++.+.|||++||++||++|||++|+|+||||++
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 232 --PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp --TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred --hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 1112222233444555667789999999999999999999999999999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.6e-55 Score=453.25 Aligned_cols=253 Identities=26% Similarity=0.477 Sum_probs=221.2
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++||||+++++++ .+...
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCCe
Confidence 46999999999999999999999999999999997432 1223356788999999999999999999999 55678
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
+|+|||||. |+|..++.....++++.++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence 999999999 5899999999999999999999999999999999999999999999999999999999999998754322
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
...+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 159 ------~~~~Gt~~Y~APE~l~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-------------- 216 (316)
T d1fota_ 159 ------YTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-------------- 216 (316)
T ss_dssp ------CCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--------------
T ss_pred ------ccccCcccccCHHHHcC--CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--------------
Confidence 34689999999999987 67999999999999999999999999998876665554320
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 314 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~ 314 (614)
.. ...+.+++++.+||.+||..||.+|+ |++++|+||||+++
T Consensus 217 --------------~~---~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 217 --------------EL---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp --------------CC---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred --------------CC---CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 01 12246789999999999999999996 99999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.5e-55 Score=459.52 Aligned_cols=254 Identities=22% Similarity=0.399 Sum_probs=221.6
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+++|+.++||||+++++++ .+..
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~ 114 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----cccc
Confidence 368999999999999999999999999999999986431 1223356788999999999999999999998 5567
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
.+|+|||||. |+|.+.+...+.+++.+++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 115 ~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 7999999999 599999998889999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
. ...+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..|...
T Consensus 195 ~------~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------------- 253 (350)
T d1rdqe_ 195 T------WTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------------- 253 (350)
T ss_dssp B------CCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------
T ss_pred c------ccccCccccCCHHHHcC--CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC-------------
Confidence 2 34689999999999987 68999999999999999999999999998876666555321
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccC
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 314 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~ 314 (614)
. ......+++++.+||++||..||.+|+ |++++|+||||+++
T Consensus 254 --------------~----~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 254 --------------K----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp --------------C----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred --------------C----CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 0 012346889999999999999999995 99999999999865
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.3e-54 Score=441.08 Aligned_cols=262 Identities=28% Similarity=0.452 Sum_probs=223.2
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCC-------hHHHHHHHHHHHHHHhcC-CCCcceeeeEecC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-------ISDAARILREIKLLRLLR-HPDIVEIKHIMLP 88 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~-------~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~ 88 (614)
.++|++++.||+|+||+||+|+++.+|+.||||+++..... ......+.+|+.+|+.|+ ||||+++++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-- 79 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-- 79 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec--
Confidence 36899999999999999999999999999999999753221 112346889999999997 99999999999
Q ss_pred CCCCCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCc
Q 007177 89 PSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 167 (614)
Q Consensus 89 ~~~~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGl 167 (614)
.+.+.+|||||||+ |+|.++|+.++.++++.++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 ---~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 80 ---ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp ---ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred ---ccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchh
Confidence 56678999999998 59999999988999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccccccCCccccCccccccc----CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhC
Q 007177 168 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 243 (614)
Q Consensus 168 a~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~----~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g 243 (614)
++....... .+..+||+.|+|||++.+. ...|+.++||||+||+||+|++|+.||.+.+..+.+..+...
T Consensus 157 a~~~~~~~~----~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~-- 230 (277)
T d1phka_ 157 SCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG-- 230 (277)
T ss_dssp CEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--
T ss_pred eeEccCCCc----eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC--
Confidence 987543322 2557899999999988531 245789999999999999999999999998877666555331
Q ss_pred CCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 244 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 244 ~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
........++++|+++++||.+||+.||.+|||++|+|+||||+..
T Consensus 231 -------------------------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 231 -------------------------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp -------------------------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred -------------------------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 1111122345789999999999999999999999999999999853
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-54 Score=454.58 Aligned_cols=285 Identities=34% Similarity=0.600 Sum_probs=233.9
Q ss_pred CeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCCCCcE
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRDFKDI 97 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~-~~~~~~~ 97 (614)
+|+.+++||+|+||+||+|+++.+|+.||||++..... ...+|+.+|+.|+||||+++++++.... ..+..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 69999999999999999999999999999999975321 2347999999999999999999986542 2455678
Q ss_pred EEEEecCCCcHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC-cEEEeecCcccccc
Q 007177 98 YVVFELMESDLHQVI----KANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAF 172 (614)
Q Consensus 98 ylV~E~~~g~L~~~i----~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~-~vKL~DFGla~~~~ 172 (614)
|||||||++++.+.+ .....+++.+++.|++||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 999999997655544 3466799999999999999999999999999999999999999875 89999999998654
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
... .....+||+.|+|||++.+. ..|+.++|||||||++|||++|++||.+.+..+++..|...+|.+..+.+..
T Consensus 175 ~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 175 RGE----PNVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp TTS----CCCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred CCc----ccccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 332 22456899999999987652 5799999999999999999999999999999999999999999999887765
Q ss_pred hhchhHHHHHHhhcccCCCccc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCCcc
Q 007177 253 VRNDKARRYLTSMRKKQPVQFS-QKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 317 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~-~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~~~ 317 (614)
......... .......++. ...+..++++.+||.+||.+||++|||++|+|+||||+++...
T Consensus 250 ~~~~~~~~~---~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 250 MNPNYTEFK---FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp HCC---CCC---CCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred hccchhhcc---ccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 433211111 1111111222 2345689999999999999999999999999999999987653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-54 Score=450.86 Aligned_cols=257 Identities=25% Similarity=0.437 Sum_probs=221.8
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..+||++++.||+|+||+||+|+++.+|+.||||+++.. ..+...+.+|+.+|+.++||||+++++++ ++.+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~ 74 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESF-----ESME 74 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETT
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECC
Confidence 346899999999999999999999999999999999753 23455688999999999999999999999 4567
Q ss_pred cEEEEEecCC-CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC--CcEEEeecCccccc
Q 007177 96 DIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN--CKLKICDFGLARVA 171 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~--~~vKL~DFGla~~~ 171 (614)
.+|||||||+ ++|.++|...+ .+++++++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 75 ~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 8999999999 59999998765 79999999999999999999999999999999999999854 48999999999875
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
.... .....++|+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..|......+
T Consensus 155 ~~~~----~~~~~~~t~~y~ape~~~~--~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~------ 222 (321)
T d1tkia_ 155 KPGD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF------ 222 (321)
T ss_dssp CTTC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC------
T ss_pred ccCC----cccccccccccccchhccC--CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------
Confidence 3322 2244679999999999887 679999999999999999999999999998877776664321111
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
....++.+|+++++||.+||..||.+|||++|+|+||||++
T Consensus 223 ---------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 223 ---------------------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ---------------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ---------------------ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 12234578999999999999999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.3e-54 Score=455.56 Aligned_cols=259 Identities=24% Similarity=0.351 Sum_probs=214.1
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC----ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE----HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~----~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
.++|++++.||+|+||.||+|.++.+|+.||||++.+... ......+..+|+.+|+.++||||+++++++ .
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~ 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----E
Confidence 3579999999999999999999999999999999864211 112222333457777778899999999998 4
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 93 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
+.+.+|||||||+ |+|.++|.....+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred ECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 5577999999999 699999999889999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
.... ....+||+.|+|||++.+. ..|+.++|||||||+||||++|+.||.+.+..+....+..
T Consensus 158 ~~~~-----~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~----------- 220 (364)
T d1omwa3 158 SKKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----------- 220 (364)
T ss_dssp SSSC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH-----------
T ss_pred CCCc-----ccccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Confidence 4332 2345899999999998642 5689999999999999999999999987654333221110
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHHcCcccccC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 314 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rps-----a~eiL~hp~f~~~ 314 (614)
. . ......+..+++++++||.+||+.||++||| ++|+|+||||+++
T Consensus 221 -------------~-~---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 221 -------------T-L---TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp -------------S-S---SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred -------------c-c---cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 0 0 1111223468999999999999999999999 8999999999976
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-54 Score=448.15 Aligned_cols=298 Identities=34% Similarity=0.544 Sum_probs=233.3
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC--
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-- 91 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~-- 91 (614)
....+||++++.||+|+||+||+|+++.+|+.||||++...........++.+|+.+|+.++||||+++++++.....
T Consensus 6 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY 85 (318)
T ss_dssp SCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred CCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence 455789999999999999999999999999999999987654444556778899999999999999999999865321
Q ss_pred -CCCCcEEEEEecCCCcHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 92 -RDFKDIYVVFELMESDLHQVI-KANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 92 -~~~~~~ylV~E~~~g~L~~~i-~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
.....+|+|||||++.+...+ .....+++..++.|++||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 234579999999997665555 445679999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCC-ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007177 170 VAFNDTPT-TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 248 (614)
Q Consensus 170 ~~~~~~~~-~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~ 248 (614)
........ .......+||++|+|||++.+. ..|+.++|||||||++|||++|++||.+.+..+.+..+...++.+..+
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 65432221 1222346899999999998763 578999999999999999999999999999999999999999999887
Q ss_pred hhhhhhchhHHHHHHhhcccCCCcccCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 249 TISRVRNDKARRYLTSMRKKQPVQFSQKF--PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 249 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~--~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
.+...........+...... ...+...+ ...+++++|||.+||++||++|||++|+|+||||+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQ-KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TSTTCCCC-------CCSSC-CBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred hccccchhhhhhhhcccccc-cccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 76655443333322221111 11111111 124778999999999999999999999999999984
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=446.26 Aligned_cols=256 Identities=24% Similarity=0.407 Sum_probs=219.1
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHH-hcCCCCcceeeeEecCCCCCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLR-LLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~-~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
++|++++.||+|+||+||+|.++.+|+.||||++++.. ........+.+|+.++. .++||||+++++++ .+.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence 57999999999999999999999999999999997431 11223455677777765 68999999999999 5567
Q ss_pred cEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 96 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
.+|||||||+ |+|.+++.....+++.+++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 7999999999 599999999889999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 175 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 175 ~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
.. ..+..+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..|..
T Consensus 157 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-------------- 217 (320)
T d1xjda_ 157 DA---KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-------------- 217 (320)
T ss_dssp TC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------------
T ss_pred cc---cccccCCCCCcCCHHHHcC--CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc--------------
Confidence 22 2355689999999999987 6899999999999999999999999999887666655421
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHH-HHHcCcccccC
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE-EALADPYFKGL 314 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~-eiL~hp~f~~~ 314 (614)
..+ .....+|+++.+||.+||+.||.+|||++ ++++||||+++
T Consensus 218 -------------~~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 218 -------------DNP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp -------------CCC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred -------------CCC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 111 11235789999999999999999999995 89999999875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-53 Score=432.81 Aligned_cols=287 Identities=36% Similarity=0.567 Sum_probs=238.6
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 97 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~~ 97 (614)
+||++++.||+|+||+||+|+++.+|+.||||+++..........++.+|+.+|+.++||||+++++++ .+...+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----ccccce
Confidence 689999999999999999999999999999999976555566778899999999999999999999999 455679
Q ss_pred EEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007177 98 YVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 176 (614)
Q Consensus 98 ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 176 (614)
++|+|++.+ +|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++.......
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999995 7777778888999999999999999999999999999999999999999999999999999987543322
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCC-CCCCChhHHHHHHHhhhCCCchhhhhhhhc
Q 007177 177 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKNVVHQLDLMTDLLGTPSLDTISRVRN 255 (614)
Q Consensus 177 ~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~p-F~g~~~~~~l~~i~~~~g~p~~~~i~~~~~ 255 (614)
......++++|+|||++.+. ..++.++|||||||++|||++|+.| |.+.+..+++..+....+.+....+.....
T Consensus 157 ---~~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 157 ---CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ---cceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 22445788999999998763 4579999999999999999998876 677888889999999999887765543221
Q ss_pred hhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 256 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 256 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
.. .+................+.+++.+.+||++||+.||++|||++|+|+||||+++.
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 233 LP--DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp ST--TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred cc--cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 10 00000001112223344567899999999999999999999999999999998764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=435.77 Aligned_cols=252 Identities=26% Similarity=0.437 Sum_probs=210.6
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCC----hHHHHHHHHHHHHHHhcC--CCCcceeeeEecCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH----ISDAARILREIKLLRLLR--HPDIVEIKHIMLPP 89 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~----~~~~~~i~~Ei~iL~~L~--HpnIv~l~~v~~~~ 89 (614)
..++|++.+.||+|+||+||+|+++.+|+.||||++.+.... .....++.+|+.+|+.++ ||||+++++++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~--- 78 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF--- 78 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE---
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE---
Confidence 357999999999999999999999999999999998743211 112344678999999997 89999999998
Q ss_pred CCCCCCcEEEEEecCC--CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC-CcEEEeecC
Q 007177 90 SRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFG 166 (614)
Q Consensus 90 ~~~~~~~~ylV~E~~~--g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~-~~vKL~DFG 166 (614)
.+.+.+|+||||+. +++.+++..+..+++++++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||
T Consensus 79 --~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 79 --ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp --ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred --eeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccc
Confidence 55677999999997 3888999888899999999999999999999999999999999999999854 799999999
Q ss_pred ccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCc
Q 007177 167 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 246 (614)
Q Consensus 167 la~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~ 246 (614)
+|+..... ..+..+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+. +..
T Consensus 157 ~a~~~~~~-----~~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~------ 218 (273)
T d1xwsa_ 157 SGALLKDT-----VYTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR------ 218 (273)
T ss_dssp TCEECCSS-----CBCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH------
T ss_pred cceecccc-----cccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCchH------Hhh------
Confidence 99864332 23457899999999998762 3356789999999999999999999976321 100
Q ss_pred hhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 247 ~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
. .. ...+.+|+++++||++||+.||++|||++|+|+||||+++.
T Consensus 219 --------------------~--~~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 219 --------------------G--QV---FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp --------------------C--CC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred --------------------c--cc---CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 0 00 11246789999999999999999999999999999998653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=447.02 Aligned_cols=263 Identities=28% Similarity=0.428 Sum_probs=210.6
Q ss_pred CCCCCeEEEe-EeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHH-hcCCCCcceeeeEecCCCCC
Q 007177 15 GDASRYKIQE-VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLR-LLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 15 ~~~~rY~i~~-~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~-~L~HpnIv~l~~v~~~~~~~ 92 (614)
...++|++++ .||+|+||+||+|.++.+|+.||||++++. ..+.+|+.++. .++||||++++++|.... .
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~ 79 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY-A 79 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-T
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-c
Confidence 3456899875 699999999999999999999999999742 34678999865 458999999999984321 2
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC---CCcEEEeecC
Q 007177 93 DFKDIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---NCKLKICDFG 166 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~---~~~vKL~DFG 166 (614)
....+|||||||+ |+|.++|... ..|++.+++.|++||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 3467999999998 5999999874 36999999999999999999999999999999999999986 4579999999
Q ss_pred ccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCc
Q 007177 167 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 246 (614)
Q Consensus 167 la~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~ 246 (614)
+|+....... ....+||+.|+|||++.+ ..|+.++||||||||||+|++|++||.+.+.......+....
T Consensus 160 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i---- 229 (335)
T d2ozaa1 160 FAKETTSHNS----LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI---- 229 (335)
T ss_dssp TCEECCCCCC----CCCCSCCCSSCCCCCCCG--GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC----
T ss_pred eeeeccCCCc----cccccCCcccCCcHHHcC--CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH----
Confidence 9987543322 245689999999999987 679999999999999999999999998876554443332111
Q ss_pred hhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccC
Q 007177 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 314 (614)
Q Consensus 247 ~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~ 314 (614)
...........++.+|+++.+||.+||+.||++|||++|+|+||||.+.
T Consensus 230 -------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 230 -------------------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp -------------------CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred -------------------hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 0111111112234678999999999999999999999999999999753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-52 Score=428.87 Aligned_cols=267 Identities=24% Similarity=0.365 Sum_probs=214.8
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
..+||++++.||+|+||.||+|.++.+|+.||||+++.... ......++.+|+.+|+.++||||+++++++.... ...
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~ 83 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAG 83 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSS
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCC
Confidence 45789999999999999999999999999999999976543 3445678899999999999999999999985432 223
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
..+|||||||+ ++|.+.+...+.+++.+++.|+.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 45899999999 59999999888999999999999999999999999999999999999999999999999999976544
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 253 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~ 253 (614)
...........+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+..
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~------------- 228 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR------------- 228 (277)
T ss_dssp ---------------TTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-------------
T ss_pred ccccccccccccCcccccCHHHHcC--CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh-------------
Confidence 4433334456789999999999987 6899999999999999999999999998886655544322
Q ss_pred hchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccc
Q 007177 254 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 312 (614)
Q Consensus 254 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~ 312 (614)
..+......++++|+.+.+||.+||+.||.+||+..+.|.|+|++
T Consensus 229 --------------~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 229 --------------EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp --------------CCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred --------------cCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 223333445678999999999999999999999444445566653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.8e-52 Score=435.97 Aligned_cols=287 Identities=31% Similarity=0.582 Sum_probs=225.4
Q ss_pred cCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCC
Q 007177 13 EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSR 91 (614)
Q Consensus 13 ~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~ 91 (614)
+++..++|++++.||+|+||+||+|+++.+|+.||||+++.. ...++.+|+.+|+.++ ||||+++++++...
T Consensus 30 ~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~-- 102 (328)
T d3bqca1 30 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDP-- 102 (328)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT--
T ss_pred CCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEec--
Confidence 356678999999999999999999999999999999999752 2456889999999996 99999999998542
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC-cEEEeecCccc
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLAR 169 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~-~vKL~DFGla~ 169 (614)
....+|+|||||. ++|..+. +.+++..++.+++||+.||.|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 103 -~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 103 -VSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp -TTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred -CCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccce
Confidence 3467999999999 4776653 4699999999999999999999999999999999999998655 69999999998
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC-ChhHHHHHHHhhhCCCchh
Q 007177 170 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-NVVHQLDLMTDLLGTPSLD 248 (614)
Q Consensus 170 ~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~-~~~~~l~~i~~~~g~p~~~ 248 (614)
....... ....++|+.|+|||++.+. ..|+.++|||||||++|+|++|..||... +..++...+...+|.|...
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~ 253 (328)
T d3bqca1 179 FYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253 (328)
T ss_dssp ECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred eccCCCc----ccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhh
Confidence 7543322 2456899999999998763 56899999999999999999999998654 5667778888877766443
Q ss_pred hhhhhhch-hHHHHHHhhcccCCCcc-----cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCcccccCC
Q 007177 249 TISRVRND-KARRYLTSMRKKQPVQF-----SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 249 ~i~~~~~~-~~~~~l~~~~~~~~~~~-----~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~~~ 315 (614)
.+...... ....+...........+ ...+..++++++|||++||++||++|||++|+|+||||+.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 33211110 00011111111111111 112235789999999999999999999999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-51 Score=422.01 Aligned_cols=267 Identities=22% Similarity=0.412 Sum_probs=216.4
Q ss_pred CCCCCCCccccccCCCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcc
Q 007177 1 MLQNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 80 (614)
Q Consensus 1 m~~~~~~~~~~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv 80 (614)
|-++++..+.|+ ...++|++.+.||+|+||+||+|.++.+|+.||||+++.... ..+.+.+|+.+|+.|+|||||
T Consensus 2 ~~p~~p~~~~we--i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv 76 (287)
T d1opja_ 2 MDPSSPNYDKWE--MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLV 76 (287)
T ss_dssp CCTTSTTCCTTB--CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBC
T ss_pred cCCCCCCCcccE--ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEe
Confidence 566666655443 345789999999999999999999999999999999975422 345788999999999999999
Q ss_pred eeeeEecCCCCCCCCcEEEEEecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCC
Q 007177 81 EIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN 157 (614)
Q Consensus 81 ~l~~v~~~~~~~~~~~~ylV~E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~ 157 (614)
++++++ .+...+|||||||+ |+|.+++... ..+++..+..|+.||+.||+|||++||+||||||+|||++.+
T Consensus 77 ~~~~~~-----~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~ 151 (287)
T d1opja_ 77 QLLGVC-----TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN 151 (287)
T ss_dssp CEEEEE-----CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred cCCccE-----eeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCC
Confidence 999998 44567899999999 6999998764 578999999999999999999999999999999999999999
Q ss_pred CcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCC-CCCCChhHHHH
Q 007177 158 CKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKNVVHQLD 236 (614)
Q Consensus 158 ~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~p-F~g~~~~~~l~ 236 (614)
+.+||+|||+|+........ ..+...||+.|+|||++.+ ..|+.++|||||||++|||++|..| |.+.+......
T Consensus 152 ~~~Kl~DFG~a~~~~~~~~~--~~~~~~g~~~y~aPE~~~~--~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~ 227 (287)
T d1opja_ 152 HLVKVADFGLSRLMTGDTYT--AHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 227 (287)
T ss_dssp GCEEECCCCCTTTCCSSSSE--EETTEEECGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred CcEEEccccceeecCCCCce--eeccccccccccChHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHH
Confidence 99999999999875443222 2234468899999999887 6899999999999999999996555 54544333222
Q ss_pred HHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcCccccc
Q 007177 237 LMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 313 (614)
Q Consensus 237 ~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~hp~f~~ 313 (614)
.+. .... ......+++.+.+||.+||+.||++|||++|+++ +|+.
T Consensus 228 ~i~---------------------------~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~ 272 (287)
T d1opja_ 228 LLE---------------------------KDYR---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFET 272 (287)
T ss_dssp HHH---------------------------TTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred HHh---------------------------cCCC---CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHH
Confidence 221 1101 1123467899999999999999999999999976 4543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=419.27 Aligned_cols=259 Identities=22% Similarity=0.285 Sum_probs=209.5
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
-..++|++++.||+|+||.||+|.. +..||||+++.........+.+.+|+.+|++++|||||++++++. .
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~------~ 75 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------A 75 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC------S
T ss_pred cccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe------c
Confidence 3467899999999999999999964 346999999765555667788999999999999999999999863 2
Q ss_pred CcEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 95 KDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
..+|||||||+ |+|.+++... ..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 76 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 76 PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 45799999999 6999999764 569999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~-~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
.... ....+...||+.|+|||++.+. ...|+.++|||||||++|||++|+.||.+.+...++..+...
T Consensus 156 ~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~---------- 224 (276)
T d1uwha_ 156 RWSG-SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR---------- 224 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH----------
T ss_pred ccCC-cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhc----------
Confidence 3222 1223556899999999998642 245899999999999999999999999887765554333221
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
......+.....++++.+.+||.+||..||.+|||++|++++
T Consensus 225 ---------------~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 225 ---------------GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ---------------TSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 111112233456788999999999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=418.10 Aligned_cols=255 Identities=21% Similarity=0.338 Sum_probs=206.9
Q ss_pred eEEE-eEeeecCceEEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 20 YKIQ-EVIGKGSYGVVCSAIDT--HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 20 Y~i~-~~LG~G~~G~V~~a~d~--~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
+.+. +.||+|+||.||+|.+. .+++.||||+++...........+.+|+.+|++|+|||||++++++.. ..
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~ 81 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ES 81 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SS
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CC
Confidence 4443 47999999999999764 456789999997654455566789999999999999999999999832 34
Q ss_pred EEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCCC
Q 007177 97 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 175 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 175 (614)
.|||||||+ |+|.+++.....+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~ 161 (277)
T d1xbba_ 82 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161 (277)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccc
Confidence 799999999 6999999998999999999999999999999999999999999999999999999999999998765443
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhh
Q 007177 176 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 254 (614)
Q Consensus 176 ~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~~~ 254 (614)
..........||+.|+|||++.+ ..|+.++|||||||++|||++ |++||.+.+..+....+..
T Consensus 162 ~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~-------------- 225 (277)
T d1xbba_ 162 NYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-------------- 225 (277)
T ss_dssp SEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT--------------
T ss_pred cccccccccCCCceecCchhhcC--CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc--------------
Confidence 33333345679999999999876 679999999999999999998 8999998876554443321
Q ss_pred chhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHH---HcCcccc
Q 007177 255 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA---LADPYFK 312 (614)
Q Consensus 255 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~ei---L~hp~f~ 312 (614)
.... .....+++++.+||.+||+.||.+|||++++ |+|+|++
T Consensus 226 -------------~~~~---~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 226 -------------GERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp -------------TCCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -------------CCCC---CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 1111 1224678999999999999999999999998 4566654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-50 Score=418.13 Aligned_cols=260 Identities=25% Similarity=0.375 Sum_probs=203.0
Q ss_pred cccCCCCCCeEEEeEeeecCceEEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEec
Q 007177 11 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIML 87 (614)
Q Consensus 11 ~~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~---~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~ 87 (614)
|+...+.++|++.+.||+|+||.||+|.++.+++ .||||++... ......+.+.+|+.+|++|+|||||++++++
T Consensus 19 f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~- 96 (299)
T d1jpaa_ 19 FAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVV- 96 (299)
T ss_dssp HSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred hchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEE-
Confidence 4445567899999999999999999999987765 5889988653 3345567899999999999999999999998
Q ss_pred CCCCCCCCcEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeec
Q 007177 88 PPSRRDFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 165 (614)
Q Consensus 88 ~~~~~~~~~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DF 165 (614)
.+.+.+|+|||||+ |+|.+++... +.+++.++..|+.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 97 ----~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DF 172 (299)
T d1jpaa_ 97 ----TKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDF 172 (299)
T ss_dssp ----CSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred ----eeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCc
Confidence 34466899999999 5999988764 46999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCc--cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhh
Q 007177 166 GLARVAFNDTPTT--IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLL 242 (614)
Q Consensus 166 Gla~~~~~~~~~~--~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~ 242 (614)
|+|+......... .......||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+..+...
T Consensus 173 Gla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~- 249 (299)
T d1jpaa_ 173 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD- 249 (299)
T ss_dssp -----------------------CGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-
T ss_pred ccceEccCCCCcceeeecccccCCccccCHHHHhc--CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-
Confidence 9998764432211 11223568999999999887 689999999999999999998 89999988876555444221
Q ss_pred CCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 243 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 243 g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
... ....++++.+.+||.+||+.||++|||+.|++++
T Consensus 250 --------------------------~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 250 --------------------------YRL---PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp --------------------------CCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --------------------------CCC---CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 001 1124578899999999999999999999999764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=408.11 Aligned_cols=250 Identities=26% Similarity=0.412 Sum_probs=198.9
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
+.++|++++.||+|+||.||+|.++ ++..||||+++..... ...+.+|+++|+.++||||+++++++. +..
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~-----~~~ 73 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQA 73 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSS
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceec-----cCC
Confidence 4678999999999999999999876 5678999999754322 356889999999999999999999994 445
Q ss_pred cEEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 96 DIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
.+|+|||||+ |+|.+++... ..++++.+..|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred ceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccC
Confidence 6899999998 6999988754 5689999999999999999999999999999999999999999999999999987544
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
..... .....||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+..+....
T Consensus 154 ~~~~~--~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~---------- 219 (263)
T d1sm2a_ 154 DQYTS--STGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF---------- 219 (263)
T ss_dssp -------------CTTSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC----------
T ss_pred CCcee--ecceecCcccCChHHhcC--CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC----------
Confidence 33222 234578999999999987 689999999999999999999 577787776655554442210
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.. ......++++.+||.+||+.||++|||++|+|+|
T Consensus 220 -----------------~~---~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 220 -----------------RL---YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp -----------------CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CC---CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 00 0113467899999999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=413.93 Aligned_cols=258 Identities=22% Similarity=0.354 Sum_probs=213.7
Q ss_pred CCCeEEEeE-eeecCceEEEEEEECC--CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 17 ASRYKIQEV-IGKGSYGVVCSAIDTH--TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 17 ~~rY~i~~~-LG~G~~G~V~~a~d~~--tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
.++|.+.+. ||+|+||+||+|.++. ++..||||+++.. .......++.+|+++|++++|||||++++++..
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----- 80 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----- 80 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-----
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----
Confidence 357888885 9999999999998764 4457999999754 345567789999999999999999999998832
Q ss_pred CCcEEEEEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
..+|||||||+ |+|.+++.. +..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 81 -~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 81 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred -CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcc
Confidence 34899999999 599998765 457999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
..............||+.|+|||++.+ ..|+.++|||||||++|||++ |+.||.+.+..+.+..|..
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~---------- 227 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---------- 227 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT----------
T ss_pred cccccccccccccccCccccChHHHhC--CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc----------
Confidence 544333333345678999999999876 679999999999999999998 9999998876555544421
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHH---HcCccccc
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA---LADPYFKG 313 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~ei---L~hp~f~~ 313 (614)
.... ...+++++++.+||.+||+.||++|||+.++ |+|+|+.-
T Consensus 228 -----------------~~~~---~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 228 -----------------GKRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp -----------------TCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----------------CCCC---CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 1111 1235688999999999999999999999888 67888753
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=421.05 Aligned_cols=254 Identities=25% Similarity=0.403 Sum_probs=208.5
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCc-----EEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGE-----KVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 90 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~-----~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~ 90 (614)
.++|++++.||+|+||+||+|++..+++ .||+|++.... .......+.+|+.+|+.+ +|||||++++++
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~---- 110 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGAC---- 110 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE----
Confidence 3689999999999999999999876554 69999986532 234456788999999988 899999999999
Q ss_pred CCCCCcEEEEEecCC-CcHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeec
Q 007177 91 RRDFKDIYVVFELME-SDLHQVIKAND-----------------------DLTREHYQFFLYQLLRALKYIHTANVYHRD 146 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~-g~L~~~i~~~~-----------------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrD 146 (614)
.+.+.+|||||||+ |+|.++|+... .+++..++.|+.||+.||+|||++||+|||
T Consensus 111 -~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 111 -TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred -eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 45567899999998 69999997642 489999999999999999999999999999
Q ss_pred CCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCC
Q 007177 147 LKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPL 225 (614)
Q Consensus 147 LKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~p 225 (614)
|||+|||++.++.+||+|||+|+........ .......||+.|+|||++.+ ..|+.++|||||||++|||++ |.+|
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CchhccccccCCeEEEeeccccccccCCCce-eeeccccCCCccCChHHHcC--CCCCcceeccchhHHHHHHHhCCCCC
Confidence 9999999999999999999999875544332 22345678999999999887 689999999999999999997 8999
Q ss_pred CCCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 007177 226 FPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 305 (614)
Q Consensus 226 F~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~ei 305 (614)
|.+.+....+..+... .... .....+++++.+||.+||+.||++|||++||
T Consensus 267 f~~~~~~~~~~~~~~~--------------------------~~~~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei 317 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQN--------------------------GFKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317 (325)
T ss_dssp STTCCCSHHHHHHHHT--------------------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHHHhc--------------------------CCCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 9987765554443221 1011 1224578999999999999999999999999
Q ss_pred HcC
Q 007177 306 LAD 308 (614)
Q Consensus 306 L~h 308 (614)
++|
T Consensus 318 ~~~ 320 (325)
T d1rjba_ 318 TSF 320 (325)
T ss_dssp HHH
T ss_pred HHH
Confidence 986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=411.25 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=207.5
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++++.||+|+||.||+|.++ ++..||||+++.... ..+.+.+|+.+|++++|||||++++++.. +
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~ 80 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ------E 80 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------S
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeecc------C
Confidence 3468999999999999999999875 678899999975332 34568999999999999999999998732 3
Q ss_pred cEEEEEecCC-CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 96 DIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~--~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
.+|||||||+ |+|.+++... ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+...
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 4799999999 6998877433 359999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhC-CCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG-~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
.... ...+...||+.|+|||++.+ ..|+.++|||||||++|||+|| .+||.+.+..+.+..+..
T Consensus 161 ~~~~--~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~----------- 225 (272)
T d1qpca_ 161 DNEY--TAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER----------- 225 (272)
T ss_dssp SSCE--ECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-----------
T ss_pred CCcc--ccccccCCcccccChHHHhC--CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-----------
Confidence 3221 12244578999999999876 6799999999999999999995 666766665544443321
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc--Ccccc
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA--DPYFK 312 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~--hp~f~ 312 (614)
.... .....+++++.+||.+||+.||++|||++++++ |+||.
T Consensus 226 ----------------~~~~---~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 226 ----------------GYRM---VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ----------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------------cCCC---CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 0000 112457889999999999999999999999998 78875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=423.20 Aligned_cols=265 Identities=23% Similarity=0.380 Sum_probs=216.4
Q ss_pred CCCeEEEeEeeecCceEEEEEEE---CCCCcEEEEEEecCccC--ChHHHHHHHHHHHHHHhcCC-CCcceeeeEecCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAID---THTGEKVAIKKIHDIFE--HISDAARILREIKLLRLLRH-PDIVEIKHIMLPPS 90 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d---~~tg~~vAIK~i~~~~~--~~~~~~~i~~Ei~iL~~L~H-pnIv~l~~v~~~~~ 90 (614)
-++|++++.||+|+||+||+|.+ +.+|+.||||++++... .......+.+|+++|++++| |||+++++++
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~---- 98 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF---- 98 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE----
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee----
Confidence 36799999999999999999987 44789999999874321 22234567899999999976 8999999998
Q ss_pred CCCCCcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 91 RRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
.+...+|+|||||. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 99 -~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 99 -QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp -EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred -ccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchh
Confidence 45567999999999 5999999998899999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007177 170 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 249 (614)
Q Consensus 170 ~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~~~ 249 (614)
........ ......|++.|+|||++.+....++.++|||||||+||+|++|+.||.+.+..+....+...
T Consensus 178 ~~~~~~~~--~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~-------- 247 (322)
T d1vzoa_ 178 EFVADETE--RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR-------- 247 (322)
T ss_dssp ECCGGGGG--GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH--------
T ss_pred hhcccccc--cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh--------
Confidence 65332221 23456899999999998764346888999999999999999999999887654444333210
Q ss_pred hhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHHcCcccccCC
Q 007177 250 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGLS 315 (614)
Q Consensus 250 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rp-----sa~eiL~hp~f~~~~ 315 (614)
. .... ......+++++.+||.+||..||.+|| |++|+|+||||+++.
T Consensus 248 -----------~---~~~~-----~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 248 -----------I---LKSE-----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp -----------H---HHCC-----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred -----------c---ccCC-----CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 0 0000 112346899999999999999999999 589999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=402.55 Aligned_cols=250 Identities=22% Similarity=0.325 Sum_probs=211.1
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
+.++|++++.||+|+||+||+|+++ ++..||||+++..... ...+.+|+.+++.++||||+++++++ .+.+
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~-----~~~~ 72 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQR 72 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEE-----CCSS
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEE-----eeCC
Confidence 4578999999999999999999974 7889999999864332 35688999999999999999999998 4456
Q ss_pred cEEEEEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 96 DIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
.+|+|||||+ |+|.+++.. ...+++..+..|+.||++||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred ceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccC
Confidence 7999999998 688888765 45799999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.... ......+|..|+|||++.+ ..|+.++|||||||++|||++ |+.||.+.+..+....+....
T Consensus 153 ~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~---------- 218 (258)
T d1k2pa_ 153 DEYT--SSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL---------- 218 (258)
T ss_dssp SSCC--CCCCSCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC----------
T ss_pred CCce--eecccCCCCCcCCcHHhcC--CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC----------
Confidence 3222 2234679999999999987 689999999999999999998 899999988766555443210
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.. ......++.+.+||.+||+.||++|||++++|+|
T Consensus 219 -----------------~~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 219 -----------------RL---YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp -----------------CC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------------CC---CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 01 1123567899999999999999999999999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-49 Score=401.74 Aligned_cols=256 Identities=23% Similarity=0.346 Sum_probs=198.5
Q ss_pred CCCCCCeEEEeEeeecCceEEEEEEECCCC----cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCC
Q 007177 14 YGDASRYKIQEVIGKGSYGVVCSAIDTHTG----EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPP 89 (614)
Q Consensus 14 ~~~~~rY~i~~~LG~G~~G~V~~a~d~~tg----~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~ 89 (614)
....+.|++.++||+|+||.||+|.++.++ ..||||+++.. ........+.+|+.+|+.|+|||||++++++
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~--- 78 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI--- 78 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE---
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEE---
Confidence 345678999999999999999999887655 36999999753 3344556789999999999999999999998
Q ss_pred CCCCCCcEEEEEecCCC-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCc
Q 007177 90 SRRDFKDIYVVFELMES-DLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 167 (614)
Q Consensus 90 ~~~~~~~~ylV~E~~~g-~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGl 167 (614)
.+...+|+|||||.+ +|.+.+... ..+++.++..|+.||+.||+|||++||+||||||+||||+.++.+||+|||+
T Consensus 79 --~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGl 156 (283)
T d1mqba_ 79 --SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 156 (283)
T ss_dssp --CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred --ecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccch
Confidence 445679999999994 777777654 5799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhC-CCCCCCCChhHHHHHHHhhhCCCc
Q 007177 168 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLMTDLLGTPS 246 (614)
Q Consensus 168 a~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG-~~pF~g~~~~~~l~~i~~~~g~p~ 246 (614)
++................||+.|+|||++.+ ..|+.++|||||||++|||++| .+||.+.+..+.+..+.+
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~------ 228 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND------ 228 (283)
T ss_dssp -----------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT------
T ss_pred hhcccCCCccceEeccCCCCccccCHHHHcc--CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhc------
Confidence 9876544332222344578999999999987 6899999999999999999995 555555554333333211
Q ss_pred hhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 247 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 247 ~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.... ....++++.+.+||.+||..||++|||+.|+++
T Consensus 229 ---------------------~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 229 ---------------------GFRL---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ---------------------TCCC---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---------------------cCCC---CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 1111 122357789999999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=402.32 Aligned_cols=251 Identities=26% Similarity=0.412 Sum_probs=199.6
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCC---cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTG---EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg---~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
.++|++++.||+|+||.||+|++..++ ..||||+++.. ........+.+|+.+|+.++||||+++++++.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------ 78 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------ 78 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------
Confidence 368999999999999999999987654 46899988643 34455677899999999999999999999983
Q ss_pred CCcEEEEEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
.+.+|+|||||+ |+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+..
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 245899999999 688887655 457999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
...... ..+...||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+..+...
T Consensus 159 ~~~~~~--~~~~~~gt~~y~apE~l~~--~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~--------- 225 (273)
T d1mp8a_ 159 EDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--------- 225 (273)
T ss_dssp --------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT---------
T ss_pred cCCcce--eccceecCcccchhhHhcc--CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---------
Confidence 432221 1234578999999999987 689999999999999999998 89999988876665544221
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.. ...++++++.+.+||.+||..||.+|||++|+++|
T Consensus 226 ------------------~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 226 ------------------ER---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CC---CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 11 12345788999999999999999999999999876
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=399.96 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=204.0
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
.++|++.+.||+|+||.||+|+++.+ ..||||+++.... ..+.+.+|+.+|++++|||||++++++.. +.
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~ 85 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 85 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEec------CC
Confidence 46899999999999999999998755 5799999975433 24568899999999999999999998732 34
Q ss_pred EEEEEecCC-CcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccC
Q 007177 97 IYVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 173 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~--~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 173 (614)
+|+|||||+ |+|..++.. ...+++.++..|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence 799999999 588877743 35699999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhC-CCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007177 174 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 174 ~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG-~~pF~g~~~~~~l~~i~~~~g~p~~~~i~~ 252 (614)
.... ..+...||+.|+|||++.. ..++.++|||||||++|||++| .+||.+.+..+.+..+...
T Consensus 166 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~----------- 230 (285)
T d1fmka3 166 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG----------- 230 (285)
T ss_dssp ------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----------
T ss_pred CCce--eeccccccccccChHHHhC--CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-----------
Confidence 3221 1234579999999999987 6899999999999999999995 5666666655555444211
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc--CcccccC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA--DPYFKGL 314 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~--hp~f~~~ 314 (614)
.. ....+.+++++++||.+||+.||++|||++++++ ++||...
T Consensus 231 ----------------~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 231 ----------------YR---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ----------------CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ----------------CC---CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 11 1123567899999999999999999999999988 8898754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=397.62 Aligned_cols=259 Identities=21% Similarity=0.307 Sum_probs=202.8
Q ss_pred ccCCCCCCeEEEeEeeecCceEEEEEEECC-CC--cEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEec
Q 007177 12 SEYGDASRYKIQEVIGKGSYGVVCSAIDTH-TG--EKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIML 87 (614)
Q Consensus 12 ~~~~~~~rY~i~~~LG~G~~G~V~~a~d~~-tg--~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~ 87 (614)
|.+.+.++|++++.||+|+||.||+|.... ++ ..||||+++.... .....+.+.+|+.+|+.++||||+++++++.
T Consensus 2 t~~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp CEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ceEEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 445566789999999999999999997643 33 3689999875433 3344578899999999999999999999984
Q ss_pred CCCCCCCCcEEEEEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeec
Q 007177 88 PPSRRDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 165 (614)
Q Consensus 88 ~~~~~~~~~~ylV~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DF 165 (614)
. ..+|+|||||+ ++|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 82 ~------~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~Df 155 (273)
T d1u46a_ 82 T------PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF 155 (273)
T ss_dssp S------SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred e------cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccc
Confidence 2 34699999998 688876654 457999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCC
Q 007177 166 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGT 244 (614)
Q Consensus 166 Gla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~ 244 (614)
|+++................|+..|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+..+....
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~-- 231 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG-- 231 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC--
T ss_pred hhhhhcccCCCcceecCccccCcccCCHHHHhC--CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCC--
Confidence 999986555444434445678889999999987 689999999999999999998 899999988776665553210
Q ss_pred CchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 245 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 245 p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.. ....+.+++.+.+||.+||..||++|||++|+++
T Consensus 232 ------------------------~~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 232 ------------------------ER---LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp ------------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CC---CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 00 1223567899999999999999999999999863
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=398.36 Aligned_cols=255 Identities=24% Similarity=0.393 Sum_probs=199.2
Q ss_pred CCCeEEEeEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 90 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~-----tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~ 90 (614)
.++|++++.||+|+||.||+|.+.. +++.||||+++.. ........+.+|+.++.++ +|+||+.+++++..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-- 88 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-- 88 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc--
Confidence 3689999999999999999998754 4468999998753 3344566778888888776 68999999998743
Q ss_pred CCCCCcEEEEEecCC-CcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEE
Q 007177 91 RRDFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL 153 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~-g~L~~~i~~~----------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NIL 153 (614)
+...+|+|||||+ |+|.+++... ..+++.++..|+.||+.||+|||++||+||||||+|||
T Consensus 89 --~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 89 --PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 166 (299)
T ss_dssp --TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred --CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence 3456899999999 6999999753 24899999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhC-CCCCCCCChh
Q 007177 154 ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVV 232 (614)
Q Consensus 154 i~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG-~~pF~g~~~~ 232 (614)
++.++.+||+|||+|+........ ......+||+.|+|||++.+ ..|+.++|||||||++|||++| .+||.+.+..
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp ECGGGCEEECC------CCSCTTS-CCTTSCCCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred ECCCCcEEEccCcchhhccccccc-cccCceeeCccccchhHhhc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999865433322 22345689999999999987 6899999999999999999986 5788877654
Q ss_pred HHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 233 HQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 233 ~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
+.+..+.. ..... .....+++++.+||.+||+.||++|||++|+|+|
T Consensus 244 ~~~~~~~~--------------------------~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 244 EEFCRRLK--------------------------EGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHH--------------------------HTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHh--------------------------cCCCC---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44333211 11111 1224578899999999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-48 Score=401.77 Aligned_cols=251 Identities=22% Similarity=0.359 Sum_probs=200.7
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 93 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~----~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 93 (614)
.+|++++.||+|+||+||+|.+..+|+ +||+|+++.. ......+.+.+|+.+|+.++|||||++++++..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~----- 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence 469999999999999999999988886 5888888643 222345678999999999999999999999843
Q ss_pred CCcEEEEEecCC-CcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccc
Q 007177 94 FKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 171 (614)
Q Consensus 94 ~~~~ylV~E~~~-g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 171 (614)
...++++|+|. ++|.+.+.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 83 -~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 83 -STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp -SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred -CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 24678888887 688887765 457999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007177 172 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 250 (614)
Q Consensus 172 ~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i 250 (614)
...... .......||+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+....+...
T Consensus 162 ~~~~~~-~~~~~~~gt~~y~APE~l~~--~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~--------- 229 (317)
T d1xkka_ 162 GAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG--------- 229 (317)
T ss_dssp TTTCC---------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT---------
T ss_pred cccccc-ccccccccCccccChHHHhc--CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---------
Confidence 433222 22234578999999999887 689999999999999999998 89999887765544333210
Q ss_pred hhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 251 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 251 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
... ...+.+++.+.+||.+||..||.+|||+.|+++|
T Consensus 230 ------------------~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 230 ------------------ERL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ------------------CCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCC---CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 000 1224678899999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-47 Score=393.27 Aligned_cols=251 Identities=22% Similarity=0.290 Sum_probs=207.6
Q ss_pred CCeEEEeEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 92 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~-----tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~ 92 (614)
++|++++.||+|+||+||+|..+. ++..||||+++.. .......++.+|+.+|+.++||||+++++++.
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~----- 86 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCA----- 86 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeec-----
Confidence 479999999999999999998753 5678999999753 33445677899999999999999999999983
Q ss_pred CCCcEEEEEecCC-CcHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecC
Q 007177 93 DFKDIYVVFELME-SDLHQVIKAND------------------------DLTREHYQFFLYQLLRALKYIHTANVYHRDL 147 (614)
Q Consensus 93 ~~~~~ylV~E~~~-g~L~~~i~~~~------------------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDL 147 (614)
+...+++|||||+ |+|.+++.... .+++..+..|+.||+.||+|||+.|||||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 4567899999998 69999996532 3899999999999999999999999999999
Q ss_pred CCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCC-CCC
Q 007177 148 KPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLF 226 (614)
Q Consensus 148 KP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~-~pF 226 (614)
||+|||++.++.+||+|||+|+........ ...+...+|+.|+|||++.+ ..|+.++|||||||++|||++|. +||
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred cccceEECCCCcEEEccchhheeccCCccc-cccCCCCcCcCcCCHHHHcc--CCCChhhhhccchhhHHHHHccCCCCC
Confidence 999999999999999999999865433221 12345678999999999987 68999999999999999999985 789
Q ss_pred CCCChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHH
Q 007177 227 PGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 306 (614)
Q Consensus 227 ~g~~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL 306 (614)
.+.+..+.+..+.+ ... ......+++++.+||.+||+.||++|||+.||+
T Consensus 244 ~~~~~~e~~~~v~~---------------------------~~~---~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~ 293 (301)
T d1lufa_ 244 YGMAHEEVIYYVRD---------------------------GNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293 (301)
T ss_dssp TTSCHHHHHHHHHT---------------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCHHHHHHHHHc---------------------------CCC---CCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 88877665544422 111 112346788999999999999999999999996
Q ss_pred c
Q 007177 307 A 307 (614)
Q Consensus 307 ~ 307 (614)
+
T Consensus 294 ~ 294 (301)
T d1lufa_ 294 R 294 (301)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=386.88 Aligned_cols=245 Identities=23% Similarity=0.401 Sum_probs=197.9
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
..++|++++.||+|+||.||+|.+ +|..||||++++. ...+.+.+|+++|++++||||+++++++.. +.+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~ 74 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKG 74 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEe----cCC
Confidence 346799999999999999999987 4789999999753 345678899999999999999999998843 234
Q ss_pred cEEEEEecCC-CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCcccccc
Q 007177 96 DIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 172 (614)
Q Consensus 96 ~~ylV~E~~~-g~L~~~i~~~~--~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 172 (614)
.+|+|||||+ |+|.+++.... .+++..+..|+.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence 5799999998 69999986543 58999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007177 173 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 251 (614)
Q Consensus 173 ~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~~~~~~l~~i~~~~g~p~~~~i~ 251 (614)
... ....+|..|+|||++.+ ..|+.++|||||||++|||++ |++||.+.+..+.+..+..
T Consensus 155 ~~~------~~~~~~~~y~aPE~l~~--~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~----------- 215 (262)
T d1byga_ 155 STQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----------- 215 (262)
T ss_dssp -------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-----------
T ss_pred CCC------ccccccccCCChHHHhC--CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-----------
Confidence 322 23468899999999977 689999999999999999998 7899988766555444311
Q ss_pred hhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 252 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 252 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.... ...+.+++.+.+||++||..||.+|||+.+++++
T Consensus 216 ----------------~~~~---~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 216 ----------------GYKM---DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ----------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCC---CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1111 1234578999999999999999999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=388.83 Aligned_cols=253 Identities=24% Similarity=0.412 Sum_probs=204.8
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCC-------cEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEec
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTG-------EKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIML 87 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg-------~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~ 87 (614)
..++|++++.||+|+||.||+|.+..++ ..||||+++.. ........+.+|..++.++ +|||||++++++.
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc-cChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 3579999999999999999999876654 37999999754 3345567788999999888 7999999999994
Q ss_pred CCCCCCCCcEEEEEecCC-CcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCC
Q 007177 88 PPSRRDFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPK 150 (614)
Q Consensus 88 ~~~~~~~~~~ylV~E~~~-g~L~~~i~~~----------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~ 150 (614)
+...+|+|||||+ |+|.++|... ..+++..+..|+.||+.||+|||+.|||||||||+
T Consensus 90 -----~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 90 -----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp -----SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred -----cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 4567999999999 6999999754 35899999999999999999999999999999999
Q ss_pred cEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 007177 151 NILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 229 (614)
Q Consensus 151 NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~ 229 (614)
|||++.++.+||+|||+++......... .....++|+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~--~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~ 241 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYK-KTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTC-CCTTSCCGGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceeecCCCCeEeccchhhcccccccccc-ccccCCCChhhhhhhHhcC--CCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence 9999999999999999998765443322 2345679999999999987 689999999999999999998 79999887
Q ss_pred ChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 230 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 230 ~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
+....+..+.. .... .....+++.+.+||.+||+.||.+|||+.|+|+
T Consensus 242 ~~~~~~~~i~~---------------------------~~~~---~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 242 PVEELFKLLKE---------------------------GHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CHHHHHHHHHT---------------------------TCCC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHc---------------------------CCCC---CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 76544333311 1111 112457899999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=394.65 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=205.0
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECCCCcE--EEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEK--VAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSR 91 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~--vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~~~ 91 (614)
.+.++|++.+.||+|+||.||+|.++.+|.. ||||+++... .....+.+.+|+++|+.+ +||||+++++++.
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~---- 81 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACE---- 81 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEE----
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe----
Confidence 3457899999999999999999999888874 7788876432 223456789999999998 6999999999994
Q ss_pred CCCCcEEEEEecCC-CcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEE
Q 007177 92 RDFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA 154 (614)
Q Consensus 92 ~~~~~~ylV~E~~~-g~L~~~i~~~----------------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi 154 (614)
+.+.+|||||||+ |+|.++|... ..+++..+..++.||+.||.|||+.||+||||||+|||+
T Consensus 82 -~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~ 160 (309)
T d1fvra_ 82 -HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 160 (309)
T ss_dssp -ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred -cCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE
Confidence 4567999999999 6999999754 569999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCC-CCCCCCChhH
Q 007177 155 NANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVH 233 (614)
Q Consensus 155 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~-~pF~g~~~~~ 233 (614)
+.++.+||+|||+++........ ....||..|+|||.+.+ ..|+.++|||||||++|||++|. +||.+.+..+
T Consensus 161 ~~~~~~kl~DfG~a~~~~~~~~~----~~~~gt~~y~aPE~l~~--~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~ 234 (309)
T d1fvra_ 161 GENYVAKIADFGLSRGQEVYVKK----TMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 234 (309)
T ss_dssp CGGGCEEECCTTCEESSCEECCC--------CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred cCCCceEEccccccccccccccc----cceecCCcccchHHhcc--CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999764322221 23468999999999976 68999999999999999999964 6788777655
Q ss_pred HHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 234 QLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 234 ~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
.+..+.+ ... .....++++++.+||.+||+.||++|||++|+|+|
T Consensus 235 ~~~~i~~---------------------------~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 235 LYEKLPQ---------------------------GYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHHHGGG---------------------------TCC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHh---------------------------cCC---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4433311 101 12234678999999999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-46 Score=388.62 Aligned_cols=264 Identities=19% Similarity=0.235 Sum_probs=205.3
Q ss_pred CCCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~ 95 (614)
.++||++++.||+|+||.||+|++..+|+.||||++..... ...+.+|+++++.++|+|++..+..+. .+..
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~ 76 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGD 76 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEE----EETT
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEE----ecCC
Confidence 45789999999999999999999999999999999875322 234778999999998877666555442 3456
Q ss_pred cEEEEEecCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC---CCcEEEeecCccccc
Q 007177 96 DIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---NCKLKICDFGLARVA 171 (614)
Q Consensus 96 ~~ylV~E~~~g~L~~~i~~-~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~---~~~vKL~DFGla~~~ 171 (614)
..|+|||||+++|.+.+.. ...+++..+..++.||+.||+|||++||+||||||+|||++. +..+||+|||+|+..
T Consensus 77 ~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 77 YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 7899999999988777754 557999999999999999999999999999999999999864 457999999999876
Q ss_pred cCCCCCc----cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007177 172 FNDTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 247 (614)
Q Consensus 172 ~~~~~~~----~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p~~ 247 (614)
....... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+....+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~----- 229 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS----- 229 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH-----
T ss_pred cccccccceeccccCCcCCCccccCHHHHhC--CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh-----
Confidence 5432211 12345689999999999987 679999999999999999999999998876544333221100
Q ss_pred hhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHH---HHcCcccc
Q 007177 248 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE---ALADPYFK 312 (614)
Q Consensus 248 ~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~e---iL~hp~f~ 312 (614)
......+.....+++++++.+||.+||+.||.+||++++ +|+|+|.+
T Consensus 230 ------------------~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 230 ------------------EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp ------------------HHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ------------------cccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 000011122334678899999999999999999999874 56787764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=388.46 Aligned_cols=260 Identities=20% Similarity=0.350 Sum_probs=214.7
Q ss_pred CCCCCeEEEeEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCC
Q 007177 15 GDASRYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPP 89 (614)
Q Consensus 15 ~~~~rY~i~~~LG~G~~G~V~~a~d~~-----tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~ 89 (614)
-+.++|++++.||+|+||.||+|.+.. ++..||||+++.. ........+.+|+.+|++++||||+++++++
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~--- 92 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVV--- 92 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE---
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEE---
Confidence 345899999999999999999998753 3578999999754 3445667789999999999999999999998
Q ss_pred CCCCCCcEEEEEecCC-CcHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCC
Q 007177 90 SRRDFKDIYVVFELME-SDLHQVIKAN----------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC 158 (614)
Q Consensus 90 ~~~~~~~~ylV~E~~~-g~L~~~i~~~----------~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~ 158 (614)
.....+++|||||. |+|.+++... ..+++..+..|+.||+.||.|||+++|+||||||+|||++.++
T Consensus 93 --~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 93 --SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp --CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred --ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc
Confidence 34456899999998 6999988542 2478999999999999999999999999999999999999999
Q ss_pred cEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhC-CCCCCCCChhHHHHH
Q 007177 159 KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDL 237 (614)
Q Consensus 159 ~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG-~~pF~g~~~~~~l~~ 237 (614)
.+||+|||+|+....... .......+||+.|+|||.+.+ ..|+.++|||||||++|||++| .+||.+.+..+.+..
T Consensus 171 ~~Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~--~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~ 247 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 247 (308)
T ss_dssp CEEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred eEEEeecccceeccCCcc-eeeccceecccccCCHHHHcc--CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999987544322 222344578999999999987 6899999999999999999998 588988877666655
Q ss_pred HHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc------Cccc
Q 007177 238 MTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA------DPYF 311 (614)
Q Consensus 238 i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~------hp~f 311 (614)
+.+. . .....+.+++.+.+||.+||+.||.+|||++++++ +|+|
T Consensus 248 i~~~---------------------------~---~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~ 297 (308)
T d1p4oa_ 248 VMEG---------------------------G---LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297 (308)
T ss_dssp HHTT---------------------------C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred HHhC---------------------------C---CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 4321 0 01122457889999999999999999999999998 5665
Q ss_pred cc
Q 007177 312 KG 313 (614)
Q Consensus 312 ~~ 313 (614)
+.
T Consensus 298 ~~ 299 (308)
T d1p4oa_ 298 RE 299 (308)
T ss_dssp HH
T ss_pred cC
Confidence 43
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=385.47 Aligned_cols=254 Identities=26% Similarity=0.379 Sum_probs=210.8
Q ss_pred CCCCeEEEeEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCC
Q 007177 16 DASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPP 89 (614)
Q Consensus 16 ~~~rY~i~~~LG~G~~G~V~~a~d~-----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~ 89 (614)
..++|++.+.||+|+||.||+|... .+++.||||+++.. ........+.+|+.+++.+ +|||||++++++
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~--- 96 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGAC--- 96 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc-cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE---
Confidence 3479999999999999999999863 46678999999754 3455667889999999999 699999999999
Q ss_pred CCCCCCcEEEEEecCC-CcHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCC
Q 007177 90 SRRDFKDIYVVFELME-SDLHQVIKAND------------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPK 150 (614)
Q Consensus 90 ~~~~~~~~ylV~E~~~-g~L~~~i~~~~------------------~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~ 150 (614)
.+...+|||||||+ |+|.+++.... .+++..+..|+.||+.||+|||++||+||||||+
T Consensus 97 --~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 97 --TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp --CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred --eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 44456899999998 69999987543 5899999999999999999999999999999999
Q ss_pred cEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 007177 151 NILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 229 (614)
Q Consensus 151 NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLlt-G~~pF~g~ 229 (614)
|||++.++.+||+|||+++........ ...+..+||+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cccccccCcccccccchheeccCCCcc-eEeeecccChHHcCHHHhcC--CCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999876543322 23345689999999999986 689999999999999999998 77888777
Q ss_pred ChhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 230 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 230 ~~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
+..+.+..+..... .. .....+++.+.+||.+||+.||++|||++++|+
T Consensus 252 ~~~~~~~~~i~~~~--------------------------~~---~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 252 PVDSKFYKMIKEGF--------------------------RM---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CSSHHHHHHHHHTC--------------------------CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHhcCC--------------------------CC---CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 76555544422100 00 111356889999999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.3e-45 Score=377.91 Aligned_cols=257 Identities=18% Similarity=0.243 Sum_probs=206.5
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC-CCcceeeeEecCCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH-PDIVEIKHIMLPPSRRDFK 95 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~H-pnIv~l~~v~~~~~~~~~~ 95 (614)
.++|++++.||+|+||+||+|+++.+|+.||||++.... +...+.+|+++++.|+| +||+.+++++ .+..
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~ 74 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGL 74 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETT
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCC
Confidence 579999999999999999999999999999999986432 22346789999999975 8999999987 4556
Q ss_pred cEEEEEecCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECC-----CCcEEEeecCccc
Q 007177 96 DIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-----NCKLKICDFGLAR 169 (614)
Q Consensus 96 ~~ylV~E~~~g~L~~~i~~~~-~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~-----~~~vKL~DFGla~ 169 (614)
..|+|||||+++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 75 ~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 75 HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 789999999999999987654 7999999999999999999999999999999999999974 5689999999998
Q ss_pred cccCCCCCc----cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCC
Q 007177 170 VAFNDTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 245 (614)
Q Consensus 170 ~~~~~~~~~----~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~~~g~p 245 (614)
......... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.........+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i---- 228 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI---- 228 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH----
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcC--CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH----
Confidence 754332211 12345689999999999987 68999999999999999999999999876543332221110
Q ss_pred chhhhhhhhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHc
Q 007177 246 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 307 (614)
Q Consensus 246 ~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~ 307 (614)
.. .+...+..+..+++++++.+|+..|+..+|.+||+.+.+.+
T Consensus 229 --------~~-----------~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 229 --------GE-----------KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp --------HH-----------HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred --------Hh-----------ccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 00 00111222334667899999999999999999999877644
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-45 Score=379.12 Aligned_cols=252 Identities=21% Similarity=0.313 Sum_probs=200.3
Q ss_pred eEEEeEeeecCceEEEEEEECCCC---cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTG---EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg---~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 96 (614)
+.+.++||+|+||+||+|.+..++ ..||||+++.. .......++.+|+++|++++||||+++++++.. ..+.
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~ 103 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGS 103 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE----TTTE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe----cCCc
Confidence 345789999999999999987654 36999999753 456677889999999999999999999998742 3357
Q ss_pred EEEEEecCC-CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEeecCccccccCC
Q 007177 97 IYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 174 (614)
Q Consensus 97 ~ylV~E~~~-g~L~~~i~~~-~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 174 (614)
+|+|||||+ ++|.+++... ..+++..+..|+.||+.||.|||+.||+||||||+|||+++++.+||+|||+++.....
T Consensus 104 ~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 104 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred eEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 899999999 6898888754 45788899999999999999999999999999999999999999999999999875443
Q ss_pred CC-CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChh-HHHHHHHhhhCCCchhhhhh
Q 007177 175 TP-TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLDLMTDLLGTPSLDTISR 252 (614)
Q Consensus 175 ~~-~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~-~~l~~i~~~~g~p~~~~i~~ 252 (614)
.. .........||..|+|||++.+ ..++.++|||||||++|||++|..||...... +....+.
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~------------- 248 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------------- 248 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH-------------
T ss_pred ccccceecccccccccccChHHHhc--CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------------
Confidence 22 2222345679999999999887 68999999999999999999977776554321 1111110
Q ss_pred hhchhHHHHHHhhcccCCCcccCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 253 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 253 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
..... ...+.+++.+.+||.+||+.||++|||+.|+++|
T Consensus 249 --------------~g~~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 249 --------------QGRRL---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp --------------TTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------cCCCC---CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 11111 1123578899999999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-45 Score=386.59 Aligned_cols=282 Identities=24% Similarity=0.335 Sum_probs=211.8
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-----------CCCcceeeeEe
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-----------HPDIVEIKHIM 86 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-----------HpnIv~l~~v~ 86 (614)
+||++++.||+|+||+||+|+++.+|+.||||++++. ......+.+|+.+|+.+. |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 6899999999999999999999999999999999753 234456778999988775 57899998887
Q ss_pred cCCCCCCCCcEEEEEecCC--CcHHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeecCCCCcEEECCCC---
Q 007177 87 LPPSRRDFKDIYVVFELME--SDLHQVI--KANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANC--- 158 (614)
Q Consensus 87 ~~~~~~~~~~~ylV~E~~~--g~L~~~i--~~~~~lse~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~--- 158 (614)
... .....+++++++. ++..... .....+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 90 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 90 NHK---GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEE---ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred eec---cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 432 2344566666654 3433333 334579999999999999999999998 8999999999999998765
Q ss_pred ---cEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-----
Q 007177 159 ---KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN----- 230 (614)
Q Consensus 159 ---~vKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~Il~eLltG~~pF~g~~----- 230 (614)
.+||+|||.+....... ...+||+.|+|||++.. ..|+.++||||+||++++|++|+.||.+.+
T Consensus 167 ~~~~~kl~dfg~s~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~ 238 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEHY------TNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238 (362)
T ss_dssp TEEEEEECCCTTCEETTBCC------CSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeeEeeccccccccccc------ccccccccccChhhccc--cCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence 39999999997643322 34579999999999886 689999999999999999999999997543
Q ss_pred -hhHHHHHHHhhhCCCchhhhhhhhchhHHHHHHhhcccCCCcc-------------cCCCCCCCHHHHHHHHHhcCCCC
Q 007177 231 -VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQF-------------SQKFPNADPSALRLLERLLAFDP 296 (614)
Q Consensus 231 -~~~~l~~i~~~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~-------------~~~~~~~s~~l~dLI~~mL~~DP 296 (614)
..+.+..+...+|.+..+.+..... ...++........... .......++.+.|||.+||.+||
T Consensus 239 ~~~~~~~~~~~~lg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 239 KDDDHIAQIIELLGELPSYLLRNGKY--TRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTT--HHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred chhHHHHHHHHHhCCCCHHHhhcccc--cccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 3456777788888887666543221 1111110000000000 01122356789999999999999
Q ss_pred CCCCCHHHHHcCcccccCC
Q 007177 297 KDRPTAEEALADPYFKGLS 315 (614)
Q Consensus 297 ~~Rpsa~eiL~hp~f~~~~ 315 (614)
.+|||++|+|+||||++..
T Consensus 317 ~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 317 RKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp TTCBCHHHHHTCGGGTTCT
T ss_pred hHCcCHHHHhcCcccCCCC
Confidence 9999999999999999654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-45 Score=376.54 Aligned_cols=272 Identities=24% Similarity=0.270 Sum_probs=194.9
Q ss_pred CCCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHH--HHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007177 17 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARIL--REIKLLRLLRHPDIVEIKHIMLPPSRRDF 94 (614)
Q Consensus 17 ~~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~--~Ei~iL~~L~HpnIv~l~~v~~~~~~~~~ 94 (614)
+.+|.+.+.||+|+||.||+|+. +|+.||||+++.. ...... +|+..++.++||||+++++++.... ...
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~-----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~ 73 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTW 73 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc-----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-Ccc
Confidence 56899999999999999999975 6899999999642 223333 4555556789999999999986443 233
Q ss_pred CcEEEEEecCC-CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh--------CCeEeecCCCCcEEECCCCcEEEeec
Q 007177 95 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT--------ANVYHRDLKPKNILANANCKLKICDF 165 (614)
Q Consensus 95 ~~~ylV~E~~~-g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs--------~gIvHrDLKP~NILi~~~~~vKL~DF 165 (614)
..+|+|||||+ |+|.+++++. .++++....++.|++.||.|||+ +||+||||||+||||+.++.+||+||
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 46899999998 6999999875 59999999999999999999996 59999999999999999999999999
Q ss_pred CccccccCCCCCc-cccccccCCccccCcccccccCC----CCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 007177 166 GLARVAFNDTPTT-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 240 (614)
Q Consensus 166 Gla~~~~~~~~~~-~~~~~~vgt~~Y~APEvl~~~~~----~y~~~~DIWSLG~Il~eLltG~~pF~g~~~~~~l~~i~~ 240 (614)
|+++......... ......+||+.|+|||++.+... .++.++|||||||+||||++|.+||......... ....
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~-~~~~ 231 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-YYDL 231 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-TTTT
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc-hhhc
Confidence 9998765443322 22345789999999999875311 2677899999999999999999887543321100 0000
Q ss_pred hhCCCchhhhhhhhchhHHHHHHhhcccCCCcccCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHHcC
Q 007177 241 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKF--PNADPSALRLLERLLAFDPKDRPTAEEALAD 308 (614)
Q Consensus 241 ~~g~p~~~~i~~~~~~~~~~~l~~~~~~~~~~~~~~~--~~~s~~l~dLI~~mL~~DP~~Rpsa~eiL~h 308 (614)
....+..+.+ ...+. .......+...+ ......+.+|+.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~--------~~~~~--~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 232 VPSDPSVEEM--------RKVVC--EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SCSSCCHHHH--------HHHHT--TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccccchHHHH--------HHHHh--ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0001111111 11110 001001111111 1223458899999999999999999999773
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=1.2e-24 Score=208.31 Aligned_cols=171 Identities=16% Similarity=0.103 Sum_probs=122.2
Q ss_pred eEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCC----------------hHHHHHHHHHHHHHHhcCCCCcceee
Q 007177 20 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH----------------ISDAARILREIKLLRLLRHPDIVEIK 83 (614)
Q Consensus 20 Y~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~----------------~~~~~~i~~Ei~iL~~L~HpnIv~l~ 83 (614)
|.+.+.||+|+||+||+|.+. +|+.||||+++..... ........+|+..|..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568999999999999999885 7899999987521100 11123455789999999999999887
Q ss_pred eEecCCCCCCCCcEEEEEecCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeEeecCCCCcEEECCCCcEEEe
Q 007177 84 HIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 163 (614)
Q Consensus 84 ~v~~~~~~~~~~~~ylV~E~~~g~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~ 163 (614)
+.. ..++||||+++... ..+++..+..++.||+.+|.|||++||+||||||+|||++++ .++|+
T Consensus 81 ~~~---------~~~lvme~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 81 AWE---------GNAVLMELIDAKEL------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp EEE---------TTEEEEECCCCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEEC
T ss_pred Eec---------CCEEEEEeeccccc------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEE
Confidence 764 12799999997422 125666778899999999999999999999999999999865 59999
Q ss_pred ecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHH
Q 007177 164 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 215 (614)
Q Consensus 164 DFGla~~~~~~~~~~~~~~~~vgt~~Y~APEvl~~~~~~y~~~~DIWSLG~I 215 (614)
|||+|+......... .+...+. .-.+.+. ..|+.++|+||+.--
T Consensus 145 DFG~a~~~~~~~~~~-~l~rd~~----~~~~~f~---r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGWRE-ILERDVR----NIITYFS---RTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTHHH-HHHHHHH----HHHHHHH---HHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCcHH-HHHHHHH----HHHHHHc---CCCCCcccHHHHHHH
Confidence 999997643221110 0000000 0011121 468899999998543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.32 E-value=8e-07 Score=86.22 Aligned_cols=139 Identities=13% Similarity=0.134 Sum_probs=89.7
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCc
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKD 96 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ 96 (614)
..|++++..+.++.+.||+.. .++..+++|+....... ....+.+|...|+.|. +--+.+++... .+.+.
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~ 84 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGW 84 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCc
Confidence 467777776666667899884 56777889987643221 2334678888888775 32345555544 33456
Q ss_pred EEEEEecCCC-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------
Q 007177 97 IYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA----------------------------------- 140 (614)
Q Consensus 97 ~ylV~E~~~g-~L~~~i~~~~~lse~~~~~i~~QIl~aL~yLHs~----------------------------------- 140 (614)
.|+||++++| .+.+... +......++.++.+.|..||+.
T Consensus 85 ~~lv~~~l~G~~~~~~~~-----~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHTT-----TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred eEEEEEeccccccccccc-----ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 8999999997 5444321 1111222344444445555531
Q ss_pred ------------------------CeEeecCCCCcEEECCCCcEEEeecCcccc
Q 007177 141 ------------------------NVYHRDLKPKNILANANCKLKICDFGLARV 170 (614)
Q Consensus 141 ------------------------gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 170 (614)
.++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 279999999999999876667999998753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.76 E-value=3.1e-05 Score=79.98 Aligned_cols=81 Identities=17% Similarity=0.059 Sum_probs=49.0
Q ss_pred CCeEEEeEeeecCceEEEEEEECCCCcEEEEEEecCcc-----CChHHHHHHHHHHHHHHhcC-C--CCcceeeeEecCC
Q 007177 18 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-----EHISDAARILREIKLLRLLR-H--PDIVEIKHIMLPP 89 (614)
Q Consensus 18 ~rY~i~~~LG~G~~G~V~~a~d~~tg~~vAIK~i~~~~-----~~~~~~~~i~~Ei~iL~~L~-H--pnIv~l~~v~~~~ 89 (614)
.... .+.||.|....||++.+..+++.+++|.-.... .......+...|...|+.+. + ..+.+++.+-
T Consensus 27 ~~l~-~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--- 102 (392)
T d2pula1 27 STLT-CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--- 102 (392)
T ss_dssp -CCE-EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE---
T ss_pred CCee-EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc---
Confidence 3444 567999999999999887778899999653211 01123345667888887763 2 2355555432
Q ss_pred CCCCCCcEEEEEecCCC
Q 007177 90 SRRDFKDIYVVFELMES 106 (614)
Q Consensus 90 ~~~~~~~~ylV~E~~~g 106 (614)
....++|||++++
T Consensus 103 ----~~~~~lvmE~L~~ 115 (392)
T d2pula1 103 ----TEMAVTVMEDLSH 115 (392)
T ss_dssp ----TTTTEEEECCCTT
T ss_pred ----CCCCEEEEeccCC
Confidence 1234789999975
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.55 E-value=7.7e-05 Score=71.28 Aligned_cols=72 Identities=8% Similarity=0.012 Sum_probs=46.2
Q ss_pred eEeeecCc-eEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC--CCcceeeeEecCCCCCCCCcEEEE
Q 007177 24 EVIGKGSY-GVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH--PDIVEIKHIMLPPSRRDFKDIYVV 100 (614)
Q Consensus 24 ~~LG~G~~-G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~H--pnIv~l~~v~~~~~~~~~~~~ylV 100 (614)
+.+..|.. +.||+... ..+..+++|..... ....+.+|...|+.|.. -.+.+++.+. .+.+..|+|
T Consensus 16 ~~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~-----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~-----~~~~~~~~v 84 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLL 84 (255)
T ss_dssp EECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEE
T ss_pred EEcCCcccCCeEEEEEe-CCCCEEEEEeCCcc-----CHhHHHHHHHHHHHHHhcCCCCCceeeec-----ccccceEEE
Confidence 34555554 67898864 45667888876532 22346678888887743 2355566554 234568999
Q ss_pred EecCCC
Q 007177 101 FELMES 106 (614)
Q Consensus 101 ~E~~~g 106 (614)
|++++|
T Consensus 85 ~~~i~G 90 (255)
T d1nd4a_ 85 LGEVPG 90 (255)
T ss_dssp EECCSS
T ss_pred EEeeec
Confidence 999986
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.64 E-value=0.0021 Score=63.94 Aligned_cols=72 Identities=14% Similarity=0.062 Sum_probs=42.4
Q ss_pred ceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCC--CCCCCCcEEEEEecCCC
Q 007177 31 YGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPP--SRRDFKDIYVVFELMES 106 (614)
Q Consensus 31 ~G~V~~a~d~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~--~~~~~~~~ylV~E~~~g 106 (614)
--.||++.. .+|..|++|+..... .....+..|+..|..|....|.-..-+...+ ........+.|+++++|
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~---~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCC---CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 358999954 578889999876421 1245577899988887533222111111111 11234557889999874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.57 E-value=0.0045 Score=63.06 Aligned_cols=74 Identities=15% Similarity=0.116 Sum_probs=49.1
Q ss_pred CeEEEeEeeecCceEEEEEEECC-------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCC
Q 007177 19 RYKIQEVIGKGSYGVVCSAIDTH-------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPS 90 (614)
Q Consensus 19 rY~i~~~LG~G~~G~V~~a~d~~-------tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~~ 90 (614)
..+ ++.|+.|-.-.+|++.... .++.|.+++.-.. .. .....+|..+++.+. +.-..+++.++
T Consensus 44 ~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~---~idr~~E~~i~~~ls~~gl~Pkll~~~---- 114 (395)
T d1nw1a_ 44 HLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIF---- 114 (395)
T ss_dssp GEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEE----
T ss_pred ceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-ch---hhHHHHHHHHHHHHHhCCCCCeEEEEc----
Confidence 444 4678889999999997653 3456777776532 11 234558999998885 43345677765
Q ss_pred CCCCCcEEEEEecCCC
Q 007177 91 RRDFKDIYVVFELMES 106 (614)
Q Consensus 91 ~~~~~~~ylV~E~~~g 106 (614)
.+ .+|+||++|
T Consensus 115 -~~----g~I~efi~g 125 (395)
T d1nw1a_ 115 -SG----GRLEEYIPS 125 (395)
T ss_dssp -TT----EEEECCCCE
T ss_pred -CC----ceEEEEecc
Confidence 11 588999875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.41 E-value=0.0038 Score=61.23 Aligned_cols=30 Identities=30% Similarity=0.293 Sum_probs=26.9
Q ss_pred CCeEeecCCCCcEEECCCCcEEEeecCccc
Q 007177 140 ANVYHRDLKPKNILANANCKLKICDFGLAR 169 (614)
Q Consensus 140 ~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 169 (614)
.|+||+|+.++||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988777899999875
|